0001193125-14-087617.txt : 20140307 0001193125-14-087617.hdr.sgml : 20140307 20140307060700 ACCESSION NUMBER: 0001193125-14-087617 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140307 DATE AS OF CHANGE: 20140307 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIVERSAL HEALTH REALTY INCOME TRUST CENTRAL INDEX KEY: 0000798783 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 236858580 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09321 FILM NUMBER: 14675004 BUSINESS ADDRESS: STREET 1: UNIVERSAL CORPORATE CTR STREET 2: 367 S GULPH RD CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 610-265-0688 MAIL ADDRESS: STREET 1: UNIVERSAL CORPORATE CTR STREET 2: 367 S GULPH ROAD CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 10-K 1 d649900d10k.htm UNIVERSAL HEALTH REALTY INCOME TRUST--10-K Universal Health Realty Income Trust--10-K
Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

x    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2013

 

OR

 

¨    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                     to                     

 

Commission File No. 1-9321

 

UNIVERSAL HEALTH REALTY INCOME TRUST

 

(Exact name of registrant as specified in its charter)

 

Maryland   23-6858580

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

Universal Corporate Center

367 South Gulph Road

P.O. Box 61558

King of Prussia, Pennsylvania

 

19406-0958

(Zip Code)

(Address of principal executive offices)  

 

Registrant’s telephone number, including area code: (610) 265-0688

 

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class

Shares of beneficial interest, $.01 par value

 

Name of each exchange on which registered

New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None

 

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes  ¨    No  x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

 

Yes  ¨    No  x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes  x    No  ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes  x    No  ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  ¨    Accelerated filer  x    Non-accelerated filer  ¨   Smaller reporting company  ¨
      (Do not check if a smaller

reporting company)

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes  ¨    No  x

 

Aggregate market value of voting shares and non-voting shares held by non-affiliates as of June 28, 2013: $540,970,533 (For the purpose of this calculation only, all members of the Board of Trustees are deemed to be affiliates). Number of shares of beneficial interest outstanding of registrant as of January 31, 2014: 12,858,667

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the registrant’s definitive proxy statement for our 2014 Annual Meeting of Shareholders, which will be filed with the Securities and Exchange Commission within 120 days after December 31, 2013 (incorporated by reference under Part III).

 

 

 


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

2013 FORM 10-K ANNUAL REPORT

TABLE OF CONTENTS

 

PART I   

Item 1

 

Business

     1   

Item 1A

 

Risk Factors

     9   

Item 1B

 

Unresolved Staff Comments

     18   

Item 2

 

Properties

     19   

Item 3

 

Legal Proceedings

     25   

Item 4

 

Mine Safety Disclosures

     25   
PART II   

Item 5

 

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

     25   

Item 6

 

Selected Financial Data

     27   

Item 7

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     29   

Item 7A

 

Quantitative and Qualitative Disclosures About Market Risk

     50   

Item 8

 

Financial Statements and Supplementary Data

     51   

Item 9

 

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

     51   

Item 9A

 

Controls and Procedures

     51   

Item 9B

 

Other Information

     54   
PART III   

Item 10

 

Directors, Executive Officers and Corporate Governance

     54   

Item 11

 

Executive Compensation

     54   

Item 12

 

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

     54   

Item 13

 

Certain Relationships and Related Transactions, and Director Independence

     54   

Item 14

 

Principal Accountant Fees and Services

     54   
PART IV   

Item 15

 

Exhibits and Financial Statement Schedules

     55   

SIGNATURES

     57   

Index to Financial Statements and Schedule

     58   

Exhibit Index

     91   

Exhibit 10.2—Advisory Agreement renewal

  

Exhibit 21—Subsidiaries of Registrant

  

Exhibit 23.1—Consent of KPMG LLP

  

Exhibit 31.1—Section 302 Certification of the Chief Executive Officer

  

Exhibit 31.2—Section 302 Certification of the Chief Financial Officer

  

Exhibit 32.1—Section 906 Certification of the Chief Executive Officer

  

Exhibit 32.2—Section 906 Certification of the Chief Financial Officer

  


Table of Contents

This Annual Report on Form 10-K is for the year ended December 31, 2013. This Annual Report modifies and supersedes documents filed prior to this Annual Report. Information that we file with the Securities and Exchange Commission (the “SEC”) in the future will automatically update and supersede information contained in this Annual Report. In this Annual Report, “we,” “us,” “our” and the “Trust” refer to Universal Health Realty Income Trust and its subsidiaries.

 

As disclosed in this Annual Report, including in Part I, Item 1.-Relationship with Universal Health Services, Inc. (“UHS”), a wholly-owned subsidiary of UHS (UHS of Delaware, Inc.) serves as our Advisor pursuant to the terms of an annually renewable Advisory Agreement dated December 24, 1986. Our officers are all employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc. In addition, four of our hospital facilities are leased to subsidiaries of UHS and twelve medical office buildings, including certain properties owned by limited liability companies in which we either hold 100% of the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. Any reference to “UHS” or “UHS facilities” in this report is referring to Universal Health Services, Inc.’s subsidiaries, including UHS of Delaware, Inc.

 

In this Annual Report, the term “revenues” does not include the revenues of the unconsolidated limited liability companies (“LLCs”) in which we have various non-controlling equity interests ranging from 33% to 95%. We currently account for our share of the income/loss from these investments by the equity method (see Note 8 to the Consolidated Financial Statements included herein).


Table of Contents

PART I

 

ITEM 1. Business

 

General

 

We are a real estate investment trust (“REIT”) which commenced operations in 1986. We invest in health care and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings (“MOBs”). As of February 28, 2014 we have fifty-eight real estate investments or commitments located in sixteen states in the United States consisting of: (i) seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute; (ii) forty-seven MOBs, and; (iii) four preschool and childcare centers.

 

Available Information

 

We have our principal executive offices at Universal Corporate Center, 367 South Gulph Road, King of Prussia, PA 19406. Our telephone number is (610) 265-0688. Our website is located at http://www.uhrit.com. Copies of the annual, quarterly and current reports we file with the SEC, and any amendments to those reports, are available free of charge on our website. Additionally, we have adopted governance guidelines, a Code of Business Conduct and Ethics applicable to all of our officers and directors, a Code of Ethics for Senior Officers and charters for each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board of Trustees. These documents are also available free of charge on our website. Copies of such reports and charters are available in print to any shareholder who makes a request. Such requests should be made to our Secretary at our King of Prussia, PA corporate headquarters. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K relating to amendments to or waivers of any provision of our Code of Ethics for Senior Officers by promptly posting this information on our website. The information posted on our website is not incorporated into this Annual Report.

 

In accordance with Section 303A.12(a) of The New York Stock Exchange Listed Company Manual, we submitted our CEO’s Certification to the New York Stock Exchange in 2013. Additionally, contained in Exhibits 31.1 and 31.2 of this Annual Report are our CEO’s and CFO’s certifications regarding the quality of our public disclosure under Section 302 of the Sarbanes-Oxley Act of 2002.

 

Overview of Facilities

 

As of February 28, 2014, we have investments in fifty-eight facilities, located in sixteen states and consisting of the following:

 

Facility Name

  Location   Type of Facility   Ownership   Guarantor

Southwest Healthcare System, Inland Valley Campus(A)

  Wildomar, CA   Acute Care   100%   Universal Health Services, Inc.

McAllen Medical Center(A)

  McAllen, TX   Acute Care   100%   Universal Health Services, Inc.

Wellington Regional Medical Center(A)

  W. Palm Beach, FL   Acute Care   100%   Universal Health Services, Inc.

The Bridgeway(A)

  N.Little Rock, AR   Behavioral Health   100%   Universal Health Services, Inc.

Kindred Hospital Chicago Central(B)

  Chicago, IL   Sub-Acute Care   100%   Kindred Healthcare, Inc.

Vibra Hospital of Corpus Christi(B)

  Corpus Christi, TX   Sub-Acute Care   100%   Kindred Healthcare, Inc.

HealthSouth Deaconess Rehabilitation Hospital(F)

  Evansville, IN   Rehabilitation   100%   HealthSouth Corporation

Family Doctor’s Medical Office Bldg.(B)

  Shreveport, LA   MOB   100%   Christus Health Northern Louisiana

Kelsey-Seybold Clinic at Kings Crossing(B)

  Kingwood, TX   MOB   100%   Kelsey-Seybold
Medical Group, PLLC

Professional Bldgs. at Kings Crossing

Building A(B)

  Kingwood, TX   MOB   100%  

Building B(B)

  Kingwood, TX   MOB   100%  

Chesterbrook Academy(B)

  Audubon, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

 

1


Table of Contents

Facility Name

  Location   Type of Facility   Ownership   Guarantor

Chesterbrook Academy(B)

  New Britain, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

Chesterbrook Academy(B)

  Newtown, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

Chesterbrook Academy(B)

  Uwchlan, PA   Preschool & Childcare   100%   Nobel Learning Comm. & Subs.

Southern Crescent Center I(B)

  Riverdale, GA   MOB   100%  

Southern Crescent Center, II(D)

  Riverdale, GA   MOB   100%  

Suburban Medical Plaza II(C)

  Louisville, KY   MOB   33%  

Desert Valley Medical Center(C)

  Phoenix, AZ   MOB   90%  

Cypresswood Professional Center(B) 8101

  Spring, TX   MOB   100%  

8111

  Spring, TX   MOB   100%  

Desert Springs Medical Plaza(D)

  Las Vegas, NV   MOB   100%  

701 South Tonopah Bldg.(A)

  Las Vegas, NV   MOB   100%  

Santa Fe Professional Plaza(C)

  Scottsdale, AZ   MOB   90%  

Sheffield Medical Building(B)

  Atlanta, GA   MOB   100%  

Summerlin Hospital MOB I(D)

  Las Vegas, NV   MOB   100%  

Summerlin Hospital MOB II(D)

  Las Vegas, NV   MOB   100%  

Medical Center of Western Connecticut(B)

  Danbury, CT   MOB   100%  

Mid Coast Hospital MOB(C)

  Brunswick, ME   MOB   74%  

Rosenberg Children’s Medical Plaza(C)

  Phoenix, AZ   MOB   85%  

Gold Shadow(D)

       

700 Shadow Lane MOB

  Las Vegas, NV   MOB   100%  

2010 & 2020 Goldring MOBs

  Las Vegas, NV   MOB   100%  

St. Mary’s Professional Office Building(C)

  Reno, NV   MOB   75%  

Apache Junction Medical Plaza(E)

  Apache Junction, AZ   MOB   100%  

Spring Valley Medical Office Building(E)

  Las Vegas, NV   MOB   100%  

Spring Valley Hospital Medical Office Building II(E)

  Las Vegas, NV   MOB   100%  

Sierra San Antonio Medical Plaza(C)

  Fontana, CA   MOB   95%  

Phoenix Children’s East Valley Care Center(C)

  Phoenix, AZ   MOB   95%  

Centennial Hills Medical Office
Building(D)

  Las Vegas, NV   MOB   100%  

Palmdale Medical Plaza(D)(L)(P)

  Palmdale, CA   MOB   100%  

Summerlin Hospital Medical Office Building III(D)

  Las Vegas, NV   MOB   100%  

Vista Medical Terrace(D)(P)

  Sparks, NV   MOB   100%  

The Sparks Medical Building(D)(P)

  Sparks, NV   MOB   100%  

Auburn Medical Office Building II(E)

  Auburn, WA   MOB   100%  

Texoma Medical Plaza(G)

  Denison, TX   MOB   95%  

BRB Medical Office Building(E)

  Kingwood, TX   MOB   100%  

North Valley Medical Plaza(C)

  Phoenix, AZ   MOB   95%  

Lake Pointe Medical Arts Building(E)

  Rowlett, TX   MOB   100%  

Forney Medical Plaza(E)

  Forney, TX   MOB   100%  

Tuscan Professional Building(E)

  Irving, TX   MOB   100%  

Emory at Dunwoody Building(E)

  Atlanta, GA   MOB   100%  

PeaceHealth Medical Clinic(E)(H)

  Bellingham, WA   MOB   100%  

Forney Medical Plaza II(I)(J)

  Forney, TX   MOB   95%  

Northwest Texas Professional Office Tower(E)(K)

  Amarillo, TX   MOB   100%  

5004 Poole Road MOB(E)(M)

  Denison, TX   MOB   100%  

Ward Eagle Office Village(E)(N)

  Farmington Hills, MI   MOB   100%  

The Children’s Clinic at Springdale(E)(O)

  Springdale, AR   MOB   100%  

The Northwest Medical Center at Sugar Creek(E)(O)

  Bentonville, AR   MOB   100%  

 

(A) Real estate assets owned by us and leased to subsidiaries of Universal Health Services, Inc. (“UHS”).
(B) Real estate assets owned by us and leased to an unaffiliated third-party or parties.
(C) Real estate assets owned by a limited liability company (“LLC”) in which we have a noncontrolling ownership interest as indicated above and include tenants who are unaffiliated third-parties.
(D) Real estate assets owned by us or an LLC in which we hold 100% ownership interests and include tenants who are subsidiaries of UHS.
(E) Real estate assets owned by us or an LLC in which we hold 100% ownership interests and include tenants who are unaffiliated third-parties.
(F) The lessee on the HealthSouth Deaconess Rehabilitation Hospital (“Deaconess”) is HealthSouth/Deaconess L.L.C., a joint venture between HealthSouth Properties Corporation and Deaconess Hospital, Inc. The lease with Deaconess is scheduled to expire on May 31, 2019.

 

2


Table of Contents
(G) Real estate assets owned by an LLC in which we have a noncontrolling ownership interest as indicated above. Tenants of this MOB include subsidiaries of UHS.
(H) This MOB was acquired during the first quarter of 2012. In connection with the third-party loan agreement on this property, we are required to maintain separate financial records for the related entities.
(I) Construction on this MOB began during the third quarter of 2012 and the MOB was completed and opened during April, 2013.
(J) Real estate assets owned by a limited partnership (“LP”) in which we have a noncontrolling ownership interest as indicated above and include tenants who are unaffiliated third-parties.
(K) This MOB was acquired during the fourth quarter of 2012.
(L) This MOB had a master lease with a subsidiary of UHS through June 30, 2013. As of July 1, 2013, the master lease expired and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013.
(M) This MOB was acquired during the second quarter of 2013.
(N) This MOB was acquired during the third quarter of 2013.
(O) This MOB was acquired during the first quarter of 2014.
(P) Effective January 1, 2014, we purchased the third-party minority ownership interest in the LLC which owns this MOB, in which we formerly held a noncontrolling majority ownership interest. We now hold 100% of the ownership interest in the LLC that owns this MOB.

 

Other Information

 

Included in our portfolio at December 31, 2013 are seven hospital facilities with an aggregate investment of $142.0 million. The leases with respect to these hospital facilities comprised approximately 36% of our consolidated revenues in each of 2013 and 2012, and 65% in 2011. The decrease during 2013 and 2012, as compared to 2011, is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. As of December 31, 2013, these leases have fixed terms with an average of 3.4 years remaining and include renewal options ranging from one to five, five-year terms. The remaining lease terms for each hospital facility, which vary by hospital, are included herein in Item 2. Properties.

 

We believe a facility’s earnings before interest, taxes, depreciation, amortization and lease rental expense (“EBITDAR”) and a facility’s EBITDAR divided by the sum of minimum rent plus additional rent payable to us (“Coverage Ratio”), which are non-GAAP financial measures, are helpful to us and our investors as a measure of the operating performance of a hospital facility. EBITDAR, which is used as an indicator of a facility’s estimated cash flow generated from operations (before rent expense, capital additions and debt service), is used by us in evaluating a facility’s financial viability and its ability to pay rent. For the hospital facilities owned by us at the end of each respective year, the combined weighted average Coverage Ratio was approximately 6.3 (ranging from 2.5 to 18.5) during 2013, 5.9 (ranging from 2.1 to 14.4) during 2012 and 5.5 (ranging from 1.9 to 13.3) during 2011. The Coverage Ratio for individual facilities varies. See “Relationship with Universal Health Services, Inc.” below for Coverage Ratio information related to the four hospital facilities leased to subsidiaries of UHS.

 

Pursuant to the terms of the leases for our hospital facilities and the preschool and childcare centers, each lessee, including subsidiaries of UHS, is responsible for building operations, maintenance, renovations and property insurance. We, or the LLCs in which we have invested, are responsible for the building operations, maintenance and renovations of the MOBs, however, a portion, or in some cases all, of the expenses associated with the MOBs are passed on directly to the tenants. Cash reserves have been established to fund required building maintenance and renovations at the multi-tenant MOBs. Lessees are required to maintain all risk, replacement cost and commercial property insurance policies on the leased properties and we, or the LLC in which we have invested, are also named insureds on these policies. In addition, we, UHS or the LLCs in which we have invested, maintain property insurance on all properties. For additional information on the terms of our leases, see “Relationship with Universal Health Services, Inc.”

 

See our consolidated financial statements and accompanying notes to the consolidated financial statements included in this Annual Report for our total assets, liabilities, debt, revenues, income and other operating information.

 

3


Table of Contents

Relationship with Universal Health Services, Inc. (“UHS”)

 

Leases:    We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

 

The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 41% of our total revenue for the five years ended December 31, 2013 (approximately 30% for each of the years ended December 31, 2013 and 2012, and 55% for the year ended December 31, 2011). The decrease during 2013 and 2012, as compared to 2011, is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests and the various acquisitions of MOBs and clinics completed during 2011 and the first quarter of 2012, as mentioned above. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December 31, 2013 (approximately 22% for the year ended December 31, 2013, 21% for the year ended December 31, 2012 and 19% for the year ended December 31, 2011). In addition, twelve MOBs, that are either wholly or jointly-owned, include or will include tenants which are subsidiaries of UHS.

 

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value.

 

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

The Bridgeway

   Behavioral Health    $ 930,000         December, 2014         10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).

 

Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their

 

4


Table of Contents

lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. The Bridgeway’s lease term is scheduled to expire in December, 2014 and we can provide no assurance that this lease will be renewed at the fair market value lease rate.

 

Advisory Agreement:    UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. In December of 2013, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2014 pursuant to the same terms as the Advisory Agreement in place during 2013. In December of 2012, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the 2013 advisory fee, as compared to the 2012 advisory fee, was increased to 0.70% (from 0.65%) of our average invested real estate assets, as derived from our consolidated balance sheet.

 

The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2013, 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.4 million during 2013, $2.1 million during 2012 and $2.0 million during 2011 and were based upon average invested real estate assets of $338 million, $326 million and $309 million during 2013, 2012 and 2011, respectively.

 

Officers and Employees:    Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2013 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time special compensation awards in the form of restricted stock and/or cash bonuses.

 

Share Ownership:    As of December 31, 2013 and 2012, UHS owned 6.1% and 6.2%, respectively, of our outstanding shares of beneficial interest.

 

SEC reporting requirements of UHS:    UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 30% of our consolidated revenues for each of the years ended December 31, 2013 and 2012, and 55% of our consolidated revenues for the year ended December 31, 2011, and since a subsidiary of

 

5


Table of Contents

UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

 

Taxation

 

We believe we have operated in such a manner as to qualify for taxation as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, and we intend to continue to operate in such a manner. If we qualify for taxation as a REIT, we will generally not be subject to federal corporate income taxes on our net income that is currently distributed to shareholders. This treatment substantially eliminates the “double taxation”, i.e., at the corporate and shareholder levels, that usually results from investment in the stock of a corporation.

 

Please see the heading “If we fail to maintain our REIT status, we will become subject to federal income tax on our taxable income at regular corporate rates” under “Risk Factors” for more information.

 

Competition

 

We compete for the acquisition, leasing and financing of health care related facilities. Our competitors include, but are not limited to, other REITs, banks and other companies, including UHS. Some of these competitors are larger and may have a lower cost of capital than we do. These developments could result in fewer investment opportunities for us and lower spreads over the cost of our capital, which would hurt our growth.

 

In most geographical areas in which our facilities operate, there are other facilities that provide services comparable to those offered by our facilities. In addition, some competing facilities are owned by tax-supported governmental agencies or by nonprofit corporations and may be supported by endowments and charitable contributions and exempt from property, sales and income taxes. Such exemptions and support are not available to certain operators of our facilities, including UHS. In some markets, certain competing facilities may have greater financial resources, be better equipped and offer a broader range of services than those available at our facilities. Certain hospitals that are located in the areas served by our facilities are specialty hospitals that provide medical, surgical and behavioral health services that may not be provided by the operators of our hospitals. The increase in outpatient treatment and diagnostic facilities, outpatient surgical centers and freestanding ambulatory surgical centers also increases competition for us.

 

In addition, the number and quality of the physicians on a hospital’s staff are important factors in determining a hospital’s success and competitive advantage. Typically, physicians are responsible for making hospital admission decisions and for directing the course of patient treatment. The operators of our facilities also compete with other health care providers in recruiting and retaining qualified hospital management, nurses and other medical personnel. From time-to-time, the operators of our acute care and behavioral health care facilities may experience the effects of a shortage of skilled nursing staff nationwide, which has caused and may continue to cause an increase in salaries, wages and benefits expense in excess of the inflation rate. Our operators may experience difficulties attracting and retaining qualified physicians, nurses and medical support personnel. We anticipate that our operators, including UHS, will continue to encounter increased competition in the future that could lead to a decline in patient volumes and harm their businesses, which in turn, could harm our business.

 

A large portion of our non-hospital properties consist of MOBs which are located either close to or on the campuses of hospital facilities. These properties are either directly or indirectly affected by the factors discussed above as well as general real estate factors such as the supply and demand of office space and market rental rates. To improve our competitive position, we anticipate that we will continue investing in additional healthcare related facilities and leasing the facilities to qualified operators, perhaps including subsidiaries of UHS.

 

Regulation and Other Factors

 

During each of 2013 and 2012, 28% of our revenues were earned pursuant to leases with operators of acute care services hospitals, all of which are subsidiaries of UHS, and during 2011, 51% of our revenues were earned

 

6


Table of Contents

pursuant to leases with operators of acute care services hospitals, all of which are subsidiaries of UHS. The decrease during 2013 and 2012, as compared to 2011, is due primarily to the above-mentioned, December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests and the various acquisitions MOBs and clinics completed during 2011 and the first quarter of 2012. A significant portion of the revenue earned by the operators of our acute care hospitals is derived from federal and state healthcare programs, including Medicare and Medicaid (excluding managed Medicare and Medicaid programs).

 

Our hospital facilities derive a significant portion of their revenue from third-party payors, including the Medicare and Medicaid programs. Changes in these government programs in recent years have resulted in limitations on reimbursement and, in some cases, reduced levels of reimbursement for healthcare services. Payments from federal and state government programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions, all of which could materially increase or decrease program payments, as well as affect the cost of providing service to patients and the timing of payments to facilities. Neither we nor the operators of our hospital facilities are able to predict the effect of recent and future policy changes on our respective results of operations. In addition, the uncertainty and fiscal pressures placed upon federal and state governments as a result of, among other things, the substantial deterioration in general economic conditions and the funding requirements from the federal healthcare reform legislation, may affect the availability of taxpayer funds for Medicare and Medicaid programs. If the rates paid or the scope of services covered by government payors are reduced, there could be a material adverse effect on the business, financial position and results of operations of the operators of our hospital facilities, and in turn, ours.

 

In addition, the healthcare industry is required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things: hospital billing practices and prices for services; relationships with physicians and other referral sources; adequacy of medical care and quality of medical equipment and services; ownership of facilities; qualifications of medical and support personnel; confidentiality, maintenance, privacy and security issues associated with health-related information and patient medical records; the screening, stabilization and transfer of patients who have emergency medical conditions; certification, licensure and accreditation of our facilities; operating policies and procedures, and; construction or expansion of facilities and services.

 

These laws and regulations are extremely complex, and, in many cases, the operators of our facilities do not have the benefit of regulatory or judicial interpretation. In the future, it is possible that different interpretations or enforcement of these laws and regulations could subject the current or past practices of our operators to allegations of impropriety or illegality or could require them to make changes in their facilities, equipment, personnel, services, capital expenditure programs and operating expenses. Although UHS and the other operators of our hospital facilities believe that their policies, procedures and practices comply with governmental regulations, no assurance can be given that they will not be subjected to additional governmental inquiries or actions, or that they would not be faced with sanctions, fines or penalties if so subjected. Even if they were to ultimately prevail, a significant governmental inquiry or action under one of the above laws, regulations or rules could have a material adverse effect upon them, and in turn, us.

 

Each of our hospital facilities is deemed certified, meaning that they are accredited, properly licensed under the relevant state laws and regulations and certified under the Medicare program. The effect of maintaining certified facilities is to allow such facilities to participate in the Medicare and Medicaid programs. The operators of our hospital facilities believe that the facilities are in material compliance with applicable federal, state, local and other relevant regulations and standards. However, should any of our hospital facilities lose their deemed certified status and thereby lose certification under the Medicare or Medicaid programs, such facilities would be unable to receive reimbursement from either of those programs and their business, and in turn, ours, could be materially adversely effected.

 

7


Table of Contents

The various factors and government regulation related to the healthcare industry, such as those outlined above, affects us because:

 

(i) The financial ability of lessees to make rent payments to us may be affected by governmental regulations such as licensure, certification for participation in government programs, and government reimbursement, and;

 

(ii) Our bonus rents are based on our lessees’ net revenues which in turn are affected by the amount of reimbursement such lessees receive from the government.

 

A significant portion of the revenue earned by the operators of our acute care hospitals is derived from federal and state healthcare programs, including Medicare and Medicaid. Under the statutory framework of the Medicare and Medicaid programs, many of the general acute care operations are subject to administrative rulings, interpretations and discretion that may affect payments made under either or both of such programs as well as by other third party payors. The federal government makes payments to participating hospitals under its Medicare program based on various formulas. For inpatient services, the operators of our acute care hospitals are subject to an inpatient prospective payment system (“IPPS”). Under IPPS, hospitals are paid a predetermined fixed payment amount for each hospital discharge. The fixed payment amount is based upon each patient’s Medicare severity diagnosis related group (“MS-DRG”). Every MS-DRG is assigned a payment rate based upon the estimated intensity of hospital resources necessary to treat the average patient with that particular diagnosis. These rates are based upon historical national average costs and do not consider the actual costs incurred by a hospital in providing care. The MS-DRG rates are adjusted annually based on geographic region and are weighted based upon a statistically normal distribution of severity.

 

For outpatient services, both general acute and behavioral health hospitals are paid under an outpatient prospective payment system (“PPS”) according to ambulatory procedure codes. The outpatient PPS rate is a geographic adjusted national payment amount that includes the Medicare payment and the beneficiary co-payment. Special payments under the outpatient PPS may be made for certain new technology items and services through transitional pass-through payments and special reimbursement rates.

 

Three of our acute care hospital facilities operated by subsidiaries of UHS and two sub-acute care hospital facilities operated by an unaffiliated third-party are located in Texas, Florida, California and Illinois. The majority of these states have reported significant budget deficits that have resulted in reductions of Medicaid funding during the last few years and which could adversely affect future levels of Medicaid reimbursement received by certain operators of our facilities, including the operators of our hospital facilities. We can provide no assurance that reductions to Medicaid revenues earned by operators of certain of our facilities, particularly our hospital operators in the above-mentioned states, will not have a material adverse effect on the future operating results of those operators which, in turn, could have a material adverse effect on us.

 

Executive Officers of the Registrant

 

Name

  

Age

  

Position

Alan B. Miller

   76   

Chairman of the Board, Chief Executive Officer and President

Charles F. Boyle

   54   

Vice President and Chief Financial Officer

Cheryl K. Ramagano

   51   

Vice President, Treasurer and Secretary

Timothy J. Fowler

   58   

Vice President, Acquisition and Development

 

Mr. Alan B. Miller has been our Chairman of the Board and Chief Executive Officer since our inception in 1986 and was appointed President in February, 2003. He had previously served as our President until 1990. Mr. Miller has been Chairman of the Board and Chief Executive Officer of UHS since its inception in 1978. He previously held the title of President of UHS as well, until 2009 when Marc D. Miller was elected as President of UHS. He is the father of Marc D. Miller, who was elected to our Board of Trustees in December, 2008 and also serves as President and a member of the Board of Directors of UHS.

 

8


Table of Contents

Mr. Charles F. Boyle was appointed Chief Financial Officer in February, 2003 and had served as our Vice President and Controller since 1991. Mr. Boyle has held various positions at UHS since 1983 and currently serves as its Vice President and Controller. He was appointed Controller of UHS in 2003 and had served as its Assistant Vice President-Corporate Accounting since 1994.

 

Ms. Cheryl K. Ramagano was appointed Secretary in February, 2003 and has served as our Vice President and Treasurer since 1992. Ms. Ramagano has held various positions at UHS since 1983 and currently serves as its Vice President and Treasurer. She was appointed Treasurer of UHS in 2003 and had served as its Assistant Treasurer since 1994.

 

Mr. Timothy J. Fowler was elected as our Vice President of Acquisition and Development upon the commencement of his employment with UHS in 1993.

 

ITEM 1A. Risk Factors

 

We are subject to numerous known and unknown risks, many of which are described below and elsewhere in this Annual Report. Any of the events described below could have a material adverse effect on our business, financial condition and results of operations. Additional risks and uncertainties that we are not aware of, or that we currently deem to be immaterial, could also impact our business and results of operations.

 

The revenues and results of operations of the tenants of our hospital facilities, including UHS, and our medical office buildings, are significantly affected by payments received from the government and other third party payors.

 

The operators of our hospital facilities and tenants of our medical office buildings derive a significant portion of their revenue from third party payors, including the Medicare and Medicaid programs. Changes in these government programs in recent years have resulted in limitations on reimbursement and, in some cases, reduced levels of reimbursement for health care services. Payments from federal and state government programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions, all of which could materially increase or decrease program payments, as well as affect the cost of providing service to patients and the timing of payments to facilities. Our tenants are unable to predict the effect of recent and future policy changes on their operations.

 

Three of our acute care hospital facilities operated by subsidiaries of UHS and two sub-acute care hospital facilities operated by an unaffiliated third-party are located in Texas, Florida, California and Illinois. The majority of these states have reported significant budget deficits that have resulted in reductions of Medicaid funding during the last few years and which could adversely affect future levels of Medicaid reimbursement received by certain operators of our facilities, including the operators of our hospital facilities. We can provide no assurance that reductions to Medicaid revenues earned by operators of certain of our facilities, particularly our hospital operators in the above-mentioned states, will not have a material adverse effect on the future operating results of those operators which, in turn, could have a material adverse effect on us. In addition, the uncertainty and fiscal pressures placed upon federal and state governments as a result of, among other things, the substantial deterioration in general economic conditions and the funding requirements related to various governmental programs, may affect the availability of taxpayer funds for Medicare and Medicaid programs. If the rates paid or the scope of services covered by government payors are reduced, there could be a material adverse effect on our tenants’ business, financial position and results of operations, and in turn, ours.

 

In addition to changes in government reimbursement programs, the ability of our hospital operators to negotiate favorable contracts with private payors, including managed care providers, significantly affects the revenues and operating results of those facilities. Private payors, including managed care providers, increasingly are demanding that hospitals accept lower rates of payment. Our hospital operators expect continued third party

 

9


Table of Contents

efforts to aggressively manage reimbursement levels and cost controls. Reductions in reimbursement amounts received from third party payors could have a material adverse effect on the financial position and results of operations of our hospital operators.

 

Reductions or changes in Medicare funding could have a material adverse effect on the future operating results of the operators of our facilities, including UHS, which could, in turn, materially reduce our revenues and net income.

 

On January 3, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012 (the “2012 Act”). The 2012 Act postponed for two months sequestration cuts mandated under the Budget Control Act of 2011. The postponed sequestration cuts include a 2% annual reduction over ten years in Medicare spending to providers. Medicaid is exempt from sequestration. The 2012 Act provides a one-year fix to statutory reductions in physician reimbursement and extends other Medicare provisions. In order to offset the cost of these extensions, the 2012 Act reduces payments to other providers totaling almost $26 billion over ten years. Approximately half of those funds will come from reductions in Medicare reimbursement to hospitals. Although the Bipartisan Budget Act of 2013 has reduced certain sequestration-related budgetary cuts, spending reductions related to the Medicare program remain in place. On December 26, 2013, President Obama signed into law H.J. Res. 59, the Bipartisan Budget Act of 2013, which includes the Pathway for SGR Reform Act of 2013 (“the Act”). In addition, on February 15, 2014, Public Law 113-082 was enacted. The Act and subsequent federal legislation achieves new savings by extending sequestration for mandatory programs – including Medicare – for another three years, through 2024.

 

The 2012 Act includes a document and coding (“DCI”) adjustment and a reduction in Medicaid disproportionate share hospital (“DSH”) payments. Expected to save $10.5 billion over 10 years, the DCI adjustment decreases projected Medicare hospital payments for inpatient and overnight care through a downward adjustment in annual base payment increases. These reductions are meant to recoup what Medicare authorities consider to be “overpayments” to hospitals that occurred as a result of the transition to Medicare Severity Diagnosis Related Groups. The reduction in Medicaid DSH payments is expected to save $4.2 billion over 10 years. This provision extends the changes regarding DSH payments established by the Legislation and determines future allotments off of the rebased level. We cannot predict the effect this enactment will have on operators (including UHS), and, thus, our business.

 

The uncertainties of health care reform could materially affect the business and future results of operations of the operators of our facilities, including UHS, which could, in turn, materially reduce our revenues and net income.

 

In March, 2010, the Health Care and Education Reconciliation Act of 2010 and the Patient Protection and Affordable Care Act were enacted into law and created significant changes to health insurance coverage for U.S. citizens as well as material revisions to the federal Medicare and state Medicaid programs. The two combined primary goals of these acts are to provide for increased access to coverage for healthcare and to reduce healthcare-related expenses. Medicare, Medicaid and other health care industry changes are scheduled to be implemented at various times during this decade. We cannot predict the effect, if any, these enactments will have on operators (including UHS) and, thus, our business.

 

Increased competition in the health care industry has resulted in lower revenues and higher costs for our operators, including UHS, and may affect our revenues, property values and lease renewal terms.

 

The health care industry is highly competitive and competition among hospitals and other health care providers for patients and physicians has intensified in recent years. In most geographical areas in which our facilities are operated, there are other facilities that provide services comparable to those offered by our facilities. In addition, some competing facilities are owned by tax-supported governmental agencies or by nonprofit corporations and may be supported by endowments and charitable contributions and exempt from property, sales and income taxes. Such exemptions and support are not available to certain operators of our facilities, including UHS.

 

10


Table of Contents

In some markets, certain competing facilities may have greater financial resources, be better equipped and offer a broader range of services than those available at our facilities. Certain hospitals that are located in the areas served by our facilities are specialty hospitals that provide medical, surgical and behavioral health services that may not be provided by the operators of our hospitals. The increase in outpatient treatment and diagnostic facilities, outpatient surgical centers and freestanding ambulatory surgical centers also increases competition for our operators.

 

In addition, the operators of our facilities face competition from other health care providers, including physician owned facilities and other competing facilities, including certain facilities operated by UHS but the real property of which is not owned by us. Such competition is experienced in markets including, but not limited to, McAllen, Texas, the site of our McAllen Medical Center, a 430-bed acute care hospital, and Riverside County, California, the site of our Southwest Healthcare System-Inland Valley Campus, a 132-bed acute care hospital.

 

In addition, the number and quality of the physicians on a hospital’s staff are important factors in determining a hospital’s competitive advantage. Typically, physicians are responsible for making hospital admission decisions and for directing the course of patient treatment. The operators of our facilities also compete with other health care providers in recruiting and retaining qualified hospital management, nurses and other medical personnel. The operators of our acute care and behavioral health care facilities are experiencing the effects of a shortage of skilled nursing staff nationwide, which has caused and may continue to cause an increase in salaries, wages and benefits expense in excess of the inflation rate. Our operators may experience difficulties attracting and retaining qualified physicians, nurses and medical support personnel.

 

We anticipate that our operators, including UHS, will continue to encounter increased competition in the future that could lead to a decline in patient volumes and harm their businesses, which in turn, could harm our business.

 

Operators that fail to comply with governmental reimbursement programs such as Medicare or Medicaid, licensing and certification requirements, fraud and abuse regulations or new legislative developments may be unable to meet their obligations to us.

 

Our operators, including UHS and its subsidiaries, are subject to numerous federal, state and local laws and regulations that are subject to frequent and substantial changes (sometimes applied retroactively) resulting from legislation, adoption of rules and regulations, and administrative and judicial interpretations of existing law. The ultimate timing or effect of these changes cannot be predicted. Government regulation may have a dramatic effect on our operators’ costs of doing business and the amount of reimbursement received by both government and other third-party payors. The failure of any of our operators to comply with these laws, requirements and regulations could adversely affect their ability to meet their obligations to us. These regulations include, among other items: hospital billing practices and prices for service; relationships with physicians and other referral sources; adequacy of medical care; quality of medical equipment and services; qualifications of medical and support personnel; the implementation of an electronic health records application by 2015; confidentiality, maintenance and security issues associated with health-related information and patient medical records; the screening, stabilization and transfer of patients who have emergency medical conditions; certification, licensure and accreditation of our facilities; operating policies and procedures, and; construction or expansion of facilities and services.

 

If our operators fail to comply with applicable laws and regulations, they could be subjected to liabilities, including criminal penalties, civil penalties (including the loss of their licenses to operate one or more facilities), and exclusion of one or more facilities from participation in the Medicare, Medicaid and other federal and state health care programs. The imposition of such penalties could jeopardize that operator’s ability to make lease or mortgage payments to us or to continue operating its facility. In addition, our bonus rents are based on net revenues of the UHS hospital facilities, which in turn are affected by the amount of reimbursement that such lessees receive from the government.

 

11


Table of Contents

Although UHS and the other operators of our acute care facilities believe that their policies, procedures and practices comply with governmental regulations, no assurance can be given that they will not be subjected to governmental inquiries or actions, or that they would not be faced with sanctions, fines or penalties if so subjected. Because many of these laws and regulations are relatively new, in many cases, our operators don’t have the benefit of regulatory or judicial interpretation. In the future, it is possible that different interpretations or enforcement of these laws and regulations could subject their current or past practices to allegations of impropriety or illegality or could require them to make changes in the facilities, equipment, personnel, services, capital expenditure programs and operating expenses. Even if they were to ultimately prevail, a significant governmental inquiry or action under one of the above laws, regulations or rules could have a material adverse effect upon them, and in turn, us.

 

A worsening of the economic and employment conditions in the United States could materially affect our business and future results of operations of the operators of our facilities which could, in turn, materially reduce our revenues and net income.

 

Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Our operators’ patient volumes, revenues and financial results depend significantly on the universe of patients with health insurance, which to a large extent is dependent on the employment status of individuals in certain markets. A continuation or worsening of economic conditions may result in a continued high unemployment rate which will likely increase the number of individuals without health insurance. As a result, the operators of our facilities may experience a decrease in patient volumes. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the UHS hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties.

 

The deterioration of credit and capital markets may adversely affect our access to sources of funding and we cannot be certain of the availability and terms of capital to fund the growth of our business when needed.

 

To retain our status as a REIT, we are required to distribute 90% of our taxable income to shareholders and, therefore, we generally cannot use income from operations to fund our growth. Accordingly, our growth strategy depends, in part, upon our ability to raise additional capital at reasonable costs to fund new investments. We believe we will be able to raise additional debt and equity capital at reasonable costs to refinance our debts (including third-party debt held by various LLCs in which we own non-controlling equity interests) at or prior to their maturities and to invest at yields which exceed our cost of capital. Although the tightening in the credit markets has not had a material impact on us, we can provide no assurance that financing will be available to us on satisfactory terms when needed, which could harm our business. Given these uncertainties, our growth strategy is not assured and may fail.

 

To fund all or a portion of our future financing needs, we rely on borrowings from various sources including fixed rate, long-term debt as well as borrowings pursuant to our revolving credit agreement. If any of the lenders were unable to fulfill their future commitments, our liquidity could be impacted, which could have a material unfavorable impact on our results of operations and financial condition.

 

In addition, the degree to which we are, or in the future may become, leveraged, our ability to obtain financing could be adversely impacted and could make us more vulnerable to competitive pressures. Our ability to meet existing and future debt obligations depends upon our future performance and our ability to secure additional financing on satisfactory terms, each of which is subject to financial, business and other factors that are beyond our control. Any failure by us to meet our financial obligations would harm our business.

 

12


Table of Contents

In addition, global capital markets have experienced volatility that has tightened access to capital markets and other sources of funding. In the event we need to access the capital markets or other sources of financing, there can be no assurance that we will be able to obtain financing on acceptable terms or within an acceptable time. Our inability to obtain financing on terms acceptable to us could have a material unfavorable impact on our results of operations, financial condition and liquidity.

 

A substantial portion of our revenues are dependent upon one operator. If UHS experiences financial difficulties, or otherwise fails to make payments to us, our revenues will significantly decline.

 

For the year ended December 31, 2013, UHS accounted for 36% of our consolidated revenues. In addition, as of December 31, 2013, subsidiaries of UHS leased four of the seven hospital facilities owned by us with terms expiring in 2014 or 2016. We cannot assure you that UHS will renew the leases at existing lease rates or fair market value lease rates, or continue to satisfy its obligations to us. The failure or inability of UHS to satisfy its obligations to us could materially reduce our revenues and net income, which could in turn reduce the amount of dividends we pay and cause our stock price to decline.

 

Our relationship with UHS may create conflicts of interest.

 

In addition to being dependent upon UHS for a substantial portion of our revenues and leases, since 1986, UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, has served as our Advisor. Pursuant to our Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. Further, all of our officers are employees of the Advisor. As of December 31, 2013 we had no salaried employees although our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time special compensation awards in the form of restricted stock and/or cash bonuses. We believe that the quality and depth of the management and advisory services provided to us by our Advisor and UHS could not be replicated by contracting with unrelated third parties or by being self-advised without considerable cost increases. We believe that these relationships have been beneficial to us in the past, but we cannot guarantee that they will not become detrimental to us in the future.

 

All transactions with UHS must be approved by a majority of our Independent Trustees. We believe that our current leases and business dealings with UHS have been entered into on commercially reasonable terms. However, because of our historical and continuing relationship with UHS and its subsidiaries, in the future, our business dealings may not be on the same or as favorable terms as we might achieve with a third party with whom we do not have such a relationship. Disputes may arise between us and UHS that we are unable to resolve or the resolution of these disputes may not be as favorable to us as a resolution we might achieve with a third party.

 

We hold significant, non-controlling equity ownership interests in various LLCs.

 

For the year ended December 31, 2013, 28% of our consolidated and unconsolidated revenues were generated by LLCs in which we hold, or held, a majority, non-controlling equity ownership interest.

 

Our level of investment and lack of control exposes us to potential losses of our investments and revenues. Although our ownership arrangements have been beneficial to us in the past, we cannot guarantee that they will continue to be beneficial in the future.

 

Pursuant to the operating agreements of most of the LLCs in which we continue to hold non-controlling majority ownership interests, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering

 

13


Table of Contents

Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member.

 

In addition to the above-mentioned rights of the third-party members, from time to time, we have had discussions with third-party members about purchasing or selling the interests to each other or a third party. If we were to sell our interests, we may not be able to redeploy the proceeds into assets at the same or greater return as we currently receive. During any such time that we were not able to do so, our ability to increase or maintain our dividend at current levels could be adversely affected which could cause our stock price to decline.

 

The bankruptcy, default, insolvency or financial deterioration of our tenants could significantly delay our ability to collect unpaid rents or require us to find new operators.

 

Our financial position and our ability to make distributions to our shareholders may be adversely affected by financial difficulties experienced by any of our major tenants, including bankruptcy, insolvency or a general downturn in the business. We are exposed to the risk that our operators may not be able to meet their obligations, which may result in their bankruptcy or insolvency. Although our leases and loans provide us the right to terminate an investment, evict an operator, demand immediate repayment and other remedies, the bankruptcy laws afford certain rights to a party that has filed for bankruptcy or reorganization. An operator in bankruptcy may be able to restrict our ability to collect unpaid rents or interest during the bankruptcy proceeding.

 

Required regulatory approvals can delay or prohibit transfers of our healthcare facilities.

 

Transfers of healthcare facilities to successor tenants or operators may be subject to regulatory approvals or ratifications, including, but not limited to, change of ownership approvals under certificate of need laws and Medicare and Medicaid provider arrangements that are not required for transfers of other types of commercial operations and other types of real estate. The replacement of any tenant or operator could be delayed by the regulatory approval process of any federal, state or local government agency necessary for the transfer of the facility or the replacement of the operator licensed to manage the facility. If we are unable to find a suitable replacement tenant or operator upon favorable terms, or at all, we may take possession of a facility, which might expose us to successor liability or require us to indemnify subsequent operators to whom we might transfer the operating rights and licenses, all of which may materially adversely affect our business, results of operations, and financial condition.

 

Real estate ownership creates risks and liabilities that may result in unanticipated losses or expenses.

 

Our business is subject to risks associated with real estate acquisitions and ownership, including:

 

   

general liability, property and casualty losses, some of which may be uninsured;

 

   

the illiquid nature of real estate and the real estate market that impairs our ability to purchase or sell our assets rapidly to respond to changing economic conditions;

 

   

real estate market factors, such as the supply and demand of office space and market rental rates, changes in interest rates as well as an increase in the development of medical office condominiums in certain markets;

 

   

costs that may be incurred relating to maintenance and repair, and the need to make expenditures due to changes in governmental regulations, including the Americans with Disabilities Act;

 

   

environmental hazards at our properties for which we may be liable, including those created by prior owners or occupants, existing tenants, mortgagors or other persons, and;

 

   

defaults and bankruptcies by our tenants.

 

In addition to the foregoing risks, we cannot predict whether the leases on our properties, including the leases on the properties leased to subsidiaries of UHS, which have options to purchase the respective leased

 

14


Table of Contents

facilities at the end of the lease or renewal terms at the appraised fair market value, will be renewed at their current rates at the end of the lease terms in 2014 or 2016. The Bridgeway’s lease term is scheduled to expire in December, 2014 and we can provide no assurance that this lease will be renewed at the fair market value lease rate. If the leases are not renewed, we may be required to find other operators for these facilities and/or enter into leases with less favorable terms. The exercise of purchase options for our facilities may result in a less favorable rate of return for us than the rental revenue currently earned on such facilities. Further, the purchase options and rights of first refusal granted to the respective lessees to purchase or lease the respective leased facilities, after the expiration of the lease term, may adversely affect our ability to sell or lease a facility, and may present a potential conflict of interest between us and UHS since the price and terms offered by a third-party are likely to be dependent, in part, upon the financial performance of the facility during the final years of the lease term.

 

Significant potential liabilities and rising insurance costs and availability may have an adverse effect on the operations of our operators, which may negatively impact their ability to meet their obligations to us.

 

As is typical in the healthcare industry, in the ordinary course of business, our operators, including UHS, are subject to medical malpractice lawsuits, product liability lawsuits, class action lawsuits and other legal actions. Some of these actions may involve large claims, as well as significant defense costs. If their ultimate liability for professional and general liability claims could change materially from current estimates, if such policy limitations should be partially or fully exhausted in the future, or payments of claims exceed estimates or are not covered by insurance, it could have a material adverse effect on the operations of our operators and, in turn, us.

 

Property insurance rates, particularly for earthquake insurance in California, have also continued to increase. Two LLCs that own properties in California, in which we have various non-controlling equity interests, could not obtain earthquake insurance at rates which are economically beneficial in relation to the risks covered. Our tenants and operators, including UHS, may be unable to fulfill their insurance, indemnification and other obligations to us under their leases and mortgages and thereby potentially expose us to those risks. In addition, our tenants and operators may be unable to pay their lease or mortgage payments, which could potentially decrease our revenues and increase our collection and litigation costs. Moreover, to the extent we are required to foreclose on the affected facilities, our revenues from those facilities could be reduced or eliminated for an extended period of time. In addition, we may in some circumstances be named as a defendant in litigation involving the actions of our operators. Although we have no involvement in the activities of our operators and our standard leases generally require our operators to carry insurance to cover us in certain cases, a significant judgment against us in such litigation could exceed our and our operators’ insurance coverage, which would require us to make payments to cover the judgment.

 

If we fail to maintain our REIT status, we will become subject to federal income tax on our taxable income at regular corporate rates.

 

In order to qualify as a REIT, we must comply with certain highly technical and complex Internal Revenue Code provisions. Although we believe we have been qualified as a REIT since our inception, there can be no assurance that we have been so qualified or will remain qualified in the future. Failure to qualify as a REIT may subject us to income tax liabilities, including federal income tax at regular corporate rates. The additional income tax incurred may significantly reduce the cash flow available for distribution to shareholders and for debt service. In addition, if disqualified, we might be barred from qualification as a REIT for four years following disqualification. Also, if disqualified, we will not be allowed a deduction for distributions to stockholders in computing our taxable income and we could be subject to increased state and local income taxes.

 

Even if we remain qualified as a REIT, we may face other tax liabilities that reduce our cash flow.

 

Even if we remain qualified for taxation as a REIT, we may be subject to certain federal, state and local taxes on our income and assets, including taxes on any undistributed income, tax on income from some activities conducted as a result of a foreclosure, and state or local income, property and transfer taxes. Any of these taxes would decrease cash available for the payment of our debt obligations.

 

15


Table of Contents

Dividends paid by REITs generally do not qualify for reduced tax rates.

 

In general, dividends paid by a U.S. corporation to individual U.S. shareholders are subject to Federal income tax at a maximum rate of 20% (subject to certain additional taxes for certain taxpayers). In contrast, since we are a REIT, our distributions to individual U.S. shareholders are not eligible for the reduced rates which apply to distributions from regular corporations, and thus may be subject to Federal income tax at a rate as high as 39.6% (subject to certain additional taxes for certain taxpayers).

 

Should we be unable to comply with the strict income distribution requirements applicable to REITs utilizing only cash generated by operating activities, we would be required to generate cash from other sources which could adversely affect our financial condition.

 

To obtain the favorable tax treatment associated with qualifying as a REIT, in general, we are required each year to distribute to our shareholders at least 90% of our net taxable income. In addition, we are subject to a tax on any undistributed portion of our income at regular corporate rates and might also be subject to a 4% excise tax on this undistributed income. To meet the distribution requirements necessary to achieve the tax benefits associated with qualifying as a REIT, we could be required to: (i) seek borrowed funds even if conditions are not favorable for borrowing; (ii) issue equity which could have a dilutive effect on the future dividends and share value of our existing shareholders, and/or; (iii) divest assets that we might have otherwise decided to retain. Securing funds through these other non-operating means could adversely affect our financial condition and future results of operations.

 

Complying with REIT requirements may cause us to forego otherwise attractive opportunities.

 

To qualify as a REIT for federal income tax purposes, we continually must satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of our stock. We may be unable to pursue investments that would be otherwise advantageous to us in order to satisfy the source-of-income, asset-diversification or distribution requirements for qualifying as a REIT. Thus, compliance with the REIT requirements may hinder our ability to make certain attractive investments.

 

The market value of our common stock could be substantially affected by various factors.

 

Many factors, certain of which are outside of our control, could have an adverse effect on the share price of our common stock. These factors include certain of the risks discussed herein, our financial condition, performance and prospects, the market for similar securities issued by REITs, demographic changes, operating results of our operators and other hospital companies, changes in our financial estimates or recommendations of securities analysts, speculation in the press or investment community, the possible effects of war, terrorist and other hostilities, adverse weather conditions, the level of seasonal illnesses, changes in general conditions in the economy or the financial markets, or other developments affecting the health care industry.

 

Ownership limitations and anti-takeover provisions in our declaration of trust and bylaws and under Maryland law and in our leases with UHS may delay, defer or prevent a change in control or other transactions that could provide shareholders with a take-over premium. We are subject to significant anti-takeover provisions.

 

In order to protect us against the risk of losing our REIT status for federal income tax purposes, our declaration of trust permits our Trustees to redeem shares acquired or held in excess of 9.8% of the issued and outstanding shares of our voting stock and, which in the opinion of the Trustees, would jeopardize our REIT status. In addition, any acquisition of our common or preferred shares that would result in our disqualification as a REIT is null and void. The right of redemption may have the effect of delaying, deferring or preventing a change in control of our company and could adversely affect our shareholders’ ability to realize a premium over the market price for the shares of our common stock.

 

16


Table of Contents

Our declaration of trust authorizes our Board of Trustees to issue additional shares of common and preferred stock and to establish the preferences, rights and other terms of any series of preferred stock that we issue. Although our Board of Trustees has no intention to do so at the present time, it could establish a series of preferred stock that could delay, defer or prevent a transaction or a change in control that might involve the payment of a premium over the market price for our common stock or otherwise be in the best interests of our shareholders.

 

The Master Lease Document by and among us and certain subsidiaries of UHS, which governs the leases of all hospital properties with subsidiaries of UHS, includes a change of control provision. The change of control provision grants UHS the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties at their appraised fair market values. The exercise of this purchase option may result in a less favorable rate of return than the rental revenue currently earned on such facilities.

 

These provisions could discourage unsolicited acquisition proposals or make it more difficult for a third-party to gain control of us, which could adversely affect the market price of our securities and prevent shareholders from receiving a take-over premium.

 

We depend heavily on key management personnel and the departure of one or more of our key executives or a significant portion of our operators’ local hospital management personnel could harm our business.

 

The expertise and efforts of our senior executives and key members of our operators’ local hospital management personnel are critical to the success of our business. The loss of the services of one or more of our senior executives or of a significant portion of our operators’ local hospital management personnel could significantly undermine our management expertise and our operators’ ability to provide efficient, quality health care services at our facilities, which could harm their business, and in turn, harm our business.

 

Increasing investor interest in our sector and consolidation at the operator or REIT level could increase competition and reduce our profitability.

 

Our business is highly competitive and we expect that it may become more competitive in the future. We compete for the acquisition, leasing and financing of health care related facilities. Our competitors include, but are not limited to, other REITs, banks and other companies, including UHS, some of which are larger and may have a lower cost of capital than we do. These developments could result in fewer investment opportunities for us and lower spreads over our cost of our capital, which would hurt our growth. Increased competition makes it more challenging for us to identify and successfully capitalize on opportunities that meet our business goals and could improve the bargaining power of property owners seeking to sell, thereby impeding our investment, acquisition and development activities. If we cannot capitalize on our development pipeline, identify and purchase a sufficient quantity of healthcare facilities at favorable prices or if we are unable to finance acquisitions on commercially favorable terms, our business, results of operations and financial condition may be materially adversely affected.

 

We may be required to incur substantial renovation costs to make certain of our healthcare properties suitable for other operators and tenants.

 

Healthcare facilities are typically highly customized and may not be easily adapted to non-healthcare-related uses. The improvements generally required to conform a property to healthcare use, such as upgrading electrical, gas and plumbing infrastructure, are costly and at times tenant-specific. A new or replacement operator or tenant may require different features in a property, depending on that operator’s or tenant’s particular operations. If a current operator or tenant is unable to pay rent and vacates a property, we may incur substantial expenditures to modify a property before we are able to secure another operator or tenant. Also, if the property needs to be renovated to accommodate multiple operators or tenants, we may incur substantial expenditures before we are able to re-lease the space. These expenditures or renovations may materially adversely affect our business, results of operations and financial condition.

 

17


Table of Contents

We are subject to significant corporate regulation as a public company and failure to comply with all applicable regulations could subject us to liability or negatively affect our stock price.

 

As a publicly traded company, we are subject to a significant body of regulation, including the Sarbanes-Oxley Act of 2002. While we have developed and instituted a corporate compliance program based on what we believe are the current best practices in corporate governance and continue to update this program in response to newly implemented or changing regulatory requirements, we cannot provide assurance that we are or will be in compliance with all potentially applicable corporate regulations. For example, we cannot provide assurance that in the future our management will not find a material weakness in connection with its annual review of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act. We also cannot provide assurance that we could correct any such weakness to allow our management to assess the effectiveness of our internal control over financial reporting as of the end of our fiscal year in time to enable our independent registered public accounting firm to state that we have maintained effective internal control over financial reporting as of the end of our fiscal year. If we fail to comply with any of these regulations, we could be subject to a range of regulatory actions, fines or other sanctions or litigation. If we must disclose any material weakness in our internal control over financial reporting, our stock price could decline.

 

Different interpretations of accounting principles could have a material adverse effect on our results of operations or financial condition.

 

Generally accepted accounting principles are complex, continually evolving and may be subject to varied interpretation by us, our independent registered public accounting firm and the SEC. Such varied interpretations could result from differing views related to specific facts and circumstances. Differences in interpretation of generally accepted accounting principles could have a material adverse effect on our financial position or results of operations.

 

Item 1B. Unresolved Staff Comments

 

None.

 

18


Table of Contents
ITEM 2. Properties

 

The following table shows our investments in hospital facilities leased to UHS and other non-related parties and also provides information related to various properties in which we have significant investments, some of which are accounted for by the equity method. The capacity in terms of beds (for the hospital facilities) and the five-year occupancy levels are based on information provided by the lessees.

 

    Type of
facility
  Number
of
available
beds @
12/31/13
          Lease Term     % of RSF
under
lease with
guaranteed
escalators
    Range of
guaranteed
escalation
 

Hospital Facility Name and Location

      Average Occupancy(1)     Minimum
rent(5)
    End of
initial
or
renewed
term
    Renewal
term
(years)
     
      2013     2012     2011     2010     2009            

Southwest Healthcare System:

Inland Valley Campus(2)(7)

Wildomar, California

  Acute Care     132        58     62     70     78     77   $ 2,648,000        2016        15        0     —     

McAllen Medical Center(3)(7)

McAllen, Texas

  Acute Care     430        43     43     45     47     50     5,485,000        2016        15        0     —     

Wellington Regional Medical Center(7)

West Palm Beach, Florida

  Acute Care     158        58     69     73     70     71     3,030,000        2016        15        0     —     

The Bridgeway(7)

North Little Rock, Arkansas

  Behavioral
Health
    103        83     82     84     77     79     930,000        2014        10        0     —     

HealthSouth Deaconess Rehab. Hospital(8)

Evansville, Indiana

  Rehabilitation     85        79     79     75     71     60     775,000        2019        5        0     —     

Vibra Hospital of Corpus Christi

Corpus Christi, Texas

  Sub-Acute Care     74        58     53     54     64     61     738,000        2019        25        100     3

Kindred Hospital Chicago Central(9)

Chicago, Illinois

  Sub-Acute Care     84        51     51     46     40     45     1,458,000        2016        10        0     —     

 

    Type of
facility
                                  Lease Term              

Facility Name and Location

    Average Occupancy(1)     Minimum
rent(5)
    End of
initial
or
renewed
term
    Renewal
term
(years)
    % of RSF
under
lease
with
guaranteed
escalators
    Range of
guaranteed
escalation
 
    2013     2012     2011     2010     2009            

Desert Springs Medical Plaza(4)
Las Vegas, Nevada

    MOB        56     68     69     65     74     847,000        2015-2025        Various        79     2 %-3% 

Spring Valley MOB I(4)
Las Vegas, Nevada

    MOB        64     68     75     93     96     652,000        2014-2018        Various        52     2 %-3% 

Spring Valley MOB II(4)
Las Vegas, Nevada

    MOB        76     76     67     53     51     1,024,000        2016-2020        Various        18     1 %-2% 

Summerlin Hospital MOB I(4)
Las Vegas, Nevada

    MOB        77     81     90     91     95     1,304,000        2014-2018        Various        30     2 %-3% 

Summerlin Hospital MOB II(4)
Las Vegas, Nevada

    MOB        74     82     83     97     100     1,542,000        2014-2023        Various        35     2 %-3% 

Summerlin Hospital MOB III(4)
Las Vegas, Nevada

    MOB        81     71     64     63     63     1,571,000        2015-2023        Various        60     2 %-3% 

St. Mary’s Professional Office Building
Reno, Nevada

    MOB        98     99     100     99     99     4,375,000        2015-2025        Various        29     2 %-3% 

Rosenberg Children’s Medical Plaza
Phoenix, Arizona

    MOB        99     100     100     100     100     1,916,000        2015-2019        Various        56     2 %-3% 

Gold Shadow—700 Shadow(4)
Las Vegas, Nevada

    MOB        84     82     78     86     94     975,000        2014-2020        Various        38     2

Gold Shadow—2010 & 2020 Goldring MOBs(4)
Las Vegas, Nevada

    MOB        92     95     95     91     91     1,520,000        2014-2017        Various        9     2 %-3% 

Centennial Hills MOB(4)
Las Vegas, Nevada

    MOB        62     62     63     58     47     1,564,000        2014-2024        Various        28     2 %-3% 

Auburn II MOB(4)
Auburn, Washington

    MOB        90     90     84     79     —          1,146,000        2017-2022        Various        28     2 %-3% 

Suburban Medical Plaza II
Louisville, Kentucky

    MOB        100     100     100     98     98     2,273,000        2014-2025        Various        18     3

Forney Medical Plaza(6)
Forney, Texas

    MOB        94     97     92     —          —          1,495,000        2018-2023        Various        77     3

 

19


Table of Contents
    Type of
facility
                                  Lease Term              

Facility Name and Location

    Average Occupancy(1)     Minimum
rent(5)
    End of
initial
or
renewed
term
    Renewal
term
(years)
    % of RSF
under
lease
with
guaranteed
escalators
    Range of
guaranteed
escalation
 
    2013     2012     2011     2010     2009            

Lake Pointe Medical Arts Building(6)
Rowlett,Texas

    MOB        97     96     95     —          —          1,511,000        2017-2023        Various        24     3

Tuscan Medical Properties(6)
Las Colinas, Texas

    MOB        99     98     100     —          —          1,047,000        2014-2020        Various        100     2 %-3% 

PeaceHealth Medical Clinic(10)
Bellingham, Washington

    MOB        100     100     —          —          —          2,560,000        2021        20        100     1

 

(1) Average occupancy rate for the hospital facilities is based on the average number of available beds occupied during each of the five years ended December 31, 2013. Average available beds is the number of beds which are actually in service at any given time for immediate patient use with the necessary equipment and staff available for patient care. A hospital may have appropriate licenses for more beds than are in service for a number of reasons, including lack of demand, incomplete construction and anticipation of future needs. The average occupancy rate of a hospital is affected by a number of factors, including the number of physicians using the hospital, changes in the number of beds, the composition and size of the population of the community in which the hospital is located, general and local economic conditions, variations in local medical and surgical practices and the degree of outpatient use of the hospital services. Average occupancy rate for the multi-tenant medical office buildings is based on the occupied square footage of each building, including any applicable master leases.
(2) In July, 2002, the operations of Inland Valley Regional Medical Center (“Inland Valley”) were merged with the operations of Rancho Springs Medical Center (“Rancho Springs”), an acute care hospital located in California and also operated by UHS, the real estate assets of which are not owned by us. Inland Valley, our lessee, was merged into Universal Health Services of Rancho Springs, Inc. The merged entity is now doing business as Southwest Healthcare System (“Southwest Healthcare”). As a result of merging the operations of the two facilities, the revenues of Southwest Healthcare include the revenues of both Inland Valley and Rancho Springs. Although we do not own the real estate assets of the Rancho Springs facility, Southwest Healthcare became the lessee on the lease relating to the real estate assets of the Inland Valley facility. Since the bonus rent calculation for the Inland Valley campus is based on net revenues and the financial results of the two facilities are no longer separable, the lease was amended during 2002 to exclude from the bonus rent calculation the estimated net revenues generated at the Rancho Springs campus (as calculated pursuant to a percentage based allocation determined at the time of the merger). The average occupancy rates shown for this facility for all years were based on the combined number of beds occupied at the Inland Valley and Rancho Springs campuses.
(3) During the first quarter of 2001, UHS purchased the assets and operations of the 60-bed McAllen Heart Hospital located in McAllen, Texas. Upon the acquisition by UHS, the Heart Hospital began operating under the same license as an integrated department of McAllen Medical Center. As a result of combining the operations of the two facilities, the revenues of McAllen Medical Center include revenues generated by the Heart Hospital, the real property of which is not owned by us. Accordingly, since the bonus rent calculation for McAllen Medical Center is based on the combined net revenues of the two facilities, the McAllen Medical Center lease was amended during 2001 to exclude from the bonus rent calculation, the estimated net revenues generated at the Heart Hospital (as calculated pursuant to a percentage based allocation determined at the time of the merger). In addition, during 2000, UHS purchased the South Texas Behavioral Health Center, a behavioral health care facility located in McAllen, Texas. In 2006, a newly constructed replacement facility for the South Texas Behavioral Health Center was completed and opened. The license for this facility, the real property of which is not owned by us, was also merged with the license for McAllen Medical Center. There was no amendment to the McAllen Medical Center lease related to the operations of the South Texas Behavioral Health Center. The revenues of South Texas Behavioral Health Center are excluded from the bonus rent calculation. No assurance can be given as to the effect, if any, the consolidation of the facilities as mentioned above, had on the underlying value of McAllen Medical Center. Base rental commitments and the guarantee by UHS under the original lease continue for the remainder of the lease terms. The average occupancy rates are based upon the combined occupancy and combined number of beds at McAllen Medical Center and McAllen Heart Hospital.
(4) The real estate assets of this facility are owned by us (either directly or through an LLC in which we hold 100% of the ownership interest) and include tenants who are subsidiaries of UHS.
(5) Minimum rent amounts contain impact of straight-line rent adjustments, if applicable.
(6) These properties were acquired in 2011.

 

20


Table of Contents
(7) See Note 2 to the consolidated financial statements-Relationship with UHS and Related Party Transactions, regarding UHS’s purchase option, right of first refusal and change of control purchase option related to these properties.
(8) The lessee of this facility has a purchase option which is exercisable, subject to certain terms and conditions, at the expiration of each lease term. If exercised, the purchase option stipulates that the purchase price be the fair market value of the facility, subject to stipulated minimum and maximum prices. As currently being utilized, we believe the estimated current fair market value of the property is between the stipulated minimum and maximum prices. The lessee also has a first refusal to purchase right which, if applicable and subject to certain terms and conditions, grants the lessee the option to purchase the property at the same terms and conditions as an accepted third-party offer.
(9) The lessee of this facility has a purchase option which is exercisable, subject to certain terms and conditions, at the expiration of each lease term. If exercised, the purchase option stipulates that the purchase price be the fair market value of the facility, subject to a stipulated minimum price. We believe the estimated current fair market value of the property exceeds the stipulated minimum price. The lessee also has a first refusal to purchase right which, if applicable and subject to certain terms and conditions, grants the lessee the option to purchase the property at the same terms and conditions as an accepted third-party offer.
(10) This MOB was acquired on January, 2012.

 

Leasing Trends at Our Significant Medical Office Buildings

 

During 2013, we had a total of 106 new or renewed leases related to the medical office buildings indicated above, in which we have significant investments, some of which are accounted for by the equity method. These leases comprised approximately 13% of the aggregate rentable square feet of these properties (8% related to renewed leases and 5% related to new leases). Rental rates, tenant improvement costs and rental concessions vary from property to property based upon factors such as, but not limited to, the current occupancy and age of our buildings, local overall economic conditions, proximity to hospital campuses and the vacancy rates, rental rates and capacity of our competitors in the market. The weighted-average tenant improvement costs associated with these new or renewed leases was approximately $17 per square foot during 2013. The weighted-average leasing commissions on the new and renewed leases commencing during 2013 was approximately 3% of base rental revenue over the term of the leases. The average aggregate value of the tenant concessions, generally consisting of rent abatements, provided in connection with new and renewed leases commencing during 2013 was approximately 2% of the future aggregate base rental revenue over the lease terms. Tenant concessions were, or will be, recognized in our results of operations under the straight-line method over the lease term regardless of when payments are due. In connection with lease renewals executed during 2013, the weighted-average rental rates, as compared to rental rates on the expired leases, decreased by approximately 6%.

 

Set forth is information detailing the rentable square feet (“RSF”) associated with each of our investments as of December 31, 2013 and the percentage of RSF on which leases expire during the next five years and thereafter. For the MOBs that have scheduled lease expirations during 2014 of 20% or greater (of RSF), we have included information regarding estimated market rates relative to lease rates on the expiring leases.

 

                  Percentage of RSF with lease expirations  
     Total RSF      Available
for Lease
Jan. 1, 2014
    2014     2015     2016     2017     2018     2019
and
Later
 

Hospital Investments

               

McAllen Medical Center

     422,276         0     0     0     100     0     0     0

Wellington Regional Medical Center

     196,489         0     0     0     100     0     0     0

Southwest Healthcare System—Inland Valley Campus.

     124,644         0     0     0     100     0     0     0

Kindred Hospital Chicago Central

     115,554         0     0     0     100     0     0     0

The Bridgeway(e)

     77,901         0     100     0     0     0     0     0

HealthSouth Deaconess Rehab. Hospital

     77,440         0     0     0     0     0     0     100

Vibra Hospital of Corpus Christi

     69,700         0     0     0     0     0     0     100
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Subtotal Hospitals

     1,084,004         0     7     0     79     0     0     14
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other Investments

               

Medical Office Buildings:

               

Saint Mary’s Professional Office Building

     190,754         0     2     4     1     11     0     82

Goldshadow—2010 & 2020 Goldring MOBs(b)

     74,774         18     52     8     5     17     0     0

Goldshadow—700 Shadow Lane MOB

     42,060         3     8     37     6     11     0     35

Texoma Medical Plaza

     115,284         17     0     10     0     2     6     65

Suburban Medical Plaza II(a)

     103,011         0     21     2     9     1     6     61

Desert Springs Medical Plaza

     102,580         48     3     16     2     0     6     25

Peace Health Medical Clinic

     98,886         0     0     0     0     0     0     100

Centennial Hills Medical Office Building

     96,696         31     4     5     6     0     13     41

 

21


Table of Contents
                  Percentage of RSF with lease expirations  
     Total RSF      Available
for Lease
Jan. 1, 2014
    2014     2015     2016     2017     2018     2019
and
Later
 

Summerlin Hospital Medical Office Building II(b)

     92,313         21     20     9     7     11     9     23

Summerlin Hospital Medical Office Building I(b)

     89,636         29     27     12     27     2     3     0

The Sparks Medical Building

     35,127         11     4     9     13     0     6     57

Vista Medical Terrace

     50,921         53     8     1     1     13     9     15

North Valley Medical Plaza

     80,379         66     2     14     3     4     9     2

Summerlin Hospital Medical Office Building III

     77,713         10     0     2     13     0     6     69

Mid Coast Hospital MOB

     74,629         0     0     0     77     0     7     16

Sheffield Medical Building

     73,446         62     5     3     5     7     0     18

North West Texas Professional Office Tower

     72,351         0     0     3     46     3     0     48

Rosenberg Children’s Medical Plaza

     66,231         1     4     3     14     0     74     4

Sierra San Antonio Medical Plaza

     59,160         32     0     4     6     9     7     42

Palmdale Medical Plaza (d.)

     58,150         48     16     0     0     5     9     22

Spring Valley Medical Office Building

     57,828         40     10     19     6     21     4     0

Spring Valley Medical Office Building II

     57,432         24     0     0     13     0     39     24

Southern Crescent Center II

     53,680         35     8     0     11     0     0     46

Desert Valley Medical Center

     53,625         19     12     13     20     4     11     21

Tuscan Professional Building(c)

     52,868         7     33     33     12     0     0     15

Lake Pointe Medical Arts Building

     50,974         0     0     0     0     33     23     44

Forney Medical Plaza

     50,947         9     0     0     0     0     80     11

Southern Crescent Center I

     41,400         46     0     0     0     6     26     22

Auburn Medical Office Building

     41,311         10     0     0     0     9     0     81

BRB Medical Office Building

     40,733         0     0     17     4     0     9     70

Cypresswood Professional Center—8101

     10,200         0     0     100     0     0     0     0

Cypresswood Professional Center—8111

     29,882         17     6     51     0     11     0     15

Medical Center of Western Connecticut

     36,147         0     17     0     4     24     5     50

Phoenix Children’s East Valley Care Center

     30,960         0     0     0     0     0     0     100

Forney Medical Plaza II

     30,507         58     0     0     0     0     5     37

Apache Junction Medical Plaza

     26,901         9     0     31     4     22     0     34

Santa Fe Professional Plaza

     24,871         41     5     0     23     11     11     9

Professional Bldg at King’s Crossing—Bldg A

     11,528         87     0     0     0     0     13     0

Professional Bldg at King’s Crossing—Bldg B

     12,790         0     0     48     41     11     0     0

Kelsey-Seybold Clinic at King’s Crossing

     20,470         0     0     0     0     0     0     100

Emory at Dunwoody Building

     20,366         0     0     0     0     0     0     100

Ward Eagle Office Village

     16,282         0     0     0     0     0     0     100

Family Doctor’s MOB

     12,050         0     0     0     100     0     0     0

701 South Tonopah Building

     10,747         0     0     0     0     0     0     100

5004 Poole Road MOB

     4,400         0     0     0     0     0     0     100

Preschool and Childcare Centers:

               

Chesterbrook Academy—Audubon

     8,300         0     0     0     0     0     0     100

Chesterbrook Academy—Uwchlan

     8,163         0     0     0     0     0     0     100

Chesterbrook Academy—Newtown

     8,100         0     0     0     100     0     0     0

Chesterbrook Academy—New Britain

     7,998         0     0     0     100     0     0     0
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Sub-total Other Investments

     2,485,561         20     7     8     10     6     9     40
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

     3,569,565         14     7     5     31     4     6     33
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) The estimated market rates related to the 2014 expiring RSF are greater than the lease rates on the expiring leases by an average of approximately 2%.
(b) The estimated market rates related to the 2014 expiring RSF are greater than the lease rates on the expiring leases by an average of approximately 3%.
(c) The estimated market rates related to the 2014 expiring RSF are less than the lease rates on the expiring leases by an average of approximately 10%.
(d) The master lease commitment from UHS was effective through June 30, 2013. As of July 1, 2013, that mater lease expired and we began accounting for this LLC under the equity method on an unconsolidated basis.
(e) Pursuant to the terms of this lease, a wholly-owned subsidiary of UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024) as well certain purchase options, as discussed herein. We can provide no assurance that this lease will be renewed at the fair market value lease rate upon the scheduled expiration in December, 2014.

 

On a combined basis, based upon the aggregate revenues and square footage for the hospital facilities owned as of December 31, 2013 and 2012, the average effective annual rental per square foot was $17.85 and $17.69, respectively. On a combined basis, based upon the aggregate consolidated and unconsolidated revenues and the estimated average occupied square footage for our MOBs and childcare centers owned as of December 31, 2013 and 2012, the average effective annual rental per square foot was $27.47 and $27.22, respectively. On a combined basis, based upon the aggregate consolidated and unconsolidated revenues and estimated average occupied square footage for all of our properties owned as of December 31, 2013 and 2012, the average effective annual rental per square foot was $24.13 and $23.87, respectively. The estimated average occupied square footage for 2013 was calculated by averaging the unavailable rentable square footage on January 1, 2013 and January 1, 2014. The estimated average occupied square footage for 2012 was calculated by averaging the unavailable rentable square footage on January 1, 2012 and January 1, 2013.

 

22


Table of Contents

During 2013, one of the UHS-related hospitals (McAllen Medical Center) generated revenues that comprised more than 10% of our consolidated revenues. None of the properties had book values greater than 10% of our consolidated assets as of December 31, 2013. Including 100% of the revenues generated at the properties owned by our unconsolidated LLCs, none of our unconsolidated LLCs had revenues greater than 10% of the combined consolidated and unconsolidated revenues during 2013. Including 100% of the book values of the properties owned by our unconsolidated LLCs, none of the properties had book values greater than 10% of the consolidated and unconsolidated assets.

 

The following table sets forth the average effective annual rental per square foot for 2013, based upon average occupied square feet for McAllen Medical Center:

 

Property

   2013
Average
Occupied
Square
Feet
     2013
Revenues
     2013
Average
Effective
Rental
Per Square
Foot
 

McAllen Medical Center

     422,276       $ 7,064,000       $ 16.73   

 

The following table sets forth lease expirations for each of the next ten years:

 

     Expiring
Square
Feet
     Number
of
Tenants
     Annual Rentals of
Expiring
Leases(1)
     Percentage of
Annual
Rentals(2)
 

Hospital properties

           

2014

     77,901         1       $ 930,000         1

2015

     0         0       $ 0         0

2016

     858,963         4       $ 12,648,000         18

2017

     0         0       $ 0         0

2018

     0         0       $ 0         0

2019

     147,140         2       $ 1,501,000         2

2020

     0         0       $ 0         0

2021

     0         0       $ 0         0

2022

     0         0       $ 0         0

2023

     0         0       $ 0         0

Thereafter

     0         0       $ 0         0
  

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal-hospital facilities

     1,084,004         7       $ 15,079,000         21
  

 

 

    

 

 

    

 

 

    

 

 

 

Other consolidated properties

           

2014

     130,954         47       $ 3,785,000         5

2015

     144,291         45       $ 3,975,000         6

2016

     153,358         39       $ 3,981,000         6

2017

     90,512         24       $ 2,623,000         4

2018

     129,173         31       $ 4,058,000         6

2019

     89,294         19       $ 2,638,000         4

2020

     110,555         25       $ 3,497,000         5

2021

     163,505         13       $ 4,588,000         6

2022

     85,338         5       $ 2,110,000         3

2023

     43,797         8       $ 1,209,000         1

Thereafter

     59,994         7       $ 1,447,000         2
  

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal-other consolidated properties

     1,200,771         263       $ 33,911,000         48
  

 

 

    

 

 

    

 

 

    

 

 

 

 

23


Table of Contents
     Expiring
Square
Feet
     Number
of
Tenants
     Annual Rentals of
Expiring
Leases(1)
     Percentage of
Annual
Rentals(2)
 

Other unconsolidated properties

(MOBs)

           

2014

     51,779         21       $ 1,316,000         2

2015

     47,193         15       $ 1,215,000         1

2016

     105,698         24       $ 2,805,000         4

2017

     47,453         18       $ 1,286,000         2

2018

     100,061         26       $ 2,836,000         4

2019

     13,096         5       $ 365,000         1

2020

     137,299         12       $ 4,046,000         6

2021

     29,982         9       $ 800,000         1

2022

     56,818         11       $ 1,410,000         2

2023

     63,368         15       $ 2,006,000         3

Thereafter

     131,513         11       $ 3,765,000         5
  

 

 

    

 

 

    

 

 

    

 

 

 

Subtotal-other unconsolidated properties

     784,260         167       $ 21,850,000         31
  

 

 

    

 

 

    

 

 

    

 

 

 

Total all properties

     3,069,035         437       $ 70,840,000         100
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) The annual rentals of expiring leases reflected above were calculated based upon each property’s 2013 average rental rate per occupied square foot applied to each property’s scheduled lease expirations (on a square foot basis). These amounts include the data related to the unconsolidated LLCs in which we hold various non-controlling ownership interests at December 31, 2013 and exclude the bonus rentals earned on the UHS hospital facilities.
(2) The percentages of annual rentals reflected above were calculated based upon the annual rentals of expiring leases (as reflected above) divided by the total annual rentals of expiring leases (as reflected above).

 

24


Table of Contents
ITEM 3. Legal Proceedings

 

None

 

ITEM 4. Mine Safety Disclosures

 

Not applicable

 

PART II

 

ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Market Information

 

Our shares of beneficial interest are listed on the New York Stock Exchange. The high and low closing sales prices for our shares of beneficial interest for each quarter in the years ended December 31, 2013 and 2012 are summarized below:

 

     2013      2012  
     High
Price
     Low
Price
     High
Price
     Low
Price
 

First Quarter

   $ 58.03       $ 51.82       $ 40.94       $ 36.04   

Second Quarter

   $ 58.85       $ 41.47       $ 41.53       $ 38.99   

Third Quarter

   $ 46.53       $ 38.52       $ 46.46       $ 32.92   

Fourth Quarter

   $ 45.60       $ 40.06       $ 50.61       $ 32.21   

 

Holders

 

As of January 31, 2014, there were approximately 400 shareholders of record of our shares of beneficial interest.

 

Dividends

 

It is our intention to declare quarterly dividends to the holders of our shares of beneficial interest so as to comply with applicable sections of the Internal Revenue Code governing REITs. Our revolving credit facility limits our ability to increase dividends in excess of 95% of cash available for distribution, as defined in our revolving credit agreement, unless additional distributions are required to be made so as to comply with applicable sections of the Internal Revenue Code and related regulations governing REITs. In each of the past two years, dividends per share were declared as follows:

 

     2013      2012  

First Quarter

   $ .620       $ .610   

Second Quarter

     .625         .615   

Third Quarter

     .625         .615   

Fourth Quarter

     .625         .620   
  

 

 

    

 

 

 
   $ 2.495       $ 2.460   
  

 

 

    

 

 

 

 

Stock Price Performance Graph

 

The following graph compares our performance with that of the S&P 500 and a group of peer companies, where performance has been weighted based on market capitalization. Companies in our peer group are as follows: HCP, Inc., Nationwide Health Properties, Inc. (included until July, 2011 when it was acquired by Ventas, Inc.), Omega Healthcare Investors, Inc., Health Care REIT, Inc., Healthcare Realty Trust, Inc., LTC Properties, Inc., and National Health Investors, Inc.

 

25


Table of Contents

The Stock Price Performance Graph shall not be deemed incorporated by reference by any general statement incorporating by reference in this Form 10-K into any filing under the Securities Act of 1933 or under the Securities Exchange Act of 1934, except to the extent we specifically incorporate this information by reference, and shall not otherwise be deemed filed under such Acts.

 

The total cumulative return on investment (change in the year-end stock price plus reinvested dividends) for each of the periods for us, the peer group and the S&P 500 composite is based on the stock price or composite index at the end of fiscal 2008.

 

LOGO

 

     Base
Period

Dec 08
     INDEXED RETURNS
Years Ending
 

Company Name / Index

      Dec 09      Dec 10      Dec 11      Dec 12      Dec 13  

Universal Health Realty Income Trust

   $ 100       $ 104.94       $ 128.28       $ 145.89       $ 200.11       $ 167.42   

S&P 500 Index

   $ 100       $ 126.46       $ 145.51       $ 148.59       $ 172.37       $ 228.19   

Peer Group

   $ 100       $ 120.31       $ 143.35       $ 165.72       $ 196.50       $ 180.15   

 

26


Table of Contents
ITEM 6. Selected Financial Data

 

The following table contains our selected financial data for, or at the end of, each of the five years ended December 31, 2013. You should read this table in conjunction with our consolidated financial statements and related notes contained elsewhere in this Annual Report and Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

     (000s, except per share amounts)  
     2013     2012     2011     2010     2009  

Operating Results:

          

Total revenues(1)

   $ 54,280      $ 53,950      $ 29,494      $ 28,878      $ 31,914   

Net income(2)

   $ 13,169      $ 19,477      $ 73,794      $ 16,310      $ 18,576   

Balance Sheet Data:

          

Real estate investments, net of accumulated depreciation(1)(3)

   $ 297,748      $ 314,386      $ 288,633      $ 125,257      $ 154,540   

Investments in LLCs(1)(4)

     39,201        28,636        33,057        80,442        61,934   

Intangible assets, net of accumulated amortization(3)

     20,782        26,293        28,081        1,080        1,214   

Total assets(1)(3)

     373,145        383,038        370,929        216,135        228,825   

Total indebtedness, including debt premium(1)(3)(5)

     199,987        197,936        174,836        67,563        84,267   

Other Data:

          

Funds from operations(6)

   $ 34,955      $ 34,280      $ 32,468      $ 32,582      $ 33,325   

Cash provided by (used in):

          

Operating activities

     31,294        30,783        21,372        23,049        24,984   

Investing activities

     (13,514     (8,565     (3,284     (17,302     (12,362

Financing activities

     (17,491     (30,819     (7,426     (7,798     (10,202

Per Share Data:

          

Basic earnings per share:

          

Total basic earnings per share(2)

   $ 1.04      $ 1.54      $ 5.84      $ 1.33      $ 1.56   

Diluted earnings per share:

          

Total diluted earnings per share(2)

   $ 1.04      $ 1.54      $ 5.83      $ 1.33      $ 1.56   

Dividends per share

   $ 2.495      $ 2.460      $ 2.425      $ 2.415      $ 2.380   

Other Information (in thousands)

          

Weighted average number of shares outstanding—basic

     12,689        12,661        12,644        12,259        11,891   

Weighted average number of shares and share equivalents outstanding—diluted

     12,701        12,669        12,649        12,262        11,897   

 

(1) As discussed in Note 1 “Summary of Significant Accounting Policies—Investments in Limited Liability Companies”, our consolidated financial statements include the consolidated accounts of our consolidated investments and those investments that meet the criteria of a variable interest entity. Please see Note 1 for further discussions.
(2) Net income and earnings per share during 2013 includes approximately $200,000 of transaction costs related to the acquisition of three MOBs during 2013 and the first quarter of 2014. Net income and earnings per share during 2012 includes an $8.5 million gain on the divestitures of properties owned by two unconsolidated LLCs in which we formerly held non-controlling majority ownership interests, and $680,000 of transaction costs related to the acquisition of a medical clinic and medical office building in 2012. Net income and earnings per share data during 2011 includes: (i) a $28.6 million gain recorded in connection with our purchase of third-party minority ownership interests in various LLCs in which we formerly held non-controlling majority ownership interests (we own 100% of each of these entities since that time); (ii) a $35.8 million gain on the divestitures of properties owned by unconsolidated LLCs in which we formerly held non-controlling majority ownership interests; (iii) $518,000 of transaction costs related to the acquisition of four MOBs during 2011 and the first quarter of 2012, and; (iv) a $5.4 million charge for a provision for asset impairment recorded on a certain MOB.

 

27


Table of Contents
(3) Amounts include the fair values of the real property (as of 2011) of various previously unconsolidated LLCs, which we began consolidating during the fourth quarter of 2011 subsequent to our purchase of the third-party minority ownership interests (we owned 100% of each of these entities at December 31, 2011).
(4) Investments in LLCs at December 31, 2013, 2012 and 2011 reflect the consolidation of various LLCs, as mentioned in notes 2 and 3 above, as well as the divestiture of property owned by various unconsolidated LLCs during 2012 and 2011, as discussed herein. Additionally, at December 31, 2013, Investments in LLCs reflects the deconsolidation of Palmdale Medical Properties. This LLC was deemed to be a variable interest entity during the term of the master lease and was consolidated in our financial statements through June 30, 2013 since we were the primary beneficiary through that date. Effective July 1, 2013, this LLC is no longer be deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method.
(5) Excludes third-party debt that is non-recourse to us, incurred by unconsolidated LLCs in which we hold various non-controlling equity interests as follows: $80.1 million as of December 31, 2013, $77.5 million as of December 31, 2012, $101.8 million as of December 31, 2011, $271.7 million as of December 31, 2010 and $251.4 million as of December 31, 2009 (See Note 8 to the consolidated financial statements).
(6) Our funds from operations (“FFO”) during 2013, 2012 and 2011 are net of reductions for transaction costs of $203,000, $680,000 and $518,000, respectively.

 

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, and adjusted funds from operations (“AFFO”) and AFFO per diluted share, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. We compute FFO, as reflected below, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. AFFO was also computed for 2013, 2012 and 2011, as reflected below, since we believe it is helpful to our investors since it adjusts for the transaction costs related to acquisitions. FFO/AFFO do not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO/AFFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders.

 

A reconciliation of our reported net income to FFO is shown below:

 

     (000s)  
     2013      2012     2011     2010      2009  

Net income

   $ 13,169       $ 19,477      $ 73,794      $ 16,310       $ 18,576   

Depreciation and amortization expense on real property/intangibles:

         

Consolidated investments

     18,496         20,030        7,173        6,156         6,283   

Unconsolidated affiliates

     3,290         3,293        10,558        10,116         8,466   

Provision for asset impairment

     —           —          5,354        —           —     

Less gains:

         

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs, net

     —           —          (28,576     —           —     

Gains on divestiture of properties owned by unconsolidated LLCs, net

     —           (8,520     (35,835     —           —     
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

Funds From Operations

     34,955         34,280        32,468        32,582         33,325   

Transaction costs

     203         680        518        —           —     
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

Adjusted Funds From Operations

   $ 35,158       $ 34,960      $ 32,986      $ 32,582       $ 33,325   
  

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 

 

28


Table of Contents
ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

We are a real estate investment trust (“REIT”) that commenced operations in 1986. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings (“MOBs”). As of February 28, 2014, we have fifty-eight real estate investments or commitments in sixteen states consisting of:

 

   

seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;

 

   

forty-seven medical office buildings, including eleven owned by unconsolidated LLCs, and;

 

   

four preschool and childcare centers.

 

Forward Looking Statements

 

This report contains “forward-looking statements” that reflect our current estimates, expectations and projections about our future results, performance, prospects and opportunities. Forward-looking statements include, among other things, the information concerning our possible future results of operations, business and growth strategies, financing plans, expectations that regulatory developments or other matters will not have a material adverse effect on our business or financial condition, our competitive position and the effects of competition, the projected growth of the industry in which we operate, and the benefits and synergies to be obtained from our completed and any future acquisitions, and statements of our goals and objectives, and other similar expressions concerning matters that are not historical facts. Words such as “may,” “will,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “appears,” “projects” and similar expressions, as well as statements in future tense, identify forward-looking statements.

 

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Such factors include, among other things, the following:

 

   

a substantial portion of our revenues are dependent upon one operator, Universal Health Services, Inc. (“UHS”);

 

   

a number of legislative initiatives have recently been passed into law that may result in major changes in the health care delivery system on a national or state level to the operators of our facilities, including UHS. No assurances can be given that the implementation of these new laws will not have a material adverse effect on the business, financial condition or results of operations of our operators;

 

   

a subsidiary of UHS is our Advisor and our officers are all employees of a wholly-owned subsidiary of UHS, which may create the potential for conflicts of interest;

 

   

lost revenues from purchase option exercises and lease expirations and renewals, loan repayments and other restructuring;

 

   

the availability and terms of capital to fund the growth of our business;

 

   

the outcome of known and unknown litigation, government investigations, and liabilities and other claims asserted against us or the operators of our facilities;

 

   

failure of the operators of our hospital facilities to comply with governmental regulations related to the Medicare and Medicaid licensing and certification requirements could have a material adverse impact on our future revenues and the underlying value of the property;

 

29


Table of Contents
   

the potential unfavorable impact on our business of deterioration in national, regional and local economic and business conditions, including a continuation or worsening of unfavorable credit and/or capital market conditions, which may adversely affect, on acceptable terms, our access to sources of capital which may be required to fund the future growth of our business and refinance existing debt with near term maturities;

 

   

further deterioration in general economic conditions which could result in increases in the number of people unemployed and/or insured and likely increase the number of individuals without health insurance; as a result, the operators of our facilities may experience decreases in patient volumes which could result in decreased occupancy rates at our medical office buildings;

 

   

a worsening of the economic and employment conditions in the United States could materially affect the business of our operators, including UHS, which may unfavorably impact our future bonus rentals (on the UHS hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties;

 

   

real estate market factors, including without limitation, the supply and demand of office space and market rental rates, changes in interest rates as well as an increase in the development of medical office condominiums in certain markets;

 

   

government regulations, including changes in the reimbursement levels under the Medicare and Medicaid program resulting from, among other things, the various health care reform initiatives being implemented;

 

   

the issues facing the health care industry that affect the operators of our facilities, including UHS, such as: changes in, or the ability to comply with, existing laws and government regulations; unfavorable changes in the levels and terms of reimbursement by third party payors or government programs, including Medicare (including, but not limited to, the potential unfavorable impact of future reductions to Medicare reimbursements resulting from the Budget Control Act of 2011, as discussed below) and Medicaid (most states have reported significant budget deficits that have resulted in the reduction of Medicaid funding to the operators of our facilities, including UHS, during each of the last several years, and many states may effectuate further reductions in the level of Medicaid funding due to continued projected state budget deficits); demographic changes; the ability to enter into managed care provider agreements on acceptable terms; an increase in uninsured and self-pay patients which unfavorably impacts the collectability of patient accounts; decreasing in-patient admission trends; technological and pharmaceutical improvements that may increase the cost of providing, or reduce the demand for, health care, and; the ability to attract and retain qualified medical personnel, including physicians;

 

   

in August, 2011, the Budget Control Act of 2011 (the “2011 Act”) was enacted into law. The 2011 Act imposed annual spending limits for most federal agencies and programs aimed at reducing budget deficits by $917 billion between 2012 and 2021, according to a report released by the Congressional Budget Office. The 2011 Act provides for new spending on program integrity initiatives intended to reduce fraud and abuse under the Medicare program. Among its other provisions, the law established a bipartisan Congressional committee, known as the Joint Select Committee on Deficit Reduction (the “Joint Committee”), which was tasked with making recommendations aimed at reducing future federal budget deficits by an additional $1.5 trillion over 10 years. The Joint Committee was unable to reach an agreement by the November 23, 2011 deadline and, as a result, across-the-board cuts to discretionary, national defense and Medicare spending were implemented on March 1, 2013 resulting in Medicare payment reductions of up to 2% per fiscal year with a uniform percentage reduction across all Medicare programs. We cannot predict whether Congress will restructure the implemented Medicare payment reductions or what federal other deficit reduction initiatives may be proposed by Congress. We also cannot predict the effect this enactment will have on operators (including UHS), and, thus, our business;

 

   

in March, 2010, the Health Care and Education Reconciliation Act of 2010 and the Patient Protection and Affordable Care Act were enacted into law and created significant changes to health insurance coverage for U.S. citizens as well as material revisions to the federal Medicare and state Medicaid

 

30


Table of Contents
 

programs. The two combined primary goals of these acts are to provide for increased access to coverage for healthcare and to reduce healthcare-related expenses. Medicare, Medicaid and other health care industry changes are scheduled to be implemented at various times during this decade. We cannot predict the effect, if any, these enactments will have on operators (including UHS) and, thus, our business;

 

   

two LLCs that own properties in California, in which we have various non-controlling equity interests, could not obtain earthquake insurance at rates which are economically beneficial in relation to the risks covered;

 

   

competition for our operators from other REITs;

 

   

the operators of our facilities face competition from other health care providers, including physician owned facilities and other competing facilities, including certain facilities operated by UHS but the real property of which is not owned by us. Such competition is experienced in markets including, but not limited to, McAllen, Texas, the site of our McAllen Medical Center, a 430-bed acute care hospital, and Riverside County, California, the site of our Southwest Healthcare System-Inland Valley Campus, a 132-bed acute care hospital;

 

   

changes in, or inadvertent violations of, tax laws and regulations and other factors than can affect REITs and our status as a REIT;

 

   

should we be unable to comply with the strict income distribution requirements applicable to REITs, utilizing only cash generated by operating activities, we would be required to generate cash from other sources which could adversely affect our financial condition;

 

   

our majority ownership interests in various LLCs in which we hold non-controlling equity interests. In addition, pursuant to the operating agreements of most of the LLCs (consisting of substantially all of the LLCs that own MOBs in Arizona, Reno, Nevada and California), the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member;

 

   

fluctuations in the value of our common stock, and;

 

   

other factors referenced herein or in our other filings with the Securities and Exchange Commission.

 

Given these uncertainties, risks and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Our actual results and financial condition, including the operating results of our lessees and the facilities leased to subsidiaries of UHS, could differ materially from those expressed in, or implied by, the forward-looking statements.

 

Forward-looking statements speak only as of the date the statements are made. We assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as may be required by law. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes.

 

31


Table of Contents

A summary of our critical accounting policies is outlined in Note 1 to the consolidated financial statements. We consider our critical accounting policies to be those that require us to make significant judgments and estimates when we prepare our financial statements, including the following:

 

Revenue Recognition:    Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (“MOBs”) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

 

Real Estate Investments:    On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Depreciation is computed using the straight-line method over the useful lives of the buildings and capital improvements. The value of intangible assets is amortized over the remaining lease term.

 

Asset Impairment:    Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

 

32


Table of Contents

Investments in Limited Liability Companies (“LLCs”):    Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

As of December 31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings. As of December 31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013, as discussed below, since it was considered to be a variable interest entity where we were the primary beneficiary by virtue of its master lease with a wholly-owned subsidiary of Universal Health Services, Inc. (“UHS”), a related party to us. The master lease expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.

 

The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

In addition, at December 31, 2011, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as discussed herein (see Notes 3 and 8 to the consolidated financial statements for additional disclosure).

 

Palmdale Medical Properties had a master lease with a subsidiary of UHS through June 30, 2013. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS (through UHS of Delaware, Inc.). As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we have accounted for this LLC on a consolidated basis, since the fourth quarter of 2007 through June 30, 2013, since it was a variable interest entity and we were deemed to be the primary beneficiary. As of July 1, 2013, the master lease expired and this LLC is no longer considered a variable interest entity and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs and will begin accounting for them on a consolidated basis effective January 1, 2014. Each of the property’s assets and liabilities will be recorded at their fair values. (See Note 3 to the consolidated financial statements for additional disclosure).

 

33


Table of Contents

Federal Income Taxes:    No provision has been made for federal income tax purposes since we qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax is expected to be due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for investment losses.

 

Relationship with UHS and Related Party Transactions:    UHS is our principal tenant and through UHS of Delaware, Inc., a wholly owned subsidiary of UHS, serves as our advisor (the “Advisor”) under an Advisory Agreement dated December 24, 1986 between the Advisor and us (the “Advisory Agreement”). Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2013 we had no salaried employees, our officers do receive stock-based compensation.

 

Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees that the Advisor’s performance has been satisfactory. The Advisor is entitled to certain advisory fees for its services. See “Relationship with UHS and Related Party Transactions” in Note 2 to the consolidated financial statements for additional information on the Advisory Agreement and related fees. In December of 2013, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2014 pursuant to the same terms as the Advisory Agreement in place during 2013. In December of 2012, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the 2013 advisory fee, as compared to the 2012 advisory fee, was increased to 0.70% (from 0.65%) of our average invested real estate assets, as derived from our consolidated balance sheet. See “Relationship with Universal Health Services, Inc.” in Item 1 and Note 2 to the consolidated financial statements for additional information on the Advisory Agreement and related fees.

 

The combined revenues generated from the leases on the UHS hospital facilities comprised approximately 30%, for each of the years ended December 31, 2013 and 2012, and 55% of our revenues for the year ended December 31, 2011. The decrease during 2012 as compared to 2011 is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for 22%, 21% and 19% of the combined consolidated and unconsolidated revenues for the years ended December 31, 2013, 2012 and 2011, respectively. In addition, twelve of the MOBs, including certain properties owned by LLCs in which we hold either 100% of

 

34


Table of Contents

the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. The leases to the hospital facilities of UHS are guaranteed by UHS and cross-defaulted with one another. For additional disclosure related to our relationship with UHS, please refer to Note 2 to the consolidated financial statements—Relationship with UHS and Related Party Transactions.

 

Recent Accounting Pronouncements:    For a summary of recent accounting pronouncements, please see Note 1 to the Consolidated Financial Statements as included in this Annual Report on Form 10-K for the year ended December 31, 2013.

 

Results of Operations

 

Year ended December 31, 2013 as compared to the year ended December 31, 2012:

 

Our Consolidated Statement of Income for the year ended December 31, 2012, includes the revenue and expenses associated with Palmdale Medical Properties, an LLC in which we held a 95% non-controlling equity interest as of December 31, 2013 (we now hold 100% of the ownership in this LLC effective as of January 1, 2014). As previously discussed, effective July 1, 2013, the master lease agreement between Palmdale Medical Properties and Palmdale Regional Medical Center, a wholly-owned subsidiary of UHS, expired. Therefore, effective on July 1, 2013, this LLC was no longer considered a variable interest entity and we began accounting for this LLC on an unconsolidated basis pursuant to the equity method. Prior to the expiration of the master lease, this LLC was accounted for on a consolidated basis, through June 30, 2013. The table below reflects the “As Adjusted” Statement of Income for the twelve months ended December 31, 2012, reflecting the revenue and expense impact of the deconsolidation of this LLC as if it had been deconsolidated effective July 1, 2012, since our Consolidated Statement of Income for the first six months of 2013 includes the revenue and expenses associated with Palmdale Medical Properties. There was no material impact to our net income as a result of the deconsolidation of this LLC.

 

     Year Ended December 31, 2013     Year Ended December 31, 2012        
     As reported
in
Consolidated
Statements
of Income
    As reported
in
Consolidated
Statements
of Income
    July 1 –
December 31,
2012
Statements
of Income
for
Palmdale
Medical
Properties
    “As
Adjusted”
    “As
Adjusted”
Variance
 

Revenues

   $ 54,280      $ 53,950      $ 657      $ 53,293      $ 987   

Expenses:

          

Depreciation and amortization

     18,753        20,216        172        20,044        1,291   

Advisory fees to UHS

     2,369        2,119        —          2,119        (250

Other operating expenses

     14,409        14,575        266        14,309        (100

Transaction costs

     203        680        —          680        477   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     35,734        37,590        438        37,152        1,418   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated LLCs, interest expense and gains, net

     18,546        16,360        219        16,141        2,405   

Equity in income of unconsolidated LLCs

     2,095        2,365        (13     2,378        (283

Gains on divestiture of properties owned by unconsolidated LLCs

     —          8,520        —          8,520        (8,520

Interest expense, net

     (7,472     (7,768     (206     (7,562     90   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 13,169      $ 19,477      $ —        $ 19,477      ($ 6,308
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

35


Table of Contents

During 2013, net income decreased $6.3 million to $13.2 million as compared to $19.5 million during 2012. The decrease was primarily attributable to the following, as computed utilizing the “As Adjusted” Variance column indicated on the table above:

 

   

an unfavorable change of $8.5 million resulting from the aggregate net gains recorded during 2012 on divestiture of properties owned by two unconsolidated LLCs in which we formerly held noncontrolling majority ownership interests, as discussed below and herein (see Note 3 to the Consolidated Financial Statements);

 

   

a favorable change of $1.3 million (As Adjusted) resulting from a decrease in depreciation and amortization expense, resulting primarily from a $1.7 million decrease in amortization expense recorded on intangible assets, partially offset by an increase in depreciation expense resulting from MOBs acquired during 2013 and the fourth quarter of 2012;

 

   

a favorable change of $477,000 resulting from a decrease in transaction costs;

 

   

a favorable change of $90,000 (As Adjusted) in interest expense due primarily to a decrease in the average effective borrowing rate pursuant to the terms of our $150 million revolving credit agreement, partially offset by an increase in our average outstanding borrowings (as discussed below in Credit facilities and mortgage debt), and;

 

   

other combined net favorable changes of $354,000 including the aggregate net operating income (before depreciation and amortization and interest expense) generated at three MOBs acquired during 2013 and the fourth quarter of 2012, partially offset by the net operating losses incurred at a newly constructed MOB that opened in April, 2013 (property is owned by an unconsolidated LLC in which we hold a noncontrolling majority ownership interest).

 

Total revenues increased approximately $1.0 million (As Adjusted) during 2013, as compared to 2012, due primarily from increases resulting from MOBs acquired during 2013 and the fourth quarter of 2012, partially offset by other combined revenue decreases experienced at certain properties.

 

Included in our other operating expenses are expenses related to the consolidated medical office buildings, which totaled $12.9 million and $12.6 million (As Adjusted basis), for 2013 and 2012, respectively. The increase in other operating expenses during 2013, as compared to 2012, is primarily attributable to expenses related to the MOBs acquired during 2013 and the fourth quarter of 2012. A large portion of the expenses associated with our consolidated medical office buildings is passed on to the tenants either directly as tenant reimbursements of common area maintenance expenses or included in base rental amounts. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred and are included in tenant reimbursements and other revenue in our condensed consolidated statements of income.

 

During 2013, we had a total of 106 new or renewed leases related to the medical office buildings indicated above, in which we have significant investments, some of which are accounted for by the equity method. These leases comprised approximately 13% of the aggregate rentable square feet of these properties (8% related to renewed leases and 5% related to new leases). Rental rates, tenant improvement costs and rental concessions vary from property to property based upon factors such as, but not limited to, the current occupancy and age of our buildings, local overall economic conditions, proximity to hospital campuses and the vacancy rates, rental rates and capacity of our competitors in the market. The weighted-average tenant improvement costs associated with these new or renewed leases was approximately $17 per square foot during 2013. The weighted-average leasing commissions on the new and renewed leases commencing during 2013 was approximately 3% of base rental revenue over the term of the leases. The average aggregate value of the tenant concessions, generally consisting of rent abatements, provided in connection with new and renewed leases commencing during 2013 was approximately 2% of the future aggregate base rental revenue over the lease terms. Tenant concessions were, or will be, recognized in our results of operations under the straight-line method over the lease term regardless of when payments are due. In connection with lease renewals executed during 2013, the weighted-average rental rates, as compared to rental rates on the expired leases, decreased by approximately 6%.

 

36


Table of Contents

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, and adjusted funds from operations (“AFFO”) and AFFO per diluted share, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. We compute FFO, as reflected below, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. AFFO was also computed for 2013 and 2012, as reflected below, since we believe it is helpful to our investors since it adjusts for the transaction costs related to acquisitions. FFO/AFFO do not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO/AFFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders.

 

Below is a reconciliation of our reported net income to FFO and AFFO for 2013 and 2012 (in thousands):

 

     2013      2012  

Net income

   $ 13,169       $ 19,477   

Depreciation and amortization expense on real property/intangibles of consolidated investments

     18,496         20,030   

Depreciation and amortization expense on real property/intangibles of unconsolidated affiliates

     3,290         3,293   

Gains (net of related transaction costs) on divestiture of properties owned by unconsolidated LLCs

     —           (8,520
  

 

 

    

 

 

 

Funds From Operations

     34,955         34,280   

Transaction costs

     203         680   
  

 

 

    

 

 

 

Adjusted Funds From Operations

   $ 35,158       $ 34,960   
  

 

 

    

 

 

 

 

Our FFO increased $675,000 to $35.0 million during 2013 as compared to $34.3 million during 2012. The increase was primarily due to: (i) an unfavorable change of $6.3 million resulting from the decrease in net income, as discussed above; (ii) an unfavorable change of $1.5 million in the add-back of depreciation and amortization expense on real property/intangibles, and; (iii) a favorable change of $8.5 million in gains recorded on divestiture of properties owned by an unconsolidated LLCs. Our AFFO were $35.2 million during 2013 as compared to $35.0 million during 2012.

 

Year ended December 31, 2012 as compared to the year ended December 31, 2011:

 

Our Consolidated Statement of Income for the year ended December 31, 2012 includes the revenue and expenses associated with the below-mentioned LLCs in which we purchased the third-party minority interests during the fourth quarter of 2011. Since we now own 100% of these entities, we began consolidating the financial data effective December 12, 2011. Prior to these minority interest purchases, we previously held noncontrolling majority interests in these LLCs and they were therefore accounted for on an unconsolidated basis. Our Consolidated Statement of Income for the year ended December 31, 2011 includes a partial month of revenue and expenses associated with the below-mentioned LLCs in which we purchased the third-party minority ownership interests during the fourth quarter of 2011. The table below reflects the “As Adjusted” Statement of Income for the year ended December 31, 2011, reflecting the revenue and expense impact of the consolidation of these various LLCs as if they had been consolidated for the twelve months ended December 31, 2011. The “As Adjusted” amounts are used for comparison discussions in the Results of Operations, as they present both periods on a comparable basis. Our 2012 net income was unfavorably impacted as a result of the consolidation of these

 

37


Table of Contents

LLCs primarily due to a $6.6 million increase in depreciation and amortization resulting from the increased basis recorded in connection with the fair value recognition of the assets and liabilities related to the eleven LLCs of which we purchased the third-party minority ownership interests.

 

    Year Ended December 31, 2012     Year Ended December 31, 2011        
    As reported
in
Consolidated
Statements
of Income
    As reported
in
Consolidated
Statements
of Income
    January 1 –
December 11,
2011
Statements
of Income
for
LLCs in
which we
purchased
third-party
minority
interests
    “As
Adjusted”
    “As
Adjusted”
Variance
 

Revenues

  $ 53,950      $ 29,494      $ 16,961      $ 46,455      $ 7,495   

Expenses:

         

Depreciation and amortization

    20,216        7,306        3,922        11,228        (8,988

Advisory fees to UHS

    2,119        2,008        —          2,008        (111

Other operating expenses

    14,575        5,581        7,196        12,777        (1,798

Transaction costs

    680        518        —          518        (162

Provision for asset impairment

    —          5,354        —          5,354        5,354   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    37,590        20,767        11,118        31,885        (5,705
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated LLCs, interest expense and gains, net

    16,360        8,727        5,843        14,570        1,790   

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs, net

    —          28,576        —          28,576        (28,576

Equity in income of unconsolidated LLCs

    2,365        3,058        (1,810     1,248        1,117   

Gains on divestiture of properties owned by unconsolidated LLCs

    8,520        35,835        —          35,835        (27,315

Interest expense, net

    (7,768     (2,402     (4,033     (6,435     (1,333
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 19,477      $ 73,794      $ —        $ 73,794      ($ 54,317
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

During 2012, net income decreased $54.3 million to $19.5 million as compared to $73.8 million during 2011. The decrease was primarily attributable to the following, as computed utilizing the “As Adjusted” Variance column indicated on the table above:

 

   

an unfavorable change of $28.6 million resulting from the aggregate net gain (net of $301,000 of related transaction costs) recorded during 2011 in connection with the fair value recognition of the assets and liabilities related to eleven LLCs in which we purchased the third-party minority ownership interests, as discussed below and herein (see Note 3 to the Consolidated Financial Statements);

 

   

an unfavorable change of $27.3 million resulting from the decrease in net gains recorded on the divestiture of properties owned by unconsolidated LLCs during 2012 and 2011, as discussed below and herein (see Note 3 to the Consolidated Financial Statements);

 

   

an unfavorable change of $9.0 million (As Adjusted) in depreciation and amortization expense primarily due to a $6.6 million increase incurred during 2012 resulting from the increased basis recorded in connection with the fair value recognition of the assets and liabilities related to the eleven LLCs of which we purchased the third-party minority ownership interests during the fourth quarter of 2011, as well as a $3.0 million increase during 2012 at five MOBs and clinics acquired during 2011 and the first quarter of 2012;

 

38


Table of Contents
   

an unfavorable change of $1.3 million (As Adjusted) in interest expense, as discussed below;

 

   

a favorable change of $5.4 million resulting from the provision for asset impairment recorded during 2011 on an MOB located in Atlanta, Georgia;

 

   

a favorable change of approximately $5.2 million from the net operating income (before depreciation and amortization and interest expenses) generated at five MOBs and clinics acquired during 2011 and the first quarter of 2012;

 

   

a favorable change of $1.1 million (As Adjusted) resulting from an increase in equity in income of unconsolidated LLCs resulting primarily from increased income generated at a number of our LLCs, and;

 

   

other combined net favorable changes of $200,000.

 

Total revenue increased by $7.5 million (As Adjusted) during 2012, as compared to 2011, due primarily to the revenue, or increased revenue, generated during 2012 at five MOBs/clinic acquired at various times during 2011 and 2012, as discussed below and herein.

 

During 2012, we recorded a combined net gain of $8.5 million in connection with the sale of two medical office buildings by LLCs in which we formerly held a noncontrolling majority ownership interests, as discussed below and herein. See Note 3 to the Consolidated Financial Statements for additional disclosure related to this divestiture.

 

Interest expense, net of interest income, increased $1.3 million (As Adjusted) during 2012 as compared to 2011, primarily due to: (i) an increase in our average outstanding borrowings (to $75.4 million in 2012 from $67.8 million in 2011) as well as an increase in the average effective interest rate (to 2.4% in 2012 from 1.8% in 2011) pursuant to the terms of our new $150 million revolving credit agreement that commenced in July, 2011; (ii) interest expense incurred on the combined $29.4 million of third-party debt assumed as part of the acquisitions, as mentioned below, partially offset by; (iii) a decrease in interest expense related to the previously unconsolidated LLCs which are now consolidated in our financial statements, as discussed below. The increased borrowings during 2012, as compared to 2011, were used primarily to: (i) fund the purchases of the six acquired MOBs/clinic during 2011 and the first and fourth quarters of 2012; (ii) fund the fourth quarter of 2011 purchases of the third-party minority ownership interests in various LLCs in which we formerly held noncontrolling majority ownership interests; (iii) fund investments in, and advances to, various LLCs, partially offset by; (iv) our share of the cash proceeds generated during 2011 and 2012 in connection with the sale of MOBs by various LLCs in which we formerly held noncontrolling majority ownership interests, as discussed herein.

 

Included in our other operating expenses are expenses related to the consolidated medical office buildings, which totaled $12.9 million and $11.5 million (As Adjusted basis), for 2012 and 2011, respectively. The increase in other operating expenses during 2012 as compared to 2011, is primarily attributable to the expenses related to the five MOBs/clinic acquired during 2011 and first quarter of 2012, as previously discussed. A large portion of the expenses associated with our consolidated medical office buildings is passed on to the tenants either directly as tenant reimbursements of common area maintenance expenses or included in base rental amounts. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred and are included in tenant reimbursements and other revenue in our condensed consolidated statements of income.

 

During 2012, we had a total of 91 new or renewed leases related to the medical office buildings indicated above, in which we have significant investments, some of which are accounted for by the equity method. These leases comprised approximately 13% of the aggregate rentable square feet of these properties (8% related to renewed leases and 5% related to new leases). Rental rates, tenant improvement costs and rental concessions vary from property to property based upon factors such as, but not limited to, the current occupancy and age of our buildings, local overall economic conditions, proximity to hospital campuses and the vacancy rates, rental rates

 

39


Table of Contents

and capacity of our competitors in the market. The weighted-average tenant improvement costs associated with these new or renewed leases was approximately $23 per square foot during 2012. The weighted-average leasing commissions on the new and renewed leases commencing during 2012 was approximately 3% of base rental revenue over the term of the leases. The average aggregate value of the tenant concessions, generally consisting of rent abatements, provided in connection with new and renewed leases commencing during 2012 was approximately 3% of the future aggregate base rental revenue over the lease terms. Tenant concessions were, or will be, recognized in our results of operations under the straight-line method over the lease term regardless of when payments are due. In connection with lease renewals executed during 2012, the weighted-average rental rates, as compared to rental rates on the expired leases, decreased by approximately 1%. Rental rates on new leases were excluded from the above-mentioned market rates to expired lease rates calculation since a significant portion of the new leases occurred at then newly constructed MOBs which are leasing unoccupied space at generally fixed rental rates.

 

Below is a reconciliation of our reported net income to FFO and AFFO for 2012 and 2011 (in thousands):

 

     2012     2011  

Net income

   $ 19,477      $ 73,794   

Depreciation and amortization expense on real property/intangibles of consolidated investments

     20,030        7,173   

Depreciation and amortization expense on real property/intangibles of unconsolidated affiliates

     3,293        10,558   

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs

     —         (28,576

Gain (net of related transaction costs) on divestitures of properties owned by unconsolidated LLCs

     (8,520     (35,835

Provision for asset impairment

     —         5,354   
  

 

 

   

 

 

 

Funds From Operations

     34,280        32,468   

Transaction costs

     680        518   
  

 

 

   

 

 

 

Adjusted Funds From Operations

   $ 34,960      $ 32,986   
  

 

 

   

 

 

 

 

Our FFO increased $1.8 million to $34.3 million during 2012 as compared to $32.5 million during 2011. The increase was primarily due to: (i) an unfavorable change of $54.3 million resulting from the decrease in net income, as discussed above; (ii) a favorable change of $28.6 million from the 2011 gain on purchase of minority interests in majority-owned LLCs; (iii) plus a $5.6 million increase in the add-back of depreciation and amortization expense (including consolidated investments and unconsolidated affiliates); (iv) a favorable change of $27.3 million in gains recorded on divestiture of properties owned by an unconsolidated LLCs., and; (v) an unfavorable change of $5.4 million from the provision for asset impairment add-back during 2011.

 

Our AFFO increased $2.0 million to $35.0 million during 2012 as compared to $33.0 million during 2011. The increase in AFFO during 2012, as compared to 2011, was attributable to: (i) the above-mentioned $1.8 million increase in FFO, plus; (ii) the $200,000 increase in the add-back of the transaction costs incurred during each period.

 

Summary of Acquisitions, Divestitures and Purchases of Third-Party Minority Ownership Interests completed during 2012 and 2011:

 

Below is a summary of all transactions completed during 2012 and 2011. Each of the MOBs acquired during 2011, one of the MOBs acquired during 2012 and certain of the divestitures of MOBs by formerly jointly-owned LLCs were part of planned like-kind exchange transactions pursuant to Section 1031 of the Internal Revenue Code.

 

40


Table of Contents

Acquisitions:

 

During 2012, we paid an aggregate of $16.9 million in cash and assumed $22.4 million of third-party debt to acquire the following:

 

Property:

  

Type of facility

  

City

  

State

  

Date of
Acquisition

PeaceHealth Medical Clinic

   Single-tenant MOB    Bellingham    WA    January, 2012

Northwest Texas Professional Office Tower

   Multi-tenant MOB    Amarillo    TX    December, 2012

 

Transaction costs recorded in connection with the purchase of the two above-mentioned MOBs aggregated approximately $680,000 for the year ended December 31, 2012.

 

During 2011, we paid an aggregate of $39.6 million in cash and assumed $7.0 million of third-party debt to acquire the following:

 

Property:

  

Type of facility

  

City

  

State

  

Date of
Acquisition

Lake Pointe Medical Arts Building

   Multi-tenant MOB    Rowlett    TX    June, 2011

Forney Medical Plaza

   Multi-tenant MOB    Forney    TX    July, 2011

Tuscan Professional Building

   Multi-tenant MOB    Irving    TX    December, 2011

Emory at Dunwoody Building

   Single-tenant medical clinic    Atlanta    GA    December, 2011

 

Transaction costs recorded in connection with the purchase of the four above-mentioned MOBs aggregated approximately $518,000 for the year ended December 31, 2011.

 

Divestiture of MOBs by formerly jointly-owned LLCs:

 

During 2012, we received an aggregate of $12.2 million of net cash proceeds in connection with the divestiture of the following MOBs by two LLCs in which we formerly owned noncontrolling majority ownership interests ranging from 90% to 95%. These proceeds were net of closing costs and the minority member’s share of the proceeds. These divestitures resulted in an aggregate net gain of $8.5 million which is included in our results of operations for the year ended December 31, 2012.

 

Name of LLC:

  

Property owned by LLC:

  

City

  

State

  

Date of

Divestiture

Canyon Healthcare Properties

   Canyon Springs Medical Plaza    Gilbert    AZ    Feb, 2012

575 Hardy Investors

   Centinela Medical Building Complex    Inglewood    CA    Oct, 2012

 

During the fourth quarter of 2011, we received an aggregate of $33.8 million of net cash proceeds in connection with the divestitures of the following MOBs by various LLCs in which we formerly owned noncontrolling, majority ownership interests ranging from 75% to 95%. These proceeds were net of closing costs, the minority member’s share of the proceeds and third-party debt assumed by the purchaser. These divestitures resulted in an aggregate net gain of $35.8 million (net of related transaction costs totaling approximately $500,000) which is included in our results of operations for the year ended December 31, 2011.

 

Name of LLC:

 

Property owned by LLC:

   City    State    Date of
Divestiture

Cobre Properties

  Cobre Valley Medical Plaza    Globe    AZ    Dec, 2011

Deerval Properties

  Deer Valley Medical Office II    Phoenix    AZ    Nov, 2011

Deerval Properties II

  Deer Valley Medical Office III    Phoenix    AZ    Nov, 2011

Deerval Parking Company

  Deer Valley Parking Garage    Phoenix    AZ    Nov, 2011

DSMB Properties

  Desert Samaritan Hospital MOBs    Mesa    AZ    Dec, 2011

Litchvan Investments

  Papago Medical Park    Phoenix    AZ    Dec, 2011

Paseo Medical Properties II

  Thunderbird Paseo Medical Plaza I & II    Glendale    AZ    Dec, 2011

Willetta Medical Properties

  Edwards Medical Plaza    Phoenix    AZ    Nov, 2011

 

41


Table of Contents

Purchase of third-party minority ownership interests in majority-owned LLCs:

 

During the fourth quarter of 2011, we paid an aggregate of $4.4 million to acquire the third-party minority ownership interests in the following LLCs in which we formerly held various noncontrolling, majority ownership interests. We now own 100% of each of these entities. Our results of operations for the year ended December 31, 2011 includes an aggregate net gain of $28.6 million (net of related transaction costs totaling approximately $300,000), recorded in connection with fair value recognition of the assets and liabilities of these entities.

 

Name of LLC:

 

Property owned by LLC:

 

City

 

State

  Our
previous
ownership
%
    Minority
ownership
%
purchased
 

653 Town Center Investments

  Summerlin Hospital MOB I   Las Vegas   NV     95     5

653 Town Center Phase II

  Summerlin Hospital MOB II   Las Vegas   NV     98     2

Auburn Medical Properties II

  Auburn Medical Office Building II   Auburn   WA     95     5

ApaMed Properties

  Apache Junction Medical Plaza   Apache J.   AZ     85     15

Banburry Medical Properties

  Summerlin Hospital MOB III   Las Vegas   NV     95     5

BRB/E Building One

  BRB Medical Office Building   Kingwood   TX     95     5

Centennial Medical Properties

  Centennial Hills Medical Office Bldg. I   Las Vegas   NV     95     5

DesMed

  Desert Springs Medical Plaza   Las Vegas   NV     99     1

Gold Shadow Properties

  700 Shadow Lane & Goldring MOBs   Las Vegas   NV     98     2

Spring Valley Medical Properties

  Spring Valley Medical Office Building   Las Vegas   NV     95     5

Spring Valley Medical Properties II

  Spring Valley Medical Office Building II   Las Vegas   NV     95     5

 

Effects of Inflation

 

Inflation has not had a material impact on our results of operations over the last three years. However, since the healthcare industry is very labor intensive and salaries and benefits are subject to inflationary pressures, as are supply and other costs, we and the operators of our hospital facilities cannot predict the impact that future economic conditions may have on our/their ability to contain future expense increases. Depending on general economic and labor market conditions, the operators of our hospital facilities may experience unfavorable labor market conditions, including a shortage of nurses which may cause an increase in salaries, wages and benefits expense in excess of the inflation rate. Their ability to pass on increased costs associated with providing healthcare to Medicare and Medicaid patients is limited due to various federal, state and local laws which have been enacted that, in certain cases, limit their ability to increase prices. Therefore, there can be no assurance that these factors will not have a material adverse effect on the future results of operations of the operators of our facilities which may affect their ability to make lease payments to us.

 

Most of our leases contain provisions designed to mitigate the adverse impact of inflation. Our hospital leases require all building operating expenses, including maintenance, real estate taxes and other costs, to be paid by the lessee. In addition, certain of the hospital leases contain bonus rental provisions, which require the lessee to pay additional rent to us based on increases in the revenues of the facility over a base year amount. In addition, most of our MOB leases require the tenant to pay an allocable share of operating expenses, including common area maintenance costs, insurance and real estate taxes. These provisions may reduce our exposure to increases in operating costs resulting from inflation. To the extent that some leases do not contain such provisions, our future operating results may be adversely impacted by the effects of inflation.

 

42


Table of Contents

Liquidity and Capital Resources

 

Year ended December 31, 2013 as compared to December 31, 2012:

 

Net cash provided by operating activities

 

Net cash provided by operating activities was $31.3 million during 2013 as compared to $30.8 million during 2012. The $511,000 increase was attributable to:

 

   

a favorable change of $1.1 million due to an increase in net income plus the adjustments to reconcile net income to net cash provided by operating activities (depreciation and amortization, amortization on debt premium, restricted stock-based compensation and net gains on divestiture of properties owned by unconsolidated LLCs), as discussed above in Results of Operations;

 

   

a favorable change of $116,000 in rent receivable;

 

   

an unfavorable change of $191,000 in tenant reserves, escrows, deposits and prepaid rents, and;

 

   

other combined net unfavorable changes of $526,000, resulting primarily from an increase in leasing commissions paid during 2013, as compared to 2012.

 

Net cash used in investing activities

 

Net cash used in investing activities was $13.5 million during 2013 as compared to $8.6 million during 2012.

 

2013:

 

During 2013, we used $13.5 million of net cash in investing activities as follows:

 

   

We spent $3.0 million to fund equity investments in unconsolidated LLCs;

 

   

We spent $4.6 million in advances in the form of member loans to unconsolidated LLCs;

 

   

We spent $3.4 million on additions to real estate investments primarily for tenant improvements at various MOBs;

 

   

We spent $4.7 million to acquire the real estate assets of two medical office buildings;

 

   

We funded $150,000 consisting of a deposit on real estate assets related to the acquisition of two medical office buildings that we purchased during the first quarter of 2014;

 

   

We received $2.3 million of cash in excess of income related to our unconsolidated LLCs ($4.4 million of cash distributions received less $2.1 million of equity in income of unconsolidated LLCs);

 

   

We received $114,000 in repayments of advances previously made to an unconsolidated LLC.

 

Additionally, the cash balance reflected on our Consolidated Balance Sheet as of December 31, 2013, was reduced by $141,000 resulting from the deconsolidation of the Palmdale Medical Plaza on July 1, 2013. This amount represents the cash balance of the entity as of the date of deconsolidation.

 

2012:

 

During 2012, we used $8.6 million of net cash in investing activities as follows:

 

   

We spent $3.0 million to fund equity investments in unconsolidated LLCs;

 

   

We spent $8.0 million to fund an advance in the form of a member loan to an unconsolidated LLC that owned the Centinela Medical Building Complex to extinguish its third-party debt (this entity divested its property during the fourth quarter of 2012 and the member loan was repaid to us in full);

 

43


Table of Contents
   

We spent $4.0 million on additions to real estate investments primarily for tenant improvements at various MOBs;

 

   

We spent $16.9 million (net of certain acquired liabilities, third-part debt and prepaid deposits) to acquire the real estate assets of two medical office buildings;

 

   

We spent $711,000 on payments made in settlement of assumed liabilities related to the acquired properties;

 

   

We received $8.6 million in repayments of advances previously provided to unconsolidated LLCs as follows:

 

   

$8.0 million from the LLC that owned the Centinela Medical Building in which we had a 90% non-controlling equity interest (this property was divested during the fourth quarter of 2012), and;

 

   

$600,000 from various other LLCs in which we own non-controlling equity interests.

 

   

We received $3.2 million of cash in excess of income related to our unconsolidated LLCs ($5.6 million of cash distributions received less $2.4 million of equity in income of unconsolidated LLCs);

 

   

We received $12.2 million, net, of cash in connection with our share of the proceeds received from the divestiture of property owned by two unconsolidated LLCs, and;

 

   

We received $100,000 of refunded real estate deposits.

 

Net cash used in financing activities

 

Net cash used in financing activities was $17.5 million during 2013 as compared to $30.8 million during 2012.

 

The $17.5 million of net cash used in financing activities during 2013 consisted of: (i) generated $12.0 million of additional net borrowings on our revolving line of credit; (ii) generated $11.2 million of proceeds related to a new mortgage note payable (refinance) that is non-recourse to us; (iii) generated $5.8 million of net cash from the issuance of shares of beneficial interest, $5.5 million of which related to our at-the-market equity issuance program (as discussed below) and approximately $250,000 of which was related to our dividend reinvestment program; (iv) paid $31.8 million of dividends; (v) paid $14.4 million on mortgage and other notes payable that are non-recourse to us (including the pay-off of a mortgage note payable that was refinanced during the first quarter of 2013, resulting in the above-mentioned $11.2 million of mortgage proceeds to us); (vi) paid $101,000 as partial settlement of accrued dividend equivalent rights, and; (vii) paid $95,000 of financing costs on mortgage and other notes payable.

 

During the fourth quarter of 2013, we commenced an at-the-market (“ATM”) equity issuance program, pursuant to the terms of which we may sell, from time-to-time, common shares of our beneficial interest up to an aggregate sales price of $50 million to or through Merrill Lynch, Pierce, Fenner and Smith, Incorporated (“Merrill Lynch”), as sales agent and/or principal. Pursuant to this ATM program, we issued 154,713 shares at an average price of $41.71 per share, which generated approximately $6.0 million of net cash proceeds or receivables (net of approximately $424,000, consisting of compensation of approximately $161,000 to Merrill Lynch, as well as approximately $263,000 of other various fees and expenses). Since inception of this program, we have issued 154,713 shares at an average price of $41.71.

 

The $30.8 million of net cash used in financing activities during 2012 consisted of: (i) generated $4.6 million from additional net borrowings on our revolving line of credit; (ii) generated $14.0 million of proceeds related to two new mortgage notes payable that are non-recourse to us; (iii) generated $350,000 of net cash from the issuance of shares of beneficial interest; (iv) paid $31.2 million of dividends; (v) paid $18.1 million on mortgage and other notes payable that are non-recourse to us (including the pay-offs of two mortgage notes payable that were refinanced during the second and fourth quarters of 2012, resulting in the $14.0 million of

 

44


Table of Contents

proceeds, as mentioned above, as well as a $600,000 mortgage principal pay-down); (vi) paid $384,000 of financing costs on mortgage and other notes payable, and; (vii) paid $106,000 as partial settlement of accrued dividend equivalent rights.

 

Year ended December 31, 2012 as compared to December 31, 2011:

 

Net cash provided by operating activities

 

Net cash provided by operating activities was $30.8 million during 2012 as compared to $21.4 million during 2011. The $9.4 million increase was attributable to:

 

   

a favorable change of $9.4 million due to an increase in net income plus the adjustments to reconcile net income to net cash provided by operating activities (depreciation and amortization, amortization on debt premium, provision for asset impairment, restricted stock-based compensation, net gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs, and net gains on divestiture of properties owned by unconsolidated LLCs), as discussed above in Results of Operations;

 

   

an unfavorable change of $407,000 in rent receivable primarily resulting from an increase in straight-line rent receivable at various properties as well as other combined unfavorable changes;

 

   

a favorable change of $203,000 in tenant reserves, escrows, deposits and prepaid rents resulting primarily from increased prepaid rents collected from the medical clinic acquired during the first quarter of 2012, and;

 

   

other combined net favorable changes of $232,000.

 

Net cash used in investing activities

 

Net cash used in investing activities was $8.6 million during 2012 as compared to $3.3 million during 2011. The factors contributing to the $8.6 million of net cash used in investing activities during 2012 are detailed above.

 

2011:

 

During 2011, we used $3.3 million of net cash in investing activities as follows:

 

   

We spent $3.8 million to fund equity investments in unconsolidated LLCs.

 

   

We spent $11.5 million to fund advances to unconsolidated LLCs as follows:

 

   

$6.2 million advance made to an LLC that owns the Rosenberg Children’s Medical Plaza in which we have an 85% non-controlling equity interest (this advance was repaid in full to us during 2011, as discussed below);

 

   

$2.5 million advance made to an LLC that owns the Santa Fe Professional Plaza in which we have a 90% non-controlling equity interest (this advance, structured as a member loan to the LLC, extinguished the third-party debt related to this entity), and;

 

   

$2.8 million advanced to various other LLCs, in which we own or owned a non-controlling equity interests (consisted primarily of funding for tenant improvements for an LLC of which we now hold 100% of the ownership interest as discussed herein).

 

   

We spent $776,000 on additions to real estate investments primarily for tenant improvements at various MOBs;

 

   

We funded $634,000 consisting of deposits on real estate assets related to the acquisition of a medical clinic that we purchased during the first quarter of 2012;

 

45


Table of Contents
   

We spent $39.6 million to acquire the real estate assets of four medical office buildings;

 

   

We spent $621,000 on payments made in settlement of assumed liabilities related to the acquired properties;

 

   

We spent $4.4 million to acquire the minority interests in majority-owned LLCs;

 

   

We received $8.7 million in repayments of advances previously provided to unconsolidated LLCs as follows:

 

   

$6.2 million from an LLC that owns the Rosenberg Children’s Medical Plaza (amounts advanced previously in 2011) in which we have an 85% non-controlling equity interest;

 

   

$2.0 million from an LLC that owned the Desert Samaritan Hospital MOBs, in which we had a 76% non-controlling equity interest (this property was divested during the fourth quarter of 2011), and;

 

   

$500,000 from various other LLCs in which we own or owned non-controlling equity interests.

 

   

We received $5.2 million of cash in excess of income related to our unconsolidated LLCs ($8.3 million of cash distributions received less $3.1 million of equity in income of unconsolidated LLCs);

 

   

We received $2.1 million of cash in connection with refinancing of third-party debt by the LLC that owns the Rosenberg Children’s Medical Plaza in which we have an 85% non-controlling equity interest;

 

   

We received $4.0 million of cash in connection with the repayment of an advance previously made to a third-party partner, and;

 

   

We received $33.8 million, net, of cash in connection with our share of the proceeds received from the divestiture of property owned by unconsolidated LLCs, as discussed above.

 

Additionally, the cash balance reflected on our Consolidated Balance Sheet as of December 31, 2011 was increased by an aggregate $4.2 million resulting from the consolidation of LLCs in which we purchased third-party minority ownership interests in noncontrolled, majority-owned LLCs.

 

Net cash used in financing activities

 

Net cash used in financing activities was $30.8 million during 2012 as compared to $7.4 million during 2011. The factors contributing to the $30.8 million of net cash used in financing activities during 2012 are detailed above.

 

The $7.4 million of net cash used in financing activities during 2011 consisted of: (i) generated $24.6 million of additional net borrowings on our revolving line of credit; (ii) generated $244,000 of net cash from the issuance of shares of beneficial interest; (iii) paid $30.7 million of dividends; (iv) paid $291,000 on mortgage and other notes payable that are non-recourse to us; (v) paid $1.1 million of financing costs related to a $150 million revolving credit agreement, executed in July, 2011, and; (vi) paid $162,000 as settlement of accrued dividend equivalent rights.

 

Additional cash flow and dividends paid information for 2013, 2012 and 2011:

 

As indicated on our consolidated statements of cash flows, we generated net cash provided by operating activities of $31.3 million during 2013, $30.8 million during 2012 and $21.4 million during 2011. As also indicated on our statements of cash flows, noncash expenses such as depreciation and amortization expense, amortization on debt premium, restricted stock-based compensation expense and provision for asset impairment, as well as the gains recorded during 2012 and 2011, are the primary differences between our net income and net cash provided by operating activities for each year. In addition, as reflected in the cash flows from investing

 

46


Table of Contents

activities section, we received $2.3 million during 2013, $3.2 million during 2012 and $5.2 million during 2011, of cash distributions in excess of income from various unconsolidated LLCs which represents our share of the net cash flow distributions from these entities. These cash distributions in excess of income represent operating cash flows net of capital expenditures and debt repayments made by the LLCs.

 

We generated $33.6 million during 2013, $34.0 million during 2012 and $26.6 million during 2011 related to the operating activities of our properties recorded on a consolidated and an unconsolidated basis. We paid dividends of $31.8 million during 2013, $31.2 million during 2012 and $30.7 million during 2011. During 2013, the $33.6 million of net cash generated related to the operating activities of our properties exceeded the $31.8 million of dividends paid by approximately $1.9 million. During 2012, the $34.0 million of net cash generated related to the operating activities of our properties exceeded the $31.2 million of dividends paid by approximately $2.8 million. During 2011, the $26.6 million of net cash generated related to operating activities of our properties was approximately $4.1 million less than the $30.7 million of dividends paid during 2011. The shortfall experienced during 2011 was attributable to the debt repayments and capital expenditures made by the unconsolidated LLCs during the year as well as operating factors as discussed above in Results of Operations.

 

As indicated in the cash flows from investing activities and cash flows from financing activities sections of the statements of cash flows, there were various other sources and uses of cash during each of the last three years. Therefore, the funding source for our dividend payments is not wholly dependent on the operating cash flow generated by our properties in any given period. Rather, our dividends, as well as our capital reinvestments into our existing properties, acquisitions of real property and other investments are funded based upon the aggregate net cash inflows or outflows from all sources and uses of cash from the properties we own either in whole or through LLCs, as outlined above.

 

In determining and monitoring our dividend level on a quarterly basis, our management and Board of Trustees consider many factors in determining the amount of dividends to be paid each period. These considerations primarily include: (i) the minimum required amount of dividends to be paid in order to maintain our REIT status; (ii) the current and projected operating results of our properties, including those owned in LLCs, and; (iii) our future capital commitments and debt repayments, including those of our LLCs. Based upon the information discussed above, as well as consideration of projections and forecasts of our future operating cash flows, management and the Board of Trustees have determined that our operating cash flows have been sufficient to fund our dividend payments. Future dividend levels will be determined based upon the factors outlined above with consideration given to our projected future results of operations.

 

Included in the various sources of cash were: (i) funds generated from the repayments of advances made from us to LLCs ($114,000 in 2013, $8.6 million in 2012 and $8.7 million in 2011); (ii) cash distributions of refinancing proceeds from LLCs of $2.1 million in 2011; (iii) net borrowings on our revolving credit agreement ($12.0 million during 2013, $4.6 million during 2012 and $23.5 million during 2011 net of $1.1 million of financing costs); (iv) repayment of advance made to third-party partners of $4.0 million during 2011, and; (v) issuance of shares of beneficial interest ($5.8 million during 2013, $350,000 during 2012 and $244,000 during 2011). In addition, during 2012 and 2011, funds were generated from the divestiture of property owned by unconsolidated LLCs, our share of which was $12.2 million and $33.8 million, respectively.

 

In addition to the dividends paid, the following were also included in the various uses of cash: (i) investments in LLCs ($3.0 million during each of 2013 and 2012 and $3.8 million during 2011); (ii) advances made to LLCs/third-party partners ($4.6 million during 2013, $8.0 million during 2012 and $11.5 million during 2011); (iii) additions to real estate investments and acquisitions of real property ($3.4 million in 2013, $4.0 million in 2012 and $776,000 in 2011); (iv) acquisitions of medical office buildings ($4.7 million in 2013, $16.9 million in 2012 and $39.6 million in 2011); (v) net repayments from mortgage, construction and third-party partners and other loans payable of consolidated MOBs and LLCs, net of financing costs ($3.3 million during 2013, $4.5 million during 2012 and $291,000 during 2011); (vi), deposits on real estate assets ($150,000 during 2013 and $634,000 during 2011, related primarily to the acquisitions of an MOB and a medical clinic which were

 

47


Table of Contents

completed in early 2014 and 2012, respectively), and; (vii) payments of assumed liabilities on acquired properties ($711,000 in 2012 and $621,000 in 2011). Additionally, during 2011, we had an additional use of cash consisting of $4.4 million for the purchase of minority interests in majority-owned LLCs, as previously discussed.

 

We expect to finance all capital expenditures and acquisitions and pay dividends utilizing internally generated and additional funds. Additional funds may be obtained through: (i) the issuance of equity pursuant to our at-the-market (“ATM”) equity issuance program (which has $43.5 million of gross proceeds remaining for issuance as of December 31, 2013); (ii) borrowings under our $150 million revolving credit facility (which has $47.6 million of available borrowing capacity, net of outstanding borrowings and letters of credit, as of December 31, 2013); (iii) borrowings under or refinancing of existing third-party debt pursuant to mortgage and construction loan agreements entered into by our LLCs, and/or; (iv) the issuance of other long-term debt.

 

We believe that our operating cash flows, cash and cash equivalents, available borrowing capacity under our revolving credit facility and equity issuance capacity pursuant to the terms of the ATM program, and access to the capital markets provide us with sufficient capital resources to fund our operating, investing and financing requirements for the next twelve months, including providing sufficient capital to allow us to make distributions necessary to enable us to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986. In the event we need to access the capital markets or other sources of financing, there can be no assurance that we will be able to obtain financing on acceptable terms or within an acceptable time. Our inability to obtain financing on terms acceptable to us could have a material unfavorable impact on our results of operations, financial condition and liquidity.

 

Credit facilities and mortgage debt

 

In July, 2011, we entered into a $150 million revolving credit agreement (“Credit Agreement”) which is scheduled to expire on July 24, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December 31, 2013, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.

 

At December 31, 2013, we had $93.7 million of outstanding borrowings and $8.7 million of letters of credit outstanding against our Credit Agreement. We had $47.6 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2013. There are no compensating balance requirements. The average amounts outstanding under our Credit Agreement were $86.3 million in 2013, $75.4 million in 2012 and $67.8 million in 2011 with corresponding effective interest rates, including commitment fees, of 2.2% in 2013, 2.4% in 2012 and 1.8% in 2011. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $93.7 million at December 31, 2013.

 

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December 31, 2013. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

 

48


Table of Contents

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2013
 

Tangible net worth

   $ 125,000      $ 144,848   

Debt to total capital

     < 55     36.0

Debt service coverage ratio

     > 4.00x        19.1x   

Debt to cash flow ratio

     < 3.50x        2.21x   

 

We have twelve mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December 31, 2013, with a combined outstanding balance of $105.5 million. The following table summarizes our outstanding mortgages at December 31, 2013 (amounts in thousands):

 

Facility Name

   Outstanding
Balance
(in thousands) (a)
     Interest
Rate
    Maturity
Date
 

Summerlin Hospital Medical Office Building I fixed rate mortgage loan(b)

   $ 9,188         6.55     2014   

Spring Valley Medical Office Building fixed rate mortgage loan

     5,122         5.50     2015   

Summerlin Hospital Medical Office Building III floating rate mortgage loan

     11,347         3.42     2016   

Peace Health fixed rate mortgage loan

     21,681         5.64     2017   

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

     12,021         5.50     2017   

Auburn Medical II floating rate mortgage loan

     7,406         2.92     2017   

Medical Center of Western Connecticut fixed rate mortgage loan

     4,899         6.00     2017   

Centennial Hills Medical Office Building floating rate mortgage loan

     10,938         3.42     2018   

Vibra Hospital of Corpus Christi fixed rate mortgage loan

     2,983         6.50     2019   

BRB Medical Office Building fixed rate mortgage loan

     6,840         4.27     2022   

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

     6,766         4.54     2022   

Tuscan Professional Building fixed rate mortgage loan

     6,262         5.56     2025   
  

 

 

      

Total

   $ 105,453        
  

 

 

      

 

(a) Amortized principal payments are made on a monthly basis.
(b) In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.

 

Contractual Obligations:

 

The following table summarizes the schedule of maturities of our outstanding borrowing under our revolving credit facility (“Credit Agreement”), the outstanding mortgages applicable to our properties recorded on a consolidated basis and our other contractual obligations as of December 31, 2013 (amounts in thousands):

 

     Payments Due by Period (dollars in thousands)  

Debt and Contractual Obligation

   Total      Less than 1 Year      1-3 years      3-5 years      More than
5 years
 

Long-term non-recourse debt-fixed(a)(b)

   $ 75,762       $ 11,042       $ 8,503       $ 37,887       $ 18,330   

Long-term non-recourse debt-variable(a)(b)

     29,691         852         12,140         16,699         —     

Long-term debt-variable(c)

     93,700         —           93,700         —           —     

Estimated future interest payments on debt outstanding as of December 31, 2013(d)

     22,214         6,922         9,329         3,275         2,688   

Equity and debt financing commitments(e)

     7,499         7,499         —           —           —     
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total contractual obligations

   $ 228,866       $ 26,315       $ 123,672       $ 57,861       $ 21,018   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

49


Table of Contents

 

(a) The mortgages are secured by the real property of the buildings as well as property leases and rents. Property-specific debt is detailed above.
(b) Consists of non-recourse debt with a fair value of approximately $106.4 million as of December 31, 2013. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow. Excludes $80.1 million of combined third-party debt outstanding as of December 31, 2013, that is non-recourse to us, at the unconsolidated LLCs in which we hold various non-controlling ownership interests (see Note 8 to the consolidated financial statements).
(c) Consists of $93.7 million of borrowings outstanding as of December 31, 2013 under the terms of our $150 million Credit Agreement which matures on July 24, 2015. The amount outstanding approximates fair value as of December 31, 2013.
(d) Assumes that all debt outstanding as of December 31, 2013, including borrowings under the Credit Agreement, and the twelve loans, which are non-recourse to us, remain outstanding until the stated maturity date of the debt agreements at the same interest rates which were in effect as of December 31, 2013. We have the right to repay borrowings under the Credit Agreement and term loans at any time during the terms of the agreements, without penalty. Interest payments are expected to be paid utilizing cash flows from operating activities or borrowings under our revolving Credit Agreement.
(e) As of December 31, 2013, we have equity investment and debt financing commitments remaining in connection with our investments in various LLCs. As of December 31, 2013, we had outstanding letters of credit which secured the majority of these equity and debt financing commitments. The $47.6 million of available borrowing capacity as of December 31, 2013, pursuant to the terms of our Credit Agreement, is net of the standby letters of credit outstanding at that time. Our remaining financing commitments are as follows (in thousands):

 

     Amount  

Palmdale Medical Properties

   $ 2,756   

Grayson Properties

     2,250   

FTX MOB Phase II

     1,336   

Arlington Medical Properties

     1,157   
  

 

 

 

Total

   $ 7,499   
  

 

 

 

 

Off Balance Sheet Arrangements

 

As of December 31, 2013, we are party to certain off balance sheet arrangements consisting of standby letters of credit and equity and debt financing commitments as detailed on the above “Contractual Obligations” table. Our outstanding letters of credit at December 31, 2013 totaled $8.7 million consisting of: (i) $2.2 million related to Centennial Hills Medical Properties; (ii) $2.2 million related to Grayson Properties: (iii) $1.3 million related to Palmdale Medical Properties; (iv) $1.3 million related to Banburry Medical Properties; (v) $1.2 million related to FTX MOB Phase II; and (vi) $478,000 related to Arlington Medical Properties.

 

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk

 

Market Risks Associated with Financial Instruments

 

As of December 31, 2013, 2012, and 2011, we had no material outstanding interest rate swap agreements.

 

During the third quarter of 2013, we entered into an interest rate cap on a total notional amount of $10 million whereby we paid a premium of $136,000. Subsequent to the end of 2013, during the first quarter of 2014, we entered into two additional interest rate cap agreements on a total notional amount of $20 million whereby we paid premiums of $134,500. In exchange for the premium payments, the counterparties agreed to pay us the difference between 1.50% and one-month LIBOR if one-month LIBOR rises above 1.50% during the term of the cap. The caps expire on January 13, 2017.

 

50


Table of Contents

The sensitivity analysis related to our fixed and variable rate debt assumes current market rates with all other variables held constant. The fair value of our debt is approximately $200 million. The difference between actual amounts outstanding and fair value is approximately $941,000.

 

The table below presents information about our financial instruments that are sensitive to changes in interest rates, including debt obligations as of December 31, 2013. For debt obligations, the table presents principal cash flows and related weighted average interest rates by contractual maturity dates.

 

     Maturity Date, Year Ending December 31  

(Dollars in thousands)

   2014     2015     2016     2017     2018     Thereafter     Total  

Long-term debt:

          

Fixed rate:

          

Debt(a)

   $ 11,042      $ 6,665      $ 1,838      $ 36,886      $ 1,001      $ 18,330      $ 75,762   

Average interest rates

     5.6     5.4     5.5     5.1     5.0     4.9     5.2

Variable rate:

          

Debt(b)

   $ 852      $ 94,580      $ 11,260      $ 7,028      $ 9,671      $ —        $ 123,391   

Average interest rates

     2.4     2.5     3.3     3.5     3.4     —          3.0

Interest rate caps:

          

Notional amount(c)

   $ —        $ —        $ —        $ 30,000      $ —        $ —        $ 30,000   

Interest rates

           1.5      

 

(a) Consists of non-recourse mortgage notes payable.
(b) Includes $29.7 million of non-recourse mortgage notes payable and of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
(c) Includes two interest rate cap agreements entered into during the first quarter of 2014 on a total notional amount of $20 million, as discussed above.

 

As calculated based upon our variable rate debt outstanding as of December 31, 2013 that is subject to interest rate fluctuations, each 1% change in interest rates would impact our net income by approximately $1.8 million.

 

ITEM 8. Financial Statements and Supplementary Data

 

Our Consolidated Balance Sheets, Consolidated Statements of Income, Changes in Equity and Cash Flows, together with the report of KPMG LLP, an independent registered public accounting firm, are included elsewhere herein. Reference is made to the “Index to Financial Statements and Schedule.”

 

ITEM 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

 

None.

 

ITEM 9A. Controls and Procedures

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

As of December 31, 2013, under the supervision and with the participation of our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), we performed an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Securities and Exchange Act of 1934, as amended (the “1934 Act”). Based on this evaluation, the CEO and CFO have concluded that our disclosure controls and procedures are effective to ensure that material information is recorded, processed, summarized and reported by management on a timely basis in order to comply with our disclosure obligations under the Securities and Exchange Act of 1934 and the SEC rules thereunder.

 

51


Table of Contents

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting or in other factors during the fourth quarter of 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Management’s Report on Internal Control Over Financial Reporting

 

Management is responsible for establishing and maintaining an adequate system of internal control over our financial reporting. In order to evaluate the effectiveness of internal control over financial reporting, as required by Section 404 of the Sarbanes-Oxley Act, management has conducted an assessment, including testing, using the criteria in Internal Control—Integrated Framework (1992), issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation and fair presentation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness of internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Based on its assessment, management has concluded that we maintained effective internal control over financial reporting as of December 31, 2013, based on criteria in Internal Control—Integrated Framework (1992), issued by the COSO. The effectiveness of our internal control over financial reporting as of December 31, 2013 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein.

 

52


Table of Contents

Report of Independent Registered Public Accounting Firm

 

The Shareholders and Board of Trustees

Universal Health Realty Income Trust:

 

We have audited Universal Health Realty Income Trust’s internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control—Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Universal Health Realty Income Trust’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, Universal Health Realty Income Trust maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control—Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Universal Health Realty Income Trust and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2013, and our report dated March 7, 2014 expressed an unqualified opinion on those consolidated financial statements.

 

(signed) KPMG LLP

 

Philadelphia, Pennsylvania

March 7, 2014

 

53


Table of Contents
ITEM 9B. Other Information

 

None.

 

PART III

 

ITEM 10. Directors, Executive Officers and Corporate Governance

 

There is hereby incorporated by reference the information to appear under the captions “Proposal No. 1” (Election of Trustees), “Section 16(a) Beneficial Ownership Reporting Compliance” and “Corporate Governance” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2013. See also “Executive Officers of the Registrant” appearing in Item 1 hereof.

 

ITEM 11. Executive Compensation

 

There is hereby incorporated by reference information to appear under the caption “Executive Compensation” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2013.

 

ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

There is hereby incorporated by reference the information to appear under the caption “Security Ownership of Certain Beneficial Owners and Management” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2013.

 

ITEM 13. Certain Relationships and Related Transactions, and Director Independence

 

There is hereby incorporated by reference the information to appear under the captions “Certain Relationships and Related Transactions” and “Corporate Governance” in our Proxy Statement to be filed with the Securities and Exchange Commission within 120 days after December 31, 2013.

 

ITEM 14. Principal Accounting Fees and Services

 

There is hereby incorporated herein by reference the information to appear under the caption “Relationship with Independent Registered Public Accounting Firm” in our Proxy Statement, to be filed with the Securities and Exchange Commission within 120 days after December 31, 2013.

 

54


Table of Contents

PART IV

 

ITEM 15. Exhibits, Financial Statement Schedules

 

(a) Documents filed as part of this report:

 

  (1) Financial Statements: See “Index to Financial Statements and Schedule”

 

  (2) Financial Statement Schedules: See “Index to Financial Statements and Schedule”

 

  (3) Exhibits:

 

3.1 Declaration of Trust, dated as of August 1986, previously filed as Exhibit 4.1 to the Trust’s Registration Statement on Form S-3 (File No. 333-60638) is incorporated herein by reference.

 

3.2 Amendment to Declaration of Trust, dated as of June 15, 1993, previously filed as Exhibit 4.2 to the Trust’s Registration Statement on Form S-3 (File No. 333-60638) is incorporated herein by reference.

 

3.3 Amended and restated bylaws previously filed as Exhibit 4.3 to the Trust’s registration statement on Form S-3 (File No. 333-60638) is incorporated herein by reference.

 

3.4 Amendment to the bylaws, effective as of September 6, 2013, previously filed as Exhibit 3.2 to the Trust’s Current Report on Form 8-K dated September 6, 2013, is incorporated herein by reference.

 

10.1 Advisory Agreement, dated as of December 24, 1986, between UHS of Delaware, Inc. and the Trust, previously filed as Exhibit 10.2 to the Trust’s Current Report on Form 8-K dated December 24, 1986, is incorporated herein by reference.

 

10.2 Agreement dated December 6, 2013, to renew Advisory Agreement dated as of December 24, 1986 between Universal Health Realty Income Trust and UHS of Delaware, Inc. is filed herewith.

 

10.3 Contract of Acquisition, dated as of August 1986, between the Trust and certain subsidiaries of Universal Health Services, Inc., previously filed as Exhibit 10.2 to Amendment No. 3 of the Registration Statement on Form S-11 and S-2 of Universal Health Services, Inc. and the Trust (File No. 33-7872), is incorporated herein by reference.

 

10.4 Form of Leases, including Form of Master Lease Document Leases, between certain subsidiaries of Universal Health Services, Inc. and the Trust, previously filed as Exhibit 10.3 to Amendment No. 3 of the Registration Statement on Form S-11 and Form S-2 of Universal Health Services, Inc. and the Trust (File No. 33-7872), is incorporated herein by reference.

 

10.5 Corporate Guaranty of Obligations of Subsidiaries Pursuant to Leases and Contract of Acquisition, dated December 1986, issued by Universal Health Services, Inc. in favor of the Trust, previously filed as Exhibit 10.5 to the Trust’s Current Report on Form 8-K dated December 24, 1986, is incorporated herein by reference.

 

10.6 Lease, dated December 22, 1993, between the Trust and THC-Chicago, Inc., as lessee, previously filed as Exhibit 10.14 to the Trust’s Annual Report on Form 10-K for the year ended December 31, 1993, is incorporated herein by reference.

 

10.7* Universal Health Realty Income Trust 1997 Incentive Plan, previously filed as Exhibit 10.1 to the Trust’s Form 10-Q for the quarter ended September 30, 1997, is incorporated herein by reference.

 

10.8 Credit Agreement, dated as of July 25, 2011, by and among the Trust, the financial institutions from time to time party thereto and Wells Fargo Bank, National Association, as Administrative Agent, Bank of America, N.A., as Syndication Agent and Fifth Third Bank, N.A., JPMorgan Chase Bank, N.A. and SunTrust Bank as Co-Documentation Agents, previously filed as Exhibit 10.1 to the Trust’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, is incorporated herein by reference.

 

55


Table of Contents

10.9 Dividend Reinvestment and Share Purchase Plan included in the Trust’s Registration Statement on Form S-3 (Registration No. 333-81763) filed on June 28, 1999, is incorporated herein by reference.

 

10.10 Asset Exchange and Substitution Agreement, dated as of April 24, 2006, by and among the Trust and Universal Health Services, Inc. and certain of its subsidiaries, previously filed as Exhibit 10.1 to the Trust’s Current Report on Form 8-K dated April 25, 2006, is incorporated herein by reference.

 

10.11 Amendment No. 1 to the Master Lease Document, between certain subsidiaries of Universal Health Services, Inc. and the Trust, previously filed as Exhibit 10.2 to the Trust’s Current Report on Form 8-K dated April 25, 2006, is incorporated herein by reference.

 

10.12* Universal Health Realty Income Trust 2007 Restricted Stock Plan, previously filed as Exhibit 10.1 to the Trust’s Current Report on Form 8-K, dated April 27, 2007, is incorporated herein by reference.

 

10.13* Form of Restricted Stock Agreement, previously filed as Exhibit 10.2 to the Trust’s Current Report on Form 8-K dated April 27, 2007, is incorporated herein by reference.

 

10.14 ATM Equity OfferingSM Sales Agreement, dated November 8, 2013, among the Trust, UHS of Delaware, Inc., and Merrill Lynch, Pierce, Fenner & Smith Incorporated, previously filed as Exhibit 1.1 to the Trust’s Current Report on Form 8-K dated November 8, 2013, is incorporated herein by reference.

 

11 Statement re computation of per share earnings is set forth on the Consolidated Statements of Income.

 

21 Subsidiaries of Registrant, filed herewith.

 

23.1 Consent of Independent Registered Public Accounting Firm, filed herewith.

 

31.1 Certification from the Trust’s Chief Executive Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, filed herewith.

 

31.2 Certification from the Trust’s Chief Financial Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, filed herewith.

 

32.1 Certification from the Trust’s Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.

 

32.2 Certification from the Trust’s Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.

 

101.INS XBRL Instance Document, filed herewith.

 

101.SCH XBRL Taxonomy Extension Schema Document, filed herewith.

 

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document, filed herewith.

 

101.DEF XBRL Taxonomy Extension Definition Linkbase Document, filed herewith.

 

101.LAB XBRL Taxonomy Extension Label Linkbase Document, filed herewith.

 

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document, filed herewith.

 

* Management contract or compensatory plan or arrangement.

 

Exhibits, other than those incorporated by reference, have been included in copies of this Annual Report filed with the Securities and Exchange Commission. Shareholders of the Trust will be provided with copies of those exhibits upon written request to the Trust.

 

56


Table of Contents

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

UNIVERSAL HEALTH REALTY INCOME TRUST

By:

 

/S/    ALAN B. MILLER        

 

Alan B. Miller,

Chairman of the Board,

Chief Executive Officer and President

 

Date: March 7, 2014

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signatures

  

Title

 

Date

/S/    ALAN B. MILLER        

Alan B. Miller

  

Chairman of the Board, Chief

Executive Officer and President

(Principal Executive Officer)

  March 7, 2014

/S/    JAMES E. DALTON, JR.        

James E. Dalton, Jr.

   Trustee   March 7, 2014

/S/    MILES L. BERGER        

Miles L. Berger

   Trustee   March 7, 2014

/S/    ELLIOT J. SUSSMAN        

Elliot J. Sussman, M.D., M.B.A.

   Trustee   March 7, 2014

/S/    ROBERT F. MCCADDEN        

Robert F. McCadden

   Trustee   March 7, 2014

/S/    MARC D. MILLER        

Marc D. Miller

   Trustee   March 7, 2014

/S/    CHARLES F. BOYLE        

Charles F. Boyle

  

Vice President and Chief Financial Officer

(Principal Financial and Accounting

Officer)

  March 7, 2014

 

57


Table of Contents

INDEX TO FINANCIAL STATEMENTS AND SCHEDULE

 

     Page  

Consolidated Financial Statements:

  

Report of Independent Registered Public Accounting Firm on Consolidated Financial Statements and Schedule

     59   

Consolidated Balance Sheets—December 31, 2013 and December 31, 2012

     60   

Consolidated Statements of Income—Years Ended December 31, 2013, 2012 and 2011

     61   

Consolidated Statements of Changes in Equity—Years Ended December 31, 2013, 2012 and 2011

     62   

Consolidated Statements of Cash Flows—Years Ended December 31, 2013, 2012 and 2011

     63   

Notes to the Consolidated Financial Statements—December 31, 2013

     64   

Schedule III—Real Estate and Accumulated Depreciation—December 31, 2013

     89   

Notes to Schedule III—December 31, 2013

     90   

 

58


Table of Contents

Report of Independent Registered Public Accounting Firm

 

The Shareholders and Board of Trustees

Universal Health Realty Income Trust:

 

We have audited the accompanying consolidated balance sheets of Universal Health Realty Income Trust and subsidiaries as of December 31, 2013 and 2012, and the related consolidated statements of income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2013. In connection with our audits of the consolidated financial statements, we also have audited financial statement schedule III real estate and accumulated depreciation. These consolidated financial statements and financial statement schedule III are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Universal Health Realty Income Trust and subsidiaries as of December 31, 2013 and 2012, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2013, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related financial statement schedule III real estate and accumulated depreciation when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Universal Health Realty Income Trust’s internal control over financial reporting as of December 31, 2013, based on criteria established in Internal Control – Integrated Framework (1992) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated March 7, 2014 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

 

(signed) KPMG LLP

 

Philadelphia, Pennsylvania

March 7, 2014

 

59


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED BALANCE SHEETS

(dollar amounts in thousands)

 

     December 31,
2013
    December 31,
2012
 

Assets:

    

Real Estate Investments:

  

 

Buildings and improvements

   $ 368,295      $ 374,416   

Accumulated depreciation

     (97,921     (87,088
  

 

 

   

 

 

 
     270,374        287,328   

Land

     27,374        27,058   
  

 

 

   

 

 

 

Net Real Estate Investments

     297,748        314,386   
  

 

 

   

 

 

 

Investments in and advances to limited liability companies (“LLCs”)

     39,201        28,636   

Other Assets:

    

Cash and cash equivalents

     3,337        3,048   

Base and bonus rent receivable from UHS

     2,053        2,041   

Rent receivable—other

     3,310        2,783   

Intangible assets (net of accumulated amortization of $13.7 million and $8.2 million at December 31, 2013 and December 31, 2012, respectively)

     20,782        26,293   

Deferred charges, goodwill and other assets, net

     6,714        5,851   
  

 

 

   

 

 

 

Total Assets

   $ 373,145      $ 383,038   
  

 

 

   

 

 

 

Liabilities:

    

Line of credit borrowings

   $ 93,700      $ 81,750   

Mortgage and other notes payable, non-recourse to us (including net debt premium of $834,000 and $1.3 million at December 31, 2013 and December 31, 2012, respectively)

     106,287        116,186   

Accrued interest

     491        539   

Accrued expenses and other liabilities

     5,156        4,920   

Tenant reserves, escrows, deposits and prepaid rents

     1,881        1,898   
  

 

 

   

 

 

 

Total Liabilities

     207,515        205,293   
  

 

 

   

 

 

 

Equity:

    

Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding

     0        0   

Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2013—12,858,643 2012 -12,688,998

     128        127   

Capital in excess of par value

     220,691        214,094   

Cumulative net income

     480,044        466,875   

Cumulative dividends

     (535,176     (503,425

Accumulated other comprehensive loss

     (57     0   
  

 

 

   

 

 

 

Total Universal Health Realty Income Trust Shareholders’ Equity

     165,630        177,671   

Non-controlling equity interest

     0        74   
  

 

 

   

 

 

 

Total Equity

     165,630        177,745   
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 373,145      $ 383,038   
  

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

60


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF INCOME

(amounts in thousands, except per share amounts)

 

     Year ended December 31,  
     2013     2012     2011  

Revenues:

      

Base rental—UHS facilities

   $ 14,773      $ 15,438      $ 13,150   

Base rental—Non-related parties

     27,955        27,213        10,392   

Bonus rental—UHS facilities

     4,260        4,142        4,191   

Tenant reimbursements and other—Non-related parties

     6,812        6,674        1,654   

Tenant reimbursements and other—UHS facilities

     480        483        107   
  

 

 

   

 

 

   

 

 

 
     54,280        53,950        29,494   
  

 

 

   

 

 

   

 

 

 

Expenses:

      

Depreciation and amortization

     18,753        20,216        7,306   

Advisory fees to UHS

     2,369        2,119        2,008   

Other operating expenses

     14,409        14,575        5,581   

Transaction costs

     203        680        518   

Provision for asset impairment

     0        0        5,354   
  

 

 

   

 

 

   

 

 

 
     35,734        37,590        20,767   
  

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated limited liability companies (“LLCs”), interest expense and gains, net

     18,546        16,360        8,727   

Equity in income of unconsolidated LLCs

     2,095        2,365        3,058   

Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs, net

     0        0        28,576   

Gain on divestitures of properties owned by unconsolidated LLCs, net

     0        8,520        35,835   

Interest expense, net

     (7,472     (7,768     (2,402
  

 

 

   

 

 

   

 

 

 

Net income

   $ 13,169      $ 19,477      $ 73,794   
  

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 1.04      $ 1.54      $ 5.84   
  

 

 

   

 

 

   

 

 

 

Diluted earnings per share

   $ 1.04      $ 1.54      $ 5.83   
  

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding—Basic

     12,689        12,661        12,644   

Weighted average number of share equivalents

     12        8        5   
  

 

 

   

 

 

   

 

 

 

Weighted average number of shares and equivalents outstanding—Diluted

     12,701        12,669        12,649   
  

 

 

   

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

61


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

For the Years Ended December 31, 2013, 2012 and 2011

(amounts in thousands, except per share amounts)

 

     Common Shares      Capital in
excess of
par value
    Cumulative
net income
     Cumulative
dividends
    Accumulated  other
comprehensive
loss
    UHT
Shareholders’
Equity
    Non-controlling
Interests
    Total
Equity
 
     Number
of Shares
     Amount                  

January 1, 2011

     12,653       $ 127       $ 213,209      $ 373,604       ($ 441,527     —        $ 145,413      $ 97      $ 145,510   

Shares of Beneficial Interest:

                     

Issued

     14         —           238        —           —          —          238        —          238   

Partial settlement of dividend equivalent rights

     —           —           (162     —           —          —          (162     —          (162

Restricted stock-based compensation expense

     —           —           269        —           —          —          269        —          269   

Stock-based compensation expense

     —           —           12        —           —          —          12        —          12   

Dividends ($2.425/share)

     —           —           —          —           (30,703     —          (30,703     —          (30,703

Comprehensive income:

                     

Net income

     —           —           —          73,794         —          —          73,794        (13     73,781   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

January 1, 2012

     12,667         127         213,566        447,398         (472,230     —          188,861        84        188,945   

Shares of Beneficial Interest:

                     

Issued

     22         —           305        —           —          —          305        —          305   

Partial settlement of dividend equivalent rights

     —           —           (106     —           —          —          (106     —          (106

Restricted stock-based compensation expense

     —           —           329        —           —          —          329        —          329   

Dividends ($2.46/share)

     —           —           —          —           (31,195     —          (31,195     —          (31,195

Comprehensive income:

                     

Net income

     —           —           —          19,477         —          —          19,477        (10     19,467   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

January 1, 2013

     12,689         127         214,094        466,875         (503,425     —          177,671        74        177,745   

Shares of Beneficial Interest:

                     

Issued

     170         1         6,323        —           —          —          6,324        —          6,324   

Partial settlement of dividend equivalent rights

     —           —           (101     —           —          —          (101     —          (101

Restricted stock-based compensation expense

     —           —           375        —           —          —          375        —          375   

Dividends ($2.495/share)

     —           —           —          —           (31,751     —          (31,751     —          (31,751

Deconsolidation of LLC

     —           —           —          —           —          —          —          (74     (74

Comprehensive income:

                     

Net income

     —           —           —          13,169         —          —          13,169          13,169   

Unrealized loss on interest rate cap

     —           —           —          —           —          (57     (57     —          (57
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Subtotal—comprehensive income

             13,169           (57     13,112        0        13,112   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

December 31, 2013

     12,859       $ 128       $ 220,691      $ 480,044       ($ 535,176   ($ 57   $ 165,630      $ 0      $ 165,630   
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

See the accompanying notes to these consolidated financial statements.

 

62


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(amounts in thousands)

 

    Year ended December 31,  
    2013     2012     2011  

Cash flows from operating activities:

     

Net income

  $ 13,169      $ 19,477      $ 73,794   

Adjustments to reconcile net income to net cash provided by operating activities:

     

Depreciation and amortization

    18,843        20,216        7,306   

Amortization on debt premium

    (433     (657     (96

Provision for asset impairment

    0        0        5,354   

Restricted stock-based compensation expense

    375        329        281   

Gain on purchase of minority interests in majority-owned LLCs before transaction costs

    0        0        (28,877

Gains on divestiture of properties owned by unconsolidated LLCs before transaction costs

    0        (8,520     (36,300

Changes in assets and liabilities:

     

Rent receivable

    (746     (862     (455

Accrued expenses and other liabilities

    523        278        221   

Tenant reserves, escrows, deposits and prepaid rents

    16        207        4   

Accrued interest

    (22     66        39   

Other, net

    (431     249        101   
 

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

    31,294        30,783        21,372   
 

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

     

Investments in LLCs

    (3,013     (2,973     (3,788

Repayments of advances made to LLCs

    114        8,551        8,718   

Advances made to LLCs

    (4,580     (8,000     (11,541

Cash distributions in excess of income from LLCs

    2,346        3,169        5,260   

Cash distributions of refinancing proceeds from LLCs

    0        0        2,111   

Repayment of advance made to third-party partners

    0        0        3,967   

Additions to real estate investments

    (3,415     (3,985     (776

Deposits on real estate assets

    (150     100        (634

Net cash paid for acquisition of medical office buildings

    (4,675     (16,891     (39,578

Payment of assumed liabilities on acquired properties

    0        (711     (621

Cash paid to acquire minority interests in majority-owned LLCs

    0        0        (4,408

Cash proceeds received from divestiture of property owned by unconsolidated LLCs, net

    0        12,175        33,836   

Increase in cash and cash equivalents due to recording of LLCs on a consolidated basis

    0        0        4,170   

Decrease in cash and cash equivalents due to deconsolidation of LLCs

    (141     0        0   
 

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

    (13,514     (8,565     (3,284
 

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

     

Net borrowings on line of credit

    11,950        4,600        24,550   

Proceeds from mortgages and other notes payable

    11,150        14,000        0   

Repayments of mortgages and other notes payable

    (14,401     (18,084     (291

Financing costs paid, new Revolving Credit Facility

    0        0        (1,064

Financing costs paid on mortgage and other notes payable

    (95     (384     0   

Dividends paid

    (31,751     (31,195     (30,703

Partial settlement of dividends equivalent rights

    (101     (106     (162

Issuance of shares of beneficial interest, net

    5,757        350        244   
 

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

    (17,491     (30,819     (7,426
 

 

 

   

 

 

   

 

 

 

Increase/(decrease) in cash and cash equivalents

    289        (8,601     10,662   

Cash and cash equivalents, beginning of period

    3,048        11,649        987   
 

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of period

  $ 3,337      $ 3,048      $ 11,649   
 

 

 

   

 

 

   

 

 

 

Supplemental disclosures of cash flow information:

     

Interest paid

  $ 7,517      $ 7,994      $ 2,216   
 

 

 

   

 

 

   

 

 

 

Supplemental disclosures of non-cash transactions:

     

Debt assumed on acquisition of real estate

  $ 0      $ 22,441      $ 6,999   
 

 

 

   

 

 

   

 

 

 

Deconsolidation (2013) and consolidation (2011) of LLCs:

     

Net real estate investments

  $ 11,597      $ 0      $ 133,080   

Cash and cash equivalents

    141        0        4,170   

Intangible assets

    0        0        20,890   

Rent receivable—other

    207        0        687   

Other assets

    135        0        2,944   

Mortgage and note payable, non-recourse to us

    (6,215     0        (76,111

Other liabilities

    (368     0        (3,025

Third-party equity interests

    (54     0        0   

Gain on purchase of minority interests in majoriyt-owned LLCs

    0        0        (28,877
 

 

 

   

 

 

   

 

 

 

Investment in LLCs

  $ 5,443      $ 0      ($ 53,758
 

 

 

   

 

 

   

 

 

 

 

See accompanying notes to these consolidated financial statements.

 

63


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2013

 

(1)   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Universal Health Realty Income Trust and subsidiaries (the “Trust”) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings. As of February 28, 2014, we have fifty-eight real estate investments or commitments located in sixteen states consisting of:

 

   

seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;

 

   

forty-seven medical office buildings, including eleven owned by unconsolidated limited liability companies (“LLCs”), and;

 

   

four preschool and childcare centers.

 

Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

 

Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management’s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.

 

Revenue Recognition

 

Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (“MOBs”) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current

 

64


Table of Contents

quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

 

Real Estate Investments

 

On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December 31, 2013, and will be amortized over the remaining lease terms (aggregate weighted average of 3.5 years) and will result in an estimated aggregate amortization expense of $4.6 million, $3.9 million, $3.4 million $2.9 million and $1.7 million for 2014, 2015, 2016, 2017 and 2018, respectively. Amortization expense on intangible values of in place leases was $6.0 million for the year ended December 31, 2013, $7.8 million for the year ended December 31, 2012 and $836,000 for the year ended December 31, 2011. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $12.5 million for the year ended December 31, 2013, $12.2 million for the year ended December 31, 2012 and $6.3 million for the year ended December 31, 2011.

 

Cash and Cash Equivalents

 

We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.

 

Asset Impairment

 

Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million in connection with an MOB located on a medical campus in Atlanta, Georgia. The asset impairment charge was recorded after evaluation of property and location-specific factors including pressure on rental and occupancy rates caused, in part, by the impact of continued unfavorable economic conditions in the market as well as competitive pressures caused by increased capacity added to the market. The fair value of this property was determined based upon the present value of the expected future cash flows.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the

 

65


Table of Contents

decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

 

Investments in Limited Liability Companies (“LLCs”)

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings (including Palmdale Medical Properties, LLC and Sparks Medical Properties, LLC which, as discussed below, we purchased the minority ownership interests effective January 1, 2014 and now hold 100% of the ownership interests of these entities). As of December 31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013. As discussed below, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.

 

The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

Palmdale Medical Properties had a master lease with a subsidiary of UHS through June 30, 2013. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS (through UHS of Delaware, Inc.). As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we have accounted for this LLC on a consolidated basis, since its inception in the fourth quarter of 2007 through June 30, 2013, since it was a variable interest entity and we were deemed to be the primary beneficiary. As of July 1, 2013, the master lease expired and this LLC is no longer considered a variable interest entity and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013. The expiration of the master lease and related deconsolidation did not have a material impact on our net income and funds from operations during the second half of 2013.

 

As a result of master lease arrangements between UHS and various LLCs in which we hold or held majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB’s standards and guidance.

 

66


Table of Contents

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs and will begin accounting for them on a consolidated basis effective January 1, 2014. Each of the property’s assets and liabilities will be recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). We do not expect these transactions or the expected related aggregate gain (to be recorded during the first quarter of 2014) to have a material impact on our future results of operations.

 

In addition, effective December 12, 2011, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as discussed herein (see Notes 3 and 8 to the consolidated financial statements for additional disclosure).

 

Federal Income Taxes

 

No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.

 

The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $382 million and $256 million, respectively, at December 31, 2013.

 

Stock-Based Compensation

 

We expense the grant-date fair value of stock options and restricted stock awards over the vesting period. We recognize the grant-date fair value of stock options and other equity-based compensation and account for these transactions using the fair-value based method. We use the Black-Scholes model as our option pricing model for determining the grant-date fair value of our stock options.

 

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.

 

Fair Value

 

Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified

 

67


Table of Contents

within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.

 

The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.

 

The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.

 

See Note 3-Acquisitions and Dispositions, for disclosure related to the $28.6 million net gain recorded during 2011 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

New Accounting Standards

 

Except as noted below, there were no new accounting pronouncements during 2013 that impacted, or are expected to impact, us.

 

In February, 2013, the Financial Accounting Standards Board issued an Accounting Standards Update on reporting of amounts reclassified out of accumulated other comprehensive income. This guidance, which is effective for fiscal years beginning after December 31, 2012, required companies to provide information about amounts reclassified out of accumulated other comprehensive income by component (the respective line items of the income statement). The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.

 

In July 2013, the Financial Accounting Standards Board (FASB) issued guidance allowing the use of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a benchmark interest rate for hedge accounting purposes in addition to interest rates on direct Treasury obligations of the United States government and the LIBOR. In addition, the guidance removes the restriction on using different benchmark rates for similar hedges. The guidance became effective on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013, and did not have a material impact in the consolidated financial results.

 

68


Table of Contents
(2)   RELATIONSHIP WITH UHS AND RELATED PARTY TRANSACTIONS

 

Leases:    We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

 

The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 41% of our total revenue for the five years ended December 31, 2013 (approximately 30% for each of the years ended December 31, 2013 and 2012, and 55% for the year ended December 31, 2011). The decrease during 2013 and 2012 as compared to 2011 is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December 31, 2013 (approximately 22% for the year ended December 31, 2013, 21% for the year ended December 31, 2012 and 19% for the year ended December 31, 2011). In addition, twelve MOBs, that are either wholly or jointly-owned, include or will include tenants which are subsidiaries of UHS.

 

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value.

 

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

The Bridgeway

   Behavioral Health    $ 930,000         December, 2014         10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).

 

69


Table of Contents

Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. The Bridgeway’s lease term is scheduled to end in December, 2014. We can provide no assurance that this lease will be renewed at the fair market value lease rate.

 

As discussed above, Palmdale Medical Plaza, which is located in Palmdale, California, on the campus of a UHS hospital, had a master lease commitment by a wholly-owned subsidiary of UHS which expired on June 30, 2013. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. The LLC that owns this MOB was deemed to be a variable interest entity during the term of the master lease and was therefore consolidated in our financial statements through June 30, 2013 since we were the primary beneficiary through that date. Effective July 1, 2013, this LLC is no longer be deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs (which own MOBs) and will begin accounting for them on a consolidated basis effective January 1, 2014.

 

We have funded $2.1 million in equity as of December 31, 2013, and are committed to fund an additional $2.3 million, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a UHS acute care hospital which is owned and operated by Texoma Medical Center (“Texoma Hospital”), a wholly-owned subsidiary of UHS. This MOB has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $12.5 million, which is non-recourse to us, outstanding as of December 31, 2013. As this LLC is not considered to be a variable interest entity and does not meet the other criteria requiring consolidation of an investment, it is accounted for pursuant to the equity method.

 

Advisory Agreement:    UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. In December of 2013, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2014 pursuant to the same terms as the Advisory Agreement in place during 2013. In December of 2012, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the 2013 advisory fee, as compared to the 2012 advisory fee, was increased to 0.70% (from 0.65%) of our average invested real estate assets, as derived from our consolidated balance sheet.

 

The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an

 

70


Table of Contents

annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2013, 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.4 million during 2013, $2.1 million during 2012 and $2.0 million during 2011 and were based upon average invested real estate assets of $338 million, $326 million and $309 million during 2013, 2012 and 2011, respectively.

 

Officers and Employees:    Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2013 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time special compensation awards in the form of restricted stock and/or cash bonuses.

 

Share Ownership:    As of December 31, 2013 and 2012, UHS owned 6.1% and 6.2%, respectively, of our outstanding shares of beneficial interest.

 

SEC reporting requirements of UHS:    UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 30% of our consolidated revenues for each of the years ended December 31, 2013 and 2012, and 55% of our consolidated revenues for the year ended December 31, 2011, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

 

(3)   ACQUISITIONS AND DISPOSITIONS

 

2014:

 

Acquisitions:

 

In January, 2014, we purchased the following in a single transaction:

 

   

The Children’s Clinic at Springdale – a 9,800 square foot, single-tenant medical office building located in Springdale, Arkansas, and;

 

   

The Northwest Medical Center at Sugar Creek – a 16,700 square foot, multi-tenant medical office building located in Bentonville, Arkansas.

 

The aggregate purchase price for these MOBs was approximately $7.2 million. The net tangible and intangible property preliminary asset allocation of the total purchase price will be recorded during the first quarter of 2014, subject to a third-party fair market valuation.

 

Additionally, effective January 1, 2014, we purchased the minority ownership interests held by third-party members in two LLCs in which we previously held noncontrolling majority ownership interests (Palmdale Medical Properties and Sparks Medical Properties). As a result of these minority ownership purchases, we now own 100% of each of these LLCs and will begin accounting for each on a consolidated basis effective January 1, 2014. The aggregate cash payment made by us during the first quarter of 2014 in connection with the purchase of these minority ownership interests was approximately $170,000. Each of the property’s assets and liabilities will be recorded at their estimated fair values during the first quarter of 2014. We do not expect these transactions, or the expected related aggregate gain (to be recorded during the first quarter of 2014), to have a material impact on our future results of operations.

 

71


Table of Contents

2013:

 

Acquisition:

 

In August, 2013, we purchased the Ward Eagle Office Village located in Farmington Hills, Michigan. This multi-tenant MOB, which was purchased for approximately $4.1 million, consists of approximately 16,300 rentable square feet.

 

In June, 2013, we purchased the 5004 Poole Road MOB, located in Denison, Texas, on the campus of Texoma Medical Center, a wholly-owned subsidiary of UHS. This single-tenant MOB, which was purchased for approximately $625,000, consists of approximately 4,400 rentable square feet and is located adjacent to our Texoma Medical Plaza MOB.

 

The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years.

 

Land

   $ 316   

Buildings and improvements

     3,749   

Intangible assets

     610   

Other assets

     21   

Liabilities (real property and operating)

     (11
  

 

 

 

Net cash paid

   $ 4,685   
  

 

 

 

 

The Ward Eagle Office Village acquisition was valued utilizing the income capitalization approach. The calculated fair value, utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

New Construction:

 

The newly constructed Forney Medical Plaza II located in Forney, Texas was completed and opened in April, 2013. This multi-tenant medical office building, consisting of 30,000 rentable square feet, is owned by a limited partnership in which we hold a 95% non-controlling ownership interest. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

 

Divestitures:

 

There were no divestitures during 2013.

 

2012:

 

Acquisitions and New Construction:

 

In January and December, 2012, we purchased the:

 

   

PeaceHealth Medical Clinic (as part of a planned like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code) – a 99,000 square foot, single tenant medical office building located in Bellingham, Washington, which was acquired in January, 2012 for $30.4 million; the weighted average remaining lease term on the date of acquisition was approximately ten years, and;

 

72


Table of Contents
   

Northwest Texas Professional Office Tower – a 72,000 square foot, multi-tenant medical office building located in Amarillo, Texas, which was acquired in December, 2012 for $9.6 million; the weighted average remaining lease term at the date of acquisition was 5.1 years.

 

The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the time of acquisition which are being amortized over the then average remaining lease term of approximately 7.0 years (aggregate weighted average of 4.9 years at December 31, 2013).

 

Land

   $ 1,900   

Buildings and improvements

     32,090   

Intangible assets

     6,020   

Other assets

     799   

Liabilities (real property and operating)

     (144

Deposit paid in 2011

     (534

Debt (including fair value adjustment of $799)

     (23,240
  

 

 

 

Net cash paid

   $ 16,891   
  

 

 

 

 

The 2012 acquisitions were both valued utilizing the income capitalization approach as well as the sales comparison approach for valuing the land at the PeaceHealth Medical Clinic. The calculated fair values, utilizing the income capitalization approach, are based upon the basis of capitalization of the net estimated earnings expectancy of the properties, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair values of the properties, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:

 

Assets(b.)

   Fair Value at
December 31, 2012
    

Valuation Technique

   Unobservable inputs    Range  

PeaceHealth Medical Clinic (a.)(c.)

   $ 30,400,000       Income Capitalization Approach    Capitalization Rate      7.50
         Discount Rate      8.50

Northwest Texas Professional Office Tower

   $ 9,600,000       Income Capitalization Approach    Capitalization Rate      8.60
         Discount Rate      9.50

 

(a.) The fair value of the land was estimated based upon the sales comparison approach.
(b.) Based upon preliminary appraisals.
(c.) Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.

 

For these MOBs acquired during 2012, we recorded aggregate revenue of $2.7 million and net income of approximately $232,000 (excluding transaction expenses of $680,000) during 2012.

 

Divestiture:

 

In February, 2012, Canyon Healthcare Properties, a limited liability company (“LLC”) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing

 

73


Table of Contents

costs and the minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the year ended December 31, 2012.

 

In October, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.2 million of cash proceeds to us, net of closing costs and minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $1.1 million, which is included in our consolidated statement of income for the year ended December 31, 2012.

 

Assuming the 2012 acquisitions and divestitures, as well as the 2011 acquisitions and divestitures as discussed below, occurred on January 1, 2011, our pro forma net revenues for the year ended December 31, 2011 would have been approximately $54.0 million, and our pro forma net income for the year ended December 31, 2011 would have been approximately $4.1 million, or $0.32 per diluted share, without giving effect to the gains and transaction costs recorded during 2011. Our 2011 reported (and pro forma) net income included a provision for asset impairment of $5.4 million, or $0.42 per diluted share, as discussed herein. Assuming the 2012 acquisitions and divestitures occurred on January 1, 2012, our pro forma net revenues and net income for the year ended December 31, 2012 would have been approximately $55.4 million and $11.6 million, or $.92 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.

 

2011:

 

Acquisitions:

 

In June, July and December, 2011, utilizing a qualified third-party intermediary in connection with planned like-kind exchange transactions pursuant to Section 1031 of the Internal Revenue Code, we purchased the:

 

   

Lake Pointe Medical Arts Building—a 50,974 square foot, multi-tenant, medical office building located in Rowlett, Texas, which was acquired in June, 2011, for $12.2 million; the weighted average remaining lease term at the date of acquisition was 6.5 years;

 

   

Forney Medical Plaza—a 50,946 square foot, multi-tenant medical office building located in Forney, Texas, which was acquired in July, 2011, for $15.0 million; the weighted average remaining lease term at the date of acquisition was 6.2 years;

 

   

Tuscan Professional Building—a 53,000 square foot, multi-tenant medical office building located in Irving, Texas, which was acquired in December, 2011, for $15.5 million, including the assumption of $7.0 million of third-party financing; the weighted average remaining lease term at the date of acquisition was 4.3 years, and;

 

   

Emory at Dunwoody Building—a 50,344 square foot single-tenant medical office building located in Atlanta, Georgia, which was acquired in December, 2011, for $5.1 million; the weighted average remaining lease term at the date of acquisition was 13.5 years.

 

74


Table of Contents

The aggregate purchase price of $47.8 million for these MOBs was allocated to the assets acquired consisting of tangible property ($40.9 million) and identified intangible assets ($6.9 million), based on their respective fair values at acquisition, as detailed in the table below. Intangible assets include the value of the in-place leases at the time of acquisition.

 

Land

   $ 3,892   

Buildings and improvements

     36,940   

Intangible assets

     6,943   

Other assets

     31   
  

 

 

 

Total purchase price

     47,806   

Liabilities (real property and operating)

     (1,229

Debt

     (6,999
  

 

 

 

Net cash paid

   $ 39,578   
  

 

 

 

 

For these MOBs acquired during 2011, we recorded aggregate revenue of $1.8 million during 2011 and aggregate net income of approximately $474,000 (excluding transaction expenses).

 

In addition, on December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs. The aggregate cash expenditure made by us in connection with the purchase of these membership interests in the various LLCs, including closing costs, was approximately $4.4 million. As a result of these transactions, current accounting standards required that the Trust record each property’s assets and liabilities at their fair values and record a non-cash gain or loss for the difference between the fair values and the equity method carrying value of each investment. The aggregate fair values of these MOBs was allocated to the assets acquired consisting of tangible property ($133.1 million) and identified intangible assets ($20.9 million). As a result of the purchase of these minority interests, we recorded aggregate revenue of $18.3 million during 2012 and $991,000 during 2011. There was no material impact on our net income, other than the gain, as a result of the consolidation of these LLCs subsequent to this transaction.

 

In the aggregate, the purchase of these membership interests resulted in a $28.6 million gain (net of related transaction costs totaling approximately $300,000) on the fair value recognition resulting from the purchase of minority interests in majority-owned LLCs which is included in our consolidated statements of income for the year ended December 31, 2011. The table below reflects each of the LLCs in which we purchased the minority ownership interests, the location and property owned by the LLC, our previous noncontrolling, majority ownership interest and the noncontrolling, minority ownership interests purchased by us.

 

Name of LLC:

 

Property owned by LLC:

  City    State    Trust’s
previous
ownership
%
    Minority
ownership
%
purchased
 

653 Town Center Investments

  Summerlin Hospital MOB I(1)   Las Vegas    NV      95     5

653 Town Center Phase II

  Summerlin Hospital MOB II(1)   Las Vegas    NV      98     2

Auburn Medical Properties II

  Auburn Medical Office Building II(1)   Auburn    WA      95     5

ApaMed Properties

  Apache Junction Medical Plaza   Apache J.    AZ      85     15

Banburry Medical Properties

  Summerlin Hospital MOB III(1)   Las Vegas    NV      95     5

 

75


Table of Contents

Name of LLC:

 

Property owned by LLC:

  City    State    Trust’s
previous
ownership
%
    Minority
ownership
%
purchased
 

BRB/E Building One

  BRB Medical Office Building   Kingwood    TX      95     5

Centennial Medical Properties

  Centennial Hills Medical Office Bldg. I(1)   Las Vegas    NV      95     5

DesMed

  Desert Springs Medical Plaza(1)   Las Vegas    NV      99     1

Gold Shadow Properties

  700 Shadow Lane & Goldring MOBs(1)   Las Vegas    NV      98     2

Spring Valley Medical Properties

  Spring Valley Medical Office Building   Las Vegas    NV      95     5

Spring Valley Medical Properties II

  Spring Valley Medical Office Building II   Las Vegas    NV      95     5

 

(1) Tenants of this medical office building include subsidiaries of UHS.

 

Divestitures:

 

On November 30, 2011 and December 16, 2011, eight LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings and related real property. As partial consideration for the transaction, the buyer assumed certain existing third-party mortgage debt related to the properties. For certain of the LLCs, the sale of the medical office buildings were part of a series of planned like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code. The divestiture by the eight LLCs generated approximately $33.8 million of aggregate cash proceeds (a portion of which were sent to qualified third-party intermediaries), net of closing costs and the minority members’ share of the proceeds. In the aggregate, these transactions also resulted in a $35.8 million gain (net of related transaction costs of approximately $500,000) on divestiture which is included in our consolidated statements of income for the year ended December 31, 2011. The following table represents each of the eight LLCs that was a selling party, the location and property owned by the LLC and our former noncontrolling, majority ownership interest:

 

Name of LLC:

  

Property owned by LLC:

   City    State    Trust’s
Former
Ownership
%
 

Cobre Properties

   Cobre Valley Medical Plaza    Globe    AZ      95

Deerval Properties

   Deer Valley Medical Office II    Phoenix    AZ      90

Deerval Properties II

   Deer Valley Medical Office III    Phoenix    AZ      95

Deerval Parking Company(a)

   Deer Valley Parking Garage    Phoenix    AZ      93

DSMB Properties

   Desert Samaritan Hospital MOBs    Mesa    AZ      76

Litchvan Investments

   Papago Medical Park    Phoenix    AZ      89

Paseo Medical Properties II

   Thunderbird Paseo Medical Plaza I & II    Glendale    AZ      75

Willetta Medical Properties(b)

   Edwards Medical Plaza    Phoenix    AZ      90

 

(a) Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I & II, was 50% owned by each of Deerval Properties and Deerval Properties II.
(b) The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.

 

Assuming these 2011 acquisitions and divestitures occurred on January 1, 2011, our 2011 pro forma net revenues would have been approximately $49.8 million and our pro forma net income would have been

 

76


Table of Contents

approximately $4.6 million, or $0.37 per diluted share, without giving effect to the gains and transaction costs recorded during 2011. Our 2011 reported (and pro forma) net income included a provision for asset impairment of $5.4 million, or $0.42 per diluted share, as discussed herein.

 

As of December 31, 2013, our net intangible assets total $20.8 million (net of $13.7 million accumulated amortization) and substantially all of the amount is related to acquired, in-place leases which have a weighted average remaining amortization period of 3.5 years.

 

(4) LEASES

 

All of our leases are classified as operating leases with initial terms typically ranging from 3 to 15 years with up to five additional, five-year renewal options. Under the terms of the leases, we earn fixed monthly base rents and pursuant to the leases with subsidiaries of UHS, we may earn periodic bonus rents (see Note 1). The bonus rents from the subsidiaries of UHS, which are based upon each facility’s net revenue in excess of base amounts, are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to the corresponding quarter in the base year.

 

Minimum future base rents from non-cancelable leases, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):

 

2014

   $ 42,692   

2015

     39,631   

2016

     36,769   

2017

     21,519   

2018

     18,860   

Thereafter

     46,589   
  

 

 

 

Total minimum base rents

     $206,060   
  

 

 

 

 

Some of the leases contain gross terms where operating expenses are included in the base rent amounts. Other leases contain net terms where the operating expenses are assessed separately from the base rentals. The table above contains a mixture of both gross and net leases, and does not include any separately calculated operating expense reimbursements. Under the terms of the hospital leases, the lessees are required to pay all operating costs of the properties including property insurance and real estate taxes. Tenants of the medical office buildings generally are required to pay their pro-rata share of the property’s operating costs.

 

(5)   DEBT

 

In July, 2011, we entered into a $150 million revolving credit agreement (“Credit Agreement”) which is scheduled to expire on July 24, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December 31, 2013, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.

 

At December 31, 2013, we had $93.7 million of outstanding borrowings and $8.7 million of letters of credit outstanding against our revolving credit agreement. We had $47.6 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2013. There are no compensating balance requirements. The average amounts outstanding under our revolving credit agreement were $86.3 million

 

77


Table of Contents

in 2013, $75.4 million in 2012 and $67.8 million in 2011 with corresponding effective interest rates, including commitment fees, of 2.2% in 2013, 2.4% in 2012 and 1.8% in 2011. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $93.7 million at December 31, 2013.

 

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December 31, 2013. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

 

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2013
 

Tangible net worth

   $ 125,000      $ 144,848   

Debt to total capital

     < 55     36.0

Debt service coverage ratio

     > 4.00x        19.1x   

Debt to cash flow ratio

     < 3.50x        2.21x   

 

We have twelve mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December 31, 2013, with a combined outstanding balance of $105.5 million (excluding net debt premium, resulting from fair value recognition of third-party debt of $834,000 at December 31, 2013). The following table summarizes our outstanding mortgages, excluding net debt premium, at December 31, 2013 (amounts in thousands):

 

Facility Name

  Outstanding
Balance
(in thousands)(a)
     Interest
Rate
    Maturity
Date
 

Summerlin Hospital Medical Office Building I fixed rate mortgage loan (b)

  $ 9,188         6.55     2014   

Spring Valley Medical Office Building fixed rate mortgage loan

    5,122         5.50     2015   

Summerlin Hospital Medical Office Building III floating rate mortgage loan

    11,347         3.42     2016   

Peace Health fixed rate mortgage loan

    21,681         5.64     2017   

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

    12,021         5.50     2017   

Auburn Medical II floating rate mortgage loan

    7,406         2.92     2017   

Medical Center of Western Connecticut fixed rate mortgage loan

    4,899         6.00     2017   

Centennial Hills Medical Office Building floating rate mortgage loan

    10,938         3.42     2018   

Vibra Hospital of Corpus Christi fixed rate mortgage loan

    2,983         6.50     2019   

BRB Medical Office Building fixed rate mortgage loan

    6,840         4.27     2022   

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

    6,766         4.54     2022   

Tuscan Professional Building fixed rate mortgage loan

    6,262         5.56     2025   
 

 

 

      

Total

  $ 105,453        
 

 

 

      

 

(a) Amortized principal payments are made on a monthly basis.
(b) In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.

 

78


Table of Contents

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $106.4 million as of December 31, 2013. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

 

As of December 31, 2013, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):

 

2014

   $ 11,894   

2015(a)

     101,245   

2016

     13,098   

2017

     43,914   

2018

     10,672   

Later

     18,330   
  

 

 

 

Total

   $ 199,153   
  

 

 

 

 

(a) Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.

 

(6)   DIVIDENDS AND EQUITY ISSUANCE PROGRAM

 

Dividends of $2.495 per share were declared and paid in 2013, of which $1.96 per share was ordinary income and $.535 per share was a return of capital distribution. Dividends of $2.46 per share were declared and paid in 2012, of which $1.294 per share was ordinary income and $1.166 per share was total capital gain (total capital gain amount consists of Unrecaptured Section 1250 gain of $.281 per share and 15% rate gain of $.885 per share). Dividends of $2.425 per share were declared and paid in 2011, of which $1.234 per share was ordinary income and $1.191 per share was total capital gain (total capital gain amount consists of Unrecaptured Section 1250 gain of $.716 per share and 15% rate gain of $.475 per share).

 

During the fourth quarter of 2013, we entered into an ATM Equity Offering Sales Agreement (“Sales Agreement”) with Merrill Lynch, Pierce, Fenner and Smith Incorporated (“Merrill Lynch”), under which we may offer and sell our common shares of beneficial interest, up to an aggregate sales price of $50 million. The common shares will be offered pursuant to the Registration Statement filed with the Securities and Exchange Commission, which became effective in November, 2012, under which we can offer up to $50 million of our securities pursuant to supplemental prospectuses which we may file from time to time.

 

Pursuant to this ATM Program, we issued 154,713 shares at an average price of $41.71 per share during the three-month period ended December 31, 2013, which generated approximately $6.0 million of net cash proceeds, (net of approximately $424,000 consisting of compensation of approximately $161,000 to Merrill Lynch as well as approximately $263,000 of other various fees and expenses), which includes approximately $592,000 of net proceeds receivable at December 31, 2013, which were received by us in January, 2014. The net proceeds receivable is a non-cash item, as presented on the Consolidated Statements of Cash Flows at December 31, 2013.

 

(7)   INCENTIVE PLANS

 

We expense the grant-date fair value of stock options and restricted stock awards under the straight-line method over the stated vesting period of the award. We use the Black-Scholes option pricing model for determining the grant-date fair value of our stock options. All of our outstanding stock options have been fully expensed as of December 31, 2011.

 

During 2007, upon the expiration of our 1997 Incentive Plan, as discussed below, our Board of Trustees and shareholders approved the Universal Health Realty Income Trust 2007 Restricted Stock Plan (the “2007 Plan”). A total of 75,000 shares were authorized for issuance under this plan and a total of 47,975 shares, net of cancellations, have been issued pursuant to the terms of this plan, 28,870 of which have vested as of

 

79


Table of Contents

December 31, 2013. At December 31, 2013 there are 27,025 shares remaining for issuance under the terms of the 2007 Plan.

 

During 2013, there were 8,730 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.54 per share ($380,104 in the aggregate). These restricted shares are scheduled to vest in June of 2015 (the second anniversary of the date of grant).

 

During 2012, there were 10,375 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $39.05 per share ($405,144 in the aggregate). These restricted shares are scheduled to vest in June of 2014 (the second anniversary of the date of grant). Included the restricted stock issuances during 2012 were one-time special compensation awards made to our executive officers in recognition of their efforts and contributions in connection with various acquisitions, divestitures and purchases of third-party minority interests in certain majority-owned LLCs as completed at various times during 2011 and the first quarter of 2012.

 

During 2011, there were 7,395 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $41.90 per share ($309,850 in the aggregate). These restricted shares vested during 2013.

 

In connection with these grants, we recorded compensation expense of approximately $375,000, $329,000 and $216,000 during 2013, 2012 and 2011, respectively. The remaining expenses associated with these grants is approximately $354,000 and will be recorded over the remaining weighted average vesting period for outstanding restricted Shares of Beneficial Interest of approximately one year at December 31, 2013.

 

Prior to its expiration in 2007, the Universal Health Realty Income Trust 1997 Incentive Plan (the “1997 Plan”) provided for the granting of stock options and dividend equivalents rights (“DERs”) to employees of the Trust, including officers and trustees. Awards granted pursuant to the 1997 Plan prior to its termination date remain exercisable, in accordance with the terms of the outstanding agreements. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. The options granted vested ratably at 25% per year beginning one year after the date of grant, and expire in ten years. DERs on outstanding awards are earned in amounts equal to the cash or stock dividends declared subsequent to the date of grant. We recorded expenses relating to the dividend equivalent rights of approximately $19,000 in 2013 and $18,000 in each of 2012 and 2011. As of December 31, 2013, there were 40,000 options outstanding and exercisable under the 1997 Plan with an average exercise price of $35.65 per share.

 

There were no compensation costs recognized during 2013 and 2012, and $12,000 of compensation costs during 2011, related to outstanding stock options and DERs that were granted or have vestings after January 1, 2006. As of December 31, 2011, all of the outstanding stock options and DERs were fully vested and fully expensed. The outstanding stock options have a remaining weighted average life of 2.5 years at December 31, 2013.

 

During the fourth quarter of 2008, the Board of Trustees of the Trust approved amendments to the outstanding stock option agreements made pursuant to the 1997 Plan. These original agreements provided for the deferred payment of dividend equivalents on shares covered by the options, with payment tied to the date the options were exercised or expire. In order to meet certain recent changes to tax law requirements, the agreements, as amended, provide for the current payment of dividend equivalents in the years in which dividends are declared and paid or, if later, when the related options become vested. Dividend equivalent rights with respect to 40,000 shares were outstanding at December 31, 2013. Dividend equivalent rights with respect to 43,000 shares were outstanding at December 31, 2012. Dividend equivalent rights with respect to 51,000 shares were outstanding at December 31, 2011. In December of 2013, 2012 and 2011, dividend equivalent rights which were vested and accrued as of each respective date, were paid to officers and Trustees of the Trust amounting to $106,000, $116,000 and $178,000, respectively.

 

80


Table of Contents

Stock options to purchase shares of beneficial interest have been granted to eligible individuals, including our officers and trustees. Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:

 

Outstanding Options

   Number
of Shares
     Exercise
Weighted-
Average Price
     Grant Price Range
(High-Low)
 

Balance, January 1, 2011

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     —          —          —    
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2012

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     8,000         26.76       $ 27.65/$26.09   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2013

     43,000       $ 35.22       $ 36.53/$29.44   

Exercised

     3,000         29.44       $ 29.44/$29.44   
  

 

 

    

 

 

    

 

 

 

Outstanding options vested and exercisable as of December 31, 2013

     40,000       $ 35.65       $ 36.53/$30.06   
  

 

 

    

 

 

    

 

 

 

 

During 2013, there were 3,000 stock options exercised with a total in-the-money value of $46,290. During 2012, there were 8,000 stock options exercised with a total in-the-money value of $148,930. There were no stock options exercised during 2011.

 

There were no unvested options as of December 31, 2013.

 

The following table provides information about options outstanding and exercisable options at December 31, 2013:

 

     Options
Outstanding
and Exercisable
 

Number

     40,000   

Weighted average exercise price

   $ 35.65   

Aggregate intrinsic value

   $ 176,240   

Weighted average remaining contractual life

     2.5   

 

The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December 31, 2013 were as follows:

 

     Options Outstanding and
Exercisable
 

Exercise Price

   Shares      Weighted
Average
Exercise
Price Per
Share
     Weighted
Average
Remaining
Contractual
Life (in
Years)
 

$30.06 -$34.07

     4,000       $ 33.07         1.0   

$34.90 -$34.90

     13,000         34.90         1.7   

$36.53 -$36.53

     23,000         36.53         3.2   
  

 

 

    

 

 

    

 

 

 

Total

     40,000       $ 35.65         2.5   
  

 

 

    

 

 

    

 

 

 

 

81


Table of Contents
(8)   SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES

 

As of December 31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings. As of December 31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013. As previously disclosed, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.

 

Additionally, we have 100% ownership interests in eleven LLCs as of December 31, 2013 that were accounted for under the equity method through December 11, 2011 as previously disclosed. These eleven LLCs were subsequently consolidated into the results of operations effective December 12, 2011.

 

The following property table represents the thirteen LLCs which were accounted for under the equity method as of December 31, 2013:

 

Name of LLC/LP

  Ownership    

Property Owned by LLC

DVMC Properties(g.)

    90   Desert Valley Medical Center

Suburban Properties

    33   Suburban Medical Plaza II

Santa Fe Scottsdale

    90   Santa Fe Professional Plaza

Brunswick Associates(g.)

    74   Mid Coast Hospital MOB

PCH Medical Properties(g.)

    85   Rosenberg Children’s Medical Plaza

Arlington Medical Properties(b.)(g.)

    75   Saint Mary’s Professional Office Building

Sierra Medical Properties

    95   Sierra San Antonio Medical Plaza

PCH Southern Properties(g.)

    95   Phoenix Children’s East Valley Care Center

Sparks Medical Properties(a.)(f.)(g.)

    95   Vista Medical Terrace & The Sparks Medical Building

Grayson Properties(a.)(c.)(g.)

    95   Texoma Medical Plaza

3811 Bell Medical Properties

    95   North Valley Medical Plaza

FTX MOB Phase II(d.)(g.)

    95   Forney Medical Plaza II

Palmdale Medical Properties(a.)(e.)(f.)(g)

    95   Palmdale Medical Plaza

 

(a.) Tenants of this medical office building include or will include subsidiaries of UHS.
(b.) We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December 31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary’s Professional Office Building.
(c.) We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December 31, 2013.
(d.) During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December 31, 2013.
(e.) We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013, as discussed above.
(f.) Effective January 1, 2014, we purchased the third-party minority ownership interest (5%) in this LLC. As a result of our purchase of the minority ownership interest, as of January 1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January 1, 2014.
(g.) As disclosed below, as of December 31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us.

 

82


Table of Contents

On December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs. The aggregate cash expenditure made by us in connection with the purchase of these membership interests in the various LLCs, including closing costs, was approximately $4.4 million. As a result of these transactions, accounting standards required that we record each property’s assets and liabilities at their fair values and record a non-cash gain or loss for the difference between the fair values and the equity method carrying value of each investment. In the aggregate, the purchase of these membership interests resulted in a $28.6 million gain on fair value recognition resulting from the purchase of the minority interests which is included in our consolidated statements of income for the year ended December 31, 2011. On December 12, 2011, we began consolidating the financial data of these eleven LLCs in our consolidated financial statements. The following property table represents these eleven LLCs (the summarized financial data for these eleven LLCs through December 11, 2011, are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

  Previous
Ownership
   

Property Owned by LLC

653 Town Center Investments(a.)

    95   Summerlin Hospital Medical Office Building I

653 Town Center Phase II(a.)

    98   Summerlin Hospital Medical Office Building II

ApaMed Properties

    85   Apache Junction Medical Plaza

Auburn Medical Properties II(a.)

    95   Auburn Medical Office Building II

Banburry Medical Properties(a.)

    95   Summerlin Hospital Medical Office Building III

BRB/E Building One

    95   BRB Medical Office Building

Centennial Medical Properties(a.)

    95   Centennial Hills Medical Office Building I

DesMed(a.)

    99   Desert Springs Medical Plaza

Gold Shadow Properties(a.)

    98   700 Shadow Lane & Goldring Medical Office Buildings

Spring Valley Medical Properties

    95   Spring Valley Medical Office Building

Spring Valley Medical Properties II

    95   Spring Valley Hospital Medical Office Building II

 

(a.) Tenants of this medical office building include or will include subsidiaries of UHS.

 

On November 30, 2011 and December 16, 2011, eight LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings and related real property. As partial consideration for the transaction, the buyer assumed certain existing third-party mortgage debt related to the properties. For certain of the LLCs, the sale of the medical office buildings were part of a series of planned like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code. The divestiture by the eight LLCs generated approximately $33.8 million of aggregate cash proceeds (a portion of which were sent to qualified third-party intermediaries), net of closing costs and the minority members’ share of the proceeds. In the aggregate, these transactions also resulted in a $35.8 million gain on divestiture which is included in our consolidated statements of income for the year ended December 31, 2011. The following property table represents the eight LLCs that divested medical office buildings on November 30, 2011 and December 16, 2011 (the summarized financial data for these eight LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

  Ownership    

Property Owned by LLC

DSMB Properties

    76   Desert Samaritan Hospital MOBs

Litchvan Investments

    89   Papago Medical Park

Paseo Medical Properties II

    75   Thunderbird Paseo Medical Plaza I & II

Willetta Medical Properties

    90   Edwards Medical Plaza

Deerval Properties(a.)

    90   Deer Valley Medical Office II

Deerval Properties II(a.)

    95   Deer Valley Medical Office Building III

Deerval Parking Company(a.)

    (a.   Deer Valley Parking Garage

Cobre Properties

    95   Cobre Valley Medical Plaza

 

83


Table of Contents

 

(a.) Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.

 

The following property table represents the two LLCs that divested medical office buildings on February 3, 2012 and October 10, 2012 (the summarized financial data for these two LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

   Ownership    

Property Owned by LLC

Canyon Healthcare Properties

     95   Canyon Springs Medical Plaza

575 Hardy Investors

     90   Centinela Medical Building Complez

 

The following financial tables represent summarized financial information related to the LLCs that we accounted for under the equity method during 2013, including the financial information of the divested LLCs through their divestiture date. The 2011 table includes financial information of the divested LLCs through their divestiture date, as well as the LLCs in which we held majority noncontrolling ownership interests through December 11, 2011.

 

Below are the combined statements of income for the LLCs accounted for under the equity method. The years ended December 31, 2012 and 2011 include the prorated amounts for the LLCs that were divested through their divestiture dates, or in which we purchased the minority ownership interests, for the period in which they were accounted for under the equity method:

 

     For the Year Ended December 31,  
     2013(b.)      2012(a.)      2011(a.)  
     (amounts in thousands)  

Revenues

   $ 21,001       $ 21,448       $ 57,932   

Operating expenses

     8,705         8,974         25,503   

Depreciation and amortization

     4,039         4,140         13,066   

Interest, net

     6,353         6,056         17,630   
  

 

 

    

 

 

    

 

 

 

Net income before gains on divestitures

   $ 1,904       $ 2,278       $ 1,733   
  

 

 

    

 

 

    

 

 

 

Our share of net income before gains on divestitures(c.)

   $ 2,095       $ 2,365       $ 3,058   
  

 

 

    

 

 

    

 

 

 

Our share of gains on divestitures

   $ —        $ 8,520       $ 35,835   
  

 

 

    

 

 

    

 

 

 

 

(a.) As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
(b.) As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2103. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July 1, 2013 through December 31, 2013.
(c.) Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.

 

84


Table of Contents

Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December 31, 2013 and 2012:

 

     December 31,  
     2013(a.)      2012  
     (amounts in thousands)  

Net property, including CIP

   $ 119,547       $ 106,150   

Other assets

     9,479         9,850   
  

 

 

    

 

 

 

Total assets

   $ 129,026       $ 116,000   
  

 

 

    

 

 

 

Liabilities

   $ 5,336       $ 5,368   

Mortgage notes payable, non-recourse to us

     80,112         77,511   

Advances payable to us

     22,911         12,658   

Equity

     20,667         20,463   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 129,026       $ 116,000   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 39,201       $ 28,636   
  

 

 

    

 

 

 

 

(a.) As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis.

 

As of December 31, 2013, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2014

   $ 14,174   

2015

     41,492   

2016

     578   

2017

     11,829   

2018

     12,039   
  

 

 

 

Total

   $ 80,112   
  

 

 

 

 

Name of LLC

   Mortgage
Balance(b.)
     Maturity Date  

Grayson Properties(a.)

   $ 12,540                 2014   

Brunswick Associates

     7,941                 2015   

Arlington Medical Properties

     24,052                 2015   

DVMC Properties

     3,970                 2015   

Palmdale Medical Properties

     6,162                 2015   

FTX MOB Phase II(c.)

     5,596                 2017   

PCH Southern Properties

     6,614                 2017   

Sparks Medical Properties

     4,603                 2018   

PCH Medical Properties

     8,634                 2018   
  

 

 

    
   $ 80,112      
  

 

 

    

 

(a.) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.

 

85


Table of Contents
(b.) All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(c.) Construction loan.

 

Pursuant to the operating agreements of the jointly-owned LLCs, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member.

 

The LLCs in which we have invested maintain property insurance on all properties. Although we believe that generally our properties are adequately insured, two of the LLCs in which we own various non-controlling equity interests, own properties in California that are located in earthquake zones. These properties, in which we have invested or advanced a total of $16.3 million at December 31, 2013, are not covered by earthquake insurance since earthquake insurance is no longer available at rates which are economical in relation to the risks covered.

 

(9)   SEGMENT REPORTING

 

Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.

 

Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

 

(10)   QUARTERLY RESULTS (unaudited)

 

     2013 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,885       $ 13,502       $ 13,448       $ 13,445       $ 54,280   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,427       $ 2,941       $ 3,303       $ 3,498       $ 13,169   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

86


Table of Contents
     2012  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,351       $ 13,666       $ 13,610       $ 13,323       $ 53,950   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income before gains

   $ 2,139       $ 2,467       $ 2,986       $ 3,365       $ 10,957   

Net gains on divestiture of properties owned by unconsolidated LLCs(b.)

     7,375         —          —          1,145         8,520   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 9,514       $ 2,467       $ 2,986       $ 4,510       $ 19,477   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.75       $ 0.19       $ 0.24       $ 0.36       $ 1.54   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.75       $ 0.19       $ 0.24       $ 0.36       $ 1.54   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
(b.) During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.

 

87


Table of Contents

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2013

(amounts in thousands)

 

Description

  Initial Cost     Gross amount at
which carried
at end of period
    Accumulated
Depreciation
as of Dec. 31,
2013
    Date of
Completion
of Construction,

Acquisition or
Significant
improvement
    Date
Acquired
    Average
Depreciable
Life
 
  Encumbrance
(e.)
    Land     Building
&
Improv.
    Adjustments to
Basis (a.)
    Land     Building &
Improvements
    CIP     Total          

Inland Valley Regional

Medical Center

Wildomar, California

    —        $ 2,050      $ 10,701      $ 14,596      $ 2,050      $ 25,297        —        $ 27,347      $ 10,464        2007        1986        43 Years   

McAllen Medical Center

McAllen, Texas

    —          4,720        31,442        10,189        6,281        40,070        —          46,351        23,440        1994        1986        42 Years   

Wellington Regional Medical Center
West Palm Beach, Florida

    —          1,190        14,652        17,370        1,663        31,549        —          33,212        15,182        2006        1986        42 Years   

The Bridgeway
North Little Rock, Arkansas

    —          150        5,395        4,571        150        9,966        —          10,116        5,554        2006        1986        35 Years   

HealthSouth Deaconess Rehabilitation Hospital Evansville, Indiana

    —          500        6,945        1,062        500        8,007        —          8,507        4,867        1993        1989        40 Years   

Kindred Hospital Chicago Central
Chicago, Illinois

    —          158        6,404        1,838        158        8,242        —          8,400        8,245        1993        1986        25 Years   

Family Doctor’s Medical Office Building
Shreveport, Louisiana

    —          54        1,526        494        54        2,020        —          2,074        854        1991        1995        45 Years   

Kelsey-Seybold Clinic at King’s Crossing

    —          439        1,618        870        439        2,488        —          2,927        958        1995        1995        45 Years   

Professional Center at King’s Crossing

    —          439        1,837        183        439        2,020        —          2,459        832        1995        1995        45 Years   

Kingwood, Texas

                       

Chesterbrook Academy

Audubon, Pennsylvania

    —          307        996        —          307        996        —          1,303        391        1996        1996        45 Years   

Chesterbrook Academy
New Britain, Pennsylvania

    —          250        744        —          250        744        —          994        292        1991        1996        45 Years   

Chesterbrook Academy

Uwchlan, Pennsylvania

    —          180        815        —          180        815        —          995        320        1992        1996        45 Years   

Chesterbrook Academy

Newtown, Pennsylvania

    —          195        749        —          195        749        —          944        294        1992        1996        45 Years   

The Southern Crescent Center I (b.)

    —          1,130        5,092        (2,304     1,130        2,788        —          3,918        2,141        1994        1996        45 Years   

The Southern Crescent Center II (b.)

    —          —          —          5,015        806        4,209        —          5,015        1,742        2000        1998        35 Years   

Riverdale, Georgia

                       

The Cypresswood Professional Center

Spring ,Texas

    —          573        3,842        573        573        4,415        —          4,988        2,212        1997        1997        35 Years   

701 South Tonopah Building
Las Vegas, Nevada

    —          —          1,579        68        —          1,647        —          1,647        858        1999        1999        25 Years   

Sheffield Medical
Building (c.)
Atlanta, Georgia

    —          1,760        9,766        (7,327     736        3,463        —          4,199        936        1999        1999        25 Years   

Medical Center of Western Connecticut—Bldg. 73 Danbury, Connecticut

    4,899        1,151        5,176        430        1,151        5,606        —          6,757        2,678        2000        2000        30 Years   

Vibra Hospital of Corpus Christi
Corpus Christi, Texas

    2,983        1,104        5,508        —          1,104        5,508        —          6,612        928        2008        2008        35 Years   

Apache Junction Medical Plaza (d.)
Apache Junction, AZ

    —          240        3,590        27        240        3,617        —          3,857        283        2004        2004        30 Years   

 

88


Table of Contents

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2013—(Continued)

(amounts in thousands)

 

Description

  Initial Cost     Gross amount at
which carried
at end of period
    Accumulated
Depreciation
as of Dec. 31,
2013
    Date of
Completion
of Construction,

Acquisition or
Significant
improvement
    Date
Acquired
    Average
Depreciable
Life
 
  Encumbrance
(e.)
    Land     Building
&
Improv.
    Adjustments to
Basis (a.)
    Land     Building &
Improvements
    CIP     Total          

Auburn Medical Office Building (d.)

Auburn, WA

    7,406        —          10,200        159        —          10,359        —          10,359        694        2009        2009        36 Years   

BRB Medical Office Building (d.)
Kingwood, Texas

    6,840        430        8,970        24        430        8,994        —          9,424        591        2010        2010        37 Years   

Centennial Hills Medical Office Building (d.)
Las Vegas, NV

    10,938        —          19,890        743        —          20,633        —          20,633        1,412        2006        2006        34 Years   

Desert Springs Medical Plaza (d.)
Las Vegas, NV

    —          1,200        9,560        200        1,200        9,760        —          10,960        772        1998        1998        30 Years   

700 Shadow Lane & Goldring MOB (d.)

Las Vegas, NV

    6,766        400        11,300        968        400        12,268        —          12,668        931        2003        2003        30 Years   

Spring Valley Hospital MOB I (d.)
Las Vegas, NV

    5,122        —          9,500        111        —          9,611        —          9,611        664        2004        2004        35 Years   

Spring Valley Hospital MOB II (d.)
Las Vegas, NV

    —          —          9,800        8        —          9,808        —          9,808        693        2006        2006        34 Years   

Summerlin Hospital MOB I (d.)

                       

Las Vegas, NV

    9,188        460        15,440        451        460        15,891        —          16,351        1,251        1999        1999        30 Years   

Summerlin Hospital MOB II (d.)
Las Vegas, NV

    12,021        370        16,830        731        370        17,561        —          17,931        1,345        2000        2000        30 Years   

Summerlin Hospital MOB III (d.)
Las Vegas, NV

    11,347        —          14,900        1,443        —          16,343        —          16,343        1,044        2009        2009        36 Years   

Emory at Dunwoody
Dunwoody, GA

    —          782        3,455        —          782        3,455        —          4,237        264        2011        2011        35 Years   

Forney Medical Plaza
Forney, TX

    —          910        11,960        31        910        11,991        —          12,901        1,149        2011        2011        35 Years   

Lake Pointe Medical Arts
Rowlett, TX

    —          1,100        9,000        41        1,100        9,041        —          10,141        772        2011        2011        35 Years   

Tuscan Medical Properties
Irving, TX

    6,262        1,100        12,525        —          1,100        12,525        —          13,625        869        2011        2011        35 Years   

Peace Health Medical Clinic Bellingham, WA

    21,681        1,900        24,910        —          1,900        24,910        —          26,810        1,701        2012        2012        35 Years   

NW Texas Prof Tower
Amarillo, TX

    —          —          7,180        —          —          7,180        —          7,180        244        2012        2012        35 Years   

Ward Eagle Office Village Farmington Hills, MI

    —        $ 220        3,220        —          220        3,220        —          3,440        44        2013        2013        35 Years   

5004 Poole Road
Denison, TX

    —        $ 96        529        —          96        529        —          625        10        2013        2013        35 Years   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

TOTALS

  $ 105,453      $ 25,558      $ 317,546      $ 52,565      $ 27,374      $ 368,295      $ 0      $ 395,669      $ 97,921         
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

a. Costs capitalized/divested subsequent to acquisition.
b. During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II.
c. During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.
d. During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
e. Consists of outstanding balances as of December 31, 2013 on third-party debt that is non-recourse to us. Excludes net debt premium of $834,000.

 

89


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

 

NOTES TO SCHEDULE III

DECEMBER 31, 2013

(amounts in thousands)

 

(1) RECONCILIATION OF REAL ESTATE PROPERTIES

 

The following table reconciles the Real Estate Properties from January 1, 2011 to December 31, 2013:

 

 

     2013     2012      2011  

Balance at January 1,

   $ 401,474      $ 363,498       $ 199,940   

Impact of deconsolidation of an LLC(a.)

     (13,185 )     —          —    

Impact of consolidation of eleven LLCs(b.)

     —         —          133,080   

Property additions

     3,415        3,985         1,157   

Acquisitions

     4,065        33,991         40,832   

Disposals

     (100     —          —    

Provision for asset impairment(c.)

     —         —          (11,511
  

 

 

   

 

 

    

 

 

 

Balance at December 31,

   $ 395,669      $ 401,474       $ 363,498   
  

 

 

   

 

 

    

 

 

 

 

(2) RECONCILIATION OF ACCUMULATED DEPRECIATION

 

The following table reconciles the Accumulated Depreciation from January 1, 2011 to December 31, 2013:

 

     2013     2012      2011  

Balance at January 1,

   $ 87,088      $ 74,865       $ 74,683   

Impact of deconsolidation of an LLC(a.)

     (1,588 )     —          —    

Provision for asset impairment(c.)

     —         —          (6,157

Current year depreciation expense

     12,464        12,223         6,339   

Other

     (43 )     —          —    
  

 

 

   

 

 

    

 

 

 

Balance at December 31,

   $ 97,921      $ 87,088       $ 74,865   
  

 

 

   

 

 

    

 

 

 

 

(a.) The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.
(b.) On December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.
(c.) During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million ($11.5 million gross assets net of $6.1 million of accumulated depreciation) in connection with the Sheffield Medical Building located in Atlanta, Georgia.

 

90


Table of Contents

Exhibit Index

 

Exhibit No.

    

Exhibit

  10.2       Agreement dated December 6, 2013, to renew Advisory Agreement dated as of December 24, 1986 between Universal Health Realty Income Trust and UHS of Delaware, Inc.
  11       Statement re computation of per share earnings is set forth on the Consolidated Statements of Income.
  21       Subsidiaries of Registrant.
  23.1       Consent of Independent Registered Public Accounting Firm.
  31.1       Certification from the Trust’s Chief Executive Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934.
  31.2       Certification from the Trust’s Chief Financial Officer Pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934.
  32.1       Certification from the Trust’s Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2       Certification from the Trust’s Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
    101.INS       XBRL Instance Document
    101.SCH       XBRL Taxonomy Extension Schema Document
  101.CAL       XBRL Taxonomy Extension Calculation Linkbase Document
  101.DEF       XBRL Taxonomy Extension Definition Linkbase Document
  101.LAB       XBRL Taxonomy Extension Label Linkbase Document
  101.PRE       XBRL Taxonomy Extension Presentation Linkbase Document

 

 

91

EX-10.2 2 d649900dex102.htm EXHIBIT 10.2 Exhibit 10.2

Exhibit 10.2

 

December 6, 2013

 

Steve Filton

Senior Vice President & CFO

UHS of Delaware, Inc.

367 South Gulph Road

King of Prussia, PA 19406

 

Dear Steve;

 

The Board of Trustees of Universal Health Realty Income Trust, at today’s meeting, authorized the renewal of the current Advisory Agreement between Universal Health Realty Income Trust and UHS of Delaware, Inc. (“Agreement”) upon the same terms and conditions.

 

This letter constitutes Universal Health Realty Income Trust’s offer to renew the Agreement, through December 31, 2014, upon the same terms and conditions. Please acknowledge UHS of Delaware’s acceptance of this offer by signing in the space provided below and returning one copy of this letter to me. Thank you.

 

Sincerely,

 

/s/ Cheryl K. Ramagano

Cheryl K. Ramagano
Vice President and Treasurer

 

Agreed and Accepted:
UHS OF DELAWARE, INC.
By:  

/s/ Steve Filton

  Steve Filton
  Senior Vice President and CFO
CC:    Charles Boyle
EX-21 3 d649900dex21.htm EXHIBIT 21 Exhibit 21

Exhibit 21

 

Subsidiaries of Registrant

 

Jurisdiction

 

5004 Pool Road Properties, LP

  

Texas

73 Medical Building, LLC

  

Connecticut

653 Town Center Investments, LLC

  

Arizona

653 Town Center Phase II, LLC

  

Arizona

Auburn Medical Properties II, LLC

  

Delaware

ApaMed Properties, LLC

  

Arizona

Banburry Medical Properties, LLC

  

Delaware

BRB/E Building One, LLC

  

Texas

Centennial Medical Properties, LLC

  

Delaware

Cimarron Medical Properties, LLC

  

Texas

Cobre Properties, LLC

  

Delaware

Cypresswood Investments, L.P

  

Georgia

Deerval Properties, LLC

  

Arizona

DesMed, LLC

  

Arizona

DTX Medical Properties, LLC

  

Texas

Eagle Medical Properties, LLC

  

Michigan

Forney Deerval, LLC

  

Texas

Forney Willetta, LLC

  

Texas

Gold Shadow Properties, LLC

  

Arizona

NSHE TX Bay City, LLC

  

Texas

NSHE TX Cedar Park, LLC

  

Texas

NWTX Medical Properties, LLC

  

Texas

Oneida Medical Properties, LP

  

Texas

Paseo Medical Properties II, LLC

  

Arizona

Pax Medical Holdings, LLC

  

Delaware

Riverdale Realty, LLC

  

Georgia

Saratoga Hospital Properties, LP

  

Texas

Sheffield Properties, LLC

  

Georgia

Spring Valley Medical Properties, LLC

  

Arizona

Spring Valley Medical Properties II, LLC

  

Arizona

Saratoga Hospital Properties, LP

  

Texas

Tuscan Medical Properties, LLC

  

Delaware

UHT TRS, LLC

  

Delaware

UHT/Ensemble Properties I, LLC

  

Delaware

Willetta Medical Properties, LLC

  

Arizona

EX-23.1 4 d649900dex231.htm EXHIBIT 23.1 Exhibit 23.1

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Trustees

Universal Health Realty Income Trust:

 

We consent to the incorporation by reference in the registration statements (Nos. 333-143944 and 333-57815) on Form S-8 and in the registration statements (Nos. 333-81763 and 333-185092) on Form S-3 of Universal Health Realty Income Trust of our reports dated March 7, 2014, with respect to the consolidated balance sheets of Universal Health Realty Income Trust as of December 31, 2013 and 2012, and the related consolidated statements of income, changes in equity, and cash flows for each of the years in the three-year period ended December 31, 2013, and the related financial statement schedule III, real estate & accumulated depreciation, and the effectiveness of internal control over financial reporting as of December 31, 2013, which reports appear in the December 31, 2013 annual report on Form 10-K of Universal Health Realty Income Trust.

 

(signed) KPMG LLP

 

Philadelphia, Pennsylvania

March 7, 2014

EX-31.1 5 d649900dex311.htm EXHIBIT 31.1 Exhibit 31.1

Exhibit 31.1

 

CERTIFICATION - Chief Executive Officer

 

I, Alan B. Miller, certify that:

 

1. I have reviewed this annual report on Form 10-K of Universal Health Realty Income Trust;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 7, 2014

 

/s/ Alan B. Miller

President and Chief

Executive Officer

EX-31.2 6 d649900dex312.htm EXHIBIT 31.2 Exhibit 31.2

Exhibit 31.2

 

CERTIFICATION - Chief Financial Officer

 

I, Charles F. Boyle, certify that:

 

1. I have reviewed this annual report on Form 10-K of Universal Health Realty Income Trust;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 7, 2014

 

/s/ Charles F. Boyle

Vice President and

Chief Financial Officer

EX-32.1 7 d649900dex321.htm EXHIBIT 32.1 Exhibit 32.1

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Universal Health Realty Income Trust (the “Trust”) on Form 10-K for the year ended December 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan B. Miller, President and Chief Executive Officer of the Trust, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the end of, and for the period covered by, the Report.

 

/s/ Alan B. Miller

President and Chief Executive Officer

March 7, 2014

 

A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 8 d649900dex322.htm EXHIBIT 32.2 Exhibit 32.2

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Universal Health Realty Income Trust (the “Trust”) on Form 10-K for the year ended December 31, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles F. Boyle, Vice President and Chief Financial Officer of the Trust, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the end of, and for the period covered by, the Report.

 

/s/ Charles F. Boyle

Vice President and Chief Financial Officer

March 7, 2014

 

A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 9 uht-20131231.xml XBRL INSTANCE DOCUMENT 99000 30400000 0.95 0.95 50974 12200000 50946 15000000 540970533 16300 4100000 0.90 4400 625000 P60D 33.89 51000 74683000 145510000 987000 199940000 97000 213209000 145413000 12653000 127000 373604000 -441527000 26.09 36.53 20900000 133100000 1.00 0.018 33.89 51000 74865000 188945000 11500000 11649000 363498000 84000 213566000 188861000 12677000 127000 447398000 -472230000 26.09 36.53 300000 1.00 50344 5100000 53000 7000000 15500000 6999000 1229000 36940000 6943000 3892000 40900000 31000 39578000 47806000 0.95 0.95 0.98 0.95 0.95 0.95 0.99 0.95 0.95 0.98 0.85 12688998 0.024 35.22 43000 0.01 95000000 0.01 5000000 12688998 87088000 20463000 0 116186000 177745000 87088000 116000000 5368000 214094000 4920000 1300000 177671000 466875000 0 74000 81750000 205293000 539000 8200000 127000 383038000 2041000 5851000 503425000 27058000 314386000 287328000 26293000 374416000 116000000 28636000 383038000 3048000 401474000 28636000 1898000 9850000 106150000 12658000 2783000 77511000 74000 214094000 177671000 12689000 127000 466875000 -503425000 29.44 36.53 0.062 72000 9600000 9600000 30400000 23240000 144000 32090000 6020000 1900000 799000 16891000 40000000 799000 534000 0.90 0.95 12858643 0.022 0.90 35.65 40000 0 0.01 95000000 58 0.01 5000000 16 12858643 43914000 97921000 42692000 20667000 8700000 -57000 46589000 106287000 106400000 165630000 97921000 129026000 5336000 220691000 5156000 206060000 21519000 105453000 834000 165630000 93700000 11894000 105453000 47600000 480044000 18330000 0 39631000 13098000 0 18860000 93700000 10672000 101245000 199153000 207515000 36769000 491000 13700000 128000 373145000 93700000 4600000 2053000 6714000 535176000 27374000 27374000 297748000 270374000 20782000 368295000 129026000 3900000 39201000 2900000 368295000 1700000 0 373145000 16300000 3337000 20800000 834000 395669000 176240 317546000 3400000 39201000 25558000 0.95 2.21 93700000 125000000 1881000 9479000 13 119547000 22911000 40000 19.1 50000000 3310000 80112000 1.00 144848000 150000000 12 0.20 0.15 0.85 0.90 0.74 0.75 0.95 0.95 0.95 0.95 0.33 0.90 0.95 0.95 0.95 13 150000000 20000000 50000000 256000000 0.0065 0.0070 382000000 0 220691000 165630000 12859000 128000 480044000 -57000 -535176000 41.71 30.06 0.33 4.00 36.53 0.95 3.50 13000 4000 23000 11 6 P180D 0.061 11000 3749000 610000 316000 21000 4685000 4700000 27025 75000 354000 40000 35.65 8634000 2018 3970000 2015 7941000 2015 24052000 2015 6614000 2017 12540000 2014 6162000 2015 5596000 2017 4603000 2018 0.0342 10938000 2018 0.0550 5122000 2015 0.0342 11347000 2016 0.0556 6262000 2025 0.0427 6840000 2022 0.0292 7406000 2017 0.0454 6766000 2022 0.0564 21681000 2017 0.0600 4899000 2017 0.0550 12021000 2017 0.0655 9188000 2014 0.0650 2983000 2019 47 0.95 12500000 2300000 2100000 0.75 6300000 5200000 4400000 2100000 2500000 1100000 7 3 2 1 1 4 P3Y6M 11829000 14174000 578000 12039000 41492000 80112000 958000 439000 2488000 2927000 1618000 439000 283000 240000 3617000 3857000 3590000 240000 244000 7180000 7180000 7180000 1742000 806000 4209000 5015000 264000 782000 3455000 4237000 3455000 782000 2648000 2678000 4899000 1151000 5606000 6757000 5176000 1151000 869000 6262000 1100000 12525000 13625000 12525000 1100000 5554000 150000 9966000 10116000 5395000 150000 10464000 2050000 25297000 27347000 10701000 2050000 936000 736000 3463000 4199000 9766000 1760000 2212000 573000 4415000 4988000 3842000 573000 1412000 10938000 20633000 20633000 19890000 930000 2141000 1130000 2788000 3918000 5092000 1130000 694000 7406000 10359000 10359000 10200000 391000 307000 996000 1303000 996000 307000 931000 6766000 400000 12268000 12668000 11300000 400000 320000 180000 815000 995000 815000 180000 693000 9808000 9808000 9800000 1701000 21681000 1900000 24910000 26810000 24910000 1900000 591000 6840000 430000 8994000 9424000 8970000 430000 8245000 158000 8242000 8400000 6404000 158000 294000 195000 749000 944000 749000 195000 5485000 1345000 12021000 370000 17561000 17931000 16830000 370000 23440000 6281000 40070000 46351000 31442000 4720000 772000 1100000 9041000 10141000 9000000 1100000 1149000 910000 11991000 12901000 11960000 910000 15182000 1663000 31549000 33212000 14652000 1190000 858000 1647000 1647000 1579000 3030000 4867000 500000 8007000 8507000 6945000 500000 854000 54000 2020000 2074000 1526000 54000 1251000 9188000 460000 15891000 16351000 15440000 460000 1044000 11347000 16343000 16343000 14900000 664000 5122000 9611000 9611000 9500000 772000 1200000 9760000 10960000 9560000 1200000 832000 439000 2020000 2459000 1837000 439000 292000 250000 744000 994000 744000 250000 10000 96000 529000 625000 529000 96000 44000 220000 3220000 3440000 3220000 220000 928000 2983000 1104000 5508000 6612000 5508000 1104000 1.00 1.00 2 1.00 2 1.00 0.05 12858667 16700 9800 7200000 0.37 4600000 49800000 4400000 8100000 30000 P6Y6M P10Y P6Y2M12D 12200000 8000000 P5Y1M6D 5.84 -776000 5.83 12649000 5000 0.32 21372000 2.425 12644000 3058000 238000 30703000 28576000 73781000 4408000 28877000 57932000 474000 2600000 269000 291000 1800000 3788000 -39000 11541000 -101000 2216000 29494000 4191000 1064000 0 13150000 8727000 4100000 1733000 54000000 28600000 67800000 39578000 73794000 35835000 634000 12000 5581000 6157000 2008000 20767000 -7426000 281000 7306000 10662000 30703000 -96000 8718000 133080000 6339000 2402000 24550000 5354000 7306000 836000 6300000 12000 33800000 0 -3284000 3967000 33836000 221000 244000 1157000 5260000 0 455000 107000 11511000 1654000 6999000 4000 25503000 162000 178000 36300000 2111000 17630000 10392000 500000 51000 40832000 0.42 4170000 13066000 621000 2.425 162000 518000 309000000 2000000 0.50 0.50 0.15 0.55 0.475 -28877000 20890000 2944000 -53758000 133080000 3025000 4170000 0 76111000 687000 0.19 -13000 238000 269000 12000 162000 238000 73794000 269000 12000 30703000 162000 14000 73794000 30703000 0.716 1.191 1.234 4400000 991000.0 28600000 11 P13Y6M P4Y3M18D 41.90 7395 309850 216000 18000 BRB Medical Office Building 0.90 AZ Phoenix Deer Valley Medical Office II Spring Valley Medical Office Building 700 Shadow Lane & Goldring Medical Office Buildings 0.95 AZ Phoenix Deer Valley Medical Office III Summerlin Hospital Medical Office Building III 0.76 AZ Mesa Desert Samaritan Hospital MOBs Centennial Hills Medical Office Building I Auburn Medical Office Building II 0.75 AZ Glendale Thunderbird Paseo Medical Plaza I & II Desert Springs Medical Plaza 0.93 AZ Phoenix Deer Valley Parking Garage Spring Valley Hospital Medical Office Building II 0.95 AZ Globe Cobre Valley Medical Plaza 0.89 AZ Phoenix Papago Medical Park Summerlin Hospital Medical Office Building I 0.90 AZ Phoenix Edwards Medical Plaza Summerlin Hospital Medical Office Building II Apache Junction Medical Plaza UHT UNIVERSAL HEALTH REALTY INCOME TRUST Yes false Accelerated Filer 2013 10-K 2013-12-31 0000798783 No --12-31 FY No <div> <p style="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-4%"> <font style="font-family:Times New Roman" size="2"><b>(4) LEASES</b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">All of our leases are classified as operating leases with initial terms typically ranging from 3 to 15 years with up to five additional, five-year renewal options. Under the terms of the leases, we earn fixed monthly base rents and pursuant to the leases with subsidiaries of UHS, we may earn periodic bonus rents (see Note 1). The bonus rents from the subsidiaries of UHS, which are based upon each facility&#x2019;s net revenue in excess of base amounts, are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to the corresponding quarter in the base year.</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Minimum future base rents from non-cancelable leases, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="80%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="85%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">42,692</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">39,631</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">36,769</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">21,519</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">18,860</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Thereafter</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">46,589</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total minimum base rents</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">$206,060</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Some of the leases contain gross terms where operating expenses are included in the base rent amounts. Other leases contain net terms where the operating expenses are assessed separately from the base rentals. The table above contains a mixture of both gross and net leases, and does not include any separately calculated operating expense reimbursements. Under the terms of the hospital leases, the lessees are required to pay all operating costs of the properties including property insurance and real estate taxes. Tenants of the medical office buildings generally are required to pay their pro-rata share of the property&#x2019;s operating costs.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December&#xA0;31, 2013 were as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options Outstanding and<br /> Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 48pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise Price</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise<br /> Price&#xA0;Per<br /> Share</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Life&#xA0;(in<br /> Years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$30.06&#xA0;-$34.07</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.07</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$34.90&#xA0;-$34.90</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34.90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$36.53&#xA0;-$36.53</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 1.04 P2Y6M <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px; TEXT-INDENT: -2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Real Estate Investments</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On the date of acquisition, the purchase price of a property is allocated to the property&#x2019;s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December&#xA0;31, 2013, and will be amortized over the remaining lease terms (aggregate weighted average of 3.5 years) and will result in an estimated aggregate amortization expense of $4.6&#xA0;million, $3.9&#xA0;million, $3.4&#xA0;million $2.9 million and $1.7 million for 2014, 2015, 2016, 2017 and 2018, respectively. Amortization expense on intangible values of in place leases was $6.0 million for the year ended December&#xA0;31, 2013, $7.8 million for the year ended December&#xA0;31, 2012 and $836,000 for the year ended December&#xA0;31, 2011. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $12.5 million for the year ended December 31, 2013, $12.2 million for the year ended December 31, 2012 and $6.3 million for the year ended December 31, 2011.</font></p> </div> <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Minimum future base rents from non-cancelable leases, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="80%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="85%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">42,692</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">39,631</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">36,769</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">21,519</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">18,860</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Thereafter</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">46,589</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total minimum base rents</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">$206,060</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> -3415000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Revenue Recognition</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (&#x201C;MOBs&#x201D;) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility&#x2019;s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility&#x2019;s current quarter&#x2019;s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.</font></p> </div> 1.04 12701000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table provides information about options outstanding and exercisable options at December&#xA0;31, 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="86%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options<br /> Outstanding<br /> and&#xA0;Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Number</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average exercise price</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Aggregate intrinsic value</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">176,240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average remaining contractual life</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Asset Impairment</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management&#x2019;s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million in connection with an MOB located on a medical campus in Atlanta, Georgia. The asset impairment charge was recorded after evaluation of property and location-specific factors including pressure on rental and occupancy rates caused, in part, by the impact of continued unfavorable economic conditions in the market as well as competitive pressures caused by increased capacity added to the market. The fair value of this property was determined based upon the present value of the expected future cash flows.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.</font></p> </div> 12000 <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(7)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>INCENTIVE PLANS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We expense the grant-date fair value of stock options and restricted stock awards under the straight-line method over the stated vesting period of the award. We use the Black-Scholes option pricing model for determining the grant-date fair value of our stock options. All of our outstanding stock options have been fully expensed as of December&#xA0;31, 2011.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2007, upon the expiration of our 1997 Incentive Plan, as discussed below, our Board of Trustees and shareholders approved the Universal Health Realty Income Trust 2007 Restricted Stock Plan (the &#x201C;2007 Plan&#x201D;). A total of 75,000 shares were authorized for issuance under this plan and a total of 47,975 shares, net of cancellations, have been issued pursuant to the terms of this plan, 28,870 of which have vested as of December&#xA0;31, 2013. At December&#xA0;31, 2013 there are 27,025 shares remaining for issuance under the terms of the 2007 Plan.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2013, there were 8,730 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.54 per share ($380,104 in the aggregate). These restricted shares are scheduled to vest in June of 2015 (the second anniversary of the date of grant).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2012, there were 10,375 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $39.05 per share ($405,144 in the aggregate). These restricted shares are scheduled to vest in June of 2014 (the second anniversary of the date of grant). Included the restricted stock issuances during 2012 were one-time special compensation awards made to our executive officers in recognition of their efforts and contributions in connection with various acquisitions, divestitures and purchases of third-party minority interests in certain majority-owned LLCs as completed at various times during 2011 and the first quarter of 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2011, there were 7,395 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $41.90 per share ($309,850 in the aggregate). These restricted shares vested during 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In connection with these grants, we recorded compensation expense of approximately $375,000, $329,000 and $216,000 during 2013, 2012 and 2011, respectively. The remaining expenses associated with these grants is approximately $354,000 and will be recorded over the remaining weighted average vesting period for outstanding restricted Shares of Beneficial Interest of approximately one year at December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Prior to its expiration in 2007, the Universal Health Realty Income Trust 1997 Incentive Plan (the &#x201C;1997 Plan&#x201D;) provided for the granting of stock options and dividend equivalents rights (&#x201C;DERs&#x201D;) to employees of the Trust, including officers and trustees. Awards granted pursuant to the 1997 Plan prior to its termination date remain exercisable, in accordance with the terms of the outstanding agreements. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. The options granted vested ratably at 25%&#xA0;per year beginning one year after the date of grant, and expire in ten years. DERs on outstanding awards are earned in amounts equal to the cash or stock dividends declared subsequent to the date of grant. We recorded expenses relating to the dividend equivalent rights of approximately $19,000 in 2013 and $18,000 in each of 2012 and 2011. As of December&#xA0;31, 2013, there were 40,000 options outstanding and exercisable under the 1997 Plan with an average exercise price of $35.65 per share.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">There were no compensation costs recognized during 2013 and 2012, and $12,000 of compensation costs during 2011, related to outstanding stock options and DERs that were granted or have vestings after January&#xA0;1, 2006. As of December&#xA0;31, 2011, all of the outstanding stock options and DERs were fully vested and fully expensed. The outstanding stock options have a remaining weighted average life of 2.5 years at December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2008, the Board of Trustees of the Trust approved amendments to the outstanding stock option agreements made pursuant to the 1997 Plan. These original agreements provided for the deferred payment of dividend equivalents on shares covered by the options, with payment tied to the date the options were exercised or expire. In order to meet certain recent changes to tax law requirements, the agreements, as amended, provide for the current payment of dividend equivalents in the years in which dividends are declared and paid or, if later, when the related options become vested. Dividend equivalent rights with respect to 40,000 shares were outstanding at December&#xA0;31, 2013. Dividend equivalent rights with respect to 43,000 shares were outstanding at December&#xA0;31, 2012. Dividend equivalent rights with respect to 51,000 shares were outstanding at December&#xA0;31, 2011. In December of 2013, 2012 and 2011, dividend equivalent rights which were vested and accrued as of each respective date, were paid to officers and Trustees of the Trust amounting to $106,000, $116,000 and $178,000, respectively.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Stock options to purchase shares of beneficial interest have been granted to eligible individuals, including our officers and trustees. Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="51%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 71pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding Options</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br /> of&#xA0;Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise<br /> Weighted-<br /> Average&#xA0;Price</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Grant&#xA0;Price&#xA0;Range<br /> (High-Low)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2011</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2012</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26.76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">27.65/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.22</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding options vested and exercisable as of December&#xA0;31, 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$30.06</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During 2013, there were 3,000 stock options exercised with a total in-the-money value of $46,290. During 2012, there were 8,000 stock options exercised with a total in-the-money value of $148,930. There were no stock options exercised during 2011.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">There were no unvested options as of December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table provides information about options outstanding and exercisable options at December&#xA0;31, 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="86%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options<br /> Outstanding<br /> and&#xA0;Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Number</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average exercise price</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Aggregate intrinsic value</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">176,240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Weighted average remaining contractual life</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December&#xA0;31, 2013 were as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="73%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Options Outstanding and<br /> Exercisable</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 48pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise Price</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Exercise<br /> Price&#xA0;Per<br /> Share</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Weighted<br /> Average<br /> Remaining<br /> Contractual<br /> Life&#xA0;(in<br /> Years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$30.06&#xA0;-$34.07</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.07</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$34.90&#xA0;-$34.90</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">34.90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1.7</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">$36.53&#xA0;-$36.53</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">23,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(8)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings. As of December&#xA0;31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June&#xA0;30, 2013. As previously disclosed, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July&#xA0;1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Additionally, we have 100% ownership interests in eleven LLCs as of December&#xA0;31, 2013 that were accounted for under the equity method through December&#xA0;11, 2011 as previously disclosed. These eleven LLCs were subsequently consolidated into the results of operations effective December&#xA0;12, 2011.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following property table represents the thirteen LLCs which were accounted for under the equity method as of December&#xA0;31, 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="54%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban Medical Plaza II</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Professional Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Mid Coast Hospital MOB</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington Medical Properties(b.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Saint Mary&#x2019;s Professional Office Building</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra San Antonio Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix Children&#x2019;s East Valley Care Center</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties(a.)(f.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Vista&#xA0;Medical&#xA0;Terrace&#xA0;&amp;&#xA0;The&#xA0;Sparks&#xA0;Medical&#xA0;Building</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties(a.)(c.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Texoma Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">3811 Bell Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">North Valley Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II(d.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Forney Medical Plaza II</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale&#xA0;Medical&#xA0;Properties(a.)(e.)(f.)(g)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Plaza</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tenants of this medical office building include or will include subsidiaries of UHS.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December&#xA0;31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary&#x2019;s Professional Office Building.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(e.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013, as discussed above.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(f.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interest (5%)&#xA0;in this LLC. As a result of our purchase of the minority ownership interest, as of January&#xA0;1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January&#xA0;1, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(g.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As disclosed below, as of December&#xA0;31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On December&#xA0;12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs. The aggregate cash expenditure made by us in connection with the purchase of these membership interests in the various LLCs, including closing costs, was approximately $4.4 million. As a result of these transactions, accounting standards required that we record each property&#x2019;s assets and liabilities at their fair values and record a non-cash gain or loss for the difference between the fair values and the equity method carrying value of each investment. In the aggregate, the purchase of these membership interests resulted in a $28.6 million gain on fair value recognition resulting from the purchase of the minority interests which is included in our consolidated statements of income for the year ended December&#xA0;31, 2011. On December&#xA0;12, 2011, we began consolidating the financial data of these eleven LLCs in our consolidated financial statements. The following property table represents these eleven LLCs (the summarized financial data for these eleven LLCs through December&#xA0;11, 2011, are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="54%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Previous<br /> Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Investments(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building I</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Phase II(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">ApaMed Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Apache Junction Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical Properties II(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical Office Building II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Banburry Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building III</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB/E Building One</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Building I</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DesMed(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Springs Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Gold Shadow Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane &amp; Goldring Medical Office Buildings</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Hospital&#xA0;Medical&#xA0;Office&#xA0;Building&#xA0;II</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tenants of this medical office building include or will include subsidiaries of UHS.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On November&#xA0;30, 2011 and December&#xA0;16, 2011, eight LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings and related real property. As partial consideration for the transaction, the buyer assumed certain existing third-party mortgage debt related to the properties. For certain of the LLCs, the sale of the medical office buildings were part of a series of planned like-kind exchange transaction pursuant to Section&#xA0;1031 of the Internal Revenue Code. The divestiture by the eight LLCs generated approximately $33.8 million of aggregate cash proceeds (a portion of which were sent to qualified third-party intermediaries), net of closing costs and the minority members&#x2019; share of the proceeds. In the aggregate, these transactions also resulted in a $35.8 million gain on divestiture which is included in our consolidated statements of income for the year ended December&#xA0;31, 2011. The following property table represents the eight LLCs that divested medical office buildings on November&#xA0;30, 2011 and December&#xA0;16, 2011 (the summarized financial data for these eight LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="54%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DSMB Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Samaritan Hospital MOBs</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Litchvan Investments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Papago Medical Park</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Paseo Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Thunderbird Paseo Medical Plaza I &amp; II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Willetta Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Edwards Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties II(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office Building III</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(a.</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Parking Garage</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Valley Medical Plaza</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following property table represents the two LLCs that divested medical office buildings on February&#xA0;3, 2012 and October&#xA0;10, 2012 (the summarized financial data for these two LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td width="52%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Canyon Healthcare Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Canyon Springs Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">575 Hardy Investors</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Centinela Medical Building Complez</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following financial tables represent summarized financial information related to the LLCs that we accounted for under the equity method during 2013, including the financial information of the divested LLCs through their divestiture date. The 2011 table includes financial information of the divested LLCs through their divestiture date, as well as the LLCs in which we held majority noncontrolling ownership interests through December&#xA0;11, 2011.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined statements of income for the LLCs accounted for under the equity method. The years ended December&#xA0;31, 2012 and 2011 include the prorated amounts for the LLCs that were divested through their divestiture dates, or in which we purchased the minority ownership interests, for the period in which they were accounted for under the equity method:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>For the Year Ended December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,001</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,448</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57,932</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Operating expenses</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,974</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25,503</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,039</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,140</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,066</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Interest, net</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,353</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,056</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,630</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net income before gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,904</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,278</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,733</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income before gains on divestitures(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,095</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,365</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,058</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,520</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35,835</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2103. Prior to July&#xA0;1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July&#xA0;1, 2013 through December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December&#xA0;31, 2013 and 2012:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="82%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net property, including CIP</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">119,547</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">106,150</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,850</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">116,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,336</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,368</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Mortgage notes payable, non-recourse to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">77,511</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Advances payable to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,911</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,658</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,667</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total liabilities and equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">116,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of equity and advances to LLCs</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,201</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28,636</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. Prior to July&#xA0;1, 2013, the financial results of this entity were accounted for on a consolidated basis.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2013, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="90%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14,174</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41,492</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">578</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,829</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,039</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="79%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Mortgage<br /> Balance(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity&#xA0;Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,540</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,941</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,052</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,970</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,162</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,596</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,614</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,603</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2018</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,634</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2018</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Construction loan.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the operating agreements of the jointly-owned LLCs, the third-party member and the Trust, at any time, have the right to make an offer (&#x201C;Offering Member&#x201D;) to the other member(s) (&#x201C;Non-Offering Member&#x201D;) in which it either agrees to: (i)&#xA0;sell the entire ownership interest of the Offering Member to the Non-Offering Member (&#x201C;Offer to Sell&#x201D;) at a price as determined by the Offering Member (&#x201C;Transfer Price&#x201D;), or; (ii)&#xA0;purchase the entire ownership interest of the Non-Offering Member (&#x201C;Offer to Purchase&#x201D;) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i)&#xA0;purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii)&#xA0;sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The LLCs in which we have invested maintain property insurance on all properties. Although we believe that generally our properties are adequately insured, two of the LLCs in which we own various non-controlling equity interests, own properties in California that are located in earthquake zones. These properties, in which we have invested or advanced a total of $16.3 million at December&#xA0;31, 2013, are not covered by earthquake insurance since earthquake insurance is no longer available at rates which are economical in relation to the risks covered.</font></p> </div> <div> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013 (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,885</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,502</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,448</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,445</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">54,280</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,427</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,941</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,303</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,498</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,169</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="font-size:1px;margin-top:12px;margin-bottom:0px"> &#xA0;</p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,351</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,666</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,610</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,323</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">53,950</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income before gains</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,139</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,467</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,365</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">10,957</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net gains on divestiture of properties owned by unconsolidated LLCs(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,375</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,145</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8,520</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">9,514</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,467</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">4,510</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">19,477</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.75</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.19</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.36</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.75</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.19</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.36</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. Prior to July&#xA0;1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December&#xA0;31, 2012.</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2013, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="90%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">14,174</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">41,492</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">578</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,829</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,039</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="79%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Mortgage<br /> Balance(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity&#xA0;Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,540</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,941</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">24,052</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,970</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,162</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,596</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,614</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,603</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2018</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,634</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;2018</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Construction loan.</font></td> </tr> </table> </div> The decrease during 2013 and 2012 as compared to 2011 is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings ("MOBs") and clinics completed during 2011 and the first quarter of 2012. <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Federal Income Taxes</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $382 million and $256 million, respectively, at December&#xA0;31, 2013.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following property table represents the thirteen LLCs which were accounted for under the equity method as of December&#xA0;31, 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="54%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 59pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC/LP</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DVMC Properties(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Valley Medical Center</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Suburban Medical Plaza II</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Santa Fe Professional Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Brunswick Associates(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Mid Coast Hospital MOB</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Medical Properties(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Rosenberg Children&#x2019;s Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Arlington Medical Properties(b.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Saint Mary&#x2019;s Professional Office Building</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Sierra San Antonio Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PCH Southern Properties(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix Children&#x2019;s East Valley Care Center</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Sparks Medical Properties(a.)(f.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Vista&#xA0;Medical&#xA0;Terrace&#xA0;&amp;&#xA0;The&#xA0;Sparks&#xA0;Medical&#xA0;Building</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Grayson Properties(a.)(c.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Texoma Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">3811 Bell Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">North Valley Medical Plaza</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">FTX MOB Phase II(d.)(g.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Forney Medical Plaza II</font></td> </tr> <tr> <td valign="top" nowrap="nowrap"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale&#xA0;Medical&#xA0;Properties(a.)(e.)(f.)(g)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Plaza</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tenants of this medical office building include or will include subsidiaries of UHS.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December&#xA0;31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary&#x2019;s Professional Office Building.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(d.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(e.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013, as discussed above.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(f.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interest (5%)&#xA0;in this LLC. As a result of our purchase of the minority ownership interest, as of January&#xA0;1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January&#xA0;1, 2014.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(g.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As disclosed below, as of December&#xA0;31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;On December&#xA0;12, 2011, we began consolidating the financial data of these eleven LLCs in our consolidated financial statements. The following property table represents these eleven LLCs (the summarized financial data for these eleven LLCs through December&#xA0;11, 2011, are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="54%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Previous<br /> Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Investments(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building I</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Phase II(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">ApaMed Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Apache Junction Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical Properties II(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical Office Building II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Banburry Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building III</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB/E Building One</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Building I</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DesMed(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Springs Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Gold Shadow Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane &amp; Goldring Medical Office Buildings</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Hospital&#xA0;Medical&#xA0;Office&#xA0;Building&#xA0;II</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tenants of this medical office building include or will include subsidiaries of UHS.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;The following property table represents the eight LLCs that divested medical office buildings on November&#xA0;30, 2011 and December&#xA0;16, 2011 (the summarized financial data for these eight LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="54%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DSMB Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Samaritan Hospital MOBs</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Litchvan Investments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Papago Medical Park</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Paseo Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Thunderbird Paseo Medical Plaza I &amp; II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Willetta Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Edwards Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office II</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties II(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office Building III</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(a.</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Parking Garage</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Valley Medical Plaza</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following property table represents the two LLCs that divested medical office buildings on February&#xA0;3, 2012 and October&#xA0;10, 2012 (the summarized financial data for these two LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="39%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td width="52%"></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 86pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Canyon Healthcare Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Canyon Springs Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">575 Hardy Investors</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Centinela Medical Building Complez</font></td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(10)</b></font></td> <td width="1%" valign="top"><font size="1">&#xA0;</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>QUARTERLY RESULTS (unaudited)</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2013 (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,885</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,502</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,448</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,445</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">54,280</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,427</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,941</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,303</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,498</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,169</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.23</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.26</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.27</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.04</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="font-size:1px;margin-top:12px;margin-bottom:0px"> &#xA0;</p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="60%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>First<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Second<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Third<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fourth<br /> Quarter</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="18" align="center"><font style="font-family:Times New Roman" size="1"><b>(amounts in thousands, except per share amounts)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,351</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,666</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,610</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">13,323</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">53,950</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income before gains</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,139</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,467</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,365</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">10,957</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net gains on divestiture of properties owned by unconsolidated LLCs(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7,375</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td nowrap="nowrap" valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1,145</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8,520</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">9,514</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,467</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">4,510</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">19,477</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total basic earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.75</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.19</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.36</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Total diluted earnings per share</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.75</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.19</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">0.36</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">1.54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. Prior to July&#xA0;1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December&#xA0;31, 2012.</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2013, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="90%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,894</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015(a)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">101,245</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,098</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,914</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,672</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Later</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">18,330</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199,153</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.</font></td> </tr> </table> </div> <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="33%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="28%"></td> <td valign="bottom" width="3%"></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="border-bottom:1px solid #000000;width:33pt" align="center"><font style="font-family:Times New Roman" size="1"><b>Assets(b.)</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Fair Value at<br /> December&#xA0;31,&#xA0;2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"> <font style="font-family:Times New Roman" size="1"><b>Valuation Technique</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Unobservable inputs</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Range</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">PeaceHealth Medical Clinic (a.)(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">30,400,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="font-family:Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="font-family:Times New Roman" size="2">Capitalization&#xA0;Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">7.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="font-family:Times New Roman" size="2">Discount Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="bottom"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Northwest Texas Professional Office Tower</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">9,600,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="font-family:Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="font-family:Times New Roman" size="2">Capitalization Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">8.60</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="font-family:Times New Roman" size="2">Discount&#xA0;Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">9.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">The fair value of the land was estimated based upon the sales comparison approach.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">Based upon preliminary appraisals.</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(c.)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.</font></td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(5)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>DEBT</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In July, 2011, we entered into a $150 million revolving credit agreement (&#x201C;Credit Agreement&#x201D;) which is scheduled to expire on July&#xA0;24, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines &#x201C;Base Rate&#x201D; as the greatest of: (a)&#xA0;the administrative agent&#x2019;s prime rate; (b)&#xA0;the federal funds effective rate plus 0.50%, and; (c)&#xA0;one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December&#xA0;31, 2013, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2013, we had $93.7 million of outstanding borrowings and $8.7 million of letters of credit outstanding against our revolving credit agreement. We had $47.6 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December&#xA0;31, 2013. There are no compensating balance requirements. The average amounts outstanding under our revolving credit agreement were $86.3 million in 2013, $75.4 million in 2012 and $67.8 million in 2011 with corresponding effective interest rates, including commitment fees, of 2.2% in 2013, 2.4% in 2012 and 1.8% in 2011. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $93.7 million at December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December&#xA0;31, 2013. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Covenant</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,<br /> 2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tangible net worth</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">125,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">144,848</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to total capital</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt; 55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt service coverage ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&gt;&#xA0;4.00x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19.1x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to cash flow ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt;&#xA0;3.50x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.21x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We have twelve mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December&#xA0;31, 2013, with a combined outstanding balance of $105.5 million (excluding net debt premium, resulting from fair value recognition of third-party debt of $834,000 at December&#xA0;31, 2013). The following table summarizes our outstanding mortgages, excluding net debt premium, at December&#xA0;31, 2013 (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="72%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Facility Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding<br /> Balance<br /> (in&#xA0;thousands)(a)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Interest<br /> Rate</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity<br /> Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building I fixed rate mortgage loan (b)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,188</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,122</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building III floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,347</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.42</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Peace Health fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,681</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.64</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building II fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,021</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical II floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,406</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.92</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Medical Center of Western Connecticut fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,899</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Building floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,938</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.42</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vibra Hospital of Corpus Christi fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,983</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2019</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,840</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.27</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2022</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane and Goldring MOBs fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,766</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2022</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tuscan Professional Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,262</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.56</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2025</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">105,453</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Amortized principal payments are made on a monthly basis.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $106.4 million as of December&#xA0;31, 2013. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2013, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="90%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,894</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2015(a)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">101,245</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,098</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,914</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,672</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Later</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">18,330</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199,153</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px; TEXT-INDENT: -2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Investments in Limited Liability Companies (&#x201C;LLCs</b>&#x201D;)</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB&#x2019;s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#xA0;divestiture of property; (ii)&#xA0;annual budget approval, and; (iii)&#xA0;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings (including Palmdale Medical Properties, LLC and Sparks Medical Properties, LLC which, as discussed below, we purchased the minority ownership interests effective January&#xA0;1, 2014 and now hold 100% of the ownership interests of these entities). As of December&#xA0;31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June&#xA0;30, 2013. As discussed below, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July&#xA0;1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties had a master lease with a subsidiary of UHS through June&#xA0;30, 2013. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS (through UHS of Delaware, Inc.). As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we have accounted for this LLC on a consolidated basis, since its inception in the fourth quarter of 2007 through June&#xA0;30, 2013, since it was a variable interest entity and we were deemed to be the primary beneficiary. As of July&#xA0;1, 2013, the master lease expired and this LLC is no longer considered a variable interest entity and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. The expiration of the master lease and related deconsolidation did not have a material impact on our net income and funds from operations during the second half of 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As a result of master lease arrangements between UHS and various LLCs in which we hold or held majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB&#x2019;s standards and guidance.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs and will begin accounting for them on a consolidated basis effective January&#xA0;1, 2014. Each of the property&#x2019;s assets and liabilities will be recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). We do not expect these transactions or the expected related aggregate gain (to be recorded during the first quarter of 2014) to have a material impact on our future results of operations.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In addition, effective December&#xA0;12, 2011, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as discussed herein (see Notes 3 and 8 to the consolidated financial statements for additional disclosure).</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash and Cash Equivalents</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.</font></p> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(3)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>ACQUISITIONS AND DISPOSITIONS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2014:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisitions:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In January, 2014, we purchased the following in a single transaction:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The Children&#x2019;s Clinic at Springdale &#x2013; a 9,800 square foot, single-tenant medical office building located in Springdale, Arkansas, and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The Northwest Medical Center at Sugar Creek &#x2013; a 16,700 square foot, multi-tenant medical office building located in Bentonville, Arkansas.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price for these MOBs was approximately $7.2 million. The net tangible and intangible property preliminary asset allocation of the total purchase price will be recorded during the first quarter of 2014, subject to a third-party fair market valuation.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Additionally, effective January&#xA0;1, 2014, we purchased the minority ownership interests held by third-party members in two LLCs in which we previously held noncontrolling majority ownership interests (Palmdale Medical Properties and Sparks Medical Properties). As a result of these minority ownership purchases, we now own 100% of each of these LLCs and will begin accounting for each on a consolidated basis effective January&#xA0;1, 2014. The aggregate cash payment made by us during the first quarter of 2014 in connection with the purchase of these minority ownership interests was approximately $170,000. Each of the property&#x2019;s assets and liabilities will be recorded at their estimated fair values during the first quarter of 2014. We do not expect these transactions, or the expected related aggregate gain (to be recorded during the first quarter of 2014), to have a material impact on our future results of operations.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 18px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2013:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisition:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In August, 2013, we purchased the Ward Eagle Office Village located in Farmington Hills, Michigan. This multi-tenant MOB, which was purchased for approximately $4.1 million, consists of approximately 16,300 rentable square feet.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In June, 2013, we purchased the 5004 Poole Road MOB, located in Denison, Texas, on the campus of Texoma Medical Center, a wholly-owned subsidiary of UHS. This single-tenant MOB, which was purchased for approximately $625,000, consists of approximately 4,400 rentable square feet and is located adjacent to our Texoma Medical Plaza MOB.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">316</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">610</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(11</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,685</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The Ward Eagle Office Village acquisition was valued utilizing the income capitalization approach. The calculated fair value, utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property&#x2019;s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>New Construction:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The newly constructed Forney Medical Plaza II located in Forney, Texas was completed and opened in April, 2013. This multi-tenant medical office building, consisting of 30,000 rentable square feet, is owned by a limited partnership in which we hold a 95% non-controlling ownership interest. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Divestitures:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">There were no divestitures during 2013.</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2012:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisitions and New Construction:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In January and December, 2012, we purchased the:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">PeaceHealth Medical Clinic (as part of a planned like-kind exchange transaction pursuant to Section&#xA0;1031 of the Internal Revenue Code) &#x2013; a 99,000 square foot, single tenant medical office building located in Bellingham, Washington, which was acquired in January, 2012 for $30.4 million; the weighted average remaining lease term on the date of acquisition was approximately ten years, and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Northwest Texas Professional Office Tower &#x2013; a 72,000 square foot, multi-tenant medical office building located in Amarillo, Texas, which was acquired in December, 2012 for $9.6 million; the weighted average remaining lease term at the date of acquisition was 5.1 years.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the time of acquisition which are being amortized over the then average remaining lease term of approximately 7.0 years (aggregate weighted average of 4.9 years at December&#xA0;31, 2013).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="87%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32,090</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,020</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">799</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(144</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deposit paid in 2011</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(534</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt (including fair value adjustment of $799)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(23,240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,891</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The 2012 acquisitions were both valued utilizing the income capitalization approach as well as the sales comparison approach for valuing the land at the PeaceHealth Medical Clinic. The calculated fair values, utilizing the income capitalization approach, are based upon the basis of capitalization of the net estimated earnings expectancy of the properties, assuming continued use similar to the existing use of the acquired property&#x2019;s continued cash flow analysis were also utilized in estimating the fair values of the properties, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="33%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td width="28%"></td> <td valign="bottom" width="3%"></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 33pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Assets(b.)</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Fair Value at<br /> December&#xA0;31,&#xA0;2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Valuation Technique</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Unobservable inputs</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Range</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="bottom"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">PeaceHealth Medical Clinic (a.)(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">30,400,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalization&#xA0;Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Discount Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="bottom"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Northwest Texas Professional Office Tower</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,600,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Income&#xA0;Capitalization&#xA0;Approach</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Capitalization Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8.60</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Discount&#xA0;Rate</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The fair value of the land was estimated based upon the sales comparison approach.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Based upon preliminary appraisals.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">For these MOBs acquired during 2012, we recorded aggregate revenue of $2.7 million and net income of approximately $232,000 (excluding transaction expenses of $680,000) during 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Divestiture:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In February, 2012, Canyon Healthcare Properties, a limited liability company (&#x201C;LLC&#x201D;) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members&#x2019; share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the year ended December&#xA0;31, 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In October, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.2 million of cash proceeds to us, net of closing costs and minority members&#x2019; share of the proceeds. This divestiture resulted in a gain of approximately $1.1 million, which is included in our consolidated statement of income for the year ended December&#xA0;31, 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assuming the 2012 acquisitions and divestitures, as well as the 2011 acquisitions and divestitures as discussed below, occurred on January&#xA0;1, 2011, our pro forma net revenues for the year ended December&#xA0;31, 2011 would have been approximately $54.0 million, and our pro forma net income for the year ended December&#xA0;31, 2011 would have been approximately $4.1 million, or $0.32 per diluted share, without giving effect to the gains and transaction costs recorded during 2011. Our 2011 reported (and pro forma) net income included a provision for asset impairment of $5.4 million, or $0.42 per diluted share, as discussed herein. Assuming the 2012 acquisitions and divestitures occurred on January&#xA0;1, 2012, our pro forma net revenues and net income for the year ended December&#xA0;31, 2012 would have been approximately $55.4 million and $11.6 million, or $.92 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b><i>2011:</i></b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Acquisitions:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In June, July and December, 2011, utilizing a qualified third-party intermediary in connection with planned like-kind exchange transactions pursuant to Section&#xA0;1031 of the Internal Revenue Code, we purchased the:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Lake Pointe Medical Arts Building&#x2014;a 50,974 square foot, multi-tenant, medical office building located in Rowlett, Texas, which was acquired in June, 2011, for $12.2 million; the weighted average remaining lease term at the date of acquisition was 6.5 years;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Forney Medical Plaza&#x2014;a 50,946 square foot, multi-tenant medical office building located in Forney, Texas, which was acquired in July, 2011, for $15.0 million; the weighted average remaining lease term at the date of acquisition was 6.2 years;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tuscan Professional Building&#x2014;a 53,000 square foot, multi-tenant medical office building located in Irving, Texas, which was acquired in December, 2011, for $15.5 million, including the assumption of $7.0 million of third-party financing; the weighted average remaining lease term at the date of acquisition was 4.3 years, and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Emory at Dunwoody Building&#x2014;a 50,344 square foot single-tenant medical office building located in Atlanta, Georgia, which was acquired in December, 2011, for $5.1 million; the weighted average remaining lease term at the date of acquisition was 13.5 years.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate purchase price of $47.8 million for these MOBs was allocated to the assets acquired consisting of tangible property ($40.9 million) and identified intangible assets ($6.9 million), based on their respective fair values at acquisition, as detailed in the table below. Intangible assets include the value of the in-place leases at the time of acquisition.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="88%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,892</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,940</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,943</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">31</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total purchase price</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">47,806</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,229</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6,999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,578</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">For these MOBs acquired during 2011, we recorded aggregate revenue of $1.8 million during 2011 and aggregate net income of approximately $474,000 (excluding transaction expenses).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In addition, on December&#xA0;12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs. The aggregate cash expenditure made by us in connection with the purchase of these membership interests in the various LLCs, including closing costs, was approximately $4.4 million. As a result of these transactions, current accounting standards required that the Trust record each property&#x2019;s assets and liabilities at their fair values and record a non-cash gain or loss for the difference between the fair values and the equity method carrying value of each investment. The aggregate fair values of these MOBs was allocated to the assets acquired consisting of tangible property ($133.1 million) and identified intangible assets ($20.9 million). As a result of the purchase of these minority interests, we recorded aggregate revenue of $18.3 million during 2012 and $991,000 during 2011. There was no material impact on our net income, other than the gain, as a result of the consolidation of these LLCs subsequent to this transaction.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In the aggregate, the purchase of these membership interests resulted in a $28.6 million gain (net of related transaction costs totaling approximately $300,000) on the fair value recognition resulting from the purchase of minority interests in majority-owned LLCs which is included in our consolidated statements of income for the year ended December&#xA0;31, 2011. The table below reflects each of the LLCs in which we purchased the minority ownership interests, the location and property owned by the LLC, our previous noncontrolling, majority ownership interest and the noncontrolling, minority ownership interests purchased by us.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="41%"></td> <td valign="bottom" width="4%"></td> <td width="25%"></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 49pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Property owned by LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>City</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>State</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Trust&#x2019;s<br /> previous<br /> ownership<br /> %</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Minority<br /> ownership<br /> %<br /> purchased</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Investments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital MOB I(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las&#xA0;Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Phase II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital MOB II(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn&#xA0;Medical&#xA0;Office Building&#xA0;II(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">WA</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">ApaMed Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Apache Junction Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Apache J.</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Banburry Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital MOB III(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB/E Building One</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Kingwood</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">TX</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Bldg.&#xA0;I(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DesMed</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Springs Medical Plaza(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Gold Shadow Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane &amp; Goldring MOBs(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Medical&#xA0;Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Medical Properties&#xA0;II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building&#xA0;II</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tenants of this medical office building include subsidiaries of UHS.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><i>Divestitures:</i></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On November&#xA0;30, 2011 and December&#xA0;16, 2011, eight LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings and related real property. As partial consideration for the transaction, the buyer assumed certain existing third-party mortgage debt related to the properties. For certain of the LLCs, the sale of the medical office buildings were part of a series of planned like-kind exchange transaction pursuant to Section&#xA0;1031 of the Internal Revenue Code. The divestiture by the eight LLCs generated approximately $33.8 million of aggregate cash proceeds (a portion of which were sent to qualified third-party intermediaries), net of closing costs and the minority members&#x2019; share of the proceeds. In the aggregate, these transactions also resulted in a $35.8 million gain (net of related transaction costs of approximately $500,000) on divestiture which is included in our consolidated statements of income for the year ended December&#xA0;31, 2011. The following table represents each of the eight LLCs that was a selling party, the location and property owned by the LLC and our former noncontrolling, majority ownership interest:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="38%"></td> <td valign="bottom" width="4%"></td> <td width="36%"></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 49pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Property owned by LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>City</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>State</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Trust&#x2019;s<br /> Former<br /> Ownership<br /> %</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Valley Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Globe</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office II</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office III</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company(a)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Parking Garage</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">93</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DSMB Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Samaritan Hospital MOBs</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Mesa</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Litchvan Investments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Papago Medical Park</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Paseo Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Thunderbird Paseo Medical Plaza I &amp; II</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Glendale</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Willetta Medical Properties(b)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Edwards Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I &amp; II, was 50% owned by each of Deerval Properties and Deerval Properties II.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assuming these 2011 acquisitions and divestitures occurred on January&#xA0;1, 2011, our 2011 pro forma net revenues would have been approximately $49.8 million and our pro forma net income would have been approximately $4.6 million, or $0.37 per diluted share, without giving effect to the gains and transaction costs recorded during 2011. Our 2011 reported (and pro forma) net income included a provision for asset impairment of $5.4 million, or $0.42 per diluted share, as discussed herein.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As of December&#xA0;31, 2013, our net intangible assets total $20.8 million (net of $13.7 million accumulated amortization) and substantially all of the amount is related to acquired, in-place leases which have a weighted average remaining amortization period of 3.5 years.</font></p> </div> 31294000 3000 <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(2)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>RELATIONSHIP WITH UHS AND RELATED PARTY TRANSACTIONS</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Leases:</i>&#xA0;&#xA0;&#xA0;&#xA0;We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 41% of our total revenue for the five years ended December&#xA0;31, 2013 (approximately 30% for each of the years ended December&#xA0;31, 2013 and 2012, and 55% for the year ended December&#xA0;31, 2011). The decrease during 2013 and 2012 as compared to 2011 is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (&#x201C;MOBs&#x201D;) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December&#xA0;31, 2013 (approximately 22% for the year ended December&#xA0;31, 2013, 21% for the year ended December&#xA0;31, 2012 and 19% for the year ended December&#xA0;31, 2011). In addition, twelve MOBs, that are either wholly or jointly-owned, include or will include tenants which are subsidiaries of UHS.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December&#xA0;24, 1986 (the &#x201C;Master Lease&#x201D;), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i)&#xA0;purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii)&#xA0;renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month&#x2019;s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="49%"></td> <td valign="bottom" width="3%"></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 50pt" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Hospital Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Type&#xA0;of&#xA0;Facility</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Annual<br /> Minimum<br /> Rent</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>End&#xA0;of<br /> Lease&#xA0;Term</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Renewal<br /> Term<br /> (years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">McAllen Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,485,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December,&#xA0;2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(a)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Wellington Regional Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,030,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(b)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Southwest Healthcare System, Inland Valley Campus</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,648,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(b)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">The Bridgeway</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Behavioral&#xA0;Health</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">930,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">December, 2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">(c)&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">UHS has three 5-year renewal options at existing lease rates (through 2031).</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. The Bridgeway&#x2019;s lease term is scheduled to end in December, 2014. We can provide no assurance that this lease will be renewed at the fair market value lease rate.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As discussed above, Palmdale Medical Plaza, which is located in Palmdale, California, on the campus of a UHS hospital, had a master lease commitment by a wholly-owned subsidiary of UHS which expired on June&#xA0;30, 2013. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. The LLC that owns this MOB was deemed to be a variable interest entity during the term of the master lease and was therefore consolidated in our financial statements through June&#xA0;30, 2013 since we were the primary beneficiary through that date. Effective July&#xA0;1, 2013, this LLC is no longer be deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs (which own MOBs) and will begin accounting for them on a consolidated basis effective January&#xA0;1, 2014.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We have funded $2.1 million in equity as of December&#xA0;31, 2013, and are committed to fund an additional $2.3 million, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a UHS acute care hospital which is owned and operated by Texoma Medical Center (&#x201C;Texoma Hospital&#x201D;), a wholly-owned subsidiary of UHS. This MOB has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $12.5 million, which is non-recourse to us, outstanding as of December&#xA0;31, 2013. As this LLC is not considered to be a variable interest entity and does not meet the other criteria requiring consolidation of an investment, it is accounted for pursuant to the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Advisory Agreement:&#xA0;&#xA0;&#xA0;&#xA0;</i>UHS of Delaware, Inc. (the &#x201C;Advisor&#x201D;), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the &#x201C;Advisory Agreement&#x201D;) dated December&#xA0;24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the &#x201C;Independent Trustees&#x201D;). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December&#xA0;31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor&#x2019;s performance has been satisfactory. In December of 2013, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2014 pursuant to the same terms as the Advisory Agreement in place during 2013. In December of 2012, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the 2013 advisory fee, as compared to the 2012 advisory fee, was increased to 0.70% (from 0.65%) of our average invested real estate assets, as derived from our consolidated balance sheet.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2013, 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.4 million during 2013, $2.1 million during 2012 and $2.0 million during 2011 and were based upon average invested real estate assets of $338 million, $326 million and $309 million during 2013, 2012 and 2011, respectively.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Officers and Employees:</i>&#xA0;&#xA0;&#xA0;&#xA0;Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December&#xA0;31, 2013 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time special compensation awards in the form of restricted stock and/or cash bonuses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Share Ownership:</i>&#xA0;&#xA0;&#xA0;&#xA0;As of December&#xA0;31, 2013 and 2012, UHS owned 6.1% and 6.2%, respectively, of our outstanding shares of beneficial interest.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>SEC reporting requirements of UHS:</i>&#xA0;&#xA0;&#xA0;&#xA0;UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 30% of our consolidated revenues for each of the years ended December&#xA0;31, 2013 and 2012, and 55% of our consolidated revenues for the year ended December&#xA0;31, 2011, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC&#x2019;s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="51%"></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="8%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 71pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding Options</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Number<br /> of&#xA0;Shares</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Exercise<br /> Weighted-<br /> Average&#xA0;Price</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Grant&#xA0;Price&#xA0;Range<br /> (High-Low)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2011</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2012</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">51,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33.89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">26.76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">27.65/$26.09</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance, January&#xA0;1, 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">43,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.22</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Exercised</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">29.44/$29.44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Outstanding options vested and exercisable as of December&#xA0;31, 2013</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35.65</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.53/$30.06</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(1)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Nature of Operations</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Universal Health Realty Income Trust and subsidiaries (the &#x201C;Trust&#x201D;) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings. As of February&#xA0;28, 2014, we have fifty-eight real estate investments or commitments located in sixteen states consisting of:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">forty-seven medical office buildings, including eleven owned by unconsolidated limited liability companies (&#x201C;LLCs&#x201D;), and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">four preschool and childcare centers.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management&#x2019;s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Revenue Recognition</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (&#x201C;MOBs&#x201D;) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility&#x2019;s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility&#x2019;s current quarter&#x2019;s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px; TEXT-INDENT: -2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Real Estate Investments</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">On the date of acquisition, the purchase price of a property is allocated to the property&#x2019;s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December&#xA0;31, 2013, and will be amortized over the remaining lease terms (aggregate weighted average of 3.5 years) and will result in an estimated aggregate amortization expense of $4.6&#xA0;million, $3.9&#xA0;million, $3.4&#xA0;million $2.9 million and $1.7 million for 2014, 2015, 2016, 2017 and 2018, respectively. Amortization expense on intangible values of in place leases was $6.0 million for the year ended December&#xA0;31, 2013, $7.8 million for the year ended December&#xA0;31, 2012 and $836,000 for the year ended December&#xA0;31, 2011. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $12.5 million for the year ended December 31, 2013, $12.2 million for the year ended December 31, 2012 and $6.3 million for the year ended December 31, 2011.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Cash and Cash Equivalents</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Asset Impairment</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management&#x2019;s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million in connection with an MOB located on a medical campus in Atlanta, Georgia. The asset impairment charge was recorded after evaluation of property and location-specific factors including pressure on rental and occupancy rates caused, in part, by the impact of continued unfavorable economic conditions in the market as well as competitive pressures caused by increased capacity added to the market. The fair value of this property was determined based upon the present value of the expected future cash flows.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 0px; TEXT-INDENT: -2%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Investments in Limited Liability Companies (&#x201C;LLCs</b>&#x201D;)</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB&#x2019;s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#xA0;divestiture of property; (ii)&#xA0;annual budget approval, and; (iii)&#xA0;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">At December&#xA0;31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings (including Palmdale Medical Properties, LLC and Sparks Medical Properties, LLC which, as discussed below, we purchased the minority ownership interests effective January&#xA0;1, 2014 and now hold 100% of the ownership interests of these entities). As of December&#xA0;31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June&#xA0;30, 2013. As discussed below, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July&#xA0;1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Palmdale Medical Properties had a master lease with a subsidiary of UHS through June&#xA0;30, 2013. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS (through UHS of Delaware, Inc.). As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we have accounted for this LLC on a consolidated basis, since its inception in the fourth quarter of 2007 through June&#xA0;30, 2013, since it was a variable interest entity and we were deemed to be the primary beneficiary. As of July&#xA0;1, 2013, the master lease expired and this LLC is no longer considered a variable interest entity and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. The expiration of the master lease and related deconsolidation did not have a material impact on our net income and funds from operations during the second half of 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">As a result of master lease arrangements between UHS and various LLCs in which we hold or held majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB&#x2019;s standards and guidance.</font></p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Effective January&#xA0;1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs and will begin accounting for them on a consolidated basis effective January&#xA0;1, 2014. Each of the property&#x2019;s assets and liabilities will be recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). We do not expect these transactions or the expected related aggregate gain (to be recorded during the first quarter of 2014) to have a material impact on our future results of operations.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In addition, effective December&#xA0;12, 2011, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as discussed herein (see Notes 3 and 8 to the consolidated financial statements for additional disclosure).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Federal Income Taxes</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $382 million and $256 million, respectively, at December&#xA0;31, 2013.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Stock-Based Compensation</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We expense the grant-date fair value of stock options and restricted stock awards over the vesting period. We recognize the grant-date fair value of stock options and other equity-based compensation and account for these transactions using the fair-value based method. We use the Black-Scholes model as our option pricing model for determining the grant-date fair value of our stock options.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Fair Value</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity&#x2019;s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">See Note 3-Acquisitions and Dispositions, for disclosure related to the $28.6 million net gain recorded during 2011 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>New Accounting Standards</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Except as noted below, there were no new accounting pronouncements during 2013 that impacted, or are expected to impact, us.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In February, 2013, the Financial Accounting Standards Board issued an Accounting Standards Update on reporting of amounts reclassified out of accumulated other comprehensive income. This guidance, which is effective for fiscal years beginning after December&#xA0;31, 2012, required companies to provide information about amounts reclassified out of accumulated other comprehensive income by component (the respective line items of the income statement).&#xA0;The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In July 2013, the Financial Accounting Standards Board (FASB) issued guidance allowing the use of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a benchmark interest rate for hedge accounting purposes in addition to interest rates on direct Treasury obligations of the United States government and the LIBOR. In addition, the guidance removes the restriction on using different benchmark rates for similar hedges. The guidance became effective on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after July&#xA0;17, 2013, and did not have a material impact in the consolidated financial results.</font></p> </div> 2.495 <div> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:Times New Roman" size="2"><b>Use of Estimates</b></font></p> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></p> </div> 29.44 12689000 1 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table summarizes our outstanding mortgages, excluding net debt premium, at December&#xA0;31, 2013 (amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="72%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 47pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Facility Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Outstanding<br /> Balance<br /> (in&#xA0;thousands)(a)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Interest<br /> Rate</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Maturity<br /> Date</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building I fixed rate mortgage loan (b)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,188</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2014</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,122</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building III floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">11,347</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.42</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2016</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Peace Health fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,681</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.64</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital Medical Office Building II fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,021</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical II floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">7,406</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.92</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Medical Center of Western Connecticut fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,899</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.00</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2017</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Building floating rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">10,938</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3.42</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2018</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Vibra Hospital of Corpus Christi fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,983</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6.50</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2019</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,840</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.27</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2022</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane and Goldring MOBs fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,766</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4.54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2022</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tuscan Professional Building fixed rate mortgage loan</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,262</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5.56</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2025</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">105,453</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Amortized principal payments are made on a monthly basis.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.</font></td> </tr> </table> </div> <div> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <table cellspacing="0" cellpadding="0" width="100%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="49%"></td> <td valign="bottom" width="3%"></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap" align="center"> <p style="border-bottom:1px solid #000000;width:50pt" align="center"><font style="font-family:Times New Roman" size="1"><b>Hospital Name</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Type&#xA0;of&#xA0;Facility</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Annual<br /> Minimum<br /> Rent</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>End&#xA0;of<br /> Lease&#xA0;Term</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:Times New Roman" size="1"><b>Renewal<br /> Term<br /> (years)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">McAllen Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">5,485,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December,&#xA0;2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(a)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Wellington Regional Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">3,030,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December, 2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(b)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">Southwest Healthcare System, Inland Valley Campus</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">2,648,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December, 2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(b)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:Times New Roman" size="2">The Bridgeway</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">Behavioral&#xA0;Health</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">930,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">December, 2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="font-family:Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="font-family:Times New Roman" size="2">10</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:Times New Roman" size="2">(c)&#xA0;</font></td> </tr> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%"> &#xA0;</p> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(a)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">UHS has three 5-year renewal options at existing lease rates (through 2031).</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(b)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).</font></td> </tr> </table> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:Times New Roman" size="2">(c)</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2">UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).</font></td> </tr> </table> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>New Accounting Standards</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Except as noted below, there were no new accounting pronouncements during 2013 that impacted, or are expected to impact, us.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In February, 2013, the Financial Accounting Standards Board issued an Accounting Standards Update on reporting of amounts reclassified out of accumulated other comprehensive income. This guidance, which is effective for fiscal years beginning after December&#xA0;31, 2012, required companies to provide information about amounts reclassified out of accumulated other comprehensive income by component (the respective line items of the income statement).&#xA0;The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">In July 2013, the Financial Accounting Standards Board (FASB) issued guidance allowing the use of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a benchmark interest rate for hedge accounting purposes in addition to interest rates on direct Treasury obligations of the United States government and the LIBOR. In addition, the guidance removes the restriction on using different benchmark rates for similar hedges. The guidance became effective on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after July&#xA0;17, 2013, and did not have a material impact in the consolidated financial results.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Stock-Based Compensation</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">We expense the grant-date fair value of stock options and restricted stock awards over the vesting period. We recognize the grant-date fair value of stock options and other equity-based compensation and account for these transactions using the fair-value based method. We use the Black-Scholes model as our option pricing model for determining the grant-date fair value of our stock options.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.</font></p> </div> <div> <table style="BORDER-COLLAPSE:COLLAPSE" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="3%" valign="top" align="left"><font style="font-family:Times New Roman" size="2"><b>(9)</b></font></td> <td width="1%" valign="top"><font size="1">&#xA0;</font></td> <td align="left" valign="top"><font style="font-family:Times New Roman" size="2"><b>SEGMENT REPORTING</b></font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:-6px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.</font></p> <p style="margin-top:0px;margin-bottom:0px"><font size="1">&#xA0;</font></p> <p style="margin-top:0px;margin-bottom:0px; text-indent:4%"> <font style="font-family:Times New Roman" size="2">Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.</font></p> </div> <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Fair Value</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity&#x2019;s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">See Note 3-Acquisitions and Dispositions, for disclosure related to the $28.6 million net gain recorded during 2011 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.</font></p> </div> 2095000 6324000 31751000 0 46290 13169000 13112000 0 100000 0 21001000 1900000 375000 14401000 3013000 22000 4580000 431000 7517000 54280000 52565000 4260000 0 95000 14773000 18546000 1904000 13185000 86300000 4675000 13169000 0 150000 14409000 2369000 35734000 -17491000 375000 18753000 289000 31751000 -433000 114000 74000 57000 1588000 12464000 7472000 11950000 0 18843000 6000000 12500000 0 11150000 -13514000 0 0 523000 5757000 3415000 2346000 141000 P2Y6M 746000 54280000 480000 11 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Covenant</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,<br /> 2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Tangible net worth</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">125,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">144,848</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to total capital</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt; 55</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36.0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt service coverage ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&gt;&#xA0;4.00x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">19.1x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt to cash flow ratio</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&lt;&#xA0;3.50x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2.21x</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> </table> </div> 6812000 0 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December&#xA0;31, 2013 and 2012:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="82%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="6" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net property, including CIP</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">119,547</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">106,150</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,479</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">9,850</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">116,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,336</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5,368</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Mortgage notes payable, non-recourse to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">80,112</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">77,511</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Advances payable to us</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">22,911</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,658</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,667</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">20,463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total liabilities and equity</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">129,026</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">116,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of equity and advances to LLCs</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,201</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">28,636</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2013. Prior to July&#xA0;1, 2013, the financial results of this entity were accounted for on a consolidated basis.</font></td> </tr> </table> </div> 16000 8705000 101000 106000 0 0.04 0 6353000 27955000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Nature of Operations</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Universal Health Realty Income Trust and subsidiaries (the &#x201C;Trust&#x201D;) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings. As of February&#xA0;28, 2014, we have fifty-eight real estate investments or commitments located in sixteen states consisting of:</font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">forty-seven medical office buildings, including eleven owned by unconsolidated limited liability companies (&#x201C;LLCs&#x201D;), and;</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td width="4%"><font size="1">&#xA0;</font></td> <td valign="top" width="1%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">four preschool and childcare centers.</font></p> </td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management&#x2019;s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.</font></p> </div> 40000 P5Y 4065000 0 4039000 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The years ended December&#xA0;31, 2012 and 2011 include the prorated amounts for the LLCs that were divested through their divestiture dates, or in which we purchased the minority ownership interests, for the period in which they were accounted for under the equity method:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>For the Year Ended December&#xA0;31,</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013(b.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011(a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" colspan="10" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,001</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21,448</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">57,932</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Operating expenses</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,705</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,974</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">25,503</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,039</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,140</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">13,066</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Interest, net</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,353</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,056</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">17,630</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net income before gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,904</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,278</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,733</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income before gains on divestitures(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,095</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2,365</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,058</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of gains on divestitures</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">8,520</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">35,835</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July&#xA0;1, 2103. Prior to July&#xA0;1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July&#xA0;1, 2013 through December&#xA0;31, 2013.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.</font></td> </tr> </table> </div> 0.360 0 35.65 2.495 101000 203000 43000 338000000 2400000 --12-31 0.50 0.50 Rosenberg Children's Medical Plaza Desert Valley Medical Center Mid Coast Hospital MOB Saint Mary's Professional Office Building Phoenix Children's East Valley Care Center Texoma Medical Plaza Forney Medical Plaza II Palmdale Medical Plaza Suburban Medical Plaza II Santa Fe Professional Plaza North Valley Medical Plaza Sierra San Antonio Medical Plaza Vista Medical Terrace & The Sparks Medical Building 2014-01-01 2014-01-01 2015-07-24 0.0035 One, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. Greatest of (a) the administrative agent's prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. 50000000 0.0200 0.0175 0.01 0.0250 0.0100 0.0075 0.0150 0.0050 0.0030 0.0050 170000 0.30 0.41 0 0 135000 5443000 11597000 368000 141000 54000 6215000 207000 0.22 0.20 0 74000 6323000 375000 101000 6324000 13169000 13112000 375000 31751000 57000 101000 170000 1000 13169000 13169000 -57000 57000 31751000 0.535 1.960 P3Y 29.44 0.90 P13Y 2015 2022 P3Y P3Y P25Y P15Y 29.44 0.55 P15Y 2024 2031 P10Y P35Y P45Y 34.90 34.90 P1Y8M12D 34.90 34.07 30.06 P1Y 33.07 36.53 36.53 P3Y2M12D 36.53 2014-12 P180D P5Y 12 P90D 2 P5Y 3 2031 P5Y 2 P5Y 1 2021 P5Y 0.95 TX 0.05 Kingwood BRB Medical Office Building 0.95 NV 0.05 Las Vegas Spring Valley Medical Office Building 0.98 NV 0.02 Las Vegas 700 Shadow Lane & Goldring MOBs 0.95 NV 0.05 Las Vegas Summerlin Hospital MOB III 0.95 NV 0.05 Las Vegas Centennial Hills Medical Office Bldg. I 0.95 WA 0.05 Auburn Auburn Medical Office Building II <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The table below reflects each of the LLCs in which we purchased the minority ownership interests, the location and property owned by the LLC, our previous noncontrolling, majority ownership interest and the noncontrolling, minority ownership interests purchased by us.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="41%"></td> <td valign="bottom" width="4%"></td> <td width="25%"></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 49pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Property owned by LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>City</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>State</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Trust&#x2019;s<br /> previous<br /> ownership<br /> %</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Minority<br /> ownership<br /> %<br /> purchased</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Investments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital MOB I(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las&#xA0;Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">653 Town Center Phase II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital MOB II(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn&#xA0;Medical&#xA0;Office Building&#xA0;II(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Auburn</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">WA</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">ApaMed Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Apache Junction Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Apache J.</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">85</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">15</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Banburry Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Summerlin Hospital MOB III(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">BRB/E Building One</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">BRB Medical Office Building</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Kingwood</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">TX</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Centennial Hills Medical Office Bldg.&#xA0;I(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DesMed</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Springs Medical Plaza(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">99</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Gold Shadow Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">700 Shadow Lane &amp; Goldring MOBs(1)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">98</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">2</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Medical&#xA0;Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Spring&#xA0;Valley&#xA0;Medical Properties&#xA0;II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Spring Valley Medical Office Building&#xA0;II</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Las Vegas</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">NV</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">5</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(1)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Tenants of this medical office building include subsidiaries of UHS.</font></td> </tr> </table> </div> 0.99 NV 0.01 Las Vegas Desert Springs Medical Plaza <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table represents each of the eight LLCs that was a selling party, the location and property owned by the LLC and our former noncontrolling, majority ownership interest:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="38%"></td> <td valign="bottom" width="4%"></td> <td width="36%"></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 49pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Name of LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"> <p style="MARGIN-BOTTOM: 1px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Property owned by LLC:</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>City</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>State</b></font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Trust&#x2019;s<br /> Former<br /> Ownership<br /> %</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Cobre Valley Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Globe</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office II</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Medical Office III</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">95</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company(a)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Deer Valley Parking Garage</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">93</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">DSMB Properties</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Desert Samaritan Hospital MOBs</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Mesa</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">76</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Litchvan Investments</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Papago Medical Park</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">89</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Paseo Medical Properties II</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Thunderbird Paseo Medical Plaza I &amp; II</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Glendale</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">75</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Willetta Medical Properties(b)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">Edwards Medical Plaza</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">Phoenix</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" align="center"><font style="FONT-FAMILY: Times New Roman" size="2">AZ</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">90</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">%&#xA0;</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I &amp; II, was 50% owned by each of Deerval Properties and Deerval Properties II.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.</font></td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="87%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">32,090</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,020</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">799</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(144</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Deposit paid in 2011</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(534</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt (including fair value adjustment of $799)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(23,240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">16,891</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> P4Y10M24D 0.95 NV 0.05 Las Vegas Spring Valley Medical Office Building II <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets include the value of the in-place leases at the time of acquisition.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="88%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,892</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">36,940</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,943</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">31</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Total purchase price</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">47,806</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,229</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Debt</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6,999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">39,578</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> 0.95 NV 0.05 Las Vegas Summerlin Hospital MOB I 0.98 NV 0.02 Las Vegas Summerlin Hospital MOB II 0.85 AZ 0.15 Apache J. Apache Junction Medical Plaza <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="80%" align="center" border="0"> <tr> <td width="89%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Land</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">316</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Intangible assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">610</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">21</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Liabilities (real property and operating)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(11</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Net cash paid</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,685</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> </div> P9Y9M18D 2014-01-01 47975 43.54 P1Y 8730 380104 375000 28870 2015-06 0.25 19000 P10Y Refinance these loans during 2014 for three to ten year terms 2014-01-01 P3Y6M P45Y 870000 1995 1995 P30Y 27000 2004 2004 P35Y 2012 2012 P35Y 5015000 1998 2000 P35Y 2011 2011 2016-12 P15Y Acute Care P30Y 430000 2000 2000 P35Y 2011 2011 P35Y 4571000 1986 2006 P43Y 14596000 1986 2007 P25Y -7327000 1999 1999 P35Y 573000 1997 1997 P34Y 743000 2006 2006 2014-12 P10Y Behavioral Health P45Y -2304000 1996 1994 P36Y 159000 2009 2009 P45Y 1996 1996 P30Y 968000 2003 2003 P45Y 1996 1992 P34Y 8000 2006 2006 P35Y 2012 2012 P37Y 24000 2010 2010 P25Y 1838000 1986 1993 P45Y 1996 1992 2016-12 P15Y Acute Care P30Y 731000 2000 2000 P42Y 10189000 1986 1994 P35Y 41000 2011 2011 P35Y 31000 2011 2011 P42Y 17370000 1986 2006 P25Y 68000 1999 1999 2016-12 P15Y Acute Care P40Y 1062000 1989 1993 P45Y 494000 1995 1991 P30Y 451000 1999 1999 P36Y 1443000 2009 2009 P35Y 111000 2004 2004 P30Y 200000 1998 1998 P45Y 183000 1995 1995 P45Y 1996 1991 P35Y 2013 2013 P35Y 2013 2013 P35Y 2008 2008 <div> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Schedule III</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Universal Health Realty Income Trust</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Real Estate and Accumulated Depreciation &#x2014; December&#xA0;31, 2013</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>(amounts in thousands)</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="34%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td></td> <td></td> <td valign="bottom" width="1%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom" rowspan="2"> <p style="BORDER-BOTTOM: #000000 1px solid; WIDTH: 31pt"> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Description</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Initial Cost</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="14" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Gross amount at</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>which carried</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>at end of period</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Accumulated</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Depreciation</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>as of&#xA0;Dec. 31,</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Date of</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Completion<br /> of&#xA0;Construction,</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Acquisition&#xA0;or</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Significant<br /> improvement</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Date</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Acquired</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" rowspan="2" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Average</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Depreciable</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Life</b></font></td> <td valign="bottom" rowspan="2"><font size="1">&#xA0;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Encumbrance</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>(e.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Land</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Building</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>&amp;</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Improv.</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Adjustments&#xA0;to</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Basis (a.)</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Land</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Building &amp;</b></font><br /> <font style="FONT-FAMILY: Times New Roman" size="1"><b>Improvements</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>CIP</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>Total</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">Inland Valley Regional</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1">Medical Center</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Wildomar, California</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,050</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,701</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">14,596</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,050</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">25,297</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">27,347</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,464</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2007</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1986</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">43&#xA0;Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">McAllen Medical Center</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>McAllen, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,720</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">31,442</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,189</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,281</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">40,070</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">46,351</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">23,440</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1994</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1986</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">42 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Wellington Regional Medical Center<br /> <i>West Palm Beach, Florida</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,190</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">14,652</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">17,370</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,663</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">31,549</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">33,212</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">15,182</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2006</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1986</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">42 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">The Bridgeway<br /> <i>North Little Rock, Arkansas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">150</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,395</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,571</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">150</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,966</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,116</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,554</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2006</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1986</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">HealthSouth Deaconess Rehabilitation Hospital <i>Evansville, Indiana</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">500</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,945</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,062</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">500</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,007</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,507</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,867</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1993</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1989</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">40 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Kindred Hospital Chicago Central<br /> <i>Chicago, Illinois</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">158</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,404</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,838</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">158</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,242</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,400</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,245</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1993</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1986</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">25 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Family Doctor&#x2019;s Medical Office Building<br /> <i>Shreveport, Louisiana</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,526</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">494</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">54</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,020</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,074</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">854</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1991</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1995</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Kelsey-Seybold Clinic at King&#x2019;s Crossing</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">439</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,618</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">870</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">439</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,488</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,927</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">958</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1995</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1995</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Professional Center at King&#x2019;s Crossing</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">439</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,837</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">183</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">439</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,020</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,459</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">832</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1995</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1995</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1"><i>Kingwood, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">Chesterbrook Academy</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Audubon, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">307</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">307</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,303</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">391</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Chesterbrook Academy<br /> <i>New Britain, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">250</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">744</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">250</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">744</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">994</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">292</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1991</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">Chesterbrook Academy</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Uwchlan, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">815</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">815</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">995</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">320</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1992</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">Chesterbrook Academy</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Newtown, Pennsylvania</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">195</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">195</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">749</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">944</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">294</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1992</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">The Southern Crescent Center I (b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,130</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,092</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">(2,304</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,130</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,788</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,918</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,141</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1994</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1996</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">45 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">The Southern Crescent Center II (b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">806</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,209</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,015</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,742</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1998</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1"><i>Riverdale, Georgia</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">The Cypresswood Professional Center</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Spring ,Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">573</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,842</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">573</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">573</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,415</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,988</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,212</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1997</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1997</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">701 South Tonopah Building<br /> <i>Las Vegas, Nevada</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,579</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">68</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,647</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,647</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">858</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">25 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Sheffield Medical<br /> Building (c.)<br /> <i>Atlanta, Georgia</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,760</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,766</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">(7,327</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">736</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,463</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,199</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">936</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">25 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Medical Center of Western Connecticut&#x2014;Bldg. 73 <i>Danbury, Connecticut</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,899</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,151</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,176</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">430</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,151</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,606</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,757</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,678</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">30 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Vibra Hospital of Corpus Christi<br /> <i>Corpus Christi, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2,983</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,104</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,508</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,104</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,508</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,612</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">928</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2008</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2008</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Apache Junction Medical Plaza (d.)<br /> <i>Apache Junction, AZ</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,590</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">27</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">240</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,617</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,857</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">283</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2004</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2004</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">30 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">Auburn Medical Office Building (d.)</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Auburn, WA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">7,406</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,200</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">159</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,359</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,359</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">694</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2009</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2009</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">36 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">BRB Medical Office Building (d.)<br /> <i>Kingwood, Texas</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,840</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">430</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,970</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">24</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">430</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8,994</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,424</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">591</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2010</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2010</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">37 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Centennial Hills Medical Office Building (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,938</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">19,890</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">743</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">20,633</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">20,633</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,412</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2006</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2006</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">34 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Desert Springs Medical Plaza (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,200</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,560</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">200</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,200</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,760</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,960</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">772</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1998</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1998</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">30 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px; TEXT-INDENT: -1em"> <font style="FONT-FAMILY: Times New Roman" size="1">700 Shadow Lane&#xA0;&amp; Goldring MOB (d.)</font></p> <p style="MARGIN-BOTTOM: 1px; MARGIN-LEFT: 1em; MARGIN-TOP: 0px"> <font style="FONT-FAMILY: Times New Roman" size="1"><i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,766</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">400</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">11,300</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">968</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">400</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">12,268</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">12,668</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">931</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2003</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2003</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">30 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Spring Valley Hospital MOB I (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">5,122</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,500</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">111</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,611</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,611</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">664</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2004</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2004</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Spring Valley Hospital MOB II (d.)<br /> <i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,800</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">8</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,808</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,808</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">693</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2006</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2006</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">34 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Summerlin Hospital MOB I (d.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 2em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1"><i>Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,188</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">460</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">15,440</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">451</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">460</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">15,891</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">16,351</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,251</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1999</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">30&#xA0;Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Summerlin Hospital MOB II (d.)<i><br /> Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">12,021</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">370</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">16,830</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">731</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">370</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">17,561</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">17,931</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,345</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">30 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Summerlin Hospital MOB III (d.)<i><br /> Las Vegas, NV</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">11,347</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">14,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,443</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">16,343</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">16,343</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,044</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2009</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2009</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">36 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Emory at Dunwoody<br /> <i>Dunwoody, GA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">782</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,455</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">782</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,455</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">4,237</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">264</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Forney Medical Plaza<br /> <i>Forney, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">910</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">11,960</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">31</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">910</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">11,991</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">12,901</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,149</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Lake Pointe Medical Arts<br /> <i>Rowlett, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,000</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">41</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">9,041</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10,141</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">772</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Tuscan Medical Properties<br /> <i>Irving, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">6,262</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">12,525</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">12,525</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">13,625</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">869</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2011</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Peace Health Medical Clinic <i>Bellingham, WA</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">21,681</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">24,910</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,900</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">24,910</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">26,810</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">1,701</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2012</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2012</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">NW Texas Prof Tower<br /> <i>Amarillo, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">7,180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">7,180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">7,180</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">244</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2012</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2012</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">Ward Eagle Office Village <i>Farmington Hills, MI</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">220</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,220</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">220</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,220</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">3,440</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">44</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2013</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2013</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1">5004 Poole Road<br /> <i>Denison, TX</i></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">529</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">96</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">529</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">625</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">10</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2013</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">2013</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">35 Years</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 3em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="1"><b>TOTALS</b></font></p> </td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">105,453</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">25,558</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">317,546</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">52,565</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">27,374</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">368,295</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">0</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">395,669</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="1">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="1">97,921</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">&#xA0;</td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">a.</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">Costs capitalized/divested subsequent to acquisition.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">b.</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I &amp; Southern Crescent Center II.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">c.</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">d.</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">e.</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="1">Consists of outstanding balances as of December&#xA0;31, 2013 on third-party debt that is non-recourse to us. Excludes net debt premium of $834,000.</font></td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>UNIVERSAL HEALTH REALTY INCOME TRUST</b></font></p> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>NOTES TO SCHEDULE III</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>DECEMBER 31, 2013</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px" align="center"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>(amounts in thousands)</b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(1)</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>RECONCILIATION OF REAL ESTATE PROPERTIES</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table reconciles the Real Estate Properties from January&#xA0;1, 2011 to December&#xA0;31, 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="72%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at January&#xA0;1,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">401,474</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">363,498</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">199,940</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Impact of deconsolidation of an LLC(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(13,185</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Impact of consolidation of eleven LLCs(b.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">133,080</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Property additions</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,415</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">3,985</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">1,157</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Acquisitions</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">4,065</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">33,991</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">40,832</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Disposals</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(100</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Provision for asset impairment(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(11,511</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at December&#xA0;31,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">395,669</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">401,474</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">363,498</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(2)</b></font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>RECONCILIATION OF ACCUMULATED DEPRECIATION</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">The following table reconciles the Accumulated Depreciation from January&#xA0;1, 2011 to December&#xA0;31, 2013:</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr> <td width="76%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2013</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center"><font style="FONT-FAMILY: Times New Roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at January&#xA0;1,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">87,088</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74,865</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74,683</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Impact of deconsolidation of an LLC(a.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(1,588</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Provision for asset impairment(c.)</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(6,157</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)&#xA0;</font></td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Current year depreciation expense</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,464</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">12,223</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">6,339</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Other</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">(43</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">)</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> <td valign="bottom" nowrap="nowrap" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2014;&#xA0;&#xA0;</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 1px solid">&#xA0;</p> </td> <td>&#xA0;</td> </tr> <tr> <td valign="top"> <p style="MARGIN-LEFT: 1em; TEXT-INDENT: -1em"><font style="FONT-FAMILY: Times New Roman" size="2">Balance at December&#xA0;31,</font></p> </td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">97,921</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">87,088</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> <td valign="bottom"><font size="1">&#xA0;&#xA0;</font></td> <td valign="bottom"><font style="FONT-FAMILY: Times New Roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="FONT-FAMILY: Times New Roman" size="2">74,865</font></td> <td valign="bottom" nowrap="nowrap"><font style="FONT-FAMILY: Times New Roman" size="2">&#xA0;&#xA0;</font></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> <td valign="bottom">&#xA0;&#xA0;</td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td valign="bottom"> <p style="BORDER-TOP: #000000 3px double">&#xA0;</p> </td> <td>&#xA0;</td> </tr> </table> <p style="MARGIN-BOTTOM: 2px; BORDER-BOTTOM: #000000 0.5pt solid; MARGIN-TOP: 0px; LINE-HEIGHT: 8px; WIDTH: 10%"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(a.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July&#xA0;1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(b.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">On December&#xA0;12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.</font></td> </tr> </table> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">(c.)</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million ($11.5 million gross assets net of $6.1 million of accumulated depreciation) in connection with the Sheffield Medical Building located in Atlanta, Georgia.</font></td> </tr> </table> </div> <div> <table style="BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>(6)</b></font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"><font style="FONT-FAMILY: Times New Roman" size="2"><b>DIVIDENDS AND EQUITY ISSUANCE PROGRAM</b></font></td> </tr> </table> <p style="MARGIN-BOTTOM: -6px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Dividends of $2.495 per share were declared and paid in 2013, of which $1.96 per share was ordinary income and $.535 per share was a return of capital distribution. Dividends of $2.46 per share were declared and paid in 2012, of which $1.294 per share was ordinary income and $1.166 per share was total capital gain (total capital gain amount consists of Unrecaptured Section&#xA0;1250 gain of $.281 per share and 15% rate gain of $.885 per share). Dividends of $2.425 per share were declared and paid in 2011, of which $1.234 per share was ordinary income and $1.191 per share was total capital gain (total capital gain amount consists of Unrecaptured Section&#xA0;1250 gain of $.716 per share and 15% rate gain of $.475 per share).</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">During the fourth quarter of 2013, we entered into an ATM Equity Offering Sales Agreement (&#x201C;Sales Agreement&#x201D;) with Merrill Lynch, Pierce, Fenner and Smith Incorporated (&#x201C;Merrill Lynch&#x201D;), under which we may offer and sell our common shares of beneficial interest, up to an aggregate sales price of $50 million. The common shares will be offered pursuant to the Registration Statement filed with the Securities and Exchange Commission, which became effective in November, 2012, under which we can offer up to $50 million of our securities pursuant to supplemental prospectuses which we may file from time to time.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px"><font size="1">&#xA0;</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px; TEXT-INDENT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2">Pursuant to this ATM Program, we issued 154,713 shares at an average price of $41.71 per share during the three-month period ended December&#xA0;31, 2013, which generated approximately $6.0 million of net cash proceeds, (net of approximately $424,000 consisting of compensation of approximately $161,000 to Merrill Lynch as well as approximately $263,000 of other various fees and expenses), which includes approximately $592,000 of net proceeds receivable at December 31, 2013, which were received by us in January, 2014. The net proceeds receivable is a non-cash item, as presented on the Consolidated Statements of Cash Flows at December 31, 2013.</font></p> </div> 4600000 1.54 -3985000 1.54 12669000 8000 0.92 30783000 8000 2.460 26.76 12661000 2365000 305000 31195000 0 148930 19467000 0 0 10957000 21448000 1500000 329000 18084000 2973000 -66000 8000000 -249000 7994000 53950000 4142000 0 384000 15438000 16360000 11600000 2278000 55400000 75400000 16891000 19477000 8520000 -100000 14575000 2119000 37590000 -30819000 329000 20216000 -8601000 31195000 -657000 8551000 12223000 7768000 4600000 0 20216000 7800000 12200000 0 14000000 -8565000 0 12175000 278000 350000 3985000 3169000 0 862000 53950000 483000 6674000 22441000 207000 8974000 106000 116000 8520000 0 6056000 27213000 43000 33991000 0 4140000 711000 2.46 106000 680000 326000000 2100000 0.15 0.30 0.885 0 0 0 0 0 0 0 0 0 0 0.21 -10000 305000 329000 106000 305000 19477000 329000 31195000 106000 22000 19477000 31195000 0.281 1.166 1.294 1100000 7400000 26.09 27.65 18300000 0.0950 Income Capitalization Approach 0.0860 Capitalization Rate Professional Office Tower 232000 2700000 680000 0.0850 Income Capitalization Approach 0.0750 Capitalization Rate PeaceHealth Medical Clinic P7Y 39.05 10375 405144 329000 2014-06 18000 Centinela Medical Building Complez Canyon Springs Medical Plaza 0.27 0.27 3427000 13885000 0.75 0.75 2139000 9514000 7375000 13351000 0.19 0.19 2467000 2467000 13666000 0.23 0.23 2941000 13502000 0.24 0.24 2986000 2986000 13610000 0.26 0.26 3303000 13448000 5354000 6100000 0.36 0.36 3365000 4510000 1145000 13323000 0.27 0.27 3498000 13445000 154713 592000 424000 6000000 263000 161000 0000798783 uht:MerrillLynchAndCoNtMtnMemberuht:AtMarketAtmProgramsMember 2013-10-01 2013-12-31 0000798783 us-gaap:OtherExpenseMemberuht:AtMarketAtmProgramsMember 2013-10-01 2013-12-31 0000798783 uht:AtMarketAtmProgramsMember 2013-10-01 2013-12-31 0000798783 2013-10-01 2013-12-31 0000798783 2012-10-01 2012-12-31 0000798783 uht:SheffieldMedicalBuildingAtlantaGeorgiaMember 2011-10-01 2011-12-31 0000798783 2011-10-01 2011-12-31 0000798783 2013-07-01 2013-09-30 0000798783 2012-07-01 2012-09-30 0000798783 2013-04-01 2013-06-30 0000798783 2012-04-01 2012-06-30 0000798783 2012-01-01 2012-03-31 0000798783 2013-01-01 2013-03-31 0000798783 uht:CanyonHealthcarePropertiesMember 2012-01-01 2012-12-31 0000798783 uht:FiveSevenFiveHardyInvestorsMember 2012-01-01 2012-12-31 0000798783 uht:EquityIncentivePlanNineteenNinetySevenMember 2012-01-01 2012-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2012-01-01 2012-12-31 0000798783 uht:TwoThousandTwelveAcquisitionsMember 2012-01-01 2012-12-31 0000798783 uht:PeaceHealthMedicalClinicMemberus-gaap:FairValueInputsLevel3Member 2012-01-01 2012-12-31 0000798783 uht:MedicalOfficeBuildingsMember 2012-01-01 2012-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMemberus-gaap:FairValueInputsLevel3Member 2012-01-01 2012-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2012-01-01 2012-12-31 0000798783 us-gaap:MaximumMember 2012-01-01 2012-12-31 0000798783 us-gaap:MinimumMember 2012-01-01 2012-12-31 0000798783 uht:CanyonHealthcarePropertiesMemberuht:CanyonSpringsMedicalPlazaMember 2012-01-01 2012-12-31 0000798783 uht:FiveSeventyFiveHardyInvestorMemberuht:CentinelaMedicalBuildingComplexMember 2012-01-01 2012-12-31 0000798783 uht:OrdinaryIncomeMember 2012-01-01 2012-12-31 0000798783 uht:CapitalGainMember 2012-01-01 2012-12-31 0000798783 uht:CumulativeDividendsMember 2012-01-01 2012-12-31 0000798783 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000798783 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000798783 us-gaap:ParentMember 2012-01-01 2012-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2012-01-01 2012-12-31 0000798783 uht:UniversalHealthServicesIncMemberuht:CombinedMember 2012-01-01 2012-12-31 0000798783 uht:ConsolidationAndDeconsolidationOfLlcsMember 2012-01-01 2012-12-31 0000798783 uht:CapitalGainMemberuht:ScenarioFourMember 2012-01-01 2012-12-31 0000798783 uht:UniversalHealthServicesIncMemberuht:TotalRevenueMember 2012-01-01 2012-12-31 0000798783 uht:CapitalGainMemberuht:ScenarioThreeMember 2012-01-01 2012-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2012-01-01 2012-12-31 0000798783 2012-01-01 2012-12-31 0000798783 2008-01-01 2008-12-31 0000798783 2013-03-06 2014-03-05 0000798783 uht:VibraHospitalOfCorpusChristiCorpusChristiTexasMember 2013-01-01 2013-12-31 0000798783 uht:WardEagleOfficeVillageMedicalOfficeBuildingMember 2013-01-01 2013-12-31 0000798783 uht:FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember 2013-01-01 2013-12-31 0000798783 uht:ChesterbrookAcademyNewBritainPennsylvaniaMember 2013-01-01 2013-12-31 0000798783 uht:ProfessionalCenterAtKingCrossingKingwoodTexasMember 2013-01-01 2013-12-31 0000798783 uht:DesertSpringsMedicalPlazaLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:SpringValleyHospitalMobLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:SummerlinHospitalMobIiiLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:SummerlinHospitalMobLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember 2013-01-01 2013-12-31 0000798783 uht:HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember 2013-01-01 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterMember 2013-01-01 2013-12-31 0000798783 uht:SevenZeroOneSouthTonopahLasVegasNevadaMember 2013-01-01 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember 2013-01-01 2013-12-31 0000798783 uht:ForneyMedicalPlazaForneyTxMember 2013-01-01 2013-12-31 0000798783 uht:LakePointeMedicalArtsRowlettTxMember 2013-01-01 2013-12-31 0000798783 uht:McallenMedicalCenterMcallenTexasMember 2013-01-01 2013-12-31 0000798783 uht:SummerlinHospitalMobIiLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:McAllenMedicalCenterMember 2013-01-01 2013-12-31 0000798783 uht:ChesterbrookAcademyNewtownPennsylvaniaMember 2013-01-01 2013-12-31 0000798783 uht:KindredHospitalChicagoCentralChicagoIllinoisMember 2013-01-01 2013-12-31 0000798783 uht:BrbMedicalOfficeBuildingKingwoodTexasMember 2013-01-01 2013-12-31 0000798783 uht:PeaceHealthMedicalClinicMember 2013-01-01 2013-12-31 0000798783 uht:SpringValleyHospitalMobIiLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:ChesterbrookAcademyUwchlanPennsylvaniaMember 2013-01-01 2013-12-31 0000798783 uht:SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:ChesterbrookAcademyAudubonPennsylvaniaMember 2013-01-01 2013-12-31 0000798783 uht:AuburnMedicalOfficeBuildingAuburnWaMember 2013-01-01 2013-12-31 0000798783 uht:TheSouthernCrescentCenterMember 2013-01-01 2013-12-31 0000798783 uht:BridgewayMember 2013-01-01 2013-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingLasVegasNvMember 2013-01-01 2013-12-31 0000798783 uht:TheCypresswoodProfessionalCenterSpringTexasMember 2013-01-01 2013-12-31 0000798783 uht:SheffieldMedicalBuildingAtlantaGeorgiaMember 2013-01-01 2013-12-31 0000798783 uht:InlandValleyRegionalMedicalCenterWildomarCaliforniaMember 2013-01-01 2013-12-31 0000798783 uht:TheBridgewayNorthLittleRockArkansasMember 2013-01-01 2013-12-31 0000798783 uht:TuscanMedicalPropertiesIrvingTxMember 2013-01-01 2013-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember 2013-01-01 2013-12-31 0000798783 uht:SouthwestHealthcareSystemInlandValleyCampusMember 2013-01-01 2013-12-31 0000798783 uht:EmoryAtDunwoodyDunwoodyGaMember 2013-01-01 2013-12-31 0000798783 uht:TheSouthernCrescentCenterIiRiverdaleGeorgiaMember 2013-01-01 2013-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2013-01-01 2013-12-31 0000798783 uht:ApacheJunctionMedicalPlazaApacheJunctionAzMember 2013-01-01 2013-12-31 0000798783 uht:KelseyseyboldClinicAtKingCrossingMember 2013-01-01 2013-12-31 0000798783 uht:InPlaceLeasesMember 2013-01-01 2013-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:SierraMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:EquityIncentivePlanNineteenNinetySevenMember 2013-01-01 2013-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2013-01-01 2013-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:TwoThousandThirteenAcquisitionsMember 2013-01-01 2013-12-31 0000798783 uht:ApamedPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:SixFiveThreeTownCenterPhaseIiMember 2013-01-01 2013-12-31 0000798783 uht:SixFiveThreeTownCenterInvestmentsMember 2013-01-01 2013-12-31 0000798783 uht:TwoThousandElevenAcquisitionsMember 2013-01-01 2013-12-31 0000798783 uht:SpringValleyMedicalPropertiesIiMember 2013-01-01 2013-12-31 0000798783 uht:TwoThousandTwelveAcquisitionsMember 2013-01-01 2013-12-31 0000798783 uht:SaleOfBusinessMember 2013-01-01 2013-12-31 0000798783 uht:DesmedMember 2013-01-01 2013-12-31 0000798783 uht:PurchaseMember 2013-01-01 2013-12-31 0000798783 uht:AuburnMedicalPropertiesIiMember 2013-01-01 2013-12-31 0000798783 uht:CentennialMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:BanburryMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:GoldShadowPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:SpringValleyMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:BrbBuildingOneMember 2013-01-01 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:McAllenMedicalCenterMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:BridgewayMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:BridgewayMember 2013-01-01 2013-12-31 0000798783 uht:RangeThreeMember 2013-01-01 2013-12-31 0000798783 uht:RangeOneMember 2013-01-01 2013-12-31 0000798783 uht:RangeTwoMember 2013-01-01 2013-12-31 0000798783 us-gaap:BuildingMemberus-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 us-gaap:BuildingImprovementsMemberus-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 us-gaap:MaximumMemberuht:SierraMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMemberus-gaap:MaximumMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:BridgewayMemberus-gaap:MaximumMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 us-gaap:MaximumMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 us-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 us-gaap:BuildingMemberus-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 us-gaap:BuildingImprovementsMemberus-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 us-gaap:MinimumMemberuht:SierraMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMemberus-gaap:MinimumMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 uht:BridgewayMemberus-gaap:MinimumMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 us-gaap:MinimumMemberuht:UniversalHealthServicesIncMember 2013-01-01 2013-12-31 0000798783 us-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 uht:OrdinaryIncomeMember 2013-01-01 2013-12-31 0000798783 uht:CapitalGainMember 2013-01-01 2013-12-31 0000798783 uht:CumulativeDividendsMember 2013-01-01 2013-12-31 0000798783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000798783 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000798783 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0000798783 us-gaap:ParentMember 2013-01-01 2013-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2013-01-01 2013-12-31 0000798783 uht:PeriodOneMemberuht:UniversalHealthServicesIncMemberuht:CombinedMember 2013-01-01 2013-12-31 0000798783 uht:UniversalHealthServicesIncMemberuht:CombinedMember 2013-01-01 2013-12-31 0000798783 uht:ConsolidationAndDeconsolidationOfLlcsMember 2013-01-01 2013-12-31 0000798783 uht:PeriodOneMemberuht:UniversalHealthServicesIncMemberuht:TotalRevenueMember 2013-01-01 2013-12-31 0000798783 uht:UniversalHealthServicesIncMemberuht:TotalRevenueMember 2013-01-01 2013-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMemberus-gaap:ScenarioForecastMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberuht:FederalFundsEffectiveRateMemberus-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:BaseRateMemberus-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:BaseRateMemberus-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:BaseRateMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:MaximumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:MinimumMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember 2013-01-01 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMember 2013-01-01 2013-12-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SparksMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SierraMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ThirtyEightElevenBellMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SantaFeScottsdaleMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SuburbanPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PalmdaleMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoLpMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:GraysonPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchSouthernPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ArlingtonMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:DvmcPropertiesMember 2013-01-01 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchMedicalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:DeervalParkingCompanyMemberuht:DeervalPropertiesIiMember 2013-01-01 2013-12-31 0000798783 uht:DeervalParkingCompanyMemberuht:DeervalPropertiesMember 2013-01-01 2013-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2013-01-01 2013-12-31 0000798783 2013-01-01 2013-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:ApamedPropertiesMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SixFiveThreeTownCenterPhaseIiMember 2011-01-01 2011-12-31 0000798783 uht:WillettaMedicalPropertiesMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SixFiveThreeTownCenterInvestmentsMember 2011-01-01 2011-12-31 0000798783 uht:LitchvanInvestmentsMember 2011-01-01 2011-12-31 0000798783 uht:CobrePropertiesMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SpringValleyMedicalPropertiesIiMember 2011-01-01 2011-12-31 0000798783 uht:DeervalParkingCompanyMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:DesmedMember 2011-01-01 2011-12-31 0000798783 uht:PaseoMedicalPropertiesIiMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:AuburnMedicalPropertiesIiMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:CentennialMedicalPropertiesMember 2011-01-01 2011-12-31 0000798783 uht:DsmbPropertiesMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:BanburryMedicalPropertiesMember 2011-01-01 2011-12-31 0000798783 uht:DeervalPropertiesIiMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:GoldShadowPropertiesMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SpringValleyMedicalPropertiesMember 2011-01-01 2011-12-31 0000798783 uht:DeervalPropertiesMember 2011-01-01 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:BrbBuildingOneMember 2011-01-01 2011-12-31 0000798783 uht:EquityIncentivePlanNineteenNinetySevenMember 2011-01-01 2011-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2011-01-01 2011-12-31 0000798783 uht:BrioTuscanGrilleMember 2011-01-01 2011-12-31 0000798783 uht:EmoryUniversityMember 2011-01-01 2011-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2011-01-01 2011-12-31 0000798783 uht:OrdinaryIncomeMember 2011-01-01 2011-12-31 0000798783 uht:CapitalGainMember 2011-01-01 2011-12-31 0000798783 uht:CumulativeDividendsMember 2011-01-01 2011-12-31 0000798783 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000798783 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000798783 us-gaap:ParentMember 2011-01-01 2011-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2011-01-01 2011-12-31 0000798783 uht:UniversalHealthServicesIncMemberuht:CombinedMember 2011-01-01 2011-12-31 0000798783 uht:ConsolidationAndDeconsolidationOfLlcsMember 2011-01-01 2011-12-31 0000798783 uht:CapitalGainMemberuht:ScenarioFourMember 2011-01-01 2011-12-31 0000798783 uht:UniversalHealthServicesIncMemberuht:TotalRevenueMember 2011-01-01 2011-12-31 0000798783 uht:CapitalGainMemberuht:ScenarioThreeMember 2011-01-01 2011-12-31 0000798783 uht:DeervalParkingCompanyMemberuht:DeervalPropertiesIiMember 2011-01-01 2011-12-31 0000798783 uht:DeervalParkingCompanyMemberuht:DeervalPropertiesMember 2011-01-01 2011-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2011-01-01 2011-12-31 0000798783 2011-01-01 2011-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2012-12-01 2012-12-31 0000798783 uht:FiveSeventyFiveHardyInvestorMemberuht:CentinelaMedicalBuildingComplexMember 2012-10-01 2012-10-31 0000798783 uht:ForneyMedicalPlazaMember 2011-07-01 2011-07-31 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-01 2012-01-31 0000798783 uht:LakePointeMedicalArtsMember 2011-06-01 2011-06-30 0000798783 uht:ForneyMedicalPlazaMember 2013-04-01 2013-04-30 0000798783 uht:CanyonHealthcarePropertiesMemberuht:CanyonSpringsMedicalPlazaMember 2012-02-01 2012-02-29 0000798783 us-gaap:LimitedLiabilityCompanyMember 2011-12-11 2011-12-12 0000798783 2011-01-30 2011-01-31 0000798783 uht:TwentyFourteenAcquisitionMemberus-gaap:SubsequentEventMember 2014-01-31 0000798783 uht:BusinessAcquisitionOneMemberus-gaap:SubsequentEventMember 2014-01-31 0000798783 uht:BusinessAcquisitionTwoMemberus-gaap:SubsequentEventMember 2014-01-31 0000798783 2014-01-31 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMemberus-gaap:SubsequentEventMember 2014-01-01 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMemberus-gaap:SubsequentEventMember 2014-01-01 0000798783 uht:PalmdaleMedicalPropertiesAndSparksMedicalPropertiesMemberus-gaap:SubsequentEventMember 2014-01-01 0000798783 us-gaap:LimitedLiabilityCompanyMemberus-gaap:SubsequentEventMember 2014-01-01 0000798783 uht:VibraHospitalOfCorpusChristiCorpusChristiTexasMember 2013-12-31 0000798783 uht:WardEagleOfficeVillageMedicalOfficeBuildingMember 2013-12-31 0000798783 uht:FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember 2013-12-31 0000798783 uht:ChesterbrookAcademyNewBritainPennsylvaniaMember 2013-12-31 0000798783 uht:ProfessionalCenterAtKingCrossingKingwoodTexasMember 2013-12-31 0000798783 uht:DesertSpringsMedicalPlazaLasVegasNvMember 2013-12-31 0000798783 uht:SpringValleyHospitalMobLasVegasNvMember 2013-12-31 0000798783 uht:SummerlinHospitalMobIiiLasVegasNvMember 2013-12-31 0000798783 uht:SummerlinHospitalMobLasVegasNvMember 2013-12-31 0000798783 uht:FamilyDoctorMedicalOfficeBuildingShreveportLouisianaMember 2013-12-31 0000798783 uht:HealthsouthDeaconessRehabilitationHospitalEvansvilleIndianaMember 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterMember 2013-12-31 0000798783 uht:SevenZeroOneSouthTonopahLasVegasNevadaMember 2013-12-31 0000798783 uht:WellingtonRegionalMedicalCenterWestPalmBeachFloridaMember 2013-12-31 0000798783 uht:ForneyMedicalPlazaForneyTxMember 2013-12-31 0000798783 uht:LakePointeMedicalArtsRowlettTxMember 2013-12-31 0000798783 uht:McallenMedicalCenterMcallenTexasMember 2013-12-31 0000798783 uht:SummerlinHospitalMobIiLasVegasNvMember 2013-12-31 0000798783 uht:McAllenMedicalCenterMember 2013-12-31 0000798783 uht:ChesterbrookAcademyNewtownPennsylvaniaMember 2013-12-31 0000798783 uht:KindredHospitalChicagoCentralChicagoIllinoisMember 2013-12-31 0000798783 uht:BrbMedicalOfficeBuildingKingwoodTexasMember 2013-12-31 0000798783 uht:PeaceHealthMedicalClinicMember 2013-12-31 0000798783 uht:SpringValleyHospitalMobIiLasVegasNvMember 2013-12-31 0000798783 uht:ChesterbrookAcademyUwchlanPennsylvaniaMember 2013-12-31 0000798783 uht:SevenZeroZeroShadowLaneGoldringMobLasVegasNvMember 2013-12-31 0000798783 uht:ChesterbrookAcademyAudubonPennsylvaniaMember 2013-12-31 0000798783 uht:AuburnMedicalOfficeBuildingAuburnWaMember 2013-12-31 0000798783 uht:TheSouthernCrescentCenterMember 2013-12-31 0000798783 uht:BridgewayMember 2013-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingLasVegasNvMember 2013-12-31 0000798783 uht:TheCypresswoodProfessionalCenterSpringTexasMember 2013-12-31 0000798783 uht:SheffieldMedicalBuildingAtlantaGeorgiaMember 2013-12-31 0000798783 uht:InlandValleyRegionalMedicalCenterWildomarCaliforniaMember 2013-12-31 0000798783 uht:TheBridgewayNorthLittleRockArkansasMember 2013-12-31 0000798783 uht:TuscanMedicalPropertiesIrvingTxMember 2013-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutBuildingSevenThreeDanburyConnecticutMember 2013-12-31 0000798783 uht:SouthwestHealthcareSystemInlandValleyCampusMember 2013-12-31 0000798783 uht:EmoryAtDunwoodyDunwoodyGaMember 2013-12-31 0000798783 uht:TheSouthernCrescentCenterIiRiverdaleGeorgiaMember 2013-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2013-12-31 0000798783 uht:ApacheJunctionMedicalPlazaApacheJunctionAzMember 2013-12-31 0000798783 uht:KelseyseyboldClinicAtKingCrossingMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMember 2013-12-31 0000798783 uht:InPlaceLeasesMember 2013-12-31 0000798783 uht:PreschoolAndChildcareCenterMember 2013-12-31 0000798783 uht:RehabilitationCenterMemberuht:HospitalsMember 2013-12-31 0000798783 uht:BehavioralHealthcareCenterMemberuht:HospitalsMember 2013-12-31 0000798783 uht:SubacuteCenterMemberuht:HospitalsMember 2013-12-31 0000798783 uht:AcuteCareCenterMemberuht:HospitalsMember 2013-12-31 0000798783 uht:HospitalsMember 2013-12-31 0000798783 uht:FtxMobPhaseTwoLpMember 2013-12-31 0000798783 uht:GraysonPropertiesMember 2013-12-31 0000798783 uht:ArlingtonMedicalPropertiesMember 2013-12-31 0000798783 uht:TexomaMedicalPropertiesMember 2013-12-31 0000798783 uht:MedicalOfficeBuildingsMember 2013-12-31 0000798783 uht:VibraHospitalOfCorpusChristiFixedRateMortgageLoanMember 2013-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingOneMortgageLoanMember 2013-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingTwoMortgageLoanMember 2013-12-31 0000798783 uht:MedicalCenterOfWesternConnecticutFixedRateMortgageLoanMember 2013-12-31 0000798783 uht:PeaceHealthMedicalClinicFixedRateMortgageLoanMember 2013-12-31 0000798783 uht:SevenHundredShadowLaneAndGoldringMedicalOfficeBuildingMortgageLoanMember 2013-12-31 0000798783 uht:AuburnMedicalTwoMortgageLoanMember 2013-12-31 0000798783 uht:BrbMedicalOfficeBuildingMortgageLoanMember 2013-12-31 0000798783 uht:TuscanyProfessionalBuildingFixedRateMortgageLoanMember 2013-12-31 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingThreeMortgageLoanMember 2013-12-31 0000798783 uht:SpringValleyMedicalOfficeBuildingMortgageLoanMember 2013-12-31 0000798783 uht:CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SparksMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PalmdaleMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:GraysonPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchSouthernPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ArlingtonMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:DvmcPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchMedicalPropertiesMember 2013-12-31 0000798783 uht:EquityIncentivePlanNineteenNinetySevenMember 2013-12-31 0000798783 uht:IncentivePlanTwentyZeroSevenMember 2013-12-31 0000798783 uht:TwoThousandThirteenAcquisitionsMember 2013-12-31 0000798783 uht:UniversalHealthServicesIncMember 2013-12-31 0000798783 uht:MedicalOfficeBuildingsMemberus-gaap:MajorityOwnedSubsidiaryUnconsolidatedMember 2013-12-31 0000798783 uht:RangeThreeMember 2013-12-31 0000798783 uht:RangeOneMember 2013-12-31 0000798783 uht:RangeTwoMember 2013-12-31 0000798783 us-gaap:MaximumMember 2013-12-31 0000798783 us-gaap:MinimumMember 2013-12-31 0000798783 uht:AtMarketAtmProgramsMember 2013-12-31 0000798783 uht:CumulativeDividendsMember 2013-12-31 0000798783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000798783 us-gaap:RetainedEarningsMember 2013-12-31 0000798783 us-gaap:CommonStockMember 2013-12-31 0000798783 us-gaap:ParentMember 2013-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2013-12-31 0000798783 uht:GrossMember 2013-12-31 0000798783 uht:AfterAmendmentMember 2013-12-31 0000798783 uht:BeforeAmendmentMember 2013-12-31 0000798783 uht:NetMember 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:LetterOfCreditMember 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMemberus-gaap:ShortTermDebtMember 2013-12-31 0000798783 uht:NewRevolvingCreditFacilityAgreementMember 2013-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SparksMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SierraMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ThirtyEightElevenBellMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SantaFeScottsdaleMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:SuburbanPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PalmdaleMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:FtxMobPhaseTwoLpMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:GraysonPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchSouthernPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:ArlingtonMedicalPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:BrunswickAssociatesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:DvmcPropertiesMember 2013-12-31 0000798783 us-gaap:EquityMethodInvestmentsMemberuht:PchMedicalPropertiesMember 2013-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMemberus-gaap:MinimumMember 2013-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2013-12-31 0000798783 2013-12-31 0000798783 uht:CanyonHealthcarePropertiesMember 2012-12-31 0000798783 uht:FiveSevenFiveHardyInvestorsMember 2012-12-31 0000798783 uht:TwoThousandTwelveAcquisitionsMember 2012-12-31 0000798783 uht:PeaceHealthMedicalClinicMemberus-gaap:FairValueInputsLevel3Member 2012-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMemberus-gaap:FairValueInputsLevel3Member 2012-12-31 0000798783 uht:NorthwestTexasProfessionalOfficeTowerMember 2012-12-31 0000798783 uht:UniversalHealthServicesIncMember 2012-12-31 0000798783 us-gaap:MaximumMember 2012-12-31 0000798783 us-gaap:MinimumMember 2012-12-31 0000798783 uht:CumulativeDividendsMember 2012-12-31 0000798783 us-gaap:RetainedEarningsMember 2012-12-31 0000798783 us-gaap:CommonStockMember 2012-12-31 0000798783 us-gaap:ParentMember 2012-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2012-12-31 0000798783 2012-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:ApamedPropertiesMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SixFiveThreeTownCenterPhaseIiMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SixFiveThreeTownCenterInvestmentsMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SpringValleyMedicalPropertiesIiMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:DesmedMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:AuburnMedicalPropertiesIiMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:CentennialMedicalPropertiesMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:BanburryMedicalPropertiesMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:GoldShadowPropertiesMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:SpringValleyMedicalPropertiesMember 2011-12-31 0000798783 us-gaap:ConsolidatedPropertiesMemberuht:BrbBuildingOneMember 2011-12-31 0000798783 uht:TwoThousandElevenAcquisitionsMember 2011-12-31 0000798783 uht:BrioTuscanGrilleMember 2011-12-31 0000798783 uht:EmoryUniversityMember 2011-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2011-12-31 0000798783 us-gaap:MaximumMember 2011-12-31 0000798783 us-gaap:MinimumMember 2011-12-31 0000798783 uht:CumulativeDividendsMember 2011-12-31 0000798783 us-gaap:RetainedEarningsMember 2011-12-31 0000798783 us-gaap:CommonStockMember 2011-12-31 0000798783 us-gaap:ParentMember 2011-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2011-12-31 0000798783 2011-12-31 0000798783 us-gaap:LimitedLiabilityCompanyMember 2011-12-12 0000798783 us-gaap:MaximumMember 2010-12-31 0000798783 us-gaap:MinimumMember 2010-12-31 0000798783 uht:CumulativeDividendsMember 2010-12-31 0000798783 us-gaap:RetainedEarningsMember 2010-12-31 0000798783 us-gaap:CommonStockMember 2010-12-31 0000798783 us-gaap:ParentMember 2010-12-31 0000798783 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000798783 us-gaap:NoncontrollingInterestMember 2010-12-31 0000798783 2010-12-31 0000798783 2008-12-31 0000798783 uht:FiveZeroZeroFourPooleRoadMedicalOfficeBuildingMember 2013-06-30 0000798783 uht:FiveSeventyFiveHardyInvestorMember 2012-10-31 0000798783 uht:WardEagleOfficeVillageMedicalOfficeBuildingMember 2013-08-31 0000798783 2013-06-28 0000798783 uht:ForneyMedicalPlazaMember 2011-07-31 0000798783 uht:LakePointeMedicalArtsMember 2011-06-30 0000798783 uht:ForneyMedicalPlazaMember 2013-04-30 0000798783 uht:CanyonHealthcarePropertiesMember 2012-02-29 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-31 utr:sqft iso4217:USD pure iso4217:USD shares shares uht:Property uht:Entity uht:MortgageLoan uht:Times uht:Segment uht:RenewalOptions UHS has three 5-year renewal options at existing lease rates (through 2031). UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031). UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024). The fair value of the land was estimated based upon the sales comparison approach. Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage. Tenants of this medical office building include subsidiaries of UHS. Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I & II, was 50% owned by each of Deerval Properties and Deerval Properties II. The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest. Amortized principal payments are made on a monthly basis. Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement. Tenants of this medical office building include or will include subsidiaries of UHS. We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December 31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary's Professional Office Building. We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December 31, 2013. During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December 31, 2013. We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013, as discussed above. Effective January 1, 2014, we purchased the third-party minority ownership interest (5%) in this LLC. As a result of our purchase of the minority ownership interest, as of January 1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January 1, 2014. As disclosed below, as of December 31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us. Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II. Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively. As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method. As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2103. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July 1, 2013 through December 31, 2013. As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity. Construction loan. We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property. During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012. Costs capitalized/divested subsequent to acquisition. During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II. During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building. Consists of outstanding balances as of December 31, 2013 on third-party debt that is non-recourse to us. The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method. On December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements. During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million ($11.5 million gross assets net of $6.1 million of accumulated depreciation) in connection with the Sheffield Medical Building located in Atlanta, Georgia. During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned. In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan. We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility. EX-101.SCH 10 uht-20131231.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Consolidated Statements of Income link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Consolidated Statements Changes in Equity link:calculationLink link:presentationLink link:definitionLink 107 - Statement - Consolidated Statements Changes in Equity (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 108 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Relationship with UHS and Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Acquisitions and Dispositions link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Leases link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Dividends and Equity Issuance Program link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Incentive Plans link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Summarized Financial Information of Equity Affiliates link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - SEGMENT REPORTING link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Quarterly Results link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Real Estate and Accumulated Depreciation link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Relationship with UHS and Related Party Transactions (Tables) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Acquisitions and Dispositions (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Summarized Financial Information of Equity Affiliates (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Incentive Plans (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Quarterly Results (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Relationship with UHS and Related Party Transactions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Acquisitions and Dispositions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Unobservable Quantitative Inputs and Assumption used to Acquired Properties Categorized in Level Three (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Purchased Minority Ownership Interests, Location and Previous Property Owner (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Eight Limited Liability Companies that Completed Divestitures of Property (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Eight Limited Liability Companies that Completed Divestitures of Property (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Leases - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Schedule of minimum future base rents from non-cancelable leases (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Summary Of Outstanding Mortgages (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Dividends and Equity Issuance Program - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Incentive Plans - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalent Rights (Detail) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Options Outstanding and Exercisable Options (Detail) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Summarized Financial Information of Equity Affiliates - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 153 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 154 - Disclosure - Limited Liability Companies where Minority Ownership Interests Purchased and Consolidated (Detail) link:calculationLink link:presentationLink link:definitionLink 155 - Disclosure - Limited Liability Companies that Divested Medical Office Buildings (Detail) link:calculationLink link:presentationLink link:definitionLink 156 - Disclosure - Limited Liability Companies that Divested Medical Office Buildings (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 157 - Disclosure - Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 158 - Disclosure - Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 159 - Disclosure - Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 160 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) link:calculationLink link:presentationLink link:definitionLink 161 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 162 - Disclosure - Segment Reporting - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 163 - Disclosure - Quarterly Results (Detail) link:calculationLink link:presentationLink link:definitionLink 164 - Disclosure - Quarterly Results (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 165 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Detail) link:calculationLink link:presentationLink link:definitionLink 166 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 167 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) link:calculationLink link:presentationLink link:definitionLink 168 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 11 uht-20131231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 12 uht-20131231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 13 uht-20131231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 14 uht-20131231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 15 g649900g36l31.jpg GRAPHIC begin 644 g649900g36l31.jpg M_]C_X``02D9)1@`!`@$`8`!@``#_[0LR4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0`` M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`& M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4` M```!`"T````&```````!.$))30/X``````!P``#_____________________ M________`^@`````_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0` M````.$))300:``````!M````!@`````````````!>P```E\````&`&<`,P`V M`&P`,P`Q`````0`````````````````````````!``````````````)?```! M>P`````````````````````````````````````````````X0DE-!!$````` M``$!`#A"24T$%```````!`````(X0DE-!`P`````")8````!````<````$8` M``%0``!;X```"'H`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4` M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P, M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X. M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`S_P``1"`!&`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$` M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@) M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D M%5+!8C,T)E\K.$P]-U MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$` M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D M8N%R@I)#4Q5C+RLX3#TW7C\T:4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1 M`Q$`/P#U)K6[1H.!V3[&^`^Y)GT1\`JS\CJ`RO3;B-=C[FCU_5`.T@;W^CL_ MP;MWMWI*;.QO@/N2V-\!]R@+7%@?M`:1,DPF=D-:8<6`GB7@)*:C\GJH'MZ: MQW_7VC6''7]']'1K5(7=3(?.!6"'0S],(<)<-_\`->WV;7JQ]J9^\S_/'=-] MLJB=]<073Z@^B-'._JM24UGY'5!NV=.8Z/H_IVB3$_Z-.+^JD']0J!!X-_(_ MD_H%:.2T3)8-L;O>-)XE(9+2=H+"9VQO$S^ZDI`+,\VAGV.L5EL^IZLP[;NV MN9Z7^E_1^W_C$,W]6VO+>GU2UP#`;P-S3NW.TI=MV>SVJW1D#(I9?26V56#< MQX.A![_11)L_='W_`/F*2D.*[(L#CDX[:"#[0'A\B3S#6[4;8WP'W)39^Z/O M_P#,4IL_='W_`/F*2E;&^`^Y,YK=IT'![)VN)):8!&L`SH4G_1/P*2G_T/4V M?1'P"JOR\YN7Z#<%[J-S1]I%E8;!`W/],O\`6_1N_D*TSZ(^`59^9DMR32,. MUU>]K/7!9MAS=[K=I?ZFVMWL?[$E,,EM9Z>#8&[6`.)?4;@-HG>*F?G*@<6J MV^FO;7Z%C02W[`XM=NGFT[FT?2_2>JM)F)38UEC@_<6MU;8]O`'YK'M3_8,? MPLUY_2V?^E$E.33BMO;7CQ0;;6EY]?IMC6EPVNW.W/JK9[7;/?8M8=,P',:+ M<:A[@()])H&OT]K7;]K7._E)_L./X6?]NV?^E%6L/1ZW^F^Z+)CT_6>7R-/Y MMMA>DIM.Z=T]WTL:EWT1K6TZ-&UG;\QOT$XPL(/98,>H/K_FW!C9;IM]CH]J MH[\%Q`JHRK021N;ZH`CQ=8]G^O\`.(;7U.>6LIL#F\!MKK'CS>QE[/3_`,]) M38Z"2.C8>A/Z)O@K61F8^,S?D/%3>`7$:D_1:UOTGO=^:UJS\:O-]%M-%3JZ MZCMK8^,>MK0UH;MKI==?DI M8=3`?9ZN/?555KZ[VC8X#7VAKG6_YU2C5U*O,#OLMC6-'TG/TL`XG[-9M?7_ M`.A'_;-BL5XS6/\`4>76V`DM?802V=#Z<;6L_LJ=E-=A:Y[`YS)V.[B?I;7? M2:DIC154PN>P2Y^KK"=SG?%R(_Z)^!0,?#JHNMM9.ZT-#B8F&EY;+P-[_I_X M5'?]$_`I*?_1]39]$?`*K9U"RO(=3]CR'M:X-]9K6%AEOJ;Q-K;-C/YO^;_G M%:9]$?`(%V;Z637C^A=9ZD?I6,FMLG;^D?/MVI*:]&9GV,K;3@N97Z;3ZM[V MLU(^BVEAMM]OY_J^@E_E1SAZN_:/S:6UL!_K/MNO?M_J,8KM)_0U_P!4?D4Y M^*2G-KZ8XU$6#=829?>XV';.[9Z5/H4[?Y#%:JQ&U-:UI+&-$>G6&UL^ZL;_ M`/IJQ/Q2GXI*0MQ<9I)%0+CRYWNY[&DM.ZMQ8[VD/\`IM_J M^Y)2U+P*F`AP(:`1M=X?!3]5O@[_`#7?W(>)BLQ*C4Q]CP7%TVO=8[7^7:Y[ M]J)=4+JG5%SFAX@N:8JWP=_FN_N0\3#KQ&%E;[7 M@F2;;'VN_P`^YSW(KV[V.821N!$@P1/[I24MZK?!W^:[_P`BEZK?!W^:[^Y" MQ<.O&G8^Q^X-:?5L=9]'=QZCG;?IJPDIAZK?!W^:[_R*7JM\'?YKO[D'&P:L M:-C[7EK2V;+'OD$[]?4<[W*RDIAZK?!W^:[_`,BEZK?!W^:[^Y5\;IU6-;ZK M;;GNAP(LL<]IWEKR=CSMW-V>Q6TE,6N#B8GY@C_JDG_1/P*K5].JKR/M`LN< M_>]^UUKRV7S[?3+MFQL_HV_F*R_Z)^!24__3]2:3M'M/`\/[T\G]T_A_>OE= M))3]42?W3^']Z4G]T_A_>OE=))3]42?W3^']Z4G]T_A_>OE=))3]42?W3^'] MZ4G]T_A_>OE=))3]42?W3^']Z4G]T_A_>OE=))3]42?W3^']Z4G]T_A_>OE= M))3]42?W3^']Z9Q.T^T\'P_O7RPDDI__V3A"24T$(0``````50````$!```` M#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`7(=05-;75%B;69[?7&*@B5+8W=SA8V!HQ(Y1!)"7&AT@Y"E%",QDR4C01 M`0`"`@(#`0`"`@,!`0`````!$2%1,1)!88$"<2*1,K%"4J&R_]H`#`,!``(1 M`Q$`/P#W*5W7=?CK^"C'!8<,8X=&!"$*,,@A"$)D0[$(0MH=[V+>]].][PLS M-SE,?-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN: M]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)= MD]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/ M-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9 MY+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+ MG9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@ M'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM M'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN: M]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)= MD]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/ M-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9 MY+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+ MG9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@ M'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM M'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN: M]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)= MD]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/ M-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9 MY+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+ MG9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@ M'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM M'!<[/-S7O@'#/)=D]HX+G9YN:]\`X9Y+LGM'!<[0Z=5W7X&1#L,%AP=[F-=A MWL,89-;V$=@1@`P].D.OT1@%O6]?]=;Z,$3.W__0]XM<_N]@?B9%_@1#A9YE M,\(8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$,GGO(A\ M+7/[O8'XF1?X$0X6>93/"&`P&`P&`P&`P&`P&`P&`P&`P M&`P&!5CF7R?;>(="2&X3X@YV-(]/D-@E-,@(/-+)/,``DPL1$8H#*[$>K1DD.;(+,8-`YG')K35U1JQXU)+/,/#6Y3G5[A7P+`T MUSDM.(QM<2VXQN."$6MGA&68`%M.LN)6?:K\)+:GL+K*)V/+R)I.IJ[UBV-< MKI:Z(2E:K1:-.!HJPECY+8"SL$3L5P1-*E2E95ZHAP-3EA'W(.CB.ZK.LN16 MW:J\$K9E2")0VZE&SWAJL%T8I!*JSMJO81(-U,F=G"SVIBF]@0:,1=U?H(SL MQR]Q1$JA'EH-=\`",O0Q!6=9TZ]!VL?!D^&SNP'JSY=!HC7L+K^SG9TL2D+R M@QSQ4]K3AMK>M[9A;-(ZZ0/TVK6831W3HDSNUI524O9G=#]DDA$9J6O648;^ MU%HOR%)Y1X"](!I0N'?0M)NX=\?[6"INO+75R)[9CCI6_&.W[IJ, MB63ZQJW=JXC":H9U5MVU=(2G6VGOW+A$IEC5(*T+DC#6:]M3+5Q+V)&%O<#T MH&HA1[K+4:4V6L?F;I8[D9S(E%#T'Q]E3+6B*T^0/)J6514E4UG5U_S*L> MO&^3MW/VHFKC>],]E5+5T)L&OGF66]2UVR&Z%`FJ)IX`[((4WS)C<4$E#IO= M$STV)DZ$1Q)VU8BAF[(%7PEMA=H_PYJ\^2(I;:;L!VBMUF\BL6=9GP@5>]K1P0LY< MD01BW'X!BV!618:50_5!YOL!0-[S-ZW8$9BMV9$)BES M()UK821[WK6UG68\.)R1[3BC*CH>56=6+LFM.=E\/T'-ZMJ^6-4ZAZ6=T&[R M")QMGF)\EYRO1;V7W7K#1!``P0!$93U?VC?%R/63':@E,M MDC=.71^JV#/R]MK*SWZL(19MR,S6]5U6\SN!JAZJMHQ+I:F>$XD21:Y$&[`: M`1NBM;]@5*J57]K_``*XU-:.C#'`P&,/W(R_J4EJ"PXI>XYDZ,-*P>5S1/)* MR;6>FP)723N[9&MJES$X;3*VL&Q(C-B<^HD'+7JMVZ]I#PI9(I'9RYWDV)XG M*J$UR<9GH,0L12F,I,R1LD-22YP`EB!ZAD6NDRD:)G1,RX"=]7.QW>2=$:I" M,H-2ITS%Q\Y.TUR@CTBD-02)V<]0V1[B,UCLJADTKB<0R3>Y3<]EL\J@EAL$ M8ES(A,3'+4G0W:WVI?$GD"!OCG!N(MS%)+R M9CH3(N9*@WDB!II34W,=)('CTV5?!&[G;6Q6XJVC+A/6ZLGV/*$);?L%DPUD M6ACZD"[1ZQX3[1]PUTA,&(B^.46:.TWJ>MJII.0\RB5/'ZXK:JK5X/M/1J*6 MI;JNHZL<'8Y(TR^TG:&5ZM,@;&F3')"')<]IFQ*C=A*4NA#TC/-#+7K.:X9< ME':)<3HC<"*E'2?OBB3*9?7=>K9.Q5M9,DJ6.S^W6]`ZU="95/H'-[0.,=/$>G2C/$6F,3J-_[*D@9@F)CE2>H>;? M..8\L)QQGL3C'QNA":F(_5T_NR:M?):7/26/5Q9IS\),\10ARI-B3R!Y:D,9 M5FGI59S:0'H!TJ.@6Q!BS$5<2R4H[6[AJXQ"U)'`YE*)BYU]5-AVY%V515UN M1-'=$9KA$(Q\7T[)'^OB6NQ61*Y#)(5.#+IQ(1)S-KC-;0@$?BSK+J8[VOW$ M(^H*;M26C;G\A,%P;MGH%"=08LZSE8SB]RC4^#> M0S5O)@L/F1,G-!M`C*:QJ-RG902"S%(-@*T/1F^MT:J3%4U8U?VRUSRF*5!< M,KX]T""G[9OAKHTF/PCE,)\Y*,JIWN1UI@B2`HYQJ]O.?@)WEH&O]STSEI0> MV&`/",!?7$"6UUC>5_WOM1^'B)TM*,1^P'F53"LX[<#P0UM]:VP7'["=Z*;7 M)QLV(U?/=0)1#[)D]D^V[1BAX M*V%4WD*$HPG;J3$P[([M1.$!S2R*8.RF'F$GC`O3J3DZ,Y.6L4$D#6=933CAV@/%3EE+G"#4;8 M+S(I*D@#/:Z!!(:SM&N=R>L'U8F:D,_AYECPV*!E$6"^J?<\Y2C[KI.M#LLS M0>D.Q"8F.5S<(8#`8#`8#`8#`8#`8#`8#`8#`8$,GGO(A\E=G:NK-KB4M4S@\N2-2PU.G="4+TT`*5I=FD# M4H#SRBSB#!@.++$U-J03KL^N5O)FOKA:>6?,5L<)7+8M7,?J6/4C73Q%*/K. M0U5:+!;S%:<@KF6S:2><6>2.4Q9"E<-J#DA29GTH2)1:T>$PB+<150A\K[+Z M\[SE[Y>'(B_*P57M(+1XE/VR:EJV31FJ(_6/%.P72?HHJUL\EL"22IUED^=' MI2K_\`MV__`&<]P^1R MSK>X7FY^0GF@[I\H>CW6[K_VGW8Z.X]7]#O3I_2P7_PHCPN[.'F)8_&WC#E=V;DBY% M6IR*LQML>O4*6\./U+4K\@['JGSB1$_52VN[68M^59&Y*R+CFF5E.`492AJ. M;GAE5%`7)56S2@`VI(_54P%6791C@:>46C"6H/,-4=HUAE*D M^RP?ZMM*M[D?;N;I;.4:#FK([C.304Y@9YC;',]]8)!('F%-)T#MJ&>LX_#T]L,$<`0% M/*(=,D%@1.3AB+DY+"UC8BE#*B&K;C5G0L2@,)V:#NG7"\%_VM7FV.R[O_E` MQUQ5YQWI2+N=1U-)HO5T)JRA.1C)R(/,<8Y(["D4DE,TGDA; MSBS5(W!.G:]&]0D!I/06!1<1Q&%^^:7%=SY10FN/D587FFN6B;AA]]TE8IL? M+E32S3^&IW=MTT2Z.=_LZF00:5L#^M;W-&4M3"$$XL[I,V1HH=2)I3BQ^S[Y M9WK4EA'7;RYCDCY!/-O4'XH]W:A4M5.ROM$7E_/;84I3+9&U<[8/8T+(1-7?$C/):5U=E3[NY MAINE`'#:;JA"1U^D*CMZ8=)['/D1+H*^0^VN351+]-_9RE]G+69D"I>6,1;- M!8[8U:3"(6#,C'RT7XV22HUKK\1#D0D"VI-FJ0;)"'10Q'J7M&O*=7!V1UN6 M[>PK*?\`D'"7^-,=P\<[@KHZ:0FP)%8%=H:2U#"76F82(%I(*SA]=20V,J5_ M?J*/^[)RQP'I68?_`+IIZCMZ92K#LOYU7MKU1+EEX1-]A5.`GCC45<7Q+.2$"J#O1)+42Z6QE+8TS6 M%+MEK&X1S>6G[WTE.3D#*4O;C"\W`[A>IXDM]N.\@55TIG%S2F/ODA+K!KLY M'&VYLA[!\G8TVF.MOVA:\ZE#F2F,/,-7*EY``@.`G*3@*(!L59F;1[C=V>D4 MHCCK/JD7G0*463,GCD\#>JN+ MTJ)+$'6BP#ZFHLSQ[3.*+@,WN%PI_<[B[5-<4MR`9TT/.]R^3U>5!8, M`N2MHXN(/?S`QANCMLP3:_J&!P+4UTM]/)HR5.21.2=T4112[IDP]H` M[$3U3`*.V%[N=?%$/,RB2J:W(6>+B*M&H[#T[O<=U*$FB:UL!BE[@UA;._6_ M>C9"U-A[?W7NG066J%U@C!L0!5(FE/N=79;+N5U][O.*S2`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`J.;VI= ME:;1*(K?>^R@%DERE[[%E+6-EJ5RFP(&ZUK&W#D0[UHZ#C%LN%S(#^ M0"&=MI;<_.#W=RZIDI-?(9XI*[]:HPD62$L.M*^]S-F&FJ.SB%=DYR6B\2J) MH@/)BE4TEB?!BQ^SLL!_D=%318U/5"2N1)'Y@E\1CR.YBCVBVFTIL((5&K%Z MIH--$,X"70-:3;4O:-,\4UV8CW5<9NA@46ZSO1UK]GEQ_P"#J5:3#5:+W#YB4&;WH>B3-^/+*7'+@2[T3=/&R MUU=E-TD3T)V;,+X$JV5/&5+:=)7>)RNO)(9929<:]+`-C+7/[O8'XF1?X$0X6>93/"&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&!#)Y[R(?'.N?M"B^%A__]3WBUS^[V!^)D7^!$.%GF4S MPA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0R>>\B'QS MKG[0HOA8?__5]XM<_N]@?B9%_@1#A9YE,\(8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8$,GGO(A\+7/[O8'XF1?X$ M0X6>93/"&`P&`P&!\%F%G%EG$F`-*-`$PHTL01EF%C#H0#"QAWL(P##O6];U MO>MZW@?>`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#)Y[R(?'.N?M M"B^%A__7]XM<_N]@?B9%_@1#A9YE,\(8#`8#`H;VE>WY1Q"GK'%;>8*3DLJD MU6QAFEDIEDQKZ//ASK9T2`LK)UL.`$'3"`IK;:BU$:]UD'SMIKCI6+I>:-31^6OQ[FD5JW!4F&<,S_LAFL%>/3U0S25-\%ATLF[N2 MM4M4-C+]*G-.W%D'.![?'FM4[K24!2E0C3&K34R,02@F&E`$/>M"&'72+5E",2+DY:E,8(LSE@$PL0R3=;V$6M; MU_IOV<+7MSO/M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?R MJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57 M#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX= M?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^ M['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8 MX/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['! M]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/I MY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]// MM:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K M2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7 M]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_H MNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W M)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+ M^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?R MJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57 M#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX= M?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^ M['!]//M:7]%W)?RJX=?W8X/IY]K2_HNY+^57#K^['!]//M:7]%W)?RJX=?W8 MX/K*5;3USGS:]JWFMIS5CHPR`;`KC4_65TN>31>XC(^D.B936$_LB.#;%25] M``&AKP*M&E&:&2`/1#XYUS]H47PL/_0]XM<_N]@ M?B9%_@1#A9YE,\(8#`8#`BDX@D)LV)O<#L>'QB?0B2I-()%#YFPM@F`"+70(.MZ"NZ'@9PH1UM"ZA4<3>.K[7%>C M6J8A$Y53->2MI9G5U2-R-]D"=/(8ZX@^4TD):4VW-QWTK7$9`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`.2W)>.\-ZP4WQR"F;(W4_'GMH:9 MBZ,%=RM8\-P9*8:S,!Z%$URB3+E0CY4J0IS`@1F]4DX8][`$.QZ$1>(66C$C M:9A&H]+6$\:ICE+&TR-F4F$')C%#2]H$[FW'F)E`"STXS4:H`M@&$(P;WT;U MK>MX1WF`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P(9%_?NQO'-#]GL#PNDSPA M@,!@,!@,"&3SWD0^.=<_:%%\+#__T?>+7/[O8'XF1?X$0X6>93/"&`P&`P&` MP&`P,-[V_@U9_[$/F%CF#_T]_\`DU_X(P>?K,N$,"HE_P#/?ASQ8E[7 M`>0O(.OJHF;U&TLP:XY*ERPAS61ARB4J%5K2%2ZL*T@`A;UUC$QFM M:_1PL1,\0PJA[53B!9BU+`N+MJQ/DS>\H&:W5Y3\"G=0$W:-O3&[3IUBP29&HEKUGSPY#MVD='HNTOX&7S84>JBH.4=6SRQI8-P*C<19G19[K/1K6U+GM>2@+6($I M1QR=J;3S]@T/K"`4+JZWOV,MIUF/"K+9SNNU9Q[JJT#4D&^4DS[4INX2PN.L40?VQ\W($JEU6Z9RVE0$M4M``M0V^XE29 M-:+ND8+*%&H)5%N75$'AN64](5=OP&D%Y#;.544C4>MIRDD+>#Q*`K6=%-$T M8-=VD05970#KA`LZRE,H[72K87.Z64'?D6F=O1%AL`B)2D^D(S-F"&S.R M9%74(5I8.]7(CE-F21X!']/BUBAJ:1.[(R*RC5Q!1X3DY2SK?EUUD=K'`6J; MWS1L=@,RB]LPBL.4I@L?"E276FU.D3NBGJ_H!(/'O65(C,L,).V%@;!*.4;S) MVI^D%?1?D'0]#\:HJ9#SJ$LB5O\`9''UGLZ4!GQ7)]ZIU#"FAG?D;RH$[O\` MIB0DM!)`P;4=\)1J9:]>$@FG;><88?65<7'N"6NZ5O,XV\2>4/\`MQI2/CKL MF.64ZU+)8Z:WRJWV15:4W89FRJ.[-,%U)SS&W12\C9J52E,.6=9NG!3]HK?B M+D"GJ9[M3)O+=)D>ZR%U5G* M=$C1B:6LY/HD*TQ'I0*BN?"9=G)VDD@Y31CCY#KJJ6:P"W+FX]OMY1V=::8@ MAJ*T4$)E[5$9Y\A$#/8DPG$:`Q+Y*W]R*D*%M&N*V:<1UB=IC%(F*NI4YY.] MJ)?E.6QS70LUT4C&B^-%EQ2&U;1$QXM6_,C[B*?Z[K*2)$#]R,B]J1R"U@M? MI1.#VX@]Q0=Q1]S*./WLD6]XM8_,36%^`=J_QY*Y-%<8W%CEZ1[U;"7CZMG" M5VK)WCR6^CX@&7&U^3"FVP#KQ<&E,/I9MR4F)"CNY%KW/[[T;O6\6G7%VK18 M?;,Q^15U;B:FJ_?X+'<=)4U--J+:JF3M'I+[CO*(P],H$F-+T8#2SKPS)4W:>N"N<2:-\@::=:PB9G-J[>(<- MM!O=HPNAK0ZUE!'6?L*2Q-E3!W=DDAD+9'5B?2A&GVA/5F$`(!U='C*6==3X M9#M7G!*3>%5`\LJLAJJ&^?2U>*[4U1BT6TA8[(ZUOF[83"AN*U$Q/.DJ9V>( M%)M."`0%1P$XE!0AA,ZH@;J5F8<%+VJM-ZLY9#9%5%X0BNT-S/1M_RMNK M8NKS;;XOM4TD5C,Q"!BLM^L@,>.C,`<5J!W/8B$A_5`2/N9P50$LM>OM^S/V MGT./JY3:LLXQOE!2]J?6UY<4:].9H0=:$$8`K.OMB) MC[;?CJJ@2BR9?4-_5M%G:A&7D-5ITO;ZI[[N*'.UIQ&CS&R(E,EK.R1DD:.U MYRW-NR9">S%#2&BT5T$M.(GMDA1+4RADE84J\DP17?)!Y9Q9528JK4K MIOG!?584ERCY0^TG@\4C5[O5 MW$9KGT)?-084G2NO,!_BD>B#4#;/+W9CVNA:V6D^[>@K1E![B9I*8IZ`]:I7 MMA^0]KK!75YY6U_4E0SR2V!QSB'(5>B4O#W4>F9UE/'M"X_*0,PA+5:YEPUM M$'!>A$8SN4C8V1/(TI!H6\T2C990Y:]>+;$.,EHR6[N/%*7!,(F&#R:S:RAT MX=XN6L0KTS:IDK(C==#;U"!T>2?4`!/>,M[P%DLZT MHG&FF5OKSQM=V5G=)*R1>(,P7])!N0TOE!9*I[:A`V-&W+=%@-`,?5UU^H7Z MN'A#`8#`8#`8$,GGO(A\+7/[O8'XF1?X$0X6>93/"&`P& M`P&`P&`P,-[V_@U9_[$/F%CF#_T]_\`DU_X(P>?K,N$,#H76+1A^.+4 MOD<87E025W`D]U:&]Q.*)ZXC.XEFK$YPP%=<>]]76]:Z=[W_`-<#%]D<=ZEL MZ+*HP[Q1O83M*43O'I="TJ**SJ#2EH/"LC\S@\I;$@'"/2F/.``G)E`.L`70 M(H\LY.:<28'455QL@=8.(7ZR+>LMKCCK.)Z_A3@2)SEG>#.W M,D?CS(@*`D:&1I2(FAI1@T6G("(1QAI99@;X7#FE82X-43C38O3]T[@N;V)K M1+".ZE#(-[BI3)2SB^Z$F"`+JBUTA%O6_8WO"*6(>SAX^-UK)++3NMO>X3;= M:WDDUT:9:#\.A6N_7!S7ORFU$$`Z-&$/GRD/_)UQCYUI.UM*XZTL,2C3U7K98BY/74V:(2L$M80 MR*)+T;D@;'4!@]@4.3#[BN:PCJE'J#"@%@`(F8X0AK[*/C*U.+@M)>KB/1&_ MB7#'X^JG:0QAAA/+5GD3/379:@,"`!9W<-")%*7 MM*RK]Q-JZ15WQLK%P42L,CX%GPBQ)!$Y*_FR4*=C0;='P#C#4>DYY6TQ99>S`B*'L6MA$S=O MN;<%*0G\&Y=U[(#IJ*/\UG\J2W#M&_HTRY(Z$0B&P$@<+4Z9QA9226:"H3-` M4`6ZVI[H(72`?<]"^$>4]G=0*BXI9I>'1D3$B5)0*RF=4L)+5G(AJ0!-T+EAUC[(/BVRQ4B(F2.[ M7I`@KBKJB9E+S.VDU0PUO3EV0>^X#%VA(AB2!C3E-LY@"(*A8-&8XKT1AP%* M@TT19QTHGR\[,!+;U+W74%-/VFQ/RDY2U]?5K+K+F[\%#4![>_I7^RI_Q M^01R'N3F&QY:!G(0Z;G%P2MIA*PX6EB8!!:8Y1'ZKE?VV.-=8W!6$.I]]2.; M%!8'+Z@F47;(BK3M.VQ91\OCDS@;64)2B<2],:9RBJ0D\C0-#,2!$`(P;WH> MJEL)J.SNX[KP-Z9W(F+TUHN25]\HU#,YOJ(UL=Y_R08[!CMELKL42S)SCX0I M:;,R+/MVIE5*2R262X+6WH=-%5^<4D;T M;+E+IIWFY(X69 M;L$O)KDP'E@:F5S36%'+&KAJ6-[BF-(**"2(`R#-#WDI>TK?4!049X[PY?$( MW*K*FPGB0KI0]R>U)NY3>2N3NO3HD9FB#%`4;)'&=.D;R@$-C.A;FPD6AF`3 MZ...,,J3-L1.O!&DGBFK9HM6KG.H5318D@XI>\QDUO)3@UHT",P@L`AD"4`+/"HC]3$4 MZ-9V8'&AXM>06[*5MMS1X>(_<$;9V.8V6[2)B@C=>\;?8C994(6+R#)BV)7: M-R9>D2(U#LK;F@E3L*!.FT$OJ"YJEP:0J9GHBI*_IR.R"72B/5O&T,2C[S.G M1&]2HYB:="(9T;FYM[8S)%06AMT4C3[`F*ZJ8@L.^L+6Q;).6HW_`.17_P"U M->'CE2GVLQ/)/#7X_P!H;8..?\O=$_P:K#]B&/*D\RS+A#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`Q/<]ZT_P`>(2KL6[+#C-;PY(<2CT[2-=I.)P[R-_<#/T$S>WD*5JD?Z)10Q>Q@Y:[[$?^8_:!5U/*_I:&E<...EB0Z51! M7=/(N&*'V^;)8)*P+V8_=>\==.34"LXP]`5B!IXF"\MZVC-[J0Q%#V6<&-8C MGE957".2%J2!B:9]*Z10Q:M+B@4L=/D?#)X7('HR'$QZ=I$2!0]3E8W-X%RA MQ+3&#,)/V``!#"'>]Z#JIA=/"&`P&`P&`P(9//>1#XYUS]H47PL/_]/WBUS^ M[V!^)D7^!$.%GF4SPA@,!@,!@,!@,##7(S^7N]OX-6?^Q#YA8Y@_]/?_`)-? M^",'GZS+A#`Q)8%_414SJC8[4NNI*T>W!O"[(&>P+(AT-=5S4-2H1@CH]4=P M5*Y'QQAB0&;W0>'\]3+BRT:90I?B"2/]=F&=;7L=7"T(N:58QN?26LN0JZ(< M8IHQQ"$3ML:[$J=->U.]IZ^W%R7<*:9*MJ74;;[SL*BGF.%\EHZE MY8P@<`721LW;LVXU2:&Q@(JKD2U@#L@3'(WIS3H512L2.\3F]3TLR1SE`*\$\ M$,JR^G:PK/KQ71R>1KG,Z[*R=*MBI4389,DC@RT3@D=UQ1:Q4C(,#UE8.HLG M\XEG:VNT-0U]S.8>&S%#:T=Y(Y--2N"QZGW)&"5&^+UMJ/TQ;P,-=5Z_,CL] MV4^1QDBA:T]*D/3GFF.:-.$&A*"##:E8M6X';.-#-"#+:G_'"116I;%IJX+I MXKR-MLI@DLCO5GJ.P(?79L;D$2W'F4NK93+7*P69GB.,0 M\]5)BJSA7^!=KQQ>,IRGY]=#N_US,IY1M/ M7M/XQ&ZVN&QXI4$+N4]4UQV33FRHQ7:J'QV&AD2$Y"-Q<5*/11W<^Z@+[J7U MI:]9N:32Z>TJJ:O[GKRAH`@>[&G3YRHJ;C+8BX,1L5IKN!/ECMRIZ[0MO)MRL(A)C^]W9ZC8G-$W@#L\X84P@' M#6=968H/D=4?)V,2&<4E)#9K!H_-Y)``35*U.B2*2=[B2@M$_+(,^+TJ9!-H MPD<1#3`=VP:EL4*"30$GF;*'T5)BN6<\(8#`8#`8#`8#`8#`8#`8#`T=?_(K M_P#:FO#QRI3[68GDGAK\?[0VP<<_Y>Z)_@U6'[$,>5)YEF7"&`P&`P&`P&`P M&`P&`P&`P&`P&!T);,I"QQ**QUO4NT@DTF=D##'V-J1E[-5N3P\ MNJA*W-C>E*#L1AQY@"P!UTBWK6!KK'S!NCE`<-CX`5JA=8.<:-*OYFWRTR&. MT`D)T(XHU93<'+&QV%R.5Z&F-`0K;Q-$5[KH`MNYP!:`.-57+*5,\%Z\@4;>@1I"#3CU2D`>C6ND6ARI M:V]JWQ1YQPNIFAA52-R2-E= M.!#V-V2`/9CFTXLTE69L80[6O67+EW:O<*XI%8!-B9W+YG%Y]5JR\MN==U58 M\V'`Z5:Y,;"7FT[2;&2-J'>O8FRS1,>T*MN*1G\O=[?P:L_]B'S!','_`*>__)K_`,$8//UF M7"&!@&U.*'%N]9"CEUW<:Z!N.5MS,GCC?)[4IRN["D*&/)%SBYI&%&]2Z..[ MDE9DKD[JU!:4!H2`'JCC-!T(P>Q%N8XEA$?!&J:SL"&VMQ!K?B_Q@G\;:9A& MWIS8>+\;.;YA&I@%A,.;'A/6$PI%Z,&UKH\2$0$ MA8N@/1H(:DS?\,>\@^!9G(.U12E\O.5,U32&24?,+$IE-"($X;D4@X]RTF:0 M`<6LY0UDSF`M2YZ2$[>4Y!BLQ66$84IR'1Y_=8L34<*V$]C17[I$5M7SR^[' MF-30VHK$,Z5H5+"$I"=M0 M!),3G#%L[%';TN=0/$ETJ8/(246%<3S=%R\F%K&=9-FN$.CD&1A;H?`$M<0A MCCL'C`]M30V1]C(,/'KNYIBM;V-+ M9O"NA.&I\BW!$.E#0V46[S1V23TIN^5&RUBZ1BF(@&-^SBRTVB-;T>9U]Z#* M7MFZ\LCR3LR4+_;2R5EW[,D-.N'+J.\VUE$"A<+6MY]WH&L++*-"GHTY,HU! MI:B!HT37K6AI%PC#@J#`C[D$7CAA>M>QF8*9A5I0JK+^.BP9A3LHH.!RW5!4 MX;8D!K6>/K:JF0W:Q4#8TSB;S4^*HALSZ#8@2%B*6*6]>N3E*-*.WI?WA M?Q7+X9T[N@X_8CW/:PC$NE3A4"&3M9!,BKJ`21V/?DE<+Y&2X*1S1)''5P5= MYN!Y"53I*<`@81!)!O*DS>5M<(8#`8#`8#`8#`8#`8#`8#`T=?\`R*__`&IK MP\&)V:W=H5F('B/R2,2-O:)/$Y,R MKB1$K6QS1I'!&<'8#B0"]C!PR+@,!@,#Y$((`B&,00``'8A"%O00A"'72(0A M;Z-!"'6NG>]_Z8&O::<\4\QE+Q4G"2NE/+BUF=:)FE$J8WH$:XQU`YB[B$6[ M8O\`&A=6%2YMVCQ&FQV*IY%(Q=[F%&)4PN@>BUYGAU\9X'+K1D3/9_/:QPXE6$^-!I@RR9!,SWEP$'6C2"4(N@L M(NN&Q@LLLDLLDDL!110`EE%%A"`LLL`=!`66`.M!```=:UK6M:UK6L(^\!@0 MR+^_=C>.:'[/8'A=)GA#`8#`8#`8$,GGO(A\+7/[O8'XF M1?X$0X6>93/"&`P&`P*<\]JV?[:XPSB"L%)M/(@QT=H,K=*D73A16KS(V1DF M[`]N2V!STE_BI<6LF+EM^G9A4GN2%/[HH2RS#R]#Z<+'/+2C74&[7&"2_9J3+@LCK-VN^C) M7,:&M97:%QF`L*X9>">-T7?X;9#!:"B7+'..'NZDEV,/3*$26<&^7'$MHK>23:"7%ROX47^#E:BL.#IXU"H91,8IM-;224HW=[;+-!8B M)[IX((\4A8%J5S*1G\O=[?P:L_]B'S*S',(B&-O(:! M";NP)<,`:>T9M,)%`]$C!J%];9`A`A(%&BA:_1WO1FA]'^@M;]G!Y63PA@," M#6;8\/I^NIS:U@NY+#!ZYB;_`#66/)_1L#?'XTV*79T4!!TZ$><%(E%HLH/2 M,TS80!UL0M:P,6<3N2D1Y;T+!;UA[6\1HB4IW)!(X1)2N]I77TE@M,FTX="7K]\""7NI4ZJ-)RM:-!O8J=./R)Y8>9 MB?5A2L`J&J+(3$&"Z^P"(NY\.&RR:1PAHJ[DJ0WUY8 M"J911[2,#LSL"'W2<6N<(UBMQ1G-C@QJG!"ZHER8].8+1O5"*E+4/-'BUKWB+LT!`,<\6JD20XXU6&$"+V6\`3:.,:SMZ M*4A*,$$.Q4Z-=QAH(J^O+J4O$D?T["SI*JMF5;@];SI:[ M.VD;YZ,PTT`AJ=Z!L.NG72*G2:TW?%-\A8NLFE(V3$;.C#:_.,6= M7:).Z=S*:)*TA3FN#`\$E[TK:'A,G6$';3J2RC=IU!1V@[*-+&(3$QRRUA#` M8#`8#`8#`8#`8#`8#`8#`8&CK_Y%?_M37AXY4I]K,3R3PU^/]H;,>/$:>C*` MHP8;"EY(1T]60PDEHH#LLH(H4R;T67LZ#FF[`7K?1KK"$+HU[.][]G*D\SAF M'Y+O?I&F?_!KWZ!X/A\EWOTC3/\`X->_0/!\/DN]^D:9_P#!KWZ!X/A\EWOT MC3/_`(->_0/!\/DN]^D:9_\`!KWZ!X/A\EWOTC3/_@U[]`\'P^2[WZ1IG_P: M]^@>#X?)=[](TS_X->_0/!\/DN]^D:9_\&O?H'@^,+WO<54<8H&X6;?_`"7, MJJ$MP#MB>)6=7*0QQ4$$B/VV1YH)@2A[E#X:6'>R6]M3*UQ^_8+*%OV,$9XA MYY+H[4T[E%:5#M7'5-JPXQ%^1-?A@-46R4)]>^3UC+#3VUCBDEB=3PTBO*$9 M88)2HE:5TL.2;?6=4P$.@(L8I"UF5_:E>*BQ*=HBU($J&J8 MM?#"`]4`70%Z@39HL`1"$/8`['BTZSX;AJ6NFF^1S(9(J%Y6LUNM)`"QKCX! M)*@DI[5LW>]%DO;>VQ`]Q8U0MZ__``K"B#=?]0Y69QS#-?R7>_2-,_\`@U[] M`\'Q3&\N7$)J68;IN$RZW>1')54D+4MO'BD66L9+-V\E67O:![LMX40]%#Z: MA8S1E]U=I*O;RNY&=9.6I'T%"BQ'^&*D_#ODMRK;E2GGE>3W'ZZ=%&E+=Q"X M]/R)DA9+9W79R9LO6YF^*QF67DK&3L`5K6D1L46V:7L(DJX&]&;%Q'$+^0RH M6BN8PSPJOGI?!H='D@$##%(C%JJCD<9D1>][`D:V5HKI&W($^A"WOJ%%AUT[ MWO\`UWE2TG^2[WZ1IG_P:]^@>#X?)=[](TS_`.#7OT#P?#Y+O?I&F?\`P:]^ M@>#X?)=[](TS_P"#7OT#P?'`@B-2@<;%3JG9P>C=39(+:YS+:BE0@BKZ!["7 ML#.V-*+J%_Z:Z"="_P#KO>"?#(6$,!@,!@,!@0R>>\B'QSKG[0HOA8?_UO>+ M7/[O8'XF1?X$0X6>93/"&`P&`P&`P&`P,-[V_@U9_[$/F%CF#_T]_\` MDU_X(P>?K,N$,"DW)3L[.(?+R:L]B<@:TD$SES#%DD+:G)JN2\*[3IXXB=GE M\3(1LU9V1#F-60UV69QC[ELR.SBV))&'#OAH=E!6N^41VB^ MZ=<'5&$(M6DN71<;>S7I>GY]<5R3J'0:<7787)3DE=45LPAO8YH2R3]A,-T69H!@M;E+/ZGXU[,780.Q59OM82#D M"G4_(^N&2MZ"L9(X\HU\Q96V.79`+N:-2R./O*E;6D2CQCG7#>A6M,%:(ULQ M0`+JB6-RHHLG2E[96HX_]F-(JHN6A+ODLQ@SM*(%;'(NW;)2MJZ^IF9(Y#6-:[*G%$%4G$624C*V2(PXDS:RO*/BQ9MB6U M77(>@)U7T1MB(5Q8=%S"/6]$I%,JOM&D+2<(X]2**O::(RF(2I@>V2215$Y- MJ]`LUUC`#(4%C*,Z05(F.)56XM=E?+./$[XX2I]MZ(V$DI"Z>5=OJTJ6"NL6 M2%BY&57#((UQF",KA)YGN.,\&TT<"-5BYMMO''5W;]H)^/O`;B;`HA5M4R M%H1HX?QLYEP2S#)[($\IL9W'*U9<6/7.3LG*$UD[+3F%$Z"$(1C+$Q?IMUXF M<V&ZR)@36L:=X=6L;1Q:O8C6$498RPOK[(W8UP,8 M(>6K=7%0IV@H(QUF9XI99EPA@,!@,!@0*Q[ M5K"G8VHF-MV-!:OB206@*9/84M889'R![UTA+,>)$O;F\)HO_M#W3K"W_IK> M#EKXG_:NT8V1)YF5+P*V^0,49F\Q8MM9DCB&H>-K6+1H22A/7)GD(Z574(F\ M?=`#V>SKWH>RQAV648+?5R6UUGRIM7_)WM?.?3VG.XZP&D>%G&U9W-3KD=.6 M.7VW+GUL4Z$`A54,?L&,UTU3_P#VM=W`L.C1$<5:&#:9W4`#ONK*U^8YS*Z, M:[)GBVZ25HLWD\":)\Z6C4= M>N,;GSW$?D(ZR1QL>TYFK71$+N2_DL1Y,YFTD1;2)7@GO@C>BM&$&&&]S$'1 MQNABYE8B50N'3MK,8YO$XS,F4W_\K1*F%KD+69[(1?[C>[I5B0?Z0`[]D&_9 MUK_Z81J:Y;<:NR,I7;0[V=0M:P*UYF:O1UI&N,,3?8%R9L.0'!/4G%UA&N.` MXS94A>#%!>]'KBP=Y$;'_P!N4%DC%O[^MH#0>0>FZ9=8<83J$U!!.0;($C;F93,7-MUL03U8#P] M0#*W^?,6_2B6_M&NSDB6Z^I-TGWLYP34M@%)<]^3EL(51U>UAPOY9Z:P M#T]ZXNO&HXHXQ!P3['T&$N#\6:7OJZ$'6Q["62H]PS MSOGN[QH8R+;X.<[JQ&E"/;@X-M,1^^V`C19A99AR9RXPS^ZERQ($1G3W3O,& M]`"(>PZ+#U]U*U,.X9^TYX%.;B2SNW)F`5L]*!F%$LEZ%R'CT]C.)ZNCD_N- M>C'7;F%22,80#*V5HP)HM`WK0]Z#M9UG2X$-L*`V,VZ>:^G$0G;/L!!FG6&R M5ED[;LM4`1B4S2YD6KDO44E@$(O?6Z!ZUO>NGHPB7X#`@D35I3I%9Z8E2G-4 MHIHV!6)RCBS#T@CZX@1Q`5)01;,($<2+0PZ%K76#OIU[&%TG>$,!@,!@,!@0 MR>>\B'QSKG[0HOA8?__7]XM<_N]@?B9%_@1#A9YE,\(8#`8#`8#`8#`PUR,_ ME[O;^#5G_L0^86.86M.U>W;[."DK)G%16=:DRC-AUQ)G:'S./>:>P M7GW&D;&K,0NC=[K1]C=F-Q[U5%"#W9(I/('T=(!BU[.2X7K^IS2`?Y%?93>G M"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZ MT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2 MV?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%? M93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGB MX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G" M9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT M?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V M?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?9 M3>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX M.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9 M>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT?Y%?93>G"9>I2V?HGBX.GZT? MY%?93>G"9>I2V?HGBX.GZTU==L?VQ_`?E_P'M"B*(M"22>RI/)*R<6=G<:RL M"-)%"2-6!'W]W&-W?X^@;"!$-B`T80C-#LS8>J'I%O6L3+7Y_,Q,3,/5+QS_ M`)>Z)_@U6'[$,>5B>99EPA@,"NUV\M^,W''1!5W7C7%=NJS1&VN+/4D1&SE] M$J%L"8J-P%M&NFLE4*1AWHLM`@4F#WKV`[PL1,\0KJ'FK(4EA<5XWRV;*S^S^XJM/-:V4*D;;(.>7+>6SBS:0 MB+P@4:[]5,U]VH9/YE;,C1K#@C-:JV(TW:WOJ'.*'J]&HN?,X7W@'`ED=Y6R MV]S#L-XYAW2R*P.L<'.VE(Q4-5CEHGN0-TYQX;U"N"QY6B#T=R>WCW=E`C`: M-VY:%T!#4O6&P3"&!&95-(=!6\EWF\LC,-:E*TMN3N6G;'%:M7/#R>0,I"B3E&JUIP=ED%F#_1PM3I5#5M8&M MI>.T2<.'5#+@;"/D9?,,TNOR9MYX"Q`64GQQ>^XHX2B4D[V),_ST?=>J8$8( M\<'77V,1SE9#C[PZI'CBM>Y3$VE[F%M2\H`+`ONU7U585WV`,`Q&]$CGKR'O MM,UA-%UBFEK*;F1+T:TG1DAUK6A,S*TN$,"KUW\+.+/(Q>F?;=I2&R*9-_3M MHLEL3*X9;+"/N/<-&1VV80KCMCL`P%]&M=Z.A.OT0_\`]==!8F8XE@LSBQRR MI\@)G&#FK*9"TH@$B2U1S2C1/(.+J=E:$2)"BMYA75_?C(28SFHKTZW4O<0QY;T;YJ<8:KL&Y3^T)@1#XYUS]H47PL/__0]XM<_N]@?B9% M_@1#A9YE,\(8#`8#`8#`8#`PUR,_E[O;^#5G_L0^86.83*N?W>P/Q,B_P(AP M3S*.NM$T@^N2YY?*;JIY>'-2Q#, M,$(8M[Z=[WA+G;K_`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`A]G!4Z03=_<[;?V M,JBN';)2<>4&CTBLOFG8R!D(6*I+B-QDXX;4**0HRMZ[>%P#0.TK98 MTA-G;_W<>S#QR6P'("Z;28XXP6Q#,<'!2,6]].][P3,SS+!-@<]XXX2][I[B M/7[WS$NUB5Z:9(BKEU0-5(54[#'U1$7=R#6%+H-"U:(`#!GLS=I\E'^UL`6O M>Q!W@KS/",MW!R:WTX(9AVA%I)[UVF5E.K-QBKPIXA?$.%K2E):I(%VB9BDF M4)U!+/ M1%1020B-T01#W:;LALZ6J-_Z)VR!MZI;,710(70'1:9":/8A!#T=(M:V6(F> M(8(UV@*F>E"UQJX@JSC8J8_-933!'Z[EUG4X&'.$=FKM.)2YOZN#IY`VIU!+SIE3(=&N*4O1Q M!0M%!-#HT81CB*;$L(8#`8#`8#`KA>?$'C'R4TF.N^DH%/7E!HK31,%K.%JL M./;(%UR1Q>R8^8TSZ+FE"]D(VYR3#UO_`*X6)F.)5\,XB\CZD+T=Q5YJV*B; M$HRSDU3\MFC7*2N30)M`T4TH9RXN\.Y$QY$<6#N>QCF#J62#?26FZ=:Z!<>8 M0B=%2@SGMPL*9Y=G'"3Q^_J93L+'_WNX2":55/4RZ,0B.HP[$K?I<_M4;94H= M:ZVQ*71Y5HD)`=!UT[V(S7L8%*7'M.>&Y[@K8JRL5^Y'R9(;M/\`)WBO6EC\ MD%!BG0A`V28^5%%Y5#VP.A`WTG+G-*G!KV1&:UOIQ:]9<$'*#F+8^MAI/L_I M?&&]7U24,PY=7+7='M1(S`!W[H*8367X@[/VB3[%UMDJ&I`H,UT!UH`NMU!4 M>9?.ZE[2"QA;-GG+BD^/S8/>@?)[C-Q\W-9,40/90S.O:/(B42QC5*R^@PL! MA<&2@V'81]ST+71MD_KI24[B+RK@'*>WYN_5=/\`GS4CI2FJ0K)7R5Y>Q!H4 M(6BQT&SN0[V&OD%7DPF)*K&++;8_L+*V-6QL[-O9W7VM$`F+<5J5X.S'H^R> M.?%&*TW:U6PBL)/7[W(XPT@A;C%7@(DS,2)UG1497E-SRK M.(TH<7%`93D':I5R-Y)G)PFHN.U%)6Z M4SMM`H+WM&[64[*W%MA=-1$1HRNZNLH<6TK11FA$`4"Z"Q%B/\,.&<9.2'*< M(WCG':!-<5(?UE7X.>-DM>F:)+FS1.S`I+]Y#%)(S8]G]!9PPK6AA!&(X(9( M=':<2M[Z8MQ'":"YE]G5Q:9V.EXC;E+1HF,I--K!2=!H=V1*6=*G-"GV0CJ2 MC&>8R\@0U(^@6_Q#WO>5*FH66I_C!QPX^I"D='414E3%E$B(V?`*_B\8<5(!AT`T M2]V:FQ,Z.1QX0ZT88H.-,,Z/TA;P3,SS+.N$,!@,!@,!@,!@,!@,#C+42-R1 MJVYQ2)E[>O3'HEZ!:04J1K4:HH9"I(K2G@,(4IE)!@@&%C"(`P"WK>MZW@4R MIWBC"H58S@\'2692^(TT^FLW'2KY+ M7/[O8'XF1?X$0X6>93/"&`P&`P*G\W[1N>F>,EC6+0,,4SFS6,<1);6Q%#7J MQUK.PO4VCK'-ILBKF..C(_3];`86Y+WHIG2K$YJ\Q#HO8]`V+I+'.6H(7:*< MP$'9:VCRAJ^:<6^3,KK0"A.YVRUK)K6LAKQE3PR#.2M-:U#OD,>$ZZ\8[)Y` MK2J&PAV:6A:W;1.0-@T:-(*7AKK':F=>=?-[DO2$SJAO@3HDK6JC.-IUVW%= MCSQ-N#DE$8\N')F!CTG=#*RE$31P=D86HY:YN2E2H4#*3[)Z">@>A;$1&6.$ M?:,\D7"8K;C;)E2SMQC@W:#TWV?$EB*.O)$9()L1-8_7`)GR%8)X1+SQM0D\ MKL9,H9V4#[V_@U9_[$/F5F.8?VN[$K\% M?P4`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`]C^J%M1Q!K=5TH<'$0MZ#I.0D,.V+>M:#T[UK8J=*Z+NU%K&1*# MVZ@Z*Y,\@5O=3$B)U;*V24;`5"TL(]"Z]@#NP.G8Q%[P5'LUQ^L">:+%??:B6K($X>C9D6X['4[Q5B!HS`;` MJ#[J11#,+L+)-#U>YZ#-^N1O6]A'UM]./I_'Y2>)<'NS?BCR5*%M=U%9LS*% MW74[OR;*.1,Y[[$$.CEQ4LO*46`]HE:@0>L,28XG73OHUK6NC6F"_P!+K-DS MJIE0)6IGE=?-+6A*T0B;6Q]CB!`C)UO8M$I4:544G3E:V+>^J`.M=.\J5.G. M\XU>^'D,\J&3V]@J='G&KWP\AGE0R>WL%3I6J>\P6:*S5]BD=AZ28-D<%6[: MXS8^VJ>@T4/E]K.+RV0N#LZR:S)H-=Y.[JV@)1*8H'=3U"DHDH)@Q:UL4KV^ M=L#PZAWNE$9D_P`J)Y",TDG\-<^+4!BKM<5X%2JO9=(XFN9PM%8IY)'TVWK4 M<$XH%"YQ0IAMBI.>:83HSHU+7K/Q0.;U(YLR58Q12DVKAQQC5Z-2I-RGE M96U/778"10,POND^G488KBM&J&<)!11A[9%HLA>=Z4&DE2'6P!,PM1'N5I:2 MXO7/7D+W`HWR[XM\08(H6'*W")<-:EC3W-G@]8:(QQ>9;??)Z66J\3:7N6CC M-&O*N,%..QBT9W78]:Z"7Z9H+X)<*I"H+<+VLR<];%SXAY`'O0>@O\`1UO>M94RG_G&KWP\AGE0R>WL M%3H\XU>^'D,\J&3V]@J='G&KWP\AGE0R>WL%3H\XU>^'D,\J&3V]@J='G&KW MP\AGE0R>WL%3H\XU>^'D,\J&3V]@J='G&KWP\AGE0R>WL%3H\XU>^'D,\J&3 MV]@J='G&KWP\AGE0R>WL%3H\XU>^'D,\J&3V]@J='G&KWP\AGE0R>WL%3H\X MU>^'D,\J&3V]@J='G&KWP\AGE0R>WL%3H\XU>^'D,\J&3V]@J='G&KWP\AGE M0R>WL%3H\XU>^'D,\J&3V]@J='G&KWP\AGE0R>WL%3IP(([-3TXV*N9W-O=D M0ILD+"L;%B9>E$877T#T87I0E,-*V,&]^SKIZ=?]<$^&0L(8#`8#`8#`AD\] MY$/CG7/VA1?"P__3]XM<_N]@?B9%_@1#A9YE,\(8#`8#`PER$HQCY$UBY5H^ M2R>P'9[Q&I(QSJL'\B-SJ(R:(/R"1L+XP.*YN>6DPTAP;@@/3+D2U"K2F&$G MDF`'O6%B:4V@W9=U&P\2[PXNS&P[0FBKDXD;1WO<(E4+9K`D#LVQ2)0]#N+) MT,*U#8NPQ]CAR5*UHMM*KN!'7V<-0>88<)1VS$L@`T=Y%:(0J>0?)2K8N MZTN=QXLR#5G-HNFA=KU`K/5*7!CDLVHI5;+WICSR!=RT`4I>T_5SN1G\O=[?P:L_P#8A\RI M',)E7/[O8'XF1?X$0X)YE,\(8#`8#`8#`8#`8#`8#`8#`8#`8%8K2YK<0:34 M&H+7Y-T7!7DKV-1I]L^($2Y49U^Y:(;X>6[&RAS5"-_1T4F2&F"%[&@[W[&% MB)GB%?GKM0*(VUG/=:UGRGNQA(2C4&RR"\Z\B)@A6= M0\Q,C7U_P)JGE@B3.1P"P]*9PDC3W$[I)4&$"",9L/4BUIWY0\_7=.`(MEI=(`-"#HLT\9'Z>Q;+V/0!!%^H<5;V=/'DM.:MG-I]@T-<`Y+>[1WN;L&NIL0S-@ZHO].GHWJ4O:?"GDZC'8J5ZOTU MSCD6DD4A`%2%/#CN?_*6[)B6,K6QJ0M<`;N04[DY2LS2?>MZ3(-&FZ*$'76Z MF]:8/[:044-[.>3BT.J^SWYQW(Q\B&2EN&5:/R:!5+,US$ZQ=28X518#\J9)-N[6=WVQNMB*=MPHN MEUI.L+1L*QT7D%N^);".!G"J&<1*Z=CAQ2*E739DGF&B/MJMY?G1N M9&AO*[NO=7=A`!LH4&J!'.);WP'9@.DOO+NFM##OJ]`@[V M6ITB&N>K[+^@FC>$7-FVAK"0G-#V^U2Q<.4O*=ZL"1&` M#H0A'?)"%Q.JXF:,CHV`1">8J=C&'H`9OK>P*CW*HHN2=H7&6,F-PLTI0$0B4C;R&Y$MMHPA,2/8=@+4DS-&<;H/6ZQ?\`]I:K MQ'U][X27[=(A"DG%%P=DR@`B3I+VE7:$71?"H]L4%G=4K\,O']SD=(]?0U.Q M&(_=MN)#^EH.PC%O>Q<;_P`+.5CV8LUBQ:8"KD9&**;`ISBSXCP"XLT9Q0;M M=W+&6),*?OK-=EQ'%=0\W1IQ#^@.5#,V8/H'T;TI.WIG]A[,CA][W: M3M*ZS;$(NR1[<386!ICL:[R.;RV2-HB(\W)4:@C:Y5W MX*-Z=0"([X[W[WV<$0=;ZP1=$PU?ZY;-&MM1,S8W,[<4(AO:D*1M0$"./4") M1(4Y:5*4)0J,.4GB+(*#K8S!C&+HZ1;WO>]Y65=K0YG\1:3[[!;?)VA*\5HN MG1[3*[8@[0_;,#UNDA-'U+V%\6JN@`M]R)3F&=`=[ZO1K?06IGB&#A=I=Q]? MMZ+IV&19_=CB!F4AQ9O.0QTL9?3HL1EAR2%Q*L-$JAAV$LS3WLO?1TB$$ M.PBV*D_$[S1F0NM5O9T2]@;5)/6;WSDWR)IBH2]CT=W$P:Z-U*JY)RY$`&M; M&`!R,HPW0>C>B]""/!4;?TN,]J)-M[+?+8X5\?T`S2QC!7U4W!R)DI9.P_[J M9))9U8%%QTHT.][T$\V.*-;%U1[*UH(BC&3^OM_-<);;EP"S+H[0GF'-#.IH MH]HK!PJ/C7&!%=(A[`1NF:O8K$('UQB_W128P[J[UKK_`*(>@7ZAB#H& M@=`=*.T[7`@E65C5K=MHK&N8'7+3OIZ6N"1"/Q!NWT]7IZ44?;V]-OIZ@?\` M[?\`IK_Z82[Y3S`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`AD7]^[&\< MT/V>P/"Z3/"&`P&`P&`P(9//>1#XYUS]H47PL/_5]XM<_N]@?B9%_@1#A9YE M,\(8#`8#`8#`8#`PUR,_E[O;^#5G_L0^86.83*N?W>P/Q,B_P(AP3S*9X0P& M`P&`P&`P*]W3RRXR<="P[O*^:JK!6;W'2-DEDU8VZ4.AB@.AIR&6)[5CDSXI M4`WK8"D:0\P>O9T'>L+4SQ"A'(;G>R6C5#\T5-27+)?7CE(:\0R[D2[5T_<< MJCBD`4V1$TTSE&YM<3Y4T[>(\5'!*RSE$<;'#K$B'TC`7H0]1:KRCJ/FU MA\>8QV='+JE"+K5W<^M4UT\P.VORQ6TU]PQF;JG=* MA[+_`)7\W)`8+?>5FN^"?!"$'DA3%-RRN[.Z8@(^CI,WTY6<>Y2[7!>;SG8SN0_.'EQ;`5`NJLBE?31 MCXLUX8DV$(3FXIMXZ,,%L,]"J#L99H%\I7[,)%H.]];K#&+U#)M7\`^%U..@ MY#`>-%2(9<:=M2?/7^*HYS9"D\6@!$:KLB=_*6=JQBT6'IV:XCZ>KKI_TP7. MUO<(8&)[4OFCZ,:]O5TW#6%3-7<-J`+K'G<8A9!Y6MC#K:44A/\`0DVPR383`=.P[WK6^A9UGR^3+1[26R-"!7_%JAN.K:,(#" M9!R8O);94K``T0@Z`;4_'IA7QP2A.#6AC#NP"PBZW4T(.];%C)_7:L'X:[[7 M1);QLE<+4N?(^2S\FW7+M+(P:JC36W*3$QS:KM]E[G)%$XB]W1)B4#B#17:< M\<4.8S2M=VU'1N#21%N.?&EI/_UA\4WT1:BW$MTBST1D'DE@&5N!O-_2$(@MF+*WL71L/5"`(;27*RM7\8>-M):)\SG'^EJK, M(*"2!17E7PJ'K-@"+0^DU:P,B!6H-&;KKC&8,0QF=(A;V+>]X+F>99SPA@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"&1?W[L;QS0_9[`\+I, M\(8#`8#`8#`AD\]Y$/CG7/VA1?"P_];WBUS^[V!^)D7^!$.%GF4SPA@,!@,! M@,!@,##7(S^7N]OX-6?^Q#YA8YA,JY_=[`_$R+_`B'!/,IGA#`8#`Q[9-MU5 M33`.5V[9<`JV,%]TZ\AL281Z%LFME:!LP/NI(W%M1;&'N@>D.A[W^EKV/9U@ MJ^%,1]I73$O$8EXVUOR)Y>KNJ$)*^@*:D2FN1G';!I+HR\K+W7%';3G]?K]T M(D2C?<@C$$(]@V'"U/EA&V.87*IB)/'8@Y%J/%RK-N=U-QS/D]VF/:%= M^]0IRAO$RG+1H3CV<0`(!`1:DU.PZGV%8WN!@M[V!VLIVZX`AZXM:_3,+QXB M&?*;@5O5RH4&\1^R1HGC6J<]#-U:/)&YJUC,\6]UUO\`[=*4U"Q?D98,B7&Z M-%L1+A(R#O9WH9H-[WCXDUY_3G%6CN!*WD(8'2W%CCTR' MK'%U=7)$VA7NUJS[Y@,=%-52+*&Y-G7%,JQAD2GBIITOE-=W[.6.C.5\G/LFZYW,\LQX#`K+;W-#B90J MOW+M[D54,&D&S]IB(@Z3AC.G*U4$0@"2ML$;E:V8NBK1H>IW-.A-'U]Z#T=; M>M;+4SX8,!V@)D["6'C?Q%Y?7\6M%L#7*C:I!Q[K16'6A[[^U-N3[Q3YZYG_ M`$-Z[Y:VYTZV]=4`1B_1P5N7SW]VH5G_`/\`D8>(7$EC5G]S[L^NUC\L[*0H M@^P)5[E,A''FNT3F=L.A!+]T7<@L(]AV(>PZ&)D_K[?6N"DWG>A&\C.8LCFEC*U!.B]%GK;&FWRBG*T[6R0BV(U MP&+8]:%O>Q>S@N9\K;80P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P(9%_?NQO'-#]GL#PNDSPA@,!@,!@,"&3SWD0^.=<_:%%\+#_ MU_>+7/[O8'XF1?X$0X6>93/"&`P&`P..K5I4"52N7*4Z)$B3G*UBQ6<6F2I$ MJ8L1RA2I4'"`20G()!L8QCWH(0ZWO>]:U@1ELG\&>88EL9JF,8<*_6L^I`EF MR5];#8HNC>!SG2619C$RA>I+'V<4 MC6E-T>"Z/+-%2`B)&2 M%C+E2EO-=DT9&[(`2!0UDF:*.P/Q,B_P(AP3S+OWM\9(TTKWZ1O#7'V)J3B5N;T] MN"1J:6Y*#>M#4KW%><0C1IP;%KI&8,(==/\`KA&K^[NVM[-.BSU;6[]!$).&7!^SI<@<@&J$,ZG,+M:3/: M$O0`['6_'?S)5^F=JFX7<2**/+75%QLI2`O!9PE.Y(PUS%R9:>I'OI&J6R\YN/ MDZ]2/>][V8>K,'O>][Z?9W@N9\K-81TSO(X]'^]_=Y^9F3OONO>GNNZ(6WOG MN'N'I_UU@8DDO)[CG$$+LX2"\JJ1@9>Z@7(B9S M'7)[VL+.TE`T((\UKUK\[OZQ<(*5*W)$QZ]6L&!.028<,!8BU.E=I#SR9J;4 M%&H+Q0AX1CZG<-'M,Q M!(-ZWO9F_D/L9?1T=46]]&A4>9?F&#]IM9?,7%]I'US#6FCZKE M5_3H`3?8`F#8US/$*A)!R8L6M]T^0RD&S0[_`$1@%K063^NGZ%]G+7LL`$?( MB^.6'*(XSI-6M5GWQ)8=7JI2;O8S]&5)09=.5@M;^N+82DRYJ7!+*Z`"$/HV M+8O4+,5#QBXXT`F`EH^B*BJ8`"ADB/KZO8K%5Z@!NM!-VM:8,>M?I;W@N9YEG/"&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&!#(O[]V-XYH?L]@>%TF>$,!@,!@,!@0R>>\B'QSKG[0 MHOA8?__0]XM<_N]@?B9%_@1#A9YE,\(8#`8#`UV=JLUP9\X1V:S63-W&MH6X M22I/=B>%P(-FQ6,B;K9A;PV*K5A!CDTIWVG%[PVIT4I+.4%IPLZH\1V^Y!'K M$K^>7GQ31N!6YV)W.%V00=NK3S-/8W76:<&BG@N)>TAUZ"E2F)'#+:=">MM>D@M_\`9`FZT(OQ MM@N%DJ2K$9F.XD$=,[451VN?#N0QXE[0O`[B%QQ2U-3FW%S0[5%:G>Z!:HDE MEA;Z87K;61_NZ4[TH[WWI_R?_FFXKM-+"I9DOGA]7_(VSW"!4#-&"\SK71-\ M_%#T;LE3RWCHR1`N9)$\HCZ]1`W1Y?SVEY6I2'-2B97%PV(A,WCEK\DZB[)[M"HA7O&"OU4*)*7V*G!;L_0I70SY2 M34[2[1I:U,SL>%B=5J!`28#OY*6D=G)_#4UB?U&7&>.P?YB6"^HY'R)Y'4CR M]=$70J3&\H9%S)F:=`ZC*$$U0T-L"O2L&AN;"C1=*=!WN:G`4'11O=R^MH2D M[1XA=>H^RUY#4D).*LI)VCND>R]@Z"M,I_73^_A(YA.@MBE7:%\F%FR0A" MAU$EG$2"A+T/8MJ>_P`#=P$7`@71UNO^B+C3^:X-6JHT6!Z MY?\`,Q\+]@2P&^5C;%]N!^@;Z3S#X!QEAZIOZQ^^Z]R0F)$_3KJ:+T3TE;%Q MI_-]GX)5HS;S=/,EZ/,Z0=V'VDW+"/@"GZF@Z3>YT+3Q=G,!K?6%LP:81X]C MWH1@@Z`$(OU_\-=FG0AFBPN5=V#(2BN@04TK[03G)+$&CM`V7I6%KD4U)'V>7!X[:@( M`F:=X%$7\(=%[%L/<`/M+.0$PM]??6V7H&Q>QUNGHUT*]':=RGV^%'&_32>Q MIN$/#EM;#VQ4S][LT,B3&-.W+4AJ!0F0*F>E4*MLZ4AP@!&G,*,+UOI`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`@ACJ:XV*-X1MZ!;\MDFA)VQS4NR71>J^@?< MQ:6*FEE-$,6O]0]PUH/_`$WO!/AD+"&`P&`P&`P(9//>1#XYUS]H47PL/__1 M]XM<_N]@?B9%_@1#A9YE,\(8#`8#`^1!",(@#"$8!AV$01:T((@BUT""(.^G M0@BUOHWK?^N!UK&QL\99FF.QYK0LC"Q-R)H96=L3%(FYK:VY.6D0-Z%(0$!* M9(D3%!++`'6@A"'6M8')5H$*_:7:Y$D6;0JREZ+:M,2HVC7$!,`2M2[.`/O= M62`T6@F`Z!AT+>M;]G>`$@0C6E.0T20;B0G,2$N`DQ(EI*4X8##DQ2K8-GEI MS3"PB$#0M!%O6M[UTZP*X\KJWKN84=YH52I"$M5_NAT4,/09^EKV?9PL+ M7/[O8'XF1?X$0X6>93/"&`P&`P&`P&`P,-[V_@U9_[$/F%CF$RKG]WL M#\3(O\"(<$\RF>$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0R+^_=C>.:'[/8'A=)GA#`8# M`8#`8$,GGO(A\+7/[O8'XF1?X$0X6>93/"&`P&`P&`P&`P M,-[V_@U9_[$/F%CF$RKG]WL#\3(O\"(<$\RF>$,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@0R+^_=C>.:'[/8'A=)GA#`8#`8#`8$,GGO(A\+7/[O M8'XF1?X$0X6>93/"&`P&`P&`P&`P,-[V_@U9_[$/F%CF$RKG]WL#\3( MO\"(<$\RF>$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0R+^_=C>.:'[/8'A=)GA#`8#`8#` M8$,GGO(A\+7/[O8'XF1?X$0X6>93/"&`P&`P&!23F?S.;^ M)2*JV=LK60V_:=W2IWBM9UZQ2"&PXIT.C+(.2R=P=9;/7V/Q]K3MS06$!!`3 M#UJU8H)*)($#NQI)8BV#)IVGZ>/O]30F-\1N2\JLJT*G06RMJUY)JJI;!KQO M3UD,C&\L=:K8^.4`F2UN;CI(@;G)Z3H MS$21T6$DAT:`T)VUG7'*YW(S^7N]OX-6?^Q#YE2.83*N?W>P/Q,B_P`"(<$\ MRF>$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@0R+^_=C>.:'[/8'A=)GA#`8#`8#`8$,GGO( MA\V M+5)>E11@"P&R6OS,1+7Q8O920-L90JCHHYENB0A4J5=[G*B<4O:+MEH_LT^1 M**Q'6K$,@JN0\6YMV@%4=H%,[,D(U M!3^"2I0H42A5THA&]Q!HEQ]IM[Y&?R]WM_!JS_V(?,J1S#^UW!60=?P46UTQ MUL4.C`MZ#8E@`#K>V1#O?5`"3A``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`=F;"'_`*:U@GPR%A#` M8#`8#`8$,GGO(A\P/Q,B_P(AP3S*9X0P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&!#(O[]V-XYH?L]@>%TF>$,!@,!@,!@0R>>\B'QSKG[0HOA8?_0]XM< M_N]@?B9%_@1#A9YE,\(8#`8#`8#`8#`PUR,_E[O;^#5G_L0^86.83*N?W>P/ MQ,B_P(AP3S*9X0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#(O[]V-XYH?L]@>%TF>$,!@,! M@,!@0R>>\B'QSKG[0HOA8?_1]XM<_N]@?B9%_@1#A9YE,\(8#`8#`8#`8#`P MUR,_E[O;^#5G_L0^86.83*N?W>P/Q,B_P(AP3S*9X0P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&!#(O[]V-XYH?L]@>%TF>$,!@,!@,!@0R>>\B'QSKG[0HOA8?_2]XM<_N]@ M?B9%_@1#A9YE,\(8#`8#`8#`8#`PUR,_E[O;^#5G_L0^86.83*N?W>P/Q,B_ MP(AP3S*9X0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#(O[]V-XYH?L]@>%TF>$,!@,!@,!@ M0R>>\B'QSKG[0HOA8?_3]XM<_N]@?B9%_@1#A9YE,\(8#`8#`8#`\]'::WYR M*IOD_').=?=L4;QEAS?6VFBR:0B=975#ZNL-V8[D6S95RVHQ6,FV9)%I$R)F M6 MYAA"JI55`]ZF0]+)])AL`YD.='2#J2L=!TW])`4W>GL;%1Q7AO)Y&?R] MWM_!JS_V(?,K,P+7LZP3'M+OQ/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S M)Z'>2_J!L'XKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'> M2_J!L'XKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J! ML'XKP5[/Q/,GH=Y+^H&P?BO!7MT3+S$@TB-?2&2L>1SD;&7Q1&GXM-0=AB$U MOR5&@<%#6JZS2'JJB43FG,WK73KJFA]G!7MWOXGF3T.\E_4#8/Q7@KV?B>9/ M0[R7]0-@_%>"O9^)YD]#O)?U`V#\5X*]GXGF3T.\E_4#8/Q7@KV?B>9/0[R7 M]0-@_%>"O9^)YD]#O)?U`V#\5X*]GXGF3T.\E_4#8/Q7@KV?B>9/0[R7]0-@ M_%>"O9^)YD]#O)?U`V#\5X*]GXGF3T.\E_4#8/Q7@KVZ)1S$@R62M,.45AR. M*D[ZQR&2M#*.@[#[\7L,37QAKD;H0'33L&TS0X31J*.WO>MZ&N+Z-;Z=]`KV M[W\3S)Z'>2_J!L'XKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3 MS)Z'>2_J!L'XKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z' M>2_J!L'XKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J M!L'XKP5[=%(>8D&B:!.Z2.L.1S0WJGR,1I.K5T'882C7Z:25IAT6:P;`TCWW MR]R=]1HB-='1LY0'6]ZUT[T*]N]_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'X MKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'XKP5[ M/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'XKP5[/Q/, MGH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'XKP5[=%&.8D&F MD:CTQBU8J+-+WO6M[`/ M73K6"O;O?Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'X MKP5[/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'XKP5[ M/Q/,GH=Y+^H&P?BO!7L_$\R>AWDOZ@;!^*\%>S\3S)Z'>2_J!L'XKP5[/Q/, MGH=Y+^H&P?BO!7MW]'6H=(&QWU4542,LE M0T/J5*JV2I8Y&B4E'`T,H8#]:T+K!$$(GPSQA#`8#`8#`8$,GGO(A\S6S:T$=G6 M3)_D^EF"%IGD]C$3MACB#?+$T/C]KPV-29IB\\;XNMEZE0D$X)#C^Y]9&888 MWG'I3%+$S'#O!.-,PC4AB3\0-4QREC=HX\IBSSD MQBAI>T"AL<2"U*<99Z<9J-4,.A@$$8-[Z=;UO6L(YS6VI&=L;FA``12%J0I& MU$4(8S1%I$*HE:EA2FI3IK*UDTD(C%2A3I7(%[:TM*E44%088%*4-"R)PZ*+ZI>M@WO6 MND6]["5X#`8#`8#`8#`8#`BRN&1Y=-8_82E$,L2)*MFI3"C!E(95%D1XRM[V6>`O99F MA%C$'82K`8#`8#`8#`8#`8#`BL$A$0VNXDE-0Q6!16/0N,H3U2A<][P)5@,!@,!@,!@,!@,"+1^&1 MZ+NTY>V5$-*Y6-*4DSEQXE2I0%RD*&%0^O4RTLE0<:2@`"*0-L3]R("65L1& MS=AV888,02G`8#`8#`8#`AD\]Y$/CG7/VA1?"P__U?>+7/[O8'XF1?X$0X6> M93/"&`P&`P&`P&!JU[1?E9RRXK,[_9M40OCVV4-5E//MG6!95_RAS+'8T]3/ M`T$9XUU'&X=+&B4-5ERI"EV>5<7KM1[[%+ M999+55]:17C'3O([B[QGN&*3M/,_Q!DRB_&FO54VD;2[)WIGAD8\"2*CM+D8>H7BUZQO*.1_M8;^-0U]=[Q650._'7D4JYRLM`Q6/*90R MW`W/?$".6H]QH5A2Z3R,,(<2;G5U&X)"R$[4T^X1RE-LU0I`(P9:SK'UG+LO M>T5L+FY)K-CJ3B$_44W$Y63`8#`8#`8%=N4$LY#1&K]*N,%?0N>V MJ[RZ(QT@^RI`E8*XKN,.[R03+[6GH/=^-OL@C$#8`G*SVMF4;>%HNH%,6/>A M:PL5YX:E*N[3;E7?B^J:,J6*<:Q7U-;2Y@111+OXON`!2VNL1F>&*F?MIKVM:F9YR*IJ ML*:3UUQ>XZ<<;LY/1:9BFSE,97(KL>92@D<%II[:7]B8XN3"VJ%."PAP=TKU MW\:(E*,E.+8S0K.L73-97:Q3T')YNC3B3QX140\<]4O`-JKO;S*OQ7+9"]-2 M8J,7V4C,=RXP.JGR3NB#0$H6;8]-BPL_:_K[[GBTZX]TWO963`8#`8#`8'22 M5P=FF./[JPL"B6/C8R.K@RQ9(X-S2JDKLB0GJ6Y@3.KP>E:&Q0\K"P)@*%1I M:8D1FAFB"#0MZ#07(.U6Y84`U\D6;DG4O'V06C4O&>J+O(C='2.6*F2G+.NV MWX_3,'XV\@W]0]3=H53TMYEZ5R,7,JM.E6MC>L-(+"G&G5BEM]8FJX98E_:# M\OZEKOM`X])*7IRZ.07!IAA\Y?'.L'MVK.IQU98E#S&W6NR'F-6++Y#,EI4% M6MXV4ZN:]W)0$$DA-3&B%W08B(\[ M;;J2LYMNVF*BN9F2C0L]N5A`;.:D1AP%!B-MGL4:94A2F'EZ"`X:=*[!!L>M M:T+>NG7^N5F<89/P&`P&`P&`P-17(#F?R^H?D]74=#'RU:6Q`$]=&M5)BIF%O<(8#`8#`8#`UU<_.07*KC]'B M9K1T9X_,M5PFO;$LNZ+KY)R5>DA3,.)D->X=4\6C40E[!-UXB\CN35>6L5-E M%H.R[E*TJY4=6]:NC4\1ADB3A`H>VGJ=KW=O=-KE77&L8[?@]?QAR934;^BC$&B<@: MY"JT%O>"-.7??E<@D\0?)J_LSN)P1.+.I1%*@(SA%(1I=@5[BS M$5<-L^5DP&`P&`P&!@[D?)[SB%.2YYXUUHQVU=NO<5M@D.E4D;HI$]K7E_:V MIPD@\X`@EBKSPT^0/M..4-D2F(\9X MJR<97CD5,^6%M<=V"_&%!9C]Q/D$:I"BTUWV/-8Y&2I>@FSL_P`=[Z#'U+2" M3=[EN7^Z!<:#0B@1:CGP[IW[4[D29QAXGW;&N/4%/5V]R5C''"\96LF6E4&J M^4)^1SM14N0QJ'`>FJ>2-7)4S`L7,6R_R9YP M\D^.W*NH*^>XW0:"I+JY$U51U6P1U4R=9?-KQ26I&(JQKH89>@ER2MH(W5L_ MO(TQVL2QV+2]8"PD:@@L1(B)B=MO>5DP&`P&`P(9//>1#XYUS]H47PL/_ MUO>+7/[O8'XF1?X$0X6>93/"&`P&`P&`P&!K4Y?=GY*^45^4[?;#RFFM.N5& M1\])7T/35945MPMEFJYT`24TD9A MFQ%B:BJ0M^[+A-);,52=XY&3I96T]MJA^0M^U,*$P=*CN&]Z$98ZWMD-'V.-8K)+V"T'!-8"XTF<$>PMAJ_8SAK!`!O M2CM/U8[BGP3.X\V<[W-.KMD-Y6-NCZ]XT0YT<(/#Z[:H=1]9.CF]1V.:98>3 MW)_DBUT<]GN#NJ-ZQPB@`((3$Z[EE29N*IL#PA@,!@,!@,"HO-[BNKYF4"^4 M$7<$RI9IE+RQK)/(80@:7)R?X\SJ#%JF&.2-YUM$HCC\M`GVO)%K8%9!&TYH M3"#C2QEB:FZ59WV;-EIV&E71IYG2QLO'CL=9D=IVVF[C_0D79(I3-KP>(0Z1 M4[NGZXC,"@BUF9E4.(=F1?U2UK:X#%KI-3ZT1D6^<88P6=BE6+3"AU-5MYV+ M6E/6!35*T=R5A*9AC#^OOB)T<^NCY'G?4K6@2.5=2]^U('%$Z*VXLY.:@6"+ M(3IQA";BCMZ9_DO9O,TWY11V_IK<#Q)8?#[@CM]1>L%=;5LED3=8,,CY[)!6 M)3=K>SI+!\#3Y5W8\@A=`W+Q>FO+2RK+I*XXVZ^Z3&?55(Q"8H;<43:+3UBOA MUM>.P\%F6!8D;?(N#90Y$Z.9*@LP(3M"T0GT7*:G]9NLK#Q7L^QAK7FTP6S> M;M%?$5MR&FM.21AXWO:(9@T`G$_7<3=;#U8L3Z;(J[@D4`0]^R/>NG?^N5E,J;J-7BJ?KQW[,IAH&UJEEH;KF,VJSC.5>H M.*],NL8C30DI\7(AX-<)]MUFK5H+[8Y3H&#>SA]`]"9N. M,K)47Q/CU%MW*9N:98\OH.4W(2U>0;^8X(D*845>+4BT1BSA'F?2;>]+&QJ3 MQ(LTDT[H-&,X6A>QK65+X2SBCQ[9N*7'2I..L?D+G+&6I(FGB;=(WE*E1.CN MG3JE2H*M:E1;VD(.$)5O6PE[ZO1K!,W-K"80P&`P&`P&!KGYNK[2A#I.'+O&*;A[+%78Y,D_$^3\56=C0M+0H9V=LD%CLME)IPFVK`,1SRRNK&422D,!M(,KIZ^M_Z M94O%*]\%.SWFG")U?RTW+.>/\/8*H8)'!'NO)W7A MU75M%(-%99$YNQ/QQBL2D13B!6`!H%.O]P)DI>W.&2BNS8KY-Q0HOBHFL28[ M::7O"$<@54\6(VE7)Y[84;MMRNJ2+7XCJ$-Z)/-)L]K!F`(UT(DQH2B?T2PX MH[9F7%N?L\7F\;2<':8\I;=<>/K]6%(S% M\CK*LG]Y9$RYV8VL@&S5'=^]5*0"DT.ZD37C+9;A#`8#`8#`AD\]Y$/CG7/V MA1?"P__7]XM<_N]@?B9%_@1#A9YE,\(8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8# M`8#`8#`8#`8#`8#`8#`8$,GGO(A\+7/[O8'XF1?X$0X6> M93/"&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&` MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#)Y[R( M?'.N?M"B^%A__]'WBUS^[V!^)D7^!$.%GF4SPA@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@0R>>\B'QSKG[0HOA8?__2]XM<_N]@?B9% M_@1#A9YE,\(8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8 M$,GGO(A\+7/[O8'XF1?X$0X6>93/"&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P& M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#)Y[R(?'.N?M"B^%A__]3WBUS^ M[V!^)D7^!$.%GF4SPA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@0R>>\B'QSKG[0HOA8?__5]XM<_N]@?B9%_@1#A9YE,\(8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#` M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$,GGO(A\\&#Y[_7+^7O!@^>_UR_E[P8/GO\`7+^7O!@^>_UR_E[P8/GO]\&#Y[_7+^7O!@^>_P!\&#Y[_7+^7O!@^>_UR_E[P8/GO]\&#Y[_ M`%R_E[P8/GO]\&#Y[_7+^7O!@^>_UR_E[P8/GO\`7+^7O!@^>_UR_E[P M8/GO]\&#Y[_7+^7O!@^>_P!\&#Y[_7+^7O!@^>_UR_E[P8/GO]\&#Y[_`%R_E[P8/GO]\&#Y[_7+^7O!@^>_UR_E[P8/GO\`7+^7O!@^ M>_UR_E[P8/GO]\&#Y[_7+^7O!@^>_P!\&#Y[_7+^7O!@^>_UR_E[ MP8/GO]\&#Y[_`%R_E[P8/GO]\&#Y[_7+^7O!@^>_UR_E[P8/GO\` M7+^7O!@^>_UR_E[P8/GO]\&#Y[_7+^7O!@^>_P!\&#Y[_7+^7O!@ M^>_UR_E[P8/GO]\&#Y[_`%R_E[P8/GO]\&#Y[_7+^7O!@^>_UR_E M[P8/GO\`7+^7O!@^>_UR_E[P8/GO]\&#Y[_7+^7O!@^>_P!\&#Y[ M_7+^7O!@^>_UR_E[P8/GO]\&#Y[_`%R_E[P8/GO]\&#Y[_7+^7O! M@^>_UR_E[P8/GO\`7+^7O!@^>_UR_E[P8/GO]\&#Y[_7+^7O!@^>_P!< MOY>\&#Y[_7+^7O!@^>_UR_E[P8/GO]\&#Y[_`%R_E[P8/GO]\&#Y M[_7+^7O!A#YQ\M?<5%UO/%T?+"O?_P`GX?\`J];Y?1KJ]' XML 16 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule of minimum future base rents from non-cancelable leases (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Leases Future Minimum Payments [Line Items]  
2014 $ 42,692
2015 39,631
2016 36,769
2017 21,519
2018 18,860
Thereafter 46,589
Total minimum base rents $ 206,060
XML 17 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Limited Liability Companies that Divested Medical Office Buildings (Detail)
12 Months Ended 12 Months Ended
Dec. 31, 2011
DSMB Properties
Dec. 31, 2011
Litchvan Investments
Dec. 31, 2011
Paseo Medical Properties II
Dec. 31, 2011
Willetta Medical Properties
Dec. 31, 2011
Deerval Properties
Dec. 31, 2011
Deerval Properties II
Dec. 31, 2011
Deerval Parking Company
Dec. 31, 2011
Cobre Properties
Dec. 31, 2012
Canyon Healthcare Properties
Feb. 29, 2012
Canyon Healthcare Properties
Dec. 31, 2012
575 Hardy Investors
Schedule of Equity Method Investments [Line Items]                      
Ownership 76.00% 89.00% 75.00% 90.00% [1] 90.00% [2] 95.00% [2] 93.00% [3] 95.00%      
Property Owned by LLC Desert Samaritan Hospital MOBs Papago Medical Park Thunderbird Paseo Medical Plaza I & II Edwards Medical Plaza [1] Deer Valley Medical Office II [2] Deer Valley Medical Office III [2] Deer Valley Parking Garage [2],[3] Cobre Valley Medical Plaza      
Non-controlling ownership interests                 95.00% 95.00% 90.00%
Property Owned by LLC                 Canyon Springs Medical Plaza   Centinela Medical Building Complez
[1] The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.
[2] Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.
[3] Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I & II, was 50% owned by each of Deerval Properties and Deerval Properties II.
XML 18 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
Options Outstanding and Exercisable Options (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number 40,000 43,000 51,000 51,000
Weighted average exercise price $ 35.65 $ 35.22 $ 33.89 $ 33.89
Aggregate intrinsic value $ 176,240      
Weighted average remaining contractual life 2 years 6 months      
EXCEL 19 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!O4(MF1@(``-HG```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VM]NVC`4!O#[27N'R+<3 M,;;CK)N`7NS/Y59IW0-XR8%$)'9DNQV\_9S05E7%J-"0]MT00>QS/BSE=Y.S MN-[U779//K3.+IG(YRPC6[FZM9LE^WG[=7;%LA"-K4WG+"W9G@*[7KU]L[C= M#Q2RM-N&)6MB'#YR'JJ&>A-R-Y!-=];.]R:FKW[#!U-MS8:XG,]+7CD;R<99 M'&NPU>(SKGSWQ_*I_ M1)]FS"X>X'GM4SG2!-:-=T-(LVB>SC^%QV&SQLV.C6T]=4QS M;.]=J>*V?5@^@8B)G:13'&HX<85?= MWFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B] MSCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8`"````"$`@&%A19X"``"+ M)P``&@`(`7AL+U]R96QS+W=OA4J<0U?WZ_;N[S^%0 MI_RFV.Z'6.15NEBI-J7A8UG&I@W'.B[Z(73YRK8?CW7*A^.N'.KFN=Z%4B^7 MOAPOUU#K5VL6CYM*C8\;[57Q=!KR1_]_\7Z[W3?AH6]>CJ%+__B,\GL_/LRSD!7]C?#XLSZ^0&/8.P0UBTPOA%7;2"$Z:VSEIF5+N+S'3J3_! M=XO@%7;P"<186_;=L>CN&#;)!J)LV%UN8)O;/%7,%WP3MV^C;)=HLZQCE^-0 M.8YM*0PT2U;$18JPK(58:$B'%L1#BK"LW/'P]SQLZ9R M3*=#_@IH>NS\=8P$SF8%H\(VIH/&9+=Q1[]-!S]+%L1%BK"L:<)AZ<) MMB0\E,1J5G9B6X]A\R6-^=>ORQGG\C0:==CD0'#8$0@34-CV%&A/S;:GAO;4 M;'MJ:$_#1L=`=BS;GA;:T['MZ:`]9=8$O&*V$&A/P\Y``T/0LNUIH3T=VYX. MVM.SV?&0'<^6A(>2H*.#1@MV!L((%+8^!>I3V/H4K$_V7AFX68;-L<$1R,X< M!S/'L3/'39E3OOH+W?HG````__\#`%!+`P04``8`"````"$`RW6@>*\%```P M%```#P```'AL+W=O)HK<1$\"AU\N/SSC_-#7O[< MY/G/#@DH?1'LC2G>=[LZWHN,ZW=Y(11]LLW+C!M:EKNN+DK!$[T7PF1I-^KU M1MV,2Q4<%=Z7OZ.1;[RT('E^=;F8KOQQUU>%%\ MXQG%_9`&G91K,T^D$KW=Z[XN0N[UY?I/DNZ!?.TC?4[]V5+V]9T<898K-E9'FD2W4T7V94PJM MZPO:61ATRO>2_B@726@#1Y4K,C%/9<+)(O:1IUS%@JWMHQHD1H3$22-Z@P9; M[KB:/`9J)PU@UE76<;+1^O$6NZ4I'K@RK!I'.>5,A#+&?%V2M.X M*;."HF$':?;L[LNZIL=^@C)(S*0I,XW_K:26=?G53\^D+O*G-U`E@F#"7E/F MJ^":&LN+D6=(1^B!.A,;9ZM(0>@A.9/W,A$JT&`"F/O1`7,\_7\^_ MW;+5?'FSNEU\^XR/8E6&'GQ_5[PTHDP?V4IHZF-.]$A_Z!&W$A3MG`X!(VH# M";4JJZCGTG9F6$5C)"[TD&LG%\MHC,R%'G3M[#I"B!TUX$:_:Z67@;ECQ#'R M<&S/KQ,0DAIYI![K@-WR3>J4PQC!C#PP;3F\\A!"&7E0-FA^Y7F$,?)@](AZ M10&9/)Z3V!#;@:#4G?KJ&`F-7B'T90+PFQD*31#1R$-T_B"UH=&'U8E@MZ+, MCDUC)90X0$"1$Y!':+L.`C%!U/MO)-010M3['J+3-,WC>DRR)\>R*N,]M5RV M+&F<8MA+)XAZWR.T7<<)"%'O>\S>J7RC17EO46?$DIU9*#YJK@M55&!UW]'Q M,'[>2L*NI"^2 MBDRFO&=2R:S*V+8R52G8QAD[)HY!'M-UD_E%-,XQ,$&#!A[24/4K06=Q279; MDU-ICV,P>H"E08OFOIX&H9LMNZE,?4>QE7N=EV;'=Z`S09\'/M&[72EV]G!S MQM\GVU`'?1YX0$];=3#Q$VP>`X_H]G$%A>C.``/+P&.ZV>+=[,'6!D[*/*9O MBN.`]U'0C4*P:?)/I8T=R)G)V0WJ.%9[2#_K8+[J"\N#*&.).H[5'M(_ZNL1 M<3.EFRO?"9II[$W2II]RB#J.TQ[2[>E#_JF](H6DTAXB&CHX' M=;N.FWML^$,/ZS:EPQXCPH8_]+!NTS&H$]*5^65Z'GI8MPOAUH;8B&C1*'QJ M%ANI*/NG&]W3M3#/!-OBSI#JH4=UNXX3$&(]]+`^";E79AL5;1H""GMXE@T] MKE]:")W+=$LHJ.E/,WNOTVQ6.4*.11[8[4*XM1%V$%HTO%Z+75WG*U%07[4% MACW$B0C-'GE@^]/B3!@NZ5>9T\$Z0J!IT0C%5UCRDGK07ABZ`J,.'C.B&>&'(YDW?[R[;!??&WZH>V.=TNV\I:+YKCM=NWQZ6[YS]_\ M4[I<#&-]W-7[[MC<+;\WP_*7^Y]_NGWM^B_#<].,"_!P'.Z6S^-XNEFOA^US MH2O_=-Z./5-O9M(A_W:][QX?:C;XU)ZN.FO\=$]/K;; MINBV+X?F.$HG?;.O1YC_\-R>!NWML+W&W:'NO[R[91"OHL0+&,`7#\TP\E:X7"ZV M+\/8'?Z3(*9<22>^<@*?,T[>(0:*")^*Z+-5&D5AG"9P^7>8H6+"Y\=TEUS))4\Z+>JSO;_ON=0$;"=(PG&JQ+=D->-/) MEG$RZ7\K^Y!VX>2S\#+Y@L0.L&2_WJ?>[?HKK+*M@F02`D7"0!A&Y!HAEI3P M6E!#20V<&BK+L`:%1B:L(RHS@)TQOZ:U*D$BJLB<,PFQ5?E$E4885=IP#D00 M84ZI(9K#M>',2 M3M5K6K6($(5!BAV6E,`1(6`1V3F514"9A7ISO5(!)DK)JLLD))Z4^LDF(N.Y M'+>48H+/2&A*2N`V@7G!AJYABX"40GV\7JD`$Z5DA682(I6&?DP"GLMA2RC" MLY!,NZ1XCO$;4C0J"X]D0OVU98I:?+E("1*1F^`5ETF(E!NGC$P_E\.67(2/ M$[(C2HKG-I[%$<%7%A[)%0TC.7HNRQ4D(I=LL$Q"PFD=A_0@J4932P\AF8,&B[[A>L.Q2D&!2,C*F.QE1.WV/Q",WPWH_%L8B"#$M MY>@+.YA6=Q_5:99^"M))$9.*.&8JX/(5(1FD$-Y\JBZG_@'+DV`R=5]![7"Y6="A)*ZD/&[&8GB)*`9#U7`'L5(TH2 MT8I?.A2.KN)[24P/7IN"%8OVPU(LNJKXXJT?DTT+4DXNF2F,KL_PB`$?TKD" MV,IQJQ30UK-T*!Q=)4U\,HO*9F#AHAAH2L1#V\86C7'9" M=L281ZILQG2[-+._XZ) MA3M4YM'37('F*Z`9U!H*99$:TL@GF2[5.%I4<`^)MQQ'7H(HI8]6JGDWYYJ% MH_.AGLYW>SKFD66=*9"4^2D)$Q*V7`&LHD$H24P6>>E0.*;X(4U.95.P9%C' M=`^P1#SIO;`-?$&D:X*LPTR!U-.4@#DMG@*0+).:5V`W&W@J@Y=!J0#G(')$ M28+$N9^Q*3@BI/&;'I%>%1&W!V2TW\Q\"=K(YTLK[[P2IV>@N1J_%!#LA?8# MI?)BQ\-F1"OZV*NR&3@Z61BI>)D"R5+!_#@E1VBN`&<9!:7$Y!PJ M'0JGE)"LP,JF8.FDE[SR['![2L;(-#-?@N39X3RP,J/GP\/&.^51#VHX-PZF MVP1<.RHS"'"L=Z:3O"+5;B?)J*+,1WVAG]#^(5<`.]68$M-26CH43JX2AV1! M538%2R>]Y/L=D2][2'ARH".>N:;<-16NJ71-W#55R(1G/M/3B;NC#_[`Y<\T M>?1Y=Z9`XA&"Z7L9(_LI/Z-T=`K75+HF[IHJ9$*ZQ<*D=4GTLA_4/;DAISJC M/8T"$=WD[,_/**/;-96NB;NF"IFP;M*RB:(D;O<^JGNNER.9S`()(KI)+Y*? M46?=AJA-I8OBKJE")JQ[IF_[D7S/=''T,4H62!#138I)?D9ID85K*ET3=TT5 M,F'=HH\AY^^/Z);M$-JY].%^!F]=B%,;ZZ8W*OD9==9MB-I4NBCNFL1['NJ* M0)2ZY7L;\C?\0],_-7FSWP^+;?)=D M*M/.B`\COBC@SDB@WS^A(^!LUI=_D\]Y*OP;^*7;O0*'2\_9/_LI#*0S#*B\ M,+(1(VLS*7@GY50_-7_4_5-['!;[YA'BXZW$6R"]?*M%?AF[T_0C_T,WPMLH MT[_/\/91`V\@>"L`/W;=J+^("YCWF>[_!P``__\#`%!+`P04``8`"````"$` M6-2Z+$4$```$$0``&0```'AL+W=O/OU/4NM-U:(A.<[FSB>;;$\XG&2GW;V]W]?OCS8EI!A'HOXLR8M,!"+G;V6I2SUNZ69CD-EK8%'-L\.,QB=@SCZX9RR4:*5@:2N`OSLE% MW*UET1QS65B\7B]?(IY=P,0A21/Y41JUK2S:?#OEO`@/*<3]3H(PNMLN+SKF MLR0JN.!'Z8`Y%XEV8UZ[:QP87E/Y#[_] MP9+364*Y%Q"1"FP3?SPS$4%&P8Q#%\I2Q%,@`*]6EJC6@(R$[^7_6Q++\\[V ME\YBY?D$X-:!"?F2*).V%5V%Y-E_""+:%!JAV@C\UT:H[P1TL7J88<5%1F6` MSZ$,]]N"WRSH&O`I+J'J0;(!RRJR`#@ACRK6H5`A1F7D45G9V=#N<%Q`?=[V MA/K>UGV#I$8:](0@>*U!%<(%.A4GX-'DU)_ENVL%5JY5UA67)_R@Z8;VN_'; M;NZAC[M3AZ!\S2"H3RH'2`%!00.TK!"M2`'2C%11\*$[QRFH0SL;PJSS2/TZ M1J2`H&59B\"#OWX"4&J3@"K_.`%UJ$/`KQP@`02M2P+^PEDNJN];&5A^AH`Z MU"$05`Z0`(*:12!D75>JQ6+59C$>O@)WO-?AH7<$-;T/M("Z1_0,X#@%=6BR M"Q$T@\*Z36'#6@[5O)D9'XZ=DC*&(3PZ=1]?15'-L4E%09%*:GCZ#`&13,\=,HG09_.`V? M4D&""F=P,"=0HYH=2"@94"("L&8R)GI!H3N]\%#E&=NPM`DWM(94#G7BIX10 M/0-,SZ%&S6%AJ.%$#GIEL`Y0YP!1U3RLJQRU>_&G))#T:F`]:=HUHB9=]TC@ MC$E$>3-:T+P-$D3A)!)_\#Y(#`V<]S!0GNIT86<46VH8.`,5H(88SJ-0GNI0 M,"=1HYHM"`]H0T0,91SO0MJGB$$]Y-@*&M4D4#=JJQ&IDK>?%L7RU.0=4:/F ML#!D<2('O7)8!ZAS@"@]#K``U(W2S@#P:V9@PK="=QK`'$6*J&G?/3HX/8MJ MB^ER,&=1HW`683T8>B:EA@K.'(1>-:Q3K&O04L.1&AAR.)-#KRQVAA%1S2XD M-#"?3'$9Q5TM8\6)_<;25%@1OZI%D\!S=?5IM00_TG*-K;Z`'?02GMA?87%* M\G(:`<``+4A```9````>&PO=V]R M:W-H965T6]@80=%35JR+Y(H]$L MSRD(1=1`4)+JZO[[N8YS'7Q=2:CNAPX?`]R8LTNVXT M?3C6!LEUGQW2Z^M&^^=O^\M2&Q1E?#W$Y^R:;+2?2:']\?S[;T_O6?ZM."5) M.8`(UV*CGNHN.5)?*A$E_/(&(_G MHTN<7C4>89T_$B,['M-]8F;[MTMR+7F0/#G')=2_.*6W`J-=]H^$N\3YM[?; MEWUVN4&(E_28^SJBQ+^DN[SK,B.Y1#" MC7A%U3:O1JL11'I^.J30`I;V09X<-]I7?1WI"VWT_%0EZ-\T>2_N/@^*4_;N MY.DA3*\)9!M\8@Z\9-DW1O4.#`+Q2%';E0-_YH-# M08M8P]:'GV92["&C$&9HS%BD?7:&"L#_@TO*N@9D)/Y1/=_30WG::)/Y<+88 M3W2@#UZ2HK13%E(;[-^*,KO\QTEZ'8H',>H@\*R#&,9PH8]7DP4$Z1!.:B$\ M:^%\J$_'T4'4JK'P%,5-C=EB636VH\!Y+80G%KAZJ(&+ M6@A/%$Z'#Q4)`[2J*SQKI=YMPJH6P/.31>G0ZW@G8-V/&_R0#ZQ&7`@?L-#' M$J-CG]$;[^][GFK&B/?<:B"8<1D_/^79^P!F%RB[N,5LKM+7+!H.`1Y"#(JV M,0&#@47YRL)L-$@W=/<"!O+W9]V8&D^C[S#Z]C5IJY*6\Z7,V2&'#386V:2` M10$;@;NRY:`.,C"H2P&/`CX%`@[PHHM3JK@X(^M\5QD8#P/@5:)CPR4 M!`BT2L)>1M3%D`R#Y>4O&,94BF'D_;_EI"[#D(%--Q%H;;J%#)38"%2&D7>@ M@S^VQG.1@?$\!%HE/C)0$B#0*@E[&1$R2#,DK]C.FRY7^Z=$IE*\(@ND+2=U M>84,;+6)0&NK+62@Q.;`:LG7R/+X=I#=&L]%!L;S$&B5^,A`28!`JR3L942< MH31#\@KV4K_@%5,I7I$Y:\M)75XA`UMM(M#::@L9*+$1:)4XO0P7&1C40Z`U MJ(\,E`0(M$I"SEA4G6HZ';-_*NAB2:VP_J]C6__ZJ9+)O*YT.L9K4Y9N@ M8.M-@;0VWQ(4%-D":14Y_1174#"N5R/S*M/&T,\]Y] M(#O-HYW!F)+3CVW-ZFC,3E!P$)D":;H'>4-;@H(B6R"M(J>?X@H*QO4$TAK7 M%Q04!0)I1##3D3X3?L`B[8PZ*;*-D&/%QOZUJ\YD=$Z>D5&RK5F=-O)`4W%J M:/:++$'!S-DUPM<:^GS"QB.IC2-4379)WEQ!P<">0%I%OJ"@*!!(JRCLIT2= M%-E$=@QP/Q:[=_7L,@G,@XD?:[Q5H9T*F2IDJ9"M0HX*N2KDJ9"O0H$*A2H4 M29"<++8%OT\6'F!]]G*!;^6EPQ'Z-MKJG,2FU;MW%AG1NX:%AI@J9*F0K4*. M"KDJY*F0KT*!"H4J%$F0G&JV>::I9JOVSZ::;\+E)"K+>$XBJ2;+Q!UL@ONG%^[\R]E=JNN)%^R$J[+JX\G^/.( M!.[;QD,@'[.LQ"^L`/$'%\__`P``__\#`%!+`P04``8`"````"$`6_RBV?X' M``!6*@``&0```'AL+W=O(]R:!`-E$FZT6JMY5NDJGT_UX9A.R04U"!&RW_>]O[#'&S!#LY*7=A,_# MYYG/\QGBQX\_3L?)][RJB_*\\?SIW)ODYVVY*\ZO&^^?OS]_>/`F=9.==]FQ M/.<;[V=>>Q^??OWE\;VLOM6'/&\F$.%<;[Q#TUS6LUF]/>2GK)Z6E_P,5_9E M=ATG`7S>3P[9<79PPCKRB5&N=\7V_Q3N7T[Y><&@U3Y M,6N`?WTH+G4;[;1U"7?*JF]OEP_;\G2!$"_%L6A^RJ#>Y+1=?WD]EU7V'G<%S$"D?5+E^XWW[*_3 M./!F3X\R0?\6^7MM_#VI#^7[;U6Q^Z,XYY!MJ).HP$M9?A/0+SOQ%0R>L=&? M907^K":[?)^]'9N_RO??\^+UT$"Y(YB1F-AZ]_-37F\AHQ!F&D0BTK8\`@'X M=W(JA#0@(]F/C1?`C8M=<]AXBW@:+><+'^"3E[QN/A?H/0;X* MA4$6*@C\KX(\=#'XN!ERD%/ZE#79TV-5OD]`)W"7^I()U?EKB"7FLH",8`0] MNVN3@UF)(,\BRL8#@G&47=+5!; MB#&3!RN"R@M!;F27?;+C]15@RI"6%S$F0X)(6P0MKS"R@9XQ3DD,LDH.06.< M6@3EM.IS&NR,,Y'H/A6N)04RTP)B MHH0TBJ;&)SW>P@B;,'0^O8`BUJYDR(UG,J+BT1!&1S35F^7C8RNVM"R%&N6% M@08*)SJLPT!/"-)Z6K+R(4"T`KUZK]J?/]#'G6Q:#K3JK>W4!I.` M:B!5H1P)W]3D?=[EXYAIL&WC'4M6ZQ9":QV03N^V]9*CK$:H4&-K0T,8+]+O MG348\-;/-:A`6H,/)*6I`KB5-!@P`R<-RH$V#2J0F47H>;3`"N5(^":7"+A+ MQ-&2]$$%,EDRBAB'&T4`H\RV[*A!,>^O:>`X"XKD:.L^FMMHNLNH#]2_U2%8: M':^91-N$I4!F;D!8Y*5"JE$T/0OB$!9&W!;BF#S*)C+D^&9.0QB=`1,0W"VT M<"-O4=$"46:F:'/5$,9+=%UCS^OA?&!:5`UP6E`+V^<'4SMX`9 M4JX..12CK&)#D)E"$%O73?')01*`MXA.6\\%L0=+I;DGQ#%Y_$UD2(L`,0YO M8XN[+$".LKJH0IG98P)L;8()D'1[=P'RQC\@0`2-"!`!_9(&CB[N\ M0(ZR*K#M\]UZ\H.8O%].52A7NC=9Q();!#!@3;"U@(XGJW4+H;4.B4NX[>3D M**L&%6I,@QK">!&O<-9@R&V#:U"!KFM0`6A1N]7?TV`XX"1.CQ-RH$V&"F2F M$41`G\$5RI4Q\9CQ3AAR8XGH2X!$@4R:5(4:PJH-HVZWD5",LJL04:.\6@CC M=9-AA-PP!J2'H!'I7;.+D-B%I6;8W8&L720XS"PHB[ M`]R,:"0)$35:KA;"^-SE!2&V>="XWC8-_2S%S8!03U4@;O0A:?KNS8SW_P%% M(6A$40B@K:%[(.PULVC`$9R:F1QH:V8*9)871$`?(13*E3'QBG$91MP@HB79 M5B8*9-*DU=80JL)HP`WL>V(YRMK,%&J4E[B]6-.,%^GYSBJ,>/OG*E2@ZRI4 M`%K3+O-]%<(4J2.XJ5`,M*H0068:_6#9[3#QV2)"E"OCF[PBPBX//U=!F?"W M6_Y5VONJGQ]B!J*8PG]N/)P0<9F0XUB M7(>,97Z'#+C/^#YIRDFD;*0WI6#9[8G5JM$PRC8><)8[-"O#]%>X/^_,##6K M0+W,PA(G!4@[&"-+3$5V2_'CQXTZB+G=``^J6H6B=*GG=#!&5W1]\M+HGMR* M,"2WP9(E%U&4+1&,.`TG@@%,L\73;7@4[)17KWF:'X_U9%N^B9-KT`V?'O77 M>*P.UL@ZA74"(=B5%5Q9#5V)YW`63QZGHV-B<4I/-EUV)6C/[Y$K<+#O64Z! M?)]`J,%($&@(_QQ%P%<>S:.1HABNQ$,SB99P92D3J`?!J;Y+]II_S:K7XEQ/ MCOD>?+F'=5W@N$#\TY05R"F?[R@;.\\D_#W!^,X=#:/,I@/=EV;0?1(7T MB="G_P$``/__`P!02P,$%``&``@````A`(Z"K#6>`P``/0T``!D```!X;"]W M;W)K&ULE%=1CYLX$'X_J?\!\5[`!`A$2:HFA+M* MK52=KNVS`TYB+6"$O9O=?W]CG)#8K&"3AQCL;SYFOIDQ9OGEM2JM%])RRNJ5 MC1S/MDB=LX+6QY7]Z[_L7`V@H+N&V/+F]:@HO.J"I=W_,BM\*TMA7#HOT( M!SL<:$Y2EC]7I!:*I"4E%N`_/]&&7]FJ_"-T%6Z?GIO/.:L:H-C3DHJWCM2V MJGSQ[5BS%N]+B/L5!3B_14XX]V8(X-:><)%126E;^3,7K/JC0.A"I4C\"PF, M%Q(4.WXR2:Z,(!X\..N"I)7`-EEV)%D`LDQV`D^\G&[(L;;Y* MH\X4T!P*]&6-_'FR=%^@K/(+:#,$^3IB.XE()Q&[240V1,3QK/?$!1UZ,:#: M3#%FT#_C8D@C78P$S7O^3K#-$(/\R)3C75"D,Z5#4!R'.F8WQ$2AX5$VQ,1Q MT/-HJD#W/*Z*-)*JR/U!ULS&G-B:$ZDYL3,GLNN$U=?=??":T]"MCSLMC6"[ MLF_\"$5&!C8*!/^]$P9B.XE()Q&[240VAM"D@'9^7`IIM+*A2OHHD\"HH8W" M)-T&$#B!I_UNQ=3E?WL/]AVC9%.U"B'UCS-$W=W;1\ZM@3OV;,Q>$P/VN,?% MD$:Z&,B/O;Y;5($KD%+#=Y"^NKU?10[2I/(,<*K`8VK?--[ MO332)8!"N#U`%8("C6DPB4@G$;M)1*80O4K>325-B$078KP&)%@7(/',%[_" MC,4_B4@5(E1;"XH"H]EVDPQP0I:>ON^%BE^=@-5IJ,%'\@.W1UISJR0'V(5D M6=E6J\Z_ZD:PIGO1[YF`8+/%`*O-\\!\($Q<;V1)^S^PV?]/P```/__ M`P!02P,$%``&``@````A`,M4L*99!@``3R```!D```!X;"]W;W)K&ULE%K;CIM($'U?:?\!\1YS]57CB<9$V8VTD5:KO3PSN&VC M&&,!DTG^?JMON*G"=/LE,\:GB]-5IT\Q5)X^_JC.WG?6M&5]V?K1+/0]=BGJ M?7DY;OU__O[\8>5[;9=?]OFYOK"M_Y.U_L?G7W]Y>J^;;^V)L";0]U4>0"W/9?=3 M!/6]JMA\.5[J)G\]P[Y_1&E>Z-CB`PE?E453M_6AFT&X0!*E>UX'ZP`B/3_M M2]@!3[O7L,/6?XDV6;KR@^&K][[:E^_ZTI]W^4%P;9ACKQ"KS6 M]3<._;+GEV!Q0%9_%A7XL_'V[)"_G;N_ZO??67D\=5#N.>R(;VRS__F)M05D M%,+,XCF/5-1G(`#_>E7)I0$9R7]L_1AN7.Z[T]9/%K/Y,DPB@'NOK.T^ESRD M[Q5O;5=7_TE0I$+)((D*`C]5D/@6@ZX+)`>QI4]YES\_-?6[!SJ!N[37G*LN MVD`LOI<46,@(_>[N;0YVQ8.\\"A;'P0.RUNHR/?G*%[%3\%W2&.A0+L1T!"1 M:03//O#K24*F,$F>\`=)\BB<)*\(9[W3%VZL,>=,0S`C2)7):+ST.CL<+,K= M9R=9+H9;WTE,:F00(3*-P%1@C3L5#@:]&;>)PE6"N$C0%!>-P%R@*"87<3*6 M_!3<.1PZ0WS=,$.@'TQ+@M8KH:]PMIX/:6?R^PC.`PP&U'$3=CY"`CT,#TC8E.H7FVT@/>< M/X(]/,"&HX=L1B0E069RHG")+"03-^8I)/7B'NR>'VK["7%]WNB!MLF(E$M# M"!UD\Q;Y2%NVR8W>RTK/A M#/5^,R(T;>PW4!0ND'=DD40Y$D8]P5)MV@F2=82]2X(FQ:(4R,PA M;`>?885R9/M06XBEGYOY3-;X.5*!3):$XKV^$,,J,WD6Y7&T77D2-0LJ%C-]"1UJTI6O&U.Z)G#6$\$&^[FYVJ"=,ESJAC2!9KU'+5""3):YT#\&5 M3I#K6^APM-6X1,SID]!#"!_DZ\[*2ZC%CRA/H6[*0[G,%,"QEMQ^4;HO&,TU7A&V M$N7(%G44B\_0-K((T?UWB01-*D]#<*53U#.FZ0BT57D*-<6GAQ`^#W6%E':% M$;DIU$UN^#65`M"GH_2AIB#0MDZJ0&9RX#4X?LO1HTA^4%NPU(OV@D6(G'Z7 M2I#)"!M%#R%T8)5I_!8Z'&V7CT1-\M$0PN>K:?(UMV< M2:RRRDA;]\"94&DS%6I$V,C@+753=BS'@&)^E9)+V>#28.(!$]&!2G0>'ARB MB3##Q)A#%CD$42#^IO7V"HB>+V79\>TUHIRYR@%EQ9HCR]CYW'I%_<;GJ7.8 M_/17^UGOBUB/KN]@!BPRA:_'&YCI@6+1]9=T"4/CY<@WNW2EQ\E!OPC&N=?\ MR+[FS;&\M-Z9'8!>.%N""!LY$)8?NOHJ1JRO=0>#7/'K"0;W#*:/X0S`A[KN M]`=^C/K_"O#\/P```/__`P!02P,$%``&``@````A`!)+U?BZ!@``6A\``!D` M``!X;"]W;W)K&ULK%G;DJ)($'W?B/T'@O=1`:]$ MVQ/C!<5[;.SEF5948E0,H*=G_GZS*!.M3!#MF)>F/77RD)699$'5R]>?QX/V MPX_B(#QU=:-2TS7_M`XWP6G7U?_YV_G2UK4X\4X;[Q">_*[^RX_UKZ]__O'R M$4;?X[WO)QHHG.*NOD^2LUVMQNN]?_3B2GCV3S"R#:.CE\#/:%>-SY'O;5*C MXZ%JUFK-ZM$+3KI4L*-'-,+M-EC[@W#]?O1/B12)_(.7@/_Q/CC'J'9K5UY^R'Y*_P8^\%N MGT"Z&S`C,3%[\VO@QVN(*,A4S(906H<'<`#^:L=`E`9$Q/N97C^"3;+OZE:S MTFC5+`/HVIL?)TX@)'5M_1XGX?$_23(N4E+$O(C`%45J3XM8%Q&X7D1,B,:# M'M0OQG!%#QJ5=J-1;[9;C\\#F&DPX(HN6!6C7FN*6-R9?_-B!U>TJ[2,6L<2 M][YCU[K8P17M6MG]'IPY/,BISW!%C:=#W[EHP!4U6M<)/.B(`=F2I22*6):) M^;0K1E:0\`^J?"*5\,Q=O+D69?UY;[`HC9NJ;#P?&BQ/\63BI%K/UZ>!A2;^ MN>A8]0WV)P@\-NC,$.CY[HM<;MA#&%B(+-VLJ13T%FHE0 M^29DNCJ4(;2+&!KACU?#[-1>JC^@>ZTOI%X.267TD2%:E=`=4&!(`8<"(PJ, M*>!28$*!*05F%)A38$&!I01DKQ1S62%P$Z-L^E5(1Y83*-K?D1,A(W*"P>Q) M`-S(DM0V,P_2>/?+*8-RRA#O7'PC!RGHW`B!8ILQ4M#&1:#89H(4M)DB4&PS M0PK:S"5P+W`+3K$::FR7G-)IMU7.BG-N9)0B@9[T.XI$R"A%(H';N=9-0_6R MG\>IJYQ!'J>ICND%N/D8.&KD(W!JU5&\FR$&C M*0)7(UC625.;(0FMYA)0`FB0`"XXIVD2X>4#G%4>YQI`I5Y@%6+U8L%BG?^N MB'U=6,%;X4W+,(PF26-/DN!OUE<(HU_*&)0RAJ4,!QF8BA$"A8Z-D8$F+@*% M)A-DH,D4@4*3&3+09(Y`HFTT[>"6J5%:X.,MSOJ8SD@XRW25H=DG)@[4I MM8E/XUPEXI.;JT1\FCRB-,U3ZI"5:Y:G9%+6/$^*ONLL.(F682EC=8^AE"%\ M92ME>'_9$VRU]N!SAM153Y)NBX_XWR]E#$H9PU*&@PQ<748(%#[?8V2@B8M` MHB0:E^6C*_H>-;GE6(0^Y^W'[WWBT&P MU6+@C4AR[M5"*6-0RAB6,AQD8,A'"!2&?(P,-'$1*#29(`--I@@4FLR0@29S M!`I-%IP!#R%9`9:<1!["%6>`S+75*H4!>V!/%(9@P[[)]1._QY`^0P8,&3+$ M81OV*;5SPXMSEJ&F0KI']E77.4&2(TY"R'0R,.C3GD1P:,2A,8=<#DTX-.70C$-S#BTXM.20.-.[!`>F+7,DS^CDUOK1CW9^WS\< M8FT=OHOS-Z,.7[\9?#D<[-C0,T&`X-#"X-0P/?AC(^(\,5UNV(B))XUD!(X@ MOUFY=[%ARYK??6C:L#>;@ULV;,5Q?&3:L"^;@ULV[,)QW#5MV)/-P2T;-N`X M/C5MV(_-P2T;MMX`KV83AI/-L[?SYUZT"TZQ=O"W$'G8<(!/U4B>C#2UW;AF&"/\0-LE/QU_\!``#__P,`4$L#!!0` M!@`(````(0"J!>I++0,``*4)```9````>&PO=V]R:W-H965T;N6T) MB:L4%ZPBD?U*A'V[_OQI=63\2>2$2`L8*A'9N93UTG5%DI,2"X?5I()(QGB) M)=SRO2MJ3G#:;"H+UYM,0K?$M+(UPY*_AX-E&4U(S))#22JI23@IL(3\14YK MT;*5R7OH2LR?#O5-PLH:*':TH/*U(;6M,ED^[BO&\:X`W2]HBI.6N[D9T92H^C]MD3. MCE\X3;_1BD"QP29EP(ZQ)P5]3-42;'9'NQ\:`WYP*R49/A3R)SM^)72?2W`[ M`$%*US)]C8E(H*!`XWB!8DI8`0G`U2JIZ@PH"'YIOH\TE7ED^Z$3S"8^`KBU M(T(^4$5I6\E!2%;^U2!THM(DWHD$OD\D*'2F7C";?X3%/['`N2V+YWCS``7A M]5QI"YJ+%J9+0$YK8^6DU7L7,%@THIDCO%$MGPS$`M M!)C\O$:>MUBYSV!-<@)M-`BN;Z`AXKY%*!\4;VPN;'L++BCH9$!I^S+^;V^; MK0*K;-MC-GJAGYEG9#9&^,$0$H\AQZ*)@8 M1FPT)FS:<#J!CZ%N$/='\;@?#]`HOCT?'^@"L]ZO2X$-79[IF\8L&EU^X(2& M[GLC[AG=%P_BOC,WGL_M^?A`5_@170ILZC+.W6C,3/]MS$)O:AJF`5#VSG2C M8>.KB.TEQ$#>;"A//7<^C)W+;:DV&3)]0\5&8_HJ$%H@HS?'(%/J502,4Y5, M_Z`W#BU5CTL]!TK"]^2>%(6P$G90HQ"!$]UJ-Z7OO&;0=@&8DC7>D^^8[VDE MK()DL'7BS*"+N)ZS^D:RNIDR.R9A/C8_2K+\\JVB^@DTK"PY%ED8#G(/`U+>,R/=G'.1;BO!J6)[3J.9Z=AG)GD894_ MXD,>#G$DN(PNJNW49SD];<\WO\19P*B#7G"#.RD?$'H MCSV^@L%V9_1SE8$_;.A`'DPH:TMF84.XPO(#\O&Z9R[RU_0I!C6J0WP-2$<$-@1%$OYQ> M5'&P@7##&F+19MV?AQLY!".YFU>?7H#OAJVK$>DB)C,5PKL0D#QO0`K=B4H7 M@SR]6SXWVC@(DM%B"1,LF@FJ`/D$@L0U4K2H!Z,(/H109,`T[:C?:F4X^CAH M8T*T&H8@8ZG)()!75 M_FWSHDN?S""BB=%'%A4!WE<$X*".`*9&V"=0G0%@J`D,%'M7(6_;U0PI`N9? M$8"#.@*T)>L3:%F5T&1FN9H]4.P3:Z&5(+]O5P1@2^_9+X?7``[J")AH&2`0 M"7"7UG2JV@/%[EGSCQ*AO9+L#Q31\BL2<%!'@D;1)U"3`T_;,P/-KN>(*W8E M1TH.H=A*&@U^A5>J+N58=?@WJCUX5WV`]J%JP%;:TC*2#&J?:$%RM4GQ&J+J4X+"DK99@#,`'`"I[;'^/ MLZ=FJ;'7EJ+/"'5_+:N`N:6O%%X#^A.D\@?,)_@C6ET,S'4_CBUTJF"$ZI^] M7@T$N9L@7OOH`ZC\L?D]'G]JE5K\]5,1GLU!9=_<-?NACEM!>.VC/P:J`NQ] MCRN@3ME6X'I:M_49@?HGKR6,0OB@%U4"=K^6A,=.J(QZYMAV1*A!+:,07L_5 M[T75@HVPI65D.Z*VV4X'+(C.=J0TWY[FS!2`9SGZ\6(`H++''O@X>^J8&OO. M=M3NJWU'"Z8`^M@3X('HNY_JS15Z=#NJ4?VSTVJH(7=W7*X"%(E*_%VM,0]7 M3X7N\->WHQI5;T>.Y6@)"FK`@$"\WL`MK1]""NCZ@K[N4Y$?12"2I#`B><&K M"1=.QLW;YMKDR<7/8NV]SU;P*0[O[<8`MQGG\"A^AODQS@HC$0=PZ5ASV$=S MN@^AAU*>JSN%G2SA'J/Z>8)[*P$?\XX%X(.4Y>T!)VANPK;_`P``__\#`%!+ M`P04``8`"````"$`EA<:3.T%``"U&@``&0```'AL+W=O7Q5#>O[8[SS@(+AW9I[[KN^.`X M;;'C5=[.ZB,_P,BF;JJ\@Y_-UFF/#<_7_:1J[WBNNW"JO#S8:.&AN<5&O=F4 M!<_JXJWBAPZ--'R?=^!_NRN/[=E:5=QBKLJ;U[?CEZ*NCF#BI=R7W8_>J&U5 MQ<.W[:%N\I<]\/Y@\[PXV^Y_&.:KLFCJMMYT,S#GH*,FY]B)';"T>ER7P$"$ MW6KX9FD_L8?,=VUG]=@'Z-^2GUKEN]7NZM-O3;G^HSQPB#;D263@I:Y?!?3; M6ER"R8XQ^[G/P)^-M>:;_&W?_56??N?E=M=!N@-@)(@]K']DO"T@HF!FY@7" M4E'OP0'X;U6E*`V(2/[1?Y[*=;=;VOYB%H2NSP!NO?"V>RZ%2=LJWMJNKOY# M$).FT(@GC<"G-,(6,R\*6+"XPXHOK1)6%G:T#00BQ:R_+YB+`H?G7=(32%!R0B( M(M(S0N1!V,V4"PXX?/$:(JEZ/9[-LW,"+)P[6TWP`MB^>.MICI@(/Z"0S(1$ M@Q7B+"3N=F<%&(I,\0TB&=%[)PB"=%T(+"@BO8K(IA#$?;C-[>X+\-*&V%P\ M`_=CZER"H+"O$Y>.I1-CF3K&8"$=YA*'H3%5AT5)PQ+SDY8_%XF8I#L>#S?H MRS%!$+BAL(N9QL`$:(S3,0D@\E0FL@$08L^!7.(I,8T)>.^,9ZI MXP%3QPF!\#,$Q"2#@$^CG"`("3!WH7K0,TP)@)F`C`#"2+5`.(BM@+9"7B\G M,D*CYZ'IT&1QZ7IN?34)()IC0,Z66 MIG6K1QO>&ZJ*&CD>0VP%:6@"DDU"*`ML7)J'K&;E`,Y-,IB`T%T(3[V>" M2JHQT7<<3-7;*-2E("7CS/7UJLL((/3C(1*4@]#%^SF@FFH<]$T'0U2,VR9_ M%FB*GA*`'\_<>:S\:4MW1M!S-AL:D3(2*GD_(]16C9'F<,)4B?8CE[D:(B6( MN1NPN8;(",)WXR@8VHT0\301GV[U'JTM5IX[9+UOTT2BU/J'1P--HM-QE)Z/ M$=1@B#*Y2\@]E&B2"O.I2*)PT8+R-Y6#(F"[I2]\&4%X=-=+"8`S]]>4)V89 M*=$54*(DD4`\7M#U.94(-6E#H''YG810*I\2_T.B2;A%`.=VFZ.`,##A`AY;':./.0 MJ$D.4Y(MRVH*0CEHJGXE#R-J/M+BB,*3#V;V;^H1P,A#WP2`>C^BY'/@?H7% MF)(S7W@B82%4F;8Q#*!--SZ\P&--QINNXARCU[O'"8&&" MC*Z>@E`6FH9?83&FW4S3W<13M7OL$$<"5)H&`[0Q#B$,Q)F'NB[=MLOM9QGK MDQ;J1*)P7^4',R,7$C#N)G;V)`29X%L"//ZN>+/E*=_O6ZNHW\0;``_*^7+U M\G;BR1/GQMKU!-Y:]$?\SF4`7AH<\RW_GC?;\M!:>[X!D^XLA)YK\+4#_NCJ M8W_H_E)W\+J@_[J#UT,<3KO=&8`W==V=?\"-GZ:RT6NW'-2%.@@9PA,ED MYM]OE:N_JFS*)CJYR$PJ;Y?[<55WOQ!\]]O/PW[THSS5N^IX/XXFL_&H/&ZK MI]WQY7[\GW]_^W(S'M7GS?%ILZ^.Y?WX5UF/?WOXZU_N/JK3]_JU+,\CR'"L M[\>OY_/;[71:;U_+PZ:>5&_E$7[S7)T.FS/\>'J9UF^G M-KOCF#+D.VQ.W]_? MOFRKPQND>-SM=^=?3=+QZ+"]_?WE6)TVCWO@_AFEFZW-W?S02G_8;4]573V? M)Y!N2A-M,R^GRRED>KA[V@$!WO;1J7R^'W^-;HML.9X^W#4WZ+^[\J,._C^J M7ZN/OYUV3W_LCB7<;:@35N"QJKZC]/YLB)')@-%$&"SADX-9]V]TFSKH!C6%&N=*.)SR4D$WUU_ MS;EB915NMC9P<4BA*1@/K(N0!]=(`ON0SH6#FEW#31GNL2]ST]\YB1;-BEDF MBQE^"3"2I*XGUS9P&4Q3,+#Y9\!P4`LLX;/.231OP&XZN4@1<-G`92Y-P;@6 MG$LO%(I;/*G@(1'QI(MY5Z%($@#9P&4@3<&`T(R(7;J_`W%0"TSL13F)3*'F M21<820*P<,PB2SO&%*%DOKCA$H:VY&AZK5#<0A);04ZBY4W3?/$D6O*OXHM8 MA2L:$`"*#&EK2,$4T63!+[$,!S#:"/:-ZRO9C&IQ+T2/&A75\L)N8C0!JXM< M;E-5PO'P?+ZZ42,ZU>%8#/?*&XE'*E/7V60I6GEETH1L-$0Y-PHWR%_;]Q-G MPV-;L$4+-(T])T%$Y[W`:[DC4E'UHEF69K@8^3U8F518D.!6BX@$I3RA+6T$4_N"]6XWSJ#XB(*D$W9)>%5PC-_>)7((8@JB2GG^"H)L&U' MSKLV^I41A86B83!UUZ*M0FD2SH5G?L`US'M%Y!0$GU@FN5$I$UTYB:^:9D), M&VH23H<&(*#K65MD%V`=N!L+EK+5AIJI:":XBJS$4]F(3]VJF2;A5'CX!U0# M:T:60=1,^K"(5%FSR-(XEB\R5T80]B,-4.*/^5+FE&MC5%T3FY4Q'Y MC*=*.%Z'+UG`)J27+^[R);&T7485]A>\T!/N9>54;LVYB`*H^1<."#T6]B6N MN7GO:]081[7J)YV)47'`1)[83N4!*7LX3K1&X09UW0,.B,=_L/"&;2HQF0:^ M`!.Y91J5<9;)Q/:H68E1\44<'2LS(FS7?GOB!O7#PCW[!"R.DM5,Y*D>DTJI MRLI)?"E[!Q5N4#\=GOY!*7L6(7F%GE,/73BPJU16XJELI&O*M(.J>7F#?LJI MQ%U.I=V@I'(-:AK3_M/5H-:#>%@;46`U"8=%,Q"4<.!J)`LA5J-86WFL&0TR M,$[BZ7H'%6Y0UPW@=,+`]#0H^8N^!NUU(:O82CR5C71-V32H)N%4:`:NKQE9 M"%&SU@Y**M.@V<1VIK*#6FOB86U$@=4D#!;?';L>MAG5VD&E!S4J;:]Q$D?G M(I?I5`FG$W9&;]"$7$1/@QJ52F7MB*>R$85*DW`J]`M7-VB"HUHUDQ[;J-R; M1S-Q+*Z,(#C1741AHVMWWS/.AO;@>C8;E5&@/KJ\9F0JQ8;;ZD52F M'^$-9.XYX_`-9%-":U8\K(THL)J$P^+9'\#VE)"<@H"4KXP24OE%)XZ-E1&$ MBTZS(*:`FH0S?RXU*;4_K27S%;$2IF";A='CR#Z\8^018]=J; M1XGF)DP?6HFGLA&?6FQ1A9J74^$1'U`-R$85*DW`J//,#JF$-FN*H5LUD@QK5Y0W3"((-TT44-KIV M]SWC;&@*KF'\I34G7/@K86)_&5ZQU4N$%=-X#3P;5#NIY^1'6O M2TE)I5)9B:>RD:XITR&GYN54>,1?7S,R!KQF\H-*>4HJTX^+2_=?#DF/@L*DP(WFJ^0K3H%;B2VDC2BDU":?#LS^@ZVE0 M<@JP0K03/=7\A*&R$D]E(SZU/-'5O)P*[4%`-7##)%/!:]9N4%*9!HUD@[+/ M81A8:U8\K(THL)J$P^+9+V!Q3?24DAP#ATV%&K>'=2HM!W421R5BURF4B6<"L_^H&8]5.04>*T2^=(G(Y5IS"%OB)D1 MP<[I(@KD8-N2P81#R&&KL!DE;4LJW[$U*K6$>'E\?]Z7T$84.DW"2X@^87@) MR57T[)P9J50J*_%4-J)0:1).A3YA.!6J9:UB:3$S4JE_C#6:L%@T"KZ[LT8> M"&Y0EX1CX7$?8`UL13()T!)N"E&4RO=F,\U*T![I)+YHO8,*-\A?W=\`3H?' M?4#7LYN0.8"6"*A:G^G(-`MAJ*S$4]F(3^VGW`PJU+R<"AW!<"KR#[Q6[58D M%7WZ&9Z*:;[$Y\`RZT0\EHTH6)J$8^'!/AR+;`!\9-#.)L]:H54[M&Z'"A;B M<\+C.)@3+@_\E-65CV3`,S7M[:"U+>US M0N(W\`#1UP1G)N(Y/%C45$K&X]M50R+CR2T\\]#.LXYOUUWQ(KZ%)R!`/W6) MX+FAM\U+^8_-Z65WK$?[\ADP9_#F[GATHB>/Z(=S]=8\>?-8G>&)H>:_K_"$ M6`F/O,PF('ZNJK/]`2_P89\Y>_@_````__\#`%!+`P04``8`"````"$`AOV] M`R0#``!_"@``&0```'AL+W=OW5[4M5.L]42,;K-<*NCQQ:ISQC]6Z-_OQ^O)DC1RI29Z3D-5VC5RK1 M[>;SI]6!BR=94*H<8*CE&A5*-4O/DVE!*R)=WM`:_LFYJ(B"1['S9",HR8]CY&U6)D%_&3W(WG='%OSP1;#L.ZLI9!OJ MI"NPY?Q)0[]E^B=8[)VM?C05^"FA/E_3DDZ!"#`,)A`)>%-1CJAYR^]UE';*4M*.J!3HB!-$#Z MWB]+:_`:@:V^=#*2MJ#$5B6(?=_O``-E*/)T90T>*D?1HN.UGBVF%8ZB>33O M``/AV37"&CP2CD^&K+#%+.;&LN^&[Z0ZN497@\>ZI^ZQNA83V4PO7`RI/KWP MV^;UB=#;;I?KK<'C(,:[S&)L$($;O".[N$96@X>R\V3LW6(F-#B&G3S=L4%_ MN+M:U!3UT7B[G&]L1]9H@YW:V):]177]%NL]UGN=QM"@[;$>1Y-+;]##(L"( M'6^Y%F6K'[JGWA@J7S7?L)U=_20$L_&6:T%3*J#GT73;&OUQ_2UJBOI54TX? MZ:/.Q_ALW+0HF_1QL>T5PIZP#=G1'T3L6"V=DN8PM'TW`0EA+Q#V0?'&'&-; MKN#@-U\+N.A1.&9]%\`YY^KXH*\HW=5Q\Q\``/__`P!02P,$%``&``@````A M``$U?MT4"```%"P``!D```!X;"]W;W)K&ULG%I= MC]HX%'U?:?\#RGN!)$X"HV&J2;K=K;0KK5;[\9R!`%&!H"13VG^_U_;%V->?GB]5_;79%T4[@15.SS8UZ>/+G"4^VR1K7=ENOB4[5^ M/Q:G5BY2%X>\!?[-OCPWU]6.:Y?ECGG]]?W\85T=S[#$6WDHVQ]B46]R7#]] MV9VJ.G\[P'U_]UF^OJXM_K"6/Y;KNFJJ;3N%Y6:2J'W/R]ER!BN]/&]*N`.> M]DE=;%?>J_^4Q8DW>WD6"?JW+"Z-]ONDV5>77^MR\WMY*B#;4"=>@;>J^LJA M7S;\)0B>6=&?107^K">;8IN_']J_JLMO1;G;MU#N".Z(W]C3YL>GHEE#1F&9 M:1#QE=;5`0C`OY-CR5L#,I)_%_]?RDV[7WEA/(V2>>@#?/)6-.WGDB_I3=;O M35L=_Y,@'Y>2BP2X"/Q_6X0%4;(0J_1$AA@)_V.DO[B]O1TXD_1%-C[E;?[R M7%>7";08$&S..6]8_PD6XVD((9G=:8#[YS&O/$B$`KJ!VGU[\?W(?YY]@X2O M$91*$,R+`@4F(KLB>)V`CN($Z1C.B0>9G$)FOE\J(0M1`GX?F?:"00`2H1/H M3P8'0]*T^X1DD%M-)8AIH-@DEUT1-!D0HW,1?9KPGGQ0(QZW\N`.5?J!5FB^ M:2I!B2SA/&(4D$F`#QVA+7-;Q<@:4*),'[<2#[)HTL))$'!1)&CVK@B:O=CD MU%])#GY820GJXW)%4"Z)R<6YDCS.2M&M!F(D4PF*1267_F)A%CJ3EXTZ+I<* M8Y21.QQ1!-^EX7B<13-2[R%I2M!R(7B"8$9S_2?\Y0,9G$P&&,2AC]6J!O/E M2.8\SF)..BR5(+WNP"-11,3M91+DQI:C:*(?SXN(,LFRF%0[19!.EMQ.IB"T M2WWB"/TC(]`/9P91O7RD&3!AVKH9^%RDQ_2C"#0SU:&`B)*#$_D![3^\SM.E MQ,?W;]-G-*#/15SC^B!W4O*)1-]Z6TZ,6'/EX$81TY`XR/H`/1UL) M(XV3^A*EUW*9T#E0(*N[1ID$WY@19BR^R1-#U3C[A&T813AE\ M/-)^_(XAD!$=M26V\(">DQGXG6Y`9#A3*#H%`9'^?DH";=:4)7/3>5($]76; M@EAT!DE^()4:Q$L31&O#BZA>/O@"@Y M!7XP#T@N,P0X3L$@#PBWB.Y+3?#P=IOT!;!*GV(PJ[/I@N`UOM$6.W?0@IUWNL?V,A MT!8ADI$447HQ.]I>H:S^&J7V89?:4PE#D,Z,D,\4Q*(U2.U#)[5'5"^?>VH? MCE5[$6@5T4J5ON-G"^W9CWQP@:LXMOT@L0^=Q!Y1V/;SJ3V8C9*ZD44K61,-_J(TJG1IE<0VO1LD-8+],-G.XCJY7-/Z]E8 MK1>!-%7TX76**-SBS)N9X/$7J`MAE3L$85=[_(Q%R/L,6!0`7?I M%VB+'FFD%%%Z;7T_IAM%A;+:;93T,UOZX4WIE@=1.C7"/E,0B]<@[6=.VH^H M7C[WM)^-U7X1:%61:C^B\//NV80C3(#$666EB6DPU,$Z@*A>/O>\(!KK!2+0S%3'OA]1<@CB!2.VFN%UMR&(!EF!0%L$J14@"H>` M38/$F(*.(<`(>P@B*("[%0BT18_T48HHO;3+A#[R42"KV48Y060[`:-?-:0( MTHD1[IF"6+0&&4'D9`2(ZN5SSPBBL48@`JT:$HE*$84SD,16GN2'!,<9&&0$ MD9,1($K-0,2,&>CX>A@C.F9@D!%$3D:`*+VT'3-PSP?B43X@HLS*LH3L8U,$ MZ<1H;16$SD`\R`<$^J$/(*J7SST?B,?Z@`@T,]7A`XB21U[B@.XK,[SN-@/Q M(!\0:(L@]0%$X0S`][V1\>@_L9\&880]`S$4P-T'!-JB1_HH191>6M@,D0,[ MF4)9W4:,H/\!52P-`(X/P#KRJTO[I^*K#@N=')1F_^"W>[F>YWWY'P``__\#`%!+`P04 M``8`"````"$`$BN=5F\#``!*"@``&0```'AL+W=OCS>WSW7E/!$N*&NV+IKYKD.:C.6T.6S=/[\?;E:N M(R1N4LEU[GLA*4F,Q8RUIP%(P M7F,)K_S@B983G&NGNO("WU]X-::-:R*L^4=BL**@&;EGV;$FC31!.*FP!/ZB MI*TX1ZNSCX2K,7\\MC<9JUL(L:<5E2\ZJ.O4V?K;H6$<[RO(^QE%.#O'UB^3 M\#7-.!.LD#,(YQFBTYQC+_8@TFZ34\A`R>YP4FS=.[1.4>!ZNXT6Z"\E)S'X M[XB2G;YPFG^G#0&UH4ZJ`GO&'A7T6ZZ6P-F;>#_H"OSD3DX*?*SD+W;Z2NBA ME%#N.62D$EOG+_=$9*`HA)D%LY*:&CH^"R`*D!H!@7_9[":&P MEW94N\68XV6=%'A`S*I%8LP=L="/5_TG=1^DQC[5:7D-!P4><%B.OY$8L^$0 MA;%=R]38IQS4?!HT]F4=%'C`P9S@19+NY&-?4T'!ZW;3M4\Z4-=$<8SF%B+M$&^PL0[= MR[5!W6EK)H8ZMY+I4CI:&C4$#,]1[JIK(^@H,R3ZD?=>#^LPEBB#'NQ$,2>J MPO:=&JWL=NY"P:,_Y,QX-I.I)OQ`4E)5PLG848W>$(Z&?M5<"Q*X%FA_:_T. MJ?N"ULJR)"@XWR2\W@23O,4'\@/S`VV$4Y$"/N?/EJ`/-W&ULC%3);MLP M$+T7Z#\0O$>4Y'B%Y2!ND#9`"Q1%ES--C20BHBB0=)S\?8>DK=AQ%U\D47KS MWKQ9M+QY5BUY`F.E[@J:)2DET`E=RJXNZ(_O]U`BDE2BP>ZDX;OFG1]W-VS<6!.QS.Z)441EM=N03I6$STW/.^[,1`5=#;;+$>4[9:AOK\E+"S1\_$-GKWT5^+\N4.K,""(DV2AS2$;C$! MO!(E_61@0?ASN.]DZ9J"CB;)>)J.,H23#5AW+STE)6)KG5:_(BCS20TD^9X$ M[WN2+$_RV3@;3_[/PF)&P>`==WRU-'I'<&A0T_;M(X@W(`!E`\(ANI#"BA[G,*?BWJ0]N!3Z7GV M5CEB9J&EQT*C4R'O=82S\&]!'X2X(QOH=3(X"0591]#U$>@5<>(5(9=[]>"" MHINA@B@]>R,=0?/0A?DH>:W%B2ZV]')=#S[3G;_1C:!I[/XX';Y&V;A*<=(4 MF!H^0-M:(O36KTF&4!T'R9BHQWN3GAL\%<).*EI@N!*:W&ULG-K;]'6I19?GSL*X-1OY<>M_DN.[X^]O_Z MT_AMT>^557+<)?O\F#[V?Z5E__>G__[GX2,OOI=O:5KU6(5C^=A_JZK3:C@L MMV_I(2D'^2D]LD]>\N*05.S'XG58GHHTV9U_Z;`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`MH0TH:(-L17#4-VR"['C9UPTG'[^FQO#@_7_/`THUDW#9\[0)5WP*8MQE.9 M:&VR(%5T0=@@+KD@PH#"A,*"PFX+.AJG3>AHW#8AH_':@F[';Q.ZG:!-:)6P M36B5J$UHE;A-KJI(>6,702EO_#HQ9E?8[MSQWY)R1QLVM$&C#;IHN(X0N[20 MT]6X!9FW(.M+-)&3;]^"G%N0^R4B)YIW"_)O0<$M*+P%1;>@&"`I8>P^*26L M.UE<2\FB#1O:H-$&732(!QE^MS&:AL^K%8L:.<7-+]%8#HC5H.:":],&AS:X MM,&C#3YM")H&J;\SN2OA+2CZ$LWE2C%`TM%D#SMW'$VNV?7DZC;!=CRYK:\% M8IVXW$O(4#=0:%#H4!A0F%!84-A0.%"X4'A0^%`$4(101%#$74)*'GM.OB-Y M7#_VV7WP$BJ6O*4<_+5`R_-SK3J8+*>CJR]R*]H03#*JD8_5R?+JBT1>%[@C M\@84)A06%#84#A0N%!X4/A0!%"$4$11QEY#"R-ZH[@@CUS",`G5D8@.%!H4. MA0&%"84EA#BQE,&2G"NV_+&Z)(]A#OE\3#YW80<\*'PH`BA"*"(HXBXA18[/ MZUV_T7<_1W%-([>@+^X"=44."@T*'0H#"A,*"PH;"@<*5P@1[-%@.I;N&"/R MM.A=:V6@S*97MX0EN1GY!"^5JWO1B-R,`MC3$(H(BKA+2-E9K%57*#'1,-$Q,3`Q,;$PL3%Q,'$Q\3#Q,0EJLER< MG^I'`X5,NH0(1'@C<2>1<\@G>F^_;?._3N!K8ZTZ;GT[#IM?S^O:E-9TA%F0ZBXRH&)B8F%B8V)@XF+B8>)CXF M`28A)A$F<2>1P\CGEN\(HYB*)F$D<[MK1:B.%&TPT3#1:S(3?RJ=3N8*>2

;DGBIS39\@%.?YKOFZ`J$Y'%B3IA::11 M%-NI;^$S/DKWHR5;7$MB9N`B)B86)C8F#B8N)AXF/B8! M)B$F$29Q)Q%1%*MWQEDU_&W"U^N1]K6R M8HLBV^VZLF++'-OM%E]]_$7[6EVMOZJ_45=LY4R[CJ:NV`(:UCZ\=(@M(CXE MKZF?%*_9L>SMTQ;P;/=#6X#O"J4\H]O2_)"[KUSDA8%JCR`@&]<\?;OGFD%"P2:(1]:)R1(` MX!-5PG8&)(2^MM\[D9HBP8-Q,)I$`P)RM.':/`AKB1';:B.K/TY$]E;.)-Z; M#(!^OQX'\71$1N./74)'U`9X3PU=+I3<(6@:.%,WU+8@F8.SC6P(3(ZCB_52 MJ!"C-;FS+@F&;H?M&LKSLB3Q;+0(7R"I;"]:O2/R%>N#PM8"^#I("/T8\OVT M'UBLV++8,EBXE7L!WAUM+RY[6./_P;)B'VM()B=43M.7LCZ%QS;QV:ZKJ]WT M85V=J`^R3^%!VION:([TU]6*_02^4U%W,5V:)R\7\'5T@[BL%N`T=[0G#]1E8M:HY)G8!D%$V@UY2X' M]V!DTP[8C30PU-N?!=SA'(82]"E&F93F\&!'7O>O8/D7``#__P,`4$L#!!0` M!@`(````(0`]LHP*=@8``,$;```9````>&PO=V]R:W-H965TEE56G!8Z&YBZEIZ28I>=7A?Z/W_[ M7R:Z5M7Q:1LO\_>B_%8=TK360.%4+?1#79]GAE$EAS2/ MJT%Q3D_0LB_*/*[A9_EJ5.D7R MEJ>G6HB4Z3&N8?S5(3M7J)8G'Y'+X_+;V_E+4N1GD'C)CEG]LQ'5M3R9A:^G MHHQ?CC#O'VP8)ZC=_%#D\RPIBZK8UP.0,\1`U3E/C:D!2LOY+H,9\+1K9;I? MZ+^Q6<0]_K3H4[T&9[7[/3BED&WSB#KP4Q3=.#7<<@F!# MB?8;!_XLM5VZC]^.]5_%^R;-7@\UV.W`C/C$9KN?7EHED%&0&5C-,)+B"`.` MOUJ>\=*`C,0_FNM[MJL/"]T>#9RQ:3.@:R]I5?L9E]2UY*VJB_P_06)\4*V( M=1&!ZQ61.X'V)1"NET#F#*R)PYP1[_Y.Y/`2"=?GN@399L)PQ2Y'=WN"UB8` MKL_U-+X$PO42:%D?FQS[5S9H\":`CX"G2R310-D MH.B&`B$%MA2(>H`!N6L3"+>@DD`;++V^'F"^>)2<+WLH#]H5E'ZV;$>FK)"" M\_(0Z%(QG8SEH#5R,,A'H`NRY)``&1BR0:`+H6,+D8(Q6P2ZF`GI)T(*Q$@Y MAM7J$SGF4;"Z]LJ-L1&M24&"1:VM2<)8(0,GXB%P,V2-#`SQ$;@9$B`#0S8( MW`P)D8$A6P1NAD3(@!`IP3!_)<%LS!]@#^J8!RYT\*U+GTWN/E=P[J48&3@3 M#X&>K%R2:V1@B"^`<;/V6,PTR2@"T%2%WY;8O MXHRG-JWR!R*2,6#`YXSA@=08,A!7<&`X;49H[2,#L^PA<#-DC0P,\04P:HR9 MC$V2K4`T/_!%TIB.R5(97M4@'6W[&I;CF,3[Z(&(9`ML33YG"P^4;9F20G4% MY9XKR,`4>PC<=@49&.(+0+@R-.VI?",$HOF!*Y(&&YJR1GA5@[K2UV"V2=?G MZ(&(Y`KL^S[G"@^471G9I#QB`BV0);&,66QSLD'D4](?>]*SCW/$$&)MA# MX+8GR,`07P#"$S8UR2`"T?S`D[Z&98WI<^6J!O6DK\'&M$"C!QJ2)7!<^80E M/$JV!#;Y9'OI"M(]3Y"!"?80N.T),C#$%X#PQ#*G)%6!:)8],4D-;R0->T0T MPFL:%EVMMWT1VW2(L=$C$^RP2)))%L#E8="S/FJ=!:A7P5"E1HHT*A"FU5*)(@.8G\'$0K\3.WLSA/ MR35&%F27F\/71)E%#B.KCM4EL0U$:*VR?!4*5&BC0J$*;56(?V:XC!X&(9(H M/AN(-ZQY6KZFJ_1XK+2D>..?!&">RWD+X_<*_L&B>2B0%ECLH,7BCPNEQ886 M^VK+$%J:)Z<2XT!+\T5":9G!2U6U%Y\/[`KN6C-X\ZCR/6L&+Q=5W+=F\`91 MQ3?6#-X2JO@6IMW@1CM0^(!RCE_3/^+R-3M5VC'=0S;-P1@,*,4G&/&C+L[- M6]67HH9/)\V_!_A4EL(>PAP`>5\4-?Z`CHWVX]OR?P```/__`P!02P,$%``& M``@````A`'4Y_=V1`@``6P8``!D```!X;"]W;W)K&ULC%5;;]HP&'V?M/]@^;UQ$@H%1*@*4;=*JS1-NSP;QTDLXCBRS:7_?I]C M"`2VEA>(X_,=G_-=G-GC7E9HR[41JDYP%(08\9JI3-1%@G_]?+X;8V0LK3-: MJ9HG^(T;_#C__&FV4WIM2LXM`H;:)+BTMID28EC))36!:G@-.[G2DEI8ZH*8 M1G.:M4&R(G$8CHBDHL:>8:IOX5!Y+AA/%=M(7EM/HGE%+>@WI6C,D4VR6^@D MU>M-<\>4;(!B)2IAWUI2C"2;OA2UTG15@>]]=$_9D;M=7-%+P;0R*K*A8V*J`@'PBZ1PG0$)H?OV?R?V?5?#H2)X<2\L%+@R49SN/XLED1K:05'8`+3P(1N($ZB.61X3+ MH.--SUX0$-RIAER7&/B/F)YC1@,^Y#T&C(^L?3T M#_KZ7=8'T)7O^W!!@#O/7S0:]34L/`@JV27Y`K'\$)&^A^C9@&/.RW";#1>4 M8,A5IS`:A.&%#0^:^%8*+CIIV=^]+,/Y;AR<['OI?LC]#$BN"[[D56404QLW MP!&'NG^ZS,/\+``#__P,`4$L#!!0`!@`(````(0"8 MRZ^B:`,``,<+```9````>&PO=V]R:W-H965T(&[3&%3S)*"N1@%MV,'G-,$J; M265A.I;EFR4BE:X45NP]&C3+2()#FAQ+7`DEPG"!!,3/N1.SI M6-\EM*Q!8D\*(EX;45TKD]7CH:(,[0O(^\6>H>2BW=QFDL3E#;KE$`&TG:-X2S0'^Q5O-#-S;KQYQ?!)][YK_&S8Z;`GQC6HHS="S$=WKZC,DA%U!M#Q*2>:W2UQ#S M!`P%&U;QWU07R2Z1A8#E?@&,K=;F5[.L&FZ.5_* M.YZ[G`3;H).J[;J#(+8*FG4@OPVA*(GA40:M>*<0LD'.A@ M=%OMI37(;ZN8>;/=/=>;698U<*!+#)Z%(\^B[K.;RG&7F/FP'!$MPKRU2FWO?[:JO(*@1A;]P;>A9-$-+U,/";2,P%>;%T3WG<* MY*2!&>Y\<%JW"AK)=#=)A)-$-$G$8T3/BOG_6"$G3;X0%#1FQ2013A+1)!&/ M$3TK9(MWX],W_F*0DP:[8F8O^^=^JR#U9O#M6R=$$2-FA9-$-$E`8R6#O;V* MLD(U3JHC*#$[X!TN"JXE]"B;(@<.>3O:]FL/COPJ#L9WT,6J4Y,W0A:-WW(G@KHH)J_.33,&#[NE@%P1JFXW,#" M9MN";_X```#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO M=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1N MAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+ M2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL> MD@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH! MGXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY, M%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^ M=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0 M,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W M.&<=+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS M'"LY1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I M#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$ MB)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX; M.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ M,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4 MQ>Q,O91&\\!)0.YF.+"XF M)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W M"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\ MJIB4OR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1 M`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE M2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//- MJ63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60', M"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A M/X#:BN#[A28&80-1?F#R`Y+<B!!9.]'G MW>9B$:XW3NP]>+X7OS!:IK%>7+]_#,+(>?`!ZG//1C1P)G[2:_F#N^]Q!Y^+.5L_;\E^1P'P\PQTA_M_;`3'BPDW`X M+Y\'1)/)-$88G$P#/$)E6H-(#AZLE\GYN40FCM>PF5<;_7&\F!3U@7 M!SILPRNW%>$3/3Y,3=N&'-+K=E&MU&`G8C:9=X'?V9A=#<\FV<`>V".EDG&^ M>&@W9#BP5:JR@:']=O3N;.I4SZQ*NC0-GRL",.#4:M&#T*V)[Y&-KW/XR9DG M-*46@P(N?NM[CT$RW6YW&ZCH%I&WB5%S9>H]J;1,-F[J80F@R-#WWMK=&A_= MK\:/X=H)$"2=6MFONP,KHMB-`AL^&.G[^Y<-E.D! M+-[0Y3K)[QI^_1@Y+[T^"P6Q`=O0]Y:(XG'.%@=I<3:_NK/G=XPO02:*HH*H M;<]')R!Z-YO,U2.=3R:JB?9M>"DF^G:(+\5$;?AOKDRGZ81EJ0*9TS-B#Q?S MWI&_!_VSR.ST"U3H=FKJM2A!HLBI!H,FJ;#W949#YTTB! MUIKF6"4(-%F5(-!DU9'B##S2;E6"0)-5"0)-5F5=4(6Q"AUES;%*$&BR*D&@ MR:K*BL\T`T^T6Y4@T&15@N#<5LV65?.[.YOUQ`XKL^KZF*WD8.WX$$9+Z`YE M)[%ZN'I,CMW>^.XJAE5BY#T^X=\XW,"_#V$/#VTXV(OM; M,Q+.'\*IPJD9/WF+S\",:WLD>!,6I^*09R(+*WQK9'5'UK!_E2RB%+%>NTMO MMSZ4+N==ZBN@1M1ML^!$AT'.)'6'HD7:02NDYA,-Y.P/1<@F1/W]S/CX,!C)*!&9Z]))CF)SQCE)PS$DYWY>(VDB=2`P6Y MZ2J384]-AS*H8"(C20:L<4R=$=/Y&J;_A>O[GW!"_LT()OH9^M_,&YA/FK]`>\2BMU:C`!=>HZ/"H1P)(_0P!&T($`EJ<9 M`G!/'0A@*94A``-V.<40T$@JX,2;RAKRM% M4@RZV39,F*NF?PD6>U:U0,%"V_-^WU?.JL9':JUHT M`:UL>+)Z2E:.8`NVEB)+:;R/S\&;`[!W:CR%D?<++#+Q?KX%''`C$^__C+T% M/?(UY M&N*H;-;HJX2YL`(J<^=YN;7(1+AP4JIGZHYX(IW.&=(Y&ZXJ5XNNC:948Y'Q MD1[4CTK-I)6Y6A^!@DZ;:I0[J(Q=E,>N#'.M'HE]#GTVKSI=@GWZNKEIEIX> M:*RK:'QDE?>QMAGL]V/J$-KL#(H4OL8<;^`-47BJ2FI]T`1;#*B,TF@H-W&' M6@[E29=3ZK'0X-*"A13N$EC*ZT'[&&W1$&!7UTDN]LA\>90":ZY8DE"(;M$A M(;6OG*DI6D=[A6/5`Q7QJ\I2G,)OZ4GU*#-C"[J.&+&&-D!+X>#.;;7S*,63 MSER@CDY=4^@<&*0:196`7LW\WL6/U*Q=50GBU0)UI8YP M,2:#YIQ30Y***3J)2NN<0-M6L,H395M`1Q44$HE<,'%2&YY*1^J3]_[L:)'^ M;%_X%$:KBH#&3*F`!!)5["B>)* M#0R\LF9W]6RO:CHKJ8GDZA$`4CK;ZYEPJTI&\>IH/P40:YS4(4H]5[P[0;$U MI()L*2#5(*!^TM9WH4!44OQ03,=,FWURK?6I=59J7IKK)>JC/KUB`)0IO(H^ M(L$KQ=U6WS6Q>4Y;"OI_6VD;ICWJ/*7S".EF2&CG]10*$J`5I32YF8_85WEY MH#3L2+IXW4"E-2J8$)1++9\!E$`X-N3KF8M$_*D:F#3&ZU'R(7XR/*\C5I); M_6L;DP3HZZE=!'!75>A@_;JB4,C@XEFS>?57N?0Z%FAC\`+A?-U'5E6GL*X4 M%I*5C\(BF*1YVDW+1[Z4+?JE1S%K,"G/2\@3Y2<(->(WU(QTQ=06HAJEJ?'$ M8[VE05V-X/XO2VPAT(<:%2D3^$@IHK)!SX=N>70ESH>1&A\]&;Q#)?-5CGYU M@@(%N@N"25>,F+2O`/?:/J[R&O/8M%`OOTA\20<^!AX_HID9N M5<@(NJ@:9B=UX;-`;'1Q\)*\6*TL$(\UEK3^7H^S-RY!&K,5:E;EY1-T]A+N MDM,;=,2OY%66PL1Q$C\45EPYS,I<5A8+[$8ZN'6.;$3&;T.6WVAGX.-BX"%[ MW=\;%\;;!4J6G[O#DS8/.\^'+8;Q#CJ\"7*QV\).FK/D8'I9:AVM_$(2O.R& MTH*@E*4%%)(E.)Y@H+3@=A=96L`^H34`:0DMV*--FA:T#%):\([2@E/ALKA@ M2$J+U_U04/=6F1W9#?[$CB"R""Y*J[`C:([(.`"196D5=L2;BPDN$%F65F%' M0$AH6#>N""Y*J[`C[ZL# M05^EM`H[\KZ*(LOB*NP(5(F^+/A"EE9A1SY/6()Y@LI8V)'7_5!0]_L9E??X MOJ#')U0*V\$[HB.LN$1TE%`IK,9[^4#0RQ,JA;UX_[8$_3NA4E@*Z!&)+/A" M7*+<1@->NY:@=F?.,LNZO,/@/","`YXBMMCY\)C<$!^RR^XVQZ4S$0BO^Q2B M].0N/AMSV#PT)\3'`TZC(H3NGC>^$SAQ&+T8>(=Y3HXW^E"0W)_",-<13P$O M.Q,!]&=X)#$\[=@`O20:XGT8[^R5(9/'`J\>W&Y*A@R,3M#P_H<;`\F0@=$) M&3ZI8OTD0N9]L-GE%N)S*4[=(B0^>,%G=\E[#J]A;#.(4/KH[N+(R?V/#ZF^ MH&(^XI:S.0T^120/RLOVQTWKSX^PPVRF1"SN2>S@*DT$^%]W,5$CCB)$\`8E M$2+W7@P[@V=!S)%`6$(D0MCU(2>QEU$$:?S=B0*,%BYT]WRT0J)B#PVH_I?/ MQ?;#3.\Q/K2;;4RS\^#[_S M[]V_?_\W]\MU@L M"]Z=+/YT[V*YG/WAX7Y6ARKQA,5Y,E\^X^?OSD7K&:C/ZVJ@[#M4=[._>^_VXQ^OZ[ MY??/IX/59359%JRD>#%9CI;7Q='$IV#EQ<;'X^?%_0??/5Q^_]U#O>*O[>X5 M;Z:3Y<6"=X;5L'W[>378+O9W-XN]G=W]]LV_E)-T\U'GYHJ;>T_[WTR+S5?X MU]>C254<+:O+Q7^V1_NZ?2&-<'(]J]HWO][=V?KW]L4#H#,T"+T-%9Z`TR_MJ/IH*KL/B>;E<_]S+T6)0CHL?JW)>O`0CB\X\?8!,TX37PVS] M`[S\L3WFR;P4-1;'UY>GTW'[[M0G5O"TO.[OZ^N/; MH_]X\>'XX'7QZL7!ZY-7Q0?]\V-Q]/;PW9L7QW7=7L+7._S?-]\^_>9IAZX.5_.Y*#D'YCK(?[VUM;NWM;_;'C[L\(=J/-[Z M>3*]FA3'5;F`08?%T6*QJN;M%[Y^.VU?"F/$Y7RH9M/YT@"]+)<]J/VQZJ`[ M#/$?T_%JLBSGU^QIC"A9,Y/=+`XAL//IO`NQ@\&@XFUN#WV<-<,<3B\OX?CC MY73P\V9Q?%'.JT7Q;K4T*<7ZU[SV?G4Z'@V*E^-IN6P_;381'"-J\6BF"XOJOG5:%$5BUDU&)V-;A8Y M>^UU?*B@J1=L9(FDF'RJ%DMQ].(/[>>>K49C\<3"Q.'HK-X6RTWBY/ILNQPX&M`T!Z.IXO^ M(3O$D>VS&$UL0^7PDS"P*);38CRZ'(DBQJ/R=#26V!],+V?E9,3MC7NO7Q\N M[G6D_CNAH3A8+,!?!W:'Y>+"9AGHC^IOJ]&GGT\EJ41C/ M`K^*YT_'57$VGUX6'U\=MU_[P%@\')_;,IIH/W0$NTS.1QJGM&46&Q-`-CTK MR@QAY:4X\A=#F.[=W]W?_J:X'(W'4GE:VOVGVWOUA66!0JLN3]E\5&KV5/OJ MWB8+%(4N1Y^J\74'?L^KLPH9-2P&,-=Y!7V?3Z?#*^:UX6Q'8=V;!>MN[\[( M),"_?>]UP"/XZZ#&-"3['##W:`GGCMZ?#F3Z1**F)77 M0@ZKFDZV0,)T-0>)D!$(W!A-!N.5J1+!>EB=+@L8XG*TNC3@/MU_M(G0=KCN M;N__Z^$*,\Y7@'4T658@H`.W>+_ZC`6U8#M"L6\ODC]@:P/CI)I(Q3%@-4=D M;!;58@#<^`.&GRY&R#"-PU9GY6C(Y`5\LKSN8.S]/)+*PN4P MV#NM)M79"#DS3AO=+.YO[^R"G7D!LZVJ/Q:/!6H#=WBQ7"TOIO/1+]7PCT)> M58RDQX8.@O7"/2@#'Z0[S;; MWW[[M`VN(=7D*@=8R3P_JAX>C3:(AQ MUT%\+MN=2B0:Y]4%Q*/1Q]-%YQU'],<)]^<+EOP*C;.\,%EM%K764IS,5QCW MQ\+HQ70\Y,FO"R>`]E[>PF8##.SY%)F$C29QRCCK"-QG[Q^J0X*&^OYG;]37 M[UDV)G^U'&&K/EBOOUL2>'.MZ&UO^O=('S%C+6_:(]Z9C1('_>X1.NSVNT=R M[FF__O5OO_[V:_OBG?:5&YG@I??Q9$/=.G+29Z/+4ZEOAU]2A5MWF.VV(6[>6H!. MFXA?!*W<48+/,[O:A%9NM[5'.1A^&BUP?XJS"@6/9=)C0KXS^U66-Z:?I&J8 MN3T6GO%D46+%80T.IHNN"8OYSFRZ3:3$+;8";Z$(WD]:(^[6EG)>C":9,CY7IJH&WUL\K]Z"] MR[_N_N?F7_F+P0_8.:V2R&S\GP"4W`9HVLU-AR9.P#>BMEJ M/KB0ZP`8+D<3;)I,(2ZTW,OR)[NZA=^.A:-%]FXPSHT!@+$X6JZ8S2P+=\KD M`?D(I]=M@*\=\Z_[[/Y19YM<;L,)%\6,U(B-WB6^76O`_/5Q9T1$!@XXL:.) MN:Z0=V'2N3WS\]%X)9?O]B=_J$;G%WJTQ)R1/S!9F?<#Z(/_E-H1S[;DSRF4AW.(-EG) M56(D<:H0`V]>5G@>3&>;_%WFY+@, ML+>7%TRC#3#L%=P3%\QN)("U-@1U)AAM8=NR#/!,>0KIH,&%T0(MPEX5>#@; MXZISE_=U=VGQ!P-/@:UKU[K+T81K8*1;&F@Q^KQ%*`W['UY4`!ALYSOEH?ET M=7[1#2MTD-F'.=`VFHC7X[;.<,>9[&\K;`28G]F<5@G[88_H-P^8/&3F8`$0OAD^K`8'>X@JO97P=Q*L3NLP'P2JPA4%:DW7AMA9) M!T."$I!FR=B8\\Y[1@IKMF7W1G-:.G4W7ODET)@#$.!"2N+H8#2[$"!DL M7/)'YL5CSMRPS:1B3$',%Q>C&3MW>8ZNPFI[AP<-XC3AC M-/%(Y8Q9BD<&MPF]9M+)]]S+&E68C6F-1:2_C$FR704&YY'(+VLPO2+P[D3< MX.(.7?;HNN<9Y@P[HHTF:1HS0YN@`K&0K6](`F1%P,[HYRTAIP+)N[R:.M'F MJ/K7X$?@O"N.MHFX(5]<'+$J7LUT190F;&8!^`.$MJA)RA%N90M&UL'V),9NU/#^?([&7"&]_HK$#7Y]#$$E-!+/6(#+V M`K4C2-N\VI"<%B1/KA6/*G`1!=LU2@XBDZCHQ#X[)/)#5#!!T$I@"7BU_1TE M_`TB55)C#:E^D=I!\/\+U$XN*/LUS@D;1+":%YC`=I;888&DA2N"W(KL`*W# M#K4^"AHZX,F`%L:T(?NUSS9NKE3C%4--ID@JQ)+%"O%+!J:;)9=SRJVI.A`= ML92:%F2&&RU*PT>AU+8U#G.EFWGEAQ>$X0N>-E'B[[4V#D1'0 MLSHN'%?6<:6//.A+J#X8\)W0+]' MOFY.>,S2J235K]9FRNV),WO"@B2U7E7HZI-%%SOD>3#\B1R$ZW?\+RDTO"V\ MO4PQ<%V_+(^+Y!>OFU][MPD:N=7)C>'Y&(CY7:$=O%?L!LRDVX)UF@5!R5+J M>(^D6%!JMX5[[CQ/IO-"[ED&<)9@["#C`U0D%(34=YN0+5RY-CQT)_2TAVS3 MS,B*(22P;J"95B6!O*?VN!2YE-?):NP->;1?(6#KQ0AY7*3]D*T7YP`E51!O8-%0RJ:KCPNH.^,=+>1#1A:YA7'LPA M,C$?;LU0D]?*3"XG)/7:FX@.KH6ES0A"%&-PZ0E`M;>"/KW[+#VV>!]U)M2O@O?UU)>Y+W$6>&*JD%E9;@=`!:3ZM/\MJ2]NN)[+7 M7R8.MPP.S#D:2I9>%:2AIN-/DGF'7@_STI-QGZ8P]QH;6Y:[%=9!C6;R&L!.:Z\@6F,WJY)(/WVTT,9-9)>'&U"I MD;29V6LYI_V^T5\?BVTJ)AV"FVS'PZ=?\'8EVEKWWO%J1GA.XA:/1A$G"CEB M[L>6+HY``B`_\9Z1G!V%'?VK7D3>-#QQQ"V;(K-6NG5:SU7*@(0WN1ME;2W$ M,SW0`4G#3M]0^/>!D6=;BNC6S@/!:)TPR6:Y24$!BF:E77M)GFSMUU=O\CJS MB<)]-Q28]0^75ZJ MGA?X'X](=A(-5N*$BB/E)"23WE,O.^BI"SC^^.;-P8GET M>/#VI#@X/'SW\>W)T=L_%^_?O3XZ/'IQW%[56ZJ.L9.9\AW\9(3=`<.="I?$ ML(O5Z6(T')';0I)O*)SWC[__+ZMK^L??_S="`-DS)ZEDWB"!J+)XPW:I^U5] M'%S7,7PPW_%'M@N"A:ZX!+D+*YX:*`BD-R]6E\0`586GV'F,EM0`FU"R^#]9!$]BX;WO)1\^>1&^<5 M>!P@3+#X"/U?4#EL\X9+MO)U9I>%E$'(R^IT3M+F^K=?PY&'1Y:78[5*A)TM MK[8L++\O]*4'U!N01T+(X5&1..G0Q[%D/\=$;,>G`QG8X-OQVL M=X+@2N*FDA/#K>)EMIJ+8DXI:!Z#O"7^$)*(:I@0U-$ MBP!%S!,S+!/N0I8(@Z7E(=Z%^E6X8KK\!A3*TT1=7)081$NRX[ M**=S,WH4X>ZCV9#HL\5WX6RK"DBJ:](YV%-LH(0U24<\'KLP@O$QA;;[YG3U M*]#,T&^@4.G-PCB[Q`PEC:-24D>TC$I-$]8P-D^$$%-U!7+!^:4;S7IDI?S< M^%K$;A6_$NNZGG9=NV4(F49F58]%BLF%,0KI9TQ[:FL@0T1&%T#0`H2H]SLD MF$A/S.Q^`/1@`W:(4<#`?T9>JN`A;'W=IH3*?"\GS+ZTJI0\\]V8L882!$LR MWX\U0#X#CEHH`W9:3GX6Y+368.8"8#U,$9!'%RB-\/3GK"2_+,DC!E/>:V$0 MFDP%*7B#78H;];XG6,#A:K%=O)I>Z25+T:&%4.]B;A(RLNL(5:'!C'UJ*/.0 M^R$]<-/1`$T9)Q/C\"":_6`0)#<3D0 MXCGE[M05Q&H%GP1B.(,*%QU1]Z:'A6T6_8Y=)-,/R M%`3I^`?`F8_8&M.P+!PNY3<5Z!3Y*%J'3,3R76#OF*+2=BP7P"$O6QPE?J-+ M3I#H[6)#::,X$.JY*:7%SO.J4=6:3Q'3L"`5@;*%+BK=3];B8@DH1@BY=T2@ M["GHA_6(Q>4WJ.A"BZ.(4X8B'!^LV&7Y.80S$!Y>S=N!H,168RL6G(.KD\"N MS4JQS=GHL_8?I1!`L/R;T)=0S`K\MXM^^"`<.0I$NPV^S,=%5"A[#^"]O`I1Z7(.R51"E M4R\FJ,[1';+M@;:"6(E]=#A\N!ISQU82M4.4;-7G8/8[BJS0(!I96D(6)W;U MR>$5"=%&>L2DM`GA--QHLC4;E_!%0+W)'!!,8\=KDNQ)@ M=-/DJK@4%HC' MW9J"5.K4PP:\G:2E]DA-F9VZ0VAFD-*H"Q4+.FK"#A`5@*+Q.@C0!H8=D?E! M(O:%9TCJB$HG9/'.=V#%4V*;.N%AME==+XXR@D[U2#0H,:)`TSBZRP%0P=IT M_"MD@9YIU.FA#)HA+P,?@DST),$:C0+C'P"!QJGKV[$A.C$S4:$*5`U*R9YO M\18\JXI=!(F9U8'A1%;VITZ2,0[TQO2R("S:@J\E3&"D^-9KZ.#%$<-A)\$E M`0X"CM;?W6!4Z#R@X=8M,>3D[8CL;[_&,[(LG$6:!7<*N2AL;H(_26D.B:)A M19:V$Y/7.%VIS@UWL%6'SCKVJ6LS>]P]+!N>K0?O$W,[8@'6BP5S<7)GL4"& MVO7]1]M/?OLUG/RE['I_^]OFST?I9T%52:K0MIU1I%V?&I9>)[9*`(?_/K;_ M/K'_?F//B+2F0'_0[O!*0_R4YKW^&MW8XL3XD>^^-%2F5U MI#GQ7Y,UPPJO3>8QC(]!-Z9O#1EM#PV[:XFW/B=!(B/0C(Z$6!PJ*I!U2,ZI M1,%)J\+GM[N',IZ01.:HU6FUKB=[H-8!Q1$ZN/]`EVDH*$'^7[TTMY]B>+HK M2Z4S492CZ@HV$#05./`)S"Q5V*"0R8-(S2YXKPP M0I#RQ)WG%A*JK4C1:E1HL#O&M7F+[%Y6,S/).T<$U0\Y;"XJM(G$MJ<#Q;BX M=&"%-?MZ^<,*F7'A,6V#Q]_QB35_+7X['O(F$I_CW#4W1:8Q2B>&2;QQ@1XW M?'G02@9$B$+%C>GAEW7YA/:'G^,;6&W47&B];(5 M\][8++R=6^8>*C%:'J(G98Y(B'+\6G8B`"38/XY&`2N*@5^-ZNGUL+`.4YZ` M&POD8:#Z%I"J#4AFH8RY&`5D<*BESE=%H!`QY)Q/H@+"%0W_)D$"#*E?!-/@ M!\G*#81[&EK"6`,KKX,WHKZR2"U&@?D[!MAZ26[`L"PX)>>2N"AH-Z>*^D4L M9X\Z2CMBW8?-8D1A!FDK^29.2M!H.')%M@=HW`4$7\8%;DNK MXT$RY"X)3RL=((*U):?6#/J5F&J-+$H*OK:,HU*/;-TA6,GCQ<+$?]#_28AY MC!\6H(Z"XC2<#X>(8)=M);! MRV[*SQ36K.8(\4L1&\C5UI$X1.K#"GT%@"CJ)[19Y(<@6A)KL7;FOH38$@:A M#+NH<5N;90+G"$6D<"H(:M14EVF%?@WD,<.D`MS2Z9'/379(@,6*Y@PAVQ5([,0:3&4E!CEK M^21Z_O[C[4?)V,6"1DQ.D,V20,;4O$T\RT2I%(@$$\<6_=@C)]YF((:W#I:X M5.H2\.>*Y/:H=--RW;2RT>KEG4$4*'6:LR1)&\GNBK+(_ETZ4YB,_V?$P%RM*;/8CVCZ=6A8%ILI71>'BI)YP[*0O'=APMOZ__?\ M9_&+@$$?S)U[#[__;C`=N_=Z2U82 M&5#@42/HPD,;=/F]B@327%E;S'=H9Z$U1=?K+*-Y"^ZVN)$D2>U.3WHZG-(T M'2)%+WY5!R`8H"9$MQFP3CB$94 MC!N2_7`$H7+G,T$1"R$J%IFT]0%U02C57[EDRJNZ+RVJ90P#@%I`]Z`X055Z MO4XM&^+GH*+-J-2#Z7%K?X,1[5DF11;=(8L=/);3/]!([<%OOZXI:?XC=W6[ MG$PTV>EJ>(X5:"T$($^+M-DC>J:NX$1:Q^(@VUAS]3'W1@.S($_W][^2H/[V M\5=`KMF!2N=N.P>>W:4-JCCDJF"84.AAR6EI*A6-N;VNFY8K@:3E`D=S-F`$ M%(H(:P,7GT?5V,8(Z03`:Y`(5L7$)E1,&93SR/V)P@6HD*O2I4#0=&,/>$D+RW@(A@&/@:4S[Q\XK^`0C`&/`H`\!8%5 MH(!6MAH.':U;J$UF5_75S0SSL""L9F^WT9X0$[47FY=@2G0%*X.S$8T'\)0R M_F-#R93JG'K/6@:^[[2;2%U8-DW+"@7'P.GG1=V1HO6(<;PYT(H&K$`1%D-% M,:_9BO%T$7"&MO!YK4E,WPG^X'VI,(%G=O=V?G MJXC\/LPY77GX=&DBW8!P$4N,+EC`%3)NGO.O^,L!N82(?C MD.T2A&NT`,N#3=:CP4X4-[0:*!?C]BJW6"SR%PK)V.2.@6_?MM]!CN&#.ANH MW-TE-\J1X%F?"0D/JSBU8H*/KXZ+Z-8AJ6Y:-O8@@0NR3E9=(:3*EO%.'+_] MZGC=%UZ-<@QE""[EDXQL*$0'\K5F,'EUTWRU(]C0+QT./!$5AE9%@8B@%,.V M,/73%"6]%94@=+R\LJHL5Z[4CK6:@LG(9]T>A?&'7!K<2.E!TD;ZW"Y>*`5J M@FP1J\00UE1JG6TM<)S)TX@XE7TE7RF9;,7R)/E2\8$8-8;JI.G4ZF+$!-GC M8,PL%(G3.BQ6#Q<\8C>3--XB%/V*4G*E;$W_-E1%1$D_T5!LFP<.!S.NVSU* M(3^Z,5K+%48"R#RUO)ZIO0V;I#AK.CD'["3X_=0(&G;!80'D-<1F\:^P=_?4 M&2/C;2)C#5;3=K8,.C4,C*)0"YL.0DO+`0S]R_%0/V-I95710(JJ"N'%03!4 MS@V6PV8C-M7;N+'6*;7E2]=D;)6:J65JS>-A(_)\'%Y!638V"VB"LQ8[UA)'G:G M!G4"(*"JA072SZ-&DC:QB5VR4`Q#D;PTEM M<$QT:RBQK=B5+Q8DP:YPORJX<`]##20K\DOGJ%E5MHC6+$F6I782GD).A^&- MD01N\[,=0Y2L"_0M/,-NW``-559/9(I MQAN<*T$"'K)>/$,9G,8]IZ:5^QVM`\..6D4E!>4F;0Y,A1%-L3FDP[[Y!SG& MMR0XER![.886;E^?242,<9F./?W`$+LU9'^7*=*C=MW-LHTT@AB-?6I_4=<3 MMTA^-3(%\3(TF\9)`6*#UIK%N-&U`-LRU368U:VZ!`[:1U8_@93H&(;V+!?E M&'JW<.-^1^2`HYPMFBO.23AJ[L@4L:>4:7HH+_FI)I9A",N])7R,X4EIL8BDX&E<8BQ$5?Z-=W(/(B&5AMJ]D6V+2_0=V&<`)]%]1FO^9H%W7%C8E43.+=X%H8 M).[L/[A&L-O6((N$&KF<&E=+H+ M?T4&,IMAF(YJHI5^2'$=C_<&VL[/58H!A`]_`/*/0J1.2%M#K`U4,=(X;2`3 M!-ZQ*1;+N2AXA(4Y=2^YM_I?)!$2*7CDU".9,*\%38=OCJ3P/6V[F:&F=A'5 M)\U3'K(?6*A5.;&:G/ILEB_AJG5-\'XW/N9MSK\ M$#L%I_,UEG\4B9^%(8*&HIQ<(B68^S)2!%;%%D=G&'M.`'T1]6H[B2FN+))S'<"V759TS,9<@G=G:&W:GQV9">31J( MP>%N[^[!K:49A*O96I2'4=\2 M\YX3$"V.F0FRQCO.,&I^(@0VJ%-S9$!(Q%HWI7.=E'O(M<"&.#$^!3W+VU%1 MWV:%%[$[L:@`IE!$%=*QLQ\ISV>[9)1X;`>8$`[WCS0(7SEZ>5F'HX8CC`]8 M28&).FP,U@J^/5<%X%`!F_-E@S``&BVV[4A7F M5##F%![NUPGP55Z^R(_`749DV&DSU$\HDQ1HM`Y72%HE0]<"1$O*,G,>BNX` M^H0!,CU'>9$"S:I\L%Z]FD-P.IU.?U9B"P9G$LT:=+Y#G/"[FS$^[\]LUSRH0J?0K^X-F7!UE+T?-?% MMF'G)'"/D9#-_++UGR/J),?/4<6J&LWI"GGU<%0J4;'VX"(6?(LI',-4PHV= M7_G2R3S?[&&-OJYV0DS0>@9_4*(=X1*'3O3$#%("2SO;0LU,($QL>]0,C])]Q.CW::A/.BCM0+]3!Y@PQZ7$LBB/E0 MTE>AS!5->8=USJ` M>`FNBO\0I[4IU^XX%FVO7AL15ANJK&00T[>%Z#W+M&@MY^'A)76.`.M6B:5G M3+M&]&EU1A9V,D',K<`+VME(/X2+[3"!`CE6^F;EM'X^&OI!B$7B"&\C,J"/ M:/^3$T;]ET&FB')DU*M,U.C)#RID8S?F9_",,[,]@*_``1JE$0N6S<.I31"+ MSA9`'6P7(VPP/@L08N#2@KQ*XRN8)T7.0Q'+NN4XI%#VX3E$!UGSTSSBO8#< MI12HO*U/=KG4K#6*(X#" M;9CD)PH8+/3HJ:[Z6(ZA.E/O0:(0=3;*">S%.`#W%.?)"&??^,`B:,PH2JL\ MW>=E'"I>R00!$B1H\V!EQD_@F2XG_T-E;5;D&Z@7E\!K3$U-2`OY(I*P:6'W M)H#(MKX=="S2#D6UJQ)EHLATEQ3;M$2LY(0K9\*D=N`.9+0V9TER:5>%$>PK M![JBJ'D6VS>-V:12.T:UMNA;.R%PK9H:*QD`36`@+VV@;Q/WHJB.M=AJTGQ' M@,%2&?+R\NN?J/[P2(GYDFBBO`8[6A+6HDYIBZN<,URR26X@+*U,QVQG"R!8 MW:#5.X5J15L^_J<5FOXNVNAR?^2'V$7-XO'^E08]G'W)@^V#A($*YL$MREQ, MYCZJ3#S@3[\DT5I_,ND*Q% M:Z%ZH941=9^@&92'],-]+$>"\Z_ME."P-%%W@ M>"GU%$'LB]1UH'JOF6=R%8+AA<^0#G:((-KEZ?)7VE:E M-[(PUDFL%'F+;?4#W1BHID_M'\*3(6=V;2^BY$,*R1AKR8'M!8284P_V+2>< M6G;J#`Y!(QWD+]5*1@P8>A!X?-=/:>0Q"*_+1#HY_CH(5GVIN'AE&Y3GXI63 M;=_@A7^G#J4BCL2>]W(FM@*W6D:1@(L:`31P2"$W]D6(HM<\L@\(`)BL"QU, MHAD7\763&.&D$NCUFYRHZB;9CR:I49E7\WA.\F4*J_1MB"/Y.-/8A>%KH[V[ M+C[.'(,J;)?H%:Q%*.D3/9EE*N-6]RA[CU]>=J=:NIC68N'KG&[B*$B'`HVU MJ#'4Q*6Z'$@BZ`P1A,U@!XH!(7PG MGG/>='/\G]^*/,UD.'G/O3J>@DNF;[J:$@`X(G4'@&M+60D/MG_[]83KY3#X M_?8F/R>4Y1$;.% MJBRO1#?:NWR$``8"],5+RBP619V?/+XJ9\4'R8P-5ON.8Y`3.QKIGYM/=_&[ M$`J0PV1P(9L"D*+:D\DANJ'IQCD@K3DY!111I3&K(['9>)7PBU+7Z*,E'X,U M[YTH0M:.**R=?F-B>J2#M/&Y`E*3Y.5KGZ^/GKW[X(79*8.DZPDJA.QYRSP" M8<7B7"A>S>]AI!CL)!28MFF&L46?%A3;CXEZVS:QE44_:>Q3_QI4S4@,:KT5 M8I!/=BOT)3B%](7P(VEE-#*L9,RR-5H[`D;=,_4OPX!2$EC4P&V6GDJS3%Q9 M+6RHC/@FBB%)]UN(-UAR:X@W$&Q'3'^PYC:^'E>?'U\=FZ*R.ZS\O97`G&3Q MN;8(__#B]<')T;NWQZ^.WA<_')V\*C3&P=OGA=UY\;QX?_#AY,?BY,/!V^.# M0WNT.88=@WBMRIG8*_:__VC#;WQF5O\CUHG0@>@&;+9.8D+/EBZ24`KY;^$/ M^:>$<:C3B<5KC?H=LTHC%$>,3!=1JX16'5#DWVR<4\*7T1`%32%^K/2-EX,R M%UVY0O\ST;[5$^FDDC1;3D'!5K"B.WRAWFV)DH(0]Z1!WGD)MB5)AA:=%KNQ M(8#95/XQ)WIM)I9'ESS>LMX(G-2J^_/VY\>"F4UN!7S>%Q M!FJTIC&MG99I-H&/G$9D/+9O_6;L[+O,/8:U4<(L8_)X80R?(HHKU@Y_UKVU MXE$*#T"$K)@!2EWFC>E#AMSC#+!\YK#>U-8F`B*\SJZ]TQ(`UFMW;%B3X5P& M;DX90IC1&L#`(HJGHZW<,U6<60PW4J1M4MF2K6%U5J+%('O#L?I8E1AA6%Y! M3,"$V9D?B49(ZM0*9)-)&0MA(2:EIC+Z!&[ZI7G[>H`%E<+L$I_-+,NCW:^T M,<6T[.LI"6YZ5(.>JV#MBP2!?7 MC28II02::+6[.BR2B.$H&0.[`W59IM*XF8@9"PT<2K3J+DB'Y)O&S M[-&EZSU,L(&L\8HZ=UNCC*O]E*!]HL6"0/#V%V M)N3T'TJ*L5]`3*PWRSHCF2"+!UR[IS+R]FX:00<*1P/'2/BN8<*9QZR=Z'H^ MQ2C;)+8ZRT]+]#!($,_&IG6XH5LEI\,M<4_MTJU0+AR-+9Q8==!!,1GWU<>: MW-P,FN*?X,0]N"8P2^+]!E($OM:.HI#[)YAU;^]NO(99O8>LB#/=Q):P'$O= M_?9N3XN)CVH#%W!R,!B\J#!-L`67$J05\KB:D][7.0XI%3O4$#\=&J,L<"K/ M*(N/R^)ML+PI9*@+T$@]0KUCK+W/CGB)(-]XY?%KDS+/I[B+<)8,%NT4?PRR M6+G>[3547'70@<](ZGAM[+/)/"1 MP-%>,B73LTTO-U*'KWZ8XOU9UTO9[O M/8##>]"I]1MTR3(#PJ,E8))0!3>YED`BJG/O=!Y/6[9@+9OGQM5"8AZ70@V7209PX#0?'=(-U;?6B00PQ[Q MYI2U81N7+J.BM-ZM%G<-D7C+TK8(1%O/.<D/,.0W'J"63/NRX`S6]B2IH'ZB;BK;TO?R$&NVT<- M_.P[^,J@*!@(%'[H0K/I_(#3(!YM^.R`%AA97`F4Q(L.8W(!-X&LZ06M,T,WBG%H&!(4[^-J[ MIK$FA%L2I0"=W831HV=:5T:^BA!X2QO(]D;D6K:OG5S/."HX/?OMUY=KOL1S M8*>>V^^]P3JA17#[\@>6V+[V8C+4#.W+KZ4BB(XA']JW&$54WK[<]^B&V28X)S5Y<*3[VBFSX\H*\6E4< M7T/T9.V.)I9)I0)F3'+ZT+JJM%?.0AN+?%;QXT2Z>I]G;V,9+:8V^@SMP>)^V&G-^@=KU_]/3DU`I9YZ M[U$7=&_J+!3-]"=40LUP#M50'L&/8'+/UV0?`8LU@8`8_[?C0FVYN`[.B,L; M(>=Y%&D#]\D]&^$K">6IIQ;GL8Y_+O>)3,DRD$1%!=02&R7IT?NP$7&0]FIK M1=KZV[P232_''4N4;+YEF3BBWE'-EA,._R#6<3!9C,'0(WSJP.].@[J+9"88 MMI<^!6(23"'MU/);%I%95_E7+JS-7M9[WBQ-G`.WGN(.?*<>%$C,;SJZ!HM\ M_[K#-=,*?+C'38ZWND=]:2&$M8"S,RW0W@C##C\? M8)62.?)6`Z89-WO.HH_+7^@:Y4Z!IJ\_SQ//,VTB$"GOGY*'X$D!$VR&SE-0 M2=D($U'S$KX\49^L5+0DM/@P#X?9;CP[[XLAV6DG")FP>;A1V&"EN'.RFJU# MOZ@U;"%X:;W.B@J_%;GQ.(%L=4A*=D(PZ;0QL[53"VK&W=O9>2K2]O$M0*OG M&F?JM$&+0CNE$!=PC))EE_WCJ_6Z\_R,Y0WG'O,50;N!'9NS:@/:DIC#OS/; M<.]OBM!$<=:$;#A_*E94@%K;]"*M1J\=KKL8-J*5!\K!K/IX7?M@*)L7//@' MB@]G/^'Q<-CT!A!H>[S5##;>M"DH!?YJ130\\I3[)MI6B,6$DN2V)LQVTVJQ M`:<`$RHM<6"@&PUE!!-.&]\6PI,>LJ#1_]^'!3>8BJ>K)&N::WRM[61:W@H-YB4#'.QDGUF69?R2)^GWRV!]`>@FFH,DL$&343 MXG\Z#X<""@F?(.1<$XM$UH4NOT90S^[RC;`]V#CJAJT9G[`A=DXWM?B"H6@JS5?X@ M/W<=55J1NVF8)&0;7?N@4(3M+5)V."6")4LNM69S@RLU:/."$JVCUC`*:[`A MME770D/MRZ[,_A+A:^GD@]ABXB`VP?I#3/DZ3__WIYCE:)D8&(9K?3>NB[3A]E39+9_L'I-?:PFE"#2$QC#*:1O]7H,V*O, M!Z-TB!M#^8V_*HQ;A))@'2!D0^<&^K09)Z2[8%MMW^Q+4+^H"*N>"H2<<3+" M@R]QW!C>-`&4RHC4*.5<_?QTYM#D,1.#UP!9V@>!Y6`MU_0GL9`^@*6*&!48 M*2>OMLAN-GA\64T5K12`F+[M&XT\]2` MHS/Y:NBOFXH!EU'6G!%!JM$72F_M2HMG8MFI1<'E/V$$&=N8B!A"HW.8LX(& M^!C?:J:M](D=\U5BK$!H9*F/9$RGK('>R_,+YMI$>&024-:1?V@DQ>)W]XU! M6I`@_?__'A+"2`/J'3AJWSRUUWI*1A=&AU4B&+QWMK_9^:K8L'SQSO:3QU\] M2$BE^H[/'`2I"W;R$RY>TFRSHF^0@G"1"CY$#;4^YVKC*$&()W0+2HZ05>H94K=2L'[HT\6UK.@V M/[,<^G.*U.UTI$QMDCX(6%X2>1C-UR5%P"X[.4&EC?>S],.=P:(&8W"2E7V[ M.&EP%:(N?"L\!A)T%B(7#/593IA>#!0K.JH@;"8=!H#U*4M$D3KU,@5+L M?9#._*_5)A`..R?@I*.^7P!#F%Z'W^TUZ]#GC($F,#92A'!!9"^NSX"^AB%2 MA7H=3@5]3LANZW!FQ*@_.U]BOV4#SE6;Z[LW8:NTFMV,,*`<7YWU=-TM/U#$ ME9A1%,/5K@$Z_JTJC3,2#'605@B8"7(KE>*@J2F(W1"3$O$T7@8GMBN?/9PV M8'U\[AI_6+T_,CEDF#6).-UCQ:]&*CPY"%ZX=QT'>..R;$_-C MGG>5?_14)-MF*9$>9MM"NKG5U30/2P/`5E+;`O_DZE(>^I4_N1H`J5VQ<9J) MY@P&1GMUO2-F=^VI':;H6*_L^HCM_X2TWCWP*+4%E,-%8>Q.;\"'>AK:`9)I M,60[RY@Y(#NI7H-KT2H=%-CC*!H%7NH)C% M_A-J.X_'';,CH)ZSB-Z8"#@(D=T=;D/& MK>RO#KOC$]B,_^$PDIV*;E,H,F++PWO4KX><0HAKYE^60QC`B7Y\`85FR#;' M6)>[JU%].E5+K)>SNGM>Q\2^;P'5D'O4+67D2YEAMRDSIH@K6J3/5*G^N%4H M*!!P9!PQOTFT*@+M)#`'M.@HW"G35&*V3'NQ;`T%$EDJVC39%5W@I$"K[.8' M5]?IM.K0HH@'K465`V8SPZ=C"8-%CL/%BR,&L;HP^CB]\SQ*LHWO9!`8B(+W M1U^[NJ-HZ!03OU!^<'NHIZZ.2_T0TD_I=IXP,3I,#H2Q?&VF]@0,,EOXPX2J M"OB=8G$?/BS2!W.1+$;3O]#AY5%)[7KYNC7XE<##)7Y^XB.8G&SLG&(V^`BD M4TPQ2^0?-W^RM:]7*(^R'[5JZR'.VS_=6S;5.R MU_P+5)4K#HO_F*0';K1*VTY^?S:5%UT8;5__J-9!-X9Z?ZQAH9V]AOMYUDXW M0\FV=\?DBM$.B3`_AOTM;RQLUAND#//V_!'[>X8V.[W\B8Q?DC+C!BMER7/= M<@>K>`=HOW(Z";M!7)#2>F'*C.^R@[G-/.G2[0=I_+CZWY[+D63L,L_Q#2HU M+I;KB49Q6&LVLSVE&"E>'USQ(A:ON:@VE+,)9!6!Z$%)U`M]41LPJ^#QW6A& MG<9A7V_@4_:MP,++T>&'XZD<<'CX@14XF,)S?GT6@Z[%\),87P710N!*(>Q? M41\1DR!ZPF]V3\--72TR4S;$=)3H.5Z\+>@`@E:/2MF\L2*A$`M@E$6/A2## MX5)_0>3?D368'5@N#Q:!!(B/)6?T&(%\<6M5"*Y[?\"G!>G6.IT\I;:`=>=MBTI?8$ M^@4-(N8$YW]'LV(X=@KB>_P;_Y1IVEV6BVA8130@Y#P2%8789'+;,"_.K+R8 MP1.O+RVMC?:GFB!P,,5^M.T6AZU#Z$&WS"E3O4%KA*!"1!2CA.8;C0H60-45 MN8^!U<;*N@CH/CBM+:P-@,G%4H[ATTCH6,X<(:,4P^I0^Y98P.X:\!XA=3() MQ,L-LA/FT+TX+K@[P-PIC84#CW`1Z-JG*':H@8:H)G7$YX4'XJ>='?A^+V2[YC]*ATV@@I5U+5QOW+;*2>>74`3VFR1 M+X]1@L[-I[HS[_54LP.IK5Z,Q*_>9LZY*C\\Z8Q@9P_#!,J/M@G*\02+8K-1 M>JKPZ028^A1X]JTR?WLI1P'>!YNMR(AL;G&+@>YFTS38\!(@2SN7%35O(87. M37C.)Y?5Y/;.+R_7&F-/#O7KZ$J5SZ]^_@CHW0.=K(N;-#(X4S%WRW9_$?KX MU6#S*1WR2M/=VV9E^D0,@@"^+&4H_'C$0GB".H7+^K0+=$!=?3Q@@E3*+-ZP M_&18HP"8O"*@:(:=UHGP%H+2@5$G@T8@D#LVK"A_;+0`H>OYE.^MW\+'#'5$ M77$Q,R7R,MF;3:;TQ4=I(N8+-9=3B$<;480=1_!F>,4OQ0\H=P8+#5TPK8U= M&>N88PVFVR7HWQ@LQ344+EC'6BX11[)WI3%&%R/.4JV5XAC]5MD:>TU(=2?F M6_%8(SIU]=1G8`"+Y82TK-$+\FBI,8CFC+/)\;@C+.V1D(%EJ">_0I.T"@O9 MQN`@$"^W=)\<'3#'$O\7E+E`!F`A%7IEH^&=9UX!:1+%PH!+0L"W>=9>Y!;R MGUC!TFS#^4Q#_A6Y2VP.`Y[+]=0$D1'[M9'(^UF=]L=!^= M?Q+<*!&S@AT_+P6*VS(&KZ@YFOD9]_CCY,F/2JU/N8F%[MJ!86C6SK`7JD8B M%8Y5)E2W:?\ZN@FV#)^BBE7X"4*^]BQ^@F=>%/3NF/*<'PBA@:MHCZ)Z%$>W M#J)$AQ!*O\B*H<''B2KN./W]LLLELXC>8%9)@:YV`G]QN=;O MPLCN"[0C+F*_S+()VO(1^237`7*;*RWD.IKQ`$67W&.;ND;$-L.O[)M#$.OB MF(-L*_>S>PS$@AHQ!+%U-/1^V2\.>9\F.+>V5`33^MPJOZ7R!Z(TBE?,)_D[ M4?TDKBV(`Y=OM3L)Q1-\G+C;6_V.5W$AA/BD#U?0D_9M;NNKYI?7FI*YYX1&\`=['QE8@$*<-2>>7U_M>8^8=S'< MLU`QBA;;[')N(I5S8!F@#T?0,"&B?21$01AI13W8^>M%K&0)3#DD$*0TCM- MJW'PH__?XMHE5RBT6)8>8_9!*-1&^7=]2V?.J%_8`++H<$Y/WN+._<68:>H( M#77IM8QQH]1/O-%MMBW+:OYDL:'%%ZEK/>&`FB([;,6*D5?J1[Z'9MQY?C0Y M?7=Y_K_;]O??M8W(ZU4.<`XT=='#9$=OH\6OYT_;TQ#TPI+\_&FG8TI^_K1] M!49!YO5WZ^<.`'7]S%=ML?5S$H"LPW3?\S/K*_6'NINQ]H7U(_'#GS_U?5E0 MJ=\P]$UNV:AZ&G>3=S@;MX4Y)[0:Y)2-\Z$/JYYE/G95!ERX!II'8+"VJ_3< MYG-E5F&;D$[A(1?XL;+E8V%IWGQ!!,4Y2MI,3(O>$@J_!]20D3^'RN9555X3G/574 M!%ON8F@^#&:I&,N=VWAJYBLE$:GOTTIS1869US`8C*\7DY-K@IHD:8J3J>#U M\B,2MN@4@.8>\MH00\D,CFESWOQ4:>FJ/")&8S4:*"4I".4V=*K]DF32VFCLOK:G:U;#YEF%YJ=^#J@AY[B?'N^H9(3(8Q^HT.X\$'S@MRZ%H125,TG\=[@?O+, MU`@O-FBCJ(*;I-PAEK^WTN.^CD<6DN$[U0XWLS$9+I53!R^L[(0V/S7EZFH+ M`=,C^.]+Q&B1%P3=(]G_1'U_'#_7-]='WQ)W^4@M@9P2U,0++:T$K`_IEKXB M5G7YY-=CG=SBEX2QDO_JV1VI`[J/'1=[DT\+4*^8I.WJ6]S431BVOY!"[H8VR<",2*&1Q+TK]YNBTG!$^ M&NC_./&^ MX%/R\^F:20PA^6OB!&&2CQ1"XGYDS%#L*F+O)$=IJ_=1S7+H'F'-,ZQ*IB+@ M];6,7^:LZ?GB(ZCTP>]UXI*(T+FEQ=45#0(!,!V]!(W"AP MN4+^.>]+`C<+ON7%T1YPM`ORM#C`/2]QFT#[=2EY$P.SULC4(,K=+2:%()!\ MQM8\9QHM03[H=FX]\T`+;G.DM=XC=6X_Y%$QC.E16.==K?K1!0E]#[I4VL5, M//=!["G.;@0RM[RWG\ MXX3PN_:9Q-"VBD^C+/KW?_VWX]'ZTL+6YEHW6:UTI2[,XH0^F'X@[$+NP[VN MU)0L`'R%;:KQ3I,&OZ`C=6-QW=UF3:K7ADTZ MXS6[!L%F:K?Y58S/RH\:GM2_2^(,I6"7;[\@2-?H5F%N6Q.+#6[MXALF](>C M]N[RPW2*SMF%ZM+"ZEJ'SAZ?$[I]BU%_>[PP^F8RO7ZK+D/]49Y>P"J\$*#U M!8%"0#406V-+'NG&DHW;YJ_,K6V2[1`O4)>/\A+-9TMK&XI:Q("6V6SWI*C, M*S"22GZ^-H&D";1*68&;-U&+T?S<1O'\;Q7$&->),M%`$@`>3%/1,SVQBA;\ M4Q(M4DX8B@TIM[7G:'YY865EJ_ZK?#+UW^8W%K:VFB=A>>6E]?@\8',(JJ2" M97PH?1[+!1X42IK=5W[C7D_(VN::<:T'/"%MR`2C,;:D03TI*]KSQ':!W.J! M$CBE"A36=.N:N"$OGA"_VV#9+Y!3<'^#+N7FSWAL)FT^F]0@J8LIGTZ.Z8>S M;-V5D:_)G!)6"D]5+ND"94XL]G^M)NG[B3<8%QI8$W(&_;1LGS,5G`C)?K#!&$/0)$=EQV<_E!8J)B;ZSX76@UJ M$'1@F)A)ZG1LI1BQVX:@5*^FOW52//`>75]_U)E28IQE1.=2U/IFRR7333V< M8#@[MUY>7`AE9,:`4<=XD48SB56(V++3`WNPQV)GZ*=Z;9TVZ@:(`.X)M>;*SG$ M(G%5^B@_F:'I)BSE7<3+-4$;V]S*,(2#%:62@RQXTK?!-YA1SV0)4[NMF,-WH/=31ENY]^2>2C#S-P_+& M;RZ5N01?AG&?T!+,9)%51D2W@'L7Y?($I:*?'8/O^*]#E26&[<*8YIU(5'VB M,)^"/=#%IE8NU%Q:(`"#&RMV/[#0?(B^IW;H:E2O>DA@MM%XC$>+'==/7P5? M:_WW=)[ZAZ_J/[P*(*C_GDY?_["QOCHBJ^ERM`.Y0OGNH[9"_?K10Z+1DVLJ MSD:Q3YNRZ4?C^>4F&OCR^.;SI^_I/-0<\?7W];+U#O;IG3,9C>`4+,=C<6J,)FU:<:.AAQN\WOZ7^M%GQY<``3LQ+3BXA4&8 M]QW\V<&S/^PF@W.T=]D@/D^DCU;`K#?YOV"HLF#KOQ_]<_T70]Q+^MWF1N3# M,"T>MMJ69CL79V\9;]AWO.>3&P!6?YV_HER%2LDJMM=#&-\HYY;R^3,*QX9W MJ<+(\-#+8]IY_YXFYW\5JE8L_:'E^$[JPS>H&WPQ_R5T;^1@.+$"ZJ MCSSPG>(\HHS^MQ[X5-^+1Z&OHXDG`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`'J$?OK''I"0E&3";HO&;5H^.@I;17^0WM M^]28HO[X#U0^$+#+^2D9-WO&F^R>?3"7UZL@_GLQ<^`N%R2\8Z#"Q;9(MEO! M*`8E@C8D>&O7FDHU+M6,I;S^N(M*B\6,2&!P[]_ZTE?9:HQF=MIF!KC'?VL2 MXAX:W>6(G?>X)EVPPC5A86JO*T85W;_'F-,VX@$PR/O@'%8@<'>A/4>^&WOM MJC&V]6Z^6[.?,E<`X>&:U+T))P\GE]@B"`MCDU6&B4\>&+&L2/?(RL/86WT=FF)"!H62&D-"CE[O;A[F$#3&JW65":@57MH'[0@@UI_+J^(@-)Z('E^6.*A&$SHZY[YWJX*-3 MU"=:?^C.FPZ3JA@(2(X&+[EN#.7!$L;LL+_A6&L! MCVQU5-8KC:#DHD.3-?%W_6A[4ZI`P[#Q$6K,'=,P+#16W)`YL)$`3TC.."5S M5`V.'!VM\RM=#/0AV">24RG=E>O[U`9GI!B90@2,2E6JH#HMJ8/YSX2SIY=W M>C-BA/:JW#5U=']#:(O$?0H_R=K&[Z&G'*Z@OROL-!X(`/>#3AD">GEV\W6C M'1\IE\TF>M:T=F1,"#O)H)"/7S]W&/+=M<-`E')1RTBF=S88X"1G=4,%<<8. MW(8/P2EA6JCQ\0RI7+Z]U,_YU/**3'_](.CO1=4LTP MX9_P!V0$&.HYEX$_(?N#@U68&W`X_/$C?[JA(9[UT>-LIA$2YP6*ZI@OCT;' M_23-J[=KVLVHZ%KL`@H']EEU"4VF2W-9SEA*<;'JAS*@19$QX''<%;=DL<50%$?1HTQ_3 M<`NKCD@F>7=VFDW]4GA,GZ=NBUYD:&[KCFCU0@'ZND#24_-^X,Q>HV'19%D$ M5%B(%\3M<2^\L3+TQLT'SB)V\0?Z3U_?TCXNC'`)"-_LPSP:7(5RV2650!SS MR2`B(VLS#NK*2I0$D,7UM;?KHX<'R0&$B$,\(S[VA\:_OW?ZH5$I.KY)/@5M'%R*4X M_]G%\>CE^-G>`8XT&+#V?75%ST=C\MBA*`O=(>?+BYOK7TEO6%DT(X;MPY/8 MVC.)]`.1R(PKT0K?5UK62@/8$5MP@X+I`^">8L_Z*#C*%V\D))CWK,FD^FLU M_`!+_/+6\AP0.83SQ`T9O:P1HWKZS81+0/_4&"CLI-3H3H_Y69:T00!Y><9K M&O.I89JFRI2P6^8,V]:7'2S%*E@R,-F[L=6;!@Q?J\UFB!W?(?3X5^'^TX;0 M%L*L/0>*7P/(K\8]=ED+!;3%?+MOV1XJ]44(P8'.:?3TAA9&N&L5@S>1!]ZJ M\0V;[ZOD=C=6BQ2IBY!CCP%+QB6]LP4K[2B@3WHR7:!9HI5LF7!HRV3*5\^ED=3F"9(#C)+ZRMG M&R&%,/?X9O7CGV(/_K0-','.,I+S5F`K/YH>]1T_L$/CCZWI95B$]!%*D.XA M9=2[3,/LX[R(LC>Q8UUL'!#UJG);4`JH>#\D,)SXWMS3C2(Y!6:")%BE`?IF MF8WO?U[Q2]DH4R_]%RHU-'"UJ]AF0HV`-]6YB(6N=:;C+$INP MSP]]PLP+528J4196S25J\(0;7>I7Q**6XI=)39EH5#&E<1=43US:\(5RK\7O MD!E(6ZJ1HA949T-`.TD6C[0OCE$;_3*6=E4WU-&>EK>>;MC!HO/A>O(V3%1! M011[M(;9I9:9,]T(N]R186A\17OCT+:E<[M-VY9ZZ_,9[>$T848_)HU^X"X4 MNCFA#RU#%GB)!^&=[O7R)B'5-VA@KZ7?W/&9?'LB_H*\Q*^=#!C<4./KD5Y/ M;8W=U'`B-;4/@7YXS8UUMAE0\=+!=3<6W3C;XT?\8^T)8B5P.< MFA8R8"U&0JL/U*'1^L>CV&HP$57]A+*8&_E;/_3[B]L_TA>\_K.]2YQ`(]#L MNGV0CT1[_>COW][^\?,GBN:6FH#)\M;B'70R=J5H"W MMLN"$A#7S0B73NT(Q8`HIC,YTL440ZXYBJ^;=W0!E5(( M'70N)[!YIQ,A[`DF`6L5G?WC&KPZM[Q4U'B,BHQMW:68&L;:Y/WY'1VM*B]' M(1&4'1O3`(TN<_6U+:$//5WUI/!>,F527!_).)U8WP\!HCQ#`=1<;]_NN?=K ML[I.7F#=T.7QXT@Y<352[&6`UC\]8S`'DJ?^,_U[I']'VNL)K!E#1;FOWSQ` M,:__]NH8/T5/IMWSGF?[TI>"_5X%;HC;N-_2U-L(9.(_V$D]P:B9\F8&5ZR/ M])AMTGV004/NYFCW6J]LK4UBS_ZA`]8O/6H[,Q^RRKQ[W#EBN,W2MS3I!?&F M@!9IBZ'B\?3N=N:M/)@$%NOD'P'I[\]/KH]S')<=[C"K`$-[YQT=H&[/9][< M/3ER,Z]1YX_)!NIDC\V\TGV%>C,OLBUZLK9"F.67I^=7:)FATX"K8>8!P5)& M7\4C^0XM#+_E>9NC.W;7-NH,#E1T&4F2NTOS8*`6D\ULP]>DZQ``\BF^+'IZ M.KER502,(49BDQ;5WR4[LTB,-Z9B40SSM.!BO9BRO.?#IU(^))GI?K?J+XGZ ME/R)!""(NR+GXLA.Z>KN:(C:4A@AVVM,)2^3G2-Y-%%?:I^!CM6K=T6FY2!% M9;V3!Q`7E70Z4SF3T]-D%2&"@.>\D=N7I8>"RUNX8]YZ%U7Y*R%JEB1M(1=9 MO\KU65[:R'4O@^)[$6I1AR;3^-$4?T06B\DA[;U2H6!A)F`]<.`>HN[W]3/! M!K@"SDQ-X\0>CF$&34'F%N5-X@9#GX,P^4A3W!KP;@^J&[K,;/*@E8:B"""? ML)/`25P3;&.?CPQSR-_:(U%?`K4F-6ALZ`HTTU[$2;MV*7\H MU8W"X'57@)#)R5`%UX<=*ZN9G7ZA^?C[\?/]]]_?S0)K?L_OF[\=%?1N/#P^^V7^_LCO8/]KXY MV'[5O)2V(5#@)-A:MQB_>^C-LW$V(0XK6M)&U9I:9I-[-WC'==JYY<6MC?)% M;I)>4C[_@^M6*$FOSRVNKW8^P',JK8']6!5-<-%U3-G%4895V&3G4_*^#.U1 MW1>*/:YLK;'0^P2X[+D3OO#/?\[=@-XH2$'M&-]]=HBWU!!@J`GM M`&9U5L!LE?N4,=P#A"\)F,WE\B8&`+-&CR&"7!Y7:NM+GR/OEL8[9]/KD\)2;R8T*0"MLD='^+^?H<_!8, M=YS8V*MR`J;:E"VC=$SS5$%G:!`.!L.]DW:$&VM=R297!"15ABLU69VQ9&L+ M'S-/"Z[!SL(A%N,[8,^U_^]@\E:N)IGJ#%%2--'":YJCIF$P'%E7`2E(Z5!Z MLV"Q^S,Q`X2?$A#?G]MX[YBA<`+]P$!*1VC*7S=>")E7`%)[!0>0G[8XD0XH MN64J@G^_/,#-'8XOV[#4-`+=FIE"]`(5P=LY._1UF!!G5JA%;DG^LQ&=^YV$ M#]0R857@[J9M<5+UKE]>7UO87%Z-5X?]JOO!8Z8.9OE>UHA*E01XEC';`EY/ M/%CCF2)@M+I5];H)["B#&=T;W:X.LJ\[?QE,[);]9\#:$4G;764()_J5QBM`KG#"PCH`/B MQY\%UJB;;`+Y6#;Y7G,:&EH=I"CJBS5@&H>1B-'2L5D4H(E>,/6R=I6HRLA\ M1QW#7J"ZL51VK*>]-E@)QY&ZCI.*--++)D]KC,+P^FC\/5K#R^W73;+6#Y`B MDQGH:FC[>DO^P.V3,ZB\*'C6-=NLT1"==1J7S@F/$9_S'\-LSJQ;Q028)Y8` MXXWP\R`/RTR@YH1EA%H!S?F4X&-KF?L8:K6_/+LX/OWQR>$IG?ZY]Q#F%C'I MY??3LPFQ4/G-PSAF_54+#1[(N,;M]/3'>"A"B>Z2UB^EWM@]>D[6E&^9;"Z' M'AJ5W5Y#H,O-A04)MK*TM"G^'3""=R35G4$5<'4&'+E%&I.G&W'# M:*:9T>:8`T7$6B<_HZ^:S$S(#=8A^;LA$.6YH:CB\7.1!P:EH*QI!ORATZ,N M:BYED\H%!7]!2Y_U8KP-UG2JRG`CTK(\+A6\1:>.?R64,\8^`F6C!;B4-#)R M+,2R;I/N)`6VA)3/@1==]0W>;#OZ)2&EQFH%UF\NK.)5*"[G[P/IT;6WEK)9 M"=(SNW[A*:;1([A-$`Q!3Y?BV##I<6]#'GB7,1?$U`=3,+TU=T>5CEH8C*A2 M:N$RTL/)/UE=\0DWDH]S*Q3U2CTOMN/VDZ$8N^/BN"=9/.#?Q4=77+,T"A\$ MLV]NI@P&%P)%>RYMV,8<=77L5:P;?5>;B,:C*,<&O*:TJ?R=IA3!B"%K?)** MI;HU*VZUQH<2W*Q7:Z$WYUJ.YJ[VL3*H`<"7"GD7ZA<8(6'FZ6`SZ4D]FEI2 MD.RWJ"#)(O&VPSJUJ-'P(IA67453\(5S6-J(=1JB(A%5$(5"2>5X7M&^GN\> MT'+Z_WZM4TS@`M./$MJ@D)8V(5XF%B5>IZ4M0X.G46>\&,UV`@[4>E,Z@(1W M!IC4*5R"YA8P">HW+M9Z?4J_>O+M]6V%+$"-G/>AG16J&%(Z!V&1^2%]5]M" M&^]"Q-2=N$T/CBN9QKX7#6MZ]6#J`PY]Q]SHP?<.].[XF.L64>2G&W#B".4A M?BF`(A`\:CG'(3_V=K2RSF@#>:<,ST[PC:!/@,L9]=YP./MX_(9M&,4=F!N2 M638,$1;O?8CCCSO4OCIP\"N1>J-J$;8B2+[7_`10M3RBF?+./!D5TL&1_!0=(>!+Y/>,A6/B ML)AI+K<8S5XATZ4,K6EX%#*CP)M()^!&LFK`5-B]86CP:81&V$2TABZ`+1`) MC#REA/C`%@PV;AL'^M'NNL9R(+>"\KN+V8X52XBF4R-$Z"W@"GXL6RN=)?

?9R?8&3;!V'R\]=;;?FM,E4W4)+5,:5^;EF748BCQG"$(%;^O/DD]H:L!! M`F,IPU[@9IDKMO*#5',\T^PDMKMGGSW$:APF&$W*/"O"J8&84$WDS(W+X,HU MG!,!&?EA1JO!<3->%7J$@""L83\X6XN'-SZ/M6+B31>.>AXX.T]'C MUFM6C-1M_0@E/@"Y)'XI9+7`V/0:^45^-=3'?Z,RRE>)Z9`1%B>H/OB,'=5S M&*>'41I\@T8F^`1F%F[%8%HB3[\2D^)$LWP@-!YV?\!,'UAYU`G6W=?[F!/` MZ<&1R.;%5J1'-XIKO)R^4V97;<%?4#.NY7MWKXW)F*S\&@9+]^:B[6[%3*-7 M0Q>>_!U=*C>!:Y[$J;+L3-]\.FK?>G%O>-,E6Z=IU:/:P]#3J\J,)&+U$ M?+@GOE-XM2(_YUVR8-^>JYZ1,D0IB&@\-QT]#PNW<[RLZXTO43S)$%$PI\9' M:$1G=S*^I,',Z>D#9XBBHW'9'>&N,Y\9'AZV.?)*O$ M66!V7R%+H*EZW"O$PY[OJ@;KZSOY\>N_3M]\_G1H2%__LAN4Q?KO/X1RZ2?U M#]L>M?G\:5^GK7_]1M[R\)O&2_4,Y)K_%FW]R@$S@C@@K` M>F,5@7UV2#=+/5_ MX$IQ5_=YW!>6UYXN;'$JY=[&55%,AY8L5,L'5-L[&_`#1XT7,`3IOG6:Q/E@ M]\J=E1D0A;OD-,7U.[(/SEK>XQ3'N*\*QA#@ZWW^N^3X@&][P#8:?U!FJAUOWBX1X._5G`N>O_VPKP_);J6/+UX\?1`NF_F%' MKF2_^?JGER#"YT\DUM4__`5?P$TC1S1P>FGC\Z._U:._%**2X;;]X,7XYWC[JZ2HR MZ!_`I6KVHC5[$%@IEI'2)KN"B&:N2F*%LOS'?.OROM].T.UI)Q2S0M1"=J@V M?M!.7C7?KKQ=.&E@F\'!AT9E*Z-O$=BD_6D9^+?,X,;A%O8=XN4,G9.:]0ZY M(COE$5HS6;JMZY=$ M`HD_7WP,,8O4NL0*IVA<@ODG"\MLS?OV[@8F4B%5.KL\\FI]G!22WN)_9C*: M&@\7DN5J]X*G#O"'VQ%RZ'KN^UX,2:/9.AKY=33";ON,#@-HT_A(:)X747&9 M?E.&<>6@`C]#J[T`3'9O2D@7HP:VQ?-^6WDIN?^!"7&?_@N+7H9R._;! M[##D?BMT0=O7-6-9T3[="#+T>`"KBZLI=H&^HUTT<#MBF5Q=AWJ`5(%8/;>] MZ%^HS_71Z"-@,P3D1F\HVF;_X>5^S<4"(7T&]AU_0&/-2H&Q(61X>G MT]O;&S&)9JWX")][0XFJX;6R$=H>S<^N[R[I5D'Z##W3/'QTTW?:5Z08[TSI MV);K26BT77]X?^?;'H;5M]X!S.82F^\MZ?5,@"2;WWHD=`Y?K[ZM1M]O;V'! MZ;'$%#6)M^\[A\<.R0VE?J;]UL"#7,QH^Y+M MT><@O=0'LG7?81F2-F5VX[VP6WT**WRFW-KT6#I7_76;1AT!E1[ONY$71_]L?>/W0Y_W M^;-^Z+SHF9/6TY#2LNKYE*''W=*/E!FSM[(@SYJ)8>@Y-1YM>_HFD1]`O" MV5G-]BAG]\AVB6O'`.4]*T;+H-ZC:>V:9>!:NR=/@(2D/);SLD2$<2N&GR'Y M1I>49H]+9&2`+7L:&4$4.U@_OV>`3-[.82CZB?7\=T$M%!*NA:_\GLN M)3?V+7<7>@(;W[M0B:P;T4`ZT+O2/=(L;VOY6S7[C;ER?598@TB@)4?MV67$ MKIOR;,:;0+UDRZKJY;_U7+<"_2U!H6>>VX>8]^;Y'U?!X/M['>0V]F!PRE%V M_(CH$IB1<,H'%)9\1!GAG0D$*T^+GEM>((ABPP#L$$@0+<;.'/ZJ.3"NI^^- MGU8?S6@'\09CQJ.+:TIG$M2W?R>+P*7B;@BV: M_MW/$+AU%U_Y0]J[%LQ.)YPTQQEBI3\">F]VF=_+^S5?QJSN!&ZE_(85,A0! MR;R^[2N.-)M9!CW>_*'(XS^8W:5K.%#Z26\ON!X]9_KX=>%6W\9;75C\NE M7(_>&FID4K];?RK97;_R.^/Z0U6'CVR%8;7U':IZOO(0])AZSX8'5_6M_QB@ MM5,+S,X?&BO5][GBA?[14K&K2`,XO%M8S'UK!K^7MYLIW`M]9FK_:*F^5>OV M(/5XJ7[,:D,4&`DPIN`<23;_H(N@OVE.!TUJE*I'3<7!RS+FF$U^5G<:DR^Y>57L2N&>A2+:(+XKXKRB_0W'F9D_A`*M'.,=5GZL MD;TI%E'W$?THOB:T*0'X]ZW__#`\R*=FZ.WDFSX!U3XUH$+HP5H`M7I$C\`- M@W;"M)\=W&`V\JG5O-C>X!FZ;R_(WHXN`;E"W(YO.B_!%<*+?_N0H;$Y4\;C M,=_#34'3:K/9+<(6:P5Z@"A%N.?/`T.&9J4WVHV[J\'\OC-1VXO)R?4=<2+, M(?.#K-AY]DYO&2S&1$;*1.5[7)F=UHH]>%#W_T]*VP%+85;?3J@[?T>[8F7M M6!08:5RC:7AV)MUQG:+<;_%`J)9=;'UZW2ZG?(E+$@]2L"1J7&I8@A?YEWH# M79Z=V60PYU+`NDQMS4^526^5!A)8JD7[HQL1:I,I-Q3KSSE\()Q;FJU177X2 M!FTH9%*.Q6LVCJ>A9.!BZFY16_Z`A^2#18N1F=*`?N4GS'%)=]4+16^T/]M6 MZ>(SOUYRY%4.OM9!JU6&LB`:QO=,!KC9ZOITLJA[;>['V]4./B\X&'":.)LP M"`?8&A!0![QW4*SVZGP\IX4DUA3/S#%Z[O&&<(JF+!1^TU![_+!GE@%*P:%` M;H:F1*5E^!;-I95O.I.7H4FT>!'654+;:+=M;%-3GV(W"M3W_'VE3^8*JGU_ M[Q^W4Z]Z((?S7OCR2: MCO[9\*H]>9J5S"X]2VUG9EAC_K2%56>=F;Y,K$&I8"2!P#,L&&31G-YX5'_T M^RG$F881+2'IRUVOF2T5R4D6_]`1"#7UH"N0[XO1J$(E-"(` MX\4>A'^I_)+6G!?45`,3WM>OSB`-0(FAM-L1+0U`*9(9PTVZ/9^X\4Z`KH?! MQ6#/K`SN/I=AYBXSD?5@U-T4(&"VTA"^$7*/KTZT$0VA4J;MC)LTK"/+M]>@ MJ-N&5EZ>>WO_'@WB5>S;?TEW4S+BCC\J@Q)";8)=-=UNGS&;E(;]\1TAX%WS MZ5T+S]?O^F;)BCU1$VK%B:2V>K9!_6R'0(N,B./X?;XK$5F_]U^)3"W&_A]% MICV`@&#ZXJ#9JR$WGS?MC?+US*O"DYOHLL0/ZP'6S=G5%43+2%QY1E+AVO5T MBVX>,$`%"FGQLS8VCPA=0R$4Y_2)R]AN_/.GYZAX]8O].5?U4RHJ*O\'BFZ: ME_;E!LZPSGK]S'UY>_6S5>)E_7/+>0=MC2:GJT>8EA#0?P<*3>+]0+9>O3// MB4N&R+`-U//-I_5B_7F4]5.65!(G:2"_K).T&0FXO2PQ0*BJ^B;D7RRR#6T4 MS"CYH%:/Z$&G_">JX3$!=9R`2M-0VQG3$J0BG9IGL*^5=39AUH*22=\',=;8 M%R%L"K/().P[,@"JC<3HIC=5MJI2/4JVNGT9\>RMM8-0,^I[L+\V#@[2#BVW MWJ!B1[$\#U9]L(=V(;F@:FK!Z`O!GA24`UIPC:NBLS9\2%\3&!7C3!EH,EFM MVC+H'E$LCNA7=''^BYY_?"ON1CM00!S?VRM:+G5KTE@/;TP/F;[ZVQU^C MB_2]DNPN\HHF4"6KV[$`^)0!D25G76*TK;5>V0IN^9`0^&54?,*+CO9YO MYR/HH4,L=3N`H*`KQ.N,U(K]%J&WT)Z]_H#ZU!Q1*'LCJ.SK/2TCNY2Y=.?: M?,I@F.D`#^X49"#A\\8^HSNS55'/*,X#.J9GJH<_=([SNKLSM]O[OJ`,J@V: M+9&7+&CX-03@/V[_-7S"#KL;*<%C=VL]B@;O5IR32QQ86KQEYL.KG,>8DCN- M*%+SFWM_1_*X33N/DB&"(R`6BI!F$ZA:*6!"#QP;RCUBVZWCAP8MV+EBA>"5 M>H!8#XG$"O.@4YEPL++PB\7QMG$G6N62)9]$,0>4\U13,=S\BHF&XS.@!$)0 M\V*K6T43SN!PN&:+$%CJM7:I*<-]A6=*?*5Q.)?)T\4'(>@=A&X"B_8'\3G@10)*'D12RU.0;B2/8M(8:I&:P&M$[0 M517*'&1NN`EG`Q%RCXO$!G1DV0AU"V$B#.8>[W[S:?7TT.MC=WSLX M&K_^IE9S9%#!IU!P)-,[;B9O)?XM59GZ4&O=!@ETX2T/8BKX3,Q9=ZSCJ,VXSU)&?AF( M]9\FM,XF=.P"\,;:C-W@'.7ND*+@*'F1M.=-^C)W>XMC:&(:H':DB_9)M0Y9 MTUZF)W\%-O(X.T_E?6_%#!YZ@W+=?S'B?9+HG5NYG'R(J>%:#=D-(IW"QFZL MV"[!LR!QT]*LY8Q!B0ZJ-'"5@++5#)B=H:B<^M^`?@[P9X)VK1>US[2QLQQ>IW0FN2(+'Q[C*'!@)D4E(J:N0!< MX]83Q;?S1YT8&X1>)GY`3=9Q/2TIB8'FS*%EJ)&6R&@O"Z/GS\YYK18E>1G$ MP:%N]81K"5N[`O:Q[S,^^YOS]^<,Y7#_4&C*0C@5U9.)A^B)=F4H*S`2PY[( M-`&BR^C,FO"%A@(?47RZ*Z[&Z$_3U5%CX<`A[)))%_EA[>DSE,M+J5GKG^^0 M3R3Q?1P=>"EH\\!WVP='NP/NN_FMO<&!!U4.H-473@^`X:D[A MOCZ1P*DU[0/?\1E.@O>^_IH_?79^<2=*1(RJC>`]SP]$#^IE]5B?!495R1`4>?@F1+2#5$>FH"O!+:57&+1`*D6$V MXN.YIUZ*O,Z89RHCKU'AXN*B$7VFIR M&"6SL3=="Q>Y`AL/KHOPR/02CN0$`>Z9\S%?A5Y3U>/SDG$H2PC;! M$YT3^.TY!"&UN:=%(9J5!3@(38/-\2GA0;YGWKXWA'U?&G_;!%HS`4:[MJ!) MGNW3T[OW&@+,9YY/`)C:!H-:-1=B2L/D[`Z]EJR>^K=9&NK6[\RZ#P82_%N/ M45,O1R8RGDOK-E/_-$8S$IWM3%O!\PWS8Z`RPP7\"O6K?CN:NTWKQ/I';!_R M`(P+0\C3YO<"LO6K]P$:&E2S,^RX10T(:5X57D[?U'_V')>^B]-B.X6WK5EQ M.ROAGS]-VWX%YQ2JD)!('X'ZHPRLH_>QS>*I?[)%*1&M_QY/WM.K23URZL=W MF7_WGLF5:)'U3S&]I_Z[98O7?QS;3AONN)T:X=U\_G3;S"U^IBF/O5I,_/CH MGJ\97)K07D_XQPPG65AM'W](RZH]E/,GNOYU/6?_O%V]//[BW^XN:+]P#_]SKCZ M]4^3W_W)$\VL?P(\XAB>*7_`P>2=!V==1L:D_)%OC-7TO_O\O_,__.D?;WY1 M2=8__6YS/P/MO+M_V/O7'?B2I(\_BI'HVD5+6$W&'S[TE*9BQL-&`38/;NM_5!` MV:#&54P5V,UH'V:?99YL?__(RSDG,\^IPF9&J]5H=V:ZJ9/WR,BX_"/BYQT\ MS/,O0IZNFI:!MA_'_VE^Q<#\Y_;GS;72BF]__@LZCR*LX^1)C7$^^C2U_`ZS MG#K\SXRE1$G3J^P4*5Y2V-K;GW?=`K:G@!MGK;P;6!YE$`ZDGA[KR:5$'JFF M($NG4N/C$AO+ZQCU+^/K^?C^RAB_/D^'7IX=W%W-N6:'%$A M;GY_S0E?Y=0.=;Q!\;:ZL;:9+K"_HW)/QPALY((7F;\=3V>?\AU1KUOWNK1S'8`@ MH1_Y9V-R?I;I1!PHM%HM'M7+M76WW.H42^/-Z+*31/=Y2S^0)0HI\]WXRRAG M32>7Q&Y?C:%`SUW3B03BKTKPJ^$MYW<[ZESX"H4UGB4^Y&Y>UN;O$BL*-:01 MAMY<7WQZ6KW<^->RLVV+;2,=%J*$E4>AUHK;+%;4X&>4+2JRF47UI].-WVI5 MI^ZXM$/>`XB+=&:8)=&&PA9:=J.JE/,B:<%+])_IR`O"_HJ]*J43E_378=K9 MQHOR=O15T2Z-L/&RW(]=3T^9#/?+(^(H*U45T78=G'+DV@^ MGSVH5>^[V,[S@`^8&D&FQG>03%,5G*B0SZ2O04>+0MAJ9_<;)%PLDG8ICE.] M/&S,CL]W\.A;E8KMNXFX9_8HA;_#A3+JVRVD*$K/V7W#!?MK^LN^/%5'\JS7 MF0>'E$U*OSN>?B5'"U)`WH4OSQ[O970XI'WLX9"9?,J[Z&:71XA[8Q]I$"^^ MER-<[[35__^S!3U0YTI%=CFB+&1@`&V>^.Y7)W/8R\>CA1LF7?\0T1U9H`W,YGZ MHDD2@QD*2JNV&'H&OV.;0/B47N\@L'K[>^0Y4SE[/MC+5G">_26N22DE6=/S MIYLQZ]$_;TVIM!4%MVQ^%]E?6C/&1Q@`&KA4V,06T";H8G\DYR.0P8PC1(%ILI`!236=7V M4_N:G?A\=?=9)/CG5QM6%2R;\?MWE)X]/AGN5[_L#/=/?\$?Q/]0R_[=UN'! M3G5Z_/[D-+VM[P[)_UN='E8G6[_L;+_?WRG9$8]WM@[))*QDP3Z%L'JN=DY. MR1Y<'1T?'NV`"LCS")]"`74TH/.Y:ZG`@E585@32-#>B@`0B,.=LDK5I74ZZ M'$:1`=_?^$P=;&^CAW3A6)YP^6L_"[9[3,*X9TINLA5\#NNO,OCLC]W=L]RV M8Z"1$:6D`OI=0+CPZ6ZSA[UA&,Q^V[Z:XPBG2$4ZH14R;J5_8Z@>+EE2K5;@ M2\_SL@F-+6\=4#I@3DC#K:WW!^_WH:-MJBH=\8$CLK3E$J34L.M")EP8;S%W M2(P&*5QGV=^7%ZOKS1(.\_7GKCNI`:/CWV/*@JL8,?!!3NJA# M;D`F&7/3].E20]IN2])-,@' M4>R"QV9R&5C2&7*R'KFFY+-"&:"F@\XYARPLR?RR^OY%.S\D",GH/FM>Q1\E M?$/=I+RM^9C9_-P+YK!GG3-Z/YFB.,R^&(P/E(KB#EDO MP,R]R0V9%IT+53EK;&8$D;%BQ(?@_I+*%V2-+23\3WA(5$90NXWU_!H(*%$2 MZ5S-4=V<O.%@4D>603935N;F6 M[FX5!=C!VZI;DY5<30>2K=5^5"MN`7R`RDOF-;EP$>NUM;%<;8`_U:597`T# ME`*3;]LE>5\_?>6K=Z:+ME>\[S3VOFOQ'>OKN/&VQ-T8K[^H;$O0-!Q9Q8T3,0TI=_DS4DY MI;V?K9)`3IMH'4VZ^<,8)$"TE(]6'GH$VK;>1IQ7/&"?9+W5*<@$=*O4Z7)K MO;/PY2,7WJY`G/>E\.6::R_!L8/(0`A!L);5(0_!;I8N0A3DC"MGEFG%XR$A M*"^*Z2DS%0#Q)F(#VX:ZGN'PTJJ#*-EH'R+[<0A#UN['(/X&D!RJK]GM9-Q" MV`YEHGHAA[:_ZB5KT[T3P")CBA7F<#?/7V?G!;`L^5!(:>MR"Q73GQL#:6Y@ MRE-E0R:HI-$_7MCE-\J6J[WB+2=':[[J;G!F9O$RL;Q;?(\006[-`8".S]@1 M=^]NA7$'224;G)BEF=S>88PD`=0YV@.:`+(POV>;MBWS99>NT%"`CJ7$"RPC M=87$##+)'DLKF5=OB1M`%W+)["49"[RSA8@X08HUNS!X"1#LU3!4,$A/KEFY M+ES1;*:GD%-ZO.@$PG&,&X>Q+:B\_8D#1$E@P.I860FS#6[*N3Z<8AZ"T;D+$)>O4_A_H,9M M@RAE&$U],$&#SYLS2&65Q(IU7-/]2^L0A^C"7$XH?\KQ]*2KKCLVQC']%3W] MR0B$3M8L>.*G28K1M(,#_RH\.31DO_3^JXLK#$ZKB?"1-CSB23N_Q,MKU'BN M>EZ6!]"AT?*U^J33V0];SHM;.>!N&4J;2F8->U4Z+:SR3ZLUEUUJ,_U1J^,) M$??9471G^GL>^U(;=72-ET[WL4?U*S-]E-\[`Z.G@[\;9_-9="5^VUI8[&S9#G=.342K(J8]G' MNW*1W,&&UU5>N-P4V;00GF7O<5?=NST4/IV8H19-0B_P'.L2ICG"JJ.0/BKT M[JR.J$<9_:0K^Y9.,T_?8W2:5<5^C$XS=]1C=)HQS9UX*EA,*<<#,XSD@M(K M>HRZ`>9$KJYNH@3!&]FSTW,?`'\VY3?[8;/K!T^!60,PZL6>6J[`#D<<=E<< M[81-4`G$`"+.$9&.(>FXH<[4B6079U9Z">"E#,Z(]Z/\0PXG>?C&$,J=!S:C_[(59Y=_PUJP15"+4.ZO MRI8$5[J#T#F%5\]_T/\0ZLC-F"F]A4WIYOIN7KUVORFKC8="6?1H^$:QK^,+ MP:0(`X^3EELF/4\7&W4.J,H'@>N&24LY$T8^VO3]-9191.)=OLH8.)X.P-/F MIH:-X]MJXT2JOFI"?4*\H:]/+)I+A_XFM]4WBYJ\^P?X*;3)O'H37%\P,-26 MV5<=LA092[.?3A)3$1M*TH,[J(;D'^#C..N/8QG5V>IQM?X3_[B]RT'*M'IO_ M/DV2D+CJ2^>V*PJ3QEBR9"I<3O;+C70BG0O5)=K&!O$5[E=<8.B#%_N";@GQ\4UC&RQW;+A MN].!6_Z`)SQX^+,B`UG?,-*#J?*:@9D;HX^RAG)8N@"VJ&&/CKO MF%L+J2C2JJ>99==92W1L=D&.T2D*5_YUZI7WH,4@[#F\E+W,_N$^[9B':0K7#..Z"),*N1,?Y> MMO*J/.ZQ9Q=^71SN8PZ[;W?'^!)6`HLG1VCG.+15Z18,N#^;3]:?I7]/YF*4*4OW&+3<"6'TX'Z6QD9&6;6WXD\5K'):6S1RLJ8CD(N M8O>PQ[2&RD5^)1L94Z MS$9'USS>NMR0G40/*-+/V+)%M(8QF;).#B9QL"EAIOU#XXTYNK-0_TC33DIE MENJCGD!?;W$?F64Z4C">/F#QSW?@%IFJC3E5).>N^FF) MY7&O7Q3N=6`]:E.MF-"3&6T'F7$TG>%@?:TL,#WNL8!J8^V79$PC218VYMK8 M/.&FS$!&A]BDEE"=+:B6@>C/,&Y>4!-'C\7/'">7&SZCMK!KH9GQF6]LV]&L MR8]*+`A&O;&>GD/OPDS;PSOV.QJ@4R2_884/ZN17YS]5E%)(L`"8R=7;VN(D M,4@,(5P+N_F*2;!A>J].[@D-SU_N9VO/LE6'B_'?2)EX/4F'\(E#S6Y8>FAL M?.]JECB!]>?I"=1S^>N^OYH_PZFI.1*.9I7Z1`I%M,J6IGE;/7KL"5.F14Z&JNV5> M1"EMKHO06T/ICZR%'#QPKL&\D(J)T#Z^?QO'[/WPM*#V)5+[B.7XN3N M$R$.N.C'OZ==23CLQ:I:HKG*^R"UE1G-#>\(I.^R&?S:&5T9IKD@/P91Z?3N M*H5MI+-/@B&[TERES88WHHR./BDK$I>3T523X#*:ZHFE36?07%4VB`OW39M8 M"'/Z1_.8ABKSZ8]O0F;7_IO;)^,,$6\EAIC^*'W\S'L:T[%JG(1)KQX.01C, MA2`=+3-U]O;*@`GQ.TP4`L$H[3QSC02NU=X%5ZZ\L M5W4ZR?XCD0X)ZN;2?;9:_?%D>*M6H?A]A"4$-*8&R MTT:#%WYAS\*ZL+$H6W?VH3=.5>ONP^I%^;/07Y=3,>[D1ARP8\N#58Z1W):G M4ZK)*A@[#?<4R5&<-L<7U*UD9T?OL7+MJ@J_H*%E&G?A%6`W;L:3`IQJ2Q9_ MK/7._F_3N4!6Q=$FB);5M]*-"_SZ6VGP]<\:ITR6]',OVT M*E^IO^BF$U6928^(G-S46ZRO%>%)KJ,8I$N?Y(.E-S_0 M*AMK36=N;$9,HO8`=YBT"U_6)Y5V6V)C"@BIL&)_'A&Z[Q.$HFI6)RH'MHID M8LE#TYYHU!-`B2>,'D+>T;)2ZDP1:"T8/7WX0&ZO./(.M6!%BE$F``Y#>$I&A-@S(C70<+DEE3E_`>Q8.U6^EB M9=@BI=7W=]`N3SK;YB6U#U;[B%)K8V)AW\LFFAZ^VL(PN)N2].'HYN,;P;VL3R2"=3NFR6=HN82X1.RRV@,?3&YC[3G0@'"8I MP7G7`UJQLOQ+Z9B#F$HJ^^5=EEG*(J=1&&_"PB*W3QO'78I?5#]$?\A%^G7G M;/>R+Q?D^,HSW`YF:Q[@?D* M>Q*,98L(J1&S'_)4/`.SE?4E'+/L=/E\^M*&9>,F*<-D4=X12ST*#&@!4'(S8+_`@^=S6V[6D;7[,>)F#Y3@=82_&=O6^ ME(.>$O/YM`='E]/QY"HSXX0K*<$44;)F2C^DT^H?+]NGP=;T#&@%;Y22N(53 M*5^%M]=45T_'B^7@V\7LT\]:T^+1_UW^ZK)M.6$= MC.?YM3T:W2@9:UP0(V;CG%[>*73VC'P\!,'/QXW/+7?^GJ?KPC&])12B9#\; M[%P`50'T$`FJ,R/<,6&`#YN2:5PM-R.FPOIW$"DIS*4"J[QEN M>PL,8I!V&,SG[*N+;7<0@?2S$/VCXT#[L0BMCRY""R"&DF;$"*V),*AUA);Y M9X"%U'ZNHK3L%^:COGB_;0A"%P5/Z_=*6CS2PIWLBN8(H5G[!4N`]=RWP$R1_&!E@T$]^TD+@+#_Q&N8;[VM)"K:P@KB` MEE+$7^.T6_-)E]F^I5BX/)Q*]7W@>0[/!$1U;J_D`P$%(7B7V<"1! M.#+F+AW;(!S(HDI[EG\0D`0805_?'J")L*IT'VZ$(.5!344"3:=63\O3>SS82(\Q91A>;D># M:2=^11\=0`F$3=!N%)CI,[ND;0:'$_18"FPHO!67#R!`%5+ZP]MT]_?>'!Y7 M!G%62I\;(CW/#8_-,TZ``*H9"4BX`&;87'_Z$A@T5K]G3Y^O@97&C@^Z3"Y9 ML3F;PY(]K86>R`RT]D,FIEM_NBS046<%BL%;J!S?O6&W5T8_VDQ&%^+`@,91 M]<#6(*E,;DTK4JX3]4@IS3/W:#^B@'$&W?`>V">GX!XYN;I3A%D/WA>S)4(RHA,AV=''%$>L@TH8/'+=[ M!WIFX)[CQQG\>W1:NJ*,DFC2CAHQLST!\3!*XH9;26A/D1GMM?5,.X;"+Y3V M3+#:LTP5XA"]0FP(NE^M3H-)6YZ3KZPIL]K5W]H(NI069X`\A,*654;)/S>Y MX2,%+W5_K[*Z+DD#)?@2:O9N93D<\4+U"Q-%JN\"7#*V; MMM`?LR!$_3$+(EQH5_+N^Z57HE%>I?-95(4`UYCVR>Y^.%BLL;ES4;V_3GOG MC\^>IW^L7;KN:8*MV/P98P!2LJ%B%5G`^K3=AX\HPXC0)?%:GG7"H:W M3X#O/>%Y%D!Q97AZ\&/7(.G,9/'#^^[,]S"N@S&UPTA1MW\_R;T3EI=5V#[Y MZ].>#MO!?>G/WFMA`73I;^\G:"JC&[GU@31*6$286W_V?*WX]3J2LG&&3SCP MTZ[JG>XC*=`\5#ME,!T'P:T`^L,).>>T.:73OIM+,!=V\2OF+ZYC$9^U?QZ` M+0&'%NV0=FNN=.)NYG>Y!A2`X&KNO=SX5,IX!BF'#A/4PDS,;REAU=&]-W1( M<*X_,YJ4OS>=J`:X"7US8F-RH!3JHN'QXG&5CH#=E$PLWVPC"?>DU=^"1[M! MS9Y.L\O;?*O14Y6H7>I95]M;1&HA#_QE(J/2/YP3,/^.E"U01JM,`- M@,,2.@@/)V&,\D'%1SG=Z.YFCEBYIRX"C>1HHF"S5(YSK'6-:6ZMDQN,[9%0 M3L@>4F6UTB&@*R)X5AUM99MF7MN:3@)ZNZ>G=%'U9.Z,\3-ZZ"6;1=JV35*` M(]>R![GNW@%*JM$=KXS+7BIX`]GP/VIKV8%8+WG MM[A;4':8,`2?!]EFG:]6'X3I@@JQM17*4DIT>?YDK2B6;1;^WGK1`@_P-YM- MY>Z<26$^GU(FTJ>V=2;E])S+'4VH/'\/(ZQ[L!=#P6_LDO^K'K"TN\&Z,8OT MS^NO7[\T1IG^<.AS!]M!C;F8(C-M$QK2)MB`/(-UD8!:D=%] MU_"/F[=KH?AJN%^/N<[J!!CO>"+3QX6Y3J,@-9S)NF=9@)2LHOE=>'*'=2A^&%=&>K#-7WR'=N.6ZB8S\&YL[8W['%';\>Y._JG;HK;?0 M/PJ+U_4MG88V&18C_/"0&>[TKOEMS5]7*3BZX)!:7X?)9+-L?87W01>^0]MN M?>H>J/3JI2<=;FM3/C)UQ9V>V5S#-XO\:A'G%P38XRA9H59B0W[$-'!^NVQ^ MB^;5O(E-_K[J[BB9QFNI`0,;S.C$Q&>W;B?0KH9L>Y7#MC5O M<+*U78+74DVSUWT<;MR27+5W8EGOM21C7G1_F)*0JQ4,=O_!BY0GRV_N51:) MX;:01ZH]<80)C&*<@N7520FVN]'=C=Z18J/F-++`$O]&5Z\\2AXEM(C,;W:R MD4YK$'*!+0H#K(4D;8"3X)+"T%&GDM"LUT0LG.((TB? M1P]+IB0L-8*\98*8W"Q*:,'A!_1SQ@EKQ$_P`)LG5LDW?#*!!M0Y/:#:H&3J MLLF(^#.Q/K@P&HP/?F`QV%):EZU6:()3A9$!TA@%25THS-`B1DB!3"RD@;.> M`K)%RB-):12DD?29[M/@13GG0FVX,T?E!76%L49S\?&%NGS*+IDR@X?E*]N2 M3/DCF`1%'O.BN_L]M3SJ3-%2G-X;6VZ;$FNVW_Y[/=.<'P'!,EQ5@O4RP^XL MVPIR+M[-SG#DMI!,!8C-X`2]:E3MZG%HP&S+$+(#+$];4^!%+4Q7-OCQ=#Z> MD`;Q4T79[!"_V)I(UN0$.\8MR*79/3[:UDP28WO>\@H3X*AB&408$W]\E>#` ML@8>H]>5]''S`U3R*NXW/!YEA[!%H M&#O3)):A\'$Z.^2@^SD7FBW0-80.TR_B))[GDZ">,X73XRS*A^CJQ2=D5/QT M]_2OAD<^@JV2OVG/O5!P!?'"BBWQJNX5:J05RC*O;9)M?YMWDN4)+ M"+TA28$<]DLL3,G4T=O,!Q?2`L6X5&/O<[$!>SQ&CMO[]$6*>VHJD%0^HDS\ M)18#Y?FN\2KPJ$+.\E_'=(E9T;U`/DS*O4[5W8TT>ZH=$0KG4I>)WXR=PT&B MUH721\?,)Z@<'_W85%3BH?9M]-Z=CE_Y:^NAFXH_8&^ZINE<\@:Q6F MPCN!#83[LV3"IFKE^0]6&XKO[52?$NC`:F?C^=VUX4,$W0I=:U?5.4@1%X&7 MOS^!<)(9J@26\F-5EG#-=Y.WME?&S\3TF:]R5I@.3,BAQ3R8%803`:#$O1]! M+0TW%KHZRZ@1*V9OYM!_&MP'G-JNWEK8;GR M?I[[$"=_[R_RAMT>L>([@I=P3IP!`<@HXSMEJ0>Z3U&C>W)5&8VDO+>QS!2^D4Q+*8+"?%=C?/PAE*`5-?0!9R_"<=]T30!]9"/O"A&ICR+ M3%I+(F#J,*]R^X)$U$16&Z MKMR(/DFM4`7@.Q\[*1SK>6?M:+.K2ZO<,^355@9]C@]LZPIIJET2OO< M&3QX?(I6CG`^WL:,C?2[BDPM=+8@68H*<)Z%M\T$U^+K6E9<'O.M?8K2Z+-D MMI]@2;A>DQA=>TG8E"%[\;4`S#U8+0%)M^IN=8BCV?M=VZ>8P(+B6^^^O];6 MPF.)R+(.7T/[^C5L+BG7Z?P0X.IB1;VO]9O9W63^]0J@"V'84Q6XSA7]OO9# M!0U_4K:U:%;I-!CT];/]X6"KQ];0U[1,T`_9PM2\\)"V1UN_N&1RXUF?L:1O M`4N7%>GK1/-8?`3_\AO2R8!/G+4LGW+VVAT#GZ"*%T8LGATSA/#V?T[/:%!_ M!IO!2J0OE9+9;+\H<9M>MR#@Q)0&;!7FZE=GV3,5.I-.[$!D?-.=K0Q3:LQ6MI$OJ6Z9.96:*\B1&RVQ:)^F798^(]]W#OGD\YH'JC^R MZ&B6[JB/?/8FP#*9T!;81I)6,*'T'-M?!)MRB'O^S*9^*9=VJLO(8<.;*FKK M*MO;T)TS^?45BNK:IGRZ`"PO@J']&)#!=,+Z`C-RKHSJ5UP&6+%G)-7H=+\( M(2^R08"5>89^W+_553U7F]EGY/=IIEYI+":=(_"M'*QGPX7<5%F+]=>O,K17 MP!$$JK$JC"5(YF9'_8&#XU=HF+/&"?7]:489*T/%G`1)_&5_/Q_=/ M3L;W9[)7;S&YJW.%:RHM"=/8FDWG<_XQW0EL1A_9=G=%_=7,6UDO7Z<"XA8I M<@NA@'?[;*::-L-SLCY^O@>TKU(Z]LNHP%GH,+NE)Y>X M1*[&D'.X1+'#X2V'>3OJW(K0P%,T;XAXG)V#C]LC.3NRXQM+M/-R@V"L":YT M0JRQJ%I<'[^G=V6PT<$U%@9$;4UG-QA?MRYG^(^O.BZ1WJ3LI(;D+N"PD-9< M_$E8F'ER\4^T?H77_F`1WZAY/5"_4Q"8S8PW32E(TJT_)K("FR4%$(,6 MT=3=&KOZ7?K@FT6`:C028*E28BXT(1_(ZO4:A\%(9UXWR1HT*E:EK79Z4>!U MGX5I!+A,0D=&\ M9SY+M"QAC7/6OSIP$L@4:-V$SQ_JYN8X<:`O]F9/-(U?R#ST74"UHJC7KE;5PEI0M9`Y22`']27[Z?Y_/;G_Q4```#__P,`4$L#!!0`!@`(```` M(0!.;!.\"P,``!$*```8````>&PO=V]R:W-H965T&ULG)9; M;]HP%,??)^T[1'YO+@1R082JI.I6:9.F:9=GDSC$:A)'MEO:;[]C&R@Q-"OE M`1+\/__\SO'E9'']W#;.$^&"LBY#@>LCAW0%*VFWR=#O7W=7"7*$Q%V)&]:1 M#+T0@:Z7GS\MMHP_B)H0Z8!#)S)42]G//4\4-6FQ<%E/.ABI&&^QA%N^\43/ M"2YU4-MX$]^/O!;3#AF'.7^/!ZLJ6I!;5CRVI)/&A),&2^`7->W%WJTMWF/7 M8O[PV%\5K.W!8DT;*E^T*7+:8GZ_Z1C'ZP;R?@ZFN-A[ZYL3^Y86G`E621?L M/`-ZFG/JI1XX+1"+#AKD:V,)-)P,UTBV2I&,@HY*AE`JK9X=.:,GS5*;,%%P_*LC.3-%?CF M\``JO01*B2VHV((R$K/RTO-+;U0R@`O@2'Y_R;3:PCLYGY5CA@Q?`&TDB:;6 MRLQW/GM-E"1I^NHS!+3ZR/B<0J\^J9]]..\T^X>?!S0^>\U90-/43<_K\89\ MQWQ#.^$TI((-Y[LQ'`#]N:26C%^K*&5R\"C<]W05PQ)O3OMYIJ0U=A>^R79.P^%*?K4AMJVNSP_K?-\PLB'+J5O>O[X])QNF)7UGFW:([E`58V35OG/7QLMTYW;,M\/3Q4[QWINJ%3 MY]7!Q@C+]I88S693%>5S4[S5Y:''(&VYSWO@W^VJ8W>*5A>WA*OS]O7M^%`T M]1%"O%3[JO\Y!+6MNEA^W1Z:-G_9P[Y_"#\O3K&'#[/P=56T3==L^@6$EQ7<$.5-JMMMRL[,]BF7F^[3P]#@GZMRK?.^-OJ]LU[[^UU?J/ MZE!"MJ%.J@(O3?.JH%_7ZBMXV)D]_66HP)^MM2XW^=N^_ZMY_[VLMKL>RAW` MCM3&ENN?SV570$8AS$(&*E+1[($`_&O5E6H-R$C^8_C_O5KWNY7MA8L@+>@:>&=WS%4/BB5$/K\CV(K"?E;@X1$@VT$9OC]YWJ/S'3)7:$B*$&C\ M$2(I(ILCO&"$.$!KY`8[-KFIK'M0N^LLJOVE1E?$`*0 M$)/`]1>(A!B(25V M6S>IAQC!A+X_10@2E##3$6NWC`#BR),7"$:4X/5N4V!*S'<9,828\A-*[ M3_E1M4T)\5F?IP(Q.G$>EYB,KKM&W2DQI<9&P]U65X$:3@@R"4LU1K>>&[#\ M9FS=GPI/"2J1-@A>'U2!DDZ(L:JE&G/*G&"3G)%U&<43<4I,:;1!3&4N_-`P M!2H[(F42UI#IE-?%#!(K&^C*CB-ASO4D2*;F[+$*@P$/_C7(1 ML,Y*->:\7FA)P3#G(93>758AYEYA%$47U?2"Q(M,Z):8TG^G=#3\0 MU%.,()O(5"(&"8HXGB6.KB<7YE7>Y10#FA%CF4DU!HE)-X+DC;G1N4._.2&" MBU(LF5M<'X4!3<\G`6OT5&/.*X5FIUYZZ0A#BWO&*3XV,_5+F!=W*L[`(=48 M'(JIM31!#,`7*37F$;?YK)Q[13!-G*:&&'R[,'XH:')T>72TB4=VCH MT25"EI148W1/23><*PE&T0CAN\DT\Y3<71XAYQX1LEE,-09?[<>NRP^F&46$ M81Q-0T/),9?X8"3F[A!R=Y"F.SP$7B`B-M(9@[B>+R_04]IVO]X-3U%9":?3 M&?:=QF#?/?#!SLCRU!PD=QYSB=M.=L-3C-S4.9JC,95&DT,,UPO-RUPT[@4HI[M,PD-Y)YQ81Z4: MH]-Q-F&F24#"(N-,2LG=91)P!\O5-YQ$2B<,,?JFZ=QQ6$?1B'/'8;RHQ7O, MNFRW95;N]YU5-&_J$E;":6?\%B^(4[&$6S^XF&7?9W!Q/'SOC`MP;WO,M^6W MO-U6A\[:EQL(Z2[48;'%FU_\T#?'X9KQI>GAQG;X&PO=V]R:W-H965TF&;[Y\.>Y>.+[;^_EP7CE M=5-4QY7)9K9I\&->;8KC;F7^\W=Z%YA&TV;'37:HCGQE_N2-^>WAUU_NWZKZ MN=ESWAK`<&Q6YKYM3TO+:O(]+[-F5IWX$9YLJ[K,6OA:[ZSF5/-LTSF5!\NQ M;=\JL^)H(L.ROH6CVFZ+G*^K_*7DQQ9):G[(6EA_LR].C60K\UOHRJQ^?CG= MY55Y`HJGXE"T/SM2TRCSY??=L:JSIP/H?F=>EDON[LN$OBSRNFJJ;3L#.@L7 M.M4<6J$%3`_WFP(4B&TW:KY=F8]LF3K,M![NNPWZM^!OC?*_T>RKM]_J8O.C M.'+8;8B3B,!353T+Z/>-,(&S-?%.NPC\61L;OLU>#NU?U=OOO-CM6PCW'!0) M80O35N5_R&H4S20.#T)?)XAN>#H]H[PV3LR6&]!$8*@9D>0CH@E0D18\*ZI(:&&5#%8 M(&G0!5&DNES(R_,9)64()UV&Z^E+C!"BBG!T1"P1@X@SK'/=)Y$^X]8$A#:5 M$%%'JE#(NL\+%4Y0)&HH7)>\,4(0Y.@0+U]?=BP1@U1I^-`EN8I()8(*A86H M0B]'4H!7)NS9L';F,5M??H2@19>OGLV\!0EVC`"OZSA=/JH>KN]Z8:!3)BJ` MA6'HD7>F"J461F@!JKJN#A>BVUU)6>$W$4 MN:X=T$@C@.SIN/%:]!>Z_,NY+<"ZYH!1R8C!U;D>&U_;]=48'RN)K>%#FA^) M^IBQ^4+/C%2ATV2)^4PY7"[+$F`JBZ1@A!B4Y=D^E86/%5DJWG7#D!1&HC[W M[("VP%0AU(2%GQ$FP%08Z3018KR^0FV22[%\/.2G-'RI*0Q*BJ,=<*L8!,J@=+!_+[2&RQ[$Y([%.>X3X&!H8L\=`:`%F8JZX M.74[M"X)VD3B! M7#E3&:)09+"P`W)"QCU`U:BZ++R`EG6B<2X\/R`[FZJYD)-)-UM-Z1LR% MM<=,0L9ZEI:Q$NDHT3OU6^M/SYP>H&_MA^4LY@XE#RZ?1.*G)]$=."3GHAZ$ M"V2.YY/DB'N`FNC(*UTEE'/8BJ)"TQ'F&#RJDIF9I2S:2K)&/.%V/IX"V,%B6E M%>-AV8,TE8%#QX,1-8I$=G"4IF2*$O>3HFDC"D7B?2->=Y6\WO&8'PZ-D5-!5&K4[2[CP@741>^+`C>D9^R,+@"@X\P1R'9Z$ MYYXX-I#A#>KP&KC^/&4[_D=6[XIC8QSX%B39LP6D:(T7J/BEK4[=C=93U<+% M9_?O'BZZ.=RNV3,`;ZNJE5]`AC5^6=X]UY7QA!DGM%F9KN68!FY2FI&F6)F_?R4WD6EP@9H,5;3!*_,% M<_-N_?G3\DC9(R\Q%@8P-'QEED*T"]OF:8EKQ"W:X@9F@^]F=H?3,K083^IJDC'*:"POH;!WH M5/.M?6L#TWJ9$5`@;3<8SE?FO;M(`M->+Y4_?P@^\MZ[P4MZ_,)(]HTT&,R& M-,D$["E]E-"'3'Z"Q?9D=:(2\(,9&<[1H1(_Z?$K)D4I(-L!")*Z%ME+C'D* MA@*-Y:DP4EI!`/!KU$16!AB"GM7S2#)1KDP_M(*YX[L`-_:8BX1(2M-(#US0 M^J\&N3*HCL0[D<#S1.(&ULP+YM%'6/P32WAA\2PO"MP@O!Z+K74IFV(DT'K) MZ-&`TH/(>8MD(;L+8#[[H]5TCOW/,!`I2>XEB^("+S@D^6GMSISYTGZ"U*0G MT&8*BL)HB-EJ#!R^"]$0$9\1TF"Y]V[\(>E]L$%E)Q7L'TOUH:!>+X6S,KEH MJ,R?#2/:3"&1-X1LIY`1(IXB_&!(LIM"QOLDKT#F;D-NR$5P!/KI M\?V1E(T&S7J@L`M!I6Q[%1%?1>RN(I*W$`,K(-2^%6\7A`2O3#"ZJ]#;4:(V M&C)7YR#P@U&];/O3SM"9^(VY77]N2IOTIV>A:(5;Z_U:)7BH%8[UZ,AN M-`AV[PP9IULCM!_1^/C$_5G7[\6MC_=5>F@?,LK7`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`'0],U8$W9*GXHBN!OD:JK7Y5F`T^ MJ;4Q'MNG>!5);>+0*FZFL.?\MC/JJ3WG[B4O,.SD)<-A>"[C-.:IG!XWSR=1 M\=>79QSA65Q%1.57KN&Y/(7YDMU,4>S;@=53[JEBBA2-AZ>6F=7T3Q+>3^=CJ>Q%=Q$,%"9E5&&`41O143_%@T0O*>**5(T M.,AWC2.N?A:W#&@2P]._BN@\0SB<3J<78""/'^>%=I["=F#=;ZJ8(D7CEU:P M[7Y9[/SB?!>1^!V'9UIAP;`(*L-V8-UPJI@B16/XN34\+]];ZIW/<]YA5;J* M2+R?#J0?161%&]IXHI4C0X.-55=[.XWEG<,CCBE!>)5OOS^`S5 M<9/'JXMO!]8O?JJ8(D7C]O*(6Q:W;FEV0S%?1:35?GXY7.!JWD10&;8#ZX93 MQ10I&L-<:MNO[ZQN+3\/L%Y=572<%S2X_+?R8+F9E2/K?G/)%$I:QYQO-E?T M(&FHOHT-!US!5:07^7(ZGR^PI*FBNLK-.<>GX8@SX=XHQO-XO`#IJ5$,E\NE MFFVM9XXZVSU+,&H\C^,2C.943EFM MA2F4M*8YXE2F>27/`^L@P0C,PQ.]JBI8@V]%LE1ZE+EFJ/=R4@`@&J4%P*'F M<0`2A>BOE#A%RQJFUD%4(0"3+`#LR#(T+)?W?-PIE+0`..54`.*;%V]Q_7KN MYKJH]`;V='(+G"6KQ;4="5RGDDF?71]XZYJCSG;7$HR@WN&N?!U$):Z'I^WV.9(4]G>'-P&R4)``&[35U4I@>/I`I5[4P'?B):) M,\`P;U75]Z-K0)3-9LD4CM(6`T>?BDHR!20HU2BJ6XJN^Z)9GP`6MI9*L",+ M&(!W'U+)%$I:SYQ^MGN6K%1[[L2X053J^G2XP.WPIH+Z;A>%,+W4J60JX_;@ M-;8/#T6Y6=U&.1]L5*2NG\555[&49< M!VY%5>9Y.;)J\)Y+IE#2,N`DM'F>'R0WM?/\"/>QJZK`.Z2?6U$MWJ-4IF6? M2J8R;H]@ZYV>X0/>68W7_8C1YB`J\.YJWU2+=SO2>];J/95,G;^^W"5:[YR6 MJNN^L?8E8\'UA_OSE5_7)%(U@^59S%YN1;(`2$^ZEY-6&4VAI`7`N>EQ`)*V MJ`J7?.*#_2'-9+C6^HLF2T7VXZL M>KH?4LD42EK;')(JVYN#_4'2%1!P,UY4=K,?7N!V>--ADF"OJF#AN.>2*90T M5/B5C)I*7`RSNKT!X`W]JAH!<3Z\P*WQIH]7$Z`<6:^$7#*%DM;S0UEO[&8] M6'2NJM)I_T1;6WCI3@6U[3SKE9-6R4RAI+5-%?S`I69U>ZE]L!]%I*[/X\E= M;!'4KNW(JJ6[CAK,@2F4M*XY+E73/BEP"5?T'.N;&VQ7KJ.HQ/9A/.(4\E4QNWA:;US%*JF_,;:EP`%#/`5^S&* M61+LBV0!D)YT+R?UW,WC3J&D!<"YZ7$`DK9HH:K7/BCMZYAFLEN1+`#2D^[E MI.6O0Y%,H:0%`%DOJ?YNP,-@/S8!;[BX&[P\7J_Y=F35TET'K9=2YSH:I7%] M?"C+S6JWUL,V_:HJN=4-Q_,)ZN&F@LIV.;)N.Y=,H:2U#7%N<[`_=I,=!GM5 M*0'ZJ`%>>!4DP5Y5P96^YY(IE+14.&=5:T`\!8ZL;HL!0\U5-0KB?(8).0H_7O@2HE@%^X.)ZC&+6[.56)`N`]*1[.:GG3M>\ M:)0&P`D2WK;)/Y^5?H!<5?T2%`!%4@"4(ZON[KED"B4M`,AZ7DS+L`&I>SEIEF60WW]]&]8'\2E=SI3J/[ M.*D^7MWHRI%52_=<,H62UC5'))CLF[XQ<))LU<[W$6.]J@3`\?0,]X.;/IZD M>E6%I9!'O7"4%@K]I1I*4@JL;DO!I?J3:%:KWQY>JM^.!'602J;R9WNCM)8? MRGFG;LZ#N])557+Q+Y3S5R?2%]4R MR_UY4"[WQOL94EWL?5:WBSJYPE"CJGI:7IZP](NH6"]'>D]:2C^73*&DM0YY;EOI MGWNY#M][O*JJ1@"7\58D"X`\VY635AE-H:0%0#5*WR,7?=SX]X0NV9WMX,6U'`M.I9"KC]D9I M3=,UJ:]Z8IK5..-=HC^+2NYSY\L1`N]-'Z_N<^5([_GJ9)=!Z=_5NWLX2NL: MDAS7^J9$?^Z&.C!X597EFS.^9*F/)XE>58'C>RZ90DD+A2/6YAO?60(9S=%R M/5RB5XTD^D[U6Z9;JM^.+(/"0GDO8ZY*IE#26N;PM-VR1*W:#]6=1R<5_ MH<_?0,K3Q^OJ3R/I+9LMKNU(X#J53/IW^V`: MU\\0Z+;=U.>SW#*/@5Y5];,81O>N;%$5!N7(.H-<,H62E@$DN_@61[]#XV]Q M+M"K"KS#W?]65(OW/-25DU;Q3*&D]4X5O+WJGUF-U]T%>E6!=TST1;5XE]'K M\W!Q+R<%WJ-16N^SEI^>O` M:`HE+0!"O0,`GY4F^F=1!1?S5B0+@/2D>SDI`!"-T@*`F)?,_&ZV@SE]Y=]. M(CSV*B5\*NM6'EY,VPFKCN[EI%7)%$I:TP_%N&CV[[K MXU6F*4=6+=USR11*6M>>2*92T4#AC55"2^I=$5I-PB?[94MO\^UWNEWW*PTOUVPE!':22J8S;&Z6U MS.EINV7)6K7E3J)_%I6&VX/[C*T^7E=_FN'NY:2>)7G-,I0TKE\@YL47>E;# M;=XE>A6IZ:-[Z4(?KTR7(ZN.[KED"B6MZ8=RW4LOU[F/W:BJ7&JX[]_T\=IU MGNC*2:M@IE#2NJ9BK0M\6ZIYX;/@DON/TZNJ7I\ZB;ZHRB0O1U8-WG/)%$I: M!I#LDG+O)3J7Z%]\..N\1%]4BW=_'B2V>SEI%<\42EKOG'XV+W`ODI7:!E75U_WB?A"CB!;K,GA]FK.>2J8R;H].:QWBW,;2[\6Z$SS1ZTN:TFY%L@!( M3[J7DWKN9)D/)2T`B'8;`4C$HSJM=C3N]V]>1!53;]JZ%Y.6I5,H:3US/%H^X27,-5. M>)?G7T2E*NN@R2Q/DRR*KA>RZ90DG#Y/)0RIO5[2W?Q7G5K-1^>;34?CFR[CB73*&D M=?Q0Q+MT(Q[4]E554ON')_>U>'V\JOUR)'"=IL`I'*5U#1$O7N4NG6CGTKR* MS#3^--]-'Z]-R[#!_>!>3EKE,H62UC3GJ,W+W$52%RQS\/K[5552WB_N\S;E MX:6^\S!73@I,1Z.TICD>5::WW=`O$JK`/+X\KZKZ`E*8!T2WHEH8R.CU>3"% M[N6D@$$T2LL`4EU2[;TTY\+\Q0H=`EWB7 MM-5>=Q?F+SZ379[P'>@B6JS[TYSU5#*5<7/K#T6Y2R_*G5S)I]'LI@/5"UUZ MTKV<,]#CFA\";R-KUU M7IK MHI!Q8^>IAIQ'&G#.,>D!YY*J:/QZ!81EZ#H\B4R3[A%_D9EFA`B:&6&'EJ%A M7)H1J8;,1QHPS_GH`?,2IQKS+N0/3Z)2[Y<#ACT3--[E'/JW8/7>4PUYCS3@ MG2/4`]XE<37>_6=QAB<+9OS6U,6%O>7QJNCME,A[JB'OD0:\15:A2+,=38%40R@B#:!X*`'2;S03N7;EHQ?HXJGP#!^OIF)(4Q[=#TQ3<;!#426D&N(0:5H.G$QVK`OS:>F' M=0:5U>L"7-C;HEDXY*=13X*-8`!TB*R8S0AA'MC'`-B0:5K0:B\GCE M/8IPLR_RGFJHHT6D`>]DHZZ!S#O+<4%T+_4/35L+^NB*"P6E`45E7H8.ZH7, MIQHR'VG`/&L&?VF?U.+@M0NE$,7]TY05VD%3_,@S7UH7?(I2>$TSCZ#;,0WF\*@H9-RZ*5$-% M$6G`.0>K!YQ+#J.B6ZZ@;V!$%W4&9"^&NW<`3%#'Y+!;A2T'40RTRQYIP#Q' MJ0?,2_)JS/LM0M/WXD!='^#;"?1=W!E.X]T.+5A]R:<:NO"1!KQSAGK`NT2N MQGMGBU"Z3'#1O^!;X+0$6'*KBMX.1=Y3#7F/-."=TU/E?6,DTG82P`"N[W7H M=)WHY>,BJU!$JN6?P+*F``&( MA!OG@[:>:$FMLB(.D08X<')Z8$9(T*+QZU#@9X3E,;XWC.X+;/3# M=#/&QKL=6D9>:E@7Q'+:JH:\1^.`=\Y.#WB7J`7>X=,NM!I8(F/O]",DF`G* MXU7]VRFKONBZIQKR'FG`.T>G![Q+TJJ]^QA<6E2L776+:Y5S.Q0Y3S7D/-*` M:<`[!Z<'O$O.:KS[%*Q= M+/1ML_$)5@-:\2VN5=[M4.0]U9#W2`/>(0DF\4<[4#3>.RFX-*J8:_X"=T3R M;OFL\FZ'(N^IAKQ'&O#.$:FZ[EOO=I*L@(%+P9VV%,/HOJ<_%%F%(HINMNBG M&D(1:5H4D!!)*J M``',#1 MXRY1BZ;BD)Y&'%(-<8@TP('#4E4)6SE(QJ)_ZQ0('XLB#E$4TQ1<-!6']#3B MD&J(0Z0!#AR<*@[9HB`YBSC7_OV,L#C&]X:#^P5*>L--ZZ3R;H>6D?U<2#7D M/=*`=XY.#WB7I`7>70HN+2W8^_,1'J?VQQ;8*N]V*/*>:LA[I`'O')T>\"Y) MJ_;N4W!I:+%VU2VN5<[M4.0\U9#S2`/..3@]X%QR5NV\EX)++XNUJVYQK?)N MAR+OJ8:\1QKPSL'I`>^2LQKO/@67+A9LG7JMX[:O/%Y9CP*LAZ- M`]8Y*#U@77)58[T3@DN[B[GD+W`CH,EN\:SR;H=6?=$BGVK(>Z1IO<^M)RKO M&V]VVK$"&+@0W&EL02N1>W^PR!84Y5"`(M=0X_/MKP+._28J%,G]3MM3M`A\ M".YTL>B%X"*K$$3136=".6T5$R&(QH%J(#I12<$%U5% M@)].F!GO0SDM(A"-`P0X'U5%L'4^2*QJBP%[(%^'L,^%AK^BJ3A$HFBD.V M*$C,:NO`?UJD=,G@>\/P`I\JN@WE\8\TX)V3TP/>)6B!=[CG MT[6W/,;>7_#C#^3='J^\VZ'HNJ<:\AYIP#LGIP>\2]"JO?L07!I?K%UU2VN5 M[5#D/=60]T@#WCDX/7#5 M)6B<$EVX7 M['WTGX,ICR_>RZ'@LN>:B9I;T+5<"P_@G1-2Y7WC35^[6@`#%X([S2\H`<*G MQVY#D54HHN2F95!.6\5%**)Q``6YJ5$D]SMM<=$B\"&XTPFC%X*+K$+`SV?M M*AJ"5$,((@T@X)1454.&0$(5('`AN-/WHA."BZHB$(4V(Y!JB$"D`0*#Q*J6!/:;N%);N>R2TF0P3<7!#JT6^GTY;55#'*)Q@`-GI1T<)&(1[S`$ MAPTRY@M+'"RM51SLT#*Z"\'EM%4-<8C&`0Z.?D](!W"5K@W87@TC"#O3^[MG-#>;SR'D4X\YYJ MR'ND`>^^1IO4^=[38[ET;8#3>?0@N;3+8^L6_]5$> M7ZR70X'U7#,-H0:L0Q!,%CIM?=%8[X3@TB&#O1_\J^#E\-/7[A?`P(7@3I.,7@@NL@H%/Z\D`9;3(A31.(""H](#,T"2 M58O`A^!.RXQ>""ZR"D$4W:P:4@U50Z0!!)R2'D`@H0H0N!#B#1BBHM#+]A!PWC8"FMXF"'EM%=^,V')@[1.,"!\Q)PV/:U,6VIT9:$ MS\%-.P_Z9I=[-5@%[??&\!>RWPYY!X_[!@VQV1X0Y^88^]A(%@,V+B2(=0`&LYV^R:4 MI$(H&_B0QG70KB!:-O2I`OPPCPI2-E$(M;))-50VD0;8<.H#-OS1X&1[IYU" M`(S;VG0:BM"G(&`!O0TJ2_%$"=7PI!K"$VD`#X="P+-QQ9$XV1+"RJ#2\:FS MM_-164K(CP:P[[V_"!HB%(T#A#@N[B,D01,(N8U1IPU)9V.DJA10%&ZMA%(- M`8HT`*@3DK?,,(F:+9TS_(HFU4^42&=#-+U,LVP6RJ$@UN0:XF!#]\8!#IP/ MH5"V<)!822M:"6!TYW8?FPF;E!@'2Z@5!SNTC`Z3@29,JB$.D08X:C;QEF4<%0=QN*;C5E)-!,L0;` M[(Z^VMVD!M.+OBJ3#',\/,&]G-A(%DW91)%5BR9LN*)%$VJ`#7G;-Z.TZTG# MQD=?50F:WH1208J&GV<2?<,^+(8F&@?0SH"`9]M]2GNJM*7CHV^G]0I]*\.]Q*>RE%`466W=235$*-(` M(0Z!^PA)?`1"+OIV>K-<\&Y$,TP&2P%%D=4`I1H"%&D`$*=#`+1EADFH;.D\ MPZ::9EB4/6=#Q,8T2^0KAU9OS+32V&FK&N(0:8`#I\,='"14THI6(D0O^N:M M7XB#Y=.*@QU:1H>`0AQ2#7&(-,`!HF_R(H,V9VGKP+])4'JX<*@[/<,L(N\6 M/ROO=BCRGFK(>Z1IO<]]5ZH:2+QKFQ;P[MX$4)GU!V:$)#L:OUX-8P!\Y+;&O-^HZ*M8=3[Q;]] M47K'5*M!E`C->ZJA"Q]IP#LDRZSD)9$UWCL[$6W\(N8/A\'M1$IGF,I\%/;, M?*HA\Y$&S'-\JB[\QL\.:&\7@`#;":I^'\XH4WL4)JM0V*%>[1J*5$,H(@V@ MX`15H'0;U&#.=ED.[241!1DEBLLF":J*RD*$"#9&)-$#FH;!XT&8P-'ZI M]\Z+WB;3LC@?X9U]`F+)L"H+.[0,#5.)S*<:,A]IP#QGJVJ-S.8$RZ$67%@\ M-/UJZ-.?WKL,4P5E.R>XJ.3=3EOE0]XC#7CG:/6`=TEB<.'!V_50FL;,;P2Y M?C7+X]5UCS*>W!N7TR+OT3C@G;-4Y7WK/4$B&#"`)8\8^*1&00F63IH")JM0 MV*%5FU0&J8;*(-(`"LY4%8IL"D@$:Q&XK'CH=(OI(K!`5R&P0Q&"5$,((@T@ MX%#U``+)8(``L^*ATR[&MY]?5!6!*./9?$@U1"#2``&.4Q6!K?-!4EA+XMG? M&Z.P)EF1WA:E9\!OX54<[%!4":F&.$2:E@/?GW=PF$_+LZ+*@D7^=BB:A4,Y M%'#(-=,R=&\AXA.U/9R"!IV8B,_BU7`H:B*95J"$RD M`3`01?GVLW&YZ:92>+[70],;ASXG"S=K8B/CI&RBB&E%DVJ(3:0!-ASE]A6- MA,!F2OG=2M,ZYT@OK,!'K`\J2-%$D=/0I!I"$VD`#4>\?6@D'#9H_"O?A]+> MAF?4I3.C9)@4311%#4VJ(321!M!P]@,T^0<$#MNZ[9BL7B)ZZ5Y'2_%$.=7P MI!K"$VD`#T="P+-QP9$PV5:.W_]T6N%T"`><._]0=!,L08`=2+RAAG6[=_S#$^$Z$1Y M=+[BMT6S;!7RTXA#.C1QB#3`@2XT3J4M'/BT?,L4-M`Q#C)4O77,3R,.=MIJ MSB$.D08X[(Z^VBB'_E0)7,\#?%J/*D)RIB3?XXN_3ZL`I@K,N[8E)F^?4/.@E9C!"0"1?ZA:2?F\,@TMIPE/-#SDG M-I]JR'RD`?,<]1XP+\D0S,-KAV1>9&+^1-^:<>8M85;F[=!29W`:7?E40^8C M#9CG,%>9WQ[LM9<.<'`O+966.YS0CNYK[`=]'"8%#$.3(@J=>H/--80F&@?0 M<)BKT&230K)?SLND:TQ[S=QVG9'O)^?W:^= M'TI?GLI[%`;->ZHA[Y&F]6RZ&@ZG/-M`S=&P?,[PN,VDRG*8#1?2OBT.FYT_E6Q");ZJ!SIKLMY!I" ML3TSSHUQML\![:/3(O![KDZ[G2X"&@>KP0[UKJ).A<[H@(D01.-`-4!<3-9` M;:$#"%PFZG3:H6TGS!B:$);=JBJP0Q&"5$,((@T@X!!55<'&-YVTHTZ+`B?] M]1`VWIFO*7&P&%=QL$,1AU1#'"(-<.`\M8.#Q##B7;8-M#K")Q*)0Y36C(-I M*@YV:!D=ROV^86CB$(T#'':'16VW4Y=$9P>E*KU/7%Y@]E`Y2'J#L`BRMR:C M"US`>S11$)RI$YI(`V@X7%4EDJT6DL5J'KT=E';J$2##X+X`=2BM?*JZB&*> M+96IALQ'&C#/X>H!\Y+%P+S;06FO'C%_.CWYU&"9KC)OAZ(KGVK(?*0!\YRN M'C`O8:PV[[<)VJHGN.X6Z2KK=BBRGFK(>J1IK<]M=+9;UZX[M?7>-D%EZ]>] M=.]9S)=#@?E<,QU"#9B'M)C,>.VWTYCWVP15B??SV7V2_U#:]E3>HUBG$[Z< MMLJ'O$?C@'>R\4#-=SL"^6U":=HSOYES67Y%5**)<9V60:J@,(@V@X`A5HHR#);:*@QU:1H=J)PZIACA$&N#` MT0DX;'OGMM\TR$\.RV9\FZ`[-KZPKL.TFX0GV&*_/80-@&RJV)]:Q4=H(@V@ MX6BU#XV$LG:V^`^F:6+9R#@IFR@#&IM40VPB3Q]/$4 MC?RUN&I2#:&)-("&96JB%"D08(<5#<1T@B M)A!RZ:_3J*CW!HK*4D)1KC5"J88(11H@U,G'6Z:8Q,P6#RXM-,6B-#H;HOEE MFF6?4`XM:[Z?2W;:JH8X1!K@P-D0*F4+!XF4M-HO=Z?.FRIA9R/C8.FTXF"' MEM$]AU1#'")-RV%N1`0Y9HK'`3:[DZ^V.*K9T+8:/%T/*A,XPQ-]6[]U?3-%2\>GW["EDBXD MN8;@;$^_.W!MI.*6(CXZ1L1$;_EK4>+L3]$/9NFOD1FV@<8,-A/YJOG%1#>"(-X.$("'@VWL?%+3Q1*9T/$QC1+)BZ'HJ7&3EO5$(=(TW*8FR<]SD%[+M&=L-PO>N^E MY*V9;H>B63B40\OH4%KWY;15S11K@,/N_*OMD^J2Z.P-5"5WZO,+OC9,&"2. MME.ELS<(NS7I7,DUQ&9[_)V[($&-;%MOM7]2S8;*Q*TFI;PETYE/-DP$)M50S40: M`,,I4*5I7BBW&IX4@WAB30MGKG+$N#9EFVT/U-+R.\E.VV<>H14EA'JC.:6G5PS M'4(-$-J=C+6[$A!RZ:_3A(D(0:G=#BI+"46Y5FNH\Q>!(A&*Q@%"Y'#'%.OU MA1KQ@T370]ZLB=CP,VB_U5<.!3>H7$,<;.C>.,"A$X8W+#7:38E.+K?2WEXR M;+HT7UCB8.ETV4N60\OH<*WORVFK&N)@0_TGMKV2O M^EY&M]ZJHITKG M<$91E8BBI>/C;]BDR>#(4&2_U"Y4%\&)-`"'T^`^.)(C`8[;,I6^2IQCGH^P M%A,:&:9%T]DSE7%6?=.LBJ*M%4ZD`38QD2`);.`Z4>&(3`J'?C867Z<@ M.J)HZ70*1V1!41"<5$.%$VD`#@?"?7`D2C9P_-Y`^R]%;&2"NMEP MR]:N3``&(MOUT&G>1)VY078S68:G,QK,X;L-%4R]*=8`GMW95YLSM83\[J#3 MPZE+2,)H2BC*K%I`G;\(%(E0-`X0(H?[%AYMX@2$X(Y$-<1_H/W>V3#Z#;C* M4D)^-'!/-91JB%"D`4+[4K&V@J*_4Y(%^89/*);.EYSFEVF65%P.+:-[ M#G;:JH8X1!K@P!EQQU+#I^4_CA9VAC(.,E3]XVCY:50/=EK$(=(`!XZ#P&'; M[4@;0+4E@2F%2D+RIMZ..A^T4D$Z5Z+<:JM)JJ$:B33`AN/@/C82)(&-VQQH MXRAAWVI@B86,RNL>4+(!WZPV:*=8`F[W)=^PWRX(WI*\F MDR\)/KON@?9XBB:*JE(V-E2`C]!$XP`:FA(XI?(]T]AOG@6;(>+"HV/>=6_[ MFRS%XT?SE9-J"$^D`3P<"?>L.&.WGY;;,YFLOISTO13\.+G)4D)1@K4"2C5$ M*-(`(0Z+^PCQF;#NC/@J'M60R(`03,&;R5)"?C1?0ZF&"$4:(,21$0AMF6*2 M-*E6RSI)>R;<4HZE+]R,-9<^<;"`6G&P0\OH@(\XI!KB$&F`P][L.VKKJ[HD_#LJII([ M]=FWF3%!.U7\&RJFJV>>9Q/EVAD[L8DTP(;#(-3(QA0C,;)F0PG/3Q=+F_.G MB=R^8-3>6BT;%WY-%J.Q/[5:6H0FT@`:SH+[T$B*!#2XG1RUG98FO($"%GPW MQ10IG"BUVETHU1"<2-/"X:>T#\Y\)MZ%7!O04662\"ZN#Z@]WJ+Q^TG3A853 M_E90.*$&V.Q.OYV>7VX_.98.6RLSJMOPR\^H,LRJZ?ORIU8U4ZP!,#0C=A8- MG^F*!A;'Z]@T_!H.])%^G%'=CE\=./+WXJI)-00GT@`3WDYTN6UU",EI**$JU1BC5$*%( M`X1VIV/MH@6$7`+L--OJ_!+$J+*44)1MC5"J(4*1!@AQ9H0:VK"?[+8`N^`+ MYV/8;&LV1//+4NNRCRJ'HJ7&3EO5$(=(`QPX'N[@(*DRVT^&+;6,@P74BH,= M6O5(2VZJ(0Z1IN4P]\@"#MOV3-I=JYXQG?VDJN1.?:(8@R%&!>U4Z>PG54J3.!<3G[/I((6CD\Q86,N74=R#;'9 M_M+OW`-K7]T0%9]BW%)2FFSQSF`87(K1QULTG3U3&2>J&WE*06T1FT@#=;,[ M_6K[+*@;J//KJ#*MFW,'SK;T&W;KLKI)$S*QB33`AM/@OKJ1'-FP\3N#IO_7 MI8=&AFGKIC.E1$;_!LM-JB$TD0;0$J=SR[YZN,I MFBBQ6M6D&D(3:0`-1T!`LR&U:.,MX.+>:.KTYZ*O7?@[E>30%$\45PU/JB$\ MD0;P[(Z]VI^K)>0W!ITV7EU"DD-30E%<-4*IA@A%&B#4B;T;8XYD2B#D-@:= M7E_^U[-'5:6`HAQK@%(-`8HT`(@CXXX9)DFSI7/Q-ZPHD,Z&;F/I&+;DX7(H M6H33H8E#I&DY\*JR@\-\6OK9O%%EP5WEMF@6#OEI]^6T5593K`$.N[.O=OQJ M2\)].654F6:8%Y]]59#-E;#!F,Z57$-LMF??N:$7S)5MBXFV`@,V+ON6CF%\ MHW8O;>JC+9A.\BVCK%8$50T]%0KC04$2F4@#5;,[^79;F;DOK=-[/C7=B0S*HF2K6SAMA$&F##27!?U4B&;*K&)U_M+1:@D6%2-"*C?]>3 M;]C'S-!$XP`:3H+[T$B&;-!TDF_I-S8G7_P9X`%Y=\.\W&.E^ZL-%2/%%B-3RIAO!$&L##$1#P;%R* M)3RVA'SR[70DZQ*2T5)"46(U0JF&"$4:(,09M/`O5ZC MLI10%%F-4*HA0I$&"'$ZK`AE4TO"9(OEXMZ%"UN:S49HV;%<6D4].Q2MOJF& M_$>:UO_2::1EZ M>9;+[@0X[(Z\VL6L+HG.2^&JTAOTX'X;9%1!.T4Z+X6'3=.,311G9PVQB33` MAKS5,O&Y[HR3.]R&QKVDF3>Z#SNXK5)IFS;7S#4\J8;P1)H6S^Y6<&.W%9S?2';Z ML_4(J2PCU!EMB;5**-=,]N3[MS0@M#L>:W>UMH;\=W4Z3=AZGZU264HH"K=& M*-40H4@#A,CACBG6[0MW@5/+S7:38U.#C>48=,UXV`)M>)@AY;1_8Q)-<0AT@`'SH+`8=O.0+NGU3.F MLZ%4E=V-G@[N=M1M^M;948;=VFRR1,EVUA"<2`-P.`_N@R-)LH;3^[).:;'& M^;?SK/BYKJ57PY-J"$^D`3P<%/=-*XF8 M+2&_H^QT7^L2DM%20E&N-4*IA@A%&B"T.Q]K-@";7B8(>6T=V.,A^:.$3C`(?=X5=;IM4SIK.C M5)7>C>B##O"V-M6#I-%VKG1VE&&+-ILL4;*=-00GT@`QK`[F\&)TJW!B30`A_/@/CB2)`$.Y!1:3$1F+Y7>O6!Z/_X M6N&KM+-:PZ:S/5"9PGDZPIIT&U60LN$GFN3?L-F;L8G& M`38/KU-"(@L6%5IX4@T1BC1`J!-^-Q+JY5]<)P.13A>^.`_TX;SR;J=$WE,- M>8\TX)UCW@-S0%(A>(?;*GD7F=QWZ54Y?V.Q=%F9MT.1^51#YB--:WYN7K;= MO/8ZJ\W[5_E+0[25RUX>7YR70X'S7#.-H0:<0RI-2EY[F-7.>R_CJVS]LI=> M:)7Y#;&SG+8*B,Q'XX!Y\O%`S6OCLL:\S^&J$N_'P^BV_J7_6>6=GT@2*\MI MD?=H'/#.$>N!DI=$UG@?T=MU+#W-N.@/_JOQY?'*>Y3U-#.6TR+OT3C@G<-3 MY7WC)_6U)QDP<)&ZT[IL.#[!_OQ&K_7H-:]0V*%5F_?EM%4-38%H'$#!*:E" MD9#JB$"D08(<$1ZH`@D434$CD\N]X7-QC3W%4WE/\IKYC_5D/]( M`_XY)E7^MZX'DJYHW0GS;]A8S#A84*LXV*%E=)=_\Z&)0S0.<.#$5''(%@,) M6$T==/)O:1[&]X3+X#XC4QZOO$?1S6H@U9#W2--ZQ[YEB?=^OS*7?U6FKSL- MG88-I0?9XKX<"JY\KIFH\RM=SK54`>XA!F[_7E*W+9G_Z=[2`(R+P']R01]N M7QL88+?PEKX.&3C2NL@U1"8:!\A0>3\P)[2-5STG_-:@]/I:F1'E\:HF^&FL M74MSGFK(>:0!YQRHMJ\&VKBK=M[;&JBLS`C_G9'2`:QR'V4[0 M$;/U0")7X][O#;3QEYJGOH$N%9;68)7Y*,V9^51#YB,-F.?T],"EE[#5F.]L M#MHV8H-KVSB6OEZ5^2C'F?E40^8C#9B'/+@Q#6CC+8#@=@>=_ER]:%QD%8HH MT!F*5$,H(@V@X`SU0!U(Y&H1^-U!IPU7%X$%N`J!'8KNC*F&$$0:0,#QZ0$$ MDK8`@=L==/IV=78'1541B-*<%4&J(0*1!@APB'J`@&2NAL#QR1.(HMELY#:6 MSEN5__2T^W+::I60_VBR&GI3UF9C-;FLHF`F'];-(7#AR*#(O?SXH*C(?:<`\),'-NP.:]ST. MD.NO)I.?VL<;!I6`C)+L#DP6N*8Y$27`>=DA,I$&R'"FVKPV'K5A%9$OD]WM M#DP4S`C^H[P7J&:$'5H&AE6$K*<:LAYIP#HGJ@>L2P"KK7>V!T=M964SHE,+ M%N0J\W8H,I]JR'RD`?.0$;.U4")78][M#H[:ODHO_-/0,6_1K3)OAR+SJ8;, M1QHPS^GI@2LO8:LQ[W<'Q]*@BC?%OGWC\GCE/8IQ$H:6TU;YD/=H'/#.N:GR MOC4,2-P"!O^?M2M:;N((@K_BX@,"$H=E4X2J6+8J+_D(APA#!1!EF\KOI^=V M9V]V9C1S2_$&_<;I]T4NN;@\E)HG*<\0(34D1^CJ5(,9`BPB@IR$() M*;)KH#BN7@+=XM@*K#%S)6"8D(!+9V<::V"*@001II>`=J0!"6:XMD3F>9JI MPK`4MUW"WAPLJ$4!YX5F%\@QAV7HY026<90"9*'6-X$39H79-;XHSZ':3PTC M^$=^KEX$[64>MVH`0HSBCWZ6_%>N!S4#"D:C3;'SZ,P41D7-)PL=Z`QZ-]!* MR^C+_+$._+*S&/1!A%$ZD&<2?;#>(CI)5?:)^JE+JKK<7JI/FR!#,6W4WHND M&W6[<6U9:2+_QRT2890TY*F$-,DZ67.>(/W"PWZJ,E78>9?8\J+$]1&Y M.^Z+%(.^B#"*/'FJ`?+%@BGR=GTHL$I^^V:K[BC0#NSE!'LN+<+:J4\Q8!]A M%'LR50/LBP>3[.WM08UQ"B:>G9R@SJ6(>HH!]0BCJ(^91#[)1`Q-?7)><^(V]/ZBQ3)4\OD-INY[=FR#/I8A\B@'Y M"*/(DX$:(%_\5D?>N3]H84QT?W!EOL$ZM>.">^3D>+U+,>`>87KN1%X=P? M5%39&[>;RRO]R3J/D]T@A&E*=<_(,=!FO4N<$XJ$-MDU4DR8%`3WCG:5*+#J M%NR7;*<6C"0:(_)W3#[%@'R$48U!IFJ`?/%@BKRY0:B11K4=)OO4V=1"CP3[ MR-\Q^Q0#]A%&L2=7-<"^F##)WMX@U+2B8.+9R@GJ7(I6A!0#ZA%&42=3-4"] M>#!)W?O\H$8411//9DZPYU+$/L6`?83IV=/7JP;8SW#USJ&]0:BH2AYKH/D\ ML2+D1T>M%)#/,8*(110*P#FS:A`Y>6T1(Z9&U0O)9L`]@"XP=KT$_9&W:;*[LQLF<3Y+D4D4\Q(!]A%'FR3P/DB]M2 MY-4,86,LL(`\NS9!GDL1^10#\A%&D2?W-$"^F*V.O&.)"BK@SIY-<.=2Q#W% M@'N$Z;GK[*"DZVMB3\?=>&Z@P98V:"6/0MT$<@RD6.\-Y[B<]9=`3=?I);"& MR`GA<27`.+H;N!1)D&(@0811W4#>:4""8K4POMC_[",53M2.8X@:2C1!9.6X M"5(,%(@P2@'R3D*!M==#L5Q2B6OSZ_=3GL^S7S!"ALC/L0PI!C)$&"7#S_G" MFH\#N45#F!\EF<(8G6J(&D;H$!DZUB'%0(<(HW0@[R3:(=L:BM62;>"].]B2 M[&#';1/*^W#GEV;((\EY:V M4C[K;@H3=F:!0#X:1Y$GZS1`OC@M2=Z^-]B";LY-.]LUP9Q+$?,4`^811C$G MXS3`O/@LR=Q[:["FV!0KZ$X[^S5!GDL1^10#\A&F)S_'S:PG7]-I.O+6!E=4 MY6ZC[Z86XXY+$-[XRCNR@HF:YT;B&-^E&1JT3/4]-8%M\.">F39 MZE+77N;1JE=[B%'4,8.RYU?N^F[HS6OC@IW4&?ULW'YJ("$$G57XAM_=\K)( MB&@<)00YI8'^+\:JZ__7U@,[<3..`&S2A`!<.DL.`J087`011@E`'FE`@&*I ME`#F+4$G4L9QP`TE%(@L&U\+*08*1!BEP,]9OQHQTREAOE-U@Q\ARWH:EP)C MA`Y= MQ4"':!RE`YDFH4.V+12/U?6!\P%Y"Y:A;>%:<0!U=FJ".I?.TL)BD&)`/<(H MZN2:!J@7DZ6H&P?<(E^(^INMVB[`G;V:X,ZEB'N*`?<(H[B3:1K@7CR6Y&X- M<,MS.3/I[-,$<2Y%Q%,,B$>8GO@>,UAD<0]_]OB6LY,>CN^<&^E@'N. M.2"'&C-YSD8H[F,6T(N'L?:WI;$0=>>YV79<4%]A`=O+SLH#ZM$XBCIF<*#? M_0`8\[%XA>U>$'?[1$!+8A'4Z3S.S5;=\=O+(NK1.(HZV2/1\2MWNAJ2HCI? M+6B[.7-76VY&7$V=*52]^0^?#CZ?GT M]<_CYX>YDGZ>7P-*NHG4/0IBQ3G1%],6;XOO+O>_N0RR#<>B@*RI@:RI@:RL M*;)D7GX%V6*".A;ZU\Y`MJ`ZLKMK9>;`M<$$5U,#5U,#5UE37,FO**[T7,;P MQ!;?TW&U3W1SJHF$[:PI7V"":_D#D(EKX&IJX"IK/=*M=G1>O502';1R,U54U\-7]G=. M%IC@6IQ3-Z\6!ZX25[B^?/IT/#[?WC_?OW_W]?CX<-P?OWQYNOAP^O$-R\85 MK%"K7CP>/_[^`B?ZZNTL&_Z^/;:A8_,"JX]MWN[=^O;M?NY'A?\#2RG&PGKJ M_9W+'1W;^<>NZ-B5?^R:CEW3L9?M#SZ]?_?]_N'XU_WCP^=O3Q=?CA]!_=5O M%(OP6!;E\I_GTW>LV"\N_CX]8\&>__GI>/_/\9'0`'\\G9[Y/_0'_CL]_CO+ M^_Y_````__\#`%!+`P04``8`"````"$`##R/#@``&0```'AL+W=O MW(C=>>2TS46Y, M-K--@Y>)2+/RN#'__NOYV](T9!.7:9R+DF_,=R[-[]N??UI?1/TB3YPW!C"4 MFJ9:699,3KR(Y4Q4O(0O!U$7<0.O]=&25\;(BDYGG<0/SRE%6R9RN2S]`5 MDII&D:Q^'$M1Q_L<=+\Q+TYZ[O;EAK[(DEI(<6AF0&=1H+>:`RNP@&F[3C-0 M@&DW:G[8F$]LM6.>:6W7;8+^R?A%COXWY$ELY)!MJ!-68"_$"T)_ MI&@"9^O&^[FMP!^UD?)#?,Z;/\7E5YX=3PV4>PZ*4-@J?=]QF4!&@6;FS)$I M$3D$`'^-(L.E`1F)W]KG)4N;T\9T_=E\8;L,X,:>R^8Y0TK32,ZR$<6_!&(= M%9$X'0D\>Q)WQCS;1XX'?F[G!\_.+WB(]SH\//O?&05[^T,6B6USMXN;>+NN MQ<6`!0ER9!7C\F8K(,.D>1\F#;*%/D_HU+H"6D*E7[?,M=G:>H7R)!TH)!#L MK@'DJ(BH1V`MD'?7&ZXN[GSPL2#B(6S(KQZV"ROF?JW[L-%)#=OU!OHV@I`@ MR[:F&%*D&W8C@Q(15.[_1X1.L,Y&.6+,][68"`3%&1*I(:(>,22R-]QS4:(& M5CUJML#],9%*]-N8D(MK3)ZMQ4V8!:T/%LR]A0J(","@;@,+8ZX*VBDLML_F MUY]1E$#(7U*"?JH2%NBK@C!^JR3P%H$:8D2?)W0H',N/5/A?5(%^J@K?TST*%R^,NA MILJJPN%`.QZGSQETTB5HRSHD#$E8VHQI$B/Z/J%A3+)8S-FUXHH(:"6ZB$]M MA;@S"DPW&"40CM@1K1]PD=8Q+F^/,/BH$L7Q+2.NI*KIV%COX.U$FQ M?5\_KCH`/AZ<5QJ-YU\KKQ2%8;/3EM:GJM(ZZF*T+1!V(!)S=[-WB"DUU)([ MG@?;G6%?U.1,[Y362]>BY3WL0-1(W,#1)XVH`TQ)H8Z4 M/)XI&+5:R&;??,-;4W1KVBDF-0!L>:,`^IF,IKIAM)UJT3!KZ]OWIKN&'0@S M>%W3KJV?1E=8KQ)'>:0'3S!1_#2:TWA9\/K((Y[GTDC$&<=N#]KG8*4K0H.5@K0!6J`H>GG6VK(MQ+8, M29M-_KY##BE10UJB^Y*-S.S!]Q;E95OO MJLMAX_W]U^WNOF:WLLRVX!$2[MQCMV MW?5QN6RWQ_)#[R?)<5![[.XN*K8HM/ACAS]6VJ=MZWSU`N"42->\Y7:9+ MB/3\M*O@#GC:%TVYWW@O[#&/U][R^4DDZ)^J?&^U_R_:8_W^2U/M?JLN)60; MZL0K\%K77SGTRXY_!9.7QNS/H@)_-(M=N2_>3MV?]?NO974X=E#N&.Z(W]CC M[L>GLMU"1B',0Q#S2-OZ!`3@W\6YXM*`C!3?Q=_W:M<=-UZ8/,0K/V0`7[R6 M;?>YXB&]Q?:M[>KSOPAB,A0&"600^&L),C$QE!/AKYP80`QSPA)9BR1\*KKB M^:FIWQ>@+.#57@NN4_8(0?C=)Y!#^]W#;?,Y+WR2F`KH%DKV[9F%?OBT_`9Y MWDI0AB!8)CTH&"-RA>#E`3H])[@#RBF$$Z?@LB`@@1P`##?1:8FS0 MVZAVR9CC=)XX6"-&:I'AL"06^NEZ3#S'<3-/JWLX<+#&836^1H;#R"$*4UK+ M',=-#KP_:0M[.@\TXN`9:JW.6NC-@KN=U,CDL>@1\:/&X9+",.Z]R)Q$1C81-59A*%Q-8^ M8X9:\X0%;%G M1U[HL+!>M#LW]CE,^?"`,G@I".45$*MV+JZ8.%M1']/6)@&.8O"RM`D.GLY8B-OT&7.3J$E>M_;[H:49 M.,E-3#121N4F46AN8;JBO5:.NZDMY`ZM&?%,[M#/9]0F8HXMQ%1;#S*J"CG7 M&3FJC<^BJ6,D-5F(J,FJ*HC!B[0!1UYH]'-J,]L!6<)YJ"`&+TLS<%.;M1\8 M:D,4JBUA"?6V$,<=U48:Q(S:T,_GU*98NL+C.PRLA!1 MDVI3$(,7Z0*.:D,+GU.;,OHA8X;:%(3RBBR]P$EM8B)=H-IV&MN!1*':XCBE MO.3X6&V!]B/B:%<>61J$&UFT]AGEB?!CGX/>2SI<+E%CRFS8=HT96UK'O!PC M/HOFECY@9Q(U)<<>8I2=M`DW.4;8+F;D*%&3O#"0N1..N%MK[8OS]QQK4E#63:_"+T^SD)JJXPNKXA084RRFKI M'0YRLS4.[=V!7,J(FBRK@AB\2)]PE!N:_)S<5"L84F:XC((8O"S=PDUNMH9A MR@U1*+5&.LB,W-#PY^2FVL*0.W@A1_I>'BD435]L:1[S MGD[M8EN_\3,YO/OTW^)YH0S."P7\70?Y_B6.X""1V)61$5`HC(BS/<9(`B.) M)5H6KV!D91U9PX@X9++LP\&!H6MQ*'\OFD-U:1>G<@_D_8<59+O!(T?XH:NO MX@S+:]W!42'QWR,<#2MA@?L/`-[7=:<^\!3UA\V>_P,``/__`P!02P,$%``& M``@````A`']Q3672`@``*0@``!D```!X;"]W;W)K&ULG%79;MLP$'POT'\@^!Y+LF(Y-BP'28.T`5J@*'H\TQ0E$1%%@:3CY.^[ M*\8ZZAQ"7PP=LS.SL_1J<_FH*O(@C)6Z3FDT"RD1-=>9K(N4_OIY>W9!B76L MSEBE:Y'2)V'IY?;CA\U!FWM;"N$(,-0VI:5SS3H(+"^%8G:F&U'#FUP;Q1S< MFB*PC1$L:XM4%3B1O.]$K7S)$94S(%_6\K&'MD4 MGT*GF+G?-V=1&6YV[ M&=`%WNAISZM@%0#3=I-)Z`!C)T;D*;V*UM=12(/MI@WHMQ0'.[@FMM2'ST9F M7V4M(&V8$TY@I_4]0N\R?`3%P4GU;3N![X9D(F?[ROW0AR]"%J6#<2^@(VQL MG3W=",LA4:"9S1?(Q'4%!N"7*(E'`Q)ACRF=@[#,7)G2.)DMEF$<`9SLA'6W M$BDIX7OKM/KC05%KRG.UUFZ88]N-T0<"\P:T;1B>GF@-Q.@I@Z.7:/QC*S%^6B<#@#!8_5Y$G:\7MQCAN*]O9%R M,E:>UC\6O3L"#YI@8?D_%K!H'`*D>_%/"AXTM+`*XPXSR@%7_.!?^/8$$#P6 MOUCV1]Q/P&.&VJ],8#56GC8!+'IW`AXTP0+LW%'WTSRT5>,87IC!,VKH8I7T MB\D/P6]LOQ:5,(7X)*K*$J[WN(TCV&?=T^Y+<35OUVKW`A9UPPKQC9E"UI94 M(H?2<+:$OX+QJ][?.-VT2W>G':SH]K*$3[*`S17.`)QK[8XW^#'I/O+;OP`` M`/__`P!02P,$%``&``@````A`'K+QN%H`@``IP4``!D```!X;"]W;W)K&ULE%3+;MLP$+P7Z#\0O$?4PW820W)@UT@;H`&*HH\S M3:TDPJ(HD'2<_'V78J+8M5&X%TJD9F=VA[O*[YY52Y[`6*F[@B913`ET0I>R MJPOZ\\?]U0TEUO&NY*WNH*`O8.G=XN.'?*_-UC8`CB!#9PO:.-?/&;.B`<5M MI'OH\$NEC>(.MZ9FMC?`RR%(M2R-XQE37'8T,,S-)1RZJJ2`M18[!9T+)`9: M[C!_V\C>OK$I<0F=XF:[ZZ^$5CU2;&0KWZTX9O6JS[.9EP\<8] M;$[HE11&6UVY".E82/2TYEMVRY!ID9<2*_"V$P-509?)?#6E;)$/_OR2L+<' M[\0V>O_9R/*K[`#-QFOR%[#1>NNA#Z4_PF!V$GT_7,`W0TJH^*YUW_7^"\BZ M<7C;4RS(US4O7]9@!1J*-%$ZI"%TBPG@2I3TG8&&\.?AN9>E:PJ:S:+I=9PE M""<;L.Y>>DI*Q,XZK7X'4.*3&DG25Q)\OI(DLVB23J]O+F!A(:.AP#5W?)$; MO2?8-*AI>^Y;,)DC\_F*,`N/77IP0;&I,5F+M_"T2++D-F=/Z)UX!:T""-=W MT(A@J#I*H]SETA[LI;TC/I=5.#B42<_+9/\CX\%',N'@4";)TOB\TN18R7=) MAKWV;T]]$.(.[>G!!T@&FH>_?QX/I1]^%`?AZ;$L*K5RR3_M MPGUP>GTL;S?N7W:Y%"?>:>\=PI/_6/[EQ^6_G_[[GX>/,/H>O_E^4@*%4_Q8 M?DN2'(/F5BI9+QUUK^'H*(^_Y`/W^*>K>#K73?YC\,=A%81R^)!60JZH3Y7UV MJDX5E)X>]@'T0`Y[*?)?'LO?1&LKS'+UZ2$=H/\%_D><^5V*W\*/?A3L)\') MA]&&.LD*/(?A=TD=[B4$P546[:856$2EO?_BO1^25?@Q\(/7MP3*;4&/9,=: M^U]=/][!B(),Q;"DTBX\P`G`W](QD-:`$?%^IL>/8)^\/9;-1L5JUDP!]-*S M'R=N("7+I=U[G(3'_RN2N$@I$>,B`L>+B&%7;,NJ-^PFJ-R)-"^1<+Q$.G?Y M]0L?CK^9"VK-2P`<"R6`*S`](3AB`J=BV):P&G+H M[PP:#%$:"4?,5*D;5M-.:W8G4("]5+6ESU0EBU9*7)T"/S#MW=,4:`OP/T9D MS77O1+'.(E/H@J,CW:\ZF2EUP?'!HHMLU8LY66#]Y8]BXX,.$!D+6,4L(-`# M\LDIDZ:H?1-R;$)9XX<3+]`X!9$RK!$!H:L$+B% MT%ZND8(Q&P1N,3;)LT4*Q&@.A(7G#QPHH^`^2!]6,F^T%0F6I^O8DX'O(`,[ MTD4@-Z2'#`QQ$<@-Z2,#0P8(Y(8,D8$A(P1R0\;(P)`)`KDATR\9LR\9540(LB9VJ0CQ=:^(B*N+6#5R/?:+B`QT$=LF MW1D6$1GI(NP68*S:Z^GCBES>)WI`0]3TF7!*VAODJI[I[:9%BC2G"1?9`*MN MV"3A4K7?K]I*$S$=BXBL:=8-`C9'S M6&`6^8!&YJPEMF''5]F$MF40_OJSA(9#YM]-5L2T;'I[N?U,I79[$-`,"T_R MS+"%5G,92#Q;(Y=^6W'4:F[6';(.=U0S*3-=S#4-LT::>T4TW*R&X=3)>/:+ M:`RR&F;=('/(L(C&**M1M^BZ/%;-F84\R_]D9M6:^N5A'E.^Q_8UM"O0O/OL=AKV#:V9!>BLV;FQ;A:X M!B+4XRR70WT.#3@TY-"(0V,.33@TY=",0W,.+3BTY-"*0VL.;3BTU2#=`O*U M[K]A`?5Z&$IUN[[IG5=;[HIS"Y"UO'-C8;V['.IQR.50GT,##@TY-.+0F$,3 M#DTY-./0G$,+#BTYM.+0FD,;#LDOO4[_N$0EW;A MN_QZ!CXJ>'JXPNK3GHW1@HTG$"#X-U&#;W[2SW9("\S\T)*N_*P%Q,"87`U\ M`BWI%T0LI@4[OCQB(9-\@K>-%NR+TZWCYS"!;Y72GV_P;9H/=UFU"I!?PC#!?V2"Z]=N3_\```#_ M_P,`4$L#!!0`!@`(````(0!$Q'LF000``'L.```9````>&PO=V]R:W-H965T M__C*_D?J%GC%N-%"HZ$(_-\TE,$V: MGG&94(-<<`5OCJ0NDP8>ZY-)+S5.LC:H+$S;LJ9FF>25SA6"^C,:Y'C,4QR2 M]%KBJN$B-2Z2!L9/S_F%"K4R_8Q99#!LQVK<;'A?X# M!7M/-Y?SUI]_G0TQ3,!1D#-ME2BDI8`#PJY4YJPPP M)'EKVUN>->>%[DP-U[,A3HJ+V)T(M`]$G@0Z M72"T72!R#-]U)U/?@^Z?1$ZZ2&B_UB7(M@E#*[J<&!/;]?PVXR==3KM(:+_6 MI=<%0BL";1.F$:P6 MN]FV[R6AAIJ\I-H*#9,F6]5[Q[HSV;C(<9#"+?/]!` MZ)[(J+CA[!A-QO-]@K%AG^`G-]O^5@JR5I!0038*$BG(5D%V"A(KR'Z(C!*% M$W>4*#M(V,;XQ8.$R4AE*)?0BG/0J%:1-(GKGB165*@@&P6)%&2K(#L%B15D M/T1&-L']0K%I`J9^T28F(]MTK\#VY%QQCF23=#RL>U)ODX)L%"12D*V"[!0D M5A"X=+?U;K?7Y_:8Y9=H?D4I<7W":UP45$O)E5V09[#U]&AW=W<#*$H8O82O MI@',P@/X://`S[ MAF4`^4A((QY8!_UGX_(_````__\#`%!+`P04``8`"````"$`DD68;ED$``!2 M$0``&````'AL+W=O M-V`(^:&*'!A[P5N_P247!N$-@(/P?[MAGCPF'&;[N MAGQNENV/VCK24W+-Q9_L]BO-SA8QN1M9WO@+CN*R\[V%[-@Z?H$<.M`N7C.4-*VTBL7K/A'0J25DB)^ M*P+_6Q%"9JL@F"]6R^DJ\U8%_G? M;$"XFQX9II^P_YLOF"@4>4*5G0V%!E/!8=%>]^[6>85E25LBE`3\[0FB$E%' MX!J@:#RXX(#;WC(LQ=#RXY7LG"&,SCK54%X8&O$T(R;AJT1L$O.>4*S"@D^W MBC`\7H,I"GK59D9"2<`R]9.X4(GH0R(>(Q3O,,QT[P@W1=([6ZK.0DD,O:]4 M(C()+5T\1BC>H:BF>T=8];Y6G862&'HGVO,=F8AN?HQ0S"\^8QYAU3S1"BN4 M2-"4Y9PL?"U=)#\?IM.MCQ&*]>5GK".L6==*,93(T!K1:C$R$=W]&*&XQR\* M@[UP?&-!6'-_WP1DN4I$<:]5=&0BNOLQ0G&__HQ[A#7WVL"A1!3W6DU')J*) MQ&.$XI[`UX'AY&,C\N':^"(T=VDYM&TE;!DEB%X"#Q@]R2BB1L'&-?DY(K+- M04OIMTY/VUS"EAE&\+0JCQXP1@0YU%#FCJ@1L,--CR#[H1)!KV0BF>'8GE[* M#YB[O_8[@2ES1]0(V.BF1Y!M48F@ES,Q6Z>GU_,#YNZOC6#*W!$U`LS6)R(@ MK=:"=Q>6.Q*1C+(*>E$_8#29>!11(V#7F[X*LD,$<&4N2-J!&R!@P@3-U?9.(=1?&W7"N:A%%LWW#^*M@M5BH3US\:B,&@7[X2#*!_U!=D\E@K$SC778-L*'"!Y\ ML?J63$T+1KIDI-R#WWG'ON-=?+ZZ>V M<1ZID(QW&<*NCQS:Y;Q@796A7S_OKE+D2$6Z@C2\HQEZIA)=KSY^6.ZX>)`U MIS&O:$NGRGG80*;EHB8)'47FR%Y04)JEMO,#W$Z\EK$.6 M82'>P\'+DN7TEN?;EG;*D@C:$`7URYKU\L#6YN^A:XEXV/97.6][H-BPAJEG M0XJ<-E_<5QT79-.`[R<T+>W,/F%;+@H$# MW79'T#)#-WBQQC[R5DO3H-^,[N3HNR-KOOLL6/&5=12Z#7/2$]AP_J"A]X7^ M"9*]%]EW9@+?A5/0DFP;]8/OOE!6U0K&'8,C;6Q1/-]2F4-'@<8-8LV4\P8* M@/].R_31@(Z0)_.Y8X6J,Q0F;CSS0PQP9T.ENF.:$CGY5BK>_K$@O*>R),&> M!#[W)#AP@S3&$D562\%W#IP:T)0]T6<0+X!9.XM>=0:6=,Z- M3C*I@)8PCL<5QOYLZ3U"#_,]:&U!\`H,H&!`>*`^E`"RTQ)"&-'YYAY*T$FG M)8310&^J7%M(:B8[U@O_1T\GP=A&;L!R.E&TH&@$2@;$B66`C"V_;56#,Q28 M/@<^GMJTX9D)1T$R?Z7+,-3W2VKP2#(>7-C.VG!B),-Y$N(A?N(RN412@T>2 MQ\9921O>2R:S9'Y>72&JPECR^AU%XM&*[:S%6-TKB]!@_&2CLV`N\&O1$.3HZLLI[ MD#V^@9_`W\2SWNDT]`24GUW!@=9V'5N'Q3OS5+9<`5KV'RMX=JEL/1\%\`EY^KPH"^, MX2)?_04``/__`P!02P,$%``&``@````A`+,C3&(&`P``H`D``!D```!X;"]W M;W)K&ULE)9=;YLP%(;O)^T_(-^7KS1I$H54#56W M29LT3?NX=L"`5<#(=IKVW^\D&"_?OV<US53I/3"HNZH@$ MKD\<5BD3^_'Z[FQ%&:UBDM1Q6AL3R4JJ@5\5O%%'MRIYCUU%Y>.NN4I$U8#%EI=\ M%I)N2XC[.;BFR=&[O1G85SR10HE,NV#G&=!AS`MOX8'3>I5RB`#3[DB61>0N M6,:!3[SUJDW07\[VZN2_HPJQ_R)Y^IW7#+(-=<(*;(5X1.FW%(=@L3=8_=!6 MX*=T4I;17:E_B?U7QO-"0[FG$!$&MDQ?[IE*(*-@XX93=$I$"0!P=2J.1P,R M0I_;WSU/=1&1R(V@#OJ:;KE11[!TX-[*D:BFX*D)@?1YHS(5L1'!=8"^#I("/T4\GS:CRPH1A8L M`\)MS`!X=W!A;]^A8OXJL4@@1>\G03&D\V3CP)]/[+TW1G1](IK9BGA,8<&! MR2G9M:7VW-QV;:;AV'J\Q6(1PVC].B(MZ MA('O]PB-Z#Q">PSB,84%.;,AQ].'XC=K;$1C<&,*"^[F(W`H'F0NZ&7.B+K: M3NWI^.*TA86=[LQK9#QWN&B`]_K@F:?7B,9R-Z:P(!5!=K>WG>H)F&:/I%Q63.8E:6RDG$#IM="&^#;K1K MQ'FPYD:+INU26Z&A M,[9_"_@28O!F]UT09T+HXPUNT'U;K?\#``#__P,`4$L#!!0`!@`(````(0`^ MSH9;LQ0``(%T```9````>&PO=V]R:W-H965T.K22JL2V7I4QFWG[19(/=P$]1 MEFMN1IFOT6@0C08;+9KZ\.N?3X\7?VQ>]]O=\\?+R6A\>;%YOM\];)^_?;S\ MSV_Q+S>7%_O#W?/#W>/N>?/Q\J_-_O+73__\QX>?N]??]]\WF\,%:7C>?[S\ M?CB\+*^N]O??-T]W^]'N9?-,+5]WKT]W!_K?UV]7^Y?7S=U#T^GI\6HZ'B^N MGNZVSY>MAN7K6W3LOG[=WF_"W?V/I\WSH57RNGF\.Y#]^^_;ESUK>[I_B[JG MN]???[S\B$57[:/V\-?C=++BZ?[9?;M>?=Z]^61KOO/R?SNGG4W_P/J MG[;WK[O][NMA1.JN6D/QFF^O;J](TZ?7I M0^.@_VXW/_?>OR_VWW<_D]?M0[E]WI"W:9[,#'S9[7XWHMF#0=3Y"GK'S0S\ MZ_7B8?/U[L?CX=^[G^EF^^W[@:8[H"LR%[9\^"O<[._)HZ1F-`V,IOO=(QE` M_[UXVIK0((_<_=E\_MP^'+[3O^:CX'H\FY#XQ9?-_A!OC3\>WLF@P9&'QN^]%GS^`#'4EM<^GT MR1UGH\E\O#!7/M!O8?O1I^UW.RA_;>7I\ZP+HR7:V$>?;QJ'K&CDZ=/*3Q>C MZ4TP"4Y=T83"KHT"$W_M#`]?TZ2+&_K'65XU2W"74(-( M@UB#1(-4@TR#7(-"@U*#2H/:`\*9M#[^#F<:-13O-,I`M%HAFM=.:*'"M1/I M7`PD`A(#28"D0#(@.9`"2`FD`E+[1'B;LH'P=O\MES.`D6ZA738R3N/SV]G73=A&]W!SK#-2$O;++GM1E\#"8%$0&(@"9`42`8D M!U(`*8%40&J?"(?1S5PXS.3Y:3`B^3,SO5$D?=F2J;]2YK?S;MZ:3+[NA#@\ M0B`1D!A(`B0%D@')@11`2B`5D-HGPKVT]Q'N'5XK1EKZT!(O'H&$0"(@,9`$ M2`HD`Y(#*8"40"H@M4^$PTQ]IO<=[XI'HTCZLB4J'@,5CYU0%X]`(B`QD`1( M"B0#D@,I@)1`*B"U3X1[:73CBI+B8118AB1`FB%%&&*$=4("H1 M58AJ@:2WS7;97_[#\6FJ,16@C+P(110BBA#%B!)$*:(,48ZH0%0BJA#5`DG_ MF1VR[S\3K;,;%B$)*$*I&%&"*$64(

G/16DZY.\$O96QVMG11W#%U'1A&B&%&"*$64 M("[U*\DVI)R`BA$%"&*$26(4D09HAQ1 M@:A$5"&J!9+^,QM]WW\F6@/:%9U9O$_:@D'$:E=#N%@-QF,=JYT4!V9H=7G) M-D(4(TH0I8@R1#FB`E&)J$)4"R1];6H$W]T%(+," MBE$J090BRA#EB`I$):(*42V0\-_T;ZND&DVRDK)([`."L?X>P4EUT8HH0A0C M2A"EB#)$.:("48FH0E0+)+U]7B5E'*=V^XR\?0"B$%&$*$:4($H198AR1`6B M$E&%J!9(^J^ODGI'9IUB&661&;O["B$8P]#A%%B&)$":(4488H1U0@*A%5B&J! MI$M->7.&2VTUY.)O98Y<9(&T1A0BBA#%B!)$*:(,48ZH0%0BJA#5`DG_Z3)J M>+,TQ5K)(O<]X!I(""0"$@-)@*1`,B`YD`)(":0"4OM$NNR\6FB*M9!%ISIYY1X9#3!==8.EU.*IBH$J=R4JR^=NH)R4G4!=F)N,>Z:]HBFD0>;FT1 M;:T9A1:IZ5'?'$1.BCO&J"M!E+J.GF?&ZE@M__[:F=`[_-*YDF$Y@[W>6H++3^/MTC, MAY7RYZ-%L^MNBB*KRT,QJW<=$T2IZ^AY9ZQ.B3(GQ=[)45>!J,2.%:):=!2> MGNDZ;CC$&W%9K%ED[KY=!@HF>@/,4GX&@C4$8WS0,FM*#UJ47,$C1I MG0&@.F&I00-2EJ)T['0M]&Q9*?HPS\#-9J,;)9&SGD&;"I8:M*EDJ4&;*BME M/CK+@XG:]-6LZYA=,C9TU?FN53C#8M2BN6]%,-&W-NYHUCP_;PCS&EJI6?-T MZ(CZQ[K'P MG5GD'E=<.S0X8VW'FWHH=CIXHR8.#2@/D5=&:+"(P:]&IA&L[GDBX5LIM:2.KGH+>3,]-SRVZ[6-<=CR5)U:-^3KON%3*4F[\ MC,>?-^/3WPM M9)?8%9_(V49<[=4L\G-VAYR=L)C#62OE)>@(46P1?>O"235Q:$!]BKHR1+G3 MQ>H+AP;4EZBK0E0[79"S::K/<;P15XYODN;"2ODY MVZ(V9\]G/2O02IS(V5:*/HX;D+*9@_DQLU*L9M*E@J4&;2I8: MM*ER-KGK"R9J\UZSKF-VR45)(XK8>%_.-EI4R+3H5,ZV'6E]'I^QD,K61KW+ MF9%%-F?W14S;YU3.?LOX*8Z?\?@V9]^.YFK_G[/$L=S8;/8+5CWH@)*E1!!A MSK:7+'+V5!TAU:?LDN%QWA'2#(^0&+FDNG9H<-);72)G`XJ=+DZJB4,#ZE,K MY:G/$.5.%ZLO'!I07Z*N"E'M=$'.IM4+Z]+\*:$)E#8FG4=LTNLU;D^"].I_+?="^7HWE-' M"BL^=FS4R%S.R%O##CG[\5YOI>B#ET^$*':Z6"IQ:$!]BKHR1+G3Q>H+AP;4 MEZBK0E0[77H-S_4!U/"&MQ%7CK>'3^ZL8,ACT7RJ^2I.E5<.RD.D!!1A"A&E"!*$66(VD7$AV'1E%*!4C2A"EB#)$.:("48FH0E0+ M)%UJ:O,S7&K$54A:Y(X0P/;RM`1=#:+0(F'Z?*$JO,A)=:8+7=)TO4G65MC7`;:M%LD8?ZX3,4GX< M80G&4EZ-SNAXCTR'S=VPT73/7Q,G>D^W@GY1O5 M'*B%+"6\HH\$(AZQ/;Z;!2-])!"S!%G;.YITP7G;P@"WA1;)*9^JH]TU2XF+ MTZ M<[)(!L1,F;?FCB<"PJKW#H]9O3V\':F5%7/[V^:>)D-<]XFK->(J]UKD9RI` M80`H0A0C2A"EB#)$.:("48FH0E0+)->.V03Y<7/"?W;/Y$=+B^3^=::/-(-. MBG-XB"A"%"-*$*6(,D0YH@)1B:A"5`LD77K>_BO`_1-;*;$I#6;JV]K(2?'RCQ$E MB%)$&:(<48&H1%0AJBWJV>N:I=Q\A!;)S?), M':=&3LIYNE5/'1DE*)4BRA#EB`I$):(*46U1GZ?/V\0OE.&>+K4MB6RNDB*O1PS)YENB[4@9B*4B*^6A M&#LFB%+7T3DKF*F"-'-2/&*.N@I$I>LXH+YR4JR^%KIDZC^O^%E@\6.1\+*5 M\KW<(L^ED>WHH9C5NXX)HM1U]-P`?]_CI-@-.>HJ$)6NHZ=>EU>5DV+UM=`E MO:S+J^%M\@*+*HN$EZV46D6'TM=$DOZY+O M?=L8K`07+1+.MU*^\UOD[48BV]%#L47"^:`KQ8X9HAQU%8A*U]'WM-I>54[* M>=JW2WKZO$IP@96@1?)@2C_LMF8IBN%N@P*;BI"EW#8P8N3.(N5+76(6&-P@ M)2PU.'[*4N0N9Z4^&,NL%#\N-!OI^T+.>@9M*EAJT*:2I9Q/*FF`RFE^XCP+!Y,LY>^3K/KVV?M)SX.#'=U[H*?U=B;;3(*+!(90%5#JQ9:C#B0Y9R$1\Q:K/`M"<*6(+"Y7B` M)2PU:$#*4LZ`S")>\_3#&2KMYMQIT(""I08-*%G*&5`I`T;J_EISEV/#RS`P MY?;;=S'71ES-MT7>$W\L1;>(XS,06BEZ<)'O3A&BV.EBJ<2A`?4IZLH0Y4X7 MJR\<&E!?HJX*4>UTD7KI>'UJ\+[UAX<)URT267@"#[)9J>&_0`I9RB6AB-6W M67C>\]0N2QQ+0^WNE%4/9L&4I<0B@=LPCWCT*[J<)09M*GBT09M*EG).J5C] MD6^):FX_-KR,#)(22U)'QML>SJ5?,8*E:I&_5#LT$.RAU47/K_(JB1#%/*)3 MGS@TH#Y%71FBW.EB(PJ'!M27J*M"9'[UJ?%78WT[(>VO.+6_+_.T>?VV66\> M'_<7][L?YA>:;LS[%SK<_GS4*E@LS1=89"&T7%-+D\:AY89:FF%URWRZ-$]H M]FB;SZBE^4MPZ#.GEN;;!&@)J*7Y42EH(:O;2@A:R&IZ>J?'@BG]4E;[A)?N M,R6KVU=:00M93>^#ZM-&5M.6H:^%K*9GSGM:YF0!/1+-SY= M)[T[NZ^%/-U^EZ1'F9"GZ07&?7W(T_0>7FRAT]%E324CMM"/HGWNC4)C6(_\ MR@1`#_\\6WZF988#K,C:7D[SV#N--(N]DTASV'\ZZ)2/6OJ<3B=3U-)WC72:0BU]5TG5/[7TV49G M\4MSTHZVT6$QM?391@>%7MVT-"]FPC[T;B%JZ8M1>O$-M?2E#'J?$ZVSOI;5 M_':Y:K_<48EA32WKWA9ZV'!I'B5$V^A9OJ5Y4J^O94(M?;ZF)Q"7<6\+O59K M:5X?A-KH55I+\Z*LOI8;:NGS#KUUB%KZM-'[M9;FU4*HC5ZSM31O&,*6%;6L M>EO6U++N;:%7CBW-"\50&[WMBEKZK`[):O.B)>Q#[R%;FO&ULK)U=<]NX MLJ[O=]7^#RG?KT34!RVYDNP:FY*HS]IU:I]SKCV),W%-$D_9GC5K_?O]@N@F M&OU2I)2:FW'F80-HOF@`#8@2W__7O[Y_>_//A^>7QZK__L_JW_,K]Z\O-[_^'S_[>G'PX>K?S^\7/W7Q__\C_=_/3W__O+U MX>'U#6KX\?+AZNOKZQ\W[]Z]?/KZ\/W^Y>W3'P\_<.7+T_/W^U?\[_-O[U[^ M>'ZX_]P4^O[MW7@T*M]]OW_\<15KN'D^IXZG+U\>/SU43Y_^_/[PXS56\OSP M[?X5_K]\??SC16O[_NFOCM\?7?S>57KWY_NEF M\]N/I^?[7[_AOO]53.\_:=W-_U#UWQ\_/3^]/'UY?8OJWD5'^9X7[Q;O4-/' M]Y\?<0=!]C?/#U\^7/U2W!R+V?SJWM5TP7\_O_G\\.7^SV^O_^?IK_KA\;>O MK^CO&6XIW-G-YW]7#R^?("FJ>3N>A9H^/7V#`_COF^^/(38@R?V_/EQ-T?#C MY]>O'ZXFY=O9]6A2P/S-KP\OKZO'4.75FT]_OKP^??__T:B0JF(EL&PJP5^I MI%CT%BBE`/Y*@?G;Z7AV/6]:[6GI6@KBKQ2X6VBOA'Y?<9S'6%O&/BUK$G417\0\I M6)A`Z-&V0.C$HBF&^N[R78S`)J"K^]?[C^^?G_YZ@VD"]_KRQWV8=(J;4*F& MY3L8V@#K7\$JKY<(6>1MB^8$3^\^-L>OW^W3\QB#Z)S2W;%+G%G5J$ M$1.JK3Q8>K#R8.U![<'&@ZT'.P_V'AP\.!KP#M*V^B(D_@Y]0S5!7U7F5D$2 M?.S$5`LM4GFP]&#EP=J#VH.-!UL/=A[L/3AX<#0@$Q/#Y.\0,U2#>$JT#>ZJM4_:SZ:I6.8EW,F\[/^"5FT MK=\1J8@LB:R(K(G41#9$MD1V1/9$#D2.EF2"8?G/!`LS_F0>$A59S,^>]$-- MN9B1C.V@F4T7KK];(XV/BLB2R(K(FDA-9$-D2V1'9$_D0.1H2:8OLJ1,W_Z` M#-:YAD),0!*IB"R)K(BLB=1$-D2V1'9$]D0.1(Z69(*%;9%-0?H%"]:Y8)'D M03<;N:!KC=J@([(DLB*R)E(3V1#9$MD1V1,Y$#E:DFF(]/@"#8-UKJ$0$W1$ M*B)+(BLB:R(UD0V1+9$=D3V1`Y&C)9E@87=P@6*->2Z9(!=WE-*&=CYX%^,4M&&JMA=!M26DB:,JD[(A61)9$5 MD361VI+\-D)":6\C;BG?7B/!>/WZ^.GWVR=D'.C\CGD^9(BRH92TU-Y=1#/\ M:5/RVPHI&,]=XBXRH@E6H+;@M'`KQ%(*PDKU7'%=:T:UH'`NT58_FTW: M!2A7)^2V5IT.%9"*M3)(*FQEB&B&/Z:Y:=M>2)"US24)V>8$D,1G%D-30O2TB%%+22"+*21"227+O1MY)*AJ*$FJJU]4R2,B45N20A';Q`DI@]9E$2D9.$ MIE0I:"419"6)2"29I\$N`TAXEJ?I,DO%EF6YCGF>Z@IPD?GK5 M@B9*%!E)!.EE-3M:)4$?J34W5VGH6,-B!)JJDY-V2@Y-=.&K.^"*)$DT4:)H'2F=#J,SZ7&DDA:)05!O315 M3FE6[K":S=-REKL7TC7OWGQQSD(JB9[U3U#N'TV1'5:S^8FE;.+3P2#?#-E# M_RK?%,M'IJ+<.3]9=5G-YDGB3+Q)R&*\>$4Q;0Z/!AR4!,BHU]0&GZV#LWE: MS^(>N-LJ:9P[&!()[^`9ZDG^89T3E#N75A9QKM,J:9P[%Q9^[UPQ0A4#TH5R MKF\%Y=ZE25Z\Z[1*.`?[(N6_4$Y?ZE&5?\Z[(RIURY?V%! MM/X-."6+L'4J(F26N@C?30A5C):,5HS6C&I&&T9;1CM&>T8'1L<,Y?J%=='J M%R:6T8[1D=&!TSE,N-T,_D'@C78.[&N"#S:4LX(@]6"56,EHQ6C-:,:D8; M1EM&.T9[1@=&QPSE^ODT8D`_3AXF$9E/6XA41)9$5D361&I+\MOPZ<;`;7". M,8EHBJ%C1E9:H&5D24$;&1&%$#4%W?*ZE.IAI>-O)KO_L;=H%DDA:9R6)*)-D,D_-B212T$HBR$:)U!4E MH0\*IG(9?_JB1.I-3=52,/LX:3)/BN>2^&QT($HX!9U&E$DR6Z3F1!(IF/RL MI&`6)5*71$F*;(D2N3P@"355IZ:2EK-%2I-S27P"?/81\)1S84&9.N4H[9E% M'2EHU1%D`R:BD].*7!Y0AYJJU6T[K92CE%/FZL#JDC$4S-U,&U$FR63AULN[ ML`Z'@E820582J>M4P,CE`4FHJ5I;QY4T^,QJD$L2LL4+IA5)+NVT$E$F23GR MN<=4"EI)!%E)I*Y3DLCE`4FHJ5I;MY*4H]1MN2279953SBH%.4EH/9:"5A)! M5I*(=."D<2_3BEP>D(2:JM7M7)(T:^62A#311LGYTXKDG#9@).>TV4HYHJ59 M"EIU!%EUI"X)&#=SKZ9R>4`=:JJ6@MDZ5([26IFI,_.):_\ZU)CGTXH@%S#N M;NZTH)%$D9%$ZSHQAO1ROR1:;VJJ5F0#9CI*09U+XG/:LP,F',2Y25>04\>- MA#LMF%RN%%EU8O4ZG%*\Q^&D30VH(SZFINK45)IT2_-\6JY.R`7M,*D9+1BM&:T8UHPVC+:,=HSVC`Z-CAG+]T#V9?DUTG?'Q07CN MT`>7("P::;6DCP^TH+4Z^?%!^)PKR7GL]TK*&U/[YI*,6LD5#%:,EHQ M6C.J&6T8;1GM&.T9'1@=,Y1W;TCS[/`(W?MSIY`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`ZIKIH//OS M*-\A9_W._H*/J02Y]=EED7=JE<6@7S(KMI=_C9J%9>_^_!WOU*K7I;U:];IT4*OHT@2_ M7>=FE:-:G/(I'\+0]^\8PJ$:-X0%I3%VMVA1ZE,Z\JK$*AO"L:!!JU27CK%U M0CW5UUS]AM$VU:75[Q+JJ7[/=1T8'5-=-(01)%F']!]V+H*Y$UZ0>?)6K1*J M&"T9K1BM&=6,-HRVC':,]HP.C(X9R@,:PR?3+TR!XQ'FB0$A0SDGI"`[(/FY MVT6'55&DCTYR[SH/,*;-.V&''.13BX6@W$':-758E>:)\=Q!S!HDWUD/+B]" M22>@H-P_6C4ZK/#[GNU!5>8?#M*=@_W=&NUSMY39'V7L8%4'PUN90ON(J/3I M`E[+1`SO92*&%S,1PYN9B.'53,3P;B9B>#D3,;R=B1A>SV29D]-OR8;DY+U7 M,8HL?YYCXC++.V.F4RH4;HLJ@\+$H#`Q*$P,"A.#PL2@,#$H3`P*$X/"Q*"P M94YAO\<:4IAW4\WOM8:QE=(R?NVB6?[$A?]X"-JU M9D:[M@5ET*YE/:U"SK:Z\#[N\5@5Q`S.].HF9OB3S&@/WM8FQ[_%@M[@#AVE*F1QJ2J_ M!8:TYS@&M<]Q#!T@9N+8"-]Z]9]LMC:G''.!W)F97_IKL<6(LW1EV6%H87Y` MKQEYZ#HI.A3R8I8^7L,L$9D("]PM8\2%OI25RRL;<244__,5&LV,.%H M;1BW;6W\U%1;FXSK\6+DGP#%2UQE-P-54E4\X:A9KV-XV:O4UNL87@`K9CH3 MXG=+:<)1FU..Y?'=O/2UK^O.^S"LT)?'VKA79N,^L1[9\"+=N),Q1VUXDRXQ M]$)D]@C=L)XF(#E5!WV)X0V[M@DG7M@@6/$&5E1$-B6^PK)IN:2O51=:=&!: M5K,LW'A%U4;C!S"SR<2=AD#8Z&KVFR&4^>"]Q7)'O6Y!:S'K=0OR2Z/J5NEV M[^B,`;=<_X2=C.V?YA3NC%_4*_1ENEDXQWV1RWW\TSE:-+QYZ?3$@`B7VM)C M2HAP87%XST>XW?;\*7[2T)J<&MV-&?I%:NIU`OU"3J`3,B>NKV?^%R30"V)R MR@G7"V%39'MA:)3()BK3/C(W2M+IG"0O^G;?WG"$]M*"35Z$Z2>WXX6_;8P) M<0)W?[IGH;W4WNL$M"7##CAN@1.9%TR-!R"O==>6+:RMBSU!\W8$#J:91DE M,P1[6UW**!/K:0(R4A.0D1ATLTTXD<+.RLX9/QFW<8.&54-OXA8?BC1ZNJG$ M+8"(6RF*OFW#NTM.,<.M)+..!5<:U8'=F5&*S=#T7]9VP+.Y;9GK`)^*(^VB69Y3$$/=M=1HRF-%;UM,$ M)*?JH"\QQ'U;'>^D,)'UBG?6HQ,%CNAYSHC,S==N1D7E@ M6V6Q"2=>V&)9\0:6Q/`9GU\2E:6'"^X*9E!$RB:[90>#(F2W[F"X?;+#[1/# M[1/;=;!]!SMTL&/.G)QADV3E#(OG=?D62]F0L+)/RZ)/F!U1_/Q!H6^MMF:E M^6J7VD.M+H=-'C^AQL4L,/4X,/4X,/4X,/4X,/4X,/4X, M/4X,/4X,/4X,/4X,/6Z9DS-L"BZ1,VXB@0I#7*>8D*[R--@[SV-#.$EGW?2P86\5#JXT0Z^CMV&FME) MMN/\6LUB=E-,"__]2MRPN'1F=A,RUDNZ2S+<;!V)#/LN$8&."O0UV`B;7A&D M..I7W,HIVUNVX/V=\E=QRSQ7R\1Y:ZG3:9>&(X!,M@ MMXN9/1R1HGB)=9!SYK^E@_N50OASQOTV+\.^X'[UY=FVAX6E'J;-A98:Z&$U MLSVLE[<^R[0BT& MQKN:V8Y7)H-[S-_F;6L_L^M]NCB0BV&0T0RG+.T?<(]BAW'7&8"R11&S[$"* M&7JWK8YVS:''_XZNE`0KB^G(@NCM32`3RS>QN%H.MNE@VPZV MZV#[#G;H8,>=`E<@9[+V=D*>/"\/"H8@0MO16D]`A*>@0A/8*.'D%& M@]Q=AV3HDKN.R5.VV(?'#Z'$P,NJ"S$+ATN=XU8GQ5A;<+DU*_VS+%"L-=,H MA63B7(I<:-:R5)V=+9I6H6-;73(K9^XS2&C;FFFK$+=M@8=H2+RLNG[R.>], M4UXTGHL>B^-.:64?R+L$R=%&7 M-/:N2X1E*40YH]V/%L7BT>F8S`QJ9G-C;2'F"]<+_WS4"K^XTH1*R!I.5[Y6 ML_"!YFFSNC5+/FR4A:6Z+5K2+WRT9J<<*#IU$J%F* M/,@O+<3P+XO2)0R07RR&HE_,AJ)?S)(/D#^RP>@?<,3)'[8=%ZS'^D[[3/Y0 MA_]1]M(%Z%VA17LC#]$?:\.#$[KN07YI(4[^L]G"C7G(+Q:X^79JMDN>1K]4 MWNL#HI]\@/S2`OZT+92ERZ\P^8C9*4><_'#D(OF#O5][(\LG?Q^@D%_,>B,/ M\HM9BCS(+TRBOS1?&6UTA?QB,13]Y_@`^:K9*4><_&%#92>?G]LU365?ELU)D;E!P0FIF.'N>GM%S+)!(2P. M"CQ=X<1`KXC%T*`XQP?T"OF`7HG,#0KG".:D`4=O@!G9HOT7]\WT35+\54=GN9_,+L@9G:X5*OUK$H]C!F_B<&=:D)Y)8M MZVD"4K9FV@2D)`;=+',BH5,SD7XR=$,U?D*)+,F)R4/,AB8/,I;:^ MHU[33U.;64V4A/K":,* M7X1K.@_[3@VC90=;*/#JKB;JCZ*:#;7/FQ`N;I@N&\RQNLK(S*&7I@:*[ M@AD4D;+)#HH0@R+$UAT,MT]VN'UBN'UBNPZV[V"'#G;,F9,S[&ZLG#$6,5`& MILF9[*C2N+XME&%^;J?$CN>.NLQ*\_NNSD/X0AX&A88<#.7\Z!"6.^@6&,1" MAYE]DMTY&%)D*^&08S&ESB-26.Z8VQ;`L0ZSTGSEQCD6DL=+'(O)9NZ8L+1\ MP0MB&"K$,%2(8:@0PU`AAJ%"#$.%&(8*,0P58A@JQ#!4B&&H6.;D##FCE3,, MET'AM;I_O?_X M_OO#\V\/=P_?OKV\^?3T9]B&X#6F!K]Y?OCRX0IKZORFJ0L"M47TVGB&:YA^ MNJY-PC5\K-UU;5:$.INLANJ%:LY?GWL/74>,U M;@[OC.NZ@N[!V]"ZKBQPI9EI?#MSR(%W4G646<`#_$)=QY70+=V],D.9[CXI MX37>--U16PG?\([BCBO7\`V!V'4%@N--L5U7<*&+0YI.9=!X9]M%$R9=-16A MLSO;'N,>\6`D>Q4^0;]I/O?E:^%C\YOFLUZ^%CX7OVD^\^5KOQ0WOW1'(]SK M\.$6\=ME_\ODYI XML 21 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Incentive Plans - Additional Information (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Equity Incentive Plan [Line Items]      
Compensation expenses $ 0 $ 0 $ 12,000
Outstanding stock options, remaining weighted average life 2 years 6 months    
Dividend equivalent rights, outstanding 40,000 43,000 51,000
Dividend equivalent rights paid to officers and Trustees 106,000 116,000 178,000
Number of stock options exercised during the period, shares 3,000 8,000  
Value of stock options exercised during the period 46,290 148,930  
Number of unvested options during the period 0    
Incentive Plan 2007
     
Equity Incentive Plan [Line Items]      
Number of shares authorized for issuance 75,000    
Shares issued, net of cancellation 47,975    
Number of shares vested 28,870    
Number of shares remaining for issuance 27,025    
Restricted shares issued, net of cancellation 8,730 10,375 7,395
Restricted shares issued, weighted average grant price $ 43.54 $ 39.05 $ 41.90
Restricted shares of beneficial interest, net of cancellations, issued, value 380,104 405,144 309,850
Restricted shares, Vesting Period 2015-06 2014-06  
Compensation expenses 375,000 329,000 216,000
Compensation expenses remained to be recognized in future 354,000    
Compensation expenses not yet recognized, period of recognition 1 year    
1997 Plan
     
Equity Incentive Plan [Line Items]      
Compensation expenses $ 19,000 $ 18,000 $ 18,000
Options granted, vesting percentage per year starting from one year from date of grant 25.00%    
Options, expiration period 10 years    
Options outstanding and exercisable 40,000    
Options outstanding and exercisable, average price per share $ 35.65    
XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) (2012 Acquisitions, USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
2012 Acquisitions
 
Business Acquisition [Line Items]  
Debt, fair value adjustment $ 799
XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 24 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Schedule of Equity Method Investments [Line Items]      
Interest income earned on various advances made to LLCs $ 1.9 $ 1.5 $ 2.6
XML 25 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2013
Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalent Rights

Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:

 

Outstanding Options

   Number
of Shares
     Exercise
Weighted-
Average Price
     Grant Price Range
(High-Low)
 

Balance, January 1, 2011

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     —          —          —    
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2012

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     8,000         26.76       $ 27.65/$26.09   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2013

     43,000       $ 35.22       $ 36.53/$29.44   

Exercised

     3,000         29.44       $ 29.44/$29.44   
  

 

 

    

 

 

    

 

 

 

Outstanding options vested and exercisable as of December 31, 2013

     40,000       $ 35.65       $ 36.53/$30.06   
  

 

 

    

 

 

    

 

 

 
Information about Options Outstanding and Exercisable Options

The following table provides information about options outstanding and exercisable options at December 31, 2013:

 

     Options
Outstanding
and Exercisable
 

Number

     40,000   

Weighted average exercise price

   $ 35.65   

Aggregate intrinsic value

   $ 176,240   

Weighted average remaining contractual life

     2.5   
Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and to Options Exercisable

The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December 31, 2013 were as follows:

 

     Options Outstanding and
Exercisable
 

Exercise Price

   Shares      Weighted
Average
Exercise
Price Per
Share
     Weighted
Average
Remaining
Contractual
Life (in
Years)
 

$30.06 -$34.07

     4,000       $ 33.07         1.0   

$34.90 -$34.90

     13,000         34.90         1.7   

$36.53 -$36.53

     23,000         36.53         3.2   
  

 

 

    

 

 

    

 

 

 

Total

     40,000       $ 35.65         2.5   
  

 

 

    

 

 

    

 

 

 
XML 26 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summarized Financial Information of Equity Affiliates - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2012
Mar. 31, 2012
Dec. 31, 2013
Entity
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2008
Dec. 12, 2011
Limited Liability Companies
Dec. 31, 2011
Limited Liability Companies
Entity
Schedule of Equity Method Investments [Line Items]                
Number of limited liability companies where company has investments or commitments     13          
Number of limited liability companies, third party minority ownership interests, purchased     11         11
Ownership interests in LLCs after acquisition     100.00%         100.00%
Aggregate cash expenditure made on purchasing LLCs             $ 4,400,000 $ 4,400,000
Net gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs         28,600,000     28,600,000
Cash proceeds received from divestiture of property owned by eight LLCs, net     0 12,175,000 33,836,000      
Gain on divestitures of properties owned by unconsolidated LLCs, net 1,145,000 [1] 7,375,000 [1] 0 8,520,000 [1],[2] 35,835,000 [2]      
Number of days for Non-Offering Member either to purchase or sell its entire ownership interest to or from Offering Member           60 days    
Investment or advance in two LLCs which own properties in California     $ 16,300,000          
[1] During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
[2] As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
XML 27 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary Of Outstanding Mortgages (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Debt Disclosure [Line Items]  
Outstanding Balance $ 105,453 [1]
Summerlin Hospital Medical Office Building I fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 9,188 [1],[2]
Interest Rate 6.55% [2]
Maturity Date 2014 [2]
Spring Valley Medical Office Building fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 5,122 [1]
Interest Rate 5.50%
Maturity Date 2015
Summerlin Hospital Medical Office Building III floating rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 11,347 [1]
Interest Rate 3.42%
Maturity Date 2016
Peace Health fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 21,681 [1]
Interest Rate 5.64%
Maturity Date 2017
Summerlin Hospital Medical Office Building II fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 12,021 [1]
Interest Rate 5.50%
Maturity Date 2017
Auburn Medical II floating rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 7,406 [1]
Interest Rate 2.92%
Maturity Date 2017
Medical Center of Western Connecticut fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 4,899 [1]
Interest Rate 6.00%
Maturity Date 2017
Centennial Hills Medical Office Building fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 10,938 [1]
Interest Rate 3.42%
Maturity Date 2018
Vibra Hospital of Corpus Christi Fixed Rate Mortgage Loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 2,983 [1]
Interest Rate 6.50%
Maturity Date 2019
BRB Medical Office Building fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 6,840 [1]
Interest Rate 4.27%
Maturity Date 2022
700 Shadow Lane and Goldring MOBs fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance 6,766 [1]
Interest Rate 4.54%
Maturity Date 2022
Tuscan Professional Building fixed rate mortgage loan
 
Debt Disclosure [Line Items]  
Outstanding Balance $ 6,262 [1]
Interest Rate 5.56%
Maturity Date 2025
[1] Amortized principal payments are made on a monthly basis.
[2] In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.
XML 28 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Eight Limited Liability Companies that Completed Divestitures of Property (Parenthetical) (Detail)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2011
Investment [Line Items]    
Noncontrolling ownership interest of Trust in Master LLC 90.00%  
Deerval Parking Company | Deerval Properties
   
Investment [Line Items]    
Percentage of joint venture ownership 50.00% 50.00%
Deerval Parking Company | Deerval Properties II
   
Investment [Line Items]    
Percentage of joint venture ownership 50.00% 50.00%
XML 29 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Grayson Properties
Dec. 31, 2013
FTX MOB Phase II limited partnership
Dec. 31, 2013
Palmdale Medical Properties and Sparks Medical Properties
Dec. 31, 2013
Arlington Medical Properties
Jan. 01, 2014
Subsequent Event
Palmdale Medical Properties and Sparks Medical Properties
Schedule of Equity Method Investments [Line Items]          
Committed investment in equity and debt financing $ 4.4 $ 2.5   $ 6.3  
Committed investment in equity and debt financing, funded $ 2.1 $ 1.1   $ 5.2  
Non-controlling interest percentage       75.00% 100.00%
Percentage of ownership interest purchased         5.00%
Effective date of acquisition     Jan. 01, 2014    
XML 30 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
Reconciliation of Real Estate Properties and Accumulated Depreciation (Parenthetical) (Detail) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2008
Real Estate and Accumulated Depreciation [Line Items]          
Asset impairment charge $ 5,354,000 $ 0 $ 0 $ 5,354,000 $ 4,600,000
Impaired asset, gross value 11,500,000     11,500,000  
Sheffield Medical Building Atlanta, Georgia
         
Real Estate and Accumulated Depreciation [Line Items]          
Impaired asset, accumulated depreciation $ 6,100,000        
XML 31 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting - Additional Information (Detail)
12 Months Ended
Dec. 31, 2013
Segment
Segment Reporting Information [Line Items]  
Number of reportable segments 1
XML 32 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalent Rights (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2010
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares outstanding options, beginning balance 43,000 51,000 51,000
Number of shares outstanding options, exercised 3,000 8,000  
Number of shares outstanding options, ending balance 40,000 43,000 51,000
Exercise weighted average price, outstanding option beginning balance $ 35.22 $ 33.89 $ 33.89
Exercise weighted average price, outstanding option Exercised $ 29.44 $ 26.76  
Exercise weighted average price, outstanding option Ending balance $ 35.65 $ 35.22 $ 33.89
Maximum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant price, Beginning balance $ 36.53 $ 36.53 $ 36.53
Grant price, Exercised $ 29.44 $ 27.65  
Grant price, ending Balance   $ 36.53 $ 36.53
Grant price, vested and exercisable $ 36.53    
Minimum
     
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Grant price, Beginning balance $ 29.44 $ 26.09 $ 26.09
Grant price, Exercised $ 29.44 $ 26.09  
Grant price, ending Balance   $ 29.44 $ 26.09
Grant price, vested and exercisable $ 30.06    
XML 33 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Relationship with UHS and Related Party Transactions
12 Months Ended
Dec. 31, 2013
Relationship with UHS and Related Party Transactions
(2)   RELATIONSHIP WITH UHS AND RELATED PARTY TRANSACTIONS

 

Leases:    We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

 

The combined revenues generated from the leases on the UHS hospital facilities accounted for approximately 41% of our total revenue for the five years ended December 31, 2013 (approximately 30% for each of the years ended December 31, 2013 and 2012, and 55% for the year ended December 31, 2011). The decrease during 2013 and 2012 as compared to 2011 is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 20% of the combined consolidated and unconsolidated revenue for the five years ended December 31, 2013 (approximately 22% for the year ended December 31, 2013, 21% for the year ended December 31, 2012 and 19% for the year ended December 31, 2011). In addition, twelve MOBs, that are either wholly or jointly-owned, include or will include tenants which are subsidiaries of UHS.

 

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value.

 

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

The Bridgeway

   Behavioral Health    $ 930,000         December, 2014         10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).

 

Management cannot predict whether the leases with subsidiaries of UHS, which have renewal options at existing lease rates or fair market value lease rates, or any of our other leases, will be renewed at the end of their lease term. If the leases are not renewed at their current rates or the fair market value lease rates, we would be required to find other operators for those facilities and/or enter into leases on terms potentially less favorable to us than the current leases. The Bridgeway’s lease term is scheduled to end in December, 2014. We can provide no assurance that this lease will be renewed at the fair market value lease rate.

 

As discussed above, Palmdale Medical Plaza, which is located in Palmdale, California, on the campus of a UHS hospital, had a master lease commitment by a wholly-owned subsidiary of UHS which expired on June 30, 2013. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. The LLC that owns this MOB was deemed to be a variable interest entity during the term of the master lease and was therefore consolidated in our financial statements through June 30, 2013 since we were the primary beneficiary through that date. Effective July 1, 2013, this LLC is no longer be deemed a variable interest entity and is accounted for in our financial statements on an unconsolidated basis pursuant to the equity method.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs (which own MOBs) and will begin accounting for them on a consolidated basis effective January 1, 2014.

 

We have funded $2.1 million in equity as of December 31, 2013, and are committed to fund an additional $2.3 million, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a UHS acute care hospital which is owned and operated by Texoma Medical Center (“Texoma Hospital”), a wholly-owned subsidiary of UHS. This MOB has tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $12.5 million, which is non-recourse to us, outstanding as of December 31, 2013. As this LLC is not considered to be a variable interest entity and does not meet the other criteria requiring consolidation of an investment, it is accounted for pursuant to the equity method.

 

Advisory Agreement:    UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. In December of 2013, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2014 pursuant to the same terms as the Advisory Agreement in place during 2013. In December of 2012, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the 2013 advisory fee, as compared to the 2012 advisory fee, was increased to 0.70% (from 0.65%) of our average invested real estate assets, as derived from our consolidated balance sheet.

 

The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during 2013, 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $2.4 million during 2013, $2.1 million during 2012 and $2.0 million during 2011 and were based upon average invested real estate assets of $338 million, $326 million and $309 million during 2013, 2012 and 2011, respectively.

 

Officers and Employees:    Our officers are all employees of a wholly-owned subsidiary of UHS and although as of December 31, 2013 we had no salaried employees, our officers do typically receive annual stock-based compensation awards in the form of restricted stock. In special circumstances, if warranted and deemed appropriate by the Compensation Committee of the Board of Trustees, our officers may also receive one-time special compensation awards in the form of restricted stock and/or cash bonuses.

 

Share Ownership:    As of December 31, 2013 and 2012, UHS owned 6.1% and 6.2%, respectively, of our outstanding shares of beneficial interest.

 

SEC reporting requirements of UHS:    UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 30% of our consolidated revenues for each of the years ended December 31, 2013 and 2012, and 55% of our consolidated revenues for the year ended December 31, 2011, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

XML 34 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Quarterly Financial Information [Line Items]                      
Revenues $ 13,445 [1] $ 13,448 [1] $ 13,502 [1] $ 13,885 [1] $ 13,323 $ 13,610 $ 13,666 $ 13,351 $ 54,280 [1] $ 53,950  
Net income before gains         3,365 2,986 2,467 2,139   10,957  
Net gains on divestiture of properties owned by unconsolidated LLCs         1,145 [2]     7,375 [2] 0 8,520 [2],[3] 35,835 [3]
Net income $ 3,498 [1] $ 3,303 [1] $ 2,941 [1] $ 3,427 [1] $ 4,510 $ 2,986 $ 2,467 $ 9,514 $ 13,169 [1] $ 19,477 $ 73,794
Total basic earnings per share $ 0.27 [1] $ 0.26 [1] $ 0.23 [1] $ 0.27 [1] $ 0.36 $ 0.24 $ 0.19 $ 0.75 $ 1.04 [1] $ 1.54 $ 5.84
Total diluted earnings per share $ 0.27 [1] $ 0.26 [1] $ 0.23 [1] $ 0.27 [1] $ 0.36 $ 0.24 $ 0.19 $ 0.75 $ 1.04 [1] $ 1.54 $ 5.83
[1] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
[2] During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
[3] As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
EXCEL 35 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ M9#8X,6$Y-S'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;G-O;&ED871E9%]3=&%T96UE;G1S7V]F7T-A M#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)E;&%T:6]N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C M<75I#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D1I=FED96YD#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN M8V5N=&EV95]0;&%N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-%1TU%3E1?4D503U)4 M24Y'/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E M;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT,CPO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E)E;&%T:6]N#I7;W)K&ES=&EN9U],96%S95]497)M#I7;W)K&ES=&EN9U],96%S95]497)M M#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%L;&]C871I;VY?;V9? M4'5R8VAA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%L;&]C871I;VY?;V9?4'5R8VAA#I7;W)K#I7;W)K#I7;W)K5]#;VUP86X\+W@Z3F%M93X-"B`@("`\>#I7;W)K M5]#;VUP M86XQ/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O5]O9E]297%U:7)E9%]# M;VUP;&EA;F-E/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O5]/9E]/=71S=&%N9&EN9U]-;W)T9V%G/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1I=FED96YD#I7;W)K#I7;W)K#I7;W)K#I7;W)K MF5D7T9I;F%N8VEA;%]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE M/DQI;6ET961?3&EA8FEL:71Y7T-O;7!A;FEE#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DQI;6ET961?3&EA8FEL:71Y7T-O M;7!A;FEE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DQI;6ET961?3&EA8FEL:71Y7T-O;7!A;FEE#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?4F5P;W)T:6YG7T%D9&ET:6]N86Q? M23PO>#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E%U87)T97)L>5]297-U;'1S7U!A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-C:&5D=6QE7TE)25]296%L7T5S=&%T95]A;F1? M03$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I%>&-E;%=O M#I! M8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E M;%=O7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U5(5#QS<&%N/CPO'0^)SQS<&%N/CPO2!#96YT3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)S`P,#`W.3@W.#,\'0^)SQS<&%N M/CPO'0^)RTM,3(M,S$\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)UEE'0^)TYO M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)T%C8V5L97)A=&5D($9I;&5R/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4L(&YO;BUR96-O=7)S92!T;R!U3H\+W-TF5D.R!I2!I;G1E7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P,"PP M,#`\'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO2!F965S('1O(%5(4SPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!I;B!I;F-O;64@;V8@=6YC;VYS M;VQI9&%T960@;&EM:71E9"!L:6%B:6QI='D@8V]M<&%N:65S("@B3$Q#&EM871E;'D@)#$N.2!M:6QL:6]N+"`D,2XU(&UI;&QI;VX@86YD M("0R+C8@;6EL;&EO;BP@2UO M=VYE9"!B>2!U2!A8V-O=6YT960@9F]R(&]N M(&%N('5N8V]NF$@;VX@86X@=6YC;VYS;VQI9&%T M960@8F%S:7,@<'5R2!M971H;V0@87,@;V8@ M2G5L>2`Q+"`R,#$S+B!02!W97)E(')E8V]R9&5D(&]N M(&$@8V]N'10 M87)T7V,R-F4Y-V,V7S,W-F9?-&4W.5\Y9#DX7SDT.3%D-C@Q83DW-PT*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C,C9E.3=C-E\S-S9F7S1E-SE? M.60Y.%\Y-#DQ9#8X,6$Y-S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`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`@("`\=&%B;&4@8VQA M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XQ."PX-#,\F%T:6]N(&]N(&1E8G0@<')E;6EU;3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S2UO=VYE9"!,3$-S(&)E9F]R92!T'0^ M)SQS<&%N/CPO2!O<&5R871I;F<@86-T:79I=&EE M'0^)SQS<&%N/CPO6UE;G1S M(&]F(&%D=F%N8V5S(&UA9&4@=&\@3$Q#2!P87)T;F5R2!I;G1E'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!I;G1E2`Q+"`R,#$S+"!T:&4@9FEN86YC:6%L(')EF$N(%1H97)E M('=A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F M7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO8S(V93DW8S9?,S'0O M:'1M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX- M"B`\=&%B;&4@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/E-534U!4ED@3T8@4TE'3DE&24-!3E0- M"B!!0T-/54Y424Y'(%!/3$E#2453/"]B/CPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X M.R!-05)'24XM5$]0.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CQB/DYA='5R92!O9@T*($]P97)A=&EO M;G,\+V(^/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]- M.B`M-G!X.R!-05)'24XM5$]0.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@2!);F-O;64@5')U#(P,40[*2!I M0T*(&-E;G1E2UE:6=H="!R96%L M(&5S=&%T92!I;G9E6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z M(#!P>"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S M='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/F9O0T*('5N8V]N6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=7(@9G5T M=7)E#0H@2!R97-U;'0@:6X@9&5C2!R871E2!P;W1E;G1I86QL>2!H879E M#0H@82!N96=A=&EV92!I;7!A8W0@;VX@=&AE(&9U='5R92!L96%S92!R96YE M=V%L('1E0T*(&EN8W)E87-E(&]UF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2P@=&AA="!T:&4@9F%C=&]R2!T;R!M965T M('1H96ER(&]B;&EG871I;VYS('5N9&5R('1H92!T97)M2!A9F9E8W1E9"!I;B!T:&4@;F5A M6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T M>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CX\8CY2979E;G5E#0H@4F5C;V=N:71I;VX\+V(^/"]F;VYT/CPO M<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`M-G!X.R!-05)'24XM M5$]0.B`P<'@G/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@&5S(&%N9`T*('5T:6QI=&EE6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!M M:6YI;75M#0H@0T*(&]U65A MF5D('5S:6YG('1H92!S=')A:6=H M="UL:6YE(&UE=&AO9"!U;F1EF5D(&5V96YL>2!O=F5R('1H92!L96%S92!T97)M#0H@ M6UE;G1S(&%R92!D=64N(%1H92!A;6]U M;G0@;V8@&ES=&EN9PT* M(&QE87-E65AF5D('=H96X@96%R;F5D(&)A M28C>#(P,3D[ M&-E28C>#(P,3D['!E;G-E"<^ M/&9O;G0@#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4 M+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D]N('1H92!D871E(&]F#0H@86-Q M=6ES:71I;VXL('1H92!P=7)C:&%S92!P28C>#(P,3D[65AF%T:6]N(&5X<&5N$$P.VUI;&QI;VXL("0S M+C0F(WA!,#MM:6QL:6]N("0R+CD-"B!M:6QL:6]N(&%N9"`D,2XW(&UI;&QI M;VX@9F]R(#(P,30L(#(P,34L(#(P,38L(#(P,3<@86YD(#(P,3@L#0H@65A$$P.S,Q+"`R,#$S+`T* M("0W+C@@;6EL;&EO;B!F;W(@=&AE('EE87(@96YD960@1&5C96UB97(F(WA! M,#LS,2P@,C`Q,B!A;F0@)#@S-BPP,#`-"B!F;W(@=&AE('EE87(@96YD960@ M1&5C96UB97(F(WA!,#LS,2P@,C`Q,2X@1&5P'!E;G-E('=A"<^/&9O;G0@"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E(&-O;G-I9&5R(&%L;`T*(&AI9VAL>2!L:7%U:60@:6YV M97-T;65N="!I;G-TF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/CQB/D%S6QE/3-$)TU!4D=)3BU"3U143TTZ M("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`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`T*(&EN8V]M92X@5&\@=&AE(&5X=&5N="!E6EN9R!V86QU92!O9B!T:&4@<')O<&5R='DL('1H92!L;W-S('=I;&P@8F4@ M;65A6EN9R!A;6]U M;G0@;V8@=&AE('!R;W!E"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY!6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D1U"<^/&9O;G0@#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!;B!O=&AE2!A;F0-"B!D=7)A=&EO;B!O9B!T:&4@9&5C;&EN92!I;B!V86QU92P@:6YC M;'5D:6YG('!R;VIE8W1E9"!D96-L:6YE6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=7(-"B!C;VYS M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D92!T:&4@8V]N M2!W:&5R92!W M92!A2X@26X@86-C;W)D86YC M92!W:71H('1H92!&05-")B-X,C`Q.3MS('-T86YD87)D$$P.V1I=F5S=&ET=7)E(&]F('!R;W!E2!B92!A M;&QO8V%T960@9&ES<')O<&]R=&EO;F%T96QY(&%S#0H@8V]M<&%R960@=&\@ M;W=N97)S:&EP(&EN=&5R97-TF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$S+"!W92!H879E(&YO;BUC;VYT2!M971H;V0@2!A$$P.S,P+`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`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY086QM9&%L90T*($UE9&EC86P@4')O<&5R M=&EE2P@54A3(&]F($1E;&%W87)E+"!A#0H@=VAO;&QY+6]W;F5D('-U8G-I9&EA M2!A9W)E96UE;G0@86YD(&UA;F%G97,@ M;W5R(&1A>2UT;RUD87D@869F86ER$$P.S,P+"`R,#$S M+"!S:6YC92!I="!W87,@82!V87)I86)L90T*(&EN=&5R97-T(&5N=&ET>2!A M;F0@=V4@=V5R92!D965M960@=&\@8F4@=&AE('!R:6UA28C>$$P.S$L(#(P,3,L('1H92!M87-T97(@;&5A M2!A;F0@=V4@=&AEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@#(P,3D[#L@34%21TE. M+51/4#H@,3)P>"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@ M-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5F9F5C=&EV90T*($IA;G5A28C>#(P,3D[F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!M:6YO2!O=VYE"<^/&9O;G0@"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U14 M3TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY.;R!P2!A&5S(&%N9"!W90T*(&%R92!R97%U:7)E9"!T;R!D:7-T&%B;&4@:6YC;VUE('1O(&]U"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!A&-I65A"!E<75A;',@ M-"4@;V8@=&AE(&%M;W5N="!B>2!W:&EC:"`X-24@;V8@;W5R(&]R9&EN87)Y M#0H@:6YC;VUE('!L=7,@.34E(&]F(&%N>2!C87!I=&%L(&=A:6X@:6YC;VUE M(&9O65A<@T*(&5X8V5E9',@8V%S:"!D:7-T65A"!W M87,@9'5E+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@ M86=G2P@870@1&5C96UB97(F(WA! M,#LS,2P@,C`Q,RX\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF M(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CY3=&]C:RU"87-E M9`T*($-O;7!E;G-A=&EO;CPO8CX\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$ M)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@ M#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY792!E>'!E;G-E('1H90T*(&=R86YT+61A=&4@ M9F%IF4@=&AE(&=R86YT+61A=&4@9F%I2UB87-E9"!C;VUP96YS871I;VX@86YD M(&%C8V]U;G0@9F]R#0H@=&AE"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY4:&4@97AP96YS90T*(&%S'!E M;G-E(&ES(&%N(&%D:G5S=&UE;G0@=&\@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D9A:7(-"B!686QU93PO8CX\+V9O;G0^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`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`^#0H@/'`@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY3964@3F]T90T*(#,M06-Q=6ES:71I;VYS(&%N9"!$ M:7-P;W-I=&EO;G,L(&9O2UO=VYE9"!,3$-S+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/CQB/E5S92!O9@T* M($5S=&EM871E6QE/3-$)TU!4D=) M3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY4:&4@<')E<&%R871I;VX-"B!O9B!F:6YA;F-I86P@6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CY.97<@06-C;W5N=&EN M9PT*(%-T86YD87)D6QE/3-$)TU! M4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY%>&-E<'0@87,@;F]T960-"B!B96QO=RP@=&AE'!E8W1E9"!T;R!I;7!A M8W0L('5S+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$R+`T*(')E<75I$$P.U1H92!A9&]P=&EO;B!O9B!T M:&ES('-T86YD87)D(&1I9"!N;W0@:&%V92!A#0H@;6%T97)I86P@:6UP86-T M(&]N(&]UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2`R,#$S+`T*('1H92!&:6YA;F-I M86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A"!3=V%P M(%)A=&4I(&%S(&$@8F5N8VAM87)K(&EN=&5R97-T(')A=&4@9F]R(&AE9&=E M(&%C8V]U;G1I;F<-"B!P=7)P;W-E28C>$$P.S$W+"`R,#$S+"!A;F0@ M9&ED#0H@;F]T(&AA=F4@82!M871E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA2!42!46QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/B@R*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$=&]P('=I9'1H/3-$,24^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@65A65A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/E1H92!C;VUB:6YE9`T* M(')E=F5N=65S(&=E;F5R871E9"!F$$P.S,Q+"`R,#$S("AA<'!R;WAI M;6%T96QY(#,P)2!F;W(@96%C:"!O9@T*('1H92!Y96%R$$P.S,Q+"`R,#$S(&%N9"`R,#$R+"!A;F0@-34E(&9O&EM871E;'D@,C`E(&]F('1H92!C;VUB:6YE9`T*(&-O;G-O M;&ED871E9"!A;F0@=6YC;VYS;VQI9&%T960@65A$$P.S,Q+"`R,#$S("AA<'!R M;WAI;6%T96QY(#(R)2!F;W(@=&AE('EE87(@96YD960-"B!$96-E;6)E$$P.S,Q+"`R,#$S+"`R,24@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M8F5R M)B-X03`[,S$L#0H@,C`Q,B!A;F0@,3DE(&9O65A$$P.S,Q+"`R,#$Q*2X@26X-"B!A9&1I=&EO;BP@='=E;'9E M($U/0G,L('1H870@87)E(&5I=&AE2UO=VYE M9"P-"B!I;F-L=61E(&]R('=I;&P@:6YC;'5D92!T96YA;G1S('=H:6-H(&%R M92!S=6)S:61I87)I97,@;V8-"B!52%,N/"]F;VYT/CPO<#X-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O M;G0@#L@5$585"U)3D1% M3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY0=7)S=6%N="!T;R!T:&4-"B!-87-T97(@ M3&5A#(P,4,[36%S=&5R($QE87-E)B-X,C`Q1#LI+`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`^ M#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!724142#H@-3!P="<@86QI9VX],T1C96YT97(^/&9O;G0@7!E)B-X03`[;V8F(WA!,#M&86-I;&ET>3PO8CX\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D%N;G5A;#QB MF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@8V]L65A6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`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`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E;&QI;F=T;VX@4F5G:6]N86P@365D:6-A;`T*($-E;G1E MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#,P+#`P,#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C$U/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M7-T96TL($EN;&%N9"!686QL M97D@0V%M<'5S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY$96-E;6)E6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@0G)I M9&=E=V%Y/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C$P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P M>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE. M+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F M(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/BAB*3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E5(4R!H87,@;VYE(#4M>65A6QE M/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P#L@34%21TE.+51/4#H@,3)P>"<^#0H@)B-X03`[ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DUA;F%G M96UE;G0-"B!C86YN;W0@<')E9&EC="!W:&5T:&5R('1H92!L96%S97,@=VET M:"!S=6)S:61I87)I97,@;V8@54A3+"!W:&EC:`T*(&AA=F4@2!O9B!O=7(@;W1H97(@;&5A M28C>#(P,3D[6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP M('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D%S(&1I2!O9B!52%,@=VAI M8V@@97AP:7)E9"!O;@T*($IU;F4F(WA!,#LS,"P@,C`Q,RX@5&AI2!D M=7)I;F<@=&AE('1E2!M971H;V0N/"]F;VYT/CPO<#X-"B`\<"!S='EL M93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O M;G0@#L@5$585"U)3D1% M3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY%9F9E8W1I=F4-"B!*86YU87)Y)B-X03`[ M,2P@,C`Q-"P@=V4@<'5R8VAA2!M:6YO0T*(&]W;F5R2!H96QD#0H@;F]N+6-O;G1R M;VQL:6YG(&UA:F]R:71Y(&]W;F5RF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@2!I;G1E&%S+"!W:&EC:"!W87,@8V]M<&QE=&5D#0H@86YD(&]P96YE9"!D=7)I M;F<@=&AE(&9I2!497AO;6$@ M365D:6-A;"!#96YT97(@*"8C>#(P,4,[5&5X;VUA($AO2!T97)M(&QO86X@ M;V8@)#$R+C4-"B!M:6QL:6]N+"!W:&EC:"!I2!A;F0@9&]E"<^/&9O;G0@ M#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CX\:3Y!9'9I0T*($%G#(P,4,[ M061V:7-O0T*($%GF4@:6YD97!E;F1E;G0@<')O9F5S2!B>2!U2!B92!T97)M:6YA=&5D(&9O$$P.S,Q(&]F(&5A8V@@>65A2X@26X@1&5C M96UB97(@;V8-"B`R,#$S+"!B87-E9"!U<&]N(&$@2!F964@86YD(&]T:&5R(&=E;F5R86P@86YD#0H@861M:6YI2!!9W)E96UE;G0@:6X@<&QA8V4@9'5R:6YG(#(P,3,N($EN M($1E8V5M8F5R(&]F#0H@,C`Q,BP@8F%S960@=7!O;B!A(')E=FEE=R!O9B!O M=7(@861V:7-O2!P965R(&=R;W5P+"!T:&4-"B`R,#$S(&%D=FES;W)Y(&9E92P@87,@8V]M M<&%R960@=&\@=&AE(#(P,3(@861V:7-OF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@&-L=61E#0H@8V5R=&%I;B!I=&5M6%B;&4@<75A65A&-E961S(#$U)2!O9@T*(&]U2!A8V-E<'1E9"!A8V-O M=6YT:6YG('!R:6YC:7!L97,@=VET:&]U=`T*(')E9'5C=&EO;B!F;W(@2X\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQI/D]F9FEC97)S(&%N9`T*($5M<&QO>65E M2!O9B!52%,@86YD(&%L=&AO=6=H(&%S(&]F#0H@1&5C96UB97(F(WA!,#LS M,2P@,C`Q,R!W92!H860@;F\@7!I8V%L;'D@2!T:&4@0V]M<&5N M2!A;'-O(')E8V5I=F4@;VYE+71I;64@"<^/&9O;G0@#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`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`@("`\=&%B;&4@8VQAF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D%#455)4TE424].4R!!3D0-"B!$25-03U-)5$E/3E,\+V(^ M/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$ M)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@ M"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\:3Y!8W%U M:7-I=&EO;G,Z/"]I/CPO9F]N=#X\+W`^#0H@/'`@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN($IA;G5A6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"=" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E1H92!.;W)T:'=E"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`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`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN($%U9W5S="P-"B`R,#$S+"!W92!P=7)C:&%S960@=&AE M(%=A2`D-"XQ M(&UI;&QI;VXL(&-O;G-I&EM871E;'D-"B`Q-BPS,#`@ M"<^/&9O;G0@ M#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY);B!*=6YE+"`R,#$S+`T*('=E('!U&]M82!-961I8V%L($-E M;G1E2!O9@T*(%5(4RX@5&AI M0T*("0V,C4L,#`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C,L-S0Y/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C8Q,#PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D]T:&5R(&%SF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Q/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q,3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT"<^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY.970@8V%S M:"!P86ED/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L M-C@U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@FEN9R!T:&4@:6YC;VUE#0H@8V%P:71A;&EZ871I;VX@87!PFEN9R!T:&4-"B!I M;F-O;64@8V%P:71A;&EZ871I;VX@87!P2!O9B!T:&4-"B!P2P@ M87-S=6UI;F<@8V]N=&EN=65D('5S92!S:6UI;&%R('1O('1H92!E>&ES=&EN M9R!U7-I2P@=VAE2!C87-H#0H@9FQO=W,@9G)O;2!T:&4@=F%R:6]UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CQI/DYE=PT*($-O;G-TF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/CQI/C(P,3(Z/"]I/CPO8CX\+V9O;G0^/"]P/@T*(#QP('-T M>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^ M/&9O;G0@"<^/&9O;G0@ M#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN M($IA;G5AF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1T;W`@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@&EM871E;'D-"B!T96X@>65A6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@1D].5"U325I%.B`Q<'@[($U!4D=)3BU4 M3U`Z(#9P>"<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$ M15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O M<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYO M#(P M,3,[(&$@-S(L,#`P#0H@&%S+"!W:&EC:"!W87,@86-Q=6ER960@:6X@1&5C96UB97(L(#(P,3(@9F]R M("0Y+C8-"B!M:6QL:6]N.R!T:&4@=V5I9VAT960@879E65A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@86=G2!A;F0-"B!I9&5N=&EF:65D(&EN=&%N9VEB;&4@87-S971S+"!B87-E M9"!O;B!T:&5I2!A;&P-"B!O9B!T:&4@:6YT86YG:6)L92!A2`W+C`@>65A"<^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY,86YD/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C$L.3`P/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,R+#`Y,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-% M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=&%N M9VEB;&4-"B!A6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXV+#`R,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]T:&5R(&%SF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DQI86)I;&ET:65S("AR96%L('!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXH,30T M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E<&]S M:70@<&%I9"!I;@T*(#(P,3$\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXH-3,T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D1E8G0@*&EN8VQU9&EN M9R!F86ER('9A;'5E#0H@861J=7-T;65N="!O9B`D-SDY*3PO9F]N=#X\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B@R,RPR-#`\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXI)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/"]TF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=- M05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY4:&4@,C`Q,@T*(&%C<75IFEN9R!T:&4@:6YC;VUE(&-A<&ET86QI>F%T:6]N M#0H@87!PF%T:6]N(&]F('1H92!N970@97-T:6UA=&5D(&5A&ES=&EN9R!UF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'`@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU# M3TQ,05!313H@8V]L;&%P6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!724142#H@,S-P="<@86QI9VX],T1C96YT97(^/&9O;G0@"<@86QI9VX],T1C96YT97(^#0H@/&9O M;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/E5N;V)S97)V86)L92!I;G!U M=',\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!E86-E2&5A;'1H($UE9&EC86P@0VQI;FEC M#0H@*&$N*2AC+BD\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.T%P<')O86-H/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-A<&ET86QI>F%T:6]N)B-X03`[4F%T93PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QTF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY.;W)T:'=E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDL-C`P+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.T%P<')O86-H/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-A<&ET86QI>F%T:6]N#0H@4F%T93PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QTF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXY+C4P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`R M<'@[($)/4D1%4BU"3U143TTZ(",P,#`P,#`@,"XU<'0@#L@3$E.12U(14E'2%0Z(#AP>#L@5TE$5$@Z(#$P)2<^#0H@ M)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z M(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA+BD\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY4:&4@9F%I6QE M/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D)A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X M)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4 M+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D9O&EM871E;'D@)#(S,BPP,#`@*&5X8VQU9&EN9R!T6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T M>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CX\:3Y$:79EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6]N($AE86QT:&-A2!C;VUP86YY#0H@*"8C>#(P,4,[3$Q#)B-X,C`Q1#LI(&EN('=H:6-H M('=E(&]W;F5D(&$@.34E(&YO;F-O;G1R;VQL:6YG#0H@;W=N97)S:&EP(&EN M=&5R97-T+"!C;VUP;&5T960@=&AE(&1I=F5S=&ET=7)E(&]F('1H92!#86YY M;VX@4W!R:6YGF$N($%S('!A&EM871E;'D@)#@N,0T*(&UI;&QI;VX@;V8@ M8V%S:"!P2`D-RXT(&UI;&QI;VX@=VAI8V@@:7,@:6YC M;'5D960-"B!I;B!O=7(@8V]N6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN M($]C=&]B97(L#0H@,C`Q,BP@-3&EM871E;'D@ M)#$R+C(@;6EL;&EO;B!O9@T*(&-A0T*(&UE;6)E2`D,2XQ(&UI;&QI M;VXL('=H:6-H(&ES(&EN8VQU9&5D(&EN(&]U<@T*(&-O;G-O;&ED871E9"!S M=&%T96UE;G0@;V8@:6YC;VUE(&9O65A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY!$$P.S,Q+"`R,#$Q('=O=6QD(&AA=F4@8F5E;B!A<'!R;WAI;6%T M96QY("0U-"XP(&UI;&QI;VXL#0H@86YD(&]U2`D-34N-"!M:6QL:6]N#0H@86YD("0Q M,2XV(&UI;&QI;VXL(&]R("0N.3(@<&5R(&1I;'5T960@2P@=VET:&]U=`T*(&=I=FEN9R!E9F9E8W0@=&\@=&AE(&=A:6YS M(&%N9"!TF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CQB/CQI/C(P,3$Z/"]I/CPO8CX\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);B!*=6YE+"!* M=6QY#0H@86YD($1E8V5M8F5R+"`R,#$Q+"!U=&EL:7II;F<@82!Q=6%L:69I M960@=&AI6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU4 M3U`Z(#!P>"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O M;&QA<'-E)R!C96QL6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P M,C([/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^ M#0H@/'`@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D9O2!-961I8V%L(%!L M87IA)B-X,C`Q-#MA(#4P+#DT-B!S<75A&%S+"!W:&EC:"!W87,-"B!A8W%U:7)E9"!I;B!*=6QY+"`R,#$Q+"!F M;W(@)#$U+C`@;6EL;&EO;CL@=&AE('=E:6=H=&5D(&%V97)A9V4-"B!R96UA M:6YI;F<@;&5A65AF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T M;W`@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@#(P,30[82`U,RPP,#`@#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT M86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5M;W)Y(&%T($1U;G=O;V1Y($)U:6QD:6YG)B-X M,C`Q-#MA(#4P+#,T-"!S<75A#L@34%21TE.+51/4#H@,3)P>"<^#0H@)B-X03`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`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"=6EL9&EN M9W,@86YD#0H@:6UPF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8L.30S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4;W1A;"!P=7)C:&%S M90T*('!R:6-E/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q+#(R.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$96)T/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!C87-H('!A:60\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@&EM871E;'D@)#0W-"PP,#`-"B`H97AC;'5D:6YG('1R86YS86-T M:6]N(&5X<&5N6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN(&%D9&ET:6]N+"!O;@T*($1E8V5M8F5R)B-X03`[,3(L M(#(P,3$L('1H92!4'!E;F1I='5R92!M861E(&)Y('5S(&EN(&-O;FYE8W1I;VX@ M=VET:"!T:&4@<'5R8VAA2`D-"XT(&UI;&QI;VXN($%S(&$@ M2`H)#$S,RXQ(&UI;&QI;VXI(&%N9`T*(&ED96YT:69I960@:6YT M86YG:6)L92!A2!I;G1EF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!I;G1E2!O=VYE9"!B>2!T:&4@3$Q#+"!O=7(@ M<')E=FEO=7,-"B!N;VYC;VYT"<^/&9O;G0@"<@86QI9VX],T1C96YT97(^#0H@/&9O;G0@2!,3$,Z/"]B/CPO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/CQB/D-I='D\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E1R=7-T)B-X,C`Q.3MS/&)R("\^#0H@<')E=FEO=7,\8G(@ M+SX-"B!O=VYE3QB6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXV-3,@5&]W;B!#96YT97(-"B!);G9EF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXU/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C8U,R!4;W=N($-E;G1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/CDX/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY!=6)U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U8G5R;B8C>$$P.TUE9&EC86PF(WA!,#M/9F9I8V4-"B!" M=6EL9&EN9R8C>$$P.TE)*#$I/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1&-E M;G1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY!<&%-960-"B!06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%:/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXX-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D)A;F)U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/DY6/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)20B!-961I8V%L($]F9FEC92!"=6EL9&EN9SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-E;G1E;FYI86P@365D:6-A;`T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-E;G1E;FYI86P@2&EL;',@365D:6-A;"!/9F9I8V4-"B!" M;&1G+B8C>$$P.TDH,2D\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DY6/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C4\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D=O;&0@4VAA9&]W#0H@4')O M<&5R=&EEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DY6/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY.#PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C(\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T$$P.U!R M;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E-PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DY6/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C4\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-PF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@ M$$P.SPO<#X-"B`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`Q,2!A;F0@1&5C96UB97(F(WA!,#LQ-BP@,C`Q,2P@96EG:'0@3$Q#2X@07,@<&%R=&EA;"!C;VYS:61E65R(&%S&ES=&EN9R!T:&ER9"UP87)T>0T*(&UO&-H86YG92!T2!I;G1E&EM871E;'D@)#4P,"PP,#`I(&]N(&1I=F5S=&ET M=7)E('=H:6-H#0H@:7,@:6YC;'5D960@:6X@;W5R(&-O;G-O;&ED871E9"!S M=&%T96UE;G1S(&]F(&EN8V]M92!F;W(@=&AE('EE87(-"B!E;F1E9"!$96-E M;6)E$$P.S,Q+"`R,#$Q+B!4:&4@9F]L;&]W:6YG('1A8FQE(')E<')E M2P@=&AE(&QO8V%T:6]N(&%N9`T*('!R;W!EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!724142#H@-#EP="<^#0H@ M/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1C96YT97(^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/CQB/E!R;W!E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1C96YT97(^/&9O;G0@6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY#;V)R92!06QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D1E97(@5F%L;&5Y($UE M9&EC86P@3V9F:6-E($E)/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E!H;V5N:7@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D1E97)V86P@4')O<&5R=&EEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1C96YT97(^/&9O;G0@#PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@2AA*3PO9F]N=#X\+W`^#0H@/"]T M9#X-"B`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`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXX.3PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY087-E;R!-961I8V%L(%!R;W!EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D=L96YD86QE/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%:/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW-3PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY7:6QL971T82!-961I8V%L M#0H@4')O<&5R=&EEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E!H;V5N:7@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`R<'@[($)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,"XU<'0@#L@3$E.12U( M14E'2%0Z(#AP>#L@5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T*(#QT86)L M92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA*3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1T;W`@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D1E97)V86P@4&%R:VEN M9R!#;VUP86YY+`T*($Q,0RP@=VAI8V@@;W=N960@=&AE(')E86P@<')O<&5R M='D@;V8@82!P87)K:6YG(&=A2!-961I8V%L($]F9FEC92!"=6EL9&EN9W,@22`F86UP.R!)22P@=V%S M(#4P)2!O=VYE9"!B>0T*(&5A8V@@;V8@1&5E6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BAB*3PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E1H92!M96UB97)S:&EP(&EN=&5R97-T(&]F#0H@=&AI"<^/&9O;G0@ M#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY!0T*("0T.2XX(&UI;&QI M;VX@86YD(&]U"<^/&9O;G0@#L@5$58 M5"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!65A'1087)T7V,R-F4Y-V,V7S,W-F9?-&4W.5\Y9#DX7SDT.3%D-C@Q83DW M-PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C,C9E.3=C-E\S-S9F M7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)VUA3I4:6UEF4],T0R/CQB M/B@T*0T*($Q%05-%4SPO8CX\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$;6%R M9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HM-G!X/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0R/D%L;"!O9B!O=7(-"B!L96%S97,@87)E(&-L87-S:69I960@87,@;W!E M7!I8V%L;'D@ M65A2!E87)N('!EF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0R/DUI;FEM=6T@9G5T M=7)E#0H@8F%S92!R96YT#MM87)G:6XM8F]T=&]M.C!P>#X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!C96QL M3I4:6UEF4],T0R/C(P,30\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/C0R+#8Y,CPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/C(P,38\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VUA3I4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C(Q+#4Q M.3PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E1H97)E869T97(\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N M="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1&UAF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/E-O;64@ M;V8@=&AE#0H@;&5A'!E;G-E2!F2!A;&P@;W!E2!A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D1%0E0\+V(^/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=) M3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);B!*=6QY+"`R M,#$Q+`T*('=E(&5N=&5R960@:6YT;R!A("0Q-3`@;6EL;&EO;B!R979O;'9I M;F<@8W)E9&ET(&%G2!B;W)R;W=I;F<@8V%P86-I='D@8GD@86X-"B!A9&1I M=&EO;F%L("0U,"!M:6QL:6]N+"!S=6)J96-T('1O(&QE;F1E#(P,4,[0F%S92!2871E)B-X M,C`Q1#L@87,@=&AE(&=R96%T97-T(&]F.B`H82DF(WA!,#MT:&4-"B!A9&UI M;FES=')A=&EV92!A9V5N="8C>#(P,3D[6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D%T#0H@1&5C96UB M97(F(WA!,#LS,2P@,C`Q,RP@=V4@:&%D("0Y,RXW(&UI;&QI;VX@;V8@;W5T M"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY#;W9E;F%N=',-"B!R96QA=&EN9R!T;R!T:&4@06=R965M M96YT(')E<75I2!T;R!I;F-R96%S M92!D:79I9&5N9',@:6X-"B!E>&-EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@ M2!O9B!T:&4@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@8V]L6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$T-"PX-#@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY$96)T('1O('1O=&%L#0H@8V%P:71A;#PO M9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9L=#L@ M-34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXS-BXP/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D1E8G0@$$P.S0N,#!X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ.2XQ>#PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E8G0@=&\@ M8V%S:"!F;&]W#0H@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF;'0[)B-X03`[,RXU,'@\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(N,C%X M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P M>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E M(&AA=F4@='=E;'9E#0H@;6]R=&=A9V5S+"!A;&P@;V8@=VAI8V@@87)E(&YO M;BUR96-O=7)S92!T;R!U2!D96)T#0H@;V8@)#@S-"PP,#`@870@1&5C96UB97(F(WA!,#LS M,2P@,C`Q,RDN(%1H92!F;VQL;W=I;F<@=&%B;&4-"B!S=6UM87)I>F5S(&]U M6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/D9A8VEL:71Y#0H@3F%M93PO M8CX\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DUA='5R:71Y/&)R("\^#0H@1&%T93PO8CX\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-% M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-U;6UE MF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P M,30\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY3<')I;F<@5F%L;&5Y($UE9&EC86P-"B!/9F9I8V4@0G5I;&1I;F<@9FEX M960@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C4N-3`\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR M,#$U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q M+#,T-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C(P,38\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY096%C92!(96%L M=&@@9FEX960@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXR,2PV.#$\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4N M-C0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXR,#$W/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXU+C4P/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U8G5R M;B!-961I8V%L($E)(&9L;V%T:6YG#0H@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(N.3(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$W/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@&5D(')A M=&4@;6]R=&=A9V4@;&]A;CPO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L.#DY/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV+C`P/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-E M;G1E;FYI86P@2&EL;',@365D:6-A;`T*($]F9FEC92!"=6EL9&EN9R!F;&]A M=&EN9R!R871E(&UO6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXQ,"PY,S@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C,N-#(\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXR,#$X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR+#DX,SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3D\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`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`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,C(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW,#`@4VAA9&]W($QA;F4@ M86YD#0H@1V]L9')I;F<@34]"6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV+#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C(P,C(\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4=7-C86X@4')O9F5SF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C4N-38\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXR,#(U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R M/@T*(#PO=&%B;&4^#0H@/'`@$$P.SPO<#X-"B`\=&%B;&4@2P@=V4@=VEL;"!E>'!L;W)E(&]T:&5R(&9I;F%N8VEN9R!A;'1E M#L@34%21TE.+51/ M4#H@,3)P>"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G M/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!M;W)T9V%G97,-"B!A2!T M:&4@2!O9B!T:&4@8G5I;&1I;F=S(&%S('=E;&P@87,- M"B!P2!L96%S97,@86YD(')E;G1S+B!4:&4@;6]R=&=A9V5S(&AA M=F4@82!C;VUB:6YE9"!F86ER('9A;'5E#0H@;V8@87!P2`D M,3`V+C0@;6EL;&EO;B!A$$P.S,Q+"`R,#$S+@T* M($-H86YG97,@:6X@;6%R:V5T(')A=&5S(&]N(&]UF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$S+"!O=7(@86=G6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)TU!4D=) M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$T M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q+#@Y-#PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P M,34H82D\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXQ,#$L,C0U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C$S+#`Y.#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(P,3<\+V9O;G0^ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXT,RPY,30\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXR,#$X/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ."PS,S`\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\=&%B;&4@6UE;G0@ M;V8@)#DS+C<-"B!M:6QL:6]N(&]F(&]U='-T86YD:6YG(&)O3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y M-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/B@V M*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$ M,24^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!I;F-O;64@86YD("0N-3,U('!EF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@2!O9F9E&-H86YG90T*($-O;6UIF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$S M+"!W:&EC:"!G96YE2`D-BXP(&UI;&QI;VX- M"B!O9B!N970@8V%S:"!P2`D,38Q+#`P,"!T;R!-97)R:6QL($QY;F-H(&%S('=E;&P@ M87,-"B!A<'!R;WAI;6%T96QY("0R-C,L,#`P(&]F(&]T:&5R('9A&EM M871E;'D@)#4Y,BPP,#`@;V8@;F5T('!R;V-E961S(')E8V5I=F%B;&4@870- M"B!$96-E;6)E2!U M'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/B@W*3PO8CX\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)TU!4D=)3BU" M3U143TTZ("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY792!E>'!E;G-E('1H90T*(&=R86YT+61A=&4@9F%I$$P.S,Q+"`R,#$Q+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$S('1H97)E(&%R92`R-RPP,C4@6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G M/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`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`P,"!I;B`R M,#$S(&%N9"`D,3@L,#`P(&EN(&5A8V@@;V8@,C`Q,@T*(&%N9"`R,#$Q+B!! M$$P.S,Q+"`R,#$S+"!T:&5R92!W97)E(#0P+#`P M,"!O<'1I;VYS#0H@;W5T6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H97)E('=E2!V97-T960@86YD(&9U;&QY#0H@97AP M96YS960N(%1H92!O=71S=&%N9&EN9R!S=&]C:R!O<'1I;VYS(&AA=F4@82!R M96UA:6YI;F<@=V5I9VAT960-"B!A=F5R86=E(&QI9F4@;V8@,BXU('EE87)S M(&%T($1E8V5M8F5R)B-X03`[,S$L(#(P,3,N/"]F;VYT/CPO<#X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^ M/&9O;G0@#L@5$585"U) M3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$=7)I;F<@=&AE#0H@9F]U65A$$P.S,Q+"`R,#$Q+B!);@T*($1E8V5M8F5R(&]F(#(P,3,L(#(P,3(@ M86YD(#(P,3$L(&1I=FED96YD(&5Q=6EV86QE;G0@#L@ M34%21TE.+51/4#H@,3)P>"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E. M1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E-T;V-K(&]P=&EO;G,-"B!T;R!P=7)C M:&%S92!S:&%R97,@;V8@8F5N969I8VEA;"!I;G1EF5D(&%S M(&9O;&QO=W,Z/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]4 M5$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D]U='-T86YD:6YG#0H@3W!T:6]N$$P.U-H87)EF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/D=R86YT)B-X03`[4')I8V4F M(WA!,#M286YG93QB6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"86QA;F-E+"!* M86YU87)Y)B-X03`[,2P-"B`R,#$Q/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`S96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY%>&5R8VES960\+V9O;G0^/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"86QA;F-E+"!* M86YU87)Y)B-X03`[,2P-"B`R,#$R/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`S96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY%>&5R8VES960\+V9O;G0^/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXX+#`P,#PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L M;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D)A;&%N8V4L($IA;G5A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXT,RPP,#`\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C,V+C4S+R0R.2XT-#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D5X97)C:7-E9#PO M9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#`P M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`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`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0P M+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U+C8U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@&5R8VES960@9'5R:6YG(#(P,3$N/"]F;VYT/CPO<#X- M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z M(#!P>"<^/&9O;G0@#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&5R92!W97)E(&YO#0H@ M=6YV97-T960@;W!T:6]N$$P.S,Q+"`R,#$S M+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P&5R8VES86)L93PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYU;6)EF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0P+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E=E:6=H=&5D(&%V97)A9V4@97AE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D%G9W)E9V%T92!I;G1R:6YS M:6,-"B!V86QU93PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU" M3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF M(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!W96EG:'1E9`T*(&%V97)A9V4@&5R M8VES86)L92!O<'1I;VYS(&%T($1E8V5M8F5R)B-X03`[,S$L(#(P,3,-"B!W M97)E(&%S(&9O;&QO=W,Z/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)' M24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0Q,"!A;&EG;CTS1&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/D5X97)C:7-E#0H@4')I8V4\+V(^ M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@8V]L&5R8VES93QBF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/E=E:6=H=&5D/&)R("\^#0H@ M079E$$P.RAI;CQBF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C M0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0S M,"XP-B8C>$$P.RTD,S0N,#<\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXT+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C,S+C`W/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXQ+C`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXD,S0N.3`F(WA!,#LM)#,T+CDP/"]F;VYT/CPO<#X-"B`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`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,N,CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXT,"PP,#`\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA2!!9F9I;&EA=&5S/&)R/CPOF5D($9I M;F%N8VEA;"!);F9O'0^)SQD:78^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$S+"!W92!H879E(&YO;BUC;VYT M2!M971H;V0@2!A$$P.S,P M+`T*(#(P,3,N($%S('!R979I;W5S;'D@9&ES8VQO'!I MF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'`@2!C;VYS;VQI9&%T960@:6YT;R!T:&4@"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY4:&4@9F]L;&]W:6YG#0H@<')O<&5R='D@=&%B;&4@$$P.S,Q M+`T*(#(P,3,Z/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]4 M5$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB M/D]W;F5RF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E!R;W!E M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1634,-"B!0F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E-U8G5R8F%N#0H@ M4')O<&5R=&EEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C,S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E-A;G1A($9E#0H@4V-O='1S9&%L93PO9F]N=#X\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW-#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY00T@@365D M:6-A;`T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E)O#(P,3D[6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D%R;&EN9W1O;B!-961I M8V%L#0H@4')O<&5R=&EE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E-A:6YT($UA6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-I M97)R82!-961I8V%L#0H@4')O<&5R=&EEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY00T@@4V]U=&AEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E9I$$P.U1E$$P.U1H928C>$$P.U-P87)K$$P.TUE9&EC86PF(WA!,#M"=6EL M9&EN9SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1T;W`@;F]W6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY'F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXS.#$Q($)E;&P@365D:6-A;`T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$@24D\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QTF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@0D]2 M1$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/4#H@ M,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA!,#L\ M+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P M6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1E M;F%N=',@;V8@=&AI6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E=E(&AA=F4@8V]M;6ET=&5D('1O(&EN M=F5S=`T*('5P('1O("0V+C,@;6EL;&EO;B!I;B!E<75I='D@86YD(&1E8G0@ M9FEN86YC:6YG+"!O9B!W:&EC:"`D-2XR#0H@;6EL;&EO;B!H87,@8F5E;B!F M=6YD960@87,@;V8@1&5C96UB97(F(WA!,#LS,2P@,C`Q,RP@:6X@97AC:&%N M9V4-"B!F;W(@82`W-24@;F]N+6-O;G1R;VQL:6YG(&5Q=6ET>2!I;G1E6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/E=E(&AA=F4@8V]M;6ET=&5D M('1O(&EN=F5S=`T*('5P('1O("0T+C0@;6EL;&EO;B!I;B!E<75I='D@86YD M(&1E8G0@9FEN86YC:6YG+"!O9B!W:&EC:"`D,BXQ#0H@;6EL;&EO;B!H87,@ M8F5E;B!F=6YD960@87,@;V8@1&5C96UB97(F(WA!,#LS,2P@,C`Q,RX\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'1A8FQE('-T>6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1U2!-961I8V%L(%!L87IA($E)+`T* M('=H:6-H('=A2!A;F0@9&5B="!F:6YA;F-I;F$$P.S,Q+`T*(#(P,3,N/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/BAE+BD\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY7 M92!B96=A;B!T;R!A8V-O=6YT(&9O<@T*('1H:7,@3$Q#(&]N(&%N('5N8V]N M28C>$$P.S$L(#(P,3,L(&%S(&1I6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D5F9F5C=&EV92!*86YU87)Y M)B-X03`[,2P-"B`R,#$T+"!W92!P=7)C:&%S960@=&AE('1H:7)D+7!A0T*(&]W;F5R28C M>$$P.S$L(#(P,30@=V4@:&]L9"`Q,#`E(&]F('1H90T*(&]W;F5R6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L M;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D%S(&1I$$P.S,Q M+"`R,#$S+"!T:&ES($Q,0R!H87,@82!T:&ER9"UP87)T>2!L;V%N#0H@;W5T M#L@34%21TE.+51/4#H@,3)P M>"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]N#0H@1&5C96UB97(F(WA!,#LQ,BP@,C`Q,2P@=&AE(%1R=7-T M('!U2!O=VYE2!M971H;V0@8V%RF4@ M=&AE(&-O;6)I;F5D('-T871E;65N=',@;V8@:6YC;VUE(&%N9"!C;VUB:6YE M9`T*(&)A;&%N8V4@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!724142#H@-#=P="<^#0H@/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/E!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E-U;6UE6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/E-U;6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D%P84UE9`T*(%!R;W!E6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXX-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY!=6)U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%U8G5R;B!-961I8V%L($]F9FEC92!"=6EL9&EN M9R!)23PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D)A;F)UF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDY/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CDX/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3<')I;F<@5F%L;&5Y($UE9&EC86P- M"B!06QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E-P6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY3<')I;F<@5F%L;&5Y($UE9&EC86P-"B!06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-P$$P.U9A;&QE>28C>$$P.TAO M$$P.T]F9FEC928C>$$P.T)U:6QD:6YG M)B-X03`[24D\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'`@ M$$P.SPO<#X-"B`\=&%B;&4@ M"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/ M;@T*($YO=F5M8F5R)B-X03`[,S`L(#(P,3$@86YD($1E8V5M8F5R)B-X03`[ M,38L(#(P,3$L(&5I9VAT($Q,0W,@:6X-"B!W:&EC:"!W92!O=VYE9"!V87)I M;W5S(&YO;F-O;G1R;VQL:6YG+"!M86IO2!O=VYE2`D,S,N."!M:6QL M:6]N(&]F(&%G9W)E9V%T90T*(&-A#(P,3D[('-H87)E(&]F('1H92!P2!T86)L90T*(')E<')E$$P.S,P+"`R,#$Q(&%N9"!$96-E;6)E$$P.S$V+"`R,#$Q("AT:&4@ M"<^/&9O;G0@F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/D]W;F5RF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/DQI=&-H=F%N#0H@26YV97-T;65N=',\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXX.3PO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!A6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1H=6YD97)B:7)D(%!AF$@22`F86UP.R!)23PO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=I;&QE M='1A($UE9&EC86P-"B!06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D5D=V%R9',@365D:6-A;"!0;&%Z83PO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E M97)V86P-"B!0F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D1E97)V86P@4')O<&5R=&EEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@2!-961I8V%L($]F9FEC92!"=6EL9&EN M9R!)24D\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$965R=F%L(%!AF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA M+CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY#;V)R92!06QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D-O8G)E(%9A;&QE>2!-961I M8V%L(%!L87IA/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@0D]21$52+4)/5%1/33H@ M(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/4#H@,'!X.R!,24Y%+4A% M24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE M('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D1E97)V86P@4&%R:VEN M9R!#;VUP86YY+`T*($Q,0RP@=VAI8V@@;W=N960@=&AE(')E86P@<')O<&5R M='D@;V8@82!P87)K:6YG(&=A2!-961I8V%L($]F9FEC92!"=6EL9&EN9W,@24D@86YD($E)22P@=V%S M(#4P)2!O=VYE9"!B>0T*(&5A8V@@;V8@1&5E6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!F M;VQL;W=I;F<-"B!P2!T86)L92!R97!R97-E;G1S('1H92!T=V\@ M3$Q#$$P.S$P M+"`R,#$R("AT:&4-"B!S=6UM87)I>F5D(&9I;F%N8VEA;"!D871A(&9O0T*(&UE=&AO M9"DZ/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P M<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D]W M;F5RF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E!R;W!E6]N($AE86QT:&-A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D-A;GEO;B!3<')I;F=S($UE9&EC86P@4&QA>F$\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXU-S4@2&%R9'D-"B!);G9E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P M>"<^/&9O;G0@#L@5$58 M5"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@9F]L;&]W:6YG#0H@9FEN M86YC:6%L('1A8FQE2!N;VYC;VYTF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@2!M971H M;V0N(%1H92!Y96%R$$P.S,Q+"`R,#$R(&%N M9"`R,#$Q#0H@:6YC;'5D92!T:&4@<')O2!M971H;V0Z/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)' M24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0Q,"!A;&EG;CTS1&-E;G1E$$P.S,Q+#PO8CX\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/CQB/C(P,3$H82XI/"]B M/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M8V]L6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/BAA;6]U M;G1S(&EN#0H@=&AO=7-A;F1S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E)E=F5N=65S/"]F;VYT/CPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(Q+#`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D]P97)A=&EN9PT*(&5X<&5NF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@L.36QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR-2PU,#,\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY$97!R96-I871I;VX@86YD#0H@86UOF%T M:6]N/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C0L,30P/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ M,RPP-C8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#QT6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY);G1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C8L,#4V/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXQ-RPV,S`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!I;F-O M;64@8F5F;W)E(&=A:6YS(&]N#0H@9&EV97-T:71U6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C$L.3`T/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]TF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C(L,S8U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D]UF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`R<'@[($)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,"XU<'0@#L@3$E.12U(14E' M2%0Z(#AP>#L@5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S M='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!2!R M96-O2!O=VYE9"!V87)I;W5S(&YO;F-O;G1R;VQL:6YG+`T*(&UA:F]R:71Y M(&]W;F5R2X@3W5R('-H87)E(&]F('1H90T*(&9I;F%N8VEA;"!R97-U M;'1S(&]F('1H92!D:79E6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BAB+BD\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY!"UM;VYT:"!P M97)I;V0@;V8@2G5L>28C>$$P.S$L(#(P,3,@=&AR;W5G:`T*($1E8V5M8F5R M)B-X03`[,S$L(#(P,3,N/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/BAC+BD\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=7(@ M2`D,2XY(&UI;&QI;VXL#0H@)#$N-2!M:6QL:6]N(&%N9"`D,BXV(&UI M;&QI;VXL(')E2X\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO M=&%B;&4^#0H@/'`@#L@34%21TE.+51/4#H@,3)P>"<^#0H@)B-X03`[/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D)E;&]W(&%R92!T M:&4-"B!C;VUB:6YE9"!B86QA;F-E('-H965T$$P.S,Q+"`R,#$S(&%N9"`R,#$R.CPO9F]N M=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.S,Q+#PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/CQB/BAA;6]U;G1S(&EN#0H@ M=&AO=7-A;F1S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!P2P@:6YC;'5D:6YG#0H@0TE0 M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q.2PU-#<\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CDL.#4P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L(&%SF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C M0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DUO M6%B;&4L#0H@;F]N+7)E8V]U6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXW-RPU,3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!9'9A;F-E6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR M,BPY,3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C$R+#8U.#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D5Q=6ET>3PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C(P+#8V-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1O=&%L(&QI86)I;&ET:65S(&%N M9`T*(&5Q=6ET>3PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@ M34%21TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E M)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ, M05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%S(&UE;G1I;VYE9"!A8F]V92P@=V4-"B!B96=A;B!T;R!A M8V-O=6YT(&9O2!M971H M;V0@87,@;V8@2G5L>28C>$$P.S$L(#(P,3,N(%!R:6]R#0H@=&\@2G5L>28C M>$$P.S$L(#(P,3,L('1H92!F:6YA;F-I86P@2!W97)E#0H@86-C;W5N=&5D(&9OF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@$$P.S,Q M+"`R,#$S+"!A9V=R96=A=&4@<')I;F-I<&%L(&%M;W5N=',@9'5E(&]N(&UO M2!U;F-O;G-O;&ED871E9"!,3$-S M+"!W:&EC:"!A"<^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXR,#$T/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$T+#$W-#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,34\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXT,2PT.3(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$V/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q M+#@R.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C(P,3@\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,BPP,SD\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]- M.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DUOF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DUA='5R:71Y)B-X03`[1&%T93PO8CX\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D=R87ES;VX-"B!0 MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P M.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,30\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C M>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,34\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY!6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR-"PP-3(\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P M.R8C>$$P.R8C>$$P.R8C>$$P.S(P,34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`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`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/E!A;&UD86QE M($UE9&EC86P-"B!0F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P M,34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY&5%@@34]"(%!H87-E#0H@24DH8RXI/"]F;VYT/CPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P M.S(P,3<\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY00T@@4V]U=&AEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P M.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,3<\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3<&%R:W,@365D:6-A;`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`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!#2"!-961I8V%L#0H@4')O<&5R=&EEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C@L-C,T/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#LF(WA!,#LF(WA!,#LF(WA!,#LF(WA!,#LF M(WA!,#LF(WA!,#LR,#$X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/"]T86)L M93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`R<'@[($)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,"XU<'0@#L@ M3$E.12U(14E'2%0Z(#AP>#L@5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T* M(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C M96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!B96QI M979E('1H92!T97)M'!L M;W)E(&]T:&5R(&9I;F%N8VEN9R!A;'1E0T*(&EN=F5S=&UE;G0@:6X@=&AE('!R;W!EFEN9R!F=6YD6UE;G1S('1H2!A;F0@:6YC;'5D92!A(&)A;&QO;VX@<')I;F-I<&%L('!A M>6UE;G0@=7!O;@T*(&UA='5R:71Y+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/"]T86)L93X-"B`\=&%B;&4@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@2!T:6UE+"!H879E('1H92!R:6=H="!T;R!M86ME M(&%N(&]F9F5R#0H@*"8C>#(P,4,[3V9F97)I;F<@365M8F5R)B-X,C`Q1#LI M('1O('1H92!O=&AE#(P,4,[3V9F97(@=&\@4V5L;"8C>#(P,40[*2!A M="!A('!R:6-E#0H@87,@9&5T97)M:6YE9"!B>2!T:&4@3V9F97)I;F<@365M M8F5R("@F(W@R,#%#.U1R86YS9F5R#0H@4')I8V4F(W@R,#%$.RDL(&]R.R`H M:6DI)B-X03`[<'5R8VAA#(P,40[*2!A="!T:&4-"B!E<75I=F%L96YT('!R M;W!O7,@=&\@96ET:&5R.B`H:2DF(WA!,#MP=7)C M:&%S92!T:&4@96YT:7)E(&]W;F5RF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'`@2!I;G1E'1087)T7V,R M-F4Y-V,V7S,W-F9?-&4W.5\Y9#DX7SDT.3%D-C@Q83DW-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y M-#DQ9#8X,6$Y-S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3I4:6UEF4],T0R/CQB/B@Y*3PO8CX\+V9O;G0^ M/"]T9#X-"B`\=&0@=VED=&@],T0Q)2!V86QI9VX],T1T;W`^/&9O;G0@#X\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)VUA2!F6QE/3-$;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@'1087)T7V,R M-F4Y-V,V7S,W-F9?-&4W.5\Y9#DX7SDT.3%D-C@Q83DW-PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y M-#DQ9#8X,6$Y-S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!297-U;'1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/&1I=CX-"B`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`^#0H@/'`@3I4:6UEF4],T0R/E)E M=F5N=65S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P M>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@"!S;VQI9"`C M,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S M;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@3I4:6UEF4],T0R/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#(W/"]F;VYT/CPO=&0^#0H@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#DX/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N M,C<\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C<\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/"]T'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C,\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C$N,#0\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)OF4Z,7!X.VUA#MM87)G:6XM8F]T=&]M M.C!P>#X-"B`F(WA!,#L\+W`^#0H@/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E(&)O3I4:6UEF4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QTF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0Q/CQB/D9IF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB/E-E8V]N M9#QBF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@3I4:6UE MF4],T0R/E)E=F5N=65S/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O M$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)V)O$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@"!S;VQI9"`C,#`P,#`P M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/DYE M="!I;F-O;64@8F5F;W)E#0H@9V%I;G,\+V9O;G0^/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C(L,3,Y/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4] M,T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@"!S;VQI9"`C,#`P,#`P M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C M,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M3I4:6UEF4],T0R/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/CDL-3$T/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C0L-3$P/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)V)O6QE M/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N-S4\+V9O M;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,S8\+V9O;G0^/"]T M9#X-"B`\=&0@;F]W3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)V)O6QE/3-$ M)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,3D\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/C$N-30\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO<#X-"B`\=&%B;&4@3I4:6UEF4],T0R/BAA+BD\+V9O M;G0^/"]T9#X-"B`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0R/E=E(&)E9V%N(')E9FQE8W1I;F<@=&AE#0H@;W!E6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@2!D:7-C M=7-S960@:6X@3F]T92`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`Z(#!P>"<^/&9O;G0@"!S;VQI9#L@5TE$5$@Z(#,Q<'0G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D1E MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0Q-"!A;&EG;CTS1&-E;G1E MF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D=R;W-S(&%M M;W5N=`T*(&%T/"]B/CPO9F]N=#X\8G(@+SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3X\8CYW:&EC M:`T*(&-A6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/F%T M(&5N9"!O9@T*('!EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/CQB/D1E<')E8VEA=&EO M;CPO8CX\+V9O;G0^/&)R("\^#0H@/&9O;G0@$$P M.T1E8RX@,S$L/"]B/CPO9F]N=#X\8G(@+SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3X\8CXR,#$S M/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@$$P.V]R/"]B/CPO9F]N=#X\8G(@+SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3X\8CY3:6=N:69I8V%N=#QBF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI M9VX],T1B;W1T;VT@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DQI9F4\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!R;W=S<&%N/3-$,CX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QTF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/CQB/D5N8W5M8G)A;F-E/"]B/CPO9F]N=#X\8G(@+SX-"B`\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3X\ M8CXH92XI/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DEM<')O=BX\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/D%D:G5S=&UE;G1S)B-X03`[ M=&\\+V(^/"]F;VYT/CQB6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/CQB/D)AF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V M86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E1O=&%L/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+4Q%1E0Z(#%E;3L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@+3%E M;2<^#0H@/&9O;G0@0T*(%)E9VEO;F%L/"]F;VYT M/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=) M3BU,1494.B`Q96T[($U!4D=)3BU43U`Z(#!P>"<^#0H@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQI/E=I;&1O;6%R+`T*($-A;&EF;W)N:6$\+VD^ M/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/C(L,#4P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.#8\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/C0S)B-X03`[665A6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+4Q% M1E0Z(#%E;3L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@+3%E;2<^ M#0H@/&9O;G0@"<^#0H@/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P M,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`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`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C8L,C@Q/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XT,"PP-S`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ.3@V M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XT,B!996%R6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/E=E;&QI;F=T M;VX@4F5G:6]N86P@365D:6-A;`T*($-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$L-C8S/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XS,2PU-#D\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`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`V/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ.3@V/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XT,B!996%R6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.#8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/C,U(%EE87)S/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XU,#`\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C8L.30U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ+#`V,CPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XX+#`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ.3DS/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ.3@Y/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XT,"!996%R6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/DMI;F1R960@2&]S<&ET86P@0VAI M8V%G;PT*($-E;G1R86P\8G(@+SX-"B`\:3Y#:&EC86=O+"!);&QI;F]I6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XQ-3@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C8L-#`T/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ.3DS/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XQ.3@V/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR-2!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D9A;6EL>2!$;V-T;W(F(W@R,#$Y.W,-"B!-961I8V%L M($]F9FEC92!"=6EL9&EN9SQB6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XR+#`W-#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ.3DQ/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XQ.3DU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XT-2!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/DME;'-E M>2U397EB;VQD($-L:6YI8R!A=`T*($MI;F6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XT,SD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/C$L-C$X/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XX-S`\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XY-3@\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.34\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C0U(%EE87)S/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XT,SD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C$L.#,W/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ.#,\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C0S.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(L-#4Y/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XX,S(\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/C$Y.34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/C0U(%EE87)S/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@"<^#0H@ M/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XY.38\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`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`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XQ.3DV/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XT-2!996%R6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/D-H97-T97)B6QV86YI83PO:3X\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XR-3`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`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`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XQ.3DV/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XT-2!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L M;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@"<^#0H@/&9O;G0@$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XX,34\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XY.34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQI/DYE=W1O=VXL#0H@4&5N;G-Y;'9A;FEA/"]I M/CPO9F]N=#X\+W`^#0H@/"]T9#X-"B`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`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XQ.34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`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`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.3(\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.38\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C0U(%EE87)S/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$L,3,P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XU+#`Y,CPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/C(L-S@X/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.38\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C0U(%EE87)S/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XU+#`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR,#`P/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XQ.3DX/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XS-2!996%R6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(] M,T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/CQI/E)I=F5R9&%L92P-"B!'96]R9VEA/"]I/CPO9F]N=#X\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+4Q%1E0Z(#%E;3L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@ M+3%E;2<^#0H@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQI/E-P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XU M-S,\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C,L.#0R/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XU-S,\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XR+#(Q,CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XW M,#$@4V]U=&@@5&]N;W!A:`T*($)U:6QD:6YG/&)R("\^#0H@/&D^3&%S(%9E M9V%S+"!.979A9&$\+VD^/"]F;VYT/CPO<#X-"B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3Y3:&5F9FEE;&0@365D:6-A;#QBF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C$L-S8P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`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`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3Y- M961I8V%L($-E;G1EF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C0L.#DY/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`V/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XV+#6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,#`\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/C,P(%EE87)S/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XR+#DX,SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/C4L-3`X/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[ M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ+#$P-#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]WF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C8L-C$R/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XY M,C@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,#@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C(P,#@\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C,U M(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XR-#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/C,L-3DP/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XW+#0P-CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XQ-3D\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C(P,#D\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,#D\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C,V(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XU.3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C(P,3`\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C(P,3`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C,W(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3Y$97-EF$@*&0N*3QB$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/CDL-38P/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR M,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$L,C`P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/C$Y.3@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$Y.3@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/C,P(%EE87)S/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@#L@5$585"U)3D1%3E0Z("TQ96TG/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C6QE/3-$)TU!4D=)3BU" M3U143TTZ(#%P>#L@34%21TE.+4Q%1E0Z(#%E;3L@34%21TE.+51/4#H@,'!X M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3X\:3Y,87,@5F5G87,L#0H@3E8\+VD^/"]F;VYT/CPO M<#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C0P M,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ,BPV-C@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`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`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3Y3<')I;F<@5F%L;&5Y($AOF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]WF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CDL-3`P/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ,3$\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]WF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/CDL-C$Q/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`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`T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XR,#`T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XS-2!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CDL.#`X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`V/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XR,#`V/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XS-"!996%R6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/E-U;6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CDL,3@X M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,3XT-C`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`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`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/E-U;6UE6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XQ,BPP,C$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C,W,#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ-RPY,S$\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C$L,S0U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XR,#`P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR,#`P/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XS,"!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/E-U;6UE6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>#(P M,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ-"PY,#`\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C$L M-#0S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ-BPS-#,\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C(P,#D\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C,V(%EE M87)S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@2P@1T$\ M+VD^/"]F;VYT/CPO<#X-"B`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`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3Y&;W)N97D@365D:6-A;"!0;&%Z83QB2P@5%@\+VD^/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XQ,2PY-C`\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C,Q/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XY,3`\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`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`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3Y,86ME(%!O:6YT92!-961I8V%L#0H@07)TF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]WF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C$L,3`P/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XY+#`P M,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C$L,3`P/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XY+#`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C,U(%EE87)S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`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`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3$\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/C(P,3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/C,U(%EE87)S/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XQ+#DP,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XQ+#DP,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>#(P,30[)B-X03`[)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XR-BPX,3`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C$L-S`Q/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,3XR,#$R/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,3XR,#$R/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XS-2!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/DY7(%1E>&%S(%!R;V8@5&]W97(\8G(@+SX-"B`\:3Y! M;6%R:6QL;RP@5%@\+VD^/"]F;VYT/CPO<#X-"B`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`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR,#$R/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,3XS-2!996%R6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/E=A6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,3XR,#$S/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR,#$S/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XS-2!996%R6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/C4P,#0@4&]O;&4@4F]A M9#QBF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XY-CPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XV,C4\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/C$P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,3XR,#$S/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XR,#$S/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XS M-2!996%R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]TF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B0\ M+V9O;G0^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/CDW+#DR,3PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/"]T6QE/3-$)TU!4D=) M3BU"3U143TTZ(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S M;VQI9#L@34%21TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!72414 M2#H@,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1% M4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0Q/F(N/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0Q/D1U6QE M/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P2!H96QD M(&YO;F-O;G1R;VQL:6YG(&UA:F]R:71Y(&]W;F5D(&EN=&5R97-T2UO M=VYE9"X\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/'1A8FQE M('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P&-L=61E6QE M/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@1D].5"U325I%.B`Q<'@[($U!4D=) M3BU43U`Z(#$R<'@G/@T*("8C>$$P.SPO<#X-"B`\<"!S='EL93TS1"=-05)' M24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<@86QI9VX],T1C96YT M97(^#0H@/&9O;G0@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/DY/5$53(%1/#0H@4T-(14153$4@24E)/"]B/CPO9F]N M=#X\+W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D1% M0T5-0D52(#,Q+`T*(#(P,3,\+V(^/"]F;VYT/CPO<#X-"B`\<"!S='EL93TS M1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<@86QI9VX] M,T1C96YT97(^#0H@/&9O;G0@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/E)%0T].0TE,24%424].($]&(%)%04P-"B!%4U1! M5$4@4%)/4$525$E%4SPO8CX\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B M;&4^#0H@/'`@#L@34%21TE. M+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T* M(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1H92!F;VQL;W=I M;F<-"B!T86)L92!R96-O;F-I;&5S('1H92!296%L($5S=&%T92!028C>$$P.S$L#0H@,C`Q,2!T;R!$96-E;6)E$$P.S,Q+"`R,#$S.CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%PF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Y.2PY M-#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY);7!A8W0@;V8@9&5C;VYS;VQI9&%T:6]N#0H@;V8@86X@3$Q#*&$N*3PO M9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@Q,RPQ M.#4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXI/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,S,L,#@P/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R M87`^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,S+#DY M,3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXH,3$L-3$Q/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C,Y-2PV-CD\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@ M,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$ M15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CQB/B@R*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\8CY214-/3D-)3$E!5$E/3B!/1@T* M($%#0U5-54Q!5$5$($1%4%)%0TE!5$E/3CPO8CX\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#PO=&%B;&4^#0H@/'`@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/E1H92!F;VQL;W=I;F<-"B!T86)L92!R96-O;F-I;&5S('1H92!!8V-U;75L M871E9"!$97!R96-I871I;VX@9G)O;2!*86YU87)Y)B-X03`[,2P-"B`R,#$Q M('1O($1E8V5M8F5R)B-X03`[,S$L(#(P,3,Z/"]F;VYT/CPO<#X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>"<^ M/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/C(P,3,\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/C(P M,3$\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY"86QA;F-E(&%T#0H@2F%N=6%R>28C>$$P.S$L/"]F;VYT/CPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C@W+#`X.#PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEM<&%C="!O9B!D96-O;G-O;&ED871I;VX- M"B!O9B!A;B!,3$,H82XI/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`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`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`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`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D]T:&5R/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CDW+#DR,3PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@W+#`X M.#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P M+C5P="!S;VQI9#L@34%21TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X M.R!724142#H@,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E1H92!M87-T97(@;&5A28C>$$P.S$L(#(P,3,@86YD+"!A2!M971H;V0N/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/BAB+BD\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY/;B!$96-E;6)E$$P.S$R+"`R,#$Q+`T*('1H92!40T*('1H:7)D+7!A2!H96QD#0H@;F]N8V]N=')O;&QI;F<@;6%J;W)I M='D@;W=N97)S:&EP(&EN=&5R97-T2!O=VYE6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D1U3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA2!O9B!3 M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A0;VQI8VEE"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ M("TV<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY5;FEV97)S86P-"B!(96%L=&@@4F5A;'1Y($EN8V]M92!428C>$$P.S(X+"`R,#$T+"!W92!H879E(&9I9G1Y+65I9VAT(')E86P@ M97-T871E(&EN=F5S=&UE;G1S#0H@;W(@8V]M;6ET;65N=',@;&]C871E9"!I M;B!S:7AT965N('-T871E#L@34%21TE.+51/4#H@ M,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L M92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>#(P,C([/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/G-E=F5N(&AOF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%PF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^/&9O;G0@#L@34%2 M1TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P M/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E M)R!C96QL6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>#(P,C([/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#$E/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^#0H@/'`@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/F9O=7(@<')E6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D]U2!T:&4@;W!E M"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY-86YA9V5M96YT(&ES#0H@=6YA8FQE('1O('!R961I8W0@ M=&AE(&5F9F5C="P@:68@86YY+"!T:&%T('1H92!F86-T;W)S(&1I"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@ M-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]U"<^ M/&9O;G0@#L@5$585"U) M3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@;6EN:6UU;0T*(')E;G0@9F]R M(&%L;"!H;W-P:71A;"!F86-I;&ET:65S(&ES(&9I>&5D(&]V97(@=&AE(&EN M:71I86P@=&5R;2!O<@T*(')E;F5W86P@=&5R;2!O9B!T:&4@&-E2!R96YT86P@8V]N8V5S M&ES=&EN9R!I;BUP;&%C92!L96%S97,@=VET:"!T97)M M&-E2!V87)Y#0H@9G)O;2!P97)I;V0M=&\M<&5R:6]D+B!";VYU'0^)SQD M:78^#0H@/'`@#L@5$585"U)3D1%3E0Z("TR)2<^ M#0H@/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[ M($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/;B!T M:&4@9&%T92!O9@T*(&%C<75I2!I'!E;G-E(&]F#0H@)#0N-B8C>$$P.VUI;&QI;VXL("0S+CDF M(WA!,#MM:6QL:6]N+"`D,RXT)B-X03`[;6EL;&EO;B`D,BXY#0H@;6EL;&EO M;B!A;F0@)#$N-R!M:6QL:6]N(&9O2X@06UOF%T:6]N(&5X<&5N M65A65A65A65A"<^/&9O;G0@#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=) M3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@ M-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E=E(&-O;G-I9&5R(&%L;`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`^#0H@/'`@2!M86YA9V5M96YT+"!I;F-L=61I;F<@=&AE(&5X M<&5C=&5D(&-O=7)S92!O9B!A8W1I;VX@870-"B!T:&4@8F%L86YC92!S:&5E M="!D871E('1H870@=V]U;&0@;&5A9"!T;R!S=6-H(&-A2P@=&AE(&QO&-E2X\ M+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE. M+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D%S&-EF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`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`@#L@5$585"U)3D1%3E0Z("TR)2<^ M#0H@/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=7(-"B!C M;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:6YC;'5D92!T:&4@ M8V]N2!W:&5R M92!W92!A2X@26X@86-C;W)D M86YC92!W:71H('1H92!&05-")B-X,C`Q.3MS('-T86YD87)D$$P.V1I=F5S=&ET=7)E(&]F('!R;W!E2!B M92!A;&QO8V%T960@9&ES<')O<&]R=&EO;F%T96QY(&%S#0H@8V]M<&%R960@ M=&\@;W=N97)S:&EP(&EN=&5R97-TF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@$$P.S,Q+"`R,#$S+"!W92!H879E(&YO;BUC;VYT M2!M971H;V0@2!A$$P.S,P+`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`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY086QM9&%L90T*($UE9&EC86P@4')O M<&5R=&EE2P@54A3(&]F($1E;&%W87)E+"!A#0H@=VAO;&QY+6]W;F5D('-U8G-I M9&EA2!A9W)E96UE;G0@86YD(&UA;F%G M97,@;W5R(&1A>2UT;RUD87D@869F86ER$$P.S,P+"`R M,#$S+"!S:6YC92!I="!W87,@82!V87)I86)L90T*(&EN=&5R97-T(&5N=&ET M>2!A;F0@=V4@=V5R92!D965M960@=&\@8F4@=&AE('!R:6UA28C>$$P.S$L(#(P,3,L('1H92!M87-T97(@ M;&5A2!A;F0@=V4@=&AE MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@#(P,3D[ M#L@34%2 M1TE.+51/4#H@,3)P>"<^#0H@)B-X03`[/"]P/@T*(#QP('-T>6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5F9F5C=&EV90T*($IA;G5A28C>#(P,3D[F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@2!M:6YO2!O=VYE&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=CX-"B`\ M<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P M>"<^/&9O;G0@6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY.;R!P2!A&5S M(&%N9"!W90T*(&%R92!R97%U:7)E9"!T;R!D:7-T&%B;&4@ M:6YC;VUE('1O(&]U"<^ M/&9O;G0@#L@5$585"U) M3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!A&-I65A M"!E<75A;',@-"4@;V8@=&AE(&%M M;W5N="!B>2!W:&EC:"`X-24@;V8@;W5R(&]R9&EN87)Y#0H@:6YC;VUE('!L M=7,@.34E(&]F(&%N>2!C87!I=&%L(&=A:6X@:6YC;VUE(&9O65A<@T*(&5X8V5E9',@8V%S:"!D:7-T65A"!W87,@9'5E+CPO9F]N M=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^ M#0H@/'`@"<^/&9O;G0@#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4:&4@86=G2P@870@1&5C96UB97(F(WA!,#LS,2P@,C`Q,RX\ M+V9O;G0^/"]P/@T*(#PO9&EV/CQS<&%N/CPO"<^ M/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W`^#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@ M/'`@2!O M<&5R871I;F<@86-T:79I=&EE'0^)SQD:78^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CQB/D9A:7(-"B!686QU93PO8CX\+V9O;G0^/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U143TTZ("TV<'@[($U!4D=)3BU4 M3U`Z(#!P>"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`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`^#0H@/'`@&-L=61E9"!F"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX- M"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY3964@3F]T90T*(#,M06-Q=6ES:71I;VYS(&%N9"!$:7-P M;W-I=&EO;G,L(&9O2UO M=VYE9"!,3$-S+CPO9F]N=#X\+W`^#0H@/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@#MM87)G:6XM8F]T=&]M.BTV<'@^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@'0^)SQD:78^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/CQB/DYE=R!!8V-O=6YT:6YG#0H@ M4W1A;F1A#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X8V5P="!A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY) M;B!&96)R=6%R>2P-"B`R,#$S+"!T:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@ M4W1A;F1A65A"<^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E M)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY);B!*=6QY(#(P,3,L#0H@=&AE($9I;F%N8VEA;"!! M8V-O=6YT:6YG(%-T86YD87)D0T*(&]B;&EG871I;VYS(&]F('1H92!5 M;FET960@4W1A=&5S(&=O=F5R;FUE;G0@86YD('1H92!,24)/4BX@26X-"B!A M9&1I=&EO;BP@=&AE(&=U:61A;F-E(')E;6]V97,@=&AE(')E6EN9R!N97<@;W(@ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R M/E1H92!T86)L92!B96QO=PT*(&1E=&%I;',@=&AE(&5X:7-T:6YG(&QE87-E M('1E#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!C96QL6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q!4%-%(&%L:6=N/3-$ M8V5N=&5R/@T*(#QT"!S;VQI9"`C,#`P,#`P.W=I9'1H.C4P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@$$P.V]F)B-X03`[ M1F%C:6QI='D\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB/E)E;F5W86P\8G(@+SX-"B!497)M/&)R("\^#0H@*'EE M87)S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M3I4:6UEF4],T0R/DUC06QL96X@365D:6-A;`T*($-E;G1EF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C4L-#@U+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/BAA*28C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@3I4:6UEF4],T0R/E=E;&QI;F=T;VX@4F5G:6]N86P@365D:6-A M;`T*($-E;G1EF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4 M:6UEF4],T0R/C,L,#,P+#`P,#PO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`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`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0R/D1E8V5M8F5R+"`R,#$V/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4],T0R/CDS,"PP,#`\+V9O;G0^/"]T M9#X-"B`\=&0@;F]W3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4] M,T0R/D1E8V5M8F5R+"`R,#$T/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VQI;F4M:&5I9VAT.CAP>#MM87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C)P>#MB;W)D97(M8F]T=&]M.C`N-7!T('-O;&ED(",P M,#`P,#`[=VED=&@Z,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE M/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q!4%-%(&)O3I4:6UEF4],T0R/E5(4R!H87,@=&AR964@-2UY96%R(')E;F5W M86P-"B!O<'1I;VYS(&%T(&5X:7-T:6YG(&QE87-E(')A=&5S("AT:')O=6=H M(#(P,S$I+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\=&%B M;&4@3I4:6UEF4],T0R/BAB*3PO9F]N=#X\+W1D/@T*(#QT9"!A;&EG;CTS M1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/BAC*3PO9F]N=#X\+W1D/@T*(#QT9"!A;&EG M;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y M.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8S(V93DW8S9?,S'0O:'1M;#L@8VAA M'0^)SQD M:78^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3I4:6UEF4],T0R/E1H92!F;VQL;W=I M;F<-"B!T86)L92!S=6UM87)I>F5S('-I9VYI9FEC86YT('5N;V)S97)V86)L M92!Q=6%N=&ET871I=F4@:6YP=71S(&%N9`T*(&%S3H\+V9O M;G0^/"]P/@T*(#QP('-T>6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O M='1O;3HP<'@^/&9O;G0@3I4:6UEF4],T0Q/CQB/D%S3I4:6UEF4],T0Q/CQB/D9A:7(@5F%L M=64@870\8G(@+SX-"B!$96-E;6)E$$P.S,Q+"8C>$$P.S(P,3(\+V(^ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE M/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(@#MM87)G:6XM8F]T=&]M.C%P>"!A;&EG;CTS1&-E;G1E M3I4:6UEF4],T0Q/CQB/E9A;'5A=&EO;@T*(%1E8VAN:7%U93PO8CX\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@"!S;VQI9"`C,#`P,#`P)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB/E)A;F=E/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/D-A<&ET86QI>F%T:6]N)B-X03`[4F%T93PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UE MF4],T0R/C3I4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QTF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@3I4:6UEF4],T0R/DYO6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/CDL-C`P+#`P,#PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/D-A<&ET86QI>F%T:6]N#0H@4F%T93PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C@N-C`\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\+W1R/@T*(#QTF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)VQI;F4M:&5I9VAT.CAP>#MM87)G:6XM=&]P.C!P M>#MM87)G:6XM8F]T=&]M.C)P>#MB;W)D97(M8F]T=&]M.C`N-7!T('-O;&ED M(",P,#`P,#`[=VED=&@Z,3`E)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T M>6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q!4%-%(&)O6QE/3-$0D]21$52+4-/3$Q!4%-%.D-/3$Q!4%-% M(&)O6QE/3-$0D]21$52+4-/3$Q! M4%-%.D-/3$Q!4%-%(&)O'0^)SQS<&%N/CPO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA;F0\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY"=6EL9&EN9W,@86YD#0H@:6UPF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C8L,#(P/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B@Q-#0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXI)B-X M03`[/"]F;VYT/CPO=&0^#0H@/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@U,S0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXI)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/BDF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY. M970@8V%S:"!P86ED/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C$V+#@Y,3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3=6)S=&%N M=&EA;&QY#0H@86QL(&]F('1H92!I;G1A;F=I8FQE(&%SF5D(&]V97(@=&AE(&%V97)A9V4@ M6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z M(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/DQA;F0\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L-S0Y/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C8Q,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]T:&5R(&%SF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Q/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B@Q,3PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/BDF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY.970@8V%S:"!P86ED/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C0L-C@U/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@'0^)SQS<&%N M/CPO6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DEN=&%N9VEB;&4-"B!AF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%PF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D)U:6QD:6YG6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXS-BPY-#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);G1A;F=I M8FQE#0H@87-S971S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY/=&AE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS,3PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/E1O=&%L('!U6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXT-RPX,#8\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY,:6%B:6QI=&EE0T*(&%N9"!O<&5R M871I;F$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D1E8G0\+V9O;G0^/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXH-BPY.3D\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXI M)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/"]TF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQAF5D($9I;F%N8VEA;"!);F9O'0^)SQD:78^#0H@/'`@2!M971H;V0@ M87,@;V8@1&5C96UB97(F(WA!,#LS,2P-"B`R,#$S.CPO9F]N=#X\+W`^#0H@ M/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A8FQE M('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!724142#H@-3EP="<^#0H@/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1C96YT97(^#0H@/'`@2!/=VYE9"!B>2!,3$,\+V(^/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1T;W`@;F]W6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$5DU##0H@ M4')O<&5R=&EE6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXY,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@2!-961I8V%L($-E;G1E6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY3=6)U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS,SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY386YT82!&90T*(%-C;W1T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D)R M=6YS=VEC:PT*($%S6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/DUI9"!#;V%S="!(;W-P:71A;"!-3T(\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QTF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C@U/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY!F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY3:65R6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@"!#:&EL9')E;B8C>#(P,3D[2!#87)E#0H@0V5N=&5R/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-P87)KF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@$$P.TUE9&EC86PF M(WA!,#M497)R86-E)B-X03`[)F%M<#LF(WA!,#M4:&4F(WA!,#M3<&%R:W,F M(WA!,#M-961I8V%L)B-X03`[0G5I;&1I;F<\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT7-O;@T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DYO2!-961I8V%L(%!L87IA/"]F;VYT/CPO=&0^#0H@/"]T M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D946"!-3T(@4&AA6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D9O2!-961I8V%L(%!L87IA($E) M/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E!A;&UD86QE)B-X M03`[365D:6-A;"8C>$$P.U!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@#L@3$E.12U(14E'2%0Z(#AP>#L@ M5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"=" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY496YA;G1S(&]F('1H:7,@;65D:6-A;`T* M(&]F9FEC92!B=6EL9&EN9R!I;F-L=61E(&]R('=I;&P@:6YC;'5D92!S=6)S M:61I87)I97,@;V8-"B!52%,N/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/BAB+BD\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY7 M92!H879E(&-O;6UI='1E9"!T;R!I;G9E28C>#(P,3D[6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BAC+BD\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY792!H879E(&-O;6UI='1E9"!T;R!I;G9E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/BAD+BD\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$ M=7)I;F<@=&AE('1H:7)D('%U87)T97(@;V8-"B`R,#$R+"!T:&ES(&QI;6ET M960@<&%R=&YE6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/BAF+BD\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY%9F9E8W1I=F4@2F%N=6%R>28C>$$P.S$L#0H@,C`Q-"P@=V4@<'5R M8VAA2!M:6YO2!O=VYE28C>$$P.S$L(#(P,30N/"]F M;VYT/CPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/BAG+BD\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$=&]P M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@1D].5"U325I% M.B`Q<'@[($U!4D=)3BU43U`Z(#$R<'@G/@T*("8C>$$P.SPO<#X-"B`\<"!S M='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U!4D=)3BU43U`Z(#!P>#L@ M5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#M/;@T*($1E8V5M M8F5R)B-X03`[,3(L(#(P,3$L('=E(&)E9V%N(&-O;G-O;&ED871I;F<@=&AE M(&9I;F%N8VEA;"!D871A#0H@;V8@=&AE$$P.S$Q+"`R M,#$Q+"!A6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z M(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYA;64@;V8-"B!,3$,\+V(^/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M8V]LF4],T0Q/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C M96YT97(^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8U,R!4;W=N($-E;G1E<@T*($EN=F5S=&UE;G1S*&$N*3PO M9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C8U,R!4 M;W=N($-E;G1EF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDX/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY!<&%-960-"B!06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D%P86-H92!*=6YC=&EO;B!-961I8V%L M(%!L87IA/"]F;VYT/CPO=&0^#0H@/"]TF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY" M86YB=7)R>2!-961I8V%L#0H@4')O<&5R=&EE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D)20B]%($)U:6QD:6YG M#0H@3VYE/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D)20B!-961I8V%L($]F M9FEC92!"=6EL9&EN9SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D-E;G1E;FYI86P@365D M:6-A;`T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D-E;G1E;FYI86P@2&EL;',@365D:6-A;"!/9F9I8V4@0G5I;&1I;F<@23PO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXY.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D=O;&0@4VAA9&]W#0H@4')O<&5R=&EE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY.#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@2!-961I8V%L#0H@4')O<&5R=&EEF4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M2!-961I8V%L M#0H@4')O<&5R=&EEF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.TUE9&EC86PF(WA! M,#M/9F9I8V4F(WA!,#M"=6EL9&EN9R8C>$$P.TE)/"]F;VYT/CPO=&0^#0H@ M/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ M(#)P>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%2 M1TE.+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX- M"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1E;F%N=',@;V8@=&AIF4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'`@F5D(&9I;F%N8VEA;"!D871A(&9O6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%2 M1TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P M/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E M)R!C96QL"!S;VQI9#L@5TE$5$@Z(#0W<'0G/@T* M(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYA;64@;V8-"B!,3$,\+V(^/"]F;VYT/CPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!724142#H@.#9P="<@86QI M9VX],T1C96YT97(^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$4TU"(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW-CPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@Y/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW-3PO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E97(@5F%L;&5Y($UE9&EC86P@3V9F:6-E($E)/"]F;VYT/CPO M=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E97(@5F%L;&5Y($UE9&EC86P@3V9F:6-E($)U M:6QD:6YG($E)23PO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D1E97)V86P@4&%R:VEN9PT* M($-O;7!A;GDH82XI/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@2!087)K:6YG($=A6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D-O8G)E(%!R M;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY M-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F$\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^ M#0H@/'`@$$P.SPO<#X-"B`\ M=&%B;&4@2!O9B!A('!AF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W`^#0H@/'`@6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%0 M4T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/DYA;64@;V8-"B!,3$,\+V(^/"]F M;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED M.R!724142#H@.#9P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY#86YY;VX@2&5A;'1H8V%R90T*(%!R;W!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6]N(%-P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4W-2!(87)D>0T*($EN=F5S=&]RF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/CDP/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F5D($EN8V]M93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQD M:78^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%PF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q M/CQB/C(P,3(H82XI/"]B/CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY2979E;G5EF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CY/<&5R871I;F<-"B!E>'!E;G-EF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C@L-S`U/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`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`],T1N;W=R M87`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`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV+#`U-CPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY.970@:6YC;VUE(&)E9F]R M92!G86ENF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C(L,C6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^ M#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D]U6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,L,#4X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY/=7(@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/C@L-3(P/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\=&%B;&4@2P@ M9'5R:6YG('1H92!F;W5R=&@@<75A2!O=VYEF$@;VX@86X@=6YC;VYS;VQI9&%T960-"B!B M87-IF$@9F]R('1H92!S:7@M;6]N=&@@<&5R:6]D(&]F M($IU;'DF(WA!,#LQ+"`R,#$S('1H$$P.S,Q M+"`R,#$S+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\=&%B M;&4@2!U&EM871E;'D@)#$N M.2!M:6QL:6]N+`T*("0Q+C4@;6EL;&EO;B!A;F0@)#(N-B!M:6QL:6]N+"!R M97-P96-T:79E;'DN/"]F;VYT/CPO=&0^#0H@/"]T2!-971H;V0\ M+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!4 M15A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/D)E;&]W(&%R92!T:&4-"B!C M;VUB:6YE9"!B86QA;F-E('-H965T$$P.S,Q+"`R,#$S(&%N9"`R,#$R.CPO9F]N=#X\+W`^ M#0H@/'`@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W`^#0H@/'1A M8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.S,Q+#PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/BAA;6]U;G1S(&EN#0H@=&AO=7-A M;F1S*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE="!P2P@:6YC;'5D:6YG#0H@0TE0/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C$Q.2PU-#<\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDL M.#4P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@ M/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@ M/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L(&%SF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149& M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/DUO6%B;&4L#0H@;F]N+7)E8V]U6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXW-RPU,3$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4 M.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY!9'9A;F-E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,BPY,3$\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R+#8U.#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-% M149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5Q=6ET M>3PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P M+#8V-SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1O=&%L(&QI86)I;&ET:65S(&%N9`T*(&5Q M=6ET>3PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`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`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P M>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE. M+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F M(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D%S(&UE;G1I;VYE9"!A8F]V92P@=V4-"B!B96=A;B!T;R!A8V-O=6YT M(&9O2!M971H;V0@87,@ M;V8@2G5L>28C>$$P.S$L(#(P,3,N(%!R:6]R#0H@=&\@2G5L>28C>$$P.S$L M(#(P,3,L('1H92!F:6YA;F-I86P@2!W M97)E#0H@86-C;W5N=&5D(&9O'0^)SQD:78^#0H@/'`@$$P.S,Q+"`R M,#$S+"!A9V=R96=A=&4@<')I;F-I<&%L(&%M;W5N=',@9'5E(&]N(&UO2!U;F-O;G-O;&ED871E9"!,3$-S+"!W M:&EC:"!A"<^ M/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXR,#$T/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C$T+#$W-#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,34\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXT,2PT.3(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494 M.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$V/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q+#@R M.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3@\+V9O;G0^/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXQ,BPP,SD\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P M<'@[($U!4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DUOF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/CQB/DUA='5R:71Y)B-X03`[1&%T93PO8CX\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/D=R87ES;VX-"B!0F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P.R8C M>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,30\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q M96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P M.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,34\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY!6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR-"PP-3(\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C M>$$P.R8C>$$P.R8C>$$P.S(P,34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`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`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E!A;&UD86QE($UE M9&EC86P-"B!0F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,34\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY& M5%@@34]"(%!H87-E#0H@24DH8RXI/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P M,3<\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY00T@@4V]U=&AEF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.R8C>$$P.R8C>$$P.R8C M>$$P.R8C>$$P.R8C>$$P.R8C>$$P.S(P,3<\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3<&%R:W,@365D:6-A;`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`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!#2"!-961I8V%L#0H@4')O<&5R=&EEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C@L-C,T/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#LF(WA!,#LF(WA!,#LF(WA!,#LF(WA!,#LF(WA!,#LF(WA! M,#LF(WA!,#LR,#$X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT M9"!V86QI9VX],T1T;W`^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X- M"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`R<'@[($)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,"XU<'0@#L@3$E. M12U(14E'2%0Z(#AP>#L@5TE$5$@Z(#$P)2<^#0H@)B-X03`[/"]P/@T*(#QT M86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY792!B96QI979E M('1H92!T97)M'!L;W)E M(&]T:&5R(&9I;F%N8VEN9R!A;'1E0T*(&EN=F5S=&UE;G0@:6X@=&AE('!R;W!EFEN M9R!F=6YD6UE;G1S('1H2!A;F0@:6YC;'5D92!A(&)A;&QO;VX@<')I;F-I<&%L('!A>6UE M;G0@=7!O;@T*(&UA='5R:71Y+CPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T M86)L93X-"B`\=&%B;&4@2!#;VUP86YI97,@06-C;W5N=&5D(&9O#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4 M:&4@=&%B;&4@8F5L;W<-"B!R969L96-T2!O=VYE2!O=VYE0T*('5S+CPO9F]N=#X\+W`^#0H@/'`@F4],T0Q/B8C>$$P M.SPO9F]N=#X\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!3 M13H@8V]L;&%P6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!724142#H@ M-#EP="<^#0H@/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1C96YT97(^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/CQB/E!R;W!E6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C M96YT97(^/&9O;G0@F4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E-U;6UEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV-3,@5&]W M;B!#96YT97(@4&AAF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DY6/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXY.#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^ M#0H@/"]T6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E=!/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXY-3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/"]TF4] M,T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F$\+V9O;G0^ M/"]T9#X-"B`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`\+W1R/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`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`],T1N;W=R87`^/&9O;G0@$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D)20B]%($)U:6QD M:6YG#0H@3VYE/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F M(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY#96YT96YN:6%L($UE9&EC86P-"B!0 M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO M='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T M;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1EF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDY/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R M/@T*(#QT6QE/3-$)TU! M4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY' M;VQD(%-H861O=PT*(%!R;W!E6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXR/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX] M,T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/E-P$$P.U9A;&QE>28C>$$P M.TUE9&EC86PF(WA!,#M06QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E-P$$P.U9A;&QE>28C>$$P.TUE9&EC86P@4')O<&5R=&EE M$$P.TE)/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/DY6/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY-3PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C4\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P>#L@ M0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE.+51/ M4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F(WA! M,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L M;&%P'0^)SQS<&%N/CPO'0^)SQD:78^#0H@/'`@6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/ M4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT M86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!C96QL M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYA;64@;V8-"B!,3$,Z/"]B/CPO9F]N=#X\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$8V5N=&5R/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#%P>#L@34%21TE.+51/4#H@,'!X)R!A;&EG;CTS1&-E;G1E0T*(&]W;F5D(&)Y($Q,0SH\+V(^/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@3PO8CX\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0Q/CQB/E-T871E/"]B/CPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L MF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF$\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C M96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O M;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@ M/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E97)V M86P-"B!02!-961I8V%L($]F9FEC92!)23PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D%:/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY$965R=F%L(%!R;W!EF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E!H;V5N:7@\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1C96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E97)V86P@4&%R:VEN9PT*($-O;7!A;GDH82D\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E97(@5F%L;&5Y(%!A6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E!H;V5N:7@\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1C96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/CDS/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D1334(@4')O<&5R=&EEF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/DUEF4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1C96YT97(^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQI=&-H=F%N#0H@26YV97-T;65N=',\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E!A<&%G;R!-961I8V%L(%!AF4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1C96YT97(^/&9O;G0@#PO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/E1H=6YD97)B:7)D(%!AF$@22`F86UP.R!)23PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D5D=V%R9',@365D:6-A;"!0;&%Z83PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/D%:/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXY,#PO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#PO=&%B M;&4^#0H@/'`@$$P.SPO<#X- M"B`\=&%B;&4@2P-"B!,3$,L('=H:6-H(&]W;F5D('1H92!R96%L M('!R;W!E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA'0^ M)SQD:78^#0H@/'`@'0M:6YD96YT.C0E)SX-"B`\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0R/DUI;FEM=6T@ M9G5T=7)E#0H@8F%S92!R96YT#MM87)G:6XM8F]T=&]M.C!P M>#X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]P/@T*(#QT86)L92!C M96QL3I4:6UEF4],T0R/C(P,30\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/C0R+#8Y,CPO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/C(P,38\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)VUA3I4 M:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0R/C(Q M+#4Q.3PO9F]N=#X\+W1D/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@'0M M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E1H97)E869T97(\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V)O M$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!O9B!297%U:7)E9"!#;VUP M;&EA;F-E(%)A=&EO'0^)SQD:78^#0H@/'`@2!O M9B!T:&4@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C$T-"PX-#@\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY$96)T('1O M('1O=&%L#0H@8V%P:71A;#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B9L=#L@-34\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXS-BXP/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C M0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E M8G0@$$P.S0N,#!X/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXQ.2XQ>#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1E8G0@=&\@8V%S:"!F;&]W#0H@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF;'0[)B-X03`[,RXU M,'@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(N,C%X/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@#L@5$585"U)3D1%3E0Z(#0E)SX-"B`\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY4:&4@9F]L;&]W:6YG#0H@=&%B;&4@&-L=61I;F<@;F5T(&1E8G0-"B!P6QE/3-$)TU!4D=)3BU"3U14 M3TTZ(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA! M,#L\+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%0 M4T4Z(&-O;&QA<'-E)R!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D9A8VEL:71Y#0H@3F%M93PO8CX\+V9O M;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/CQB/DUA='5R:71Y/&)R("\^#0H@1&%T93PO8CX\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E-U;6UEF4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,30\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)TU!4D=) M3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY3<')I M;F<@5F%L;&5Y($UE9&EC86P-"B!/9F9I8V4@0G5I;&1I;F<@9FEX960@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C4N-3`\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$U/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Q+#,T-SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/C(P,38\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[ M(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY096%C92!(96%L=&@@9FEX M960@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXR,2PV.#$\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C4N-C0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXR,#$W/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXU+C4P/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T* M(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/D%U8G5R;B!-961I M8V%L($E)(&9L;V%T:6YG#0H@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C(N.3(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N)R!S:7IE/3-$,CXR,#$W/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@&5D(')A=&4@;6]R M=&=A9V4@;&]A;CPO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C0L.#DY/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV+C`P/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/D-E;G1E;FYI M86P@2&EL;',@365D:6-A;`T*($]F9FEC92!"=6EL9&EN9R!F;&]A=&EN9R!R M871E(&UO6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXQ,"PY,S@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C,N-#(\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$X M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR+#DX,SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,3D\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`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`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C(P,C(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXW,#`@4VAA9&]W($QA;F4@86YD#0H@ M1V]L9')I;F<@34]"6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXV+#6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B4F(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(P,C(\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CY4=7-C86X@4')O9F5SF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C4N M-38\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXE)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXR,#(U/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1% M6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY4;W1A;#PO9F]N=#X\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@ M/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#PO M=&%B;&4^#0H@/'`@$$P.SPO M<#X-"B`\=&%B;&4@2P@=V4@=VEL;"!E>'!L;W)E(&]T:&5R(&9I;F%N8VEN9R!A;'1E6QE/3-$ M)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E. M1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/D%S(&]F#0H@1&5C96UB97(F(WA!,#LS M,2P@,C`Q,RP@;W5R(&%G9W)E9V%T92!C;VYS;VQI9&%T960@6UE;G1S("AI;F-L=61I;F<@;6]R=&=A9V5S*2!A"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$ M14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N)R!S:7IE/3-$,CXR,#$U*&$I/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L M;W(],T0C0T-%149&/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C(P,38\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXQ,RPP.3@\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CXR,#$W/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P+#8W,CPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DQA M=&5R/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M6QE/3-$)TU!4D=)3BU"3U143TTZ(#)P M>#L@0D]21$52+4)/5%1/33H@(S`P,#`P,"`P+C5P="!S;VQI9#L@34%21TE. M+51/4#H@,'!X.R!,24Y%+4A%24=(5#H@.'!X.R!724142#H@,3`E)SX-"B`F M(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@ M8V]L;&%P7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA#L@5$585"U)3D1%3E0Z M(#0E)SX-"B`\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CY);F9O6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@ M34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^ M/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA M<'-E)R!C96QL6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!724142#H@-S%P="<^#0H@ M/&9O;G0@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/DYU M;6)E&5R M8VES93QBF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.U)A;F=E M/&)R("\^#0H@*$AI9V@M3&]W*3PO8CX\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D)A;&%N8V4L($IA;G5A6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXU,2PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,V M+C4S+R0R-BXP.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X97)C:7-E9#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]WF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]WF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/D)A;&%N8V4L($IA;G5A6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXU,2PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,V M+C4S+R0R-BXP.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D5X97)C:7-E9#PO9F]N=#X\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@L,#`P/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXR-BXW-CPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(W+C8U+R0R-BXP.3PO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T28C>$$P.S$L#0H@,C`Q,SPO9F]N=#X\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C0S+#`P,#PO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,U+C(R M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C(Y+C0T/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CY/=71S=&%N9&EN9R!O<'1I;VYS('9E&5R M8VES86)L92!A$$P.S,Q+"`R,#$S/"]F;VYT/CPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@ M/"]T86)L93X-"B`\+V1I=CX\6QE/3-$)TU! M4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@,'!X.R!415A4+4E.1$5. M5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!F;VQL;W=I;F<-"B!T86)L92!P6QE/3-$)TU!4D=)3BU"3U143TTZ M(#!P>#L@34%21TE.+51/4#H@,'!X)SX\9F]N="!S:7IE/3-$,3XF(WA!,#L\ M+V9O;G0^/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z M(&-O;&QA<'-E)R!C96QLF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY.=6UB97(\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXT,"PP M,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M+W1R/@T*(#QT6QE/3-$ M)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CY796EG:'1E9"!A=F5R86=E(&5X97)C:7-E#0H@<')I8V4\+V9O;G0^/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$ M,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE M/3-$)TU!4D=)3BU,1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CY!9V=R96=A=&4@:6YT6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT M9"!V86QI9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/E=E:6=H=&5D(&%V97)A M9V4@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/C(N-3PO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/"]T86)L93X- M"B`\+V1I=CX\6QE/3-$)TU!4D=)3BU"3U143TTZ(#!P>#L@34%21TE.+51/4#H@ M,'!X.R!415A4+4E.1$5.5#H@-"4G/@T*(#QF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/E1H92!W96EG:'1E M9`T*(&%V97)A9V4@&5R8VES86)L92!O<'1I;VYS(&%T M($1E8V5M8F5R)B-X03`[,S$L(#(P,3,-"B!W97)E(&%S(&9O;&QO=W,Z/"]F M;VYT/CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM0D]45$]-.B`P<'@[($U! M4D=)3BU43U`Z(#!P>"<^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0Q M,"!A;&EG;CTS1&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0Q/CQB/D5X97)C:7-E#0H@4')I8V4\+V(^/"]F;VYT/CPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L&5R M8VES93QBF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/E=E:6=H=&5D/&)R("\^#0H@079E$$P M.RAI;CQBF4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D M/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V86QI M9VX],T1T;W`^#0H@/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B0S,"XP-B8C>$$P.RTD,S0N,#<\ M+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXT+#`P M,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,S+C`W/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXQ+C`\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QT M6QE/3-$)TU!4D=)3BU, M1494.B`Q96T[(%1%6%0M24Y$14Y4.B`M,65M)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXD,S0N.3`F M(WA!,#LM)#,T+CDP/"]F;VYT/CPO<#X-"B`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`P,#PO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C,N,CPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/"]T6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXT,"PP,#`\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`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`C,#`P,#`P)SX\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q M/CQB/E-E8V]N9#QBF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#PO='(^#0H@/'1R(&)G8V]L;W(],T0C0T-%149&/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/E)E=F5N=65S/"]F;VYT M/CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)V)O$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C,L-#(W/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3I4:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O M;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4] M,T0R/C,L-#DX/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P M>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D M;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O6QE/3-$)V)O M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE M=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,C<\+V9O;G0^/"]T M9#X-"B`\=&0@;F]W3I4:6UEF4] M,T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4 M:6UEF4],T0R/C`N,C<\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V)O M6QE/3-$)V)O$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/C`N,C,\+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ MF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C$N,#0\ M+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)V)O6QE M/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)OF4Z M,7!X.VUA#MM87)G:6XM8F]T=&]M.C!P>#X-"B`F(WA! M,#L\+W`^#0H@/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`@=VED=&@],T0Q,#`E(&)O"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3I4:6UEF4],T0Q/CQB/C(P M,3(\+V(^/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"B`\+W1R/@T*(#QTF4],T0Q/B8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`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`^#0H@/'`@3I4:6UEF4],T0R/E)E=F5N=65S/"]F;VYT/CPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI M9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R/@T*(#QT9"!V M86QI9VX],T1T;W`^#0H@/'`@3I4:6UEF4],T0R/DYE="!I;F-O;64@8F5F M;W)E#0H@9V%I;G,\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/C(L,3,Y/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`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`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UE MF4],T0R/B8C>#(P,30[)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>#(P,30[ M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)V)O$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@"!S;VQI9"`C,#`P M,#`P)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)V)O$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^ M#0H@/'1R/@T*(#QT9"!V86QI9VX],T1T;W`^#0H@/'`@F4],T0R M/DYE="!I;F-O;64\+V9O;G0^/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4],T0R M/CDL-3$T/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2 M;VUA;B<@3I4:6UEF4],T0R/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C0L M-3$P/"]F;VYT/CPO=&0^#0H@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@3I4 M:6UEF4],T0R/C`N-S4\+V9O;G0^/"]T9#X-"B`\ M=&0@;F]W3I4:6UEF4],T0R/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3I4 M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I M;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,S8\+V9O;G0^/"]T9#X-"B`\=&0@;F]W M3I4:6UEF4],T0R/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3I4:6UEF4],T0R/B0\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B M;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P M,#`P,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P M,"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T M'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@F4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.E1I;65S($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C`N,3D\ M+V9O;G0^/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3I4:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S M($YE=R!2;VUA;B<@3I4:6UEF4],T0R/C$N-30\+V9O;G0^ M/"]T9#X-"B`\=&0@;F]W3I4:6UEF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#PO='(^#0H@/'1R M('-T>6QE/3-$9F]N="US:7IE.C%P>#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)V)O6QE/3-$)V)O M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O$$P.SPO M<#X-"B`\=&%B;&4@3I4 M:6UEF4],T0R/BAA+BD\+V9O;G0^/"]T9#X-"B`\ M=&0@86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3I4:6UEF4],T0R/E=E(&)E9V%N M(')E9FQE8W1I;F<@=&AE#0H@;W!EF$@;VX@86X@=6YC;VYS;VQI9&%T960-"B!B87-I M6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.E1I;65S($YE=R!2;VUA M;B<@2!D:7-C=7-S960@:6X@3F]T M92`S+"!T=V\@3$Q#3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C,C9E M.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA2!O9B!3:6=N:69I M8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("T@061D:71I;VYA;"!);F9O3QB3QB3QB2P@56YC;VYS;VQI9&%T960\8G(^4')O<&5R='D\ M8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q M,SQB3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'!E;G-E+"!I;G1A;F=I8FQE(&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!P;&%N="!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!M:6YO2!O=VYE M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!R871E('=H96X@86UO=6YT(&]F(#@U)2!O9B!O2!I;F-O;64@<&QU'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO2!I;G1E'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,30M,3(\'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)RTM,3(M,S$\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y M-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^ M)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T%C=71E($-A M'0^)S(P M,38M,3(\65A65A'0^)SQS<&%N/CPO7-T M96TL($EN;&%N9"!686QL97D@0V%M<'5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N M/CPO3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T%C=71E($-A'0^)S$U('EE87)S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E(&]F($9A8VEL:71Y/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG0F5H879I;W)A;"!(96%L=&@\'0^)S$P('EE87)S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65A7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'!I'0^)SQS<&%N/CPO M65A'0^ M)S(P,C(\&EM=6T@?"!4:&4@0G)I9&=E=V%Y/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO65A'0^)S(P,C0\&EM=6T@?"!796QL M:6YG=&]N(%)E9VEO;F%L($UE9&EC86P@0V5N=&5R($%N9"!3;W5T:'=E7-T96T\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6]N($AE86QT:&-A6]N($AE86QT:&-A#QBF$\8G(^2!-961I8V%L(%!L87IA M/&)R/G-Q9G0\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^2F%N M+B`S,2P@,C`Q,CQB3QB'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!P87)E;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO6UE;G0@;6%D92!F;W(@86-Q=6ES:71I M;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SD@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S<@ M>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S8@>65A'0^)SQS<&%N M/CPO7,\65A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2UO=VYE9"!,3$-S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)S,@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2UO=VYE9"!B>2!U2!A8V-O M=6YT960@9F]R(&]N(&%N('5N8V]N'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!A;F0@;W!E'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0^)U!E86-E2&5A;'1H M($UE9&EC86P@0VQI;FEC/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%SF%T:6]N($%P<')O86-H/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)U!R;V9E M'0^)TEN8V]M92!#87!I=&%L:7IA=&EO;B!!<'!R M;V%C:#QS<&%N/CPO'0^)T-A M<&ET86QI>F%T:6]N(%)A=&4\F%T:6]N(')A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!/=VYE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)TY6/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!O=VYE2!/=VYE9"!B M>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)T%U8G5R;CQS<&%N/CPO'0^)T%P86-H92!*=6YC=&EO;B!-961I8V%L(%!L87IA M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T%:/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!O=VYE2!/=VYE9"!B>2!, M3$,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)TY6 M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!O=VYE'0^)T)20B!-961I8V%L($]F9FEC92!"=6EL9&EN9SQS<&%N/CPO M3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)TMI;F=W;V]D/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)U18/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!O=VYE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)TY6/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!O=VYE2!/=VYE9"!B>2!,3$,\+W1D M/@T*("`@("`@("`\=&0@8VQA2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)TY6/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2!O=VYE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!-961I8V%L($]F9FEC92!"=6EL M9&EN9R!)23QS<&%N/CPO3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)TQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!#;VUP86YI97,@=&AA="!#;VUP;&5T960@1&EV97-T:71U'0^ M)T1E97(@5F%L;&5Y($UE9&EC86P@3V9F:6-E($E)/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T%:/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)T%:/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T-O8G)E(%9A;&QE>2!-961I M8V%L(%!L87IA/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!/=VYE9"!B>2!, M3$,\+W1D/@T*("`@("`@("`\=&0@8VQA2!087)K:6YG($=A3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)U!H;V5N:7@\'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)U!A<&%G;R!-961I8V%L(%!A'0^)T%: M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)U1H=6YD97)B:7)D(%!AF$@22`F($E)/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@3$Q#+"!W:&EC:"!O=VYE9"!T:&4@2!O M9B!A('!A2!- M961I8V%L($]F9FEC92!"=6EL9&EN9W,@22`F86UP.R!)22P@=V%S(#4P)2!O M=VYE9"!B>2!E86-H(&]F($1E97)V86P@4')O<&5R=&EE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!#;VUP86YI M97,@=&AA="!#;VUP;&5T960@1&EV97-T:71U'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C M-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)T]N92P@='=O+"!T:')E92P@;W(@('-I M>"!M;VYT:"!,24)/4B!P;'5S(&%N(&%P<&QI8V%B;&4@;6%R9VEN(')A;F=I M;F<@9G)O;2`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`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ M9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW M8S9?,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!/9B!/=71S=&%N9&EN9R!-;W)T9V%G97,@*$1E=&%I;"D@ M*%531"`D*3QB2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG,C`Q-#QS<&%N/CPO&5D(')A=&4@;6]R=&=A9V4@;&]A;CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)S(P,34\'0^)S(P,38\'0^)SQS<&%N M/CPO2!$871E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q-SQS<&%N/CPO M&5D(')A=&4@;6]R=&=A9V4@ M;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO&5D(')A=&4@;6]R=&=A9V4@ M;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)S(P,3<\'0^)S(P,3@\&5D M(%)A=&4@36]R=&=A9V4@3&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)S(P,3D\'0^)SQS<&%N/CPO2!$871E/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG,C`R,CQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,C4\6UE;G1S(&%R92!M861E(&]N(&$@;6]N=&AL>2!B87-I'1087)T7V,R-F4Y-V,V7S,W-F9?-&4W.5\Y9#DX7SDT.3%D-C@Q83DW-PT* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C,C9E.3=C-E\S-S9F7S1E M-SE?.60Y.%\Y-#DQ9#8X,6$Y-S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^ M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'!I'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6UE;G0@07=A M'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO&5R8VES92!0'0^ M)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPOF5D('5N9&5R(%-T;V-K($]P=&EO;B!0;&%N M&5R8VES92!P&5R8VES92!P'0^)S,@>65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!!9F9I;&EA=&5S("T@061D:71I M;VYA;"!);F9O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C;VUP86YI97,@=VAE2!H87,@:6YV97-T M;65N=',@;W(@8V]M;6ET;65N=',\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M;F1I='5R92!M861E(&]N('!U'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!U;F-O;G-O;&ED M871E9"!,3$-S+"!N970\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO65A2!R96-O2X@3W5R('-H87)E(&]F('1H92!F M:6YA;F-I86P@2!M971H;V0N/"]T9#X-"B`@("`@ M(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL/@T*#0HM M+2TM+2T]7TYE>'1087)T7V,R-F4Y-V,V7S,W-F9?-&4W.5\Y9#DX7SDT.3%D M-C@Q83DW-PT*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B]C,C9E.3=C M-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!#;VUP86YI97,@06-C;W5N=&5D(&9O2!-971H;V0@26YV M97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\ M=&0@8VQA2!/=VYE9"!B>2!, M3$,\+W1D/@T*("`@("`@("`\=&0@8VQA2!-971H;V0@26YV97-T;65N=',@6TQI M;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!/=VYE9"!B M>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA2!/ M=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U-I97)R M82!386X@06YT;VYI;R!-961I8V%L(%!L87IA/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!#:&EL9')E;B=S($5A7-O;B!02!-971H;V0@26YV97-T;65N=',@ M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)U1E>&]M82!-961I8V%L(%!L87IA/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)TYO M2!-961I8V%L(%!L87IA/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S2!/=VYE9"!B>2!, M3$,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!M971H;V0@ M87,@;V8@2G5L>2`Q+"`R,#$S+"!A'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!#;VUP86YI97,@06-C;W5N=&5D M(&9O7-O;B!02!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-=/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO2!A;F0@ M9&5B="!F:6YA;F-I;F'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^2F%N(#$L#0H) M"3(P,30\'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!/=VYE'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\=&0@ M8VQA2!/=VYE9"!B>2!,3$,\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO2!/=VYE9"!B M>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\=&0@8VQA2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U-P2!(;W-P:71A;"!-961I8V%L($]F9FEC92!"=6EL9&EN9R!)23QS<&%N M/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ M9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW M8S9?,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)T1E'0^)U1H=6YD97)B:7)D(%!AF$@22`F M($E)/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)T5D=V%R9',@365D:6-A;"!0;&%Z83QS<&%N/CPO'0^)T1E97(@5F%L;&5Y($UE9&EC86P@ M3V9F:6-E($E)/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S MF$\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A M(&UA2P@3$Q#+"!W:&EC:"!O=VYE9"!T:&4@2!O9B!A('!A M2!-961I8V%L M($]F9FEC92!"=6EL9&EN9W,@24D@86YD($E)22P@=V%S(#4P)2!O=VYE9"!B M>2!E86-H(&]F($1E97)V86P@4')O<&5R=&EE2P@3$Q#+"!W:&EC:"!O=VYE9"!T M:&4@2!O9B!A('!A2!-961I8V%L($]F9FEC92!"=6EL9&EN9W,@22`F M86UP.R!)22P@=V%S(#4P)2!O=VYE9"!B>2!E86-H(&]F($1E97)V86P@4')O M<&5R=&EE3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ M9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW M8S9?,S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO2P@9'5R:6YG('1H M92!F;W5R=&@@<75A2!O=VYE9"!V87)I;W5S(&YO M;F-O;G1R;VQL:6YG+"!M86IO2!O=VYE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C,C9E.3=C-E\S-S9F7S1E-SE? M.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO8S(V93DW8S9?,S'0O:'1M;#L@ M8VAA2!-971H M;V0@*$1E=&%I;"D@*%531"`D*3QB2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6%B;&4L(&YO;BUR96-O=7)S92!T M;R!U6%B;&4@=&\@=7,\+W1D/@T*("`@("`@("`\=&0@ M8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!A;F0@861V M86YC97,@=&\@3$Q#2`Q+"`R,#$S+"!T:&4@9FEN86YC:6%L(')E'0O:'1M;#L@8VAA2!-971H;V0@26YV97-T;65N=',\+W1D/@T*("`@("`@("`\=&0@ M8VQA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#XG,C`Q-#QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!-971H;V0@26YV97-T;65N=',@6TQI;F4@271E;7-= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q-3QS M<&%N/CPOF$\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M2!-971H;V0@26YV97-T;65N=',@?"!00T@@4V]U=&AE'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)S(P,3<\2!-971H;V0@26YV97-T;65N M=',@?"!3<&%R:W,@365D:6-A;"!02!-971H;V0@26YV97-T M;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG,C`Q.#QS<&%N/CPO'0^)S(P,3@\6UE;G0@;V8@)#DS+C<@;6EL;&EO;B!O9B!O=71S=&%N9&EN M9R!B;W)R;W=I;F=S('5N9&5R('1H92!T97)M2!P M2!A;F0@:6YC;'5D M92!A(&)A;&QO;VX@<')I;F-I<&%L('!A>6UE;G0@=7!O;B!M871U2X\ M+W1D/@T*("`@("`@/"]T2!I;G9E M2!U=&EL:7II;F<@9G5N9',@8F]R'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA6%B;&4@8GD@56YC;VYS;VQI9&%T M960@3$Q#2!-971H;V0@*%!A'0^)SQS<&%N/CPO'0^)U)E9FEN86YC92!T:&5S92!L;V%N65A2!-971H;V0@26YV97-T;65N=',@ M6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E8W1E9"!T97)M M(&EN('EE87)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,3`@ M>65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!297-U;'1S("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO M=7-A;F1S+"!E>&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO2!M971H;V0@87,@;V8@2G5L>2`Q+"`R,#$S+B!02!W97)E(')E8V]R9&5D(&]N(&$@8V]N2UO=VYE9"!B>2!U2!A M8V-O=6YT960@9F]R(&]N(&%N('5N8V]N'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!D:7-C=7-S960@:6X@3F]T M92`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`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M&%S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.#8\'0^)SQS<&%N/CPO'0^)S0R('EE87)S/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)S(P,#8\'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!.;W)T:"!,:71T;&4@4F]C M:RP@07)K86YS87,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.#8\'0^)SQS<&%N/CPO'0^)S,U('EE87)S/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.3,\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO65A'0^)SQS<&%N/CPO2!$;V-T;W(G'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A M'0^)SQS<&%N/CPO2U3 M97EB;VQD($-L:6YI8R!A="!+:6YG)W,@0W)O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.34\'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO6QV86YI83PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.38\'0^)SQS<&%N/CPO'0^)S0U('EE87)S/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!. M97<@0G)I=&%I;BP@4&5N;G-Y;'9A;FEA/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.38\'0^)SQS<&%N/CPO'0^)S0U('EE87)S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO2!5=V-H M;&%N+"!096YN'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO65A'0^)SQS<&%N/CPO6QV86YI83PO=&0^#0H@("`@("`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`\'0^)SQS<&%N/CPO M'0^)S$Y.3@\ M'0^ M)SQS<&%N/CPO65A'0^)SQS<&%N/CPO&%S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.3<\'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Y.3D\'0^)SQS<&%N/CPO'0^)S(U('EE87)S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(U('EE87)S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)S(P,#`\'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO&%S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,#0\'0^)SQS<&%N/CPO'0^)S(P,#0\'0^)SQS<&%N/CPO65A'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&%S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,3`\'0^)SQS M<&%N/CPO'0^ M)S(P,3`\'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)S(P,#8\'0^)SQS<&%N/CPO'0^)S(P,#8\'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)S,P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)S(P,#`\'0^)SQS<&%N/CPO'0^)S(P,#`\'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)S(P,#D\'0^)SQS<&%N/CPO M'0^)S(P,#D\ M'0^ M)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)S(P,3$\'0^ M)SQS<&%N/CPO'0^)S,U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,3$\'0^)SQS<&%N/CPO'0^)S,U('EE87)S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,3$\'0^)SQS<&%N/CPO'0^)S,U('EE M87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S(P,3(\ M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M&%S(%!R;V9E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)S(P,3,\'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M65A'0^ M)SQS<&%N/CPO2!D M96)T('1H870@:7,@;F]N+7)E8V]UF5D+V1I=F5S M=&5D('-U8G-E<75E;G0@=&\@86-Q=6ES:71I;VXN/"]T9#X-"B`@("`@(#PO M='(^#0H@("`@("`\='(@8VQA2!O=VYE9"!I;G1E2UO=VYE9"X\+W1D/@T*("`@ M("`@/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M,C9E.3=C-E\S-S9F7S1E-SE?.60Y.%\Y-#DQ9#8X,6$Y-S<-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8S(V93DW8S9?,S'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^ M)SQS<&%N/CPO2UO=VYE9"!S=6)S:61I87)Y M(&]F(%5(4R!R96QA=&5D('1O(%!A;&UD86QE($UE9&EC86P@4')O<&5R=&EE M'!I2!H96QD(&YO;F-O;G1R;VQL:6YG M(&UA:F]R:71Y(&]W;F5R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B M=7)N.G-C:&5M87,M;6EC XML 36 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
Aggregate Consolidated Scheduled Debt Repayment (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]  
2014 $ 11,894
2015 101,245 [1]
2016 13,098
2017 43,914
2018 10,672
Later 18,330
Total $ 199,153
[1] Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
XML 37 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
McAllen Medical Center
 
Operating Leased Assets [Line Items]  
Type of Facility Acute Care
Annual Minimum Rent $ 5,485,000
End of Lease Term 2016-12
Renewal Term (years) 15 years [1]
Wellington Regional Medical Center
 
Operating Leased Assets [Line Items]  
Type of Facility Acute Care
Annual Minimum Rent 3,030,000
End of Lease Term 2016-12
Renewal Term (years) 15 years [2]
Southwest Healthcare System, Inland Valley Campus
 
Operating Leased Assets [Line Items]  
Type of Facility Acute Care
Annual Minimum Rent 2,648,000
End of Lease Term 2016-12
Renewal Term (years) 15 years [2]
The Bridgeway
 
Operating Leased Assets [Line Items]  
Type of Facility Behavioral Health
Annual Minimum Rent $ 930,000
End of Lease Term 2014-12
Renewal Term (years) 10 years [3]
[1] UHS has three 5-year renewal options at existing lease rates (through 2031).
[2] UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
[3] UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).
XML 38 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Relationship with UHS and Related Party Transactions - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2013
Prior annual advisory fee before 1/1/13 amendment
Dec. 31, 2013
After Amendment
Dec. 31, 2013
Minimum
Dec. 31, 2013
Maximum
Dec. 31, 2013
Universal Health Services, Inc
Property
Times
Dec. 31, 2012
Universal Health Services, Inc
Dec. 31, 2013
Universal Health Services, Inc
Total revenue
Dec. 31, 2012
Universal Health Services, Inc
Total revenue
Dec. 31, 2011
Universal Health Services, Inc
Total revenue
Dec. 31, 2013
Universal Health Services, Inc
Combined, including 100% revenue generated from unconsolidated LLCs
Dec. 31, 2012
Universal Health Services, Inc
Combined, including 100% revenue generated from unconsolidated LLCs
Dec. 31, 2011
Universal Health Services, Inc
Combined, including 100% revenue generated from unconsolidated LLCs
Dec. 31, 2013
Universal Health Services, Inc
Minimum
Dec. 31, 2013
Universal Health Services, Inc
Maximum
Dec. 31, 2013
Universal Health Services, Inc
For five years ended December 31, 2013
Total revenue
Dec. 31, 2013
Universal Health Services, Inc
For five years ended December 31, 2013
Combined, including 100% revenue generated from unconsolidated LLCs
Dec. 31, 2013
The Bridgeway
Dec. 31, 2013
Palmdale Medical Properties and Sparks Medical Properties
Jan. 01, 2014
Palmdale Medical Properties and Sparks Medical Properties
Subsequent Event
Property
Dec. 31, 2013
Universal Health Services of Delaware Inc
Dec. 31, 2012
Universal Health Services of Delaware Inc
Dec. 31, 2011
Universal Health Services of Delaware Inc
Dec. 31, 2013
Universal Health Services of Delaware Inc
Minimum
Dec. 31, 2013
Texoma Medical Properties
Related Party Transaction [Line Items]                                                  
Initial lease terms                           13 years 15 years                    
Number of term renewal options           6                                      
Additional renewal terms           5 years                                      
Percentage of revenues generated from leases               30.00% 30.00% 55.00% 22.00% 21.00% 19.00%     41.00% 20.00%                
Non-controlling equity interest, ownership percentage       33.00% 95.00%                                        
Number of office buildings, owned by LLCs, in which the company holds ownership interest           12                                      
Acquisition of Third-party minority ownership interest The decrease during 2013 and 2012 as compared to 2011 is due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of the entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings ("MOBs") and clinics completed during 2011 and the first quarter of 2012.                                                
Option to renew lease, notice period prior to termination date of current term           90 days                                      
Period to purchase respective leased facilities at same price after lease terms           180 days                                      
Renewal period of respective leased facilities at same price after lease terms           180 days                                      
Lease term scheduled end date                                   2014-12              
Number of real estate investments                                       2          
Non-controlling interest percentage                                       100.00%         95.00%
Effective date of acquisition                                     Jan. 01, 2014            
Committed investment in equity, funded                                                 $ 2.1
Committed investment in equity and debt financing                                                 2.3
Third-party term loan                                                 12.5
Advisory agreement expiration date of each year                                         --12-31        
Annual advisory fee as percentage of of average invested real estate assets   0.65% 0.70%                                            
Annual incentive fee to Advisor as percentage of cash available for distribution                                         20.00%        
Percentage of equity to be exceeded for incentive distribution                                               15.00%  
Advisory fee                                         2.4 2.1 2.0    
Average invested real estate assets                                         $ 338 $ 326 $ 309    
Percentage ownership of outstanding shares           6.10% 6.20%                                    
XML 39 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Schedule of Equity Method Investments [Line Items]          
Revenues     $ 21,001 [1] $ 21,448 [2] $ 57,932 [2]
Operating expenses     8,705 [1] 8,974 [2] 25,503 [2]
Depreciation and amortization     4,039 [1] 4,140 [2] 13,066 [2]
Interest, net     6,353 [1] 6,056 [2] 17,630 [2]
Net income before gains on divestitures     1,904 [1] 2,278 [2] 1,733 [2]
Our share of net income before gains on divestitures     2,095 [1],[3] 2,365 [2],[3] 3,058 [2],[3]
Our share of gains on divestitures $ 1,145 [4] $ 7,375 [4] $ 0 $ 8,520 [2],[4] $ 35,835 [2]
[1] As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2103. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July 1, 2013 through December 31, 2013.
[2] As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
[3] Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.
[4] During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
XML 40 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]  
Repayment of outstanding borrowings $ 93.7
Revolving credit agreement value $ 150
XML 41 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) (Universal Health Services, Inc)
12 Months Ended
Dec. 31, 2013
Times
McAllen Medical Center
 
Operating Leased Assets [Line Items]  
Number of renewal options at existing lease rates 3
Renewal options term at existing lease rates 5 years
Renewal options at existing lease rates expiration year 2031
The Bridgeway
 
Operating Leased Assets [Line Items]  
Number of renewal options at fair market value lease rates 2
Renewal options term at fair market value lease rates 5 years
Wellington Regional Medical Center And Southwest Healthcare System
 
Operating Leased Assets [Line Items]  
Number of renewal options at existing lease rates 1
Renewal options term at existing lease rates 5 years
Renewal options at existing lease rates expiration year 2021
Number of renewal options at fair market value lease rates 2
Renewal options term at fair market value lease rates 5 years
Minimum | The Bridgeway
 
Operating Leased Assets [Line Items]  
Renewal options at fair market value lease rates expiration year 2015
Minimum | Wellington Regional Medical Center And Southwest Healthcare System
 
Operating Leased Assets [Line Items]  
Renewal options at fair market value lease rates expiration year 2022
Maximum | The Bridgeway
 
Operating Leased Assets [Line Items]  
Renewal options at fair market value lease rates expiration year 2024
Maximum | Wellington Regional Medical Center And Southwest Healthcare System
 
Operating Leased Assets [Line Items]  
Renewal options at fair market value lease rates expiration year 2031
XML 42 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Dispositions - Additional Information (Detail) (USD $)
0 Months Ended 3 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Jan. 31, 2011
Dec. 31, 2012
Mar. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2008
Dec. 31, 2013
In Place Leases
Dec. 31, 2012
Canyon Healthcare Properties
Feb. 29, 2012
Canyon Healthcare Properties
Feb. 29, 2012
Canyon Healthcare Properties
Canyon Springs Medical Plaza
Dec. 31, 2012
Canyon Healthcare Properties
Canyon Springs Medical Plaza
Oct. 31, 2012
575 Hardy Investor
Oct. 31, 2012
575 Hardy Investor
Centinela Medical Building Complex
Dec. 31, 2012
575 Hardy Investor
Centinela Medical Building Complex
Jan. 31, 2014
Children's Clinic at Springdale
Subsequent Event
sqft
Jan. 31, 2014
Northwest Medical Center at Sugar Creek
Subsequent Event
sqft
Jan. 31, 2014
2014 Acquisitions
Subsequent Event
Dec. 31, 2013
Palmdale Medical Properties and Sparks Medical Properties
Dec. 31, 2013
Palmdale Medical Properties and Sparks Medical Properties
First Quarter 2014
Jan. 01, 2014
Palmdale Medical Properties and Sparks Medical Properties
Subsequent Event
Property
Aug. 31, 2013
Ward Eagle Office Village Medical Office Building
sqft
Jun. 30, 2013
5004 Poole Road medical office building
sqft
Dec. 31, 2013
2013 Acquisitions
Apr. 30, 2013
Forney Medical Plaza
sqft
Jul. 31, 2011
Forney Medical Plaza
sqft
Jan. 31, 2012
Peace Health Medical Clinic
sqft
Dec. 31, 2012
Northwest Texas Professional Office Tower
sqft
Dec. 31, 2011
2011 Acquisitions
Dec. 31, 2012
Medical office buildings
Jun. 30, 2011
Lake Pointe Medical Arts
sqft
Dec. 31, 2011
Tuscan
sqft
Dec. 31, 2011
Emory
sqft
Dec. 31, 2013
2012 Acquisitions
Dec. 31, 2012
2012 Acquisitions
Dec. 12, 2011
Limited Liability Companies
Dec. 31, 2012
Limited Liability Companies
Dec. 31, 2011
Limited Liability Companies
Business Acquisitions and Dispositions [Line Items]                                                                              
Area of acquired building                                 9,800 16,700                 50,946 99,000 72,000     50,974 53,000 50,344          
Total purchase price                                     $ 7,200,000       $ 4,100,000 $ 625,000 $ 4,700,000   $ 15,000,000 $ 30,400,000 $ 9,600,000 $ 47,806,000   $ 12,200,000 $ 15,500,000 $ 5,100,000   $ 40,000,000      
Number of real estate investments                                           2                                  
Percentage of minority ownership interests by parent                                           100.00%                                  
Effective date of acquisition                                       Jan. 01, 2014                                      
Aggregate cash payment made for acquisitions                                         170,000                               4,400,000   4,400,000
Net rentable area                                             16,300 4,400                              
Intangible assets amortization period, years                                                 9 years 9 months 18 days                   4 years 10 months 24 days 7 years      
Non-controlling ownership interest                   95.00% 95.00%     90.00%                       95.00%                          
Rentable medical office building                                                   30,000                          
Weighted average remaining lease term                                                     6 years 2 months 12 days 10 years 5 years 1 month 6 days     6 years 6 months 4 years 3 months 18 days 13 years 6 months          
Aggregate revenue from acquired entity             1,800,000                                               2,700,000             18,300,000 991,000.0
Aggregate net income from acquired entity             474,000                                               232,000                
Transaction Expenses                                                             680,000                
Cash proceeds from divestiture, net of closing costs and minority members' share             33,800,000         8,100,000     12,200,000                                                
Gain on divestiture of property owned by an unconsolidated LLC, net   1,145,000 [1] 7,375,000 [1]   0 8,520,000 [1],[2] 35,835,000 [2]           7,400,000                                                    
Repayment of previously provided member loan                             8,000,000                                                
Gain related to divestiture                               1,100,000                                              
Acquired aggregate revenue 49,800,000         55,400,000 54,000,000                                                                
Acquired aggregate net income 4,600,000         11,600,000 4,100,000                                                                
Business Acquisition Pro Forma Earnings Per Share, Diluted $ 0.37         $ 0.92 $ 0.32                                                                
Provision for asset impairment       5,354,000 0 0 5,354,000 4,600,000                                                              
Provision for asset impairment, per diluted shares             $ 0.42                                                                
Third-Party Financing                                                                 7,000,000            
Purchase price allocation, tangible property                                                           40,900,000             133,100,000    
Purchase price allocated to Intangible property                                                 610,000         6,943,000           6,020,000 20,900,000    
Percentage of ownership interest owned                                                                         100.00%    
Net gain on fair value recognition resulting from purchase of minority interests in majority-owned LLCs             28,600,000                                                               28,600,000
Business acquisition, transaction costs                                                                             300,000
Transaction costs, divestiture             500,000                                                                
Net intangible assets         20,800,000                                                                    
Intangible assets, accumulated amortization   $ 8,200,000     $ 13,700,000 $ 8,200,000                                                                  
Weighted average remaining amortization period                 3 years 6 months                                                            
[1] During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
[2] As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
XML 43 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2013
Summary of Significant Accounting Policies
(1)   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations

 

Universal Health Realty Income Trust and subsidiaries (the “Trust”) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings. As of February 28, 2014, we have fifty-eight real estate investments or commitments located in sixteen states consisting of:

 

   

seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;

 

   

forty-seven medical office buildings, including eleven owned by unconsolidated limited liability companies (“LLCs”), and;

 

   

four preschool and childcare centers.

 

Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

 

Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management’s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.

 

Revenue Recognition

 

Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (“MOBs”) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

 

Real Estate Investments

 

On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December 31, 2013, and will be amortized over the remaining lease terms (aggregate weighted average of 3.5 years) and will result in an estimated aggregate amortization expense of $4.6 million, $3.9 million, $3.4 million $2.9 million and $1.7 million for 2014, 2015, 2016, 2017 and 2018, respectively. Amortization expense on intangible values of in place leases was $6.0 million for the year ended December 31, 2013, $7.8 million for the year ended December 31, 2012 and $836,000 for the year ended December 31, 2011. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $12.5 million for the year ended December 31, 2013, $12.2 million for the year ended December 31, 2012 and $6.3 million for the year ended December 31, 2011.

 

Cash and Cash Equivalents

 

We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.

 

Asset Impairment

 

Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million in connection with an MOB located on a medical campus in Atlanta, Georgia. The asset impairment charge was recorded after evaluation of property and location-specific factors including pressure on rental and occupancy rates caused, in part, by the impact of continued unfavorable economic conditions in the market as well as competitive pressures caused by increased capacity added to the market. The fair value of this property was determined based upon the present value of the expected future cash flows.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

 

Investments in Limited Liability Companies (“LLCs”)

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings (including Palmdale Medical Properties, LLC and Sparks Medical Properties, LLC which, as discussed below, we purchased the minority ownership interests effective January 1, 2014 and now hold 100% of the ownership interests of these entities). As of December 31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013. As discussed below, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.

 

The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

Palmdale Medical Properties had a master lease with a subsidiary of UHS through June 30, 2013. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS (through UHS of Delaware, Inc.). As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we have accounted for this LLC on a consolidated basis, since its inception in the fourth quarter of 2007 through June 30, 2013, since it was a variable interest entity and we were deemed to be the primary beneficiary. As of July 1, 2013, the master lease expired and this LLC is no longer considered a variable interest entity and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013. The expiration of the master lease and related deconsolidation did not have a material impact on our net income and funds from operations during the second half of 2013.

 

As a result of master lease arrangements between UHS and various LLCs in which we hold or held majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB’s standards and guidance.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs and will begin accounting for them on a consolidated basis effective January 1, 2014. Each of the property’s assets and liabilities will be recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). We do not expect these transactions or the expected related aggregate gain (to be recorded during the first quarter of 2014) to have a material impact on our future results of operations.

 

In addition, effective December 12, 2011, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as discussed herein (see Notes 3 and 8 to the consolidated financial statements for additional disclosure).

 

Federal Income Taxes

 

No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.

 

The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $382 million and $256 million, respectively, at December 31, 2013.

 

Stock-Based Compensation

 

We expense the grant-date fair value of stock options and restricted stock awards over the vesting period. We recognize the grant-date fair value of stock options and other equity-based compensation and account for these transactions using the fair-value based method. We use the Black-Scholes model as our option pricing model for determining the grant-date fair value of our stock options.

 

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.

 

Fair Value

 

Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.

 

The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.

 

The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.

 

See Note 3-Acquisitions and Dispositions, for disclosure related to the $28.6 million net gain recorded during 2011 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

New Accounting Standards

 

Except as noted below, there were no new accounting pronouncements during 2013 that impacted, or are expected to impact, us.

 

In February, 2013, the Financial Accounting Standards Board issued an Accounting Standards Update on reporting of amounts reclassified out of accumulated other comprehensive income. This guidance, which is effective for fiscal years beginning after December 31, 2012, required companies to provide information about amounts reclassified out of accumulated other comprehensive income by component (the respective line items of the income statement). The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.

 

In July 2013, the Financial Accounting Standards Board (FASB) issued guidance allowing the use of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a benchmark interest rate for hedge accounting purposes in addition to interest rates on direct Treasury obligations of the United States government and the LIBOR. In addition, the guidance removes the restriction on using different benchmark rates for similar hedges. The guidance became effective on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013, and did not have a material impact in the consolidated financial results.

XML 44 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) (USD $)
Dec. 31, 2011
2011 Acquisitions
Dec. 31, 2012
2012 Acquisitions
Dec. 31, 2013
2013 Acquisitions
Business Acquisition [Line Items]      
Land $ 3,892,000 $ 1,900,000 $ 316,000
Buildings and improvements 36,940,000 32,090,000 3,749,000
Intangible assets 6,943,000 6,020,000 610,000
Other assets 31,000 799,000 21,000
Total purchase price 47,806,000 40,000,000 4,700,000
Liabilities (real property and operating) (1,229,000) (144,000) (11,000)
Deposit paid in 2011   (534,000)  
Net cash paid     4,685,000
Debt (6,999,000) (23,240,000)  
Net cash paid $ 39,578,000 $ 16,891,000  
XML 45 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt - Additional Information (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
MortgageLoan
Dec. 31, 2012
Dec. 31, 2011
Debt [Line Items]      
Outstanding borrowings under revolving credit agreement $ 93,700,000    
Outstanding borrowings under letter of credit 8,700,000    
Available borrowing capacity 47,600,000    
Average amounts outstanding under our revolving credit agreement 86,300,000 75,400,000 67,800,000
Effective interest rate 2.20% 2.40% 1.80%
Line of credit, fair value of borrowings outstanding 93,700,000    
Percentage of increase dividends in excess of cash available for distribution 95.00%    
Balance of Non Recourse Mortgages 105,453,000 [1]    
Net debt premiums 834,000    
Number of non-recourse mortgages 12    
Mortgage loan fair value 106,400,000    
New Revolving Credit Facility Agreement
     
Debt [Line Items]      
Unsecured revolving credit agreement terminated Jul. 24, 2015    
Outstanding borrowing 150,000,000    
Revolving credit borrowing capacity additional amount 50,000,000    
Credit facility, Interest Rate Terms One, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%.    
Base rate description Greatest of (a) the administrative agent's prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%.    
Fee payable on unused portion of commitment 0.35%    
New Revolving Credit Facility Agreement | Minimum
     
Debt [Line Items]      
Fee payable on unused portion of commitment 0.30%    
New Revolving Credit Facility Agreement | Maximum
     
Debt [Line Items]      
Fee payable on unused portion of commitment 0.50%    
New Revolving Credit Facility Agreement | LIBOR
     
Debt [Line Items]      
Margin points added to the reference rate 2.00%    
New Revolving Credit Facility Agreement | LIBOR | Minimum
     
Debt [Line Items]      
Margin points added to the reference rate 1.75%    
Margin points added to the base rate 1.00%    
New Revolving Credit Facility Agreement | LIBOR | Maximum
     
Debt [Line Items]      
Margin points added to the reference rate 2.50%    
New Revolving Credit Facility Agreement | Base Rate
     
Debt [Line Items]      
Margin points added to the reference rate 1.00%    
New Revolving Credit Facility Agreement | Base Rate | Minimum
     
Debt [Line Items]      
Margin points added to the reference rate 0.75%    
New Revolving Credit Facility Agreement | Base Rate | Maximum
     
Debt [Line Items]      
Margin points added to the reference rate 1.50%    
New Revolving Credit Facility Agreement | Federal Funds Effective Rate | Minimum
     
Debt [Line Items]      
Margin points added to the base rate 0.50%    
New Revolving Credit Facility Agreement | Letter of Credit
     
Debt [Line Items]      
Outstanding borrowing 50,000,000    
New Revolving Credit Facility Agreement | Short-term Debt
     
Debt [Line Items]      
Outstanding borrowing $ 20,000,000    
[1] Amortized principal payments are made on a monthly basis.
XML 46 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Limited Liability Companies where Minority Ownership Interests Purchased and Consolidated (Detail) (Consolidated Properties)
12 Months Ended
Dec. 31, 2011
653 Town Center Investments
 
Investment [Line Items]  
Previous ownership 95.00% [1]
Property Owned by LLC Summerlin Hospital Medical Office Building I [1]
653 Town Center Phase II
 
Investment [Line Items]  
Previous ownership 98.00% [1]
Property Owned by LLC Summerlin Hospital Medical Office Building II [1]
ApaMed Properties
 
Investment [Line Items]  
Previous ownership 85.00%
Property Owned by LLC Apache Junction Medical Plaza
Auburn Medical Properties II
 
Investment [Line Items]  
Previous ownership 95.00% [1]
Property Owned by LLC Auburn Medical Office Building II [1]
Banburry Medical Properties
 
Investment [Line Items]  
Previous ownership 95.00% [1]
Property Owned by LLC Summerlin Hospital Medical Office Building III [1]
BRB/E Building One
 
Investment [Line Items]  
Previous ownership 95.00%
Property Owned by LLC BRB Medical Office Building
Centennial Medical Properties
 
Investment [Line Items]  
Previous ownership 95.00% [1]
Property Owned by LLC Centennial Hills Medical Office Building I [1]
DesMed
 
Investment [Line Items]  
Previous ownership 99.00% [1]
Property Owned by LLC Desert Springs Medical Plaza [1]
Gold Shadow Properties
 
Investment [Line Items]  
Previous ownership 98.00% [1]
Property Owned by LLC 700 Shadow Lane & Goldring Medical Office Buildings [1]
Spring Valley Medical Properties
 
Investment [Line Items]  
Previous ownership 95.00%
Property Owned by LLC Spring Valley Medical Office Building
Spring Valley Medical Properties II
 
Investment [Line Items]  
Previous ownership 95.00%
Property Owned by LLC Spring Valley Hospital Medical Office Building II
[1] Tenants of this medical office building include or will include subsidiaries of UHS.
XML 47 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Real Estate Investments:    
Buildings and improvements $ 368,295 $ 374,416
Accumulated depreciation (97,921) (87,088)
Real Estate Investment Property, Net, Total 270,374 287,328
Land 27,374 27,058
Net Real Estate Investments 297,748 314,386
Investments in and advances to limited liability companies ("LLCs") 39,201 28,636
Other Assets:    
Cash and cash equivalents 3,337 3,048
Base and bonus rent receivable from UHS 2,053 2,041
Rent receivable-other 3,310 2,783
Intangible assets (net of accumulated amortization of $13.7 million and $8.2 million at December 31, 2013 and December 31, 2012, respectively) 20,782 26,293
Deferred charges, goodwill and other assets, net 6,714 5,851
Total Assets 373,145 383,038
Liabilities:    
Line of credit borrowings 93,700 81,750
Mortgage and other notes payable, non-recourse to us (including net debt premium of $834,000 and $1.3 million at December 31, 2013 and December 31, 2012, respectively) 106,287 116,186
Accrued interest 491 539
Accrued expenses and other liabilities 5,156 4,920
Tenant reserves, escrows, deposits and prepaid rents 1,881 1,898
Total Liabilities 207,515 205,293
Equity:    
Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding 0 0
Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2013-12,858,643 2012 -12,688,998 128 127
Capital in excess of par value 220,691 214,094
Cumulative net income 480,044 466,875
Cumulative dividends (535,176) (503,425)
Accumulated other comprehensive loss (57) 0
Total Universal Health Realty Income Trust Shareholders' Equity 165,630 177,671
Non-controlling equity interest 0 74
Total Equity 165,630 177,745
Total Liabilities and Equity $ 373,145 $ 383,038
XML 48 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Dividends and Equity Issuance Program - Additional Information (Detail) (USD $)
12 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
At-The-Market (ATM) Equity Issuance Program
Dec. 31, 2013
At-The-Market (ATM) Equity Issuance Program
Compensation to Merrill Lynch
Dec. 31, 2013
At-The-Market (ATM) Equity Issuance Program
Other expense
Dec. 31, 2013
Ordinary income
Dec. 31, 2012
Ordinary income
Dec. 31, 2011
Ordinary income
Dec. 31, 2013
Capital gain
Dec. 31, 2012
Capital gain
Dec. 31, 2011
Capital gain
Dec. 31, 2012
Capital gain
Unrecaptured Section 1250 gain
Dec. 31, 2011
Capital gain
Unrecaptured Section 1250 gain
Dec. 31, 2012
Capital gain
15% rate gain
Dec. 31, 2011
Capital gain
15% rate gain
Dividends [Line Items]                                
Declared and paid dividends, per share $ 2.495 $ 2.460 $ 2.425                          
Declared and paid dividends, per share             $ 1.960 $ 1.294 $ 1.234              
Capital gain per share                   $ 0.535 $ 1.166 $ 1.191        
Declared and paid dividends, per share                     $ 0.281 $ 0.716        
Declared and paid dividends, per share                         15.00% 15.00%    
Declared and paid dividends, per share                             $ 0.885 $ 0.475
Securities, aggregate sales price $ 50,000,000                              
Share issued       154,713                        
Average sale price per share       $ 41.71                        
Net cash proceeds from stock issued       6,000,000                        
Payment of stock issuance cost       424,000 161,000 263,000                    
Net proceeds receivable       $ 592,000                        
XML 49 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Changes in Equity (Parenthetical) (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dividend, per share $ 2.495 $ 2.46 $ 2.425
XML 50 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]  
2014 $ 11,894
2015 101,245 [1]
2016 13,098
2017 43,914
2018 10,672
Mortgage Balance 199,153
Equity Method Investments
 
Schedule of Equity Method Investments [Line Items]  
2014 14,174
2015 41,492
2016 578
2017 11,829
2018 12,039
Mortgage Balance 80,112 [2]
Equity Method Investments | Grayson Properties
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 12,540 [2],[3]
Maturity Date 2014 [3]
Equity Method Investments | Brunswick Associates
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 7,941 [2]
Maturity Date 2015
Equity Method Investments | Arlington Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 24,052 [2]
Maturity Date 2015
Equity Method Investments | DVMC Properties
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 3,970 [2]
Maturity Date 2015
Equity Method Investments | Palmdale Medical Plaza
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 6,162 [2]
Maturity Date 2015
Equity Method Investments | FTX MOB Phase II
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 5,596 [2],[4]
Maturity Date 2017 [4]
Equity Method Investments | PCH Southern Properties
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 6,614 [2]
Maturity Date 2017
Equity Method Investments | Sparks Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance 4,603 [2]
Maturity Date 2018
Equity Method Investments | PCH Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Mortgage Balance $ 8,634 [2]
Maturity Date 2018
[1] Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
[2] All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
[3] We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.
[4] Construction loan.
XML 51 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Purchased Minority Ownership Interests, Location and Previous Property Owner (Detail)
12 Months Ended
Dec. 31, 2013
653 Town Center Investments
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Summerlin Hospital MOB I [1]
City Las Vegas
State NV
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
653 Town Center Phase II
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Summerlin Hospital MOB II [1]
City Las Vegas
State NV
Trust's previous ownership 98.00%
Minority ownership % purchased 2.00%
Auburn Medical Properties II
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Auburn Medical Office Building II [1]
City Auburn
State WA
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
ApaMed Properties
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Apache Junction Medical Plaza
City Apache J.
State AZ
Trust's previous ownership 85.00%
Minority ownership % purchased 15.00%
Banburry Medical Properties
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Summerlin Hospital MOB III [1]
City Las Vegas
State NV
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
BRB/E Building One
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC BRB Medical Office Building
City Kingwood
State TX
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
Centennial Medical Properties
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Centennial Hills Medical Office Bldg. I [1]
City Las Vegas
State NV
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
DesMed
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Desert Springs Medical Plaza [1]
City Las Vegas
State NV
Trust's previous ownership 99.00%
Minority ownership % purchased 1.00%
Gold Shadow Properties
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC 700 Shadow Lane & Goldring MOBs [1]
City Las Vegas
State NV
Trust's previous ownership 98.00%
Minority ownership % purchased 2.00%
Spring Valley Medical Properties
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Spring Valley Medical Office Building
City Las Vegas
State NV
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
Spring Valley Medical Properties II
 
Business Acquisition, Contingent Consideration [Line Items]  
Property Owned by LLC Spring Valley Medical Office Building II
City Las Vegas
State NV
Trust's previous ownership 95.00%
Minority ownership % purchased 5.00%
[1] Tenants of this medical office building include subsidiaries of UHS.
XML 52 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2008
Real Estate and Accumulated Depreciation [Line Items]          
Provision for asset impairment $ 5,354 $ 0 $ 0 $ 5,354 $ 4,600
Net debt premium   $ 834 $ 1,300    
XML 53 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summarized Financial Information of Equity Affiliates (Tables)
12 Months Ended
Dec. 31, 2013
Limited Liability Companies Accounted for Under Equity Method

The following property table represents the thirteen LLCs which were accounted for under the equity method as of December 31, 2013:

 

Name of LLC/LP

  Ownership    

Property Owned by LLC

DVMC Properties(g.)

    90   Desert Valley Medical Center

Suburban Properties

    33   Suburban Medical Plaza II

Santa Fe Scottsdale

    90   Santa Fe Professional Plaza

Brunswick Associates(g.)

    74   Mid Coast Hospital MOB

PCH Medical Properties(g.)

    85   Rosenberg Children’s Medical Plaza

Arlington Medical Properties(b.)(g.)

    75   Saint Mary’s Professional Office Building

Sierra Medical Properties

    95   Sierra San Antonio Medical Plaza

PCH Southern Properties(g.)

    95   Phoenix Children’s East Valley Care Center

Sparks Medical Properties(a.)(f.)(g.)

    95   Vista Medical Terrace & The Sparks Medical Building

Grayson Properties(a.)(c.)(g.)

    95   Texoma Medical Plaza

3811 Bell Medical Properties

    95   North Valley Medical Plaza

FTX MOB Phase II(d.)(g.)

    95   Forney Medical Plaza II

Palmdale Medical Properties(a.)(e.)(f.)(g)

    95   Palmdale Medical Plaza

 

(a.) Tenants of this medical office building include or will include subsidiaries of UHS.
(b.) We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December 31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary’s Professional Office Building.
(c.) We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December 31, 2013.
(d.) During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December 31, 2013.
(e.) We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013, as discussed above.
(f.) Effective January 1, 2014, we purchased the third-party minority ownership interest (5%) in this LLC. As a result of our purchase of the minority ownership interest, as of January 1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January 1, 2014.
(g.) As disclosed below, as of December 31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us.

 

 On December 12, 2011, we began consolidating the financial data of these eleven LLCs in our consolidated financial statements. The following property table represents these eleven LLCs (the summarized financial data for these eleven LLCs through December 11, 2011, are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

  Previous
Ownership
   

Property Owned by LLC

653 Town Center Investments(a.)

    95   Summerlin Hospital Medical Office Building I

653 Town Center Phase II(a.)

    98   Summerlin Hospital Medical Office Building II

ApaMed Properties

    85   Apache Junction Medical Plaza

Auburn Medical Properties II(a.)

    95   Auburn Medical Office Building II

Banburry Medical Properties(a.)

    95   Summerlin Hospital Medical Office Building III

BRB/E Building One

    95   BRB Medical Office Building

Centennial Medical Properties(a.)

    95   Centennial Hills Medical Office Building I

DesMed(a.)

    99   Desert Springs Medical Plaza

Gold Shadow Properties(a.)

    98   700 Shadow Lane & Goldring Medical Office Buildings

Spring Valley Medical Properties

    95   Spring Valley Medical Office Building

Spring Valley Medical Properties II

    95   Spring Valley Hospital Medical Office Building II

 

(a.) Tenants of this medical office building include or will include subsidiaries of UHS.

 

 The following property table represents the eight LLCs that divested medical office buildings on November 30, 2011 and December 16, 2011 (the summarized financial data for these eight LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

  Ownership    

Property Owned by LLC

DSMB Properties

    76   Desert Samaritan Hospital MOBs

Litchvan Investments

    89   Papago Medical Park

Paseo Medical Properties II

    75   Thunderbird Paseo Medical Plaza I & II

Willetta Medical Properties

    90   Edwards Medical Plaza

Deerval Properties(a.)

    90   Deer Valley Medical Office II

Deerval Properties II(a.)

    95   Deer Valley Medical Office Building III

Deerval Parking Company(a.)

    (a.   Deer Valley Parking Garage

Cobre Properties

    95   Cobre Valley Medical Plaza

 

(a.) Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.

 

The following property table represents the two LLCs that divested medical office buildings on February 3, 2012 and October 10, 2012 (the summarized financial data for these two LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

   Ownership    

Property Owned by LLC

Canyon Healthcare Properties

     95   Canyon Springs Medical Plaza

575 Hardy Investors

     90   Centinela Medical Building Complez
Equity Method Investments Summarized Income

The years ended December 31, 2012 and 2011 include the prorated amounts for the LLCs that were divested through their divestiture dates, or in which we purchased the minority ownership interests, for the period in which they were accounted for under the equity method:

 

     For the Year Ended December 31,  
     2013(b.)      2012(a.)      2011(a.)  
     (amounts in thousands)  

Revenues

   $ 21,001       $ 21,448       $ 57,932   

Operating expenses

     8,705         8,974         25,503   

Depreciation and amortization

     4,039         4,140         13,066   

Interest, net

     6,353         6,056         17,630   
  

 

 

    

 

 

    

 

 

 

Net income before gains on divestitures

   $ 1,904       $ 2,278       $ 1,733   
  

 

 

    

 

 

    

 

 

 

Our share of net income before gains on divestitures(c.)

   $ 2,095       $ 2,365       $ 3,058   
  

 

 

    

 

 

    

 

 

 

Our share of gains on divestitures

   $ —        $ 8,520       $ 35,835   
  

 

 

    

 

 

    

 

 

 

 

(a.) As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
(b.) As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2103. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July 1, 2013 through December 31, 2013.
(c.) Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.
Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method

Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December 31, 2013 and 2012:

 

     December 31,  
     2013(a.)      2012  
     (amounts in thousands)  

Net property, including CIP

   $ 119,547       $ 106,150   

Other assets

     9,479         9,850   
  

 

 

    

 

 

 

Total assets

   $ 129,026       $ 116,000   
  

 

 

    

 

 

 

Liabilities

   $ 5,336       $ 5,368   

Mortgage notes payable, non-recourse to us

     80,112         77,511   

Advances payable to us

     22,911         12,658   

Equity

     20,667         20,463   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 129,026       $ 116,000   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 39,201       $ 28,636   
  

 

 

    

 

 

 

 

(a.) As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis.
Aggregate Principal Amounts Due on Mortgage and Construction Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method

As of December 31, 2013, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2014

   $ 14,174   

2015

     41,492   

2016

     578   

2017

     11,829   

2018

     12,039   
  

 

 

 

Total

   $ 80,112   
  

 

 

 

 

Name of LLC

   Mortgage
Balance(b.)
     Maturity Date  

Grayson Properties(a.)

   $ 12,540                 2014   

Brunswick Associates

     7,941                 2015   

Arlington Medical Properties

     24,052                 2015   

DVMC Properties

     3,970                 2015   

Palmdale Medical Properties

     6,162                 2015   

FTX MOB Phase II(c.)

     5,596                 2017   

PCH Southern Properties

     6,614                 2017   

Sparks Medical Properties

     4,603                 2018   

PCH Medical Properties

     8,634                 2018   
  

 

 

    
   $ 80,112      
  

 

 

    

 

(a.) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.
(b.) All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(c.) Construction loan.
Purchased minority ownership interest
 
Limited Liability Companies Accounted for Under Equity Method

The table below reflects each of the LLCs in which we purchased the minority ownership interests, the location and property owned by the LLC, our previous noncontrolling, majority ownership interest and the noncontrolling, minority ownership interests purchased by us.

 

Name of LLC:

 

Property owned by LLC:

  City    State    Trust’s
previous
ownership
%
    Minority
ownership
%
purchased
 

653 Town Center Investments

  Summerlin Hospital MOB I(1)   Las Vegas    NV      95     5

653 Town Center Phase II

  Summerlin Hospital MOB II(1)   Las Vegas    NV      98     2

Auburn Medical Properties II

  Auburn Medical Office Building II(1)   Auburn    WA      95     5

ApaMed Properties

  Apache Junction Medical Plaza   Apache J.    AZ      85     15

Banburry Medical Properties

  Summerlin Hospital MOB III(1)   Las Vegas    NV      95     5

BRB/E Building One

  BRB Medical Office Building   Kingwood    TX      95     5

Centennial Medical Properties

  Centennial Hills Medical Office Bldg. I(1)   Las Vegas    NV      95     5

DesMed

  Desert Springs Medical Plaza(1)   Las Vegas    NV      99     1

Gold Shadow Properties

  700 Shadow Lane & Goldring MOBs(1)   Las Vegas    NV      98     2

Spring Valley Medical Properties

  Spring Valley Medical Office Building   Las Vegas    NV      95     5

Spring Valley Medical Properties II

  Spring Valley Medical Office Building II   Las Vegas    NV      95     5

 

(1) Tenants of this medical office building include subsidiaries of UHS.
Selling parties
 
Limited Liability Companies Accounted for Under Equity Method

The following table represents each of the eight LLCs that was a selling party, the location and property owned by the LLC and our former noncontrolling, majority ownership interest:

 

Name of LLC:

  

Property owned by LLC:

   City    State    Trust’s
Former
Ownership
%
 

Cobre Properties

   Cobre Valley Medical Plaza    Globe    AZ      95

Deerval Properties

   Deer Valley Medical Office II    Phoenix    AZ      90

Deerval Properties II

   Deer Valley Medical Office III    Phoenix    AZ      95

Deerval Parking Company(a)

   Deer Valley Parking Garage    Phoenix    AZ      93

DSMB Properties

   Desert Samaritan Hospital MOBs    Mesa    AZ      76

Litchvan Investments

   Papago Medical Park    Phoenix    AZ      89

Paseo Medical Properties II

   Thunderbird Paseo Medical Plaza I & II    Glendale    AZ      75

Willetta Medical Properties(b)

   Edwards Medical Plaza    Phoenix    AZ      90

 

(a) Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I & II, was 50% owned by each of Deerval Properties and Deerval Properties II.
(b) The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.
XML 54 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Eight Limited Liability Companies that Completed Divestitures of Property (Detail)
12 Months Ended
Dec. 31, 2011
Deerval Properties
 
Investment [Line Items]  
Property Owned by LLC Deer Valley Medical Office II [1]
City Phoenix
State AZ
Trust's Former Ownership % 90.00% [1]
Deerval Properties II
 
Investment [Line Items]  
Property Owned by LLC Deer Valley Medical Office III [1]
City Phoenix
State AZ
Trust's Former Ownership % 95.00% [1]
Cobre Properties
 
Investment [Line Items]  
Property Owned by LLC Cobre Valley Medical Plaza
City Globe
State AZ
Trust's Former Ownership % 95.00%
Deerval Parking Company
 
Investment [Line Items]  
Property Owned by LLC Deer Valley Parking Garage [1],[2]
City Phoenix [2]
State AZ [2]
Trust's Former Ownership % 93.00% [2]
DSMB Properties
 
Investment [Line Items]  
Property Owned by LLC Desert Samaritan Hospital MOBs
City Mesa
State AZ
Trust's Former Ownership % 76.00%
Litchvan Investments
 
Investment [Line Items]  
Property Owned by LLC Papago Medical Park
City Phoenix
State AZ
Trust's Former Ownership % 89.00%
Paseo Medical Properties II
 
Investment [Line Items]  
Property Owned by LLC Thunderbird Paseo Medical Plaza I & II
City Glendale
State AZ
Trust's Former Ownership % 75.00%
Willetta Medical Properties
 
Investment [Line Items]  
Property Owned by LLC Edwards Medical Plaza [3]
City Phoenix [3]
State AZ [3]
Trust's Former Ownership % 90.00% [3]
[1] Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.
[2] Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I & II, was 50% owned by each of Deerval Properties and Deerval Properties II.
[3] The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.
XML 55 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt (Tables)
12 Months Ended
Dec. 31, 2013
Summary of Required Compliance Ratios Giving Effect to New Covenants in Credit Agreement

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2013
 

Tangible net worth

   $ 125,000      $ 144,848   

Debt to total capital

     < 55     36.0

Debt service coverage ratio

     > 4.00x        19.1x   

Debt to cash flow ratio

     < 3.50x        2.21x   
Outstanding Mortgages

The following table summarizes our outstanding mortgages, excluding net debt premium, at December 31, 2013 (amounts in thousands):

 

Facility Name

  Outstanding
Balance
(in thousands)(a)
     Interest
Rate
    Maturity
Date
 

Summerlin Hospital Medical Office Building I fixed rate mortgage loan (b)

  $ 9,188         6.55     2014   

Spring Valley Medical Office Building fixed rate mortgage loan

    5,122         5.50     2015   

Summerlin Hospital Medical Office Building III floating rate mortgage loan

    11,347         3.42     2016   

Peace Health fixed rate mortgage loan

    21,681         5.64     2017   

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

    12,021         5.50     2017   

Auburn Medical II floating rate mortgage loan

    7,406         2.92     2017   

Medical Center of Western Connecticut fixed rate mortgage loan

    4,899         6.00     2017   

Centennial Hills Medical Office Building floating rate mortgage loan

    10,938         3.42     2018   

Vibra Hospital of Corpus Christi fixed rate mortgage loan

    2,983         6.50     2019   

BRB Medical Office Building fixed rate mortgage loan

    6,840         4.27     2022   

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

    6,766         4.54     2022   

Tuscan Professional Building fixed rate mortgage loan

    6,262         5.56     2025   
 

 

 

      

Total

  $ 105,453        
 

 

 

      

 

(a) Amortized principal payments are made on a monthly basis.
(b) In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.
Aggregate Consolidated Scheduled Debt Repayments

As of December 31, 2013, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):

 

2014

   $ 11,894   

2015(a)

     101,245   

2016

     13,098   

2017

     43,914   

2018

     10,672   

Later

     18,330   
  

 

 

 

Total

   $ 199,153   
  

 

 

 

 

(a) Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
XML 56 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 57 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net income $ 13,169 [1] $ 19,477 $ 73,794
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 18,843 20,216 7,306
Amortization on debt premium (433) (657) (96)
Provision for asset impairment 0 0 5,354
Restricted stock-based compensation expense 375 329 281
Gain on purchase of minority interests in majority-owned LLCs before transaction costs 0 0 (28,877)
Gains on divestiture of properties owned by unconsolidated LLCs before transaction costs 0 (8,520) (36,300)
Changes in assets and liabilities:      
Rent receivable (746) (862) (455)
Accrued expenses and other liabilities 523 278 221
Tenant reserves, escrows, deposits and prepaid rents 16 207 4
Accrued interest (22) 66 39
Other, net (431) 249 101
Net cash provided by operating activities 31,294 30,783 21,372
Cash flows from investing activities:      
Investments in LLCs (3,013) (2,973) (3,788)
Repayments of advances made to LLCs 114 8,551 8,718
Advances made to LLCs (4,580) (8,000) (11,541)
Cash distributions in excess of income from LLCs 2,346 3,169 5,260
Cash distributions of refinancing proceeds from LLCs 0 0 2,111
Repayment of advance made to third-party partners 0 0 3,967
Additions to real estate investments (3,415) (3,985) (776)
Deposits on real estate assets (150) 100 (634)
Net cash paid for acquisition of medical office buildings (4,675) (16,891) (39,578)
Payment of assumed liabilities on acquired properties 0 (711) (621)
Cash paid to acquire minority interests in majority-owned LLCs 0 0 (4,408)
Cash proceeds received from divestiture of property owned by unconsolidated LLCs, net 0 12,175 33,836
Increase in cash and cash equivalents due to recording of LLCs on a consolidated basis 0 0 4,170
Decrease in cash and cash equivalents due to deconsolidation of LLCs (141) 0 0
Net cash used in investing activities (13,514) (8,565) (3,284)
Cash flows from financing activities:      
Net borrowings on line of credit 11,950 4,600 24,550
Proceeds from mortgages and other notes payable 11,150 14,000 0
Repayments of mortgages and other notes payable (14,401) (18,084) (291)
Financing costs paid, new Revolving Credit Facility 0 0 (1,064)
Financing costs paid on mortgage and other notes payable (95) (384) 0
Dividends paid (31,751) (31,195) (30,703)
Partial settlement of dividends equivalent rights (101) (106) (162)
Issuance of shares of beneficial interest, net 5,757 350 244
Net cash used in financing activities (17,491) (30,819) (7,426)
Increase/(decrease) in cash and cash equivalents 289 (8,601) 10,662
Cash and cash equivalents, beginning of period 3,048 11,649 987
Cash and cash equivalents, end of period 3,337 3,048 11,649
Supplemental disclosures of cash flow information:      
Interest paid 7,517 7,994 2,216
Supplemental disclosures of non-cash transactions:      
Debt assumed on acquisition of real estate 0 22,441 6,999
Consolidation (2011) and deconsolidation (2010) of LLCs
     
Supplemental disclosures of non-cash transactions:      
Net real estate investments 11,597 0 133,080
Cash and cash equivalents 141 0 4,170
Intangible assets 0 0 20,890
Rent receivable-other 207 0 687
Other assets 135 0 2,944
Mortgage and note payable, non-recourse to us (6,215) 0 (76,111)
Other liabilities (368) 0 (3,025)
Third-party equity interests (54) 0 0
Gain on purchase of minority interests in majoriyt-owned LLCs 0 0 (28,877)
Investment in LLCs $ 5,443 $ 0 $ (53,758)
[1] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 58 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (Parenthetical) (USD $)
Dec. 31, 2013
Dec. 31, 2012
Intangible assets, accumulated amortization $ 13,700,000 $ 8,200,000
Mortgage and other notes payable, non-recourse to us, debt premium $ 834,000 $ 1,300,000
Preferred shares of beneficial interest, par value $ 0.01 $ 0.01
Preferred shares of beneficial interest, shares authorized 5,000,000 5,000,000
Preferred shares of beneficial interest, issued      
Preferred shares of beneficial interest, outstanding      
Common shares, par value $ 0.01 $ 0.01
Common shares, shares authorized 95,000,000 95,000,000
Common shares, issued 12,858,643 12,688,998
Common shares, outstanding 12,858,643 12,688,998
XML 59 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results
12 Months Ended
Dec. 31, 2013
Quarterly Results
(10)   QUARTERLY RESULTS (unaudited)

 

     2013 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,885       $ 13,502       $ 13,448       $ 13,445       $ 54,280   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,427       $ 2,941       $ 3,303       $ 3,498       $ 13,169   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     2012  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,351       $ 13,666       $ 13,610       $ 13,323       $ 53,950   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income before gains

   $ 2,139       $ 2,467       $ 2,986       $ 3,365       $ 10,957   

Net gains on divestiture of properties owned by unconsolidated LLCs(b.)

     7,375         —          —          1,145         8,520   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 9,514       $ 2,467       $ 2,986       $ 4,510       $ 19,477   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.75       $ 0.19       $ 0.24       $ 0.36       $ 1.54   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.75       $ 0.19       $ 0.24       $ 0.36       $ 1.54   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
(b.) During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
XML 60 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information (USD $)
12 Months Ended
Dec. 31, 2013
Jan. 31, 2014
Jun. 28, 2013
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2013    
Document Fiscal Year Focus 2013    
Document Fiscal Period Focus FY    
Trading Symbol UHT    
Entity Registrant Name UNIVERSAL HEALTH REALTY INCOME TRUST    
Entity Central Index Key 0000798783    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   12,858,667  
Entity Public Float     $ 540,970,533
XML 61 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Real Estate and Accumulated Depreciation
12 Months Ended
Mar. 05, 2014
Real Estate and Accumulated Depreciation

Schedule III

Universal Health Realty Income Trust

Real Estate and Accumulated Depreciation — December 31, 2013

(amounts in thousands)

 

Description

  Initial Cost     Gross amount at
which carried
at end of period
    Accumulated
Depreciation
as of Dec. 31,
2013
    Date of
Completion
of Construction,

Acquisition or
Significant
improvement
    Date
Acquired
    Average
Depreciable
Life
 
  Encumbrance
(e.)
    Land     Building
&
Improv.
    Adjustments to
Basis (a.)
    Land     Building &
Improvements
    CIP     Total          

Inland Valley Regional

Medical Center

Wildomar, California

    —        $ 2,050      $ 10,701      $ 14,596      $ 2,050      $ 25,297        —        $ 27,347      $ 10,464        2007        1986        43 Years   

McAllen Medical Center

McAllen, Texas

    —          4,720        31,442        10,189        6,281        40,070        —          46,351        23,440        1994        1986        42 Years   

Wellington Regional Medical Center
West Palm Beach, Florida

    —          1,190        14,652        17,370        1,663        31,549        —          33,212        15,182        2006        1986        42 Years   

The Bridgeway
North Little Rock, Arkansas

    —          150        5,395        4,571        150        9,966        —          10,116        5,554        2006        1986        35 Years   

HealthSouth Deaconess Rehabilitation Hospital Evansville, Indiana

    —          500        6,945        1,062        500        8,007        —          8,507        4,867        1993        1989        40 Years   

Kindred Hospital Chicago Central
Chicago, Illinois

    —          158        6,404        1,838        158        8,242        —          8,400        8,245        1993        1986        25 Years   

Family Doctor’s Medical Office Building
Shreveport, Louisiana

    —          54        1,526        494        54        2,020        —          2,074        854        1991        1995        45 Years   

Kelsey-Seybold Clinic at King’s Crossing

    —          439        1,618        870        439        2,488        —          2,927        958        1995        1995        45 Years   

Professional Center at King’s Crossing

    —          439        1,837        183        439        2,020        —          2,459        832        1995        1995        45 Years   

Kingwood, Texas

                       

Chesterbrook Academy

Audubon, Pennsylvania

    —          307        996        —          307        996        —          1,303        391        1996        1996        45 Years   

Chesterbrook Academy
New Britain, Pennsylvania

    —          250        744        —          250        744        —          994        292        1991        1996        45 Years   

Chesterbrook Academy

Uwchlan, Pennsylvania

    —          180        815        —          180        815        —          995        320        1992        1996        45 Years   

Chesterbrook Academy

Newtown, Pennsylvania

    —          195        749        —          195        749        —          944        294        1992        1996        45 Years   

The Southern Crescent Center I (b.)

    —          1,130        5,092        (2,304     1,130        2,788        —          3,918        2,141        1994        1996        45 Years   

The Southern Crescent Center II (b.)

    —          —          —          5,015        806        4,209        —          5,015        1,742        2000        1998        35 Years   

Riverdale, Georgia

                       

The Cypresswood Professional Center

Spring ,Texas

    —          573        3,842        573        573        4,415        —          4,988        2,212        1997        1997        35 Years   

701 South Tonopah Building
Las Vegas, Nevada

    —          —          1,579        68        —          1,647        —          1,647        858        1999        1999        25 Years   

Sheffield Medical
Building (c.)
Atlanta, Georgia

    —          1,760        9,766        (7,327     736        3,463        —          4,199        936        1999        1999        25 Years   

Medical Center of Western Connecticut—Bldg. 73 Danbury, Connecticut

    4,899        1,151        5,176        430        1,151        5,606        —          6,757        2,678        2000        2000        30 Years   

Vibra Hospital of Corpus Christi
Corpus Christi, Texas

    2,983        1,104        5,508        —          1,104        5,508        —          6,612        928        2008        2008        35 Years   

Apache Junction Medical Plaza (d.)
Apache Junction, AZ

    —          240        3,590        27        240        3,617        —          3,857        283        2004        2004        30 Years   

Auburn Medical Office Building (d.)

Auburn, WA

    7,406        —          10,200        159        —          10,359        —          10,359        694        2009        2009        36 Years   

BRB Medical Office Building (d.)
Kingwood, Texas

    6,840        430        8,970        24        430        8,994        —          9,424        591        2010        2010        37 Years   

Centennial Hills Medical Office Building (d.)
Las Vegas, NV

    10,938        —          19,890        743        —          20,633        —          20,633        1,412        2006        2006        34 Years   

Desert Springs Medical Plaza (d.)
Las Vegas, NV

    —          1,200        9,560        200        1,200        9,760        —          10,960        772        1998        1998        30 Years   

700 Shadow Lane & Goldring MOB (d.)

Las Vegas, NV

    6,766        400        11,300        968        400        12,268        —          12,668        931        2003        2003        30 Years   

Spring Valley Hospital MOB I (d.)
Las Vegas, NV

    5,122        —          9,500        111        —          9,611        —          9,611        664        2004        2004        35 Years   

Spring Valley Hospital MOB II (d.)
Las Vegas, NV

    —          —          9,800        8        —          9,808        —          9,808        693        2006        2006        34 Years   

Summerlin Hospital MOB I (d.)

                       

Las Vegas, NV

    9,188        460        15,440        451        460        15,891        —          16,351        1,251        1999        1999        30 Years   

Summerlin Hospital MOB II (d.)
Las Vegas, NV

    12,021        370        16,830        731        370        17,561        —          17,931        1,345        2000        2000        30 Years   

Summerlin Hospital MOB III (d.)
Las Vegas, NV

    11,347        —          14,900        1,443        —          16,343        —          16,343        1,044        2009        2009        36 Years   

Emory at Dunwoody
Dunwoody, GA

    —          782        3,455        —          782        3,455        —          4,237        264        2011        2011        35 Years   

Forney Medical Plaza
Forney, TX

    —          910        11,960        31        910        11,991        —          12,901        1,149        2011        2011        35 Years   

Lake Pointe Medical Arts
Rowlett, TX

    —          1,100        9,000        41        1,100        9,041        —          10,141        772        2011        2011        35 Years   

Tuscan Medical Properties
Irving, TX

    6,262        1,100        12,525        —          1,100        12,525        —          13,625        869        2011        2011        35 Years   

Peace Health Medical Clinic Bellingham, WA

    21,681        1,900        24,910        —          1,900        24,910        —          26,810        1,701        2012        2012        35 Years   

NW Texas Prof Tower
Amarillo, TX

    —          —          7,180        —          —          7,180        —          7,180        244        2012        2012        35 Years   

Ward Eagle Office Village Farmington Hills, MI

    —        $ 220        3,220        —          220        3,220        —          3,440        44        2013        2013        35 Years   

5004 Poole Road
Denison, TX

    —        $ 96        529        —          96        529        —          625        10        2013        2013        35 Years   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

TOTALS

  $ 105,453      $ 25,558      $ 317,546      $ 52,565      $ 27,374      $ 368,295      $ 0      $ 395,669      $ 97,921         
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

       

 

a. Costs capitalized/divested subsequent to acquisition.
b. During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II.
c. During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.
d. During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
e. Consists of outstanding balances as of December 31, 2013 on third-party debt that is non-recourse to us. Excludes net debt premium of $834,000.

 

UNIVERSAL HEALTH REALTY INCOME TRUST

 

NOTES TO SCHEDULE III

DECEMBER 31, 2013

(amounts in thousands)

 

(1) RECONCILIATION OF REAL ESTATE PROPERTIES

 

The following table reconciles the Real Estate Properties from January 1, 2011 to December 31, 2013:

 

 

     2013     2012      2011  

Balance at January 1,

   $ 401,474      $ 363,498       $ 199,940   

Impact of deconsolidation of an LLC(a.)

     (13,185 )     —          —    

Impact of consolidation of eleven LLCs(b.)

     —         —          133,080   

Property additions

     3,415        3,985         1,157   

Acquisitions

     4,065        33,991         40,832   

Disposals

     (100     —          —    

Provision for asset impairment(c.)

     —         —          (11,511
  

 

 

   

 

 

    

 

 

 

Balance at December 31,

   $ 395,669      $ 401,474       $ 363,498   
  

 

 

   

 

 

    

 

 

 

 

(2) RECONCILIATION OF ACCUMULATED DEPRECIATION

 

The following table reconciles the Accumulated Depreciation from January 1, 2011 to December 31, 2013:

 

     2013     2012      2011  

Balance at January 1,

   $ 87,088      $ 74,865       $ 74,683   

Impact of deconsolidation of an LLC(a.)

     (1,588 )     —          —    

Provision for asset impairment(c.)

     —         —          (6,157

Current year depreciation expense

     12,464        12,223         6,339   

Other

     (43 )     —          —    
  

 

 

   

 

 

    

 

 

 

Balance at December 31,

   $ 97,921      $ 87,088       $ 74,865   
  

 

 

   

 

 

    

 

 

 

 

(a.) The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.
(b.) On December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.
(c.) During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million ($11.5 million gross assets net of $6.1 million of accumulated depreciation) in connection with the Sheffield Medical Building located in Atlanta, Georgia.
XML 62 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Revenues:      
Base rental-UHS facilities $ 14,773 $ 15,438 $ 13,150
Base rental-Non-related parties 27,955 27,213 10,392
Bonus rental-UHS facilities 4,260 4,142 4,191
Tenant reimbursements and other-Non-related parties 6,812 6,674 1,654
Tenant reimbursements and other-UHS facilities 480 483 107
Revenue 54,280 53,950 29,494
Expenses:      
Depreciation and amortization 18,753 20,216 7,306
Advisory fees to UHS 2,369 2,119 2,008
Other operating expenses 14,409 14,575 5,581
Transaction costs 203 680 518
Provision for asset impairment 0 0 5,354
Costs and Expenses, Total 35,734 37,590 20,767
Income before equity in income of unconsolidated limited liability companies ("LLCs"), interest expense and gains, net 18,546 16,360 8,727
Equity in income of unconsolidated LLCs 2,095 [1],[2] 2,365 [1],[3] 3,058 [1],[3]
Gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs, net 0 0 28,576
Gain on divestitures of properties owned by unconsolidated LLCs, net 0 8,520 [3],[4] 35,835 [3]
Interest expense, net (7,472) (7,768) (2,402)
Net income $ 13,169 [5] $ 19,477 $ 73,794
Basic earnings per share $ 1.04 [5] $ 1.54 $ 5.84
Diluted earnings per share $ 1.04 [5] $ 1.54 $ 5.83
Weighted average number of shares outstanding-Basic 12,689 12,661 12,644
Weighted average number of share equivalents 12 8 5
Weighted average number of shares and equivalents outstanding-Diluted 12,701 12,669 12,649
[1] Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.
[2] As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2103. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July 1, 2013 through December 31, 2013.
[3] As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
[4] During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
[5] We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
XML 63 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Debt
12 Months Ended
Dec. 31, 2013
Debt
(5)   DEBT

 

In July, 2011, we entered into a $150 million revolving credit agreement (“Credit Agreement”) which is scheduled to expire on July 24, 2015. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate; (b) the federal funds effective rate plus 0.50%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At December 31, 2013, the applicable margin over the LIBOR rate was 2.00%, the margin over the Base Rate was 1.00%, and the commitment fee was 0.35%.

 

At December 31, 2013, we had $93.7 million of outstanding borrowings and $8.7 million of letters of credit outstanding against our revolving credit agreement. We had $47.6 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of December 31, 2013. There are no compensating balance requirements. The average amounts outstanding under our revolving credit agreement were $86.3 million in 2013, $75.4 million in 2012 and $67.8 million in 2011 with corresponding effective interest rates, including commitment fees, of 2.2% in 2013, 2.4% in 2012 and 1.8% in 2011. The carrying amount and fair value of borrowings outstanding pursuant to the Credit Agreement was $93.7 million at December 31, 2013.

 

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at December 31, 2013. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

 

The following table includes a summary of the required compliance ratios, giving effect to the covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     December 31,
2013
 

Tangible net worth

   $ 125,000      $ 144,848   

Debt to total capital

     < 55     36.0

Debt service coverage ratio

     > 4.00x        19.1x   

Debt to cash flow ratio

     < 3.50x        2.21x   

 

We have twelve mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of December 31, 2013, with a combined outstanding balance of $105.5 million (excluding net debt premium, resulting from fair value recognition of third-party debt of $834,000 at December 31, 2013). The following table summarizes our outstanding mortgages, excluding net debt premium, at December 31, 2013 (amounts in thousands):

 

Facility Name

  Outstanding
Balance
(in thousands)(a)
     Interest
Rate
    Maturity
Date
 

Summerlin Hospital Medical Office Building I fixed rate mortgage loan (b)

  $ 9,188         6.55     2014   

Spring Valley Medical Office Building fixed rate mortgage loan

    5,122         5.50     2015   

Summerlin Hospital Medical Office Building III floating rate mortgage loan

    11,347         3.42     2016   

Peace Health fixed rate mortgage loan

    21,681         5.64     2017   

Summerlin Hospital Medical Office Building II fixed rate mortgage loan

    12,021         5.50     2017   

Auburn Medical II floating rate mortgage loan

    7,406         2.92     2017   

Medical Center of Western Connecticut fixed rate mortgage loan

    4,899         6.00     2017   

Centennial Hills Medical Office Building floating rate mortgage loan

    10,938         3.42     2018   

Vibra Hospital of Corpus Christi fixed rate mortgage loan

    2,983         6.50     2019   

BRB Medical Office Building fixed rate mortgage loan

    6,840         4.27     2022   

700 Shadow Lane and Goldring MOBs fixed rate mortgage loan

    6,766         4.54     2022   

Tuscan Professional Building fixed rate mortgage loan

    6,262         5.56     2025   
 

 

 

      

Total

  $ 105,453        
 

 

 

      

 

(a) Amortized principal payments are made on a monthly basis.
(b) In the event we are unable to refinance this loan on acceptable terms upon its scheduled maturity, we will explore other financing alternatives including potentially utilizing funds borrowed under our revolving credit facility to repay all or a portion of the loan.

 

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $106.4 million as of December 31, 2013. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

 

As of December 31, 2013, our aggregate consolidated scheduled debt repayments (including mortgages) are as follows (amounts in thousands):

 

2014

   $ 11,894   

2015(a)

     101,245   

2016

     13,098   

2017

     43,914   

2018

     10,672   

Later

     18,330   
  

 

 

 

Total

   $ 199,153   
  

 

 

 

 

(a) Includes repayment of $93.7 million of outstanding borrowings under the terms of our $150 million revolving credit agreement.
XML 64 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Leases
12 Months Ended
Dec. 31, 2013
Leases

(4) LEASES

 

All of our leases are classified as operating leases with initial terms typically ranging from 3 to 15 years with up to five additional, five-year renewal options. Under the terms of the leases, we earn fixed monthly base rents and pursuant to the leases with subsidiaries of UHS, we may earn periodic bonus rents (see Note 1). The bonus rents from the subsidiaries of UHS, which are based upon each facility’s net revenue in excess of base amounts, are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to the corresponding quarter in the base year.

 

Minimum future base rents from non-cancelable leases, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):

 

2014

   $ 42,692   

2015

     39,631   

2016

     36,769   

2017

     21,519   

2018

     18,860   

Thereafter

     46,589   
  

 

 

 

Total minimum base rents

     $206,060   
  

 

 

 

 

Some of the leases contain gross terms where operating expenses are included in the base rent amounts. Other leases contain net terms where the operating expenses are assessed separately from the base rentals. The table above contains a mixture of both gross and net leases, and does not include any separately calculated operating expense reimbursements. Under the terms of the hospital leases, the lessees are required to pay all operating costs of the properties including property insurance and real estate taxes. Tenants of the medical office buildings generally are required to pay their pro-rata share of the property’s operating costs.

XML 65 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Leases (Tables)
12 Months Ended
Dec. 31, 2013
Schedule of Minimum Future Base Rents from Non-Cancelable Leases

Minimum future base rents from non-cancelable leases, excluding increases resulting from changes in the consumer price index, bonus rents and the impact of straight line rent, are as follows (amounts in thousands):

 

2014

   $ 42,692   

2015

     39,631   

2016

     36,769   

2017

     21,519   

2018

     18,860   

Thereafter

     46,589   
  

 

 

 

Total minimum base rents

     $206,060   
  

 

 

 
XML 66 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2013
Nature of Operations

Nature of Operations

 

Universal Health Realty Income Trust and subsidiaries (the “Trust”) is organized as a Maryland real estate investment trust. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings. As of February 28, 2014, we have fifty-eight real estate investments or commitments located in sixteen states consisting of:

 

   

seven hospital facilities including three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;

 

   

forty-seven medical office buildings, including eleven owned by unconsolidated limited liability companies (“LLCs”), and;

 

   

four preschool and childcare centers.

 

Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

 

Management is unable to predict the effect, if any, that the factors discussed above will have on the operating results of our lessees or on their ability to meet their obligations under the terms of their leases with us. Management’s estimate of future cash flows from our leased properties could be materially affected in the near term, if certain of the leases are not renewed or renewed with less favorable terms at the end of their lease terms.

Revenue Recognition

Revenue Recognition

 

Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

 

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (“MOBs”) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

Real Estate Investments

Real Estate Investments

 

On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Intangible assets include the value of in-place leases, above market leases and leasehold interest in land at the time of acquisition. Substantially all of our intangible assets consist of the value of in-place leases at December 31, 2013, and will be amortized over the remaining lease terms (aggregate weighted average of 3.5 years) and will result in an estimated aggregate amortization expense of $4.6 million, $3.9 million, $3.4 million $2.9 million and $1.7 million for 2014, 2015, 2016, 2017 and 2018, respectively. Amortization expense on intangible values of in place leases was $6.0 million for the year ended December 31, 2013, $7.8 million for the year ended December 31, 2012 and $836,000 for the year ended December 31, 2011. Depreciation is computed using the straight-line method over the estimated useful lives of the buildings and capital improvements. The estimated original useful lives of our buildings ranges from 25-45 years and the estimated original useful lives of capital improvements ranges from 3-35 years. On a consolidated basis, depreciation expense was $12.5 million for the year ended December 31, 2013, $12.2 million for the year ended December 31, 2012 and $6.3 million for the year ended December 31, 2011.

Cash and Cash Equivalents

Cash and Cash Equivalents

 

We consider all highly liquid investment instruments with original maturities of three months or less to be cash equivalents.

Asset Impairment

Asset Impairment

 

Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

 

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs. If we determine that the intangible assets are not recoverable from future cash flows, the excess of carrying value of the intangible asset over its estimated fair value is charged to income.

 

During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million in connection with an MOB located on a medical campus in Atlanta, Georgia. The asset impairment charge was recorded after evaluation of property and location-specific factors including pressure on rental and occupancy rates caused, in part, by the impact of continued unfavorable economic conditions in the market as well as competitive pressures caused by increased capacity added to the market. The fair value of this property was determined based upon the present value of the expected future cash flows.

 

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

Investments in Limited Liability Companies ("LLCs")

Investments in Limited Liability Companies (“LLCs”)

 

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

 

At December 31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings (including Palmdale Medical Properties, LLC and Sparks Medical Properties, LLC which, as discussed below, we purchased the minority ownership interests effective January 1, 2014 and now hold 100% of the ownership interests of these entities). As of December 31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013. As discussed below, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.

 

The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or member loans.

 

Palmdale Medical Properties had a master lease with a subsidiary of UHS through June 30, 2013. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS (through UHS of Delaware, Inc.). As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we have accounted for this LLC on a consolidated basis, since its inception in the fourth quarter of 2007 through June 30, 2013, since it was a variable interest entity and we were deemed to be the primary beneficiary. As of July 1, 2013, the master lease expired and this LLC is no longer considered a variable interest entity and we therefore began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013. The expiration of the master lease and related deconsolidation did not have a material impact on our net income and funds from operations during the second half of 2013.

 

As a result of master lease arrangements between UHS and various LLCs in which we hold or held majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB’s standards and guidance.

 

Effective January 1, 2014, we purchased the third-party minority ownership interests in two LLCs (Palmdale Medical Properties and Sparks Medical Properties) in which we formerly held non-controlling majority ownership interest. As a result of our purchase of the minority ownership interests, we now hold 100% of the ownership interests in these LLCs which own MOBs and will begin accounting for them on a consolidated basis effective January 1, 2014. Each of the property’s assets and liabilities will be recorded at their fair values (see Note 3 to the consolidated financial statements for additional disclosure). We do not expect these transactions or the expected related aggregate gain (to be recorded during the first quarter of 2014) to have a material impact on our future results of operations.

 

In addition, effective December 12, 2011, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as discussed herein (see Notes 3 and 8 to the consolidated financial statements for additional disclosure).

Federal Income Taxes

Federal Income Taxes

 

No provision has been made for federal income tax purposes since we qualify as a real estate investment trust under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

 

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax was due.

 

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for impairment losses.

 

The aggregate gross cost basis and net book value of the properties for federal income tax purposes are approximately $382 million and $256 million, respectively, at December 31, 2013.

Stock-Based Compensation

Stock-Based Compensation

 

We expense the grant-date fair value of stock options and restricted stock awards over the vesting period. We recognize the grant-date fair value of stock options and other equity-based compensation and account for these transactions using the fair-value based method. We use the Black-Scholes model as our option pricing model for determining the grant-date fair value of our stock options.

 

The expense associated with share-based compensation arrangements is a non-cash charge. In the Consolidated Statements of Cash Flows, share-based compensation expense is an adjustment to reconcile net income to cash provided by operating activities.

Fair Value

Fair Value

 

Fair value is a market-based measurement, not an entity-specific measurement and determined based upon the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, accounting requirements establish a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Level 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances when it is necessary to establish the fair value of our real estate investments and investments in LLCs we use unobservable inputs which are typically based on our own assumptions.

 

The fair value of our real estate investments, components of real estate investments and debt assumed in conjunction with acquisition and impairment activity, are considered to be Level 3 valuations as they are primarily based upon an income capitalization approach. Significant inputs into the models used to determine fair value of real estate investments and components of real estate investments include future cash flow projections, holding period, terminal capitalization rate and discount rates. Additionally the fair value of land takes into consideration comparable sales, as adjusted for site specific factors. The fair value of real estate investments is based upon significant judgments made by management, and accordingly, we typically obtain assistance from third party valuation specialists. Significant inputs into the models used to determine the fair value of assumed mortgages included the outstanding balance, term, stated interest rate and current market rate of the mortgage.

 

The carrying amounts reported in the balance sheet for cash, receivables, and short-term borrowings approximate their fair values due to the short-term nature of these instruments. Accordingly, these items are excluded from the fair value disclosures included elsewhere in these notes to the consolidated financial statements.

 

See Note 3-Acquisitions and Dispositions, for disclosure related to the $28.6 million net gain recorded during 2011 in connection with the fair value recognition of the assets and liabilities, including third-party debt, resulting from the purchase of minority ownership interests in majority-owned LLCs.

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

New Accounting Standards

New Accounting Standards

 

Except as noted below, there were no new accounting pronouncements during 2013 that impacted, or are expected to impact, us.

 

In February, 2013, the Financial Accounting Standards Board issued an Accounting Standards Update on reporting of amounts reclassified out of accumulated other comprehensive income. This guidance, which is effective for fiscal years beginning after December 31, 2012, required companies to provide information about amounts reclassified out of accumulated other comprehensive income by component (the respective line items of the income statement). The adoption of this standard did not have a material impact on our consolidated financial position or results of operations.

 

In July 2013, the Financial Accounting Standards Board (FASB) issued guidance allowing the use of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a benchmark interest rate for hedge accounting purposes in addition to interest rates on direct Treasury obligations of the United States government and the LIBOR. In addition, the guidance removes the restriction on using different benchmark rates for similar hedges. The guidance became effective on a prospective basis for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013, and did not have a material impact in the consolidated financial results.

XML 67 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summarized Financial Information of Equity Affiliates
12 Months Ended
Dec. 31, 2013
Summarized Financial Information of Equity Affiliates
(8)   SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES

 

As of December 31, 2013, we have non-controlling equity investments or commitments in thirteen LLCs which own medical office buildings. As of December 31, 2013, we accounted for these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities. Palmdale Medical Properties was consolidated in our financial statements through June 30, 2013. As previously disclosed, the master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties under the equity method.

 

Additionally, we have 100% ownership interests in eleven LLCs as of December 31, 2013 that were accounted for under the equity method through December 11, 2011 as previously disclosed. These eleven LLCs were subsequently consolidated into the results of operations effective December 12, 2011.

 

The following property table represents the thirteen LLCs which were accounted for under the equity method as of December 31, 2013:

 

Name of LLC/LP

  Ownership    

Property Owned by LLC

DVMC Properties(g.)

    90   Desert Valley Medical Center

Suburban Properties

    33   Suburban Medical Plaza II

Santa Fe Scottsdale

    90   Santa Fe Professional Plaza

Brunswick Associates(g.)

    74   Mid Coast Hospital MOB

PCH Medical Properties(g.)

    85   Rosenberg Children’s Medical Plaza

Arlington Medical Properties(b.)(g.)

    75   Saint Mary’s Professional Office Building

Sierra Medical Properties

    95   Sierra San Antonio Medical Plaza

PCH Southern Properties(g.)

    95   Phoenix Children’s East Valley Care Center

Sparks Medical Properties(a.)(f.)(g.)

    95   Vista Medical Terrace & The Sparks Medical Building

Grayson Properties(a.)(c.)(g.)

    95   Texoma Medical Plaza

3811 Bell Medical Properties

    95   North Valley Medical Plaza

FTX MOB Phase II(d.)(g.)

    95   Forney Medical Plaza II

Palmdale Medical Properties(a.)(e.)(f.)(g)

    95   Palmdale Medical Plaza

 

(a.) Tenants of this medical office building include or will include subsidiaries of UHS.
(b.) We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December 31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary’s Professional Office Building.
(c.) We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December 31, 2013.
(d.) During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December 31, 2013.
(e.) We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013, as discussed above.
(f.) Effective January 1, 2014, we purchased the third-party minority ownership interest (5%) in this LLC. As a result of our purchase of the minority ownership interest, as of January 1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January 1, 2014.
(g.) As disclosed below, as of December 31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us.

 

On December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs. The aggregate cash expenditure made by us in connection with the purchase of these membership interests in the various LLCs, including closing costs, was approximately $4.4 million. As a result of these transactions, accounting standards required that we record each property’s assets and liabilities at their fair values and record a non-cash gain or loss for the difference between the fair values and the equity method carrying value of each investment. In the aggregate, the purchase of these membership interests resulted in a $28.6 million gain on fair value recognition resulting from the purchase of the minority interests which is included in our consolidated statements of income for the year ended December 31, 2011. On December 12, 2011, we began consolidating the financial data of these eleven LLCs in our consolidated financial statements. The following property table represents these eleven LLCs (the summarized financial data for these eleven LLCs through December 11, 2011, are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

  Previous
Ownership
   

Property Owned by LLC

653 Town Center Investments(a.)

    95   Summerlin Hospital Medical Office Building I

653 Town Center Phase II(a.)

    98   Summerlin Hospital Medical Office Building II

ApaMed Properties

    85   Apache Junction Medical Plaza

Auburn Medical Properties II(a.)

    95   Auburn Medical Office Building II

Banburry Medical Properties(a.)

    95   Summerlin Hospital Medical Office Building III

BRB/E Building One

    95   BRB Medical Office Building

Centennial Medical Properties(a.)

    95   Centennial Hills Medical Office Building I

DesMed(a.)

    99   Desert Springs Medical Plaza

Gold Shadow Properties(a.)

    98   700 Shadow Lane & Goldring Medical Office Buildings

Spring Valley Medical Properties

    95   Spring Valley Medical Office Building

Spring Valley Medical Properties II

    95   Spring Valley Hospital Medical Office Building II

 

(a.) Tenants of this medical office building include or will include subsidiaries of UHS.

 

On November 30, 2011 and December 16, 2011, eight LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings and related real property. As partial consideration for the transaction, the buyer assumed certain existing third-party mortgage debt related to the properties. For certain of the LLCs, the sale of the medical office buildings were part of a series of planned like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code. The divestiture by the eight LLCs generated approximately $33.8 million of aggregate cash proceeds (a portion of which were sent to qualified third-party intermediaries), net of closing costs and the minority members’ share of the proceeds. In the aggregate, these transactions also resulted in a $35.8 million gain on divestiture which is included in our consolidated statements of income for the year ended December 31, 2011. The following property table represents the eight LLCs that divested medical office buildings on November 30, 2011 and December 16, 2011 (the summarized financial data for these eight LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

  Ownership    

Property Owned by LLC

DSMB Properties

    76   Desert Samaritan Hospital MOBs

Litchvan Investments

    89   Papago Medical Park

Paseo Medical Properties II

    75   Thunderbird Paseo Medical Plaza I & II

Willetta Medical Properties

    90   Edwards Medical Plaza

Deerval Properties(a.)

    90   Deer Valley Medical Office II

Deerval Properties II(a.)

    95   Deer Valley Medical Office Building III

Deerval Parking Company(a.)

    (a.   Deer Valley Parking Garage

Cobre Properties

    95   Cobre Valley Medical Plaza

 

(a.) Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings II and III, was 50% owned by each of Deerval Properties and Deerval Properties II.

 

The following property table represents the two LLCs that divested medical office buildings on February 3, 2012 and October 10, 2012 (the summarized financial data for these two LLCs through the date of divestiture are included in the financial tables below, which summarize the combined statements of income and combined balance sheets for the LLCs accounted for under the equity method):

 

Name of LLC

   Ownership    

Property Owned by LLC

Canyon Healthcare Properties

     95   Canyon Springs Medical Plaza

575 Hardy Investors

     90   Centinela Medical Building Complez

 

The following financial tables represent summarized financial information related to the LLCs that we accounted for under the equity method during 2013, including the financial information of the divested LLCs through their divestiture date. The 2011 table includes financial information of the divested LLCs through their divestiture date, as well as the LLCs in which we held majority noncontrolling ownership interests through December 11, 2011.

 

Below are the combined statements of income for the LLCs accounted for under the equity method. The years ended December 31, 2012 and 2011 include the prorated amounts for the LLCs that were divested through their divestiture dates, or in which we purchased the minority ownership interests, for the period in which they were accounted for under the equity method:

 

     For the Year Ended December 31,  
     2013(b.)      2012(a.)      2011(a.)  
     (amounts in thousands)  

Revenues

   $ 21,001       $ 21,448       $ 57,932   

Operating expenses

     8,705         8,974         25,503   

Depreciation and amortization

     4,039         4,140         13,066   

Interest, net

     6,353         6,056         17,630   
  

 

 

    

 

 

    

 

 

 

Net income before gains on divestitures

   $ 1,904       $ 2,278       $ 1,733   
  

 

 

    

 

 

    

 

 

 

Our share of net income before gains on divestitures(c.)

   $ 2,095       $ 2,365       $ 3,058   
  

 

 

    

 

 

    

 

 

 

Our share of gains on divestitures

   $ —        $ 8,520       $ 35,835   
  

 

 

    

 

 

    

 

 

 

 

(a.) As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
(b.) As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2103. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis. Included in the 2013 amounts reflected on the table above are the financial results for Palmdale Medical Plaza for the six-month period of July 1, 2013 through December 31, 2013.
(c.) Our share of net income during 2013, 2012 and 2011, includes interest income earned by us on various advances made to LLCs of approximately $1.9 million, $1.5 million and $2.6 million, respectively.

 

Below are the combined balance sheets for the LLCs that were accounted for under the equity method as of December 31, 2013 and 2012:

 

     December 31,  
     2013(a.)      2012  
     (amounts in thousands)  

Net property, including CIP

   $ 119,547       $ 106,150   

Other assets

     9,479         9,850   
  

 

 

    

 

 

 

Total assets

   $ 129,026       $ 116,000   
  

 

 

    

 

 

 

Liabilities

   $ 5,336       $ 5,368   

Mortgage notes payable, non-recourse to us

     80,112         77,511   

Advances payable to us

     22,911         12,658   

Equity

     20,667         20,463   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 129,026       $ 116,000   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 39,201       $ 28,636   
  

 

 

    

 

 

 

 

(a.) As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis.

 

As of December 31, 2013, aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2014

   $ 14,174   

2015

     41,492   

2016

     578   

2017

     11,829   

2018

     12,039   
  

 

 

 

Total

   $ 80,112   
  

 

 

 

 

Name of LLC

   Mortgage
Balance(b.)
     Maturity Date  

Grayson Properties(a.)

   $ 12,540                 2014   

Brunswick Associates

     7,941                 2015   

Arlington Medical Properties

     24,052                 2015   

DVMC Properties

     3,970                 2015   

Palmdale Medical Properties

     6,162                 2015   

FTX MOB Phase II(c.)

     5,596                 2017   

PCH Southern Properties

     6,614                 2017   

Sparks Medical Properties

     4,603                 2018   

PCH Medical Properties

     8,634                 2018   
  

 

 

    
   $ 80,112      
  

 

 

    

 

(a.) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan during 2014 for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.
(b.) All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(c.) Construction loan.

 

Pursuant to the operating agreements of the jointly-owned LLCs, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member.

 

The LLCs in which we have invested maintain property insurance on all properties. Although we believe that generally our properties are adequately insured, two of the LLCs in which we own various non-controlling equity interests, own properties in California that are located in earthquake zones. These properties, in which we have invested or advanced a total of $16.3 million at December 31, 2013, are not covered by earthquake insurance since earthquake insurance is no longer available at rates which are economical in relation to the risks covered.

XML 68 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) (Sierra Medical Properties)
12 Months Ended
Dec. 31, 2013
Schedule of Equity Method Investments [Line Items]  
Refinance of loan term Refinance these loans during 2014 for three to ten year terms
Minimum
 
Schedule of Equity Method Investments [Line Items]  
Refinancing of loan, expected term in years 3 years
Maximum
 
Schedule of Equity Method Investments [Line Items]  
Refinancing of loan, expected term in years 10 years
XML 69 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Dividends and Equity Issuance Program
12 Months Ended
Mar. 05, 2014
Dividends and Equity Issuance Program
(6)   DIVIDENDS AND EQUITY ISSUANCE PROGRAM

 

Dividends of $2.495 per share were declared and paid in 2013, of which $1.96 per share was ordinary income and $.535 per share was a return of capital distribution. Dividends of $2.46 per share were declared and paid in 2012, of which $1.294 per share was ordinary income and $1.166 per share was total capital gain (total capital gain amount consists of Unrecaptured Section 1250 gain of $.281 per share and 15% rate gain of $.885 per share). Dividends of $2.425 per share were declared and paid in 2011, of which $1.234 per share was ordinary income and $1.191 per share was total capital gain (total capital gain amount consists of Unrecaptured Section 1250 gain of $.716 per share and 15% rate gain of $.475 per share).

 

During the fourth quarter of 2013, we entered into an ATM Equity Offering Sales Agreement (“Sales Agreement”) with Merrill Lynch, Pierce, Fenner and Smith Incorporated (“Merrill Lynch”), under which we may offer and sell our common shares of beneficial interest, up to an aggregate sales price of $50 million. The common shares will be offered pursuant to the Registration Statement filed with the Securities and Exchange Commission, which became effective in November, 2012, under which we can offer up to $50 million of our securities pursuant to supplemental prospectuses which we may file from time to time.

 

Pursuant to this ATM Program, we issued 154,713 shares at an average price of $41.71 per share during the three-month period ended December 31, 2013, which generated approximately $6.0 million of net cash proceeds, (net of approximately $424,000 consisting of compensation of approximately $161,000 to Merrill Lynch as well as approximately $263,000 of other various fees and expenses), which includes approximately $592,000 of net proceeds receivable at December 31, 2013, which were received by us in January, 2014. The net proceeds receivable is a non-cash item, as presented on the Consolidated Statements of Cash Flows at December 31, 2013.

XML 70 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Incentive Plans
12 Months Ended
Dec. 31, 2013
Incentive Plans
(7)   INCENTIVE PLANS

 

We expense the grant-date fair value of stock options and restricted stock awards under the straight-line method over the stated vesting period of the award. We use the Black-Scholes option pricing model for determining the grant-date fair value of our stock options. All of our outstanding stock options have been fully expensed as of December 31, 2011.

 

During 2007, upon the expiration of our 1997 Incentive Plan, as discussed below, our Board of Trustees and shareholders approved the Universal Health Realty Income Trust 2007 Restricted Stock Plan (the “2007 Plan”). A total of 75,000 shares were authorized for issuance under this plan and a total of 47,975 shares, net of cancellations, have been issued pursuant to the terms of this plan, 28,870 of which have vested as of December 31, 2013. At December 31, 2013 there are 27,025 shares remaining for issuance under the terms of the 2007 Plan.

 

During 2013, there were 8,730 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $43.54 per share ($380,104 in the aggregate). These restricted shares are scheduled to vest in June of 2015 (the second anniversary of the date of grant).

 

During 2012, there were 10,375 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $39.05 per share ($405,144 in the aggregate). These restricted shares are scheduled to vest in June of 2014 (the second anniversary of the date of grant). Included the restricted stock issuances during 2012 were one-time special compensation awards made to our executive officers in recognition of their efforts and contributions in connection with various acquisitions, divestitures and purchases of third-party minority interests in certain majority-owned LLCs as completed at various times during 2011 and the first quarter of 2012.

 

During 2011, there were 7,395 restricted Shares of Beneficial Interest, net of cancellations, issued to the Trustees and officers of the Trust pursuant to the 2007 Plan at a weighted average grant price of $41.90 per share ($309,850 in the aggregate). These restricted shares vested during 2013.

 

In connection with these grants, we recorded compensation expense of approximately $375,000, $329,000 and $216,000 during 2013, 2012 and 2011, respectively. The remaining expenses associated with these grants is approximately $354,000 and will be recorded over the remaining weighted average vesting period for outstanding restricted Shares of Beneficial Interest of approximately one year at December 31, 2013.

 

Prior to its expiration in 2007, the Universal Health Realty Income Trust 1997 Incentive Plan (the “1997 Plan”) provided for the granting of stock options and dividend equivalents rights (“DERs”) to employees of the Trust, including officers and trustees. Awards granted pursuant to the 1997 Plan prior to its termination date remain exercisable, in accordance with the terms of the outstanding agreements. All stock options were granted with an exercise price equal to the fair market value on the date of the grant. The options granted vested ratably at 25% per year beginning one year after the date of grant, and expire in ten years. DERs on outstanding awards are earned in amounts equal to the cash or stock dividends declared subsequent to the date of grant. We recorded expenses relating to the dividend equivalent rights of approximately $19,000 in 2013 and $18,000 in each of 2012 and 2011. As of December 31, 2013, there were 40,000 options outstanding and exercisable under the 1997 Plan with an average exercise price of $35.65 per share.

 

There were no compensation costs recognized during 2013 and 2012, and $12,000 of compensation costs during 2011, related to outstanding stock options and DERs that were granted or have vestings after January 1, 2006. As of December 31, 2011, all of the outstanding stock options and DERs were fully vested and fully expensed. The outstanding stock options have a remaining weighted average life of 2.5 years at December 31, 2013.

 

During the fourth quarter of 2008, the Board of Trustees of the Trust approved amendments to the outstanding stock option agreements made pursuant to the 1997 Plan. These original agreements provided for the deferred payment of dividend equivalents on shares covered by the options, with payment tied to the date the options were exercised or expire. In order to meet certain recent changes to tax law requirements, the agreements, as amended, provide for the current payment of dividend equivalents in the years in which dividends are declared and paid or, if later, when the related options become vested. Dividend equivalent rights with respect to 40,000 shares were outstanding at December 31, 2013. Dividend equivalent rights with respect to 43,000 shares were outstanding at December 31, 2012. Dividend equivalent rights with respect to 51,000 shares were outstanding at December 31, 2011. In December of 2013, 2012 and 2011, dividend equivalent rights which were vested and accrued as of each respective date, were paid to officers and Trustees of the Trust amounting to $106,000, $116,000 and $178,000, respectively.

 

Stock options to purchase shares of beneficial interest have been granted to eligible individuals, including our officers and trustees. Information with respect to these options, before adjustment to the option price to give effect to the dividend equivalent rights, is summarized as follows:

 

Outstanding Options

   Number
of Shares
     Exercise
Weighted-
Average Price
     Grant Price Range
(High-Low)
 

Balance, January 1, 2011

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     —          —          —    
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2012

     51,000       $ 33.89       $ 36.53/$26.09   

Exercised

     8,000         26.76       $ 27.65/$26.09   
  

 

 

    

 

 

    

 

 

 

Balance, January 1, 2013

     43,000       $ 35.22       $ 36.53/$29.44   

Exercised

     3,000         29.44       $ 29.44/$29.44   
  

 

 

    

 

 

    

 

 

 

Outstanding options vested and exercisable as of December 31, 2013

     40,000       $ 35.65       $ 36.53/$30.06   
  

 

 

    

 

 

    

 

 

 

 

During 2013, there were 3,000 stock options exercised with a total in-the-money value of $46,290. During 2012, there were 8,000 stock options exercised with a total in-the-money value of $148,930. There were no stock options exercised during 2011.

 

There were no unvested options as of December 31, 2013.

 

The following table provides information about options outstanding and exercisable options at December 31, 2013:

 

     Options
Outstanding
and Exercisable
 

Number

     40,000   

Weighted average exercise price

   $ 35.65   

Aggregate intrinsic value

   $ 176,240   

Weighted average remaining contractual life

     2.5   

 

The weighted average remaining contractual life and weighted average exercise price for options outstanding and the weighted average exercise prices per share for exercisable options at December 31, 2013 were as follows:

 

     Options Outstanding and
Exercisable
 

Exercise Price

   Shares      Weighted
Average
Exercise
Price Per
Share
     Weighted
Average
Remaining
Contractual
Life (in
Years)
 

$30.06 -$34.07

     4,000       $ 33.07         1.0   

$34.90 -$34.90

     13,000         34.90         1.7   

$36.53 -$36.53

     23,000         36.53         3.2   
  

 

 

    

 

 

    

 

 

 

Total

     40,000       $ 35.65         2.5   
  

 

 

    

 

 

    

 

 

 
XML 71 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT REPORTING
12 Months Ended
Dec. 31, 2013
SEGMENT REPORTING
(9)   SEGMENT REPORTING

 

Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.

 

Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

XML 72 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule III Real Estate and Accumulated Depreciation (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance $ 105,453 [1]      
Initial Cost, Land 25,558      
Initial Cost, Building & Improvements 317,546      
Adjustments to Basis 52,565 [2]      
Land 27,374      
Buildings and Improvements 368,295      
CIP 0      
Total 395,669 401,474 363,498 199,940
Accumulated Depreciation 97,921 87,088    
Inland Valley Regional Medical Center Wildomar, California
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 2,050      
Initial Cost, Building & Improvements 10,701      
Adjustments to Basis 14,596 [2]      
Land 2,050      
Buildings and Improvements 25,297      
Total 27,347      
Accumulated Depreciation 10,464      
Date of Completion of Construction, Acquisition or Significant Improvement 2007      
Date Acquired 1986      
Average Depreciable Life 43 years      
McAllen Medical Center McAllen, Texas
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 4,720      
Initial Cost, Building & Improvements 31,442      
Adjustments to Basis 10,189 [2]      
Land 6,281      
Buildings and Improvements 40,070      
Total 46,351      
Accumulated Depreciation 23,440      
Date of Completion of Construction, Acquisition or Significant Improvement 1994      
Date Acquired 1986      
Average Depreciable Life 42 years      
Wellington Regional Medical Center West Palm Beach, Florida
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,190      
Initial Cost, Building & Improvements 14,652      
Adjustments to Basis 17,370 [2]      
Land 1,663      
Buildings and Improvements 31,549      
Total 33,212      
Accumulated Depreciation 15,182      
Date of Completion of Construction, Acquisition or Significant Improvement 2006      
Date Acquired 1986      
Average Depreciable Life 42 years      
The Bridgeway North Little Rock, Arkansas
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 150      
Initial Cost, Building & Improvements 5,395      
Adjustments to Basis 4,571 [2]      
Land 150      
Buildings and Improvements 9,966      
Total 10,116      
Accumulated Depreciation 5,554      
Date of Completion of Construction, Acquisition or Significant Improvement 2006      
Date Acquired 1986      
Average Depreciable Life 35 years      
HealthSouth Deaconess Rehabilitation Hospital Evansville, Indiana
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 500      
Initial Cost, Building & Improvements 6,945      
Adjustments to Basis 1,062 [2]      
Land 500      
Buildings and Improvements 8,007      
Total 8,507      
Accumulated Depreciation 4,867      
Date of Completion of Construction, Acquisition or Significant Improvement 1993      
Date Acquired 1989      
Average Depreciable Life 40 years      
Kindred Hospital Chicago Central Chicago, Illinois
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 158      
Initial Cost, Building & Improvements 6,404      
Adjustments to Basis 1,838 [2]      
Land 158      
Buildings and Improvements 8,242      
Total 8,400      
Accumulated Depreciation 8,245      
Date of Completion of Construction, Acquisition or Significant Improvement 1993      
Date Acquired 1986      
Average Depreciable Life 25 years      
Family Doctor's Medical Office Building Shreveport, Louisiana
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 54      
Initial Cost, Building & Improvements 1,526      
Adjustments to Basis 494 [2]      
Land 54      
Buildings and Improvements 2,020      
Total 2,074      
Accumulated Depreciation 854      
Date of Completion of Construction, Acquisition or Significant Improvement 1991      
Date Acquired 1995      
Average Depreciable Life 45 years      
Kelsey-Seybold Clinic at King's Crossing
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 439      
Initial Cost, Building & Improvements 1,618      
Adjustments to Basis 870 [2]      
Land 439      
Buildings and Improvements 2,488      
Total 2,927      
Accumulated Depreciation 958      
Date of Completion of Construction, Acquisition or Significant Improvement 1995      
Date Acquired 1995      
Average Depreciable Life 45 years      
Professional Center at King's Crossing Kingwood, Texas
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 439      
Initial Cost, Building & Improvements 1,837      
Adjustments to Basis 183 [2]      
Land 439      
Buildings and Improvements 2,020      
Total 2,459      
Accumulated Depreciation 832      
Date of Completion of Construction, Acquisition or Significant Improvement 1995      
Date Acquired 1995      
Average Depreciable Life 45 years      
Chesterbrook Academy Audubon, Pennsylvania
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 307      
Initial Cost, Building & Improvements 996      
Land 307      
Buildings and Improvements 996      
Total 1,303      
Accumulated Depreciation 391      
Date of Completion of Construction, Acquisition or Significant Improvement 1996      
Date Acquired 1996      
Average Depreciable Life 45 years      
Chesterbrook Academy New Britain, Pennsylvania
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 250      
Initial Cost, Building & Improvements 744      
Land 250      
Buildings and Improvements 744      
Total 994      
Accumulated Depreciation 292      
Date of Completion of Construction, Acquisition or Significant Improvement 1991      
Date Acquired 1996      
Average Depreciable Life 45 years      
Chesterbrook Academy Uwchlan, Pennsylvania
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 180      
Initial Cost, Building & Improvements 815      
Land 180      
Buildings and Improvements 815      
Total 995      
Accumulated Depreciation 320      
Date of Completion of Construction, Acquisition or Significant Improvement 1992      
Date Acquired 1996      
Average Depreciable Life 45 years      
Chesterbrook Academy Newtown, Pennsylvania
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 195      
Initial Cost, Building & Improvements 749      
Land 195      
Buildings and Improvements 749      
Total 944      
Accumulated Depreciation 294      
Date of Completion of Construction, Acquisition or Significant Improvement 1992      
Date Acquired 1996      
Average Depreciable Life 45 years      
The Southern Crescent Center I
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,130 [3]      
Initial Cost, Building & Improvements 5,092 [3]      
Adjustments to Basis (2,304) [2],[3]      
Land 1,130 [3]      
Buildings and Improvements 2,788 [3]      
Total 3,918 [3]      
Accumulated Depreciation 2,141 [3]      
Date of Completion of Construction, Acquisition or Significant Improvement 1994 [3]      
Date Acquired 1996 [3]      
Average Depreciable Life 45 years [3]      
The Southern Crescent Center II Riverdale, Georgia
       
Real Estate and Accumulated Depreciation [Line Items]        
Adjustments to Basis 5,015 [2],[3]      
Land 806 [3]      
Buildings and Improvements 4,209 [3]      
Total 5,015 [3]      
Accumulated Depreciation 1,742 [3]      
Date of Completion of Construction, Acquisition or Significant Improvement 2000 [3]      
Date Acquired 1998 [3]      
Average Depreciable Life 35 years [3]      
The Cypresswood Professional Center Spring,Texas
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 573      
Initial Cost, Building & Improvements 3,842      
Adjustments to Basis 573 [2]      
Land 573      
Buildings and Improvements 4,415      
Total 4,988      
Accumulated Depreciation 2,212      
Date of Completion of Construction, Acquisition or Significant Improvement 1997      
Date Acquired 1997      
Average Depreciable Life 35 years      
701 South Tonopah Building Las Vegas, Nevada
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Building & Improvements 1,579      
Adjustments to Basis 68 [2]      
Buildings and Improvements 1,647      
Total 1,647      
Accumulated Depreciation 858      
Date of Completion of Construction, Acquisition or Significant Improvement 1999      
Date Acquired 1999      
Average Depreciable Life 25 years      
Sheffield Medical Building Atlanta, Georgia
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,760 [4]      
Initial Cost, Building & Improvements 9,766 [4]      
Adjustments to Basis (7,327) [2],[4]      
Land 736 [4]      
Buildings and Improvements 3,463 [4]      
Total 4,199 [4]      
Accumulated Depreciation 936 [4]      
Date of Completion of Construction, Acquisition or Significant Improvement 1999 [4]      
Date Acquired 1999 [4]      
Average Depreciable Life 25 years [4]      
Medical Center of Western Connecticut - Bldg. 73 Danbury, Connecticut
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 4,899 [1]      
Initial Cost, Land 1,151      
Initial Cost, Building & Improvements 5,176      
Adjustments to Basis 430 [2]      
Land 1,151      
Buildings and Improvements 5,606      
Total 6,757      
Accumulated Depreciation 2,678      
Date of Completion of Construction, Acquisition or Significant Improvement 2000      
Date Acquired 2000      
Average Depreciable Life 30 years      
Vibra Hospital of Corpus Christi Corpus Christi, Texas
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 2,983 [1]      
Initial Cost, Land 1,104      
Initial Cost, Building & Improvements 5,508      
Land 1,104      
Buildings and Improvements 5,508      
Total 6,612      
Accumulated Depreciation 928      
Date of Completion of Construction, Acquisition or Significant Improvement 2008      
Date Acquired 2008      
Average Depreciable Life 35 years      
Apache Junction Medical Plaza Apache Junction, AZ
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 240 [5]      
Initial Cost, Building & Improvements 3,590 [5]      
Adjustments to Basis 27 [2],[5]      
Land 240 [5]      
Buildings and Improvements 3,617 [5]      
Total 3,857 [5]      
Accumulated Depreciation 283 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2004 [5]      
Date Acquired 2004 [5]      
Average Depreciable Life 30 years [5]      
Auburn Medical Office Building Auburn, WA
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 7,406 [1],[5]      
Initial Cost, Building & Improvements 10,200 [5]      
Adjustments to Basis 159 [2],[5]      
Buildings and Improvements 10,359 [5]      
Total 10,359 [5]      
Accumulated Depreciation 694 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2009 [5]      
Date Acquired 2009 [5]      
Average Depreciable Life 36 years [5]      
BRB Medical Office Building Kingwood, Texas
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,840 [1],[5]      
Initial Cost, Land 430 [5]      
Initial Cost, Building & Improvements 8,970 [5]      
Adjustments to Basis 24 [2],[5]      
Land 430 [5]      
Buildings and Improvements 8,994 [5]      
Total 9,424 [5]      
Accumulated Depreciation 591 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2010 [5]      
Date Acquired 2010 [5]      
Average Depreciable Life 37 years [5]      
Centennial Hills Medical Office Building Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 10,938 [1],[5]      
Initial Cost, Building & Improvements 19,890 [5]      
Adjustments to Basis 743 [2],[5]      
Buildings and Improvements 20,633 [5]      
Total 20,633 [5]      
Accumulated Depreciation 1,412 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2006 [5]      
Date Acquired 2006 [5]      
Average Depreciable Life 34 years [5]      
Desert Springs Medical Plaza Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,200 [5]      
Initial Cost, Building & Improvements 9,560 [5]      
Adjustments to Basis 200 [2],[5]      
Land 1,200 [5]      
Buildings and Improvements 9,760 [5]      
Total 10,960 [5]      
Accumulated Depreciation 772 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 1998 [5]      
Date Acquired 1998 [5]      
Average Depreciable Life 30 years [5]      
700 Shadow Lane & Goldring MOB Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,766 [1],[5]      
Initial Cost, Land 400 [5]      
Initial Cost, Building & Improvements 11,300 [5]      
Adjustments to Basis 968 [2],[5]      
Land 400 [5]      
Buildings and Improvements 12,268 [5]      
Total 12,668 [5]      
Accumulated Depreciation 931 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2003 [5]      
Date Acquired 2003 [5]      
Average Depreciable Life 30 years [5]      
Spring Valley Hospital MOB I Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 5,122 [1],[5]      
Initial Cost, Building & Improvements 9,500 [5]      
Adjustments to Basis 111 [2],[5]      
Buildings and Improvements 9,611 [5]      
Total 9,611 [5]      
Accumulated Depreciation 664 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2004 [5]      
Date Acquired 2004 [5]      
Average Depreciable Life 35 years [5]      
Spring Valley Hospital MOB II Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Building & Improvements 9,800 [5]      
Adjustments to Basis 8 [2],[5]      
Buildings and Improvements 9,808 [5]      
Total 9,808 [5]      
Accumulated Depreciation 693 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2006 [5]      
Date Acquired 2006 [5]      
Average Depreciable Life 34 years [5]      
Summerlin Hospital MOB Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 9,188 [1],[5]      
Initial Cost, Land 460 [5]      
Initial Cost, Building & Improvements 15,440 [5]      
Adjustments to Basis 451 [2],[5]      
Land 460 [5]      
Buildings and Improvements 15,891 [5]      
Total 16,351 [5]      
Accumulated Depreciation 1,251 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 1999 [5]      
Date Acquired 1999 [5]      
Average Depreciable Life 30 years [5]      
Summerlin Hospital MOB II Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 12,021 [1],[5]      
Initial Cost, Land 370 [5]      
Initial Cost, Building & Improvements 16,830 [5]      
Adjustments to Basis 731 [2],[5]      
Land 370 [5]      
Buildings and Improvements 17,561 [5]      
Total 17,931 [5]      
Accumulated Depreciation 1,345 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2000 [5]      
Date Acquired 2000 [5]      
Average Depreciable Life 30 years [5]      
Summerlin Hospital MOB III Las Vegas, NV
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 11,347 [1],[5]      
Initial Cost, Building & Improvements 14,900 [5]      
Adjustments to Basis 1,443 [2],[5]      
Buildings and Improvements 16,343 [5]      
Total 16,343 [5]      
Accumulated Depreciation 1,044 [5]      
Date of Completion of Construction, Acquisition or Significant Improvement 2009 [5]      
Date Acquired 2009 [5]      
Average Depreciable Life 36 years [5]      
Emory at Dunwoody Dunwoody, GA
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 782      
Initial Cost, Building & Improvements 3,455      
Land 782      
Buildings and Improvements 3,455      
Total 4,237      
Accumulated Depreciation 264      
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Forney Medical Plaza Forney, TX
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 910      
Initial Cost, Building & Improvements 11,960      
Adjustments to Basis 31 [2]      
Land 910      
Buildings and Improvements 11,991      
Total 12,901      
Accumulated Depreciation 1,149      
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Lake Pointe Medical Arts Rowlett, TX
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 1,100      
Initial Cost, Building & Improvements 9,000      
Adjustments to Basis 41 [2]      
Land 1,100      
Buildings and Improvements 9,041      
Total 10,141      
Accumulated Depreciation 772      
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Tuscan Medical Properties Irving, TX
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 6,262 [1]      
Initial Cost, Land 1,100      
Initial Cost, Building & Improvements 12,525      
Land 1,100      
Buildings and Improvements 12,525      
Total 13,625      
Accumulated Depreciation 869      
Date of Completion of Construction, Acquisition or Significant Improvement 2011      
Date Acquired 2011      
Average Depreciable Life 35 years      
Peace Health Medical Clinic
       
Real Estate and Accumulated Depreciation [Line Items]        
Encumbrance 21,681 [1]      
Initial Cost, Land 1,900      
Initial Cost, Building & Improvements 24,910      
Land 1,900      
Buildings and Improvements 24,910      
Total 26,810      
Accumulated Depreciation 1,701      
Date of Completion of Construction, Acquisition or Significant Improvement 2012      
Date Acquired 2012      
Average Depreciable Life 35 years      
Northwest Texas Professional Office Tower
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Building & Improvements 7,180      
Buildings and Improvements 7,180      
Total 7,180      
Accumulated Depreciation 244      
Date of Completion of Construction, Acquisition or Significant Improvement 2012      
Date Acquired 2012      
Average Depreciable Life 35 years      
Ward Eagle Office Village Medical Office Building
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 220      
Initial Cost, Building & Improvements 3,220      
Land 220      
Buildings and Improvements 3,220      
Total 3,440      
Accumulated Depreciation 44      
Date of Completion of Construction, Acquisition or Significant Improvement 2013      
Date Acquired 2013      
Average Depreciable Life 35 years      
5004 Poole Road medical office building
       
Real Estate and Accumulated Depreciation [Line Items]        
Initial Cost, Land 96      
Initial Cost, Building & Improvements 529      
Land 96      
Buildings and Improvements 529      
Total 625      
Accumulated Depreciation $ 10      
Date of Completion of Construction, Acquisition or Significant Improvement 2013      
Date Acquired 2013      
Average Depreciable Life 35 years      
[1] Consists of outstanding balances as of December 31, 2013 on third-party debt that is non-recourse to us.
[2] Costs capitalized/divested subsequent to acquisition.
[3] During 2008, a $4.6 million provision for asset impairment was recorded in connection with the real estate assets of Southern Crescent Center I & Southern Crescent Center II.
[4] During 2011, a $5.4 million provision for asset impairment was recorded in connection with the real estate assets of Sheffield Medical Building.
[5] During 2011, we purchased the third-party minority interests in these properties in which we previously held noncontrolling majority owned interests. Since that time, these properties are wholly-owned.
XML 73 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Real Estate and Accumulated Depreciation [Line Items]      
Beginning balance $ 401,474 $ 363,498 $ 199,940
Impact of deconsolidation of an LLC (13,185) [1]    
Impact of consolidation of eleven LLCs     133,080 [2]
Property additions 3,415 3,985 1,157
Acquisitions 4,065 33,991 40,832
Disposals (100)    
Provision for asset impairment     (11,511) [3]
Ending balance 395,669 401,474 363,498
Beginning balance 87,088 74,865 74,683
Impact of deconsolidation of two LLCs (1,588) [1]    
Provision for asset impairment     (6,157) [3]
Current year depreciation expense 12,464 12,223 6,339
Other (43)    
Ending balance $ 97,921 $ 87,088 $ 74,865
[1] The master lease with a wholly-owned subsidiary of UHS related to Palmdale Medical Properties expired effective as of July 1, 2013 and, as of that date, we began accounting for Palmdale Medical Properties on an unconsolidated basis under the equity method.
[2] On December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs and the financial results are included in our consolidated financial statements.
[3] During the fourth quarter of 2011, we recorded an asset impairment charge of $5.4 million ($11.5 million gross assets net of $6.1 million of accumulated depreciation) in connection with the Sheffield Medical Building located in Atlanta, Georgia.
XML 74 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results (Parenthetical) (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Quarterly Financial Information [Line Items]          
Gain on divestitures of properties owned by unconsolidated LLCs, net $ 1,145 [1] $ 7,375 [1] $ 0 $ 8,520 [1],[2] $ 35,835 [2]
[1] During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
[2] As mentioned above, beginning in the fourth quarter of 2011, eleven of our LLCs that were previously recorded on unconsolidated basis became wholly-owned by us and are included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011, the first quarter of 2012 and the fourth quarter of 2012, eleven LLCs in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
XML 75 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Unobservable Quantitative Inputs and Assumption used to Acquired Properties Categorized in Level Three (Detail) (Fair Value, Inputs, Level 3, USD $)
12 Months Ended
Dec. 31, 2012
Peace Health Medical Clinic
 
Quantitative Information About Significant Unobservable Inputs [Line Items]  
Assets PeaceHealth Medical Clinic [1],[2]
Fair Value of Assets $ 30,400,000 [1],[2]
Valuation Technique Income Capitalization Approach [1],[2]
Unobservable inputs Capitalization Rate [1],[2]
Capitalization rate 7.50% [1],[2]
Discount rate 8.50% [1],[2]
Northwest Texas Professional Office Tower
 
Quantitative Information About Significant Unobservable Inputs [Line Items]  
Assets Professional Office Tower
Fair Value of Assets $ 9,600,000
Valuation Technique Income Capitalization Approach
Unobservable inputs Capitalization Rate
Capitalization rate 8.60%
Discount rate 9.50%
[1] The fair value of the land was estimated based upon the sales comparison approach.
[2] Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.
XML 76 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Limited Liability Companies Accounted for Under Equity Method (Detail) (Equity Method Investments)
12 Months Ended
Dec. 31, 2013
DVMC Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 90.00% [1]
Property Owned by LLC Desert Valley Medical Center [1]
Suburban Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 33.00%
Property Owned by LLC Suburban Medical Plaza II
Santa Fe Scottsdale
 
Schedule of Equity Method Investments [Line Items]  
Ownership 90.00%
Property Owned by LLC Santa Fe Professional Plaza
Brunswick Associates
 
Schedule of Equity Method Investments [Line Items]  
Ownership 74.00% [1]
Property Owned by LLC Mid Coast Hospital MOB [1]
PCH Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 85.00% [1]
Property Owned by LLC Rosenberg Children's Medical Plaza [1]
Arlington Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 75.00% [1],[2]
Property Owned by LLC Saint Mary's Professional Office Building [1],[2]
Sierra Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%
Property Owned by LLC Sierra San Antonio Medical Plaza
PCH Southern Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00% [1]
Property Owned by LLC Phoenix Children's East Valley Care Center [1]
Sparks Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00% [1],[3],[4]
Property Owned by LLC Vista Medical Terrace & The Sparks Medical Building [1],[3],[4]
Grayson Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00% [1],[3],[5]
Property Owned by LLC Texoma Medical Plaza [1],[3],[5]
3811 Bell Medical Properties
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00%
Property Owned by LLC North Valley Medical Plaza
FTX MOB Phase II limited partnership
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00% [1],[6]
Property Owned by LLC Forney Medical Plaza II [1],[6]
Palmdale Medical Plaza
 
Schedule of Equity Method Investments [Line Items]  
Ownership 95.00% [1],[3],[4],[7]
Property Owned by LLC Palmdale Medical Plaza [1],[3],[4],[7]
[1] As disclosed below, as of December 31, 2013, this LLC has a third-party loan outstanding, which is non-recourse to us.
[2] We have committed to invest up to $6.3 million in equity and debt financing, of which $5.2 million has been funded as of December 31, 2013, in exchange for a 75% non-controlling equity interest in an LLC that owns and operates the Saint Mary's Professional Office Building.
[3] Tenants of this medical office building include or will include subsidiaries of UHS.
[4] Effective January 1, 2014, we purchased the third-party minority ownership interest (5%) in this LLC. As a result of our purchase of the minority ownership interest, as of January 1, 2014 we hold 100% of the ownership interest in this LLC and will begin accounting for it on a consolidated basis effective January 1, 2014.
[5] We have committed to invest up to $4.4 million in equity and debt financing, of which $2.1 million has been funded as of December 31, 2013.
[6] During the third quarter of 2012, this limited partnership entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which was completed and opened in April, 2013. We have committed to invest up to $2.5 million in equity and debt financing, $1.1 million of which has been funded as of December 31, 2013.
[7] We began to account for this LLC on an unconsolidated basis pursuant to the equity method as of July 1, 2013, as discussed above.
XML 77 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Dispositions (Tables)
12 Months Ended
Dec. 31, 2013
Unobservable Quantitative Inputs and Assumption used to Acquired Properties Categorized in Level Three

The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:

 

Assets(b.)

   Fair Value at
December 31, 2012
    

Valuation Technique

   Unobservable inputs    Range  

PeaceHealth Medical Clinic (a.)(c.)

   $ 30,400,000       Income Capitalization Approach    Capitalization Rate      7.50
         Discount Rate      8.50

Northwest Texas Professional Office Tower

   $ 9,600,000       Income Capitalization Approach    Capitalization Rate      8.60
         Discount Rate      9.50

 

(a.) The fair value of the land was estimated based upon the sales comparison approach.
(b.) Based upon preliminary appraisals.
(c.) Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.
2012 Acquisitions
 
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

Land

   $ 1,900   

Buildings and improvements

     32,090   

Intangible assets

     6,020   

Other assets

     799   

Liabilities (real property and operating)

     (144

Deposit paid in 2011

     (534

Debt (including fair value adjustment of $799)

     (23,240
  

 

 

 

Net cash paid

   $ 16,891   
  

 

 

 
2013 Acquisitions
 
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years.

 

Land

   $ 316   

Buildings and improvements

     3,749   

Intangible assets

     610   

Other assets

     21   

Liabilities (real property and operating)

     (11
  

 

 

 

Net cash paid

   $ 4,685   
  

 

 

 
2011 Acquisitions
 
Allocation of Purchase Price to Assets Acquired and Liabilities Assumed

Intangible assets include the value of the in-place leases at the time of acquisition.

 

Land

   $ 3,892   

Buildings and improvements

     36,940   

Intangible assets

     6,943   

Other assets

     31   
  

 

 

 

Total purchase price

     47,806   

Liabilities (real property and operating)

     (1,229

Debt

     (6,999
  

 

 

 

Net cash paid

   $ 39,578   
  

 

 

 
XML 78 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Quarterly Results (Tables)
12 Months Ended
Dec. 31, 2013
Quarterly Results for Operating Activities
     2013 (a.)  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,885       $ 13,502       $ 13,448       $ 13,445       $ 54,280   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 3,427       $ 2,941       $ 3,303       $ 3,498       $ 13,169   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.27       $ 0.23       $ 0.26       $ 0.27       $ 1.04   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

     2012  
     First
Quarter
     Second
Quarter
     Third
Quarter
     Fourth
Quarter
     Total  
     (amounts in thousands, except per share amounts)  

Revenues

   $ 13,351       $ 13,666       $ 13,610       $ 13,323       $ 53,950   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income before gains

   $ 2,139       $ 2,467       $ 2,986       $ 3,365       $ 10,957   

Net gains on divestiture of properties owned by unconsolidated LLCs(b.)

     7,375         —          —          1,145         8,520   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 9,514       $ 2,467       $ 2,986       $ 4,510       $ 19,477   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total basic earnings per share

   $ 0.75       $ 0.19       $ 0.24       $ 0.36       $ 1.54   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total diluted earnings per share

   $ 0.75       $ 0.19       $ 0.24       $ 0.36       $ 1.54   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) We began reflecting the operating results for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were recorded on a consolidated basis. The revenues for the first and second quarters of 2013, as reflected above, include the revenue for Palmdale Medical Plaza. There was no material impact to our net income as a result of the deconsolidation of this property.
(b.) During the first and fourth quarters of 2012, as previously discussed in Note 3, two LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings. As a result, the net income amounts presented for 2012 include amounts only up to the divested date for each of these two LLCs. In the aggregate, these divestitures resulted in an $8.5 million gain which is included in our consolidated statements of income for the year ended December 31, 2012.
XML 79 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) (USD $)
12 Months Ended
Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options outstanding and Exercisable, shares 40,000
Options outstanding and Exercisable, weighted average exercise price per share $ 35.65
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 2 years 6 months
Price Range 1
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of exercise prices, lower limit $ 30.06
Range of exercise prices, upper limit $ 34.07
Options outstanding and Exercisable, shares 4,000
Options outstanding and Exercisable, weighted average exercise price per share $ 33.07
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 1 year
Price Range 2
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of exercise prices, lower limit $ 34.90
Range of exercise prices, upper limit $ 34.90
Options outstanding and Exercisable, shares 13,000
Options outstanding and Exercisable, weighted average exercise price per share $ 34.90
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 1 year 8 months 12 days
Price Range 3
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Range of exercise prices, lower limit $ 36.53
Range of exercise prices, upper limit $ 36.53
Options outstanding and Exercisable, shares 23,000
Options outstanding and Exercisable, weighted average exercise price per share $ 36.53
Options outstanding and Exercisable, weighted average remaining contractual life (in Years) 3 years 2 months 12 days
XML 80 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Debt Instrument [Line Items]  
Covenant, Tangible net worth $ 125,000
Tangible net worth $ 144,848
Debt to total capital 36.00%
Debt service coverage ratio 19.1
Debt to cash flow ratio 2.21
Maximum
 
Debt Instrument [Line Items]  
Covenant, Debt to total capital 55.00%
Covenant, Debt to cash flow ratio 3.50
Minimum
 
Debt Instrument [Line Items]  
Covenant, Debt service coverage ratio 4.00
XML 81 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Changes in Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Total
Common stock
Capital in excess of par value
Cumulative net income
Accumulated other comprehensive loss
UHT Shareholders' Equity
Non-controlling Interests
Cumulative dividends
Beginning Balance at Dec. 31, 2010 $ 145,510 $ 127 $ 213,209 $ 373,604   $ 145,413 $ 97 $ (441,527)
Beginning Balance, Shares at Dec. 31, 2010   12,653,000            
Shares of Beneficial Interest:                
Issued (in shares)   14,000            
Issued 238   238     238    
Partial settlement of dividend equivalent rights (162)   (162)     (162)    
Restricted stock-based compensation expense 269   269     269    
Stock-based compensation expense 12   12     12    
Dividends ($2.495/share) in 2013, ($2.46/share) in 2012 and ($2.425/share) in 2011 (30,703)         (30,703)   (30,703)
Comprehensive income:                
Net income 73,781     73,794   73,794 (13)  
Ending Balance at Dec. 31, 2011 188,945 127 213,566 447,398   188,861 84 (472,230)
Ending Balance, Shares at Dec. 31, 2011   12,677,000            
Shares of Beneficial Interest:                
Issued (in shares)   22,000            
Issued 305   305     305    
Partial settlement of dividend equivalent rights (106)   (106)     (106)    
Restricted stock-based compensation expense 329   329     329    
Dividends ($2.495/share) in 2013, ($2.46/share) in 2012 and ($2.425/share) in 2011 (31,195)         (31,195)   (31,195)
Comprehensive income:                
Net income 19,467     19,477   19,477 (10)  
Ending Balance at Dec. 31, 2012 177,745 127 214,094 466,875   177,671 74 (503,425)
Ending Balance, Shares at Dec. 31, 2012   12,689,000            
Shares of Beneficial Interest:                
Issued (in shares)   170,000            
Issued 6,324 1 6,323     6,324    
Partial settlement of dividend equivalent rights (101)   (101)     (101)    
Restricted stock-based compensation expense 375   375     375    
Dividends ($2.495/share) in 2013, ($2.46/share) in 2012 and ($2.425/share) in 2011 (31,751)         (31,751)   (31,751)
Deconsolidation of LLC (74)           (74)  
Comprehensive income:                
Net income 13,169     13,169   13,169    
Unrealized loss on interest rate cap (57)       (57) (57)    
Subtotal-comprehensive income 13,112     13,169 (57) 13,112 0  
Ending Balance at Dec. 31, 2013 $ 165,630 $ 128 $ 220,691 $ 480,044 $ (57) $ 165,630 $ 0 $ (535,176)
Ending Balance, Shares at Dec. 31, 2013   12,859,000            
XML 82 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Dispositions
12 Months Ended
Dec. 31, 2013
Acquisitions and Dispositions
(3)   ACQUISITIONS AND DISPOSITIONS

 

2014:

 

Acquisitions:

 

In January, 2014, we purchased the following in a single transaction:

 

   

The Children’s Clinic at Springdale – a 9,800 square foot, single-tenant medical office building located in Springdale, Arkansas, and;

 

   

The Northwest Medical Center at Sugar Creek – a 16,700 square foot, multi-tenant medical office building located in Bentonville, Arkansas.

 

The aggregate purchase price for these MOBs was approximately $7.2 million. The net tangible and intangible property preliminary asset allocation of the total purchase price will be recorded during the first quarter of 2014, subject to a third-party fair market valuation.

 

Additionally, effective January 1, 2014, we purchased the minority ownership interests held by third-party members in two LLCs in which we previously held noncontrolling majority ownership interests (Palmdale Medical Properties and Sparks Medical Properties). As a result of these minority ownership purchases, we now own 100% of each of these LLCs and will begin accounting for each on a consolidated basis effective January 1, 2014. The aggregate cash payment made by us during the first quarter of 2014 in connection with the purchase of these minority ownership interests was approximately $170,000. Each of the property’s assets and liabilities will be recorded at their estimated fair values during the first quarter of 2014. We do not expect these transactions, or the expected related aggregate gain (to be recorded during the first quarter of 2014), to have a material impact on our future results of operations.

 

2013:

 

Acquisition:

 

In August, 2013, we purchased the Ward Eagle Office Village located in Farmington Hills, Michigan. This multi-tenant MOB, which was purchased for approximately $4.1 million, consists of approximately 16,300 rentable square feet.

 

In June, 2013, we purchased the 5004 Poole Road MOB, located in Denison, Texas, on the campus of Texoma Medical Center, a wholly-owned subsidiary of UHS. This single-tenant MOB, which was purchased for approximately $625,000, consists of approximately 4,400 rentable square feet and is located adjacent to our Texoma Medical Plaza MOB.

 

The aggregate purchase price of approximately $4.7 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identifiable intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at Ward Eagle Office Village at the time of acquisition which will be amortized over the average remaining lease term of approximately 9.8 years.

 

Land

   $ 316   

Buildings and improvements

     3,749   

Intangible assets

     610   

Other assets

     21   

Liabilities (real property and operating)

     (11
  

 

 

 

Net cash paid

   $ 4,685   
  

 

 

 

 

The Ward Eagle Office Village acquisition was valued utilizing the income capitalization approach. The calculated fair value, utilizing the income capitalization approach, is based upon the basis of capitalization of the net estimated earnings expectancy of the property, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair value of the property, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

New Construction:

 

The newly constructed Forney Medical Plaza II located in Forney, Texas was completed and opened in April, 2013. This multi-tenant medical office building, consisting of 30,000 rentable square feet, is owned by a limited partnership in which we hold a 95% non-controlling ownership interest. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

 

Divestitures:

 

There were no divestitures during 2013.

 

2012:

 

Acquisitions and New Construction:

 

In January and December, 2012, we purchased the:

 

   

PeaceHealth Medical Clinic (as part of a planned like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code) – a 99,000 square foot, single tenant medical office building located in Bellingham, Washington, which was acquired in January, 2012 for $30.4 million; the weighted average remaining lease term on the date of acquisition was approximately ten years, and;

 

   

Northwest Texas Professional Office Tower – a 72,000 square foot, multi-tenant medical office building located in Amarillo, Texas, which was acquired in December, 2012 for $9.6 million; the weighted average remaining lease term at the date of acquisition was 5.1 years.

 

The aggregate purchase price of $40.0 million for these MOBs was allocated to the assets and liabilities acquired consisting of tangible property and identified intangible assets, based on their respective fair values at acquisition, as detailed in the table below. Substantially all of the intangible assets include the value of the in-place leases at the time of acquisition which are being amortized over the then average remaining lease term of approximately 7.0 years (aggregate weighted average of 4.9 years at December 31, 2013).

 

Land

   $ 1,900   

Buildings and improvements

     32,090   

Intangible assets

     6,020   

Other assets

     799   

Liabilities (real property and operating)

     (144

Deposit paid in 2011

     (534

Debt (including fair value adjustment of $799)

     (23,240
  

 

 

 

Net cash paid

   $ 16,891   
  

 

 

 

 

The 2012 acquisitions were both valued utilizing the income capitalization approach as well as the sales comparison approach for valuing the land at the PeaceHealth Medical Clinic. The calculated fair values, utilizing the income capitalization approach, are based upon the basis of capitalization of the net estimated earnings expectancy of the properties, assuming continued use similar to the existing use of the acquired property’s continued cash flow analysis were also utilized in estimating the fair values of the properties, whereby cash flows from the various tenants are calculated based upon lease commencement and termination dates.

 

The following table summarizes significant unobservable quantitative inputs and assumptions used for the 2012 acquired properties categorized in Level 3 of the fair value hierarchy:

 

Assets(b.)

   Fair Value at
December 31, 2012
    

Valuation Technique

   Unobservable inputs    Range  

PeaceHealth Medical Clinic (a.)(c.)

   $ 30,400,000       Income Capitalization Approach    Capitalization Rate      7.50
         Discount Rate      8.50

Northwest Texas Professional Office Tower

   $ 9,600,000       Income Capitalization Approach    Capitalization Rate      8.60
         Discount Rate      9.50

 

(a.) The fair value of the land was estimated based upon the sales comparison approach.
(b.) Based upon preliminary appraisals.
(c.) Debt is recorded at its current estimated fair value based upon significant inputs including outstanding loan balance, term, stated interest rate and current market rate of the mortgage.

 

For these MOBs acquired during 2012, we recorded aggregate revenue of $2.7 million and net income of approximately $232,000 (excluding transaction expenses of $680,000) during 2012.

 

Divestiture:

 

In February, 2012, Canyon Healthcare Properties, a limited liability company (“LLC”) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the year ended December 31, 2012.

 

In October, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.2 million of cash proceeds to us, net of closing costs and minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $1.1 million, which is included in our consolidated statement of income for the year ended December 31, 2012.

 

Assuming the 2012 acquisitions and divestitures, as well as the 2011 acquisitions and divestitures as discussed below, occurred on January 1, 2011, our pro forma net revenues for the year ended December 31, 2011 would have been approximately $54.0 million, and our pro forma net income for the year ended December 31, 2011 would have been approximately $4.1 million, or $0.32 per diluted share, without giving effect to the gains and transaction costs recorded during 2011. Our 2011 reported (and pro forma) net income included a provision for asset impairment of $5.4 million, or $0.42 per diluted share, as discussed herein. Assuming the 2012 acquisitions and divestitures occurred on January 1, 2012, our pro forma net revenues and net income for the year ended December 31, 2012 would have been approximately $55.4 million and $11.6 million, or $.92 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.

 

2011:

 

Acquisitions:

 

In June, July and December, 2011, utilizing a qualified third-party intermediary in connection with planned like-kind exchange transactions pursuant to Section 1031 of the Internal Revenue Code, we purchased the:

 

   

Lake Pointe Medical Arts Building—a 50,974 square foot, multi-tenant, medical office building located in Rowlett, Texas, which was acquired in June, 2011, for $12.2 million; the weighted average remaining lease term at the date of acquisition was 6.5 years;

 

   

Forney Medical Plaza—a 50,946 square foot, multi-tenant medical office building located in Forney, Texas, which was acquired in July, 2011, for $15.0 million; the weighted average remaining lease term at the date of acquisition was 6.2 years;

 

   

Tuscan Professional Building—a 53,000 square foot, multi-tenant medical office building located in Irving, Texas, which was acquired in December, 2011, for $15.5 million, including the assumption of $7.0 million of third-party financing; the weighted average remaining lease term at the date of acquisition was 4.3 years, and;

 

   

Emory at Dunwoody Building—a 50,344 square foot single-tenant medical office building located in Atlanta, Georgia, which was acquired in December, 2011, for $5.1 million; the weighted average remaining lease term at the date of acquisition was 13.5 years.

 

The aggregate purchase price of $47.8 million for these MOBs was allocated to the assets acquired consisting of tangible property ($40.9 million) and identified intangible assets ($6.9 million), based on their respective fair values at acquisition, as detailed in the table below. Intangible assets include the value of the in-place leases at the time of acquisition.

 

Land

   $ 3,892   

Buildings and improvements

     36,940   

Intangible assets

     6,943   

Other assets

     31   
  

 

 

 

Total purchase price

     47,806   

Liabilities (real property and operating)

     (1,229

Debt

     (6,999
  

 

 

 

Net cash paid

   $ 39,578   
  

 

 

 

 

For these MOBs acquired during 2011, we recorded aggregate revenue of $1.8 million during 2011 and aggregate net income of approximately $474,000 (excluding transaction expenses).

 

In addition, on December 12, 2011, the Trust purchased the minority ownership interests held by third-party members in eleven LLCs in which we previously held noncontrolling majority ownership interests. As a result of these minority ownership purchases, the Trust and our subsidiaries now own 100% of each of these LLCs. The aggregate cash expenditure made by us in connection with the purchase of these membership interests in the various LLCs, including closing costs, was approximately $4.4 million. As a result of these transactions, current accounting standards required that the Trust record each property’s assets and liabilities at their fair values and record a non-cash gain or loss for the difference between the fair values and the equity method carrying value of each investment. The aggregate fair values of these MOBs was allocated to the assets acquired consisting of tangible property ($133.1 million) and identified intangible assets ($20.9 million). As a result of the purchase of these minority interests, we recorded aggregate revenue of $18.3 million during 2012 and $991,000 during 2011. There was no material impact on our net income, other than the gain, as a result of the consolidation of these LLCs subsequent to this transaction.

 

In the aggregate, the purchase of these membership interests resulted in a $28.6 million gain (net of related transaction costs totaling approximately $300,000) on the fair value recognition resulting from the purchase of minority interests in majority-owned LLCs which is included in our consolidated statements of income for the year ended December 31, 2011. The table below reflects each of the LLCs in which we purchased the minority ownership interests, the location and property owned by the LLC, our previous noncontrolling, majority ownership interest and the noncontrolling, minority ownership interests purchased by us.

 

Name of LLC:

 

Property owned by LLC:

  City    State    Trust’s
previous
ownership
%
    Minority
ownership
%
purchased
 

653 Town Center Investments

  Summerlin Hospital MOB I(1)   Las Vegas    NV      95     5

653 Town Center Phase II

  Summerlin Hospital MOB II(1)   Las Vegas    NV      98     2

Auburn Medical Properties II

  Auburn Medical Office Building II(1)   Auburn    WA      95     5

ApaMed Properties

  Apache Junction Medical Plaza   Apache J.    AZ      85     15

Banburry Medical Properties

  Summerlin Hospital MOB III(1)   Las Vegas    NV      95     5

BRB/E Building One

  BRB Medical Office Building   Kingwood    TX      95     5

Centennial Medical Properties

  Centennial Hills Medical Office Bldg. I(1)   Las Vegas    NV      95     5

DesMed

  Desert Springs Medical Plaza(1)   Las Vegas    NV      99     1

Gold Shadow Properties

  700 Shadow Lane & Goldring MOBs(1)   Las Vegas    NV      98     2

Spring Valley Medical Properties

  Spring Valley Medical Office Building   Las Vegas    NV      95     5

Spring Valley Medical Properties II

  Spring Valley Medical Office Building II   Las Vegas    NV      95     5

 

(1) Tenants of this medical office building include subsidiaries of UHS.

 

Divestitures:

 

On November 30, 2011 and December 16, 2011, eight LLCs in which we owned various noncontrolling, majority ownership interests, completed the divestitures of medical office buildings and related real property. As partial consideration for the transaction, the buyer assumed certain existing third-party mortgage debt related to the properties. For certain of the LLCs, the sale of the medical office buildings were part of a series of planned like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code. The divestiture by the eight LLCs generated approximately $33.8 million of aggregate cash proceeds (a portion of which were sent to qualified third-party intermediaries), net of closing costs and the minority members’ share of the proceeds. In the aggregate, these transactions also resulted in a $35.8 million gain (net of related transaction costs of approximately $500,000) on divestiture which is included in our consolidated statements of income for the year ended December 31, 2011. The following table represents each of the eight LLCs that was a selling party, the location and property owned by the LLC and our former noncontrolling, majority ownership interest:

 

Name of LLC:

  

Property owned by LLC:

   City    State    Trust’s
Former
Ownership
%
 

Cobre Properties

   Cobre Valley Medical Plaza    Globe    AZ      95

Deerval Properties

   Deer Valley Medical Office II    Phoenix    AZ      90

Deerval Properties II

   Deer Valley Medical Office III    Phoenix    AZ      95

Deerval Parking Company(a)

   Deer Valley Parking Garage    Phoenix    AZ      93

DSMB Properties

   Desert Samaritan Hospital MOBs    Mesa    AZ      76

Litchvan Investments

   Papago Medical Park    Phoenix    AZ      89

Paseo Medical Properties II

   Thunderbird Paseo Medical Plaza I & II    Glendale    AZ      75

Willetta Medical Properties(b)

   Edwards Medical Plaza    Phoenix    AZ      90

 

(a) Deerval Parking Company, LLC, which owned the real property of a parking garage located near Deer Valley Medical Office Buildings I & II, was 50% owned by each of Deerval Properties and Deerval Properties II.
(b) The membership interest of this entity was held by a master LLC in which the Trust held a 90% noncontrolling ownership interest.

 

Assuming these 2011 acquisitions and divestitures occurred on January 1, 2011, our 2011 pro forma net revenues would have been approximately $49.8 million and our pro forma net income would have been approximately $4.6 million, or $0.37 per diluted share, without giving effect to the gains and transaction costs recorded during 2011. Our 2011 reported (and pro forma) net income included a provision for asset impairment of $5.4 million, or $0.42 per diluted share, as discussed herein.

 

As of December 31, 2013, our net intangible assets total $20.8 million (net of $13.7 million accumulated amortization) and substantially all of the amount is related to acquired, in-place leases which have a weighted average remaining amortization period of 3.5 years.

XML 83 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Schedule of Equity Method Investments [Line Items]    
Net property, including CIP $ 119,547 [1] $ 106,150
Other assets 9,479 [1] 9,850
Total assets 129,026 [1] 116,000
Liabilities 5,336 [1] 5,368
Mortgage notes payable, non-recourse to us 80,112 [1] 77,511
Advances payable to us 22,911 [1] 12,658
Equity 20,667 [1] 20,463
Total liabilities and equity 129,026 [1] 116,000
Our share of equity and advances to LLCs $ 39,201 [1] $ 28,636
[1] As mentioned above, we began to account for Palmdale Medical Plaza on an unconsolidated basis pursuant to the equity method as of July 1, 2013. Prior to July 1, 2013, the financial results of this entity were accounted for on a consolidated basis.
XML 84 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2013
Entity
Property
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2008
Dec. 31, 2013
Minimum
Dec. 31, 2013
Maximum
Dec. 31, 2013
Hospitals
Property
Dec. 31, 2013
Hospitals
Acute Care
Property
Dec. 31, 2013
Hospitals
Behavioral Healthcare
Property
Dec. 31, 2013
Hospitals
Rehabilitation
Property
Dec. 31, 2013
Hospitals
Sub-acute
Property
Dec. 31, 2013
Medical office buildings
Property
Dec. 31, 2013
Medical office buildings
Majority-Owned Subsidiary, Unconsolidated
Property
Dec. 31, 2013
Preschool and childcare Centers
Property
Dec. 31, 2013
Buildings
Minimum
Dec. 31, 2013
Buildings
Maximum
Dec. 31, 2013
Capital Improvements
Minimum
Dec. 31, 2013
Capital Improvements
Maximum
Dec. 31, 2013
Limited Liability Companies
Property
Jan. 01, 2014
Limited Liability Companies
Subsequent Event
Dec. 31, 2013
Palmdale Medical Properties and Sparks Medical Properties
Jan. 01, 2014
Palmdale Medical Properties and Sparks Medical Properties
Subsequent Event
Property
Dec. 31, 2013
In Place Leases
Dec. 31, 2013
Gross
Dec. 31, 2013
Net
Significant Accounting Policies [Line Items]                                                    
Number of real estate investments   58           7 3 1 1 2 47 11 4                      
Number of states that real estate investments are located   16                                                
Intangible asset, useful life                                               3 years 6 months    
Amortization expense, intangible assets   $ 6,000,000 $ 7,800,000 $ 836,000                                            
Intangible assets, estimated aggregate amortization expenses for 2014   4,600,000                                                
Intangible assets, estimated aggregate amortization expenses for 2015   3,900,000                                                
Intangible assets, estimated aggregate amortization expenses for 2016   3,400,000                                                
Intangible assets, estimated aggregate amortization expenses for 2017   2,900,000                                                
Intangible assets, estimated aggregate amortization expenses for 2018   1,700,000                                                
Estimated original useful lives of property plant and equipment                               25 years 45 years 3 years 35 years              
Depreciation expense   12,500,000 12,200,000 6,300,000                                            
Asset impairment charge 5,354,000 0 0 5,354,000 4,600,000                                          
Non-controlling equity interest, ownership percentage           33.00% 95.00%                                      
Number of real estate investments                                       13     2      
Percentage of minority ownership interests by parent                                         100.00%   100.00%      
Effective date of acquisition                                       Jan. 01, 2014   Jan. 01, 2014        
Non-controlling equity interests in LLCs after acquisition   100.00%                                                
Number of limited liability companies, purchased through third party minority ownership interests   11                                                
Percentage of real estate investment taxable income that should be distributed to remain exempt from federal income taxes           90.00%                                        
Federal excise tax rate when amount of 85% of ordinary income plus 95% of any capital gain income exceeds cash distributions   4.00%                                                
Gross cost basis and net book value of properties for federal income tax purposes                                                 382,000,000 256,000,000
Net gain on fair value recognition resulting from the purchase of minority interests in majority-owned LLCs       $ 28,600,000                                            
XML 85 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 411 411 1 true 187 0 false 11 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.uhrit.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - Consolidated Balance Sheets Sheet http://www.uhrit.com/taxonomy/role/StatementOfFinancialPositionUnclassified-RealEstateOperations Consolidated Balance Sheets false false R3.htm 104 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.uhrit.com/taxonomy/role/StatementOfFinancialPositionUnclassified-RealEstateOperationsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 105 - Statement - Consolidated Statements of Income Sheet http://www.uhrit.com/taxonomy/role/StatementOfIncomeRealEstateInvestmentTrusts Consolidated Statements of Income false false R5.htm 106 - Statement - Consolidated Statements Changes in Equity Sheet http://www.uhrit.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Consolidated Statements Changes in Equity false false R6.htm 107 - Statement - Consolidated Statements Changes in Equity (Parenthetical) Sheet http://www.uhrit.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical Consolidated Statements Changes in Equity (Parenthetical) false false R7.htm 108 - Statement - Consolidated Statements of Cash Flows Sheet http://www.uhrit.com/taxonomy/role/StatementOfCashFlowsIndirectRealEstate Consolidated Statements of Cash Flows false false R8.htm 109 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Summary of Significant Accounting Policies false false R9.htm 110 - Disclosure - Relationship with UHS and Related Party Transactions Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Relationship with UHS and Related Party Transactions false false R10.htm 111 - Disclosure - Acquisitions and Dispositions Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock Acquisitions and Dispositions false false R11.htm 112 - Disclosure - Leases Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsLeasesOfLesseeDisclosureTextBlock Leases false false R12.htm 113 - Disclosure - Debt Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock Debt false false R13.htm 114 - Disclosure - Dividends and Equity Issuance Program Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Dividends and Equity Issuance Program false false R14.htm 115 - Disclosure - Incentive Plans Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlock Incentive Plans false false R15.htm 116 - Disclosure - Summarized Financial Information of Equity Affiliates Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsEquityMethodInvestmentsDisclosureTextBlock Summarized Financial Information of Equity Affiliates false false R16.htm 117 - Disclosure - SEGMENT REPORTING Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock SEGMENT REPORTING false false R17.htm 118 - Disclosure - Quarterly Results Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock Quarterly Results false false R18.htm 119 - Disclosure - Real Estate and Accumulated Depreciation Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsRealEstateAndAccumulatedDepreciationDisclosureTextBlock Real Estate and Accumulated Depreciation false false R19.htm 120 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlockPolicies Summary of Significant Accounting Policies (Policies) false false R20.htm 121 - Disclosure - Relationship with UHS and Related Party Transactions (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables Relationship with UHS and Related Party Transactions (Tables) false false R21.htm 122 - Disclosure - Acquisitions and Dispositions (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlockTables Acquisitions and Dispositions (Tables) false false R22.htm 123 - Disclosure - Summarized Financial Information of Equity Affiliates (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsEquityMethodInvestmentsDisclosureTextBlockTables Summarized Financial Information of Equity Affiliates (Tables) false false R23.htm 124 - Disclosure - Leases (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsLeasesOfLesseeDisclosureTextBlockTables Leases (Tables) false false R24.htm 125 - Disclosure - Debt (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlockTables Debt (Tables) false false R25.htm 126 - Disclosure - Incentive Plans (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlockTables Incentive Plans (Tables) false false R26.htm 127 - Disclosure - Quarterly Results (Tables) Sheet http://www.uhrit.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables Quarterly Results (Tables) false false R27.htm 128 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation Summary of Significant Accounting Policies - Additional Information (Detail) false false R28.htm 129 - Disclosure - Relationship with UHS and Related Party Transactions - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureRelationshipWithUHSAndRelatedPartyTransactionsAdditionalInformation Relationship with UHS and Related Party Transactions - Additional Information (Detail) false false R29.htm 130 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureExistingLeaseTermsAndRenewalOptionsForEachOfUHSHospitalFacilities Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Detail) false false R30.htm 131 - Disclosure - Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureExistingLeaseTermsAndRenewalOptionsForEachOfUHSHospitalFacilitiesParenthetical Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities (Parenthetical) (Detail) false false R31.htm 132 - Disclosure - Acquisitions and Dispositions - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAcquisitionsAndDispositionsAdditionalInformation Acquisitions and Dispositions - Additional Information (Detail) false false R32.htm 133 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAllocationOfPurchasePriceToAssetsAcquiredAndLiabilitiesAssumed Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail) false false R33.htm 134 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAllocationOfPurchasePriceToAssetsAcquiredAndLiabilitiesAssumedParenthetical Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) false false R34.htm 135 - Disclosure - Unobservable Quantitative Inputs and Assumption used to Acquired Properties Categorized in Level Three (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureUnobservableQuantitativeInputsAndAssumptionUsedToAcquiredPropertiesCategorizedInLevelThree Unobservable Quantitative Inputs and Assumption used to Acquired Properties Categorized in Level Three (Detail) false false R35.htm 136 - Disclosure - Purchased Minority Ownership Interests, Location and Previous Property Owner (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosurePurchasedMinorityOwnershipInterestsLocationAndPreviousPropertyOwner Purchased Minority Ownership Interests, Location and Previous Property Owner (Detail) false false R36.htm 137 - Disclosure - Eight Limited Liability Companies that Completed Divestitures of Property (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureEightLimitedLiabilityCompaniesThatCompletedDivestituresOfProperty Eight Limited Liability Companies that Completed Divestitures of Property (Detail) false false R37.htm 138 - Disclosure - Eight Limited Liability Companies that Completed Divestitures of Property (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureEightLimitedLiabilityCompaniesThatCompletedDivestituresOfPropertyParenthetical Eight Limited Liability Companies that Completed Divestitures of Property (Parenthetical) (Detail) false false R38.htm 139 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLeasesAdditionalInformation Leases - Additional Information (Detail) false false R39.htm 140 - Disclosure - Schedule of minimum future base rents from non-cancelable leases (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureScheduleOfMinimumFutureBaseRentsFromNoncancelableLeases Schedule of minimum future base rents from non-cancelable leases (Detail) false false R40.htm 141 - Disclosure - Debt - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureDebtAdditionalInformation Debt - Additional Information (Detail) false false R41.htm 142 - Disclosure - Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummaryOfRequiredComplianceRatiosInConnectionWithTermsOfCreditAgreement Summary of Required Compliance Ratios in Connection with Terms of Credit Agreement (Detail) false false R42.htm 143 - Disclosure - Summary Of Outstanding Mortgages (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummaryOfOutstandingMortgages Summary Of Outstanding Mortgages (Detail) false false R43.htm 144 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAggregateConsolidatedScheduledDebtRepayment Aggregate Consolidated Scheduled Debt Repayment (Detail) false false R44.htm 145 - Disclosure - Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureAggregateConsolidatedScheduledDebtRepaymentParenthetical Aggregate Consolidated Scheduled Debt Repayment (Parenthetical) (Detail) false false R45.htm 146 - Disclosure - Dividends and Equity Issuance Program - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureDividendsAndEquityIssuanceProgramAdditionalInformation Dividends and Equity Issuance Program - Additional Information (Detail) false false R46.htm 147 - Disclosure - Incentive Plans - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureIncentivePlansAdditionalInformation Incentive Plans - Additional Information (Detail) false false R47.htm 148 - Disclosure - Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalent Rights (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureOptionsBeforeAdjustmentToOptionPriceToGiveEffectToDilutiveEquivalentRights Options Before Adjustment to Option Price to Give Effect to Dilutive Equivalent Rights (Detail) false false R48.htm 149 - Disclosure - Options Outstanding and Exercisable Options (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureOptionsOutstandingAndExercisableOptions Options Outstanding and Exercisable Options (Detail) false false R49.htm 150 - Disclosure - Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureWeightedAverageRemainingContractualLifeAndWeightedAverageExercisePriceForOptionsOutstandingAndExercisable Weighted Average Remaining Contractual Life and Weighted Average Exercise Price for Options Outstanding and Exercisable (Detail) false false R50.htm 151 - Disclosure - Summarized Financial Information of Equity Affiliates - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSummarizedFinancialInformationOfEquityAffiliatesAdditionalInformation Summarized Financial Information of Equity Affiliates - Additional Information (Detail) false false R51.htm 152 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesAccountedForUnderEquityMethod Limited Liability Companies Accounted for Under Equity Method (Detail) false false R52.htm 153 - Disclosure - Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesAccountedForUnderEquityMethodParenthetical Limited Liability Companies Accounted for Under Equity Method (Parenthetical) (Detail) false false R53.htm 154 - Disclosure - Limited Liability Companies where Minority Ownership Interests Purchased and Consolidated (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesWhereMinorityOwnershipInterestsPurchasedAndConsolidated Limited Liability Companies where Minority Ownership Interests Purchased and Consolidated (Detail) false false R54.htm 155 - Disclosure - Limited Liability Companies that Divested Medical Office Buildings (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesThatDivestedMedicalOfficeBuildings Limited Liability Companies that Divested Medical Office Buildings (Detail) false false R55.htm 156 - Disclosure - Limited Liability Companies that Divested Medical Office Buildings (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureLimitedLiabilityCompaniesThatDivestedMedicalOfficeBuildingsParenthetical Limited Liability Companies that Divested Medical Office Buildings (Parenthetical) (Detail) false false R56.htm 157 - Disclosure - Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureCombinedStatementOfIncomeForLimitedLiabilitiesAccountedForUnderEquityMethod Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Detail) false false R57.htm 158 - Disclosure - Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureCombinedStatementOfIncomeForLimitedLiabilitiesAccountedForUnderEquityMethodParenthetical Combined Statement of Income for Limited Liabilities Accounted for under Equity Method (Parenthetical) (Detail) false false R58.htm 159 - Disclosure - Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureCombinedBalanceSheetsOfLimitedLiabilitiesAccountedForUnderEquityMethod Combined Balance Sheets of Limited Liabilities Accounted for under Equity Method (Detail) false false R59.htm 160 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) Notes http://www.uhrit.com/taxonomy/role/DisclosureAggregatePrincipalAmountsDueOnMortgageNotesPayableByUnconsolidatedLLCsAccountedUnderEquityMethod Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Detail) false false R60.htm 161 - Disclosure - Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) Notes http://www.uhrit.com/taxonomy/role/DisclosureAggregatePrincipalAmountsDueOnMortgageNotesPayableByUnconsolidatedLLCsAccountedUnderEquityMethodParenthetical Aggregate Principal Amounts Due on Mortgage Notes Payable by Unconsolidated LLCs, Accounted Under Equity Method (Parenthetical) (Detail) false false R61.htm 162 - Disclosure - Segment Reporting - Additional Information (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureSegmentReportingAdditionalInformation Segment Reporting - Additional Information (Detail) false false R62.htm 163 - Disclosure - Quarterly Results (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureQuarterlyResults Quarterly Results (Detail) false false R63.htm 164 - Disclosure - Quarterly Results (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureQuarterlyResultsParenthetical Quarterly Results (Parenthetical) (Detail) false false R64.htm 165 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureScheduleIIIRealEstateAndAccumulatedDepreciation Schedule III Real Estate and Accumulated Depreciation (Detail) false false R65.htm 166 - Disclosure - Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureScheduleIIIRealEstateAndAccumulatedDepreciationParenthetical Schedule III Real Estate and Accumulated Depreciation (Parenthetical) (Detail) false false R66.htm 167 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureReconciliationOfRealEstatePropertiesAndAccumulatedDepreciation Reconciliation of Real Estate Properties and Accumulated Depreciation (Detail) false false R67.htm 168 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Parenthetical) (Detail) Sheet http://www.uhrit.com/taxonomy/role/DisclosureReconciliationOfRealEstatePropertiesAndAccumulatedDepreciationParenthetical Reconciliation of Real Estate Properties and Accumulated Depreciation (Parenthetical) (Detail) false false All Reports Book All Reports Element us-gaap_AssetImpairmentCharges had a mix of decimals attribute values: -5 -3. Element us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual had a mix of decimals attribute values: -5 1. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets had a mix of decimals attribute values: -5 -3 0. Element us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles had a mix of decimals attribute values: -5 -3. Element us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal had a mix of decimals attribute values: -5 -3. Element us-gaap_PaymentsToAcquireBusinessesGross had a mix of decimals attribute values: -5 0. Element us-gaap_StockIssuedDuringPeriodSharesNewIssues had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '104 - Statement - Consolidated Balance Sheets (Parenthetical)' had a mix of different decimal attribute values. 'Shares' elements on report '106 - Statement - Consolidated Statements Changes in Equity' had a mix of different decimal attribute values. 'Monetary' elements on report '133 - Disclosure - Allocation of Purchase Price to Assets Acquired and Liabilities Assumed (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '141 - Disclosure - Debt - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '146 - Disclosure - Dividends and Equity Issuance Program - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '168 - Disclosure - Reconciliation of Real Estate Properties and Accumulated Depreciation (Parenthetical) (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 104 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 105 - Statement - Consolidated Statements of Income Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2013' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2013' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2012' Process Flow-Through: Removing column '3 Months Ended Mar. 31, 2012' Process Flow-Through: Removing column '3 Months Ended Dec. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' Process Flow-Through: 107 - Statement - Consolidated Statements Changes in Equity (Parenthetical) Process Flow-Through: 108 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' uht-20131231.xml uht-20131231.xsd uht-20131231_cal.xml uht-20131231_def.xml uht-20131231_lab.xml uht-20131231_pre.xml true true ZIP 86 0001193125-14-087617-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-14-087617-xbrl.zip M4$L#!!0````(`.^GO`L``00E#@``!#D!``#L75MOV\B2?E]@_X/6#XM= M8-ON^\68S`&O`V.3V'!RSIG=%X&1Z)@[LN1#4HE]?OU64Q>+E&11%])2,H,` M8TM-NNOKJNJZ=?4O?WEZ&'2^Q6F6C(;OSL@Y/NO$P]ZHGPR_OCL;9RC*>DER MULGR:-B/!J-A_.[L.<[._O+KO_[++_^&4.?VMN./AL-X,(B?.[_WXD&<1GG< MN1K:)WHQ?-D;/\3#_+\Z7Z(L[G=&P\[O[NW[#CTGG7EQ\__[]/.Y_ MC5(T&@Z287S>&SU<=!":_8V_3:9WV>G(]B\[WYXO M4/;OG4^C80:C'QZCX7/'&0PZM_:IK',;9W'Z+>Z?3U_Z]"4==`#48?;N;($^ M^_'Y*/UZ`7^"7213>,XF(R_MMX-7Q@,J?UC\YN/M!Z7QWUDQFAAC+HIO9T.3 M;,0I4:]-9C)B_NXL6?5F&$HN?O_P_E/O/GZ(4)4"8)6O4?0X?_(NRKX4STV_ MN+"H(DP0([-'^O'+'RIFE,6]\Z^C;Q?PQ8KAX_N\-*_Q?9KD!:O8L80NC,Q0 M_OP89RLG4WRSXO5V!OV\/*$IW>)B\F5I:+)RJ)P,369#L_PQ74VD_<9.@Y2G MT0.&SM/GU<],OUPQ^]XX34%NUSTW_=8^2,L/QD^]^]4/V6]6_*5D^"W.\M6/ M3+Y;\=!P_+":`?MY>F%7Y`)&Q&G2FS\`DK?YF=$059X;Y^E:3C<7\.T9R&BG M4TCIX#(K>/DVONL4(G-IW_KN+$L>'@>6L8O/HK27C@9Q/>$LGKA/XSO0G?_B[N65>STX4=%J!3L26E)B#CKC(?) MY`W9/^Y`)OIQ+WF(!B!M5Q_#LT[2?W>6]+L<-[RO&-$]*NU2U=?/:K,1CC7RXVD5$FUAUGL&=D&>CF+\FP4/VW<6_T M=9C\,^Y?]6'O2>Z2Z,L@=K(LSC.G]X]QDL9]9]A_#Q\G@R1/X@R^`T;J3X8< M&*:I?NW^]9._B!82>X!%SGYEF&-$79M*$:2*WPL+3RC'* M"9&4KL4".\A1U"#I&A-@)AW,U&&Q.)"Z(5@NDJXXIY1LJ6X89YP[(4;:$!=Q MJA1R?((&-XB>G;C;!5%_=U`<+U`VAM&5U4FB MZK"5)WSFA]I#KA=XB`<@4RY3`<(.X5++T*6^7F0K+D^0K5Z'J3Y;U0?+LI7` M+;$5>!67`3R`PP$0[Y&,-L0#-;5(#=MJ9*EY9> M:(7YMHHW"&&K-0Q)XC*[Z!S("R4BQ*.$>H'6S'3);-%!@RVL>&7V1R88F]#9 M0M_6Q@BT""<_BG5'\!2_PKK3G`ENMK)H&`:YD9(@3_L^B`X&LSC$@)NF//`" M0I34BQ8-WMNBV5>>2CNT%I(;NJ4\&:U"Z@&O.%P1L&/!@',E<9#0(L2!ZW*/ MA'-YXOR4Q.EU<&HKU/H(`5=(*MH1IOO\\N/XX4N<7M]]3B,;1O6CYRTQPMH& M#;K+)'LDX!X'6\T8"0I$:0U[K*5;&?@4I`2'K%O0>R.Q#]2NGDV9(S[=1VGL MVN"LC6[&PZQ`PTG3:/@UMM+B/K\,N8F>[4?.]RCM7S_:@=GU."^BP_#RO\I:X<\$K`BX<- MS5",N!^$R`UY#.F+Y>WT>N.'\0!^ZOOQ8PH$ M31(%!^3,D@7`EN,4F&NF70\QAPB[DQFD.6'(A:U,4R%H2,E\)U-@+;,24AM) MJ3!3/NK]<3\:]&&SFVR$5\/>8&R!NAFE!\7GT<32T4*2CP0"& M7`$HL/+;FLC[P$-`C5'P0Y`C'0,.:0C(T%P26B\!**IQ1:TIR M4;#3(C\=A.PRE%Z4W8/RM_^SK_P6#8`),R?WHC1]AJ?^%@W&!U5QFY`*E$>$ M923.P9M@AL(FX/K($',1LC%UCM?(T"I"CD>`N@H;*?"3PF#E MU@DG[RY.NDO(5)R,:ER4C@)4@C6N877N`2KKRBFFE#"*S4^"*V.F6=VONA/' M>*+[8?-L'MC"`EJP,O;&"/Z]:F'M`0\H?(L.M0%;\*^6#:U%0HZ2@FAQ7UD7&(AT)/L3!DKO!G MU2B%R0%^YL3,;2K.NH!)<\#/LK,W`UAL&&'5ZJ/ED5-9!FOY,=9D\F@M1"^Z MZB6OX65$7)&08\BYJH`<>9@Y)#016[HXD"&CJ$!GUAO MW";.,-$O'+,5+:>045@&L+&,0A%X8W]F%%;#?L",P@SHT\XHO,J9A\@H%.&H M(J.@93D/>@H9A7W@J>5GL7E&@=C=4VO#1>,.[`OR+W4)LYW5R;U1@S`MVQB8 M"\.8!\8VL\(6"@^YOI;(`V@8B)IO@H5*P&G-UBHN6D=+\]F4O;BD3C;%EMP7 MV13P/'DYG/O6^91]:*^53YDI$#"\N-&GE4\A[>93V#R?8I6)_D$C8550&\ZG ML%D^Q6)*"1-2_B2X-IM/8?-\RG3GTY(T#^R>^91EC)K*I["92TA8D4]1:MG, M/+)\RB9P#L]`DWQ*P3\_:CYE"=1F\RELED^QH'*N6&7+_5%Q;3J?PF;Y%(NK M#0-1UF#ET'&'[,E;Y5-$H3'^S*=LM3AMY5-DL>$=63ZE"$9GB7V;=26O[V;1 MZ(;I<.KU;,U"_7)P="-?1G$C$F`@1#^!/N4)CI(SG"/`D ML4OT\3#RN,N4 MXM3E8?@28*@9?*]2U,9AP2:(\_G/N)< M$*2%\9$,/4\(!>J>FA>N*I>"M<]57M&#)%_XXCJ_WS6;L!:W^FQ6'STP%E63 MAU37('/D`MX&\L7YX&JPN6D)/^3[K8.PM+KO1\.OG^/TP698]UL$38PR=0YI M+SM,W%%2">$B3X,ER*D(D&,41H$A1ON>RXD@D]HG>?:K-)7.+*UBU-SR+'QR M`@LABB8,S2W$PB?-0>Z.DX'U!4X!\**PK'I^I!$PCK20[$"(.S[8=)[KH4![ M#N+8H4B[6L-?E=HA5(?:-_,Z2P"<-09X*R5D[\';/0'NMND\;6ASZ@1@.(DZ MO9V07V'6U.9R>V*_T4K)315ZS1FQDY$'L.Q;$0%;HD6:MNL7(#D(_+^-1OWO MR6"PVIB*3\&D5("[$4H?`OI-F6#?-LJY`@-(@[F"!N'(Q(R(!)U[,=/(O8I+2* M>]HP;WLBWPH=@;D1S:-#\&FBPYAH@W?,%!U]4NA(#H-:0$><).]($"S5`CKJ M)-%1%+,6]`[F)XF.*=HN-(^.GJ)C3@D=,%4H8RWL6>04>4QZ.I^RY'*8#-Z=Y>DXWI5.:I9N&VCRU.,R-8<[]Y4X]E-743I=?I)ULZ MTB]*]T`JBI>WP)Y[:&G8[8ISSB^@U:-JL\(^\)YT&%VMEW3UTH;DC//[46IC M?D>VG]*S7\U2;_A7IK^6SM/D5$:JG%J#I,UL>JS+394M?*RL]NL$;&#L)BRH MPZPLKV4IKCU6=.C3YZ\R]H%.GU.;@]`*ZW5G1VN=/E_=S/W3^.$A*C@B3(;1 M$)X<7`W!H7@HWC!YID5(_%!(7P$&OC&6"[0+D$B)`L>71`JL'1D`%TC;+8?+ M\@Z^.X&5(M47-(N\H[4'TO@>3`*P7Z^&O=%#_'Z491_C_/KN<_34)CHU942# M]ENH5MV.GHHI&/?`9>CO4&W7`J%$%^?)B:Z<9WV9\Q$5V=UJ9L?P6[F`V>5)HQPX330 M$1)9G*,L'\"I04B9]CN8:]+NM:]Z-Z M'>SVA*V-X!VI2F5XN<=-==9K9198XA2L`4[ML1"&F5XGR"L)J=IZD[W&7D-X M&_?BY)N5C6S[XO0VU#`N(G&D8N6M(V`UH44SAID)O-LE\BU0RD%]:;&:TA44 M5,1S(L$@WG[R+>G'P_X1DLC4I']"Y;;'%7.OR.GV1[9:H,8ZFPJ+BB0N':M: M%?8YPK61]K`-9Y5(Y\K)UP_8':5*`3FC6C%:/SJWI%BJ.R@,")ZFD<_9B9?C M([SHSBBK1F`=6JK4SP":G9`%S33[\>KA,1U]BX^4R^WVJ>!;68&@)D'[1Q+; MWWWJ!1'IP2*P]2^O/D(8M-4-DLD:*%2#I,=J5HB5%N-*&Z*!OL\M4&ALORY> M)N^M6S[O0W;=EL]%UIYCPBM1EVU:/B^P\]40`'/ZWT"@X^SSR+F[`X\"7@(O MV+517@N+KU8)[)94O51[?XY!G\%,LSB%-P19+QU]S_SX<90EA?E]D\:/45+X M'4A;(VY_`_9":O&-M"X"6+>9Z M`-K`"I9D3P@W4WX`'CSJ3*V87/NI]^?$Y<@MO*T<#MFERT,;]HB]O]^.##*,V_1E_CCR-0\]/`[_'Q`GBA2@E"]N*%5:0>3T526W#!75%#T(O?S$]WI,(?^#>[(!I5A8!LWYT7O\C\O=:BQ.FU=ZD"*)F#Z MK6]UV-0&X#8N"D1NHG1WW]J"*Q5]LH>0V':GQJE/'2<4`?*9XX!7I00RGE(H M#,"9="4XFH+/@Z+X'$M:H[5!F:9&.LF_4#[IRTVU*+E"=3K)`WF&^@PCL,*! M]M`!-C+40UAH<":]P`^XF'>25^66H2=R/\$FF.K72-4'RX8%9=OW$Q2?S67/ M3[+>8)2-=SWN6L8+?A-**&LL*5/C=H?E2U*(KSWBA`H%W*7VP*`#J@M^%(0=$.F6&^&PC'W,:^"JR1,'HG&U$KZ@HB M&9*AY"",7"+-E8.,<7WNPV>V,<6LC3UEM,%FWB?9Q_XM5L*>?^:\L74XZC;V M;X&W;6-/)_VF?\(V]F^!N&UCCVES@!]K&_NWP-JF#IOLI=YL&_N]VZ:_!>0, MG(`&+X0YC;[I;P&\;18@M3E(R_H3ZYN^*]S+_ILHW#>/(#\4&'$<4N2X'+Q] M1EVB'%#Y8RMLJA:T`TU M*'JA_9"X3BN03LLL%O9P&9\CURP>=:IGY]&L?;LWOG1;)YBJK?J-0(X94UV4^+3#NO:J$E9V_:>74]G0?HYD?:[KRZ3,VA.J_.VJXN]`C=H^UJ]0CX M"J9VG\M)O(4.T,Z$J$M>&FM,6S7S:__LN: MUX,$V=T0/)[BY==WDTV@)6"IXMP3F")!L0%][RG8T8F/0BFU%["02M]]T0\5 M4`]/=0O]?G>1_#UL@R/K]]NTA=!DO]^FK;C]^OW.&'DI#[V][[=,Z"REO8E4 MA=U0";!\7"E"Q%V?(8^P[N0V]H7.KZ]-O>FFQBV+X[$U-6Z8 MI_=N:CQ7SQ:5[&KX]_ND=Q^`YY\_7\/BV`^/C;EM'T^YS-RO4-!8'^>F-1:O MY7>N+25>3`U_B/)Q6@1F;N/'R7Z=7=^!"3GL)8_V0,;_Q%$:CL;[6WQ;]':6 MC##?$XB'A`/QUNHC!2`\D%*24&MWG@_@S)!R2GE?6VD23I_[+O:>1][,,"=0Z\&+L-KZ8'\V2P M)=HF(),&*?G87[\1R>)5+%)U9A4U"PRZ/:W#_+Z,C"OCV.3/P-\<0L+%M^=O MA3^W29]WTZ8"TN`RD>8ZAP@_PBHY[2"X=YF&F$OF(@7G-8[2>)J&E*+-:NGPI$IYGG-:_:'?S>^>SS4P^9A-Y5".ZW MT:K4G=,85U^CX`,(@1\%3S6WI8:;2Z/@CPULVYKT+M<[MQF-(YH1E<5LF[QP M#%1>Q&T<\2B+=^XHKS-BZ+9&W0<@SX^ZKS6=:=11]R&N'4X?!#^U5&TTVJC[`)!Q MU+UB2I?]L*:C[FMZ*=/SN;:1"=6TC=/5BH.W2PS[,?P/*0\UZ<"9UDRQ5B[H M$;"+28WEPP53M0UR_OB<+>'+?ZW]:*F`]+#,<2-8!M?%ID1:G9(X,HQ$AK/4 MT"QSON=34I_MHTHJ<2G9T0CBH`LC0GCP#D)9<9H&"[PO(H1A<#7]U_-A_/N` MOGMO5H#$!";RQ%EFX@48'7*\[P']W<_YXX_Y.Z#B:\@;7S_7B^$^ MO(KWZ"7\`3PJ^-N"-;WT1<&*%*?=B-@,U\.Z8 M$&H/=\=82F5Y%F:SW3$-KDJ$"2S_,K+X$=)9K*\,<-R<%>)R:J<)PKYW[(0( M&!KNV*GM.][]7$W4)\9F0@<"TLXGWN'J^!)Z]W4]G^:-X'YEF+/MS>,>7Z_K MF4+D-4]KU*ZO9JH?18%FF.A5P/=_:]L%RT?`>MM9%2+",9=\X@L[JQH7`4S5 MU$G_C%&:?=(*7E?=]W,U28)\*H#QT@+?-O`N$S1)X!H;D!TK!027!S],.P7J M][@9Q4K'V#'5"98?3=I$%3F.6=%&M\SS'9`-O>(NQ/ECY4XIY3^]%7==8MZZ ME@Z[RLXLW<@[[D*$N7['76G71<@==R$\5;^D1["RK6JTXZXJ_U$DM7NL6.T] MET-?XBMB`'0^*V(HC2$_]I6Q,N/D+N]1;O'R,"`Z[^S5F)NB[#_[9$! M3AU+$YPQ\N6=BH-NCPSAG?BMGYYSMD2$T,?>QI^7EZ&,BVR-#A%\8B5KN M5(F":6^/#%"7QWLK:JRRXLV\O*&S<%U\6(G/,YU\V,HD7#_K-0/("4XY=_!7 MU1"3SC(P:#]>%R'PMK*S$%SMQZOM<.QG@\*/C*1[Z[M9NE+]]@F[L\P-^3[2 M1>:PZKQ)MNPRO'-COGQ:K7\?3B%9^7JZ>_S9MTMP@N[GFVG*DSEY$:T+I8>U MOR&\-5691*LRKY5>^C^P?66S>EP\X%TZN6,^VO[OU6+Y]"=\YW,?\U@:C/?/ M$BG@&`FS(L?G'DM`T'.2IS:)%6,LYT>E<-LJR)= M;"U6)E_1($/&;N=2D20Q_+S,"<\M)9)'BCC#.!&)M!&3PJ4RV697.;7UU6!% MZNQ"N3!6F*)I*.L M+!"T]6*Y6=P/RM>YJ#AF(YG+F+`\Y40JRTB<44%DAH0E.:4V.U1*&V,^K``Q9$9)W=B'K86Y<^`\:.E>%P\6_9ERFW)+?)?R M4;66Q4_/F)NJH+HAJHY7<+*9>D_9V>;_&`I3]$\U;D#:, M$O[X[/VI'[/%([["Y:LUV-1M@W@?!14O#S=-=)QD+*8$PF5&9"0-L=K`S>)) MZA)G,A'GQ\--U?F^M);@#DRA?W&WPN_-'U<_/R*Q`9!3(VR4IB`8"K?N:0;. M8)9*(FS".%415;'83T;B;SC;(J_XL,>KU708$*+/?"\#X8;!;;3`'\'?^ZQ_GF_D: MM&BVN0=Z-L64=K2XX!9_GRW\0_L$0W^_%]C:PV;Y)G`.)+3)WH]42E`O^8S[ M_J0Y+#_H"/#`U&Z*WM\7W\`=V?>B_T8W>;;LHY!T.Y+ONF^?B32R1J6$)Z@5 MA`7I4$:01&96TSSC4LM#9J18-/KB1^\F#UNF=@^A'QYGOC`1?]-W_.'`#[SU MQ,2W4#HE32=!>1EY#S=MTK,Z_(`*QUCW^W9>WGQQ16YY8.<_E@_SM:\5W`:A M>!";DQG@'S%ZW5V#XTEF<%K;[T,7IPAA!QAQ>7Z1%<\SFX%]TSF%F"BE,8XQ MS(A-:**S2,,WX6^GTI?$':S<*(R<>@S_`Q8&?L,&32Q.6Q_&Y6,=7#ZTC>[- MD'^["7C*HAC-_>X=+#-PK,03QO8Y.A;'/=^[=FG[J9O%-?I5&_L-7N:N\J/O;Q M!?^Q>OR!;3.KV1(;!Q9>1@*JL9K!*_:KG2JQ"Q_]W`U_OUJNBV$/.^GN;KAW MOPG_\EZ>8WS)U*D37O7!J^_B2?KED)6YFZV_S)^.\>]X\Q7/\2^8/\X?X]Z!4?C(,1)[_@G\Q[?HG5M#=[C%6D>SK M`#[,AK8#9X9*#2Q!A";W^]JX88HUV_Z$G3=<*.P>%6!*XI383$*\K,#&FE08 ME4@41K7ES';?US8.,T+*AIOLZC+#)K_5[SHS@%:K09B16V:,O%%FM'%*#\*, M+IBYU=L$_Y;#Z!G;VU[(D9C1BC7/&49OG1F(W@;1,XS?.#/.R(:>3EUF MQ&TS8ZFV:ABK7^4G6.P7[\^_AOZ,"3@IB<::&/E\I7;6([S_X`-3&/ M641R3H$BGG!BNVGUIUE`5L@7),6/R M_)7=)39)+2>Y3YE::D!1NYQDQH#8P&]W)CU*T(%]E+0"[N#7B^O0KB6C08U>36??#D*$AMH=UQ/VY>/.(+_72U4ZT`/3I\& M=O1V(_-I!]X+:Y@G(D"GY/0O0.R3VLE/:;KCZ[V5"I`.2JK$?WA2*S9#O%Y> M-01!@_*J/[F"U_)6W-=*JF5,R&%-L_ID]Z2>#P,9I+DRN+S6$6=Y3DR:YV/8$5478/7;S/VG#U5\2?3W^3W\\6Z%_^FH0/J?\\67K_@] MV^CFI,2Z-<75!4)M*';6.)9)3B*+]86)5B3**`0M&8ZQ:1D" M.MU?+W@W^H[2PR=ROKL96VGO,77>OC#+Z$PZ*4BFN2!2JHPX$RM"\RS)$\6E M,\==F&*7$&X&ZZ6VO9Y+\SOP4:N+;Y=#D&^N-_"]5+X_"5GM2K%F[(+AZ?FJ M:W_5_8C#-TK\VU_U$N\]7?6CJCDUV%7OI>6Z`Q.U+KDL7BS$&_7B);_8EGU# M36![/O'?9J"6,/[)[T682DO8+1Z/8YRK@8Z'[3KV_O]TVIV.Y<+1H2Z/7S'` MIW%Y"MN[^ZG#XT!1A="ZXQ>9U`;D',R5T_CDJJCY9:1C3KU0[/#V?7[&K:%Q M;I2!<%:K')L2(U4A*J`)BRSS,7%DY=,8D:<4S&!B#VWL8LUR]76IH$'I4_+ M.DX__4FWY>&_XS:J3?'6'#T\^$:TV2,8_D7[2I93P&4K;9(TNV4;X<>Z'[WR8]2#59V=;=E;. M\S,\Y5&4@[.6"EQ")8TB+C&&Y!DW-M;@U"EY%*&!9U.CI?`4T^F=CI\WN*0: M(I9O?RV67J?@;N(O2]0F;Q^PO^;S8G:TN`A[=OA-VQ_R=N'NZVS9 M-0]0?1`7]$O5:6AK\]Q82O*4,YSQ`0J&24)>)V:,8^/#]A)M3A^<9^#M$V'_/T*B&W@S/VZ?DI.*%. MS[?8:\U&-7J5B-NAV1Z>&>_P<%!/J,/;]G!S)4>U>I60V\'9GIX<[?3\R)Q0 MI^=GWVFF1]6;E8C;H1E9;UHAK!2A#L^/6E/*Z1$/KQIQ.S0CZ\WMJ)10A^>G MP4E-Q9B'5XFX'9I6D=[I]^V+*V9/Q[A4S_G")ULTPPO)+^U=O(:K5`ZV?8G``<'=Y+D2 M='T)K@\>C3]UXK2EL01C6$$^AMH:AIBT]$JMZ;59<>VEEQ?2J]3%K:%C26\9 M=/_2ZT-^Q3@?67@+I*U1B#9.3S#AU51=;2]HCUQ,5_660?E5M1Y.VTOO=JZMYGILU5L@;8W""R^? MK.H%M_Y:L71[Y+007LG-Y(2W!+I_X?7CJK4M9;Q&$-XMTM8HML++)RJ\QFIS M;7!I>[]!%\++W>3\AC+H_OT&GS0RDNJ1A;=`VAJ%:),L"B:\.`1I$.%EN^%[ M4LFI"6\9=/^:US\V@-R,+;P%TM8HIJUY+8`;1O/*G<^KIR>\)=#]:UY?'L*9 MMFQLZ=U";0UCTJK74D6M&41Z32&]FDXM678&NG_I]8_TTCHWKO#ND+9&,7'A MM<9<&[C37GC59#.]9Z#[%UZU+5*@?&35NX/:&L;4I=>*:_M)VDOOSNO52DU/ M>NVE<7@]2:_W>AVS(S^R[9"V1B':5-8$$UXK+!_&ZW5[X9V[U4))>0EW_\.NCA\/7TY#T`&"QO(5Q9&B2':ZUGX`_^LF&`,L:Z["A3K:T^K>!PN;"",T2 M0G.096D-@%4F!_TMLDRR)-;\,)?L8(='/=D`8%DQ0ZRQ=1K.U\;M=?*E39&M M?>W=,.Q6KO;0H'UMN'40;E"F!@LW]J.")TV!$N*DL*17"OPC="<,H46,JVDZ/+8T#N+C_-MLL<2Y MN]]P8\K_^CD3VTFEF)GIP($3N)9<,GINV)(DAN^4.0'7A1+)(T6<89R(1-J( M2>%2F>SCC@_B7_K=UJPU_.R7>YZ*Y!,0\W'^?3L]8_/'YP_KQ?)^\1V7#.+/ MYZOG#OFSCNU05CGM&$^)`)>-R$S%))*9(SJQEJLTM[FPAXP#L]Q59AP:@>W` MUWO@Z.[G_/''_!T0]K6+V(3B#3=-2V8N]T\W!MU1WNZ^KN<=4ES!B,,=P<9V M$S>/M>O]7/RX!;JD?T057>\G@.TJ7S_;+[T(1Y=?727=Y=[JNEB'Z'@-,AO` M5TJ#R\1>["\OOG(P^(>(;^=L1/?WS]^>_=SM=/Y]#9_.6\D.%*!+RXVJM1"X M8O%;YK@1$,Z:'$=]6IV2.#)^WB=+#CEI1,6[3=.=L/P88?>?OM^WKU8]XQE1*, M1PPGI;TD=]TIN$3NW]:KS29ZVOV:/V>/SUVL6RBZ++Y3JB"Y90,Z M-%W*#T-[_09T:!XU[DIDERS"S1G0H>D"`RJL>AT&=&BN\+5#N>9W](8,Z-`4 M\G9:;GH&U"HYJ+,AC#>@4HYO0(>ZL0$H!&-@O,?["HQ!`+KL5;INR!@$X$JT M%*U.QB"4>A-"\W93R&H2R!2J-X9[,T;7;SV8SA!\*XR]I*J?SVZ:W`> M,;DAU:7+>&NZ:W"Z+*IZQ?*ES!N783H9DAK>; M?U#7]7);)\.,4(.P,Q/9$K[\UWJVO.]2C1J,KZIA)VWA3L(U"T$:5BXSQ5ZW M;Q:"2/#-E.XA0)^`;Q:"+HM#X5[!PU,(K@2./#?-1>M&?+,0%/*6:FYR+T]` MEF@W*K>N(^M3LU9?LJ,WYW<,3E?56.Q;]SL&)TT=]XR^8K]C<"*U'_G!7T52 M*`1?X'@PH?^/O&MK;MM8TO_EO",[]\NIK50!(+#EJMARV04($0&((8)^B6!*%_M#37]^G$J]!>1Z=@\7;*M=P7(_.,60M M+5W_7`^A:ZW_:-]A*]#UD%*.H[+B`R^D43EV%O6`(["HM6H`V(1#V`A>$[M^/E4`\0LG9FKG\4JFG+.\;J8N4&+R@1(^E.\`$8CEZ0T9.H M!R!Q>%$R.XKA"Q]XX?2B+M\&.$@6]0`6AJ)$DPM3N#VF40\8LI:6KG\\:H0R MG98,B@T`O,K#'1B+>H`+>_PJX1H+B7K`T?7XJ:K!V6%QJ`>XL,>/5C9]#(A" M/6`%%&K+%[&-B4$]0(B!J*O$#YU!I0*'HU.PE&M@8W0<(SX^\)*XVNQRR]]K M"O6!(X[XB,J9E4%1J`^XD$)MY,FBG M`3MSY5`J;L&@';1B^<`+-]$3RYLON>JF%ZM#0]ZVC2&.3RFI>*<;.JCC3H8+ MX,<0??K`RW7D\I&707T`B=2IQ['#U0=X-.H@["3Q]P0?BI18L9T$%%GSZ`Q*$64BS;'`6' M=HV7>1VO89%HUV"Y3J+M':-CV]VGE2;=3M,2I`5PV4816?F`"R(K3B[OBNQU M8.4#QV)(8PR@:E19'-]X(5>!U.5 M>`W*[>@<++[-18[6\>@<0];.T/7/\;"BY;V>=9TTE\[EK`JK@<7M'N#"BN@5 M;@_I-X=ZP!$XU(RC'=<'6@9CT>&O)_(!%6^G6$-A3P\(LG8FKI?LV6GEF)FB M&-J#&RT[/+!=0X@97$/&$4QY@,N\"M>PN*!KK+C#:J1%/:-HG:W\%^RI4\6% M7)7[%8:5EO2!%\7^4F6:+Z3H;5[2!VH84]FQ)R9]`(E=IL(5X8?/I3[PP@&- MXK0.G$Q]@,7;*M=`0BL?&+*6EJYWL94EM-OK5!EW>U]OT5'4@>_A`RXLB9H6 M%VGWUO7P`1J61,<^W^(#1TSGVLJN\$$Y'C[@PB!>L"JXAN-W^,`*$[IN?^0X MW0X?$+)V5JY_7@>31'>Z#]&E/`P3506$815$?>#EMLU?GKWM-X-ZP%$YO;O\ M0N0^,*@'N(!!376/QX`8U`-6P*`*?FNT#.H!0M;.RO6/0;E4GWLUL, MB'9!H![@WI`D+4S M<57L>9LM3A8;V+ON0&2$ MC:@MP0=J.*+=(N\X+,?,`XXX+J6E:JY]?73-/."%XU*Z>AAT0,Z9![!P7$J9 M2Y/;/7;//&#(VAFZOB4W#&'$=)L(``,65:Q%1^20:-0+ MD,H--5[!(;D]C7K!"Z\P4%P.GD:]@(5W&%`QVDL,O&"(579=.4H[)!XUDG=Z MXP-WFYBU'L4U0%[@\\%(@7GUW](!HU`-82*-" MR=$F='U@Z(+12V\D[`>/&MTI6/!9.#=5V2$_^$U87B#$N$J)RR^%Z`4?=`^7 M>16N(=%!]U@A'4C=;1/S3=IR#97*6K(.H48S.>H$+"?3RG4.]YD\?,.+:2-*B<:V' M_.D#+MP:2?3@9V>]8.7B3C;66_2\0,A:&;G^T2>SBG6ZY\JZ6AZK[/@>U%RH M%[PHUHE-\[4F?1T+]0(:KHQLT9XP+*_#`X[*K=091Q>1#[Q!^>BVXXKZCP/4KE/9V">AP>\J+OELD6MLQO7HRM+ MYP%)5S3FXO)^K#[0J`>\S.MX#8A&/8#ENH@NOK"@ISM38H6O`!),XY*CJ*X,H'7.95N(9#"CZPPC''BRMZO>4$35FG MK,KDF&;??<`EW?:ZD6?U<[Q)NW/".%_*[4A\X.^/@4`]PN7O.+I\TZS>%>L!Q1*TR/N#"5ADA MJ_1N0`SJ`2O,M1G>/",^%`;U`"%K9^5Z1Z!"$-WITE=*BUM:QD&@/N`"`F5R MY#&H#QS=+2UCN"?4"UJ8EJR\2FDX].D#*MY.L0;"GCX09.U,7._84RIA.^V- MX46GZ3AV@/M`"Q>O->\!'Q1W^H`1N%.R4:R+\8&6P<7S59-[P^%.'U#Q=HHU M$.[T@2!K9>'Z1YU&DT[+Q]RX+0'C&''T@1;&G5?(-_:;.SW@B,O6K@%D'\C3 M`URX:ZVZ?7Y`[.D!*]Y2M89"GQX@9.VL7._XTW`CNAW+<)=?6G:#16L==)3Z M@(MBGMLT;X_O[8RC#]"*ZT9&OEK!!Y`8LDO2?,*VAVZ'#[@P9E M4K4&XG;X@)"U-'-G_(ZW^7RQS)]_O@'YET#'=W_.L^7J6_[]?;:\!W2G7[/H MY_OI$KYL")(@E#B0B";2_J6IXHH#9$0S`O\GE-HOL7]_66;[6+$CJ$C"(A;1 M,$@9D8%@,0L,,VF`TZ5I8L'UX_(SQQV(.+#WRSY.#82\$3J@0MJJ"]`)F4X2 MFJC`,@OHH%OOLV>ORV:'K9F2&U")J%,P?Q)Q ML"PATI7@09K*U$:3B$^4P:Y"IPD4MQKO5*%**/^B&PK\W51T%FDN4O#UI$@M M.,A"!%&4)`'C.A(,_LA$AEO1K6DN^>:H@)I\R>?.9?Z0W2^^SO._L]F;&1R9 M_"''K=CA:I7MS@HXW!MCC59ZM7IY@G]T/W)5S#37M88DY1%R*;$FBDDICR2DY059L65Y.BZ@KX/ MQCG92D@L%_=9-ENER\73),>208ZW%V`^:/-;H$)W#_%T]:WX?B-;81$>1AA\ M@?"`AIB_#`.7S;EN3)J_M&%4M+/!B0F-D@QT1*1I("1+`AM!V`DV/Y$A47&" M*K/V=4WY,MDVDN^"J0_H[:&!=C3X?ID]Y:LF51!>I+J(@"_(CL.YH>H5#C\. MBV*C0ZO#-%`J0@Q(B-DM&ZC(VH1P%1*NMQCLW5QQ^OGWY7N:YO/-S1:?LN53 M4]DH4?NR:2$8HT?/SP47(DQ)8"PJ/-,Z@$A/!%+11'%*50(NJ'M^8('WZ@_U M=O/\Y>>[TK/30F,W7D/Q[$91>JQ_DMHDT@D/>*S!>TH3&41)&`6&AI-8AQ,; M;@XK/CLE?_AX=/!S]A]]HU)EM9$3/DE-'$1Q`B8W`;6).$0_)`0'R:@T8A.S M#SM[2]GDS.-[L2CK]^-V$FTMBK;" M:$I40`T329Q0JM4.EF([S35-RO?"=-\]_+:8-BA`]P43ZF[?V+J2T91-.`@@#0CB@H0Q"R^*`2&-"H(=)(N1.R^4?]*VJJ>1E M-S.:KO+[!D(HN?8;KN!%3[2-8F%T`$Y'$@B1T""45$$0!Q\?$15Q;$V!O_>/ M7^4O1NS4]:005?4>^*%\,0-?:A"+:.)1D'Y/WX-M*YJPCPMR.NOMW&0=),73-T+YM4O^&0P]#]9_O4; M_&OX(UM.OV:;G.GZ9R](355B<"SSB9==5VB!AEB5[DYM*%,-0*I^-9S][TO1 M9M,W8'AQV\H94,[+Y2^S<-5#P\%4P.^P0*<4'&,FP;%,(AHD++6)GJ@X5=$V MM\"NEUL`@D=ZA]_YD<^R6?3S]U4&UF9[4UQX_YS_0PN#OPJ_/9%CSW@=/11WS>EJB0S!VR2ATDO#(X*=UK6TN:0P"1E"2`5_HAK87J7_>F^X]DT6`$! MK^8!V`$(8UG*@TB0!&)9JJB.K8F3!---]G.QE`@8E_%#'&H)=3H%AZR\/D9] M-(@<^]^))OQDCFWOX<_6/3X^9]_W2*50EDV5\,U\G:S+(/(`?Q2B1OP#_P5! M2"\/`VZ_,;+D8U]1Z*.4PD/^W"PA[_]@4/"_-=>&EG,"ZV<_DX(.9S.'T?1Q MA\_'ER^K?)9/ESUU%YAV"6CS>@+ZG&2'P.#K1[CNYA^GC]G=PT9G;L,.-8'0 M>!Z,/MS9LT5X`DX2&A M!H!@-C8FX_Y_#[;LTL3;/*\?WZ9/G:'Y''N7E*22ITD04+I)!!6&S`M:1(HL,"I MB6,EB%J7_$J7S'4E?=E7VYQ6]'+NGK]ERPX5[53Z3H0FE$G`Z80'0G(3&$MH M0"--)T:J*"9D[:.72Z(G'KW4DK&-;]%.;0T4>N]OYO'T>_X\?=PDQ;(9-HQE M\]5:'5?/R_P>@V;T>GX'N58?L@+,[&.V_)'?KW-,ZY)^LVFB&SAT2.;J,('B M&9YRTO'[UK_ZF-V#6S";9%^ND6"YOGN(\?+1S54G'[^-_5J;OML:KA,GLZ;E MPGZIJEK]U00_XU;UW'&@X#F`SWC&@ZKT& M=UDO3Q#%;'UI55\SJ4XK`&A4./N!PWJ`XL-#_IB#QO02`-P@1*6@)U7@I!CG M=,#QW38[MS;7?7W_`MX_)?2,`E2)=-IC09[JJ;P"V991==)=63]WF0Z=+>QE M5@R%L>)H,5WQP*6#N6V1_G"=:LG5A0%+)&B)S`^?NMI/^6TQ_XIEXM^0W.X> M8B#]O)?ZQ_&:,')T$=$92:IR=^MX#4[D8M5/@N5`L"/?BC@UM"X\O^J MB"(^8O48?_EM/L^?7I[<]VX1@-=-TL&+YK2TQZ^Q9!7`M.F1]2@ZD(K13)\6 MO4U#;,NVX"OXVC4+F9@E*+?O7Y;WW\"@8#IT-^50[#/PB\_T%,B##>AL804&!J&&&26%,+7D*BG! MG_-LMAG9?3N=`UNC_OF/XFLJ`=Y10DI]!J_)4.Y#Q#G\K:;T4D+,@X,948=O MN?SDM7I-MYF-?O>:"HI]^H*ILLM14Z927]W):F0?Y7:]4X?F[/3#'PIXL))P MC@'&\CG_V[^4-?79H#])#M_M*R*4#BQH`/P`_@>]L1_31R3'X8R@".:2K.J0 MYYM(57KWMVF1;.C9G&R5K&B0W'_W=P]8'P=WVBWC<;.H+TTFPOR]5C!8I>7N M9^6H'HZ,%X^/V7WQBP,I51I,J])2"%Q;I"K'S'DJ-PN&)#621Z$(+(D$R#Z) M@BA626`GG$>,:ZF$+'PPRKES04YZ84="E.@IB3_>?P-O[#%[\^;-6>=M_^LU M]_?1,<6,$"\5[R^7]'1-]Q8PU/7=W.V6Y-#:EYZ[V@X,IW3(W26>I8K265%* MAA_7U;QY^C[-E\Y;!\_G:T\]L?4WQ4(T5+V7MJQ?`AX^/B_OI9B3T*";IW`H?OT9C)*@H?"B= M4!T(;4Q@8QV!,H?P5X"3.95%&W`YKU9+%*_;*RY_ZREEE$<1"2+KM5I]JX9AJX2LUB:Q5U5"Z[[J!EN$5$QL54L6[I,Q!U4N^-V.M,Z>%6].Y\#N0CVW;!]<=L1G(Z"-,6$(N M\A8%5N=DV$G[*9M/\3OYTY>7Y:JX$65CN=?=3KY/6YSOLI[B9RUKSM6(;J]KDI)H*M&\JOSRO M]T??S?>X:'^C=Q]/LL![H:RU6_GK"/*:\=K@M\J6$/4DJ_OEXL_5IIL)@'R_ MA/`PGWWH[?P@A##B%.[$VZ+&IV@:.S#D3`MXA=1=(=<.Z@ M31\_9L_/CUFQ^G);`-V1\0=(XC+@I6S>49\^Z;!=C@6I]6B1/WQ\7 M/[,LRN;9`ZC=I^7+JD,R.7%WC(EIS'0:A)&:!`(U)"0Q"T0X25(11@2(@7L;Y0KI8\Q^'& M_Y^$%+,XAJK)4432=5JJ#9'TI:.V)GFZ#C2BU$7D>;X%UWG]Z[7]Z\AZKS1Q MM]G9N.F\[ZM[IO[QJV)T+Y!I)-*I6&9]RF^TL+AI,Z[=;2X^)<6>C:XQ??1* M&'C;J+8A*/(PNKVRZ'MI1F_>V`7M;7A=`-V%N]6.UWJ2"3"5:0S&@'+P8,(H"N#[4H/EM!S^$!@!%WEP M8LF>_WE&JGT6WYC6 MLRZWB2S]!'D'RIL]E509A?LE^7:K`,'&Y\2Q*U9VO^R?%)9&-K4(=`#%]C[] MZ9X!A.X7D"QY596*;21ZNGMZ>GJF;_^.@RC[';Z!L4&S36!KDVV:@J:4_;]D M+""[4>M6R91<&_[QBJ=COSA+XRU9\OBVXLBRK+8!L%7VN!5::D[Y"K*>BWY5 M4\T=T"_G;6VVH/]K!":"/\3O]6Y8^(LHJ0+>]%3WD?KL,`P=>[9*HBEA@TY5 M5!\-2==T>2-VK%7*GZX%:LN+^9:X&973"841/D]8$FZ0_C7^HEB;'["ER<@/ M4=.E1XRZEX6-^.&VQ38PT^$]50+Q4&V5MV$,7O8LT;0<^+2M,G[0SL;J1'.# MQ7153:+Q+=<<+EY%I/,0>W"L_Y,D,?*SKNE4L@8.%LIB4=E9'P@)F:72@Z!> M&E1;\F!YL6OJMVN@9&7!,=C>S8G&V`T;VE2,5/WL5WYU^>MIVBJ=Z4'L\'18 MQALV%36^7S;@C;!@F..]=B5=2U@P/OC2Q*(C8H-,:P(JB[DPC[1U.#&6G8NH M<5_!?GEDP(I195TUUN#26F0OX5\E(F*\^&I4Q]PKIQ1S,N]N$P+77ET-A)CN M5WQH+QI)77>)S8:6SGUG[@7=<3!$F+IV7).X=22DDU-%1Z!;`G[V.[P*A2. MPBCW>/L'.$V'Y\]M5;33EF4EZ2+L\=).29>_TZ#S9OJ7'4D#D?VS]]"ZB1QJ ML;G]S\RS59X['"_3_IF^%Y?3?A4U5OS8*>NH;=*8IFYP>]X;Z7DO07,F?V[N M!GUT>]'>).BT&1WLU#QW'=3:-=6>@6=K55@[Q-UV;QPZ@.V6M<%NT,^>IKWB-=VY^W;@RGD(D-#216VA^W\5O=6<%JHY\%O'R@V, M)FV)IE@DK\P2-";W"H-S_>2)9>,W+P>*K`A[H9P>RS#-JR7)"J-\!6TK6U84 MA9-JY7,!)R1-E4'M:;*V@!,K(L(<2Q1-2?%X1W=%7A$-AS=,1^`=Q99U79%L MQ?-PCZ1!08HR71EJ!6$'VKQT4[Z)L]K45FU8=QJO8NDT19?:O&F)#N\YNNQY MLJVV/8G=E!=WAR;M$-?:7TO3_7;6:4`47=6V#$74>%E6/5YQ1-QU+ M=6Q1L$6;B6+SK7;0A3$:W))D22I!`:8W]GM=!E&YX4,U;&L`\%*WDL.QG;?X8JBX9,QPPX:VVZWB\+ED" M<$!P>%N`):N8NB0JMBC9KE2JMFM1_J9=%NE)TQCN%'L3-K,YR<<.*!07-B:G MK;1Y15%%WE#--J]YCJ.JNFZ*DLFP!P/E6ODF7XI&>P7^2\O&6TGB1ZP7@OTT M_DJNXJT'/^D5;MXT2T:L]!WZ]3KW?G0UI"E7Z0U+QV@(_!`M!AY]:4F@E=HMCV9%WP@+,:6`"N*_&V;,B\JUNJ[(JJ M;LOY0J&]\EKFR@+\S\#)YYG@QN=OO83*]6=,P%.:J>Y_PN:<^.D7YEP_S[^: MVN726+YQK,]=B29'&.KT\7\S2O=91[8^=S3#\#P=K!*O+>&VZFF\+2HFKPF> M)LNZ:$BR7D9)3_=KWJ:R[)X8`N:4I&_#$%GP7$U3X``E6+"WBKK)6Y+5Y@57 M4CT!1A$LO4PIF>H!L!$_,!LOKQ=)6_C83_.ME*W+&I:I%6!;*C310A7T1UW0 M)6DVA=\UI-G^8G.7I!=TX;QR MU>\'7<(5W?[R',.UJ)K2*#0TFJZV<7S)5;^TP6P"!PA2RJ-JVIQQS<[]+>NZ!(+Y MUR8DX6`O"\G3])J^N-AB->^/>%503+4)G28*.-,W0]S;%["BAGK;(T-D66U$ MR9O(#UT0.-C$>O$#]\F/"/\`>23<]IBBJ+.]%S*M-SNG8D>B[GQ-;4'JB>JTL62/\E2?T#57)U MJ:-*+@5$N1L?"P)E?G6)7]G;V"S[I-Y4]2:4G([3[,!Z)%$4`.4?@S!,%ZNX M@V:*+@ER([:_@DRQ1K>C)%JB[8])V1NB9D@[4?9ZKNR/Q:C-.;$UM0>J[.N2 M!0+_6TBB'DS=@2K\NA2"PN_26Z#I,==^RF)R]5]'?I_^]Q%?IX]<`L7 M(RR,)O2<@=->[(+TIB.=Y,@QJ3A:-F@G*D[)S^WRD:BXG!-;4WN@*JXN60=_ M;J]+X-2Y_=I/_D)+Y3F'K-$,09-DN9%;6W'VUG:-@_L1Z3E#%$1A-WI. M/*[[R8(36U-[F'JN-EG4E(MO#]2.JTT>:#DGODW(]/7DL1DL!I!EJ#M9R!I; MR(9Y)`LYY\36U![H0JY+UJ$;++4)A*5\[0_]N\HY#&R6@[949$F5&O$NB)MZ M%XY*MZBJK299AZ_::A((JLWM84!M_1N5?1)M MZ(T'S1=,86B"+S1XP!KZW7O"_7L4,65;4SYZ),#B],C'FZ?!;;QY MMIA<5-.?(DG175=OBQ+O@6#PBB99O*WH,F\*INO)6MMSVMKW/$-:./OUZ\?. M_[V;P6:,),OF^4+NL#:P'V6?_<'F^K4)7&%M?OU\\;O[Y<;ZQ'UTK4^=C]P7 M_/&-N_CL7%VZ7.?+UYNUVNR3$]I:DQU&$JIR> MP'",?CONTE0*+TAAF7\C?N+!D^;$8TU68]UA`,(07H#3+-*=IV%SBW1-3#%1 M#Z!.8HJ(S*+'LB[QEBKB:?$.,ICP41Q$ML)O&;4!:V;&%Y$/?+X'_(\ MLHRM#U"D34,WY`EU,8G<-.Y_D##\3Q0_1#?$3V/8G6BAB\V+>39!`YP$/L=5 MW!<@-Z8AUX5CJ6]:I_PD1_T@8"PSB%DVP'T+9#.&XV1T-; MD'1/-7E3U'5><3V--VQ3@=\DT5(\058MF2G&?X79AU[PXU]WV0?`%?\:Y\`"L]RM[S MRL]G%:A]H*P`C+_S?7\0A$_O.\&`I-QG\L!]B0=^=,:EP=\$#_3X+KYXB[^\ M4=X"G$^N=>/>X,-WM\7'[Q!8^<=P8SIX;?A8CL60I`B(["&Z[W]ZM(1&QJ(\ MJ_*H`1998)0`EI`+&T1HAH9^F03\`N\)/.;3^:0OMXBL/07;/!5BL M"PX*&4D&*;R>/0WQX!`^<9C6B=_N)_&`D[DLYD25>P(5DK\Y&N*S?O"#<'Y9 MY>D<0.`C'K_(@>HA#P`\9FF>+>XKADIP&9Q4Z'B(-?[!$#KG'@@'KT44QB-@ M/0`.W`,JF/>(P#*@*^IQPU&2CL!LQO''KU.LX-5T=)L&OT]Y M3E,T@3FR#!4<\G_OOR$^`CXQ!05H9&SYD[]`+$)S6>S^CCS!' MF.NR7:$`4"*2\[,;P\B#A,>CBA_@[Q=)ZX^8/LHS,I5U[W'U.JT M8#SVXH1],>&&"=YT(!&/YQ-2"O)!)QL^A*GN9BA0>,3$#'@N#"*&&14K5`G] M.`SC!Q#^7-X`)'T]'J4`*7W[_F`F.&.5[L$62X$N8!!-I\6_AZA\\K\?@EYV M_\N9(?Q\!FQ)0-?0QSF6]M67MON%=ZX^?;*N;]SWQ2]GG!\&=]$O9WC-2Y*J M2&1)]8]>.8#ZE<,Z75&,#1)O&'OYRQGV>-,F"+*9B6XL.46?7%RFR- M<1L47MD\UV3QZ(7W6%2P=A+GW8JS=JYKYM&+\V$*KWX2WIT*KR2>J^+Q"^^Q MZ&+C),X[%6?1.#C%^0"%MW-/$N+WX0A]$N'='NVT<]5X`1JY.B;"?B_F M5T4K)V^M25Z$X1KO3J\?=IE$+[@`1RZ-PZ#'_22P()4Y@K&IN.]RO#E?;V2C M7(+^?M1-C-%?@_S^%:]=Z05JE*4G];-3]?-:$K1SX07LH<>I@&10"+UXA/?A M^]%`]0?<3`6]HY?]2_3*BW0DW<0#DOM#QUY7 ML$J?S.4;1.A6(KW"DT/&_JC"J=CB6*OT'-$/T\*5ROPW_FW\@Q0C`B30WH_H-J-^SSB[S^E$+R>BD_O*``0^ MZ<4P>!1G!8T<1N%6QN_Z87<4TBBZ&:SISA`,;D=)2BL5+W9%WQ=AQ86CCCF8 M,5@#'71(?$)H,X$>NDN'_A-HUK`R8C?&/M4YM"&+N0VH#R]W^`&4_/$3/$Q' M"3H'*85@/8<_R"))Q#L7*4)>IC)+N/>F-:-K% MW(JVK`V2-A'J?WD/I*D&Z3D&GVD7]!_VGQH#78V M%A1)X27!,'E%<%V%MP1%LQT/HVOLE:$UE]:7WRX^\_95IW-U^9ZC.B5_ MUKFZSA]TW/_O\!>?V^[GSGMNL9;QKCYW>,^ZO/CT[3VWZI#&/>05T5&>65%T MD)>\[#WE4>*S%B%AT&>26;Q1?I_D7*;"C(+8CY,BS(.+1QD(,8L>P+>SRI@+ M(:08E\$$DP++/Z=ZHP#L9UR;=`GV61@K=%D\YW"N`-`#F?!KK^N^7F,FFO)@ M+W!%`]?#T!^FY&Q='[CRYC[L)6[OII[_$X=>[VYG M@^-)O4-)[2//I)`7RRJW';GR0#MS'L!5`*(?H73/"\K81NN)Y9LT7#!O.,!= MC544,R_H-Q+N74Z).]8^E,3;DMBF^;K9D66YP$Z=M^;INE63\H'[XZ+=^0B; MC3',ZFPW4XQWQ^J>[LS+N/J,I_7ZHBOM2'*9^?.LPO@/YG[11&9*3>0]9>8K MC^G'3.Y+=ERS>_+*%^@4GV;X"&:X[!(U]=P9&\]3GWP"4WK,J#=!-/4YYF:D M;P]JKZGK,^`)TXSO+C@!GC]P\QK66@)VIA`_K6LM(2C"PA8 MG^"=7@"OCX9R#JMU-L.)@M%NC<[V+Z-'U1Y?EN0OI-,4O<#F+K2-< MS/4"(O:Q-RDM4YC:F\PYC#[M3P%2^HTUR]QKEMK9&$>VDPO"I6C@]Y<_.F^ MYPXV5BZ_7*:N^]F;Y3F243=6KM$!YWS]Q+\3_PZ&?X=^[T+#PD_6ZJX]`,+) M6MW]9#^S"T!M:7,*'9RF^`6N9ZEUA#/]THS4<:+%OJR$[4<\3#/KQ,$3!Q?I MAYFTHMF,A=VG($RF/+A^@D%$Z35`R0<,NMMG*92M,8(T5B11__[UIOU]2)+O M-*H^7=XLHZV;MJ,8.B]KLLLKBBOREBIJ//8@D&U!LV79P/K$6$BY)2ACILTE M8BJU`Y_?3G/32K#$),W'L9_&7[GVG_"1A8T.\G#=2K1N$::5QV65@5B5R*L. M20928[D>AJ%:N@IOB&U1YQ7=,'C3T6U>5BP`( MY/I%](.D&:T<#0?![E/S>3"R9]JNXFB\HNH"KR"#3$,4`8K3%@W)+*$QH&?_%6F*U*DZ*_W<8@I5@%& MJ0(*6,43"<`L)IIV&+"$SPJ[6MS-Z!87/9;D#?/,PGY.Q2RA6`\T2+,BBV\1 MFC`@@%B<.'7.4KP"&.R6EIY-,MS<.""-)4B6R6&O\L34/&7RC7]WEY`[G/B9 M]"Y`0V[E]8+?E@.\*DJ<(C/\J)P9>*\$E2-`M661O\FX\%II58(]!P"/BMAK MN67.?ZS,/.9>2RT30!5_(F*OQ99>/L#4,RQ*25FCTO\U^K].OXL%>LX9%4/2 MS8(?)'QJ<=9*=(UE8)22_@BS#G]03KW*$Y@GEGO79^FYP0!4Q(\BF;,L[L@ MHFFR4R#I0AH#3%AY79JY+*FPB^7UK?.D17A_%N@,R'D852$#%)F7<]`M[HH5 M9X[HY2R%3(LWGX-Q5F%E(414-$0XG5=D=LD4<>,UC6])T^\`E"5OY<*@M>0E M8U54"5?*P8K[UAE#>Z%ILB@EV*/EE?-BRU]H;GEN,J5>G%P5FF2:*[.^CT5J'YU*E!]*E#=1"S4 MJ4#UJ4#U\Q<1.DR9/16HWJWPG@I4GPI4OR1Q/A6H/A6H/E;A/16H/A6H?D'B M?"I0?2I0?>0B?"I0O>]0CE.!ZHW0/Q6H?LGJYU2@^ED5T#^O0/6R2+(:GJM) M9QB&I;"H%-80^R)WR[0)^]ELW%@U6(R79WQAHJL[HFH[O*PH!J_(IL3;NMWF M'5N4+^BVB8Q,["F0Q1=BRW MS8N:I/&*:WI(E,Q;DN$Z9MN0VY[01%G?N7IEJT`ERIE76(^L9`Z5QU.0TG20 MTJCL@RM$/F9GQ_(HU9$X"##." M]XH=GA99?U.M?OZVZOQ$T,S].5F*?&*8PN$^4ZP;!RI*L+_")M>("XVW&&`8 M"ZP;#H-T*)@N816[SV'C]S3B"SOEP>66GX[_;']["6"$K M\9[%13321#?R.,IC/ZCC/231'?:,IVL$%<[?-&IG:9S/B-;9IXN'+;RRNG@> M$9"0*C19TJNPID".YTPD2!%2J0(0..JQ"8)S-+[S/0\/?PKD!F?.-4AGW%: M%6!&%P@-,@7$P'?R`#Z`E/S%PR#D+",$0\"EX1"MKYZ.E$B+9@2;-<1:/SAJ&2^#ODJ MP4A1:&+)-9$56U4$9#!P`YRZEZ0BB0`#,R8X*(=!=@;5>Z%8"FA3F*.;]H83QVT4).(SW7A:L"GP-,U/LRDL^*"RR)FP4[H,'RG#/6 M"YM.N@F3KG=J1FJ]L.6TS_3JJH,5V6Z3Y12V7AHL^QV#B"6.X\`M6NH@F MGM,7+^?*P85WDE6T&JY"!5:?\2?AQ=)S1M MWS5MSQPZV9Z,\=CUI?1E6./K_"H[9@NM%^&N^GQA7SQ@]C=V]NQ M[\EYZZS=ZU6,BVZ]TFR=M"N]XXM6Y;S1[G:/>XWSYNEYGHY]B2;0?TS3=:NW MUWOF^S4^_#Q"&(8(QT,66Q8[TLNP"N*8X=[D#W@&3#O@9D1J.G7@>#J%>]!8 MF=E-WH(=F.X@F.+B>T!?X+D<=4_;_71'EKGNG';#HB.B9`EF;4I78;'.=5^< M=J#1A]%A)>WC^#'?P=\GW)('@GC*8$I(B"''RL]BS'@^B0=J)IYJ`(F8P)Y) MGQR$M]S#P<1@#.+6,`S:FV@CO(JKT[F3YR5NQH<7X&EO?VCB"U@WFP8HJE+3 M+??Y`K2'C@=:IC=`*L@#%#QOPLW#"#(#*.N.Z8C+%56XD8YA9?.(DA'P19*0 M>!!H)J;FLV_$$=\)S_^'=*J!E]SE:5YXJ(X3&>"8Y.SC\P]Q0HLT\%V8JY`D MZ)$.;I9/XOAHA-_CT(;@L^VA+G,'N"_A41#XQ`H!1`9X2A,?VSE4IET.3AW4 MIS:CX?WP\$WP$$B<$J=88L-:Z,!?\,GF"#321O,9H\*`:,::H2\&0NC\X@458,'3(2](5#POU&=%>8'!H5A(V M)`&(L6)&S#4]$?XMWL)'Z)B!.1,'EV*80A%1_&UQH"O/&9?!=G"*UC"\F4^@ M/HLT!NM'4LGLA$VD37W3DX8U?"2I`*)AG)0KD&W"V_^!B\>69)Y1LT!I'4EU M'ZFR"2F$81`FUM[`,(A3:LOQO`CS9LH9%J:G@NA2(E]'Y]ZHE('`5P'B,<1.XB*S2KAM2G#2IH&'?I)< MVY"+C(`'+K(:,`4@%'_+!&\ME)+)3(NTHT4/B^-P\-@:S[)DM@4!-5$"A.2F M&`7S(CP8$.;01*!*D].)+$Y`20]3T+V$N6&>5+W%*2,61B#39#S,.+@Q0S"/"S[\`417](7R9'%7H2K MM!+[2.S/`E>Z%33=8/S`&H-1!A@8-$'Y1``J:"P1L5K59H35 M@^&G8]M,0G[=@'#^8S7?N-.^[89#*+ M:D77#\Q+#!'O4Z$'0"&(_$1D&@D-#;N''RKH=]`!+^=/D1<"<:1PRP[3A"@* M&@R"&;C7N>:2]@P8QKHZP6@!Y?0XL(P197!E:-H!N8T1NW>$,L"(;6*%446RB=BUV-+0/I<.7`IS,0"'>> M%&S*TTLL$7]BPWL*Z01,W=75*5@W:5N3V6>KHXVX+;2+PC(G%F=)(RU2Q!#T M*Z5"E$B%*TU3J!&&O(&;^GG(!Y1D!Z.DSI.Q*TC77T)`Y%,2/"ER`XNQ5H(< M$_1O`Y&F+=,J@9F M4CV>1O7XQ-+426'9VL/SZJ/3Z75/*\V.T:@T MCSNGE>.ZT:T<=VO-;K-Q?-:[Z*W:H=M+PLY&&3K)DX/P]4:<[8.7#W>U)?BN M\Z32\;9UZOFN2;Q$_,H2M1O,>+YK68W[2IBS("A=Y MYS)5.%IX4'M5#<88B/%I)Q8;?*O<#"8.I;+38"A5`5^?.D-NR9W:,(X*MV]6 M3@NW'E)3JVK'2;C=9.)BF@2TNNQS^N" M"^,2DIF<*T(RAI_3-VW`1F#T,>GJSI:IX7936)@N.S`E/JHM,"1 M@.(U8=E!@6BH6;ANP"[IDDG<5K.C]SHMV99.5P%(%`6PIT7DA.]CT<6&81*S MP,4.PLW`Y%Z'[`FI6N_JW4Y-[/_A)3AJ!I4W%/HUV;LPY?7PT]@O3AW^JW?T M6CV<17S,'1["+-)B86LF(KG2L@PM$T#1@M8D:UV]TZ@E;;F(`9&:(IH;X%VV M2WD4LUJFI"1)`4KIG+B/YD8HS46TU MT6_(VY'OWC:Z-=VH-<,5?72$]9[6W[1S&,X4&I`BAJ_&]ZU@-/<2J/WWP.9R M2Z9%Z@U+,=PVP"T"6]H+=QZMP^39&8WSO1*_+/&K+XB?4=,;8+$**G^-7K76 M2LE?L];2C>8>Y*^YM?QI8ODKW=MBM):PI![N*(3\$6QQ;%ZAR@2T5T>7%N,% M7QSHT78[C)?**WSG@X`\ M,X@+`R]UHU$'MT]Q(YTS$SV&486)T'6YPPIN#N)INNW0!DIXI"SZ$4<*-(^_ MZ/>*\X!;;U=7IUZX]V=Q$@$_&H5/@AY3S$B@68],U_,7]G+KRA!D&0)CP1!T M]$:OL':@:51[M;0?JO7T;JNVG1V0L50L6PTE.['L7"8M`[0DKB43,8DC7OK0 M)&6Q4@5$*.S_3EN3L&Y[VQ`1.)8*J?TIX8^&]!BZXM-_M>Y0H$:UNP4+0XC>] M"%VW!,6%\-&;A:6P"`^2:T]:+R^M/<+3P//P#C[/O MF24JFZ"X+2%+G)U_74"6@!ESN3F,Y2W=+HJ#$66%%Z!? M!2]LD0":B!%$+E'B;#?A^4..UW4I&77!R5%V(XG5@1[E*M$Z:6$W&64@86I) MN4328-*8@+I$>VVB!);,MOB=V;#6F,?4)ZFKM1^52_B_J"HG+YH6#0B ML=4=[OG90_&%<&BT^RVMU/I=3\:=`(_'-K// MX=$DCEM\;R!Q#$^;P6,4+9'ROR86EY*KBX0P+Y@B`N<_0E1EO;\R(_YTGPGX MTS*V!_SI[AOPYW5VO17,4=8=X$5Y?@Q@Z&?MS\NSVX\?M(XQ\Y]CDQ91A%+[ M@PE,H4TNE2HL)DG%&!0H`;CDC.+)B=W6=73=.]32*V:/1+OB"PP*LV(K"]_+ M+-EX[M<1,(YBWHLS[S<,?19Y$7W\B@NN!?Z]^PA\K5PY#T_*C'W%V&8GXC:K MGK7')$^_8Q>UJJ_'3VWJ[ M6BL@IW>(B]78AZ,*`[IAGMW1WKCXW('L4L[CD_]FR:BFA$,)AQ(.)1Q;+_.2 M744'%RO6>@7^[1COKS6SR##`W&JM-6O"ZS6ZIWJNU6:=R2 MVFO)RUI7T4_13^VU[':OI:&"VWU7&6RHZ+;L$4^C5:UG[%HJ%I>(Q7*OI5=M M-HO':;771EK:OHI^BG]EJV M,7^)6ZX1IH5`3#AZLP3"]!BLM0J#][TK4U-Q<-EC(P(L4RPN-8O%KDRC5JT5 M\%"Y;.%O`Z*!H1.`@WNI^./I/>8S@%,45!1<91\V+BE59@3"C$HC$HXM!0<9 M8>M):%-9RL:T*_!B9>K8',$E[\-J36^;;;W>JU6U9$&)=#63I3Z.WFS22Z(/ MH]G5>^"IM!@M%-JPG95#3Z!]*BS*U6"K@2V!Z2)HT<=J!BEB)HDI8=$$.I.` M(Y,@D0CS&".YL;X3^!&1%R"&8VV@!B)6K,-=+#,.FRCD*!W*4X#8NNWM@=@Z MN8(D>Q)+7G8EE%]$H@1*6@)U*+''M/`+?!E/_#S61)IV/R+`KFF]Y?HF]YMX M, M3U:5WWH]S%ZA4HK79>1UM8"@9V6[=%D>S`=%/T6_0](O[_LNMWB[4$6KZFY" M"2(8E:Y?>A;G1)]+D-=;_""U3*@,BH**@H>FX"-Y_S\-S7O\^,M/@5<9,S;[ M<.I,9]SVZ";_L3T\G\XL9\[Y";?YR/2O+69[M_R[?V(Y@V^_0BO:+^&;YW\' MIC__Q/V),[PDJ(4IMWWOS/0&EN,%+H_>HP1[^/"5C_[U`W>LN^OS;JW1J,`? MHV'4*O^NU8SVW-:_1@^GAS7NA>ML_9)]PY?_!4G*^<:TFX?R>@;99\G M%PCAZXTXD]WBHV>7,[9D1M>[[I/RJ9(C,W[<*'C8KNT]3/7F/Y]@904>[TR[ MN/Q\_/GT\O@*>K_\?/'EZZ?CV\LOG[4O%]KY__SG\O:_VO'%Q>75Y?'M^N#9A]XB]8E?H1@VH%%Z'X60G-#,V$="0 MXX+*3:>F^`)^U/R)Z?J9<1=_U!X84B0U!J"'$[C:R+29/3#A<<^'[P6M_(GK!..) M]GM@)](K&[6P<$L5R3)S^;WI!)XUUX;"(/,A`1=I4^;!Z#2+,Z"#A"=ZF`"O MYA4@-]V0\H*^9PY-YLZ1O/_Y>*.YW*)Q`3'6S81_GYDN-<%'(S[PS?L0T?3W MP$H5F:&1XB4$73[@3YBOX>2)9WT^)M9(WJ$8(?/6]1W88(D3K(*W!;,4JD]" MC\&/H:=GP&Z4EU!GT9NAMG'7FYBS2(!),;G%[T.U9(_:`<%(<2LMI7@K^1,) M]'*CAFC4P'ZS)!IMP"TI='*0U#G*,'0$&@,O+.B65&F886`):S324(Z8!-J* M9#=C1'5=X6X]`A4U$THYEYA1+@?6>=)T\4P[GQ87:")+8$)Q68/B)2V@N@29 M%8:&D6=O^TN0:^Y-[NK[)W0=759LKGKF<%?)6KV=7B7[S*9<6%[0FI^NKM=% ML;O>]G\TTL_O!9,MFTS@X)/EMYN&Z1W/RRY#IT#\@:"[3E* M]-/$>?-CN4U4>__'=&=_?#H]>I.(6=^-J^]SH+]EW-P_>(KLCSDS#\\470C@ M7%_[`]8-L.0-5U^G9!FVVD?)OY;>!/W`[=/J,]94I:5[NG&EM'2'7`U%-]X> ML=@_3+N\+)N*,MMGV@7NN]T,@'`>[@DI%56.-/]<#447?Q[MQ0D]+9F2 MGKB![3V8@V^T3^\Y`Y/Y*N3=HZ9V#EWGL5R:^LD<:J<.\WSMH^/-3*S?\.G+ M2Z7'^W.W2H]W&QB;\-HGYL[3^IN*D[]0#@B,X$1F M@91,H6],[KHL4YN5%N]G>:NT>*=:+`085KG:L0V.R71*[8`Q?+YQ`JP'E]XO M5GY7:6PQN'H]<;AM?E\1/9_C^E>>^IR*3,=R'OK,F/O-RPZC&831(Q5**Y4N M"E?_,#V?Q;U+H8Z_N$4?G83EI7_A?XEG)HG?A7:L:;&DX?AO+IM[CKUL#@;* M'"AS4!2NWO+O\&6IX_!&US"T$VY9:NFLU+2@:OK9?ENJ/RI4M2BU%%2U?CE5XU6Y-U+\0%/-PG:ST6.EQ`;BZ M?)ET:V>[\:WP.EXM6W']HE9MS?SP`L;2;;VKR\_GE8_GE[]]!+WNXC?RCH91 MBZ_NK<:/R!?J07.GJ`=H=3:7F1WC$-QRF^&51KJZ;'KA-?6C-XL7U373'EC! MD..5]P<3EBCAY^B6-=Y>IKM=__EXDW&O=!OY*S6[^P=D]Y_RHK0`+9!7X06D M`?0=S/#CVW:UH4V!Q:9CT\5I<6T5RX$.>=\/;_/;8QVE1MQ\?=NJUJ&!\"T( MB;4^7HX=X>W7M7==)<`!]O-],&'V&&-IO#?+M$[KQ]4H#!*:P$3P`[Q[)2YL M.P]8:]3&N[?B)C07MW6?=BROI'BU%`_R+L7-:G-K*:Y7C6=(L1*7U>(R/*"X MG`4NFH[PUOY0^SM@+H*'D+<"SM5UX?PL$\0)&#V#GT,,"3HF#.$6P-2PL\GMN.3.=L!E\-QCX.L&]H)Q)"T0=KUAM$7B%P`X`Z0)YGEF<2BV+ MUVV!H7(\AQ+4=^ZY$I+50C(Z MH)"<1V`QOS,[B.,DXJ90\"9!&H$\#'#'M8UQW5+K(?92QLAIW`0/Y%A#"0]$ M+68VI"6&1<:2%CJ@/!AEIB&<3!@J(3MI&3K#UQ&3AJ348+4:9.Z@OY`:''LQ M*A,PWG(>]`W`HO18:M!MLI1:6`Y=PG;BLN6Z=+'P"BYO7`Z2Y8*L@X4-O&=* MQEI0H#2Z;GJ7QJ@G\'97;\0<&*/IBYW)B!#.2D##W;H!Z'+:4"T;)XJ90GRP M";<(Q"-ESZB3)>PP^!BB/1V]2<)Y41O`T.1R=;\B1(`%-&*9DHT6#.(&@]G`,"R::SL`DR9:PU_!YA!4$0M$` M=+E[A"1"9:._'7B8XF%4H=G,=;Z;4Q@=4#:YEEMR%V):OLMLC]$0J9&$N2:U M8^[0@Y<@>'%)(@C<34/5@_4`42B$^TIM$%"`XW&?-A5@?<#ZID50B!HT`#V; MKC9B\#\P1P$7#\DVF=BZ$)0=,T1"=,$6>%X(WPB&!MR$RQ&!L<_]!XRU\>O% M]H2S2F.'#9CKSG%N]%S$Y!B;LJI=BM8B)NL4[V6P+9MI@KYB^<%@/=&MMA.K M!#$?.S%6FO;8)E0^^3*Y2M>9IKJEC<6T1L:=1F91[BU&`)))'XOB'J-(0F/P ML#/E$5GGG+FP:L.W5UILHZH]:DE"^,9$Y^$J,L:SA"]9-*4%_+Z,L6,)V"@OV3Z@-'ET`+3;XFP0JS:6"$-&`N3_$B/7D: MG2?=9+20C49"3P-K^B8N8S-YAO(=/@$-])G%4!V\"4>5"SDJ(!LW0V%\KT#S MLL(V!9KW@J!YS<[^0/-H9OUHQH<]GD]3:++!J2W MQB'L,1>EW6IHMQB9B[LG,(!$O8'L4V"5<*(23O+&U1L(\#A>V4\@BLAC#7&" M&IV?:KO+)LN%QB9S/96Z[DU=NTI=#Z2N1=?7XQG[1"M)=6M"P?\4B:L@N(,) MQUHH8I=U/Q9XP&R;HSE?"!R@U56J: M?ZYN%>\67F>_GOQT'DT(=SAMA2"MU+0`7`7)7:67!==)VBNR;9-E7^-7GE2I M:#&XFA#DCZ9E>:7=YCWC'DQ-*>;^%+.G%'.'7)5EC&YF>*]E7]C0AU'%WS!/ M^V;"ALZ#\IKJO*6`7.W4:E*`M2MFKCNIJYI:W45:EKWK@J1#GN7LAT_#G<"%X#`B5T M.P,*-OIFR[UBA:FSF?%3F#HOA*GSLCXSF*,!HX7)6X9Z`N!!7`##[%^Z;T?"(N5D M44KH$AI=++/H#I'+X9GPBA!=A\/[BKA+AU>-S"&"3F`.B;P^`V\G+L>)^X/] M8,Y=O-D60)^@T*[/"(#'].0=I^@6)+P]=5Q_S,9<0$>$HY!P`+,H6J@BQD74 MEKSD19?]CL3-,P]!RL++7RNF"B1V.^68"14+$ MH.0$DX`%\-*-N+:8X'&M882CN$3.(/+/5[P8%7#MU!ER<3DRP1NM/YM(&W`9%B`\Z'GO:.:3,@;0IU@Z;O"701A"FQ MS)%)"6W)BZDD4$A!L@_O=\X:AY$[SD)0D2CBWC M^F!TQS-YTQ*,INNE!)7=Q3%_=>T\4]=4/O::*K;NCMY"#X MYM.)VJS>]^Y7IZUVO_9P&LPP>O.9G2KT7?03I2O3'TSN"4$I<5E6*>9^+O6H M-(U=>KT7:[6F&[=:I7VNYEI M*F':[T)0$H8DNLC_"+.L1`(IIC^E\CA%NN-,OCHF/Z!9SH`2X6S.$"UV@]@. M[VQ0:A;$>#I54FAA$0AY<`]MA,4@EAO+2Y5XO,WVBA_ MS7]P'L\UA%:2V8;:!>^[Z:)"#(!OW)@%'R_DLNGM4R6BVC=[B,%M)<1FB:5J>E?63N$"-) MD8OHN$H_U>%ML?238U%$;D4I0?&QT"E=3OUG*RU5B_WD8G]IW1LM][-7W:8- M"]4IDS43+5G=4-ZLC?<%'OAF5^BT(16Z/WHCB]+&-3;3B_)DM_+B9[3U@+WB M&.)UO^FFUONX"R`N5=+U1;%\E1L`7MS)T9M'NWFD$RR\"ZT\P#H72_!&)$G4 M7Q4E5Z-+UPNU5[,KO8:=KBY[F+'==;CM@0-+^`ENW-`>SR9W0C?9C3E:J&4J M9`GO\GJ/7>85&US((N*H@$J0UY;E7>PI=KFP+21UR(W%[U$!]W2$9$A*6JJ: M,&XEK2YV#B^'_4,0;SK#N"'X;DY#.7JSF4JKK:JL6%`VT&F7Y5)LX;O>:B=M M_U%1#C:KC-J>MD8NI&WY+\(?G*/%/%I1FYYF=JCM+"41+[5]B<'>N[X\^"S6 M[F59Z%^/#IX5_0]!?^/@]"^;N7MYO_8N#-X)<`N"W\"#<-_+%UNU_A@HX4"` M^O].3\_/+RY^R![`X78I)915B3JUF;#^$G>Y)[H$+BL;AT9%5SS>*X];';W7J!>/QWD_)?LR(_Q)VH;FWV?<]LKLBW)R2-;5.[5# MGV.7WE[EAM>]3E/Q^E7PNM[26[5&\9A=O&73&9[4#DQQ6@GK3CR@0>!C\Q_Z M2GFP/4MZ4Z\U#HT^I:S:2_'::!XZJT?Q^F5X;33T6OO0>(\E7&9=RF0#`G]7 MWFG/4MS6&ZT"AF&*UT_B=:U50(.E>/T4[]31VXT"AB)+ZZMDIS>7_W?^`4]D M5RRR%ABX$:-7#7&#=Q=]HSQ!IK2TY>/C#.'8UI?MM<.,QQ7]%/UR0[_B[;Q\ MYGZ8/]SG(\?E5#-(UM5)EL@J;Y1[V),P0^_5U(9RJ5EJ=1 MP"5JV2+9!CCVH1/T+?Y2H<33>\QG+*8HJ"BXVC[D+7K]$KAQ"4T["F5A(`O! M;"J4?3=X"9C2U^D(ZWKMX)@.*M;9,XL;;<7B4K.XH==:!5RQJ'`VOZ&$HJ"B MX*$I6+SMV52`6\"=V=VZA"@%/K!6+ MMXA]6WJW4<#UC0I^\QMX*`HJ"AZ:@JI2AJJ406\>>QI"QYD.(LFQOG//==HP M'YNVC,68AS@9W@@QG@[>B-0WF8NOS>= MP+/FFLL'2.XA[K\'"`Y(DD)0<7WFF5B88,!HM_YA`NR<5\)*&5H@ZF$L5C?` M#F,@15CZ!)9/N_OL",'Q%MNO:L<@!CA1!JWK$J`Q>W)';^3T!%BCZ_D+,Q?P M=RL)4T<:2M(L`24F:"*F>,]<_+R`F8A-1'"*FE-AK]?!D-X+^P&\!DWPEY3YR_9M9TR(`3Z>K>60*!39!(S`+7"Q@T(!%8 MT^"JC.3P]\!*%%Y!7$JCUJAJUZ!-6*('WEQ^@L!8TQ"L*P*=A1"8$(K+A]9?.`+ZT?59D@TB70AI&?&D)+4@U;2]`N!+3WS>V4* M;)R$$)>9I,'Q2*#-HQ48=?204KG5*I=Y4OQ"*K?Z<%LZ,B':*6A6/08##MU& MF-[)F1MY5W03=N2%V/`>Z_J`AC.$=)7%A[`DU@QUI4Q-< ME6.CJX+/K?`S#>!MO=J.'D")GH$"@->PYONL895>WZ;C4*.>6/&N#C7S"O,K M"RYEEEN*<74SH&S1%JXPH:OM0"A$=05[FV5M9`/=E?6,,O:$Y#MK7MG5]P?K MNFS0>\]'6FSO":)/HJO9V7X,ASZ35$S>@LFUMFZT"IAWD/P([#W$MIR\!VP2"4 M]=J[0-?K>J^(`JV8_:0M,+U="D";W$=HYY1RK*S7OJU736^W54+(JV%VLZW0 M91]_3AT4YGICMSSTR_NJ0ARK6O'FKBRJR$ONG=5!ZROPRNJ@57GCDAT3*@KN MVB/G?Z6:.GUVMJ"[#4/*YW]781C]^5M\ZO MKU$4W*VW5EAT24U?':>\#BRZ7,!*(2S206"EMG(+VP'E[!R:Y<"P.<>>P.U; MC6BC:VP\=D&2?,2I,X%+,[QM("^"#P..;)C*G**C-^FL(D)*2F/783"N2U@_ MM@WRCL0R7$Y2TD4[B.UC68"&.*,="0EN3L^>]2[]0*B:Q32$&<8"27.N\[*K37*(,X%WYM7 M>5DOFI=57KMRX-IL!;V/5C9SH@ZJBK'M^FPH],X3]EV;AX-"WWO76V'T9IF= M%;*^$@@Y.L5L=F;^G-+-^-..\.*X-270`K.CPDCI] MX6H_R7&?B&(.416?%23=`17WT68Y.,/\`(MKQ;,Y8SX_*#>*MS3^S65SCXI0 M7PL<:)-[V3D$*JS=T2JYU2Q@OGFQ>)R3+9%,2CSC7]EGNGD7G;POXT_

>I>EC#2EVDL*L\7U[RGM/0"3%?*GT99H MCQFD-:_-::\J^06LQ$]4AT%R\NB\Z):PK'X&CTH"2G[A(;K-M1"PHX#C@O/@ MC`0ZO`LN>!7.39=<3G#!S7!FRN1RHPL.B',3)E,C7'!)G(TP)QJV"PX,?;2Q MP%$AG1FL)GMJ"Q2RW`KY`##YSQ5,J!5Z-$GJ-4DR0VM++G*#<"45]=!!AI4B M*#%)"VC[7K/4[%[V9&+"PQYII5(Y*LVCTCPJS8-4FB7YZ8"U8A';-J[TCL)9 M73@[]*":1'Z.[#2.4UJH^@&C)0;KB>\'.933:('P.NNPJZ,^!5%E\'>83)+U M?J>87Y:".U9'B8>\"-9G?BTCQ2H.]YA?&.!XC%$HA2GUIZ.<@51/UO]A4:ZFP!ZD.2]06'^ MW]-HXF5]).-'Z,%@*U"NI:::P:D0G!LJUS`&FH?WDAR/)1'<_\@.A["@N,3$ M@>'3Z998;1B]@Q@'87B[B[P5T8TNT7UREXAJZPB&:P!GAOT@`GB7\ZR:$,V` MJ&F&=J"XM&$.,W$19LD*XNO7#=']Q9T!&`--P/N0FY)FBQM"O\BC[A'Y\@]&Z@(9FHAS41!Y.C?.,V,0!M15E^S_@P(.\ M6]DT7$?I&@^2JQ8@&C3`KTA3'Z1QZSR%M&GOZB@S?HPL`B@+Q06 M^>-UD&X%P\4C7%*30_:Z'H32?1OJ.AD;9A@A:0%"02N!J,<>:P;J/4ED*^4:]SGC`LI;W1E:% MLKJ$BCRV7&N/U?51I/&3L,U971)%'E%9\ZK5U4ZDT95S+:K6-3%4>I09J.!Z M/54N4AP%W'@-54UH<0R'>_1^=AT]EO][C]N?W,=-$/^R1_(7&\Q:(H.=1!"/ M!,Z.&?-T(NV*H4\J2JBLF2B*`"C?20N5$V5T!0[R`Z*?S!]G\27F11GQ>3$[ M%L;\29:\P'H0=N?RRH8Q'6J\\G,,C/<.&%HRFE1.48/+_6`V84426-W0HBV& MU3"-$D%3UA$IMB/T\A_G$7*)X4)F%'D\"9+!%CZ$((HUI$'I"5>8A-GB,+>N M71`]GD@F:_IB9R#M'V].N(+D9!-A&),7@/V&^.#C,1KS'6CFVQ:$Y'L_!LM5 M/:).-%1GV@5US,W1]7H3HAV$%S`B)SR)YSB-66GO4M-,?,L"DB>(MX$'V8?M M'F7O.?2SKQK/40+"ZN_4]G:/DG_"A/9S6D;!'UF#HP#Y-PCO_Y3Y3SB'Y3C&M)":YGW*A*723LH7G M4P8SP1A$RTQ$O=B50_;>GHR!9/_QE7"A(%KFSWAC,_=^]C)&M1I;KF-R<8I) M<56*;GPU-OR9+)'$TRA_(46$/,?V0Z;M-TA/$GD.MQ"3$4$^QL08&;( MN'7P:8F:[PN9_76]RGH_1`DU_^8M)VO<^OPP.'6L[U/Z8,T6>2C()$U6U&0' MM?,&[CXN4VL+@I"*(D35R"Y0ST2K;6?RBA[#]C53&'1>/^;Z3AV6/9NX?B72 M1!#3#Y?CI/N4`=1-D(>P,7 M#U._XJYE0FT;U6>/PL'B<\QT=2M:#;NY2+E*`<$3AO$(J:6)_/V2R(88>$D* M0GJ1/O5$U3:06'FG8]Y]*YT+D9\9J,`:,LU]O6XUTDQY*T.5>K)`X8P['T>] M9^HM^[KQB-)B)>LRI;,?C^4&(;Y M$!:I^`VRMB>LV,'J. M\\[J4F4&=$"&S]SJ["*S)!([RLTGTEG"GKJX[*Q.)E9D7OR<&N.U!7O`4IRR M8SZEKP<53-$#9#Y__"PT$'F%2A(,0P3N+2"D))0A65>J*DI3=HGC98ADT.,X MPXP7)'J+6?4]1F\4KYU,(E-Y=RU4P,Y(*[54N9)J^@`N$X<3_ M5[JOPH'R'S)%8(X^$V2O%POHD1^N@C"ER-=D0(?3-(>;1G<'7H-UNA9VQ#D> M8P1*D8'6$F;8L1>OE]KQ:K@-]U_6MC-3D M@5P3YW5%J=^VS#*W(X*_8JSI-7FFOH_CU#*0/".[NP7),WQ0#WYZ(<5,@.`& MV;CYS>?>WL7[F\=U$06&NKD]\L\YHG\RFQ/7$2@KOP-7;3072\0 M%L7?GS??8+1/=0^9KRE%51/BD4YB'J%F(Q)#B:KB9M/&*Z MV8K=ES+ILF6_3YHP+KIQ5T`]6T6[$GU<[50;78>8#-,O[?6;`:S.?>B7F%U\ M_#;F/[AR]"3CK&R,YC=+8LWJEM4I`_U0^NS&&ZOCZUVF,3,"QR.$:OO85>^]%3.GI*C?C^IE%"U((X\'HI--NXG^/4 M&_W,;]+//-:3TUA/;O3)V&L*MM,\/AJ#1\5/AS'87A^>]<24-;HYG#U@FL2G MDOD;=F(8S>*5](*8,/E(8',;+&B6B^B^WB#<9#L:C48V&HW>;GH",V(U6VX6 M!MAHTJ76@UKM'TY:]A?2WA*_(]F_T M-]6YDQDX;"-@$\`JUE*K8'.&T)+*@#%BR\+G/'O]LMF;CF:H\<4`<6` M>H;*X8)ML0F=BE[A@AVO$9VJ=F;[F;EC]`;J90]Q-\W#SHTB; M3E1[3IAPHSZEZS7(R'(31"#R`A!.HP7"ZXQTLT5>!'"R6`1A`!)"1M\/LY<( MXG@5;*9$VR7O>A)7D[O;8-1^,XVDF&/@9XVK=J*O4AUEXICO`\SB.=J_F07# MAO%G3#@#YZ0W3M-`R+*%#E%D:I]MLB#_J#R7#!HK+F"$_!AY$/KQ#9&MGP`U M.V5=JLB?B:*<[*@@FTSRAA6;W/3#_ARJRQ@)H2*/SC41P!-8/D3QE\@CZA`* M`Y^V/BN'$&@S%/X#$=WD*QF9XCIWT[>PV9@B]B,=-\:WR"]@)7YRL4_"R>;T M7VEMI6I,:Q`JS*?$2SE$&U2;*L(25#+NG!F:5YOO15%F.&S/B/@Z#]G#T8Z` MB?@PH>DT6X4:-3 M#0DSX?#DBI03SZ./'J2-RS,7<94L:AY.IH%R@LF(98*B.^@''@CW3PS9F9O* MUCA%@]WT`J=1_!)XWR=QC+S,Q\N%AS]6`R!7V[4G01/FL-$!6+_#$-9;^S6Z M^XXFV8$'Y44'3:94;Y0\F*SY]F#'.>Q2JI[Q2@$>_F`]H#RAE"H7,@Q"-%H' M,'O#`'U1_(L=QT7#@DMNHHX$4D`>N!OXY*$DB?-CPJ$5;Z2-_C^>K"((D^NT MI(TT&'V\"C[>#A?8G'J\#H`W`WV,%@(3C=0"4/J?X&14N\)8R5:C77!QJ.')/X(N."T4<>6] MZ"[X(M10%9BC7'`RJ"$K$K)=\"^H8=ML`#7N+=!_<\6BA/D0KAZ.-%]9*]&U M-VA%\?N*)3/5WBGV(\RUU)6HVAM(HH:JFG19XC\4"8MG%RXQ'8I\U6B!*U$V M)6>54:=P`=(P.49;:)FF6')-K\;]U>)XVK:(_?;)!M3XY[3!%-XLP5XJ_\C'#,DZ6,4[VJ/SR M$\<)I[B()7A6DV*^HB1O,+//B,ES0FJ%`[HMYG(\HJTQ8CRX!",=C!@C0F$+"UT4,'&:"H]_*+(&RQN,4-TOMCECPJ'2:BLT&>\V"3R M52,%VJ]EMB9$!5!!#R#><%M@%P9G"R8X#G^G4,XQNLJ=Z"I->*7/,?P]I2K- MEOR',%B>/=8"J.=D/U&H(F>T)9`++SI_O-/0_S;V:=;CG))]O=FYI_77QB9\ M18U`M*!KNR-+7CR0CR"P.)A-'LU&[[G%<5WR6';015P(]I(GA$IPFZ%8K]&# M9Y_3BF/"&;:G3FC),^Z>Z]UCJV1P,A_><:[:1*KV>A=2&K131NBQ,9[X,'JV M>W#S\NP(;\''S=>A5/W7II3>!C-0PY=V3.75@:PK"F^CG4F`;=N,)JN",+ZM MR(O,+[IYJ-!)-,'+2LDP'1$9&["&ODPQ0%A3Z3RO@HQ>9:!;^8",5A&KZ M$Z^(T*T&UVP'.%FN5\X@]^-R6O1GN8`+A&&7!BWU%097[6<,HG$]B,;M(D>< M8CFO-\$V;S4_1R]1)CSAQN*&"C-[`S)SS@E$=IE96JK[T/8$7T$8PKH@+@)/ M:E[?`+8#S[&B.M*'W`6CM`[43ZZ.<GT5#B M0I"&:ETEEAG&A1@,-3PE[#W&`S'TUWP[LL,,K\J.R$0QO!([4N+6\,KM2(K! MQNOLU,*HFHU2S$SEX89%R1&DE5'(YL`H!;0'4ZI`;.AT.'"C&3'I&`6+(S3D ML3QOM8$QY<*B%`0;T-46JBWE3#4?=#F(&E16A:O,5R"Y"C*D_+UX.5LL`@\6 M:G&L(3+EDCS;*/J5',5DY0$,98(-FJ;H"()`SW*P,,=I"12`>$OD>8"_$TJ? M]#&O@2$:K1$8&1L[?VP?@,B#H1&(>/TL`P%KV!C383ZFH\_&9!/?#W*./HV( M*K8&+,]\BQ7LP=!\8SEVK1OR4#W1DL/T'[\"[._R+1'FW]#F.0.-++D-$F^U M!9&,SYD_5DMAEA@B%0]NPX0Q@(4=1)&UZ7Y*D/>=:3_*S49S#*(8>`*.I;[. M&#)B:663FJ5MK-S20U^L;T$8PB11Z(S5-,,5WP1;2!Y>U(/@*1U>X$/3NCCV\T`>!76.((0\"B]+P(B`X%KSA!3\T6U"'%_D@H>T;CWIX MFPXTVSTL8XT@ZX-A-!%0W>9A37'GL5,U4^>/0++,"YX*]JIA^B[N=(<2CP6XTV(T&NYYL M4XU"HG'3W%BHUU)+B]6&!R*Z/),S[S_1+)O,R+B81F0"O$'XQ"C1U*15S?;P M-A1<2E&:Q13\`?W/!*Q;%,>SB)!_@V(0GN#0>AD-2C![SZ=TO0:8[GH31"#R M@B-KZQ7<8$C^EEWHR)^L$1&8_F`&E/>P@R&DBTSFZ]<-X3DLZX".5>TYO6*X M[V&2LPMZ(I6.L\JZAC[UC+PO@'8JV'\55A]6/>NZ\KD?:41#JI9.(;>B"0J4 M)^R&R`L+Z1[59A MQVV>'8*OAF@`+5Z0G)PS0IA:A)1@Y*@MC]KRJ"V/VO*H+;,9J7$M>!0F^,+$ M!0B)I@"?5A`F\6PQ^DZUN"/4?$KN.%(F<0P5D9-:T)"G+-^]R-]Z(#Q8@K[.I4U%#E"!CJT'[$77H*\.V&FN2Y49L--7I4^EHT.%:2.98#)BF:!Z'V5N[9?&*1I,-Q*7 MP/M.9#)$@QL%\/#':BF)\YQ,HY@H9_1LWH$DI:?LGQ"PJ^)P!^L`9;OV9$KS ML(89L1*'P3(@9YHRLQG^C%&ZN4'X!@3X*PC)!J0^:I#O3I( MV8==:HX)+$[.*.,@"[^+]/0!X_;;)RWMB)+7._3\L`(QG+\@?@C2()I\T:.;H+\V-RB:#F'>$U?6,[).AIB&L;]VT\^Y"/<@%W&D&:+@Q@X MC>Z)>#E_@>$6WJ$H6?'>P&YK6D\%*AK1VN$ZL#^LY0;6*.6]9^W6<@+K.=E= MV\?.%W,#[Q>D#6NRE):6;^':!R&45_N:9N@`RELIP,,?K`>4)Y126Z7,\RT: M;:/7>:Q).486G*GWVM,&X.^Q_+46C^\_U`$N0!H>9,R3(HNJ%HVJZ59><3(> M*2%7LO`LU"!ZH`7TT%U_DZL8NN#!4$-58,DU[K/0CFRS-7V`#0JDT>8V^' M&WO;&0_E*,[A1C#>@==@G:Z%DB$ M%*R.L!["3G=X#&$:0YC<#V$*(,9`(81).-X5IUD#UN:M,L-U'(EBT&IO7U6Y M/&+L-F$D<(7)(N1*)!CC<:UB=")AN>!`:<+H6+(U[_J0NTAOS@5KHV?:BDL] M^J9M=Q.(S5?#=RE*6AR-NQ!'_XE^AT%%/AK](T/PCSSE+/L1;FBGMF@Y\?T@ M!ZI2X&@HM?*'9<2]3RF'GRWR;T>/\/YC\@PP@@EF#2ZGA[!R]"YV^Q_EK"_R M*QG!F`]=H_%,9NIHW.CKX5`^H?9*"7P%0^%TLA])!2H-6<]H24<1/U>US)@0 M)?Z1`IQ`'.X>89P2;F@B&N(:X(B0/";:V-,*8'@!XL#CL%3V6"/.[A-(KH(P M36`M%J)A]!C\P!;21=U"V0167<9,X\>B1>P%)/P%4K!F.`?L"5!N7+I)KE\3 M#`@+"2*`=QG_F43^9;I.0\*5MO!ZL8`>C7C=ASF1PW6YHHH>3Q@YS]ZCG+]_ M%XZ['[-%^Z,Q&MR,!V;.+GC+$5;E)_8-(E-=D)ND`;1'N(51RMJ_^&44U5L* MJ\IGLS#BRAR7(4JEK0EV.,3E*;"P3$`[],[[B%KM5^U$0'6)R[Q'MB]:G+S3 M5CN"NGUTMI)EW.%S-H0/^IGQN*-F4Y:2H.1T@?M3^X.FU(Q1.3:E'-NBQHT* M$D=!&G6747>Q^-7N()L:4G3&Y[P2F;!W*TVG4_K-KN,$))"H7$2_RI4NZ%_! M#8:TC)]RC`*[_JZ6/SC-SI_\D__>"D#^'KT#464=^M@9@+PFO M@%%$;M>O01C&S*UO0?R57*WX?LN%NM4R.L!?T6`D_(P1^C[Q@`_7NTGJI\\T M4#&*XEVX!00H/M@JT_L!]QZ^7!`>0=AT6XB%*_0&=()>ND#,F=X/N%]>O%4( M6H/+GZXE9SR&.'DB;Q/1O*N<5.+6R<_5`.CU&N'=)+E*(\J&=L5_?^:3LFF& MRYY<=NL;L`Y"LIY'AC-9X!.9O,WB'FY1&L0!B/C4Z["8#E2"+?QOB!']/UHK MZ0$1L>41`9\)"A^)-LOH`!_A".ZJ5R+_R_R5#VK3%`U@_4HDO&05T[JG5Q`0 M[03&\2-'_[7-"2KH(`O1+=81`/HM^`[?$!$V2WJ54]P$C^BEQ`F MB8#Q2$USW[RHJZ3'OQ#>>RMWER&(8T'Q`FAQD(.J\SZI<7H&(*/*[RA@^'AI7 MUX#L/9'@5B\$B(R(Y*,O"+_/7KU<.IJC%T)G'C(JLTT<_*SW?/FXT?ISF5`R M\?^5'CII,^^`S$P=7:>(T`1S(:HX&-D#QV\\)9Z@`Z3*5\Q/Z?%K*V=):K.* MD/0NH4K-+HE.I-&>F3+V8K[E+IC"%-#<3^'0VY])ZC3 M\5C4U[(5Z]M@`;_$T+]!N/KGGSH@SUW27AJ(LRO5UM`2(-Z\(2U#/?%^3P-< M3P5JL\09P9XMJK::#L"?+&3V?'VF\N$D*5Z$K&)TXX%B3C*+1QD,44@]/)]Z M$W+R*^FH?$>53FHOGT4PZY`U1Q':@-7!IP.WP.=;3Y6FZP27_M_3"OCHA;P3 M\#,*?>J6ND//$HZL%HOH`'T%B8H,P\(9<0@)2$(0)>`S)`=08*=6FJX#W,S/ ME]O%"\LFHW?V<1*U=?H$W!U,#4"E<8>J+>R MG>(M_7)\)Y+,2@N+95;\2:-+U+_%^?Q[Q)&>Z##)_??0^EX MO1)I"RM7*"+=*O:A)("%E2<4":"6TE)B;F&=B>Z8B[-C2N3=E_K4TE9*S-V7 M_=3RBTK,!R'NB2U0);+N"WDM[(0E^NX+=2WLNR7Z[LMT:E[-`^8_NR_%J7D9 M2\S=%^6T1G&7A'%?Q&MG0R\IX+ZHIUZ#H,3>?5E/H91!B;;[@IY28802Y);;K:]5VN-1*]\VE!MBD>%S$I1=KL'J_B#G)`\C M0]OJ?B'&:,//[;>Z[8@N>DG5SK&Z'\DY3PZ[(H;QWB6VDD?F;MFK[78FF7S= MQI(<]FK"&D\0._V_)(*]*K)&(BC4#B@CK^W5H=M3ID,UC)(P]FK79R%,6=VD M),D;EX#YU7I*$LD)P@[T[-#4H:M]391)',.$O/$@P)2E7:X`YG<]Y@PV4\KGYPHRAS M]H>]9+_3O'WFI^`/-$WL$I3Y"J-TN;I!A%HY%Y+YMBH@H\IUSC+*NK', M_:B*'($YZ6T6)6Y@9*7H+61CE6%FR9B]7R+N*S'#!`9/((1Q]4ARX*Z/,P+M M]27;1,SF%=5_7[]N8!1ST>N^\&@!&BU`HP5H.$80>3D%9&W;4G$#9?A/Q<`QQ<=A!;5REY(T%K[W1**VVEL%AAVBUM@V_B3`M M'4JJ:K"66X12\)6HUA]WS]'XQH/81F_IV-/=CI[NH^=GF)X?*4\#Y,:!-+L? M^'.MZ].84#-.XS?@3G2U-^!HDA^;ZEA2?M:46>QM^UW&>A"C`\H9]7@,09:3 M8H;M?%(34E7=4.>SD]RC!,9S=!-$("+@AD\4GRPA_BE81L&"O)U10O"BR?/D M^7Q`8>`%9`;9\(*(E=_'0&P;30N2WXZM:4A.-H)7<3J;-%;&0*/PBBP))X-& MM:B;J,0_(T=N@),O,V!11Y(@DBS#N'PCK2RP+Y\V+3%?)+>7Q/*`YMQ7-,8'%# M1.@L>.\.`NJWRW2*#!RYTR(_WP1VI:8XPU=!O$$QK4UZBZ+E;;`EF@/5)N-I MY(4IM5)-HP1$RX"PK?P'%3KTL9,1BD6$$\(Y>)5$FS?<#.P'K5@2>-YX]S4: MII_A'B3DBLX6,_*6YWYV,9UDIICXT/?PI?+P8O)HIY$'*ZQ4[OLK+V/&=;6% M49K%4RQS$4<.N>9Y1E2S%<#P`A#A_A*M:5Q/'AZ2R7BT-&!$.S42AOD0@DC\ ME+99:52>>U:>SPCGEYAPI>LX"=8$%!Y-3P:-2OZHY)]3R9=Z705[!\N9#/(X?TJ=3L0DZ.'&;J-@'CB3>C3Z7TJ3S"+(#C M`=`X*$P8#LCSH\J,DC'XP>K@!Y4/R+-8R:\P6G+&,(C10N*^A:0-\S!N,!G? M[5;O=D:$#N$0X^O=XUNQ3\Z>+8J`XJ?T^5_02^9HAB=;$(3TX]T@O+=C1LM; MHC4U/NF=EQW?^?&=']_YP;SSW=G,^/A;]/A?I#'YVG%\B=;/Y->LO?Q>LLRU?&-=NZ-[JJ;=W^I*X4C]RTL MH;#`3?,\$]R]A%>?T!_ZM,8@450A,84W68O:+Y":0PBG\A)6QA5BP=SJQW)S-(+W'P5X`2J@R>8 MIQG`%QANH3)XO%GFY%!I8:`(KY4B@G%YM&_,!>?3A8#;+KCS&8?Y*%RI$F(- M$B-+_Q+0R;C./=H01AN"G`=`DQ`YG-CS+CJ/\1!S6TPN-B+6R.I5*^#98%?B MI`*,MJ7!VI8ZE",A#QD&7I*"@TP?61S^R_T+T!(KC)\6D&82!O1]&]P#I3S))X#R]** MK?3:%I6F:;I2C=/H#6:=4:SSFC6D4H,'U91!+TRYP`,5SWH'<8-6?IJ M9W13>HW74A@M>F_,HI>%VL>SQ2U!B(@>PTV\;J]6-).(K6DTSW-?M1X53=.* MYBBCCS*Z@"`2S,NX'<$6H<.)]WA,J+;X'3O$.=RDM`+D'3DXZW3]2#XL"!_` M+OO"M43'6#%$MLO:X^L^ON[CZSZ8UUT3PQDE`)LD`!0MYQ"OK^!S,C@M?%CO M/?M3<:P!S+'C>SR^Q^-[/)CWF,,0QO?5]O=UU*KM?65+(9=^LFD4$S8B%=HF M,5%'5%'[1)M(?EGTJ#9JTTV2_J]YS+(;%/5&Z1FNY!<9A2+1K%H%(O< M%XL4V:-Q.:D'PPS_S3(?U*@?6]EGPGA@V"@15UH;)^2;K%!((-]G>-&Q`XX% M&9A\_)8$E[/"*7LM>"C(SA_%LE$L,_%LRQ]PXY+9^%Z7[W6U<]%R7N\HE@Q"+!D?[O'A/F>6B0J#'=]N1]_N MT2EE\>MV,'FQ.ZIF?XTG:;)"64;<%W*.<"9PY[U6LR]]L;M^)3)03SQDF!+/KZB[ZGUPH;I40'P$87A#<(O`*O6U95;9903 M1SEQE!,'(RA:I&?*%&H>B7F@OG";OZ%%8 M8%2?1J%O%/I&H>_\59E&MY[M;_93?O@>X09AFJLWX,=Z8(^9Q(?CO!@2,\?G M>7R>Q^=Y,,^S%+,8WV6+WN5_I``G$(>[PV_54H;CTVSSTRSY[=@/AN3D\8$> M'^CQ@1[,`RW+,L8WVKDW>@RHL?>E+EU4XF^I%O:@LM;XCH_O^/B.#^8=;\E0 MQF?=HF?]$1(<8OH_)Y$_\;QTG8;D?_A7<(,A&4KA&,WDCKSP;3\F^Y%IN]KX MRH^O_/C*#^:5;\U4QG>>_\[_[2/=XAG$D/R/_Q]02P,$%`````@`YS!G1-AH ML#1&S```&A\+`!0`'`!U:'0M,C`Q,S$R,S%?;&%B+GAM;%54"0`#8J@94V*H M&5-U>`L``00E#@``!#D!``#<7?EOXSB6_GV`^1^X&6"G&X@32[[B0E2<_1?OR1UVSHHFQ+EH+JK$IM\?.^1W\?'^Z=_ MO*XL\(R(BQW[XXEVUCT!R#8<$]N+CR>_/G8FCU?3ZVD66A-_"'@2Q$H(?`$WQU;&?U!F[A#%DNN,7V]QETT2E@?YO`L<$?EP^W M0#_3`%AZWOK#^?G+R\L9,A>0=!S;PC8Z,YS5.>ATPJ)^\Y7Z`(9G.M4K\+#WP M@_$C3=P==&B.'G@X>SA+V/??X-&Q79IZM8;V&YA8%GA@N5SP@%Q$GI%Y%@BU M`GL!]:;M?CQ)F/@Z(]:90Q;GM)C>>9CPY*]_`7[B#Z\N3F5XZ87)M?,_/M\^ M&DNT@AULNQZTC51&)BPKJS8>C\_YMWYJ%W]PN91;Q^!>$E`0Y*9@OW7"9!WV M44?3.SWM[-4U3WYF!?Y$'`L]H#G@.GSPWM;HXXF+5VL+G02?+0F:9VMA$7+. M\I_;:$'KTF0EC%D)VI"5\+?@8][03@!+^>O#-->@<4J6G^G<5])BO["&FE(3 MO7K(-I$9*LJR%[B+2^>>YD*96,=(";28SQV2:3B7-8?NC`O6YX2>\<7:Z6N#DOP4??YL8!D6"1Z%Z[UC8P,B=S%R/0,,+2^,V?CP1R'`> MZ<^RI"P@R'4VQ$"57.)73T4MOEDSEFEET2R,?Y#=^?7Q!&#SXPDVO_6[?4V[ M&'T;:;WNH/=-^Z:=_!S+`J$P\#44]W\_^7K(-#&Q("$$4,&`2TY^J@QIDJW6DU:CUS6R M76HRI"8[W&2KV.0&P2?>=K=P*.@Q19##L18!-BP@`&FJ"."7`5@A@)8"[N8L M=E>&WMJOD7*&1:4K1O$^S7T+SY5]V%)D?T:K&2+[MY4@?[O0["LE MVG2'_>ZP$HZ_^O+5!;HUV/]>H)MNSQ5!F_!;-;ANEA['H*:'"%QZM,"-AZX@ M05?(IK6:C;3<=)(193K4>BJ?ST2(*B'8@OI=;3#XUO-;$!4#F!S@"ZH7+)D\ M(<4:38$U^="78I*>-DD)D,M@P0%;:*V2?M0T,<,-M.XA-J?V%5QC#^82=$[J M)OO(;!6$!V7:..P1(T&`2:(](`AD*>K\)!C&<1!D!-BF`TX#T<#AM8C\CP+L:1W\VO\C$UDFS?_V6#J6?J9ORB6 M%2E(+J'I2%2N^F(M^J+?&_0O@A@V5@!X#H`QD-=4APYMZ(:OQ2EKYTP/X$:* ML-9O!JH`%.D"^,*G>]9L%*S0D]JV)Y\<4$")@1H@UH--DH6:@%B58"U8KA^S MUBM;YLX^\^=]Q>:F+,2OA^.BP4$-%:$F7"JWXW%)!T%\.P>;KT"VRVGS@56U MBSWTB,@S-M`](M@Q'Y#A+&PNY3?6^>8&`#47VVC05J\M@O&0WAT-*W->K!=( M*@8BS4"@&O!U`PGEP&]YT543`62+?,YCT$?/,;YW?%<:25<&:XEJH]!F0)X. M9!NHH58SYN6N8:Y'L$&[=]Y8?J76N*7&'@H`25JTD4_EF"8\;S,:=/>B5W"9 MQ:^AIH"K"KBN0K3;==\#%4\<%I6;EV^_4H.G]MV:[6W&]F)B>#1>]P2V5]91E"K*E:2_*(0' MNC;(Y-5(#[Y?);E_A7[)E`&A-N#R#3!]&/5&&H%8)?4;0U7[5\^85"*1?VWJ M7^S[EW[.?C.8>]>A>V=OP(G<"B--/K2&2"6C.Y-YPW]06"2"*(10(FL^'93WGV M:0KM*]X5(-%(/64DC(Q$L9'LG`^;+"Z3`K_I.CYFY^C6;>-7;YR M&X;'HA(B^78.*A2$4D$@5E'W(-5:?<=:-E9BUJ[SC6RL@Q!MG:F^0<@_ZL$V MI2,<>X%G%IJX+MK=#B>621G,MC41CD=&T;SM%L9BB<`7V09\'63F+KB"L.L4 MX-A8F&NL&ISE-[FDV=$Z`]3 M^QFY-!A\0-"Z<3T:%V8C2H+$IJL)7,/35'#'*`^M4 MBZ+_P3/_.G@JB*:YL^*^HGV[J/!Q3`@3"X'A()`4`;@A8"M;T_!Y%^*)IKK M=(16V1%@\J?*6>HZG:'OU2J4,=N>'!!1V3ZNE,-=*V3>$[:_@"V1%S%45L+F M>2A#"\&^E`XE])AMJ(]!+$@9FQQJ3L@9JP;-*2.%0VW2,ZM((;0+()(`<)[9 M2J9(:-!W-X\CGD"QM[RQ>E[R)J=%AQ#B"*N35^GH\F:9I9::I[`9E&JKO4X>-](V"8(MZ21&O M*.DOV8S`=+6&F#!D7BTA6>1?0IJ=N,F^,E,#X3GUWB@$#Y,#8D$@D*2HESS< M*CVV"L=6&5Q2+48](S)S:C=+XW;Q+<[L:G8P=X@_E9>P4FD`4`B?5/>?[PP9 MG7^F]'M$^/Z6:VQMO/B&\21;"^5K.@P044IT'KD[ZHZ#6"`'\VS2/=C)%5I"Y\J`+7*(80]IJR0*(P<&@^ M4!#N:_3AQ44"-C6%`8X'K=+^LIK.0Z;S$Q-8W_DIO&R$%U]VEC*= MJ/&V6O5\G3[01\DVJ_ZPX?YFQ-&KXL-]F0UEMR6K?TJ"J_&)=@7\4@JV0I)L]D^=?!@%B:RM9_J'$<"`FKV%Z9EO!Z06/; M!4B>'V0,=;S/D'Q'WL1;T8!O0>"J8((S-VW30YH\101;1V\P[(4[K#SPM$3` MEP=^F#Q]_A&$,A6MYDDQ3@N,"PRCPAHRJWBH(L4VOW_S.K3B.JF*8_>Q>6]@ MZKH;]M9::+&R<4D9MJ*Q2*%;9*!\,]N0<+;T;C['!KH,%GS\KWZ'^:@7SMLT M"X@J)CI)3AM7N-#!\TGX/>)(HJHQ7)-V'+P.U1)(K58KU>J M=V644A7($<54`B[0K0-M,2;( MSJ22##(U$FU$%\-1=I!!I8)0+&!RU5'!X09FL<&.@6UAA,/-S2(%2NISR_%O MV^*/;*]"VZVI*IZ5DGX62M(,_@LDYA,M9?**+#F:S[(#E!U^9!%4+4GM;H0M;T=@1V<3`LUI186]G`RS=1+S%35LPFB+>S9 M1%RBHF=CMVD]T`ZV\.F[K40-]FWIDL4/HO3U$!\N`DR`XK?L#K!#3]FALEO+ M;BO)?BW#3"D=&Y7*^@WK"[M>GK^,S)]-VMW[7I*Z\0XM5Q7!)C`>]WO!CEBV MCLQWI0&XXO=2.7-@(=8N"'I&]H8R/O$OU/^3#@'8IDJ/YEC[3T.P7U^6V%CR M#RU$PVD$7J`+G)F%^6-B8&.;B'")_`)O0JA>R+\'G*`%C5>LX,U$:+\%CVZS M"%31"\NQ+B8@PJ5UJ+@.":Q;YUO73"]<2@UQ#USL M#AE$A2C.4/F]RMGIFB:G+"5$K^_MCH=Z$&-S,:JO5C[<&*UY8XK1>[!%P39[ MS+;79]S*,_-MU<[IGQ[E:\7W+Q=B)\)PKE.DH'<)GZFWH/5/!"UO:>0\_9ZJ MI)(LC6.Z6!_AD5#&XQ=@7 M<(<,&B"S<.O*G9TS+LY+UC3<,W00W<%\,>SW`X@_7)[?Q+N0J"1%P#[4&A_, M9-:@+<4`/M0@/;MZE"&V`!D12O-LEH/,S!UF_TO_?W$<\PF]PH+)[@JYF\>Q MJ&JB([>NUA]$\,[=<1@6<`IX$57%I>%X.`P7X@I0J&Y36DT6E_).6W:IU61_*>O, M\2O;I-*:36O5`5W&/O5M8KLDV%R@%_A6P##I%(W32*IXT9:C#<*GVB(!8,4E M-+PD<(#Z6EI]E<#>WP@]7&N*A*B#9693C[&W:Z0<@#E/&]>`]B\$6U;1!$!F MPN;AEJ&%:)0XT`91#XT=X`L"OB15@X&#[=%4V%.&QT.-\F')92C$8P$R$K#, MLU4*.C>V^X*-[Q/7=0Q,0XBB`7]>VL8QFJ.(8`N@_PS#P7PH"L2R&L:G#%NT M/%N4@E2&97J56FH&M26(B8%;9+^2O6E!-#U=L4?F_;THQ?O4\C,TN6K#"$RS=7SS#T5L[UVIS^YV$2$SPW7$Q(%4.^,I* M`KRH]@!3JE,*NKZ]O:(0U*+(*`&\D(M;0P:N=S%.TR6?SQW?"A*;\TD"B.IU'T5D@3SDD3!$P2A)?P M@I'G!:5D((Z,4D(0=*N,18C*Q=_X#\%G'E?<7UC3RQA[:RIZV9$V&H9[DO<% M>UADLXLBS7CF,!JLU3/%*RO-N,=?(A6TN)&EEX-Y(EJ;.:>/]9)$1MV%.@F6C$WQ]'%Q=DP3PJ`;`B(L`'WVJMB7%D>8(C M.C;:9$:'KXKZ\EH6T`BT\)(XILQU+8'R'C,9;9FRJ#P,[P["ARRRY\[:.`6Q MGY$%$X3MG5&H.G5PR!R!Z'"@\.!@47+U(7W%DVH7K.5T"X)V=<<)9=F6#WW% MQPME&>COQ%ABRR3(_KL+KFA)V`#0`X]K@NV%"2UU9PX%P%40)1]R!K&VSO,> MT69`0;F@'?QO#IO'G+)CS,CUW#">%V=Z$6%J.UP!#45[J>&%5K1,$)?$8F._ M+!`5%HV.6]-+R_:,?^-'[`0:*SLO-E5LB=<`!Z+!FIJVA&ZV'Q1VY!5@4=+% MB_JU+7Q`G$\.6<$;2&RV*:CD)>#]!2GF@6+MA)>R>X.B/IF6`G@Q("Q'^2.Z MS;@D/W@OH:V2M7UDQ/42/?!*_^C5B(B+;QT'53>Z$O_4:/2AU%/= M\DJTDV]Y2Q@GA>`*;!/[K25C(#<,U;X@;VH;S@K=.FZ%U86<_&I'/-E*B4;U MX^%X7`34.*RGXH$O'[`"6C.\D6"__[A'N*T!+A;L+FH/`9N:C+G(E@U#VH7$?B_-P2/*-;`,( MMUJI*/R2'JHG%&\H6M((07>P57)+.%PLT"$G!%$/K>HFAY!V0%$7+:,2I[ MVRMG-<,V!V1R)7-^2[][6D);ZW:#!8XOU"..[5'O6(DUCD>\L/&<5I!-8XCU MIO1P@?SR%/3LTHT0WS@SVH[2$[JDMPO,`5,','T`52AF6L** MEY`L(+;O@W7L7^C/#]'+1Q/^\)!X0Q81II;/!#04#N4U_:*`K(*20%@48&6! MN##@E]8:$I+M&3_,01[@7J`.F4-,P#.T-BA\6XO[B=JWL?CF$@;U:$,%(Z2( MA'"T[82*6L%_\T\[C)I,<'M[50^3/R,R,GJ3`N831Y5=-> M#@PF^&LGORKEM([U*B@OC,1QX0`TF^X"/=X'R]7EU"UZ"Q]9/DYNVP.>U4FM M:DVTA,WB`>#49/4YQVPOS\1U47RZ86*;M_1C;&'VO#'];K.B'_(DXHWWT(+4 M\MF!VHM.>/3[VO;Z7Y+0$G-G236`7TA\7P?;=)=0!02Z!.E:PV=-.M6_SH,_ M>!]-"JT)-FK:4,$*:K$WAE6\H9#,);%3"9O+\/RQTWETAW0##38NZTA)/3)` M>"+[0M^^"E8FKQ=>`'Y)+QKFQ)V2CYL8M\T1G6@;#;I%J[JRV#'YW?NBR(,< M'[Q,RC;\W?,-?Y^H5K9!@YYW1IAY.*^9-3,K1^+I!QFJ7B.^@R#Q1<&V]YH* M5'0"HQYK!"\*Z^O:8/O.!IG4%RB6_$[)49`6.+F^_J5V)X]])]M\"_6.>N0T.CX(^E]W)@?S$7K203\0Q#9!!?$8WSG`?H3L'.&/[X;MCC:@N^1SCN^%M!+(JXNL0F-FY?U%TM\_!]!?IF?J::0J8 MJH#I^AZ"/\D5$BS:9/OF*(E3E`UJHU6A"CIVTKT/Q@SWM)%Y-,4-3;MF2^\- M0""_[",EV5R#A/<^=H=USON%^@&N($\6J7C\\X%RO%^P`(+Y^_'O=?6CE`GJ M(MKB>CLB@OW%<B?00OC?UHFC#N@N^A@+;<_78?C;J^]JH M$,,[#;$$B&G/M`1-CQY:)Z[,8/&,]Q;>(CNUPZLU'M`*079)&HMUV#6&X@UB M[Q+48G5?M<6/1/2+EA]9\:GK<7P%XKNEIW9\F4Y*"7[I:VOHH!$W-Z3P3:+J53JA+[M>@D25E. M14="2M02?HYQH(VWSG8D)`,F"R1D\P_4',^0:;#6!H.%GN^0:;5_B"YAF\%$ MG`(S+D/UT0=!F&Z?81#QD@0RN8+VFV/_$T'+6QJ0H&!&APYWYPB9UT MTHND2Z'Z]0N`=Q(@#TD0@/)]9[U[>YR+Q_1!+[]CF@Q+H)'7^(G3!6Z_JRP_4G_.SZ]!:.B0/0N4HC MWW6[U76=BR6]J*J\#`(/DCD,?,>2ZMK?A=B)\&><_+=7%@A$:.=COEW@$]7K M[:*+EA,-*%.!,AUZ-E%-%H554D8D>?/?_[)/9?R5KG;N/@Z"VU.]&\@MD30( MSX'G[MZ[KF*$O:L?P56#X-<19MLE6Z#+1!MP$Z-\SZLM:]US`W')3UD`(#E! MDC+G$+U\=J,X=)_.;`_6M?_EQP[3.]"NV>5Q7XE3-^[1C8N#U.]7P?'D^/S: ME",%*I_'&&,M,%/GL_5RELQXI)N47)\NY;+-2/N2=M7+",I\+_BIHI#NT4I4 MTJO/$J6(:D6IVGSC]CO*%>N84U$6J(+.]I5`DSBY`V!\9\T=/9 MY,=K!GMB->G]YJ7O+W>Q^\I.VQ07D7<<=G^E]O#P=WA[(*P&R?Z'3\[T?=7 M\5JL;;3%?A<"V)J\CU1B:+\&C]$5"&FZP)]_UW33IFI M(V(-BPCZ_JISU\W44;&'YXFV;M8(FLC[54/CJHCF;GW\+0CC9^<9WP1.RRZ] MP;(,)#RNH=`)%A+D>4_6(_I0IA!1C<81WOB(]&.]1D0,I[[Q\>G'?P?W!QF- MATZ,T3$+DR=('%.HL)5*^O"A.-A223';]@PXF-3YCC:2$Q@$3,W58KM<-\@L MW]"NZ/Q.-W')\+).4*J]!'*0#%?K7--T53^/=*"OR1=M@9'$"ZZ//2?5DY$1 MG=[R\(]6;NA^3P,_=!H%/0^[V,ZW!4LP=HEDA5/K4MWTZJZF0$G M;Y=3R9J90J[/-LQGG90!!F:9-F!1DD$=+S@BW^PI#((_+G?.'A_?+\_[\U/@ MWQ'JBMZ]5X<0F)A!^KRNFDAZV`9,NO5J/)1*O\"E35HZH!,Y;W5 MY;U"Y]O99JH(V/V^OS;R&0#MG(/ZQFX:*OJ.WSZ%;NRX@]FH58)^0FHS#WK+ MZ6*VGK5P$E&!4AV&\I*T((BIJ10$@^E)6B#$#"7,!H-8"H+Z%J+JC.)D7!4' M;V.(2O"Z$2S%MPW:5Y\O5ZMVBJ+RS:4G"=ZWT6*FJ/G0PJ"IY@Q?*XSZDF%YX1P%ZV-;-R%J%B]"\W MC7;&4N],._9'>V3S/-(&Y39HY)@5^BP%G+18+]ZWH++R@'(XEK5#Z[4L9E8V ML$C?5PR[P49;9:.UXFRP"W;9A0MZ)LL[LU47:S;['RC$K]@_8_2,?7IS+W&2 MG3TX^P0I4>"Y>_8[K4<1N(@HP-@(C)8#`L'Q2,MK![L_/KNO[A[[^[RZ#]V3 M?.>X^_IG[?.JRHW^`'N@)Y\7:VN98^C(BN$3L2B76Q2@2DY$WPGN=YD07%-Y M;2=7(^X\AU[R0\]\T\MK:'7G1/B%YG)5`Q*WLM$>&B_-:.2WH\+G]."LU]C( MFJ_SS9!E4&EJG*1X8Y>\B:@,0R#!:7-:_=6<['=.>!L^Q+3)9E6-1+49>[RI M!Q`B<\`,O,F/J98A0L2B6]+@,,%)R39M)1`GQ`3P<=WU:BU&3B++$-0,<(R' M&%?HDS:85'.L%2*E(!@!C]MS',5D/.GZS]#O6'Y%)U!*=D!I>+7,[B;GH:4D MT!#(#'61AYN@W3MMX.%D8"N"ZC'1#*/6HM;UQ_3`I5?AWMDRW^];ALAT%:G[ MH**_)SPD_.O/,ZL8QOPGVBXO9K,9_;]F=^P_T_:&S;F5(/0?B*6&95]LEIN+ MU6)._VTC^HO59G.QW6X,`9FXDC$OK)K`=,)^Q!:)+OW]E^/)"]XQ_H1]?'#C M._*1H\Y:IWU$J`4AV"YHQVAK+S<^*L9>+USN0;*?H'2!=@0OQ`[2'1^7&?K@7=!R'R(DPI= M]&KYQX#6T0G\F`23V/2;Y?%+$IA0%9AE)A`B^H1 M(U!N!4K-0&4[T&.`JI;DUTMKJGJN,9ZKI!36$S/RIUTEL$E%4MU\,P$4ZY0D M._A_`M;J*L8WD;:/RV(]"]%9EK6R)F8S_47]#`BQW0QQPFMZR_E-B]8)"6Y$ M\3]91,?ZPR'K1-Z[T1]W.*2_<)ZQ)44H[8#O#"Y<+*9\1+TA`5APIY MR-(%>4DN,MR6_&'5?]GVNZB^_\ZCEYAH'A=UYV05DQU1T@2L?!-CUXYWR"MJ M@26T`[PB8]OY\**TFU/_SG'9/MHM/FH&46?^U4#4'A`I.\PS'\*__F M]G#C[=H.A<#?5KXW'6P:<`/U;+;=YAO72Z+8U/*^*IZR.=TFK;@^T40^6TV? MZ71E33SMSE,%6C?&3Q,`NQF`OQ`H67_E?GOZI]E?LQ30MU.^-[*+;?3]PJBI M,6?=]+/CW3YY[C.S[*L;[1SOO[`3?G/B<^C&[P^[%[P_D]X^Z_)W+D.,D:FV M.S#<4&@O=68O\P%\K@X5^E"B$%&-*%.),IV(*35B[4)5K!A+7#X_A_B9%E*] M"\DXW#V1"%T>@S.]%.;SF73S_:(0+;O[C2`K#L^L`C_Z'L2D&W;GO+/8/;VC MWYHG;R[0Y6Y'Y9%__^;O<8C2ZV>^X?B%?_>LP@[.>$S6>D`COYT>:HKBB*[^ M_*!K0U(2#1#\Z9]7PMP$`B MR`@4#/")CX,6G_0@H9I88BR4(J`%#>?CV7/H;I[\)*CHPW&>5(F%IGIPW\&R MLSV6N9#B&+-<&&P33WPVIMBW`F&L0XN:1_LVCY2!0)Q/%0P(G)OI39`BT'(LU7V27;7%R7%/%'"E."8&K<^)2BF>V40"&0">?<6SU?W@[ M%N'=S\_!Z[_OL9LT8>2'>LM%?D7TAR%!4S&U\,7??R:$6_M4K8\J:+O:]$/[ M/*O9(F^\F*3*/-X7.J]/I*F%@#2_["%^38T$2()1('1&04)C]AD_Q9=11-J. M_:U_N?O'V8W<9$[_'CO>ERAN)CWX-<5-',0FZ#4V\_DZO2.`2D5.(I9.UCJ% MX&2+!LDHS&2K7=N3[JV5>YN*1;<^*@E.+O`FWB:RU;>)TCVV^WU?78UF'XAF M[2NCZ]C?&S,@;0\J:$9Y9@!O6QR1?\SY^8%E868,+7#1!D>\1$\ MM4>=[>%8M_@`[G!+5:/7`IMR.R>*@73PLN7DS@^1/*45M,P$:%W_V79E"0#+ MY.C$:G]'^#B=T)$>$.WO#1^>8F_4([.""3XJ"[=U=3:OV98:BI^6M6C.@XH[ MF57MX$,_BTK:%T*TKD6/],?NYX_*3B4_F>H=2H[O^K/_DQ.YT<.)C&G)J/!W M)W0I,N_)4%!TC@C\NC:DB&WJ,9`1X(?)1HEP.AF2B4=4OJ[S1I.XS^#VS0F? M71^=`I?N373V>[Q'<8#B%XQ(1N(0$WBP*^'-06!W0HMQV1$Z2;W'0M]5\(I] MQX_I;Q]P^.KN<$1_%SK/5*T;"/H/?21HZ'7V,`^Z=K5<;C:E'FD)D9D*Q/Z0 M*4&9%L34*.^O3A4"+BGI"T%G3W>J.*2G+1*1%XGC42(5[3*_0Y'?JOK$`Y!> M[B_W#=ZD_/08T"KM7[W@K3\SU=\UAI-JA@%3<+Y9+"P(&Y&FDMU20!48141C M_`90T*,:OP>RSQCG>;Q#OO*.>GN@WAK*.0+T=K,-+U@3\PS;6'_EG%SRG^), M>,]/+!!B$//P+83>U+.V[3F$@@@4F2*4:BJ51S"&BR1$`D9*2B,QF)TDA$-` M4^RD#"$K)MI$DFJ'/H2M6H(W&6T]D@_BDI'B=QS_+0CC%_#W;KQH!#W5K0). M&RR6VTY*RD2STDY,N`$D-,K?=N)1Y.\`JAGE=(U>_H-G;Q MV&:0#&VP[3`,7.QYL5SS<9O7B7>H=3VN#U4W/S<^S+5$BV#1WHVU/MT37^/OG.ES3@YM&LHGQ MB[BM[5AB&!0>"*=^3_\1&5EP*DDLOS,B;`2X;7 M#&SW^.#Z#MTB%QR0%S@^(I8FK+)DR>M*Y#)]86]XJ^@Y("AXC2NF0SVJIT&)O.JQ\K(8-?2G;(E1C-C^8,''/Z21\-U M_>WH=^>(6^ND"1_7UEH6-H#'-?96T$!269J+IDEQCM?IO.CV3D][V,PY<1-8 MBX?T5N\NB,G_NHY'!X%??L3TZIK`O\.A&S1N.N_WLM96LS2MTIRO=*OI-5]IQ_H"X1\GO*-SS+2+ MC5P?O9.V3%M1J_Y8YC?,G8'3WU!S3T"W/*FM>>YSU':VL6T!U/0<');D$<-/ M7GZ?WCX1^,\_,+??.=(KY7[)][3P\^T)/]=B(_N M^?@=MU6W@4K0!J96LZ`E1>?V3+!3IR0>9?)1JH#NI3,!??)"P%!)=PCN:1A. MB1"#EC%`62P&9'>@C`)J:EO?',A>,P&2J2W0D=IF+3K64\9A*M0PZ`UQ-9FP M*=^P$L0O.$0^NUKEE%RM_X<7500.DDD7G'X%"B,A<4E M'R.YIP9,$.&40R)IC"Y<"6W\7<-(N^?2X,9:V(ORE+/6@ES#C+?4&=\YY!WF M@0WV0-78E;\`RW52$JKZE#\PIM#!B'/LZ^URO2T?(C:E?D`6*$``TH"##H'OIYOMY4ZT`:<\1_C2`%64P[MC_'&+G\6 M@P[E`X[?3WC0ON>1>I,.SX\]#;U=K\JE9TTZ#2_%-4N;:P`<2_"O`FACCJ_W M.:@^_9'T78B="%_[E#\N_3W]#[WN]=7QZ#S^YS-^#.[Q+@CWKO]\>[AQCRZ] M)')\%T>W?O4F6>YYTND5*B>9*;V!-E[69K9(:.H>[].+?ET_ M:<'V9S;[Y`?("_QG')(_[+PSM8;5X3L$X9'\LGX'\+]%R=M$"GVJ\F>ZI!B_ MIT^HOJ+"F'"GU)G8@Z[]I/=#;ZME/Y2,8I6H=PTE-M&"T/6 M;F6>X'0QX-8WPP*^J$0\RV\Z_\I^P*6(ITF_K]XJSU8L;ZXT+NNKX-JB]9C\ MTTEI?\B`DC1L3O@'L2+1^2Z\_*[M:>7,+S0%.BNPG:T66>^2"4.IM)0+WO7< M@2?+,TN;9QV=2SGNV2WNZ6.83C05]-`>!HG8#H,3#F/")-=N)[*;SVK"=<,0 M8'(L5\OMIH;J7!:ZOM:+Z7%>62*O7`/P/,XU6_C!=&-9B)XZDOD!F`+'"3%?+&9B!)L!WP$.B"7`K3&@!4)6RE6T8W8S'7`8XOU5$,41 M&2K'-Q.A"$FC8WEF3R4"-2U=4F.AW;% MP]V+$S[CZ`(]!\'^S?6\TCXFAPF_H.7X]&[DZ]CCIA-4]::O(2!N3 MH?>3AZ.VS;O"%S2`JFD%..-FVSJFJ#!4DJ9S'ZX4]XKJ>!0Z3X%_CA"[%#K, M92*:T>BW7Q],P)$X"7DP$@1'#XI.)*0NM[/'>T0I4@J]X#W;F^(BCN)M75`8 M:+]=MY^=H/(CS:6KFHE2S>V:M[JSF313E\E64VARU]_0E.LU,\"\N5[:S=1G M':VR./U8&.-?$QJT?7`Z_-.!$4'ZB2##"XIN!)&?/3P,2L)7-6%*9`^8EQ?6 MB@.N7*R!,)/B\L?!6U>RBH#7&B8I\WL1#N.'4^CZS]$WO'=WCG?G.?]T;ISH M=_SL1-]?6V;\H.\JGP,$&@:]P(=>;)C-"E+1*)6-4N&(24=$/&+R+]#WWW7- M%D[AN@5W'7U_U3JM.(7[=K\OKV\"LB>6BRG)/E&3PSI'O&\CEN+/ZKDCUPU= M$[9FQ:(!C9\VZ`^S/$/W<6K+NZ`[S'R["+Q&Y#7RN02NJE]:^LWY_>FW![K> M3X;K#`#WV*/;>MC$Z<.+$^(G)\+[.^>=%7*X?(KBT-D)9RS'"579UQYE*?14 M['RUR;95Y_KH?K^R1I2J3-<9"J4HTXK^GNG552E$7;#L6K""MF!=)-'ZJ5>X ME/7UI0"L,@H8_QEDM-0ND><^G:GFWWPR+'%.,3%I_X#95N-;'S^^!5_=5_Q_ M<1C\XKBTPA"SBL?P@V6I[@,,-11Z0&&U7&0=AI(J5-:%4F6(:$-$':+Z$%6( MJ$9Z1B/!@]H^AI+(6`9'IKT/HR0\:8=GYSDT&G3&X^2X>[1W7]T]]O>$*$\D M!)$H!$HZ1&-I(^\]C8JH%`),HEKLGKYWGU^:>R/:'E5.7WP[P/7R%HOL-L94 M4NE(`TID*68="0Y9&ASJ(`L)7MD5KXIS$"ADLBY0<(ZCF'`$&=KK(X-V"!58 M;PF(GE%3RJC"GG+V=Z5CF50I=*;Q7?YQHG.V+BO'H+_]J_[S8+O^= MM7!_I:>!Z/>[2'Z_JO[:9NTC^XM=>\/2.UZHI5:UZU\.D];,O_PAOAFT\HP. M!%#%X+L5EM:RA@(R="0"M(VRASIA0YU0GLOE9.'F<^ZKUIQN+PY?>TI'7O>K MEKY<+1:-S-9;_WV$(_7L-J'4.S]QN!DNN;![)O:FK7)<\R%-`X["`NCRVL*V M-M6A1J2QD-PX-^H0G-H-T.!BH"]U%';XHG(4T<1"??Q0\UDF#N\<=_\8?#F> MO.`=XT_8QPEL,=TPO)Q&,_5(\P%=F.MS/<=JO=VL&WWH":\:Z01;?^OK768]9X!8HPT1OX M&GKA"1]<:79?^OLOK$S8M4\KC"7G!P0[B:"OJ08BP"9P=='5?);",Y6*?D+Y MC[2_E*A`)1U3[P$20EBVWU;%[TLMSK8C7K;']GB/E1!$#[#FM`&-U?#9W0CO M?GX.7O]]C]UD8I?\4)_/);_*3?GJ1CM6&M,-]E_)[^KS8^W/*IC;;34`>@'7 MJBBIE256(BN]I`\Q:6K!(\\Q>XAC4V,$E&04&-UQ4(T&>A4O#`O%DUJ0D*N' MIXNUY>.`BC(#!<.["#*O'1EGIUD`A#H@XI20OUQ=_3&^=;OE[U.<78J"B' MD^F\WE-*>Q)$$**2]&%AN$-V7X=4YCXWF>I)W_1=7;8_$K$MGX7]67%N4YWP M#+#K/$]?UY?'O8VW0<:KS-ER2M13-7=/QI18='R"E,[D/:9ZRHMC`W0"=+&< M9_>1/7S[I+]BYEA7$K01*8;4RASKC\WY--HFGEH@D4\TB1R6`('61U9SJ7ZGU686;>;D&0+M-ZY6=;E;/Q!2[#]B%,#L]&WO' M.Y55SG1W"&>NM6Y(&.T4X%IL"=^*^97R"P.A0F(_^QZ MYQCO@9\Q>UHCZE,3H+FT663W:G)PG\HR`_E#'$NW2+`7#4;_H&]6PO^^EX>Z M&*`&I38.*`=$"PMX[K/[Y+&ITMOPES`XG[X&X5?'#7]WO#.^/;$%:/%!-?C[ M*ID":A3T],QBNTJW+&:BV>0XN@T1DXZ(>$3E(Z8`)1JTGH&;)@9V,P9!%H-# MSQ@H0V??%*_@M5<8)8RAOQR#\/TR_GSVWX)@_Y[]]Q='.)SN>D/QR+K#'.B0 M;KY:IX42F$#DQ"@3E?]P@7ZYU#,-)M-)JW#RDN,D^L71."J7Z:C=_35UC=>! MJ,N&[I"HR.*"WWR7=+0B-Q9?W\A_3@?NZT8`\V.S7&=%8)/\*.1HQ/91'!7RUHE2$APHVN8YJZ5^GAYT>:$^RBYF;ST=UJ/[GL0_Q>F5X<$S[[[3[S/=L*%Z:_H M@0_;+[.=$OGIQ=3`8IJ155XLE6/,C42)E2@9\%:>H8:2!V-$3$6%K<6&SA"5 MS$7<(BP*1A[F?A-&8960IM>K1,@G87W'[):A5!T[S47C&ARRW^JN>J^'32KC M(?4?]T]%VX6DY"5VG=KCB^,G(TGA-(LV>_X,9-[E)/P>FJVEDM?+0M.WDXL3 MJ>WI!(NFZQ,_QK=JX?L0TV(RF)VP?\(EVJ<5S`YG6@CS3\GT4`)20OJ@CSW] M;D9VXLK%W)/+S;\KVL]840K?U[U-#P9FK^LY\#O.`1OJ@(I]C=SDR#8V-GU4 ME*WO5]B/0\>[]O?XQ__"[Z+X-YY3F;UUY?"=K0N[E,7O*)6#F"!$)&G*YE$. MV7T=4I;=HF2J9#G7=V79'AR/@?\0![L_6)L1W1:E=\4?J^TEM3AHL02>0UDQ MARR'F%#$I"9=1=(];*](K`0BLGRU!;Y>`)U5"!]`=M:PU!4D9<`ZAR&[DOA$ M[[_SGQ]B)^:>;FU]7"V8N#;`.QAU&"7B4"X/)0*UX6>\>_9`]Q0BIC7M:E@1 M!T052KA5;1M_5HJ"7N5?Z4'H927K]12Q'66^#31?718W:]9R'525I5]=#X=7 M3HR?@U`\(*@^I31G*ZKAWWXVJZ0NDX(R,;H2>+@O=B]?U&4S-WVJ2=UT6E5N MWYV?/'?WU0N<>ITK_C-*\[JDN,?9XTTEJQ,9B`G1E=-#_;![^*$NGSDI4\WF MNKNJ/].;EQP__NX49G15=X_.9W7>IA"#J!Q=>3W"&[N?-^JR MFY]$U03G^*TJQW\/O+,?.V'29(@'E/7GE&9Y33F<\];5-,_E).VYMJ'C&'_L MGOZHRW1!*E53G>>ZJES_&_:\_^4';_X#=J+`Q_OK*#HW-FIV/Z\T]P5&])C1 MKO9?J#S$!*),(DI$ZD*##`_MFH<__0'U4!T^.M*OBI.VH&C9:/./,[&JXS+L MVD,JMZ14-,.ODMIDV_K9^]JOG1[AA@UV0]G6"&[*5/8K--W5E]MT#P0!FA^W M7HW%?U9YIM<,@'+E=EY+^%R.YMNRQGME]_9*+0X$Z=6$`R\(,LZH,.'7Q%K2 MOKSB.Q+2FY8+M5H?5WUBI<46Z,F(A9T?7$ER)!>'J#Q]%VY)<\[2Z%S[B199 M'MK#/51RZ@6`L/SP2U=,ID'\=Z(CQCCY[_L#?L6^^+!:G]?U,X+0-FB*K6;V MNHTA,@7)#^^(J=!TZFTJ]ULX1(/[?5E%3@P8RUC;[9KY;1"9=(*WA5S:0S,- MV8CN%Q(^JI]$^FR!I55/K-8NA8;[AZ3XU-:3T'4KD13'VCH0>N\JZH)/"[1E M;&D>.W;^AN.78'^='"S`=!$#,(@6OJ1\-"VR!#H!8Z^6RPIJ$H$HD\B6H8P8 M84OQE,$HD4'Y]:+;/;5#[:YL;(ZY6\-B!JS8I4/[/3MO23=WYP7TP=];+$$K MX(1F07-R95N6&'W)%52Y_/+U":8`44X$&"K3.J7OZ/:-+GL\O:.;FRNS$-F9 MR.WP;`^6.5BE'R",7MS3'0YI:^T\-_K"O=_7CE..4>"68[UJ:2,92G/IJ!`_ M"49/0>32[E-_F(X-P)RA-)=B$@.-=8UY]CWP?R*L$!-#/+J'/<@_J>L3N_!$ M%X)#*EQ.D]!`K_44N!Y*4-T,+(J;.?Q[CQV/'EW^A73C;H(HNO4_NQ$!OM,O M05K$:&=CL6W0P_>SY7S;0B$G^0];3./L%B%'CNWJ%E)$C':YH-9EEX'H?QO*P8L9FO MVW-:UI<&A1#@S`QWHNT<'Q.9EP@'QO6%,IB$U%THAZX$89' M;Y/9W:9TMYP=898V%0_7^TM(_BF<W#"7#)+KO84RY` MM5&]OGY^V8UN;O' MOY-_T`XC:+W31,-NCX;3-QJ: MT=L%`0"J6\-J$-I)V[TC'65BXB/^$7\B!OS1+W]X`O1CG&,5>!_[=K'N@G'2H M_O""<5SJ-K#=LL(.IWP%1DR'#[4>F..K^<:J'IWA`+G4G\ML0*D1B%E1[MR9 M,`6N)&@=[-6V24"G#"QM<83=H*#MP7M>D MV=R^/1'+FF\[#J-$YD[<#O.6`;AM-%OM9/UF2">K9^X"1KJF`K%@DGPFO<0A MEU&$>VY6``G4#EZ(E>!;RC;+5<=&ILX%BT3C-("GEWCU![ST"*W87CEV<9XC M]%8OLON`H1OSX`A.-CR"6)"="J3'Q>-+?T\EG>C+WW%C<\5TBHP8.(WU`KK# M;V5O%^VC*"AAH/Q,)[.';?#(+4+?)]I&WF^0I32J4FA83U0'#+^4AC8_]Y(= M8[A`KK_SSO2Z(W1U?6?6V$L6];4/Q*1\`$WT_YEN5B>_8Y;Z^\LCO9GGGS(9 MLTW#!R#\%O.ADQB+Q78VENG+9C`J*AMB/+_+"N)(8E@,U;KY;*K6$PGT21OFC1S M)SU"I4GYCS:$K\)@[!"^%#M-?;CKM(3$EQ_TBG9Q0<5Q4C]`7ZUF,C"?M[9E MC>Z?9:I1JMOX+MF86(UD1R6QDM[S&A.P='=?(D#?T76Y_#*F1\4+YD?I195V M!TEL@LM2#>]/E4R%=ADVUFQTIZJD]N/TK(;&*ETR;?78Y#X6!R1C.UKU4'Y` MOD@G_J2.P;CB/PZ#Y#:#X3'KK$C5ATKR>?VIQFM3++R.CE]I&=8KQ8+.`>$/ M.:9K`YE$XJE&6]-X[UL0QL_.,_X>Q#BZ<]Y;J^A+$/T!1GX\NX'SH;/U:K4: M._S+]"-F`$HM,'X0.#IL(WE88=BDCP='QXYU\?((^"P"IT0.&2(&_D\AWA$W M(TQKB9P-*]TI#!<[CIN<=W4CIN0=,;TVOA1U46K\0L.^2<:)$C\ M"%1:F`O,[J6][B)1`"50M5.><)!*G@-C-)8VIXZ1?,(<&*B$*IF[&H^!R*.0 M4?18BZ%.8FQ9VY0E]J-09/^5N_5V02_PD<$!4Z]U2B?+H=&2PICZ5H9UA(QQ MYV569SB=,?QXWKE\[G<''$RBX?.!J9G@!'C[CI_CRARM< M`Q`]KA+*`AO@14*7V5;1BB1T>T!4%OH[E::KOH4,YVR.VWAK>_I!D[A270))MO%G8K@JA(W;>&R_.T!4X7W:[JA%4S,[O` M50N1A#'_5\<-OSGA'SC^W?'..,7P_K_/:>T9SM"E\Q7%8_4N>Z##)'L]2\?A M5")*1"(F,X=.2:S2$;94'RV]/K:.BZ4ZFAY7I41PH.Z^,C^=7)JN@2\4=-F@ M%A04'>TM-8R9].D]__%7%XKDN82T! MV:=W5/I7+APQZ5K[MA,X;U>=ORCYJ[^CVR]WRRUSCTAI!>6U?SK'4;)&\+_/ MCA^[M`U]Q>#ZMN,%Z@!O;RO!)?=GJR:@$VU9]9^R/K/JL*J-$D/^;W[P%.'P ME;E>BPP+&CTX0"PX'T\L1N<([^F,].7N'V"Y5[VL#Z.2"T`9_8JNU>DB7\B"E%9 M1J!ZB%])E7OG1%+-2ZN4H%#@D"9XU;*K!3KE`!@`"WK;%JU4"\=&Y0U]`"F; M`;UJ;;-:+40HR>29`Y7!'B9CR\P?PY#"2[@6N#2"8`!F6`L_;[T$KNT-?9@I MFP$?+645_YN82;HZ<\T7P,ERLC$D3.1=9&X:!")>!K:`J!$2K2#ZAAUZNR.= M'DHNRDK^%SS4ZWQ?!\"ZC`*7HIK9RP;<2L+3V^&R_Q@T:I,:@1H6C8`>-&^Y M0`1%QQ181LVYH]9ERGXR-,-3:!AX:6^Q:K:(907\:52]JYK31:(&5:#'.M'; MF=Y="&X/G#$HIK](9F3P[L5W_W$6UG<"OZX;NQR;P%,)]J(Y^*O`-A>."ND& MH76L[PRH'!^-@V=+WG8B4Q0DK:"\99/(7SSWV7WR\'6,C[?A+V%P/L%:U:[7 M=8"RPR9P8JZWS76+1#;*A",J'=V&B,DWI1V5&8#&R#,1?E$+00`)@7+D`I.; MBUQ($*7L)#JZ'FFB=^3Q;WCO[ASO]G!P=_C3V?7H10\/Y.57?`K"^"8XNY'K M^`Y_>F><,.6[CX9:"JV\;MG9Q9F)+I0H^[<(I?I0HA!E&E&A\@+E2J>=0!)O M7%(2'JL1'D!P5,6F8\.3D@#9H_-'WV:IL;Q2;*,:%6H9'(GW9"CC??FQM!/&6'?L MLCLX<2L'M#).T=HF_S-\=_1 M+EDW9@6"LF>(9(SW$?E;](+V;A2'[M.9)INV\X9MZ,LY0A1=>>C_>O;WT9?# M`>_HG@ZJ0-P-ZGA##R>(S(%>Z;A<;+95>F`242Z2(4M3?T6BBY9>%R$L(L5/ MN\M/S8#O`EP-^ZTQT3+%X?INC&^(,?MK`DZ?C>.2W6&7.X+8LT=L;+V$;;@@ ME=,>O:V#9NELD6_<9#H04X(*+=GVS9(>G;=\J0E(=KU$%H.DI,H%*&D,RM.AZA6E*A%B5[S:$)RK$2408N!'A/">'X.\3/MVY2I(Z]JAPY!B$C* M+TPE$SBVH,0"_`3FD\Q_82?\2IZ5DH:Y,&-));,0"A![F=TP,81,J#9$U7T$ M#AD4&FG4(#.2*[*0?PRN8"?YI.5;(LUHMF`F0C$Q7R\7(^E">%321+[H M'QQIA+'Z6(11P,)#Z]?W/^.PBO//)!VVK.])!@!B'4S0*7&MS.-R`: M^/2.F`;$5.@M03-1&.PB##^)PO`$#8,!&!$X0!@_*)?/`P`>AL*@&`7!M8PP'_'@E,HW#:5\_[>(FP5J?VU#(E?(0B+`L)(8!ZAY3J+O^ M<[DC?X=#-]A;_;][JS0S(-AF(K2[N%IN88/G7%EU&)VH0Y9QN)46'/X`NCI6 M/C&Y%^B=C!=-Q3D$'D`"Z(RM68"]X(67:2.>@)']2.UF:XP6-;")&/_/M'R0&\$H3_\ZH3[ M]^0>D2",Q#OX.]]1O8>_RR#HC7S6S%ZGN_CI/F\FD^U@04PJRL5JVL@OU4]+ MNY_MN_FE.LN88KE>UAW4MHT?BKM\(S\H'#(9(7YOJ.JF!/%+NCA!:!'PK.EB MOERD1WN*_'%323_KP;\#TD<\']Q M&-#_H[MN[@+BT'W@[+E'C%M9H;<8#3S1UT9@VBU7BZU=ZDY0%QJ01L4R-2"<;31J6A)]FLT4Y#L//\0DUO6*:L+JL`>8283)3\\@(] M_A]-+"333:O#3?3X0R>SR'35!GQ1;>P!1%_.%)#`3,(*/=C`%!;HEROSC;6J MH#]K:$Y4EN)AC0Q?Q!`W"=@#'!,"VAP40]$K&;7QCV_!T]V+$^''M^#F),8L M_T'5B.5:`;W[;T/ONT_P&O]`1!!BDNBV5G1S4HS7\9Y8(D]THG6\6PE629?I MV^VGU*WK:^2Y1Y?NPCTY8>P3"U[5HU.L6F`%E[M5TML[)=3!@JI*&2.+5XE>26I<>M=N1*\BVYV8V] M'+/;$W/W7!_A?YS=^)W=Q+BGES\?7-_Q=Z[_?($.3/\D?K_B\"F8WG,+X'J; MGTH8K9M1/CV\(4%M;!1=!"G^SV%&XPZC8%N MM-E86:5U*A)1F>C61U0JO5X]D5LB&,FLLDU<]=GQM7W;[B+)'B]RE^GN/V(O MZR8$!W1T_2"D/KL^X3HB/*+(.](]Z>2W/P5O/H'ESG^QW%`X1.@X#)-E^OU^E8GB5;*A,]!J@LE1YNH4@C@I4.&.2Z:>EV MLW4`(=?7@C_"U-I>MK.@79;BNSN@-DP MX^W<>'UH:N1Q@:"J4Q)0\RMVO/B%!#]^^8P=8AJ.HGO\XCRYGIMD]*]!Q"[Z M^?+J^-&KZWGXVM^W7N0W7J9BA(XV&+IA:36WTTYRHO*!JD2Y3E15BC*MJ%![ M@5+%>CA!;:2L(E)1[TBI"50K":F-EBTEKW31GC0BRLA23O!E4&RJ1MPYJ3^A MFOZJZH%)-YNMLPT\N0!-I#3"?DNA_>U<,<()N^*$-@3S\SS'(\=!'2MBU\>3 MXX84#[?A9SKRF7O?C+O#Q)# MLO_\G5J$F$F:RN+I#BZCC*3L26&*SL6^"6%97A^<*NX2^@E$*S&+6'%'OM_C M&SW&3(\`LA/-PJX#X"7%O8ENBZ#[N1:;53I:RF72DQT^(L:L]70U)#MG<9Q+ MI":G?I/"(_HZ)9+=M07?4E>/!8ZXK!,##(B6?@V[@IGN??C$ME71)<_;L+P7 MHIAY_?(C#IWL@N?K&!^C2W]_E5R&2)Q++D*-;@^7NQV]%9HPX=4+^;Q8M%U( MC6Z5?1\5#H'WVRWL@BKH-=MLZU)B&&*K\Z1K5-_.5%KLJ!B(F(6(F(@*&].[ M>R/Z8F$F2NW4U$,R[A.4ZIJRSY!N7Z07H&O=)Z44^97.E+)/I)=0OY)P)ULZ MO^'X)=AW[Y^$O:N%T%H,@N\M7"^;A$0%9]N=$]'Z=U/*=YN10.HE8=Z4"H(# M.I.?_(@,#?9LHY1H\^1HG]O.44SWL9G;M^<012].R/SU^41(=YJ6=H@90HP` M!/.)K2N`^HCI@8S`,#7D\BDBU+H3E5(7/:V=F%Z(,N#L'E)``5&F^%R>QZM'Y`5Q,%#VN'$U-&Z`9-EMGU2W3#".B#%J2 MD^%=4CD#[W'H>*CPTH1QD#C5FF`11$$33D+L1/@S3OY[[:=31-$]WF'WU7GR M1)=:@%Y5BY].>Z#9MK46ZQQ+3!K*Q)*\RV9QZ=:O3+(V5,GU.9^%/87!#N-] MA,)6%Q6"#)RG-<#!`F0,^,(SNWB#G1LN;!1?YM93B&Y`"BT#I^ELN6R')E6! M,ATEB,J__@U>'F+*6+!:$9G?V9%SX\#:F=>=L&T/EU$`OG&3G;`NI@LQ[)C\ M[8GT6NC*2^EO?9,%*M8$D`-MA=Y]N-A86P#L2Y+9*FQ2=R)77/Z[02WV5/&R MR\R0W[=.2U,%+"Y>>S2T\T5/&($8I$^"4W+PKA^WQ[5Z2@`K0RA,BJ\`[ M+5=V6T>@P'PJWX3EC"E"D)1D2Y;SZ:)I=G\D07D)W_]A%L"[S3BQ<*T`M:@57@'JN]L=I`6VNN,^@:U7.7$P/6:V>B+NAJOV'P[,C> M#GBV!4C.7NZ:QGOLQ^()*\@KZO=QM]H#+22T6:^7^2[N)IZHT*DGJ;@$(MM% M,65,ZB*`)J1[RHB!>:5YZJT'TDH[N+LC,0D#/&+?H9HB'+[BZ$M$W'N+/N-3 M$+DQ[>C?A?CDN/M[06'ID0*ULT;L MRYES2J,2BJ*BAP.'<(V8(7M'6B)_7OM73O1"]XJ3_]"=F*^.1_5\/N/'@-`V MVU+^?'NX22X1R>9'WJ^"X\GQR;#RUO^MLC/WDQ,U=X!-KU`3_T[C#?!TNCU? MK.P:/Q-2WA%3&'C8#[@P"NW/F%:8##.[Z#[C[':8;*;@'>TRV^A>X]JVZR=J MGMK[0PP*=97B";-34Y*S/O2'DE&(6$4+E^9VL2/5::ASTU!N&SU:5+4.,?/T M-00&A-L>E]FL!CI)80 M77;/8^X1Q4>-!-,-IH(>.H(@!=PDB/O?'<_#[_?XF4 M,UG#!&C1Q(4URQI MOUJUZCN.O_Q(*UK]$@3[-]<3+R4#7E6ZO-]M#W2_F;6:Y?OSZN7AZ'[R7##* M).O:A"/99[OF<[K]YB_T!']P0,YNEY3AP'OD'(,P=O^9C'W(W_[5FO^\1D>B MD?Z"-L?_NOG9+GX1TW4$ENUH;ET@FI#LJ?IO[0LZDW[".UKKPWO_J]Z]!'!X M5'<1`+^+)LRS7<=?DBV4XM2J/*46R675T`2VM\7*5;I=/I6@;[?-"$<6%4_2 M_:X&[*[A)D\M^1M>Z\SSY)@:V\;3\9W*3VK(]Y)Z<+&IM;VIY7QZDI")T=8J MC?+'KOB3%H[!3D@O&B0MR:L3NL$Y0L[^U2'Y&J&CLV>L/J4!&ZEJ\*[$^7Q6PP65('_K95],#/&CB@>Z?&Y"EM=2AI?A M96?U9O<[W:]U=0[IWHM+?_^=N)G\H_-SB=_4@@*A.=#.Q6QN;QO(8%)1*I8M M`A>"=>-%CL>5PT-F'"L$YR8?6NUQT0.W5Z(^"-_OL>-]B6@1C:O`C^+PS"[L MOJ;W>9'V6GQ0$/BZ4N#!;`)W[9>;''VI9$1%HT0V*@NGFS)2\;HP.('SR0&? MZSN]V.N7J%4`]@B*E.GUK(K@Y?[5C8CBKQC3AI4[D2IZ5OE4N\`08*IL-MMY MOI$@$X4R68@(8]TYQ9/N,GRRM/C4,?TNP[&D@V&#O9@ZNUO3A6:UV%E=W<'$C$]GUZ-3WZ2;FOUX?3R%P2MN+XP-?5]QAQ!D M%'C995,LR.8YE@ED0['\'V7Q^GJ$\KUG",ND)&^5PO:L(CY;4 MON)5<#RZ_++SPN>T]1%+1D`/%UJ;1=H_++U,YX`3"E2]JW^L)W7\E^3H[`\. M=<P9 MUZ.BI5?,K1\L>DI'S[A7\5S2JYPW6WP]18%E>-+H'VNL^]N1.MP^LI3:OB.R M^SJ*SCB$C/Q*3^K(\D(]/#^6VT:F)V+,&`P.=*F>\ITN*<_[9E)Q<[_FO\;\ MAW%\Y5E]&.C+DLLFWV@K6@07=[<./ZF%UZUO71B@=U M("'7#L^7U;S9[:%BDGL&=6-@F$.-WD^'0\JSOY%.W-2O.J]WMA!ZR8'H>2VS M@0,OV%YOM\UYZZZ`M%'H!$UW[E_[^,MT. M^1A<'@ZNYY)(1Y?Q5\<-?W>\LWB;=S\I6L`%,@TZY3PG25F'7,2J+OM[E.F@ M]2X*+>@R1E0/8HIT8U%^-.QZ--SD`$>^PS8.6FNK_.5?Z-;;?]%\5&,0'/@8 MAX=82QMB]X/W9PX+BR8`7='09&U;`>UJ;1BL9H4R:ME+(DAULH!#HH/(N MI3#]N%U+?E"TX.:14T]5\)`.?#SV**])4F:[;@ZGF`C=,.CO1V,4)?9#>;8_ MUDN#MOBKMQ_X2%2UWEG:>%!+;R[3#KXLS5XVQTA4B.9[24?Y4\_X#G_4]Z+J MR<3O*%5\UY_]5Z2+]AR$Z:ED?C$*^(O:T,&S!IQ=&[LYV\RRJRI55[V':1QN M])W,N'T4FIMB<`DC(V&[T/\,7#_^G2@ZA_CVS2>?[,4]W6'RJ?W8>>85GN]Z M0_$6H@YS@!FT7B(WXY4^\9+!+ZZ_#_'^UR!BM^=< MO;@[YSF@]>G"_%_7'I$2N.(2<@.$J&:=WA9"6S=[.5NG!)3H0)D2E,I%J9KL MWQAK&8M=J>5DQ/+:9`2ZXN;#L]=T&%H41:7F>5RM/#-K)LORS MV_S3108`0&6H[XK#5/"^#]X\',>//_KAO/Z:"8"OV02LM#K;+.==R$\E7Z#' M_V,0"XSQMYT.4LGH\8=IS##&YU:**']CH^A"`-!6WN!%2<<:QHWC-ZIYE/^D MI-&-\"/Z:WYOP7 M=KBM5\O3JALML2G0@YF$QA9I6U6[I.4",7EL=QN5J+9YDN29Q?,L=>QR2L?: M&R))WC&$?B%NT&NOF)./.#SJ.!PL[7O9Q0>C%^J@*-T1M4>8'@QV8FW%<@`L MD3>A'=&0SUG":[.,N"]KS'U+J]DVNU#"A`NRQKO"IR1=-V*-]R<]L^#C-]+Q MI?R#_O).$CW2L\6Y"QH"B,J]_8H)3T/R/8C='6[')^]1'1#EV`$=#\T7VVT9 MI:FH"Y0(TP;5L2Y9#9<4>-2-V+%N,=#>GACUL`LTB;CD'KL+Y"?^G9A4="+_ M&])G:'/L^@E;T7:8=CK2,JKL;UKAW@*V"N)%<9,,^B2RE`P[/F#I08V`+ZR` M7B:T7,UF'+BC-*4FZX9"L#[0&P[2I_8&C/.!+E6:YB!%NR%0;4*$!]2:XUJF MG-CE4X+C0X*'5$Y#532#CQ)LLH7A[$HS30>#)+AA@]U0-FG%39G*]%7375E- M4/39C79>$)U#?".HC]#^K(Z&B&<(D.KF"]M:E]JB"!6RIB^:T-H@C?;*TN15 M=\,TVC5[F&O*FJDV&%5:*F$D)@`T[U2>^#G-0.YSMHW\9[X2@GC"HWI0_/9W M1H1='><.Y7@D@JR^$XB=&!$A=>@YQ!:4?CW3G>??7-\]GH]WSCL[7-/=`G>\ MI@7#[39!%Q%7V^VL`NE$+$KEHDRP[D9:HK>6"=X"6$"BR[8$E]71!`RD5=8` M!&M:$FEO]5M>,8<\^C0VV]EF9<.(0UO'0)*3(+[0VV&0Y"F()DSH2'0C$,`. M>LL<)(;='FYP%&%`YHGEM('U+-TM0H=5.K.X*/W014Y($`GQP MU$(38[DM%C2?:8U!)D%+:9"Q7M@]O)@ZUUM2A6:UR%4]+4-,/LGMX2K$>S=N M+?K!?50I_S?U0^M;?)\-E4(I/Y&CN93':*?LDE-!YI1>@A=G5)73!9[K M@T&467-[CJ/8\=FM0\?@++SIN/,UY?`0VP+-JO5RLRI#)2IAI204)5)UHD:2 MK\G.EY)G3T$8!F_L.JVSOR>X\G)X[0R!5W>F-J'6$2XML$OKH;I85'>M_(1* M,!5JP3=E%\MSQ4PJO%$&@G?37/[KY)Q>4I]XY2@;H' M\=+IT2?VV;0I( M!1(&>F#G'N2C[-(X7&_:-_.EFN4UEW4G]5=GQ^"6C.U+@WW`-Q._JPD&0H/@ MW97-AHZ9K1"_!MXK_5.*.>=5,@UYG-(BRV MA]`8D+[BT'G&X`GG/B)T0U9@%WQ**KOJ68C<1(,YT])318$!.?/68>]'*"AY MG:"9>/21$-V1^IW`;HNL*?@N#I1_=F)L]4B<^IN:T5PS!SS11OY?.XA+)0^H M9&29@]TQ/C/(_N9'>'>F547%L,R/46.]997@R=L%3%[83,'C-^<'W9;W*>L( M73DG\I>6N(C0C5&07=`)BNRGF6?A0336@7`7*=)B#62E1$'><38-H5SYW M8;4U7*:`]A[3ZVB(=6-@VR)$,W#%EH&3=K:PVZ&;ZS`:O)(BD7:7'=>CNZX+ M\*)=B\7W7/V%6/QK6.CY6E&'LA(\';98K.[ M`)F)NKQ=1(5"1#3JN^A+:808MJF[)^>=-9]D8'Y.`G,*0C9.ITLTN2;3<-X+ M*%T\``^O+IZ("I/3J]6+XS$M>=3ZFF+4M]D"3=W-QBI-%D<5=+LA8E)+I[OT M`5B:LYP5TPMTH,Z^,F?);TO+/4'[ZI9*P$(RMH[+SJC).&_MQKN75\:;MH'07 M=/(3TJW^RP`Q?9)`Y?9PCQWO"^&\&-^%P0F'I/GF3!A!7E$-Z0Y[H`4?5[:= M%>!-)=(V@(=Y/#/L'^H^>7R9YQR#@,X.@]37FZ_4*BGPFV!CH]W<3AOWIO!P,_OZN M,O0+/=$-_PK,(/@O`J!E[!SX^X#T0\CW>W+\/VX/!TP&&/?$I)OK3[?W[?OK M0>^J'$5##`+/`EGK[&HJ)A;EP28:$:`]V@^.;$YY`= M![W'I[2&W^WA+G3]G7MRO,L#^;[T]K:O[BL$-[W$:8)6'QO!VW'F^:T25?05 MRE"AC0[?J\J>=T4U`Y)?Q&P>X?-<.Q?^]_QC_CQ M#7NOF%WD**Q=,TJFF2S0-!2^:&G;0ZG@VD=4+4KT)K>U3E1;1R(AC(P58P62 MKHL/0@IB7`QD!D'\C*<'>?V"DBQ3Z:!G@T=/>Z]&T,#'Z0X,#$V&^LV'0;VD M?D`M7A\#Y23#I&4*E64TRHEZ\/C4LL:CG.C[*"CO&YH,Y>N/A?)2NH]#>1:O M#X'R1Z)=6F.>"#,9Y\Q"\/AU-;XY9PH_"-+[!R>#^NI#0;V2\Z.P7D3L8X#] M+9"6*T24T4!_"^!=T]*:\%"8OP4?!>0]`Y-!?/FQ(%YD^CB`I]'2#>_.RVRX MSVH":-\[7"S;7O&GSPRXIV:T7PQ`HE5S'0!JOXU&Z*\N",29-409YV*:UD<5 M`Z"N'YHGB_EZ4^1_G*<_E:/EPAII3MF94S_E7EUTN:42$Z+DJD."&P03$/$Y MH&?C@9\O?5@C*A(+P,6&MIN9&!>)+$.0,<"Q%FRTN*8+'=5$:\-'*10ZNTTW M@>-'=\DYWX[&O?*HADY363]X&6TYV];[3$P.2@7I[2\-=HFAXO'%#?<_G1RZ MO9V!@VX`THT&45+QND\-]W4@X9OSWP$9X;S?OOEX_W!^BMR]ZX3OO_G$X2CP MW#VMR]:Z&;R/!(6XZ6$6F)%7VW2N+Q..F'14B$=5^9IWAD\5`[L<@Y_J,;BH M!4$G)@>D=QFJ?0.H#<'YF3+/B:*6$9#@8=6X;%@`'C!L-]L2!$N'&ZDDK>,@ M"8[9`QQ3BB1AFC5`PP^$&?AH'0\)']>*D5Y#!\M:+]=M*-$Z*I+B7`M2#!@7 M=:5<.UH&CXVX)X._.>&SZ]_ZGYP(W_,/`C<>47SNMZX?F`GSU6([3X[Y)A+0 MK8^H#'8\3^F1WE$>6"H]:#VN.\H-N^3&*7#I,IBSWY.>81R@^`6C)^I7J/'P MK@@)V5E=KO=Z6BQ6D[9CU%5^1FG;5%(,OMO)LNPLSY,2RKH'1D.=L$M.Z&UB M.#E2;5?J+LIH3':.YV'_&]Z[Y*[2RH#I8)1(AFEO[Y`3+B>TE(3N)S@.I'1=#GYM0*/VULV^6[;X"^M MK<'KA=:\&82'2@JC7#:UB5E$^+!RYA!9`JUHLMK,9FUL\;-B6I#B3TH%B`L* MG>B7XET+XO5!O`L^!:Q;8R`#RF71MX>_X8C\U[\*?!_O8G=WCC^=78\6X'S` MKX1+Z+;(SX[_=`[?2\^(L2]1NFJRD&- M9N536\[+DC^*"B+_ZOY(ZBEEQ3?H4O9PYFX39QI5M]@*'3TLBW$B"!-,95)R M+"]V0K4:2L6R(M2#>_5$:!S7R@I3#W(]L##1*5AT+%?-,995`3P#IM&N>,OC MS=O#P=WAC+9;YL3:'M?#>UQ;H&W]UMHNJ[R6B,N[1KJFO&3Y9NGS#<(UXQVL M<$F0./B4R=/,$JVHJK&`.!)24!Z&KN?=O/N[ETM_?Q5\C[_%;;V?EL>5HUQL M"WBM;VM9&XR(2%U`E^2>I=6]#JQ+\C$II1X<3]B/DMK1 M<8`J/NL#?#?`"L!WA$/+^JWK=Z_?5IY1N7Y;5@S>#G;!+ M3FA=O^7E2&7]MN&BIE1F&V!9,672IQ9_C^IC:A.ZHAM^T?',SG,ZVG8K$_SA3M]P6MQ3F.S>1:BG?#(`)64^W?X?1BWLJ M[KS[]$Z"78IU\@CPR\+E:<01V$CHT8'M(JNAT``Q_!,?G!]],VA>$ MY,WM%)^/V-(K@JPGM36BF8$F:JOM/J-?CV<$M2B0WQ[P+/ MW;T+Z\1`7E$\8]5E#WBI9#U;)+-6B42ZDI3+1(E0M3NNI'IFM7NFLT:.;%?M MDJM!R55M\]-0E&535J!HZ.C"?,?QE1.]W(7!J[O'^T_OOT5X?^U_=7W'WY&F MZ7(7NZ^L&):@O>@A0&$'!FX5M.:9M9C8,9]3S3/-G:ZDHPUG88?9K.EQ.;V MA>!!AF>XU[;`6\_;?"47#S]X+:VUNJ?)_>3ARQ`[8LZJ/*6VQ2JK!D]HS&?+ M(F$S"8B*T-9J#?8C;[?"S`]'X(="_N>E3:T%:#BL)\/?+G>[X.S3?B+I0/KD MQQUF%W$E^R8Z]C0-%:,4(_UL`]1Y%^8R48[)AP=4NG(R<0KWI`XB;\Y_^2R42(< M9=)1+EYKSW0*Y^T>SNOKW?;$;M'[[1,R&2Q#''&BEV*RB,XIT4._Y#]?_G%V M7QV/,AWOZP+?5,TP,+.`*6?-E_8FY9=$<'DVE'_C.D^,UO*'0%^XGT3MS-/+7.CTS<+.+FC@X3.3A@J==%-2JA7E:HLG M-7/5=#$2QB\XO(PB M#.QF\=XSANI*1D%SD(1J!2`T)ADEH@WAK*'.=C/3Y,X.))^A'C.*29QRA$[I M)1<.#+LII!Z/Z8DB8ZB^7:;&RV911LDR:/GXY6*^!?-&2;Y)Y#'4;2B#3.;V M-G';Q\_TMLZ!1#+8^T5!)UZ[AP9P"@>Q0&*IQV=2=F%7/]_1FY^_L`I'V9GZ M?C0CEF(,WPA-A$X5;.TY9`3&]""F""6:\HH.A8H/K M!4VU5&K:Y5:\\B752Q'%%$+-&2R-@C=ULP+?+&`S1$*U%*];Y?WPYJ<<#>Q\R'&<]CLJ']:F;IT36!?F7_U.(=\27"-.JU&=S2*4=ND)J:8G: M%`1SCQWO2T3PBXMYX^@[;IQ.ZO6N;I(1&09LL]9KV[:$-$.%HT1Z::DE0H)M MQ^J(1HK7(JI1[76_SHD4UTN;;XFO./'5+>09PRQ=F!5R2VN8IF$7/[['.^R^ M4A)CLS^PS]E\33^G-&P"-F7SV6JV%8]HZ%9O\C^99/03"JAPS>.:L>Z*><2G MN_1S;YED(QADG+^,/.ZKG_*G0.2<)MH0@K&%,?AAD40613';ZM0*I^*IX"/V MD:"!0GJ8!VRKEMOUW"[8I%0.N#8%><$MD*R<5::*@-4=`74!Z.2:J:(`N;K'`:G>N4\ MTJ#0F8/LUAN\6E_1CM=>YZQG&WNQ;(>FWON^I/G(;5I;UW?U`DY\/UAG2#3! MZ#Z=N/V,GX35D&I/J05+637TZ.AFNRAFT5`F`5$1V@`QV`^&@4\.>7+'2NA7 M7,IFJJ=9G01<.C+J"R5[-\]Q1$_T4FBG;FH&-@\3-2PW?)8R&`_CES?""H_X MAQ/=A<$!1Q%I9;,+%OY(!QL&K0SMEDNEMD`/!6.F'14%I_= M^LP4:"K^,I'OED&^=XR\IPF`W2L`^D;:O3%=C++[!4X&`YVIM-O##>WO[XG* M$PY%V\%%CZKF%H$=T%6G+2WNEQ`)DT1;6(_)HK4\4V%J&4.&1U;)HULR.DT\ MNIO6HW8>D.&67?U0]3OODUDV5GR5'C.C.]70VXN[>T'Q"T8[MIGP';T$WC[B M7%RFC2,Z4)<30EL$9:*_ST':SG=T\<'(\XOKE64OZ\1@S%E7J4[6N<*HPZI2 M/:W1AY=ZZN6>[O)]Y6\OA!,*RB!]B](N!!2$]$_D;;V;$J"`;3#(Y$=2NQ2E M=8_P_FL0?DKW='_#\4NP'Y($+=),HQ^QJ="E;MM:+'H0TP7*5:(#R=NG_)Q$ MHM8LXI(4'CBEE:)#5-(JU]-'9QSC20I1C0M-VV\UGD#`I-<14!5T>$=2Z(7V MZHIS+MD%M/F":C[M_?D5P9::1Z6!/X$4L9GTZ@1X%.>9#CES`X/]/A M,PUVIOY:L0Y@38ZA-A:#Q+W\+8EGATVP5NJ,=]2(GM^/?`SPZ\Y`MP M+9G)?5Q36\JS!=IOG%O+>;TUK!S^.682%6^--`]O3>@!K%$2[5@$S4'>E!,.97(/9+96/(1TN]&>3$0&\# M>"*-,3VK]("?C[P:W]TO:&G\ZE9`FX7E>KEJ`B23AC)QNMN]4>XU6KW\YU(\:`4SN M!ZC7.=29&K+WY'VV*$^/N-P>#IBM5"1[.A%V6172.,CG@.FVDPA['G()XDGJ MN`3TS4EC^@9YD%U07).INSO+`5V]+UN/K([&.+_H^,N/$_:CSNO"Q<\K;'B% M1D`/7&VWJW6"MN)^[TR6]MN]Y7C'X)=)T'I1=V>*E9O'=N>U(J3S\FW>DSI0 MT?L6:&N[VJ[J>)C\.NZN^ZS'^K-*BD`R+YXP:7IP4:D@O>F:-DQGOSCGR]8P MQ1LE__(O=*OUO_SUHFB`<)*FK%3Z5FIZ)*^Y&M,?)8$Q>G4/Z%<8E M0R;$/(2FED&S=;VP&[-.W4!%J183>OQ2(\$:5I)?BP^`T5HB#X!J.4(&(_;: M_^J^XO_"3@@;=X,$F8?24+)P7,NR$@\9]:!^X[+Y6P@GHFJCX'G03')\+S^&'BNI_

'XE6.0UT29*)B"[,@Q;+FMF+[3!(,UT?`M,#HY*!>O4A0-W,\4&H MKL7*;%B_!7)`G#^Y=):#`3T6_`QX#PD(AF8EQ\#S+7,'@;E[^,)G-9L/`'*AR&@8#XR'G5QOW.:B86!N9O<` M,->B90"8DRTP;$4*C("S)+CD98N3]>='.^GWWY]0`=G1_>0"0X":P(W/-M;P`V,GOR]+OR# M@)?QEQ]NE#]USSM$-$J6WETO<$.A6_1G>66]YM:78M-^[>@K(JT'S^`**\UGFH8;L2T:#]QYO'=Z$FKQL3.ATT6H'PV:/0$Z M791::?$CS'L.8I<>-*EXOI,J[2;!Y"FMW,9,@(Y,9M:67]Z!X4\G`?5W@\'>]9WP/=E5\]E] M=??8WT=W.'QX<4)NZ9:.-U2CM-T<8'K,UYMEULE(!:8[RBY0+O."7F^%F%BU M");HHL5QL?!P8@?;L2W12X;SSWCGD1?WK$+:R7'W:%]\28(H%(D<50)[&/!R M"@!$1SH=)/5,.[]5^IA6X"B'?T]$31-E3,8P`>XPD7UI*[T M@/(`?^R*/TG%1#.`6H4$'YTEA[5L,:<5C9/R;UTE=3E/JMPFWE0/W?@\W]I9 MSY35;\ZJ]^DNH#O2([OND=[RN>)$JNS/%CBM+??I588A?L%^Y+[B!)*_^;2F MO_M/O/_%<7U:16M&?-56%!8B:P$K_HEL?E:Q`J1G5FV81L40NU+=)''W\3(OR=H)= M3S@7-)ZEH'DT7H%?%`>F,U9HYYRTTX=L+#:(1^H'T$A947SI[]/2X_EXOSWS M^*^H)Q2N'="$MHHS#RD_D/0E\K*J^"B7J+%)E^%CJ6T/\MFTM(BWWD-:@`3D MP$X<$6TH2JWA#UO%#ZI&3$4[M']H+69V&2<9/#2-\N3X4\)$B@3M0.#F4"/] MFRYK2_KB/E&Z8,-F2R[W_WU.[ZQJ^VX=;ZJ&1;LYX".Q"[O2GI1OQ\WEHI)@ MC<"1Z'%2*[IXF=Y/],F)7/TM"RP_&P@#Q$8+Y-Y\O$\O[GW_YOC.,SN%3)M# M(=;:7E$)LA8[P#T9V\Y&$[.F#,`/7; MKP]:X03(O0J.NJ(A8<'@SO&.>\'>W3E><:4UZ1P^G)SPCZCQ%^&JPG!9 MBI<>!AL*G`3?S-?;5;(^D:E"J<32#>]L72M1Q_NKEI4,-9&QNB)SJ2\RK0LC M:L)CCTH<7>LLHYDD6XP9%^0I.;$_\QG&;[V&>/02DVTGBYE!3P,K]S:+VFULFJRB,*APIEO>`%S/EVEH&"OJUY9FJP M"RSA?_OU,=D']1)X>Z+JW]`7=H&CSNX_+U_*W?V&QU*:,H(4QWO`<>RQP6-'-PVZ";3C37+6SPF'46Y>'85=;[1#N<: M4,A4_*RX(9S(>:OL?"&>EF$I=AD6&E"B0OD2[J0A6`Q*`'VM:7^(%TUKSQA* MH:0(!XVV_-IMZ5RWOJ"<=MJL`2;:QEIM[(QHB#Q>]_/Z6M<4@#0'K78'7:U= M;&E>VAV?41\Q0(!64$%G0*2`_SVAF'7N:!CP1OLNH=95HFFZ>`=E$FC,1":C:H(:1!X"\8JG\T]NIFW.R)0[SQ%K_RM3F'`HZ41FM'7(+S MAGQ#P)M-[/6L`KX($7DH%8@>`Y2+U+4O6Z*?BW0;`!42H:.SQW0;P,W-E=9M M-:`LY,"J)2*:P41:W1W&^^@K\?,S/@61&Y,VN=@"Q%IG\DM:IJ#[J_>2I@>` M?4R$MPUKBP/-3!6BNE"FC/9RRUOCR@H-`.YT\5DD1X/3*)`.+CTK@'`2!8>= M8C($VT-`(4!][W#JY(/2'&)'HI2?U(#CDGKX]>/K90VCY9EQW<@;[%&"JGQR MFYZV-P%%G%3B(:3NMM[LS_N^@&%>\W$M.*C:`+^]R+:;8"A&%1W1HEJ"#MCS'((R?G6?,]F,%;+>Z']#JI"?GW7GRM)Z%Z$I'/HPXH=*) M)=++3:9U+O=[UK@YWG5Z0O+:?S@_1>[>=4+.//%@.1K0!S8.S.C;37V(1X=U MB1)4:$&9&GKK:5F1;LA.%!&&Y2LG>DD`3`:"Z=PH.KI^$+KQ>W[^-B(_D>'B M?[/?_A2PK?*FC!I[@X(']7XA-H(#/IU=;T^H"0SVX@6=J,ZM@%^ZO:QW,4OP MS<49`]*!#C(T?L'T5.;]]J`V,C,5L15 MXV4(M"+7QV3L'/T2!E$/@%5?TPNSBBW0EF%C6?4N;`5LF5#$I&I=@I#C:W(P MZODY9$A/P,>.[I)F@%ZFS.9("?9.Q(T7AQ7L$#5\HSU_Q>%3H-!WB^?\*5V' M88[7&,@TFN&BM(-LFN$R@G*N_5?C1D[(3:O?0X7R1^6/7^)J$ET.[?VEI:Z5:FW8OV M`T5RW+'$[NCC&Q&N_2\_=CB*;@^/3OB,X\]N%(?NTYF" M[\YQ]U^#\-JGK[JON/PW[ODK^4J4MH3SJ^)P=A"HUI@F MZR2^?R8TZ^8Q.6"V>SZMJH>R5@\>A[S,23S,:WN&D8O[BG;>)<=8>[()_%[&CE5:!3P3/MLO5IR MN\:YX&*W:B9:&PO*<9;#^S1'1ZLG!._:DJ/MTVBD:IIP&RSYZN\6DH7F:0*4*K!'$X9X3F, M651X/IQ@1KC?Z`SEOI,4",YQ%#L^W8";W!^K;\FS/Z!!Q,.)W-3TTYMQS"(9 MZ.3(8K99+QJ\PD670432SSL0=YA&%OUG[`AP"B&J%L';)`L:[:8`1D#,1WE0@X&<<@H_V&;E9+*%T_<243([187P]+@)` MPDZ4F,S8X\*0=!1#_.H&YZCH(YI)1$)0PYB('RG)5-1 M?WH?NA-EC&2-U#7";&BQV,5VTQRS"O:54.6$UU"F'CV]&[G-1%78.#PH#-NG M4M@^O9N[G415[#BC[+2W&P`,G&]12[?E#S@^4&Z"1C15$C$O%)D:L!Q$K"!N'AEL!+^#O'18;M)J$V(,BM/J$%3KEZZ`:IK6U9%419FBX9'&%^&59$@M9SKL.]8.BB M(]0#G?9ZQTX8(>S3";'/>,?$H;EU@6AFZ@5=`P15W%6]EP:]Q^`NW1-\CZ,3 MWM%IL!NZ\6L]53]LM''![%_<0ALK3`>8"AT$[18FTO*\`GH_A,&2JT MH40=*O2E"_'L]XBIU$`44P>F3"F/T,!<*@D,@("FCHY=39MLLSX9J^;1\9+H M'$II$Z/(.6)T"FGAWB2)V%,H%L5*':>-8))6BV!SK>L5M8ZA7M%'LH$DM%B*E)UAT*^G_9P M/Y5-+X&2LC+=U!T?+>@BLG`8XN2ZPSLGO`T?Z!S[_G?'.V/"%@_TM('HF\-> M5HDVD$70;)QM\C+;F=STCD\B&=V&*)&-F'!$I",F7A,`Y;MN5UU/#I[0Q9@G MEKX[ERV<)%MQ+M")Q.25ZM(*S%[Y7`$H/'[Z@#CQLT4T-$K@7L! M+GU!,]@2*Z`9:%G+62O0$G'F@&R`>_T`Y@H=UHFJ:C)V(:H4)%/0=%L<;.WQ MMU(8NIAZ\'65N;?F(^ETT(%$-HO[^]`/.O_X\LXHAV'^BY<5L-J/_U^P: M_B?R`Q^G+5IR"ZB)J*NDJAAI16!EK.*02.U>@L"[]/=7+ZZWWY'876$:9?&2 M:N<[JE=EN@R"EK^A6^+3U9=,)$N77"A*I&I:C)7JIE5U\U*YF^TK)E)]M9N? M=%?S5=]*!Q2!^8H&*#1Z6MZ`'HN(OA+GK@+/H^LL@7][N-R_.B0&C\'EX>!Z MKA.+&V2P`*7M--0JZ'T]]F*6`S"1C:AP5$BG&^=3^>P*LDR#KI9]D@@P6-[C M4W;7&JV^F4B,DGO^XD#_G62]<[K:(`H37P`M0^: M]/.M/>?104D/Y8/2Y<7TFNVL3'*F33\;3!(71@;,T5,6''8\;5\HNT`^9C2Q M\P)VP?$NH-4L:.?]F!4G/;(.;_1OR9C?%*[H"QH15?2*O&ZFH'/ME,V):<'Q M&/ALK@*07OSW-'$`UQAP8L]6,Q[@,Z$,VTQL,E>G']KCW4W*91&<[II8CMB$ MI`GK2,`L%>%0'"9C0!<^.!ZQ[PLKW=#GRU=?U`V[BC7@WN5FQ1U-%[@+$95+ M\9=(-@AYPSUFT,M]).UDQX0Y:4V-0R$W;3MAV(R9;AS>T*:9T$.(]ZYPBZ[P M>4VHJQ@!9OWYG`LV)HRU<$RU:#B\#,.09G_HEV'?CBIJ,(5LU`:4<3&1;3/?B]4<5]3Q>Z>,;`\W#) M'3M2H>P0BX%X&^UOWI?,H48:,Q\1Q%4!/&2#?DBEGXV\/W M(,;1G?-.:Z<`/KSP54W`$]D#[ES-Y@L>]DH+%01V3#)*1>M'GQ2G[8K3;`R7 M7?&"Q*X%%D&P-G&Y4)OW<6QIU\NL3#N/W._(=XTM_ M3SN_IV-+E:"^8C2A%6(;.(G7_&75;/#'M*!,#6)ZV,:'7)-^($N/!V>F-<0[ M[+[2P^O\1L(58XB!P=H[82YTJR9GR8SCZAK"CP MW#U;S6N-EPZ&[$,F(K8$QUW*UK3@@*.(C:^2[2V7\?\BG<*K,(CH>@#]^2T( M]H_XAQ.U;%;K+T7Y]K7>)D*+"V[FLW6VH:U0DFWO7MSI;&![\$UI38=&AM-S3A_V/3I_9'HYA72[?&FVH:_RQSP\?_-W*[Q"&=N MAK(*E:RGQ.U$7E=0=Y&Z[93=ONAR6F%7`YJYM3X(*&)&@9%:QB_/V^--$\!8 MF`--R_G26@+`F"2EGFJY$SD-QZ+.*KO]4Q>$QEK,C$+C;Q$^G+T;]]"R'-GY MI@EH+,R!)J:]7%@`-":"$95L&!8'NLRP^"6*W2.;3`]"]]FELU+GQ%&/3L97 MIN%/.5IQVV*.=G@V[H)==J%T6J-Y?;NVH24W^?,A9--U"8#[WV>":9&2Y?_D4G.,']]EW#^Z.//&;'SQ%.'Q-;BXZG>/HQO7Q=8RYE;,E"%4, M[/$60Q=V5XO%*B&#LDY44HJ85E12B\IZ4:(8_9VJ1DRW6AI1'"OK(\2JE;04 M!\Q6$#`5="B/FC(*E?0A=-+N(V__XWB!'X5N'^';!S>V;5D+.53+U'X0ENT? M(BD,.V&(IB'7_G&20JSB.!G-J8^-;:MR8J]C2H>8'9*<\MZ_DM&[3P^DE8S_ M[$;T:/$A@153J])K+9C0`IY47TO"&`5=))C:6>[*KLR4N?(4;;#(#K2/OR3 M[36(>`P9P_5`;*E?`8W8U*S2,M[J>LDD-NG3V5TL-_,9D$GT#(QD^@DC$(VC M&YG.PGA#^Q`%"$<071@\U'C$/^)/GK@@$?!E4P86N47@^Q^V2S#^B&S$A)LX MC!CF>0V,]S@Z>_R=FT:,#!K9"AX05,.C`X;WY&NT[6(L_JX03+E2<-8L9^GX MF[VJ=ZT@N?$T\L72,0?IIGHPV.B[*@]4@>Z`!7^1$=\"KIAZZ= MS;?9Q&3R79D(C1`;ZH*EU(5NF`WUHP&TN5:@<9*^`K6ZF]+`]A9T0"U_0`O0 M,NU`$J4]["K,W@*=(!MDOJ70?`#`!OG0@)>M%U[U-*^"J^*BEF$.=KPO$;WB M^7)'8'%FEPU\QJ<0[UPN0,#OJ1P2=1D#/LF_R.XZIR)1(A.5A**RU$EP<<*A M&^R_^/O6(914AQ?L7`6[^`X].1XMISNA:P^Q$\;JG%M2YS[A9]?W._Q3-G"$ M0JXRG`0%14;CW*6(%7KB<3;L1=6-.<@J8`>.UL5)MS1"^.$B*2ZGMO67[R^8 M#Z=P=YNXZ^-GJD[87YC`:\:*0H^4="!Z03'O6,!C862'@YGW&>_/[#XDX9)! M7S$F=4=JMD&/%UBVU1N-J%"C')A*PK%(S\&^NK1D%SH$(7)H#1;D'D^.&^H^ M\SDTW7NU_;P`&HGMXH&'P!/=#]97BDG(KIH&OO@ROQ4,!.SR0U2-L<`>$PV& MZVN"X1V[[VN/BT*J-`;D5_&;_IM`!V9\+W1SHBBYG_^/,R%/;FLK?E!C/[ZP M`MBCLS:+V8K7;R\D:>ND#W2&PQ83.],^83?>HZ1\6H<7JKO=363PNMDUCW4W MO84YCR]A<'Y^^1H0,DG.!$#ZT^WO:VIN6XV"WY&UY3:TA7"42D=E\9KV24SB M?;6D7W9;D3&-*"AW1-L0A`^"@`#P_8-G*OX_ MO6>4S#WQ,D*28:BOF=>C_A=O8:X-\)_>BUM=]!P@4106!O2'+U?H8?>"]V=Z MV/WZ^J(R2^"T!.J"5O2%1,HDLA#@I2]/\,)N*D5<.6'X[OK/&;=].KL>7;*- MR"O7QU,8O&)V9=6(+`2K,(Q4H':#9Z!FVW5/MLE,*/4SGC:N M^#BLT'KN?TQ<3>6%:]^-7<>["J)I)CE@\@WC#I#1T,[U?+V8]6235#^B!GS4 MN0WY,6244P[-11X8]/\XQ]-_?JAYCE[`Z\M"\.!_"%X:.;W1E&4RW_09N,\W MJ[Y3IW5N,7M68UQD.(SQ$28XA+D_B@:,G]J@5^O\%N']UR`L_]H:D3Y"D881 M@,A.\,KDS.9M4FSC`:J27EJUIWNOJG_BUJ(P@P^D!"K9^_B*0^<9YY[3LN6B MR[M,(HSQY.#L\6I9Y43X!A,C8LWR+5&E^TG3FXS-(7_[CQ%OOH"N9+.IY=)S[DI9A M%<\2Z)PA"0UGVWLV46K>.?#QOG8?^W9\>NK;C(%16VKR1T+"".G%V%>\QR&M M&K\+COC1^?')B<35VCO>TH(RKBG@@Y'VG#-9F8I$B4Q$A"(F5??LQ'A76;OX M2QA$$=I1+GFB$MBDA(_)OX+@#_3J>&?6;)Z2`Q(NCEAME4,:%#<)2DR")>#%LOF,TZM- M4O8R+O9",Z$FU&$<[:RQ11A'>P:OP#B>18/8\12YM:)N/5*%9A!?&UOP>4\8 M`JFS'M>L#A<6#3E:1X9=[VJ;V^@P#%JQ>&&O.-,9F?`+M95GN^Z-JD/PVYQF@,1L`J:A``9\2_:89OZ@ MSP)39[E9KIJE9R_0=6N50V6>#BYUMN(YNK*4H^&-+>*@I)6F9.A`B$6LP5<5L\<-`9NKO M,'<8\,QFN%Y%LUI&H+*2HF`0%@$R#7/?\1#`T;<,01LQ!5Y78MF M8\]_2>!_&(<>6.T144R,0=-O?K%=".\K.][8'2G_,W#]^'?R)*@2^F#!NG'9 MRUKXH&79VG6,4%5MI>6@^U&3^XB8;I0I-PCETP4M/?2;]SSIU/#^E2Z"(]?/ MKS%!;R_N[@4%;WYYSXU+"[]Y[B$(?=I>U,9.5.SA5^P;=`>1,!'YD.-'1R^6[MCV MI&M_%V(GPI]Q\M_.#RUX30NJ^+:`.X_6EE.<)Y&),J$HDZH;8!)\319DLGM( M4!R@D#J.$\==TX:<[0G*!UI+E#2C+>]H7/X`[/>N/:X'714;P,>PES/.J_=! MXP7-V$FL@/+T>KOES'*6T9/(,P@_`QP4(:C+09W8J:9?%WI*09&R\>[%>7(] M-]GN=D6::!Q^P\WPPH>5;\(360(\6SJSMMM\*UY9%DJ$H;\GXJ9!@WA' MGA2W+$UN=>S#E>*;W?1-WY:\+NP4&_-:?=?3#K+--'<.Z5UTM'^-!Y6V>W7M MX&KD\V*=(MDNQ81H;^9&^6/W\T==JR9*IFIKQO5==_8_AHX?.3M8`;".US0A M@V<+.*]F,XN'DY),(^IZ2?26@Z(^WNI`55N2BC`FC)-!B.M>.^]X33_B^BXM M6_9FONY`G`F+Z!*=;0=_DOKC"%8@`$8;%H%35!K MM;8[T?CI'=5Z75JG&B>)`:]O:^QSEA*74B8Z9 MSE&>,&S_#;O/+Q3"3EI0/LQ=\YAKL<`U-1.?(E@4$Y[<$$B!I(_?'._V1+%` M!4?9M@/'2Y;HN5^D\R7ED.VR"%J.8CV;YQ!F,E$BE"5_A`JQZ?X3Q:"6ZJ:E MV#X.(@C1N]IY0F`8 M,+>VR]5FVT(7J73C:$.&UV+V4.MU3Q:1X;I==CVI'D87)0500+7&-R&[!2PG&HBA(PNP]WF'WE>I@F^L%7Z+^ ME`:TUDR`[J.9;>QE`M7'%XS2NBJT#=B[AP,F_4R:"SA^P]A'1"[M><:TV7#> MDR-B(4XNUT!/[\A)FP3G.<2LOCZ;?RJ]E=88#D*$?YRP3SX5^/;=?Q() MI`5V$%TIH:/=GSRZ[LKJ&%_0%P)V%"5ZCV(RFHS='1,=.FD#G=0[/@8A574B M(4Z"]\S`!U8D>?C@,BH^R*ZS=]10$9O2?&D/8F,ZPAE,0Q^7T4 M4;=#]A/&%Z7VV7O_&3V0KG'?IE_"\X(V>1Z,M=QRZ3^<$Y'%P MP0J9N7X4TS]?H!UYB[@>NM$?M&1)0&OI$!EL!M%)=?^LG*S')'/.U*B0DIQD MTL/28WS)*;KTJ7\*1+ZHXF4!)Y9)F>>T%$9.B>?VE7 M=T_8\'N.:2M">XF?@C`,WN@%X&W?0_R2 M+I0*+0)VI!>+[6I5`V[$;KLM246%6#U8EN.EI==+&.3EN-ID@:#DZ%.KHTK! MWPG#!A^T!TC/IH?,-,I5_C.=C;DAG7_RSRO6.14NIW>]IW2#0X[,0.`?'^BQ/2G0Y1I43QP=VUM&*=+RI%5)>ZMI;V9B;"D:;SN_+\^AB`X1SC[0Z!E,F65^PW+P@L_47YM`E3"_S$\^W< MVF1S(^Q%Q;,?_8VUIC:V8Q*CO\5VR6*-TQ&51"WF'`I_]+033/]]LBQ'<_HN M\-S=>_<9BJ[WE+8>'<:`2W.5=C$PD:@D$R5"C3@D(=-?6^"OWN8%F);5E@82 M%HTH$Y\<3/^L'C/@$V_;^69>@8:V(N\#[%YUM%F*TUIP]*[DF,XD[3Q@7GM, M0]+V/5.]M*U9-7D-."X^PI5*CT9S775^TO`R>\01;U'?/YGOIJNW5\'QZ,;" M:S#Y3ZH?&_#,`"Z^V]O9;)V/%=*9?BH)%:)4CQY&NV.I=Z=K?#':)[OJ4[I[ MK-CPI^^BJV[0E,8EPCA(@.Z#X^';PZ=S1!=U!)-3HL<4@Y9G`_0H@;712I)X<5C-0%S3909+@4.JRC MQY@8\Q"3H=4=)I^5@.B9_"(OO?L)'X(0EXZ>"_I"_>4H['/V-@X\^%[/9E5` M,26HT$)_5]0Q3A25BQ-,@K=30.OBO[9V7J>-R9R!\C$\1_&_1?G>0GI'2")= M3X=]6I^9R[>3>OB*PZ=`IX]6Y;M^#<(C#DOY_3]TCF,&4UEYH#,L?+J9FYY6 M).8^O#BAZ,H)X>.:>+AL`WC@/,M.M-;HEIW6)-(0$Z>?7`8[EQR`3\M?1-3) MY"3JB1X*$OFF`V"\C!/AJ!$-77");@]%=?&6SUA]3C%`*LK!&Z%F]J9`!MO> M52H(KVMWUTAWV+ZNSVY$NC..I[6*DS!YZBG?]%;*2)NT0E_QPRZ(XVA/M+0, MMOE/*A]O<\V`GE"QMXM\R$T$H:\8%:(4#[;'.V()'-$ZY![OEMWC^Z@9>;>" MI!A\BUW7TBR1+J83N@'I2N.=$\6MF[P$#ZMLH+@60&E]MTH2^D@G0+8*VM:W#;ZX7?D.=J.*/23$`@$.]80C\S:=- MRBEF9XT><'+=A&4O9T9`D@.+.B;KWNOL)O[FT^(H[L'%^]8+C,3/:^@L-HP` MEWW>KJP:)$JR--]J),<[N^S=!=@]U3U(8=[Q.I'\B.B!S0O>G\O+K>5;HS^] ME_YU%?BQZS^3!HK\%+E[G!1=>J2'!849($>Z4DA*,1F^TVV]S@"<**YL.BCK MIM=-E/Z-"O6HHA_]G5F@#?3JXV=7XA>(XO=4B=_%H`"JHQ6IN*R2D+PO9#AE M2>(FDTFH%UKF:WL^D&T^"JGTCP>,/2YJ]/'!2$(&&Y@">WJ^_]J/XI"-EJ.N M4UR`%[5`6V0-N.G;SC9-,%.IJ"36@)- M1#)*1*-"(_NM<\I"Q5!?R+WHD>'@-3D-Y,\CZXKL712!3#AM.M+YN$WEY# MQ=EBL>V%7#/&R])<[P-8DT;&D%3NA=.AHV#!VG.F+:UXZ7A7P2LF/Z:*A(/; M?B\K7ZF&6@;,P>726JZS!>PB!W/I*!>OMDKZ1(XV>(;C*&+R=0[OI_,_(9OS M\>B$[_0[WV=WBUP%QY/GT@LKT#U-O@C]XK+SQU\.![R+Z?T;W_%;*4BNG]6) MO4]?8=OI[I1H9OKD\OT6+7\GAWI8K3)[:&D%X!VL%Q M4F5KZ7F,,!CBN4K(]TYY,G M>IG1/8L^#_=$59R&,A2_2;T=^1`#]^=VCLM]#+2M\<8CV[P;`HMDVG M7'L2$%",%JZ!V0;M]-NS^:))*X6.:BEZMNI@'G],$)+D_.$SZ4S0PUULXT#@ MN7M6PCA3G%0,1T5I:C.HH1\&^"S0(Z)Z`5\EI/UE%&'H!$;+JUJ`+;8'/(,^ MYX&YU@'8HT2R*5,7DMQNM.T#W%:/U>[TY>.S(VAZ,7F7WFWX<'[Z;S):>PQN MP\M7QV6=J$8?`MXH#Q2K!:,"H9EQ! MT!A+?/GA1J40)+>`T^LQJM>#1^SFS"_.[H72R6^_/J!?@^CDT@'6U_RB;#-H M9!SB^!0SXFOHI9_TT*'WGL^B7/OD2QZ+/8UPSNDC2PO1]#`0O`XP6\^:[)(K M*DU2EE09."J8*C2,0XIPW./H[,4)613L>DDO[C6((0:`@D\+?:.JEPON\RN: MK_=DA,:.8B2=);;A,23_\O*@ M$5"''U`SZ$HJ;OE$)N\SZ:8X=DG3':'E]U(YMNC3>^4OH"F1/K(TT1780'"; MOEEPNCNI.,3DE>M4LA,3U;\:,I$R56P:,ROBV+#3$^#@Z*"5WE@1D4>_6.NE MB`?\3.>G[_$I"&GOM-1C^_2>_A%&$'!)6N@!;!YX:G%KVTUR2"6A7$]E)$3X M(7O`$&:8)BP-7F@-"Z,&0%S4DT)O=/`IH5^0-1,"K4!)5[OW=*<-)O1%S;P, M"9,]L\TSA,B*9]+UW\LW)]P#:6*D?#WD,AZP";S*Q?TP'L\YL?E08=#!I7G"B M?A9$G77O^H;=%#Z50QA]2%;"Y_YS,2]XKGTRQ7\*!NX]?;R8<2:_IF5AW&-:+XR.H6EQ'GK3X-GQT(U[P&SBOO%\+=;)8F0R M7UFNH4#?C8/\3^E;E%/^G/P,6PJ8-`^,Y.G"BRA=J7[ON>8Y6+!)/-MI+?AX MP=;F[,@2\VB)+Z-LK\"[@6N92N*6UGPH9E"=I^`<"_FK1%K9,T:3%QAKO<@) M]@DTDT_)R/O`\[X&83Y[T(-I0%+TT`K$-/",UH;+(16JH$I0JL5$NI`>CZ0* M5.I]>FO@Y?Z_SVF]G+PO4^QS^,5]Q:5SHI]=[QRS7_WC[+XZ'EN@H)TG4TBC M#T8$#`&.NA8Z^'*5F7I]?5U<"G2YVYV/9[98^AF?0KQS&;&5?_[R@_*=<$9N MO&"5I#':6B!N;'L[S]8LT1=TE1]70M?L_RM=AX5*RE%98_4?J7Y-Y*(V;HQO MKLYA2'GB'3LAVI=#@<6A4$8=TO!481,Y8=9",'A'2^K3XVFB'"H]H1+RA5IH MF[?>Y)5;DY?9$4--R!MH/H-05JR1]=B#^`6'R`]B'*&3\T[;I0OR3_\GDD/$ M[HBUV^<(_<7U=]Z9=?1]'!/D/<7TRMRC>S[2>>I_WOG"*_;>_ZH5R,V\K2"R%GX] MT*KN:;A\BMA"=/5T9;AFSW$-W68:$^X M*D!:HF$"6CZ[TC*\ZP&E!V5[;6@=>OCM2X\MB5O&R"%,9-1N!"_8O_7L[\G/=&'%VI3J1XD!*+,@KY^/J`UJRR?J")G5'K++ MWB'3>?^@C@`R*EV3X;8XTVX_1>C@_B"A95>+'K-P>8(,4U)_43)EY=4997X# M6=3\?W$8W/KX(3C'+X^!'YR(1D8^8`I1J($D>(:;C`B5:-%V?.E4$+'@$E`2@F_:FB$)*;5;-]9SW M&UF@EF'W:FW-&C3% M_J?<"O\_SO'TGY5VN)*ROVLFK6FB4J>N1E2*>`1/91I[-8'"IHD)MX_6E1W: MR:PW.30HK5\TM4Q-<;=MB:9!^`^KG'[B6@!=.K=6JVS"2;#E4=/TTGBO&,+N M<12'[HYNDXCH9IOTL,RNO*?3A*T!K3E7F4,2!T8;6)Y:3B*F!Q&?Z@<1V?_\ MCEDYOV17UQTF241:[F?AMJ%)=*F&JFP'X)>T+>8EI+>?M,W/*_/.V2;_FYJ3 M;LE#A4$:"4-K;"L;'I^)7D(Z%^@U#=,I%TI_3#8H1;&33'*SFO4!Z0"P7[-_ MT8+5=.L$$Z2=FJ9">(/9)OF"YO0BFMXT3F@GMQJ5;AJ]I7MP'E\J;:?X.C=Y>().[9Z^WO3L4-W#W*B MS_=GIM[L*&=ZDI/]\3-IMK\Z;OB[XYU;^[%&V/0-0=1/U!S*$_=R,@]WMVM!)O6<"=-."L]XU.](32_R\T%V!&T]&>P#)! MQE+(9`ZE@Q1J];?`CU\N_?U_D1$?;_99N0VJ%V)4.PA<9IRMUO--NHX#X?VG M%MZ_@!'_13Z70FV^0,QJME^#VJUV(*5+CK/U[ZT?+P/-?)J;)N5U=N\T;(C?+2UT$ZMM5S-9=&B`7O* MU<;-SN/647>TH^QH1]R,'R0TP">E=W\S8D>[9C;Z?J8;$-("+J4Z4K+35JCG M(W"5R'CP>-S>KF515V)+7KBI7.?N@S&9E*@R8DMC$ARR20ZGJ/U'B\S1.0\Z M&_XA*:L+H5(8K/5;?&1"*UT&R&91)D[BAKH/2&]U'\#WL-CSU70L5[D@]!?1 M3H&/0W>CHLQGO3`OQ_EG(ST1BJ?@/NZ'T3G56K6/CH.;W3/I\C_*%"G/>.C6 MR=5BL^TQ_=F/L!)3/L:,YN@@3L7Z$P9QFCG(T9'D,_NK,`Y&SRJV,=?H&4-A MJ#]4=S6=W2R5BTW\DMW[$.KY"!U4D?'@`KX+2QI'<:J2I[SUP?JC4H):V0@< MU&H@8T,*MT^%32F]S];/\,&IK+:-H5*$?OIT;M7^,6FOS25PQ>*YW7$,:AP9 M=MSZ\.%94MHW@'+G1;Y%BVW.8FN!>CM5Z,YO+&OH7))A9@J@I'V/H/SZ*TIN2Z:,XS=A_ M?"C++<(%/:N;1>+T,7<5M3+8Z`D`<;P_8K=YVJ-N'_=`VYCC4K.-M9*VE?)/ M4&-59?/EAQ`XD!KBW"G+,(!6G,]F=6LRA^P3I[9FH@+*5L M`>#;?,0^6^G2OVL_)CD1N;M)3L-VZOM`/3FA$]!UTOE\+JT6`>_ZQMRJ#WGF M5&J4&1%>/C^'^)D>#7+SR+R*(O-1>GB=T)79V6O_&!^<^29=KV[J^9A,UVMI MU9I9&^E+-&6&FW"].ND/??'WBLAM0&`7W"TVY068()^"2_[]Y'BBG922`O9` MRV.9&[(E/&1/^-GU_:FCIK+]'!"OT@#B3])(3K?S@1_I#]XH:MCY`-7^,1M0 M":ONL^UZ/>G`0Y<$*^TO M9+(^[!:DH<0M:Y/2H._U,1H\80E8U>K_?`U=W\*?F^5ZVZ>1DTJI$U=IU=BZ M#?L,FEJVB3]#^WR#R=]CT6C5TMG]3QIG$DP.V+(1L$^0.8(_27>`7P=8Q_?Z MB/L"Q4[>9T5*K@(_#IU=?'8\NG';GF@_V!!+/M!^P@'N0>>^UIO%3.Y>P]8V M++<7E0QF9T"0_3&W(D[];9+C(J68LFO?BJ78HAY08Q[8=[BVCN2ODI"N1'V?TY@JAE[@P=^DT_XC)Q4JKDTM]_^7'"M(CT8T!_I??< M_$BC/M"B\CA/X5=P;*2O-2>6L]+LF>WH,6"__O.?P%?XV9KSG^G^_S]141,Y M)"1S*5#"!S:R-8A$?K/_>23V$9_O2%I^=X[X8#\4V/9J MW>.*JZB=D)/_I?8P,J86(6H2^GMBE*DUY:>.+R/.],J1)$9M`3&&*D<@M!]OJCZ MOHD]>+.DUH5[K5PBAYH'?UIS2#MQ@30MUSZ]*=Q]Q;2-B>X"S]V]]\)"NR3M M]-EJ'OB&Y:W5=?8JT<.Z?KDFU@F,4*++)/Z2%Y2D[@>=8OZI&13S^`64]MTD MT1T_,W?X]#]L42+YCE%:JZIP1X,^A&LM'*M//%6`^@Z%DL9UV4 MDIA2NLL',6,0LR8CG(1BJETEQ$PR]D(SI2%NO>3L@A/CLR#&%\."K)?O9(&_ MFQ*E?-2/SYK!&PY3QXYNOXN%)*G\L`Q:]0/<"YEUEG$?RZ/,LNQG:MN?@4Q' M1#NY[I:%(SC4CCP1FO18N#Q1H#XF(?)Q/1TM3M2LE!=K$NG=ANP/=RD M+S-M@Z;_RPPX!V72YVFMTE^2?9%613%K2[0BOF_?&ZWBL3)Y9 MN/Y<*Y,"7$^V,LG[/+*&5M'MX1/V\<'=N8YW[9.\PU%\^10Q-A;U*MI?TC$( M:;4(F,_;S;:R0!?1A'[*I=);-YC8G]7WR^6Y9Y77B`6VM5N4YU1V4LG+P#IS5=E,%3B%# MXD9;\KA;6M/]PV8"XM-HO5)NL' MI-)1*AYE\E&JX`*E*M#?$R73-)KBWL%$[ELP]]5XW]%EF"@$=L\,T->3Z(_N MHD_1,WARV,@[W!.6IIT6-BPBZ&:G_\3E:]O?4,\Y;>9`>ZCKV6:6TXQW0&6) M*!>II92K//\LC?YUT88T)Q.FP+MSZ,8NG?5P\JL:(\8WU=I>5+I.*.A'ER]8VOE32\1DE1=I&)TM:^27+)SEWZ* M,Y?T=L>%N53MD//=EM$(NC@,G;35O0L#,CZBU"'N@[<^K[H!;#,&NB=H:<^7 M:?/'Q.4=K$*@VE9/FE-6JU,ZN\K27+1[?S#' ME[M=6_XB\J!#[$*.LJBP+"L$HDSS]L6HQ*4AW MV#+"X0Z>D.ZU+<-K-1S2![$%F8`C-C6K/-)]%GT_:O*226S"+`*FV'*VW=I` M)F%R#2*1_G[""&1"/X=S1W]G8;PA=E8[953@"**+(DA:AMFMIN$?\2>B_`_1 M.!'VLLK!.,@B<'D3:[F%XH_(1DRXKC&[?,\3,)Z/1R=\I^OI'4'0.L+OE<:5 M03\\;MKQ^8^S&[ELG^REO__L1J<@2>+,,GH^MHD"AGN M;1=]I-ZZQG''<)>YO)%]5;-(@PO'=L)HQD4&603G^.6-$-&OV/'BEYT3XH?W M*,;':Y\$?/^[XWGX_,E0325\#H0>;MTLKV^V0J4"%#I0HN4") M&I3H08DBM=PR:0"LC@!P_==).Y-&PY:6#DK8:2C^J43NJ0YJ+=^[LIH0,(J'+H=P9# M"LQ#UW].:.37(#JYL>-]"YZNW1LG^AT_.]'WUQ;(0]]5#G^@8<"69[U=S+*. M"!.=-2Z9@ICOAFFA!5I8V)I@@"AY5`03"$H:8("8>M1"$YN#_P'H7T@.ZTS!;,49L6X@"O:>?O9I&`5O1VS]OXJC33H6TQ2KJ_ M+=14]E?K`UR%48>AO#'`7Q!K&$D9`PAC,%U(VF*;E<'X\H^S&[_3NIZ!3_?DM.VP M;WU'Y:;9-D.`*3?;KI;97K.\>DLB#Q4"]>Z,E^8F0U8?YY3M9(6D867+:F=, MM*+IINO2\^:#.G!ST_#C_+'[^:,<$XUDX@+A1O\%V)DI MMX80'TUB&5[64-,T,-+ MY>AI248NCD2QT8RHKZ[O^+0\\EV0',^`(TO\JAZ$">V!]F4VZW6C%2)(R^6B M3+!)B)/C=1-YO;W6@,#.Y!4@L3UFFA')KCAX";P]28*D%PJ'9,N[>C`I-@C< ME9HO%QQ0E@5GXRJ#4"G)[R8LRX+_#>:X!F!VY[``F1UQTPK-AQWVG=`-(%,8 ME6=U0*]L`+@E*,ZWY"F7R3%CIF*P5PF0NGU1CA5>4G&QT7!=*Q:X=;/X#^G( M_CZED\C_YENCB\&ZEHI0X]VHSSEHK/74FC+<%-=@S/49P04FUHI1UEW)1K M@*@9)#,PTCES8<9TQLVL,P1][D'"M\!MB,;1E M6&_6EABJN6:4JD9EW>@Q0%7M^_ MU+,RL9LTAD[;VX[!D36CG?D>Q/BS&^V\(#J'N+,^-?A]K:V%P"APN48KKQ+/ M:1"H<%1(-Z%2]20!8)V[S^ZKN\?^/BE0F36)472FY$;WR#Z'SM$LJ'=D=#N: MVP*G#;#7;)*G/!V2W'3[';^Q/XF7GD`OJX9JIT7@Z>W99EN>6DP$UV86TRNG MB?#D[],4:H%A5*[G#*"ISW]Q_70"\:^3^/>*PZ=`N8=6:]J$'BP;R]GG527K.8: MVN4:X7>IQV4@'/G9"4`@)R*F@4Y"+Z1%CB%@'-7*K-?V'`C,C]`%D100AMC$ MZSZ-KJGH'MO6=D151A6!\Y.S.\TQUG0".#=#3X_/Y*KLK(Y62 M%4'74P=@K"N6]:>_I)R9&VPG^%C#D1_9%KFII@L]/$?['F1YV M?B7_PX=OZ[,JFU*>`>#[&%>K=9[UJ1C$Y.A*>VE>V3ROM+9H;5E5:;6$OAL` MAD>BK^V?9I7M_76Q[#*T".D*S5;6G9OPDSN&E5(#N.X4T:(^K*G\A!)X$\9<>K-H->$0PEAQO0?'XU&.XBG M'Y&V15\=E;X%,HF4*\U,&N69"NX[K-?;_B3Z%AC?ZQP?E=Z\68^*^:PY.D;] M.?.#=CM;V:4G6PJC/@E7TGOH0!=2`M_4SH%N(XS49PPPF&#/Y9>!]I]OU=C/K MH!=SV664T^WD8C:WC'*\G5I,9I9AQ**25P:RBHF<,K3YLK>KEEDNDF.&TLDH M?]O(Q&`F&>5S&X\82R)#*$0"@:QHIN-E]PI<^X<@/#J0(O[`MY5N MT0&9!#Z&M[3RM;="<'&=!"K)UE^@:P+?[8;O^[S20934EB2A.-!0N(4JO86] M^N5T=;\//((2VOM'$G_WR$1Q.U[7#^1SRUK,TTG53`(B M(A"3H;1A'N6`I="!UJ9VE!=VQ0M:$_9-Y(6*1E24]5F#R?55!MJP[_CQ/7:/ M3V<2ZB.[CLW?W\8O./SJ[%S/I;N%>,&'O:@:F2"KH)=QVPL[Q>NUCYS=+@CW MK%K/FQN_)&?[%R=\)DW'_DS>1,2HO4=T(9H>R"5/QLRMGTG#2MZ/'=>C!_!H M6T-K"07)7#K32[018D;XAW,DG'V1ODA>*@<$'9UWM`M><4B$XV.$HO/N!9&N M9.S\H!+.<1JG"R9_%QR/I"%W0NP0P;1:,(Y^5DM7\K]J0F))=*J"$9&,F&A4 MR-9`;O)]MDL^US*"Y1$5_=-OOSZ@0ZO?2NBP%RWE)`F/V<34^3WP[['GQ'A_ MYX0#&+3YOD%$VC`.O)UBLUR/Y=/_/YU.2J?COBV(58D*E.I`J1*SZ'5<#$`L M2U3\%*8Q.(ECH)MJA30&85Q^&"42;X3#5QQ]B8B;;]%G?*+WS5'M=X04''=_ M3XUI^?2@US71+L0V\/WLV_DR8=W+8W`F6>G$C&R?DL*Z*'K!9/2SIQLOXA?R MMQ="74\84V[<8?>59.C3.WN!**5%*]E#)=[=!9Z'=W'&VFSN@Y`F2W1"@Q$F MSV2Y'@?D1\=#.*+WTB!Z&B&Y@(/\^A7[A*\IW[Z]N(1!L]]0>_P@1N_$RLRN MX-EW_TGD4401-L7OB(8%N817]Z_,*Z*)M"8Q,:QH6?9)Q2B'_FM_)G\ANFBD M"=\3Y&(4_[!+J"*$IE)X^&RRK?$R)?WB&V/2142'U+;Z:F-=]KTX0.[ MO"3[54$IB%7'=7;QF;S_1(*\>]'5KDA/WFJSDHA'J7R4*6`M3*H",1WZ6A7I M$:@V*HGX"X(BIN`"[;,8T'0XI3$(13%0V:KTX>AZHP*.HI0VY4=P=-)]68"# MA^W/*V\U6HR!=EX6ZTW:.4_$Y7OU-!U$E.>4U>J4QK5">2[:O;^;&A(`@*I` M?5O]-YU!LWCCU\'^S^N`S_@5-#N5JL)6HNF!YMC#1A(*Q^@4`*`M'%4!-&PQZ2%AH):Q@- ME(AK0"SE$-A#<*9S#/X54;\CVA*-U^X]O?EQ[WCX%TSBX3IM!-93AGH"ZV<@ M,%/G\Y4]+P@LTX$R)5F*7E^C7,\%2C5IH[`)0V%UA\(M0J$F$ET<-F$X[&&9 MH9'%AG%!B<4&1'-*%NO/688Q5+_I@N4J6PUHSSK#N&>`D]U,8R"I#/`30"'& MT45/_?P1TE[ZO-VW'FVS#SI\Y986+0=.5[**.A".DR!-M1 M=15$_#UL]4=4-Q(U_<`>Q6*U7&1-1"$![:@(Q7N5QCA@U1U@(C2T"V.ZG@=Y3C4J(4>"NPWJ>EBQ) MQ/*&.XGD"_3X?]2"5[J?%L1/]/A#9R=0NM/VF(^KA!3Z@#-G"G"WDU M+BOG]I76L[MW8E@9WX&"M!!,7RO!LYF;U:+,.._5Q=R\6"!3A:@NC=4F%83" M&AX*[3PU:6#*Q,6/BVG%),?Q1)7:!H56!M>]$69X_TJR)<;8O]S]X^Q&+B4* M,:EUO*&:O=K-`?:>U_.UG=$4$X@RB:@D4M.DET0/+:T>ME.,1#<9EY!<7Y1] MTS<,@F$L)P1`(*0@/WA\"TJ)-[[R/4WU`->HKVJ$=R]5LFRVID/=I'8=,@EH< M#S?>RHV_G=CX=F0.]\"&AE\)!KE9GL.MZ:4$9/WFTWWVD>/]BATO?GE(ZY]< M^SMAL]OYBF+T==D#[;E9\VR),Y>($I'H(2\+0Z0J1:=4YZQ6YZAO&MM7J9[: MPSZC"I1#$9?A'A27Z9C@]O`9>\Z;$^(!G,![V0QVX%@&/:FU7JTV'3Q!6Y-, MOBF4,=;C#O*XK7IL'I&,];^=4B!?7".[M*"X@V=$89/".,$3K>I$JW1>^Z=S MXPX%[C/*^:-F`#1I%EO+RFBB$(&8#,5\,,8#2Z$'';`>XX;=<,.E,K2-MX6Y M7\"1YZX4U(5XYYSBSGYQ7/^S2ZLB^OOH#H?TN)WSC+D?HI<` MY7CM8QVT4VD3&1F8"_DH58"H!D157*!%/.$31"_FS/G89@O&">GK';AI>2J85O[J'^+VN M_(&&%_;=.Z7H9Z@N$Z%S6HM5,871AZ;0@RA;5;*4U"B(J2I=5F!Z.)0U82SZ M,I;4@'Q,VH)20`MW@:*HXV:YWR)\>_@2Q>[1B9MW0O`?4GA/7%4S]$JTQ3;O M)T1L72"7H.?&MQ%>V)D708<7JJYMXR=,^78VCK<2FN;?W:?0R>YFO#U'I M'%V]A"Y15/E'>]W"06(4-\Y#;`32\&:^R8X[,BW%Y9TDOQ+9*!5>^^>%BM)] MHH9Z\HA8G(C<=D1$>RW#R:-B#\\37D)VN1WV3$S(?_UEZ&8^7H;"$S?Y68]2X^#416(Z4") M0)1JR4]7I[_.CREJX;II(V$9&(E6=ILV'/:@<.CBL\%,D#'9L&#JF(KY&Z;% MW_#^\A6'Q,3O9VK-9]<[D]^Q2:+H]AQ'L>-36R_W_WV.8DHO@CF'H=(43NX, M-!%:MFEKY^!/%:%4$TI4H517,ML:H9(V5*C3,V6D(C9V)39.&AL_B0WIZK!Y M6(3_<79?'4_;U5URT%&>H!H36V.(X?8@LKA/1K5(T4T$8M.@2;[99%=MB0B` M;A@3,"8NJTGM\=%R?]AYHK1_WGVP*X`Z';K#_+^R$O/J9?26HGJSH9QZT MGO?67J?+40VXYBI060=*E""F1>TDQ801X!.6K@BT3TY,&`8^7X5Y&)QR&$Y, MB;9YB6&`SVW;;Q1N.XF0'_HZ0 MYL-[%..C>)YUM$SE5#;28.B6I_G2WF;DEJDDV9SH1,=THFV7W(A".]U1IA>] MY(I1Q#2KK<"A-D16+429SGPN,KTTAEZGGNM%A6*4:-8Y8ZLT7K:<>.FC3DDD M5)"IC.A/3Z]#*=1(FNR7M\MY5INL.V]-8KH!7D+9S%BV&N`SD)$,99Q!K**4 M.?Y&J.O.\8Z?L+-[^>H%H;L7WVPZ7)99#",V%)J;]M):0UD'476(ZD-,X05* M56I:$E<2&RA7U6*C)C1C.$Q2?*`]+5'N&$IXW70"),&.,,L@1M?SFAI];"=<22Z:7>XJ8TW8&C+V0$0 MD@1NJ4,WY&WR;_(O\L.3$V'RC_\/4$L#!!0````(`.R:4MW*>DU7* MSE25I\\7!Y*$)'11@)H79P$) M_/_>L?\;OJ-_^C]73P_O/OSPT[MWRS1=_^7]^]?7UQ]@N`#Q]P1'",,?`K)Z M_^[[[\L)OQ:D_>7=O_WP@5)7^^6)9#BD?Z_]Z3J&QHO[S[\^-.?OO_Q MY^]__&7VX<>__/CO?_GQI_^JMR;K;8P6R_3=_Q/\O[3QC[]\3WO\_.[IAZ^>Z%KC#0Q_V`T:[=;[CF**D[]]5UOB MVTL<_4#BQ7LZS<_ORX;?_??_]JYH_)>W!!UT>/VY;/[3^__SZ>$Y6,(5^![A M)`4X..C(!N-U_>G/?_[S^_S7HG6"_I+DHSR0($=)@Y41_]XX-^^7I_H#Z;!FC--\Z MZ6XGOF?-WDM'>M^1S"?:\?=GNM2(#;#%QQ$($G0','P M^R<(HMN$M9ZNV:&AOR=ZB^DVE?W5/H(8:GZ_[O.E2YBB`$3&UW]/;\D5K.:] MQQN8I.RW69PE:?MOVSBPZ94\+RE02Q*%]*J]_5=&3\D$AU,*7,SN//H3Q`G: MP(*NULO2F\7J&KMM5/VI>MNCUR!9WD7D-;G'(8IAD%:[JO7R9&-VI?\&)4%$ MDBR&S]EJ!>(M11,M,#WB`<#I)`CHDY]2SN211"A`,)F$87X5@*C]"V%D2G,+ M?X)1<7LMT?HWE"Z__/I,MT_^5QC2W9)N9S'`"0CR1D8!,#&U.2!NWU#"@'^` ME,&8P7B5Y,1@^`JBZ3HGX8[$MR!83N>4TE])LD8IB.Y`@")*&-2\@$U./"`0 M#N\76XB8O>4JPB8!O5\+;H"11']8D_(_39X,[7D,+C&*=NSZ=/Z8Q<&2?H+' M&`5P1B9)`M,DIRV&(:7K`8&7'>+T-\KXAJT7W&W6H2S?R.XW28(Y8+Y@\L*D M3_`2P;]G@`DWE$;&5JRSE&W2?/[\<'ZALC>E=4?E8TPHA\PHO*;W^H+$Z`\8 MWN,'N('1C$ZKR1F73Z(MWCU,84T8[*<5C2O%C M##>(9,F.PJ)Q6WQ,3&WP96$JC`>T0O1M+W?MMM!QT`\Q6X*4_4<$Z<\WB`D@ M**6]$GH$=@2U?DPZ3SP@$,P\KV:I,`=/_MZ;?4EE0QJ4'H(E#+,(3N?TK*%5 MMKK+&&17=&[*MJ3)74Q6GPD.F"HM8O=5059KR:'E=.86?`-?4J/?23Q@#S+> M$RP>@GR;(X;2$YN+2IC73`N;RQM,(,E93RJ!TJ8HG2SHR\!$TL[R7L?I>P!D M2A],IK.D///=[QS4W#F]N0;]!!A&5 M.#%Y'P$FGY] MF>RY-S753NETOM/ES^>4/Z=7+(3B-.Z23Q%QS"N*#L$TR7 MI+6ZJ>5LMI=KY+DW,?49@/AM"6,HUESLE1OT>-;Y%N.HM*7C#!`Q2;T0T&'X MBU)TYS<'"27A!6'*GA^;[^F9/2*W MK[O3)`F#!,;(WNF-'O.078&(R3[/2PC39#H_\S;J.'L/8C=E!2D_M`;19,4F M3FXR.,6E!N,S29EY<&ZHM884+W3=3D0FE5WG(5(@^(" M7+![Y`FN*8E,+C$J#B@-;FXQ?\]`3#FH:/L$DRQJ+_Z?C-,?B48VGWQ0\P:) M^_O[REV*F42#(%MEN8/-#5S'D,I]G;:-YC36%FCDXW6:TZ3'%KV,@EPNST7U MBI;*L&W^4W><=2C+-[(13))@Q`4S?ZUF9*_*V7.=B=2W<`;?TJN(!-_T@.@\ MVR#67/[AO&O?S]HS!B(ORFH3&__X.E,.9_4SQN$9VP3Z$_>,Q%664"DK20IQ M*[]_>MP"BK,-8LUF/[S6G#VOORZ-5,$<_6]^[7E[QJ'P>IG.'^AW@;#';=\\ MD>V5FOW0JM/UO6J"%\Q'AKDHF/^FW,%MK,CPMY-,T3=?EM*I#@*56-L>SZ7Z MA#VOG%D.(&4&=KZVMW1$LH7P"F(X1VGNJF%\\5IS#FC]9K=[BYD'\SJ?_UWN M_08X4C/V>?85INIYM7ME'\_%POB"%6<;Q)K-GG&M.7N7/)L5@[W*X.VFWZ&R MKF73>*`@',!#&T,<,A>+XJ^,E.Y)$?*)Z=24C(/9\A@H$A]^C=UD>6:(!`8_ M+,CF?0C1>_:%V#_R3_7]CS_M\D+\#_JGWR=TZI!-?Q>!13EDMQK M[H@DY6[]@UB244#S"&-$PCOZMX2#HKCMN>EDGU"-RJKE^6BL?4EZ]N$]O5)D MA'*;GX_:XCN*SPZ_W?GHF]%A)63E/_=/37Y&F?ZY<*X](>?P]S/1L[V&S"N7 MOM(A?/M/N!71==+N;/21U8K@7'K,DVO4W8'%Q,HZG8WRXL78<[V,,^!>-]+F MYZ+VAC`W;2%UNY_/1B[3%[B5!P%Q%P_"CSVYR+KB>X M0.S1Q^EGL!)>,,?-SD7=5Q)EE.V,BX\F/@;'[T<7,(?TW@X?BK4*" M7E;@464^2U@.6:L*E9]&CGST\/,&T`NA/'B"^AJ&" MZ)=10W3T`%>P_-NH8>%SQA4Z_].C=0(-8A.>YA^ M&C>S+-<'52B-FWD6Z`DJ>,;-1',58Q4XXV:A573%%5;CYJ8Y6LP*&O>X:*[9 MI<3B1)?FLGY'BH1\!Y6P_/BCB\`(-*J'!Z8TD)QOA_SU_;$/2)^>(=TJ3+36 M,,]!\I*#E"7?+P!8%VIF&*5)^9=C??/NS[]/@B#.#L/3=[GV:W\Z=IO0ZMM> M;]YI5:6CD*ANP`-)DL^0?J<9>!.O3VL4*RO=QS4_`A3>XVN09PX7K4C0V@KE M>>IG$:'%C_;H$GD,\1O9H).5D6`Y>NC_5)G?DDEZ#>)X2WFUKR#*C@V8>GVM MK*KB/J4+.&YFA=;B=J"7P3X!HXA<3DL;%-_LGMEKDJ3[RUIZ$&4];*[@*5<" M!!#EV=+9'=RP`$X'5[Q"VJ-YSWQ8%X@"4GQ2BLKM6Q!E3-;[2$CXBB+14Z+4 MU=*:\DQFNUPG.X41W;HL@73Q'^(E-?:TLZ(RQ*%,QT5I*O]Y3WD2LBF9TC%F*("AH#P>@LK%);Z\Q/#VS&AIPVMTLO1]S><-:6N5M?$B[$2 M-+)#IR(3.Q"V]92,QATB[#`,^N_Q3N'SR)QQZ+9-TQB]9"G;$C/"M":L6@6) M(J9GD#/"A@8W\$3-(#V,]/EAE1AA:6&Y8Z9%Q9LX+%+0:KU(26-B]<`>:6;[#VGAZ[]N;?"D6=".L_%RCBO"18."(<#Y_'#VW"KH?/;VDC5CB=5;"X%6MM=",= MZ-_::%B&OWW$]M53;21'/^M8J@<]5+CBGZMI'O2@D9DV74WSH(?0J3^@JWD= MNNZ<=D;E;OD?7+FXF[U\NR6"N""<%!QR#O?AH=.+Z_8GOI//Z"+ZF^&0'4!W M`_K5?9;J&''=LEW-KM(.HM/X5E`5.9^EWK05`N M+J^BU,5.8HV7]![3NRU/8/8%@Q53O]"]0)GZ%AK$-Z_4LZ#(7^YD>@ MJ9>/P/01F-H1F#ZJ8P!J9*F5I@U#X+IGK!IRS4RJZ^ZQ:CBILCNN.\VV0>N4 MB7+=6[8]2B6+YKJO;'N$^,GS1^U'I:1[\WY5C4H][U@EU1IZ_ZIFU:2K57.\ M-Y#W!G+:&\B:K:\P`O.\YV=QEJ1V:E@PT?E^M08H9H1"GV`NQ%,&AY?&MJ&U#9W359;0K9PD],%XH5W\MD.@^@9%62HT8HA:>YMI<1-\ M@E3:":LGACT[3/9A5P#S0YKB&Y2L22*L=Z,]C)T$^*5?U1WE0O@DBU/[J_2U MMZH]Y]!@BA&UMEE`8G>!"RD^;.4M[04NGREWM=^4`NP.VUA)>5ZXHN%%^4HW M)3X7MK=*?2/2O)96*7Z@C!Q,CH[[)X31*EOEOSW!#<3"=.[ZXUA+J,_XP(H- MW!,N6IBLBY4UO&)F5BM"ZS\!#!8YQ#EW*UJ#K(L5KPP8!TS$6N22EL@)X["1 MG3SC^5X5YY3?_6R3ML;,\4?-O._*$#)M2S,> M&`@FX3^S0H80[,VVHPUFY=.YB%J=%4M&&=!*3XB3J53TQK"IK&\0-,=HUO%^ M>1>XZIHHU_W+58Y:I23NYD8^_,=,S;/U%#/O,][`*7F/ M<:'UM)NWN"MG2M$5931NXU*PC'I,=LO+Z0JD^FY?G;(+7H3DJWIRCYR6VJ45 MO*S49BK`'/DC=4LCZ,H]+W"N=3]C8!MP]CZ\[;(%N@:/IG71_0R!K4%3,;MW M2Q_H-'PRVWVW2JD7=,W[@#TY'+)]-HJ`O?QP'&8PQ<+DKE:B]YISSGZ"[+P+ M/%74^]OPQ1'DLY:O2-K'@+-:]<"P4O7\V7(=-8B>89I&NZU4)DZN*G@^L6N9 MY^MF>@8[GZYY#?GI>@$)JR&X8I)7?I"?8*$"@,\PWJ"`I;5`)'R"`5G@?)1= MZG?!U^]YVD%C>76ZJ"2-49#NLJI\H2M)&A?:%5I#5%C.12N]9$[;6:+V^+(N MDXNWJP,D6JO161Q`JL&=OZ_9##Q>G$3^_(TN;6LE*+LJ/,`%O?K=!P`7K"K; MA@33^YI+J+RM#\C<*4"Y)_(&!C%S]6%V'OIO@A,2H5"6($!_G.&L5OH22KM8 M#!\\N8&_X/C4$D*9CDU^PR63F'(C>'&3Q>QRSIF1O$8'=]%FY[`2W)=K!:1? M]J")G;309(Y227QNK8&=X+[#,D)2-`6-#3SI.P7>_`KBO'@1B)K8%+5.5F+Z M%`.)AA$JU)K:WS_8C9@\>O,3S@.LUL?'J6KE6&\NB"1:@K2OF]&WIN@T4R)7 ML#XC@WMU#JG5ESBG^%K_I/XSE'J/*!UY6K-ELLZZFO3B-6S MANIG=&6`T+;NVB`B_)A>N,W\:XIKE;8.+P70RD&CA!BNE2?G2] M6*\R-@WF7]<=[I1Q$BDB7'>Y4]](ZEX2KGO<*6-VJ"%TW9-.&1:YBKR;YYP+ M,,EMC*XF`/$Y8\J-HJ60/BG_K2!V5\BYM86,(W;/USCR[XYKK&124+#BG,8$G#[:SST^CC>CDXC2@`^^48&%=/',IO6NU2.%P$^Z(%20N'OW8)'=R#KC=[A$_O8-2H MWBWM0_$@WV(GMBS/,ZME\H<+A4?%*6F,6:#E?DX^5K@Y5I@OHN[#ACU"/II: M%DU=V)^6,$4!I;R[F_2>UZW*I!^Z.G';N!)+Y%94CGI#B<$4;S8TS8]1=>;;\D,+S'^YRWDR"E%R/+JMWP:/T$)]3(\L MO;%OWP*8)--Y<6,QP\<#6B%FJD#@A=46R%4[`/-+2'8=/<(XPH%XJ948#^LT@/S9X9'-Z5U%=/#KNK(\)R;#=ENNDZ MK(D/7;?&T8F/['/3^4,42)+<:/0V0"Q[">G#DJU@.,6U9.=L&^UY(XYB2J6; M$?**.X59V7DWT$T&"WXF9L82"HYHDT_Q%UP!2?D;D)R&F/<_H95$1;4*B/3? M$=SMK,-2B-SCI-3UDE62W$VGF[?^8\Q)"=)Z'!M;I*+EF6[SZ;PTY]:J1'#W M1W._(:PFU^CK+^:DFXVU'#-7K.Q$$&=,-"OLY_0N@O1R>LFE.<'*-`<9U#K+ MFY4)GCOC3%7ZKOI-=^6JPPX#BSUI.U^S!BY(8X"!K.\`_QV-.OM9.("!Y^!T MMJ?\&B^/#.?F;^S2"UEE_;4$QO32NDV"F+PF]-DFE#=CN_PQAFN`PB?>'=A] M0(-+.ANWU_.$=@Y7<:4SWU39"3ILY0VY.V]+F/*TH!S940"LQ@##7E_#$]-B MH`&MM](+M/R>O`&&O;YVWU,VT(#6R[%2Z*V3-\"PU]?N>P[-G'-4STNTE%H; M`VS&3CE808U*)+W'.JKBKB/VNJB<@<\M7'JDU_OU3Z!$ MX-3KW"NILR6*\ZK4V\.2E7HTBT?I@W@Z.L`+1&4C]4UPTJPDPD\IS&Y(_$DW%!I@HK@D_F< MDLDQ12GUL;R*NA&V5)Y,<77L:N8S86+QEJ/97'GM,#2LJM[2+L5[\?6:<)[+ MIN8V::?[O3B^571R5:GZ.7M)4(A`+):+],<9Q&JO,A0QU9SRLJH.@Z"_V2HE M[6*I"L+^`KHF402#PO"O?EFK#S"D]3T0O*`'8?5``,Z=*//T?3D/(#Y5K<:R MO6J6H(E]B6E5QD$AOTMS/]FJ>X'K_`#&Y M(A&()#I=;:^I9G#?<9_;QPC@=%(DMEH7U9,;UZEVHKT!4 M?N][/"?QJG!!;M@LBKUM1L3U&6=UD+U*R=&V4_:Y"X@_/!?:"I%@KB>O.QO4 M@C"U3DGK-C!^(1YA.3O4+@N>W\''^"HXN+N?-:]WL-O'3K3+J.?!/]WI.L[C MG?+N7<#M8BK(<)^%1"E8SOD2;(91U?!F:%=#S4/;Z.G6K?R9!Y;COU1!ZF;5 MM#-<`QQ?H0I5-VNL]7\#<#TN*UC=5$KT#JO(3;`"5D<%<4F,[9EW[($+;H6N MC@+"HZOI-;R'^6=7<_$;A5F@NS^Y^I*U1$_86S>#086PFS5@3.Y.O5CW/;*_N*E&[VGG"G*,5&BZJBDW MC:S86NTI-[6DYH$4^]166+JI#I="+ MLH)/1PEZ"==;?P`VGFH=S>?XH!1'./EE[.G,IPYJI_0D_<:BU]2H6AJT:= M[@^6=@*N"E37K#L];\SF+$85M%ZV4GWYU=)L5,BVD+`N(JJO^TW0=Z;ZZANX MZ3S>_0OT71FJ^@(C,[=HWB\Z&=8K3-O(:A>K4]2,X#O*B5VY18Q*X:4;HMY+ M>&6%_:BN8?T-JYR4OT*TC59L^%=`8U:FO?)+ITIDA9J;'CWBK$KM]ADOQ-G- MV[,3I^"-X+):EN05CW.S]EJ!>+M=/Z,%IA>M`$S@P5Y^E#F>T0B%#"9 MKF:&W"/YG84DO1S2Y'EY)1T,5**:!%D**8<-KR';.J6:ZI`283L;68X/L\4V M59M3ZV1E'8)4K'SZ^8T-;(`KN`0;>K1!]"L$4;H,FO="8Q<;<)8.,!2DF&SR MVS/AKZ"Y@TWZE6BV2F?"HMF2FM_6[7S.O!`W\(:^UM-Y[9>?A.O0&L3F.J_) MZH7*AHR0*WKH*`?_F,7!$B20985A]BGZZOP!66KP3%C:I.5@-M9=3WTN6,U! MD_[KS=\>Q)8?4'3RLX$+\0Y2CHF**&\!2N`,O#UQZE^)FMGX8'<(HQ0^T),3 M'K]K]5?O]HTEHX:?*<X71!GXB.%V*WIN.@PX?AW]`$-_1MD;6OQ_L0M9- M,M$#TW*PRUCWC$YO[H,7HUW(RE^)N773L0:VZJOM)_!/$E]'@+(4XHHR.B,, M;(45=9_!"DJK0^F.,JR5?DG@/(L>T%S_H-:Z&F`#\G3V0A&H_JN!R7XE29Y( M2#SA<0L#D][CQP@$\(&9;<43\UIUY_E0;GHI-DSQ[^.M4OSU]UHZP"3)8,PY MWK*6%BGE'E)YV_YY:4$:IQH[?=S"QO7`]_#=2D5C>1\;J\AO6TK)]!7#&TW+D76T\`&?031*@01 MW+T]%5P3'#ZO0?PM.?E%>'>U'\O$0O:7T'1^NIDG<_J/FG&$1[W>`(9)GH$W MYLU1!.O,R!7"';6]7O MUJB32@;U%E8HW#,!Q]?<+L*93W5#+[LKJ;VIDHTA:CX4VJ47C*2#@4?I"2X+ MKCBWSS2\1I+&=J#<)Z?BV_4E#6W3.XL!3D">="NYVM9_D6YDY0%LK*\QU/5H M.>+V!C:VU(WSX3B\H[;)%3OV3>*!,[,J>44G*]]>%M%P_-VY;4T`FKV`W,%4 M?HUQFUD!+7M)X+\R2L;MAOX?*??`;SL`JALX?E'K@5`NOZ"$[:T6#F]T_2Y3 M"JA<,*['S;3P]ZA'0F@[4XP83YEW294GB^,MX&JQ607G`X9+@^7?U1VEY/!0 M/XL-]OQV14E=PJF;_MK5Q,F^[MC1%2[WMZB?.+&'P_@PXI\W0>!;]:*YF2M' M%9[FL+!V)3'<0TJFB',]6[@J1GSYOEVBZLM!1\/:=I3GM]FDY?HUKF'7JV-W M'$597>=N'L".,/&"95VO=G)BC3PH`%$W!KI^QCB6SP,>\M!ILCI*;E80:4+C MT.^V7=VE"T*CP5(KJ)IR8AEU_@PU6H5+'N@DQJ[GJ=.'6< M%!S1VA70N22P1*X#)^H/U=";ZAPZRO!H>R\<7NZG@+M^J2NG_CX($JWNJ;Y3 M;0T)1/ATZEPYQ$L,\< M-9UJCCF)MIFD'\X6)FN-*S__N+.%QSJ].HV9$2K8O,1R^ECKUC:HT&PAT5PV M\S/R6F;:\#2$E[M;VZPU4EKQKB5^?J?)8S5+G#YXG+2B$DKJV7NX!.L7#U935&<)U;]YJ-JX,I;P_4\/'R?TI43GWSTZ.K+4"(K/^@K7 M"@5ZI8F4&KB&$:,D]M@79-2J_(?[5GO9*E^)FH3YS8/.G:X@J(D:Z)F M)J;'.`-1N?B5B`R.:6)0^T?T3=07I7H;- M7YK?S@0!,0H7\!4(2@QQ6OC2NV@X=2TH37HVI MN\?K3%@2:_ZM$6%F.1-C="3KG.VL/X"!"?%E%; MHX3(/X^)#\/;L[XF8O>:B-P/>[1U\R`3RF,SMVG.YY6U-D7,$\24EX@^DQ0% M4'CRA$U]GP9:7>5O6U,7Z?8:H]`7S>BF8=]%U[-AU M%(I+E\F:^G)Z_,7L;O=IKHN2(7K4T!=,XU`'3O5,BXU\ITTB_['TNA3#1M_8;[SOT,$G?M>)J.D3^:=7I;;Q*W#%6G[(D MO8(,2TB%GZMMVX_3960SBZ0<&J^LPN&/QJ;BUT$X_MG8=%,LJ)7%:6%LTADI M_1*?(#,VL2]7/#%W(-KMIF!8X_R-C\\3HMQG+%TV[Y*)IOM38^>EWHK[7 M@ZC8E&JW`:WEI-2,VEJJ;D-:B_VZ:]S'ZH!'SU^.REPK5/(H=.J%M)V.H16% MHKYCJEUGBOHE#+,(,@%/9:MRB\MU&FL,-><,4>V+OMFFO&O1M_87Z`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`Y!!Y#R`O(CV>#'BVQ5ES(#KD9RJ&"E>*:Y'8JK" MU>*UNX,/73:"2&NY]+0PU`M&M71)!J= MH#J-LA]5H@Q%)UR9B.DZ2ZHC:#?Z'7F0FB2=T;FWZ0'6=-F=TRA\L6:J(BY^ M"5,F#7F;E;?2>"N-M:(Q?9<0=LZ6=!G5C"_#XL7/;CE)#UZ8)\HX\THPMA_K M?`NY`RC^!.)O,/T*H@R:6(]X2//+:L:RDN0$[A%=1^Q_44)`NZY-=>"^E\A8 MM'9G2G&<\RR@PUG2&\Y7:+W$"JU.5`F]2%>(X5;6'(VKQT"KJ#680%D!*)'5 MKZW'A<*8WAMC``HX[XUQ;F\,-TW!W6WDCF8U->2FHG)'NY[?M)-!74?'X3T3 M)$"J"K7>-4$91!6-CG=?:'&X);H*UST=C)]Q)2S==#4U>M25]9RN>Z3Z^J(2 MO9Y*?5%7:U"TJR_:ILC$):`AU*BV*`?IJ(.V]^KSF32'ZK'F_2`UW/I.6];76_;6ADDYF=+?UB3\C_W9>+N\9S$JYP& M/7]:,Q;220P!4X(<94L]"=UN:F[#NIMOJOO5FDK'>7F@)2OR(+)4"QH;,)7R M1WZ$\3/]%[Q!4996VZAF#E7K9X#`*WI`9ED2`/PQ1E$D<`<1-[3Q;3E%QO)_ MQA!*G42:^PUE-6*G"E'K@5!^39)T5^.-7M<%CUIC*]C/&BM3&LW$(=">^O9M M#7'"=5+K,-A`/J*T8I_JMY,-TL\GFV+)[25K/A#8Z7MYQY[[6Q!CRAPUO1+M M!^H'_F,VYD2A+?\SX*)4C)(M('IBSFS6J3)$FV*O4DZG!UG>C2 M\;K.8J;!JOTP39?"4(=SS'SIB-[C%.`%HHW/L0WKLUTZUS%C778NQG2C_0$:J!+W,$$4.Q\81F`W_%6&HI!.1S?0.H)O M8M*4^AD@\'9%XNW.T0*EX@07_':NI+EH?XFP*XS!D2Y)N*N?"S^#E5S]V]!I M&.M@]_*^MFU5\%9Y2:+^PUD=,Q"Q5XQ)@[FD@PM=BE`2T![&QEKO$$8I?*`G MM<:WE(]SD*VRW)A.95YZ__Y16/3XJVTQT,#6>[7-#>)-F5YT1AC8"BOJ&B\= MW5$&MM+/4,24-70:V#J>($.7/N7U@U-D*139--J.9H`]N*.3/C/-1KIE__P5 MQ.&VN/F(.*&.0B=#I/T7C`G[?W`3`>&.99K.YRB`)>,D)59[&!/D MDQC#K1*?*FQJ@(Q"$YK?Y#-2$Q[8T9G.9^"-0T]S'P.$W6.ZTJ"((A`+%KQ6 M)HKB@&_PD2"P3?`+'9SF"2Y*USQ^6?D59)23J>W"6)W48+\`\/T;T'` M3%PPI$_)U;8NQO"([S":@<4\@F@5@JB\2VN%T7'XO`;QM^3D%^%W:#^6C MYD&?D9T6M53JP>1C+#:=-W8S\5$@?64+_5T9O4^[(''VEX8.1D@J;ZCI?']M ME?<83T7:T,'*%X])`&&8W,5D56.DIO/J$^8\U35(EL7O0N^;5D,9^`Q["62? MK9<#/:>1D:FK.W\Z?XSA"O$=X00-C9"P+DX?O2X).!&].2WL))@JRN?2^QH& M($FE7)>@L4VZ.65_I:2?MK>;UHNO-Q1I@26:JDY#6L$`+3#]#@&S]_'QXOBMK5"-;\0-)]J;ML!4,VJ#\G0 M%K0>".7R[2]L;^#IGKWF"DJ2Q?22Q+7C)>1IFWH8(8K,EB1+``YO(Z9"K1][ M"6'-O(_:?S'/B#^9S=I"EEJD!Y04#23A( M#2?/_"OK%FNH>5Y?T?FOAMEX^'Q!LE(%>)U-R]DR`4P=/G%N.6>K91A`K8]T M`LX6UNB"=U?W3F?+:QC8Q%K^TYWJ:E`^Z86X#*5N\C9G*VL8P++9#[A3!0WG M]^))T("S90(,@-4Z5-'9PG\&0-6(IG>VZ$E'ID?DW.UL693.>)WZX3M;@K(? M`:9K]CAGRU2>#>XVB0XKU+V`T^!HI9Q*NL+4,7VW">Z\5F-+`39N*N\/0VI/IAUDY"4`$Y M2HGKI.0U-U7LR/V"A77!A=[7^X+@'K%#Q+HE.RMA]1OQ&%91KJ<2L0\>L2/$ M6F6<*^'\V<.IS,.<5M+QDOJM2+C$_8/LWHLLUK6< ME*G3P&Z'N;.7J\2MN:1=)4XXI@ULA9=*69@JO8ACFH'V=:<4'U9^ M42?73VS+*E?EEN36BZGVH%N82>J^E++^[4'A1-?AF.+_I.B0WUQ19.0G#/;KB-.J'?)VD)G!UY!TS2)H$$2K5,*[> M6L8IR.OIT M7GJ5/,9Y5D$%)ZCO+)0W4,YS%!4?2;V?C6(-#1F(%-9@J\P$AY83NW(S^547 MFVLPF5]'NG*#$UTZ7ONLDF>`K)KKTE';N5X7+7=>U[W#QYG40,4+DQ3>P%SU M7OOA&);^)[STK77@T=S[GJK/=NG(/0`L*AAI?)J+QTI\1'N>[=*1RSU!>T>, MS7+Q2!$/)S_]0(#&DU@HY;V*TFRW/RN-K6 M_NO`K>;HRVL/XXL:NE_4<"#YK0U6RW`M8_-Y\L^[EG?Y7+6F7$NM['/0FT'K M1.O<5\AW(>9WRE#M$5;5"3N;NGH`,/-S%[3)P!XG]:X:.-P M1%(0>8R5%+CM\FK_N0`:4X$_W;6]?*C/8-%JEY7;2;3[TJ]W2^;M;XZ.:OEV MR;W]#F^AL>^6T?MR=GIC1%]KU:^KLK:/>Q&&=.A9!<:7$<0`8"/.#M(O>K5G MYISQW)?IV5S4HUO"E,5B>#=G[^;LF)OS:'T7N-;?.X#B3R#^!M.O(&*%B)@T M,@G_F14AFSQGTL8NWJ7")9<*[Q2@;-X>CU.`-].:T)HV7[YC<9WPJ@JOJO"J MBLL!3%55X5[Z2*^I,*BI^(+)2P+C#4/H[QE@AP^PBN[W>)VE+(M$KI/(:?V2 ML%)JI>:B2J!V#5*XH*MC-@'\`#`UA!O@U^YJM%%'I87<$G"-B3D\N;IQM<>O/KC3&8 M5;(_Y'?D#`9+C/Z5">-QE;M?OL:3JP7\3.)T^0J3=`;?`*L?.J>/3,XW3N?S MW)[T"F.A-E"GMP%B'R$(8)%B=Y=([)IV08&0OH8.)DC:%:MCY;_"J^T#6J&T MM8Z@F9 M!YG:]5CQT0"I(YEP\>0)9ZX::[TYJ%8:QAQ3N^=*%#EY9T-DS:/:K#1W-A"V M-S#5]1W.QK[VSP:S];\XC=76WD%6/Y)$"O5U@JN-PCMSCPRATNA*/ MNU$KO<#:&/WCMZ<<1T/7[AC\;\KHH/`3PCF%3+Z)DR5:WV.Z`)A01':A1!,< M/L9P@TB6U(6A6,_1AJO5GJS!JN[2([38"!H:4*Q/LI(($P>,:5S`Z?R$GRL=J+G^,"K]G'.+,13K"5@LP'-*@F]<'*\@E4)@ MK1:BX`70'V?@D:V"I]E0P*MT=`-;]1F]L0+D>4C!C+SB_#&,JY*VXGM:M6=O M1#XRP4XBP*CT,D%<7ASU*X@B>"J6R,A3ZMW(N\109^6=[JH%W3!R1\?/ MNZT=H=:H<1FCJYH<,8&:S%F?@[9`->K-G'4L:(T85ZGGK(]`6Y@4U"?.N@6T MQ>Q0L^.LK;\M/#+=C[.6_-:0G7?1&RD)2^DTI(%-^1N**!N?`G5OOZ8>-F5%--`C8(<6Q,`A%D`SXF[0)B[BL,RC4M3((11I.5PW3'=N#.O8!@@0FDS!$!3FUTAIZNM5A*?#X7OYLK4\0PU<037/X9S!>\5S[ M^0UM"-6[[R//,7_4R!1426V;2$J#B]OV0(BHD#>_G5=,[1A\\(96V8JOP^>V ML:0^:Z;RH(V!#39=Y['1>)'O(';.>7N.L]R5RH5?8L,]+ZYJ`;20$;$7SJIUFY[GT>D!E!#A7.7.^IVI M`2(_9%Z\'XUX?\+=G)R74].&PT@<:W%'TF+D&X`!&[+HMKM=+5N@XH$TI/M+NBSV";6Y5:E:L M-'3KESRYND72Q6M>BLUT*"[Q$;O)1&6S5'L/>&776[6P)8PCF MJ5!UJ3_.T!6?`<R:^HVD(+I(\+R=3@<<]9WHC546 MC%6VU/`W\"4U[#G97LS-E?\@E;O?'#6R(8Y?TRV`TCL0Y('_$EU MZ@A&,L"\"!-_G/[NL[WZ3SG#L5/F+#Y4&B?T4GEF6KDG0QL MP3O("I=%=QD.D_UM*F9R%7IXMX32/)32"WTZ+UA6J*4I9EU5* M!AG*.KD^?(WMAT+]%YPE,"Q!O2:K%]@LVS6?CQ;JT\J]K`\[/!#_!@&1QDEM'!(`>MS(!:<;6/)W3H>/=T)](G"[H98!!"&>5S*P7,EV!_B]C[FWE#,_3GS@B[IR2J?0BFEO)8VG6C%MLJZ MKPG?0NBL[X2"7;3TF=!XY_9P?7#,5U;))%O?3A(1SO4]);;_U@$26X'&A8\@ M)ZR>!%:=.\=\@EM`=NQ"4V'C9EE8)6Q4S#`54(Z5AA6909ONZQ.%L,LQ#*T0 M$BN878Y2:(1*(BFY''70B$NC#XO+L02:Z,C\T%R.%="$JV=+?[>^KP)G6]< M+?S>D9OD^GU76(V0\WYH]$JHX!D3ZVW*R%>A-T*._,1<7*$Q)J:[38A`A=28 M>/)&2W\%RQA9;KY_4J6>=8S%5HR\.*CXTA#IX+H)22W2XU1&.0X5J/:48ZQV M:YRX;@X53&[Q1@/.!F`IWUJ3X_7XDFSH("/SN'$W.WX;A,2/78F3WTDB7Y(2 M(><**+9"B%.`XN=Q`W/*8[N;ST?HW>IK+NC57/C@F%)0$0U!S84/?6NQK-5< MR%8K$&^G\R?XKPS1I5V3U3I"K,3"$YLTN$\L[9^[O: M2`UU_G1`PH02U8M\3380`V:&?TF?8;Q!`4S8WYB](@?TF+X6(_1*](PPQ>Y= M1%[UR3WNVS.A,Y:G\!JL$?T?<=!DNT%Z(WU&+R!$7^C/,/V-2M9+97)/.MI/ M]W*BM9.F=JE:VZ=<%CS,:VEH.^C<"+V>?;53WM-YUCRYAL[H<)/SN)6#Q0?( M^AB][C%ZW,M#X>T4OY*#CH[BODZN2Z8-S$1==Z'"1SGK26X"+OF[ZZR;N2GH M!(R;LW[GYK;<$9_IK/NY'F*RV\LQQQ?]K:1R3SGF!J,/4M.-Y)K?>9MM)+I[ M7',Z;U9QC-9,WX")Q&CHK&E,$1+A27/7>.C=?[P5U7"M=C?="%O:E'L/?;=N M1:V%)%7>V]T57Y/L)8OQ)QBB`$2S5U*._4``%J;44^AD0"=W%;_LIIC.YY0A MOW'&D?E'*'QIQI9:#V4 MM#1.!-<0*&AEWVQ9C^E[IM<9##L4M#=$ MTQX+Q$EWH0`L:D!BF>(V'0+-TMH?@L8FTAL7#T3^;,33^6_T#,)X[UH59.D= M>BORF"D]/YV&&U4&W4<(`O@K!%&Z+$&C75"@AW>;40P0_PPW$/^:X9!RR\]+ M$)+7!X#A!(,K[PYBV^I4D MN<*Z$U_99;2S+2:OOFYP.:+QSK<@19&JRV@F_!^R)`!X^QB3.4R27/`MY]2[ MSEH.9&`)7]%+#$KTIO-K$J^SY)H*V$F*]-;0=B3;JM<&AQ"1A.*L@JU9+E1, MK=#"ZV,#XQ?B"#(ZDJ+KN4V:(&N05%U/7B)0?XS/2-B,AUST===6J(",[*QY M&^%H;(0RI9#L!(T5'WXR\DY2I.OF1D4(VV@1G$W+WJX'82M/H MNN>UT?W'U]*X[H2M!J&*BX#KSM=J2'4SQ;CNIZV&80=7"M=]N-4`;*T'==W! M6PT^':\CU]V^%9]88Z9$9].1:^'9UA9SO@SEMIPA)XM%#!=T^?1)34B$0J9] M?@Z6,,PB&#)4G^`:;,>3-L:[)YWGR];S!$L?Z4TT>X71AMZB.%W*_,S:CSEX%,Q] M_MI8E[%JDHFR2K0;ZR)6G:O83"V[&.PRUOUZDH.HRU!6ZH'O.)SI_/9?&2L% M"=,E">_Q!B9Y$:WDQ!1]M%*-`0:Y/EE.+<7.`_?-T43"5;1W]HR\J M;]&"+7+=^'=&M6P7-C6G`UKIL)SXQJP2&[;D`\-ZBYL.6Z2?%LH![I M,%PW0)K#M:NAD250NG"L1NZ;VAJF-IOQG/Z:%V"7>,P_RQ*FS"+FC13>2"&, M9ZI>O3L2U[)_[,LX\[(;*'0R0MJ&1!LZ&C,_5L735:%Z-YL0+ M[]5H9KAGQ5O8Z\G$Z`D>BM&KP;P(XD40DR+(#=J@D`Z23'!8('*?)!DKMO48 MDT4,5I,P1`6E]WA.XE5.B8D$/,'Y>TFTOG[MJ9H-/9/D4%;C-S(YM3"QWV$#5Y0D[7=)\0XUJ)B.&MF@ M\Q[3E[7(99$GI&8S,1Y(?`)E/0:T`NGIE/>QM(H8`I9^I?C?>SP)`I)19NX) M!A!M).H+I:YVUE1RI`UI#3D-[=-[33?'@C*\?^1;0UJ02Z&CHXK:3U240%'T ML,7!DG+?U^1S^BF5)5B4-#=`SC0.$0;QMCC?)VP:AZ*F'L:)$F+#;6;C&$S3 M)8QOW]80)_(Z=)R&-NA]+)14T_D=Q0\'""_HULKY]%(,O"9)*KI[5'M;65E, M`@C#Y"XFJY(:%M6X%T1$:VKL9T5'#YC*(I__,494.!>-428 MLX\X+>%I(X-3%VD?FN:NM[)C5RGH^(*3-0S0',%0REB)VYN`;@FC^1-<,*$V M?UOW#-Q7$&6\V[VIAQ5(2Q)*K"2,$;^M':IW-R+]H!D+;*7'$9$P/Y')9_B: M_R1>AE)G`UN$H^3XZ<,O/S+51OUM%Y=&UAR@'Y(+5^0[-$^WQQ.+^)@VHU@U M:/)T/0>)%X_5+*[;`P1ZI=*OEG'V4@#)4Q:O=/.QA&TA4S*C3D;(*"$5@?#G[,1`$K` M-X3G=5!"\F&LD$BI`^N[B>1BZ#X2><[YKE_\E2=$_>U"\31*:Z68O/!GR=!9@W^.WL=*L\M MR=F"AFW1J?N+5>"X67%!ZJ=T&(XH1/%\Q\M6["%]Y>GP:`,?(X`3`X&&9MRU M)E$^."PT_%<@@93]6C'6(B=IQV4(W+44.]MP0YN\@CALB"8X;&,G1*S<'KEN M?(_<$XP8K+GV-\?VA6&[4Q>I9+6MJ,AB- M.;+,R.UJ'9$MA%<0PSE*DUF<);QT+$K=K(2*[2AYAO$&!9!_Z#Z3G/^#8;Z[ MDQG+1%;_G7W^SR3]!TQ9(><%1G_DM8D1">](O/M3;G\7[*XS$^$4SM5(1:=< MD)LM`9[F;Y3HGK)'SR6'9W*OA%W4?_TM/C$[U:X":?-^R/E,QT\A+/YWFY<- M$CK_:W7OAUQ1G*^PJ0$R#D=]I?_>,D\7.58*G2X_],Z0"_^>.:A?(),X!GB1 M,_I7VQ/^(;]`\O_SE=Y"""^*9USL0M_K7-90.[F63U=R=;R2\JA0_BLK$K@> M7<,?Z1!I["F\\(M;Y*E2Z;BA<;O!N$\ MEXS6!J"(L2)4U,@/4,^@G4QG\X@>TO8U%QA,'C_N^!>U67;7Q.T;Y290PCY< ML2;3NT0XSX6C=?1$[7Z!N8-L_QA*9[=Y\/:DKE'A>LXRS9L\>?P)+G$S]D*U#26#/-.)Z+Q51A8%L*&O; MRES.%#%4U!6L:"[GH=#^+&WD1)9R^H^S/(H"*Z6SR4,MZ#0XC@7.1L_9A5?N MB>!J9.M9K^,N]E1GP_HU+VMQL)3+&8K;("2/XW(VS+:M2D'3$-LI@\3@,SH: M0E!FVJT`],)5;[Y-%"4YG_5/"I?'DNIO$S&=X.4[3T:,+ M7[G95"(SJQO<,27-&7'6BQNN$.];?6,KNT"I;28MM'K:Q0B7" MS50>M+%!Y1.[CR79@:K?K5$G1;#>PD[%QR4,L[P"0NL7CYL]POCX@PR8$)%\ M(E:;"GQZ:)FX9!A!8345+0TYOE]H.%)ZNNP$+^J.KM'MJ?9M7=M M+['!8F+W'I12S&R0R`R[-B\2N6B.\6>9H%YZHH>H; MZD`+-`HD.!4J^+I/9^-L%=$XU+$Z&QG;E[)Q?+X4?2+)NH&NFYI#<9YWPW#I'?&;`F6W<)K6SI':X]/F1?%^WQ[G^_!^GQ[/UOO M9VO%7^\>IS'""0IZJ7S5.-^%H^>]E-WP#?4%+NP5N/!.0=XI:)1.0=[=8=!( M>BO]Y6M/I%9Z-UW*!O\A5$U?COJX#?WS'`N$SM:-Z/^#G)NW[^00HYGO!3=>,A]NB@5SGC8P->6,-FB8 MM-[$V+2OI&'2?8,A&C,*K\ZJGMH7^B;$-2=/ENF*RFD'-W:QK`X6CHZ3#D?U MJK20TV6T,X5TGNSR<2.O,-XM:H5$CVRO4_864-Z2OC)=:Z/)_?1VLD/'T`!L M(EC'4#(HVBX&:$6ARAK8JO1=_/7Z9;T^]_5Z/.6X+%%=F2]7;0G>/.5CUC6C MM#F"I^O6A28H:I*IZYK\1BCJN@'GM>AG$?F]@;MW>'V0_SG0[4NS,U8_`U,Z ML?Z^T;$6:9S!ZX/_3B?BJ+.EY<_WG>RI'YTM0'^Y'Z^;ZG.<@?&7^4&55:R= M@NDO(D3Q.5NM0`[J'<(`!PA$]WA.XE4^XW1>5/J9S.YZ4KF3;^ M"8*(P<1`>R!),L7TX*])0F\=/O[:PPQGK0F]XO^#()Q^I?^1L>="[GNF.XIW M[RIPRX4/^@(B\$*?A'3+WFF`MU*7*GD?`Y;9DN_F3X0@S][?W.<BL;V[RT9\[(CCLHGR:8?(SI'2C8Z8W=#`!)/PFKNT@95RIHGGRVR9S^H\88 M<##6',`*_#$)(`R3.RJ#/`.F_YRF2QC3/Z\AW;6,X4\G1&FXZPH1G;R$7,9265YT MWJS>";^V:N1.1O`Q[$MM0=IYRW0G//45[9T,PR[O4)%.\'Q&UXN"RZ"VJ%/^ M<1<0]JZ[[6!J5%>,R"%7%S.=8W].9UE;GB="B6\2!(RW@^$=B7-/GSI>>JXF M7/O))*8M%BG!GV"(`A#M>"$ZLS!S06,7`V:=JSC#R2L*ODV2A`2YLXV0'G%; M`X3<;%:!`B;<9MX3X_1P0_@9K.1.20V=AK$.=DGM5065_D#+OX+7?SBK&ZX/ MB?&52OTUY'T,7#%WZ=LG\O+(Q/K9*WE8"R\904,#)'R,J;!!L,)%)VK9_:Y# M.;;%MRS^??P5B[_^7GT$CF<0OXT5ZKB7G*C5Y7M4\=TS0+0*0035N8NF'B:( M"I8:](@;FR'EF61,*E4Y?++6)HC9Z<'8NQ1>;056:!Y=:AU-9!T!])F\@\\! M2=.DV"8"K$0MA^CD(.)X)%[/G88<(@;>D47#D:7#`4)4<@;JUY^\O0F"UB#^ MEF@0)&UO@J#L)8M?@,I]+&QJ@`QFX4VWMRPVYS:"&XBO8!2IPZ35?5CN*SP1 ML=21\\5QUZV)>AB)-[#K0;*:.(EX"=>-?GHP251QKH=YZ@$E$RM<-^/I(=6L M=';=**=Y4\F9-M?]@;6/H5BD[E0@USFH&GCO\]6DO02PA#K2"B8WF MCQ+2=/]2,6O(]]7A,S!V/-LX8W-]5#I%8*T)\W'O"-VLR/V8_Z%EC!E`JD37MF]9?*[G<]AP/B' M&Y#275?[Y2>!>N_1BS!?.8\.2>L+=$?F$J&*A0D4ANC/:^9,ENDIRON*(X]>;8OG M4W`>=4;HTV.97@"ZOFKMQ[*;>JU&J*1TL:CY4&B7!AE).@S2>_1$7>&]8[MY MQQI:5_:2P']E3`+=T/\C#23BMQT`U3,ZG\S57-!Z()1+C[FXO3?@7;3FPQMC MCLO<-;S>_+09IZ_E&'%JZ_#CJ'^P.D2-#BN.NKNJ(]1!G'#=!U8=1!U_83== M8-N;,P5J#)^$4P285!/F>K'<;BX(6LH>5]V$S*:`U+4HN!X*9QQ5J3W*]8`Y M[^'1MWE=I&G90>8]$I2$TP/,?O&878H7AR4K-AO,Y%D5(HRI5@M/Y`X`' MYP_TVY*R7N+D^_M,_53.OZZEHS7A'+0&*QBJN`3Q&QHPDDY8BH%3:?P>B6EI MZ&$B9R3`=(YXJVZ?;>IA))'ERU5&SR#EUJ=8G*V(V\S`]-?T;$",$=!('=+< MQX;EIWZ(FA:ATL5$;E"8T/,ES@E:_]E[9]G/!6:Y[9PT[?Z,@#^#;'=K`&6T"9^05YTQ?W)@36:-G;T3FYF:)J*'2 MRTCB0E9>[2N((G@J0,C(4^K7-X'MR+NX?('*V]QUNXD)V(X.GNO&$^>R!!QR5"C/N,PDJ0\;A&!Q+(=BL[%4K7\W1T;GJ_*D!V>B3_*CK MZ+D9:QP/+Y);`D;G"-<,A[+WEGO9C=3!,9/%:(2[2W:QN^O/YF,-PE#5-SJ]WA.XA7@>5FU&&$X*_15U&UG M'Z1/\C.KU,+^\2N(PVTQ,8G%=U%S'T?](1]0&BPW`*MX2HG;&LE3ET"BXW?4 MT,&[7?)=_P`3#9Y3$GSCJMD+[?HL!CBAQU%\-^N/XQT=!YJJ[L2HX%/Q=4O% MQ[U,?D-1!--4HU1U4X_+L7SR!0+O;U?'2/(0>Y>[`U-G`Z/@/>[J:#5>.][C M[N"F$NE/O-.=%":>^XIWMFO04GK?NSI4`HVR=[L[`*G1&N!][NIX*>B"7/6W M\\F9C4'I'1=&8V0>)I[R+(`M='JN>LQV3Y?J/6G-;,I6Y5M;L"RCA5)@274] M\-=VS4WGO#)[RITZWK?ZXK):7J!CG>D"I=Z;;`C>9-Z=Z]+:-#/;HC0WC3K8P$,WM!X^K5TC*%9*4S7^A*PZ?6:AY;JZ:WV/: M`=Z1^$A9R2+U@X!DF/Z-_OJ%SAS70=3328Y#\<409:'\Z`\8?J1D/9`DF6(* M_YHD]-OK:(PDPPQGK1>@'.-/^9RM5B!F^-XA#'"`#FR,-Y">0_JW_(K#X61% MJ#CS!S>0LX<9+"VZ3#]V^[:&..%I#4V,.IR]*Z?[,TR+BY&=/:W=K#.NI4\] MI?(Y8.5(=U_E9('&QKV4S_W$/"@SO3!FM1%M(%#ML#O*1PDN7<%:U?IZ`X%7 MCE^R;F!Z)A.OU^CU4$(5GB$VR76#SWD!ELI9KIN,S@OUB70W>B]: MX[?PD.\NP;`^F%'<%EU9LG"G=`B>NZ)*67BGGE7)>*>>5V>0[:<]!]<-!7(`(X@,]+"--D.O=^26;X93V^>$B4.\CIMU$P3I($:GY& MI0$M>:$4LY?92![IF4_I)V(CK5GGS_#D^_8WT:5L@:*/P2VP&_!2UE][!`R" M4!_U`I'8;6:C^X([O*6+XA.)TP58P,\DA[+Z[Z\[LOKOKSNR[:GB0I;/WK5F5'$#Q@'[Z%FVJ_G%-DV#FFN M._1TEN:\0YK).X$O,[E>D,;"O2O8PV[6L3G_%5$J-ERO>6/U\JTID+H5RQGG M(U<_^(X6S_&V8&\+/JLM>+)8Q'3WI/`Q1O3F6H-HLF(VW^0F@U,N=W.U_8(# M@A,2H1`P>_'#=64H[F@EYJI#)S%ML4@IKZ5<\+"QBP$M[5605!=^HW$)8 M<(V$'G%;([EU7])[G*1QQC;P)Y!F;*?]`P)^>EUA8Q.D;%:!2HY?7C,K!J$( M+1#=T^S`3^./,O1%QBGM?,P/0?8[!-"%:XP$4M MO76PV#0/!"]F,%ZQUU:PKPZ:V*9QQP?0#_D$UV";']GI?,\2WN//E-6/`F.36/D_$ZO?CW49JR:9Z,9O-]9%K'I&9S?VL8O!+F/= MK\38JNE0!IZF1Q"M0A!!=1&PJ8<)HH*E!CWBQF9(>289TY.K/-^RUD-T-E') MP*SI@B(=(B]@?I>0WB;XGZL9:WM^KAI*O;J*M)U84FUU7-:FJ+ MTKPI%*&ZV7M<@TFB.W7=PJ,'5+/NN\++5Y`1*:`KC-QT@]/#J)&7KN!RT[5- M#RZ^4J["R,VL:9I;2B9^5%"YZ7"F!U4#@UF!Y:;GF/:^4D#*31\P'Z%@#$I= M$Y""*]+I+G3+7\X'=_@J80-V$.QHO/)Q,<;`W=L+?$",64P+VY//SFP4U<*. MZ4-@S(*:F\1]S(LJJ#Y^11P?)'-F'7ULBG?^[^;\KV$2V_O^>Q1UM0IR2:@$ MUF]/?77-@X]-,1F;8BC]=WN?"/YC=T,IOX%)$*/\,PA<(M3Z&@\O>:1HT[<& M1(R9N67?.*'S/$*ZA\)C2O4Z^P@)'R%A)T+"+=_S3^`-K;*5-$KCL(T5*A%N MIO*@C0TJGP!>R+P,J]^M42=%L-YBB$Y_WK'3.W:>R[$34>X8:#AV2ML/RS`L M]3>0K]MUK9VWHGM3L.D]=<(5U'?+P:,\"B0.K]`Z%D=,GNM6UR8T#AGSL=M+ MO<.$'9N*7(/C[K%#_>QQ]68HN1GJ M&2[8LI_@FE#1&2\F88@*PFI9'EVIAN66+OQSQGCMZ;SX=FS#[SZF2-B=WX\:%W4=3!D[<3[EIBT^^.\9B"FAT?8) M)AE]#FUX3-V"&-,/ECS"^'E)O_,52%`@>%/Y;:TXQ!Q1?8(@8LGW/U*R'DB23#'=LVN2T`,C`%AW&!MK+4J@,T*N(+V=("-K&A>$ M/0-VH5?&W-LW>O_3"PAA$&_SVVN"P^MLE47T,MC`V_DX@3CCS5_^XJ72`7"T+4]G:2%4V8#.0JA]1Y2H[<]&!8UC M.;C:07->#L99KY).X.NSRIW\4>@8B'TH%Z$\XL^<]9#HMM_X@GDG3X@-C%_( M..#::P0Z^>->-F`CUY5KPZ.S`\=@IS_63QH*[_3*,UO*,[?4/%Z!'-YKG7IN\3'>.&O?W]^R$W29T*CC!X20("C48#&\@ M)8)52]#V-^77U5T#.N=_9#A@`Y81HA'X`QS^,OE#7&=7=P@#;_TD>\GB)71#I7[&BD0_,*=Z3_I_WLE))S!-R`K&:S>VP"QUW1O M0XSI$?P515'"G?H!)%_IA99\W@BI;C6,"?*7S+T_?HD)^38)0`A7VTD69B\L ML`GC9!MM`"5*3+9.]W[(_0Q?K^@=01_5MA1+1^B-Z)2\=J%8T+T?3M*;#+-K:%O^[T"`BYI(@7T688$^23&,-M_4@4?YF]B4EMZF*`K%\IAY2K.D_HUMZS20;^I;">QQ*]TGW,0TL[![3"S+\"NC8 MVR>XR!GK'90Y:Q#_1K\P/6?Q-14B*:LONX';CV7'7V]#B:(77<6]7Y,\5#CG M@.]989P`"AV\E+L;^$C_":,$;NG__T*B\)JV1L$D97SE=4SE>=DQ5NUI@DB$ M0RK@E7OV>DF_^X*P#Q_O_^L^HJ,0)&:B6PQB@/0'\`T^LNPR98FM29PF3^0U M@FDJN7B4NGEM>IE,XY\DWOF/;*\CD"22G&&"QL.@6YK=4=C"6KY2('$3ZT>?TOL]?O8([FI%7BK-H,3J];6S\*:L.5SUN+.%V MH9@,_YGMXLH%9T"EIXD2VI1I@@4356Z,_($35]&6=S!!4NTK%KOT\+55TR2U M&<5*.DL%M6>1`'HZO\7TYY<8X$`8Q-!ZN*&N_6I;/@2R0.\V(PUUQ=<@CK=, M-[O[3.5]S)Q#[U?KF&R@[.(P.L6E8/1`92:#>.3##77MREX3+0<;ZKKO,6() MO*Y)TL^A4!O_(M#I>!Q.QQKJJA_0''Y)8'A'XOJ??^JP>.&0P\5`GF5#;PPC MT5/-$[+:1I/@7QF*3R."VPQQ1K*G\[J.J@/Q1P/9W5\?&5\\2"T&,4'Z$L[G"$:E$6;O"I%&`*?@ M(Z0;4**?U^IN@MS_9&9&L:ST5B2P+[(&^VA%$#2E-F>@V^3>)O`"<2Q9%Z7S.$ M7F^9DUW"=%&G.JOB:,@U7?ICF"$\?V>8ZIA.'="9BMGNT1/:P#@$$6RZ2O7' MZ)-P?3(-$I4E`<`GY2KNXPW[X>5F50!5O#K\"KL_CQJ[+J[A>PP_C)MG4?9?K0!S+"^7)F"M_(@J\!S+JZ4)GEYH686: MFU7=.J`FCW"K@!NW-*$7ME:A-FZ90B\VL4)M]&*$7`-<`35NX:&%CK^";MS" M0@N[3@7=N&4%/4^(/6H_CULZT/-JJ%`;MXA@--*F`G7\97'\`,9DT1(/M"`1X_*7Z:R33. M67]AN+@VE)KI\H7\L6\H1=,^-YRSY6'/"2TGI5*G5ZU$7LZ6G#6%M5)R MT4ZU:,>`8OMT@YVJUGIH=;-=5G"[J5[K#+=Z,OX*2C=5;P9W+C\O6@5@&YT< M24$T&@`U$K)5X9)>(#A$M4-ZP@I4-]5Y9P&U2E59P>DEJ]:/OCAM:P5OWP+6 MA92\-%3/O7UJS4F2P)1R8@#%[!*_7H)X(4P_+VAL(R7H#7Q)[_.+D%'R!8,5 MB5-6PO\D"U6.[#:4KL,S['/OV9 MMSO:QLS;S;S=;*CP2D40$%60/M6$&N=:JP3.I'B/=I1Z-8GCC_8ME$N1^"G%#VV!7I,R6,)94=)>\_5'G=:V:\9J:39L;**@L')LV;D-O)E_X:U#I,\T"5*"I] MB&K-[`*9%*'.\RMNKO(>"JU=Y#\'KILEAL87JFWX)1,+G%,3I:&#D,_?ME-]_ M+F#$]#).=VW'`"&'C?0Q'>K>;8*=B`/F:#NP$Y,E2[P(MQ7'I" M.;]=B,4X0%-5PG0+LRBXEEL\'AC[":P8(_>G:/5J%ULQTD.N:C5M%V$Q*E!- MJ`[/%VEQ:2!K^"^TJP8[JKVJXG'2K4JL]D-_F6YE(X\$\KYQ_7U9>6WQHR\K M:#P,NKG?O;'Y4+TEO%^,]XOIWR]&R7L!"KV=FUT:Q'WM?@Y.:H*4Z?T;OX&P MHP'@]2IYG6"OU=V;^0?`8/N]_X_UO M+@I>J9:KEY#3,0"GPHW[K*L:YF>)H'8^[YOS:E@_DQ0F,W*',,!TL=$S0R// M&OF,%AC-*2>(4XH*RS!)F<%'$J$`T1YTPBLJF'VSHDP](:=!X2'IX)6J0U2J M*NX]_M=6[&QE7>7I:M)9<1I:I5>F0SUJ9/,U:+X9#DS!1ZMSE5/S:J.C;2(^ MA@?;0_$2_FN0+*G8@9-N/\%T2<)*SMX!))O[!G^" M@*FY#%`]I0J9YIF))['$09LVC< MTSL0+Q"]O8L?='#H8R8KB&%ZD\,9>%-YMK!/X.4 M'M'I?+J&<>'_)L=)I8N-#_T9OM8>W)@R'1D.8.TJ5?O^VL/8<:W80)SE?HX+ MC!0^FG(_*XJ#)>6CKT`"PVNR8E[3A=MFSJ>RZC04?_HU-O`Q`EC^E+89R:MV M>E;MG)'.+PF]E6Z3%*TH*2),CQIY%=30A&>O@M)302D]XJ-1/#5801L?3M>- MH&I`2=AFUW,+J`&DJ$UQW?5-<3?U(7*[GF)`#=H&C9/KQ1Q5;S.1`L/U"HV* MUJLV$EBWVHRN0*>A*W6][*(:8,N5X@T5N2O26YE27Y">8N MF8^`N57'],$"1<:+RFW;@$/BL`R60S$PF-)N\S]@8Z1J0[VU3B M;7;)ZJ;S,K3O.7OY)PS2&9G&DPU`$=N(=R3>V0GQX@&"I)$%[3RLYTL]7^KL MB^GY4F-FB,[7EV=6/;/JF54.LWJ5)12`)+DFJQ?ZZV$:"ZL!VHJ4\=]#QVYB.[ MZCN[^YW.-RO@:#L>[S.TJ1PC?Y[ M!AA=@#EGWN,YB5#EI"!&/W&#LV2N9+4F6`!S>1BQ6J5Y549B+ M7*676>)F2Q2G4)\\23_#!+[":`.UR1/U&H((W,C2E,&`2C"X+N%T0DVRNUT/ M#^R"F_C*T9T"HG]`$']B MZ7#H9BHY`R4U6[HB;K`"ZHQA0&PFF?,Y6*Q`S M9K*04V!X!2)Z:<'G)82ILK;=_`3G6'*1,6-_.1M=K?+8`]K%39='8[?+-YEP M-])C%@=+D$"A=O6H@8G"G8")>N5K)"[0R6OF31_NNH@I:RR/]ZQ7A1\!Q#]A M8]1\>QVN"*V6W)Y7ZWJU;K?,=CX39>VF-LC'CUSIW8,<.!HEN/08=U35C":! MI;$N"MR08L23D4<')=/Y`MPGER-W-^]9>R"\@:M#%'C6R1Z?L4\I(E_6[ M?(6<5T]=@GJ*?]*\'.SE8$4&6N$*=%V#Z9EDSPGVPPFZE9GM4OA!QSBHO?_I M7<:4WI\01JML]<0V>O0(MOE./,E:E&C&?G49V_.5GJ]T]UGT?&5'M_E.UY;G M/3WOZ7E/'N])\&(&X]4-?$FM9EAC!%2L;P./)VCLBGNK6YPG?XL)F'=N6\\9 MNL<9RL^[YQ`]AZBJ>>1?+Y[C\QR?Y_A4.3Y[P6J>[W.5[ZM$=_;9[C']6)E2 MF(I"1Q,1&I5FH3PDUV0#Z3_3!JVG7F>[T.\\UU!N7ZB??#V]KN(PGE'WC+IG MU#VC?N*UK'/9CH9S5U1\BU]/UX.==)%2?>Q&$Y+A94,O&^K(AL\I/1]+$M&5 M[S*=L+;>-UD8@J^4)\+[HHR993\KG:K'5[0$U?[V@WJ](.(%D;8,H_HQ&8TL MXCE%SRGJ<(K79+6&."D^#@YO5^N(;"&\@AC.4?H8`9Q8=2?1HH__&FH-X4T0 M0V0T'TE"]RO[;FS3[KYL^/YS(] ME^FYS(Y`%QJ>&+U-/$@\JQ4DDR!%&[J)-3U76@]L M&8\:@4\DBNY(_`IBW5)\:J-XB<9+-,XR6UZB,>UEH7@UC4:H486M]0OGW7S. MQ7MYQR`OB'M!O%/9(U<$<+=+S/2Z4G6'$XT!O"K%"T[G>!-\R0`O:_;+R.K< MFJ,1HCQ#ZAE2+4]UN&#_^P37)&9IGQSF1!WC7XX^7`,;+&P^!-HU/*L5>GIN MTAUNTK-&QR];P[$?(_^LJ?]4N7P\O^CY1<\OQVS@8EL.-OQU-[&S M;4?S#*UG:)U]4;M=+9ZO;>)K6U]AGK/UG.WP.=N_OF=TOH`$TO_X_P%02P,$ M%`````@`YS!G1$9T%MSS(P``^*D!`!``'`!U:'0M,C`Q,S$R,S$N>'-D550) M``-BJ!E38J@94W5X"P`!!"4.```$.0$``.P]:9/CMI7?4Y7_@.T/6TZ5U>K# MXWBF/$[U.:.DI]51:SS>?$E!)"1AAP04`)1:_O6+!QZB!`HB=?107E;%F1;Q M3KR'XSUC]R>?GUM7S3:=S\K=?_ORG MG_^KU4*]'KKEC)$@('/TFT<"(K`BJ(]?../A'#U[8Q+B[]$`2^(CSM!OU[T' M='%ZCM!8JE?G+T[^^G=V?F_\M!\,A=T-%;H M.^\O&OCL34MC7*+>:>\TI]9_HV?.I(8.)YC-T540H!Y@2=0CDH@I\4\3HM)H MBW05,OG^)*?@[/*4BU%;LSAO__;I(:Z5DS__"<6P[UX&(J!+&/`EQ;EL4R85 M9A[)H>BZ^NK`@&*H]#P3"R41Z_SMV[=M4YJ#CF1KA/$D@Q]B.3#024$;JJIU M=MZZ/%_&4O,)D85HIF0-WE@M21:-!57&%0#\_&()F&G31&&Q\KX2;>#3UD`M M#44$]?*HF_$L'(#Q%^+EZ_E-.R[,07O:*Y68+X-+XIV.^+2=%!;7@1<)H=O: M.M2D%'`O+%R?T&(T75#,C;QXXV(4*"G&H6Q*I"K&BLN*\:2:B&(L*`&<\QR. MPF)$U",.B9Q@CY3Q"]WOA(2I>R["6S+$4:"%_$^$`SJDQ#]!6"E!!Y$B2P`1 M6X#\`E1^QHQQ93H0\QN^3":4#7GR4W^`5O).\(#TM;,@^.-SK[-&1)7T@FT` M:]]R+P(A,?/OF*)JWM&$16C8G2#JOS]Q0F0BI$+X9$@9-<*>GYVC%DK1\W]J M4BBFA7+$?FZO4E@E'NGNNLM^,7][./"BP"`^Z-\)<@+A0IP(W3\RM07F0K+U M>,G7U!;[,-&SEM4X4G=X3YGN<"D.GK@T@GQF7H"E-.[2ZA$L MQD1176'[LKDANL'P/Y0W//IN2I(;DH5M.F8X@[*^B*1:T[HW M8KE-^L9ETJQ`(CY$,:?&D!L-^3S6KC_F@:_CAKO_1'KDNV)^5S<%`1-X7428 MI%,2UV>Q5:N1<)OXQY(FOAEC-B(2489BEHVI]VOJ$OUV=7H;C/_7;8W?=."5 MG>$&R_%]P&>RPWPJB*<6O7*QM5T(;K/^5+[;!B;(<&E,6&S"1ZZ([/-LSK2H MOVM(5[5&-05[4=<"]KSGC[DS*;?:W$%A1Z05<1H*` M#T1AB,4<[)QC@!8<4,JB,7Y5X_=(`,U)=X-JWA>82>R9F?+"`-4\H`H]IQN< MGZVZ@2$-M,9T@F94C='GC\\F\DZ8(L,5Y=DV#E'5(:XC21F14@_%`UT*DFWK M"R5)N=W@?-4-KCP]=,?QGC36UZ63)`!L[%W9W@\$2R*[PP=M*$*V-?5F*FXK M7ZQ:.2;8F+.R.3D;]0ED7P>JH@D+,=UFNUPU&R`W1JL\`U.ZJI<"(H#=MBV6 MI^8V[@^6<>F4^H3Y<;>;1%`=*2.3$GL2?"1PV%B_JO4AZ-41KU%%!\)WX23@ M+/J`SHHURQT=(X,G<;:5:T=-YM/1(VYOTAC M;CW?KD#.;>D?BZ,N^KN>5V=\\XM;$(XE?<#5<$@#JD5J_*%ZWT]&\&^/3+B` M6';K7K\$';<'_-7R@+L/G^X>^ZAW]]3M]3N/'QKK5K7N/R,=DA(1S+.R7`NJ M9N"2I-PV_FG5QAE5V&03!=,S#9.\`H1 M8P5'J$S4[0Q6(G"KZ+%QDL.E\2OX1EE:;I>PTH"@;<@Z[:[E11<2?\V+G#@S%`%XU=0LFJ M+PFHNT-GW'[E^T;():LEQU7V0LIM<2LO6"$-H&?^&<>E*=YWMT1AVNRJW.PC M^;#ZBXZJ=5"M^^]UT7PI7]D'2;?/%&01MT@.--ZSL_?`>>SKN4EG:<9\$G9YS:24=4X9QC(`, MR\1Q#%.4<$7:/1#PA7X)G"MEC1:\&\=Y/<5C`HV+ ME7:Q?%)0FS^?$BPUC%7&=[M)Q:1E,SCM[@"!#CN,X-WA4R2\L6Z-3X)ZI,^O MI"1*&@L(XFOK/E`\2)J<+HM".%.^X@Z[47,[AY7$7'"#SB'EAPQ#I#B*6:*4 MI_&?'%>4L&V\Y96\Q3D<[9.TVX^LS.?>_*@9AK;TJ\^,#^`.&4A:_#/"<%,# M5N:,X212,+"8*C8S@L]:+.T2B2V>!)\0`5:XT1',B)LEC0Y[(%,2],>"D%4W M.R`GM]=9.=J\)"@O"HIEB7=Z9-(@L(?QQM0-%Q*AG$AP>M((A8Q4C1.6=L*T MX?N?*--UJ>;=&2,"HN4.4T3K!2EZ+\W>/@DRI3R2B15BX%5OVP=)MUM9*>", M)4IYHHPIRKA^CU*^QLU2SJE/)3B-\Y2/U>`JK`<:4D6RX6D>WY4%VW[&6,&/ M@,#F,`KKN51I+*G'NJ3&K?!L9X)NQ[&2R(8A2CAFX]L<93R1TDQ1QA7EV9J! M,_6=QFM>S6O<$?Y^J;O]R4I1[]&?FGG5EOX5K^F7BN1=H&[+6XGF9"=!$YWO MOCCEC8D?!:0[U(,Y#:/P/H+F<:WKMP>+BO>"AX^<>7#"*X")9%SUUL+4EF2< M=O_!WIN:L('&&\:,T-!P,A=?(F&N@QAJ9@BN)5RP0T&R]Z1QC)*.`1L\2C7K M]8!NXUH)6[.EI&G2^UMO[I$XCC,#((6VT`-]9(?=P)VK9OT-5@9-:KP[O-&@ M5%V-=$P'^PG6KCWO2-;M%59^-K<.G3)&"\XH9@TAZ8)YO/08)_SA:A@C`,HD M:%RINBMU(P47X\+MQ)^X4",\*A@#G,!NLZ_9/JJCQ"'*D4,9O<:(Y5.J(^WY M(ZQ(_OJD="3UH=?MD0F>%[7Y*JAN`]LIT93TRJU.*?%X.,C(-_8^A+W=^?)M MZ;@]P4I35O:$)EC;=DZ7WM\`>T/-WOOT\H;D[H9R$[[MJ+B]PLHREKIKHIDN M[NX4V8Y>LZ&WE`>407&;V\H-KNXK;@R[LV&3_2W71%<>N?+_-THNS.5Q0;+T M^4'7^=UPJ&?.?7Y+@PAL`*UMB@.X3<"\O[!J_SU2=KN)E?)+]^S$K-&"-ZQ; MQ86+5540`,42P,]4!K00(GU?HG&JBDZ5FY/#*/!"A$LQ'-[0Y6 M'C!UAWR(8(:+!>4,IK%Q61M_(=`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`G/X>HA?S16F@]R>2PF4,)\DW+#S`7W*YV>4I%Z/V^=NW M;]L&JCW)JKN=DDT)6-@O`Q$8_(NSL\O85U?J+Y$JI3`69/C^)!JKUL79^>7Y MQ>7YOS7"Z4L8I!"**F!RLR"#@(X.\W$0G+3KJ_BR%3?KK>$+]+[-J!R)V@$> MD*"%.+TGRH$"OUHI7@L^MN4I8Q8*:>`O5?_[C+B)P MUMI2#,X>MY.DL'YW-PQ\J6H70U82[W3$IVV3K1;STN(4X:4_=A,D$GK&Y!F* M%Y4DR2-FOUH+,M5E\0FM7"$I#ORQ4T60%V]9$B-WJR?D-@=^HG$@[2JQ;U MV/GO-<7QH*][`]V-O/,YG`CJ*!+";/@$X8$TYX+>GR@1P9"N1:3O]%!/N=\W MB'XDDGB9T<#<4I3"RFA@KBF#T@^"1Y/W)S$ZU>37:)"=A)1]OEB(>,+4[[`; M;"XTA\<7X,48HE20['U)3UD7G_@TNN^;<%QKL3XA9SHB$O.B:AOB0&ZHM[AL M$&]RT`5D0-6>:G-*)1?S[,Z8NY<)C;G>ZC`O7SL;`//:CCYQ'0S>XFW5W8=B M0^V_5_J##Q\M/R\LK96;:R%PD-;Z/8'KF9^(@+/C>$2ZP^2\7?R@(?%SF4ES MPW).U5T));6BJV02HU4R:CR7W9.SZOYS3/X>,7/Y4;+E]2G`O^/EDJO?+7M7 MQJR5+TQPF+\UN4"[PO):Z:"+V4@M*G^]-ALA:Z47M))..,%4P->;,18C`@WL M6?]%S$G\]#B+4:X<^%*;,T7?L"=5G[#X2M25"I/+2&R3K0>IE:VB0218X3[] MN.@+MC0KCU);31<-J$.=^A4!UE:K_HRG>Y4>.&9.Q=;`UDJWTN-YN?&ZWM/. M:\RT><1\XV"P$;!.-DPO@<7!(V>Y]^>R=\=BC1Q`A[.=9^Z&W(^:\6TXZ^;6 M:XIK92@RQE/*!0X^ZN:CQM[:@'@S9*WT$H-T=.HR8NE26%HS^0N'VG_H_V9< MLR0OV.XBJB`=@[:N8:T*3KUTI?Z(S/#<5FBEH&92\WXD/:P1-+6"%E5<7B\= M(B9GU/NJYP?<,W>HV&JL!:F5)I&DC$B9>\CNADO5':;/^-S!NS_YQU[O7N"1 M\*71=P<:1S&QLO4K&@F<4#6W^>KCB`\:`.1S6]F!E;>K5D[WIG56M[^X3ZRD MJ@G&*ZOIJW?C.60,HX&IZ-(*0["VV5]S4'7TU_A@HJ$+.ZQ&S#QQYL/-GT,* M/$H\Q'=+C`ES!7:-'(K/SGU=EO<]8!R2U$'NL1OHRW-]-_PLJ+2-",?0T]]@ M-N=L$96LCZ$W0]:I!<72/D^@@Y+Y3'VQ6@[`>FEEU@\_:!EL/:RBFDJ>Y:D+ MA<^5UBE]?8/E6(^&>L`;'T5,Z3_<"V7T(@H=K+WC):[H;G>/H4U9TA*W( MP_AN1C;2_89'B"^WK;!MB!U%K4$^B#&*@X^:F"R,SQ^P_)6,L'R<6LU_*^Q: M]1`E-(#PPI'6V(%$/6MB8V*[!&C=---SIP`GTJ9&B9\_UDCF]&(2: MU[=OB9?_TAT^!%Z!+2H@U4K;^`P"+)T6P]2)TW,BY9Q$JC+\LG@W`G$ MA5+EH(]B"1M4R5_O:660UP+4*%F\+.-*7KBPL)8I8)"TPS3SR.R(XU.B0T0% M7Y^)F.H`0,(W\TP&L%]6L1)B7GV?>#3$P3?;R[I>^#Z'R/D^X+/2^EHHQZ)I MGRLA[N4?*J\7WGO+=06OX_9B&K"CT1]T0'M>).Z-OS!LO/[ M2XHLJ_()JPAN1_\?@L4Z=9=A\BJ.X%--_/>)*XAM<0"O[MZ]Z!^20K`'O-=I MYL99:JN)]WU;EUTS'M9W%"PQ4!S)D.#L_&O?S9?KT(^DZ];332P)'/V28W@^ M0O^S..,%USGV.2RY"I.;7+WH=I'#[K+EBQ.OL:1+#>NP?(YD.JY;ISE=]S5) M$F)F[11S`M4KJHH%=6R[=X#46I.->M13"ZF%*U@H7K\H4P&E9IJ&=N9H^6NM MY,TM#WYF@GAX`ILR_&?B)7O2^C-^3Z?D7T3P#R:]O+H`O0.).JU2;SZ>7.Z< ML00UY+?7HVA77E%9G2:2J7APXKO/[\))P.>$7!-&AE3)OHBD*E#&"7T"VGNQ"_0 MQ2ZNE0;FAOP.@_!6RZEGE:Q@K'1#U:B9%PCZJ`55A,3_SI_)E%C[?:IAU=Q\ M*X//>HA:#D/YQR7B0\7Q&P(X@*WD,&-^X%)V67RB``>:@;0KBQX]RHW+QNQ]\J*N`^Y]W51GV]-=:A\J_?[MIF4;]8LWS&8/@NVCRLJ3 M/([:KY>XWASN407CWY M/3'W+G7J)'RX_O#;UF;Z!G)RBG*W&K2(_5%KK>B9J-VJKICBP9KPP0=AM[9= M+2.&MXKL`\![(O='];RN&A.Q>N7,SH3^H$.%T;'P>.9^J!U#\[S'5,27?_V* M@XATAV:7X.(JS46=;(8\`C>YQR$-YK?<4UP4GE)Y'@L=NL*5KP\<-DAB9B5< M=J%1IU#XGOBZ7PSN7CPJ21^_])9VBQ:7UFB%/Q'P/F*^O!L.8;UH"MM"K-L2 M-@+6RBA:-I,\@3\^8N'/X_Z'"RN'60*TEIJIN27P6M46>JB73WSP-,82 MEM,?)I86:\KKJX-;@UK*#^^5YV:3-SP,J37)<@$=P?P*$L;)I8A]GKNG0SX2 MU1WJ:<1"U1*@1Y%E_L`#_WF,?3Y;O]SH@JF3CWX0>"XY6G!9('GN M8YVDC2]VD3Q2XUN"/0XWW/3(.(XC#9N/7)JMMG=3S.04+JKK,+\H,MD#J5K5 M3"*L94NKH$Y2+Z\NZ9U4*/T.ERDG,SY%%T M[K8:?7.FIP<;3/60=2<]P68W)#Y?7\]@>7.DQ7DO\KUD/2O$=&%-[N2<*J^,+F M+SK\U;V?N,$!'>JHR[[V8`<2]>ID]6C@$6,U:^@K+*R7]&GLDGNS!C;9YG58 M"W(<;<\9PAUO\/9W3IGZ5?_645AWQHB08SHI.@6V$;!&:>)_$,UEKO\WT#'8 M34`9]:X4W"U^`P%!03:N-$*=6IV6S]>SGG1B?#/6G=Z(0Z\GLE^=0"O#J=6E M;(-;)]T?\%?R!!Y)DL[^2BA+22=0[;7I\5E`E++3J>6@:Z7?\F3$O#2GYW#+ M)\N=0/F>U!PM-\7?KH?9,`D[BMF7$5+'&F0&[YHHZI%"-0HAZJM)=V(V$!(1 M%NN1+Z^A%M)YQ8T#)*_+-]Y?OBKERF;K-<6OK$"YG=:QK/?_U]VU-2>.*^&? MM+NG:M_."Y`P9ZJ&P`9F\JS8`EQK+$JV`>^O7[5\0;9D6\806N5B23V[M6]?11H].4<E@- MB-Z"Z/"T\,"8$M6,*,4S8RTG6WI,']/"F^ACUG"UTZ#"H@YPN?V0:4"CF1@; M>#UY:5*YJ,$-PV;/*7V1%?HRA48#?\].G9+6/+A07WJ*=>2^'M<+0GG4W8WT M;[R3"A<>#F6]?F21)Z\)V%NR2`SZZZ+"A.>-2(/;MO!G%V=)%@9>9@BWZJ>L MX4(01?5&M7E'>81*"_3\3D\L/$F3(-PTSHDG+Y8F.S'U`:6.Q)H%%5(6>7## M!@ZSTJ7=?-^FX+1E<,',KX,I[PVOIX/OD44AC=$=N2TM8TB*)?G_`7)C?,D0 M'B?\)-H!;?8!EP62LS*P/@\"M))&![.;8A$`BFRPO5^$3NHFY'+7*]8!B%[4 MPB&M&=R$?S5/*$:E6H#W`!8GY\.ZXY>EQ'X,$(O=:S_I6&AW?2'[ACOQ/):*0?ISQJ>9&N@[ M`'-7)TY)8Y5R#V)F_.M.:Q%$#/*X5S-/M>EZ2<&(WKP8?N1OH/QHQ'3-J=`_ MCRN+GN%[,5-A?#EJE^$&),UVC!@VG(`9\H5D!@"UQM'W_/<K)A_[V[A'[Z4>[XC8`&9^$2?)ZR6(*RHPL,>MLAG2A2J@O`C[B7Y_ M]N1CB:>1I&&$9#IZPIJMXGCPZ762KBBGRLTVP<&, M;JC8V_=_O!TTJ%3K[=>0-('RCM07G42HT%#BT3P51.F;)J/8K+S9;F)V`;TM M4)R8RKN?Y5:ZU)Q((/O\'KU>/!K'D"^'[VBB5E."@-HYXU6*";5-G9T>T#>> M^RD5796#H5QCC;A(/24W M7[3E>^AE@-D`R-.S/HZLTCC9$IA M8J4^]:?9P/5L5(=8973)%V>P<6S8]#IJ>1E=Y+HMFLGE]4(/Q_:7Y?;><$WS MHN/)):B_!=4S]3CU-<&(?G#(:X2W!R/F`WR1^\KFL,NGR+:@HN-EI%G=M`9\ MH]ZPT@7AG<;'//]S[J!3N.&#^0S6!9.Q=T07N$S"*[$8>'O&0G#(WP>A[Q%. MS>%N%J2HM*QXD.6CK"=L@;^A)IXQ9/$F9F3HP1@A?6G$BF9VP\EJ@*WH[:;- M+WIWBX]/4U[C.2:]_)42*/1)\MMQI=@G2Y-UL(N";>`)BI\1^X0<@/DZ?$R- MR03NT=<7+X,/$4TC$<'8?KY^9V"1ID"`XF(6"C-3D1'SNV%%CTO_[4/6==Q+ MBU*/[R026VQ]P]1\CFG.DF.3$=S&4==:\(U;SPK??(YJS%64Q\3STD,J+4MJ MD;E&I(0M_>-NC^[GX*=BJ,NN&=1K<,P$#NAF3<19K[!W,KIIW#6HB'S.G:8TD2YVZY M30@M!*A0>#0BHF^HM:@!,+1A'+O12&-LQ#7Z/?53>,LK:]Z,G60EG-PF:\AE M-H2GAA5!5C.9$?%_JKT=4[P6@@LI7 MRXA*)]L-B]B1['^0^!?=D?B-GHBOU7L9QH42KZSV5:FQTB'[K#"<6E$/X$6% M'6*((-NM#U>--(KS.QO.P58+=-/L2E+XSD_.A/ME8A2P_\-.:=>K)Q0IN%D$9)RQ;)5[5='GG;FMV3=GBH,2*5^,: M^UJWM-R[7UQVC+'HE//7!X70)^I/3I2+->R;Z"*!#^WU0CD4IU]QL=+=3Z[# M?_EJD'A^B.07H(<@7AF^^Z4R5WYUI+SO:<,R`\\GLXG8D3`>_$/]GY$O!IJ( MK6B.%ZI]QK672%Y4EG.A(@VQCA1TTHS43-'RI)\?.3VC54`?\L:[.6@">LJ0 M\,],]Q9+0Q[5=<8,$NP)M"D);9;AIPT+X2H>+[=3&E%QGI3.-T7`3S&2AB![ M:!'Y(*WW5!R1:>@7!^;RJ#Q)0K!A?:.,[_02H\.XD5N`XN\^"4>])MV+GP$N@H267-@.MM-0UZ!:[:>A((*V)4Z,#6"/EK M\_!Q"(Y89[$@5PM0S\CAF.K:',Z*"KE=DAJ'$M&LCS`QY'(O*^`NV.?WH,,` M:\_B`-+!.-U!.?QRY19FY.B[TN]8DCN#"=`_C,(2X\6V*BDIO-/F`(B17+'J+`V:NC?2">J?!X1/J M#$ASP"3RI7/"-2^!`M*2W@E'T2XP;RQJR^\TD,TI44"0,XU?8X^S<_Q"96YV M`+?B]$@"'WS2#9*PXWK8YW!7.5S$_-)[+.@A0S5A[>F4!_Z.GDDFRR;]""!+ M[#OS_I[POTD4ZPDM!K`@0SK+CIS&,63;T+-RY&ARN2U.R4HZM>9S.Z^#KW'? M^AG!)C`F87[;O!8'O<`3TWND94/OI\2DBY;1+K%Z(3KA M#$3O(,(/H2BHX#:EQ-O/0\8#/8I[1!>H)"&ZH$G2?_O02_A$5/_]+?;V8O81 M?_X+4$L!`AX#%`````@`YS!G1)ELU[Z>]P$`S,0<`!``&````````0```*2! M`````'5H="TR,#$S,3(S,2YX;6Q55`4``V*H&5-U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#G,&=$SYL2[NT9``"[@@$`%``8```````!````I('H]P$` M=6AT+3(P,3,Q,C,Q7V-A;"YX;6Q55`4``V*H&5-U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#G,&=$X&78%>%J``!E"0@`%``8```````!````I($C$@(` M=6AT+3(P,3,Q,C,Q7V1E9BYX;6Q55`4``V*H&5-U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#G,&=$V&BP-$;,```:'PL`%``8```````!````I(%2?0(` M=6AT+3(P,3,Q,C,Q7VQA8BYX;6Q55`4``V*H&5-U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#G,&=$$0'+A1EP``#88`D`%``8```````!````I('F20,` M=6AT+3(P,3,Q,C,Q7W!R92YX;6Q55`4``V*H&5-U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`#G,&=$1G06W/,C``#XJ0$`$``8```````!````I(%-N@,` M=6AT+3(P,3,Q,C,Q+GAS9%54!0`#8J@94W5X"P`!!"4.```$.0$``%!+!08` 1````!@`&`!0"``"*W@,````` ` end XML 87 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Leases - Additional Information (Detail)
12 Months Ended
Dec. 31, 2013
Leases Disclosure [Line Items]  
Renewal option term 5 years
Minimum
 
Leases Disclosure [Line Items]  
Maximum term of a lease 3 years
Maximum
 
Leases Disclosure [Line Items]  
Maximum term of a lease 15 years

XML 88 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Relationship with UHS and Related Party Transactions (Tables)
12 Months Ended
Dec. 31, 2013
Existing Lease Terms and Renewal Options for Each of UHS Hospital Facilities

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of
Lease Term
     Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000         December, 2016         15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000         December, 2016         15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000         December, 2016         15 (b) 

The Bridgeway

   Behavioral Health    $ 930,000         December, 2014         10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).

MS,$WZ/K8\YR!"6ZDQ&G:.5&.CMYKJG3MU\'K/1C",M1TSWUT>.QB)5O?L<,< MS52''[O]JG+R?:]81Y>!'M\O+=H,PG M*CE1CI;>ZA40&T#Q.A^&L(#XFP4,%4\_:C=.@#4\;14FOFR8V"[BX:'BM;*. M)0T3;V;,_>:I1?,A-*2IMVL%Q&!6O,Z'-2S!E=-BQ(K*.!Y`81!D3X6*KX/7 MRCAF&L>"7]HJSQW0W=-O_\]MM_`HNB%3UT2+Y*Q>5O*+;D?+=/FU^)94(U$6B)!6T_$TNWU)K9/R3F,\A7"+I+P@B"0F)#N@FRB9B[OAL,$!8Z M?,!%>0&!!"'S)R!-,9SOC,U1>#S4+2<83Z"5J;SG2\"[0D1!)[0^R*$#32Z] MJP4STH?P/24YJR4G,R_EA23G-"$8T!F*A@+,WF)[-`V%#FVAG67DX]@8')/0 M(X(OY]I?#O@=:UYQ'NP(^EIX*-,=5F;,)>L])>AM4C3\\=8-/%]'9\;LN722 M$R9],*W>L/,I^\81LMT9C4CKWTD"@IL\_?D+?HE#^I1$]8:?SGY^'X*X"R\C M^G[GO5]LXK-C5]8V`XY&H'B#N^`F-48$P)(['[`U\WW,4P_44H!Z@RM#GP@$ M<;V).8L=LR390I]';\+Q9@PH8]+X]`UTEAXKTA)-UH!`Y#UMR-%7F\B4_CRK MVW3+MR[83T'F:VPDU3@87O=GF&URNK/`'6`:VOHIH_",MIS;M6QY:7Y"&-'" M@^%`>XP1`'@(4'.$;@^G("90U6ZS>X4FH'6M7=.&;$[%DP1K/Z39N79^%(^L M96H8J*4'180DP5F2'-/WUDB.%)#EJ%S M_`H&^R@O0Q`5$`Q+]L"'8*X?G)"_FNZ7WSPL$\HDX_#M M^458M^32!BY.:9"W.*NH"0S$??CPE8_^]0-WK+OK\VZMT:C`'Z-AU"K_KM6, M]MW-[=E=H]VZ0VH;]89Q!Y&K.?S7#^;PKEEK&D:WUWGGOO&XT[_#%7W'6=8X'.:9ZKIL76\%,OPGS[66Y?6&ZGD^?8L0^ MZ2H/RO]7RY`;#*2&BB/YX<@M;OPHAN2'(1>P$/0GBB/YX4B,[Z[BA17@<+[*5\9GR\P?.E"^[ M5K69\?Q`"@+E^@9(,CF+HQ1_-^V\OEE-#\7?@O*WH3CZ*?HI^BWSC$5(5^# MTIJT/O/,`5Z0L?%R/R;"P&`H%6;9&:NMC^>'7K6JVODH-WO5PKC4[-V@M(1B M;W'9JXQS>=D+4=,&>+8Y8Z_:],AIT*_HI^BGZ*?H]UKI5X`\#K'%,32M@-`4 MU2:'BJ-5'*TV.11[U2;'JV:O,L[E9:_:Y%!!OEHD*?HI^BGZ*?H]EWZ;(HVG M'-7/V>J0*(G.3[U77KZ7K5XR!].(0F0*&I!^-?==D M6M_FJ^'TH9'F%#IFOABBT#'SQA&%CIDSABATS+QQ1*%C'C`RW`T+%3JF0LMIYB\#8F6J4-E9C!K8;>:Q5/@\N1>E`Z ME#A%/44]13U%O==&O0+PEKJKK1J-X6%V*OYOS MM]E6"=EEYF^OJW:NRLO?AMYHJZH?Y>6O4=-[K>(9Z$*>DF%H2:&DYMC:T+SG MGF_Z@\[#S8?:OVY%D`@:E-$SO".[]75J?>N+\L[ES$4 M?,YH%IYF2#"4918^3\N$<#-U09?!> M`Z.[>JNN#OS4QKP+U"G7@M^Q:2[*M,HJ'V:+X MJT[X%'\%?]4)7YGYVP3[7+QUKN+OQAM6/;W9*9Z!+L=&1@E!@Q3]%/T4_13] M7BO]"IEZHLKA'0:,6.61E)J]ADI=+S-[ZVK?LLSL;:AMK?*RUZBVBJ>]:M,C MIT&_HI^BGZ*?HM]KI5\!\CA4.3RUR:'B:+7)H=BK-CD4>]4FQVM@K]KD4$&^ M6B0I^BGZ*?HI^CV7?IN6P[-,FU5LA+UZJH55LS/WWM MYF>J,_;!D&7HL,/5TQ*U\^185M?`2]3+6ZRKMUAW+UEG+^6:T_R2CS5_C$,( MW/$)XQG,/&.96&;+(I-LKNEK:YHRTWP-K'C/?T+5ZS6A4M6O7='`C"][, M?$*G!D>FS>R!":,)APHM^A/HFML^=O7`"=#0Y0.4CB$-5TMAS-!(J]HMM.;* MJ@XT7]&\Z_DP/YR11^69'+68M)<&_)X9B;, M5-+B*,+:F5>W"E67+$*)-3$39>AE-/$L<*7RQ0('LH*ED:#K!8&KD\#-0*A, M)_"LN38TO4'@>2![IJU]=GRNH6X\.`2>!-]!$P\3QP,"/=9"ZOQP7E08?<[V).2-I@\ZYYWLZJ,UT9G&4R*O36CD%'PVHU,"4/R^`,24UPIJ$600/A0XX-,PYF MH3T18X!74)7I/NV#V?*[+9U+S$&,4M`2S]K9; M;6G`0`NU"9&L(F*:7C@Z>A:U,V55/!_^FG);6"0Y56E6H)$Y9S!6&]\^XP,^ M[7,WMG`-8>+JSU36GV!F^/&7GP*O,F9L]N%F,.'#P.)?1K+&EC6_"`WHI0VC MFY+=N,6&;OEW_\1R!M]^A>:T7\(F3E%@P"0%S/K2!_FG%RY`!)GU7YC3)P9T M!!$*>THWA23"8Y"O?/2O'[ACW5V?=VN-1@7^&`VC5OEWK6:T[VYNS^X:[=8= M6E>CWC#NP$R8PW_]8`[OFK6F870[=ZW:\=EQH]FHU"\N.I5FMU6O=,_/3RL7 M7:-K].KPOW;C#E_\%0DAZ;`8U7PZ_OK;Y>?*R9?;VR^?/F@8R6CRN]LOU_*+ MV_/_O:UP+];"7;T:.$ M,@I*`:)CSD"M0@T8!AR=V-1Q_3$;HRS9H/.@/FQ.QCD;1$V78DM5GP8#;$HJ M6@!"Z$K=6'#/8(7P>3`3%?2?X,LY*EX`K5$[Z"/S=;->S>:NM'9 M8+]U<0@+^Z_/&\0.-EQS*+,9)\AED=EG=+Q+X6T:>K-7+[[P%L($9YRY*7'> MJ3BW.MWBRW(.)3?CHKB2W-U&$8;>K6^04I-WX2V$(WC&&ZG'68\7B@O&=>$+Z5=.>P: MNUO3#:,,RY2"FY/XM/VE[,G3>]S.H*P^UR_BMBN=%#YGW[7SA'W7YK[W70_8 M]6;>9XW962'KH50MN<^?M3\OSVX_?M":G9G_G`,5(Z),'__QF4UE99FKJU.: M63^:<5X'0\ MOH*D.Z#B/MHL!V?DF6H\FS/F\X-RHWA+X]]<-O<9==/*^C#]Q`]M[,`??CC`ARW,&)KB1 MPE5Y+IQR=/1>TRB>-"M>Y\,0;G#5/&^B4[SH\-C%#%C?L<.L[%21RV77P>OE04L9I2X>'5/!8DO MJ35MW6BK&/%U\%I9R"+$B!>W_ZM]^G*B74^8AQ?1+B_?#TB'AXJ7BOK6-(P M\6;&W&^>6C0?0D.:>KO6*)Y(*U[GPQJ6X,II,6)%91P/H#!=O=U0H>+KX+4R MCIG&L>"7MLIS!W3W]-O_<]LM/(INR-0UT2(YJY>5_*+;T3)=?BV^)=WXPBY" M;6LK;JPE0+7_[V$=8P".D=WLG<`2+W4^_T;G2)-^E5DJC` M\NN50,";&[G-,+E3X]A=YP3*;9G\7D!'^]R=2KQ0`K6V'&83]N:#"9]M;1"X M+H=^ILS]QGV!Y?G@FH3=/8"_$42ZJAW[(0RT#WWK"`3,O\^XP)5VN<#0YHD> MA@*0&*_A2,Q:EQ/TI\_Q-(/`:\70F"_&.>%+@PF!@S47KYD@`J_$O@ULT3L6 MK;O'%_P)-`.#PHD%-HG6BH'1!3Z7,\^1C^$@:$(/IF7AK&"ESS4'SUU";'"8 M"+/@09OYB/2K'[V1R+V$>,C>CBSK#D^BOUA*XCQ*Q!2 MJ0E$#4:`7X%XRB.(;2WP38#9$GNP&9K$O6/="S[!VM_7 M1J`EEKE?A.ZB:^9&&-U[TLQCD*\0=)>$$02%Q(9T$V03,7=]-Q@0\KI\P$5Y M`8$$(?,G($TQG.^,S04Z-.B6$XP1Z'LJ[_D2\&X((,^T/LBA`TTNO:L%,]*' M\#TE.:LE)S,OY84DYS0A&-`9BL;.D;V?!M.^.N\\.OMZ(H`EIPKB7< M6H-TC##FF4>X]N![ANAUX#L#P=T19ALT#GR9"7HKX>9#S&Y=/(;E+0:8^Q36 M7P`'X@XKT!:":)OV`IA^#*6/+H-;Z/Q"D'X)SXV>+`'M/^'6<`&E/P.D/]'N MNX>PJ(>L>!'7%R&(??Q@$L$>BV9D5,T0[A__!_+_GF@:UA9@ ML(RP-H[W[X].7$^T&\/H`YF@,O46H@9II!3\15$F1A!&Q=P.7'ZK`W M&4ZKRB7!^M^R[]=`E\%\]SCWM4:M<]X].ZO46F>=2K,.XGY\T6Q7>G6CT3P^ MO;CHU<]W@7/_W'T!2T)57'"P]L!E01@8"-!&'F3T(TNW\DACU8@K[;T`$QVX M$,!G!T/&>Y!)<@M@1T!UP2),V5!4BAA)8LKB$3[[C@9GYGC0)H@W:!%H.RB! M98[F5`U&Q,80!I/J)D-4<#^>7!YH-WP@M++;:J-AZ[9KTAC`^R3X-K3Q512M MT4Z=(9DWH]=MZS(R@>B8;"5*N8D/4;0^96!"/.?HC1R3R8=5+/SA!8.)'H;W M_#N?PK)TY#K3C/G!Q+"'!ZKXX?(P?*+.AB8X4;,?P,3`X%A@T7VM5_L1QX9V M*S'Q='0.S5)@$_8B*NE0>>R)8\$(O`QG?+@B!0<6RC\%F[R@_Q>(R1&57V(1 MI_CW@>D)240#377'14$E9H%,P*J0EH9Q125H(/$.1\'P8)RA\Q$U([!DA7!_ MW5;$3_)=S!5++>+!Y6LA=UMX#J(]./*I@,.2[Z@2LBXD+MIG4SB@4X0'/(<29^0`&)3.]0&#Q1?@A;XV"* MO93%3IIJ$F`A7@Z8+!$WH0A['O<]:5%%*.9!&$7!5>#Q46!I%NY7X(>A4$2I M@\92DX@@@P#5=LH>6`QTKFY>$-TU6A8*6QBZ0 M*,DM)#$*2]]QON$B,8@"_EF4K)'D?VRS4CZ;:N;,X)7OQ&:([]\VNO6HO!3V M\K;>:N.*7GR%^P<>[I2!'%AS'?W>ZJI!CW!T> MU=M#2:?C>O>T5ZM5C'J[66F>-FJ5DU-8V9W7:YU:O=<\:;2.+OW"TFS)NDQ';^+*3"O+)F9*`KR))"YSV:5G MXW\VGH#_V3@<_N>:KJ.J4"LQ0@^'[=GJ[0_;\Z>KZTV7E"\"3)E?Z,@OX1[1 M.GJ]!(E>H,T,"CY9>KMMD-[]L.0Z=`Y?J!8GK'V>C%:[>?[-)JK],I@B1RD` MSO%+7!=]GG`6--^Q=V@PD1]S9AZ>*;H0P+F^]@>S+#Z/2C>?DF5X9"A%T]*; MH!^X??;2UQ9?I98V#GTWIUQ:&HKN0HGZR\NRJ2BS?:9=X&;%S0`(YR$JC5)1 MY4CSS]50=-&WC+B'>Y2AGI9,2;/AEE7(NS=-/7BEXG)IZB=SJ)TZ>,SZT?'$ M4=NG+RZ.M=.):0U=;LNAU&M&[VIQ3VEQ3O58B'`L,K5CFUP3*93:@>\$N9.^5VEL<7@ZO7$X;;Y M?47T?([K7WGJ<\I<=+WE//19C=&&]V'?C50HK52Z*%S]P_1\%OPP\]>T/?,H8I].3=\7 MF!P"9@/Z#F;X\6V[VHBN,R/$D;BVBA>;A[SOQX!\.DJ-N/GZME6M'T4WGF,D M!83.XVOONM)-5YWZ^3Z8,'N,L33>FV5:I_4CPB95DKA)[!!P`)TZIFK2U=NG'6XGK5>(84*W%9+2[#`XK+ M68P-0]!N"XT;J:(1(SJ0%HHY7K+;PJK_$#F!)N#3YNBT@:(YGKFE)&=.RA/\H MQ$H*A;]>;6TH_&^-E,Q'NK"%\`LB*O%?(_[\T&#$"":(`BS`*22>#`D]^D[" M+=$".P,;_!]8\EHG(JR,JDND-`L]#">H[]UD(24I( MI)",#B@DYZ.10*C1?F=V$,=)Q$VAX$V"?PO!,H?;0&5"`^]:/[Z/VR2L)"%\ MA"[')*!EB!NV",D9MHUQW5+K>BB$RR,7X-"AA<&R'!3P/GCV M!RE@V64HM$"@8I2WP/1]DBIRN<+&F1\L;A/P"(TMP9$$6I-12(1B.1:'<(OQ..H'@AC",-.(+%R@3%P@B4(HKW"O0JR^PJT*L7!+UJ=O8'>D4S MZTCI]X6H_R7$K(*RG2739@+#6.(0]GB6W6PWM%C=W1.[X M$>)L1U":V:BZ^OQC'VBE:3*>E;P'47B*@CN8,*UWP-;%([;3^+S@902 MX?@24XI44SE2%?<6B*L+IJ5+3_'-UJWBW\#K[]>2G M\VA"N,-I*P18I:8%X"I([BJ]++A.TEZ1;9LL^QJN\J1*18O!U80@?S0MRROM M-N\9]V!J2C'WIY@]I9@[Y*HL0W(SEKGGCJA#EN'LAT_'G<"-X#8B+T.T,*,?HFRWWBA4FQF;& M3V%BO!`FQLO>?,C-/9^M[M9H'(U[>$.&^=K0Q`1=2BF27%SDH8>77S\[]XM7 MNVKB#HT$D\BX9-.6#^`%GDVN[T`KJ='1_1T:-%XM0F$3@S7]`*O(+]_<03)D MW]W9XN;.T9NLNSO;WMPY>K-\%UC=W,FTE>KFCKJY\YIN[J@K.D\3775%9R?3M1NU;Z7OYVV6O[NX3B(8?3F,SM5J;/H6\I7IC^8W!,$0N*VG%+,_63U MJW/:77+UFLW8.%'ZB[G?"JZ-U\SCSJI4?J64^_&6:K-XEUR]G=`61!^!_!;$ M68#J)4YL"Y\?_*=I6=SW52W-ESSE?D1A3>84K-5+=47TXY57C[0LI9HGMOD9K"DEICO+1G)'&L'((O3HF/Z!9SH!@HVW. M,&=J@]@.D[8I-0MB/)V*@K00LUX>W$,;G.$81MKR0H=>R_CZ\E)E'FZSO7?_1/+&7S[%=[4?@F?_I^`:JM:\XMP#7EI MPVINRA`7.7H'JVKY\.$K'_WK!^Y8=]?GW5JC48$_1L.H5?Y=JQGMNYO;L[M& MNW6'-=:,>L.X@V62.?S7#^;PKEEK&D:WGAZ?UL].ZG?XXJ\X.3FW359NX3^2BZ^E-=OBFBZYAMM@I?;C#]MM M9>&_*R,V-:WYA_6J'X9A[XS:^VV"XG`""R/;B1HD9[>F]:=.]7_^<_SU]OSK MU7^UK^WP4V"X98TW=S*FRZ&39E[MBT*S"!#[BQ(#\*'?^PPYV% M)V[C/B[7*Q<2*\2U72O+%4;5=2&[WFJW9_^>>]?17KQ/8G27=@"E-@O]#JU, MM*(/U_A/-:4+BW?TMUIT%'.H_917P^ZE;;&7Y?:%Z7H^?8H+[$0'0\51_+#D5NLYZP8DA^&7#B!ZT\41_+#D5L'`;I4O'"0\'`W+'S'IGC\ M[HDL`"?PF#WT,/N%?Q_PF:_-N*MY$\P7D`_F*S[4^F,@D0.KW_]W>GI^?G'Q M0_8`5FU`RQ4\[D]\,*JU&FY!XQY5Q;2'0.8/%?'E\[8KOF()]Z!XQT(;3_#M M]H+]Z&;SQIT;#;V[266[A?WEG1)@#RQ0#$XPN%6K*P:7F<'-Y@:`YHK!16:P M,M'E97"KJ=>[&YSYYHS!2]%DLD]L&U=.*R+*A2%OQ-M5(]S@W<7`52[P\"1J MQ>IN]66"0_>7\;BBGJ*>HIZBWJNFWO-RZ5YD*^,S]^4=CV77JC8SGA](0:!< M[Q0NCE+\W;3SNMYK&HJ_I>5O0V_4&HJ_)>9OXJ_!>6OT="-]@:`NCEC M<#DV,AH08`^=`!-@7R:B?WZ'N5H0*?H=>CJ*?HI^BG[K'%,1\C4HK4GK,\\< M:)RY-EV*G%$%+$J%67;&:NOC^:%7K:IV/LK-7K4P+C5[-R@0I-A;7/8JXUQ> M]D+4U"P<>]6F1TZ#?D4_13]%/T6_UTJ_`N1QB"V.H6D%B+RI-CE4'*WB:+7) MH=BK-CE>-WN5<2XO>]4FAPKRU2))T4_13]%/T>^Y]-L4,C/EJ'Y.`&@:]94( MFMC&ZI$JB,Q-OE==OY:N7S$&THM#9`H8DGXT]EV3:7V;KX;3AT::4^B8^6*( M0L?,&T<4.F;.&*+0,?/&$86.><#(<##;W14H@#I69PNZU. MI_1DWOM8IGH`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`5]AX[(+9\[DNGTG-0XQ1T!+,VMMNM:4!`RW4)D2RBHAI>N'H MZ%G4SI15\7SX:\IM89'D5*59@4;FG,%8;7S[C`_XM,_=V,(UA(FK/U-9?X*9 MX<=??@J\RIBQV0=96LN^OS;JW1 MJ,`?HV'4*O^NU8SVW]]GG[XOC8.#ZNW^&+O^)DY5P7(Y=/QU]_ MN_Q<.?ER>_OETP<-HQ5-?G?[Y5I^<7O^O[>5R\]GYY]O/VC-E!U*ZO/%E\^W ME8OC3Y=7__V@K57H8T\@G*UD+6@H2DPDBPNR(TD.8@WD)>\U8W,A3.^$U*&] MF#JN/V9C[KW7J)@3NBW+2+6-=JC6]K;6EV"5 M+(O-/+[L,=;63)8F.2R=%CNBQWU++X\ED7>=>RVY>'5^`:)NX+%D2O@KQHI# MR('6R`YE!F6^]8 MX5`FG\2S@\IOS=#KFX")Y5V`"V&&,\[!E#SO5IX;>JW7+;XXYU!X,^YO*^'= MJ?`V&WIO$YR:O`MO(6QQAI%0XKSCV$)O=^K%%^>\">\5"VNQ*^G=H_1V]49C M`U":O$MOJM.;R_\[!ZG,:VZ+W'.B'2UY+*E%^(#[.-O=:8<9CQ?<35(^>WDM MS8&WCGH]W6AM4+!769C]6I@XJ^.E3,S3>]S.QJS.'UDX3\`,$4V.-/PN'&PB M5R3CI.;J\O-YY>/YY6\?P>1@)HKVY^79[4<0@>6`ALH2*>S$&M./?&DJ[TU6K7$^RZ_=ZQ[?'7@\J'I:VSL5YO%ILW)R7&]66NU6K7G>Z-0O6MU'#T_7IGF1/B;OM*T^.-TX$0)S M<,09)G`93RZ%O@93Z!H>\^#AL6V.S`&F%`6VT_>X>T_/_)V@KF82V67:#O/@ M_1F2&N3,D]D%*&J48<`&?P?O#3V!45NY#%SZK-:YY_$;64TQ"K1VRP<3V_P[X`71F4/JR7\2@OC)[O%:\]FXDGKIEMF8]_B)`$-><#?A'SBQ_$F65GUJF;0Y@ M.'C%X-V@Q"54#ULMNJ8W:S4=M.#Q4>3L5NJ!;?*SIGLIRM=$@SEE,UC\6>8_ MY*_B[X]GL*YC@TF)2;%JZE]A%9NS:>]*P@^H[YUJZ\":_N.>3I;S(QZ'>BX? ML\J_Q3DSO0%>+]"4B=F'B>D6V,04)6+^[+C^Y(%[/BQLOS-/NW:=$?<\<*#, M@@%]$5?8;IV'XJ6^%"-N[NEM%3:KL#DO83-TJ9S9?IQ9N[#.3,7+19A5_DU- M&"^KM?F>8XK"!LX*>>=5(>_,PP@M[17(0($>8A'`%8_F]<_B(-2(@'LO-LR*?G,Z;S M(E/YDSM/>>S5ZKW.>?VL8C1;M4JSUFY4>B?'9Y5V_>+LU.AU.]W5>#'Y2@QN M[#0Q&-^D$_5WK;493VMSA<.)_;A1&+I=VWN8ZMGYR>W&0?SB^]- M&A#.Q:&$9)PA#-3ES!-(@3Y5]!B!?;$0ABW*D-<&#(T.?C47#:#-\6F[.CD_ M'0?[%Q>`@1:GK/HX25X[B3+NH84I&_(E?,:EL3]`PUH?P#T,?JQP#6*["BQ@@$_9H]Q MHB/7F6I&M=/Z$8=4AQ7=C]@4](##PX"*-NK"MD0L)5O+;*L6MF5@6]D<@E:& M?`0<];2DP$:])2458;9P*/`N_.+A18[(B4=W')2 MXGL_(]X=Z"$Y\)^U=_UT`]J(`^]0%@)[B-SBHQ%"=-Z+%\3T:S@C'246&A@D M&@!F+!/>@,D?0TLC3@%#K=JH$5VHE9#/VF`"-!0PF3B,P*:4^1G(>80GB;.# M%0@HA)`JI*B@/.C1/4@<=:HGF(4ZA:W%;\EQ(&Q9(FK".Q](+P<[0N@S$DO2 MB8'8KH4IX+OK<-4(XV]))FA@^).@"!)1KK7JU1I2T9\L/QO/`!\TQ(-R,BDB MT&3P&:!JZ\>,^.MP*&N'1L)[C%W@7B9L*.X*K;@I!"TD[@HA_=]VTP\OF_'T MZPRA&SU?"-CJ6T3:GW(PS4ZUG6@?6[AGID4"M6R4=4*SE$'XBAM.(GA?.TX) MA[N:6!(C%D<#>F,[M`_`;4]`]KC9`LM)Z1/'S;:56;$;W$UW7!J':GVEWXQ0!C0\"FL+@"AP** M3^.(+5QJV>/IB7536N,\#$\0%+5:_S$>3+W:_#$U!J/:#;\P!$$&S'7G1'&B M"!+4'B[LR"1XEZ16ML.$%A(N$_B8%F?P7FNXJJQ%?"@'IM=F0D9=;@G!EI2. M"2PE7)ILE!:;)!^XQC3TNM-@>H27QR`,0(U%[7S``W]BLS?C`UB:X](]QHY& MIP.2)L(\$=RPO@C"1(R&8)UQR(6^*7PZA2DK)4K8C'`]COL(W*1T<&&^HFX6 M.A&!(*Q,(5`$MR\NG_'O`^Z19>A!((.6@WF3A#W",':(@8;9#T0X%M@6OA&/ M%^.;Q!,>V0])10JS"=AW3GJYZ#\]5,K0"N)OEZB=2(2O`M9:.W6&1'M88K=I M>L0YCG^/`XN)'L?H5&UAC6&:%NZ@(+U,&\%WB:V^&WAHLOX4<0%H+`W+)-[2 MT)AE)4,0*2N/J!>UAQ%XGULF#!E>9VC00"0":TC#02%:Z,^45_T"Z#+BJ43Y MC6P0:'KDF_A0*?)C%SD3BS)QIW,>>LU(&!,L")5R;-Z+1H2'".U!S'_<0`(. M"B#FS%7,NR'NX)!61\"X"A9W,UC<[A-@<5N'N\"Y]ZZWNAZYT\VR_9P#IR5M M$8XAAJ?9XM[04S?Q%BX$A='`4S8M#TS_`E,]^R:GE;KMB8[UH%PI(+A1(AK% MG0>,1]<[@OSE@Q0&ZZC>VBRU-&]81X$[77G+4MAP%O:ZU#PZ)OGKQ6!#.5$_8VVM5#^Z']W^8YL-5"K`6\KH,[ M`KC1C7LZN'>@;-=+V*[4<)K56NU[\9RS,FA;X(A6C0)RN"CA%VWNCRSG01FQ M%P[`$OL=U98R8J7F>;U:+[X1VSA1L90G3)2J@:=Y#]RZYXG35D\/SPE%2J'( ME;`KF,P=N)AHYVA!E%4@4IW$B>]"56"13N%-./5"$=][LS/SG&-$E:$^1<@RM?6;3 M%P5Y?-0+Y_>H[$ML#^F[^(#L1-C[A6_?F0F,A=C:A@,Q&W"#M) M.:RB\16OR!=/A<;U-N;.7REPP]$:S4SQE4/[L*7EWU>:A0Q?E MS_;CS]K%4^&\+\"H@)`F*PC%JZS$J;IR3'N4:4-O=XWB2;5R3$]::+4/O8.D M'--^'%,!8\O2+[34GN$++[+J>JVN?-GK8+;:-"PG7\OAR_+FN8Z#?N#:48'6 MQ![@T1OEH%Y*MCMZLU;`'03EGYYTS:.G-@'+R-=2^*?\K[6B6N*4ZHGW2?[D M'J+_P5!.'=M&:,!!X*LUULN*?U/O]GK%DW_EPIZ42'AP'"/EPI0+*\@2BQR5 M;2.D[T?3LKQUN80J_^*%1=ZHZ;V&2H!_'..G$]?T?%.MNEY8\O5>MU$\T5?>ZVG7M]2JJX1\Q1*=:"\LL&(QR4R]KNO1N\]"V2[FI%]H(KM8/O8FDW-1>W%01[UT6 M;Y'5J=6TFPD;.@_:%;/#"MN_.=:0[B-_^G+B*??UTNZKTU;I&:^#U\UJ2Z7" MEY"OY7!?>7-6MX$W8+9V[3HC[GEA74>%C7$H/U5O%U#(E9]Z6IK[H4,2Y:?V MXZ?*@(V1[/3F\O_./R"0XXJUU@+[-F)S>F`;O+'H&R7<)"$R+V--9O2QK8?: M:X=/H\%*QFZH6`=Y+H^7A^^=M'<*]=_$96,#!J<168U=*SE^(;&U7;2$82X>O-N'*'Q4?/=6LA M[O]&5I&&L;N^CW&3"#X/-<1>'9@SVDV:L?F48S46+)HS94..Q7&8-H4N)M9< MZS//]*I;K4^6)*S4#,V"3'\AAEYB_1RN\7O@G_;`B8.!+>OX^([F\I%I4PTB M?V)Z`N(=F3L8\)G@B<_=J:<%,_C6!!'P!A,^#"R.1V)3B";EOD/[5H&]M!# M]KG.`\@B?,)[9H$+P[UWK'M\9.#RH8GEC$:R1HF8#8BJJ//D@H#.4)C#.DAB MW_.98KJVQ%`Z.$@;/:.>"!=6V[4#5\_"@"5A+^1N>%C%F<>],KL(;P/AD04EHIZ$B6[6%PC M*ZYG=43UJM@,FOIN@KQQD).W1JU=;4:ELAXKPE4]PN189H])]$!HW6_B-*JN4\9,C?X4I8'5C:CI%QT,*Z^FG('38>NWR,S$F58HLL45C8 MC+1?.*IWD8V)I>P]B3,P3!0T\Y)%QM`8JC)CFY09Z]6V+S/6>.F"6_G?#LJN M&%"6&JX'WA=ZM/#?T6J\$UP-S*+P9>=Y*>'>;C=C0>V4H[E0(6YQA))0X[QIMH=TI8(9: MWFWQ%8.5M)+>?4MO5V\T"GB-[8#'R2I-:RT-BNVNT:HGW%X_(-39V.GGGV_=/0O,>/O_P4>)4Q M8[,/5XX]OH6AG/&^?\N_^R>6,_CV*SRN_1(^U_YZ%\_<,>ZNS[OUAJ-"OPQ&D:M\N]:S6C?W=R>W37:K3L\ M$#3J#>,.1,L<_NL'F= MG->;YT:OW6JW[_#%7W$BB^&9?R$M$+VC0M+4K M>5R?HBY^'4F0'\)\&0_=:@L4U:8!:W!%^(T61PFUV24\@!6"/Z)ECC**!].?T-,7QS` M2'D!#(]Y(A,$!VA)Y?2=#_#6._-]K`1#3'L"U@4N99"$:3$_PU/)QYAMXP#Z MP7`,(D$Y+^")=&@-"$P/)Y^.DZL&SA2ZGD:)->FYZ8*4(C\"6()NI]'X$:?2 M:_T(0[&!->E4`Y-+_'] MR'6F.C60F&I5NPY<+V`P0YC=`&C,*+4C\H`X%0N<%!.-`"\\9@$S@=(#SH7\ MXX>1*:7:.8DF)ZR&:1@";2EB@E:H`& MVR4QR2*UQD8(J>[-^,`<\HA<#O*#LZ$T)7\"ST\<:RAEM\^Y#9/Q M30]?4UE&B2PC3`U:EV($-H9(N*@)D9PFO3!F<\7J)H38='VD/AHN:;:`LV!O M!/25(Z"OHA0Y,@Y1=M(ULZ9#D,$(*>M:&`<3;2=*&4KA#8C,MR1J\>)#U*N. MN4T@=X,`9'8($F$Y#S2[6>`.)@R_$VYF:MH.IFUF"B`?C1"_'^CQ.P-SY,YC MD@F*-6E(L,Z%EE``-8SO0[W(:E'\!$:)W!>,^7U5VR3U*_8<;&8%E1P'^@[)=^5R:-33>*WPM#+:ZCD7:@U3JE#N3*849@01H MK1.,)]KO@"/$-UEK'(3/1D&)M..<@;TC=^AI8X@^78H+ M/&Z-*AYX?R;R><%;8WXO^G?,@H460`#0RPEA@][%NSY%5F@Q38Q3HA=0A"E0 M-H45GN&S%/M$3[@H0"Z/(U*/N_>F4/54("BS1=^9E%<,ZU!4_/>"'J8G:04" M[`*%H=L`)GEL87;HF.)G(+>)8_#G,Q1FF*P-KMP>.P)N(]+Z8(;>/QR6I$'@ M2:/D):FX8)-H4A6:5$P+4C`(,W31D`_R`DWA.$P,G3!6-&&)@IGSH=[)``CM MX M2]V]LU\<(%DBT0T"'`"4K/GU;V96X>(EBH=(T)C8;=LD6*C,RLK[2'@2:/81 MO-85^=T/M)'^$Y$MURN!JS+BAZ#\@!X%7&<(>Z$F)^+D.;B18.79F3C#![1@ MALBG!/\'C'`;@`H!EA6L?+<,)N'0L,@2'CUVD(4_PC+!IJ>EQCV7(T+.;]-_P&O9I.I%SPQ MLA((G'<)!C@^"M!=^8-+KOXXP!FBF1%[U(IZ'?)Y* MOQ:UKII@8B[WE[`I5=X((^\>((S1!`4+.Q0SHS1%:3Q#+-F:J&CE7"+D#BLZ M11`S6(6$_'F(ATPLIE]PD!3<(WB\JY6<)5J74)/$&8"DX%*/-$A@*8!;V24>OD3=7:/(\2H<`LO)U4FA M"I:'FWMWN/(P9-D6\!=#=TA\713P8($.P(PF2E82@]2=6?FT'*_O(D$F1#F: MX\-9*'P[J,WBFT`I<;Q[3BVPWXICYVMG2^?Y^G M.61S.+?]B4B.6&F1UC*S9V%+R\0H&A8"P,0EL[BXQ@^&7DU72,[.\UYR?,+8$7(D7N7@W0`E@J4;NB3@1 M>2KXSC(GKD-1!S?,%5O"P4:,29^#F$FZL"[F0QY+_1H(7DXU1XW="T`;8>]1 MS/Z9.O'1FAC$`H,_AF!-0<^+I?D:^>4Y*PC65":9*[A3JR9.#KA4<1HN>/%4CLE7) M5S2O[B:W-$HNW"(?6G4#F8?5[,O$5X&9O(25I(Q@,Y_F6C[`PS6\UK2@0Z]4 MG`MN6]0)B7ND5S&2R.4F68F"M]%]Q&TLOY'/Y(XM1/G7AO"+T?XVV.1-?XA_ MX*^`J61/I@D">XOZUPW3M#IU#H_XI+ MNW4\']%")]GF]>`Y%.6"]55\/L7,6KCI(82!]T:3"S5A-R!CO71)Q2SF*A*E(+B66GDG?Z>_77<:UJ6()8#]N=_->*0TM!;79_O]^O[J]NKNZ_GPK-3]W M,!YW=7MS+3[:&`U;YC>>`,_:%R;Q+R[^!35.WC["33=7;K:^!Q01*IH#8(@1 MZ2/1/(;*B)?#Z-;"]!/QX&46.V]>@OHL>DS003KBO9PR:VK+_B4'0NKQI$:6 M0+Q_=IRQ^GURYL24U[0=1<]F.?E+!4M*)?N#"]W,[;'K#4/F%]T5;;#,W`'Z M(FZQX=R(?$K9(_HO0.)VS5(PP3E"RQXO0!#7!-W+,?,Q6KDBUT9*LK'(H,K> M4).:X=]X72)*+GN&@$]9V%67J[I<8W03A/'X$3T3B;^51MZ'=+%F(R>4VF#T M_#U_L]1ZK;%XM28S+W9?=+-:\++`?W"]_-5ZSGC:6]N]H0W\ M:\!RF7#D=:;`:+$]7N-22ZI!DD1HC+_%CC]RD5V@"\+UTW^F7?JF(<.$$!\C MI>1'SB7+\D`VA0RP_G!^4PO>Y7FW['SL%W6;:-;_B]S!`=!BW@-('FG>I^^" M=]ZC/51^V%S\+Y]%47#$OB#ZL^AIS076(^Y%I;:/R[/HDVA0T0D+5/2`\<6< M&W93+RQZ/9^)+*V)*_%XT,6;G*>9WY,E#N74_9Q&@-!]FP6`6!9H28.5A?#. M?'"'_\"G]Z\+[ZP)[LS?>_)&)85BU'67YT8]%_'@/!DVX3,R![)0ZEQH;#EJ M\J>QA+FH#:6F*,J!8E%8)C'A?NU<5(I#+*)12V&^W"3(5)/(+;XLSK1YE`G# M#$OC3#7D8YN$F5(*Y15\>PDSK0U@6WL/8!_";Z)7?I-G_":5VV25VZ0Y&\VB M.,FB7R+I_G3"(7`L,!F34>1_``_BP_!RBFS/"8$CCD"9E3[`]\`Q/H%<A?M43R\7['Z3LI(%YDG,:EFFAE-1[6$,41A>=@%=#*=46A1LG< MNA/*.6/+*GB_6PT(O64SGXET/116\X=N*HHAW0280_PE<(;\O++SECK,=R,\ MC3OV#5T!@9\D/``&9G0V\`V\> MI^FFJ:E'J]=0"\5D/$'@+J8;I]47>4T+%#$G$S@\-8'%CLOKF9/4:GH+%2== M2K=`^_"ZI!Z4)TSSNLRY7>3+J"]R#=7YP_+4`_),.\7':UBVD]1+4Q$$%?ZF M6TZNE]`PG72>1?`@ZHQ`0PMA%=+")J#KD3>#LB8Q97SQ3.U+2WIB3GA::4![ M=OQ9.W8%M^R7=P6O5UW!%[O(^<.7N,VJUDZ;OUU?UNFW;&V=3HU@6]G@#ZYO MY,K"SI>03Z0;HEYK&';Y:?KTV?)5JLJ@!D?*3$7_#%G-+\K#">[X(GX::^`:G#)H2G^G7ILDG^_/:67O&'J M^;9D/C6.\YG%26S6K:SU0XW=J-6MQYC[H3 M<6?],#>AESOML:'#Q9ND69#[']X4@OSGSF#,4UH&CC>8>7,Y';7B4N@YXMTA M5BQ5PT@6#V+0)&(:.DN9-104F?N5""I0L\DTH80YH4^>*I[[X?B#9'SM13:I MMD9=5":\JR9F]Q#4$0/D35S/"=,>&]]$3&:69M.@NID$;9;GPV0K9EVK'-_Q MGA`.:ESB>!$6*W/<\)"+`"#-^$E1.)][4^-]8?M/^7&SHLD&/I>T?>"QR$@T MFDK/)H=BSI[DH]-55/DS/'Q%1^K3CXF3JL5ATXX$+X/-GF]/0 M];+N-O,9&Y.T@^95=$IR6QI9K_&>/SSR#[?-23O_8H9DED67];B@ MBG('N^U>+#:X6-'7(M=@*&E_+!H+7;P1U:JK&PS5L&.2&\W5G^?:8HH\AT*G MH._^+G>R+LU5A=K*6QR*'EL^$E&NL76:E[I#IZ830-H>B*E?H"I`AU9E-CY7 M$4ILO!*F+RX4%6'7I/D*23YM,?^QJ@CUJJ*U4RI:NV'.@'U@CA>/L^1*7@OZ M#C,C09/B0S"FGN.CHN6Y?S/Y;Y>HG7T#RO9'A>3^0M/O6U[XD*NQ4'0UL9>N M4%?R20G\@HV$P))J!T/V?J'LU"85<$G5J?2<-IG77EN,]+RQ,ZF!Q0V*'J47 M%_.&4[O1S2K`Z2:3WO:#KEP:25;A+P3#(T,7&VJ_SR2S<4L9;;6%/+GYT@[4 M"9G/4]U>K2SVV>*%^D:U"Q5'^>XY2E8"R^W$FS"X9U'$VU\)[]9=`*KK_#UO M:'C/+W8N@FU.P!KSO"!-)\\2O?/WNRBJ^06W+^L7;];?\.7WFV?")O<[X22Y M&VY>JALEKU:>TNU3P'\PE$ME3=;W0L[WQ9N797TOS_E&GZG(^F;#=3G?:S.^ M<2_/YGP_D_%]\6:CG.^U&=]\'_2NE4G=>#O[#'&R)*T;_I]Z;JZ[+@NYW0TX M.+H>H'7DSGCA\L$/C4M;/`K[7#JVY()7'SW78._[SA-OO#Q/?,U/]O-Y"9-> MJCSQPXT`KME*E7I898J?4V*6#CJN?09$??JB%Q8D:,6S#T[OFE[3C&,KVU653U7E M4U7YG(.OM5ZS[&/7#%9E/E69SQD'KS'-H)@9((I-X,3&ZPI[YJIJ<`U1C8,A MXD?F>?@G/A\Y'HLH)]\)L:->]B!&P_$569V/1\/1>*AW=1;8FM*A"`.M&^PW M5SM$@>-"\1`LD90/[5`\=/$F7X'CLFB;\J$L>KYK^1">D!<%FY4/17/U0RY' M;+Z&:)L*(CR;M(;HG"N(#G1;T_$N%TF?/:`GS"SZ#\-NDB/?O8=K`JO/_*"/ M<]#IF7]CYB,0,65WN/YTEK9=)GJ<\EL_2UI-QH(M+%`RRT`D'XZ#RC.,$1^ZQJV!#>JRG>/DVCNW3>^USWA/72-+.T`.2[:9=\&EDGS>%3^2< M<;$*]B]@V)X8W'LC\F->^L:E>>SK_N.!\CA.AT*.]=QI0%4"KM-Q(VJV(E5L MYC!LQBHSFRF%ZCQ70@L;6%E$6RG0AR%RNU:O].=*?SXA_1G>64FT0TFT^K'O M>:4XETME/8U='$1QK@SU@RL7Y=6@-T[CTC`HM,*;KUR:TSB)L"ZD8Z\]@]!MOCGA+.WXL_W+[Y9V/?9X M>@NV5\FRM.8:1*],2UN2=/02VCOKH^X?\:A;V?E-0X9M=7TGI,H\.#C'A?-< MEB]6'9TXNJ6!K5,"`U2BGL`8[%JVX1"?D$'MB<2:1[&#BA'\S M\8U@(]A':.2,V(YD]5VE*?8*':XN9_?5&F3 M37?5/[W%%M=5:]U5K75[K!]2"\Z+-X*4VX[_!!R*9Q4,,.WY)I_RG3:`3UJY M/7&EPT?1]2Y+XF[_\O%C._MGYY?WA3;QO*,\]8G'+O&Y)O$7;Y:TB:_EFN!3 M$\#L;!/N)O9].\4;@#>UT&:?^LQCIU47/DGZR_/4["1).'>_:DG:_.R)=X68 M3:C[?I;+'H_=<"CC@D\I7X7[[F6=[ZAQ?I+B3Q]'XNTPF#`V##"]\S@3)"1X'=>$/%D_$ATV^-`@&(1A+SU/2;K M1?E$>RD:.V%^N@8M+*8)Y+9[@3U7HYDG^KPZTLAQ_25LJY$U;Q5G[:9M\:@1 M$OQH%M(!H&5",),P2RI;!4-,S@2;T$G,YS]>FFY8;EYWF$M]/8@#[+J9WFFS M84H?G'#X)%WY>*8!=;WE(Q>674IEL^$-ZV_E!2\8:6/;1A]N1GHAD^Y84IM^ M_>T2=I4*N3%>HZGS1`1!PQMFD>B.#.(42S*`SK";EHNR%FY(UHV2TS-W';+MY4]^V` M]ZV9%$%QBLM*3?+=_O.S(VKS%678O.+BS?H?4:-2-QK,(K0AJ#EI30H&I.UC MWU/XO6BFG:&-'Q;\%UDNT`V>\L0AVA6::?3"@U>EQV#F#:6Q\X#=29D_3Y"F MD=W'FM!S%]^^DNC6]1I]]MU&_C)@IV'E4M/[@J;CP&&TL: MN0]XZ+=/!7>D,=SLJB1`^A!E38+A"LQK39@YD)5<0%!\T@T.8!*U`)5K>Y/FH^ M&84NK9!<(+8<8:TB*ZTF>,L*PIJS<%[(8)ZELQQ.!)G]`.=0+Q+`I;T425ES M8.\II05897-J6$X+XO:7ECGNP?#J%RPPO!'5.)AEMFE^'$QEG*Z<^S+SX;K^ M<^8E#35_%Q%!\M"/=X>/&^;D:J*+>VY;]7%J^O[?&0&7?W%H1M+1VY$ MZY,!.J61_<'UT_F;238"W)C77 MFB&(NL1FRZP9XQ=',I6:W3`*PR30\,F-DZAM,$\"-O((1F2<#)/`4-?2<1*< M'_"K3[,D\M9:<93$Q3/=\8O#)!9&2=0O35B!6N`_- M'%V\PT9]]4`8\F0\>X4+4_%&VQF!N/+QCT]>X.UZ@97-[C\-_AN M%@T54\N MECG7+2G.F=9^[\)ND9A_$5ZU;29$Y5F"R)XQ+O57GOE6\86*+QR&+W0G`8Y$ MC:7.S'\,@N'3:AU=-PHZ.FR&SW9\`5=HQF`FQTY-^HT%XK`8.? MU'._F!_[QJ/42P:_;3SV#6/^?/#;U6&FNYV4<_C4YJ5MT6FK7LU+J^:EO6+/ MCYIE:R_?P;'+%4^]_W0U+^V8-%VOV4?O6FO3]U(W'KYB?O4 M2+F:E_::'+J:&O#\#HV_4VN:=NQII.<^U:ZBXD-3,5@Y1Y^I6PVJ.S_= M\-2X236H[C7,3;MF-JSRZWUE9RO5H+H3*(HY4D\)=9.>$FH6HH=5+\-??:[*74*,&Y2.K]18Y#M&RO*3!1'D)1\@DK1+-^Y&+E#1JZ M(!3PEQ*FFN&B#"1:BF.LED M29:^2`NQ"V`F61_)F#_<0"YCL5C93`"\5CDCW"$]D*),<5< M&`JQBE4=7N:/*A6O,`,1_3PEC\B*68R5P\6"1;D4]Z!`"( M1.-Q@(,;P_`)04R39>C,7>I`@*%=.G!D?^F1+TYL7)=R)*#.,]#G4XY47<]R MT3;,.=+R:4K+COKBS2+A91/K%&\[5K4L]S;S*-?3A5:ZVK5*6;Z'\ M^`Y+?0E'/G9,0`(-L=$)%A(/8LR/PB+L3`P`RZ+X#5":GU:Y4E94`MA%.J@S MZQV0#0P5-Y9N.!PZ;]60]#S)$7TE,0H2(RZ2>VTYQUK.KPKM5V"5'S0K*W?F M=_>=Z$J1MJ%9*%B.T9'.$[+G>)FNB`Y207;!Q<5%@AWYO+*"[X*OD(Y*S4.P M2/2XX43@R+S#"-+.Q9N5#2M6M*N(%OM57+QYMGE`=D/$B%'*[P-`[CV0'5$B MARYXBOJ\+'U67N!2-Y/6SX;:BM0K):23J&EO[ M^1FHACV-=Q$U?XY M(W\/*&N#P%J'GM=UY)X6;F[CI#]\N9%S\`FB9"L7C&+Z*AM6G.A:&.E'6?-TC^^34%Q?6OFB\W53QQE7/G5II$YI5ZE[YA7R M.G<[HI<">SN;3%@(II+T(8AH[`_ZEJ2K=^H+6HD?$+IY37*ODT<^.E&VM3_8 MR%ERO$>-F.X5VL]_G!ATNX%S(FDFMKDS3>^V@L%V-D'?#`UO'VNVP]\]9U(7X&BTQ).>X7PS^:)07<6 M3+JR7L_Q5,MSJ*=NO3:GSB=JG)R)V+.3KE-G,&;81YIG117;XI["G3RLY!3@ M/S<`LM3"L_E_)P;=6;!9JSQ\M@R,Z$1.52W/J9;/<&TY/A@J8=I\_:PEZTJ' M\/=ADU8>X4JR5F;I*3"B$SG5\AQJ"07KE]9/W=3_">^_]E^A&=3KDC'`F%JG MW.6;.7Q/X9+N5;#\#T"%+>Q/3+SL%<:[_STQZ,Z"S5;"\QQ/M3R'>NH^74I$ M\GVL!?X>K-`U"*AD;25KOU.N7,G:;TCUV\^:?(%;E_:QO[>?<=\1S30QR$-TB3-!0NX).\+ M29ZTXB_.;H&?_?[A]KFJT=*.>-J5*\$O7?Q+Q\76F32I)N+]GMUT;R_>J%P_ M.EX.,`3C&BYN)/-:>"]MI-I/L\/ M4[AXDQ_+,@@F4X_%8LK#,'>.---":+US=X4&S\!^DW$;A4F^-"4&)S9A+B)- MI1G23-_`S\VNR`WHX+-`^K,G%N+^Y?S/Y;Q2[*W2XE/D9F;(1/-$1..2HJ" MXL@8P("9P\"R@3'%1<1V%P?&F;E1,?GC($SAO=IAH`N-$6W#C)X1:]7@UP!>=5$E&HBRLZ(>G8B2H]TE[D/KT]R'DKYA-4JI66UIZ_>"N;[^NWX3Y+_5@RXW"!6#+C2=GPF_UTO+; M$BB\MY]:WXFC@7=^<29.Z,9.L:'W6>?`?V+16;NL*ZY["*[;J)>6ZYX:C_WH MQH/Q@X.)G:\ZAOY8%'SC3)U1D,7,0,4]L1M:*;85BST^B[7*TV"K?(KMC1.Q MX'CC58]%VG?CF3]D8=\-A](<"C!U0;K*M6\Z;__N;Q[SAXYWUCZ5BB\?1/6M M'+S[XL)_NI['XMA9VJ;]7?^,G;S=X:,3#J/O)W.L4H/+1J(GPFY+F]!0%9YO M)GH.5'B^+$3X2H7GO"TSPL%UZ1EM-+BU:(N7Z/R/U/Y,2U,@76P7A#?MYC7(FJ2%SZ^NMJQ(/ZL M:6Z9QO):S0ZHCIDJ:O-5E[P2C-H?@(C#8G`D@S'SJ#3)D29.!`]2<:?K"\)$ MDJ0R"OZ<(]G*C[!(L=IS287GV;9*.$!+@"96N_/J=E[(S!L!#/X]@QF M<*QCYX%)?<;\8J4SK/*#8>=JII.:W^)BHH!Y;BGX\5S9M'%93U:"C872#\JE MWI"`FP!HWHP*H['D&[B3&X^#60PKC-P'1`R[OV>#.*GLQ\IM446^4*P=L@'> M?\#6+.1I(KQ8^CK!0\BPM!T>>(<+I("\ST.2%F\[%U0!_0#G(-H6.%&$SP$/ M=T/TS2/'_,&\-.8!,S0$#'X^!QI>HY M-&G+8TZ$5XP8*=T+1WJD0GQ\YP,C:1ZR"9`S$GE^%T@\;H#[@+?JER9U!8B> MH92?@$/@/__?3[-('CG.].?6+')]%D6@=/1=GU;N`/5Y001,Y(Y]BUN@3/S] M*_Q>^G_);SZSN.U$XQLD>[@#K:??@52O_.LI=>_P1TVX;@\N*0`H`F"1+^S^ M'V]9X'V]Z5J*KLOP/U57%?E_%$6M?[V]ZWS5Z^97/#Q5T]6O(+!GOLM_Y4:! MH:F-K[_?=MY*0S8`7N%%_W@KZV\E=PA?#[\:BJ&J5N.KVFVT5;/5EG7#L&1# MMS6YU6AUY'9+U9OU9L-L=>"AKZKY]E=XC6V`PISA87.8BKBXC0$]5\">V;!# M_.2&CN46[W)$7UY/B4%WO[%PX.*=WATGQ"FB/#JN/O<6\&$TS9:F`A9Z;5.3 M#;/9DBVMH\F-7L/J]%JMIMJJ?\6%?]4+J'@Y2$64?.%$?X,=(^YR#3>6T-7V MN)B'56^UZ]UN1S;-;EJ8 M^,L^*9L:5S;[*5_87.U,`/MQ.^'Q2BIM"NJ7[L?FW=7UY]L/5S=@X=Y]P,9< M\/KFYXY$WW4[TDWSR]V_I+LOS<^WS38]O#%VMM1+S[-7%?Z2&GA])$F6[^BU MS"6UY&]_,NPL!8K2`%75J6@`A9$UL#!4VZJCY3&=A8.Q0PV"LJ9-U#9(M&PJ MM&*[#X.).'/4X-P)]1LB#1,%KM"C\ROU'>!%0G<$)C?%QDL/3,CX9-U+Z5-` M)A+O@B-$-S8](G<@=?)!01_3][&+"B]U3EH"GB142Q(VI#:"A*<^6-@>B4!3 M==R1:L(*)-I)YY5F4_PT,3L'.?/29+\.X_9`+XJ"?W8;OX M!.@__.T$@&C.A9^*-^->R-"_!T[GH0D(;#]18%CWSU=,T('Y)`XQU* M$Z"C,>I#V.,*UQ'O\:(@6X6_)@@PH.M MFOX-!@WL&-X$NW`CVLL0T$-?\E]Q/8F:&>$'*+YR"!$+)(8.Z6CP7(CG'_C4 MZ"]YQ.4-I0AR:)H:ZH]XJFA90-31, MQ34B@X9L9;AXPQFR4A5OB),(V:1+S M$-?<'1IECJ='?"][P&:&\&)R/LTYG=:W-)3>/:(?8N3XPB>0"(9[,(3\@4N' MC-WAHK1%&OK$.*V(IFW9H_F.;9P%Y=JY<19%D@'_`W3]7@BGI!MCP9>SOI_B MNZQ?2?L7RC=._]WYA8Q3:0#@NX,HU[,Q.U,UZ:X'2]V[(4BTA,W!:_&@L8$> M>C?P>51F$^B77#$G%J1*7"Z#=^&@R+;-=9Z4<\>$GF4`/FD.2$<3HMT.[Z<[ MK.L_(EW9YH^UY?<95EARH]?>9RV#*\=%"D`@FN;@6G;I\]=TK5]B_M)KVH^% MEGX;+`'_59?]:/E/THL+@*CVYK]+F,(5>>B$D`;4/S(/P$6*JW%"1IG%7)1, M<-(!2C=XPU\!'*/W)%/@H$97A;?+A>\>7<]+_QV+AKN9L)^3H5PZ5D(O%Q;/ M^H.*&_Q)>.2)<7>"P8Q&H[LSIW$*3JG&I[?"5@BE7 M[`*N\>97Y\IWHIH)E1;TS4'H]A/=E0P*TD.1PX!FA0P6%IO1S_&'L60KZ)AU MGB(4;7AMN%C#]827+!-DS$^T2OI^X=XD6Z?P-D'$V6[([F<1ZMW!S]([]WV& M\E16JN6PK?MW./9+.)"6"<1MOT#T`;8')5_X9-G M:IB)(,?GO6,S00W""$5Z$/X"&\[O>.X<$M9<,*6*>W]*=L(P8'!?6P%!CN'C M7F"G!0B6;CW71!=AF.L(3#!<*&H*N$?[,8G2,S1BULPF7 MGO0:@0H>%*0P5*V`6$0*XB;SF-^#+I61R#+>X+E1G%Y@CG8WG,,A>O3S6*P$ M1\%:XGY.PB`R-P;2P./GGC;/+G`*[AD@TN4<-UIBHZRPIFK+XW).'P2"C"(* MEA-V&[TAJOK]+G,0)WD']LL;\^K[ZZ:[Q5+5JY__?*<>PANTMMVXI;"I3.,# M]==,ZV*QS_`Z%WO5UC;I2/HT9=GN@_OL[SVA.6T3QSDQS!V\KVO3]V>.1__, MVK-^P?GCQ^_8Z=*]F6";.G7GY+O9:`W&`@SBM8SZ18IO'KNR%(MFSJ:VE,^YB@,?#((13TJII'')P3JN--9KBJY4TOB[X<>%G)=* M"'\?AWY\(=S?7@B?OF%\&\SB\2-6)GY@CA>/!SP9]?8IBMFD)EWY'H:I1&UK M&_`P.^-6:)64/L`%UFIUPZJD]'?#L"LI_1T>>JFE]*G)9,PE:87N<,0>G:?S ME;8M-G8>W"!TO&P+7`DYJQMZ7.EK5Q;R=\2&"[+7J`[]NSAT]=BW^]U@6]E; M]>3:3`\YOYY<659TR)BHK\VR5=-\6">>SYW%NJ@(:R7"8#8:`Y_3U?=5#ZR3 M[(&5G#%FNA%LP-2/ M33C9B2\0SF8GKIJ%$]>,74]\;9H\`7A[]7]P]NI\VKRJB;SY]>+FR%4,GQS? M&5&1+2PS<'P_B+$$>.@.8JQHH4+$?&^&%77YHJ4BK$%EJ9LR]2!L2(((U$\&D2L4/_D M#W_"DA"?=TF(`['7"VK2P.M(ID',DB99'HM@)>-C`2!59F/G0[[RW&G!&N*\UJ&U*CDJ-&I+^]@A]K#TIR;=.-X$&^D7 M6UDG34X1^Z)W*1Q@\BP>8!O8-Y"@[\*SHKIP0.$>W@`U7X94@VL]S)I5)L6# MV(;%C=/R6%&QS,N4,R[QE/3NX!MBWZ8N[Z$(*_QSYN?2D76%UV1C\P38]Z?K M5BTM:88U!$"BUCG/A?AMYWS(R=?H4^_$*?.SFKZT4T*Q1E^Q.#F*!IS8:0:? MS`.<=9WAS1VP92>1.,`;$9W#$K!GVL*0`5.EJ]/'#G18IT_W,VT+*IJ!YG>% M%R^M`BN\&<%XY!6%(8,S8\6R^OG.";!$KG="HEWES$J%K7"RV6%G75H4PX@>/P#1!`Q!= M/L1E7H4#;#TKL)"VI*9N$-S^08%)MW#D^LDMH!8>7!V9K&R+PC8XP8KB\ZF* M7&^]GXE^(3]HEVK:M13[Y7!>X42\6??J9B*B[U0J'$6K4EP865.N/Q>\0L\: MV.([OHG*;VJM@KU9EM#P7%L7_!TLBPSVW1W[!I`MG>3Q7G!M]L`\^&Q8(Z*) MP]D@QG^0`!.BDNN[O,M!<44QH2BG3728[T:X>WC0B1*-HR"!+]ZLD,'+^N0H MF>#/ZRVD*2Q33QS*WL`$EJQ@.M5ZN!:2@XHDP=,\4#P/M=@!2#R25%H6.W%0 M?^+UFDX.##)JA0I#9R#4EXNE33G$#_$X\8=.@:>2?N`%CL_[ZFJ7V,`6>WL]UZ3G4EKL$+3X M9MY1)-DHJ)PZ M;,-RV&BH\&NPT('8Z?:AP(AF9+C0(8_\-?W:/9'P&P\+]]3'H&/'[$MOE@$:6V"?4_ZO,,+&+VB MT6/:$H51Q^]`=(>$E5W/==)VC[C``F5<`1E-L=L+>7F250JT03UC0':@7HD\ M"@\F!9*38>[4"S16I(>)\R3-8MC3?Y!3IN]%5-ZS*")]``6"6#MI.4/<.M7Z M:F`+CM`4CYUO7*P1-\U^Q%EB-D$B1XTA47QA[G7< M+1!Q8;],-B%KH$8IZ!W^!03^(V@S82(9N,>1NK'@6VM29.<0X('UICBI9@2F M^[2VDGN1RI;X0/&4T3Y8$*Y9>RC<2E2@_=Q:H!=2+_Y\S\OE&-%.!2.\+6?N M?0N_1UAYX[_"4X\.;US)NWS2D\IE`RR_=]1E4;FLFS^^3P$2PP/23M5O&G1[07C4&OJI2<8A:=0#+IEBEVDU$5O$-R MCJS``$"QQX<_S,)I@$$!L,.$AI[T]P-]=1)MOPAF0#)QKSKFOX%]1C'QP/I7SM0C2:QB^SAL[87Y7!,\#Q8-TA MNV$T([)YK(8/#26^I0EQ&\4O@%FN2,U'IJZB=:C(I% MQ$P0X.5D*0_HGV$A7MRT]Q8")F[>/?8M3=I3 M+U/T@#P8&T:2:HJ](`8R_T`T1A^.0,QJ2JFE$HD4,N'?"8?T!&DM@M%AW^_! M@$W)FYVY@*;`6PFK1GI-U-2XHN!3%/LW@KNP;WMH6 MOE26?*D*;PYM-B^ZUTBVA/>BST+7 MK(ND]U3)P"6&/I]&&":4W)U,O>");35/`L=X!>ER(4X>0'.%)4MRA]PSP3]R MC"96Z?,^*-[A&MN/@][IH8]LF+V0CZ-*MH24#1K:TQ3]>=Z3D(PL$241CM>1 M.;6B2@<*(A?X#A\`S%D]YQ88?T/2`C8WH/EA^%N28$AM*-@&;@@B')UIW%"[ M!QTPI.D#B:LS"6RAI0I<&J^`,#?:^;>WA7LXC2VT`M@.#V1FMD@>3K+(J,%J M`F'@,YE"E6)WW.N\`L*5\"4I!X)UDX[!GAM[]7U>*AK8!$M=)_&<+6Y3\YD8 M@B`C;A^1GXUN5/U2_9&^J%]J/]8*_*^6)L=D;EZ4.S1="K]+P[C>NE&1U?'> M=MLD6M#OA;*G(*$Y']OBP/$,*8Z=TZQY(^15[\%O82\B`KZ02N2EO(TOP6?" M)0/M%G1QUR=W12RD[,6;W*"7)0O,_+5+7$JWJ,8(';PX-V#9Q``OM8SS`F)Y M^(.X5TC-AQ>'>0@:GPOMIQ,4HC)#=].L4%:*S@VD+W(8,=HM862X^/CY<1&UR.@@>R%S!/ M3;S%$9DB@!_>T!N#0Z2%\W[@A1$\J-7BC$\PK_F(BS[2'1BLC#QHFXSC7!RR M^(*)>'/3!45:V_5]?N[>%R#-7A"BO+Q#C.Y_G%ZS;:EUHVG)3;5KRT9=4^1F MW>C(FJDV>UU;T\RFL6JPLB@9(``4UN?Y23G7@6!W M_`D,VH5B.L"(7':%;M:)A9KS@(@F_[6$ATYP+,Y_D$4@M7M@:)YUIVMKQT;7 MIOKR1M?6\5I$G_.K=^I.O8R>-VY'W5"G\2Y\8*YUZ75!SQ0LE"#LIY"?2@'S MZ3:`_3PCE<$K-'O-=Z?FXV'7X;7JSWO`1LIB%._<`?TI9DG+,M?JF4\*3WV&1)/X2@ M2A2ZX2F+HX.=XJX;V2>=9TY'X\RP5A%'11P5<53$\6(S+_^JM*'$"EMOCIPV M(KM5N-K@MRN\CN0Q7[3UEZ#AI=+UH"]<\GB%OPI_)X._L<1]/3E8. MH)(==N4`JHZX<@!5#J#3)=\3$4?5](?OYZR!636JH0]G+9:TQF7=/!NQ5/E: M3L76K?!7X:_RM>S7UZ)7RNV!I:&A5]KMN6L\NGFI+?%:5D=\1D4697KK(_L:\$C/ANQ5/E:3L76K?!7X:_RM;R$ M_>6J7--!1KR_U05OT<*XCDOUWL]UAJ_4X$-[9:JIMV>O&^GF9?W88\>K(WX- MKXRN7"HE#"J?F_JK@S8P#&8@X%Y+_]C^C:>IP%48K#"XBC\LS!I=;'/UPFY5 M_?;YJG?5;GZ^@_;HR3+2?U MRO6C-ZW<%UH_._$L9+QW[G7:6'L=`C?9\0D@Z`!=Z](NB+"*Z(/X!?]XPB:( MP41,CN'M&?.M*)<,,:(GLP]P;!#V;0Q'CI]THG.D3T[XY/$&Y/FQ#KF!.C$N M0R-S^8?8F'=,.Z,19OC;\0S@2&:ZP$J>:'.9:ZB9GPVS,/Z,&O"-G0*%);![[)@W3>==07._!E3(?-W\\]$L'#'J1,[;],!'@['K#>G=XB/:_T1, M5>,]BZ7^#!["CI$T4HS(ML?Z83%S1;-R(R7Y&#[W/GZ2J=%2H95XKAT[K(0M MB],!M(4IMSB4AH:RQ#3,CD:7\>'3P?V6O0(/=$>.)_>R$?+[%RB9L-JG;$GN MGZ;M*#PW4U.7BL:42O8'5X2=99>VSLUN>CP.<0A.>M]Q8#/>Z:5WG;ZL1^P>G-_P9TCQEV5M=F^_^VN!HO">97YY54B<_2(UY]"AOID[3XXICHB7/ MG;C\3WYOGO@`*)]T@KPV@/-Z"\I`C<<#JOM4W:ZY+]SXH_"PG#.`$E?L9VFX7;\20<8H7YH8C#8*9-\2!BS/_WGD`D=[WGG!( MD3,0+=/13>/Z,S(':'84ROU8S*=.IN(Q>"J8N`,:N^GRE<5T+%I?##@7HT3Y MV+IT0(@_$^/YI"D+IAYN18Q<&28S0F:^ZV-S]2$.%+L=TYHT+S$8#&9\&"-. M*4E?`SM-9N/A$\!.!_`M:>4T40R);A7W1K/J$1@,-Z^RV59BMTE'?EB%.2'G MZJ+1."(U"*.DD?\RW4J,JD8`2!3,XYQ^R(\L-W4-3"3IG1AVL,2^G.NSO^2] M?*X[HF@:Q#@+BB;6H-&#,D3RV8@/,DPV(2:W\'W0*`4QZ=+CDQBY7D<&*PTD M]9Y0U@'OF*5S9=)=9-.M<+94,H<(5):=`X*P#+3BO"X:4``_CZDY+\VQ$&12>&N* M+_@6`!1R'IX4D_Y0I7;\O\FX]HL#,,!^C&=\O\&#F/PZ=<"(1Q4$T<8'3HQI M(B2./,#I18Z$`RQ"E\\;$R>*4U<_)--+<>X9ZO0^7GT_P&E9L]!)!FS`QN\I]P%%],L8*\X"R8(P^"1WR]^I\GDSNU4'`$ND.Z9IOP) M=.$X>T(,RU^2$:P:X^#9D"8\\==PW\4,)\X=S)E6/FGPR?&=D1B6&M'-I=/E M0YF!%W*BYX,1:,24XS]E8VDE/F4VHGEXLRCBZ2A]($I.!G2<@G$(^4(C9C*A M`X>&H_AH:2)$-O:5`@_RL!@/@AGUER]02W%4>#TS4+D//O2TOD M^_)/?^$R&7;P!5C_R"?V5+FG5ZF$.15&^"AQ.`K.-_&>^*0VKG*(>6]B(##( M-P<'PPJYR;V[V>0D^!W.1)[,)GQ0[+N^T!IPJ?>U.6V&SS]*YX-S5VK^-MYBW3&XEFGQ++EGT-X'D@6N*X\:XJ$#Y0Y[G3+F(G6_I MI$T:CTZ2O*QWZ$`#C<59TB'!&C3"&+G\,G\A');[#4D@45! M>TQX8C9+3K#'2[B^?LS'\&*D!.@/;7GA-UF8C86JTIPS995.#S\O^%(^7;>* MOA0>\R"?9Y`P:U0DOPUP>"Q*+U_,WB)MS6/^"-@U#4DCAH/AF%G$?:;HT0@= MU`AESX6?35@\#H9"AM'EX1T#ERPJ$G M]O8X!A5YZCQ-TG6&,\9G[8IAQ>FE3NY^:@_BENG>%?=,AYX-4Z)#SH;6PT4# MHGGBT1U2"O(^8Q!Q/%Y(D[C2#<`/DDT`\(A7%.UH`/`YEHAY()*,ST0B"6'( M=Y/9C1R3[!L/KB0BF\\P3RPWFM0\^/?,C82N2@$WQ^-#WW+"'?4;6(+4EV1) M>)?,A\D+4B#AS&7Q4JK`.!-94ARIM254D$=F',P=!YEF#PX?NHNG,46#9BC' M@W0JPTELS$2(@!1,,?0^FF,,6?QP;L<'R2^BW.EU M2KXNWCQ,1*CE76DX2138A#]R>;4"S>3.6($0ZXEMEC/L[AWX#WE=(AR$/+\$ MES=,;";USLSQ[9HP4(7G(C'"<'H[_A5GR)._@L^FQ4M+F13"W*(1QXB+#%V7 MTNVLC]49PH.&*A&A%*%8!#31KH7"LVJ;W">YNHB##_,D*[M/(ATDUW_R^E;( M)GR*:B(+A:QZYXQ&J"K`P3^*^5'IT'38AGYIPL^QK'P@W%9S[:?&[A^:2__V%CX&&?`VQ=OBO/9U;2+?OY(^.TQD]'HM-)%0OI$3C[#_7<;/K%::SKC@\Q MT[BTMOHU'S__@Z77L<[DXLV+?JQ>PG?3$(=T<]=H)"0O5Q'6ZZLI=64T,(O8 M_!:N^\#A!H(+AB$L07R9ZZ+9.D'HCER?7-AS2])%RA8,<6*6 M,`PU4S8$O>;,DPC\J$B(@T M5.W2S-'LFB.2LCN-O]+F?P.KK/F5((;ZI;[F73E6(J5T4#;%8M\>HC:Z^A!Y M;3YMOIO.>:V4AJ68^Y-QZ866ED-R80P<`D2>YP+JAOG\0@Q2A#-^KH2A'U9D?;*A41B;BWJ9MR&?G#)^<[-.S=%-9G4&"DC-TQ,Q`H:,HD,#-NY MX6`V03UP0!^@TRE.0V<4_G/"D`*'F?^#%.U$J9Y0DBF&`OKM#':'\>UF M]AB_&V/F"6\7ZLUNE-Y,_!?M&<4?>HLH]##9(`)"[I%4HUN(A]1(]XFBG'A- MI"@)OJ&+/P"9R#?(0[B%F&P"0@V]-6Y$92#".X`\(IC%F=X-F`U'I*U3M#DB MIXPOM(L4DX7H9* MR_4.XX5.8OL3D"9TAH#B`CGE(G@A"@_T($59^5%./XR0-+.;49OS6*;$`"N' MD3#[>`9KG*BYO`>B%(TQ1DG6-%UW2N9`2X&L8Z*N;%N4KP(F(VP.V4J.A^2T MZA40.:$;<9N.]-_<;]'^'+A3;I?Q;?*+B.3O<)&'.80X0>$'%S4T?N)CP[-8C0-Y'W.A084G6#TQN,*DP4 MD3Q-C<54UO&0/US*&3?21+P\23;B8INB=]($"V;ZC$3;D'%W=U*S@?[MA/P] M%Z0UOY2."",4!2U*6-Q'@#Y9D/F3%8D%8A?87$.HLD#,"8O`*TU")^4X,U)B M)W#WTQZGF*`UO`D/CF,\IH!S'PJUF7AJIP8_J9^#[C+-]8O7P^T_7K;02B2(L M221T`#B;171.4C,&"18[->DW%H0CUQ$APA6O?G2BW!;O8?+KX0L9Y0X*X,7@($DAAJEFY'T3,3#2@N:R-`<.ZKHU\L4!YFJ98IG(E/LL M,[60K+8L%55$8[@"QME_HL"E>MH#2_>6O!Y?FH302`%V!GB!G2'WLHCKS5?E MN,S=$^(D<%E2'"$^21UP]P77+:H[EXD:7RC2B>7` M)E,@B/`I3]@4A,Z9B#\YPP=2Z;BO^^/'-D^,FP^MKM8V\EZ02'#FG'&69](\ MZ(&>P\(5(O()"*@;F M=:T<.C"[EO*G0[QIF;"@GR^#=C/Q@#]/!419Q<-Q`IM7A4)3..^/HCCH8UH< MU%Y3')3YA_*I+96SJ)#])FYHZMS/DJW)AR2R7;+PXES.$6]H077`]TE*4AP& MGL>&"\ZG>!Q$A>IAKMHE.:ZX$[CV:"SQD.L#6'S$*U+/"*;JH^B@;&U0&5#_ MX[("T_4P6Z3/?`:RUH5_89R4-A@.B:OQI!5XNM>\;15=0=1@S@F'21K<:.;R MW^33H)RT>0=%&19=:WG'&[K)N$OHD26_I)\ACN:RM/(KN<1W*8.7ET8`OPM( M7Q>(S86I4-]&WYF(3]WG=I@FXH_=<"BCRH#/80PDD?YS)\'S??Z-Z5\X2^M/>AAPYP9^ M23E.W)\JLJDQ%T><6YHI'2<>-BZF:#-N7U0YQ$$MD8-NE/L2)3LLQT`$2/!)T23Y/$B0'BR,@!7,9`7+O'=H_2X:[4*H%;.9II"LTCO"D36!04 M(#\&)#:?!%M#YKU"UE)-UYHC0BMN7H-P>9W24D4BJ4OZY\QG.9"59&H.(6;A M"+E9&2%CX)XH;N;#J0.E/LE43'[Q)NL?0TZEWS_G7G<^"DA>=(Y52QL+@/? M^4M<6N&I2ZX"*H%_!4"WX-%G+ M'+C,1D));T<7\XBYK9S4;H*LBYAW+T<@_1WR;I!+TLG,4/3\P.))OC^^/0D: MHF:%'-,EWU/R@[08S.5<.`W.94\(_VNFD2;]B\B=FU,$AZP?$Q.^1QW+`XJ$ MB_^>XX/,=L25"/S`:[&*K.EAC'(T%H629-7&3U,D9@#6!U'NCP(B]^S6SZ8H M_9-M"1S,$C=PE,?B'$\BH&0"*L,%73!0,VJB+@:S$U?*AL17PWS9,L9D\)!0WP*J5::0YIPE+!%XHJ/LZ3 M0+./`EY:2+HN;82'`(1>"5R5$3\$Y8="ITY:,2Q.GH,;"5:>G8GPY5`6MN#_ M02AL`-#J'+_RE^483,*A89$E/#JI(5Z40`LBA_C*"AF72+A"T3>**6I9[CF/ MU#7((=LO$VR+[ZC1S>8Q%3AF-T+5`.]I)DS(Y2<"..A.YT\]98:`*(#GS`\I M;>@\87D%_(&UG(X;4JRV20F]]`!7XT+.;]-_P*M%7(C@O$LPP/%1@`XK M\KGZDQ2').L+]BQX%#>\0:T`_IO8H+AV4CB>/XQ:&I\21=L\EPH_&H$"A]4T M5-$ZD\`S&$2!,\<)`7W"![O:B5GB=8EU"1Q M!B`I4@\Q"``/)``+\][>-0X9@JLYN#.)TX-6;8%_,70'8HV`X7J_8OYJOW,RNY%F$RO.'8^F)[G(`M'EK_KB3:8\`\DRV`6<>T1+FCB M:4OL.6S&P"AS0VB<&[F(!-^8MX9@L3S-Q,WKQ_%0MURM]=1/F(]-#-['<8)55AONB,Z#H(!6:/\JL%;K_8\`/[MTZ MDXYK@T6?1>[[]WF:0S8WP:XJ1'+$2HNTEID]"UM:)D;1L$BJEX1+8IU!0QCQ M0<_..S)$(L1J^RY+,Q@PJ2R'/9S"F)`ZZ5G`8+7KR5*TFLEN< M174WN:5I*<`B'UIU`T4/Q27BJ\!,7L)*4D:PF4]S+1_@X9JD$CBG0Z]4G`MN M6]0)B7ND5S&2R.4F68F"M]%]Q&TLOY%EI>9]E5+TV)!:9?$&W+"1.^P`4I53 M+$/:YX![EK`Y`W%1T8&-,B^1J.\%,H5R'SO?BVI,L;V2!@% M%&EAO,L"%L9*4<`M48]";*1&H&>LECBJV#>PZ6.11[D`G_"6/G*;FF4:+'JT MDA@E0_&*NG@LV9R3;WIYNK?V,,5HB/AH MUL=D)V[X.NE)L6\X\9DH,:EN%:P72\G`;N#%D<1[DSR!W&\H"2""?:9I3CS] MN_\D^+QEIN<)&@APWU!TN<.3FWI@6-G\">QPDKA12741SR0UFH7]\$U0#)H< MF\5H=T[)*?R*RPYVCT[V2Q`6%V^RZTKOR0&6WMV0W7N%9F6I"$&S.Q,B#OK" MZ:>4JS@K7]K6(>TM)_23(F>.=3[%=7?LRC)@15WKE@>G;@MN=;.1R`4*?6B4&_'TRXJ>BN& M`%-+Z`*[)&$M2^ZT*"@/Q-(/@K^7UJ*XQ?//>%9!9I/:BM&8;W3,H$O_H%M: ML?^"9M8OTO+V6J&W0@WEWNJ@?FE/=%^Z)\W/DELBV1NS-YD?.55_PC6B/FFM MP'4_Z@XF4[E=,;L^0LRF$W*YSQI%*`DZ_B7&8(84/DY*MR@M#_FFZ*KU9ZZ1 M%CVPZG4D*>=?R%/.N?M=Y@G>@]P)<[,P<^^G8?R"(R3+;\07ROR%?#&1&(&[ MG*4(:7D.4-3M`$0(H'$"FC`5,I!ZPF,PV,6'[%_Z[IX\LEP\9=[VE6@E/30/ M:6FO\(&8LB!/-`:B*$"!EW1O)+(\)>\B$;3SMOYM MIIS!T5`3BQZO[L[QPTB[+WG>ODT3*Z6D!(JD@JH\B5+ MN4!*?2AWE\R]N1)XZ>%LJ!KX,5;U"J:!#@2HLD)(3ED9%N+P&&SW$V&2* M@J19W5CNF333I%@WE55-80Q\(EBR2'"B*GOT+%*--,_BY$7:,TJ43OECKJ8E MS.:OB"@#5[(XUTZ"O-RI.+]^80^NG^.G"'P&"SK^L@!!(7L)701]S\4>-<6? MCUVXA.%@_"02[WA_RAD\F^"/J9D"!<&J/\"^93+Y,'+>2XS/C22>.9)W,S_;+FG!M.&%?8I=ZHO[(^9,K?O1J*)\ M%4"[R[/'&-9,8:X!L-?L'!-Y7A2LJ_Q!B<6U4!>!'BJDVCP(`H"+-UDGYEP> M5'K6I!`4\55:]GT@45ZX:HM'5"RJ0!D;^(DL7G^2E!E'B.=.%V`@?\W\?,EN MUE-0L+B<,2SD[1-OB)++,.&1L(1,TSK"B%<:I-F$63/O?-/5U!TE7%1).SPR M_IS!F%I5Y!("Q37!7BH\K(K:)#?\R?.9>CSF]>05&.3=X58A<2[K/BG`FJ]J M3PH>$>H:16XR;;XFB386'JDS!2"IA().1O27X'7&Q>2TN4O+:8(Z0F9M9>:: MRO#J#C[&"@M+>.@K5P:#=H,+[YXOBEY6+[P*<6[&P^DH\VF;?\V&HZ0B!?`U MU^2$DQ9/LP!$H;G^F&<67`8@I;JC2-GE$X@3,L7@,=3!@@>M>C"4A.S%@A9PRQ.EYYSTB`XK?D.\>-IH'XH,:]%>F9 MY`M:.$W\H%F7]=0[B48L15KFLT,P#6%9JPS1E",[_S`;&%(H\$YLU083G>B:R(!Q0%-A5)6)FE"NHD+#-% M;V/:\BA3,I:U/N):Q[QESDP\ELX4*(:>+HJ);(G:)EA"VOEEQ+BAM^2R M9EW;ACFQOQ0A1=.SL"729?FH''HL[=F?B\[F0G'"I=Q,AGI0:AEY#]#WD(_Q M\<8`*<*^^VN.WS=3@D,[)$GXK:[[TECT-[RG/%[/KVM6.!J*D@B?3U,IW./` MA[\/!.%GDE*7Q!"49+1B#1UB7'42V9G8!H&^K&%Y7%GI]3#ID3W6#S%]-ZGI MY94DO9399)2=T;74"N`/WEJ"&H`M)W_I]REG8'Z.T2"O3+7SG!<+76%BOL-@ M-A%#6WB(BL9TL3%P+YKRF71AQ&J3))L^R60@8S/+\N2I!]$@G31)NZJX M&8Y8CCU?O,ER,MPLYYKWT,K]F%HA#.%.`6G=A11=H`*.W+1,`<'OOIO&$.&> M8PS<3TLAJ:?)5>OZ"_JV+[+489P,>0XTY]S7K6,FF_@%0/@G7?L6]SR@L'?O\+OI?^7 M_*9-LP\ITZ23Y)K=L/`60\08,[[!<5RH,\//O[#[?[QE@??UIFLINB[#_U1= M5>3_412U_O7VKO-5KYM?$1&JIJM?E;YO_RHT"0U,;7W^_[7P%YO250M#1 M6RSW`CW6B_[Q5G\KN4-X+3XV1E1E)I^QF;S( M2XL?>(B&U]:ZF65VYU32;LM%6X&]*SY+K M]9YEZ?5>K]E2N1!4,YA7;WSN*HHYK]?W'=:/K[+(3JKN[$V8-Q6MW>GIJFRW MFG`A;$V1+4,#B&Q#4WJ*KG6,QK/"_(CY"H$P5I!K\Z#S;(*A_O^(IB;Y2&D: M3JV)"!A7G..D'1((PHD[FSR3P"V]2QB]"(4%LPA>$+W_^92L4H$,_D8P:CK= M+W+[^N/'YLUM]V>@'L]SIA%[*PV8YT78QML?_>.MPO\]1=-'_/O1'<9C>+FB M_/@6+$/0Q?_Q=D`&Q%N,80Y9B(_E7QSF_S%,%FB(ML"TT7A8?.9!+,P5G?2E MYNJ?[.OS[_'5/Q6/*%R_*S]X#)WI/][R/_,G/9TCKX2@_TNA_V$;"8E,P5^D M/Z\Z=Q_@UC>F\2[W7IU//>6#D&&USV`U;ZK9/W<06]V]^34W1,W;!7S#U83[ MZ)/R4KQOVX86YK"6DZWT62C])+;>XID,KT/X:^!XBS7/ MX@2OA/=K[J#0S5;"(RGQ07SBTQR?Y@ZB<^R#F.?P4G\$N`A`5/]7N]WM]GIO MEV\@#I8S^,((`)5-YEO^PT<[!CYO06MCH>?ZTH<@XO7"6:O?:]X^N"7:!TM7 M8)!_PP8I:*(G2AUU-)3>]9_I[G_\6_!2U/SPXOOE.UBB M-6R_A^WX]V&EPUZ/>(<7[_.LZY>F>>2C_O'8PN8O=!54M:8;C?)=ADJ>;;$-_=(XMNI2R;/#R+-Z^:[P MJ1M@-\P!^?2!.5X\SEE9L)%*,+T"3:NUNJ66CZHKP;25H54_M@>I$DR'$4PE MU"W/WM"J?(:O;&1I-46K9-GW<=B5T_`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`1P8A&[HX4^A>S"CAT`"IXGA5FK@IT?RW9(`N]WON2*9+AF<^.TEJ MU>2IFQ#G[<9/M[/^7VP0WP778?/!<3U\92\(K_DP7G_TD3D1V_]<*D5M-G6[ M8\FM;K['6[35MY?B[54<8I.PU)#%@#0^+I9] MPQ18H`X/<29(%^<#ALQGCY@P*Z8>XFQ7Y@S&?)0@3:[]<"N-D[Q:05,N#K(: MN41O3(Q(#.AIIQ\\,!G/&9:CNR#>$&TZH^J%XSDW5)X79>26#',5*T[^LFS> MQPH&F_!4^^7SJ?273VK:XU+5JY__?*=15ZMI*+TFG"*3>Y%ZZQ(M\Q>"\V=3 MF<:;3*#9@,W,#:!)4^U?>_[5[K[P9(C<9IC<$[[NGJ8LVWMPG_T]F26V#HG' MQ=OJ:4:OB\.F[\^XKS`W\NB3Z[N3V63NTR^POP,CM#JDI8?4]8<%.B^>"^EL MV?=WH(A4QW2,8_K"U;*YXTG.(S^$[XDY873 M'Y?YA]NB6G0#&30]C_FYFFK>%^241>1.`#<'LYA);;"D3^S2[035(4(Y&[_< MK!F665,VZ6DQKT+N$P^I3"%;X-9/'YD42QFY@PPVGK[%,5L4H,-7?D>QJ+^X/-,VX"* M652)YU)!=53QK-7JAE6)Y^^#65?B^7L[\3*+YQ,4QI@IT@K=X8@].D]G*V9; M;.P\N$'H>-D.N/)Q3A?TJ&+7KFSB[X4%%X3N!DT(JA,O^XFK1[[7[P;;"MW5 M2?J>ZS-YS!`Y/UM9;N'R5$-,X2^&XG.)^W-I5GO(S<_R!W.YAO,YB?,YB_D< MQ35J1RYY^T79U"\*'SQ++?FW+6A"6[^:TE,=S'(-&9-,&;,5DIQ3>'>2U^K$ M\SFPV/HADM[![X+9:`Q\35??'S)7O]P'O$FF_F$/./!7'N\FIZNI[RGA.7X, MQ#(7;Q:RGV&=>\<-)>`$?[,889BQXH+8JT42J\("%=4\Q\./S1;2XU[.%)X] M;M4L'+=F['KK]JU7']^VUO4+;P$27-U^JL+ M3#9'7/<;ECY)<*G\(*;2#JHTJ6'=1\BD1_R/'TAPR;!*2J!5FA8H4!K.J%4@ MDA'\SL$Z)7<"K`L6K%%M4HC%*E.&'V!-"?^R)LV6U=%MBYS2'\65+_58/YPY MX5.-V)*JTS%(/5Y8!B(MH^R,KJ56`'](;A3-`+N.OX+\I=^G0^R+!8(U9%0J M!HL$]Y(SP8:T0G/EL,O,Y38()M.0C9D?N0\, MB]N"";N4[K"<;C1SAUA<5Y,>Q^Y@#%N"%7@E$3Z+54CW;H0-DBG[%"@--'.? M"N;N<;1:8H]FYZ6K9)MJ-1+K_YZY(>P#=^#X+B`22`DH\<$=XD9@^8G#%8<^ M[E\`1K]<`&U#P*3^$_P>OP%%!<[T'1Y'R**I``EM#\F-V21*JN[X[^!'40QK MX_4`T9)E1F,QU5#H-_0+0%LDCD@:NFA]Q2#B8&GG@BH.68CGSB\,GAV6!0)O M)WN%-G^?$LM]"'?P7%=/[#0 M1PN6XJ9#]BW[_CWR9@?NBC\8HTH#%`9$@5%7:G.'EPH4C1'+L6=89#H+@1RH M^E1"G9+H`CEO_L>H?@/1A5CI=Q>"]C$+D=R#/JAKG%X2"'[W7:2UVYA^-0IP MNTC;7/F&!SY>@8Y["7M'-(CW<>:5X`=(R` M/A>3$$K`Y1M%,",7-$1'@!LAS\FMWF<#!^YKRFT0#JS:!OZ0WE:JW*:E_CT# ME?3^"=^*DHTNS)!%H*72G<(WB(G$S..8&+O32*(4,_@>L!A(_*)QSH6$E)&] MVJ@)[HWH@5L-"V7W>N%6N[QH>?FMICW077[F[BYJH"_5&>KHEU-?WAE8\%#H#5&\_QQ7I[4SI-N]%KU$'I;'=[NFQT#%UN==6Z MK.EFJV%:#:MG/%^L^XI*YVT,Z),)69B)F,-7I70NS^0D==#'HN4Q7M51Z(`) M2/H)V6[<:`/F$R%F,]..:ILYZX!+PK]T'I$WXWT'KD0W";@,UU+AF@7#2^E/ M9#B#8.3#%CA/6O$Z$MOS+^3:`2H?\9/W1C<=2A'QQ*1V$ M@.V1L(A?YMHBB1NV_`#J0>*1%3+OTNH MH>G;DON#+T(1_]7NZO-O&T.^:6QJ;2P*9?L>F>6K-R>Y!B$"4@A>A%9# M'T48=WS6=G3)PGZ3X,)E+L$N/E?TZ`!M&_X4PWKC#&!=$LV'"&'?6P*Z\P!_)*.8%CHGE M!^17QF9#9!3Q%0:,#4F@1`ZJ$+CU^&F*Q3)@\X:,_YQL&3*!A@Q0$$R%&`K) M]0,J#_MUTF1"AF0QXR_("4-\YXCY M*/MP#3HK$,NIHT3H2.C'S*V=4,2FRM+AF]X<^?*G5X0\?2"F"9WB>J*C;<%W M4)/&0.\/F',"M#0,D,#AIT,>Y@-Z&^/QCF"!J5!V$]<5-^='+`"E=CJF,6NI M/9]W>*!OSZ.MT%QK%L$R`_P\!&I%%X>P#,A=")H)L@!.*"YZ`C)]R,_[UD!3 M<[(V2N*"/M&>?*(24!3TZ4XV4`2XA\ M-^_UR!_1BQ72Y_7)H@+:`^OH#S2./A&)D#9^V+B:8>E*MV$;LJHVZ[)1[];E MEM)KRIIIV4:[HS3M1O>47!R((7@](:ER:BQ#52^SL-$H(ST`(]!R8N:GE%4C ML0[,`,VB^$E&!Z5[[P[RSPA5(K'IT5HK7%^T2V<3X:8@D2KBW5,'2!Y;6?*K M^!C,O"$Y%MS,9R!^C[(;5`K7Z5.KHDNI29[F'%=%GR28BL0S%]PS4-< MSQS)NYF?;9>$`VUX89]BE_KB_LAAX?H8H0(#\H_"(CO' MQ,=5=#:%H.O10S$K*%7$3Y`ZEEX4^2^NM/2LN0%W_$*#!)B5B(Q M_R0A%+O%PMHS4KK(87#U(DI'=R=>0A-4O1F#T2I0D1P'7Y>"\"'7+]'`),V.NR&Y58:^=%#\ MI52X@:H8!Z&(VQ4YQ"K$N1D/IZ.,N8#EI(52)T1$ M>;QI;\8LN`Q`2G4Y47^2GZ`U(Z8P#`4B-8MC_YK22%^!+&&-R3Y)1 M94FO8+*AZ!1@;0P^XU'W'8_G5N!Z-9Y>,)P+!A.AS4*,H0K9@%3)37*Q/?ZF MBA\6^>'`"<,G[GS)\F%0(G,NAJ@3^)=``6$4Z*&[64-G.W-)/$4)V45C^"6W M;'A39U@YXNSFFXO17V%_9=2`*51,=-LM+B",+WY^I,6E+9>"4\\X`*'T\0/FG59E\!@]Y`AH2]K MA!P,8STA'EV6@Z<*P>NSG-SEB^3.7T1$\QW#R23@>TN,`C+L\QW,B4/*Q"%) MV-=$>@+U,4_(;`HJ]=CA"3#`^P+LFIZY<+F;@M@6J7L3YR]Z0N;N/=3^7FSQ M;VS`%^W^*U(,/@91U(.]=RG&^XGBL5M&5# MZ^ERRU"ZE`"B-MJVU>YVO]J*8G^%QQ1%`T34=A:(CC3#B9]UR>=YC9FTQQ+XM1R)>[EE4]?A8Q]83E#_C>'_+?0=CWE'W6\L'+@\0^!`R%KB46R:+4T%NNFU34TVS&9+MK2. M)C=Z#:O3:[6::JN.N'K[JU'7[`UORU*HYFY.&-R[,7*=4^83NO;V5WA?W2Y> MG'3O19C:^5Q@SE8_L_CZ_L[Y=I4(PQL^;J,9QZ';GY&K_2[X'/B(A#"@5G4) M@9TT8@Q"#/T]0\R>$;"976<'"%Q&D?DU<=/6FHEJ``JZ-#CSHKJQ`XSSZG=R,Y#!7(LRC$,AP5Q`0JN.^5]F5];5C@XB4[=DRU94 M66TUU(YEUEMM1>%(4.TYPE^R]2)LS30E#WE"R@QN'!=PUN9.NN6)2 MOA@_C[XPKKNP6YX?P47TEYP-=\(B!EDE,)$"_EX9/<6S^<*FJ<9\RP:@[PUQ MG-4I,B,=F:YAS-W`%0`\(V9/G.^J2";PIJ6FS3(@%FQYK&%A'<;_1*U^$()2 MFUS5+ZFG#E29DT2`#MQ6FS?I7P#4\O/O!6%S^(#.2T#B_;WKN:^M7VP*OPVV MB6DI2PE@*13/40#QY;3`6K"54SU]4,0-77WF^%=!M%RP(CL]47`-L-D;IMI8 M*E7%ON>Y-JD0)^F/`V!,0YLCW63#13#H!#.%^8\DR)23B*]\7K;6T-6NW.A9 M'=FPZAVYU6P`F`U-[324;M?N=>`=AO(5"-34S'I1D&\`SAQ;8B'6`S@CAN.< M3O$P@0T;6GV.#15VO5J=^!CX(YRW\Q$]4-?W;9K;>8KW3R_ZS)Z%896[M)=, M/6T'T6GJ%3KH%7.>\E7;G[NIAI;Q3UQT:CJ%6] M&+(5B,DB#B<).KJV+-.H+X<]V_SN)CP(JR/A8D-#WB`;UMC9CB\`.L\&$R&` M=RGO%+H-O`.ZPK=W:*GD^K3,.:F]#HPBR,@A$P:93'QL\F3FZRQWHTDI!:_J MV5![AJY9#5O66PULV]-4Y*;:`RST6DJWWFO:6M?XJJ&DL^KZG&OC)4`]8W&V M9BXE*IVD7,#0H5%O+)<,BR#,-V0ZUH7?E/G9RP(>:Z[O"M-)^OA'U5!A7[S#*VH"?99RAD-MQBJ2.[-]<:5B_!+PEQ@SR MR:8_[/*2Y%2^GB2!*-R=9B_:,"N@F(,74U22AFZ?TH3#U]=]-X07F("FS_&` M=3#,AT'AHPPG)PDA.LUTLZ$759OYG2\P;RRSOQ&%\*VGWR/TJ*6V0#.MA3_% MRVR`VB*K#<-6YUG[AD!MTNCE%`&O+X81EF^^""!PM!#3=T4[@B8FP2;IT2=( MT!8:+0VS:+"M@6'NR@()P`/X!TJ_!\>C?C\4#YGW)I[B&1L:<"RKR+!>`M/< MT1\GE^N%X;&E.5TK,KGR)W]]CT&?CDCLOPG9Q)U-3O)0@6$9>I&BGP5D(?QW-;K^Y)$-O!2JT41M3E$<\)K:89-0O]NQ_85SEW MFEGGS+Q4.J*WIZL8EF[A)6RJIFS4%5NV#!6PIUJ:I9FFUM-4X>TQ+6N%LV.!">MVK/.P>>`V5.*\'*D:NTD+--WO"`W:VW=<7ZJB.CKRMS3NWU4*P^\).$#W/9-7,.PORNYT[0 M$ZUYEEO+!^?!B[4*EF4VT>"1U8[:D(V&90< M__?,I1YQ)XD5:R56-@%IPVS2CUEE+/RZF(Z7^^X4$:2JF,"ESRFTN\&YFHRP MH@P=&==AOG#B%/%B*&A)S]G2SX.RVD#.HF5WO!=>+\`9%*+:_@03(3"&8JBK M\B">`4C@81R3H[;C1KP>#)^^\G&^3!2AQH6."#(GW`DV!$QHZ*F=CO,X0=+0 ML`!&3S*(=@8Q0U5VWY9[MSLSAAQ;]'<`7KYJR6O_=S_?E*%%[;M.$)4ZA5[5 M%).'Q4"&Z>7:(GT:-6?Q.*!+T)W0'[@MV]\PDP&%VD M[U'M^I,&4+*A2)3YPB8.=6)OHRO3&<0SQT,;>G]MK+5>U^K6.W*]IX"IT%%: MZ,?IRE9;@?O=K,-#RE<#2_9NM'_5/W&4GQ0JLA-:E$%?*$TCJ6PX16I6R7&= M\87G8,B@/4:N:*O9[-0[/1V;GA-0IFQ;(!5:C8:A=@R]973MKR8:SKDL]FRO MV>;OJ,?G%^9.^K,PXAU?$O6@ES7L/4''#R9[Y2#;#)`,\,\SG$RUA@O=B)XG MPSOLD()*]M,GT?KD.NE\DG@/H[RK?0_(ZE+/P/4F=QT(V`0BD'MMNPXF=U<# MG:#>DNVN:H&&@#$'0SC)58ZBPX&<8\[IE,0TV;0=//!&LG=44;[WSJN-NJ5U MN@U@E:;21<[9E''$H=PR+:73ZAA:2S7VT7GU4*W[`C%E"IOQB*Z(U+T)>W=& ME+O[E#3T*8Q,\UP^A@EY?E231F`BTR)\9%+6WTE@G_#-^V2*#EC"A]T'Z4@R4&/BR=?#`_`%S\QES]DWU]?K17%R"_Q)C M?>EL2_HVE'X20*#0.NJIS%]"J3\"Q`3`TOZKW>YV>[VWRS>0#&59P=D_=GL@ M`%4VF1.),GRT8W_R.Q'&P89X%]CM.HS'S_2.>UT^L';UET+[PXO?EQ!SB";9 MCF]7-;,&U^CE>_"#Q]"9_N,M_W/7CO3[/X9#,+"2':UAU"S#*M_1;J8V'(\_ M45L15*V#.-^=^7Q9U`XOWB=!TS;@UY)I'IFH?SPK-G4BQZO7+X\MAS8_U_)I M5<2UDO%FZ!%`/^[%&^X[J'C7:_"NPG:,2T7Y5C[A7#&TS14P^U(MX0F71?U* MQVA43.R5%;" MH1Y35FBXS"W.ELDUVSE0!%3OMDU3T1NRJ6MM`+M7EZUNMR[;5MVL]S3#U%J= M$XV`MAC.PJ+!;S309"`06!S/0^,+*69)H^1H0M\C3K418PC%W.`9)KI6^NS)2\_G^2FJ5L4XERE^28Q3>WF,<\U/]O7YT5Y=Q3CG MHVWUUXZVG4QHK3K[0T5:D3^_OI>=&R\/1751L4A>NVKF_6:7)D=4$>.9*MVS30:+]_#L;T0U2&_X)"5 M>DTUCQT!/$-_.1_!P^>`GB^'.A%WJ5TS&G;Y:+@ZZZW.VCH'?E5XZ>W5_W5_ M1E-CA>8U=WX;G?.J+6[PVWEN*4PC(6_/>*O?.;$ M':80GKUL/G:*LUU3M'KY&'5UR"\Q$>OES&,_-VFL`W,?!K.^QUY+G&S_QM.4 MQ^>$P5.WC7--;RKQ>QC.;-9TO1*^YW[$]3.H,SI]<^%3$,8C9\0`=3$\->7= M`6NP$3_PY9`-`DS=PN38V1GSLQ-Q_UA*3151T5*1?7786VRCT:B9JEJ^PSYU M!4P,1DAY&?`NV$3%O0Y.T)I6L\M(T-5A;^4"J]7-2D-[!7[&L\,K[G5H[J74 MZO4J(>2[.6RCKI?OL,_-M7L^@<(*?^?MUN5A52_7N=WQA[`-=N;2N0JT?@=2 MN0JT5M+XS,*$%0;W+9%/WU*^GL$5Q"[U6)4K*G6YE'82GV`<4*UO):\/P\IU MNZ8IE0OPK,]8LVKU,H;?*VE]NK*FPN!^I?5"=YI5'28T[#"QHCI8N32G,;?V ME_3L^'CUN2M_Z%[]]@&$MX6?_'G5N?L`ETC)&GBLAN\@32@VZCJ1UU.2GQM9 M!PN/W>_*(=.R\HWX(^UC?R]O1A)VCW$#;'?B](,'5I,>L0=*GXT<'Q4@T=V$ M>IO<.-YDZ,!)?&)#=^!XTHWG_,>1`A\4)VE6F)>$2]#0J.DLQ#EGZ2R(93U1 M_CGSGK+3%^U0+J6;T`VHE4JP_(D:+7B?M$R20A;-O#CB@RK@U8PFF%"3%M3J M"FU:<,]2?L-\NY>=:.-DMY)V%Z31=UH$`:/48=-@\BE)DHW M(9LZ[A"G!YWD&"\:/KMN[M%+`'RN55*&_[3;5@[IZ3Q",?KU=?'5U9N*:@&6 M-+/3D`T#Y_3J#45N-_26V6@K/MAF*F"-L+H!G>J,F6X]VR./:H$=?U M?JNPMGT0%'EBYVV&I:;;6M-7IRLU7OR`822%-I:[+1['1[1K.E*`U%#%M2 MLKNT"13/W1AL0X9D])OC^A^#*+KV.VX$=\_Q?@OAGZ=(`EEWM:U`RC#28Z`D M.%[W&PZJNW.^?=E//SD0BRP/J;8`J-*V6DJKVY1[JEZ7#;5MRTVS:3EFN]1X@W$UZ))/)#C[^ M?'O9H;_]M:Z;^DZR8P[,#&BDVS7C?51D.N-S6X`(8)'!_XOJPJ/:6NVH9NM-O[Z*FX MJWO%$SU^.&)`_X8]I,CA[M-^JD^O=*2NVK%E@!*(I_T+/9E]T/GEO036 M3Q""!8<7&(TL1_KDA$\>K@8:M2P*Z#362+ M%Y:HP<)CSI:)@/*_!E3(?-W\\]$L'+'P"5;A/:O@H\'8]8;T;O$1[7\B[-;@ M_AX!Z,_@(=AJ="DU(TZV/=8/9X"JC(HTBZQ-`PUC"?:.%N=]_"330-H\-G.X MC&`E,#+A'$'*T`<2,`8R,P&ID?LM9@S^Q%\17P3+$S5QV,*6O3\/=$>.YW?) M7"U;`;'6?9+L9J]NG/3^:=KV^WF!YW.I(RBEDOW!%>&TWO0*+K_I\3AD+'?? M:U+@Y4?8NKPU0Q#JO#&!Y'MROZCY5 M]ZG,]VD62E.P.0?C(/!(7BRH>$N<]WNG\,,T63^R+8*I,/T^2"PQH0+&3)[)Y77]&YL"0Q3B2G?\6-=X1\]$O M)3%X*IBX`WQZZ/*5'\?N8"S6Y^_F+6)=$02(DE'A/HV.QWU-63#U<"N,>S.' M2`\_4?-]UP=C@`TO88';,:U)C?J#P6`6`K^-I8GSE+T&G0CTDB$]`>QT\(2S M?#!A%T>_(M&MXMYH5CT"@^'F%;QS-DC`Y6/2@9_/&%H"S`DY5Z40`2!3,XYQ^R(\,&)D_B^!]Z+4`61#P]R^Q+V^YW09R!TS,RV7O M?<^M)$#1-(@Q?.9X\$HT>E"&2#X;P9&"!91L@K]*[,-#1.(^V",L"A0PX487 M-UAI+H+WA+(.>,>,)>/DTUV(KK:P"[#&AIPZ\/4UL4!"0WF+:^*$?[,8-A@! M:3)_)7'R%1;(,B5'8B=\$KU8T@1IN1 M^?BD()/"6U-\P;<`H)#S\.0`EG'H5O0=_V\RKN'!+/*)C[LQ=WE*.%J/%IDZ M8,2C"H)H>P(JC!!3%UBLCSB#6P/O193@"NF)SF"W'X)'_!FA'ODK&/U]+/K' M3F&S$&.5"`Q>K`SC;`T&7;@F^-+D==Y3[H(3K@8![!7P!E(Y#![Y_>)WFDSN MW$[%$>`"Z9YQA01=<2`0P_*79`2KPA4`2R68C<;B-=QW`#&%CJ/1P475*'?P'?>]L&1I6W MOQK*0EQT=?SW(^/!`!1GUU-*R``L[LVYW^M9IF6TVG*W831D0ZGWY%:[U9(M MK5&WNYVV8O0:/$1Q8_Z+[WGYCK(=9^.B:AFPK+4,V]$X+ MH*IW9;NCZRU-;YAUP^3#OP#B+.ZR?.>+*2]7/H;XFOX0_\B.+NK,V%WP!>1Y MB+K9]?W*\-ZU_WO!KFY1DM(I1C7M-*IY6.!W"WAV&`@%^`S_#CMK3@+@A?_A M&M8)!C\UI#O=WBGXN0;D%TQIXU&>6R1Y_.;P`]I:3<5J&Y8JU]6Z+1N69<@M M36O++0M1U&GK5OM4![2!\BST5V#8I%"LG**F)5/45.%<8UP5#E'M1T-13"&Y M#Y(A;7/3W`!P."PV3%5%+D;YQR[I`WAWP(@"H4PJN;#5&*8Z#L:D%."Z$] MNT;]Y>/B]..-BSOG5Y_;"*4BD6\S+4M5#C1LJ2>XR[_0VNBNXYD$V8KDC#V@ M<_V:%46\ZORZ?C6_[ICSZZKY@4?%OWIT_)\;NWM]N58-$=Q+Z?L7$9M:K\I7 M1<];%SVK-:4J;#_[,S:,$K:TK,[X!7WE&S5;+V&'[5-OCY:6'F)RA*@^/%]9 M=")=+*U:0S'+1\O566]UUG;#J,[ZNSAKS:R9RCETISUYLRD?^$M:A>6"?Y4$ M.S"E&S5%KV8;?R]GK1HE;/)9G?4V+5WUFE(_@QYQIR:ODBK]FN2SN)).!Z;B M>DTW2ZB&56>]U5DK9@D95G76VTBG1JVNEU`5.;<.INFR9Y3)_D*@Q4&CXW!4_?#%B8-^:DJ>_%F7IDMJ++O!LOF`E3J M['YT'<6NG7$9WW$>DTYBZ'RE3I[,JI$A<$*@\?&8/G MV?V*A"V$XMS[]RDD!5JP@_DI(JM2C`Z2_FUJ)8Q85T?\`MW7K%EZ">V;2OD] M7<6CPF"%P6-CL)I,6TVFI5\NF4Q+#O.1Z^?[)V-?^'@L_7OFA#%O#HZM/FKI M/`7>3S;M\09+4&NU:<@>W&`6>=@,'!LG8I/5^1FV8H)MGPT<\M8_CN$XG^1D M1H,TX_V:T>X1O>:HS2MU'5X<2NM+#JRQ9.3L7+?KX2SD,U66``<+EM MAX,I/(8`Y@U`W(+HI0XK+'93I]%4-%"*M_@6C76?+J6">:\8^IMKWT?# M?ZF5>O&\+Y9-`EYQ\BM;[NTX)OBLF4;_M)C&28RS5I4CC;/&3O\I8\+E\45) M$\P+'/9P[_'^U*(E-R=-WJ\;;]SR+>6Q!ZL4\9>TMHS<;_($CG$LFERNG/2= MM-J\6-/74Z^NW.HKMS12_$I7;G5P6P@R3MJ%UJS)X".:[<'%1I+>F:G0[V6&_79:.NFK+=[1BR;K5533&;BMG2^01JY5*O)XW6 MU^PZ/W+\B0_F;D;1;)(UKZ:NU=03/&3#FWRO_=/KV%U/.W:_$)H,#;=XDW`( M[1";=C,_(H*@3Z/F#&B)2.=WU$MN8R`.W@4>^*X?=;\!6MV(@9@9L"^./V+7 MLSB*@>3A%C;]H?@>:8O_*OJ31EBR81,GA(Q888'](O@K`/IUL9G_XM!K4^MU MK6Z](]=[2ELV.DI+;JE65[;:2KO>;=;A(>6K@>WC=?.R;G)LGPS2ELV.AW<2 M=WP-?"XA7=N`F]G09:!36S:TGBZW#*4KM[IJ76VT;:O=[7ZU%<7^"H\I"C:= MURX-VYR?'2^@R`!L#O^:"99V%V0&#`Z9QS;U_)[CX&3'NV5Q[#%^'PXX*^(% M]_F%2(%[K2IJVC-^SZ!G.+T+@2(=FB+5#J)71LJ&$[-58.Z:DDT/G]_S\F$4 M@]ED1J9=OH7&-0X7>MTA`8IAZ18R\B:(+J.NV+)EJ#JR&,W23&`^FBJ&4V00 M;@9'[F9PQL!E/AOF?AY%;/M#_=I03-NVOS7T1KUN;0!^?5%\:X:I:H8BMWMM MD&.J;LAVL]62X7NST6@KM@XO`CJG&?%PW-Q_)HA^/53Y21V)KM,PJ<> M8W@W7@UP]^VWJ\I$Y'9PCM">PYP6EW;;: M'4N3>P22I31D2[-[!(U9@!;O1X2`I;W^%5VFRKB;L:^U^,\#^&8!R_@<\ M@'.`$C_/[AIG"IAM*W7C:T,U--,",`U#L=9HHXNZ0J=IM2P-U$]%:0(*NITN M:J.6W#7:1J=N6%9#55(4*)>F.-)GP#H6_&;=M`\`OX;PJUO!+_33)WQHV'I: M/E7F:0+T'$_#X+1U(;QX.&S/]O9QI$OT1%)X50TS>"\,@8@8MA&-MA MA/A9AT6P9^D/Q_/84XJ%-O5E+A$:`.SZ(F??"`T&HN$32*!V@!,1/R03)S]= MMTJ$@'K#-A=E^D8(J",";AVX]](G)WQ*;@2`<<^BB+17Z9H[Y%O"(5\BQ,"? MQI8LPZ+Q:N.`^>ZW!8;116(1UZ:-)ESI[DRC;JI+!D%MQ#H41,T=^Q9,G-*R MSH9E;,LS5`WA[P6AGV.:W+]]=54B%-@-HVYOB0*=;L?2($EY,&`I="W=#MUPK\SRV,'W2J21XXS_;DUBUP?[E]N2&J7!@R[#PR-]^O[W#?J M3M@RP4)5ZWI]212HJ[6TEMJ4>YH"2-+:FFQI5D_6[+K6Z]JFU=#-S)L"=TY6 M5/@_@'HK*(Z)`K=NNRK=F``=UJRD`T+;G=[5J]>J-KMVP= M,:`=`@,?X9?7]VV:M=YS!D0L11?.+F!;IJ*!S%0:C469V3:4NJ8I==E2;4,V MS+HAVRU3EWM*K]?M]."B&,W4X0*KFK+2D#4C`WN#K3\/Z^_^#",]#@;IZ9K` MO4$W%CKF]N&<*6!@I3MF%^RH#?3'*(INKD?-1I`6$8;!UBL_BL,9CRGSX/H7 MP.P=30@_-F&8;W^]]EE-BA\#3'<)&:,YJI@K(O%LOTM2CY#J,[7O` M.S%W8^*$(]>70L0>DZ_'=8-`A=BAM>W__AA"Z^'7^YT]3IO1T&V(:__A8RG&8;8R+% M.^<](<\93EP?1!M>2TP#&@$HB5$L34-WPB01 MQ!).1D]Q_*/[\<<:YE_`KP;OI.WG<;8G`0%ZE&K45=`3 M=+6A[I]9VY\$Z1=*HJ[#GO9.&@N@9BR.4WM<.$.SXLU MT[#L0].-15=,Y823Q*#7<^,C6WV'QHA-&#&%#:CLW08\&?0=YGIA(A[@KYZC MJ/WB3R3O8G(?S]1-O#4L^BT,HIWL-JNA(V(LPP0T:7533UU,S]D4BW&\9J?9 M;#5M6S95S9(-NVW(5E.SY49/M^HMHUTW-(5[H4"%5AMS!L4S0!91T@Y\1!7W MTWQQH[\SW.W$H@D=!OR;F'*]`31D`(]>EY6^J!)V.VI'54OW'KX#HN!KXV3-,P@#PT6U/7V59;XB/+"S+4;?#Q MF^/Z'X%.KOU;QX-;1TF0N3J'77$"O,3>Y%ILG:Y/WJ@&S]C?$*9,,'\&/#G1 MN(EN#LKJOP(<^2,71/C.69ZO"+Z:%BP\"]`:V'FD`DL;$%]E@A_YHFZFR9X; M0;8)(C*:N?*7QW5V*&%Y712!QH]\:`,<;03T&NQE*<6Y*X>-_\N`)P/T?5![ M[,9J1*V";^.;E2LB*@5.3%!Q];JUZ?7*@;<.)?@O?XA_9(44)<$'J!^JH:[! MQU+8-J&/N[$;#K'FY(F7'291BI(@IHY,9@,Z60GF&AQ]"L)X!/H+(/9S$#/0 M>RD$5`J\&&]_K6OJ&@&U'+BU3-:'_0X8$!>6M.U2@?.ZJ*!`^EKNN@#8ZRGP MEF;@`PW43)AE&#BT"6.(:!G@8TN3;C(-V9CYD?O`>#4VB./K M^SOG&^^:X/JC&QSO'/C-.`[=_HPJON^"SX5^*`D3V@&%=MU4O@$F-4S2.V!! MH_551?&C&P6S9\]X*")Y^3,=-@B9$S$,9\+?T[X56*-?'C2"/&\8!:_*BZ$M M(HNJDZ^B:,:&'6J><$.-,_YPO!D@%#&X%8Q,HF];;+2\"_`/)#%]N;T&M_!XA!4/#$*G;+P@=WP/C[070$(]_= M"P&^&GX;H%\WS`)Z7QE7)U34R/`&MA?=GVJ?:`O^70]YB>Z0=\*:B MMX$4EOE`^F;0'4>/*R)D_]2$/FV!E5/2X4S-.NPM,C#'J^PJW&MAR5B&I8-J M<">'ZKJA;.D@WQ#5=?P/H5J>DYP'1?2)*2BOA>;7T4_VK>1:JEK,H=X_?DS, M]MQ0QP6M0R@6B)J=^R1^;:B*J9K?+*U1;ZR0>AMW36Q;S6;=L`Q9,9H:P-M0 M9-MN]&2SU:FWM4:[K30L'HZA&@-3%_T2EP&4@7L=PF5SPB=.&GOK$)E";NB& M\BJ0&R)W3+VTDR:OS\"60P+L!(C?'WU$C_B.18G%/-TY4'H]R[2,5EON-HR& M#*RA)[?:K9:,%&)W.VW%Z#72M,`;_5\"D,7]/=>=M1EB(2&IQ*VG[!&18=E\ M=,*AZ!V:ZRTZUT;T-U@BQ@+8O31A79G!O$U+5MMJV&K7T.2FA4U_VW53;G85 M`_ZC]I1>O=XQ>IVO:B-)\];L2\-8UY?U<.C*=1-(8WXDZ5"B<KUT47SO?8,7)=#?'S-;%37:W86MJIR.W;5N1#;7;DVW-4.5.4S=[ MW:ZNMAK-7":KG70;W@.T^0:.+MIY1/]9<3:73OO!R7R@?)X'J5U+M5NBH:'1 M;JG`@\R6K``2K);=JJN]+)_W1DUN[KI]K^(_F#;`'AU/$%PS[CEN^,D)_V8Q M&2OT$!8H1-F*_V+.#CD3J_&`72ELR_[6J*NFNMCPL:UUVB:`C[VWF[)AM0S9 M[MD-6>UU++.AMI1NIY[ONF`NXV?;PELF_%FJ;FJ+XL!LM9IFKV/+NMZ&NV4T M&MB]P9*;/;6IM4RKWFYF->J:0BD6!\!?L0CH)HAQJH/CH:#I?HM1=]S[75O7 M]J7>JMMM6^O(:A>DO-'#&@+-K,M6M]M5;-7LVIJY*"0W!V+!R*>6)]AZ.VYR MO]$4E_@]8O1!_\R+1W^!4KKDI8_AFIVFJ`,@$AKME$UL.5F4VW! MA8('[&Z]K6.,'T-\:@KVYB`<&V;X8XDZM!',&L(,ZON-9FX%\Z$4/%Y)M(V" ME]0YW*CF>6IX$46U`X>F(\_.,"$C(WKV181VS(5$.;= MIFRV.ZIL-.H=N=DQ3;G=;9DMK=OL=DUA@O`.O>8R]KH);*^EO2$&]J&]+=[* M9FU-X&CG;6W[*XI95#? M!-@[JV\ZJ6\(M[Z=+G,TH'?0WPP$V@:8C9U@WNM`G=^G\'+Z&U6%[8PL_+/Q M&F.&J'N?;G`WRRM@YH!G\#%X+.L9J(<]@SG,O/8DKCFM]PN;."Z.MVUCZ,T9 MQ#/.EO=U8-L=@8G"XU_6)U7KO.;`K0UQ11:]XM5"6:1S]G9* M*"R/++(TW59>17&@L1!Z_=+4*UETO#-0#WL&WX3IY\/15]' M%S!^'[-P/T'F->&L5J/=:=I=0VYV[*YL:/6&;'?MIFS6VWJ]V6XIG::6AO!N M@&HZ:4[6=G#D!RCGHA7T7:XR9^<@PZXA/%T$JVZ2"-[SV\WUI9E-^BR\ON>X M$/[IG?I:K6B]DKB^\]S@ZG-ONX8CIH@O)02]"HJYZRD0\SF(TY+&HQ,KIK78 M":VNVN7*N&$"^,;QM/W`.Q]C34^YN(_U75,WBL3J"?]:&D9\,?@;!F#QTKPZ M$K=&CYJ[^[N`]6(JZWYSH_2I0V#&QJ9U.?*ZM1>0S)%9>9+NL14KWR@I)-%3SIB5[Y(SHXLF:N?)RE^)O+"Q MYWGR])U)BWBZ=H8\?6?,[(NG)XX_:EE.?H=\/1!.%PVCL3MML?L@9'>AXT?. M8,?Z)AI5NHZZ@F+-DJP=V9@_0HG9:[5Y#M5'@ MU7E;1SLW9N;%X.6,L&!`)(37,&G!G-B%M_%.8U6*F-@:6A!/=_\K;+'G-KN\ MR"W%0U*H+:8Z[&)I'OZ4^0P4<[&*;24XFYUJVXUW&!6\IT,%SO<_<%\?@V#X M_-'BCE]O&/*>(`0.UOK22L<;7]_?HWMW]RG'K\_*3,6PS4,0N:J4C)4)3&P- M+;"RSW^<*"L[Y"F?-"O;]5"!E7UT(ND/-G*B$^5ENX((O.QVBFTX)+!I//9T M%EQ-U\W#B&Y;<#6K+%R-8V)K:$^:JQWPE#E7TTZ4J^UXJ&7@:CN""%RMH2C2 M[=@9!H_21\=GTG\[D^DOTF^!-R1N]^FZ%96)I]4->.P@U&Z63%,3F-@:VE/F M:8<\Y9/6U'8]U!+PM%U!1$UM-IFPT'-]Z4,042DT\C'IZNJJ7*S,+A1Y[(_( M&Z5C9?:2ZJ3-H3UM5G:X4SYQ5K;;H9:"E>T&(K"R-AP9\WT76-@'U_.B!;O3 M&XXNI5+QM8:FZ`=QLRAZR?B:P,36T`)?^[-YHGSMD*=\TGQMUT,%OM:<]6>A M?Z),;5?XU`2^52XT:1RU%KK=A];:FM,TF%C`I;W_];R_^9>@^_/Y=7UW=_WI9TF9?OM%$I_=7=^(#^ZZ_WLG7WWN=#_? M_2P9/[[-+70/H"5K]:X_W\F]YJ>KC__Z6:($->DS>Y2^!!/'?RM%[G\87D'\ M\=V82=336>HS+WB$M4)V[[%!'$G,&8REX%Z*X9&/']N1!!KUX]B%#Q^9-!69 MRT/Z>N+Z00B8AY\'R26$Q\7\S1H]XPE2EAQ_*$W%X=+C0ZG_E+READO,0GB` M/;C!+)+\0J?IFC1Q_J)7+7D1K0SKP!(+OQ(;7+:]'"Q]A&`672(^?T*$(HKH M'],MC^QML@(_'L*\RC]$5\M_?6LJOZQ_&S\=\<;6]9=.]XO>MJ9S!)U>1>?.X>M+OO\FAMB MYNT"NHN7>@.&I2YC6*N7V1'EB4`70H*X_CDC?P\H0Q5O'7KV@)'2XH;LFC-` M#DAP$-L^V40'0=1=.(MB`0JHM/8O$7T52C\)"!)=:^[C5%6:^_S'`R/]*&N> M[O%]$JKK2TXG?[B)K5]R)*OQM9*E4BM!*AVXA0JS3< MM@Q\Z$1.52O-H9;/1)T+I&8M9LY2L')HL]<+L+,/>"`9WIZ$DK.OOA/I*U!T M6L)IKQ#^V3PQZ,Z"25?6ZSF>:GD.]=2MU^;4`6D#[\U$[-E)UZDS&#/IGS.? MIWFF2H7G_,C.@LU6PO,<3[4\AWKJ M/MU<:?WW8(4^TTD`HZ;82R`7,CT9Z[2R1BMK]`18;R50S_%4RW.HY;-&.RSZ MQ):8+N66I``5J`@2[P<;%0.EERT#ZSF14U5+LK<^E;8876PU7XK,2GY7XK$IBSOM4JY*8PPE4;I7EROEI7,>:HI'S ME;D;#2PYB5M=B=M*W)X"8ZX\O.=XJN4YU%.W5C<4KGD[-E>!^7W*U[4(J&1M M)6N_4ZY/(][GWHVD29H+%G!)WD_F$KC^P)L-X0QF_<@=NDX(^@W^[/XB+#?1C'62\AR6&N-@E&>(B,+$UM*<\G.J0 MI\R'N*BG.<1EUT,MP7"J74%4W_ZZ+A'FA$>XV*II+4ZP,=N*82D=56X81D\V MFD9';AFJ(5MJO='H-O56JW'*(USN00$('GG-#U<50C:%VX.H*PQR8:CE\7$N M\=B)I4>@4T>*&,U)D:8.G!:.8-E\8`M]BQ-;@`E/J$_R"R:V_+S>*?!]#UK1 MK8,,6M'KU:"5#3^OIIV\IIMC0QQ5F"^PUCX\.H%S,?FI])XX&GN#B3)S0C9UB`^^SSGG_ MQ**S=EE77/<07+=1+RW7/34>^]&-!^,'Q[]XY;'SQZ+@&V?JC((L9@8J[HG= MT$JQK5CL\5FL59Z&6N53;&^ MQRY6Z5&!");6A0P>SJKN[B4'J_/HIR,*_/'Z/'C:9PZ6W:U)RTBZT41SNGR- MRO],Y<>T,`762:H%%_-:J-1OR<=75SL6P)\US2W36%ZKN0'0T81-^G-5E[P2 MC-H=@(C#RDPD@S'SJ#3)D29.!`]2<:?K"\)$DJ0R"OZ<(]G*CQ?SM9Y+*CR/ MW1IA,&;#&?8/^,(&P<@'Y`ROA@CUOL.4#=-HR)9JJ[+=L/5>K]-0M(Z^JOAXSW?' MVK%HU6J\O+ITS4_V\WGY7%$?@=6>KZ'SPU&51[5F*\?6'[N#H1@TC7:LK1C:(]$/7I<^8K/W;\D0M"%][MD`)14?>!J;M> M4[0S(.Y3(^5K4.K#BH9?*4)P]%E(WP5[SEEPTKN"#P79-;8J@G\X,>@I9QQ( M.!&2?Z<:QI%I_OW9,.L.FP:1&TM3QQU*+B:&:8JZ9!)71DTSCJUL[T#R M^7?=7OU?E[I]K:#[N8/;Z(!74;Q4 M`O4SBZ6!$XU)HIXO7SFRK[5>L^QCSPO=A^%3JT7@<;.&O8P/G&^)>J?-*, M3H:J+:$YC-T^R'_W. MAWKZ_>AW!A'8V48#N:2KJ^U[TY]8-HFEVB`&%I"F-W2CI[6Z9W3MG9HL_\FA[R^_F\?*ZL*F7G@.D-8$4>>VSV M&0:`JY2=8])TO68?W='Z7<2$JY2=8Z3LV,:QFS"=(<>N4G9>DT-7CNOGGZOB M85O&PTY?;MX%V.ML.@L'8S"PX?W3T!TL:8Y0L9V]LAVC4;.48[?2.D/96:4& MG@Z-OU-KFG;LA-AS3ZRJJ/C05`Q6SM'3NJMUXJ&5@9#N"N(:1E8N3X5\.0N,&YV16:50RCHFMH05.UOR_4^5D M!SQEXF3JJ:ID.QXJ<++FU`$K3/KGY:ERLAU!5#,09SYG*H66Q^>3H&U8=MU< MP%2];K1Z/<"/INDMV=``27;7UF7=UGI*MVE:BF6?:(+V[:P/]`?X=#R/PF:> MEZ5C)UE6&V=NPP)9[O:?3CB4NLX(?B]R]O]P/0\;G183N_-IW;``;T_Y"(]* M?7B4UR8!`PL>6$@_<^`ON$J8U"_Q=TK`(28B3WPZ#8-OP)ABYCU)]J4E/3$G MC*J<\26^Z.3W=I4S7N6,G[8[7:UR**J,\7,*-^NUAG'L:'.5,%X1]V$2QM4S MJ(4X-4*NTL5?D8*U7&5QG@[%OUO6@+!*?JN2WPHO7/)XJ81HE?SV M&D4/M;IU[!F*5>Y;E?MV;GW"5H0@FKJFZ6VC+;=TJRT;[48=_J;T9+/3[76[ M;;5)J3,B?^;&_I?]2;7VW2:L-8MVZH2FP&D\Q@%4-65'A_S)4 MO`R*N7#5V`E9RXG8$*-9S(\(6CW^#! M.+H2Z-T!0[JJFM\:=<.J&[F8;83OCO)1VZO/O04,JD:C4>\8#;D!J$)2:LM6 M2S=EO:$(J/=N4_A5.< MCP5;5J_7L!2YU]'@7-0>,&+5L.6ZTJOK>D.UM.1<@/_. MQ-(VORS*VU^MAJZ\_EV9.P],<*('V+`SPS9X_"FZ-?2^_OR6#LF5\OA=S-W= M'+M`\KJEJ$J>%[T$/KL]<!Z#`?(OYH0'$DN;WU&=U&)35NH[(G9;#"R13`LL8/'U_?G7TW_$ M*[Z@'A)EF84[(]FJ*UKC1=F08(QUZW4#S`VE605?^UXF9?"5J0A[%"0W?9/3@S2/'["V]UAT2!TISMJ*89F6M\LW=3T)1F8 MK;K=MK6.K':!LQD]M/HULRY;W6Y7L56S:VLFX(S3![S;]1U_0(F,$_"`W:VW=<7Z"DJ8CGSX M1O]7_=,F7K)LVT5`LP1O$&[-P6`VF7G(BCIL&@*[HYN$OX+?HX&6_WBG@[W*C9[5D4%9Z,BM9D.5FPU-[324;M?N==!!9GU5T4(U MS)R)N@LX1<20+I`MA]H^9T7IB*AH7_`_)VWDQ2*>S7%DH+VH%.3-!J!EPF83 MC*)2M(=RU6VA/XRC;@%X$X,1:Q*!LV M1(>F40.X&O;`/^Z7((RS2V M9ICH4R`.L6BUW!5[8!_V2OA:[7M:V%@FH>YEJ\HN`4 M\!].<`*.0'":\&>)1.?.5,&5:ZND/&)G\+GH5,Z'1RQI$+$IR]3.1W3NC`@N M.M7R7HO=P%>V`7_IM<#N`U@LG?EQ]Q1[$I#:IKI$26@T];95;\B695NRH3?A M;V:K(7<[+=U0+$O5M=97702>ZG*B(ZS9Z$IH=LXRV`,O M[YZF[/J^YPRH!<)Q]XU='`:SF$EM)V1\]\7MG1!K-=2&9F\M:>S2^RT$_`=4 MOVRD8T,ODVMS9Z)0MU$_3D;,[`S^>6E?@`Y]27K)AE+W0!;:D:[%;H@HM_:U M,_C[T[Y.XEH8#7-K]R;V>BJYXT+`?\"@('6M,\R&6B;1N2M5D./"JI>51^P* M/A>=+P3_='E$0U47,]@V18>("AIZ>7D$A_^`/(*B@JIAVO4R,8E=R:+D3&)7 M\#F3:)P+D[",NK6UN2&RB[02*Q(<_@.:X)1=)#?T4F4/[$P6/`1BEY5)[`J^ ML@WX)\LDS#IPS:W142^]M2'@/R"3J%.8M*&7B$7L3!2<1;Q0D)X,B]@9?&4; M\$^:16RM5FF)0\(H-8LXJ+&AD4.B892-1>Q$%.HV!OE)L8B=P-^?/^+`$>.Z M:JI+]*5-(I:&B!@;IQ`QW@D.(U^B];H1XYWV#9>LQ<;.@QN$CB=]`#*+QR<> M.*Z;]27E8YL*7Z/T-3$"_@,JI$3.LJ8K1HGDS,1>Q$%%PE+:MC:V?PE6W`/UD6T:@WE.V3 M;93#Z!''N!8[(Z+V`?]T680-*-B:8VIG)#EW143))>>NX'/)>2X%I8B.K4UP MS2I]&$3`?T#)R9NUE$EN[DH2Y0Z"[`S^>25E6G5U66W7AGGL!TJE.,:UV!D1 MY6[$L#/XY]6(P5;4[?M2:+JX%HW2RDT!_P'E)E6T:F6*YNQ,$YQ#E+40<&?P ME6W`/UT.H9G*8@/53?.VZZ5/5!;P'[":@7Q2JJ672;G>F2K*7#$.PHA;)?XI9Y2JY:=X#ABJY:= M]EVF5BUVP[:VK[]72A\2%/`?3OT"'&%^MUZF>O.=B:+5 M:`7HL!I;HT-ME#U>G,!_P!+A!C*),I4P[$X3I>YJM3OX^^MJ==BPF*6:^I)A MJ1N%9;03"HOM!L?QPF*[[;M$83%+K>O:UN4/BFA/;I0V+);`?T!5U.0^[[I6 M)CFS*U5P3;2TVGI7&F5O5I/`?T`>09JH89-[6,`:MF[627P'S`L)J8YE*G#ZNY44>IV5KN#?U;MK"Q=T[8WO+1&Z4/G M`OX#JA%D::AJF=2(G8F"LX@7)J"=#(O8&7QE&_!/ET4T5&UKCJF9I;J!][N#KVP#_NFR"$O?H:C4+KV_4L!_0'^E+2JMR\0B M=B6*'1&E+K3>'?SSVF6I MVV?3W&MW1/!\[9+VBMT=?&4;\$_W6EB-[7N$ZM8978M=$5'R:[$K^.=U+4"I M-+8/<"GG5T#AVU__VXM_&;H/ M_SV*?P$(\%]3*8J?//:/MY^:7WZ[^BRWKN_NKC_]+"G3;[](XK.[ZQOZX*WD M>.[(_\?;`5C7+'R;6^8>0$E6ZEU_OI-[S4]7'__ULW3G3E@D?6:/TI=@XOAO MI2!GW#M]!_3D]O[[[[[P,+( M\6`Y/@U.0H*(GZ0K?Q!,F'07SJ*X7#`A`!(G:5C0\8=2CJRE/%U+_^U,IK_\ MUS7@9$LP3=-^U'YARDBU[\N=OH>2U[9NO[2Z7Z1V]-'4&KC_ZQUN%_WOJ#(?)OQ_=83R&ERO*C_.XE?I!.&0A/I9_<9C_ MQS!90#=^3('Z*1X6GWD0"_>#.`XFZ4NUU3_9U^?5JZM75Z]^Y5>K^WOU%J\X M082<\ZM_*@J$"YPU^D/Z\Z M=Q]^EG1U&N\B_-6B\.^P:!"Z4]1O-I7WSQW`5A)^?LT-T?)V`<^@`'`\J\8R ME6D/*+ORW=@E';@=K-=V7P-1WQGR?PN#*)*XQHKZ^CK\]T/II_W=E,>Q.QC# M4@,G#%TV?+7W.K'$P"H)[F&Y*15G5B2WG*]FY*<=B/IRIN&KG7_>!'T]HHM@ MG>`^.T$P=R]!]M1>;0?/V='/:0%S\K8B^NT)$,@=:>&U3KX=3*8>2\@]MW:> M'O,NRM-U[=^#X\=SB[F0:!@\,DX&J6W,JM^9U MZ3)<*Y2JHW\]+>&!A<[H]4X_T1#ZWNN]$X.%)T-M+[+$CTN(!R>^K@\J:C]T M_,'K$<,[=KDV6O#=&24'/^6/CE^9@:^*\=;,]3!V]&J7BM"&__]J;[PB'?*R MHJO7I*M<$G\&4!R\VJ&WG,A%8_^=4_'PBH>?-\83'HY[/1)W9?RF5\?^BL?> MOKJI$/Z:"+\+8L<[1Y1_MVO.6]A2?P14%(3_>/M?[7:WV^N]7;Z!.)CFO]DD MX>UCMW?WLZ2RR4+NV"_27?=_[^2KSYWN9WA$AF?RBV]'M%>^ATE_?SB>QYY@ MI2]LY`:^(-^5,?#=`-E]UY_8T!WP=W.UVJ[[2;O&7+O[E3Y"_\'6(B9)M M()'[(/1=A_;K+N<4KYYX,,\L_>`Q=*;_>,O_W)5#[F\C"><.W=$XWL^V*+$U MM\43Q-HI\]67@O7#R]&ZQS/7:HJI5`=[?@>K*K6&HE8G>X8G:]1,NUZ=[/F= M;,6,S_5@S9IF-ZJ3K93K2KG^GJY]HZ8;U;4_PY,%[=JH&]7)'N)D=^&)^[R\ MBE)=W7,^8!SE6!WP&1^PH6<;P8X64?E.>[.4QM,/KWP:-#V/^5))`Q9B^QBO MN&/?'$Y(5:BBLJ8JOGX,OEYK:)6;[)Q/6%=KAJ%51WS&1PP6M&K9U1&?\1'7 M:YI512#/^80-I:8T*E%<:>*5)OY]WO]Z33ZX_BP$^+1):&->;*!GGA M`XMBZ<;Q)E*+.8-Q3>H!J.ZP*GVHK)B*>QY//-94N])PS_J$C5K=K.()9WW$ MC9I>N2+/^XAK];I>G?`9G["NUDRC"@I6FGBEB7^?]U^O:6JEIYWS$:MF3;6J M(S[G(]84I7(WG_,!5_&$,S_@\XDG+-_M\:('=V,FM4)W.&*/SA,NLRQ,\#D( MX['TT8UCC\$B@[]K4C/\V_&CJO*@LD\JOGA,Y;7R,)[S^9HUW3:K$S[C$S9J M9J-*6#SG$ZYX]'F?KUVSZY7U6:G@E0K^75Y_K!M4J_M_SD=LUDRS2D@_YQ.N M(@1G?L!5A.#,#U@WSR5"UDYVO5JL;.E0I>J>#?[?4WJ^M_UB=LU*QZ M=<+G?,*J;5=UH.=]P%5KV+,^8$,YE_#!\MT>+UCP/ZX_#-DPBP:TQ^[`&047 MO#=1R$=:+ZLZ$`_6I"ML:Q6=;YG?+[UFJ%464[G?,)J MS=*K.WS6)USQZ+,^7ZNF56-H*A6\4L&_U^MO5,'@,S]AK4K8.>L3KF(%9W_` M5:G!61^P5I4:O%KTH.=,7.])Z@2#.`@SW=?^!>L-Q)0#Z?K^WATPJ35SO:'K MC_!MR^()M^.0/;!I$,8UZ6,PDQ66I75GO7QJC53JW2AK:9HE4.Q4K\K]?M[O?Z-BL&?\PE;E0`_Z_-5;;OJ'GKF M!US%`\_Y@(VSB28LW^T1*P^8%[$G^98]]0-O*+4]UW<'DA/#3OX'PP3Y:(+4 M#H,H$L&#*@I0F2$5"WQ%%JA7Q77G?+YJK:Y6>GXK,^WXM#G?;Y: MS;`J#ETIX)4"_IU>?UNK.M2<\PG;56'@69]OY2:N#K@ZX#(?\/G$`4Z_JN`F M#.Y9%+F!C_V(F!^SL(H+5&9)Q1)/C"567J>S/E_L1U.9G6=]PE95ZWS.YUMQ MZ/,^WZH^H%+`*P7\.[[^AEDQ^',^84NOVLF=\_E6;N/J@*L#+O,!GT]<8/EN M-XH":(>(`N`OJ?,/>OT?@V!8@SW_8N[G?;X5\7)>8V=DJV=;$FO7M6$IR=O])P2)L M<9G75EZBY&.A;C',ON]])%;*=A+L*8([2`"0J,8RV,H^4B@X@R MWXZ#*P9@W&'<6ZG\,.ZT^<*XP[C#N+=4^7U<[DF:K^4C^9;.+133*?+LFCFB!<8=Q;Z7RP[C3 MY@OC#N,.X]Y2Y[3YVCC]FC1?TT<(C#I@1$@H`Z83(5E>6\1#UAH/4;_/ MDTO$0S"K@DVOC4TW,:LBS;?CX%(1&'<8]U8J/XP[;;XP[C#N,.XM57X?Z6*D M^5K(""+-%_$0^H`1#Z$,F$X\9$49(VL\G&HTD6R8%/E$IC';264VEG&NJK&C M_I(I&["-TZUWW[8:`01,0V`$USK*<=/&QAW*A%UNP%,E37C#XK91]6SS'Z;4'_*A"UN.CA:B#)A$X>_D0>,2`!EP'0B M`INSGA9J5H8%]D;%/\EQD7)5Z(8):;\_!I*56O58O<1.F8!OC^?FD MRV(5O3P2<2YX$S*),6&I5:_!6*YAPM+Q<"8*9<*^(HR3"2D3WNAPVZIZU0%7 MF:V!;,>&YE+F:W/'0_H*G&\XWZU4?X>;6(LB3=C'`$Z:+Q:3`1B`FPR83K2@ M_JD-UU&#FXO,DC/V66;J7[&JRDX2QW*9;ZPT=0)N]S# M-7((""`@T$[U]WC'K3J0#\)K76[B7@<)!*0)XY(Q``;@!@.V#2HA@>6UK2X` M\"D\307;2[)9F(M(!P!VDG169'K]?Y*&61[JLI=E#-^A->+(?1F8CR1[/,V/V]1?V;4#A^I/1T?'U5Y9'&*X+?V:0H3@MTL78PM'963B6"S<<7$<9 M'@\8/-8J\TFM>GD3])/A75NX*NQSKZQE3:,=))2YPQTD\&,^C?ET.]7?-+B% M[%#:B%T3N4WN`W]A_Y#_Z'_0$P2L>=CN94R7S4_@P(#,``W%K#M M40F8+*]M=;D5VR?;-S&/AQ$/59GO95;\4WWE,DD"G,ST2EX*[V)G)FG".,R= M-M\N]SL@3)FPA8DD9;PPT+3Y*@.-I2`L]6.IOYWJ[W,'`SAIPJZ/RY0H\U5V M&QX:``-P8P';'2HK_?4_5ZF\E#F.0Q&QO3"*LBHUV,@P@AE()316OWWH/^D$?LV#E^BS-1CCRHN@QH)#V04`&7FQ9V M7&`:BFEH*]7?YRX6&DD3-DW,0F'>8=Y;J?P^]Z#^4'^H/]0?A"D2]CQOA]U(!)VP+2E5KU6+Y,)X:A5K]5+.$B,IS[O M(F)!FC!V1<*XP[BW4O6U<8?Z0_VA_E!_$"9(V/.QHYHR7]P3`,``W&3`N`AB M;=&)8CJ5:13&]R(3;*!J\M>G,54ISU5]#VU!6]`6M`5M05O0%K2EOFU9ZU89 M:QW.J'X2IVL^\<6K7>,TNUCCI$S8P14%I/F:+G<<(*:,V'&1-D.:+TPT:;[* M1'=]J#`VDF`C23OUW^,VAG#:B+D%PK0)^[X/P``,P$T%;!MW%<&FDE?=5+*X MJ^1V.7\A[[4QZ:XD%,&TN&'!6Z&,V.Y@28DR7S6E[-I`3!EQ!Q@_P[WX?701LP=!V<;P<+#PK=3_3WEX4'_ MH?_0?^@_$)-$S`T'=_50)FP9!C:D`S``-Q:P[5&)/2RO;761AOXT2:^8R-EN M$5\F27"EBUIVD=;-[SG[T"L;5M/``N8DM>HU&,/5[V?N6N!+F*_-'1>;H6#> M8=Y;J?XP[[3YPKS#O,.\MU;]'6[9V#)&F;#E(9Q`FJ]A(AL)@`&XL8!METHX MH?ZI#+\E:2ROV($,PK&(V'$D_A2ZM&4QAOEW.1O]7]E61!@P1X%]K,`^^B8V MM5/F:YK&&A:?/5%AHW'<`#AP?>4OVWN&]`_TDCYJ:#7VNK#`OOBO9,=)&.?R)C:@*M%+\[*OEP4'3I++2.8Y MH@.8F\`H5NRXXM`;TH1]CL,<:1-VX+=2Q@L339VP,M'08?C@\,';J?ZFP4WH M/VG$G0[R`"GSQ>(Q``-PDP'3B0[4/XU@5&1C$2^$"H[39";3/)2/!@P&Z448 MG]<]7D!"$SQN>?!6*!/&BA)YPA9W+1Q,@24E+"FU4_]AX:D3AH6'A8>%;Z_^ MV]R#_I-&W/604D"9+]:4`1B`FPR83M!@>6VK"Q$<2S&6;$^**)_T$X5Q M.%X,"VS+2'UV/A%3SC[7^BH#$O)NF=SKPJ111FSB%ESBA"V'X\01K!QAY:BE M^@\+3YTP+#PL/"Q\B_7?XUWH/VG$)N_@2"G2A)7IQBY,``;@Q@*F$QVH?TK! MX6[F,-"_:'^M6DFA*/YPH&Q@3IAJ'^M>JU>P@'U!^$&$+8<7+M,FB_6 MO@$8@!L,F$YP8WEMJPME?!9IP/KB/)+LZ.PL'$OV*8PB<2X7@QB_B70:QN=Y M$K,]]=N,LX-!V3@$,S`I:9=!?%/M0&=A)D)ZG.,@#*L.J]Y2]8?RT^8+\P[S M#O/>8O5W'*@_9<(())#&J\RV#<``#,!-!4PGD%#_+`G7,!QVG"215+\5@2YH M68;$KHS#+(F1(('I24MM8[4Q!=\#5<(CGFOA7%>8=)CT5BH_;#MIO+#ML.VP M[2U5?ES(0)LOSM0BC1=+S0`,P$T&3"B6L/C2X>#?_??,G'U])*#P`.&34-^O MV!.>>!BMV#XZV>V?;(Z.CM^SOQGE?[J*+$NB,%CVCA\-%ZSUA<_K`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`_7JK#C-Y!^%5`7G"1/C/XHP"_,PB?^JOG\A7)19GE;'H M=5_JX4=)A_I6)K5(S62:A[+\['(2CB>JN%+6Y$68%%ETQ29:+.(D5O*4IPJ8 M?O%4_&=>9G(9E])V7?(6&X;Q6+]?Y+HJJ@W\VU>)5*IWJ:*N-LOG(6./@I95 M>BIQ%F9S^Z"&$F4R8MU5ZKVG(A**L@)9_G)7CN7T5*9WSJ2MI%*G`K,DOB>* M@3S-2]E@8:;*44*UJ2U6D2KY4`Y/H>2G_W4<%8$J.U;6K?R^$L5I6$S5F]0C M;[JVPY7O^T*1>'.T4&?C4X^#D=EY4]ON_'1 MO=*/M6G36]:H^[+WQ,!7_;KP\&C4'[+1D2IMN+/7W_VXWU?>T^"E??:ZC=CM M[_0/MOLG3.FE*O$V2;\Q#=@0TZ2(RX&K'.#4P*2,4?9N+:UXL>36:SQR5C0> M/41B?K?WUSY&/:C.27_GZ'!GL#_HC09'A^SHM]+2J??WAZ/>J,^.3XZ.^R>C M0?^[J2&K&$)J8`X?I-K+3OFW3CP]PSVIXOAK!RP6N) ME_/],?Z5)6]%>[?G+:]J[_;\[8YA\.)5BOB&:7.S6UVFY[P62SA7,!ZM36U?6I%5`K^N5OW.IG]QKZU7 MVVO33`@'Q2G:W8AX;SR<1Y1E)"]D.29F&Z?U'A2A)HWN-0RK$`DXT3\\3[1M M;G0Q3USYJ'@=H;U2;];!0CTB+CG6OSZC'PEIMKEC5CTA)+IF61O"?N53?O)+ MES5A;7+3[32/=?-F<+V[5"B,46N/K'&CPC,E,4:]PABE!BF_NG.O,$B];J"< M=VVK>;#K/G_:#;-9DHD(`]+ZXVA&U?/_=S4;AFJS@H5UO_H-6[5I)H2#XF3L M^-L\=%6)NTSTC3'":%`/A-$@$G42B=;[T"9WS:KG_$]WHRL\?OA^%9_P[,,A M&!:\81,K4[BLJJ]U%4ZM6]G9V/!Q_W>Z/^ M+MOM'ZNOS'_[Y'KC,*H?/8RJ-QX7TR(2N0S4?&RF?AO.LW[H'$=5NP.B/!P0 M59-7XX"H5SPR!P=$O7:/XX`H'!`U-VSUWRZ!`Z*J65?J=KC1;>"R$I:%_^KM M'8=WVY.AT%K&7M=N'N.ZQREQ.E1]=N1PM_+Q"8=#8?M=S;??U::9$`Z*TS/L M9H=ZU-QV-K9Q$(GZ#:O!B=O/'\S>]W&P)TB3?45HE=2I&I>>!E;SC$\ MK=OCXVKTH?H?[ M5M5'9Q!=FL$>0?HK,I7O)&OD;D%J_BFE)$^D%S?)1Z74@\],!+5T`N(C^23& MECO+YS[UDNS-_<%A?W.O/_BPI]S8KO[D\V!WM*>,CW&7ROEX^RAG("_?)ON8 M"*TXWU@GP4Y%ELN415)D4C4QGS"AWGLY4;UZM9E#D)QQ,MB[-47H1)D45791FJ M@#C14I:G"K&6S:GXSZ.OW6*]C`FE05D1E7OH53TSJ;QF1\H85*25A2 MI'=:J:5=.9BJ"/4DTU*CBY5"5?:F^'D;]).ZG+,P%O$X5/HRKX7Z3:IK$,;C MJ`A4UZG&ZC?<4YR[A[)F6SU?2E]TBU6)8LE8@E4W_HU#" M+=/_*1,T2JW1@JR/.T@U<&U:]:[5A3VK3$E>>B[U]]^X6XX23R7;I5'=>&.: M6^[-!^P\3;)L_KB20UG*]!MOR[S]@DX)N3M(016PN#OHG18V)6BQ'A[4E\L1 M2%=\.%%C1JA5],:X;Q=A%,Q/:XB2<2F4ZME>'HDX%YQ]D$EZ'HH7RN3/07BA M?_S[ST6V>2[$[/V)%%&_E/E>'"R<"+%X(,1NF(VC)"M2.9)?\VU5O?_^0Q7( M_GY3R#!7'ZDQ58EFUB^'G,,DETL>TWV1JQ].Y-FO/\DD^G+<[QJVO:G^,VW3 MV/RG89C>E^%H]XOMN5]T`,6P#?>+TH(P^/6G,/CB&(YI=CM?^J[A.*;7V_2< M'7O3Z;F_;?IF?WNSWS>T+ITJ=M.NM1N=D*LL"WFRY]KU7B+E+ MD1?I]8W48S$+'N65ZWH.OYHFNVTT=SX5ZP\:2S\14._NZ-Y]+M]#:C[H M*/M!1^DQ>!E3U5&^^=2.6D#\_^Q=ZV[C2'9^@KR#T?J<4Z0DDJ(D2J(H&LEB,3/=NO'[ZM2YUZD" M58<0E;D$__I%D>(J;2"*JQ(1O]48V_.-,CJW'E@Z7?`U9;_?M(G,)+JX@2DXR#^=V@$.HW*M[.\%W7H(()L^SQ/A3I5_) MOP,^;+ZE]"N?\Q!Z&1--!I@<>,R_.@5'(`\A)A/PZHRTI)FH_8BG\>/(1!*+ MH`B^[?DB8V/P!*B>4.I2`_(Y&3WD3JAM@B3C4WZYP-1%Z"BC:.DY` MC1:TZ'`5A\U_PF:U0%Q!RN`-H]D0%,'0&-K-D^(68O8$6R;;H(-G6/2WT03^ M,'[',,LN!&8@/!A_/0S2GR@;#W$\3#]?_"V/R2H?Y91_QLQM;C+P.3//83;! MPQK9)EG_&)'$?`SDMJ1C,&WW"W>],7"5#U')S(=0NK'3%AS>!!,H%X]QOLOR M$R+I;Y^7.R7/1J35+Q,.77P9(EL`Q6`V'KV:R*74WG!19=-8[^S=F!!\OW@Q MZ9U\K(YY+S<*!A,[&WYAA`[7=#:U#-DCT"0F<0D188KZ?7@!Y&5*QR\F499* MQUAH'S\;C6>_C$P5G_=?S!Q!MF.[KL>JC<$G7_YVWP"1TF6,1Q^F^?++$6KO(PB/Q0,(O9GK"X M=)3E,28L(53H.T334'I9N,JE*3FL0-<_?1EA.$BF(.+I=9S`_;^CY3$46L=`UJH!S/YUI93++0XCPDEBN(M."[*?-L";CU/87?^_0[ M^2+X"F@MB#+.5;+BVB@9L.X)9O9!N,R_VX5<6E.V!I2$RB?"\RW&N;8X(%"H.S3[Q9SM"BMZBXDV]X7)KA7.892Q_D>, M'0WQT,TLT/<7U!I7C_E[S>?2JY:-R[300IX,QYCYZ6+'K(N(KUU7`=_\[]-4B&%7;3RVFV`!7EMGC]VH13Y]%`U)/:=K5C44H]\$$#:6DFN!4* MK;DDGLNYO`?OD]R##:/RBY(%,>N4H$8.P9J):,OI;=7JT M_S*O=&S*'$ZHK9@%=LL!/14QR^-V:'DAD43YCO;#$/>5)E M4&4>\CV6HA>Y2.?WT(`S#6@)</Q>;08);MZZC]<"VN:;Y53^S@:RUDOX#5T> MC"*Y=EC#[=+`YP&_\7$T1ZW39SUAPF>'2U7>.^@\9K(A!64&=D+8Y!QX\>,L MB?'C5TGQ"U8=I.';/!DL*K67\WB2NM.AGW7_C%[CT-1\0$&[RYY4WQ2*NF5- M,^8Q[;D6)SY$S8)!U$QDX>Y,?5K@@M1@*&LJ4M[=C$ M(IXB@1;2\VT[(X&(2DZ^YM$K)8=EN@JUUU)M8>1Y.?6SUH;ZF.HFQI:6!\R! MH27[$W"E-W'F",2W&SX4$^HH5ALGU(%8,WVE^@FZ MR`_)"Z8%LZUZLZQN?H][N=8$ZT125DW8'JCJ!2":)>[P%<_%`XN/CZ/Q"-M/ M^DB`DR4W:R6@%L4N$3"*>9D5SO5*7Y>?P_)3[NQ8_TV0ZDTK*M2>XN40`BO' MX;5V-7_NJMXV3D0OLUL`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`L04OI0$1%E<:6TYOO)` MH%WX%<9L1D26)"XN82,8FS5RL>R(9]G3Z\&[.8'?Q[V+U22^UJ#1`$VC"#O+ MPO4^PF8886M1.]F-]E`VNM!TE=::-F&'81K,S59 MNZY)Q2V24]Z+K&&GV]?1X`<69H!)^'2Y M4:CP6A]Y(K"IJC7)8W%NEB8\.8(QU%52[*KO(R\EG-`/[G`U/Z58P!-&">2ZW'-OC0$#@69XO0\L)&/,H4T)RD?F+6T9G M[`"4\_!S;G)$06%68'H)IODA3E-TN[#R96**T60T7XG7.QKRP;2G.P;'IS"R M&#-Q-,055:OM5I]8"UYBU-L/YK#$$VCT35]Y-?VS-)O<,Z/)>T@ERUVZDX-? MD;RNVVY,]7$Y@*F'-&%Y3$NZ%+A=&%9HS]$=?7P=_%T@+!& MDQ\O29J==5^8G;P3HFL5T3"M(#[]SA>#,QH#:0;\.Q[$.)M+VA`_A"M2*MZ( M@#5`187X8PX1^3;TLS`.8&5T;W!61B_EB6$WE2V7].R#IZ!?EB-J M0++N9N'D>3Q[CV//S)&=I]FM&!WFP5SM$Y^JR'(]&8#E!`%Q;9]:W`W"B+N> M#3NHV&>;ZY8&*';MF,W=5W\DG1_6;R8"NMA:=BBP+7$*JN;'19=&J0#RH8(5 MLO2P6T!XG.(]9Y&OH=J%H%?:0AZE=NMK@O!EGCG3@`.6/X03AR9;4;)R8[<\ M_[I./8$5:3;.K:$2Q7FO;$V';K85/6@K;9BX`>>;,<W(B MRT%-R]`+^:5D,$T'IB[8VQ9YK$N99JM%"JGRS`4)R0Y#91HF'A:LW5$M*??* M%H[CO"FFI-0-H,HUJ#;E@E`.BC+R01<0!J;;]3P+7A<*]*;#X(=`!V3%%BJ7 M!?[=J(K6>Z%9W>$K/%OR'L7Q,;-C]P:^WKG2'#@ZF:0`>R.:%>#B]4/Y[4-X MYQ!&>$4]DI^9/X(%K14#%G!0WKTBMB#B35,E%2MP\@Q/L5TQ-IJE:[C@.(": MB(R(_5!6#XA,\>^S^VAN1NE_K]Y(CN8#5!I#/HA4]`T;1IF]%Q]A0`(@T[810BT4N<5P?7@U$Q@<6A[X4AP]NPU6TB*L8MX;%JVE\]VL6C5[C M_XR3&?)YK.5<4J-LFV\6E=,-8D:R!)*EM5@8U`,YV#['SR3L6YAFM&`,]+OC MR-/Y64:,Q/;!?E5,*T&"*!@+=A7<0[R]9'PL\WX MZT`UX6`E+I?3UM.!W;*C&[#3".X6WE;.2V&?'3$#U7ZF-N?R,:BPMU!1"ZN)5-SAA?$8U+V7YTY_$$YD`_'8"'$+ M/]]FR?P)W#P@%;N;CVS5[I83OIF3>EA;-6FQS^>HP:W=DD"W*=$U3-V%,QJB M5'C#B<,9MO30*=DKG&EM;#K@=:2PWP`VQ.8GS69!-$OR(>K9=(O=(]1/>K/$ M$CJQM4U/"IWA/]JZ9N*###+NGM[>3#7N3WJZ^T7H)%?=K7I@S#EMGM\8P_:N MH6G/*'0&/;]90S6[6>/#:<#.)*@W*K"M>1YGX+#1=(\^JOC.&.J!CL\N9FM3 MRFL[0A#!^6J='W.M] M5$9-R>7N5SQ^C:/1X_R]6L,[LOC4=;F)Y05K"&8UV5BLW(6WV'EK-`>^ZZ.R M@1,8OA`I%XVVZX!6<*\65QV9HX'MRP%GW.X$.4?DYJ)QZO`,^0YL*Q*0F[R# M]&X&[\.C^B@]F#R_>KP;O!U!`X$8Z$TYW&$._(E3H9$4P9W#!AC;@;E%U/)U M$."4)&%YD2TMHBD/_9`0)?6RAX,46QEV8CS/O-<%0YH*6ZD%0TKC=5,',11J M5TM!N17R",_[T=!RO%!:W":A<&WIATZT;/90U?'&!TZ#!7YW7HR[XU[Y00@;M]DY6CDDY-1RM0\4^U)8;FAS^`>) M[$C*@$>!Z28C>)\=E5]L)Y/&KMGZR.LD"=G@3K2\3@S726*?_1M0%Q/7U^^4PSOYLKM0;T?3AV)S>6!ZS>_`]'[)@SNW4CZ%OCHTQW-!@E)L5S M.7V&=5L,6KPYXESKDCBJ!1?P)Z&$PA!`.7I+88.O2[#M::7`(18L`OJ8H);# M/=N2GG"HQWW/08UN9W>6VZ!G1(&W+<`V,/!M=9ENBG]AB+V+'WY.1_]S5."W MC8ZJQ`3:)VZDP))Y%&V]"]L7_BB4"PZE)E$4>4M;G_DX%[FSMVC+=Y^?D]G@ MX6<-%3L0;I4,^)4/)A0F0+"UW"P4.:9BU#3[@<=_L0QHWM*S10^&T0CYS7[%27YB MH1&L0\Q+.$BF>,-#?F-L%U:&.Q#5'W)D5VKIGW47OM_O3+E9T?^+!0_SO\6`\_WGQ+1Z.'L#P^>/1=/1P MN/\3P6PZA'E"MMBCF*!1WJGP51/@Q'DQM.&F0Z%FVCZ3QYR4;> M8L_@W<_!-,^!F$Q'>IG_[*8TR'(_'D$O`Z%[4Y)KN2%WVCAAI`(JJ?1<,,8@ MD5R(`(_Y^Y9/P4P'H<"I!LO%8,X76^RZ;N4,3)YG@5M?OV:#)IJO&-YN93-U MAA6KJ;&;-]1T&9G?^]'6A4--]L9V[[0YO3AWP!:$\TK!?3^D70Y)/YX=J744 M*6U;44")Q4DD+8]PQY)V)!E31%.FEJJ>T_B.;T8U*Y!M0 MB8C>#[3N" M!;ZE3>S,(XZ(F<5$Y#F.[_*`.ME(%!^>#*+E\6#I12ZN,+U`G./XKUW%T%I< MYR,DKQ0?0HC1U3ZXQ?`8M\^)N8IVP/#7H`TJ\G39HND`Y_`\-`?MV(B9 MV:R%F2B>ZP8R@'#1#WUS/@9\:^URRU.*DX`SS+;X%!>/[OL;?0:AX^/\WE MB=6]9'8W:C`_8DN<\ZC[#G'*73@_DKK?PEL;TI[-&.-2?7!U?W*:>`U-K3FR M78$PFDU*V8%F8ZWL^$8.^N*\!3N'9NL4)]^%L]48<3>^-L*K3`,YB^M`3K*U M.@!AMI:PZ6FW%LT4A=.5,67Y7`[>\=;J'J?6O#D+!LRVKY49V& MKFCB-32UIMFZ`I$Y#<3N0+.Q5G9\(XW-#P'*H"BSF1'X$N'P=`A@LI@LFRBFQ^H>ONSDD>U,\!)V?&8)X>-CE\B6\ M6)ASM/.FN.:'SNOFPF',IY;+_I>]:VU.7,>V?^76?.]I2_+SU)FI(B3IYA[R MJ,!T5\TW82O@B9&XLGG-K[^2S<,D-#AI3"3DKG2#C=O!6DM;>V_M![2^V+=. M^\O5M>]^:0OV(=!VKX,;=QL)7$YRK?QP=6B))VE<4&F-L`LM$7V*+#WK<[K' MGE,C+;'N)J9V(:-?-:373DNL?YC$`FT[KVH!?LY.PKF>."\&8'_>3L*YGK/8 M28#H'*KS2<1@);W%_J28C/,_YWEC,HX_WRFTSD(L"YVH3M6Y_H=8J%!X^\6[OKEU@FOO MJNV7(J0=VP,EQ^]':F:];2N\6CC3CS1XKS84E8,DJX^&T,&<`+Y6*HX^V:OZ M8>N.8K?K%I]"M=@,JCA#WMG[Z=.&0W93A[LV5\6'>U-1;=/B='W9PW.;C<>, MYO_W3&.QKX9.Y<&0!MBF3U35!_L\9L@4),N7->B`7:4P[0=YLJY#`5UT`IY\ MQO@@-P#US2.T"FH'+OCX^*R>-_\")WK>_,;BUB1/&%X=B6-9-RR+GV/"_R<- M1V1,_O&W499-_OCZ=3Z?_STEX=^';/:UW?E+J"_BCQ?XGB_6CNU_V]XJ)4/Y MB/_\9PDW24-\S8/[#Z[RVAQPS^_[OT][_KU:].@OYR0[6]M97>8 MOY"LE8W%A!]R/$Z/_,JOZV=?C?+7G6'^<[)-$2I&*L,\S^>2N0_HBX#4`N(> MF[.;"PF-2I?!+PC(6T>EB_[\6KKYGU]7S*F!1H58T9!&JXOR=)!5CD-#H/,1 M2%7*-,CM,;+JQDK/T8$JC@ZL-CJP]M'9OSFBY*R_P_]A?%U.H)W@--W._-Z( M/(O[)]$J36J=.];*$DPS_(TP/HQQC<(`5`,4G`M0M>BNS.BLMW*5&AWTQ?(J MB4HK^"+[O-8G*E4<'5AM=&"=H[,3.ZC4Z`A2V-6XX]8[.E#%T8'51@>>8720 M>E)9/#:H-CJH-JF\D[FIU.B@:J.#:AR=@YGE2NIH/?$;HZG%RRX8JT]Z*@5(@YV08!U*B]59X)]>DG!\LJ7"C6LK-Z3^[6R3??,8^6Q76, MFP9VN;"(DF#G55IVO2WKFBVR%Z?`[U%86O:J=D$UAPJOEYNUW\4"8AZ-E5XB!9'5DC@^R<2'7>3N\"(>3\=F(I5WD],&*:'6&8C4+QLM*HG; M)SHYJW_'>$C%@X:89F4CL"707*7-I%?ESB.OO]NJ[.A*3\R+CII(RKW]42^4 ME!MO;+9\XX]5@)9D51_X581'41QX81@YRSV,E:3CIJGQ%L'=KL=&`E:TV]8% ML%*#;K/0L@+7L18^`,A65,G?A$L78ET*04;%81F]37KT!EH34?2``_WZ0PMJ M07%M)Y!,3$$2K7-.S801B1^M82PEFAF*(`KTGHB/PE2CF9G@6;ZJ"405P=OV MQ'C$L3"!5MJ-D6A:/K05W;:JB.8]HW(0.$L2L21VQ'!P8:@:!J;O>T@8%;:\ MP`/`]:"P"868553*/I&\W)60HCM-;X7%7_YDJ\'^BPKEE:S!VQ)ELO),(TC5E)?"*YZJ6@QR1^(\N&>+D)O\V1Z7*P_.U$$)S MS,EQ^7)1(*J5PZ7,\%B^@L-C^96&1UQ6Y_`XDCVVA2Q'L>$I4OMD:^/#[+'S MRYPZAP?M5FGP?>2KNC-UJ$K#CWC`\7>6YLNIK+S&)].T/>)QFL4[!WD0:ZVE M6RKF=M9._-?(.KYG*1KV=`C9G[*'-Q[*\!,9;?PC3A(\)'NCS,V$U;4##2>L MC`.2J6#RK[2('QE+R!/#48/L&EG;MCQ%+>1#R+9',@*,#SAC+ZT01V2\O"?S M*Q[+K>9'0FFZ3&:8UEHS1UU0D8\L11-Q#X%:3ON0\7*$M[*_9(P<9^(L'V)RNSC](%@0H1L#>=F;SH>$Y[$M(1D)XY-!Q,&KH8*[SXP34<20%4S8@^:+G@< M)\MK%N;9"WNLE=Z(DQF9,)YUF4Q$P-1,71>X2,'(T,D)':`AHDPK)%L\2Y_8/"%99BJ2T/(U%+=WH?08T5T%J#AGK$?7"\3X:[C_LM]K9+:K M(:^[J"&6=V'K[;PT$C_DN!K:F/OW0C,V-WXCU`MD41[]$/TKIA$GT5JVMD=B M8@Z9G)E\<]21M@N+#5TU+:!J`N`A7*_X8*\OU_B-[:+0K7Z`?K"R[65BZ`6V MI2&&O]C--EZ;E7!JN+&R1QOZUSP<);C1ACS7`QK:)QO'>U[5?X0C-N]B2KZQ M))(SU_@M;HFKI6A9OW?.U-8TF@Y8,U-=QT4:6J*MZ6#*Z5X5M_CHI[EP:J@9 M]4?%1B?AM,U)*KNL&.P=A5$2--4.GS>9CP4UJBYCJ"F@??%(>HIVVOB M$*(=*I"+"K?0_O`@@3`;8][&2?S,N*FFBFT+4:P?O$(.;S2CO/E0-\XRF1P: MOK3XBRS'8ZC\!9ZJ%9,.PCE-0[RV/+?M*#I\)E=3(\.$))100[?0CI!]>/Z9 M.XEHFU%*PBP.I]DF`T+Z!?,R0]>8#J9\6;K&2,!1X.BXB9;[&&3OMVU#F=Y2 M@#XN+\%M/)Y,S13)""E;;>P0K#=CQI>M['I*I:6S7+]^,U--$B!"#4'\I0NP M$S_)RF$13HC)QDW>?5,_6$_1;O-"`?4<7T-SIC7!XOO\[Y3F143+.0^[G[3^ M:RRJ&D[3OTB2DJ7X&;`D*B*+=BNB&`BIFMC[).R1FU26NMUZ M%$JQ?S@92_7GC=.A1:/>!/.7],TGI@&<-YU$#E1U\_OWFT[VQ#?@V'2@$0". MC.&UH*+!]JTYYE%_.2DA5V#;H=*D$?):B&%Z'U,B$"Y>E[E[R4@@7=MW%8W\ MW`/D#H3]N7B_S`,%#80/N@Y2>D6]F@JM59B:I>:YS8+Z7GQM/W`575`/XMN? ML_Z(35-,H_XHYE+2EILH&XFE+.BHXUQM380:%!D^$1'R577,'P2O%R]D9>1\ MZZS/YK3PZ#Z.A`W:B@%0=C?E\*S$TM6WOL10Z"Q5 M2[D=A.Z:I.-:F]FJ"YEO(ZAHHL-A=\Z4A]*D,!(T#UJJ;GH)7'-?.W)H21*#H(.8IN2QU$41:J*,I6 MF`Z@)>2IA@`>M.:-1!+ZKJWC5+SB@W7VR`,U33,%K@<7O@T0*I7V1HZ..4)' M*K?+#>-?)94<`?T=P6&)`"QZ%/`N^UPF#.8!MNG5LOS)T4[;]?;7UH2&!E7. M;?CU&?RZ\-HM#:G.2"HU:=0@^SO(JBP@WHNLJ06?@&-!V84S4+7B]Q.FPU+< M:GZ81VZ8")07``@5=0;L`\I`.C^21X[N*6O5K M35<&ZV?"3I=I&!-YCZME*:Q_X\LI?#4G4W]+C-FHWXMX/#WF%3"!-):';$7W MF3]$FLYXPMF,5`F#;`CT>P12/M'OP[@UJ82?2JS&97U2EW7MLZ#Q0M1%>Y4] M%.=U838DUH[$:M*V89(.3+HP[EPH4F*V!XW[X0.DB6E#FL;]T!#H=PBDI?NA M$FZ-^^%3B=6X'^IV/YQV%C3Z=EVT;]P/#8FU);&:M&V8I`.3+HP[EX:4Y0!' MS')DJUI:XCJ>R1M%I37I@0O[$'-9>Y*-38LJ*@"#GK(M+?8`UL9Y4_AO.#:L MH*05N(XE3!Z`;$7]L#U9G7EKX+;9>,*H=+F4T)N.IV*U$TO;!EH34?2`:UN* M5L4ZAN*Z^&L8%EB2Z$&V))'7<3*2=YL1$Z7I&ED'^HHJN161?2*9$*XDNL&< MQG1HZ`1%XD=K&,7Y,:.]C(4OAB*(`KTGHK`(Q4DSP;-\2U,M9[T^1E&>[XZ3 M1QQ'';K26XU$T_*AJHVY*J)YSZ@NE):MK4]'T/"7/1EA>\7CN)J%IIE^.IV>+XS>!W\T" MIX\TZC.A:#_)FNU3TWQ0OV2P8IQM:*4AK8#KVT[3V>KTY-K$#19G;QDG(3;/ MO,QKA@@N>+8.60=M+FB2W>(P3N*RC+HG_SO@G$Q,? M]E-'W8@11:EC8M#*:^K8+EAXT+']H"%2M1`-,L@Z-,WX5-YU^Q5N240X3FZG M-$IOGI])*#?]GP2:#8//P&"A\MNP644_SN"U)HG3VDG;K-C[2=N(785)VTC: M,FD;FM9'4S-(!#S0+->_3:DNHQ&C^?;\`-.7!Z%WBB\C2=;M7#T\-:OX^;G< MK.+Z<;E9W,M<;MA[=O9>,+=,8].E0>E93J#DYE><5Y+X8UMFHI.F4\+KW/BZ M2&R%^HUUV1Q/36S7NY!V"@6E:/[MSK89KA6](+69:EA:YN/,TLUU>MT[3V M-)L.IM(MTXBS+<^\P+-5\U3KSK-?>AP:NGF>;[O-ZGE2NMUFBSLV>!SA5+8> MZTX:EGF>ZP#%E6HNOJE$W>MI;OMD`-'K::?EVQ:=6D\S?=ET@B!8>$%@N5NF.:X3*-:B("+Q'UTRQ,E- M_FU*8H(0/I-UVOB+#'.J%#9Q3BFV^GH;>G7BAF!RN;0:@M5#,"/IA3S7U850 MOZB#\O!\31(\QYP8UB:B=M@T'1ZP*?6_"A>1Q5ODD6-YLLL?A(JY4K:%@03I M4UDNI12F^JJ\\;I:&8EJJ-3R^TZ5B3BL_LU^9SJ":GP#G\`WY'NHX=MY8N06 MMV)1Z(\X(7TVIT4KN7PSK%9]467R`4^QO:_3P?TS3A*296<-BE08:NA`JY$S MGR=GJKMF+I2``/J*[1*<#O)NG(6C&::F@PPL8"GFH3\=R&TVX,3P9<1R(6K4 MU3/E#_&8#G]@H<4LW^@P9BJLA8-33<*=SLGX'A_HA<(,+,MOI,QY2)>.:^U* MH"[+?.#ZBA81.D5@>4I8LVRL@B^AA9Q&GIS%J2L39]Z&R1E*/-<.'*\AWEFL M,^EEH33&9\U$59EZ#E(LD.F$6DLZ'AB/K[BL$2UGB<;%5"QJ_*T5;B3Q%(Q; MTS623&&0$7+L1KJ<)5N.)5%OA",V-UVP6$);;CCWZ;YE(\FG8+"LGN&KZD(, M?==NUK0SY:\-KJ:Q^&UT>+S%YJ6Q#0'@+#S?M:"G)K]:<\RC_G)2`JR`M$-# M>?\9>4PPO8\I$<`6K\N>K/-E))"N[:NZY[@'R!T(^W/Q?OEOPIF)\.5-.+W` M`8ZB,8X'FW!>B0'I3],0TV]<1C(:"9[OB%5;0_!NQHPO5RDH^5)I('8*%HD^ MCMVG%8I6$4=+B,Z%;R/;4A3'ZW@F;Q2EVYGWP(72B;E49=C8-*%9``8]U],' ML#:>Q!E.ON'8,/W$"ES'6O@`*-L=;=.,N[`.I!!D5!R6T9N.IPF6^N8&6A-1 M](`#?46US&,H;IP.F9B")+K!G`JSW5`8D?C1&D9Q?LQH+V/ABZ$(HD#OB?B( M.:FU9Y#"X%F^I>E:N/;(1%%N3L@P[CCJT)5V8R2:E@]5JW[_3C3O&96#P%DB MR__EK=I(:MK4]'T/":/"EA=X`+@>%#:A$+.*2MDGDN2[(F+\EGV.:8I#.2'3 MJV7YDZ.%0HZ7!WD_V7HA$:9IS,HI9>.!5+J,I)1E!:IUB*L$V7KK37J-Q&"1 ML'SFX;F;A*8ISSF>GF=9>7/ZR_9"G()#ZS.W;,J-I(HMCF&SFIR85GTF*/PD M=_JFAGD^5[1"$`2-!'J/!,J+5!C&E:889Q-"?7:"*1A?>#$$,Y)>33%.?4%4 MJQBG"L,#Y.C`5Q$DT'=4=2`>C/ZY9SP;S87DZI,%3H6<>A97YD[AA^=G0?P^ MFY,Z[3XHD3H.*#P#H-8*4``L6=?##E"P[3F.'%NQ=H(G[+0F)%X>=)DMY=OO MF$?+XDIV#/KJWS(>4O&H(:99B8>I=$K%Z80)>2OLU)+5NILL+?B;K(LCKH.U MY5J?D$6]W+2J<=.JEYO`\LK"Q@?(!XIZ(P\*FUO&Z3:))\'_Q?6NI%ZEI4)< M5J]DD86MRX&B+@`Z+A6/!(>DT(I6$+:3F,9U:D.PVG*?7U87AE8Q`UWQ9HNA M;4.H:,6"@QAV\0MY9+%X]A6$+5YW^4>WVB1TOR"K1@"1997%83>C`H1"@4;S;*F0\=R_.VQ;$@4*W7U@EKQ6"Z9+00NR%^1U'/%V0:G,U.Q[`&E$L=#,%G1Q2 MGAY=-&O3>O(UT]XHKI8'99@7UD`<5E;H'5]`BT5!N9\N,T=(E)Y.G MTT%*_F\JI;NTJ4LYC_LO..TTBZE@C;A:XK0D"+$?5\-;#V8QO/SR> M&-ZPXWWL\!!"\$+8T9^SAAT?9,>GK[QG?F9KWXS(JWSX/O)4C3$\4.4CK]^; MC".80)T9M@_I*^MVZ/IO/%^@3N%&NMPMPY[%-LJ'-&ZEAR0WY%EETB MJ46=-UVD.VDZ);RAS6?2IO!PZ$N;W_)U-/1X0P^T+5D6^+E4\55-#K_#_V%\ M)0J6[02G)>7E1SS@^#M+\XC6A^7:@8932P:3R()>\J_T MMSTREI`GAJ,+A\NV+55;E1Z"JSV2VT]\P!E[:84X(N/E/9E?\5@66W@DE*;+ M9(9I?.+=G<]$"OG(4DR)J8)4.4ROZ-C9ROZ2(5&#IQ?)$(P<#54-W;A]!%P@.@:OEWE;1Q/(Z3Y34+\ZCN/0IX M;\3)C$P8S[I,>FHQO2!-#[A(QW6IB/M*V30;71,LAD"H?4]D5/BN\B(.Z\EV M(U3S=":K[W9H=&'8.4C5S8V#K@J2E^+)&'TBPUQ77X=-YRK[!>$#?4]#*RI/ M>9&^B0=*>G*&]1EE$SS:K%EDAJ-+FD;0`1K"=&0:_21I)K>#KH1X'-TFC,<7 MA1D(5$O%KJ1KO(E2+\[T3YRN]9G06+ZR32O_G[VK;6Y;-]9_Q9/[Y?8#CPF` M(,#,:6=(O9R3UGF9V.F9N5\\M,38G$BD2U&1U5]_`+Y6*Q4)GFX`Z0S_EJEI1EI\R#7=Y";_=^(G,0V7ZDL/U9M[)Y+!`/ MM859\L-YB`Z^Y[+`YVX+#?1^$CX=0=TQ"J%^"]^%#J\ME?FJFPM++)`[U-IG MIG^EV;1(I@^N;7`CAM!U+L=0\?BO=S(+8OL8("W_>BOCMFHA2'$QZR%54&;`9&)&67V9SJ;+0XZM"Y&!])<+5P>$BYML+X5SFPA M4PA/"XVW;TT=2RUXW+.M/_%18?=-(H91,IO^U!DS+,4+4AG_D>3%=9[XKN]\ISM6)`%MX_K%Y@57 M-HC_T8+R?"TL.=^=U@;Q_';9(8](B+7',:EL-9KGQ3HLA\M,!N_KAS__Z%`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`QGW6.@/N;:WMZN3% M_,"W=8GE>=,\U].FHR:BW+=TO?QY$VVW7:QWZR(?K-3QVMY@DWV+I!MMND_ M%\]@NI0G&1Z^T-.?)LF'>+[G)>H<==LB=1'"[PM%>G6!JVM_3;TSHF*!"`F" M7E2O(ZIG3^[NCKXV%1N]OEY'7]VL.MGJ"GD>ZG7U2GYK+VMI4-/7: M>AUM=;PJ:R,P#R&?]@)['8%%Q3);K-+)MW"QR"=I7'9)6<03_^F5]3K*&GZ? M3[KHKC!#M(^U7B_6ZN1,2!"B\AP+%UM:5!2NXF*ZG]S>6NM=)CO6I-^33[,X M^Y!FB;#9]L_UIAJB.];Q/6N79`]89\\N%ROQ]_6F!7]7;()]2NZXQP-;=R5% MRT4JSV0.)_^11V;O.%NY4K[*+V[RY2+.IA-W^=)\3V=)`LQT#IC M+N;*VJ!?=%>&&>'L;A<6C^_C*DNFY\NK13I-XV+])1/V6N2S="I_KQ,ZHJX8 M]I@$MAYR]SG.KG?FR"=U[SA"Q+/4&YW+P/E'QFV0SV_S3&;Z M=DH7E_.E"&;%*\\P_2ZO.NV.:<1$X=FZN>@ETSQD?":3K8&2Z4>Y]"R_5R0W M$NU[(EY)\WD78JH'X$#_LD$5<[K8T''B8!($WW(94*Q+/*9K!MZ)_?YB\"["Q;BG!%90(ML;7/_:*'S M29+%XO9W*T_S12>F_*T1*'-M/?A5883PJQ@,H?AL.N_(O')O#>&\;)]7GEHC M2K[F1=)!V*?MC]Y&PK5/&H$A$1#6.)[+#_'K7 M&JO/R?=\]GUS$,K>=ZZ+)#EBP!Q?)'97BHLLT\6-1/WX5>YAW0\ISI)RTRUH M2Z2S*L&!K7-:*U1R?I,7Y<7])NB.B>17DT4K[,-<&LA$+O$MRSZEF[6.G26/ M=XO%4D2>^TXUG:=E,CU+MZ>+;-[GXFS=#<-X#W71^ZT`+#=3RRJAN[O!_Z"" M",7$LBBN]0H2]UUTLJGT806YR+-L>;SM"MJ4+J]'Z?5-.9K)PO(HF5DNMKT@NJD=U^?4LO>*UFM'MNZ\BKNU!_^0>+9= M:GKQ]+UG&FC(PN.KI6P55%#;:L'FQ588L')G%J[A(7FZ:T6_M_%D)OX[M[;>, M<5O8=,_XIPYX'"/;(B!]4\H@SM9YMM7N1*@58&+!T`:DR-H^=$)"V[ZGK'`%]^VTX)']SU;);/O"4C7,W#S<%\$;>)?E%$F MMR^+)]Q"8SUW\JBNR.VQ%6FT?OSKG^*&XF)RLSX30WBV']8]?NE==KLL%YMO MD.Z(!G/JM5\T'_*BO%D)?WN1W,6+W:,`M]W8+O)54O0*,J>@7U0SK3!3WQ.S M7>;JNXI9\/CMRWN]8NH)[O'W7:PL-TW?%LEFV_1MD>PT2]\6R3*+]&V1;#=1 MWQ;)4@O9M`IE_)[1SP=`RZS'XU$%+L/8LL+`(XXJ>)QJ?YP!+-=XEW:(45ABMU>4:^G MJ.,+U5JD*M?'I/=30(TU"A$C_CN>S9+UD^+"#GDJ%B#7Y;VF0`J<"?=4/`V4NJ,F2@CU>C6!;(//9]/SFWB:KSHI)%?,<[V07OT=KCN*PMSW M>M<$M,'YZN$<89/'E0)*:'N`.@I88*EHCMU(L&T]"+*1`-H\+*"(6EJOH#1/ M)!['Q7(QB;,_BG1FL(\?N$4X%6ZWA189S7-YW/BF7'?CZ[IB$`M;@+]LD%=J M`PYHG+YVVH;'W]=.O\KC[VNG+3=-7SMMLVWZVFD[S=+73EMFD;YVVG83];73 MEEK(IMIIB'M&N']GKB](A,T9Q^W?F16/WS4]-IX\_OZ=^54>?__.;+EI^G=F MFVW3OS/;:9;^G=DRB_3OS+:;J']GMM1"-KTSF[YGEUMWSRXWWMW8]8F[4QU$ M?2^PU%DJBQWDML#_2XI<_F^<+XM/>3Y+/N?Q]+X8<-M6[J&@R]BX)([K.\0U MV0?`W=LFZ!'J6?KNJK&Q;[E^TMK7F`FQ(YZZV2'']PKR*&>NI:.7;9?,4HX:F/%Z#@OLA_5 MX+/XO['!E+'+S.;S]^=IYGD86W:TS%$V.8N_)9_R5-SZO5W"PNBN?A999N MS;+XS]?R\1G/DWBQ+))_+,OBK?S@]].'GVPAY&_]]/OI(ORL^.P+I5GSZ!$+^L!J+2W'3EXL;,286CVC3S1+-CV/SQ M,`ML>^D^WJKK0P=^_]QSKIR*0 M4K[_\`BSV54D/SD" MX7P[)@]BW']V!,KG)$M6XN7H=K-IZ2#8_E>>QY3.8_;V:YZ765XF9VGV[>1. M>)=O;XM\MN\"Y3=_RXOK4^RZY%1^?"J_^.;^^^7Z5GQ?.(0DFR;31TY;_%D^ MN?_:39%\_?N;_TFGEY[K(<39)6(A&7"?.9P'W/%(*/Y&(^:,AA'Q7"YB(1Q= MHDOOX4*S^"J9B2%:'V%+57"2`^/-J6:JN#%5#$65-*9*H*AZC:EZ.J@..*6# MB#N#`6*.A\8C)^0^=R@E./`B3K$[NI2YW^>I5D2H3W7(!R@!ZE/ M>!1@1M#(86,^=#SN#YTH9,@)&49#YHY&P7@H'@[RE(2K@P`05FFX.@@`8:J# M,`4D[.L@[`,2YCH(&*:"&J0X-4T`-4QT:IH`: MYCIF.@XXTW$=,QT'G.FX#B_!`;T$U^$E.*"7X#J\!`?T$ER'E^"`7B)0OM-5 M!S%-&+L:".^"&">L?D6J#@)`N+D?QEK>FH^^5G,_O`L"0+BY']X%`2#7((!>@NB()0A@+$%TN#4"Z-:(#K=&`-T:T>'6"*!; M\W2X-0_0K>E8X\"`:QQ8QY(!!EPRP#J6###@D@'6L62``9<,,-4Q-5/`J9GJ M&'04<-#I6)3!@(LR6,>B#`9@HX*#3L<9!`-&7M@E7!S%.6-WHH#J( M<<+J=@?508P35C<]J`YBG##509@"$O9U$/8!"3,=A!D@8:Z#,`02@ZT*#F`5+*.E1$,N#(B=_ M"@3EYDK>0X&@W%S)>R@`E)LK>1?$.&$M:WP$`"7"B(\])`/.A8Z'!F/'HX0Y M(0H'CHN&@\CW1@$?#BZ5^P>K(IBEJNRA6A6A-E5A-<[8F#B4C"-A/HJ=P(M< MQX]H@"-O$`4NOB0O'"59`P2`L&)\U0"I3U@8;S3$D8-&8^YX#(FA,@Z8,QX. M,$%8_'"P.052>:!`#1``PHJIH0:(<<+*[O$U0``(:WC".L*;8Z^E;&1=`P2` ML,I+5`^QU^(Z-,P!-:P\-[`&"`!A#1K6T0?O^&MI MT+".K'LXXN$@LC"5J@!@GK.Q*40/$.&&F@S`#)*R<.&J`&">L[.58`Z0VX2@,A_Y0O(X- M1@/A0DE`G8"'GA,QYJ&A1R+QPJO.[51%,$U5,2-713!-53$75T4P354Q"U=% M,$M5.9U513!-M:E6,916E2<85D4P3;6I5G4D1HZZD#*2J8I@FFI3K>K(F1]Y MH:9:U7&(WI$7:JI5'2FFHRZDS"]513!-M:E6=:25CKQ04ZWJ2"@=>:&F6M61 M2CKJ0LH7KJH(]:F.(W>$"76\P8@X'HN&#A]YXKH4^90-":,#[X5XM2*"8:K* MQL>5(0R350=752$,DU7/KE4AS)+%+^2X:H`8)ZR>O*J#&">L]F#508P35C8R MK0%BG+`R950#Q#AA9(J@AFJ2IC\JH(AJF^$.76`#%.6#E_U0`Q3E@9 MEM<`,4Y8&9;7`#%.6+F26P/$.&%E6%X#Q#AA95A>`\0L864,5A7!+%5E#%85 MP2Q5UI@J@Z*JC,&J(IBEJHS!JB+4ISHFQ)6[*KR`,L<;DM`)F/@;'X;B^F%` M(NZJ"R2J(IBFJGJJ%1$,4U5F$"I#F"6K#KXJ(IBEJDP;5$4P2U4=(59$,$M5 M'1M61#!+59FLK8I@FFI3=Z4CO7'4A=2Q=D4$LU35479%!+-4U?%U183:5(9P[QB;B:-T).2)'OR#)S$KE^1`B7<[CBW-+*$,;)*@[WJPQAFBQ6M$VH M#&&+&G^9(F6)SNF_I`AX@R# MP!=7XI'#/=]W1N'01SYU>>B/Q.A0.8.*"*:IJEQ!10335!615E4$TU0557-5 M$4Q3553-544P357EKRHBF*:J:(M1%<$T595CK8A@FJKB?.JJ"+6ICER/$QX- M'!(BZGB^&X@+B>M&B&..*<5C>?J*RJ]613!+55G;5Q6A/E7,6#1F0R<8\=#Q M7!HX42#F<2X^'T?1R"4!>7'[:@T0`,*JQUL=!("P8O*J`6*K`5$4Q35<63%1%,4U5%DA413%-5I$&J(IBEBAL/*PPU MK-3^JB*"::I-AY6.TM\C+]1T6.GH=7#DA9H.*QV]#HZZ$&D\K`C4L%*_/U9$ M,$VUZ;#2DEPZ[D)-AY6.M@Q'7JCIL-+1EF'D$T2&`^IX8^3)O29C)T)#F7OU M1K[OHS'GT7 M/\]/;N+%22D>6G)"G742%R=%DB6K>':2WY9IGBU.XO(DN4L799I=G\R2>)&< M%'&9+$[^5_Q6OKR^.9$-\__VV^^G^S=6YW8Q!KG=/'OF9H^Y5XS^=A)GTY-R ME2N>V-4?Q6W(&Y,"N'_R[O2YF:1:_U7J-2;K4IX!,U:23X`DE).3>Y,U4S= M^W$*2]@F)8,"PA[/K\\YW:#%2[?F!KWAG/B3;8'@.ZML06U:Z#4\MJO>TVZ%XU_+D'^4E7 MJ_,*3H2+KXN9M2^:IYD%'^(WEQ7\"1>2YB,=;[AZ;V+R_[T^GNIF_Y`_%*,( MU[NN<'\L*I!+JVX=A/Q4;$!2X$GW(#$08U=NI6R4Q,"2NKNVW)1@1H4\"9QQ M%)C^=1UG410-&(;U/6@+X63H"M7KS/KVVVQFO3R6ZT>K?JE`TZC`IH!#P4%V M1;-_192YM>M/?,@;T*PEPRD<72'[X)=;_YMOM\6K]?=>?M\I^:6]_%KKUOI= M_K3[DW5[.Y.^ZL]_VU_Q[M4JMV@5GYL.CA5'I=;,8BO MJJMU7>WAUK;2E4&:Y]<91431=2TS0;8H?P$[V#7@9.4.32]_?2K0*_,&Y)># MVR%E`Z]4^\?M*W);V8Z"+;ZN^F\5:2!U]Y!0\U]B<1-:3R5H#6#!/TXY^*YN MFOI%>DQ7;<`,4/-(Q:TZLK&^./[\<'93/-?;9SQQW8#G[:W\`7)(O-(8\A'S M*X?S7TF^=6.]`/!KD[&87]YKP/2,S-#M\(\OP8TX MZ!A(H/AGASR!7+C!;."^!,&M030SA*THXHM_XQ[.P?SPKB@JZQZM"`BC5?2Z MEF1D"6=FX5X9,_GE/Z\?X?8@LP+YYE;H2V:Q3ZFEO_Z!O^`L2!60H?:/D(T` M\RBB1GJ6^25:[0\Y'&_]/6]>?]\B==\7;0OW]CXXC*(SY[JF>H'.O!OO5^O, MO7%^K<[&D=:54]:N0;.1W/58-AOKGUW>8%`#0+BIS$SY^[8$62+SPX=#["JD MCC<#-53MONG6^QD:WZGMR8NNZJ8Z24:^W^:_Y"KS MD&+'>(O%P+;`J_Y#6 M7?$`.D/-K==U!TI#3I&Z1K*H)6UTF+6T];;<#*4:?+SKFK;+E991@[TD-% MB%98&Q6FE1UB7)8PX1=G-N38[:E?RY-`U+VX.NSA6L^0?M?P:[YYQL91JPHV M,$G0J;1YV6O[6;:H@+\A"L9#%)0Q\1@^\>(03X/CQW#=G:*![>LH@KYRFR7! M&J;"'NP0DV:*^2I5QDBSOH>S]X]O4B*0>+&%[*8:^%I*3V;7+R!^<(/B&<4, M$CST`>M/8NE=LN3+AP8OU60K8M@H:[6>\#*%E M`V6F3..WX+>;8Z+W&2SY6=F``;U)`E7__K,SW8-`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`*8M#B%#)M@'1NP/J2M`JOJ69XDHVK$\ M:RB`X5-L*_3P,6F1)^0/#PWX];Z8]4><(5#WIR0(GOLE.BGM'O*#",OV7?EQ MYDYRQ8&B>;B3'N3@3W*U2R$;I6\3%7<<$[TN,V9UBRLW\EVYS[H+I&W\4'>82516!G>VQN_*Y/3@L-;@ M\P/&:=M<>7Q\$"J6T3D.^+RO(-3'`N@'%QD,,6;,,9UWY8DRIDMENV_?C=75 MJJ;VLS:LJK>.G5YPX3I/!^1=W]H&KY+VS]J;)[9R_&48XXQ MCIE\M6GZ9TW6EY,*!3WK;3P`^34POL&Q^QX@[_.9]=<"I%7FH^CERK/< ML_A\V?3VZ+"J_=<60X55%O]_S]R<>N4/X`.%XMM]^01\BS_O+H7.J?16"3(93$8FAJV2'%*(5%-'2OXM^;8FD-#2&I13FNAO"VK;&7+UM5AT4<5@X%3E/E&/!.5U'O``8$,IR)6-V^ MA,Q>!C4(36V_H@\78\M`A:ST;M7>?;Z&DT";$LD:+'TA$,HZ4MT4^HETU^+=C9RM>C^6P5VEKHSI MC[3%?DQWF4%"VMW6U=$@?YW1S8Y6-\.Z'M?]]NU4;!7,SDP1#L6KJ77^S7$5 M'U:<,BST,XC#C/W?L=T+K3)IAD?$[IOZZ>SA+B=,1!8%H1U%,;[*-('?_#2T MEXL4LN4HL>UT/6>UM),HB&S?%V[LI9'O MSL_W#_T`5#0Y32VBS$E6H!HO=7&;N01`P9]^F$1N&#FKU>K=4Z`?X!)<<4W. M""_&)9CJ2X^+KKZT9$A87WI<)/7EGN\+R49?%^":G+Z6L1L*9VF'JVAA>U&P ML-,D=.PD=)U%.%\NX]4"]][RM+A.9CKD<.GXD#(NGRFN@"FNB"FNF"4NGZE_ M^4S]RV?J7SY3_XH,^0;5/"HRY!MT<>GYD"XN/1_2Q:7G0[JX]'Q(%5>L[;.= MK&6BA_Z.)RF?*\ M`1=A??'D>9"*1\:<$TGQ=,XY=@&K\$T_CE M,8U?!ER$]<63Y_7K`2CCXLF'^O4`=''Y3/-#GREOZ-=O4,;%DP_UZS,:O@&G\"IC&KX!I_`J8QJ^`:?P*F<8O`R["^N+)\R%3/@R9 M\F'(E`_UZY8IX^+I7_KUO91Q\?0OKNM[#;@(ZXMGO1PSY?F8:;T<,XU?,=/X M%?.,7X+I9/J\GF#ZO)Y@^KR=\IGS(=%V*Q[+^<4,%TF11H8PRU\)3"N M+J;%159?/E?J\+E2A\^5.IAFOR9<9/7%-*MWF&;U3F2B>L+`]%1/&!C#C9U&%8KT(9&$_JT..BJZ^8*W7$7*DCYDH=7)=. MZ7&1U1?N,<62.A`82^I`8"RI`X"QI`X#+KKZXKJ:5'!=32JXKB853%>3&G#1 MU1?3=3B"Z2(!CUIH]IW(%VGBV?$\]6Q/+%([S8*E'2^$2%T1^H'G_V3:=H\D M*,.[PIVI/7UY(2CMQG3.U#05P;V+*$ULS\E6MN>+T$Z<)+/GSB)+`V\91XOL M)_TN@B*:FJ8N`J5_U>_T0('516&X$K8O5BF8G^_:L9?.[2#U8S?ULC2>NS\) MW`I,QQ6NX(IK:IYU.2X=#5+6EQ[7Y/0%-+%1[84.$/TJ#NW5(G.% MX\(_LQ3*2`"G?:39FYR^+L:E39S(XA),]64H3,CB\O0\[_/$15E?6IXGK"]= M?D@9EXXWZ.**#+Q!-=^(#/Y%%Y?>O^CBTOO7U'`ERRC)TKEO+\-@#L7R,K*C M50JXHB!S%FFV"AUE?.4T7ER$ND\6E M?V7G]'"E2;((%BMA9\L,XI>(?3N.$L].P]!S%IY(O65L(D"@H[5YM5$%I MV]=406E[&C1!&1J&5$$Q]"F7HT\9^KHT01F:NE1!,?0IP=&G#+UWFJ`,#6JJ MH!CZE&'I`E50#'U*WZR8(*A5.E^ZPK>];"EL+TP7=K3T`*/O!'ZX$*&?>:9Z M:G(K%BX#I7_5MYC+2SQF) M9AIF7#2CLAD753N$FHNE'9IPT:R0S;C(VJ%AG$JS2C;C(JLOPZB.+&\8<-&L ME2_`1=6_#+AH^I=AO$43E,\15&!H&))T*P,HFIK2/W!!%%3,L5]M`$4S5!E` M3<[\LM3+G.4JMKUD[MA>G,SM-%FXMA,L19!F4$")E6ED/#GSNPB48;)%%)2Q M`T\6EZ'"(HO+,%D@B\LP62"+2_^D#UU0B1V',)OT2(!K$DLTFAN>B0PF%J1-0(H M;W*;4UT(2KNA(E%0ACD63?LSE"(T01DZ[#1!&8HKFJ`,E15-4(:%32Q!A213 M"L/8@"8H0U5/T_P,)3U-4(9Z?G*@%F&<9EX4VB(0@,Q;.G;B.X&-VTZ)=!ZD M0D28T?HZ5)/;CV045)/;3>M25+&6`(FBA0R@`&/J1&[D^KZ[!$"65R&%R&0Q65X M$0)57(:%9W1Q,S4*1^F,U7KN>8 MVKF3FW]?"$K;SJ4*2MO.I0I*V\ZE"DK;SJ4)RC40!4GV,RR3I@I*3Q1$0>F) M@B@H/5&0!"4X$H7AT0.JH!@2A>%],%1!$2.*0#ABD?FVMW(\W(UD9:?.`F=U MWC((`F<51>D%(Y+X:V1*?_[F'-:WJ0B8SS\=G;T[/1I0[O@NXXM/1_?3X^'T8C0Z^L??__RG'__M M^'@PF0PN?'>E20D`YFY-GG_FHSN"">$WDDA-$&-XS__D`"^E\# M_*\[@)]^/9_<#-Z_.QL,EF&X_GAR\O3T](ZZ"R*.?>XQ3M\Y_NID<'R1=#LE_'TQ]'D#KU9KPS6#H M>8,)]@H&$QI0\4C==\F@7H+O`$C*@T]'.12?'X3WSA>+$YCFPTG:\.C/?QK$ MC3\^!VRGP].'M/G9R:^W-U-G25?DF/$@)-S9Z8B#%74]^^&''T[DU[AUP#X& M>?CJ)E*`E_]C[N_I=+WXE6E`.F[A4/6;@9\;DO5A+H MHP$.>S\9[4`?+04+)>N$"2.>8+.3O2.=M`1S`AU_FX;`:CC%>'[-.*P-(]Z= M'S"D&"Y;7G/P4C[C)!G3#CJL;H M[1NS+?R7+'`\/X@$G4:K%1$;H"9;<-CB#N'AT''@R`]!,;GS/>8P&@Q=5XH" MXC4_(;1,J0_Q"8V5IV#)UE]9N+S_:0KL(W^E+G!+N)D)P@/BR$9:":!C:GV$ MN'IF`1+^AH*",:-B%4A@.'TBWG@M0;CVQ15QEN,Y0/J3'ZQ92+QKXC`/`*,U M!;#.B7M$A%WY8HHB>J5$XO`-%%^W,<+M9NT+^EJX7R<(^@AS MS_T'M#[)@T=_C@@:-P`CJA7K*$0FE?/+S7D/MC?`FD!Y)WS0D!'""Y#K"U^P M?U%WQ&_H(_5F,&U-S>`@$.DC6[J`[BWC,%&X&3]QT-/@Q!OQD`I0M(/4/`:( M[P1]9'X4)!#&C9O21\?4&D\6=&'("'J.5[U0Z".//._UGJ3[AM1H/3A+ZD8>'<]AK[%5 MM+J.D&3G,#>H+6%P+?S5%Y\[Z$KS4%[%8#6V'!I.IP_A2_H0:ETG]8`=V'@3 M&A\$DLT94FF"8%>6&EOH$$B54^P0*$I"X<+.!G0)&UM[[6^F.\-%?IK0-=FT6;$Z M4QA!3(^^V70^C>*$/3*7UMMB%-0+=#7<&'#D+059Z94VSV?2A.X*I.*JJ M=Q[1;#E6&5H?(HDQ?DYA<#IT_QDE?F,__I!8+9\!G*OY'`3;S+]D7H3@(=T? MB0>-X[NMIOAJA$`[67("$#GMF0J'!7@<)]];XEPZO#Z$OE(D$5BNV+,M";DN1P`.H^?='VW%XUY7;I M>)[X\N=ST,]!)'?A?&X[N4;57V6.)!YQ@-,7]]RE(H;LEH9+O[&[J>%LIM'5 MHITJ3>$X`(G04H\-=.K>@HT`*S.&#>O0 M\XAY*+H:GS!MINP%XMWNE+KSZR,)@/#`.*CG+Z_O8<^^`+PI)G,O[FYR*#51JC.X;*'A'K='0U8IN:TQA#4,OBM9I39\06""-'VN725,]@R2ZV]2]URUG[@KX6 M1M`)@I803'E:S?RM*V>K=09[8PMG]#D\]WSG]WJ$:#U;+W!.?S@L[MM9.Z:! M*HHR8V+MBU]GROY@/T,-3QL3U)^X8TJ<1P%864$0FUM2_G3(`A5GZP7.>A>^ MUIP=XY^W1K)DCNZ9O_:\'=,ACGH9SV]@72CMD.W+)S*-J=Z%KCI=UUC[?($Q M,ABBH']-"PX*QWC]>:LW/+L]PQV*D-WFSZA"I.5DSC!FBP0QUH2[F+$1;Q MKPA)^YH(\;PG+R;N$)IV10TD8``:$&T'')FQY8M=WDF@D74LYB1XD,4LHN!X M0SX]"RI:?&7Y.??8!5%M'LCFJ1WYWY*)_;(`_6`:VOU M/3! ME\V,P!KO.MADVUAZ%;@%+4U`?$GG5,BD-:-L*\.4G(S"5ZJNFM=)=1?FU^[`<[.)N M9G#A-$T>5<*=:V("QC2N/I6&"CA?-3,!ZYU(SM-2%:VHI0F(BTJZI2G\RNB@ M0HR:C-0WC-6*4EFOOF"BDIK%;>M!_:J_[#RE-@VO8MC/*"6Y)62PXN`H6IWZ_PF+4X"3%#%T8Y9 M2%=I_[GP5Z]\4.ED?IE('/@"5D<6G?[^]/1H\"1S@>7?\-=:,*EE?#IZ?S2( M`@#27\>NN+YB6=N'W@]7X MU?*);9$^.WT+2.]UQ6:XGMF#:X%C(X_PKB6>8?C^S6"XHZIF"'YX,PA6/NY*\D*U]PBM:H)UKK,QBW!WEO$ M)A5=:L5F2>D=4J;/673<-R!)(U=L1IP=3>'8/NI4MM%WR)CA;Y$B41G]^(8N MP]$BG:&:V"R\,,D.#8L,U&KXO@[@R9"UR%JMAJPRJBT[Y"PR5JOA7.6"(4/? MH@.M(G\7!7UE^-IT1E7D\;HQJADQ+#JP]%Z*[->;\R2R^KS31:+7`1`9@9I8 MTM9$TN\6P3`)>^GS=Z8BK\%2(DP@(!=+(A;J(/_BQAHN$M,'!8@'')TK;5`0 MP%72VL1M;T%*_C2DZ]S;2NE>CO?>B"^E!DBM80U'OEM0A\I5X:(UA_'"+:QU1.$F?#? M`JY";%\7(S@\\>V+;YM;PLE"DEB>:2H<]G4Q$GI,!;[J(1\V4&:4O&AD)@)3 M\JHZ3C7YK#'&C:T>(A'$UPGIS63^2=976FK%CAV#6$6?KM=?!\!9P;+"[5'4 MQ`2;O7C"XTNT>J!"/NM"7?D8]L[S'=LW811?WY;&>]8">V]JI>589![T2X\ M?JP,?*RRNBK_GI71CX6VY@XO%YEY5D8)EJ):T>]A9:1@*?):':Y61A26DJB^ M#]#*V,(*^^2%)TT13-CS>^0]#JS=P('4+K8R`:\\7]:47H_`H MJ^[_LS3$L8`&93>"BGA%"S%5^-TL#4@L7LJ:[BDK`Q6;X)[W'EJ9+]K0291G M_)K>%RN#.KLB4Q5'9+O`4$.!,A*CG2BH=,L4!,:9B)HI`".-S=.8YZ][%H,7 M>Z\0N>?BM2E"!7N489_!4(`=QQ>7D4`VZE,ZB*..4R@B,(WYL4>$"]>A\[`V;,=Q\I M1M.L".^.)S0=&@S_]FBS&&%E5PW+7-?O_UD4:)V-QS&Q*!DL4V"L\3R]^BF+ M_BWO9RB>>4=4X]65+(R1ZH-9I2)UG3W;;@6M`FE2VJ43L%J6)VPYH$:4#G9F=SRAH00%1`+T+$PE M=L\W]P'*P>M4`1LZ8!OO$RDU!N@1?O$YU@*_H@%ZA-]6MC7%KVB`MYA`4RA8 MY&4;\:8T#+W$+[%-M<^V^P3]0$5BHE9W+>!NXEG`9(]6.X?Y.`WM24,WBXVP MNB,8\0+',`;7ODCJJ^;*JZH[Z&ZB/-AW[Z)H;#9"I,%M;S[\HXY+Q,KL MIXX(5.@3R\J@6112VA&!"IVB6P)]L"CAM[[7]T4,6ID.E;&-18FQ^JBBUL4R M=K$HE;8=891':4:+,XO2DO01HVSO?+`I6ZOEYE&ZVC)J?/@#4J.HPN^'[]X^ M(6I?PF34:12D:Q=U:OAF,KI8E.A:_]*V:/<4.U,5*?]V,DI5BM1PS=J:[Z^! M810WBXK,_[?),1I"EZU\CT@CN9J$15N9N=F-4"JY3['R+8]VE"KW$EOYV($WD;1*H>?B(XD61MTVFVG>5[9X5 ML8M(!PC1MO(IQ^;D[#I++2.G3=6_ZL=`O[CL*:R':%.9J'84J):W9V55J7:$ MJ9#];64IJI94*2N::E-EJG:D4,5:6%FOJATI*N29*HHNOLW3I7FRL:*$^)LE M4WG"I**Z^-ND2-*[?0:PE<7)=;)1O017*XN<=\1CBFQZ15GT/]@^5&>?MZRS M>\B22ZC(>CZ6^IXB"<5F/)^R!6=SYJ#/PI%:KBS%Y3$'14W._S/W14STPU>* MRL"6]P+HT5VR]5<6+N]_FL*6SMT6;'+O&/0/_*MG%FSK%V,04""AY_2)>&/) M%NC9OB+.1 M<)9`_#O!Y&TUFF1!ZKP&1/)*0NSF-E$]K>`A`G1.@9@!_7?D`@N`O,'3I0+\ M<1-%&'L'$_7DI=S&:)1E0'8SE^U4NX@$2J:XI3SH#T"^@DEU/!JM$<)$:=Y3 M8*C["6UG+="I"5\P:'R(+9F?S7;*W1#N'H!D4SYWXR,I]2Y,9]F1)'A8&BZC\V??=)^9YA^'+TMF,>FNZLQE*GDAK>3Q9 M>1%H'[&+`M=L>L/+/HKOZ*U6WBG81_,B,]3*^XF.%+1#B7*+(ETLHW2A'+>H18% M'%I*=L59:E'BIJ6$WW^FOGU=W33]4]M744+A&\T/I\_85.3D$)0_P'VWG64@ M+&7["E=,BC(3_0ZV;!?#U9NPN7ON/V!4-:[FSQ&!E0U)*%\374D"E@AY@]_01^K-EH)2DUBE"^+>,BZ99_S$J<``TS0>&E@P M7KTX>OR1^5&0)OO*QD:C,G$#*#,^9TL2XA\>A<^73*::AA$^C3Y/,;`:^-[L M#1D4V[_HT:FSI&Z$F5G`W6P5K:XCI"`FK\D$"$QA1ZF+Y8\\W-NVMO(>^_58$L,G78(IH/T&$^L=/=(_X<2H0I6:C!0 MO_'U(Z$'W^U`O<97GNE:$,Z-U&^,GWP]^*;C]!C;V1*T(C(/E5'2]<QKE3[AV\89FK#YTE?7/%$TSCB8?;K@3C#ML3;PA2@:4H"A)*^!3:[B>XS[B M7X!?9T_4>Z2W/@^7*I.GW9B]IX*^Y<^-90?6H&)IPQK'L@+K^)I"$]KQ8';@ M_>1KPQJ&,JHX%AU#>>VPI1BTTKC72I,MPUAIQ.LG12PSK#36M1,C/C:L-,KU MTT(J#E8:WQII\4*-MM'0KF%W]>:F>ON<5E*B/-RDKTC="7\AR*IWGH,1P,8Q MT`0KJ_?OCCVI?75.`1HZ=/\9Q14_9W[\(0GT^0SP7\WGU($/E\R+$)]7#YJ9 MQR+GV4#^>*;"80$&!B3?38+X58H$Z@X?J2`+.J$KPKA\,Y"'@CAA1+P;-J<` M]XN6"1IQS-6U+\IP->]CP@"IY#VX'3Y/*^QN'ZKJWW90AO,DY04!,5_?O/%"_RJ;>96=/62PZ\/H M8`8-Q=N:@)1NYZMGK$3_RD6E:503OJHF<+]XUJ/0<=5^7$-+O;V]3%:EJ!R? MGG%M6>X)?:1<&1/:9D2C1K8VSL];YJWH:Z5O4R\9]6U:A7>TYSE%O:#FWB-> MX6C]1M<&6H3"4=OO/"N-*FSOU/)SXJ&/;KJDF`;]\HTWO1JYN0-];[WO%@,: MTMCBV94/0Q84>>QN(EMTNKB/1A9(!K0%__):OFU'M9`2V[N*;DB2#6](4*11 MA%_\$-_)V,0O8&D1#85#F[)@L7Q'L8S7,*))I/87R=(I/HL"?SJAJ-93T?$M\\),YL7;U-![<^$YI0M<.UA$O-OGB]X%./\<$1%2 MX6TF-(B\T$BQO&+[=$*)A];I9\(X1@:,>?RT-2QHG6N3/<.8T)RR2(^K^8DGX0GG5 M=IBY35"U2J2D(NK1Q$E0&MYV("ZQ4M5L&!NX3YRTTS/[(;C[<^0E&8.CT0AI M?A5@_!*&MSE.S)2R-ODV\,W$@8-+[-WX`NH]5:^(\RX$R%O]8I;*'1GA>\&P]G%O?/`L3@ M,$PA^X5XRN#SDDY&SX-J".4/B.;+;^6!>1@"J66(E5Z<^D2K?JBT\^18<:KW M1AO!YSNX(].+\;)XG@&?:=!ERHF-D!M>`.FZF?G;F^5M$'LP90O.Y@`5#S.+ MY,[WF(,9IC#A.1Q^O]L'`VP9T2^ M8=$.HYN:M!W#]*%]OY=G!)7+(7U$J@.Z4]9Y!28'M(W]Q=2C]I6@1@ M_^@X#0&LI>^!PIKL-VS;X? MJU07QWV"^N4%7<_!W7I]BV(V+8:X?^Q%J``!E"0@`%``<`'5H="TR,#$S,3(S,5]D968N>&UL M550)``-BJ!E38J@94W5X"P`!!"4.```$.0$``.V]:Y/C.)(@^'W-]C_DY9J= MW9E=5E9E=?5,MW7OFN*5I9F(4'2$,G-ZOI0A2$AB)T6H0%(1JE]_`"F*E`B` M``D*`(-K.]W9(3S_FX!5% M:+U[=P47010D9+%WMT'T_1G$\/][1__3?T?^]%\7C[?O/OWPT[MWJR39_/7C MQY>7EQ^@OP3X`XK"(((_>&C]\=V'#\5V7W/`_OKNSS]\(K!5?GE$:>23OU?^ M=(DAR';V"4A_???IQY_^].''GS_\^,O\TX]__?'?__KC3_]='8TV.QPL5\F[ M_\?[?\G@'W_Y0&;\_.[QA\4!23T>L-B';O)F'X[I'.BM\]PACB M+?1_V"\:[O%]1R@:Q7]_7T'Q]1F'/R"\_$BV^?EC,?#]__P?[_+!?WV-@Z,) M+S\7PW_Z^%]WMT_>"J[!AR"*$Q!Y1Q/I8JRI/_WE+W_YF/U:'4W@\)/#\"I8 MOWS,?\Q'Q\%?XVS/6^1E-)5`YQUW!/U?'XIA'^B?/OSTZTK(P:1;S!8W042^9`#"!Q1GU^5+Y(4@CH-%`/T/CQ"$US$=/=O0"T9^ MC]60Z;:5>6P?`(:*WZ_[?LD*)H$'0NWX3PE'7<-RWVFTA7%"?YOC-$[:?]O& MA75C\K0BA%JAT">,^?KWE-R22>3/".$PY9#D)QC%P1;F<+5&2VT7HSAV.ZCJ M6_5V1B]!O+H)T4L\C?P`0R\I3U5K]$1K=H7_*HB]$,4IAD_I>@WPCE`S6$;D MBGL@2B:>1P2$A$@Q#R@,O`#&$]_/6`$(V[\06K;4A_@C#'/NM0HVWX)D]>77 M)W)\LK]"GYR69#?'((J!EPW22@`=6^LCQ/5K$%/"WT(B8,PA7L<9,!%\`>%L MDX%P@_`U\%:S!8'T5Q1O@@2$-\`+0@(85&3`.C>VB`C'_,441?1RN1*PB4?X M:RX-4)#(#QM4_$^=-T-Y'XTHAN%>7)\M'E+LK<@G>,"!!^=H$L-Y3G/Q&!%^_-<+==K4%?2VG7R<(^@CS)4+/5%<%SR'\1PJHM+A(,_H#^-;N$6AG.RK:)DECXZM M-;XLU.!Q&ZP#\K87IW:76T3(AYBO0$+_1PC)SUF\ ML45$T/.\ZH5"'WFR]U[O2RI:4J/VX*V@GX9PMB!W+5BGZYN4DNR"[$W$EB2^ MP6A]CR*/&MY"RJ]RL%IK#BVWTX?P%7Q.M'XG_H(]Z'B/,'\(LF,>4"H]TKV( MAGE);;:9OD$5DDST)!HH&1HDDR5Y&:A*VEG?Z[A]#P29D0>3VBR)S'V'<+($ MRPZ'4[BH1DEM22BR)`\X(5I,E&5JL/>+F^'3\_0(-V#7Y8NI;&$$,3WR9MO] M-+*38!OX,/*IU):;L*9$=J,W@SPY2PS6>GE-N]WTH3LE6T545'T(@6;-469I M?8CLE?$+2!:'$_]?Z=YNC/(?]EK+9P+.]6)!&-L<705A2L&C=-^"D`S./6%M M\=4(@7:R5!@@/6FO$'M!3)_C_>\=<6Y<7A]"WR`E$=$XMQ`3-OX(UX`('M&2 M<(P$`R])07@;+"`!XV3D'JIQY<395;.EOL;?F+ M!9'/"4ONP_C<=7.-HC]/'=E;Q`F<"'^)?(ASR.Y@LD*MS4TM=S.-KI;G7L?6 M9R#$MQ7$D&^Y.!@WR/6LRBW:J=(6CC.0B&KJN8(._3NB(Y`O,R,7UH,7:1!2 MUM7ZA>FRI16(]WM35/?71Q("PG,0$?'\U'U/[NP)N'WQ3IT@6$D8+6>G-WCT MD^P"A%3W>5I!F,2SQ9F/4U"[B2A(Y*$-""=KNG%\E<)95%@P[E%"W8L[ M*@M>[+Z03UKR_-O;RQ):;83J'2YW2*C7W'$6(#6J"W!)^<@CW!`0J5ZB51V0 M6EP?,O](`2825+A[A'$:ME?_:^OT!Z*6PR=>5+]#8CJ=EN%2U"7J>>DZS0)L MKN`&0Z+W=3HVBML80U#+Q^NTI\Z(+<*,O$POSU3U$I;2L:W_4W?S0JW,O[3XQ&0W,T*G/5^>*4] M>\:_JHV4R1S]'W[E?7NF0Q[U,EOC'VL M$`OM"$ON9@7.>N^XTIZ]:Y[-AL%>=?!VV^^I`K`G2QA.H8:B!`2MT/!+1C`0 MAN_?[1>N(GB8%43)1S]8?]R/^4@G]`@/V8HF1*/H@P\7(`T3->CJT\\#*Z(1 M;:U!S6?W"6FVPX/U#S9I; M`MD1S.22PC\LT?:C#X./ ME+/1?V0L[L.//^WKJ?PO\J??)F1KGVY_$X)EL5P(GF'X]_?UWS_V#L]EBJG= M_(9P+Q#^$P)\'?E766&!&FCED1R4 MY?#]K\._(/)WO<^>";DV4%8&4_]P]-QM"H8R2/ M^JZ!<_S[F>#974(:+D[$1Q^^_B?<\>"JC3L;?&B]1E%FULBJOE3CU/G`BB:= M#?*<)1_4,2JR,MF-=2[8'M+G M,/!N0@02+F35,>>"ZQ$N@YC&_ADFB\&1"3UX!%R=,1_<,TQX#R MUJ?=^AF%#(B.?S_`4ZH0$WP,&=$_BF7VJHB<%KV?L\!H+2$B%5LBU@O\#F$? MXK^__^G''W_XD?P_,CK3KOY*30G0__O[!*>P_".*$J+V7(>958*H;;DQ[OV[ M#9%Y:"+%W]]_>O\NC0D>:)/'&?9%AQ/%M`M%CB6H@B`__/@3)8?3F)WH>B5J MGYQ'C2.6ERC^/!@4:[I2?!H;DD6)=HOF+\VB>O!TE:G]V'C6V8%9B^&\# MP;"F1)8H_KOS*/*M<"66?W$>RP8I^(#J3S\.!%6>>EYBZKZ0PU&]2A3=%W:8 M]H(20?=%'1DS6(FO^U(/P\A2HF=(VF&ZT4Z19-IW"ZQJ2GOY=IABJ#5'ZRE" M'$/#\8:_JU-)PL0/V>$3^,/2P`VN?T$ADE<_.74 MD++_\V\3S\/I<4+POKIYY4\G1A:UN>T-0IVP*D(S>)7:;U$;@E8^? MTBI&,#UDDCZ`P)]&ER"KUH/F/YN":/,=992,A?(=!)N"D MA?MI513R7V6MK7B27`*,=^2E_@K"]-0RKS;7"%:E["%$X'28$5AS[D"8P:'D M'0]VI M.:713\N`$"3_I(0JUZ]>F%))_S-"_DL0\IX2J:F&<,IJ1^VK2^Q5;W)T: M_'_P46J<:0:C(JB\*(!$8"K^.24R"=KFX:E\X@,W!*"GR6B'AU,!HXEV""'?!/H[UQ MY(&&`*!HDB0X>$X3>B3FB%H8:"U]%(94)Q<+C9H6U\#.YS`"E%5G7=;CZ]C# MZ"4FD@?U>,5YU[,-"#+;6^TBJTX_OS=9[!&@KDG)M_;@K_S9OC`/>225#34E MVO:%?LBCS=2.2M3L"_J01ZVP_)?8F`KI,!L?8.+K"$Q(U4]T;.LX(/;)><2. M9-$2+WL9I"1>4NZ'$E][.:,DOI(!)"7&]C+,)HR5!9X2:?M"Y93Y$/-CVI<1 M(&'4K.(E&45A<\J.(L8B#[K-:3NR:/*L3#9GZRA^0CFWO8D M'B5C+%O9:O3YE]QX0/BW\I>4E+`OV:D72APS[4_VY3^UQCJ/E2A1LR_I2>L' M/5+"#>EVM93V9J/\D4)W8@H?8$:[&D&X-B,+4S'5,&/J##:G8:J>9+[SP>8T M3#4LZQ$J-N===OV"[=PO-N=GMK^R[/@OXXF:C8EO8J>KQ=EO,A^QR=]9_9C, M\">;\U#;H5G/!;$Y][0=CMS\+>-YJ-I1E8FF*;&V5Y=5/,2L)*$239M%0:5S MK)IQ69+`9G%1A03B1U5.7'0D4_FXQY[9-$$"RPQGV/C9*_$`<5:U@!,\(S/3 M<.)C7G1ADB8KL M^,67"*RIHD/.`A$6UT&ZYN#1.&TH29(]0//;)R-?^H:^!?"6O*O^J2.H\@I/ M\@\IRB1HL="8HL;2P!2?(,G)YO&2?(@:)MF"A_`Y$DRP!?[F1ZEIUAC1WW-$ M?V]1D44KG:J6XF!8I,XP3_+ZFL=H])GI-5.WD6U5MQ.V0>X58T7!SG,:)F7*H5-2UC!S,.ASR._?J5=D_G'K#: M,#..A3+$FF;]-MN513-,8%`$'!2B"KDO@<>!G3W6!JBO@C!-N/9+WFBK'"9F MZ)AQ@CM()#B_?&+HLT/E.1DSM12+0(L;(CZP0>97 MB929:[*BYYX-6Q(MB[>NJ1(==[Q1 MZ!LIS1II%.);(@X1S2^#YB"X19&W/IZZNL8JW!(I:E2F#H` MSD-,-,4(#B\1-03GB5]W(`++C,29C,C#033%B%N3:+M445EF^@K/BWD\R$SA MM^RL\HO\[7\V"5MC*;^38:/SUX9R;L(R6L'Z.<5QGM=;9#G?`(]3"UE^8L\@ MRM@HU.;K`!B#*";GGBB=3!;)&F+BR'V#P7)%?9I;\K@LX7U*39Y[[:UFLISX M_TIS29QS-MNN9@WFLP4/6A6,!:M8A&D-.)%A0FT-%P(X+`C?D*E0T:28'#OP M!;8R%XI<*6$KEDA=J'&EAJY0B7"AP)4A"@)C,MSVU%+@0!M;TX11U*!?BP;J@7-5L M78@*DSFVI>'(>/#7&)JL-Y2H_OF'$_`F$"B&$^[&=-(,)]1-TO=K/.9-&\): MPXR,5[_11A;U>`C/(S4>65'9[E1":8-@H=` M+C>JP,B@J&C@=J/V2VO$9;PWJH5A'".!R(UCO(G%FXZZSS[(<4VCB%NRR4@( M?G,EJ;NC0WL:E2\]WX0KD%/O38R1<(X&7WG)F&@S)_9NF5D*A$\P2<+]42H* MFI6-$QXI*V"YVG7O8.;3->.0W:YG$--2]6LJ@V9JR2/,51+X!/$V\&C.7(#\ M1^BA97[311UL>]_6:EI>U)&*$QQXR3[M\@O!)&Y$M"MI-4%AN+:5D,G4QQF" M]I19%R4#-390U+W+`"C5$$W8UVX:'B]&@4WV01>.-9)9518$91*]_'W,XLE% M57H,443X-1-0\5@GH>Y48FY@>2Q,3G(%/4P]_-3F3?Z-HAB%@2_*3E1?QQYL MA2^X<(K!K(O:R_$EPG5K-!&6MAEGCB>82%'1\BK%]%')A*BL8C`3:;U[&,F) MR&KI"K_LT1`SY>C0(D@$:4V5`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`I2\&8<#I&OJSJ%)?BQZC@PS!T(!EIFD!+^O9`_QN:[O)'_AW"_JR[8-YZ%3+ MK'W&C.RIUNN8."(E+$_DF,\6A3NPJ;%<\SP;L,E,A^K(U*89:OMW)%S12H<> M3JD*D]OG"2^"A#D]9UH/!S/%1:S"L^"L5$';6X'+XN#E;ZJ8RRYK!RT.H.V] MEPU2D,("EN!W1/\]C"KGF;N`AN>@OMMCQL:+*\/@_(U3>@&KJ,@=0TR8UG7L M8?02DV<;$=F,GO('#(F2[3^R>&#W!36B=#9IK^<-S5RNG*73:`?1#3H>-7J, M]I$#,&%9"QFZ(X>P"@O8C5_#$]-B(8OP+>T"+;\G:P&[\6OW/44+680OPYJO MAB=K`;OQ:_<];7-[]-W!FBEF[(V#)0G8CS]#7I"=V0N0A:Q1JJ332,54W'7% M7I'*!/C,$Z0&>G5>_P`*%$ZUR;V".E\%..LUM#ONDJ`&,W^5/H`GJX-H&1#= M2/X0U.;T`=@=PLD2+"&YY?EPI#F14-4(JFG6P.I;J"F:)I&8SQ M#<(3?TNT":*"3Q8+`B;#%24UQS`652=L83R91>6UJ[C/N#786JYF$O/*96C` MJCK2+,0']9795[QIN$G8R7G/KV^9[U(V1WI*G^/`#P#FZT7JZUB![44:A-0T M)XU6.<$*^)N]4L(IA@I&'AC0)0I#Z.6.?WEF+;^`3?C=HFA)+L+Z%H$H"S8\ M;NFIA*IX+=-8T^(!]$O,<-6K*X$B9Z)I?"BUYY3:M*?<;'%)9)R`9S=IGF<: MFT>X.3Q`5*^(.2J)RE33.%4<[D73^8<01%D[=G*&-GFX?"-^4LN8*6);B&=* M49>-T\S@4AXBE9O5/,\T-D_02PDD-+9-`H?J:"/)0AZ,B"2&OD3Q!GK!(B"P MB(K0\\<;JT%$PI4X"W^/PR59./QCJ7"'=..-/-)C?]@+`(/9Y& M"X37>?BNV$2<,+)RJ)8Z^R=N9S%S(N2*LX)6BU/!R=?L"2$<^*6+"$T MU,LMJ>2<'-:%2FU*\):DS5D@J#E>;:5#`HR6*O^ZFGP]&9+ZDX6.%:>94J59R3HQ7#N$^*W)GOE'XNQ/N)DR_IYQQ3 M4C\XTM4NG>C"W92R?%#455JHE)@;$H/&WH*:VS>WN#QE^HN]3+43]L*7N,3> M7I;8"7NA'Z7$WF+6)]>[FRE_-AJ7?K)7@NJ"=ZWO7HFPO99%29XO6SB@C'NW MUSHF_XV[A3:7M#!E(Q-&RDF5W#@Z!'QQR'@0G2W]=&U$K.%#[U'\9',`I&+A MDN/8UI,&(ZJ]G\_7(KED(D_I>@WP;K9X"I81N6D>-1AZ6;T,ZODCFH5'18J* MR?5`"[4.RLS"O1,O32!YR^`EI,3C]GYDCS/2P/>HO$A3<6ZY24;P.'LC8N8! MN(`KL"77`H2_0A`F*Z_Y+#1.,4'.PF%%B$0$](Q_<#J9-D\P";\4S$;AC&F< M;%SQE%XO%M3_OH57Y-&9+2J__,3%0VD1DWA>HO4SD0$I(!?DTI'7ZR'%WHIH M.32MCUH."=?^`])Z4"FW$F3+Q4RW9.5@(>B9,5[;SHN:C\= M_@D!OB%CM>!_6,P1O%'*>V!:+N8&WG.RO;X/GJ_F".8O2!_>9"W+L+[8W8%_ M(7P9`B)2\(N(JJQ@&88E=/=@#87%=%57L0O3+S%U#"#QX2RWV_(U9H[K+?$%F8LT/3/[OTZ.2 M__6W2BV(.$XA9EQOT4B#D#(OJ7AL_[*T&ZUNV5%,.Z%J+)YC`HN,VQ)(9B\1 M]`_AD;OC."PA3BHK&,.PB'1L>GTY@^V`6_BB;@?TU6*?KAG-3':/AJ;B# M?N"!<+98!%X9&LY],X3#C1"-"`V-1#L:8PC*[+H7;@QZ[7&\"C8/$'O4'[*$ M%[L'@/D=1U16T-%#$2;<,U#^IJE9(XH2C$(R MDER3R'_:`/P]KOW"Y5WMU]*!R($)S1;UPSQ9D']4G",LZ-46T`SR'+S2H(0\ MC'J.+N`AJS7C3'NS^?YG\'K]"M<;"41:+ZL#/4(X;X502./`5D2:D?"1-L\Q MU-B,G95TL9N3O072N\Q,JS"B4`FE>IF9@\/HMT]VX=1H[I.9::0Y&XB6HOM2 M_FX,.J&V4QUAMNW@*>O>9Z:QH6Z89;B!8BDG"`X&;[@ML`M9C&""AH?V$:YR M23_S.36\L(+!9DAY*#7!CE40##0-[QR#*`99"8WX8E?]17B0I1=X2STHF0=; M&-IYRVO7*#^Q;Q"9O0[E)KV%SI)L@J;/(`N:%;,QYC`S#2.?8_A[2L"XWI+_ M$$H/[+$60-V@Q?!&6P*YF$%QQQM-*6D1EE$-V5>.>3">I2&1PM`RD*,LG<%P MS)MO42,\#A+N>HI>@Z_:O'NT&+[;-W5#D<>UF>35?L&YH!>:E>+;8 M;U\]PWQ/N7E4F_EPDY^_.,&<)"@76LG)HMB4N.2M56G14N'%F&=^5(9CH.-G.A?6831L$N">HE( M98?E01V5\"$.L81D.X))10>K5C!R#V]A1+'Q`JJ]H2^7`FMU0>9.^#>5<;*Z ME')/7UZN8(?5Y93/2)E#88.2(!86&STW0?(:%R5)+#0ZG)DD>;F3DB(6&@C/ M39&L\$U9LM9"7:$31:3"S4OT+6QKU`G]XQ)>)9Y#DR!Y%11+C`LE MQ08C36K+X[6Z+T!KVK#+@IJO^]\7)VU,T"M1'YISK\99!T*.-/#_$'ED>&#Z)5 MER2JXAS>!GYM#[(RO:T:OFP!GJU^QFWHTS=!0%B"WOI&U_34WRYXW3,?V M492"L,#S!I*7/ZZ:?29;HNLO82X*0[\4%=CMM32LJ`,I=:#[!^H"DK,,F[\T M>YP.`'#@+^$+X-3-9HP8^TF=M9]4!:;9XI;\-E^!B##U_>TY=O@5ANB*`#2- M-BFWXUU_^VDXFCE0O.KG]0$F/M@E(0>A2L[]'X/X>\G4>,=0.&5XC;)2*B64 M1A/RS=9!]B\6QQ6-UM+,@IQK$&8U,\I'FUMA6#A<"S@%GI6'D;8E9<+"&ZL5 M$/'GT?%AQD8?C;!J:_1Q1FB5:X8R#^+)5(^2P(-<3L$=.C9KV9>Y0=%R#O'Z%A&-[@'L6*7B1$.'V$1C[%IA<]<*IYM) M4';D\_L'B(:./2W8R.RY^RRSFXDH>C)P[%K`;@%P">+59`N",`\@NG[UB*Y) M(XKP$B:',"(J;Q,AEWS9::8U456]\AOK._2P2=\-&RHV3_9M59FMO57#*:WN MTCBY@)26D"AK%[NV'Z?+RGJ0)!(:JP[H\8_:MF(7[CS]^;S;Z1';\Q5G$:>: M/&.$MDWGJ`BW>H34M46/2OZFW0"/OA.4M5$S>?9'*E?R/W>;M<:V`BZW%1B+ M\9\?_D%4P+_EE6.7G681+A94\V7/? M4D<$7="OH)^&D&IA,D>5V;*@TUIOH9/!V$I@;"70D8'.X2M92]YL(1ZO`R"4 M@/`1$DQ3OA;#&*1AZR\1T3-P7!1=?H)X&WBTV(W'!:1Q2G]@S197A.F]``Q; M`,B:?/Y`.YX;O,CB4L';<%8C>3A=EM@UCEG MFB(KR;854YY-N+!"M:51L?VR\:RHQ[A4#)[FZS>/);9/\>&6V+:PK$?'$MNF M2MB,);9;UV5NT(!4$S@LK,DLI=J8+\*L`\]:%+WQZO?U@KV*!NWC[+%69K4A M5O%M0\7&R..2L[EQV64PYL7-6%VKN"6N,IX*JXL4=^`-X@P(JTL3MSW9K6OL MV5BEN./UKH<:6EUYN,-![S$WR^K:Q"T/"#]ZWNJRPRVQ[1",9'7-86T/(M<_ M;G6!X2YGGY?&8G5)X:ZO0;=ZJP.1"+M56QV6>-B^UNIP!$9A#JS5U89;:[L- MJ`Y+,F0GMUE=-;CEAVTLEF)UD>"V2'>MAF)U'>#V`J_V5!ZK:P)KH%.G5!JK MBPAW?B=J!1"L+AS:4@: MP=/*1"YT#)9&CE.2S'P3>8TXLNOKE2@:.J/-Q4UUY#DH5?FUN7R[+F*(RM?; M7,M=%_XRE^RVIE38S** M!]L!MS"SF3M0"[S,7\"#T8;%DU'=HN8[:(!9.V5Z'!S!\VL7D@T^C$$3^5T".]>X2K# M%A8.T6/F0IBW+)Z25]2%,&U9E%MPZ2VG)C=Q,7NYNXVV%#$5Y# M@J*]?33>C`/:TIKI#8XD6GV9YW=IZP>66'/T$:OBPRS4/"@G\9G\X=87>N[% M(VYOFG]W_ZC%17HTN?MEN+3QZI-W!M@;BHE/HP7"ZTP>5`L!U.,PF6`(J&)S4DNIEE_6--R$LR<[ M.M/UADC:6<'>%2U2R7-<<09K\)RP5WZ`^(G\"UX%89I`5D*WW#P-`%Z0RS%/ M8P]$GW$0AOPFP9R!)KXMH_AV]D\,Q:V?F^?9@@W?Q\H;;0GDERA.]K7/,?1S M2:3R4-&?%3"36DW')5#>FBCJY$5C1J9T6,R2CRBL9"_[[42+]//)*GU+93Y* M.=P2LI/W\H8^]]<`1T0$:GHEVB_4#_E/Q9B:<4S\.?C3SP,N,_Q#9:HEIR@N MOOX]$2`B(H+"6Q0K\%S.?-NPV]?A;8%7,;.?8S5_02I,J!QNDL"5WE\71-`D MDE#1\.DS^?`F7I*"4)XR>K:SEW;[2]8[T53VL81:Y0V8^K0EPB*@ST=NZBA$1/+` M%,VF:.7B.$[7A35$GEQ=-W*=7IE_Z&G2-4[2!];3!]-G?Q^J1C_0':("*/T,'4/1L13`$^^4O MTB#TR7:TYV$(7_F@2-Y2L]O9LK=JENDXSUR;1%PG__2/WAK&Q;;&09?A>[#*G9E-A!Y45+,.PA*Z1 MZ:BN\F8P-90@*(#R'O(DV89)EN'Q""E]B=A291)YA2F>[Z/M:AI$H1NRZ1.U M@"0[^L]?`?9W.9='_&H;$I,T@?;?$"/Z?SGGD M,E^)8HW2414??(C-!R->_*< M9HF,<_@*J&=O`>,X"YG+/_\,4C+UB7/GRT>,%P' M[(`YSD`M(&SRVT?8)0(UY9LQPDQ=FKP9'>'7T`-Q(I2Z.(--PLUM2\P!O3[> M:>@-&6/*I`FVC9=GL1=8%3LM:80&P3(B7\*C?DU6>!X(XXMJH*T(]S9+68IS M!4SQD6ZSU!O$V=0-%W4S/46+.=8(U.P.G&RHF6,M@)KVSA!1FS/:$LC%%X`[ M7H/`-7_)S,HHQ>1IB"H7C*N)-,W0`A2:KU`:@\B_#JGANWKQ!8`US](+W'P5 MG!)!"CS!/,T`OL!P"Y7!X\W249@08/\:+*G(0@TW7X,P!$NHYF)07T-+1<5@ MN:*^Z"W$9#>!HX@6`F%I3:HKF*O5()VN=ZC2)LSM*7LYVULM1@?*E4R"`\I_ MLKY@/RWI86_9*&5ZM.#@)1T&Q`#:^W;J'X,N'$');KVEF%5YX8-CHL#TK_86UQ+&6DEYV5)@4$]_1(: M68FYO55%E3$7QS24*-M;/U0996&T3HGQ@&0\7DV5$MD!"7"<=(P2UP$):5*V MD!+SH/U]>H%TUM6YQ!8(CBE,H98.KT+ M\?:GAE\US>HZZ1HP[R/9W>J2ZAVO6J?`0*L+JVLX3$K1LU975-=XLV2+=%E= M45T#/9IC,\@^-5+'XDBYO1NZ5ZX)3)C(, M3!96*0M<$F&84G!3S;P2_V%*O&UJ>Y8T&9XTK)SX51+#D%SG#RT)7[6CJ(.JM2GGLZ?++<.FB5"MZ3XX_ M#Y<\3_S5Q#\^:8:[FZ^X69P M`=(P86/>HL:[Y+5GEQ4W+C?)1=^?ERR_?;*!,,W7I&41^>+>,(LQEQ?%R@,A MJ(U6.A6%VV;^2KYNRH4K=9!WUY\3!$\=/A?GO+\?XN]2D M4Q2(&37/;**2Z/`8))(KCT*7HG?'4J2@PUC);"PTSNLDA%Q7L_+1-&5YE&0R MHM*`K$>&\2*9OP-RK*(SJG9<>#EDQ64(&VQ%]GQ9B4O=5+90@&N=>O?Z>P,%):5SPYM[KI_,,U$>LR'=6P(' M4X4]&;#4O$K-X)=33.(PMK\^/[T.U67.0+)R+]>IM@^MRT>>N5]X=5,--49U M0G@%,]M\Y8=3LO2_H>M':^R>WA:76Q#Q&JMHW\9Y6O&O:,^[N4XY?@]3W;LX M3RD4>;40]%L4+6D*\A5\/@L=&V%PB,J?$?)?@C`\S[ELW*W_MIC'OITCY&H_ MCTTZ3STNK`B*BUWE?QW%3W"[_$@N,[9@&'X+!LLK$"K7C+6QPMIYJD[:6"?M M7)7`C95"&RM/BO&L&2[94<&R[]H0*T^V))Y^-=OJ6GH64*EB5[6ZS)X%I&+G MAMI8D<\"8K$LSU87];.`9O4JL?:&L1CE[%6CH-55`%6)=08_A]45!"TX7,=Y MK#:6';2!2,TF4ZO+$)Z7A,WV4/.5!P<6WMZ,;L$AN05'QY:D>\?NM.>!^3C.[]BQ(EEE=.V8MFDU/YCF';ZC M`CPJP&]-`?X2H><8XBU%[A\IH!\1T"9DW&9$DV.C,@?;XG6-3!M_IS:KWG- M40\=#Z?S8G?XYZ\!Q(37K7;9=1.057*R4;QR5G,)-H^$D33A<3S8`K@ISZ!U M@>6!/YIA`0;9,?B9K9U*S#"*P1T$E%UG(F3]@`NYIMH:;P)+0W92)HST#YEA M?@Z]513\GG+3?Z2GNV]@8QJ=[A%.5B\P3N;P%=#F+`ORCF9RY6RQR%P9+Q!S MC4\JLS4`^P"!!_,J@/O*)9=D2N!QX6N8H`.D?=\$6@/?O]AQNL*S0).;J`'$ M8\G\T.%N\HS2I%)-IBK,[SDUSVJO9U&3J#%MO]T7U(!2;6D&E/4Q5MEQQ!;> MIDMLWI33`])*;':,X+?8IJ^F41V5ZU23R&PBB*B&Z7GH884G0*9X:1NQFTD5 MEGYED^-K$&;NNF]'J\!4L/^N_="LG$Z[^(K[=OPNB#+IZT\_;?3#\)/(?,-P&*(VKXAA6\^DS MC6.3#5A7HP>XAE_.0`WVN4GZG.*HJ!Y^V&`:\&%IF*&CN"&(R!YX5]N$"U33 M#!U`X>QR[`P3^<\H])]6P$P8/S M3&O*[@$TVO8I0=YW)ATO(!'48:7_">=A4%_'\EPFSK.F*<5)N+J&H_H4O-(6 MAUGD[QR]1-ECB,ON67P^+3NS-R`?J%(D$/YE9ND`+FMJ1%3N$-9%>A%X4O/Z M!K`=>.XEMTF?<_-^OK-A?W*!!AG]T6@S,!_QT0?6'&.-U;ZWML@V6F"L=K"U MQIIIXK':5]8650FEWFKW6%N\CVT&5ON\VJ(HL@P8]VCU\A++"&..%GKK@#GC M/396O^TM1F"J)-K+6H1;YM^+]>DAAF-I(G6;&"RW*ORIDJ/9L&J^>I]Q0NQ- MN24EG%(-6C$C=5-F21VG5`AE_B%G62^I84K+&%@L=!]U+V3LTBX'4O5'D4$4 M"+D.EJN$+0`0>7N^`DG> M=QH?%CX`_)U\^+WX(W#"\T=K!$;&.<`?VP<@\F!H!")>/\M`P!KF%("3F;R0KYN1,#PGNP%D=+-4SJ3M4@6S3'(O_W*?SY7W\K_2XU460/LV"@ M$3A9[ES.H*%&J02)M]J"2,8WS!\[ALN*8;)HP!,F.`3$7LKK\J M]+[SWAI!(&RG)34`X5427J3NYX"]5PU,@!I<,"43W=3;*+ M*EF<=/IUZ(PW.N"L=<"-'K#1`V:O!XQY1?X#D5?A*UF1\*>#?%4*78RKTC3# M?;>,Q=T99J MG]+:F^_#/K6U1]^'(35UM+3IL\DTOIWEU[;/>*YFD>GPF!FW,_9LCW#:T*+5 MY#1:9D;+C&G+S"T$,8PGOA_DH%3J6K9ON&A>EV='PE%<'V$$7T`XRT@_AWC- M"G]C#]0%0EPAOZ"?#G]L#X#PNM^PQXTZZ_Z9!Z_!.ET+>]T=CS&D63=#>31& MPP&;;;(TEFB9G2!Z?UAGG#7*!(D>0;04Z=+E[\:@$WZ^ZHAS]L5HY&<'?RR; MWPQ0'U(B"_.6&-<`=&''>W"-6VNDRGT+GTB'M1PIW!B,<=1:C&@MM:>I]GGJ MQC)[`RT93]F)W:0JJKA@ZVS"Z%A$5#5HFM`)2SUY_SEN4FJRN\B9>1+?$/RI M[0I$'@PIX\BYR3#UQ3A'?D^)![#+PGV;];:&:?V")];F!%-&Q2Z_M<=R&9MB M5RFOCJ[L;(LQNTPQSF3K+@@6BUB,YS2B!4C_"0'7C]QB(;OQ12G6@^]A(:OQ MS8K+:D&XLI+=&+\@/?@6ZUB,[7P%,02+A&L945_G_/83.1'CV)0B>O<';551 M(%;+)\]F-_09Z%!E(&Z8HOHD1>7U,&ZV,DV,BNA@M69^%EJ48J/Q("6SM*@^ MP58GYO=/"@N2]17,O\VF`WNMW(9MP2;,8=((,G5"N*G#7EX_5GT%>"`LFUZUWZ2PD(PW3QN5S#V<+#)T[>KP&502^'7L(1Y M'(O`8`K3]6(!/=I4FI]'U&H-N[!DA@!)SC*/26,*'W>XP[!;P9F_1&"-0YY]064%+WNPS-UVR_ON8(WO]2E6I-(A7]//,%IED MRW^`N<-M@7U.-A7G]XHG#00/97;!O$PWD!9`#V_2R(\/KQI?U9"8,3JU\Z]W M"Q/RL,X6N1`NU-R80\W!'!>0S-(D3D!$N\M-UI21"^$73#.""WD""H@.BF8& M3@4^'D)2J72",T0O- ML08;\DN]<'6;)6S!\1'2EXI`U@5+P2*VX"EJ\\T?;POT7Z(TAGY!U$NT7@=9 MAMX-;-:1VZ]G"ONX!#?`7T&8PM+H*T!2.,T(+BCR491I[\\@^CXCHAB!CPIB MM].+V:-8X)"::PBK);5"4%GW0&D^%HRQ&H3B.X"7032+"HLZ0PJN#1D3XJQ* MB+N'+X]PB\(M?2Z.19TEAEGP#5?#D9]K@ISW*'J$'DIQG/FH.`0]':6#I"G% M>;8@2^/]TG<()TO"S%EF&.%P'=TC*K4WIY&'J9/U*M@&/B2*Z32Z?O5@3)DV MB%>3+0BRT/D;A`G73G#PG+)Z+VA:U<2I>,#(@]#/L@6.GBO.^>"/'Q-"-26$ MGK.>U8KEH>&-$=Q=\^V8!D MXR8U7Q552 M^2K/L84QK"W0/HU#*O&SMUF.%'XRGI`264,-@`=D>/M^(6V.(A[:W29AE2KN\ZUY:J2#A2K6]"UQ9WA4K>Z!9T4GHUA$%8WGFO[*47>6JO[ MSK4^N]S`">,]Y_J3&)CQSR6^CDI(MXV>W1)%UT0D7)D6O" M49O@ZQ);UV2G1N]AB9JKHA$[;J&T&9DW\(H,V4TQXD>%N!MBFJ6,VOI0 M=L7`+1>$7A>$3V.8RT-MH2S8&E>F#[5$U930,+`JG,T)\[)AEO9FR^O%4>1$ M-EXDMA]4^:QYC_#/`T.8Y6#=H_JG@:%:+W'\B^6"PE@2F+Y_%MH%)#'BE`3^ M)*<$&RD)G*[7`.]H-_7?TX##!F/Z-&M$RP$Z#SEJLH"E!F+WE'%$+ MR4V(7M3!/9W;,Z!SE(#P$FP"\E_"CJ=6_9/*W%L+_;CJB#;=4!L#W-I\3MY= M-!7=)FUZ%BB^`_`/-6#'-ZF/70-'%\'Y>^S9&PW0M@^B7/"G41=!)7BUC*?J MKHU.TN<41W?0#SP0SE]0L?8M`A&W<(;$)`V*\@5^WF\Q6RS(ZWR1!F$5?2&( M"I,U@'I)V#:,H@"$OP9A&#-WGD50"O+V:VFR;`I:$)\8-5DCM0/!Z[K(&F7> M)E^-P'Y*R'_X'1[MN=+HQ#D:/-JM;;1;T_#49!_;1L/@ M!&97YE`;8!;6RN4,=A1N/;5]]T]$]G#@V>(;X1X0'R('O#2Y"5[SH@52#U"G MY=Y4I:P'"#SX*P1ALBJ(1J8$GAJ]VZRB`?@GN(71KVGD8^@_K8"/7FY!!">1 M_QF%/J:B4FOA2]O2.M#8C/H5Q9D-KI-DV66U MLR&3M0;4B`YOO?,A)*E4=5E-AULRC3T0[1XP6L`XSM3>8D\U=M9R(0TH?`V> M,2BH-UM<(KQ)XTNB8L=)H(9#VY7.71!&H*I5#;\U96J(_EE)DC2G&%KHB%7# M344C=2%;5O*4\[1:X^FP4LTC!48/EST!J:2[$L\D1HI5QQX5X-JWG M@*W""LQ0LV()PL MR'VDMKN;8"O3$TQI.)V&XM)[#.#`JZT,X7

\;-' MG==F-\U/!_$U_.K$+)3K\@)UEN%:ER>W04_\I^MN\93)]0W^TW4-GV1?PQ=\ M_L^^A*<#PK6N>5"A/PLK.O\,;>FR5> MJ\OM5/,QU._J^6J.,G@M%)?!>ZUNPENK^`K>/X7:NJ[N0V+5O>: M-4&@X]$:OI];=/GU]^HYL\>K-UX?[SP_/P0#&7YZ>7O5_T/2[OYZ>?V_6 M\(__*P````#__P,`4$L#!!0`!@`(````(0!$3O#C-`,``'X)```9````>&PO M=V]R:W-H965TE&1(]LT751@6NJ-@L]OT6!) M0B,2LNA4D%(V(ISD6()_D=%*=&I%=(M<@?G3J;J+6%&!Q)'F5+[6HKI61/YC M6C*.CSGL^\5:X*C3KE]F\@6-.!,LD0;(H<;H?,]KM$:@M-W$%':@TJYQD@3Z MSO+#E8ZVFSH_?R@YB\%W363L_(73^!LM"20;RJ0*<&3L25$?8P7!8C1;_5`7 MX`?78I+@4RY_LO-70M-,0K67L"&U+S]^#8F((*$@8]A+I12Q'`S`IU90U1F0 M$/Q2/\\TEEF@VZ;A6>;:\4#E2(1\H$I2UZ*3D*SXVY"L5JH1L5L1>+8BKF$M M3!?S?^F$/"J1G5()=#A1D"D!+?"\=3UK@YZA M;E'+V<\Y$\:A8Z@B*=EP`"#PVYN&-'^`::6B3'?A]AWPM@M[O(=#Q^B6A`-@ MY!`J^@$.E0H4!H)TKO>XB,C$,/#(U?/D5=V16Y]M?I[EO$ MJ7O@;CWQT?ZZZ%,>]OR!^4'GC*S!B;C=FB*/K;7(N@]^F"'A$!G%=L>QZV-B M>P;PWWE2E-#85X/8H_IYT\;K25VFPR$RLNJ-K5ZOH"*/[;3(($TS)!PBH]AJ MIDYO$Q/:]YU)4C)C5PTR29(S::^>U"=IB#1&FSG27($%X2DYD#P76L1.:D:L MH6][M!]?.UOUS`3?PUBKA\`4MWVX%>;\G>/OZKMFRG?\T+G`WR]]:,>YSM[U MH?87<,^'NES`5^WX17U@&'\53LEWS%-:"BTG"6P=AAYT,V\&:/,B6055@"'( M)`R^^FL&_W,(7,VF:OV$,=F]0_W/:_@,``/__`P!02P,$%``&``@````A M`*'E/D=&$@``<&4``!D```!X;"]W;W)K&ULK)U= M<]K*TH7O3]7Y#R[?;]M\&JN2G(KY$B"!A`3OM6.3A-JV21FRL_>_?WO0M$;3 M"]K8.S;2TIM&T>D;26/[PO[^?'L_^6KULUYOGC^>UBZOSL]7S_>9A_?SM MX_DB'_S1.3_;[NZ>'^X>-\^KC^?_K+;G__OTW_]\^+5Y^7/[?;7:G9'#\_;C M^??=[D=P>;F]_[YZNMM>;'ZLGFG+U\W+T]V._OOR[7+[XV5U][#?Z>GQLGYU MU;Y\NEL_GQ<.P[D^Q M>[I[^?/GCS_N-T\_R.++^G&]^V=O>G[V=!^,OCUO7NZ^/-+W_KO6O+MG[_U_ MP/YI??^RV6Z^[B[([K((%+_SS>7-)3E]^O"PIF]@#OO9R^KKQ_//M6#9Z)Q? M?OJP/T#+]>K7MO+Y;/M]\VOXLGZ(UL\K.MK43Z8'OFPV?QKIZ,$@VOD2]A[L M>R!Y.7M8?;W[^;B;;WZ%J_6W[SOJ[A9](_/%@H=_>JOM/1U1LKFHMXS3_>:1 M`J!_SY[6)C7HB-S]O?_Y:_VP^TZ?VA?->NNZ4R/]V9?5=C=8&\_SL_N?V]WF MZ?^LRGH5+G7KTJ#PB^V-]D7K^JKQ%I.F-:&?;')U46M>M=\0"(6\_SKTTWJT M+JYK5S>-Z]._3-MZT$_K4;OHM%K-=N<-)M?6A'Z6)F\]('2.[K\,_2P]WAS( MC36AG^\^(C5*RR)+3'[:!'C[,:F5R48?2INW'I4:)YOY4+J\^;C4*%>+[^22 M]NVY4N.D-1_^13"?&0X&L[?VK]*WQOEK M/KS[R-0Y@X^?7C9_#JC M099"VOZX,T-V+3#./!(49;L<&XX-#30F&)?/QN;C.?49%?TMC6=_?6I?-S]< M_D5CT+W5W**FYBNZK#`#CK'M2="78"#!4()0@I$$8PDF$D02Q!),)9A)D$B0 M2C"7(),@EV`AP;("+JF+RWZFKOT=_6QL3#]S#]TRZV(\LN)1$^7DK*K@?2!#(`,@81`1D#&0"9`(B`QD"F0&9`$2`ID#B0# MD@-9`%E6B=?[-'?P>O_PY)TKM%'O.YD[Y]:2QKY<_U&[$KUI-S?+<[U7[E!) M@>M6N9L7',U(WA"<4?O!67)3MMX%T@/2!S(`,@02`AD!&0.9`(F`Q$"F0&9` M$B`ID#F0#$@.9`%D625>!])D\`T=:-1^!Q;$94]7@IX$?0D&$@PE""4823"6 M8")!)$$LP52"F02)!*D$WU53.(NS(7G[OOZ_L_; M37$M?J!"F+._F,(9$[\++2EN`)CY6+R`+(L"%WJT1'S>I]F MW5[O'^AENA?"W6S4?C=;4BFU)7$]B-UA.!:Y$*_%)7=;$F]+.S#DBBM MA:61$[6O;_RD&I4B;FU<>C.9E,09P7>+2B,G:G?$`!F7(O:>EMY,9B5Q1M!: M4AHY4;LCKHW24L3>\]*;25829P2MY:61$]7J#?](+DH1>R\+0M?31+STHRML M+_W>57R,B9^5EE2R$DBO(*+2=/ROTB]%_%4&8#0$$I9[N:/4OA;6HU+$UF,P MF@")RKT4Z[@4L?44C&9`DG(OQ3HM16P]!Z,,2`Y[+8`LJWMY.6)N!7I)HM>H MO=Q/!T:5P<@A]VTAW7M6U:"QTPU''7&1VG,:.J\V'[FD&*?H%>*:.Z\V#YS2+'/T6N!:.F\R-Y/&W./J9HV[RO0 M]DY5-9L*U*A>)-2NQ+5@USQ4,SEG+E?Y\<&!`FU5WFF'!=JV6-\7Z$:S+JY( M!K:Q!NF.-S8\*:2056I((VZQ"*E^TQ0#U)@%:D@3;DP]2A&KU)!B;M$>I<:5 MF/]/6:"&-./&U)`25JDAI=PB=]R-&##F+%!#RK@Q-:2<56I("VZQ"*G6J,EL M6[+B6$S^66;NGVIG6;[Y06?!JX_:[&W8ZFEF4;5HETA)\YYY_DQG7G._6F0_ M?^DC&EA4&1.&#BGV(7J-$(V=%Y>]B4.*?81>,:*I\V+[F4.*?8)>*:*Y\V+[ MS"'%/D>O!:*E\X*B32FNIM-)=_U,T157WA;YL^J.J!!=5GFGD)SG]EBESH+Z M5M6XVA=M6G,$1;N(LGYL$K1/W2$WIH84LDH-:00AB>\_9ALUI`FKU)`B5JDA MQ1"2&$>G;*.&-&.5&E+"*C6D%$(2'3=G&S6DC%5J2#FKU)`6?DBTAE$L0UBR MS;&0_)I-(:DGV8DUV]B(:U>+JC6[1$K=Z)EE.K)F`QI8E5>S3[$/T7Z$:(SV M$X>4Z"/TBA%-G1<7U9E#BGV"7BFBN?-B^\PAQ3Y'KP6BI?."FDVYJZ;3:37; MN(AL*I`WT6YW1.IWS=(LLZ,Z.>JQBM+%S9#EU*=O58WFT9IM0SHV-[(U^Y20 MPI-"&D%(4+-/"6G"C:E'*6*5>I1B"`EJ]BDAS;@Q-:2$56I(*80$-?N4D#)N M3`TI9Y4:TL(/Z5#-?B4DOV:;1Q6_89YMGWA4Y]D656MVB2HG"TZ#"I4WSP8T MH&*]/SV=_=`AQ3ZTJHK]"-'8>7'5FSBDV$?H%2.:.B^VGSFDV"?HE2*:.R^V MSQQ2['/T6B!:.B^HV311\-+IE7MJ1BZ*26'WC7K4DE503U$?40#1$-$ M(:(1HC&B":((48QHBFB&*$&4(IHCRA#EB!:(EA[RRH19U/N&?MW+_7ZUJ++& M!4@/2!_(`,@02`AD!&0,9`(D`A(#F0*9`4F`I$#F0#(@.9`%D&65^%UHGMEH ME?ZDZ52]>/)#MT?Y]+QE5'G:Z)!2;'I618^DS1KH^E5-/(KI.P$W-D`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`]QAFKU/9S5KGV%XR*]CNM.LPW M;.\=:]_/=%)YF?[*?,/(QL5IG\,8!J[Q3#*8AW&(Q=-RT:F*MPH`% MQT:.HF9R8VI((:O4D$;FAA2Q2@TIYA9M2#@-88$:THP; M4T-*6*6&E'*+14C-EKQ`G;-`#2GCQM209:=MN;+G$RB:#.J%&V'E,+1LZK*`_X^HH'SXKHT=$BQ#]%KA&CL MO-A^XI!B'Z%7C&CJO-A^YI!BGZ!7BFCNO-@^3R?Y4$JF MTTD/*>EZ#;*I0&)6*]8\=>V.K\QJ6447FF[NBT6[:)'.)O-T\XI>,"`FNFQ# MLP=G(R\*AJSRSFJI"EFEAC2RJC*DFKB<';.-&M*$56I($:O4D&(94ET,;5.V M44.:L4H-*6&5&E(J0VJ(R]DYVZ@A9:Q20\I9I8:T\$.J7;3$45JRS;&0_)., M*OOOJ-G&1DR-+*K6[!(I6=XSOV%$7E[-!C2P*KI)R&5IZ)!B'Z+]"-'8>;'] MQ"'%/D*O&-'4>;']S"'%/D&O%-'<>;%]YI!BGZ/7`M'2>9&]GT[RN=O[:C8^ MCJ/ELB8IS&A1%DAFSM=" M5JDAC:R*?A3#"-;L4T*:<&-J2!&KU)!B&1+6[%-"FG%C:D@)J]204AD2UNQ3 M0LJX,36DG%5J2`L_I$,U^Y60_).,0OH=-=O8B)IMD2NJW4:)E"SO6957LXL= M*VC@O+@L#1U2[$.T'R$:.R^VGSBDV$?H%2.:.B^VGSFDV"?HE2*:.R^VSQQ2 M['/T6B!:.B^R]].)FEG8(-/&HEHY%G=9Y5`/41_1`-$048AHA&B, M:((H0A0CFB*:(4H0I8CFB#)$.:(%HJ6'_'ZE>:37K_NQN+E_,_F1%Y;SNZ[, MFB?9QQ95)Z?T6^+^=4R7=ZRJZ$7>IDBNN+E[\7+?I]6+]]6W=7CX_;L?O/3O-B=UAM^ M^E#BXJWSMXTVO7:^;;)?;*%E<8%9N81;:-U;8!8PX99>O4G[[!='"S=ZN_WG M_=,9P6_IK??[$TURT\2!%CXW@L_%6_+E#@WZ'@=VN&T%],)##/6V=D,M[Y]O M""=:NAB8I62X#ZU@#,R*,MQ"JQ8#LR;QT)8&;3FT#RU8#,R:,MR'UBT&9FD9 M;J$5H,'H8#NT*(^V'-J'%G\&9N4=NM$:T,`LP,,MM.XS,*LZ#VUIT)9#^]S2 M/K<'M]!ZVJ![<$N/MO0/MD-K&&G+H78&M(]9J(BQT2K:8'APR[P3S`_U==8) MLD,\[P3TKBML8=D)Z(U7R.F54X%Y0=*!+?4:G1*'4GS2">A-8;A'U`GH/7,' M^$U`KPA#/NT$]*(PY+-.0*\+0YYT@O20?W(3I(?TO>N`7DV(/K>=X/:0OML) MNH=XKQ/0NP'1IW<3T`O;D`\Z`;VV#?FP$]#+VY"'G8#>!GB`WP3TUC;DXTY` M[VXC?ED6`/I[%S_NOJWBNY=OZ^?MV>/J*Y5-<\_K_.RE^(L9Q7]V]JT-7S8[ M^D,7-!&EEZC37S99T?LRKRY(_'6SV?%_3`/EWTKY]/\"````__\#`%!+`P04 M``8`"````"$`&`(=SIN!```'Z`(`&0```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`-8I__,=#:J"FQ3\BR\U#:F!U%_\(-+>O[@:L M4?PC7LRM56J@UL4_`HN9WLQJ;V"U%_\(F??F(R"7"FLTK#5NO?0F:EK\(US` ME0YO8HD7_PBIS7?->JMS__R!G;GV)CQ0_".DUK3)7?M1C]79U-5I+^!:&E2O MJ=7[#RX&2ZRI2ZQM*GGEQ;10C^(?M\[,>[^A>MZ?]3[\^/"7G[]]_><;V?9* M@;[_^:'81-=^*HBQ,_,EBGNUE[9JLD`HL4 M6*;`*@76*;!)@6T*[%)@GP*'%#BFP"D%SBEP20$7RXO"N%C,B%#Q'%7/4?D< MU<]1`1U5T%$)'=7041$=5=%1&1W5T5$A'57242D=U=)1,1U5TU$Y'=7344'E MUBTL/JG%>UG6<6U+!_V_6-L%3;&V4>I'`+K8F_>=9"DC!DF]%.BGP"`%ABDP M2H%Q"DQ28)H"LQ28I\`B!98IL$J!=0IL4F";`KL4V*?`(06.*7!*@7,*7%+` M.4)B.5$JUZ48JIZC\CFJGZ,".JJ@HQ(ZJJ&C(CJJHJ,R.JJCHT(ZJJ2C4CJJ MI:-B.JJFHW(ZJJ>C@CI;T=)2EIWL_\52+FCDDU[JF_F<#D'2530H6=TQ!)[I M$=(G9$#(D)`1(6-")H1,"9D1,B=D0%=5Q9QZ5U7%O'Q75<7E=J5:E]:X/+BX88T7T>4U[I%DC:Z19(W7D\_Q&!37 M."%]0@:$#`D9$3(F9$+(E)`9(7-"%H0L"5D1LB9D0\B6D!TA>T(.A!P).1%R M)N1"B',,/3+49:C'$!?6<64=E]9Q;1T7UW%U'9?7<7T=%]AQA1V7V'&-'1?9 M<94=E]EQG1T7VG&E'9?:E6I=6N/R]N:&-5Y$E]>X1\IKO)'NU6-07..$]`D9 M$#(D9$3(F)`)(5-"9H3,"5D0LB1D1A'D-<6,>5=5Q:Q[5U7%S'U75<7L?U=5Q@QQ5V7&+'-79<9,=5=EQF MQW5V7&C'E79<:E>J=6F-RWNO&]9X$5U>XP%YB(_8NX3T".D3,B!D2,B(D#$A M$T*FA,P(F1.R(&1)R(J0-2$;0K:$[`C9$W(@Y$C(B9`S(1="G&/HD2$NJ^.Z M.BZLX\HZ+JWCVCHNKN/J.BZOX_HZ+K#C"CLNL>,:.RZRXRH[+K/C.CLNM.-* M.RZU*]6ZM*#E1?T-"[J(+B]HCS1U/:=`+P7Z*3!(@6$*C%)@G`*3%)BFP"P% MYBFP2(%E"JQ28)T"FQ38IL`N!?8I<$B!8PJ<4N"<`I<4<(Z01T*ZA%#U')7/ M4?T<%=!1!1V5T%$-'171414=E=%1'1T5TE$E'97242T=%=-1-1V5TU$]'174 MV8J6UF=Q%O6&!?H<7EZA`>K(XU#S#+R1W#LC43^9>P$JSG.9Q&8YL:]1V)$/ M&!HR-&)HS-"$H2E#,X;F#"T86C*T8FC-T"9`-9VO+4,[3;13V"I/X5ZC,(4' MAHX,G1@Z,W1A2(ZY%+8JSI;'QBT'71CK5F#&%[A<.>["N14VD",O'``=BQGSZ"A:C>3&I,5X!YA"2HMA#!ZP M<14FD!;#N14VD!;#<3""F4II,3[.8L8*=C*3XYW28E@"_K!T,(C%C$-4HG.7 M/,J6%L,2L(VE@V\L!N/(C%J)=/W#3';BX29+!^]8S)C'2J2]N,)03ZB*U_\P)=%KC^DZ\]UE;J/ATK=)T39[N,A,R?]X@Q1^:-RP-"0 MH1%#8X8F#$T9FC$T9VC!T)*A%4-KAC8!,E7?,K331/5!^R&QVEZCM/O0K!XY MZL30F:$+0])]B%^Z#V/="JQ7@56X0$[T,E^%#^14KX\S4RG=AS%C!9W,SEWR M!%RZ#\O"'U8"!K&8<8B52&X&I/NP!&QCZ>`;B\$X9@G)B6#F@W5L+HQBL8/F MVDM.>W*%>Z35V$DNMYKB`)AM-:_L9L)Y,;N;\5"IGX0HVT\\9":C7WPE+^TG M!`TY:L30F*$)0U.&9@S-&5HPM&1HQ=":H4V`3&FW#.TX<<_0@:$C0R>&S@Q= M&)+F0?60YL%8MP+K56`5)9?FP7P519?FX>/,O$GS8,S4O?A.2OVNEB[J"AO( M%P68"4:PBL8)=A$FSP*D;_"@8`]+!W]8#`8Q2T7Z!O/!(C87'K%8A4GDEH?Y M8!.?6VX2Q0DRVR3\5X;>=61#\N/W3Q___OA5'HS(=J:B>33DJT'A"T/^')KT M(GSX/19?HY464.H=(;<,[3AQS]"!H2-#)X;.#%T8DMY!59/>P5BW`NM58!4EE][! M?!5%E][AX\R\2>]@+-;=/`V*A3<8*F_Y4'J+Q=J7;T"2QU[2+<(PC`0,8>G@ M"(O!$N5NP7PPA M@\!^`*07?V3H!*A\\2V[I,/B7[QFR'IW1)Q#4.4F8D1)XX9 MFG#BE*&9)NJE=FK),[NY1F%Q+)AKR=!*$RU],A-KC0+]AKFV#.TX<<_0@1./ M#)TTT5YJ\KSGK%&XU`MS22.B0LI6B>KMNA58KR(77C$ND*T2\\$M=CW`+C87 M?K$8#&-SX1B+P3(V%P:Q&!QB.L!@L87/A"8O!%#87KK`8;&%S MX0N+P1@^M]Q/BH-\M"^2W\&1KGG#790_#EC:$WFHU&9"E&TS'C*W3/WBYX6* MGJ(W5H,`F:$/&1IQXIBA"2=.&9IIHEU)R&3HQ(EGABZ<*-V":BO=@BHIW8*Q7D4N7&!*+MV"<^$#XQ;9D/"U MP`F6#U:PN?""Q6`&FXO26PRUM[DHOL50?9N+\EL,];>Y,(#%X`";"PM8#!ZP MN3"!Q>`"GUON%L590MLM7ME]A*.'NM%\+'[YJ[B]D1*9FZ#D>7$W1$D3PL+J M`=*VT`(*AXI M%4_V6LDMUP3,6?TIHE1_!N:L_AQ17K]V1PGL#ZNP%;!&E%[`#=?8"]HAZJ0(',&?UCXA2_1.8L_IG1`7]5CU]PW8! M=?8"I(?ZM6%<+STT8&I[Z:$!R_I>;OU"6%XUKB(=MW1:GYJWOKS,#V%AY)U& M,UE6THNON@BL(CMT+)Q7+@(KYS[X[Z[93AX;R'/TJRX"2\E>!!:/7`0ZD=Q1 MAF&WPI*_2T>-E=/)3SV6CA7$8K&"6!KW7K#V<)_>Y&*EO"*(I6(%L3JL(-:" M"&K/[-236RIY@_?*O)8_.XKCJS=\=OC3KJ4MI8?*GQWUI-]VY6.K^(0Q8^P! MTD>%?4#ZT0RJDM,.`F;A8<"VE]#Z.BR77BY-&Y^-,-:6K!4PO3]H8\Z'LQFCR\U_, MA\+?&SY47M9K;"LHO>5#[>WUH?CW>E)/?@J,KP_EMWRHO^6#`2P?'&"O#Q:P M?/"`Y8,)+!]/F!5H!:THSB!J]33QY-=T.4N?H>("U" M'Y!Z:0!(HX:`U$FC`)F)&`/2ND^0J%Q30,HU0Z(NF3D@Y5H@4;F6@)1KA43E M6@-2K@T2E6L+2+EV2%2N/2#E.B!1N8Z`E.N$1.4Z`U*N"Q*52WXXS!^,-85T MC\!,7"RXEM)55%Q^0(SY4'-33?D1,1]GES&J;I<)RFZO#W6W?"B\Y4/E+1]* M;_E0>\N'XMMEA^I;/I3?\J'^E@\&L'QP@.6#!2P?/&#Y8`++!Q=XOG);D#WW M+6VA"$_:@H?:\MHQMH5Z.]FJ=>LAT3R3"M"]FJD/R-ZU\ITFHK*[OB$KCI"H M5AT#>GC>8S8[Z39G@H"LV)3%9DA4L3D@+]:H-9O)5F^!B*S:DM562%2U-2"O M5KNKI;_0ND%$5FW+:CLDJMH>D%=KU^^3#X8#`K)B1Q8[(5'%SH!"U>[D;KS\ MG.&"B*R:-#FRI30YCQE?RB\D!BQK3.E[,=6LA?09B+1"5AT@54?U-7CT<`=6/_,<`M]`)GET0>D#T\&@+2Y M#YEKA"B=KC$@59P`4JXI<\T0I5QS0,JU`*1<2^9:(4JYUH"4:P-(N;;,M4.4 MN$*.4Z`U*N"R#EDD9G#P'[(WFP@*FD-#H?=Z^EE*X6,,.' MDEOSQYKKU4D+"[EZ>=*SF`]EMWRQ[H8/A9<&%1M9K+RY/I3>\L7:&SX47Q9G MY(O5-WPHO^6+]3=\,(#EBPXP?+"`Y8L>,'PP@>6++GCF*[>%XF3G#6W!'P2U MSW[J'BH]^ZEWDFU*-T29O6@/D`ZR#\C>,%;LYKRB[$VU/?)[`W#IK@R8I-$:5B,S"K3^:`@EBSW4JF:0&>K-H24:JV`K6JK0$% MM4XCW?)LP)-5VR)*U7:@5K4]H*#6;BE%;HX^1&M'B# MU6C4T[,STAFO4H3-S?*37]$.[#JO\CO:)<5:JW:?.%1VZV8X27 MY>;3OZ6C8V*P=GZY.]C="L+@5A!V#H)5C^RO&R$<;P5A`!RP<36#ZXP/.5VT)QHO:&ME"$)\_F/%1^-M=) MWFIVBS]I5B3JGKH7('-KT`>4?00R0%3VDWK(BB,DJE7'`9*];_%A4J,3'TC) M:DU9:X9$U9H#\@\^6HV'I'N$1-4Z`_(#>WA(?]'C@H"LF/0W2TW;)F,6QIV$9XT;`\E3^62 MR>\6?T@R;=@>,JNC'Z+,HYP!(-TC#)EKA"B=KG&`9+9P%S5!E')-F6N&*.6: M`]*/FP4@Y5HRUPI1RK4&I%P;0,JU9:X=HI1K'R`SQ@.BE.O(7"=$*=<9D%[7 M!9!R29^C0DJ?HTI*GPM8Z:DM"SF0]DM7ZR[X4/A MRT_EF`^EMWRQ]H8/Q3>ED#_=Q'PHO^6+]3=\,(#EBPXP]8`%+%_T@.&#"2Q? M=,$S7[DMR,=3J2WH+[KDS_76B\2D07BH]'RN4T^^HM8-B3)E6*Z]`+6TY/T` MM6T+K'@^%Q3EY(N^WTW?:0U9<01Z/=(W!N3/$+;27_68A/]=+C*C-66M&8A5 M:P[(/VYI/S1I1W?-P)8LM@*SBJT!A>=E=^WD0M)8W`I>KQ*33^D[*CBZD9 MH\B.CE4'4-!!2C\,JF&4K724TAVO$H3![3!AZK81A(7;7K!YGYZ7D`W=58)P MN15<8#1&$#9NA].[#P_)`UWIKU<)PNE6$.:V(X25HV!Z^$#^AMY5@G"[%83# MK2#\+()JB4X]>9(L&[I75,N=NSAX>\,=>!&>]&L/E>[`._1[_O60J,VY%Z#2 MALY'R89.1UC1KT.4?%SF^C4ICJ"H'W3C`,GGG+\#3SYG)DC):DU#E/E4G2%1 MM>:`_%U5NWF7W.,L$)`56[+8"HDJM@84;N'N&\G(-@C(BFU9;(=$%=L'Z*59 M/"`EJW5DK1,25>L,R`_LOIZ>,+H@("LF_9K\(?TZ.LOTZX!E/2G].J9F3"G] MFE4'2-5!2K\.=&&4S70C(?WZ*D$8W%A3;L!#JA&$A<,-N$QKLIF0?GV5(%QN M!:.QC2!L#,]4]>NK!.%T*QC-;01AY2A8<2SF*D&XW0I&AQM!^%D$U1*=1K)O MDG[]BFJY7Q?'LV_HU_XT=^E%BH?*-^"-Y/E9Z==+`0JY>GK0LYD/9[6**=3=\*'SY!ISY4'K+%VMO^%!\4PK9(#(?RF_Y M8OT-'PQ@^:(#3#U@`TA>?P\C8N0.7;[D:R MA^Z&*/,:J`=(!]D')(TM;M!X&X>H[.?T$%'ZXFX4(//>:0S(OY5/'QY/0)*5 MFB)*I6;@U:8T!Q1NA%OUY-GE`C19L26B5&P%9A5;`_+C:J9'1S=@R6IM$:5: M.Q"KUAY0]1P>0)*5.B)*I4[@5:DS(#^'];OT3/H%-%DQ^2/0A>U+W]!SC\#4 MCR[:-FM(9ZRLOJUXBP(%':/\O6A_)<:3\@>C`X91=I+]OOS]Z'#]^6'"W6;5 MR1^59D$86%Z^%C+&[UX&H[0'@XZ,G)YF07(7^(^BI!V-P* MPMI6$$96P723"E^_",+@5A)U%4!W1::2JL/B+JN5>71POOWX+U_"G MT>T6+D#ELS"-Q%W=$&7&V`.D:Z,/2#][!H`T:@A(+3\*D)FN,2#]/N$$B%XLSX#6W!'S$OM04/)4_BDNU)MQ$2 MM?J]`+753'U`V:<>`T1E/[^&K#A"HEIU'*".?Q+7;"3/-2=(R6I-66N&1-6: M`PH/Q]JUY.'8`@%9L26+K9"H8NL`A8'=TZEFI&2UMJRU0Z)J[-SJ M15L;/9@XZ,DF+MW=1$_G!PB?6\$-KM4(PLDO"T9CYP5A=BL8#6X$86<15$=4 M;>)>F==RMRY./]_0K?UAZ5*W]E!RPYV\?.PV?)1Y-]0+D'W/':#\.\6!)NH\ MT,H8LN((]/JZ;0S(OVVC1C.Y2FO*6C,0J]8<4+CCOD__Q-7B*K$EBZW`K&)K M0.$UXGWR!&1SE=:6M78@5JT]H!DM*M8VI.M5^A"CO;5Z0P;WCK+"\QDEV$;&"O$H2_ MS;J36VZ?:@7AX/`2^)Z>[L//^6,1#AZW>K"UU8.)XTOGBFY]U0#A"L'/Y+7?%+? MF,D+6+):TM#(E-+0`J9S*1TM8-G)E$U:3-4//]X:1I/K$.6YHD\U\RFM+V!A M/]^X2_;8LDF[2A`>-VM/-FDL"!?+@[CBO4B#7E/`TR\^O_<_)P&?6SUXVPX0 M3@YZ8?MH?)[D?3W?;KR>_;)2\,>(%T;?4#Z(&$`2*.&@+1` MHP"9Z1H#T@^N"1*5:PI(N69(U`XQ!Z1<"R0JUQ*0`2G7!8G*)5V."BE=+F`F+A9-B MR?7BI'_Y.#-2Z5\!*[T783Z4W2XFU-WRH?"RF.+M,RIOWSN@])8/M;=\*+[E MJZB^;.'"-9OQHOZ6#P:P?'"`O3Y8P%X?/&#Y8`++!Q=XOG);D.>]M[2%(CQI M"QY*WHO01BXDZH&EGOR6?<%ESK+U``R1X%&H%>K MC@,D!X&*#Z\Z?4<8*5+,>$6D-66M&1)5:U[6ZC235\H+I&2UEJRUTD18?`TH M.Y,;1&45MZRX0Z*.;A^@EV;R@)2LUI&U3DA4K7-9BV;R@I2LEK0X;R1C$6EQ MT5R82]G(!2P[F=+U8FK&*W(+Z\.LZ@"I.D9IA#XN3"C_L%VT;[EJ0N%U*QB=;03A8Q5,-X[1UOD1 MPNI6,-K;",+,(JB&J-K'O3+,3PT7=1DBT#=M# MI88=('-$.22:J"%SC1"ETS4.D,P65MX$4;K?F#+7#%'*-6>N!:*4:\E<*XY: M`](Q;@`IUY:Y=HC2Z]H'R(SQ@"CE.C+7"5'*=6:N"Z*42YH<%5*:'%52FAR5 M4CH:Q_4K^`:(TZN3]N5SS5#ESI/Y4':[F&+=#1\*;_EBY;Z8`'+%SU@^&`"RQ==\,Q7;@O%X>H;'LCY ML]BE!W(>>NV!G(\RN]!>(T`ZR#X@F;JX:ZK8Q\5$C:*]U1!!\>` M_$.(VGWR>[X3L&0[^Q11JC4#L7:E.2"O=9_^):,%6+):2T2IU@J0SN0:4'8F M-XC**FX1I8J[`)F9W`-Z828/8,EJ'1&E6B<0ZTR>`;TPDQ>P9+6DQ9$II<5% M<^'31%I@2+FZ4G MS^,"M\ZIO*XHZ3725]%RQ"5<>'Y687.K!VO;\<'(87RRCTLWCL;7N0F-7E?/ M.#C;"L+'*LC[N*M&"*O;$<+>5A!F%D&]_JI]W"NJI8;=+,YN7]^PG\/+^[@` M)<_CDLGOAB@SQAX@;3-]0/H!-`"D44-`6J!1@,QTC0'I`Y<)$I5K"DBY9DA4 M,\\!*=<"B2&#S4W(W4HNI@_-E)4W3Z?0MF- MT1SJ;OE0>,N'REL^E-[RH?:6#\6W?!75=['\9KRHO^6#`2P?'&"O#Q:PUP>N5Y7(@RN]!>@,R-6Q^0W*!F]G&( MRGZ>#%EQA$2UZCA`LNLM/BQKZ0&<"5*R6E/6FB%1M>9EK4[ZJ\$+I&2UEJRU MTD0LF36@[$QN$)55W++B#HDZNGV`7IK)`U*R6D?6.B%1M+J>I>NK^01LBJ`Z3J&*41^K@PH0_IXUL7[9P? M)2QNEIXTRG"I1@\F#GKU]-N)+EHZKP>;6[UH;:,'(T?#\#X.5YD7A->M8'2V M$82/59#V<=<)PNI6,-K;",+,(JB&J-C'O:9:;MC%N>8;&K8_!EUJV.%DM+S- MC4VVTTS>VG>;(5'71B]`9FGT`>FSJ@$@W2,,F6N$*)VN<8!DMM#%)HA2KBES MS1"E7'/F6B!*N9;,M>*H-2`=XP:0KD_;E<\U0I6,Q'\IN^6+= M#1\*;_EBY;Z8`'+%SU@ M^&`"RQ==\,Q7;@O%`=H;VH(_;UMJ"^$(KOV0HS==W::/,N=^>P&RWV`(4/ZX M^$`3M1'1Y^60%4>@UP/Q8T#A%%(M_1:7"6V M9+$5F%5L#4@FWK3KY&L]FRK%QEWR5GS+BCO0J^(>T$MS>:@2H\(=6>P$9A4[ M`_)B]0Y][^PJ,6ES9$QI<\'2^ADF;6M*YXNI.NLT1-G+L2IL;8_!P\3A MFPQR9BW]'A@\__C9(=@^)^MG4!V0_`O@U"J*RN_(A*XXT M$1N\,:"LX@116<4I*\XT$8IS0%G%!:*RBDM67"%1/\G7@/QW3EMWZ?N;#0*R M8EL6VR%1Q?8!"E_'O$]_!_V`E*S6D;5.2%2M,R`_L&8]_;BY("`K)JT[N-H\ M*8NV5G=*ZPY6SY9.6G<(RZO"[&9)N`%2=9"RCPUT+Y5/=K57"<+K5C`ZVPC" MQVTO6.ND/XDHK?LJ05C="D9C&T'8.'A&?CP_>9DIK?LJ03C="D9S&T%86;\S MG'X:1F?G:PBW6\'H<",(/Y>_,TS?_8X>?TFUW+J+T]`WM&Y_>+JTXP[GJ>4& MP^SLTN\,-WV4^7CJ`=(%TV=HP-`0D*ZJ$2#E&C,T86@*2+EF@)1KSM""H24@ MY5H!4JXU0QN&MH"4:P=(N?8,'1@Z`E*N$R#E.C-T84C:'!52=J@!4S9I.6ME"$)^]9/93LZ)(6V6V& M1+VWZ07(/-7I`\I^9`X0)92Q$='-SI`51TC47CL.D#RV*%ZHM#K)<\4)4K): M4]::(5&UYH#\)V7C/OVD7"`@*[9DL14256P=H)<&MD%*5FO+6CLDJM;^%:T# M4K):1]8Z(5&USH#"+JZ9;D\O",B*27N3_[UPLAI2VIO'C".EO04L:TG9Q<74 MC">E";)JM+,.4II@H`NC?$@?,\@N[BI!^-L.,WK:",+!X1>8Z_S',Z.A1??E M52=ME$<8?6T$X>+@3SD6DVPD9!=WU0AA=#O":&XC""N_+!B=G1\AW&X%H\.- M(/PL@CIAG8I=W"O#++=KL>$M[;H(3]JUAY+CS:`].H7@)1KR5PK1"G7.D#F MNC:(4JXM<^T0I5Q[YCH@2KF.S'5"E'*=`>D8+X"42]H<%5+:G,=,):7-!4Q+ M*3V-XU!R:_Y8<[TZ:6`A5R]/6A;SH>R6+];=\*'PI5]@KN!#Z2U?K+WA0_%- M6:7A\/6A_)8OUM_PP0"6+SK`U`,6L'S1`X8/)K!\T07/?.6V4!S"ON'FK@A/ MVH*'RL>;TZ][=9L^RASJZ0'20?8!27#\I*AX+A>XLMUV""[=S8X`J>(84%9Q M@JBLXA11JC@+D#FW-`<47CJT.DD'78`F*[9$E(JMP*R-<`W('Y%M)WOK#4BR M4EM$J=0.D,[D'E!V)@^(RBH>$:6*IP"9F3P#"C/9;B8;@0MHLF+2Z8*?5$TZ M7?08/E2DTP4L.T)I?C%534PW&;*A"V%&=1`P,TCIASXN_'7R&HU2NN-5@M'J M1A#&MH*PL9RK*VYL[OF7_*[3@]'-DG?PMM6#DX.>[.>2!2'M]:H!PNQ6$`ZW M@O#SRX+&WKD21LN;&87!K2#L+()*UZ'?W(+%Y?"BAEGCE!MW<2;ZAL;MCU"7 MGLIYJ'S,N95^7:T9SE[K&'N`=/'W`>D'T0"01@T!*=<(D$:-`2G7!)!&30$I MURQ`9NKG@/0]T@*)RK4$I%PK)-I>ZF="JHB6L$&BD8#X`T MZ@A(N4X!,F,\`](Q7I"H7-+EJ)#2Y0)FXKK`]-*DI7%<++E>G+Q6"%.DLR;] M*V!Z>=*QF"^6W?"A[F:T\L(W\&D9Y#T!\Z'TMAN@]I8/Q3=EE8;#?&M@YOI0 M?\L'`UB^"@?(4[F@8?C@`7]W,!*C^5:Z7??D"B M[M)[`3(W!WU`LCW.[.<0]5+?>_X9FR$KCI"H5AT#PCNE=O**9X*`K-B4Q69( M5+$Y("_VT$G_JO8"`5FQ)8NMD*ABZP#)OE[GLM-*C\<@T2KR\1A6W"%1%?>J M6&P$.HWD7?L!*5;+?EX]U^W(6B-V M76!99SKC:9UT&J*#S^V]V0`*.D@'#X=G94W9ZY1_'"9M;P>AL(P@? MBVF*$CZD)731U7D].-WJ17,;/5@YZ%7MY3`M>4&XW0IND&H$MP%[63`:.R\( MLUO!:'`C"#N7ER'OY7"M+ZF6]G*MXI#Z]7NYY_"D:?MC[DG33M90%XFV:8?S M\;H#Z(,%D'))E_-5LV9]K(A# MP4TII:51Q:5_,=\`<7IUTK]"KEZ>="SF0]GM]<6Z&SX4WI1!.A+SH?26+];> M\*'XEB]6W\P?RF_Y8OT-'PQ@^:(##!\L8/FB!PP?3&#YH@N>^W=:/]V/)0^9%]^O>5NB'*7'TO0*6]G.,%D'))6P@.T##9_(2RF3@4W)12V@+']2OX8LWUZJ0MA%RC&ZMN=%%V M8S07ZV[X4'A3!FD+?'THO>6+M3=\*+[EB]4WUX?R6[Y8?\,'`UB^Z`##!PM8 MON@!PP<36+[H@F>^AW0Y0]F14@IYO;`<3D MQC?>#=)F>LAB(S#KN>\QH/#LMY8^MYI<)39EL1F856P.R(NU:IUD@A97B2U9 M;`5F%5L#PE]72&Y@-U=I;5EK!V+5V@-Z:18/5XD=6>P$9A4[`PJSV$Z/[%ZN M$I,NYVULW"A=+IZ`QWY.;O$\]MH7(#0UXTK9(K$J#&T6@?3"H.I'V>ZTDI<2 MLF&*UYH3A,/M,&%J*P@+XPL0[4[RDD=:YU6"<+D5A+&M(&P?U&UW+6+D\6V:[_2J_U! MY%*O#F>32V\1TKFLL#`K)B1Q8[(5'%SH!>FLL+`K)BTK'))M*Q M/6;N,*1C!RP[G;)5C:FY!@J/&[^X:&L=I'3L0.='V6[7DF?=TK&O$H3/K6"T MMA&$D66[]_Q0KIXX5!KV57JPNM6+[C9Z\'+0DX:="AIKYV84=K>"T=Q&$%9^ M63`Z.V\>3; M;85$V[`]5&K8`=*H04@T*VC(7"-$Z72-`2G7!)#>O4R9:X8HY9H#4JX%(.5: M,M>*H]:`]"39!I!R;9EKARB]KCT@O:X#(.4Z,M<)4<="3F0^DM M7ZR]X4/Q+5]%]1W*;_EB_0T?#&#YH@/,/,,"EB]ZP/#!!)8ONN"9K]P6I&7= MTA:*\.19O8?*]]SI>\INRT>9U]<]0#K(/B`Y(!-OJ?G`'**$,D95W'B3XB@D MFO?18T#^=%`]_3,5DZNTIHC2E]\S$*OMYH#\O52C]9#<"R]`DQW8$E$JM@*S MBJT!A8$EMVT;D&2EMHA2J1UX56H/Z(4Y/(`EJW5$E&J=0*Q:9T!A#MNU9&`7 MT&3%I+O)_RY&-GZ4[A8P-:3LX0*6=:3LX6)JQI)RU\VJ@X`94TH/]''AD%SC MGF[68.47#U?Y1V2PMQTF+&T%86`YE5'LX>KI_9-TS*L&"(M;/;C:ZL'#T+M+ M[Z$<+/W*`&%S*PAO6T$X^65!&/L509C="L+@5A!V%D%U!#\]@<5?5"TW:[F3 MN*59%^%)L_90^9!<.STD5_3R\N+H`=*UT0>D'SX#0!HU!*3+>A0@,UUC0'H* M:H)$Y9H"4JX9$K5%S`'IBZ,%$I5K"4BY5DA4KC4@O:X-$I5K"^A_.3NWWGAV MY;I_E8/SGF.-I+\NAFV@M^YWC>[2FW&R$P=Q[,!VC.3;9W%8BU7-5<.9V4\" M?BI6D:S5U6PV9\9]O;&A^WHG_3'QN)C"&D[] M,?71'W,?_3'YT1^SCRNQQ6#ZHS_F/_JC`*(_*B#ZHP2B/VH@^J,(HC^JH/J; MEX5RGGB'1[MZ_'CV:%=125%;41T?=1L'9Z5J]&6AHM#Y"[.R>]?Q8;\O?DDW MN*.T8,GR38)=>T-FZ(8(QLV7+!AO:36,>$]H3"\!Z*Z`%GL8?]A?NCI MD7Z&T9YHY=&>Z=JO\R51O2\O^A]2?J&78:Q76GFL-R)7^SO1<"X_:#6,^$DK MC_AE*,SE-Q'G$DOB^5S^T,\P&NJ+1[''>D5YQW@4 ML\7#)='E$`U'@,2$6O#Q@$/LIA$WV844H\!J2@$=#='1]U._\3 M1;[E4.C7`Y'WZY$-W=<3D?MZ9L-83FW8OHYX M84/W]4KDOMZ(W.J=R,?X0>16GT3NZ\M0&.,WD8_QAPW=%\J<)!)ESEBP:PGW MKJ&FJ1U3'J\VYCST#@7,ILV[AXJE_EK:?;`X$&-M/0L3$X^+B5+#`Z;Z8^IC M_YC[V#\F/_IC]N/R:\D8H7_,?_1'`41_B0*F)H'@CQJ(_BB"Z(\J2)9SY0W_ M#F5A93Y_RC,T/SY[U)VM/V-#WP<^-Q1WZHGL==))OT-V28/A+?I*@UVSH:OT MQA#V+LM]ZU"^#)1-AK'N--8]&WJL!Z(ZL)/3XWX=1X-AL"<-]LR&'FQIR`:V MW]TW7MAB&.I50[VQH8=ZGX>2.?Q@DV&L3XWUQ88>ZYN(<]@O-'YH,`PV31IM M^LV;MB)!R>)=@]_O9+D_-1F/HUXD49N:?9`3M6L?<0O_ MEL,,`2E@4\LO_:5L-AK'H\1CO$`E+.".C"D<\W34WBZZ+.'KMQQF:G.ET/@L?EV\K#W_]Y M_D;UH'N=?69688SGAF9UVLZ9>S6_I)4O#:[4US6M?+IN#&&V>.G=TLI]W:FO M>UJYKPJB=U%XJ_EW'N'^B720,72N$Q[$-K4 M\A[\,?$A#5/+?!@'4Q_]M=P'?TQ^]->R'_PQ_=%?RW_P1P%$?TT!P1\E$/TU M#01_%$'TUU2P\C$[9FNO0HNB>J^RG'_XQLO]#*,]4HKC_5&Y'/Y3C2*.$2EEBXCO=.]VUE$^MPI( MM<>)?>1P7*83U8P'SM7KW+U^#QX+NJT"4O`Q($4>1TA)KP\8%#Y*8E-]F%)J M/`:DHA'0W1T?]=N.5/EV^W'E@/0NE;N>0Y\MZ.QH>A3TK.+.S!^>& MPA`OB'S3Y9(-_1JZ(O+YNB9RJQLBOZO=$KG5'9'[NC<4^O5`Y/UZ9$/W]43D MOI[9T(6Z)/*-H!:B#Z MHPBB/ZH@VX\KQY=W6-`5\VX_KJ+Y?ER_WW16_ET:^N/!N:%P)O:":+@%LZ%+]8:H;O(LY(7G+0V&P>XTV#T;>K`'HAKL]%=_D/"1!L-@3QKL MF0T]V-(0%O9VFYR_?7QADV&L5XWUQH8>ZYUHW2Q^T&`8[%.#?;&A!_LFLED\ M[F?QAP;#8"AP(DDLY"H+FL1"SMA0E*AYK:G?M+.%G$9M@O9!H@R:.YO2O=-^ MF*B*6T6DQ,.EAT)I34-$:M@$$==Q6 M`:GT&+"I.P2DEM<';-(>*X=RCP&;PD-`ZAD!71+'#G=O4/! MKH?!9^NXBN8;<[J.LX:Q8%<4+HZ+X@1E/>SF7!+YO?_*4)BO:UKY=-T0><1; M(O=UI[[N:>6^'HC/JE58U9X; M"HO0"Z*ZV7(D+R,NZ0;>VMD.N5E>T[9FN/=J2J([LM*_1+_0RC/5**X_U M1L<>ZYUHS2Q^T,LPUB>M/-87'7NL;R*;Q?W]?F0_]#.,AMJ&_T/&08VH;<;" M-7=&%K'IVY/%4NXK0)2Z3$@U1T#4LOK M`U+::S?%ZF='*/<8D!*/`2EH!'1)9$NX#<.Q2JXMY5ZLKZH[&=>OG MLZ-J%<9X;B@,\8+(MX,NV=`OH2LBO["OV=`O[!LBW_*Z94/W=4?DON[9T'T] M$'F_'MG0?3T1N:]G-G1?2R+OUPL;NJ]7(O?UQH;NZYW(?7VPH?OZ)')?7VSH MOKZ)?(P_;.B^4.8DD2ASQH)=2WA81C#C<6N**0_"P!*N^@O*0`$SYMU#Q=*X M3'OTQ[Q'?TP\+B:NI%&1U!]3'_TQ]]$?DQ_],?MQO$Q_],?\1W\40/1'!41_ ME$#T1PU$?Q1!]$<55'_SLH"[TRYEH9AW9:&B\MC<5E7R'']V9`U]87YN:';D MHEK9N:!?B_UN.^"2;5#Y6K!D"2?!KKTA57!#!"TT7W)_OJ75,.*=687U]3T; M^G7Q0,2M.%W'V?B'P9XTV#,]>["E(2SERVUYL>ANRR]L,HSUJK'>O"&G\IUH M.)4?M!I&_-2(7VSHH_LFLJD\ZH?W0X-A,%0YD0JJ7,L"!X@'56/#$6(QUYJZ MID2?6,QIU"9M'R1JH;E;-TI4QJT"4NM!G]B.LZ8A('5LHCF2X_A-U>-II=)C MO,'S#(>Y1"2CX&;`(/`2EG!'1W MR3>/;!KFO&B7D]T[;,?5@^"S[;B*RE9&JWW):U5K&(MV1;.B;4V M$3;MK@R%^;I6JQLB_X:/6R)?<]RIKWM:^=0_$'F_'HGJ:5^UH:0A99 M$EYHY;Y>U=>;6KT3^1@_B-S7I_KZHI7WZYO(Q_A#Y+Y0Y221J'*2(U0Y8]XU ME#2UNTC\M9Q[[U"_K*UW#Q5+_3'M01PH3V87_#'Q(0U8RZD_IC[Z:[D/_IC\ MZ*]E/\P?TQ_]M?P'?Q1`])HVX[KGJ_/S"JL1,^)?-(NB%"_6XF1Y=4EK8;WDRM:^8/--9%'O"$: M1KREU3#B':T\XKVAL-A^(*I[2JR&]T,WPV#31#./-OU& MY@.`U'4,2!7C M6;`\`QR==E?R1$WCP7`4CSH/5_ST:(..\2ADBX?E7/<]N!-UO2$@M1X#4N$Q M(/6\/F"0]VB$3?)A1BGP&)!R1D!W=ZRGY*B(=?,ZK]OEY/CVR[GC>M`\+N<, M;=B:,ZLPJ>=$?FU<$/E]Z)+(K:Z(?+ZNB=SJALA]W1*YU1V1^[HW%*;^@T`L;NJ]7(O?U1N16[T0^Q@\BM_HD*I?Y: MVH,_YCWZ8^)Q,7%5C8JD_ICZ.%[F/OIC\J,_9C]NI2T9(_2/^8_^*(#H+U'` MU"00_%$#T1]%$/U1!13RI(Z>Q6@IY$7(JSIZ$Z-W(1]"/M71 MEQA]"_D1@B)@^?:TH0A4YGG#2D>09G=B>H,&4`&D)3,<_&N&)Z8X.M,D3\QR M<*99GICFZ$P3/3'3P9EF>F*JHS--]L1L!V>:;5SUF@!-^,2,!V>SC,]7`N4H M\0Z7?#UY/+OD[=`R^M:>NG1CY[A:A>\Y/S>$3[&Q%E\0V:)\<=(M5R_-H'P) M0`LFR^,K#79-SQ[LALA^U:`_>'B[5:P[C75/QQ[K@- M]DS7'FU)9"/K?XCB9:M8KQKKC8X]UCO1FEG\V"K6I\;ZHF./]4W$63SI/U7] MLU4T5#)1(RI999`6Y8A25EGYO'63F^PH8(73FKJ9J!(E3Z-2T.$BP*+'HMHP MCP[Z!&(-M%5$2CQ<=1-E'2-2Q/A`T>K-S;X$I*;'%QYJIPZ1RHX!J6-\D&$5 M,/F!Y>U&2*G'$5+>,2#%O#X@M;UAA-1[#$B-QX!4=/FH1I/.\7'W_1T35;XV MZKQ8EX/".Q3K8MYMMU74K<^Z9^:S8VOHE\*YH;@+3V1'M_?W]KL7?I>T6/=, M6C^6JM&NV=`?(VX,86.R*.:@_^3%+9L,8]UIK'LV]%@/1#:RHY/^2TP>:3&, M]J31GMG0HRT-VDSF/`INP0D#HVA6*3K3L-BDVV ME@ZO=GH'I-1CP";O$)!B7A^P:7L\0NH]!FP:#P&I:`3T_B?GWS8-0]6UI7M.&=*38I5F4^5NN*9M7:D%M=6L-P#5VIKVM:^73=&,)L<:ET M2RO?#+I37_>T:.6^7M77&ZW$Z6<8[8E6'NV9KKT*+HD83;YB'PRWXF& MD_E!JV'$3UIYQ"]#83*_B6QX1P?]^'[H9Q@-E0[_GVL3E+Y MNS4=2!3/WQJ5Z@ZC1#VL=OQ`@PX3Y7&KB$WO/JUX_C;O+AML3,XC[AUV.^:H MGUL%I-S#18_7IAJ0:\=./)8I?27FU2ID\?RX MHC#$"R)_-W9I"*-AS;\B\OFZ)G*K&R*_K=T2N=4=D?NZ-Q3Z]4#D_7ID0_?U M1.2^GMG0KXPED?MZ84/W]4KDOMZ(W.J=R,?X0>16GT3NZ\M0&.,WD??KAPW= M%^J<)!)USEBP.R/SKJ&HJ1U3'H2!ER:B#%0P8]X]E"SUU]+N@T5]4G],_.S+ M11)_3'WL'W,?9@_O3BQ&>$7![`?MHKI8GT/_F/_HCP*(KSD3!4Q-`L$?-1#] M4031'U50^SU] M/-)@&.Q)@SU[0];.)=%P*E]H-8SXJA'?V-"']VYHW51^L,DPUJ?&^F)#C_5- MM&XJ?V@P#(8B)[)$D:LLZ!*+.6/#V43=:TU=O_*\@<6<1FVB]D&B%)J[.LK# M_8/N^0:%<:N`5'E\&FS*#@&I8TOAOBPYFJK'TTJEQWA-W"$>I_WG4O"L MO-4`J?88L&D[!*22UP=LPAZ/D&*/`9O`0T#*&0%=$2R)<)5^KKFE8^73>&,%NL M8[>T5N[K@U=<;K;Q?[X;"&#]H MY;X^U=<7K=S7-Y&/\8?(?:'*F0+<#%6NLI!)5#EC/DR4-+5CRH,PL)0S.^\= MZI>Q$+=E/?2/:8_^6MZ#/R8^3!T>+K5_3'WTUW(?_#'YT5^2?2SE:HSHK^4_ M^*,`HK^F@#!>2B#Z:QH(_BB"Z*^I8.5O5A:P"MRE+*S,YTLY0_/-N9/NA*&R+Y9H?\2^5MZ&<:ZHY7' MNJ=CC_5`Q*U'^>JO1_H91GNBE4=[IFN/MB2J(Y.7K'0R#/5**P_U1K\>ZIUH MS21^T,LPUB>M/-87'7NL;Z(VB7(DAGZ&T::)9AYN^HW,)3DUY0XU.04UNW23 M51PCA*B7QO"'LIRH7F[)[9_N=6<-)JIY[4Z._9IJ$I&JCA&I849<''9W]HF2 MWA"0,@^7^D1AQX"4<=LATW4`[Y8TQB08EX?D-K>,$+J/0:DQF-` M*AH!71/).F[3,.<%NQS>WGX==U+/>L>7K(;F6W(GG;S.S"J,\9S(KXX+(K\! M71*YU161B_[:4)BN&R+?([EE0_=U1^2^[MG0KY\'(E^^/K*A^WHBKQ2^OMC0?7T3^1A_V-!]H<[9:7]W MACJGGP!H"?=4HJBI74MY\,>Q.3'[>\F/WHC^F/_IC_V#\*(/JC`J(_2B#ZHP:B/XH@^J,* MJK]Y62@GI7K"E(:SGRV;C85>G7]AB&.I50[VQH8=Z)UHWB1\T&`;[U&!?;.C!OHDXB?W( M?F@P#(;Z9E(.SXO4(S81!TB4L*FEV/]NM_MXE'D,5[3=8A'%5N\_60[;KN`%'H, MV-0=`E++ZP,V:8]GE'*/`9O"0T#J&0''R[@->9S7ZW)N?(=Z78^9SY9Q%B!R7X]$[NM)?3W3RGTM#2&+?,IZH97[>E5?;[1R7^]$WJ\/(O?UJ;Z^:.6^ MOHG41_&WG'OO4,"LK7W1 M7\M[\,?$AS3@P5+],?717\M]\,?D1W\M^V'^F/[HK^4_^*,`HK^F@."/$HC^ MF@:"/XH@^FLJ6/F;EX5RK'B'LE!/(<_*0D7==EQWO.:L/)+.SR.=&PIKT`NB MNM=RM'_4O>B\I)MAH;VBE3\Q7-.S7XPW1-S8Z1=5MW0S#'9'*P]V3\\>[('( M@NW_VN]?J]+/,-H3K3S:,Y&+94DTW$)ZH=4PXBNM/.*;H9"Y=Z)UD_E!-\-@ MG[3R8%_T[)/Y3;1V,G_H9Q@--4Y4B1IGS*<3-<[8<#Y1]EI3OV]G6W(:E<(. M4XI*6.VPFBD+\<7!4:\9%,:M(E+J\1&0ZHX1J65X+1%/Y#LPJ&P\#XY&2+7' M>(\<1C\0VPAHO7-?-1'G'`5+,-L`D(+6]8834>QPA)1X#4M!E MH.T%0[8CMV&8\YI=3F;O4+/K0>Y9S:ZHVY'K*M+92;4*8SPW%(9X0>1/]I=L MZ)?0%9$GZ)H-71`W1.[KE@W=UQV1^[IG0_?U0.2^'MG0?3T1N:]G(K=:$OE] M]H7(K5Z)W->;H3!?[T3>KP\V=%^?1.[KBPU]C-]$[NN'#=T7RIPD$F7.6+!K M"?=AHJ:I'5,>A(%GT6H71HH"9LR[AXJE_ICVZ(]YC_Z8>%Q,7%%C*:?^F/KH MC[F/_IC\Z"_)_M32[\E`=='Q4@#1'Q4PWY&S/@=_U$#L'T40_5$%V8X[8;(=CWD,PBW-!@&N]-@]VSHP1Z(;&B'I_U+W$=:#*,]:;1G;\B) M7!(-MS9?:#6,^*H1W]C0Q_=.M&XR/V@P#/:IP;[8T(-]$ZV=S!]:#*.AR.'_ M1<\N2Q2YRO#;`9Q.K.6,#><3=:\U':ASHLQCU"9L'R5*H;FS8>)JZ+9P41FW MBDBIQXA-W2$BM8ROI5RM'H_E?6Z3-N*NOP`GRCT&;`(/`2EG?$U:"8BU5??P M-@5UCP)2\3%@TW<(2#6O#]C$/1XA!1\#-HV'@%1T^2*X-F'98FY#(N>+.>AP MEZI=S+NJ75'W`-X=PCPKV]#]`[@AOSHN:#5\T+FDU7!:KVCE%^0UD4>\(1I& MO*75,.(=K3SBO:%P6WT@JH]5QXO^Z-`CW0R#/='*@ST3^?"61,/AO=!J&/&5 M5A[QC<@COA,-(W[0:ACQDU8>\$( M4<%;4[]:97V!"JY1*?`P2%3P:F=/XRH;%/"M`C;%^Z1.U'<,2#5C];>JI_J) MM>WB4>_SU;`-QI\E\#!NK#V,:_W>:H!-\V&`5'@<(/7,`>H-(\A[E,(F^1"0 M`H\!*6<$='=9_=XPS'G]A@IWJ=_%O*O?%74/X_U'4_!-`U*_#?G%?T$KOVM= M$KG5%9'/US616]T0N:];(K>Z(W)?]X;"U#\0^9/@(QNZKR2^O@R%,7X3^1A_V-!]HS;T*^6!J#[\'.SWP1YI,`SVI,&>O2$? M*9=$P]E]H=4PXJM&?&-#']Z[H753^<$FPUB?&NN+#3W6-]&ZJ?RAP3`8ZIY) M/%QG3>,N5=0]T_UP-E$*S6PJHS7U0:(Z&K-1RK='HE9N%9`JCP&; MLD-`ZMA2F"SNM@I'H<=P3=LA')5,Q>PMNG,;>#C?*B#%'@,V:8>`%/+Z@$W7 MXPQ2ZS%@TW<(2#4CH!>A;'&W89BSQ1U>HN]2Q5?F\\6=H?G#^6E7^L[,*MPC MSXG\TK@@BF56JSBMAM-Z12N_&J\-X:;G$ZA5G%;U*>&TVQR^I=]A]#M:>?1[ M^O4GD@>B&NK7?G?O>Z278:PG6GFL9R*?VR71<&Y?:#6,^$HKC_AF*"PHWHGR MB?R@DV&H3UIYJ"_Z]8G\)EHSD3_T,HPU333S8--O9#Z54U/S<"ZGH/"@-_E1 M^Z;Z$/62`_(Q3E0TUF?E<3EY5^Y='<6[H5F(1U6']$W4L,63[5P*&FO#43B* M/%SZ$X4=PU'&%@Z[JU+`V?%QP*;T,#[J.@:DBM<'I*@WC)!"CR.DNF-`:AD! M?<*2`KYIF/,"7L[AQV7X/V&!NOCU%W3F3__Q3__CK__SMW\MX,]_^K^+PW_\ MZ]_^U_]W_ON___7W?P';^TOYYMSZD8'3>IH_OD$W-']H[S\9=F968>CGAO"' MZ\<+(E_\7[*A7U971)ZW:S8\:+YNB/P5Z2T;NJ\[(O=USX;NZX'(?3VRH?MZ M(G)?SVSH8UP2^1A?V-!]O1*YKSO%N5`=:P62578_^5EH9Z_GI4%0[XP/3L5=&[HP(^X M7BBZU(97BJZUX8VB6VUXI^A>&SXH>M2&3XJ>M>%2T8LV?%7TI@W?%7UHPT]% M7]KP6]&/-D0-D$2B!E06,HD:H(P97[@N)J8\,N8\^F/2(V/68UNF/3+F/;9E MXB-CYF-;ICZR)/=3DOR)V8]MF?[(DOQ/B0`F*B"VI00B2S0P)2*8J(+:=EX# MRM'P6`/^V(JA'C"?E8:*RK?NMTVRX]/N'R" M5O:Z?^_7X:]NA7A)D^$"\4I[<,V&PQ[:&5[.(OC7X?=X^DC388]>-(>/+/AL`=+6M4>X(SW47>F\H46PPZ\:@?> MV'#8@7=:60Z.#XZ[@_@?M!AVX%,[\,6&PPY\T\IR<'2R?]I-P0]-ACU`N94K M`>6VLO&E@`I-T$Q(LD M.N-E$^N7&AZ%(;7BFZUH8WBFZUX9VB>VWXH.A1&SXI M>M:&2T4OVO!5T9LV?%?TH0T_%7UIPV]%/]H0Y4H2B7)56<@D:I,R9CRN9)CR MR)CSZ(])CXQ9CVV9]LB8]]B6B8^,F8]MF?K(DMQC=:CSPNS'MDQ_9$G^L3I4 M?U1`;$L)1)9H`*M#]4<5U+;SVE!.;L?:L.$)L1[TGM4`0[YK<'8JZ%S1A:)+ M15>*KA7=*+I5=*?H7M&#HD=%3XJ>%2T5O2AZ5?2FZ%W1AZ)/15^*OA7]*$(- MD$2B!BA+$HY%B=HE*9^2G&.YH6V3K$])VJ6S%(WZVL1T7*:59U[F*NLYUB_BST]3*'[?FG<-" M53JW?_H7=&13_TK+KG\5=?WKCSN?IE;^0#KO7WDG_`-9Y_#-,DGOMIJ]VG0^?62S+I[T'PXX6V/FVQ5='\L^=9S!\7UQ ML5?WM>/4D>W[WCEZ4>T".T_81<(N$W:5L.N$W23L-F%W";M/V$/"'A/VE+#G MA"T3]I*PUX2])>P]81\)^TS85\*^$_:3L&G*X&\9S*0P95J8,C%,F1JF3`Y3 MIH M4Z>/KFR4K?)=RH9MP7N)@%@J*W?+=C,]V>OV/B&?9L8W55"/,(A'&+0C#-(1 M!N4(@W"$03?"(!MA4(TPB$88-",,DA$&Q0B#8(1!+\(@%V%0BS"(11BT(@Q2 M$0:E"$,E$89*(JQ4$H51',SZE$FA5!)MGHFA5!*US.10*HE:9H(HE40M,TF4 M2J*6F2A*)5'+3!:EDJAE)HQ22=0RDT:I)&J9B:-4$K7,Y%$J2;3L*DG93=VE MDM3=U_D"Q)B_EH56A$$JPJ`481"*,.A$&&0B#"H1!I$(@T:$02+"H!!A$(@P MZ$,8Y"$,ZA`&<0B#-H1!&L*@#&$0AC#H0AAD(0QE0QC*AK!2-A2B;"C,I%#* MAEIF8BAE0RTS.92RH9:9($K94,M,$J5LJ&4FBE(VU#*312D;:ID)HY0-M91* M$BV[2E+V$'>I)+;G.*LDE6%OK1QA/EP<'?0[1XN]9A*JB#`(1QAT(PRR$0;5 M"(-HA$$SPB`985",,`A&&/0B#'(1!K4(@UB$02O"(!5A4(HP"$48="(,,A$& ME0A#%1&&*B*L5!&%J"(*4444HHHHS,10JHA:9G(H540M,T&4*J*6F21*%5'+ M3!2EBJAE)HM21=0R$T:I(FJ92:-4$;7,Q%&JB%IF\BA5)%IV5:3L^>]21>H[ M@OECC+TWB!LB1P?=*1C(IYF%2B(,XA$&[0B#=(1!.<(@'&'0C3#(1AA4(PRB M$0;-"(-DA$$QPB`88="+,,A%&-0B#&(1!JT(@U2$02G"4$F$H9((*Y5$(2J) MPDP*93VBEID82B51RTP.I9*H92:(4DG4,I-$J21JF8FB5!*US&11*HE:9L(H ME40M,VF42J*6F3A*)5'+3!ZEDD3+KI+T+P0WO9'1-X&+/6.S#1%AD(HP*$48 MA"(,.A$&F0B#2H1!),*@$6&0B#`H1!@$(@SZ$`9Y"(,ZA$$R*AEIHGR1D8M,U64-S)JF>FBO)%1RTP9Y8V,6F;:*&]DU#)31WDCHY:= M/KJRD;ZJ__47+%DV%1!]5;_8,U8^2O>?__!?NN.G4%#[?WQWXV<-NK[UK^DW M]4C?SR_VC,U*FC#(6!A4+`PB%@8-"X.$A4'!PB!@8="O,,A7&-0K#.(5!NT* M@W2%0;G"(%QAT*TPR%885"L,HA4&S0J#9(6AI`E#21-62II"E#2%$*3"3`NE MI*EEIH92TM0RTT,I:6J9*:*4-+7,-%%*FEIFJB@E32TS7922II:9,DI)4\M, M&Z6DJ66FCE+2U++3Q[QL+/KS,QO*QLJ^.S1C;!_'4<)+9C_N9'N\;N;/5,HN M%LHN$W:5L.N$W23L-F%W";M/V$/"'A/VE+#GA"T3]I*PUX2])>P]81\)^TS8 M5\*^$_:3,%023=ST6P;/,GB>P4P,>*9*`F5RP#-58ID)`L]4B64F"3Q3)9:9 M*/!,E5AFLL`S56*9"0//5(EE)@T\4R66F3CP3)589O+`,]7,LJLD.YYR6R2G MW,CB`D09I&)MW0Y*$0:A"(-.A$$FPJ`281"),&A$&"0B#`H1!H$(@SZ$01[" ME@F#.,0.VA`&:0B#,H1!&,*@"V&0A3"4#6$H&\)*V5"(LJ$094-AI@4L0!++ M3`U8@"26F1ZP`$DL,T5@`9)89IK``B2QS%2!!4ABF>EB6F:6F3*P`$E\9MK` M`B2QS-2!!4ABV>FC*QOEV,H.F[K8S>T//2_(O!Q`*V;G#%(1!J4(@U"$02?" M(!-A4(DPB$08-"(,$A$&A0B#0(1!'\(@#V'+A$$<8@=M"(,TA$$9PB`,8="% M,,A"&,J&,)0-8:5L*$394)A)`3NXB64FAK+:4)^9',IJ0RTS0935AEIFDBBK M#;7,1%%6&VJ9R:*L-M0R$T99;:AE)HVRVE#+3!QEM:&6F3S*:B-:=F6C'%O9 MI6S8,9?X1GE1F7_N%5+I$832(\BD1Q!)CR"1'D$@/8(\>@1Q]`C2Z!&$T2/( MHD<014#=#);7]7$&_]!W.2P6]:T_4L6G.ER%QOQ[&C"SC?E#HGSA.&:[FAW4 MM_S[\DU>F/QFP8"8_>:<#-,O#//?VJZ^-5R^5!OI:!;TA'R()R2DL<%PD*3F MS@)VNWS(6;-@0"2M.0?KLE9>C\:L;7I>KZ]3Y^FI;!]1PO-Z_R&A!3XV7NZT M^WB-TLRRC)D9]E+=K/]$/])F9B?U^`9^>K?_]@6DT6RPA^&N^B^]0V9;QSAE MR.PVO4!Z9[TX.#HX//6//:WV*9#N;7H!!;1>##H+!6S3,GI8?=2 M&K+8T+%.*>7UURY*J:_+YDJI[`#K[I:0D[UNQG!M6U/TKYEE2C$S_ZXOR,(B MS+78G>R!,LP,U:Q%..F_5A#*:!T)RFA-R2"#RG[%;_.4+PN%$J0ITMY">$]D MK$B[-$6.MXF*-,>F74[+"XM=Q7E(/,+G(J39'`%I7)PJ4M=DC@-B&00&F*!+80@X$A@6;FO]R+!!JK M-6QQ<+`G/X_2;-;5L"ZA_1NE3>4\>8^$3^*7.CV_2/O?%T)"K6G,2I90,YM= MI!:A_H;)P>'"7T*M:B9R:1;Q^A3G2&_K0TBO!$1ZYP%/3[J`R.PV`9'L%G"< M;.D#DCWK`XIO=X/$A;JA#UVJR\[\+M>N[>3/KMW*NFM7/LZ%GT'>ZLYM9BYQ M7+O&>)ONOZ,)J38+_%E?&)!J,W,=X4HVY@&1:F,UX,'!:?\]H#/^HC( MM9D-*Q8N;#/S3B#7QCCJDP/_+.]*X4BVF>!/VHEYLO=W?*VRLN]>JQCKKFLY M.L^F&ZYKFGD^+A:,,+OYZL5-LWAQ'^QU]^@K>L,JQ2]N;TIV0[M--U]M>L>F M92&4)F&5JWN:'?B7A3Z0C:,^TJPV[7):=A_C!?S''IC*:[+N4_L+8]UU+6_0 M:#94^'GS%N_)UG33/9D1O"GR6CN,YP#F\+HQMT->J]TXQ"W-]KTI\MI"C/-J M9O'2M:8'<2EWLI!:S0CQ\HT:[E)=-AYBJC?+4+MQ6'RW(V\FPW^K.\%I&`1A],#*9C9<'J@ M#@MJTY,\BD,M9H,_:<(.^1*&_#1W>C5#);-D M;"JAQ;Z_;(WYK0*3+@PS+`PS+`PS+`PS+`PS+`PS+`PS+`PS+`S3*0S3*0S3 M*>PI8<\)6R;L)6&O"7M+V'O"/A+VF;"OA'TG["=A>*^CDX!3)`G,I(#W.HEE M)@:\UTDL,SG@O4YBF0D"[W42RTP2>*^36&:BP'N=Q#*3!=[K)):9,/!>)[', MI('W.HEE)@Z\UTDL,WG@O<[,LJOAN&O,RD99!.QO<\2V[%-+`3%F1VR[ASHH MJ/W?R^')PI]LNKZ5[9]X?]E4TNIVT6Q'==_8K*0)@XR%0<7"(&)AT+`P2%@8 M%"P,`A8&_0J#?(5!O<(@7F'0KC!(5QB4*PS"%0;="H-LA4&UPB!:8="L,$A6 M&$J:,)0T8:6D*41)4PA!*LRT@!,NB66F!IQP22PS/>"$2V*9*0(G7!++3!,X MX9)89JK`"9?$,M/%E`FCE#2=NDP:I:2I92:.4M+4,I-'*6G1LBL;99MPE[)1 MMQ7G9:.R\A3;%L(G_>\V0C[-C$M(J$<8Q",,VA$&Z0B#FB+$#4,E,&CM@FEIDV<,0VL8N']8UO39?^Y?T0E\[=F9PMGOMJ3M^F8[>IN<%;.+;@>Q.Q;)SP@ MIE\8YK_WWCT](QW-@MZ1#_&$A#0V&`Z2U-RM.ROG%@R(I#7G8%W6RKN&F+4- MS^O8J=?T5%8V.GWAO=>]7D+&S`S["')_U1`"1[FTX@_ZT3@[XB_]OT M"Q=NUZ^CD^[\`S2QH5^=3,I+AEUD4E]*S%95>%]9,3#-@>5S2_]A;R4I]FF2]^\^;H;.:UL M_,8<.96FN+"-N4200+%#`K<)@01*4R2PA7`I24U#`LTLOI0W5I8#KL+][@:" M!+:H;K;^I?Q!>3NR2T[M;I'>;B,AXBSCH&#(NG<`E M.^O$$'FFGF*L.EWIJ&6EW9N)I`"](4 MB3>&/^O'BL1+4R2^LG%49#\V[5)=MDYCJC7W6S:KX6JFQ>8Q?="A;7ES5%61BFQ\QFTDR6S!:TEMWDYQR1 M0#/95'9;OYAGY'2;3B#-LTXDZW9D?9M.0`BM$X/)@1"VZ1>T,>M7LI2'5#;T MJU-/V?\8J6?+DS;E-YCD@=C8[%)N;#`=N)2KV>RDC3(HH;ECBG$I"T/:Q1]R M+`Q)E;;(8&.#+B.#X@[I$H;\-'=R*6.X\V1LJ)\K^VY[ARS\\-Y"V7G"+A)V MF;"KA%TG["9AMPF[2]A]PAX2]IBPIX0])VR9L)>$O2;L+6'O"?M(V&?"OA+V MG;"?A&%76!.,DS8)/,M@I@7L"B?-,S5@5SBQS/2`7>'$,E,$=H43RTP3V!5. M+#-58%]QIY)_[O\H_<8`K_>?QZI^K1R%M M>;+ZY^JVKO\\7?USM3DB_SS<*_^$OK.8>ZL.X5NCTW\>E9;X(MCTGZO>XCL@ MTW^N.H1O4\O^N5AU"-^%E/YS46+B:U"2?Y;NI)TI74D[4B;M_]-U9[N.G.<9 MA6_%\`7$V5*K)1FQ@9KG@357G3E(>T#LR)`%Y/;S+07)@;5X(MAXQ&:Q]GI_ M[68/U%OV/:\[/J=0GB4^(BZ,#XI3_/G+&Y\6]$N,[Z`^?AL_?;4'QG=#'[^- M;W_,XMN8C]_&]RUF25R+/5?Z\S7*1:1L_OD1W#V[>S8[G9@A]N)G6X7=JGQMR'$ER/^-H!??JGB M#]-]BB^'6OP9MT_QY5!+XP-?XOGXV)=?_J"!W#`^R>&7&)]>&U-5%[TW?(K<_SA#PJ\=G1<76)&G%Y6Z3E91&6=T56 M7A7'@I\*'`I^)A"4]T1.7A,Q>4NDY"4Q3-\ELWRSRN.[^&_.\9W]MR4YL=/M MPBXUHO5F2=:+)5COE5R]5F+U5IF^+Y_AO]G]S"N:]14E+^SEMF"+VXJM;ANV MN>W8[M9BK5N'=6X]UKL-V.`V8J/;A$UN.9:[%5CA5F*E6X55;C56NS58HT;( MWO$=R(GKXEQ^C:9YIME7M_Q;JW$ZJTR?5\^PW^S^X6[L.A=B*,I;'7;L,UMQW:W`SO<3NQTZ['>;<`&MQ$; MW29LV%O=Q*K'2KL,JMQFJW!FO<6JQUZ[!.[0EZ5.)XBD7E='`5^$MPAMUX;87E79.55$94W15)>%`/U M?3)/7R4NDY"41DG=$1EX1H_1-,LDWB]R^BY^[;]_93RWCT`C;W0[L<#NQ MT^W"+C62]6()UGLE5Z^5Z?OR&?Z;W8]%FEY683E79&55\51X"4D,TW?)+-^L\O@NWH,XOM/W!4_L=+NP2XUHO5F2]6()UGLE5Z^5 M6+U5IN_+9_AO=C_SBF9]17$TA;W<%FQQ6['5;<,VMQW;W5JL=>NPSJW'>K4_DY#4Q3M\F MTWRSS.M;?IGIV^_E77]NM]]MLO5JB=:;)5DOEF"]5W+U6HG56V7ZOGR&_V;W M"W=AT;N0K-CJMF&;VX[M;@=VN)W8Z=9CO=N`#6XC-KI-V.0V8[/;"WNYE5CI M5F&56XW5;@W6N+58Z]9AG=H3]*@D"8]*W%(L=ODYB\I9(R4LB).^( MC+PB1NF;9))O%KE]&[\A8/O6?N$_#HVPW>W`#K<3.]TN[%(C62^68+U7\=WR*W/\X0\*G'$ MQ]4E:L3E;9&6ET58WA59>544W$Y"V1DI?$,'V7S/+- M*H]OX[W?XUO[-9@XGL).MPN[U(C6FR59+Y9@O5=R]5J)U5ME^KY\AO]F]S.O M:-97%$=3V,MMP1:W%5O=-FQSV['=K<5:MP[KW'JL=QNPP6W$1K<)F]QR+' M%W%Y6Z3E97$4^$G`0>#G`%%Y4R3E11&4]T1.7A/C]&TRS3?+O+Z-]R"N;^V] M0&ZWWVVR]6J)UILE62^68+U7Y'KF[4 MJTLF;'*;L=GMA;W<%FQQ6['5K<9JMP9KW%JL=>NPSJW'>K)^1129*@^(?MD+B\+=+RL@C+ MNR(KKXJCP$\"#@(_!PC*>R(GKXF8O"52\I(8IN^26;Y9Y?$YWH,X/NM[@2=V MNEW8I4:TWBS)>K$$Z[V2J]=*K-XJT_?E,_PWNY]Y1;.^HCB:PEYN"[:XK=CJ MMF&;VX[M;BW6NG58Y]9CO=N`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`07E/ MY.0U$9.W1$I>$L/T73++-ZL\/L=[O\=G^S68.)["3K<+N]2(UILE62^68+U7 M,[Y-;'/"&/2AQ/ M\4R)6XJE;AF6J1&8]T5>7A=Q>5NDY65Q%/A)P$'@YP!1>5,DY441E/=$3EX3 MX_1M,LTWR[R^B?=7KV^^EU_GX';[W29;KY9HO5F2]6()UGLE5Z^56+U5IN_+ M9_AO=K]P%Q:]"\F*K6X;MKGMV.YV8(?;B9UN/=:[#=C@-F*CVX1-;C,VN[VP MEUN)E6X55KG56.W68(U;B[5N'=:I/4&/2I+PJ,0MQ5*W#,O<K$$Z[V2 MJ]?*]'WY#/_-[D>N;M2KBZ,I;'*;L=GMA;W<%FQQ6['5K<9JMP9KW%JL=>NP MSJW'>K)^11 MB2,^KBY1(RYOB[2\+,+RKLC*J^(H\).`@\#/`8+RGLC):R(F;XF4O"2&Z;MD MEF]6>7P3[_T>\=?TR]_L=V*GVX5=:D3KS9*L%TNPWBNY>JW$ZJTR?5\^PW^S M^YE7-.LKBJ,I[.6V8(O;BJUN&[:Y[=CNUF*M6X=U;CW6NPW8X#9BH]N$36XY MEKL56.%68J5;A55N-5:[-5BC1LC>\1URZV.>D$R(GKXEQ^C:9YIME7M_$>Q#7 M-_:7QG*[_6Z3K5=+M-XLR7JQ!.N]DJO72JS>*M/WY3/\-[M?N`N+WH4XFL)6 MMPW;W'9L=SNPP^W$3K<>Z]T&;'`;L=%MPB:W&9O=7MC+K<1*MPJKW&JL=FNP MQJW%6K<.Z]2>H$&(EY803F?9&7U\51 MX"?!'7+KM1&6=T567A51>5,DY44Q4-\G\_1U$I.W1$I>$B%Y1V3D%3%*WR23 M?+/([5.\/[)]^MZ^I]RQW>W`#K<3.]TN[%(C62^68+U7,B%[QW?(K<_SA#PJ21(4_[`=$I>W15I> M%F%Y5V3E57$4^$G`0>#G`$%Y3^3D-1&3MT1*7A+#]%TRRS>K/#[%>Q#')WTO M\,1.MPN[U(C6FR59+Y9@O5=R]5J)U5ME^KY\AO]F]S.O:-97%$=3V,MMP1:W M%5O=-FQSV['=K<5:MP[KW'JL=QNPP6W$1K<)F]QR+'%W%Y6Z3E97$4^$G` M0>#G`%%Y4R3E11&4]T1.7A/C]&TRS3?+O#[QX2OQ,4>_?"^0V^UWFVR]6J+U M9DG6BR58[Y5Z06Z^-L+PKLO*J MB,J;(BDOBH'Z/IFGKY.8O"52\I((R3LB(Z^(4?HFF>2;16Y?QZ>*;?I!9LF. M[6X'=KB=V.EV89<:R7JQ!.N]DJO7RO1]^0S_S>Y'KF[4JTLF;'*;L=GMA;W< M%FQQ6['5K<9JMP9KW%JL=>NPSJW'>K)^1129*@..?M\_N(R]LB+2^+L+PKLO*J.`K\).`@ M\'.`H+PG7\?GV!SQ,=*__)XR.;'3[<(N-:+U M9DG6BR58[Y5OB7'Z-IGFFV5>7_-QH5_;)[=RN_UNDZU72[3>+,EZL03KO9*KUTJL MWBK3]^4S_#>[7[@+B]Z%.)K"5K<-V]QV;'<[L,/MQ$ZW'NO=!FQP&['1;<(F MMQF;W5[8RZW$2K<*J]QJK'9KL,:MQ5JW#NO4GJ!')8ZG>%3BEF*I6X9E;CF6 MNQ58H49DWAB)>6$$YGV1E]?%4>`GP1URZ[41EG=%5EX547E3).5%,5#?)_/T M=1*3MT1*7A(A>4=DY!4Q2M\DDWRSR.WK^/T$FW^L]([M;@=VN)W8Z79AEQK) M>K$$Z[V2J]?*]'WY#/_-[D>N;M2KBZ,I;'*;L=GMA;W<%FQQ6['5K<9JMP9K MW%JL=>NPSJW'>K)^11B2,^KBY1(RYOB[2\+,+RKLC*J^(H\).`@\#/`8+RGLC):R(F;XF4 MO"2&Z;MDEF]6>7P5OV9_?/6]_GP9.]TN[%(C6F^69+U8@O5>R=5K)59OE>G[ M\AG^F]W/O*)97U'RPEYN"[:XK=CJMF&;VX[M;BW6NG58Y]9CO=N`#6XC-KI- MV.268[E;@15N)5:Z55CE5F.U6X,U:H3L'=\AMS[F"7E4DH1G2MQ2+'7+L$R- MP+PO\O*ZB,O;(BTOBZ/`3X(SQ,\!HO*F2,J+(BCOB9R\)L;IVV2:;Y9Y?17? MIU]?Z<^7XU%^M\G6JR5:;Y9DO5B"]5[)U6LE5F^5Z?OR&?Z;W2_3VU=><')_L>\H=V]T.['`[L=/MPBXUDO5B"=9[)5>OE>G[\AG^F]V/ M7-VH5Q='4]CD-F.SVPM[N2W8XK9BJUN-U6X-UKBU6.O689U;C_5N`S:XI5CJ MEF&96X[E;@56N)58Z59AE1HQ>\ND["43LG=\A]SZ/$_(HQ)'?%Q=HD95F$Y5V1E5?%4>`G`0>!GP,$Y3V1D]=$3-X2*7E)#--WR2S?K/+X*GZOU/&5 M_9[%.)["3K<+N]2(UILE62^68+U7,[Y-;'/"&/2AQ/\4R)6XJE;AF6J1&8]T5>7A=Q>5NDY65Q M%/A)P$'@YP!1>5,DY441E/=$3EX3X_1M,LTWR[P^XCV(ZRO[_4C<;K_;9.O5 M$JTW2[)>+,%ZK^3JM1*KM\KT??D,_\WN%^["HGK%$EY40S4]\D\?9W$Y"V1DI=$2-X1&7E%C-(WR23?+++^B/='Z@_],WX- MUK@-V.#VPEYN.[:KD:P72[#>*[EZK4S?E\_P??=/7-RCUQ8[C.M.W%(L<\NQ MW*W`"K<2J]36H%5E"_%[>X0<^I@SY%2Y0NX/^]N2KH_XTV\?]M[V]1&_ST]_ MM#%^M%%E"IE4YI"(2=[+F>,*7GH%3'2X[X`A51/DA]CP$7JI4(5Y^PI['J583%O?#- M)!OW8M,KB8,J;/_0=Q,/[/RP[UCCWL?/$,X/_9NYCX_XF]#/#_U9_/$1[YJ< M'_II!<='_*U)IU\+XTIB1_*U24;NR^3W)0:)V=0^>OH>4U=/X:6EY#I]>2QJ6D^E7(0C)]3![BU1)MA"1?TR@Y_FMK M\O/!4>G-V+@7E=Z+C5M1Z:W8N!.5WHF-&U'][V7\YF]??OS3E^S+7__ZC]__ MV]__\*^_ M^_7'KW_U[S_\]-,/?_OY?_[YRQ_^X\N/_-OQ+__QAQ]^^K__$W]VY3?__<./ M__F//W_Y\M/O_T<`````__\#`%!+`P04``8`"````"$`0SJLOF8.```K4``` M&0```'AL+W=ORSQ MHBO&$XCLSFZ`++!8[.59(\NV$,LR)$TF^?L]37:SNRZ136)>XLRIZN*I8K%/ M-T7RTX^_'U]&O^W/E\/I]7Z'VZ'__GWS_]L!R/+M?MZ\/V MY?2ZOQ__L;^,?_S\U[]\^G8Z_WIYWN^O(T1XO=R/GZ_7M_5D\<_ST^3R=MYO'YI!QY=)/IW.)\?MX77<1EB?/Q+C]/AXV.W- M:??UN'^]MD'.^Y?M%?POSX>W2XAVW'TDW'%[_O7KVP^[T_$-(;X<7@[7/YJ@ MX]%QM_[YZ?5TWGYY0=Z_9^5V%V(W_Q#ACX?=^70Y/5[O$&[2$I4YKR:K"2)] M_O1P0`:N[*/S_O%^O,G6=C4?3SY_:@KTW\/^VR7Y_]'E^?3M;^?#PR^'USVJ MC?/DSL"7T^E7Y_KS@X,P>")&_]2<@7^>1P_[Q^W7E^N_3M_^OC\\/5]QNF?( MR"6V?OC#["\[5!1A[O*9B[0[O8``_CLZ'EQKH"+;WYN_WPX/U^?[<3&_FRVF M10;WT9?]Y?K3P845^^U0[9TK0 M(TDE!6($8E.$L'%+`39Y%4NG%G\B(J$'W3A*S".MSKBYI_8(CIUT94EK:5JG MO&L,JXZ:=:,(^Q5E?[N6SIE2]DA22X$8@=@4(6PR7'^#BMD,I-0"E)0S0+?K MZ;V2@NKCXO1%NB=8K9>,3WK=,)U$1VWT-LS<_/]QXE[=8A'JYH`.%I:3.\5(2.]+(%H M,=T4GW!JEBN+Y8#),VO%@A3:ZP>=/I===9HU2>T'8I(-76,D9`E$4W"ZD*3P M3H]Z%4G+ZJ%8P]HMF]UYC9"1D"40Y>3F^X23*^N\N(LKV0]K4M8J!REK)R;I M3,I6A[4?2,K:#0R5ML2+IH">YBFXA/LN9%V89C)+R&93V@.5NX"<5]HI<4KR M?=+Y!/8F#@N0)1!-R$E)Z1,O/&F?>'$BZRJ>2IUU7H&3D9`E$*7I!.7C M-+W\I#131?*E$Y!!:[,.MP0BG-Q2,N7DVMFO"WJV0Q.I:8=0GOD*F1D"40S8&)6I-#_VDB[]0NG2;82KL*7FE*?)J( M/C$A'SPJC"5>-"&FB+>GB5RJGH=<*\:%;L92J:-7I.GELKG+TURXEGA1FDZA MDMYYAZ;7L[0]/)3VLX",6_I3(;0$HIP4UAU@S\XU>]`II&@E9`M$$G!9]>(HHO'(E4T2`TJ(*?3/2 MRQ*(J@&[J%5#,/T5;-V7ZTCEXA3R,A2R":02\U*Z2:!2BMJE0S MZ64)1#B5BIHM5T,V&TTD*F<>8F7EF[CHU9550I9`-`4F9[>;M>Q4*QRM"E!2 M5@D9"5D"44Y,D5RS#KO54TJU\A`K*]_#1:^0J)&0)1!-@:G5P%5"V+7I%F-S!`EGA1 MFKT$K92"%J"TG:6@22]+(,I)$[3Y;,BMRU)JFH=8/_,]7/0*1302L@2B.?32 MM%)J6H#2NDI-DUZ60)23HFE9OABPF2BEJ'F(E95OT:)7+&L;"P,#9(D73:&7 MJ)52U`*4EE6*FO2R!"*<9HJH95DYI%V;4%35/,3JROK*-7+*M4+>)%4V"J-7!Q.^OD M+"YN\X)M<*K@=6MQ&WUB0CYX(L/$BR0T9Y)W>UIKO*FJ>8@N;GDJ=?3J:$K( M$HC2[*5J2Y%S4.LG?E>+7K%LDI1(UXTA5ZB M-I>B%J"TK%+4I)L:9M+`P,D"5>E'\O M19M+10M06E/O%2$CO2R!*"=%T8;45*K97%.S@N_!HE8IW*MV#1*U95BAGQHAE\'S&;JV+&]C55 M\+HE9M$G)B3%C'B1A!:]Q*SQIF+F(29F+)4Z>G4T)60)1&GV$K.%%+,`)=TL M(2,A2R#*Z;N)V4**F8=8._,=6O2*995B1KQH"KW$;"'%+$!I6:6822]+(,I) M$;-A.[2%U#,/L;+R'5KTBF65>D:\:`I,SP8N>=W3BN)7WX)M>ZK@=6N6B#XQ M(1\\$6CB11-B8GA[R;N0FNR2%>E&8OS5M(S0M0VL[> M*T)&>ED"44Z*Y@V[[[B0HN%'^WT?.EIJ%M?6Z\J=QYB+4S2Z6.7H&3D9`E$*792^Y6 M4NX"E+2SA(R$+($H)T7N!MV16$G!\Q#K9KZ%BUZQJE+PB!?-H)?@K:3@!2BM MJA0\Z64)1#DI@C?L2:>5U#P/L;+R+5STBF65FD>\:`I,\]ZYICII"T>K5AY* MRRH@([TL@2@G)EO-Q#7@64=\`X._7.,A5E2^/XM>(4TC(?>)#1<>L>#5)M!^ M,J/]3,-Q?W[:U_N7E\MH=_KJ/H>136?XPD*'^X]U+%?K#4(A!K-@3EV[V5"Q MK*;XPD>S5>1C5N[;'PTC8!,2JW!;AA8R^C50MPP_9:LX`;=JV:!1V"O:-B6:)#L"/3+.@0 M[(LT"SH$.P[%,D<^^`E!LR`?W)S7+,@'M\@U"_+!K6=IV'9&LX`!GF#1+&"`!T,T"SH1CV_@,4+-@M[!PWR:!;V#9^0T M"SH$3ZHIE@(,\`Z!9@$#/)RO6<``C\AK%C#`H^>:!0SP`+AB*=$A>*Y:6C;Y M8KW!"T32@K?3UA:OFFD6,,"K7)H%#/!"E6(IP$`]SJ;(UANU#RI8W+M`6C3T M#EZ_T2SH$+P$HUG0(7B[1+'D.$Z[7N"JF>,X[8-*S++)T:-XC5"+!@9XOU2S M@`%>Z=0LZ!"\6*E9T"'Z<3*PQAOSRI@,#/#-!\T"!OB4@F8!`[S?KUG``-\) MD)9-AMY1JX,7^C%&[9T,O8.WWV6T*D/OM%]<8+7&*^*H@=:C^*3:1NT"5QKM M&.YT*O@&)U--L7+=I`RHW&RCX:BB6D344"MAA3JI94(MFLMHTM4"GVI[VS[M M_[$]/QU>+Z.7_2/6KM/F2==S^[&W]A_7TQO6M/A@V^F*C[0U__N,C_+M\0V> MJ7O<^/%TNH9_X"Q,NL_\??X_````__\#`%!+`P04``8`"````"$`]75BQ((# M``#\"@``&0```'AL+W=OHRE!!*[PRGS$W;]>? M/RW/E#WP(\;"`(:*K\RC$'5LVSP]XA)QB]:X@B\Y9242\,H.-J\91EF35!:V MYSASNT2D,EN&F+V'@^8Y27%"TU.)*]&2,%P@`?KYD=2\9RO3]]"5B#V/$=4Q[O6P,^D/PF0_^&_Q(SU\8R;Z1"H/;,$]R M!O:4/LC0^TQ"D&Q/LN^:&?C!C`SGZ%2(G_3\%9/#4TXP3\%1 MH+&\0#*EM``!\&N41"X-<`0]-<\SR<1Q9?ISRPL#-YA#O+''7-P1R6D:Z8D+ M6OYMH]R.JV7Q.A9X]BS6PG4B?P$<5_+\+@^>79[K6V$0S.;A&YFS+A.>?<6Y M%2P"6"AJ9OU,A2O<0T83# M*A@+]P+KU?[JEX!,:Y3V%;8=XC?KX6:LJ/LZ4_8G*OYE&+,P5/YK(D'.4.3E MUN^ER6!=6H=$JOAN@B1#1*L]UVLW+3-K]IJN[]_=-I))%]8BWG`J9V&D/&C: M8J>">JN3(:)I7>A:K_LD@W4Y'3+P:8(D0T2K+<_;\=;B+>1*^L_=11+INEI$ MMRER1C:I(&73$-&D1KK4ZS;)8%U.APQLFB#)$-%JPU'Y03XU3+JR#AHY-=EX MI825"5'*JI=$@%J][8'\PT7!C92>Y&'KNM#G"FYO`EO7Z:\"HR]P M1]AXLMH(W\J[PR7WMI7P2MP4:X M@%`!EX[F[Q%NF1A.0D=V34ZIZ%]D`75O7?\#``#__P,`4$L#!!0`!@`(```` M(0`$I5;IG1$``&-;```9````>&PO=V]R:W-H965T/MYNG<:EB^O$7']NO7S=TZV=[]>%P_[:V2E_7#[9[&O_N^>=Z)ML>[ MMZA[O'WY_:-Y_CJ/;.]'= M_0/4/V[N7K:[[=?]!:F[M`/%.5]?7E^2ID\?[C_GC8_WO[LUAOOGW?D[MG-",SL>7]7\EZ=T<6)347DYG1=+=] MH`'0_Y\];DQHD$5N_^S^_MS<[[]_/)]=3!:S\6Q.XF=?UKM]MC$JS\_N?NSV MV\?_6:$QJ[)*)JQD2J.WSZ?SB]G5:#H^04G$2N@O*QDOO*$WH+[>CGH_(4ZYUXZ._+$\]'I&_9GGZ M>])\QA0]UIDFC*PCWC:C<1\&Y$KI\XU-R>FV4^?]7[<\S6E=HU+OG6[-*C9=&B02_M6V?#H>R@=+`:/ELU'P\)^]0 MH.\HA?_X-)V//US^06EWQS(W**,D8I$P.6;4)AJD&F0:Y!H4&I0:5!JL-*@U M:#1H/7!)INWM2\'P=]C7J#'V%%>I#!M6DU"*P]O!_*"F"D.Z.*,6Z83+OEX)>9,AX_C?J03GIY M9_$HN\T9-:$E+)GZ>1-%4.;L7DN!(@*1`,B`YD`)(":0"L@)2 M`VF`M#X)C$M53&#SP@C71H0R9>0`))@*1`,B`YD`)(":0"L@)2`VF`M#X)#&;J M_L!B9GU\7T1VJD)S,E(QJ7=$)]4'):(4488H1U0@*A%5B%:(:D0-HC9`H;E- MN>PO`,<#U)RM5(0*\D(448(H190ARA$5B$I$%:(5HAI1@Z@-4&@_4R&?8#]; M4%/%*Y%U8ZI?,JD*25WA.BEIF"!*$66(*(B65.BE)V\RI%Y0C*EQ#7_TB'$3II$17%>@* MC66J9M]8]H;IXHKFN_^^N?O]9DLSH05^8`LP1T>^7[*U-Z6O='DS9N2G&Z"$ MI:97?<,448:Z,%R'WHK'+$6VZ:4&`HNEZ(^3FBM=J>A:=&=ZNIH>C49A=YF('(WC M7*3FO5L*04='4(H4CR"*%I$*STI$#HT@](*IH4_P@BVY@SBT:!J<@&?*+/&8 M&YJHERO2`2^PE#-+R@VG@9-GZN8T$RG:7'KUTZE:%W(W"(G/0I#KL11=4>?D MJ:H)*GE\J*O0O*;B/L&\1ES5SA:%03YSUT*\>K+4*T'.4OYB8-&4ZO_><-%, M)79F5F53+=&?7@J\EXN4LV4AR/58,E(]J@-J)0T/]1A8>:)/+\>7DDX\M#(C M%<3ZA"(-CP>Q2#DSI*(^#&(569E(^9&%5A;U]J,X\S%!(5$)5( M'>HQM/)IAQ936JM8%N1M68@21"FB#%&.J$!4(JH0K1#5B!I$;8!"^^E#BZD$ M)K,+BJ83+WTF>)YA9'KO,S2:J:TA=E*R`":(4D09HAQ1@:A$5"%:(:H1-8C: M`(76II@^8>6=&'&U)C#RHQ50(@V=5(HH0Y0C*A"5B"I$*T0UH@91&Z#0?K1R MG&(_(Z[L9Y$[O<1F$R,A1Q(@*9`,2`ZD`%("J8"L@-1`&B"M3T*342:?8C(C MKDQF4>1OX]%,5:&QN28V#5W()8S"<]%<%6&IDY+TSU!7[I!;2F`;*IPN)Q7- M5>%0.BGIL7+J!:T0U:ZAKUYMR(V3$EUMH"MTCSD=O;T6FQAQY1Z+R#W272Q2 MOB^LE/*%JEA3;DA2HBM#73FBPC7T+:/JI]))B?H*=:T0U:ZAKUZ5*HV3$O5M MH"LTO#E;^89_UQ%X8D]H_M>`/EO+]81$=@?T9J0HZ95W>03F3'IVN'%&! M#4M$%39<(:JQ88.H#1J&EC;G)VUI6V*\4A+SP)JGW>=DT5$N: M1>'!9ZY\$9N#GVGHSAR)(#?QE-%TTIET-IZH',M$@*JHP\[*13/ME"I%R M_9>BWA[>YW/^!1F&N-?36BR_9%'E6=M2+@=W;0H^8P_"Z/=@U# MCS)2>:MK")%RYDL$N;A-!?%MTWBJKUHSD2"C'796+E+'LU2DW`!*1O2G^T[= MA?=]F"[_*VGC]X\^%2DWVUJ0ZZQA1'_X?E/M>JVT\3L[[-/3CLLF`U5N,@IS M\TH5=;$T]')3D)MN*KIL;D[&\X4J2#*1.!2P=KT5U<>34Z3<`$I1+\DY5TM@ M)0)^_P.>9#.YV=;862.Z^NQ4VU8K`GYGASUY^.!^?%>EE1!\:E&8G5?*%S$W MI))*RJM$D(O75)#<1H\F2D\F$H<"EGW*8WHE.UG*#:!D]9PPN.`.=3_@TKY[ MF6PM#5U?3=@7+;C@4E9S:*[!%CHEQ[]OP34-U8)KD0FI?@F,KM3>%W<]AENH M(.?EE!%-UBQ!5_0%]'`/RT3@4."R1WF4KV0I2[G^2U'/B7-QK:91B8#?_X!+ M^_Z=2Z&S1G0=SE+;QLCUECV9RX3VUK_EH0;O4(I6EZG`;<\,@2[FA"]Q4 MI&R61HMKM15G(G`H<-FEK/F5)(7^2U;/2:KBJ1KJ?,"??>?.G]!3$_8TE*+< MYM!,PQ0UMQSO\J=IJ%+4(I6B:@>*I]S0[2V)()JJJY4PD#H4M M.[3O;3BX.ZD"!U"*>ILVTX&:B&?K]S_@T[Y_YU-&;K9-V!GY5$VV%0&_L\,Y M2M'[/I^:ALJG%JD<565X;&YAJ&&0HXS\'&5D^]4IKBE1(C ME;*JD(M%REDS$>2G+%_IV)2=7\V523-I\TK*LAK*DV,.9BG7?\GJ.66CBYG: M3:JA_@=9A&=;51\52+@ M]S_@W[Y_YU_HK!%=?)F+U/%U4J1<:I>(*D0K M06X!J`4Y70VB-D"AR\Q]@*Y,QC/WQ*_AUBB`_ M.UC*H82E**8D?%-$&>K*'3KBD,))B?H2485HA:A&U"!J`Q2:FI:EP-2O+#A& M7*4!(_M2`/.EIC@"E"!*$66(+)0>WL< M#4A%WB3"X9DSCC^\5Z+/'HD"FUE$7R:27(K-5S!HZ!Y*$*6(,D0YH@)1B:A" MM$)4(VH0M0$*[4>^".SW[N^E14:3\K=%X??2]&;.A;XE@:4O4R M.*CN2B(1*7?6246]O:TJV_]Y5)WV_SJJE)3YBJ+6']TF%FD?.J,GTL`J]XE=7X7F4D M%PUS_0%X)JK?YM6AFM0_O+_I5Y,SK$<9J416JTLL#5_Q.*OW/6Z1?#BXF$[5 MR2N3`;S-XZ<5BS,L%@6YBXG8H>&5A%&1V:]S5+^916BS.G2WIZ?5@)UXFKH7!6Y(V`L M4@XEB%)$&:(<48&H1%0A6B&J$36(V@"%(:'K,Q,2_/Z5XWLWO1E49XB@(*J] MVY/.Y?&05+1P98<=GWUKJ'UEXN/ZY=LZ7C\\[,[NMC_,&T'IF/;I0X_MZTKI M?+4TAPT*$?UD-EJ:,GK@R=R\X[3SLVXSF2S-K[P&VDRF]&0Z]"2B)W3;-M`F MFM.3;KW6_417]*3;T.#)@IYT&:6?T$0'YSFF>=++7P;Z'],\Z;4F0T]HGG:K MUKV,:3;TWHF!-A/29N],5!OZ%0P]&9H-O4SV\Z`US<`&^R!%`_SS=/F9(FA@ M4#3:P<'2B+JK?#74&_+(H$/('T,3N"%O##F#?H>Q-#^\P!'1+XZ6YO<7^(1^ M>+0T/\/`)_3[HZ7Y=='0DSD]&1HQ_7J#G@QIH]=#+,V;$%#;#?5S,]B&?N6U MC`>?T(^]EN:G7*@MF,$G].,O MLO70".C72?1D:`0W9`/SS@K41J_^6,:#3^AU'TOSN@IL0^_S6)JW5N`3>JW' MTKR\`I_0VSV6YMT=0T]HU+;-91^>](KCY]MOZ^;VY=OF:7?VL/Y*"]ZH^_CH MQ;XDV?YCSQ\C?=GNZ>7&M*G12V3I9=9K^@QC9*[(OVZW>_D'=7W9OQ[[T_\% M````__\#`%!+`P04``8`"````"$`0EF4YK(%``!B%@``&0```'AL+W=OD>S8#BJOCC>?ATZ9%3>; M,435%`YZ.A4YB6G^7));PT@J[U]R6MZ!XK&X M%LU[2VI;91Y].]]HE3U>(>XW-\ARP=V^&/1ED5>TIJ=F!G0.<]2,>>VL'6#: M;8X%1(!IMRIRVMH/;I1ZKNWL-FV"_BW(:RW];=47^OI;51S_*&X$L@TZH0*/ ME#ZAZ;VN=K<6PN6SN61U$U:(*5MY<]U M0\O_F%$;44?B<1)X'9?GS(NX./@R<1B7^X$_)%^(!R2/"#+UH8Y#-+44'0ON\!?;)P7*)2U.`@+K`JD MC74@T8%4`AR(J`L+E/\)82$+AB41#EA<9M#.+;>X9X ML#QU#@>^[G)G)(;%!I(82"HCBLLP2:>[C,:JRQQ9=]5T,)#80!(#265$\0^F MK^P?3N4E+'MB`9H\F9%'=9TAGEP>@;_4"J0SZK)M((F!I#*B1+-4HQDO$#16 M7>:(E&T#B0TD,9!41A3_<,.B+9S>XA/91A[5=89HV5YIV>Z,NFP;2&(@J8PH MT:S5:,:SC<:JRQR1LFT@L8$D!I+*B.*?"S-=3O>X@ZVUZB&'@G[V&4AL((F! MI#*B>HBM2"J(#SQDC0N69:'?WF60%[3]TYN[@2:Y,(`ITRUZWD*;AK&P@L+M MK<*URI4(JQ5KUEZXUAI9*BQ`DIY'^IH://:PZ<&SCJ<$SR#?%<%KNX<#-C`L M.EC.!MWA&P9N%79I3?A`WVN9_77H:]N.5%A`KQJD5B/%CC8]4M[_9)D9U,NL M=RV7&WP@,[=:2I%RB&GJATM=]5103],4&^'T2%G;5#1E4*^I5JH'EX_Y0%-N M)6O*F9FFGKMPM?I..;4/*9F@*;;4Z9&BM;:X,*C75%^ML6QAC/>!IMQ*UI1# M3%-WM0KGZDQ.!?4T3;'=2I&R[?X,3RG-IO0P.+EP_SAFWTDT1+` M()"Z3W?@:Z(<7#X0OR;."0,+&+>2]>;T3.\@7*PTZI133]0;F[J4A8%HX9S8 MAMY"KF]*R*O7D(__0RYJ.FE3%8C:7A.[W_J(QE89%% MJV,.R<)VT&C0S"IH+T?::9*X!I1R"/*H"XLG&3FB\9)LK57/!=17UL&$8A-* M3"A5(*7^<%,JN_GI,T9+I$6`W+!&JC6H->L#'P@/L7&*32@Q(;STXO1=[MDE M%KL.*4EU)@=RO=963I_Q@@J:Y6[3P>SV;+^.8(\*!#KNS>%:K17?^*6[<--^ M@9NXAW9-T?`]#&BCTW$//C'P[0`8'^!&<#2(XY`[@BP@.EP-X&,$Q M;0!?1G`\&L!7$1PT`'>Z"."&[YZ=R9]9=2YNM74E)TCPO.T[%;LC9"\-G[B/ MM(&[/=``;J3@+I?`9=`, MC8L'\)!]LVR9G\?VGV'P$'S_[>?Q,/E1GB_[ZO0P97>+Z:0\[:KG_>GU8?J? M?_/9:CJY7+>GY^VA.I4/TU_E9?KM\9__N/^LSM\O;V5YG8"'T^5A^G:]OF_F M\\ONK3QN+W?5>WD"RTMU/FZO\.?Y=7YY/Y?;Y[K1\3#W%HMP?MSN3U/E87,> MXZ-Z>=GORK3:?1S+TU4Y.9>'[17&?WG;OU\:;\?=&'?'[?G[Q_ML5QW?P<73 M_K"__JJ=3B?'W:9X/57G[=,!YOV3!=M=X[O^H^/^N-^=JTOUW*USN M)4OI:5<=8`#P[^2XEZ$!BFQ_UL?/_?/U[6'JAW?+ M:.$SP"=/Y>7*]]+E=++[N%RKX_\4Q+0KY<333N"HG:Q'M_5U6SCJMBRX8\$B MO*'_0/N`H_;A1:,'`-.L%8!CTQCF,7+FH6X,1]WX-^2#L=8C@&,S`O]NM5P& MX2H:?Q'@CJZ]P/'+2\06:_\&)W#=:B=P;)PLQH;#7(56':GI]KI]O#]7GQ.X M_2%X+N];F4S8!AS+$/4AT/M#%&)3MOE#-JJ;`GV!^^K'(_/8_?P'W`L[S<2* M@0FW&-]FDCXFL)FTRX0+&\EZ$#0:WH.@P>1=!&XSNR?1QX0V4W29T#/('&0W MVD,HWZZ];(2U__)?7Y]8,75FJT\D^$2*3V3X!,82$5>L%PR%!&)!7BH>=JV>LSW%FO;?]8&_,@/%R@H MN0(@I9E!HBC(VRY8L`P8"C?1!M9HA$7;.`L"MFS-P9(6AM"6=MSM*QMAB5>V M!+%B'#-,%!'JVS]<^HL%N@PIZ20C"4X2.4D(DBAGD#:$E*#K(&O,@PXX2>0-T=^%:,R#710NPI(9%JVWRRP;89G1`SI6 MC`[E$*7MI+$.SB!MB#K0["6:<#P<4QK):(332*Z1X=$* MVDGAQL-K/@LCS6M6$+;*L M9\8'LZI^K&#&:^18OB"&*^&(U40C^CIX811UBQ7:348CG$9R&A$T4C@16W)9 MW(R77)5"\WJI2LO5&^2YF M33DE\YV_Z*3MQOQUEZ#$G+H]9,8\Z('32&Z0WF$*8Q[LI'`BMLJR^FFI/.[5 M*5,UDZTVJEYB#345.EZO),8^.(_4(&H9@%UDQC[H@M-(;I#^7H2Q#_92.!%+ M<`\5D>,$KUOAA0FJ7V(-*<%]_(HU,>;!::0&J2,/>\B,>=`#IY'<(+V="&,> M[*1P(K;:OU5/>F/J20VIS#SS&5OC?*()QQHFI9&,1CB-Y!H9'JV@G10N)[;L MD!G:6<5=3WJ21C\0=.I)#3G$3&@DI9&,1CB-Y#0B:*1P(K;BLK9KY7%"<54) M6OD;)]?84Y!>7Z^#$-4QB08/O-3V',?3G' MUAEF>X/.DL9I&[U#C3T%:9VC*.K4DYH8JBM)RPJ(HC-#Z2A@G4N4(UY-6^]ERX0>M#PMLD6^J)^57.%CD`"V38PTY M8C71B+X.7KA:=U?;M)N,1CB-Y#0B:*1P(K;D-]63WIAZ4D-.R_06$-.Q=OU))-O3-"=DM).,AKA-)+3 MB*"1PHG8@M]44'IC"DH-J901^AY*>8FVZ\1MI]P4-T;+^,"3&/#B-U"!2"?C$TX[_S)@' M/7`:R0W2VXDPYL%."B=BJ_U;U:0_IIK4D,HD4$U&2Q2=B28K:"=%"XGMNPW59.^JB:MVB9`8L8:TMD$+U438QZ,FI1&,AKA-)+3B#!( MG7+P;`IC[IN-K?1-5:2O"D3X]^M7A4[=KB%'V"8TDM)(1B.<1G(:$312.!%; M<1"FG<#==;LO:92X.W6[AG0=XS/\T4VB`<PG"98AKR\0F//0]0FJ9X7?*<(T>N9E%!*O% M`@^"6\2L&\1J(L-C%):#CK[MYK.EOV31U[UHZWM3H0A;YSHY&;_!BS7D"-!$ M(SKZO-6RY_43[2:C$4XC.8T(&I&["J4T_;-6DJM=@VHOUK$\OY9)>3A<)KOJ M0^X(7,$7U.:LVJTHV`:VW,`N072^@%V,?>=CMHG[SB=LD_2=3]D&M@5U_6=L M`[N#NN[YG&U@KQ"]_. M:END^N-:O==;FYZJ*VQGK/_[!MM72]AS!CO=II.7JKHV?\@.S(;8Q_\#``#_ M_P,`4$L#!!0`!@`(````(0"F[$F[=@(``*X%```8````>&PO=V]R:W-H965T M&ULE)39CILP%(;O*_4=+-\/!A*R*6243#3M2!VIJKI<.\:` M%8R1[6QOWV,<:):I.N4BP>;G\W\VYH]'6:$]UT:H.L51$&+$:Z8R41`U/ MO8[>(.+P73 MRJCYN>GX`=S<8],J0Z? MM,B^B)I#LJ%,K@`;I;9.^I*Y+7B9W+W]W!;@JT89S^FNLM_4X3,716FAV@D$ MY.*:9:V_^#R&R9XL$H2,;A(`(YVG!C MGX5#8L1VQBKYRXNB,\I#XC-D".[/S^,@GB11,OHWA7A';8!K:NEBKM4!0=/` MF::AK@6C&9"[R+R//M:_A0HQ.LC245(,W0Y1&"C/?A$-1W.RAYRRLV;UAN9: M\=0I7`(==GVQ0>NH*[\![-YL?&/D7C%(KB7K>\GD M#^7*[.!_S#IQB@'>>XN&X^NC5UXS;=,SXJ' MTXMKTK-\0'X^?/M(K@O^Q*O*(*9VKO=C,-3O]F.YC%WB;_97,*YM&[R*%=P@#$N5*V6\#! MI/_2+GX#``#__P,`4$L#!!0`!@`(````(0#^J=MO%0P``*HX```8````>&PO M=V]R:W-H965T&ULG%M=;^,Z#GU?8/]#D/,ZD;AM,$Q=)9CKWWZ\D4A)).T[2E^E4.J1U1(J'=NV[WWYMWV8_ MN_UAT^_NY^HFFL^ZW;I_VNQ>[N?_^??713F?'8ZKW=/JK=]U]_,_N\/\MX>_ M_N7NH]]_/[QVW7&F/>P.]_/7X_']=KD\K%^[[>IPT[]W.SWSW.^WJZ/^=?^R M/+SON]63-=J^+>,HRI?;U68W!P^W^TM\],_/FW7WV*]_;+O=$9SLN[?54:__ M\+IY/SAOV_4E[K:K_?-.]? M*EVMG6_[R\#]=K/>]X?^^7BCW2UAH4/.U;)::D\/=T\;S&U__C;?O/TQV;7Z=W6<3(1^-;WWPWT]RNN?5C[?CO_J/OW>;E]>C#G>F&1EBMT]_/G:'M=Y1[>8FMLM8 M]V]Z`?K?V79C4D/OR.J7_?FQ>3J^WL^3_"8KHD1I^.Q;=SA^W1B7\]GZQ^'8 M;_\'(&46Y9W$Z$3_1"=Q<9/&65%:+Q.6"5KJGVA9AJM/V*5HI]:(QB'\FD>\9MRF'4+*X);QTFE!>4WS,6"=OG2#TXI? MN@:,SAX?A)PC&H?PA-S`29-V"L'HZ.M2.C;9"G,NST3*V-W/];;Y5:M(K+L& M3`')EZA<,&]@7NFL"$Y4PLD_,B=56A1\OJ7S15)4(5\83TU(\DS/DC1&(GQ9 MQ*]?`T:OPG,0V]`XA`^?&SAITDXA&*VTRQG`Q(V8E<:% M:%];;V"GXU/%P(@IX7%983,W+**RD8W"?',R;:XOE:]!#S35*#Z.I,AX`^/N M1)%61D\)F3.G!M27!47L>FT]ZO((4AF+9&G\=`@*.`6#7*1CZ_&&1!*J-T\M MHZ>7LP#UI2Q4)JY;*R;1:1*2P<:J\?.!![6(95O>>@,;W"CXXTR,MA(F%R87 M*#)G)-*A5E2V];TOZ6R1$@!H@C&3J"A%L%OF,U9)$<+-:1F9);3.I!F(LBX[ MI#B+PUHKI]P!)&+8>$B(T5FCUAN-^66D8M$53).R:-D-A'R&"H`@IW:1O'MI M$$!BQ$WBJI`QXH"D*,-.VYQ7H09!PJ$/2H:V M`V4FV_`6+6!_RD*=HJ*7=045@Q:1RBV7D4X1E*\:P3!&N)DT`[@/*4%;L%B>!?> M,H]93)*"BPPR M3YR2&D'C';6?#&QH4R#(MPC'V%5YT`@>FZNZ@GC8%:@\-(%X?@`$5UXDJ1*` M!KW01.,F52E,6F]BRLNB*$+]YVRNZ@[BD>Y`=B4U@K#)4?(A3N/G0UAH=Z"& MI8!.+W+RE))3,8)\_:$!&>>')H0>`T2U?I'F@QOK&``T0,Q$Y:5\_-.BC8MZ MI1^7^P=$G)AH$"ZL<"#GG%BX`A)SFF^R1!R()G:3(5!N!)**''@LVFP^/W67 M8!YU7!\I:R6E2#8)"!HO"'[2$_(C(_Q;G,0`I6D4=H_%)Q'-@8G/^2<@UDK0 M*40(:@2=H.,ZB$"'M@@J5C)/6_2'-2XIDQ-E(=%I(R-T`25C)2D%48"4LZ[= M/9#@V_C)0`E\CNY`BW"@DRJR?3Q`GVH1DI$6@?3PR`9`KMB1)L7.-^B$%`8_ M,IIRU%W8',Y&-`?3K74RTA3(-KA&$&:Z2K)!.XH(R@,P9OP(\8#9/3YZFXA`55GHDH>)",E+OU:.$0-;-`-Y<1MRHB< M%NNU]396>V/23G!>1H*OYP7"S7D%N4->5-U#IMC))G&3X3RY$1X%9`.3KN)$ M>3C"C$[ZJ5;!6DDADJT"@K!TR[\(-7[:$_(C-@+)($)L/NP/YR-ZA>EBEX*> ML[#(F^L:0;B5B19]F6Z((.DF;70U\;TG!$@@(OU*B$=P1D:@KTZXU%B)")&_ M,$'"(/-HA8=^R`E`$*VL MD'_];%*8I[%R(V;-"2G1&"@Z':>GSM%534,ZTC3(YYLU@MP1+E)2DNS2&D10 M+JQI2*)2B5/9E6&%C^F"=NI05 MC.!.E+E,U!9-`*#?W3B9=Z)KN$QGTY'N03X/J!$$2T@B^7I2@_.4%6T>E,H' M3^V]B=FGJ@PWS3Q0G^H=TI'>H0RI@(&BC4"2)&$%F'\P3SDQB\$NM'A9#!3C MS$E]JGM(0>3U@0V]*]DV)`4@?5`\2/!NT`_E==:H]49C?CDYH\WD:)W1*%!R M?J1DZY!2N=<"-8@4S%-&S**2?Y!IF<>8O@O#N&2?ZA^LE7@92=:!&D%3@?(0 M+U!^9"P*-@':20@G)YJ)R\I%-M)45*%=@2Q$$`BIF&S\9*`%/N''.@[ M+QIA^S!<`)HDYR"!G!N9(#<%X>3TM2FYZ:*1&;2,F&R5$.2*<5;)JH$`4C7\ MB)$DD;8M]Y?H[B,@.!>CYR109[B`^NLT\`6;=&$8']3J:S$V'V+B1 M42(P"1MS^K%7)KJ),S1&NH@J]/S(`T`GRH*;#"SUZ_D.^9-7XZ$`&OXS'Q M<,Z2D]!IXV@T;4U?C)0`9^C\!;A&).)-TIS(Z+DR)P)"D@N M/RI2[ZW+^SF\[I^EPU?'G6X'*C`"%O+L,W>+3+\X'#:.A^8JE<]!Y?5KJFX9 M]7"H&0X]#H=:-L379-20;*^I2.:\7/D-C_Y*:Y`_\A6C&D'F)54O]DJ^E]L$ ME./].!PRGX69"VI?&@6,X#,O^$!IV^U?NJ9[>SO,UOT/\PF724,_"I^7U?KS M,KN[NF>] MC.BFT"O?P[=F\,NQ?[=?$GWKC_H;,?O?5_U-8*<_8HIN-/BY[X_N%T/6?V7X M\'\```#__P,`4$L#!!0`!@`(````(0`E"0DUH0T``.--```8````>&PO=V]R M:W-H965T&ULK%S;;N,X%GQ?8/_!\'O'D>1KD&30L=B[`^P" MB\5>GMV.DA@=VX'MOOW]%B529/&<3D+OO$Q/ZA3I_/GV8#P?'TVIWOWK>[YJ;X<_F./SM]L]_ MNOZ^/WPY/C7-:8`>=L>;X=/I]'(U&AW73\UV=;S8OS0[1![VA^WJA#\/CZ/C MRZ%9W;>-ML^C\O)R.MJN-KMAU\/5X3U][!\>-NNFWJ^_;IO=J>ODT#RO3LC_ M^+1Y.?K>MNOW=+==';Y\??FPWF]?T,7GS?/F]+/M=#C8KJ]^?]SM#ZO/SZC[ M1S%>K7W?[1^B^^UF?=@?]P^G"W0WZA*5-2]&BQ%ZNKV^WZ`"*_O@T#S<##\6 M5V8Q'XYNKUN!_K-IOA^C_Q\"1:?VJ/P#\.@_OF8?7U^?3/_?>_-IO'IQ,.]P05V<*N[G_6S7$-1='-13FQ M/:WWST@`_QUL-W9H0)'5C_;?[YO[T]/-L)I>3&:750'ZX'-S/'W:V"Z'@_77 MXVF__6]'*EQ772>EZP3_ND[*T,R2[^7]E?*0E+;R4?;R\T09Q=$.V(X?+O% M"7$]^H9#N':<.\DIF+'T#'N\;+=U"I@(&*&`O@H<@C^@"MN+K<+__IT'HK*2 ME#W#-ZE3P$0`I8RC_P>D;'O!H<./O**\(T&\GC1-ZN@I?2$",3%"I6!@IJ64 MDXM?GHY^T-AF;>[^-^\<4K4CZ$,Z/%QTW!^?NN>'PLK+T(R21#IQDOI,X5.S M9$[-(8O^QY<"J05B8H2RF>9D8\F<38>4F#?[(UI>ELDQ[4E>WUH@)D8HP5E. M@I;,"3HDDDL@M4!,C%`VUK>366I:7'A=TJ)S#4R2_NC=>2@254*U MA`Q!G).=Z*.E82\@0Q#7@J,4UO#%(+3N9M1P4ZRJ@VIXQK+XAB'.R MDW^BZWD&570V0K+VSA)/J8M4UIX59!60<=UWXG,)UC&B$MZ0U?E+/%QCRW&' M6D`U1K.0-88H)[O`>7].+9L/M8-XH50D.Y-E8/722<@0Q&EFV9%=:B0CTD/1 MB)10+2%#$.=DY_WH<$9VE+ED*IV#1(?:0?;7@\D78>'='?W`"K(Z?PKGOB$6 MEY#E1J5T(P_%LDHWDBQ#$.=D'2"1M9C-[68G5U;G);&LSG!8UG197_:L(*N` M#+&X!.LA40FOG^AV79B.5F%"2\\*2M<2,@1Q3HDOO9&3M)[260_MB(IT&1]8 M0;J^H8<,L3A-ZPGOE\XY2'R$A:DL2P'5$C($<4YVDH]R:BU]4;0+^MPAV?E% M[#UE;R'QF9ZLE):!Y46L)60(XAJL`T0UO''XG5_$NL86XF8?`=6E@`Q!E%.5 MY3TMF[W'08GWA!U-EV9@]=))R!#$:69Y3R6]QT/AU%U*J):0(8AS4KRGNR"4 M.2`K:3T.2JPG[&>2UN.A6%5I/9)E".*<["3_[I.D MZBPA/I<=E`S(L'MQTCDO:2_`MU`=&@;I8A:GF64OE;07#\72"<>I)P/(:UA(R!'$)6=932>OQ4"RKM![),@1Q3HKU MG"FK=)Y*=9YTUQ-80=:^H8<,L;@$:PGO/ZF<@43.4PE/64JHEI`AB'(:)\YC M1^MYF\FV)W8E!_%H+=,=46!Y#6L)&8*XA"Q7&DM7\E`T6B542\@0Q#DIKG3> M:!U+6W)0(FNZ(PJL(*MP*D,L+B'+EL;2ECP4RRIM2;(,09Q38DO_QVB5EC5V M-H,!$C::9;HC"JP@:]_00X987$*698VE97DHEE5:EF09@CBGQ+)>7Q*/I2TY MB-V^3'=$@>5UJB5D".(TLVQI+&W)0[%TTI8DRQ#$.2FV5)QWD7,L? M[H@"*^@J?8E87$.6+XVE+WDHUE5852U9AB#*::+X4E&,S[EXW';%QN2@1-=T MNQ18O:X2,@1Q#5G&-)'&Y*%(5PG5$C($<4Z*,9VKJW2F26\P\12:;I@"*^C: M-_20(1;7D.5,$^E,'HIUEA$^E+#DH&:[J5"BRO8"TA M0Q`7D.5+$^E+'HI%E;XD688@SBGQ)6OW[C9GKJS2LR8=E,B:;J4"*\C:-_20 M(1:7D.59$^E9#L*5:_]K2PG5$C($<4Z:9YTYMTK/FO36$\\!Z5XJL'Q9M80, M05Q#EF=-I&=Y*!ZNTK,DRQ!$.4T5SSIO+]7VQ);E(!ZN5;J7"JQ>5@D9@KB$ M+,N:2LOR4"2KA&H)&8(XI\2R7E^=3J4K.8A7IU6Z7PJL()USI7!YRA"+T\QR MI:ET)0_%TDE7DBQ#$.>DN))=&V3.GE-I2@Y*AF.Z60JLH&G7%QIZR!"+\\\R MI:DT)0_%FDI3DBQ#$.>DF-(YFDI'FO;&$LV<5;J+"BPO8"TA0Q#GG^5(4^E( M'HHU=:P`U9)E".*<%$:2C?R4!!P M*:%:0H8@RFFFN-%9-T;:CMB,')2<_>G^*;"\A+6$#$%<0989S:09>2A254*U MA`Q!G%.6& M\F@F_2B655J29!F".*?$DEY?=; MI,`*FO8-/62(Q?EG.=)<.I*'8DVE(TF6(8ASRG*DN70D![$CC=.]4&!YG6H) M&8(XS2Q'FDM'\E`LG70DR3($44X+Q9'.6WJV/;$C.2@YR]/-4&#ULDK($,0E M9#G20CJ2AR)9)51+R!#$.26.]/H::2%-QT')B$PW0X$5I'.F$UV9(Q:GF64Z M"VDZ'HJEDZ8C688@SDDQG;-VYPMI.PY*!F2Z%PJLH*JT'6)Q!5FVLY"VXZ%8 M56D[DF4(XIP4VYGA9?OL*YX+:3P.2E1-MT*!%525QD,LKB#+>!;2>#P4JRJ- M1[(,09Q38CQVX7G>PTSX3$.Z(W90(FNZ30JL(&O7%QIZR'X%PG;?05T)W5<= MNJ\0;)O#8[-LGI^/@_7^J_UB`X[#[74/=Y^3N%O,\#V)F>U51.;^2Q,B8K]! MT68B(B4B[P\M`JVQ`]`BT!IK:R4R0QM[F M:1&TP0TT+0*M<1M+BT!KW"#2(M`:MVFT"+3`E,D$;/&^@1=`&M_&U"+3& MS70M`JUQBUJ+0&O<*%8B4VB-^Z]*9(PV>"!*B4S0!H\9:1%HC7V5%H'6>(1& MBT!K/)FB1:`UGA!1(F.TP6.96@1M\+2C%H'6>.90BT!K/.:G1:`U'K;3(M`: MC[`ID0IM\-RX%D$;/(ZM1:`U'HI6(F-HC6>-M0BTQA._6@1:XT%:)5*A#=Y= MT2)H@W="M`BTQIL96@1:X_T(+0*M\4J"%H'6>-)?B91H@[?DM`C:X,4T+0*M M\7J8%H'6>.E*BT!KO/JD1"IHC;>-E$B!-MV[Z*ECE&B#_8+2IH36G?6+-M"Z M>X!&1*`U7L#4>H/6>*]1B13X'7R:08N@-WQ<0(M`:[PIKT6@-=X_UR+0&F^! M:Q%HC9>K902?POJHCBF;LL*_L\(H^,?JZB,64_('[NS8U'#4IY:'ZM3B4)M: M&BI3?Q?CH1U"H_X(XA-;+ZO'YN^KP^-F=QP\-P]8T%VV#X@>NH]T=7^<]B_8 MK^-#6_L3/J[5_N\3/J;6X`,BEW9G\+#?G_P?*'C4?Y[M]G\```#__P,`4$L# M!!0`!@`(````(0#!+`A[70T``,]*```8````>&PO=V]R:W-H965T&ULK)Q;;]LZ$L??%]CO8/B]<2SYDAA)#AKK?L=B+\^NHR1&XRBPW=.> M;[]#B10U_.NH=M&7V/EQ.*)FAB,-1>ONCQ_[M]&?Y>&XJ][OQ].KZ_&H?-]6 M3[OWE_OQ?_[M?;H9CXZGS?O3YJUZ+^_'?Y7'\1\/__S'W??J\/7X6I:G$6EX M/]Z/7T^GC]5D' MK]\^/FVK_0>I^+)[VYW^JI6.1_OM*GQYKPZ;+V]TWC^FL\U6Z:[_`?7[W?90 M':OGTQ6IFS0#Q7.^G=Q.2-/#W=..SD"8?70HG^_'GZ>K8F:/)P]WM8'^NRN_ M'SO?1\?7ZKM_V#TEN_>2K$U^$A[X4E5?A6CX)!!UGD!OK_9`<1@]E<^;;V^G M?U7?@W+W\GHB=\_IC,2)K9[^TKBHR_E\>3MA,KQ:/OM>*KV_VN$IE)5HX0D:R7T M*97,M(Z!?@O9CSYEO_E9_9:R'WW*?I9]5D>*^GJ@]'G1`6]E/_J\Z`2GY,_Z M@.*+&NKRK*%.E6?$%]FUZYH!LTXM=53ZLNZDB?YZ,CF;T^;A[E!]'U&&(AL? M/S8BWTU70IN:1LW1VXGU=_.*)I30\EFHN1]3=-&4.5(R^//!FE_?3?ZD";R5 M,H\H,^42:R4A9JM0ZYC`-8%G`M\$@0E"$T0FB$V0F"`U06:"W`1%!TS(^*T' M*%1_AP>$&N$!9;M'!3HN,L$],DR3"U;9^T4<5IY M[1]KKI,2&R4-AXVR_SY#Y4,AS<4JRY;62Z M5JB-:B`N$`^(#R0`$@*)@,1`$B`ID`Q(#J3H$N8`*EB8`X:C6DAS.TO2B6H@ M#A`7B`?$!Q(`"8%$0&(@"9`42`8D!U)T"3.J*.:857\QK&L]W-X2&8$],P); M2[61C(!\8$$0$(@$9`82`(D!9(!R8$47<+-*LJ>"\PJJZ2N M61MDTT>[@&#-S24$L7K8!&]7:LESBR.E;*H#.KINN)1[EBZO7]H5"C[KB,T4=:5T=J851SL992ZA.M7J%4HXZNN7'$3.OJ2"V,&Y)<2RGU MA59/B`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`@,B6E!Y$K]3)A&3F[4,WLZ$MM2YZP+EOALG"%2Z%F@Y38O;%&Y"!R M$7F(?$0!HA!1A"A&E"!*$66(1A\A'%"`*$46(8D0)HA11ABA'5##$G")*"N:4 MX:1?BW/#*]0)?40.(A>1A\A'%"`*$46(8D0)HA11ABA'5##$K2QN]\W0;Z[\ M%R9]4>\8D2^1$?G&G?Q:2ZD,[R!R$7F(?$0!HA!1A"A&E"!*$66(X4 MLTKZ2=*7I9"^K7^T)=)!O4;D('(1>8A\1`&B$%&$*$:4($H198AR1`5#W,I] MY=Z2?J%U\1Y*\?3%7)3R$/F(`D0AH@A1C"A! ME"+*$.6("H:X3RZK<<56`]/P$G4C'Y"C.FHI%Y&'R$<4(`H118AB1`FB%%&& M*$=4,,2MW%?C+NSZ,?2E]SM8Y-IM^=HI0A\A$% MB$)$$:(848(H190ARA$5#'&G7%;DBLQBAKY$.JC72DHC!Y&+R$/D(PH0A8@B M1#&B!%&**$.4(RH8XE;N*W)_[4X?:UR[0>+H>GGGUER3U%(JS!U$+B(/D8\H M0!0BBA#%B!)$*:(,48ZH8(CY9'99C5N+\QI7(1WF:T0.(A>1A\A'%"`*$46( M8D0)HA11ABA'5##$K6S6N,,WE3,L9"4RPELOIC>)74NUX8W(1>0A\A$%B$)$ M$:(848(H190ARA$5#''#7U;(SK"05:@;WEC(HI2+R$/D(PH0A8@B1#&B!%&* M*$.4(RH8XE;^?84LO5/"O+1*9(2^^3A'2^G0;W111X50W`OCR\E.OR[>TXVE;?Q/LRZ('?PUV+ MFY=Y/,ZNZ6T>]0LYH$6\YZ-^\@$M%K7492^TV.K=(&:+/5N)HI#<`2US:JGW MO4++@EKJY^+0LJ26>A,&M-Q02^UV:+FEEGHNFRT6]:$%^IZQ6=2'5HE[6FRR M&ZUL]K60W6A]K:^%[$9K0GTM9#=:F.AIF9(V^OU*7PMI:QZVF. M/A;U:9Y#FGTLLC4]GNOK0[:FAT0]+>2X7K^1JEY-I*A7#YF_U_ID_%[;3\GV M],LI'!'M`%^)#:O80KN^5V)/=U_+@EKZQDO[7*FE3QMM!:<1]+70RW$^]WI8 MN+'GZ(_"(3W\L[WZ3!,S^.WLIG2I_7=:%^ M:%Y(U/QSJC[HCIA>*E2=Z$5"]==7>G%427MDZ*4MX]%S59W4/S2H2?LJJH?_ M`P``__\#`%!+`P04``8`"````"$`><+N:HTL```]"`$`&0```'AL+W=O(D3VU+;4EA2*]3M[;W__:QB9:$J/S]\>_>Z>'/U^M7]MP\/'S]_^_W=Z___G]4_;EZ_>GRZ^_;Q M[LO#M_MWK_]]__CZ/W[^O__GI[\>?OSQ^.G^_ND56OCV^.[UIZ>G[[=OWSY^ M^'3_]>[QSWAQ]>[)_SOC]_?/G[_<7_W\5SIZY>WLZNKY=NO=Y^_ MO?8MW/X8T\;#;[]]_G"_??CPY]?[;T^^D1_W7^Z>,/['3Y^_/X;6OGX8T]S7 MNQ]__/G]'Q\>OGY'$[]^_O+YZ=_G1E^_^OKAMOG]V\./NU^_X+K_52SN/H2V MS_]#S7_]_.''P^/#;T]OT-Q;/U"^YO7;]5NT]/-/'S_C"IS;7_VX_^W=ZU^* MVU.Q6KU^^_-/9P_]U^?[OQZ3_W[U^.GAK_K'YX_]YV_W<#>$,' MN!3-O)E=NY8^/'S!`/#O5U\_N]B`2^[^=?[[U^>/3Y_>O9ZMWBQFUZN;`O:O M?KU_?*H^NS9?O_KPY^/3P]?_]E:%M.5;F4DKDZ4?N%/HLA4/`?4A?^?JE&"(H"_Q%JC.P,<>0' M&@-J^6957*WGJPN=AB`J8A2-O<(01F[ZA/&^?(4A9HH8-"]W]M;/OO-DWMX] MW?W\TX^'OUYAB813'[_?N06WN'6MA6GL_3M,[.?F-2:T:^47U\R[UP@HS-A' MK$;__'FVOO[I[3^Q@'P0F_=L4VB+3;!PJX5K=FM!:4%E06W!SH+&@M:"SH+> M@KT%!PN.%IP2\!;.'Q1`D/YO*.":<0H$W[T/()'$N#M8A"I;"TH+*@MJ"W86 M-!:T%G06]!;L+3A8<+3@E`#E;DSL_PUWNV8P9]#+"Q$O1E!^,%H:#0:3000B M)9&*2$UD1Z0ATA+IB/1$]D0.1(Y$3BE1BF#!5(KD=Q!AI7'69\<'A[T7,C\O M._^8&P=+Z6*8&-O!/JHR6T==U-BP(D\8F[/68Q.R'GK?$-D2*8E41&HB.R(- MD99(1Z0GLB=R('(DB)[(@'.6CM<2!+%1+9$2B(5 MD9K(CDA#I"72$>F)[(D@]$0 MO$1*(A61FLB.2$.D)=(1Z8GLB1R('(F<4J+\C&1C@I^=M?:SD"1XB6R)E$0J M(C61'9&&2$ND(](3V1,Y$#D2.:5$.=5E9!.\>C;7;A4T2S%M.-=&C!^V7#9KXGG@)*`9K1E5#*J M&-6,=HP:1BVCCE'/:,_HP.C(Z*20]K+;_:=>=FGM-7SY\B+MMO/6VX+\$99+ M2C?!"G>&85L_NUKHR-^*U6S8^979>NOU4$]?@=LNIU=P8>2RNX[=O2\$I7%" M:,M6):.*4T9W1@=&1T4DC'B=M:3_"RWXECPH>[WGMWM@8OJ]OE_,KF M*M$J5-PR*AE5C&I&.T8-HY91QZAGM&=T8'1D=%)(.]YMORC640;K/+G92BB+:.24<6H9K1CU#!J&76, M>D9[1@=&1T8GA9279],2H;.Y7F`$Q>.HFY7YY&,338;89E0RJAC5C':,&D8M MHXY1SVC/Z,#HR.BDD/;ZM"S(+1UF60\H6=89;1F5C"I&-:,=HX91RZACU#/: M,SHP.C(Z*:2];+.@EU<0K!/D98_4(=7\RAZQ2T58Q?`>*@94LE7%J&:T8]0P M:AEUC'I&>T8'1D=&)X6TXZT M9W1@=&1T4DA[V>5)XV^0,TFKXJWOO2`W@X9,?FXS^4VT"K&\950RJAC5C':, M&D8MHXY1SVC/Z,#HR.BDD':\2P\G.%ZRR=3QE&!NW%Y3[\"WC$I&%:.:T8Y1 MPZAEU#'J&>T9'1@=&9T4TEZ>EG/...<49,*;-B=#9AK#FU`9VPI6%:.:T8Y1 MPZAEU#'J&>T9'1@=&9T4THYW>=*$\):T*@WO--/RZH8=0RZACUC/:,#HR.C$X*:4VFI9PS3CD#2OGD]+.<_F.N44%)]IV1#9$BF) M5"G10YR6G\TY/Q/D-A'#UFH1S[#]!`Q&N-T,1G@"6)\,;8,55M!HM8R?FYS; M*L4*E^2>/IP79K)7H15$8VPEZ4M?_[3,:J8("<(=NROMIIZ*H"@V/TW9:VC#GM$&0TK98FP\`-Z'B!7&E^51Z#N/+=^F;M6S!+DD5)\ M?D4!+E87%!>K5'&/W`(UQ._\RCQ=4,FXW%*;6,6YH*/<;6I35V0N&;OQX9J= MN;EF0?&<8S,?4!Q!9@9[JWF\!992,4%5;`N!KX?N-H_IT-U>:;J*L@5--JIS MCU0DS^WTVHB5^WAL<'/F(J5Y7&NTXF5:>O0KUV)Y8]*1*@QI7'CG-I&I8_[S MX?MSX9UJS3M(=^3EY$^U'E!R@_EO9Q_GEK0`@G3V49AU?!.MPGUNRZAD5#&J&>T8-8Q:1AVCGM&>T8'1D=%) M(:W)M$WG@C>=`<4PWS#:,BH958QJ1CM&#:.64<>H9[1G=&!T9'122'MYVM9V MP5M;06X)&Q9Z?-].[]HWT2J&MV\+%0,JV:IB5#/:,6H8M8PZ1CVC/:,#HR.C MDT+:\6Y?.WYA7_AM<'JJ$5`:WF(5T9:M2D85HYK1CE'#J&74,>H9[1D=&!T9 MG1327K:[^[^_L//&?^&16=AMFA.M0IAO&96,*D8UHQVCAE'+J&/4,]HS.C`Z M,CHII#5QF_D)D>_W_BKR!<4PWRP(;1F5C"I&-:,=HX91RZACU#/:,SHP.C(Z M*:2][)*,"5Z6S"7)!A:2INB%W>:UT2J&]U`QH)*M*D8UHQVCAE'+J&/4,]HS M.C`Z,CHII!WO4IH)CI<\*76\H#2\"6WQA(G9Q)>,*D8UHQVCAE'+J&/4,]HS M.C`Z,CHII+WLDJ@)7O8YEUI$/#*KM\D_-XO!*L3REE')J&)4,]HQ:ABUC#I& M/:,]HP.C(Z.30MKQTQ+2!2>D`:7AS0DI6Y6,*D8UHQVCAE'+J&/4,]HS.C`Z M,CHII+Q\;1/2E]/^L[G..@5A!KEC0WPM\F:>_#.+IV+G0XE--!_BG%')J&)4 M,]HQ:ABUC#I&/:,]HP.C(Z.30EJ!:>FG^S:).7@)*(ES1EM&):.*4D9[ M1@=&1T8GA;27;?IY81GG'/,ZFV/:#U:B50SOH6)`)5M5C&I&.T8-HY91QZAG MM&=T8'1D=%)(.WY:CGG-.69`:7ASCLE6):.*4O,B?ERH M+\+E4>,SB6M)NV)W[P7A`>`PU3:,MHQ*1A6CFM&.4<.H9=0QZAGM&1T8'1F= M%-)>MOF:"Y6;]?D[11="A5.W:T%IJ`BZ$"K>*@I5AJ;2>O,B[H[U14S+?:XY M]PDH754X]V&KDE'%J&:T8]0P:AEUC'I&>T8'1D=&)X64EYXK2\8(=WYZN")8I8OWC)XQ"58WYY.08IU\ M=_Y\]E$%`RS$V\I1>DG[*Q._I0#SNI[)C\TR7!*GE<++0NSP+. MKM9F<:N"!:3)-JTOU^UYQ^^.EK)%CG?8]X*4WOPP8+"Z(+AO/GT8,%3TZBZO M[%I>!8-QZKI-Z(3+E3UK>KD>*77Y:<"E5+P@KUBE\DKS_FG`5?*^$(EE*1\G MKMO+3KA:9VYNIQXI<=U?*\^1[_V.?2M6+D]TC+/[,?$4I%]Q6;8:S\P&"P2N7W MS1OYS46S%7Y'=K.J#IL<]0\>6`#E9*:[HEBQ4>2W_4I=HS=M]D/3/NN<\5[Z<"2L46*TS3(=S2D?G%3"KB\;8HMJ^8 MH$HUKR\)%ZZF[(4X=>9&54$QW#8K0EM&):.*4\SQ-D4DW[R42T"H&R950RJAC5C':,&D8MHXY1SVC/Z,#H MR.BDD-;$[?'2F]6%R'?F)O(%I9%/:.N^\^`J1JN24<6H9K1CU#!J&76,>D9[ M1@=&1T8GA;27W3YQ@I>=N?&R1R:\;1ZS&JQB>!,JV:IB5#/:,6H8M8PZ1CVC M/:,#HR.CDT+:\6Z7.\'Q?E.X++_-Y&6U64A%_!JO,_DG:PEHQ6,WM M4RNEM(6O2H75I8K-!U1'%-NB'G>QK6@UGYM]:3.JK3;?EDD1NU%M]?FV3#ZX MCU;AL@^Q>2`E]8U-@NQ^>=37`,^MZ'N"('P1+XQB$ZSB;78;K+".16WGYIBJ MC%:AK8K;JAGMN&+#5BU;=6S5L]6>T4%5U)ZV.=O+FYD;/C<7Y+[!D3C+IMAB M=2'%#E:IX_F\-%CY$S6\`.?*_:._SU$%HQ=G<1VLTEG,,T^LW'W8A5O;B61BD@]JNT=U6M&U6M#/>2H2128NTG_CD9G6\GQQA6BS;=D/C;I1X^J#53JK M_2!D5M^\,6?#XXN/$H1LM&R(7#9+%*9[5O*9**;.I1 M;>^H7C.J7AOJP<-#;,X79E?5C6JK#U;IK/87*+-ZS;-:RE7WS\YJ=R(P85;+ M`4+4Z?V-(/^KA.?7PS/:,BH958QJ1CM&#:.64<>H9[1G=&!T9'122-_U7/J? M>CF>N5V8*:ZBV6\*2E>^^<+LLS!<&YGQ8&:T8-8Q:1AVCGM&>T8'1D=%)(>WX:5GT9'1@=&9T4THYWV]_TCGQA7?&[Y?3D;RTH M#6]"6[8J&56,:D8[1@VCEE''J&>T9W1@=&1T4DA[V6U%4R_'?<_$-URN_:96 M">"17MBOS:'-1BK"*D;^4#&@DJTJ1C6C':.&4D9[1@=&1T8GA;0H MTY+5-2>K`:6AS\DJ6Y6,*D8UHQVCAE'+J&/4,]HS.C`Z,CHII+Q<7$W+5KV] M3E<#BR\Q6*4_[DR_[9S8#[&>8?B!43>V=Z_1;K##+XP2PT^,$L-OC!+#CXP2 MPZ^,$L//C!+#[XP2PP^-$L,OC1+#3XT2PV^-ILQ(,BV/+:XXD1U8$OL9MLTP MN%W:BW7A=F)P.S&XG1C<3@QN)P:W$X/;B<'MQ.!V8G`[,;@]9<;MTQ+;XHHS MV\!4:CM;Q^,X_WE18A8"&TIPX@9G-3CS$#Q.`\EDH00Q*$(,2 MQ*`$,2A!#$H0@Q+$H`0Q*$$,2A"#$L2@!#$HD3*CQ+2$M[CBC'=@:@)PSINQ M@]O)#FXG!K<3@]N)P>W$X'9B<#LQN)T8W$X,;B<&MQ.#VU-FW)[+@%?+R^]) M**XXXQU8\I35P-(/=?A5"<$LIG&01'I(:\ZOX\=5YDIW:0$E M6[@%$T,`$<-HB2&`B"&`B"&`B"&`B"&`B"&`B"&`B"&`B"&`B"&`B"&`4J8# MJ'!903IOSX]\NJW2A7OQN:+Q?V!I_`1V(7[$+(V?7,WY=?P\VER(VV>G%W)I M_+(OCSV^+XITKRX;!V;;C%V9856&U1FVR[`FP]H,ZS*LS[!]AATR[)AA)\V, MV]VF.G6[BY]1"Q`^IK`?]A>!J0`2NTL!Y,VBG)`D4W.>O"S`7(G;IZ97T0`>9:^\2?#$$!DA]$20P`10P`10P`10P`10P`10P`10P`10P`10P`1 M0P`10P"ES+C=;4JGN-UO8M,/N8IBV-C&>]3\VCZ^D)C%)#A6#0Q*#,T%!B6( M00EB4((8E"`&)8A!"6)0@AB4(`8EB$$)8E`B948)MT^=HH3L:]4$2/>Z804E MA@E`#&XG!K<3@]N)P>W$X'9B<#LQN)T8W$X,;B<&MQ.#VXG![2DS;K>CNWPNT)G#R)ZLN,*?A"S^``LE)4.Y'TOR[7U,JY:3+`X9ULW5^TV MD5.N6C:=ZJH]4^KS.U\*?/?67?:%Q]L'LWA:C\N6JO+:E_7"G`3AJL4"?T9< M]?G'Z=.K/N^/I[YDAC(/3@7PICO[-6A:;5 M=QO2Q_IU`+@CMBD!<+8WTS^P^$#5IH@L+X@$N9BEK\D(51.&BY)-_+D+6&IE9]NUZK)/A/WT2%\YM?V"QJ%5+T4PL$L#>'`?`@O5C=7,>E&.7YE$E7+J8X4_T M_W,ON"G<2J,N_6].7[]KTA[Q3*UE\Z5]P,2/X/):=AXHS%0@^![T:VZ6=/,* M5=-@>/8]-\7YE\2G!(/L7-)E//P:N9K%8H=[RJ!+NI:$6>S-DAE;^B&]>YTP MR#PTASVXF<5N@Y)>P=_4U.]SM*:>Z2BG-]X4;E:[C0W&^.*UBAG^1#/>GDAK M\M*;^?IZ93(7>$/&E09]ZESC(+>;>K&[)+TW2]YS M`^F)X6*'YEAZMV-)K^S2`NYW.%IC8?%$&;<@8ML,PW#)#L,E5F?8+L.:#&LS MK,NP/L/V&7;(L&.&G30S`>6V3%/<[NSMG=\S=W<>)L-\:79G4&(P"[DWE"`& M)8A!"6)0@AB4(`8EB$$)8E""&)0@!B6(00EB4((8E$B95L+="Z8H<;8W2@26 M3@!FVX)9F6%5AM49MLNP)L/:#.LRK,^P?88=,NR882?-C-OMUM?=A*LSBS(A5`X-$OHO$#A(1@T3$(!$Q2$0,$A&# M1,0@$3%(1`P2$8-$Q"!1RHQ$$_?V\M/GZM80F)H9?JN=O`X*,X,8W$X,;B<& MMQ.#VXG![<3@=F)P.S&XG1C<3@QN)P:W$X/;4V;<[K;CZ:W!S8S9M?L$>_+< M\#M[K8AG9F[$SQ##W!C,PCR`2,0@$C&(1`PB$8-(Q"`2,8A$#"(1@TC$(!(Q MB$0,(A"DS(MDLZ,*V27X[7BLA*9":&\3@=F)P.S&XG1C<3@QN)P:W$X/; MB<'MQ.!V8G`[,;B=&-Q.#&Y/F7&[RV'2N7')[9+SI*F6_'9]>K)+"$[W-:,5 M?&X17&X1/&X1'&X1_&T1W&T1O&T1G&T1?&T17&T1/&T1')T@XV>7'4WQL^1E MRL^>N9]O3+:GYN`%-V&I&FY$(2J0I%L59/^0:6A:NPA3?_. MJR"4R[9FCJ:@YIC6H'"NM94YCX'J@UE8>B'[T$-@T)T8A!_JQNN:K\S.!\$P MF(7F$`UI)(=JW$\0QS-70)<2@+Q\3T3(M#=A"'["`.V4$88("B/&A"([:$9VT(SLH!G903.R@V:#W0L.A6:#61@>-*/FH!DQ:#;43;LP M>UEH-IB%+J!9VIS6#,=I6K,+FXRSO3D1$*:/LE=T\PMF<=YMB\`PX^/-;T4W MOV`6JU:AJOM!\*0JW?QBU6B6N?F)F7Y9W(IN?J-::\/8SGY MV@C7AW)W>A.O)WFGT/DNO1_,HBL.`XO='0.3[DQOIU#\;&\F2ESBG,[L2U'B M$VV5`;AWDN'LPN7@\?INS(9@4X@9#L>#ZQ`ETAQNVDE5<[LJ![-8%5'BJ[H? M-$^JFMM0'/I+?!;,%+R_"E1(N<"Z/;^62)U+:XF812\B2J@[1(GJSK@%47*A-Q,E[J!A M2I3X@PF]EGAFUA)SVT"42-6X("!*A.FUQ,PS1`E5191X9M82"9KB0UGK"52CC]Q!)FU1)J.7D24"(O= M(4JD.;]T%1PF4HX_V>Y,F+B#D2EA(@+L;2KLF5E+S!8!=QPQBZY#E`C# MGT%JO"-=OPD<=QRJBBCQ3*\EF2@9JL8>2B)-=:)DK&M(8H$;,X(;"6>!;6 M$K->(DJD_-):,HP@B1+J#E&BNC,>191[N6>*;6DL45[TO$ M++H.:XDP1'82);POH:J($L\NKB5#U=A#+DIRK66B9$QKB!(Q4VN)9V$M,?<` M1(G4P9_!%>E+UL.QFIA%+R+)$1:[0Y1X)MV9WA`E4@5_LKWI*+F>>/AZMC=1 M(DSM2Q979F";(E1-UY+`]%IB-HUEIFH5V*6U)/2`W=K@CDR4B)ENC:-D5&MM M&!N^B!0F?!=86$N,>_JA_,):$D<0FCZ$JDEWQ\"D.]/;:2A^KC<3)>X0;L(= MQSU89M>2P.+37P@)L8MLFV'0G^R@/[$ZPW89UF08-*/VH!DQZ$1LGV$0A>P@ M"C$HD3+C=G>JE;H]/IITX?3[VI^'J20SL-7Y7/W2B)R]73B$Q8_/$!+$$!+$$!+$$!+$$!+$$!+$$!+$$!+$$!+$$!+$$!+$ M$!+$$!+$$!(I,VYW9Q-I2%QRNS_+T($@QQ_83@Q+XKPPMV8H,9B%E09*$(,2 MQ*`$,2A!#$H0@Q+$H`0Q*$$,2A"#$L2@!#$H00Q*I,PHX?+_*4KX\P*MA#`U M`8C![<3@=F)P.S&XG1C<3@QN)P:W$X/;B<'MQ.!V8G`[,;B=&-R>,N-VEU"G M;O^[#S)?^\QEAS<66V_9@9@UDR,XA!(F*0B!@D(@:)B$$B8I"(&"0B M!HF(02)BD(@8)"(&B5)F)'+9;"K1I37*9[]:"6%J9A##S"`&MQ.#VXG![<3@ M=F)P.S&XG1C<3@QN)P:W$X/;B<'MQ.#VE!FWN_1PBMM].JG=[EE\#!/!;A&< M;A%\;A%<;A$\;A$<;A'\;1'<;1&\;1&,YEW!,F`M+ M25#2XT-AVG-BISSG67*E91':BW;P'-G!<]0>/$=V\!S9P7.#79Q="_LU6'AN M,$L\ES9G/)?+QXK)KU)89I(S8=JA8A<=A5#T3#U=&-J+=G`HV<&AU!X<2G9P M*-G!H8-==.A\94X"X=#!+'%HVIQQJ$MTIH2B)$8J%#W39Y0%9;=+,4O7V\RR M',QPFQV6Y45ACF(1PV-:@PK>3)UD+@KC-0@SIC5HE6EMSH]KC&H-BDJG\6@1 M\GGV[$EFJ(-E>?!.>I)IU'7)TQ1U?;*E;KI+2<`P*8<>%YRKBMG+#\]A]D@/ M:1`L[&,B4%?,D(4,G5*L0%UOILX,%X79$$#=,:U!W4QK.77'M`9UQ2S>VJ"N M9^$$TGRNAWN&E",(ALM^05V7HTU15W(Z-7<],W/7;()P3Q:S5#;2`^J*F9Z[ M9A,$=<>T!G6]F9F[K.Z8UJ!NIK6^69_ER@,-M(J"M5,;XA['+JBAG^#&:+F0EBJ#NF-:CKS2[.W3&M0=U,:SEU MQ[0&=<5,S5W/PMPUMQ#,72D?.7==%CEE[DK6J>:N9WKNSOB^*V88WR!;3ETQ MPY_!;#'C^^Z8UJ"N-]-S=V::NN8M#W3&M05UO9N:NN8MC[HYI#>IF6LNI.Z8UJ"MF:NYZ M%N:N"6JH*W7P9_#.\[NJU<1CC;.]45>8F;LF[#9%J'IA[@:S-`@6<[KO!K,7 M6ZM"IY?F[JC6=MG6,NJ.:JT-K24?HW>!A?NNN>Q^*!\W=U?N;&'"W#W;6W7E M?")^9@XIB6TSK,PP*$)UZPR#K\FNR3!XD>S@16+P'+%]AATR[)AA)\UT(KIR M)Q"IV]UG1J-^9+PX5[4*R(%&NM[-^&MDH6IJMDA>86G&B`BB,L[-9ADB#6;A:`\B$8-(Q"`2,8A$#"(1@TC$(!(QB$0,(A&# M2,0@$C&(1`PBIW$X'9B<#LQN)T8W$X, M;B<&MQ.#VXG![<3@=F)P.S&X/67&[5C@)KG=V5NW>V8F`.4ZJ\$LF0#$H`0Q M*$$,2A"#$L2@!#$H00Q*$(,2Q*`$,2A!#$H0@Q(I\TJ\??QT?_^TO7NZ^_FG MK_<_?K_?W'_Y\OCJP\.?WW"7==_R3OBK'_>_O7O]'A]CWYX_RX8GASJA;%6@ M#+N#;-G"E9T_GN9ZUZ[L_'0IERU=V3DIXS(W%EQ8KK^YZP^;OUS9M1LGGM[+ MELU=V3Q?YMK$@T79>NX:\/1+MLQ=`QZ[R)7-;E"&]WAFR]:N[+RFT+7/KU"& MU"57;^ZN#TE$MFSFRL[W=6[373O>Y96K=^5\C5^#RI:Y<>*'?G)EA1L+?L@F M6^;ZP^]S9,N:*[>E1L+?A0S6^;\@M\>RI:Y M<>*W!+-E;ISX=;MLF1LG?H(M4[9&-?P&?*X$E?"[Y;D2A!%^/3M7`G'PB\^Y M$H07?G8X5P+1\%.YF9(;C.`F.X(;U+G)UEG#[>NLU]=P^CKK\S517CFN, M(+]N7&,$^57#+;1X9BAS/==0`<]79$J64`&/-V1*%F@-WU7*E2!"\/V47`GZ MP7<2,B77Z`>/L^=*H$]^9;V&VGA0.5-G@3IX642N!'5PG)0K@:]Q%)$K@:_Q M->%<"7R-KX;F2J"V_P#?KBQ1O\6=E1YYFU&[[V1SC6HP5\C=])R?7C;I_9Z"W@4?\0C6T-W60512?9 M/M!%M@=TD%6L@"[X`;G<:*%+]EZ(`\JK6WS.FZN%LL*5Y?1$V`NY+W M^2MQC^W=XL`[-SKWK-[M^+H^UW.+G.E;F'[F[/3^CP6-R3=E`QNZ:[-QI"Q:Q?W)L-;\\O_.(VW1L.;\_O M+\R6K5Q9+MK=^]U<62[BW7O$7%DNZMTK(''MV3+WWD=<>[;,O>P1U^Z?,S,S MU;UKT)7EQNE>=>?*.3<12MLR]:Q.QE"US+]A$ M+&7+W(LV$4O9,O=V3<12MFRW0BC=Y-:#!B5-MJ1%29LMZ5#294MZE.RS)0>4 M'+(E[U'R/ENR07U[DL5=OW-'/C\^_NZ,W_S]/#]^1WKY^]>O#T]/#U_-_ M?KJ_^WC_PQG`^+>'AZ?P/Y@\;_]Z^/''.57^^7\$````__\#`%!+`P04``8` M"````"$`*(UZMK\"```E"```&0```'AL+W=OO,6`%8V1[L\G?=XPW M7)I485\`P_$YL MTK5(\;.P^&KW\8')6H72(RHF(/X;2D;^\*F^!0Z MQ5=,\M*4:*;^Z+6ANVK\#W$YTS_L+=+E[1*\F-MCIW$="1 M$.AKSVNR)L"TVV82'/BT(R/R%%_3S0V-,=EMVP3]EN)H!\_(EOKXV[[]H*?#VKO1YFY,L6S9;18Q3,*<+07UMU)3XD1 M/UBGU9\`HB>J0)*<2.!^(J'+:)XL5I<36$B(J#5XRQS;;8T^(N@:T+0-\SU( M-\#\MB.PXK'7'IQBZ&H(UD(9'G>4QK,M>83<\1/H)H#@VH,Z!`'53AKDIDM[ ML)?VR?6QW(070YGD;9G9.3(>#-49!D_C>4<G6.M`>/34,[]YY"Q@-H*+T>M/PHXW[<3_Z7/'@L?KGJ.SAH!\Q0NX]NI+P^ M1]F#W\UX`$V0AKE[ANL6/;;]1LY/J*'Z>M:W8[`>IG489DJ80GP25641UP<_ MB2F,I^YM=TI<)^V<[S[`D&Y8(;XQ4\C:HDKDL#6.5M#J)HSYL'"Z:4?E7CL8 MS^UC"<>Q@$$41P#.M78O"W^0=`?\[B\```#__P,`4$L#!!0`!@`(````(0#\ MBWXFQ`<``+8B```9````>&PO=V]R:W-H965TB38;Y[V]>+M$ ML?]R@OO^9O3\/6IG?S#Y<[B/HR1Z35L@U\X=Y?<\:H_:H/3T<`CA#D38&W'P M^MA\-NR=837;3P]9@/X-@X^D]+V1'*./61P>UN$E@&A#GD0&7J+HBS!='`2" MP6TVVLTRL(L;A^#5?S^E?T4?\R!\.Z:0[C[8'B'(Y84 M@4\I8K7N%H'YE=T-?/ZZ)R,I`I]*Y-[<&)AA\055NO??D-&5SH@OJ/,+,E!H M66",HN*,N_,L*CQ7*:JE>W?%&5@NXHN\)?-67]KY1,KFI>.G_M-#''TTH-E! MF).K+UJG80MAG)'Y_%%S]$=3%.:F4'D6,H]-*!^8?0GTE:]/0]-X:'^%7K"7 M-F-N0RPF:"$FOI!U*)A2X%(PHV!.P8*")04K"M84>!1L*-A2L"N!-@1?90`* M]'=D0,B(#&#LQ@B*E'3UA$S0`H`S;.2;<1&2-S1A:,+!E9,;)FQ&-DP\B6D5V9:'&&Q>>..`MK/D5,*7`H MF%+@4C"C8$[!@H(E!2L*UA1X%&PHV%*P*P$MBO#P>D<4A;4>Q9R8D"75:+M] MVFKE,'@\+1E9>I]PI!(X6C(:ZD;36Y3<2J61KC131MB6YDH;R4*1LDO$[Z42 M*AD-R'JT4D:HO5;:2#Q%2D)]O"VRZ$QPH+XXLYJ2\EI(!JRF MI%6MEHM7U+583>5:9C>K*;-C0DF1=,[Q#F'O4B2=U]0M7BT+KW"^KU!>FY06 M6136:%7KA(?RM:'9H%6Q"FY1OI?%@=>4#)-V=:M8Z_6:$KONVA1/5 M':OJZC^L+G&$4*ZNG]24,">K8(Y(QR(+\T0<]HJ!M5/)02LM)!;I:U.TJM5R MT4K3&K":DM[G'6M4V;"D"7S4-:Q;;G!9.(5S4E#`G)251_HY)G%I/#(8I'3T(P[9A[?5CW?M)?Q##BG$3Z9=D34:55T9CUV(&6<@XJ_^;0B7'$.XET M[XJE/-MP343,>.B*=3?W+G_%F[]*.@?Q6S`)3J>DL8_>Q>O;[@`>)A3.WRV/ M>S:<34(KH;QOP_%:!3=@`-04_Q_/LF'/Q?G&LN'0H8(/;=C^5O"1#9LPSG>6 M#5LQSN'M^'/V@$+O0+PUK[`?=VUX#5&A8]K/^5MV*F3:<$S.!\PM&[:OG"\L M&S:QG"\M&\YZ*OC0AB.&"CZR8:/+^=JR8;O+^=BRQU5\8MF3*NY8ME/%IY8- M^WNN[UHVG(Q5\*$-IR\5?&3#AA]X6P44?C5P]=\"SX_?PDO2.`6O4):=[`PC MSG]WD/^11E>8)/#;@2B%WPMD7X_P^Y``^GA'/+:^1E&*?X@+J%^&PO=V]R:W-H965T M,9_[]'A"9!#(/BF1Y_:*V#Q.)Y,D+$B"KZH?_^O?7+V_^]?3] MY?/SMQ_?#M\-WKYY^O;I^>?/WW[]\>W__N_MWQ9OW[R\?OSV\\?GS[ MGZ>7M__UT__\'S_\\?S]'R^_/3V]OH&&;R\_OOWM]?7WN_?O7S[]]O3UX\N[ MY]^?ON'*+\_?OWY\Q?]^__7]R^_?GS[^7`_Z^N7]:#"8O?_Z\?.WMU'#W?<^ M.IY_^>7SIZ?U\Z=_?GWZ]AJ5?'_Z\O$5]K_\]OGW%]7V]5,?=5\_?O_'/W__ MVZ?GK[]#Q=\_?_G\^I]:Z=LW7S_=[7_]]OS]X]^_X+[_/9Q\_*2ZZ_\A]5\_ M?_K^_/+\R^L[J'L?#>5[7KY?OH>FGW[X^3/N(-#^YOO3+S^^_3"\>QPN%F_? M__1#S=#_^?STQTOVWV]>?GO^8_?]\\^GS]^>0#<<%5SP]^?G?P31_<\!PN#W M-'I;N^#Q^YN?GW[Y^,\OK__K^8_JZ?.OO[W"WU/<4KBSNY__LWYZ^01*H>;= M:!HT?7K^`@/P[YNOGT-L@)*/__[Q[1@3?_[Y]3?\U^S==#X8#R'^YN]/+Z_; MST'EVS>?_OGR^OSU_T:AH:B*2B:B!'\+2EH&8HIZ=OR5@3I*4HP5^U>?AN,9U.9HMY^]T. M$17U_.$_9&S'"'7K$/\A(^;O1HOI<-I%[7"DD^$_9&@OGPP10M'*%$O#Z;OY M<+`<=]V@!M`P15#'#>)RG`S_<>,-:O`,4_2TW>#[F#%U`JX_OG[\Z8?OSW^\ M05D#M2^_?PQ%1N6<9)[%2B9#A0>W:`QL/;#VP\T#E@;T'#AXX>N#D@;,'+AYX\,!C M!KP'^8T'$*%_A0>"FN`!Y>Y>@>22D77(2B5TR-H#&P]L/;#S0.6!O0<.'CAZ MX.2!LP<\20BB7S!E*#M"4U M(I/$J0?6'MAX8.N!G0>J###6HX4TUL?5_UWH=%Y_^_SI'_?/L6TNI.08JWQ< M^X,2>U,1F2+CF[HWG;KBN))AL9^O5_N(C/&G&389#FS!W#1"FLA;4K0CI(K( MR%HT;E0;4L*V,F^)"C>/SE[O/DC;NX_(%'G8W`8:Y&:NFK25#,ON7I!9$PJ; MB(PG=3^U=$1LY6I^2^/QW$ZSHVFJ9IKM-4E4(H%UGH+AL;+26AH>V?)V$3Y\)#($O)S,7Y M2@&$BPY2GSI%"DC`M4(Y)5&74+)(.1ZS1D9T42(VIJFJ-%5.24I*2PD8 MOX62(.X2)T*.$N?@5=BXAX')SK5".2512J.$*)'+^-/$/]=4U9NFJA0RB3-+ MZBTEH4.[(4IB0P?6U=GWX82!H\075I$RE(BNG)((:2U)-DN4R.4.2D1O3DDS M5>)R.KM67D-_=0,ETH[EE$3(10F55QF8[%R'<\80.#DE$;I*B5SNH(2FJM)4 M.277RFOHV7)*0F\VFH4#T"OGHMJ1A&,BV1K86M^NQ0(X27VEU8$:)0ADE`EVC1"^W4Z)ZTU250C9QKE3:<')T0Y34 MXHX2Z1OC`Z6PEUVI5(+6#&T8VC*T8ZAB:,_0@:$C0R>&S@Q=&'I@Z-%`)A=' MH9',<[%>SZ;O.I>S>J#C6YI25,QFJ1A/?.W6@;G4=)$6/6L>8HS,6RQ[++?A M4,$MMPKE,X\GOI"6I*:+*PO>*+13GKXIXJY]X:N'.?*D,;/&^9*F`W.IZ2)1 M;,D+O8XW;CB05T8YZP3R%J7E@*QKBB5*KBU+BRXGKKQ MHD]BR%*=NU8@:U^JRV)?22H[_[+VA=4OMZ^#-%DLC2087GLVX94O6]\4EQKLE$K4%@[FG*^ MF/B$3U+JIC5#&X:V#.T8JAC:,W1@Z,C0B:$S0Q>&'AAZ-)#UR6U]RUB:E!3F M]PIECW086C.T86C+T(ZABJ$]0P>&C@R=&#HS=&'H@:%'`UF6?=_27E_&TIKD M+$\8C0@E9$[(A9$O(CI`J1^QM^/ZFXS:XJ0D'A5AN)EC:FBR=+E-'$&NW M2&%/DK(T#AS;@2Z]-S(04CIPR[IV#%5I8&;7-*FW-)3:J/""#WJ._D^\L%_Q M*Z]`8$?-7ZE43D4.H4H'UD;8^_8=6H?[N2L;1R@D2N;^ MU&^)^V5@VHNM96!^P*:ZY,F6ZYZV>AEQTTS%Q["J-TU5*60C+:FWE(0>K7_C M$,+7=5L".4I2ER>4R,!DYUIUI6#9J"ZA)#5CM9*M7NZ@A*:JTE2)R^DR=826 MDM`8WD")])%YK8N0H62\2-,))3(PIT2@G!+1%2FAYQ"0D/YM44)353(P MG#>F@8O$N*7$M[\=B<,][SA"AI+I,DTGE,C`G!*!S96I6F2F5E-DANLY3J%++LI+72LN,;UXZRPAWJ1'I/1&ZS[,T&[FY6(I4%]EJAG!+1 M=2V'Y#*(:Z;B!D[U)O8KA7)*)H,4U)82W]/V#QAN;R>%]G8V<)FP$BG#CNC* MV1%=U]B1RQWLB-ZT'.L@,.33IU!$P0=SDD4'J$L0J;OR"5H#5# M&X:V#.T8JAC:,W1@Z,C0B:$S0Q>&'AAZ-)!E.;27><>JI1DKKZ5&,26KW&S@Q=&'I@Z-%`-@A"RYBSG(+@QL/1B32?N0,BY`Y'4TF4=;Z1TB.# MM>C"0(4V#&T9VC%4,;1GZ,#0D:$30V>&+@P],/1H(..3Z6UM>"UNRY]"*&3@R=&;HP],#0HX$LRZ$-SB._O;Z$)VYND1$H M'86N"%D3LB%D2\B.D"I'[&V$UC6_C9#`-Y\*3J4!SI)7(/LF/)V9ZL"TU*\% MZC@H3%*:XEO6M6.H$JC?^_#!>L-.AY-CNYR_KUAKP%%-WGI.1FD#'6N82.7- ME4)9J-S%>*80.IUE])Z.TQ;0!$QK1PE35^L:;`1*=G1SI/-<4>KESNB1/3FE#13Y5%R9<\V M#=WR#91(O0I]^@".4JHELC`G!*!A"EM!9WE$A;FG9**Y5*T)JA#4-;AG8,50SM&3HP=&3HQ-"9 MH0M##PP]&LBR7&J19^,>;_C-N"U6")6SR2A^?[,D-1NF`TMK'X+LAK5V%L1= M%`B4[?=4*D%KAC8,;1G:,50QM&?HP-"1H1-#9X8N##TP]&@@RW+H-/..YD^? M=,RDL\TK4X3,2<=LZ+K9E0S,CC76#&T8VC*T8ZAB:,_0@:$C0R>&S@Q=&'I@ MZ-%`UB>A)61.R(61+R(Z0*D?L;81F-;^-/W72 M,9.6-X^A"(5==%/2^>TP'8B`:Z1&4]=*K46JX_`C2>FN;YO4*[1CJ!*HW^'' M++2R.6$=V26=;\Z,M,SY3G^6]7=QPU+/@X#I8$;4YSV8J+_6@\GEW"_\*"[- MKL15"B%&&U?-LC,;&U:A^;V!)6FRDT^_)*[WEVW5>NKBDB9=3%SW?:]2AM'FH_PQ MZI*,WM&:H0U#6X9V#%4,[1DZ,'1DZ,30F:$+0P\,/1K(NBAL!?H'\CR(VS(O MD.EB%A._\TQ2B?BH*VML-BRU96C'4,70GJ$#0T>&3@R=&;HP],#0HX$L\7Y_ MT5YGY[RI4"BU+"N&U@QM&-HRM&.H8FC/T(&A(T,GALX,71AZ8.C10);EL,>Y M(;QE2Y35Z7F$LBZ&D#4A&T*VA.P(J0C9$W(@Y$C(B9`S(9<=21ZO?ZI=#2_W^RHM4$Y^`[62'Z7"H7?6%KD.=B,S0BJ1WZA7:*=V MX4JCB]Q=)5U):C9*QR#U2KY/4JK^D-0K=$Q0TD4SGI*N)#4;N8WX.4FI^DM2 M#\@Z,FQUX,\K/+><"Y1YKH&0GW83"IW\SLOSIL$KEE!:(%UWX MT^@:S5P8;537HGYI>S0<9"]6UZ[9J@1:[:3';QIW*M5J4Z52K3;M54IMFDQ< MNAU4HM6FHTJUVG12J5:;SBH5;9K.EV.W.;JHQ#6;;$*&?>$-"2D;S[P3D)VE MV5]XHU9S&=A:X]8JE>KE1B!\H*W^-N%Y]MJPA(7,G^]L*0AWJKEU_DJETOQ[ M-__2?Z78005:YS^JYM;Y3RJ5YC^K^GC_H^DT>Y6\)N"B$M<,L/X.&]4;_!W$ MW<8F0J8T+*DRB%!KQ*_G(I4^X+91*(;W9#!V=6*K`AC:5@7ZS%^IKC3_7B&9 M'U_?;K?*!Q5HG?^H4JWW?U*I-/]9H3C_<#R8N8;NHA+7###N7I2/&F[\G&.M MQ4:!0.;QX52O.?57V0E(Q6 MAB^/:*G,JJ;5I$JE6DW:JU0T:32:^_9,!5I-.JI4JTDGE6HUZ:Q2PM+=K-6DDTJULG36&:-)X\'4E9B+"EPSR>8S3/HK\CFHL?L_0(>E2]<<$M:@_L:XS0Y>DB_(9 MWF]U2*]OOE\$+FD4JTFG54JFC2> M+L:.DXM*7+/)IC!F:XV8GDMR4.-"1J`\A1LH^93.-M:+*)7EZX:AK4#XXM3D M^3[J*]:U9^C`ZH\):K'^Q+K.#%V2+DKA+2?):W<;= MJQ1NK8D`,E\T91F8AFD%VS"T96C'4,70GJ$#0T>&3@R=&;HP],#0HX&LB\+V MK'^=6P9Q%]<1,J^DS,:NH5W)P.S]DS5#&X:V#.T8JAC:,W1@Z,C0B:$S0Q>& M'AAZ-)`EWN_YVBO>DC=W"J4SL!5#:X8V#&T9VC%4,;1GZ,#0D:$30V>&+@P] M,/1H(,MRV'3<$-ZRN1"UEV]+T-RM"UH1L"-D2LB.D(F1/R"%'[*V&3CV_ M57^JTVO3L8S]?OYL7*'LV7B"4JGE#E*DS*LD]+!SDZ2T_FX9VC%4,;1GZ"!0 MX7GV$BM=(@QK_9\C+&AQ%5&@G+`&:B4L2MG7/_RSJDUM-W[%)QWL;P6*-QD? M4B2H9<8JZ0K/04>#[&-0M9I]$E#O'))FWS0O3=,,1CMJ&C?-M0:PF5,G4OD. MM!!K4:KC/0Q1#RF]FRU#.X8JAO8,'00JQ9II=+N9X?YV&2&[]??/$5\74A@7YHY&X9H-SB-G4=*;*<,!; MF09+IQ*@6>10**['*FB.8OF3Q0*V52P_^,BPEBG`(DT!%@D[*!:G<"29G15( M^E-K5_TS`&[Q4LP5&O\J1B/6FM2@,VZX1JU9C4`6,4GKT7+@7SD%XR)S+:\U ME$6LU3`XH8]A\(LU;(AO#_7UII&Y9IAS7=@O-7U:P77]COJ&@[CORCNU!C-Q M+W)=<1_%\N,^59=A\$*C3I?078:UQSU-`7X)0]SG4SCRS*ZI1W'@;=,P'"\A MZ$U9GM$WH:E8>TE$@,L,)MSH&%W%I$I.QV-W,@%BQ2S<_/7Z!*YEOM;5`N'= MQRS0+Y/&!U'3\S6LM/'"/B%C(`3C!'S^=1_80*\ MT&&$\P*8,%YH[\.'@R#ON8^8RY)TT*?Y%I"LG^A@![LD(<&^,&(YF_E$LN.\PPG$?]G`^`V[^1,=P$-1XET3,I8-[ M[H1&1\1@=JM+1,RD@V`Q'49X3=`=LL(E(M*5#GV,@$O("+C$&3&9N8R'2SJ, M<"X)>\/<)5WI$/>2=F45S*RL#=9.=!2S'25A8+91EZVL#=8R!6@D=:"1,/#6 MJ/-;]^$`#C4D_MZ=I3Z`]W9Z>=0L3SN$]82E/@9 M;;1G"(6L>]P4,/QX=I0S.ZF$M4R!G\^F*?8%[*!8:2=5_P1W&WF]CDV'^DO> MAKNXIW/UVE54_`*YB)F`YO9%Q5#Z4EGGN%>Q6,+'2YSI-0_GZC4;A,N$"+*D MR4^X:\1:[8(/1%NK77"+B,G2LICY#AA>ZK#+17W8F;4YKF_4QQV>J?;XG[J* MF:AOL!;6$/51S$8]87!"HRY5^X2U3`'&21WH)0Q\YE,X\L(6JR$/'NY8$O4G MR$UX!QTH]>E9*F*9,#!"&.H`86"$,,0@8;A]PG#[A.'V"3L6L%,!.Q>P2P%[ M*&"/%G.TA\U43GNHU/-9]\^4XA%[)-LX0+`\\_B5AV9H+C;+/G/F3`P[#6]B MV`3?^&73PS`F=@(IF!?9M'4QNF_$D/M-,:+60'6E4$-8B?Z$(:P(0U@1AK`B M#&%%&,**,(0580@KPA!6A"&L"$-8$8:P(@QAE6/.9TA@X[.N;`[RKDD+7R<) MS#[&G[CS9"1X(Z9E"YX@#)X@#)X@#)X@#)X@#)X@#)X@#)X@#)X@#)X@#)X@ M#)X@#)[(,><))-E-G@CRWA."9<_U\8I2E$L8:"<,M!,&V@D#[82!=L)`.V&@ MG3#03AAH)PRT$P;:"0/MA('V''.TAWU-7K2Z$D#V0:::1BS[[HDA^L7@G02! M=`^!%V%1AVCGI M;[!W>5B4&P^+&"[\-U#@CD4$;60Q?IR'0[>9W['?A/?;1^K/MALB8B.; M'.\.Z5=#&=7QQG\C9APORB6Y1_S9Z&983]?['K>C%N.V:`E4+-]_):SL#DWG MJ,ZGJO(F;R MG>NW:-,O.QA@8V@G!!MB5\]8#PU0&T$]M]XA7GWWHYAQOH MRS#<;*..3D'#I]2>@D,)P\)#V*:`P5R2VQ6PJH#M"]BA M@!T+V*F`G0O8I8`]%+!'B[F,"_U2'E!=M,?^RBZ/6<^EK'L(I'L(G'L(E'L( MC'L(A'L(?'L(=&>0N^O0--URUT'>;1;"YZ)#BXJ0;E*#OQD5Q]]Q*/XT8GFW MH@4EBMFWZ/P+/6"L$=.F%)0U,R@&SAJL95;PV*A+8K.IJU'@MA'3&4!N,P.E M%H8JA\"4Q7M=4 M3%N7J7\=$C1V=*UUW(-9$6NU"V2+F"$[8L']C:VSJ=N1@?\.0YQ+0NN9QVY' M/<323I5!L#!Q9ACMDG1H1ZNA8BGD$;>FAYXO)RZR07]'"ZWTB_FM-H!^$4LV M(-9E!G1SV5VZG1'H[S#$T>][^2[Z8P]MEJ.P,8R[M=PPVL*H6&ODH9*(MA1Y MH%\P>:(R&?B2"?Y%!%6R88?*/L)?Q%J-`/]D!/B/F`M_YK_#$,=_Z,UO"7_I MY?,N#+\Q$_AWX4\[)Q$+AZO7&0+_,D,*/?`O,\0MY'@Y=R\&@GZ1P,U?5P[Z M17FK#:"?;`#],@/^-#/,Z&N%&K%KACCZ8V9Z;X1,Q&OP]0T"]BL*^5?A$ST2^81/\L^PAN MS2OH%XFNZ.]C`^@G&T!_Q&ST%^CO,,31'[9+M]`?MU=V[8V8BW[N1F5H5_2+ MF(E^F4$.B&?^ZQ-!OTAT17\?&T`_V0#Z908;_=QY=ACBZ`\;JIS^/[EK"FI\ M38J82PIN2$6L*RE$S"2%8#$I\(J)(P->$0G\N9YQ6)%%K-4&>$7$D@WP2L1< M4CA#4)-D*/X4#;%>P?&5]4I'0UK+._H5RP_6$E:VHBXE:WQ=9>U-V*R;S$T! MVRJ&IU\JM\NPEBFJ3$R'[@O8P6*.I+#%^O\/W4GNHIT%!2=L-4N\!W-3X\V0;>'P'8&.;+#AJJ-[)Y' MP!/9TR5J[X>*I3`"W2*'8E;,%XW4*(:`U3!"I!*&2&W4J1PBM<%:I@!SC9@. M!76$@;L<<^3!AX:\KG0.\CZ=!4NOOX`DPI"[A($1PL`(86"$,-P^8;A]PG#[ MA!T+V*F`G0O8I8`]%+!'BSG:L5(:VN/:!D.[^`\#/?^"H;EI`K+P\M6D(#;+ MOGW768BL)0O##XMW&1C&>0,%LP:ZA0@Q4Q#+7_MW!J*.&0.[#`ORWC#!K&%N M^P##"F*S[/-)SK#09'(]NOVUM4E0A*?LF5L7_C4HE*@H%=Y8;;S/=]`(::5` M.A*&="0,Z4@8TI$PI"-A2$?"D(Z$(1T)0SH2AG0D#.E(&-*1,*1CCCF7A<;T M+W%9['"Q8B=G+/P'^N`S$6OW62.4^8PP^(PP^(PP^(PP^(PP^(PP^(PP^(PP M^(PP^(PP^(PP^(PP^"S'G,]"VYK[K"O_8YMKFREI?7,_T*?&D?^-6.8)PN`) MPN`)PN`)PN`)PN`)PN`)PN`)PN`)PN`)PN`)PN`)PN")'+.>F-ZX):CE7256 M+/7U*WR=0EW_L@=/ZP*V*6#;`K8K8%4!VQ>P0P$[%K!3`3L7L$L!>RA@CQ9S MM"-J;TF`L'C[!5"PU'N#]2B6()#N(7#N(5#N(3#N(1#N(?#M(=#M(;#M(9#M M(7#M(5#M(3#M(1"=08[GT#W?4&BFTFWG^PC!S+/Q<=9[U7L&<"]#4Q:`_(B% MD\-F?1_[#T/"(304'BD.=0\>X*5F:)J!CE[AN:(V=XX.;_;1!@^7M/GG%O!Z M(Z:E%VYO9E`,?B<,CF_&IOL:^Q=&$0R-F*I#-.3J7#B$W<0MX2"[#Q,.$3-/ M[<,ORH;T-+Z/&'ROIL'1)`='DQR\2G)P(<4]I2WOYY]/`%T+2.1?$0:?-6/S*=R9-GS6B.D4\%FNSODL;'UOJ7:R53;5 M+F+FM'T\ISUJ^*ZYL-U-Q0Z+GV#8NJ7%;^Y>78`+:2A<&+%PZI$-Y<6O&9K$ M2HN?:,.ZD&GCQ:^/-H2#B*4PA.\CAM/Z<.[J?ZP`<2!CT(H@HZ:,-42)B*2%02R(FM<2',VJ)7#<6%&I)8T$6)30=HL1,YW^X M`V'2,9T-D]F-ATZUO#MT$LP6$_JI1WPM"C/*RI-!U4&S[GH;X\*G:UF*AJN"]9P&&B8BD"+ZHZ MF^Y!,9F.BHFJN3:;BY)PJG-#,9G%4R!33`1S44)+CHJE^UL/%;-10DN.BJ6A MB!(YCS)^]5TAHB2*=49)41LM.;VT(4ID4A,E$;L>)3+FFM^D?575B0I$"4V' M*#'3<91TS.:B!"3?%"5!WM>2B-DE9TE+SDR&YDN.8GENCI>TY*A8&HHHB>K" M$^Z4>PNN)=?MZPX6I$B8@E MZA`E@ME:PGT)#4641*RSEC1#$_FE%:>DK1`E?;0A2D3,U)*(:2UQ:P"B1,9T MU9+&@BQ*:#I$B9G.S88HZ9C-10FR^*8H"?)^Q8F8JR7.,$2)##6U1##\:1)H M,G!-(VH)#4641*RSEC1#TPRE*"EI*T1)'VV($A%+"8%:$C&M)8X>1(E<[ZHE MC059E-!TB!(SG9L-4=(QFXL29/%-41+D?90(EK_".2,,A8,P^)\P^)\P;%4( M0\=)V+Z`P6";W=9K:A.[Q0IA5<050P;Y::XN]*^&B:AY#/&-@6Y M;0';%;"J@.T+V*&`'0O8J8"="]BE@#T4L$>+.9^%4X:\!'2\;3"/IQ(F\04+ MWVG5^`$_*^R[N"26>2*JPU#%X`G"X`G"X`G"X`G"X`G"X`G"X`G"X`G"X`G" MX`G"X`G"X(D<W"P7\?V^"3HC9W\@,_]=$&WY6T\31LWF[Q:-SLV6B/F'E1:2YRJ?#`5Q$S+Y>Q'+Q`;"AN86YF3/9'(A8I8YD3/,1UX+YAJQC+E9&;.*_%Q'+71]M\$(4,^=SDZ%C#8[IHPV^ M*F@;\TL(O;3!HS)I?CXGV-7S.1V3KVWC[!37>3=LL/)TZ?*N;,A,7D3,GICY M+[6`=V4HJE[CMM*B*V)Y$$S\RP_P;A]M\&X4,^=JDZ';M\&[?;3!NP5M)>_V MT0;OBEA^KB:8GJNY:HC5-HX)7]W4D'C=NPN_1^[P;BWO3KH$<[F;#E+DDQ@J MEKNMX%T5L[GKFJ#-4,5:M6U5S.4N>;>7MJJHK>#=7MH.JBU[5>.HV-7<5=5P MNX)I[KHEY*1C^N9NV$7>XEW9=>:5>1$QF[LC.BM5 ML=QMI=P5;29W1^[D!=X5L59M\&X4L[GKOTYYIV)=[^N4M)6\V\+>Y4VV1 MD+L1D]SU;^/#NS*F9^Z&;?`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`>4`"/XONW\&&O`J?<'N&2;"FZ^E*[`.;SN6 MKB`F\(8;7PF/5>[P3\GM'X9W'XK\A,0KZ+H'H27Y#^.[#WB_@B>_QYT4;P3W M4;P-W$7I)NY'L"@^;/?1.0+U^/T'GAMG;).[^LB;KX6G67?UT3=?PVG:Y`YG MVR7[<&T:KI5LQ+59N%;*/5R;AVLE)Z"63>[P3^D:CCHG=_BG="T\5+S#/Z5K M.-2?1'3YF5@H. M7!N':Z4XP+5)N%;B&M>FX5J):Y344/^+U_"YO!%\6[R&#^.-X(>BG;@V#M=* M=N):B(FBG;@68J(X'S[(-T+R%:^%'T8!U]A),)_AUU!P#\5KX>=.[O#5L:5Q M]V$^_%/B+'S%#6*I>`V?T!TAEHK7\('+$6*I>`T?O!PAEHK7\&G+$>ZO>"U\ MHPURLWAMC30Z%[-HO9S=[9>E_%HOYW>;92G:*US9%Z^LEPM<*:_H8/B^S#!^ MQ&D)%HOLXW>%EF"J6(WP]>D#7"N."S^;`Q:+UW;C\=T.^Y%"C.!*5;RR#@XK MQO@:+<>FV'&LD?CG8LU;H^1MBA6OPI5]\HR261RSQ9AM\GCS\_?0\"V"'\\OS\JO\3)OCC^?L_ZJ;]I_\G`````/__ M`P!02P,$%``&``@````A`$'T@([G(```_/T``!D```!X;"]W;W)K&ULK)U;4QRYLH7?3\3Y#P3OV]`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`ORCQ&T0\\1N^XFC*/4O2#S?.>A8@'J9P:I)NW#U)DN],@E9,7]QW= MJ?"+&_W`KT[E'2LC^ZF2#%(T<(.%!BG[XOW2#!ZF2#%*9%KO0;O#@1//K M_6-%%YN:ZDUNOR!UFP0Z^*5^\*_9"\N&]>OBNT')RF7/1# MDN?M5937A4HR=4LW;W]YJCQWHQ^X/]5WY.&Y6TWF[GN&BVZBXM>GFLP>//DN MXMN=T]U3Z^[U[O/'YZ??9W1/2IUY^747W>&6;J.,?-\4EVFYD_+=2-$=5)3% M1&D^G=.(T3W2"]W^_?VY7JM\O/B;[MCN+=.(&?IOBJEFF::;IW9=RS(M9J*; MN*CQMA8Z6NAJH<="TI=2MI4^$]S*0`M#+8RT,-;")!;BF\:HZU,MS+0P9R'I M:;UVE>WKPF74U2R9X*M9L5"0=NTR*NTF)FJGF^#H>K9:V&EAST+2L$IZ8(+[ M:NSL2EXV(W-)&#MS4HR=)Y1-YIMJR,E+&3KV4(G,O25RO*8,:.Q_33M>MV^EX MRGQ!RXRL-;1R9=::_+T9+RD1'2TI_)(V6$AW[SKKA*;+5)196HQPWC8+Z;PW MV;P=9CBHRT(25"MG8WHNHHB^2^C>#ACAAH,<(Q8Q92,3=JU"8QDYYZ MJK=3E]"]G;E(O::6[WD`LW`9W=321>JU>G8$5@',VF5T4YL<)-O0%A([2.Q= M0@W``1+&N$A-UV%CC90>ZGI=37ACG92%U.MKK)?2D.JSL>Y*(Z7+2S7YC/67 MHG0N:SI%J=L,8WV7IO2(&NN\-*/M:ZSUTHR3Q[HQS=#5J17'6$.F*:0"S M"&"6+E.OJ_ZL`IAU`+/)8]22L,UCU"W++H]1%MV[3$W?91\"&&-"H(8+U>O: M?W9FIZ<'N52]UL9.]S15J^BUW%H@#=W4="9KBV+(6B4-4:?4"VZL?])4I:)K MA_54&JHYD/59!KK1EV>]EX9N4LM0O$&U?DQ#U'-E-V--JBC=8)YSG;4QQ[HU M!\KQ;LWI>HYY72C'O6DHLQ;3-C^S%A>OP1&=68.UT-1"2PMM+72TT-5"3PM] M+0RT,-3"2`MC+4QB(=FE3;4PT\*1F^KJL[F<6`)U M`+-QF9K>QFT#F%T`LV>&+^+`0OHBM,N,"SD]-`T7JM?UO9Z=>FF_NI"=CLD@ M&SL?B\/L'"V&[+PMANQ<+H;L_$[UTD[PE&)G>'$B.^N+(>N$8LAQAW'L81Q_ M&#$(SPEZX_>TA)PN)+,0T8/K-RQ$$9U9B+30U$)+"VTM=+30U4)/"WTM#+0P MU,)("V,M3&(A&>NI%F9:F&MAH86E%E9:6&MAPT+:O\IUVP!FQPQ/@KT6#EHP MAI6D[=J-ODUI,,2)C1WUY*4S=MA3BAWWE&('/J78D4\I=NA3BAW[E&('/Z78 MT4\I=OA3BAW_E.),`./,`.-,`>/,`9.>!!FOT9L[&:^%;<"B*-JHI9^A7EZJ M6[E&#)')Y4&K6O&;D&@QP>6>6+MW81_>F`%LLY"TK$I&APD.Z;+@ M#>E!H@^)`1/<[)`%;[,C)CADS((W9`*)*21FD)A#8@&))216D%A#8A,3U_:# M`_HIUS;]Z]+UC?[]#C:PA\0!$L9@!)O%-'$6L8MW`AEL(&,=%+^H5Y?UJG*8 ML8ZRKWK=?;AH#14#-_2)9K4T&.PG(X;R7XNUF'3T1C]/M`ZS0,7MAW4<9ZA4 M=09L.(,=9[#E#/:<*31=9C&G-]G?L)A'='8QKUSI._68*5K+(=%B@I>[-@O> M$>XPP2%=%KPA/4CT(3%@@IL=LN!M=L0$AXQ9\(9,(#&%Q`P28CU%G>X=AE1V7<=C;C+ MZPQC_69[7(X*B)/&.LXR5_%EJ::L"6/F*G<0L`N-M:&]J%-?G-Y@(QKL1%-H MQE!H@^) M`1/<[)`%;[,C)CADS((W9`*)*21FD)A#8@&))216D%A#8@.)+21VD-A#X@`) M8QB)/I&L/CM@L%=,D^.]D\.(6_P(]H\1`_FS8$L9["F#367$5?Z^8)\9,9H_ M"[:>P=XSV'P&N\]@^YE"_V66]>CT6&9=#WO8?@K++O!U_;FLAH6*5GB,M`3A M9;`MBG>\.H)P4%<4;U`/(WV,#`3AIH>B>)L>"<)!8U&\01.,3#$RP\@<(PN, M+#&RPL@:(QN,;#&RP\@>(P>,T)F!R(.?SNNUTR9"?8Z"#A#$ORZPD6D&,(F1 MO#.*3AG@MA)O^?,$N(T.(N"V`OQF$L/Y^Q-@09-XT)\GP)5T?@%?5X`O38`Q MZ8@#;JO8FMEB0!^RR!2#XF?RI0C714`_Q[%0P>QM8J0E"*^/;5&\H]41A(.Z MHGB#>ACI8V0@"#<]%,7;]$@0#AJ+X@V:8&2*D1E&YAA98&2)D15&UAC98&2+ MD1U&]A:Y.BW>U=)U53U^..`<5`)B*Q6XA.H`9@*L9!(O>2<5U0'<5F(O?YX` MPU$=P&T%6([J`,X3X$*J`SA/@#&I#N`\`=:D.H#S!)C3%+LS6P>BLSGZJ"T^ M`A%]Z8.J!_0FK;J?:5BJ8*HW,=(2A-?*MBC>Z=@1A(.ZHGB#>ACI8V0@"#<] M%,7;]$@0#AJ+X@V:8&2*D1E&YAA98&2)D15&UAC98&2+D1U&]A@Y6"1^%[!T M>LRN'B0;G(4J0FRX`BO1S@`SB9F\LXHJ`LZ3^,N?)\!Q5!%P6P&>HXJ`\P38 MD"H"SA/@3*H(.$^`-ZDBQ'GBZ5/-?>LDP)U4$8KR9"M"=`XH71'`SB`^-D3I MTQ_744\U&]'7^U"]*)B^38RT!.%%LBU*TKKZ0$%'$`[JBN(-ZF&DCY&!(-ST M4!1OTR-!.&@LBC=H@I$I1F88F6-D@9$E1E8866-D@Y$M1G88V6/D@!':'$"? M4"F(&5M1KNF3)ZJ@L)6214,!B9&\,XJJ`.Y*XBU_G@"W417`;07XC:H`SA-@ M0:H".$^`*ZD*X#P!OJ0J@/,$.).J0%&>;!6@I3I3!0+?+(C"LL^):%^@CFHT MHB]I0]4`(BW)P@ME6Q3O=.P(PD%=4;Q!/8ST,3(0A)L>BN)M>B0(!XU%\09- M,#+%R`PCXP<,$+5`)J`J@%FF@%,XJ9D6I%S M]4<6`RQ&7TV$NQ3@.JH*.$^`[Z@JX#P!5J2J@/,$N).J@IN'7FIU^)^^"BD7 M4[>W5!M<3#,!/J7:4)0G6QNBTVYOV"'$A^/4#D$=7V]$W[R):@)$6I*%E\NV M*,F\5B]/1Q`.ZHKB#>IAI(^1@2#<]%`4;],C03AH+(HW:(*1J47LFY.7'^IJ M2LX0,,>-+#"R=)K)WKZN<(HU1C88V6)DAY$]1@X8H6(`9S\5`\PT`YC$1M[Y M1/N#N"WO;*$Z@'L3X#2J`SA/@->H#N`\`?:C.H#S!#B2Z@#.PYZDM5D>KZCE MBRH`SA/@3*H`17FR%2`Z3?B&"A`?/E050'VW3*,$CR@V,=(2A!?'MBC>E[`C M"`=U1?$&]3#2Q\A`$&YZ*(JWZ9$@'#06Q1LTP<@4(S.,S#&RP,@2(RN,K#&R MP<@6(SN,[#%RP`@5`N@3*@28"3`3O8&,\["_XJ=-T3DH_3PJL9=W!"*@0X3X`QJ1#@/`'6I$*`\P28DPI!49YL(8C.#:8+0>!C MHOBXH2H(SN>)X*'$9@DB+4%XK6R+XIV.'4$XJ"N*-ZB'D3Y&!H)PTT-1O$V/ M!.&@L2C>H`E&IAB9862.D05&EAA9862-D0U&MAC9862/D0-&J"!`$U!!P$R` MF:@@X#P!_J*]@9NG=*F_1)*J@HO5K]6VE#8(+D7)U*=1J#2XF+Z73MSGM8W) M\R,UI][RI.K@-D>8>A9N\HQ*F'[P%F!6>F+DMJ@O,,"N]%%3G*?8L-D:$1U% M?$>-B$\P9FM$68U]HQ13!?NC)D9:@O#RV1;%.P\Z@G!05Q1O4`\C?8P,!.&F MAU:Q;PK63@<)LX]-1D[06!1O?R<8F6)DAI$Y1A8866)DA9$U1C88V6)DAY$] M1@X8H1H!?4(U`C,!9J(:@?,$^(MJ!,X38#DJ#SA/@.EHVQ#GB3U6SCTQS3XL M6(^H,.#^!%B3M@TX3X`Y:=N`\[`]>7TY;?/T/H\-&D/T-:'IK6"V)$0G&-]1 M$N*#CZHDJ!+7B/[D%GHG`2(MR<)+;%L4[VK9$82#NJ)X@WH8Z6-D(`@W/;1* M/!K5F^BS8[HB\,O`,6/)XNWN!"-3C,PP,L?(`B-+C*PPLL;(!B-;C.PPLL?( M`2-4$7CPO4--%0$SS0`F,9._K0![447`_0EP'%4$G"?`,ROHM M94L5O/1-C+0$X46R+8IW-G<$X:"N*-Z@'D;Z&!D(PDT/1?$V/1*$@\:B>(,F M&)EB9(:1.486&%EB9(61-48V&-EB9(>1/48.&*$_SX-/EC8"F``ST=_FP6T% M^(O^-`_.$V`Y^K,\.$^`Z>C/\L1YXDIP?=I_9V^V3(`-Z6_RX.X$.-,$6)/^ M*`]N*\"<)L"=IMB>V4H0'8'36X,JO3,-*D)\HAY$^1@:"<--#J\2SM5+)?5SD1(U%\79X@I$I1F88F5LD MOH):WK=O+7"6)496F89*N5\7ML9I-AC98F2'D3U&#ABAF@"=0G^Q#3,!=J*: M@/,$.(QJ`LX38#JJ"3A/@.VH)N`\[,2">U0J"CA/@#>I*.`\`>ZDO]2&\[`_ MBZZKV*#9HD#KNE,4\"GE`.:FXX#P!]J0=1U&>;'&)#L7I'4=` M<8G/TE$SR7I_65'K;*-<=.+N]$<`FQAI"<)W\&U1DM;5^R`=03BH*XHWJ(>1 M/D8&@G#30U&\38\$X:"Q*-Z@"4:F&)EA9(Z1!4:6&%E9Q.YL3F_DJTFUQEDV M&-EB9(>1/48.&*&2`'U")0$S`6:B_0;.$^`OVF_@/`&6HY*`\P28CO8;.$^` M#VF_@?,$6)-*`LX38$XJ"3A/@#VI)!3ER98$*IF9D@`>/D6XWF=4U.?/&N68 M*JC&38RT!.%5LBV*=Y7L",)!75&\03V,]#$R$(2;'HKB;7HD"`>-1?$&33`R MQ<@,(W.,+#"RQ,@*(VN+\,[T5"ZR^[@-SK+%R`XC>XP<,$*E`/J$2@%F`LQ$ MI0#G"?`7E0*<)\!R5`IPG@#342G`>0)\2*4`YPFP)I4"G"?`G%0*<)X`>U(I M*,J3+071H;CT[@"4@O@,G=H5J,\&-\HQ%;NV6L][_MZT#'54]A?J#K\E""^3 M;5&\01U!.*@KBC>HAY&^1>)KNKK*^ZJJ@:3AMH?9J#A(W>Z.G*BQ*-X>3S`R MQ<@,(W.,+#"RQ,@*(VN,;#"RQ<@.(WN,'#!"U2"V2H$-J!I@)L!.5`UPG@"' M437`>0),1]4`YV';%;T^B>V\=J%WIW%;B1']>0*L2=4`MQ5@3JH&.$^`/:D: M%.7)5H/H9-P;JD%\D$Y5`W4$I%&.*5L-\O[V4=,B!:/<$H37UK8HWN'J",)! M75&\03V,]"W"MZ5YUS20--SV,!.5^W>M1D[06!1OAR<8F6)DAI$Y1A8866)D MA9$U1C88V6)DAY$]1@X8H5I0="[U]#"5:@%F`MQ$M0#G"3`8U0*<)\!S5`MP M'G9=P2I!.P.J\7\-2]=-7S5]^J*C/MC;M[PN&J"4(KZ]M4;QCUA&$@[JB M>(-Z&.E;A*^GKG9$`TG![0Y51$5%C)R(L2C>GDXP,L7(#"-SC"PPLL3("B-K MC&PPLL7(#B-[C!PP0I4`GU!E"Q58Q`38B"H!;BO`650)<)X`LU$EP'G8;D77 MGEC.:Q?:%>"V$B/Z\P18DRH!;BO`G%0)<)X`>U(E*,J3K031`;IT)0#/B.+S M=ND*H+]JK5&&9_*:&&D)PJMJ6Q3O8'4$X:"N5>RCG"JGD;CHD$>:]]BI$91N8866!DB9$51M88V6!DBY$= M1O88.6"$%G^>3MYQI&T`9@(,1(L_SA/@*5K\<1ZV6=&BG?C,?^W]@+82U_GS ML`^+^I,8T9^'K5F4)\";=&`!OX8![J0#"SA/L3^SBW]TR"V]^`=N`^*S<>DB M4+JLZ*^W*!>=H+,?'X)(2[+P$ML6Q3ML'4$XJ"N*-ZB'D3Y&!H)PTT.K\/:A MZFP&^$7@B+'D\'9V@I$I1F88F6-D@9$E1E8866-D@Y$M1G88V6/D@!&J!SSX MWJ&F>H"99@"36,G?5H"YJ![@_@3XC38#.$^`X^BQ$,[#)BQ:QT0*L29L! MW)\`<])F`.<)L"=M!HKR9.I!],G13#THW@R<<.>S0^J=WH:E"E[Z)D9:@O`J MV1;%.YT[@G!05Q1O4`\C?8P,!.&FAZ)XFQX)PD%C4;Q!$XQ,,3+#R!PC"XPL M,;+"R!HC&XQL,;+#R!XC!XP8$\`$>,D$F,DD;O).*Q/@+Y,8S)\GP'(FP',F MP'0F<9V_/P$^-&S$^*E!_&U)ZI,=)L":)L";)L"<)L"=)L">IMB?V5(0'91[ M^]:@$I^O4UL#]0Y`PU*%)0$>U&M)%EXMVZ)XA[\C"`=U1?$&]3#2Q\A`$&YZ M*(JWZ9$@'#06Q1LTP<@4(S.,S#&RP,@2(RN,K#&RP<@6(SN,[#%RP`B5!&@" M$^`E*@DX3^(F[[2BDH#S)`;SYPFP')4$W!:;SG[ZY+*>\Q%BJ@DX48`1J2;@ M/`'>I)J`\P2XDVI"G,=^3J52R?LB`:H*N+5BBV:K`BWL[ZD*49BS4=#?<%&) MJ<*J`)&69.$%LRV*=T9V!.&@KBC>H!Y&^A@9",)-#T7Q-CT2A(/&HGB#)AB9 M8F2&D3E&%AA98F2%D35&-AC98F2'D3U&#ABAJ@!-0%4!,\T`AMT4+S+7IR4F M^^X9%07<5.(O[^PT`8ZCHH#;8L_9+M>KT?=]JCXGIO/W)\"&5!-P?P*<234! MYV%OVNNB+QQWKXO-&3/E_((88$_:*!1U*%L2HI-I[]@HQ`?:J!DY(D#O(:BO M:&A4BHZ]Q>\A8*0E"*^6;5&2UM5CJXX@'-05Q1O4PT@?(P-!N.FA*-ZF1X)P MT%@4;]`$(U.,S#`RQ\@"(TN,K#"RQL@&(UN,[#"RQ\@!(U02H$^H)&"F&<`D M;O).*ZH)N*W$8/X\`9:CFH#;"C`=[1-PG@`?4DW`>0*L234!YPDP)^T3XCSV MC]VID[VT0<#-%%LS6PWH[MVI!O@K\"I1F-X@5%79;EBJ<(,0)RI`6I*%%\JV M*-Z9V!&$@[JB>(-Z&.EC9"`(-SVTBJWRM;P/#(VXP<,$+E`+J`R@%FF@%,8B?OM*)R@-M*'.;/$^`Y M*@>XK0#743G`>=B(1,I-K+J-I'*`\P18D\H!SA-@3BH'.$^`/6F'$.?Q+$+9 MHA"=44MO$<#;RO&1MNS6H*H*5Z-2=/#-;@T@TI(LO+BV1?&.:4<0#NJ*X@WJ M8:2/D8$@W/10%&_3(T$X:"R*-VB"D2E&9AB98V2!D25&5AA98V2#D2U&=AC9 M8^2`$:H%T`14"S#3#&`2-WFG%=4"W%9B,'^>`,M1+N!>KOZV0K071"[0V5(#[0IBJ!^@!EHU)T M[,U6`HBT)`LODFU1O+.P(P@'=47Q!O4PTL?(0!!N>FB5>!2B[S+5SSU'3LQ8 M%&]W)QB98F2&D3E&%AA98F2%D35&-AC98F2'D3U&#ABA0@`]0(4`,\T`)C&3 M=UI1(SDG594"W!;B0(\1[4`MQ5@ M.JH%.$^`#VE3@/,$6)-J`OJZB=WE97;SRT+%(]Y[6R+8IW,G8$X:"N*-Z@GD7B MSI0J>7^HM9]AO\_0GP(54$W)\`:U)%P'D"S$D5`><)L"=5A*(\V8H0'5E[1T6(3[JE M*T+ILJJ_GZA2=![.[A(@TI(LO%JV1?$.?T<0#NJ*X@WJ8:2/D8$@W/10%&_3 M(T$X:"R*-VB2@]3J:JLVS8'46V`'-2 M403_NF\5)*[]H8K-5VIY4IM5^JX4M>5 M>J[4=Z6!*PU=:>1*8U>:N-+4E6:N-'>EA2LM76GE2FM7VKC2UI5VKK1WI8,K M&9.CY8RWR1EPDS/B)F?(32,N\D9>),S\B9GZ$W.V)N< MP3A8D;Y!*]';@/=_O;P^/?:.#]^B33Q1Q9_UJ,;'DS)W M;/HO#S8L5,I2:JO?3"B^66FY4MN5.J[4=:6>*_5=:>!*0U<:N=+8E2:N-'6E MF2O-76GA2DM76KG2VI4VKK1UI9TK[5WIX$KDY'A.T'#S0)K4%!`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`E]UH^'YMWK-ES%S3VJS:`OW*^5D.OAOR*,Z?FSS[EE<'XX*FCW'!+I8,OL)>8R MA8J"S,R9:Z54%&``/HTRUT,#*I(\M__/>::.:]/U9_/`=AG@QHY+]9!K2=-( M3U*)\C="K)-"$:<3\)LP*B!9\HZT6.0 M+4%9)W.A/NBCS_JWJ)!1B]QKE;4)PQUNE]"?IPVSO?G*>H*BIAVT10@^>VCA M4"2Z1-R12GR)O(E8$*I/!O4:)KO>J]<`&M8!=.]THBV>(&;=<.3V&C.V>XT) M>AUBV'V/80U#JP;%A(K[O3"&0`C:VE=\1$3_).);!+$/CYE>;PVO32A.[\RS M1^81"=K1Y"Y"F/)&1#0D6`C7QT0\)%SF#P'B'=["Z=XU3+V[;QW%PB/BHW<_ M]"ZM101Q[-8^K4!,D,#32$\0^_Y[[&N8VF>AV^NB?V30/]AWAT]NB8@0MF[. MF[>6B`G!"$#,!^\QK^&Q>6]D'IFN^/K!]'HTO!Z$I*KH?`@X1(`8UZO[8.J\ M/<%HF!IWYZ/Y9(L,&O>"A4W&*Y:=(+JF\$?CQ00)*$'\A^_QK^&1?WL\ZI%! M_W?,<2Y+&U'$TR_&R#XE_EY]!JO4]/*W],B_\[9PM,7==A!,&OVL-)XO.Z3+ M.'>O!+BI0AK`]%HV>02U]"@"&U5OVT$W(^`*>@.).Y5N)/J+^;!--()>WZ9' MP-5P..V[/J,#8,L0ZDKLAU?>T(@RCNME*;0B]ST%+@DDA27C4"H M6[Y"V*4-:X@O,VQ9]4N%#/,7(1GM.!=US*T0N&W%75W)FP./>%%((Q4GO25E ML`CU9_OM\KW3;GC["[!;K9,#_R]I#GDEC8+OX59[%L`2U.!^%P^4J-L]XTXH MV*>V7X_PNX3#ELF>`;P70KT>Z!UU_TMG\P<``/__`P!02P,$%``&``@````A M`/ZDR]9S`@``PP4``!D```!X;"]W;W)K&ULC%3) M;MLP$+T7Z#\0O$>4O-NP',0UW`9H@*+HFS>+EKZ!6-6U*"X370'+7XIM5'!&"5,,& M:3IABLN61H:%N89#EZ44L-%BKZ!UD<1`PQWF;VO9V1 M>E_X5QC,7D5O0P.^&5)`R?>-^ZZ/7T!6M<-NC]&0][4HGC9@!184:9)!2$/H M!A/`*U'23P86A)_"_2@+5^=T.$G&TW28(9SLP+JM])24B+UU6OV.H,PGU9,, MGDGP_DR2#9+!;)R-)^^SL)A1,+CACJ^61A\)#@UJVH[[$& MV?B8.Q\40A%ML1N'59:.IDMVP!J*9]`Z@G`#>M!PW$,8RO8P'/7T(^T7),*I_&W=XC3L\"+WJ/^`.=;R"!VXJV5K20(FA:3)%91.W M,!Z<[L(H[+3#[0F/-?XL`6#G[/^]_OZ@\```#__P,`4$L#!!0` M!@`(````(0"QH1]KAP0``/T0```9````>&PO=V]R:W-H965TU4E7=M<\8KVT48"V6Q,E_ MWYE=P.S`Q3[[P8[Q=X;/SLS.L%E]>2]RZXU7,A/EVF:.9UN\3,4N*P]K^_NW MYX>%;LY-LO17I+>Z*I'IY/3VDHCB!BVV69_6'BA%E6QS M6/<["Y*T]:V^#-P765H)*?:U`^Y<#3I<<^B&+GC:K'89K`##;E5\O[8?V3*> M,-O=K%2`_LWX6?;^MN11G'^OLMV?64?MWA)3!V!];/*@-_ M5]:.[Y/7O/Y'G/_@V>%80[JGL")U>W/G.G<\QG(K2V7]7.&+FTK?96U*/[3(K6BSLFD<0*?K1/? MF2RF;#I#+Y]8^HTE?#:6HWI74ZL@/"5ULEE5XFQ!90&7/"58IVP)/G#U0>>A MB\>/P@%Q0">/Z&5MPY8`&V#JUYTO,"\4Z1% M04\T,Q5QJZ`L8--G:5/X.1,:0:GV;L>\J6?>,=*BSYA:!66"[%`F-L<-](-] MU88*[6BHIHQ@:5$?"]@GIBC6(@;]H(MZ>*E(H[QF=\*BW0#6-SDB+9JK3>%[ M@8;5HIM8PSM9T&QD^OA@^'GK4E8FN>]?MK;N[8VH7R$D M+7$GH6_AAD.`%Z7%=X]+PP MQ\Z@ERJ?)@]4\,(L@[A3#4(%"_D))%2;F8.;T8[)M$JWS'"FBHWR:,E(B+#M MWQXB/23Z(1JV17S2`&BX8U?/`$W[8J<:1(A,ERM)&\X4WR?M(6):1(AH]^M4 M`R(R1*X0#4?'2(MC6G7I$T:+"_V1/J$M1E)(YL85O.&T`+Q!&].J!B^D;8R- MX&F+$3PR*J[@-:U[_C^5RY(1N/T7W7B+!#=97N M!T057U2TKB8CW7P.F^=G']/U*:!/P1@I[DC="\XL?94?D+3CN1&W+J@Z5GT. MU$>@@E<''O,\EU8J7O&,-X,1W5WMSI^/RIY'SE!SX7TEUR$IIY7P/X)Z#D:[T\55_J<5) M'>^VHH9CI_KS"/]FX'#R\1P0[X6HVR\8GG/[CXO-_P```/__`P!02P,$%``& M``@````A`(-##N\."0``M#(``!D```!X;"]W;W)K&ULE)M=;]LZ$H;O%]C_8/B^L;YE!W&*2D5W#[`'6"S.Q[5B*XE0VS(DI6G_ M_0[)$4W.,))XD\3VR_'K&5E MO_[SCV^?MNM5/U278W5J+_5^_:ONUY\?__F/A_>V^]Z_UO6P@@B7?K]^'8;K M_6;3'U[K<]7?M=?Z`J\\M]VY&N!A][+IKUU='>6B\VD3!4&V.5?-9:TBW'=+ M8K3/S\VA_MH>WL[U95!!NOI4#>"_?VVN_1CM?%@2[EQUW]^NGP[M^0HAGII3 M,_R20=>K\^'^MY=+VU5/)_CE]MPO7E\D`GZJZG?>^/O5?_:OO^K:X[_:2XU M9!OJ)"KPU+;?A?2WHW@*%F_8ZF^R`O_M5L?ZN7H[#?]KW_]=-R^O`Y0[A4\D M/MC]\=?7NC]`1B',792*2(?V!`;@Y^KJI[H=OC0BY7AW>^J$]_ZU$\A/I(!$&@=^W($F4YEL996)EC"OA-ZZ,;N_. MUVV4>YF,K]50/3YT[?L*=ACXZZ^5V*_A/<0268@AERJ"SLM':8%\B"!?1)3] M&EH#EO=0RQ^/89#N'C8_H``'%!4.D:TH1X6H&_C3)B$]U*0HE:=)$468%+44 MKHOQB9OKB!@:%=009,HTY-XS8W*$>+^&4#HY<9[9;U0H36)HB*(<%=0*K#&M MC`6E&C*TZB@GJ`VU%.8BS;ZH+O&3(EU=J;2-":NE,9T M!=9#6U0J40@;6><\#&^1K,V5V6:G$R?$ML,XV]IO7B@-<4AWUBBBJ4HXBZ$0<[@P[3N1%BVPU4)B')4:+=5D(BN-NE]NNE>CV1 MZ#81L/-Q(L3,"7FG0HFTDX"\7JK7N1.QJY8G1:IM+_&6=AJ*S"+1]M<26J+P M`X)/UTJNFB4`JB9]*68[TB38:>P=>7Q=`H%00=?D):<`BDQGL-E8TE0HD;MY M#H2"L(;AF00J'ILN.0EDR/V:N*0HT"I66ECHX4BHR4[+*`U")2*.*`ZTBCD2 M8%V>(\YS!Q'$D1Q\ZT;<$9Z6*'!L,2]TAYS=X(9T?8$J[29@U?J(W*$7NJ6: M5&M+ZE"@R*P6V^(?H3LD[%XV&,A5\UP8*7UK*^9KE+`M1$B^G`NR40$%G`N1%\FEVLZ/@PNHTF[8N(`"AQM( MJD=NA-IV$V_)_BTB)3*K1?M/2UBI",*7<4',[F!KYAL#JB9]J4".-'G!/.(P MYS!`D6DG#'(R?)5:Q3+E!?1(@=CE8H@?"$7%(-G!H)X M)/5M%S%?HX3Z2KQ@+M5VFW$8H,A,$\"`G*(JM8HY\@)ZX@`ZG?$+%!%']!"C M5U M5-M[R-'XJ-)N6..CP.'&"].)`],[^DT`16:U6*D^8G1"&+VL\>6JV8$`59.^ M%/0=:2*T7CP0)!S<#@8HD>D,&$#R6F*H90-!X@5TJ;9W&1\(4&2[9`.!5K$N M)$R?Z4*%X!DNC)R^H1R:@QR(RF1444>I%\VEVLZ1@PNHTIW(N(`"OL52+Y)+ M-7-#(%V@2KMA7$"!PXT7Q5,'Q7?T:QV*S/U#N:`EK%0$X."5K'2$N1/%$\YQ1/Z7@6*S&HQ+GR$\(P@?!D7Y*K9 M>0%54[ZTA!8M(S!?S`6YT.XXS@44F4"UK%',%"$_8SCH3:SI&#"YE2Z4YD_VE$`>_$ MS(OD4LW<8IG`3FN%2@RJT6YH"6L5`3A"[F@&#PS M+V0CJ6]3!?,U2I@O+YAG'.8.&"B1F:8PH)=SE!C*43@OH&</G8M7L0("J25\JD"--7K3.U?D1\VC&&Q]%IAUH?#K):17+E!>QZ;-%&/-'#D:?P2QA2)ZQ,]'%7/DA>NJ6H:QCQ;F1;CJ&FP4B>OY]'F#)*"GXVXJO6O4A?WJ6O9SW;W497TZ]:M# M^R8NVD_A^E+]K+ZAX$LD_OM(GB_@1@.9*?I\=%^Z]%^V`=R9(&\NH"NV^IZ% MC7X)[AFX5B_U[U7WTESZU:E^!GO!G4!%I^XZ4`^&]BJOQG]J![A;0/[Y"G>' MU'"A>G`'XN>V'<8'(@GZ?I/'_P,``/__`P!02P,$%``&``@````A`%MR\U4K M!P``/R0``!D```!X;"]W;W)K&ULG%K)CMM&$+T' MR#\0O%M2<]&&T1A#&DX,)$`09#ES*$HB+(H"R?'8?Y_JAEUZ MK*KWBDL_??Q>7)UO657GY>W@LL7*=;);6A[SV_G@_OW7YP];UZF;Y'9,KN4M M.[@_LMK]^/SS3T_O9?6UOF19XT"$6WUP+TUSWR^7=7K)BJ1>E/?L!M^:K5>%DE^&*I/KZ=O^0EL4=0KSFU[SY(8*Z3I'NOYQO996\7N&\O[,@ M2=O8X@,)7^1I5=;EJ5E`N*4D2L]YM]PM(=+STS&',^!I=ZKL='!?V#X.`W?Y M_"02]$^>O=?&_YWZ4K[_4N7'W_);!MF&.O$*O);E5P[]#ZZ\7X6;E,X`[KUG=?,YY2-=)W^JF+/Z5(*9"R2">"@)_ MVR#A8AN&P7J[@2@#*WVU$OZJE4'WZW3=4K(7R?B4-,GS4U6^.]!AP*^^)[Q? MV1YB\2SXD$L90>?E45H@'SS("X]R<$$:L+R&6GY[9JNM][3\!@5(%2CJ`=F( MN$7PN@$_31+2@TGR4LTDR:-PDKR6G'74'NA88\YQ"\&,(%4FH_ZF:;/#P0<7 M0NGL!"RP3SV2F,#`K&U$W"(P%5@SG0H'0X6-GX%"^?8O11(TQ*5%8"Y0%).+ MT-2&Z^>!K-H,\75VAL(0LY(8DQ501VF,)8A!!^M<,]9%LKIJ;9,=KB$'VPS] M]1;E36(0P]`&Q2T(IVXSAPT'8S8[^X,$S9S M-LQ%H$>5J%!#=#2$\.FQ]DDU9-*&3;^B:E0@DQE4&F4S5BC.<5R/C)NMT70C M"936;+*DBA0A#RYBB26I422%W'.G,Y(.;3-"S1VQUL:-A*R(+#6*,()3,1E- M=EC&%]K-WZ-,A>JD25(EPTPL*'?CZ>FC0R!@#,F3CWTX#;.@6)\:0G(WR_"9 M-.J14:E0@WP>.3Z;9?D";1>P1Y6MGYO=M45S*E:AQ,6U-1$9LOT1!5*S[U&@ M!)D)@KY#JHC%#_.RDIK-,GA&'=Y?H]^*%,AF1!7XR.:]638OT';5>F2G4(]E MIP`T/QXR^>&*"31FLULAC2F4F2"L,0W!]?)F>;A`CPY!A1KD(X=!3WZ0@T_V M2X^:.96;`IG,V&J'/"M6*,LS=UU76@KT()9IF=/Y\H5V::D8173;/:$;L</YTPM7NJ57[G@.R>T6FI4!,)HRDPG;#T<7.\]TE9HCHI=S^;$W2';YM4*.HW_-F)J=]A/Q;H,=$JD)D@,!G<5AJ%<^3/ MFA`"C1EU7B6?FRB0S8A,4(TBC&;-"%]:N]G4/;)3*"V[#>YI!>BI&)H0(Q6C M8R'PT$.(R)<@,S^$3@LAR8%5,QJ(HT<'J"]1@WQ:".&#_'TD/=34J<3\/E/? MH23&&D48(0,?841=F\Y%7X+,!/7,18TBC&:YM$]=F@X^!;(948D],FI_EE$+ MM"WZ/HE)%]82(Q?Q*DR/Q&;9M$]M.O"0?B(%,O.#(+&&X'(%LSQ:H$$/6\EJ$D3/BV$\$$./?FB/Z!F30>:`IF9`K7A M9Z$*95_XK[JQ9]U6!+O6(48)LPN0^4'"`]X+6P]N'A)''3R=, M[;Y'JQ)D$Z9:E:AIA$,T!283%@MM\?1,2X724D;7T+'Z?B+761,BE!,"GKV# M#.05.ST46X>LW@N1^_/,=&^C)[\3%F%0GHQ7<8J8G!W\";S6_IKA!Y8J%*"P ML$,T%_XO5SHPS"<>BJL$65P#']U?QX(1J*:'*[2O.3$X5VZR,U]CPZ8(.DHZ M&U%<)0AQ11;/]U?P4"97N5]";A$HLNJ1!70\@IT=HC?Q<6\/[]NAPNCX2\BW@O2N"&$)-`==$X4^?..+ M?M'A8/O&/3EGOR?5.;_5SC4[P2FM%KRW*[D!1'YHRCLD!39QE`ULW!#_O&ULK)S;!^#'7@&+8G3%'%F=C8F-V]IC%N$VV,`^CIF;>?5"E5DO(O0U7OS,7@ M_OB5DC*5JE05WQN^[TWE_?']H!G?M9F/WOCT^[]^_/C3_\UOV2[_9 M.%\V[\^;M^/[[J'YY^[<_/7QG_^X_W$\?3N_[G:7!EEX/S\T7R^7CV&K==Z^ M[@Z;\]WQ8_=.[[P<3X?-A?YY^MHZ?YQVF^>\T>&M%;;;W=9ALW]O:@O#4Q4; MQY>7_78W/FZ_'W;O%VWDM'O;7&C\Y]?]Q]E8.VRKF#ML3M^^?_RR/1X^R,27 M_=O^\F=NM-DX;(>SK^_'T^;+&\W[CR#>;(WM_!]@_K#?GH[GX\OECLRU]$!Q MSH/6H$66'N^?]S0#Y?;&:??RT'P*ANM.O]EZO,\=]-_][L?9^;MQ?CW^F)SV MS\O]^XZ\37%2$?AR/'Y3TMFS0M2X!:VS/`+_.C6>=R^;[V^7?Q]_3'?[KZ\7 M"G>'9J0F-GS^<[P[;\FC9.8N["A+V^,;#8#^WSCLU=(@CVS^>&A&U/'^^?)* M?W7O.KUV%)"\\65WOF1[9;+9V'X_7XZ'_VE1P*:TD9B-T"L;">]Z07L0] MN5U$_JS2XX!;TFNM'@-:"7F7Z@\SR;:-S!7O!":FZH]ZG8:F4_K#M*S8*2T@ M/5Z[DN(JL0S,XE%_<)_171QV>OU\">)$6WH)YQDQWEPVC_>GXX\&;3,TW?/' M1FU:P5!9,[F@3139\5ER4%8H*T_*S$.30DWK_DP9_?MC/XKN6[]3%FY9,T)- MX"L2HU`II\R.)4@ER"282#"58";!7(*%!$L)5A*L'=`BUQ;^I47Q=_A7F5'^ M-9X9&6`='@IG&H5I,I8@E2"38"+!5(*9!',)%A(L)5A)L':`YTQ*D[_#F^^$8LHKH6HZTN20E*X&$@*)`,R`3(%,@,R![(`L@2R`K)VB>=M MV@T\;Y=?'LT.H-2Y4XTS1IJ$K@>CL"=\6(A,LS&0%$@&9`)D"F0&9`YD`60) M9`5D[1+/AW1-KN%#I?9]R&10)'X"9`PD!9(!F0"9`ID!F0-9`%D"60%9N\1S M&)4G-1RFU+[#-(FMOR082Y!*D$DPD6`JP4R"N00+"982K"18.\#S$55B-7RD MU+Z/-(DH!L76%H5]D9C6YEI:RY]H2%](9ROA0J7T?:A)[U[-( ME`V)%H5N1L!"'K/(]738E6G#HGY>34?MN*W^\Z.1L89>BI!!;Q,671W25(MB MMR:*HH[?W:R*I7FI)5$Z+:I86K*H5RS:E291._=)[TZ,;\T-Z*5P1Q39/J,6&,YY')_/3`*B^$E1N3NK!"/,:OL-2H%D@&95+(]A7:S2NWFIAT5@X[K MQ#5A4][O_+'*4@74BI^0B_V\OLFK,Z!<&QJY6\J]GZ@SJKGQU)R_L MW-'*NI$#^O!*\34EW4C="%3.=?>T*!;U<5*NLK6O/SP:AS>\&X-21OZ@ M9/VE[N/CT&VAX`^*-E%O4,IGW2BOMF^,3[44XV/DCT_L9DE0JOKL2D>V8'QJ MAG7OSBH[M!JZE-`DG&0%(@F4N\(8;US@^Y MW!\BHY`VVR+A9%F5&!%M&X4(BL*Q45%Z6A6<*(U*%Z'!`(Z31D">LF:KBID:T]6UCWM5#37RXAT,[/62Y\NJ&P%GE:VC4V->1[?;#F&Z MW*9:=%7E5&.Z7&@Y142HD1?=8""OUZQ2&VMI##B\;-X-+YO71\K>0)S>,M,] MR4H-^\&5Q=/U_4:%4*YEC;S@1FU[7>?@LNI&<%GE!EFE-!`<85:Y$6;S-/6B812* M?,G8?.3&^?,YJ^K+G7->)'?5QSQJW%Y5=P2D*S3RPQ_"8F<5O10S*MG,6>6& M7R,1?EO5YC[,>%P5PZ]*.=<5-Y8\5WYN@C.R3Z63L$!7)ZA5D;WWG')#!V76 M%M4V_LHM+\UJWB0/B\+,U$XC1OZ"#L0^FIB&-Q8TF_=BC9=DK8KT12KH]@>0 MTZQPU[>[9GS/J!K'#:K^.(?US&_'#TK%6T="M8+D`F?D!KM`5X.M57'^D:Q\ MG:9LWD&9Z3$W[TU)K?F2*=4^`^5VY!E([,\C%ET]`UF-63=C1"FB#-$$T131 M#-$74WW?%[6?72G]2)Z!5-JI54XH-(G56.<7 MS0Q*494AFB":(IHAFB-:(%HB6B%:>\AWOBK79"[K&SHUC_^TN\AT9J0JX,+7 M_4C<[T^LRKAVC"A%E"&:()HBFB&:(UH@6B):(5I[R/>V*B==;U^_'*IR0^R0 M!MFK6H)HC"A%E"&:()HBFB&:(UH@6B):(5I[R/>?*E!K^$_7L^[QB&XC*YZN`0?VO)N;];Y1.?4^ M(\K1?+*]V!Y<='UK!)5*H4@5F35FRY6K4]_F%BB0[OD#S^M&Y=5Y3@CT\<:H MG)J>$<>V*\O,S#2I%EM5)=:8+1>G[FRYSG1CB\?UB!O2&B]=<#Q;5KG!9?/Z MN`XG5[:K]I=2NWXBJY+2G:RL"Y@FIHWQ77+UNYG'+3B;M!3F%OD1V!>^3006:5=D-ISC3H]ZYXFY? MGLR-H-+R5@_MKSJFVB$N-R-BS86@&^L"66>5Q%JK*)BF$$S9O(,RTR,>XF)5 M+F&L:Q\D^*@;=A7]C?]:UH[<_:^2?U*#HC`N5=2F@%%49H@FB*:(9HCFB M!:(EHA6BM8=\EZHBM(9+=5WA+7R*^! MQ-W.).9VM%'8F<'1Q:B<8IZ1.:EU!]*UF5%4*G@Z;A%[<[:YVJ]K&'G1QI.: M45T/MU$Y=;M!_&1U$,MG4$9`_BQUI!?;CEOWTEA^ZO"2&Q%.T)6P%W(\P)F& MUV-N5$[,&='=%7TKPO]H>&;>KA9PM\*]'7`N49WT[A15J[G<)1:5QT`?6ECE M'EH09=86F?>#YQ:RMT>NU")*&GE+->J($C;IL.K&4F65NU09Z:4:]_IM47QE MQG2UM>K6CK>G6U2()BJCCD;>HL03-:MN/"(V*G=1LGEZ*1(OZHH'=ID9!/G& MJCY[+-Y199.S]?Y<>NK:R]V1<[OB;E+4%4_[$J.Z$7AMGIZ0&D>GW-"_M]"5 M%R%CW@W^IP_+.S0(UQ/7+T*Y6JQU98"0<]PT*KH8%J%PKX*W MZU%_^U)%R)7%7>W.`OTV!VQKC-Q0%\B9(%07;,NYC9`BRDR/SIT%_>L>^K<, M#KO3UUVR>WL[-[;'[^J7.^A&XN-]@?7/BM"-@:$Z)]-J$>\\Q?'PB?K`=T;T MCCK>E;W3H7?R+]0):Z.X2^_DNY1\)^@-U4=.T=I3T!\^T4-P?(<^&DIM2L<6 MM8?JX2VV>8J"X1/=C<%W1O2.>N98]DY([Y2W(;^10[$-_5#+4VD+ZJ2T#^JB M3/\4#9_H@]'8P4CU7,955,HXQ:0T)`$9HL_.8P_3WI"^G8A\UAO2=Q21SWM# M^J8B\D5O2-]71+[L#>D[BLC7M!+*^*@W')7QI#>DKVRBG7%O2%^P+>']85JF MSWI#^L8FZB>](7UODWBK6+/TDS;T=?]^;KSM7BBQVOEG24[Z1W/T M/R[\F9(OQPO]V`WM][3ATH\;[>@+&/0[*,W&R_%X,?]0'10_E_3X%P```/__ M`P!02P,$%``&``@````A`+X97T)F!```Y1(``!D```!X;"]W;W)K&ULG%C;CJLV%'VOU']`O)\0R(40)3F:Z6C:([525?7R3,!) MT`".L#.9^?MN>Q.,#01/7I)`EO?:UX7QYOM'D3OOI&(9+;>N/YFZ#BD3FF;E M<>O^\_?KMY7K,!Z7:9S3DFS=3\+<[[N??]I<:?7&3H1P!RR4;.N>.#^O/8\E M)U+$;$+/I(1_#K0J8@Z7U=%CYXK$J5Q4Y%XPG2Z](LY*%RVL*QL;]'#($O)" MDTM!2HY&*I+''/QGI^S,;M:*Q,9<$5=OE_.WA!9G,+'/\HQ_2J.N4R3K'\>2 M5O$^A[@__'FU82R#;4251@3^F;@/Y(Q2U8['56 MO\H*_%DY*3G$EYS_1:^_D>QXXE#N!40D`ENGGR^$)9!1,#,)%L)20G-P`#Z= M(A.M`1F)/^3W-4OY:>O.EI-%.)WY`'?VA/'73)ATG>3"."W^0Y",J#$2U$;@ MNS;B+R?S8!&N+*QXZ)$,\"7F\6Y3T:L#70.<[!R+'O378%E$-H/\H!]-K$.A M0HS"R).PLG6AW6$Y@_J\[Z+E*--$_33S+Y"(\`:#=YHTT3!0#SSKQ`)\-:%()HL!>]2)'3%SV6.S M)B]:U.$CW&*1R;UJ[&/>$=../IH-^""4OV>L[LX@5%V%\2.FS:T0&K,/"M(._SZU1(]U7@VR(1="\^7<^V*5GH`H M5`.-":A!V'T#LN(;\F77^G*52:\8:GK4MG8.!AO0-^3-T@V4M;;\1*%J\=H- M!+7=&.H#P+1+,=('`CW:!PBR(3?4SS(#*'%:!CHB))[]X"GV@6H2?08>DD"_ M3P--':I![1P,]\%#:NCWR:$I135(P\E6I0VXDH5!L7K0^"'E6BSBX=3QOP9;P@U9'\0O*<.0F]B),$']YPFKO-*E9ONKO*8?C!?GS!,=)!%Z8IQ,`'RCEMPMQ M$-(<4.W^!P``__\#`%!+`P04``8`"````"$`D.5AVU$-``!9FVYHDIM2>GOGV9R.@LC#\3?JA.UG^6%P7L#>[YOE[5*]?)B\?JP>ER^_OAZZ7OF'\W+B\UV_OHX?UZ]+KY>_KO8 M7/[Y[;__^?)[M?YK\W.QV%ZH#*^;KY<_M]NWNZNKSG/U,E^^7B89[M;GY%@]/2T?%OKJX=?+ MXG6;)%DOGN=;M?R;G\NW39;MY>&<="_S]5^_WOYX6+V\J13?E\_+[;^[I)<7 M+P]WW1^OJ_7\^[-:[W]J]?E#EGOW2R']R_)AO=JLGK85E>XJ6=#B.K>N6E_J]V-[NN7EY]^[+;0,%R\7MS]//%YN?JM[5>/@Z6 MKPNUM=5^BO?`]]7JKYAV'^.0FOBJ,+6YVP/.^N)Q\33_];QU5[\[B^6/GUNU MNQMJC>(5NWO\5U]L'M0656DJ6B/.]+!Z5@N@_KYX6<:'AMHB\W^^7EZK&2\? MMS_53S>5QFWUNJ;XQ??%9FLNXY27%P^_-MO52YB@6IHJ25)/DZA_TR2UVTI= M:]PV/Y)%S6^W*#>'+%I%:S9JC9L/+,MMFJ6F%CE=&.WVPVM4T[(TAW7ZQ(:) M]\1NG6J'E?K,TNQ72I7MYW=3K94MC?HAVU'U2JU>_<@&UM0QNENG>*=\?F$T MM462-$>;IE%I-AKUF^8M'GM7R7&\*PM]OIU_^[)>_;Y0YQJUVS=O\_C,5;N+ MYY$51'+X[DODO0I1I1%G^5^<9I=,'?P;5=9_?VO5;KY<_:U*\2$U[:*IY<5] M(IJ[8HG3ZC)@R(`I`U824'_OET3,I9.)N+KCN72S'.].TLM$-DE?!@8R8,O` M4`9&,N#(P%@&7!F8R(`G`WX22$Y`\=H&F7AW;<-,9&L[E8%(!F9'@2MU9.T/ M+W5>R!U>I\^SV5$4:WD4W>:/D79B5&'O]Z^6%_?%+$+H*`P4)@H+1:D6B5B97E'()/TB:8HL@R(1PBX*.9]ADJ>[)U[I*QVXZGB MVLU.&NTD<#B9WV?B4+FM6C._N?13II4W1M%H-]6\,8NF>2LVB%4T+4WDZ9QA MNF>8WAFF?X89G&'L,\SP##,ZPSAGF/$9QCW#3(I&NQ7W&%[1-)OBE.J?88*B M:6DB3WB&F9YAHC/,[)0YK'NN?-4=^"?*-YXJ5[Y)X*A\I=!EP)`!4P:L+'`X M!31O9\J(:IED)EM!3P;\+'"84^&D$&0FRQ+*P%0& M(AF8'05RAY!J]>8.H?(V2JQW_3_[]D=+DVV4Q*A#=F\.Y^I=D_,>A8["0&&B ML%!T4'11]%#T40Q0V"B&*$8H'!1C%"Z*"0H/A8\B0!&BF**(4,S*1*Y45 M!THUUE\O5;MG7X8M330XVHDI*U44.@H#A8G"0M%!T4710]%',4!AHQBB&!5% M2Q--1>>$N1;WF^.B$2=K%\4$A8?"1Q&@"%%,440H9F4B5Z[Q4[/CSN7R*VNL M1;E>B]NE=F+*RA6%CL)`8:*P,A'WA8L#JI-]=C@Q"=%%T4/11S%`8:,8HABA M<%",4;@H)B@\%#Z*`$6(8HHB0C$K$[DB50^W/E"DL99%*IH%[<24%2D*'86! MPD1A%47K6C1@.D4CBQ5%#T4?Q0"%C6*(8H3"03%&X:*8H/!0^"@"%"&**8H( MQ:Q,Y(JUIOKA<]5Z7N?\;C)9MJ+GIIVBLKIEHC,QF)A,+"8=)MV4M)J[A];5 MBJC^'GS>EY\W&M7<'[&1!]++GDR[`,0MT%""FKCI':6@9#\Z3,9R-G6Q'*X$ MXBHPX7EX3'PF`9.0R91)Q&162O*5'#\R/[XY/K.2DR?MN49M5?8_Q8-YU%6Z MY`BX9Z(S,5)RJ!Y1/J8$+?$0Q>*9=)ATF?28])D,F-A,ADQ&3!PF8R8NDPD3 MCXG/)&`2,IDRB9C,2DF^DN,GZ[*2ZZJWN;RY&X^9*]Q*B_)HIZBTDI,\)43G M+`83DXFU)W&KMR:N")W]I^^W>YGTF/29#)C83(9,1DP<)F,F+I,)$X^)SR1@ M$C*9,HF8S$I)OI#CI^RRD+7XD@Z5G#R=SUV3KT4CL5U+T'&9MJ[%A?O^!!)Y M="8&$Y.)Q:3#I,NDQZ3/9,#$9C)D,F+B,!DS<9E,F'A,?"8!DY#)E$G$9%9* M\@6MJJU0T&=/)9&M9/CBJ)>BXGD6IWC/1F1A,3";6"=*Z%BW'S@DDUJG+ MI,>DSV3`Q&8R9#)BXC`9,W&93)AX3'PF`9.0R91)Q&162O+U'`_AD!?H,^HY M&?F1NS[7Q6/`=OQ_3ZC-C$3G+`83DXEU@K1D%TWG!"K4,ZY3C[/TF0R8V$R& M3$9,'"9C)BZ3"1./B<\D8!(RF3*)F,Q*2;Z>XX$?GZCG9+Q(OIY%8[,=_Q&'-L8B5Y#8C`QF5A,.DRZ3'I,^DP&3&PF M0R8C)@Z3,1.7R82)Q\3?D_B9A;B+#/8?OOO((F0R91(QF962?/W&XTD^4+_) M\)/C^FW5"T^BRL:HI/6+1(^_4Z'\KMQ@8C*QF'28=)GTF/29#)C83(9,1DP< M)F,F+I,)$X^)GY)T#((8I1)P@I#)E$G$9):2_6B)H\$0N?*-OS+D`^6[XZ*[ MNBJZ=MLI*NNN9J(S,9B83"PF'29=)CTF?28#)C:3(9,1$X?)F(G+9,+$2TEC M-[BN7KN1O:X^YPB8A$RF3"(FLU*2K^'/#>_23@SOJHMV1SM%I;6,(\!TSF(P M,9E83#I,NDQZ3/I,!DQL)D,F(R8.DS$3E\F$B4J(SED,)B83BTF'29=) MCTF?R8")S63(9,3$83)FXC*9,/&8^$P")B&3*9.(R6Q/=FWXBM;*_3D,W<@7 MMASN5=Y;K9T8Y54_I-XU@=LI*JG6>R8Z$X.)R<1BTF'29=)CTF3R6MSH<6< MH-)21J)K2`PF)A.+28=)ETF/29_)@(G-9,ADQ,1A,F;B,IDP\9CX3((31!,/ M5L,31C0TITPB)K-2DB_G>##2<;_UF;?:R1BF7/]U0SY_BK]^M[SG^3XE:?_< M3:6>NXMHW1I_B&VHYZ>XK>3^ZU^U6BM,8?!BF$PL)ATF728])GTF`R8VDR&3 M$1.'R9B)RV3"Q&/B,PF8A$RF3"(FLU*2K_5X+).L=1[+&7]'M;QT-PXM]_0N M',=)W:=Y2J[N.A.#BSKS,OVB>%?#;&Z;8V'?S'1F1A,3"86DPZ3 M+I,>DSZ3`1.;R9#)B(G#9,S$93)AXC'QF01,0B93)E%*]N>,VJ&YO+L@SDIS MY&LY'F!U?%F&3K%D/%;^UEO<);B,S&8F$PL)ATF728])GTF`R8VDR&3$1.' MR9B)RV3"Q&/B,PE2YY]T][R83?=@-<=UOIZBDE7O/1&=B,#&96"G9=\!5\QUP+>,/T3SHR"FT M`NGR?'M,^DP&3&PF0R8C)@Z3,1.7R82)Q\1G$C`)F4R91$SB-Q2^WY><%'?R M!L+D56LOB_6/Q?WB^7ES\;#Z%;]=,!X0MX\F;SZ\K]VIEYFI[[<7\6[M3KW4 MJQ@/:G?JO5S%>*3>H'@JWM;NVKLW&E[M9Z!>;/@V_[&PY^L?R]?-Q?/B22U: MM1*_36Z=O!HQ^66[>MN]E>O[:JM>:;C[\:=ZA>5"O4VL6E'X:;7:9K^H!;K: MOQ3SV_\!``#__P,`4$L#!!0`!@`(````(0`OO(#*U`0``'01```9````>&PO M=V]R:W-H965T7=;FMZ_)IX5I-&U:G=("5VAMOJ/&_+SY]9?5`]F]BQ`]YOCIYG(33\,TI=Y5N,&G]L9I+-8H4/-2VMI M0:;-ZI2#`C+M1HW.:W/K1(D3F-9F12?H>XX>C?2WT5SQX["<\I(UILFJEK^[1--ZL:/PQ8"C"1S2TE"\N)()>P MB]7<&?@C_V#.29(MR;(V80V#-0TTW>MF$7@KZQ4:)>. M!PXZD$B`!8HZ6>#\3Y!%LA!9HJ"=`'J=KJ9!,$3(7@<..I!(@*(!FO`G:"!9 MP%P81/+&5ZO><1+,9D<*54K<43IE`^0P0!(94<3!2M'%N<&L6RV3.X_DH?)$ M63N&N+(6WUMH:CJ2"-L/D,,`261$40-URVJ>O^S$8B%DM62.++M&BP?(?H`< M!D@B(TI]L+*GUT?(:GT,\?OR=&"O`P<=2"1`*6W^7THC9+4TAK@^?>FXMJ-U M=LR_A]&[SG:#N=H->TZ"1T\*ERKIP$D+.I+OADMMZ2>(Y0G6@UAKS".B'7I!4"GN[6D^:]1(XP%[UPKMN<<`(\/I;HP/%HND;* M5D5RJ#=2Z\Q8Q(P[*5B2E2(S\])U`D?KYT0P)IGID(UVXXX8*EN2H@)BESF(1VNIJ2`1CFJ=D.Y:4LA/1C!S'VFN>O>PP]`6(>;)D M/5@W_#S$]G38=<7^LB,[,+0X6-TWEN]IIL2<14[,3]N/GXMX>MEOGI[Y[8?! M0DN=B`*F^4TV;FD6GJB%\W@GE[`UOSG4'YYBIX-&M3&6UV^&!QXH04F?"R98 M>>TX9).6*O]__K&=7O&/0;[BGZ^U6DQ'7YL?=3$_2,A=S-.S+G;M$'[T-N91 MT]H8.FAL&K[BVX_:6#:69-&,Y9!L;`>-&LM8/KT_TCX^D#:']!)$[J9T1)J> M&-N!(?P(;[U MHBW4,_QBYT5PLGV"^Q&<$9_@001G,\"M;F2X\][2"_HSK2]YU1@%.H,6F[YF M:G9K9A]:[M,1MW#;I99=X;\;"*Y'-CDNGS%NQ0`D0``!(3@``&0```'AL+W=O'F^^7VS/VQWKY]O@U[_ M]F;SNMX];%^_?[[]]Z_9+^/;F\-Q]?JP>MZ];C[?_KDYW/[CR]__]NGG;O_; MX6FS.=Z`AM?#Y]NGX_%M>G=W6#]M7E:'WNYM\PI7'G?[E]41_KG_?G=XVV]6 M#TVCE^>[L-\?W;VLMJ^W1L-T_QX=N\?'[7J3[-8_7C:O1Z-DOWE>':'_AZ?M MVX&UO:S?H^YEM?_MQ]LOZ]W+&ZCXMGW>'O]LE-[>O*RGY??7W7[U[1G&_4<0 MK=:LN_F'4O^R7>]WA]WCL0?J[DQ']9@G=Y,[T/3ET\,61H!NO]EO'C_??@VF MRV%X>_?E4^.@_VPW/P_.WS>'I]W/?+]]6&Q?-^!MB!-&X-MN]QN*E@^(H/&= M:ITU$?CG_N9A\[CZ\7S\U^YGL=E^?SI"N(=GBU`"/K/[X?#L`P]N'XQ/\->H-[_N#`,1OOFT.QVR+*F]OUC\. MQ]W+?XU00*J,DHB4P"P*D!W#V\K7&."*2KAJ6OZVT[F4W,9)C%J^8IJ/M]"?&": M'B`!?_\"_?]T]SLDS9ID9EHF\"5BEL`,0;6)!*D$F02Y!(4$I025!',)%A+4 M$BP=<`>N;?T+L^"O\"^J0?^R9V8,K,-#X4R6X":)!*D$F02Y!(4$I025!',) M%A+4$BP=X#D3\N.O<":J@?D.5IS9.O+=-R,AB&LK)$3B5J1UL2*I(IDBN2*% M(J4BE2)S11:*U(HL7>)Y&U8#S]O==S->`5"Z<2H[8V9(Z'HPBJ0/6R%NEBB2 M*I(IDBM2*%(J4BDR5V2A2*W(TB6>#^&^=H4/4=KW(9%)F_BQ(HDBJ2*9(KDB MA2*E(I4B\X(H[C%$D,&=RW$RM5)%.MMYHV/44(_SL%':'[8A(:Q=3N`G?G]B$G)GAYY")`1Q:S6%(Z$I):%Q4QW" M%J/?[_NV,I*`#ZM&3M>'?'H?!(S`UQ@G-AK=W/4M8G*:OW@CL4]7;&4E`"M.H'`Y'[.:LW M.U>LRPM&UF+)NJ(FO@-QGZ_X\BE3OGO!*]>X%\6%>PWR)_=0ELBX68.&X?G9 MS5).[A,:P#1H'1<-12YGW/#4E&K6HYREK"\+1M9BV6TQ\C.HXH:G+/I>QC+; M74[/+R!8+TLO&R0FL=CWQ=SPPB0F]=8-*34<^)-8S*R,I=R9I7(DMYW@A;5@ M9"V6K,NW*!*B8JE3%GTO@Y3GY8_NL%%/,\GME!O+U7&&9PDH!1.[G9C"8;&5 M85%B*4A8E&J4:91KE&A4:E1I5<U6FA4:[3TD.\_W!EJBN/"?0)Y`D M4215)%,D5Z10I%2D4F2NR$*16I&E2WR7X8;@"I?1_J$Y\&_NL;/`H`C\U"Z+ MT5!4J#%)>;/0-/1W1R-1IJ74$*0X_3.M*[?(=D+=J`JKRTI%(U%:E%:*+596 M/:.Y1@O;T%4O;MFUE6)=2T^7'Q[EQ97[89CN:H4QR(L'2;DKM$&P)W9')&KLE-0[.^>,+5I=N4:%;EAJ5.F& MK'KY.NN^8Z(DI/L6!?:5LVZC"V(J#"V9`'7V.F(RBWNN_-6;W9# M@T3>RAJ"I:S[$D9VWJ:,Z#@J&,@#UXPE3DU<"BGUZ4*6DI3M0$GJ*4L'\&VZ MC"FU<>UWQ+2US_-WP1VWQFK?&,14W/66W,8U=CJFN,5UL_3""HSB8@4VR,_- M>U'4Q2$UM/,U862#FQ(:F-P,@]%8%"092X"ZTVF7L^H+R4E]LATH63TGYT@L M@14+N/8[(JE&N^`N66,UZVJS4]RVEBS@&CL=2=PBNY%\=W::O;6WWM)V&SY: M+T?W(A8Q)B],!CCPX_F:,++S-67$1]7]4.C)6.+4A*7L;*W9/KG.:*0*UF4[ M4!*B[.Q8<$FQ:[XCI*UY'NQ"VZI]6Y"<*J0=QMQ1^+=0W,A_**384*2I02)- MQ4(5XR-'V-!-4T(VRBE)49K>PR-`_GJ7L<"IB4L1;8V=C:BR7[)Z2IS>1`RC M8@'7?D=(6_LVI,I8S;I.9ZEI,W"-G0XI'BY\**384(34()QS3I:*S6V,Y_$R M2PG9)$E9RF1I-)Z(6W'&`FZ6N*.DD+;&;)>45,&ZK/V2$!>Z_GRJN(%KO".> MK7$;3S72VK?4E:+4QC7FCL%/43S2^%`\S5F(M^H:)%)4W('BD!JZ*4K(35'2 M9>ZD^%2@J)8STG-RVE)`6VMG`ZHZ4+)ZDS9=-1'UT$V;CIBV]FU,E;':-P8Q M%8-=LH!K['1,\83C0S&EHQ%WYV*0R%%1ALN5`3UWQ'1%OS-J+*5NW;@HB*]6AY::Q^ED*7 M/A91;"A678-$EHH[8!Q20S=+"=D@IR1%-]+1.!)E<\8"I^8M1;0U=C:BRG[) MZDV21CTX`''_$X.J6-SM34>`V][8`"O3->OBVZKIN(UK7X>4I>Q@%XRLL9H0?)C'<51(N8UKS!VLE[.88#IG M1_C,_Q7/)S5:1'R[#I/NQ1TCYH9.`C.R7D@)<0*'(U&)9BQP:A93?-O3G+/Q M)2EKOV3U)HM@;R/F5\4"KOV.^+;VVY2EAO`U$J.:=;4I*VYC2Q9PC9V.+YYV MN'?9\R82\)3$(1?D1LY2=,@DC*-GLPJ4>9F,I.B+H M#_73/RQR:NF@/#)=QQ+?FI./=12LRZ9VJ5&ET9R1'>""D=55:[3TD!\R/`]P MLT"&[-?=&RQ?E[X9P:=Z9,P(V8D9LY1%":&H>26K<6*J4:8;YA:==;7J1&D; MVNQ04G,MM="HUFCI(=_5N$]W77UAP:&C`*>8'Q"R#Z;$&B4:I1IE&N4:%1J5 M&E4:S35::%1KM/20[S_<%[O^>^\!(W['+"R5\:JY=XL;RX8L92\'"T4J)TB"V,IR(B4:I1IE&N4:%1J5&E49SC18:U1HM M/>0['VX;GO,OI#Z*BQEA$'Y?UCHTTC.BE;(N52B%4@35@RZ6RC3*-2HT*C6J M-)IKM-"HUFCI(<^E<,>XQJ6-N.]21K8PBS5*-$HURC3*-2HT*C6J-)IKM-"H MUFCI(=]_6'*[Z\'Y*1FAN/"?0D^IT1EY7FA86K+2BY&IE% MA.P^,;;(NL!=.BG&IB%4#:PKI88.RJPND/(G*U9&_W\$48M(5X,N'&!$)'5A M(I,41*V=#1UW(Y*BN3V9!.J-)C8'DE:15EL_^^B3?/SX>;]>X'_FP/U)M?/K78_*;0+(BF^)H,3!%U90A7 MFN,U>64`5^"X0K?Y.AA/OT)7]178&$.;9J8K;1.XTBQ<\DK4GV(AWZ%MB#^% MU,PTT08>\(=>=VF#7T_ZVMDS4-6E:19.X1<\M.VO@^E7\_"`,#T;P#@Z&LS` MPYT.!B]V.C$`"^9!5,5SI"B,\G`Y7NK15T(&N%O`ZRW36V0)>89G&G5<2N(+OJ>B> M)<$8KG392:!G^/R^;@.OMTSQ,7Y]!=YRF>+3_/H*O-D"GN[J`;QZ`5>Z>C"# M@7;Q&(;9Q1,89!?/H+M=/(?.=O$"NMK94^AH(W_73C#X':^WU?=-O=I_W[X> M;IXWC[!@])MW,/;FE\#,/XYT*OYM=X1?\(*;`OS6$OQBVP9>I^[CB=_C;G?D M?X#S[MK?@/OR/P$```#__P,`4$L#!!0`!@`(````(0"2JLW6.@4``+45```9 M````>&PO=V]R:W-H965T=!T!9[7N7M2!QY#5>VHJGR#@Z;7=`>&YYOY*#J M$$1A&`=57M:^JC!O;JDAMMNRX(^B>*UXW:DB#3_D'?!O]^6Q[:M5Q2WEJKQY M>3U^*41UA!+/Y:'L?LBBOE<5\V^[6C3Y\P&>^YU-\J*O+0^<\E59-*(5VVX$ MY0)%U'WF-$@#J+1:;$IX`I3=:_AVZ3^P>38._6"UD`+]6_)3:_SOM7MQ^JTI M-W^4-0>UH4_8@6NK_$Z7=>[O8=M'L* M3X0/-M_\>.1M`8I"F5$TQ4J%.``!^.M5)4X-4"1_E[^GLLO3!&3"\ MA5:^K=)IO`C>0/Y"8]8NAMF(K$=@UX#>P!'$H1RQ4>HI;^:(59`C=A))K_L3 M9](1(=0C*"$0RB1T><;TVB!XZ4.I09LH3NP;K15F8F"(>EF/H%1@S.U4$`S] M-6Z33BD5A;E&I4=0*M"2VZD@V%8EG@PE$]]#!L&$3!S: M-UHK3"(G]W0RFX8A060*,9&A8T[?Y!XJ"*94B$_6"F/I$M.IVV.H+KAZ$;^S M!`/N@]SK9S&.H[S&1"*%L7B-J4@*PR!B!CLP=BYD^3ZUN5ZW&8)M@E%"1%DK MC$F0VJQ'4-F0L*G;=2X2_9G1-.@:FP'BT"&Q_0D=%:QF!+EF8PIDTG'=-H`< M0AB5QKSZA)`*5HN08SBF0+%TW#@<@^'H9-(0UW(,X_)V.BI<;3K4=++DTK?T M<5PW@!Q]8)Q)2+YLW.([A@/M>9W&9[^HE4R#+&Z.\S0(YY1AO>G@8\$E?51J;0D;)^0Z:;!_99QK4A?+NJ+4CXUVQSE0B7U_O-,C4SJ'S4;*S MNZ)=HDDKG35/@TPZ%VSX4;HS$N^?M.M2J!./K67)I:]L&,63V04;]L'OM.NN M!&=NA*>Q8\,^H<^S)W5MV(,HH8C$^,TVE`-)[QP;:I#5.\>&&G2;#:.[-)T-&R@3+!I"C#XR[0Q]$$T+.*A@ID'KO3"\M@AIQ01Z2X=?#`%\!'3;4 M?1IDR3-QY.D#WI&'I/?M[E,!;*XK[B(8]2EM)@-9?#(-LMT7GI_`6@2CN^)= MHN$S6GW@JR],E=/&JEVIDL! MRNDD"7;D&D.VWOM)[B8^8Z1EZTB!"%?R"I2=490KOK:8IOQ)7649VZW,F#A* M5PTB7,D3X:X66LW45>U2J9V9BC<[GO'#H?4*\8H[4.C^X:S:'5N/PWY[C%R! M?;,'V3%R?@W[:7)NTO/1/+N$?X@2N)!@[YT1,[@B=U*<*RE<2>5\&2[!IMDQ MW_'O>;,KZ]8[\"T\4CC"C:I&;;NI@TX$(P%LA MNOX`FSQLN*[^!P``__\#`%!+`P04``8`"````"$`#EK4GL\1``"%8@``&0`` M`'AL+W=OO=UH9EK#:*S] M\.??CP\G?ZU>MNO-T\?3VMG%ZYNG^YO'S9/ MJX^G_ZRVIW]^^N]_/OS:O/S8?E^M=B?D\+3]>/I]MWL.S\^W=]]7C[?;L\WS MZHD^^;IY>;S=T3]?OIUOGU]6M_?[@QX?SNL7%\'YX^WZZ31W"%^.\=A\_;J^ M6W4V=S\?5T^[W.1E]7"[H_RWW]?/6W9[O#O&[O'VY M_;,W/3UYO`N'WYXV+[=?'NA[_UUKWMZQ]_X?8/^XOGO9;#=?=V=D=YXGBM_Y M^OSZG)P^?;A?TSKK[<_'W:SS:_!:OWM M^XZ:NT7?R'RQ\/Z?SFI[1V>4;,[J+>-TMWF@!.B_)X]KTS7HC-S^_?&T08'7 M][OO]"XX:UU>-&HD/_FRVNYZ:V-Y>G+W<[O;//XO%]6L56[2M";T:DUJ9U>M M5C.XNCS>A)3[3.C5FK3.+FL7UXTW>`36@U[?G\BE-:'7PN2M9X2&U_[+T&OA M\>8SE5N=DZ$WA\N;S4J/.FG\G MUVO?WE=JW&O-FW^1#/=;,^H*FS>?&>ZYM7_5=6O<=\T;F\P[S@SWWMJ_ZKXU M[K_FS;O/3)T[L'E3N+RYS]2Y`YLW[SXS=>[`YLV;DSG/:^^^E'=N=[>?/KQL M?IW0]9%2VC[?FJMM+33.7,3SDEN4]4-5G4IM1P=[2I>BO3U=! MZ\/Y7W3YN+.:&]34?$6;%>9:86P[$G0EZ$G0EV`@P5""D021!+$$8PDF$DPE M2"1()9A),)<@DV`AP;($SJF)BW:FIOT=[6QL3#MS"]TP<`U?%XW*"CZD(T%7 M@IX$?0D&$@PE&$D021!+,)9@(L%4@D2"5(*9!',),@D6$BQ+P&M4N@;]CD8U M-C3^*4II]`9^,]Y8$?6O0B0D[4)2-#60+I`>D#Z0`9`AD!&0"$@,9`QD`F0* M)`&2`ID!F0/)@"R`+,O$:WV:.WBM7SWOY@IMU/M&YL:YR4FS&,MM"3H2="7H M2="78"#!4(*1!)$$L01C"2823"5()$@EF$DPER"38"'!L@2\MJ()FM=6^67V MS/R^V'U?W_VXV>2_="K:L$&7T_PB:TS\)K0D_W5EKICM@KAA6F]=^F.YDXL: M-%%S8_E2C.9N(>(.TP/2!S(`,@0R`A(!B8&,@4R`3($D0%(@,R!S(!F0!9!E M3F@R3F?,:WV:6'NM7]'*]).7F]FH_6:VY-H-U8*X%L1FSD4MKV1?BK[0+41% M,UM2+Z+U"Z)$&Q1&3A1<7OL];UB(.-JH\&82%<09P7>+"R,G"JXN_&CC0L3> MD\*;R;0@S@BB)861$P578O::%B+VGA7>3.8%<480+2N,G*A6;_C?;5&(V'N9 M$_K%0\3K?C3.O>[WKN)C3/Q>:4FI5P+IY$14FBO_JW0+$7^5'ACU@0R*H]Q9 M"BZ%];`0L?4(C"(@<7&48CTN1&P]`:,ID*0X2K%."Q%;S\!H#B2#HQ9`EN6C MO#Y"/]V\/J*7**/V.X,EI2M10=PWA:[>R46T2NE$P97X!=$M1'PZ>D#Z0`9` MAD!&0"(@,9`QD`F0*9`$2`ID!F0.)`.R`++,2<65B)9#O&9^5RDP)G[KYZ1. MLQ\WH6B(^MBVHG);8X>P(NJGA5,]$%>1KA5=[1<::HVK*['4T+,">G$NCF[H\>1FY9I>U0=09V>64,]Y9&] MWVW,2AVNO+[Q)Z&Y)R)JL46-\K2_=B%^W;7Y0/K-4MG%;0>S]MZ8@W+,$>O[ M>MQHUL5OC!X+:"GC<+#^42D-6*6F-.2(>4KUZZ:X&(U8H*84<3#U+,6L4E,: MMF3%H9S\46:63K51EFV>J1B_>GLC7X&E)5*N$C=FN=2,O'+1+I#2 MS3OVP.;^YOI^F'41]="^[Y!B/T"O(:*1\^(O%#FDV,?H-48T<5YL/W5(L4_0 M*T4TV#= M&T)R7MMAE3H'ZEI5XV)?M&F+!A1MF]*A2="^Z_8YF)K2@%5J2D-(27S_$=NH M*46L4E.*6:6F-(:4Q'5TPC9J2E-6J2DEK%)32B$ET7`SME%3FK-*32ECE9K2 MPD^)MGPU_16>)=L<2LD?9&81_3?4['PMG@8S%XD;L]U"UNP"*76C8P_T:G9^ M8`GUT+[OD&(_0/LAHI'SXB\4.:38Q^@U1C1Q7FP_=4BQ3]`K131S7FP_=TBQ MS]!K@6CIO,C>[TXT+5&[TW$UV[B(GVTY\B;:P97H^FVS-\<<2"^'Y[X=5GFC M44Y]NE;5:!ZLV38E*MV'@_4YF)K2@%5J2D-("6KV,2E%'$Q-*6:5FM(84H*: M?4Q*4PZFII2P2DTIA92@9A^3TIR#J2EEK%)36O@I5=7L5U+R!QD%4P?9D?-L M8R-&F47E>7:!E%[>,=O9R*M4H+N(>A:5IO%]AQ3[`7H-$8V<%U>]R"'%/D:O M,:*)\V+[J4.*?8)>*:*9\V+[N4.*?89>"T1+YP4UF^8;7G=Z94W-R$6WR1%M M:>/4VV9C(JE*J(.HBZB'J(]H@&B(:(0H0A0C&B.:()HB2A"EB&:(YH@R1`M$ M2P_Y9<+L1:5;B*Q2KW<= MJZ*;S&;?:?VB)NZ^=)V`:T$/41_1`-$0T0A1A"A&-$8T031%E"!*$R_U2SH[RL<^=IY>>VQ;I?3:=FP6)H)8(\,J^BW:Z&JZ"?6BW[0.!6L%K$7 M;[MHM$01[['BT+)LOL3/*C6G`:O4G(:LXIR"0"S.C%BAYA2Q2LTI9I6:TYA5 M14XUL8]TP@HUIRFKU)P25JDYI:SBG!IR_^>,%6I.SBQMPM,]?BTM*00Z61`7?(K*JT2::+ MJ.>\N,[V'5+L!^@U1#1R7FP?.:38Q^@U1C1Q7FP_=4BQ3]`K131S7FP_=TBQ MS]!K@6CIO,C>[S9F6?(-W29?Q?0JL5W8+$\W`[F%L&W^!MUT+GIQ-19[DE5Y MXPLKL8UH=Z/4&F)#8\\&:U!=/QRL?U1*`U:I*0TYHDVI&8@5Z1$+U)0B#J:> MI9A5:DICCFA3NKX2EX8)"]24IAQ,32EAE9I2RA'SE!H-^3>M,Q:H*$-?YED=B2(Y1R+S$`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`7D-$(^?%]I%#BGV,7F-$$^?%]E.'%/L$O5)$ M,^?%]G.'%/L,O1:(ELZ+[/WN).^[R2G`<34;;\YW MU&QC(VJV1>6:72`W\."'8LI.75[,!]:RJO#CBD&(_0/LAHI'SXJH7.:38 MQ^@U1C1Q7FP_=4BQ3]`K131S7FP_=TBQS]!K@6CIO*!FO^T>'E4?Z#86Y4_U MW3_"BE4.=1!U$?40]1$-$`T1C1!%B&)$8T031%-$":(4T0S1'%&&:(%HZ2&_ M3%#EPC+1W#_(^<#SG?GI50USJ"@-%I4GI_17XO[OF#8?6%;14YP+E9\@%4U, ML$5U0U_5-5MK9'86E>,VFF)FW.8#RZK@ROV]=)Y=_JSL_`&KCZN7;ZOVZN%A M>W*W^6F>@TT;%3]]*'#^D&[:_!::_4DTLL0GM+LM--N4\)-.O4['[&^$BV/H MD=^?J_@-/0J\RNFF3B$J(GQNA)_I&V/HFP8]4[R*URXIPG[M7J1TTVC2(?O] MVN(3VJ(8FBUC&(5V*H9FYQA^0KL30[/WL.J3&GU2=0QM3`S-WC$\AO8GAF8+ M&7Y".SW#864 M,`]">F(5ZK,@I*=4(5\&(3VK"GGG*J3''57PVG5H]BWC)U$0TA.^D,=!2,^' MJ^"7(3W:"_DD".D!7\BG04B/^4*>!&%:Y9]5A]I>)H5K9.3U[R_XU`_H^=?3;#E\V. M'O]/UQ1Z/#7][QY6])S+BS,2?]UL=OP/$Z#X'TA\^K\`````__\#`%!+`P04 M``8`"````"$`[P<\MZL-```<<0``&0```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`^G_6 M3BFLDSOL.VJ;?WIY62* MMKF/U\G:HAH)??C3LZ[)!DKU#R;W=]&NIK7>U:)%J40-AT4IYNR=YMX0M43[74^( M:KS(5=XN4HL3.1\G@=R(+5C'97%1>"@:*)HH6BC:*#HHNBAZ*'P4?10#%$,4 M(Q3CN"@6K^P=;1(W8F^=QD6LRBQN1)4`A3K=W84M.3A6AE5O:658]R-7J@-/ MS[*>RLJR;+@W#<<+4"R4[/55E1/59(,C&^KQLKG"I5W6C9OBC5B%7I(1F[-Q M@FF>8%HGF/8)II-D1%_=/<'TDHS8-'Z"*8KUW#_!#)*,.+`.3S"C)".VZ?@$ M,TDRHK^8GF!F2:9@[X=!DA';JUQ.0H>3*RNJZGSV"U'54UE1E0WWIL&*ZHW8 MUE4Y44TV.+*A'I6-^GM7-GA1PZ%W+\H9-^(F5SBLG]T)2C-NBC?7]L9H)1FQ MX=M)1FS43I(1*ZN;9,0R]Y*,J./'3>Q@UX^;V,%N$#>Q.L.XB=49)1FQS.,$ M4Q3;8A*9:,^81@U'.X*<:!:9:*)`-I3+1RU6<-0W."LXZ7V;UE9@9,.]:3B< MAU>EJ,D&1S;490U7-GBRH1$U'*TE&9?F":9U@FF?8#J1B;9(-VI(69**) M?-G0EPT#V3"4#2/9,)8-$]DPC1I2EG46F6A9`]E0+A^U6+N<^M9O[7*GG5;I MJ=3IU]'7G6)1],P58]2NOO]*)`Y1]RBJ*&HH'!1U%"X*#T4#11-%"T4;10=% M%T4/A8^BCV*`8HABA&*,8H)BBF*&(D!1+J<1*]7J.IN5ZO2.1.N[C/HFMD]J ML22ZRXHQ:6F.A+XVEQ=G$=7HS<,LQ,&@AL)!44?AHO`BH3^&.`EN'+\GOH0U MC]\37QQ:*>^UC]\37Q0ZQ^]=BX7I'K^9%7/L';\ISFK\Z+T/MT4?Q0#%$,4( MQ1C%!,44Q0Q%@*)<3B-6-/7-5'D]G*]CZ*ED1,4VKQB3%M%(Z'T[*P)8C=[\ M<+>HH7!0U%&X*#P4#11-%"T4;10=%%T4/10^BCZ*`8HABA&*,8H)BBF*&8H` M1;F<1JQ`J[N)5J#3^UJM99#%8;]B3%J04511U%`X*.HH7!0>B@:*)HH6BC:* M#HHNBAX*'T4?Q0#%$,4(Q1C%!,44Q2PNBB5Q\A7$C>C=RN4T8N4YJVXJ6($^ M[2OQ;C*9;''J50E16K1#Z3IV$8<7I<[$ M9>(Q:3!I,FDQ:3/I,.DRZ3'QF?29#)@,F8R8C)E,F$R9S)@$3,KE5&,'7MU1 M^$K@]60R\.)*?46/+U,H-?"&%':!OS:)M[-:Y2HU)@Z3.A.7B<>DP:3)I,6D MS:3#I,NDQ\1GTF#WJX/-?PO7@SECB MQ8E&)42IB3=U3.*O2@G]=Y6KU)@X3.I,7"8>DP:3)I,6DS:3#I,NDQX3GTF? MR8#)D,F(R9C)A,F4R8Q)P$0EW@0I.6MVXO7PA2\DWHQZ4+,YNC0N+L16L@8E M+\7NQO]]2,+$7R$8.DSH3EXG'I,&DR:3%I,VDPZ3+I,?$9])G,F`R M9#)B,F8R83)E,F,2,%&)3TN)G7B5QZ\D7D\FS^K%W:Q*UJ#4Q!MB$I]+[N.Q M2HUGY#"I,W&9>$P:3)I,6DS:3#I,NDQZ3'PF?28#)D,F(R9C)A,F4R8S)@$3 ME?BTE-B)UV--5!V]?<*OI?+5+BD52Y2HV)PZ3.Q&7B,6DP:3)I,6DSZ3#I,NDQ M\1-(Z5*,O^@G(G%O=Y"(Q.VL82(2]Y)&"4A[PA81^?RR=V\K91OW&@_K,/+K5P>4R= MPE4"<4*2\AVCSL1EXC%I,&DR:3%I,^DPZ3+I,?&9])D,F`R9C)B,F4R83)G, MF`1,5-;3TF9G70_%^436S<@=.^OBR%C)&F0"F+_*ZTMR=D;O0W*]NR\GWJRF MO5GCXHY%$F_ZU?>S.%Q[%)_"9>(Q:3!I,FDQ:3/I,.DRZ3'QF?29#)@,F8R8 MC)E,F$R9S)@$3%2Z3QX^E]4#)P&S.>QTYY[,I\VJ"?L$='4MTM8>H] M_!H3ATD])*6B.>2<7XGS0E>"DCB%\7@F#29-)BTF;28=)ETF/28^DSZ3`9,A MDQ&3,9,)DRF3&9.`B4I[6HBLOES_Y(Z5]O3S]AV75^-%7UP)4W)[M];B(/Y>/_NA^=W M$R;3/='S$!<;9OLW/YQ%P$3]1H<.[4<=H!UO/03G\YVY_B4M<=.M="EONH4H M->9I(X!V_7V5J]28.$SJ3%PF'I,&DR:3%I,VDPZ3+I,>$Y])G\F`R9#)B,DX M).&9G;AP..$"T]0",RX0,%$Y3XN/G7-UWFWE'+IQS>UNO'0I;['I7]'[\"AC M3M:95)G4F#A,ZDQ<)AZ3!I,FDQ:3-I,.DRZ3'A.?29_)@,F0R2@D>3-`.UNX M%B>@8ZXQH1I3KC%C$C!1*4_+F9UR/=CF"[VY&:.C9K,?-%?*BG56R:4-Y`G3 M;DCR0;/*!6I,'"9U)BX3CTF#29-)BTF;28=)ETF/B<^DSV3`9,ADQ&3,9,)D MRF3&)&"BPIX6,SOL>IR-#/NUNA4/7;N>3'3M\M<(*OH7;JEKC\CNNY(X0ZIR M@1H3ATF=BE8V,5%ATJ(U++LN__#4H0]>]H(G_![ M.I(:S\AA4@_)_J*[^%KB<@F/28-)DTF+29M)ATF728^)SZ3/9,!DR&3$9,QD MPF3*9,8D8*+BGA81.^YZ7,T7XFZ&X]@G\N(R9D7_;CSU[8;L(W8IAC)5N4:- MB<.DSL1EXC%I,&DR:3%I,^DPZ3+I,?&9])D,F`R9C)B,F4R83)G,F`1,5-[3 MDF;G78^MD7D_X5S>#,FQ\RZR6M'/<*"\(ZERE1H3ATF=B1,FH7%[^ M'HR=>CE.3H^D.2'U">/ELF)@2267-IXG/*E'4N4JM9"8G[_)%9-^#L/A,G4F M+A./28-)DTF+29M)ATF728^)SZ3/9,!DR&3$9,QDPF3*9,8D8*)"GY8D$WGS MB#?SH*77Q?KGXG[Q\K(Y>UC]TH]O*ZE;%?O6P[/E=H]T$^WWV5OU^"+UP]&B MWJJ<'Q=O][*UZWD^\/=#/KDMZHY*[K23-N)J[K2:UUW*WZE?)XS-P@;[YQI^_Q\```#__P,`4$L#!!0` M!@`(````(0`QW2+$:!```+=3```9````>&PO=V]R:W-H965TM#6_8K%8G;WV>TX'6.2.+#=TS-_ MOT61I2*K9-ENS$NG5_O MGK;OWQY'__DM^>5^=',XKMZ?5J^[]\WCZ*_-8?3KYW_^X]./W?[WP\MF<[P! MA??#X^CE>/P(;F\/ZY?-V^HPWGULWJ'E>;=_6QWAU_VWV\/'?K-Z:HW>7F^] MN[OY[=MJ^S[2"L'^$HW=\_-VO8EVZ^]OF_>C%MEO7E='\/_PLOTXH-K;^A*Y MM]7^]^\?OZQW;Q\@\77[NCW^U8J.;M[60?[M?;=??7V%Z_YS,EVM4;O]1YW1P0'X]^9M MJU(#(K+Z\W'D0+.W\"])NOF\,QV2K)T_N?)DV, ME!;QC0C\-"+3L7<_F\SF2F3`<&H,X:SV71^OQCN M=U72Z,(?R\[B)AJK6^PL_K>GPPAO`3+_+"\$P@C]H^U7^NZW2"&:'^ M<]V%3B")=*^439!.V=/^]V/&RA4<,F'CY4J>Y-`J>%LTKUW\^O4]()YI52^*)G'$8PWS)P#U(0_ M/M_/[S[=_@'S>&TX2\F9N(P0&6K2*MF(`S$'$@ZD',@XD'.@X$#)@8H#-0<: M"[B%T';QA;SX.^*K9%1\,3)+!"C@'@LF,M`DXD#,@80#*0=2.LU M[5AMDXXOV_7ORQVD--R6>D;`A[6K7M$J$7<`-&(/@.%8`Z`1?]$-4BR01%BE M`LDZ*RLD=P\LVAT)0U((H5(@E;"J!=+85DYHU>[*B6U/#&$'C$%LZ6X4#>3! M+;,K++,)7Q8@RZXL8HI&R++"C=!]NPF!"7O'IFR"#+C&S@$AG2)KT($,63#I M26O.Q\FP_+O6)]\?WS-&@3J#/I7(&O2I0M:@3S7Y1)[/)KZ;80UJG?++S0VU M![(KW$_-.[4)9Q//0'"H9/O*;UAHJ&8Y;D+%N$:&Y?LT0PTT@]3N#.$DQPU% M(@W3BWK,I&%^48^%-"POZK&2AO5%/3:.H3NV:DMFC^V9>:]W<+#%PM*T5-LM M-:ZTAPT)HL#WC)@V]*G*QL;0@A+2PAY3@@;D,ZF52Z@@+90O"1J0KZ16+:&& MM$#>#;S:GET1>+.;LP.O(59PV:(@5*=0,#S>8&V)D&477&,X4'`-PYZ^8IA3 ME!YT($/68''+#6NHX%[B4XF]#?I4(6O0IYI\HG3I*;AG_')S0VT[[=SXN8*K M-Z^0@IC:2W40",EPKN`:PS,%U[!HW1H;>=]K[X?W/;=H;0-%FF+5DS&7])^9 MSB;4?X[]3]O^O?EXP69#@8Q!!TJ4'@Q`A2PGB?@:H<8>X9JLFQ#;W#3(.N67 MFQ[@EY,>9VJVHK.UFH'LFMU!Y*<8FD@]CP$MJT#'$DH,9-T24H(&Y#.IE4NH M("U,[)*@`?E*:M42:DA+U&P8ZFL"K^@L\!IB-9OMMD+(:65XKF8;EEVS#:1K M]M3OF8&&<:9F7^)`AFX.UL?RNQP'Y2FK5$FH<>3?P,'N=P*MY"4L#]3C_\D.CB5)A\U)# M;BGWV.E6:`S/E7*C99=R`YE2#I6539#D9S\][,V1!XI,6GQ>Y M85$IG[/-=($Z@SZ5R!KTJ4+6H$\U^42>S_@MID&M4WXY*>/QLS!>RG_;?4`N M])XS6F=DK8R;,PC1)`L)(O_%;2TRK&G[!DU;\&()):2%DRPE:$`^DUJYA`K2 M0OF2H`'Y2FK5$FI(BZ^[U*-&,8?5,NW*EQE:G79$R-O[.3L;6R(+.NWF`MM' MA,3!4$02BB642"B54":A7$*%A$H)51*J)=0XD#L;KCLA\N0)D8%4%UU`9QXK M'2&Q**1:"PP1BB4KD5`JH4Q"N80*"942JB142ZAQ(#>DL)1Q\GEX,>`I.BLD M!J*SLQ!9!$42BB642"B54":A7$*%A$H)51*J)=0XD!L_=4!P^6)*W:)Y_#1D M/4XV)$(B@<0"26S$=1&JTS4N*CH;8@/1>(9JS:)8I^YB[8TA,BSW8:''*EA, M+)Q;"U< MX3?SBQX:>GI'8)^E(61?D6$1%!D6/#BT:Q\[_HF)15=D:[E7I-;-]A6=J1YF MF6UM)3P-J>2E@GPG"K)A06@[5L_*Q+"LI2O*GUZZ(N-4(KO7"ZQKKE?16?)I MR'=O0/S4Q3.&,,F&KM>PG*CPE7)LM'R]J_5G8[Y23I!Q:E?KA`!6W->$H*6[ M(3"0.^0>._$(D>5<'-\L1,BR<]H3(4"6SH+)8NY-^0X&*1#2WHB[,>A;!'JS M,0S7\`10P\X2PD!N0OC,O1`-AQ,"6=:9"LJ;,XTQFUD)ME\V]GS]I0O8U8M? M..$Q8:!@W\_98.D#A8K2()Q1)*))1**)-0+J%"0J6$*@G5$FH< MR$TZMM`FW95[#W5^QK-00^ZZV.O6=5!=14@-1'?@$%D$11**)91(*)50)J%<0H6$2@E5 M$JHEU#B0&S^U/K2S]4QA5'1VF]`0K8)#GR.10&*!)`))!9())!=((9!2()5` M:H$T-N*&3"TQJBI8K_3 M:B#=G:E`F@7S%IV*#GBLZBK"$GRH9E1UE#3I0%E*`\&:82R@P$ M6E88?'9>D!,+PU!(K5)"%1E:\E.V[J^)A?*-H^5&F6\2A\O^M-L+HO;20$Z4 M#8N"%1F6$V7-LJ`$YMV@E.Y$S20>^#%WRT)D67/=+&HB)!E!U[W"`>9 MZF^BI_+I/-K`+;;W;*N]`Z?(&NP_0Q:L1DF+'[CEA@6':LHE^&L$?E\H4&?0 MIQ)9@SY5R**8U*X#K)XU:'"J.8E'611 MQL<(Z2K@]66!<>!4UILR8%CPXW2N9-@;.9`;".<\?.^$E=T"C08=*)$UZ$"% M+'*@9@Z,V?VU09-3W;MIH+;;E^][IF;S;^U[$+)>L"%H(+:18<%N`>].L802 MTD)62M"`?":U<@D5I(7R)4$#\I74JB74D!;(NX'GIP8_-__D8<)40TX5GG@L M1T/#4F_TG$[_"%E4A&*4UU58W879,YP$&:?*D)E_QO-!!S)RP')3WH;-)9]\ M]%= MK?=Z0/1WL_0W?MXV^V^;KA9[[ZK;V+-U13H8/W!KJ7G!>HM)/!0M/C0 MTOZI)&OYXGO!%^B]QP9:U).ROA90@ZLD4`'Q/IP2&5^V*202+WZ12+`+[+('7*10!?9Y#X`27W.=G!`G2YV?T$,!'*62_R2*`3U,`?MM-`_ALXL?JVZ9>[;]M MWP\WKYMGN(7=8>_WA1?W+T;SH_G5WA`\FPK$L?$<./I"Y@4^XW:D7;YYW MNR/^HCKH/KGY^?\"````__\#`%!+`P04``8`"````"$`:JNEQ3$!``!``@`` M$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````G)%=3\,@%(;O3?P/#?DO?EX3F'3G/ M;U`6HK!*U(V%"NTAH!D_/RNE8[+Q\.@;!SYJ"%DBV<"DJ]`V1L4,DH8N7PM\;$UW.`;SW_OGG_`L` M`/__`P!02P,$%``&``@````A`(+@*C]N!```N@\``!``"`%D;V-0&UL(*($`2B@``$````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` MG%??<]HX$'Z_F?L?&-X;2*Z3WF0,'1IHPTQ2.$S:1XVP%UM76_)),H'[ZV]E M![##1KGP9DO[:3_M+^T&G[=YUMF`-D+)0??RHM_M@(Q4+&0RZ#XNOW[XL]LQ MELN89TK"H+L#T_T\_/VW8*Y5`=H*,!T\0II!-[6VN.GU3)1"SLT%;DO<62N= MRC2`+>LW-`-F%$)5:V-VP'_2:OT$8\0QN M\>#AFF<&@MYQ(;@#[HPVYT*;8;"Q-QN(K-(=(_Y%LUUU.RMNP-$9=#=<"RXM MTG)B]4_UG17&ZN%/I7^9%,":H(<"]6+UV91M?HN/P^M/E01^M27="343W&AS M7`J;@9FMYUQ;@O+UIR;GBD7-N":T]R+#V&`3:=%>;"IK;PO59'ZXPZV21F4B MYA9B]H5G7$;`PI.;_A]Y-N=OJP@M:G*19IA:([GH79#;E,L$?7R@X[Q5W[UU MD8:6&G+Y+@PRN^4M3Q_4A&6><[USY$.12(')@V'#1E&D2FE)+0O(JB`WJ2C8 MD[`I>[P+*Q>Y'1(RBOXIA1$N-4PE.1:F4,\+).(>,)1IRF-8T<3&8B-B3/1: MQ015NG@QIJR"@%2##D/?B0VP.88*K:\V$:98S+X*B6<)GAW#D#PVG'Q[F'Q? MLL5D/ELLI]^_D5)_E9@5H+,=6X`ILW8N'CRT`%0WP?IHH3(=NJ;,2W0!\AG3 ML>-W*AT[?J_2&*];&7EGOS%I-74LL"5?82TA3W4AX=M_X6:?Z(E3?,)^0U^1 M7/V&IC&3K3`6*S^K3,&6H/,ZR!<@X8E4XX?0AO;[\Q5,EJGZT7,U9%[J*,7, M97.-KS"C\W3DA=!J'J5:&=`;%P,,?>0>`ZQ"F+A3692D!?9<8O8@I'*/+9L] M26Q#7-V:DI")2%++[D4N7';="[X2FN,2[HY%S(45>YFQ=VE(#PT>?9%8EQ2LZWBX<"\#ZJ=$*[NX9]A*1O];, MUFQ6VJJ-$(2&R6)AL35L_8C5U_Q#`AM9?]S0&->%HJV^4AJLZ)^ MUKX`-B;`1O'?I;&N(V!6L9D7TC18U>)L04>"A/P$%YKHCA$VTCP!?#)RCG&` MID8CDA!_J:4+S6NACRTX]@2D&C^$-K,/\Y2^6XT]!T(SPVA?"8EV/K1ZZ-,/&=`7T0VAF(215\"Z@ MP!1V\=7,`9+9Z9,Y!LL%3CV')N;8UYX*XVR`V9*"Q=:3A(3[VC>=3C'N7[1# M9T#HFR\@4FA7K'4NH9TKFKI(-7Y(2TUK2'HQ%MT+^%X`Y'/IVY0^KI(-[+G&ZX*?5'/8H/+S]>]/_HXP#:6`MZQZ%[ M^!\```#__P,`4$L!`BT`%``&``@````A`&]0BV9&`@``VB<``!,````````` M`````````````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$` MM54P(_4```!,`@``"P````````````````!_!```7W)E;',O+G)E;'-02P$" M+0`4``8`"````"$`@&%A19X"``"+)P``&@````````````````"E!P``>&PO M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`RW6@>*\% M```P%```#P````````````````"#"P``>&PO=V]R:V)O;VLN>&UL4$L!`BT` M%``&``@````A``\*UE]A"```%"4``!@`````````````````7Q$``'AL+W=O M&UL M4$L!`BT`%``&``@````A`&![R&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`,M4L*99!@``3R```!D`````````````````&S(``'AL+W=O&PO=V]R:W-H965TI++0,``*4)```9`````````````````)P_``!X;"]W M;W)K&UL4$L!`BT`%``&``@````A``CG3%^L!``` M3A,``!D``````````````````$,``'AL+W=O&PO=V]R:W-H965T?\A'`H``+@V```9``````````````````=.``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`(;]O0,D`P``?PH``!D````````` M````````6E@``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A``"6Q'9U`@``P04``!D`````````````````IF<``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`#VRC`IV!@``P1L``!D`````````````````WW0``'AL+W=OP``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL` M`!,`````````````````\X$``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4 M``8`"````"$`"BQ+U_X,``#'?0``#0````````````````"XB```>&PO&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`-<<'=+3!0``?Q<``!D`````````````````ZD$!`'AL+W=O&PO=V]R:W-H965T`0!X;"]W;W)K&UL4$L!`BT`%``&``@````A`'K+QN%H`@``IP4``!D````````` M````````)J$!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`))%F&Y9!```4A$``!@`````````````````W+`!`'AL M+W=O&UL4$L!`BT`%``&``@````A`+,C3&(&`P``H`D``!D````````````````` MC;@!`'AL+W=O&PO=V]R:W-H965TSR0``*'+```9```````` M`````````+30`0!X;"]W;W)K&UL4$L!`BT`%``& M``@````A`$1.\.,T`P``?@D``!D`````````````````NO4!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`$)9E.:R!0``8A8``!D````` M````````````GK$"`'AL+W=O&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`*;L2;MV`@``K@4` M`!@`````````````````QL$"`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,$L"'M=#0``STH``!@````````````````` ME-X"`'AL+W=O&UL4$L!`BT`%``&``@````A`"B->K:_`@``)0@``!D````````` M````````ZQ@#`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`$'T@([G(```_/T``!D`````````````````7U0#`'AL M+W=O`# M```N#0``&0````````````````!]=0,`>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`+&A'VN'!```_1```!D`````````````````/GP#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"_/(N5U#@``&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"^\@,K4!```=!$``!D````````````` M````=+(#`'AL+W=O`D0``!(3@``&0````````````````!_MP,`>&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A``Y:U)[/$0``A6(``!D`````````````````,,T#`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&JK MI<4Q`0``0`(``!$`````````````````M_T#`&1O8U!R;W!S+V-O&UL M4$L!`BT`%``&``@````A`(+@*C]N!```N@\``!``````````````````'P`$ G`&1O8U!R;W!S+V%P<"YX;6Q02P4&`````$P`3`#&%```PP4$```` ` end XML 20 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Limited Liability Companies that Divested Medical Office Buildings (Parenthetical) (Detail) (Deerval Parking Company)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2011
Deerval Properties
   
Schedule of Equity Method Investments [Line Items]    
Percentage of joint venture ownership 50.00% 50.00%
Deerval Properties II
   
Schedule of Equity Method Investments [Line Items]    
Percentage of joint venture ownership 50.00% 50.00%